##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), genotype, depth and allele frequency for child, mother and father (TRIO).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ESP6500EA=Allele frequency in EA population of ESP6500 project.
##DESCRIPTION=ESP6500AA=Allele frequency in AA population of ESP6500 project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=MutationTaster=MutationTaster effect prediction: A=disease_causing_automatic (stop-mutations), D=disease_causing, N=polymorphism, P=polymorphism_automatic (observed in HapMap).
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PP2_HVAR=Polyphen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=PP2_HDIV=Polyphen2 (HDIV) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_hom_132=Homozygous variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_het_132=Heterozyous variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_wt_132=Wildtype variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=VUS classification from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD.
##FILTER=DP_low=Low depth variant.
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ESP6500EA	ESP6500AA	phyloP	MutationTaster	Sift	PP2_HVAR	PP2_HDIV	OMIM	ClinVar	HGMD	COSMIC	ihdb_hom_132	ihdb_het_132	ihdb_wt_132	ihdb_allsys_hom	ihdb_allsys_het	classification	validated
chr1	977330	977330	T	C	hom		QUAL=1732;DP=12;AF=1.00;MQM=60;TRIO=HOM,12,1.00,HOM,20,1.00,HOM,26,1.00	AGRN	splice_region&intron	AGRN:NM_198576.3:splice_region&intron:LOW:exon6/35:c.1178-6T>C:		rs2799066	0.8852	0.915	0.9208	0.7194						103320 [AGRN (provisional) Myasthenic syndrome,congenital,with pre- and postsynaptic defects];	RCV000116254.1 [benign]; 			0.8636	0.1136	0.0227	374	67	n/a	n/a
chr1	981931	981931	A	G	hom		QUAL=6144;DP=47;AF=1.00;MQM=60;TRIO=HOM,47,1.00,HOM,71,1.00,HOM,89,1.00	AGRN	synonymous	AGRN:NM_198576.3:synonymous:LOW:exon18/36:c.3066A>G:p.Ser1022Ser		rs2465128	0.7977	0.873	0.9098	0.5268						103320 [AGRN (provisional) Myasthenic syndrome,congenital,with pre- and postsynaptic defects];	RCV000116259.1 [benign]; 		COSM1126908	0.803	0.1667	0.0303	340	100	n/a	n/a
chr1	982994	982994	T	C	hom		QUAL=15454;DP=138;AF=0.99;MQM=59;TRIO=HOM,138,0.99,HOM,141,1.00,HOM,207,1.00	AGRN	synonymous	AGRN:NM_198576.3:synonymous:LOW:exon21/36:c.3558T>C:p.Phe1186Phe		rs10267	0.8359	0.898	0.9187	0.5422						103320 [AGRN (provisional) Myasthenic syndrome,congenital,with pre- and postsynaptic defects];	RCV000116264.1 [benign]; 		COSM4144271	0.8485	0.1288	0.0227	365	78	n/a	n/a
chr1	984302	984302	T	C	het		QUAL=584;DP=9;AF=0.56;MQM=60;TRIO=HET,9,0.56,WT,17,0.00,HOM,19,1.00	AGRN	synonymous	AGRN:NM_198576.3:synonymous:LOW:exon24/36:c.4161T>C:p.Thr1387Thr		rs9442391	0.5457	0.501	0.5494	0.2794						103320 [AGRN (provisional) Myasthenic syndrome,congenital,with pre- and postsynaptic defects];	RCV000116269.1 [benign]; 			0.303	0.4242	0.2727	134	207	n/a	n/a
chr1	987200	987200	C	T	hom		QUAL=11104;DP=65;AF=0.98;MQM=60;TRIO=HOM,65,0.98,HOM,142,1.00,HOM,156,0.99	AGRN	splice_region&intron	AGRN:NM_198576.3:splice_region&intron:LOW:exon33/35:c.5651+5C>T:		rs9803031	0.7887	0.875	0.91	0.458						103320 [AGRN (provisional) Myasthenic syndrome,congenital,with pre- and postsynaptic defects];	RCV000116279.1 [benign]; 			0.8333	0.1439	0.0227	351	91	n/a	n/a
chr1	990380	990380	C	T	hom		QUAL=14592;DP=153;AF=0.99;MQM=60;TRIO=HOM,153,0.99,HET,326,0.44,HET,424,0.49	AGRN	3'UTR	AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*19C>T:		rs3121561	0.3435	0.195	0.2722	0.476										0.1439	0.4015	0.4545	22	63	n/a	n/a
chr1	990417	990417	T	C	hom		QUAL=19463;DP=195;AF=0.99;MQM=60;TRIO=HOM,195,0.99,HET,387,0.46,HET,503,0.48	AGRN	3'UTR	AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*56T>C:		rs2465136	0.384	0	0	0										0.1439	0.4318	0.4242	21	67	n/a	n/a
chr1	990517	990517	C	T	hom		QUAL=19154;DP=117;AF=1.00;MQM=60;TRIO=HOM,117,1.00,HET,279,0.47,HOM,368,1.00	AGRN	3'UTR	AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*156C>T:		rs2710872	0.9179	0	0	0										0.7879	0.2045	0.0076	117	32	n/a	n/a
chr1	990773	990773	C	T	hom		QUAL=23324;DP=179;AF=1.00;MQM=60;TRIO=HOM,179,1.00,HET,294,0.54,HOM,404,1.00	AGRN	3'UTR	AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*412C>T:		rs2799072	0.846	0	0	0										0.7652	0.2045	0.0303	114	32	n/a	n/a
chr1	990806	990806	G	A	hom		QUAL=25095;DP=199;AF=1.00;MQM=59;TRIO=HOM,199,1.00,HET,305,0.53,HOM,441,1.00	AGRN	3'UTR	AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*445G>A:		rs2799073	0.8462	0	0	0										0.7652	0.2045	0.0303	114	32	n/a	n/a
chr1	990984	990984	G	A	hom		QUAL=16367;DP=142;AF=1.00;MQM=60;TRIO=HOM,142,1.00,HET,188,0.59,HOM,269,1.00	AGRN	3'UTR	AGRN:NM_198576.3:3'UTR:MODIFIER:exon36/36:c.*623G>A:		rs8014	0.9223	0	0	0										0.7879	0.2045	0.0076	117	32	n/a	n/a
chr1	1957037	1957037	T	C	het		QUAL=8370;DP=152;AF=0.53;MQM=59;TRIO=HET,152,0.53,WT,338,0.00,HET,393,0.49	GABRD	synonymous	GABRD:NM_000815.4:synonymous:LOW:exon4/9:c.330T>C:p.Gly110Gly		rs2229110	0.5613	0.592	0.6605	0.7308						137163 [GABRD (confirmed) Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to|Epilepsy,idiopathic generalized,10|Epilepsy,juvenile myoclonic,susceptibility to];			COSM424897	0.5909	0.3561	0.053	217	188	n/a	n/a
chr1	1960674	1960674	C	T	het		QUAL=5807;DP=114;AF=0.46;MQM=60;TRIO=HET,114,0.46,HET,256,0.55,WT,380,0.01	GABRD	synonymous	GABRD:NM_000815.4:synonymous:LOW:exon7/9:c.816C>T:p.Ser272Ser		rs28408173	0.1983	0.157	0.1313	0.0322						137163 [GABRD (confirmed) Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to|Epilepsy,idiopathic generalized,10|Epilepsy,juvenile myoclonic,susceptibility to];				0.0076	0.2197	0.7727	14	84	n/a	n/a
chr1	2337277	2337277	C	T	het		QUAL=176;DP=20;AF=0.45;MQM=60;TRIO=HET,20,0.45,WT,1,0.00,WT,1,0.00	PEX10	splice_region&intron	PEX10:NM_153818.1:splice_region&intron:LOW:exon5/5:c.973-4G>A:,PEX10:NM_002617.3:splice_region&intron:LOW:exon5/5:c.913-4G>A:		rs11586985	0.0809	0.09	0.1113	0.0247						602859 [PEX10 (confirmed) Peroxisome biogenesis disorder 6A (Zellweger)|Peroxisome biogenesis disorder 6B];				0.0379	0.1364	0.8258	26	257	n/a	n/a
chr1	5926507	5926507	T	C	het		QUAL=9520;DP=258;AF=0.50;MQM=60;TRIO=HET,258,0.50,WT,152,0.00,HOM,180,0.99	NPHP4	synonymous	NPHP4:NM_015102.4:synonymous:LOW:exon26/30:c.3570A>G:p.Glu1190Glu,NPHP4:NM_001291593.1:synonymous:LOW:exon23/27:c.2031A>G:p.Glu677Glu,NPHP4:NM_001291594.1:synonymous:LOW:exon22/26:c.2034A>G:p.Glu678Glu		rs555164	0.3197	0.375	0.4197	0.1984						607215 [NPHP4 (provisional) Nephronophthisis 4|Senior-Loken syndrome 4];	RCV000081716.2 [benign]; 		COSM1126976	0.1515	0.4697	0.3788	71	217	n/a	n/a
chr1	5935162	5935162	A	T	het		QUAL=5557;DP=85;AF=0.38;MQM=60;TRIO=HET,85,0.38,HOM,87,1.00,HET,126,0.53	NPHP4	splice_acceptor	NPHP4:NM_015102.4:splice_acceptor:HIGH:exon20/29:c.2818-2T>A:,NPHP4:NM_001291593.1:splice_acceptor:HIGH:exon17/26:c.1279-2T>A:,NPHP4:NM_001291594.1:splice_acceptor:HIGH:exon16/25:c.1282-2T>A:		rs1287637	0.8433	0.825	0.8172	0.8938	0.4520	P				607215 [NPHP4 (provisional) Nephronophthisis 4|Senior-Loken syndrome 4];	RCV000153587.1 [benign]; 		COSM3751327	0.6515	0.2576	0.0909	300	126	n/a	n/a
chr1	6526183	6526183	G	A	het		QUAL=445;DP=12;AF=0.50;MQM=59;TRIO=HET,12,0.50,WT,5,0.00,HET,19,0.68	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:NM_148965.1:5'UTR:MODIFIER:exon1/10:c.-16C>T:,TNFRSF25:NM_003790.2:5'UTR:MODIFIER:exon1/10:c.-16C>T:,TNFRSF25:NM_148966.1:5'UTR:MODIFIER:exon1/9:c.-16C>T:,TNFRSF25:NM_148967.1:5'UTR:MODIFIER:exon1/9:c.-16C>T:,TNFRSF25:NM_148970.1:5'UTR:MODIFIER:exon1/5:c.-16C>T:,TNFRSF25:NM_001039664.1:5'UTR:MODIFIER:exon1/5:c.-16C>T:,PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1440C>T:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1468C>T:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1440C>T:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1440C>T:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1440C>T:		rs3007417	0.2023	0.082	0.0577	0.3759										0.0076	0.1212	0.8712	1	21	n/a	n/a
chr1	6526203	6526210	CGTGCTCT	-	het		QUAL=384;DP=11;AF=0.27;MQM=60;TRIO=HET,11,0.27,WT,6,0.00,HET,20,0.65	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:NM_148965.1:5'UTR:MODIFIER:exon1/10:c.-43_-36delAGAGCACG:,TNFRSF25:NM_003790.2:5'UTR:MODIFIER:exon1/10:c.-43_-36delAGAGCACG:,TNFRSF25:NM_148966.1:5'UTR:MODIFIER:exon1/9:c.-43_-36delAGAGCACG:,TNFRSF25:NM_148967.1:5'UTR:MODIFIER:exon1/9:c.-43_-36delAGAGCACG:,TNFRSF25:NM_148970.1:5'UTR:MODIFIER:exon1/5:c.-43_-36delAGAGCACG:,TNFRSF25:NM_001039664.1:5'UTR:MODIFIER:exon1/5:c.-43_-36delAGAGCACG:,PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1441_*1448delAGAGCACG:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1413_*1420delAGAGCACG:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1413_*1420delAGAGCACG:		rs45616733	0.2027	0.065	0.0512	0.397										0	0.0985	0.9015	0	18	n/a	n/a
chr1	6526241	6526244	CGCC	-	het		QUAL=323;DP=6;AF=0.67;MQM=60;TRIO=HET,6,0.67,WT,3,0.00,HET,14,0.71	TNFRSF25,PLEKHG5	5'UTR,3'UTR	TNFRSF25:NM_148965.1:5'UTR:MODIFIER:exon1/10:c.-77_-74delGGCG:,TNFRSF25:NM_003790.2:5'UTR:MODIFIER:exon1/10:c.-77_-74delGGCG:,TNFRSF25:NM_148966.1:5'UTR:MODIFIER:exon1/9:c.-77_-74delGGCG:,TNFRSF25:NM_148967.1:5'UTR:MODIFIER:exon1/9:c.-77_-74delGGCG:,TNFRSF25:NM_148970.1:5'UTR:MODIFIER:exon1/5:c.-77_-74delGGCG:,TNFRSF25:NM_001039664.1:5'UTR:MODIFIER:exon1/5:c.-77_-74delGGCG:,PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1379_*1382delGGCG:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1407_*1410delGGCG:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1379_*1382delGGCG:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1379_*1382delGGCG:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1379_*1382delGGCG:	GC_rich	rs45542640	0.2025	0	0.0517	0.4246										0	0.0682	0.9318	0	10	n/a	n/a
chr1	6526319	6526319	C	T	het		QUAL=371;DP=28;AF=0.36;MQM=60;TRIO=HET,28,0.36,WT,30,0.00,HET,28,0.29	PLEKHG5	3'UTR	PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1304G>A:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1332G>A:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1304G>A:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1304G>A:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1304G>A:		rs45604837	0.0863	0	0	0										0	0.1136	0.8864	0	16	n/a	n/a
chr1	6526465	6526465	C	G	het		QUAL=4271;DP=81;AF=0.49;MQM=60;TRIO=HET,81,0.49,WT,149,0.00,HET,197,0.54	PLEKHG5	3'UTR	PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*1158G>C:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*1186G>C:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*1158G>C:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*1158G>C:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*1158G>C:	MIR3	rs2986754	0.2043	0	0	0										0	0.1515	0.8485	0	23	n/a	n/a
chr1	6526858	6526858	A	-	het		QUAL=471;DP=52;AF=0.27;MQM=60;TRIO=HET,52,0.27,HET,6,0.50,HET,6,0.17	PLEKHG5	3'UTR	PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*765delT:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*765delT:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*765delT:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*765delT:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*793delT:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*765delT:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*765delT:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*765delT:	AluSz	rs372197062	0	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr1	6527333	6527333	A	G	het		QUAL=1934;DP=71;AF=0.49;MQM=60;TRIO=HET,71,0.49,WT,52,0.00,HET,59,0.47	PLEKHG5	3'UTR	PLEKHG5:NM_001265592.1:3'UTR:MODIFIER:exon22/22:c.*290T>C:,PLEKHG5:NM_001265593.1:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:NM_001042665.1:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:NM_001042664.1:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:NM_001265594.1:3'UTR:MODIFIER:exon22/22:c.*318T>C:,PLEKHG5:NM_020631.4:3'UTR:MODIFIER:exon21/21:c.*290T>C:,PLEKHG5:NM_001042663.1:3'UTR:MODIFIER:exon22/22:c.*290T>C:,PLEKHG5:NM_198681.3:3'UTR:MODIFIER:exon22/22:c.*290T>C:		rs14708	0.267	0	0	0										0.0303	0.2955	0.6742	4	42	n/a	n/a
chr1	6529183	6529185	TCC	-	het		QUAL=1521;DP=52;AF=0.33;MQM=60;TRIO=HET,52,0.33,WT,66,0.03,HET,99,0.39	PLEKHG5	disruptive_inframe_deletion	PLEKHG5:NM_001265592.1:disruptive_inframe_deletion:MODERATE:exon20/22:c.2403_2405delGGA:p.Glu802del,PLEKHG5:NM_001265593.1:disruptive_inframe_deletion:MODERATE:exon19/21:c.2373_2375delGGA:p.Glu792del,PLEKHG5:NM_001042665.1:disruptive_inframe_deletion:MODERATE:exon19/21:c.2166_2168delGGA:p.Glu723del,PLEKHG5:NM_001042664.1:disruptive_inframe_deletion:MODERATE:exon19/21:c.2166_2168delGGA:p.Glu723del,PLEKHG5:NM_001265594.1:disruptive_inframe_deletion:MODERATE:exon19/22:c.2166_2168delGGA:p.Glu723del,PLEKHG5:NM_020631.4:disruptive_inframe_deletion:MODERATE:exon19/21:c.2166_2168delGGA:p.Glu723del,PLEKHG5:NM_001042663.1:disruptive_inframe_deletion:MODERATE:exon20/22:c.2334_2336delGGA:p.Glu779del,PLEKHG5:NM_198681.3:disruptive_inframe_deletion:MODERATE:exon20/22:c.2397_2399delGGA:p.Glu800del	(TCC)n	rs113541584	0.0972	0	0	0						611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];			COSM911543	0	0.1591	0.8409	1	105	n/a	n/a
chr1	6529443	6529443	A	G	het		QUAL=12084;DP=309;AF=0.49;MQM=59;TRIO=HET,309,0.49,WT,389,0.00,HET,486,0.48	PLEKHG5	synonymous	PLEKHG5:NM_001265592.1:synonymous:LOW:exon19/22:c.2238T>C:p.Ser746Ser,PLEKHG5:NM_001265593.1:synonymous:LOW:exon18/21:c.2208T>C:p.Ser736Ser,PLEKHG5:NM_001042665.1:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:NM_001042664.1:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:NM_001265594.1:synonymous:LOW:exon18/22:c.2001T>C:p.Ser667Ser,PLEKHG5:NM_020631.4:synonymous:LOW:exon18/21:c.2001T>C:p.Ser667Ser,PLEKHG5:NM_001042663.1:synonymous:LOW:exon19/22:c.2169T>C:p.Ser723Ser,PLEKHG5:NM_198681.3:synonymous:LOW:exon19/22:c.2232T>C:p.Ser744Ser		rs730600	0.2696	0.172	0.1403	0.5738						611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];				0.0303	0.2955	0.6742	10	136	n/a	n/a
chr1	6531589	6531589	C	T	het		QUAL=2128;DP=38;AF=0.68;MQM=59;TRIO=HET,38,0.68,WT,113,0.00,HET,114,0.44	PLEKHG5	missense	PLEKHG5:NM_001265592.1:missense:MODERATE:exon13/22:c.1477G>A:p.Ala493Thr,PLEKHG5:NM_001265593.1:missense:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr,PLEKHG5:NM_001042665.1:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:NM_001042664.1:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:NM_001265594.1:missense:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr,PLEKHG5:NM_020631.4:missense:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr,PLEKHG5:NM_001042663.1:missense:MODERATE:exon13/22:c.1408G>A:p.Ala470Thr,PLEKHG5:NM_198681.3:missense:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr		rs74809741	0.0553	0.051	0.0574	0.0878	0.6410	D	T	B,B,B,B,B	B,B,B,B,B	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];			COSM4144153	0	0.1288	0.8712	1	50	n/a	n/a
chr1	6533393	6533393	G	C	het		QUAL=531;DP=23;AF=0.35;MQM=60;TRIO=HET,23,0.35,WT,19,0.00,HET,25,0.56	PLEKHG5	missense	PLEKHG5:NM_001265592.1:missense:MODERATE:exon9/22:c.950C>G:p.Thr317Ser,PLEKHG5:NM_001265593.1:missense:MODERATE:exon8/21:c.920C>G:p.Thr307Ser,PLEKHG5:NM_001042665.1:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:NM_001042664.1:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:NM_001265594.1:missense:MODERATE:exon8/22:c.713C>G:p.Thr238Ser,PLEKHG5:NM_020631.4:missense:MODERATE:exon8/21:c.713C>G:p.Thr238Ser,PLEKHG5:NM_001042663.1:missense:MODERATE:exon9/22:c.881C>G:p.Thr294Ser,PLEKHG5:NM_198681.3:missense:MODERATE:exon9/22:c.944C>G:p.Thr315Ser		rs61741379	0.2857	0.128	0.128	0.5571	0.8480	P	T	B,B,B,B,B	B,B,B,B,B	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];			COSM3751354	0.0303	0.2727	0.697	10	131	n/a	n/a
chr1	6579521	6579521	G	C	het		QUAL=4239;DP=117;AF=0.53;MQM=60;TRIO=HET,117,0.53,HET,77,0.47,HET,91,0.52	PLEKHG5	missense	PLEKHG5:NM_198681.3:missense:MODERATE:exon1/22:c.51C>G:p.Ser17Arg		rs17438786	0.0136	0.025	0.0301	0.0062	0.0870	N	T	B,B	B,B	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4|Charcot-Marie-Tooth disease,recessive intermediate C];				0	0.053	0.947	0	19	n/a	n/a
chr1	6579607	6579607	C	T	hom		QUAL=20061;DP=175;AF=1.00;MQM=60;TRIO=HOM,175,1.00,HOM,204,1.00,HOM,269,1.00	PLEKHG5	5'UTR	PLEKHG5:NM_198681.3:5'UTR:MODIFIER:exon1/22:c.-36G>A:		rs1556035	0.746	0.851	0.8862	0.5486										0.7197	0.2727	0.0076	119	46	n/a	n/a
chr1	6579843	6579843	C	T	hom		QUAL=41660;DP=281;AF=0.99;MQM=59;TRIO=HOM,281,0.99,HOM,453,1.00,HOM,577,1.00	PLEKHG5	5'UTR	PLEKHG5:NM_198681.3:5'UTR:MODIFIER:exon1/22:c.-272G>A:		rs1010584	0.7354	0	0	0										0.697	0.2879	0.0152	106	42	n/a	n/a
chr1	10435324	10435324	C	A	het		QUAL=8860;DP=295;AF=0.45;MQM=60;TRIO=HET,295,0.45,HET,116,0.57,HET,147,0.52	KIF1B	synonymous	KIF1B:NM_015074.3:synonymous:LOW:exon46/47:c.5163C>A:p.Thr1721Thr		rs11121552	0.2316	0.272	0.3006	0.0937						605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1|Pheochromocytoma|Neuroblastoma,susceptibility to,1];	RCV000117408.3 [other]; 		COSM146393	0.0758	0.3788	0.5455	30	160	n/a	n/a
chr1	10436909	10436909	-	CA	het		QUAL=5165;DP=117;AF=0.38;MQM=59;TRIO=HET,117,0.78,HET,108,0.31,WT,126,0.52	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*279_*280dupCA:	(CA)n		0	0	0	0						605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1|Pheochromocytoma|Neuroblastoma,susceptibility to,1];				0	0	1	0	0	n/a	n/a
chr1	10436924	10436924	C	T	het		QUAL=5165;DP=117;AF=0.38;MQM=59;TRIO=HET,117,0.78,WT,108,0.31,HET,126,0.52	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*279C>T:	(CA)n	rs78490707	0.0403	0	0	0						605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1|Pheochromocytoma|Neuroblastoma,susceptibility to,1];				0	0.0152	0.9848	0	3	n/a	n/a
chr1	10438006	10438006	A	T	het		QUAL=1795;DP=80;AF=0.44;MQM=59;TRIO=HET,80,0.44,HET,58,0.52,WT,73,0.00	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*1361A>T:	AluSg	rs2847347	0.0182	0	0	0						605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1|Pheochromocytoma|Neuroblastoma,susceptibility to,1];				0.0076	0.1136	0.8788	1	18	n/a	n/a
chr1	10438687	10438687	C	T	het		QUAL=14704;DP=251;AF=0.56;MQM=60;TRIO=HET,251,0.56,HET,279,0.51,HET,352,0.51	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*2042C>T:		rs1536262	0.5465	0	0	0										0.2121	0.447	0.3409	49	95	n/a	n/a
chr1	10438892	10438892	G	A	het		QUAL=10710;DP=282;AF=0.54;MQM=59;TRIO=HET,282,0.54,HET,157,0.57,HET,189,0.52	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*2247G>A:		rs1002076	0.3337	0	0	0										0.0909	0.3864	0.5227	13	59	n/a	n/a
chr1	10440556	10440556	A	G	het		QUAL=11049;DP=305;AF=0.49;MQM=51;TRIO=HET,305,0.49,HET,179,0.49,HET,221,0.48	KIF1B	3'UTR	KIF1B:NM_015074.3:3'UTR:MODIFIER:exon47/47:c.*3911A>G:	AluSx	rs1138791	0.3488	0	0	0										0.1061	0.4015	0.4924	16	62	n/a	n/a
chr1	10441664	10441664	T	C	het		QUAL=16638;DP=451;AF=0.52;MQM=60;TRIO=HET,451,0.52,HET,268,0.44,HET,348,0.49					rs3748581	0.527	0	0	0										0.2121	0.447	0.3409	30	69	n/a	n/a
chr1	11085004	11085004	-	TGTTT	het		QUAL=15472;DP=367;AF=0.41;MQM=60;TRIO=HET,367,0.41,HET,257,0.45,HET,268,0.90	TARDBP	3'UTR	TARDBP:NM_007375.3:3'UTR:MODIFIER:exon6/6:c.*2294_*2295insGTTTT:		rs5772439	0.9151	0	0	0										0.5076	0.4394	0.053	76	66	n/a	n/a
chr1	11846092	11846092	-	T	het		QUAL=4096;DP=99;AF=0.78;MQM=59;TRIO=HET,99,0.78,HOM,35,0.89,HET,51,0.84	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4644dupA:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3567+757dupT:		rs397709443	0.9513	0	0	0										0.5303	0.1591	0.3106	86	24	n/a	n/a
chr1	11846252	11846252	G	A	hom		QUAL=15704;DP=319;AF=1.00;MQM=60;TRIO=HOM,319,1.00,HET,154,0.49,HET,182,0.54	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4485C>T:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3567+906G>A:	Tigger15a	rs4846048	0.7065	0	0	0										0.4091	0.4621	0.1288	63	68	n/a	n/a
chr1	11846447	11846447	G	A	hom		QUAL=25178;DP=376;AF=1.00;MQM=60;TRIO=HOM,376,1.00,HOM,181,1.00,HOM,212,1.00	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4290C>T:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3568-998G>A:		rs4845884	0.9333	0	0	0										1	0	0	151	0	n/a	n/a
chr1	11846660	11846663	TTTT	-	het		QUAL=1557;DP=37;AF=0.59;MQM=58;TRIO=HET,37,0.59,HET,23,0.43,HET,27,0.48	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4073_*4076delAAAA:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3568-770_3568-767delTTTT:	AluJo		0	0	0	0										0.2273	0.3636	0.4091	36	53	n/a	n/a
chr1	11846660	11846664	TTTTT	-	het		QUAL=1557;DP=37;AF=0.24;MQM=58;TRIO=HET,37,0.24,HET,23,0.26,HET,27,0.07	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*4073_*4077delAAAAA:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3568-771_3568-767delTTTTT:	AluJo		0	0	0	0										0.0152	0.2273	0.7576	2	33	n/a	n/a
chr1	11847334	11847334	-	GAA	hom		QUAL=8765;DP=177;AF=0.95;MQM=59;TRIO=HOM,177,0.95,HET,123,0.55,HET,213,0.37	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*3400_*3402dupTTC:,C1orf167:NM_001010881.1:intron:MODIFIER:exon16/20:c.3568-108_3568-106dupAGA:		rs70983598	0.5701	0	0	0										0.2803	0.5227	0.197	64	101	n/a	n/a
chr1	11847759	11847759	C	T	hom		QUAL=13331;DP=181;AF=0.99;MQM=59;TRIO=HOM,181,0.99,HET,239,0.50,HET,284,0.51	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*2978G>A:,C1orf167:NM_001010881.1:intron:MODIFIER:exon17/20:c.3674-171C>T:		rs3737966	0.5585	0	0	0										0.2879	0.5152	0.197	69	109	n/a	n/a
chr1	11848879	11848879	A	G	hom		QUAL=18805;DP=232;AF=1.00;MQM=59;TRIO=HOM,232,1.00,HOM,151,1.00,HOM,213,1.00	MTHFR,C1orf167	3'UTR,intron	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*1858T>C:,C1orf167:NM_001010881.1:intron:MODIFIER:exon20/20:c.4173+76A>G:		rs2077360	0.9305	0	0	0										1	0	0	254	1	n/a	n/a
chr1	11849447	11849447	A	G	hom		QUAL=17676;DP=146;AF=1.00;MQM=59;TRIO=HOM,146,1.00,HOM,186,1.00,HOM,225,1.00	C1orf167,MTHFR	missense,3'UTR	C1orf167:NM_001010881.1:missense:MODERATE:exon21/21:c.4294A>G:p.Arg1432Gly,MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*1290T>C:		rs868014	0.9329	0.976	0	0	-4.9500	P,P	.,T	.,B	.,B				COSM4142236	1	0	0	254	1	n/a	n/a
chr1	11850365	11850365	T	G	hom		QUAL=20881;DP=299;AF=1.00;MQM=59;TRIO=HOM,299,1.00,HET,345,0.50,HET,377,0.48	MTHFR	3'UTR	MTHFR:NM_005957.4:3'UTR:MODIFIER:exon12/12:c.*372A>C:		rs4846049	0.6284	0	0	0								CR125703 [CLASS=DFP MUT=REF PHEN="Coronary heart disease, increased risk, association with" GENE=MTHFR]; 		0.3636	0.4621	0.1742	60	69	n/a	n/a
chr1	11854457	11854457	G	A	hom		QUAL=18443;DP=118;AF=1.00;MQM=60;TRIO=HOM,118,1.00,HOM,201,1.00,HOM,261,1.00	MTHFR	synonymous	MTHFR:NM_005957.4:synonymous:LOW:exon8/12:c.1305C>T:p.Phe435Phe		rs4846051	0.903	0.97	0.997	0.6827						607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency|Schizophrenia,susceptibility to|Vascular disease,susceptibility to|Neural tube defects,susceptibility to|Thromboembolism,susceptibility to];	RCV000153514.1 [benign]; 	CM044675 [CLASS=DP MUT=REF PHEN="Preeclampsia, association with" GENE=MTHFR]; 		1	0	0	453	4	n/a	n/a
chr1	12009955	12009955	C	T	het		QUAL=8446;DP=121;AF=0.45;MQM=60;TRIO=HET,121,0.45,HET,189,0.53,HET,245,0.49	PLOD1	synonymous	PLOD1:NM_000302.3:synonymous:LOW:exon3/19:c.294C>T:p.Phe98Phe		rs7529452	0.2678	0.328	0.3119	0.0681						153454 [PLOD1 (provisional) Ehlers-Danlos syndrome,type VI];			COSM3996780	0.1136	0.4924	0.3939	58	192	n/a	n/a
chr1	12024235	12024235	C	T	het		QUAL=1467;DP=16;AF=0.56;MQM=60;TRIO=HET,16,0.56,HET,35,0.40,HET,54,0.54	PLOD1	synonymous	PLOD1:NM_000302.3:synonymous:LOW:exon12/19:c.1206C>T:p.Asn402Asn		rs1130529	0.3484	0.363	0.321	0.2907						153454 [PLOD1 (provisional) Ehlers-Danlos syndrome,type VI];			COSM3996785	0.1136	0.4848	0.4015	56	195	n/a	n/a
chr1	12040324	12040324	A	G	het		QUAL=4587;DP=34;AF=0.47;MQM=60;TRIO=HET,34,0.47,HOM,100,1.00,HET,119,0.37	MFN2	5'UTR	MFN2:NM_001127660.1:5'UTR:MODIFIER:exon1/18:c.-222A>G:,MFN2:NM_014874.3:5'UTR:MODIFIER:exon1/19:c.-367A>G:		rs2236054	0.5729	0	0	0										0.2197	0.5379	0.2424	31	78	n/a	n/a
chr1	12040479	12040479	T	C	het		QUAL=5734;DP=54;AF=0.50;MQM=60;TRIO=HET,54,0.50,HOM,111,1.00,HET,129,0.43	MFN2	5'UTR	MFN2:NM_001127660.1:5'UTR:MODIFIER:exon1/18:c.-67T>C:,MFN2:NM_014874.3:5'UTR:MODIFIER:exon1/19:c.-212T>C:		rs2180183	0.61	0	0	0										0.2197	0.5455	0.2348	31	80	n/a	n/a
chr1	12071680	12071680	A	G	hom		QUAL=28910;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HOM,312,1.00,HOM,406,1.00	MFN2	3'UTR	MFN2:NM_001127660.1:3'UTR:MODIFIER:exon18/18:c.*58A>G:,MFN2:NM_014874.3:3'UTR:MODIFIER:exon19/19:c.*58A>G:		rs1042842	0.7324	0	0.6556	0.8324										0.4545	0.4545	0.0909	121	116	n/a	n/a
chr1	12072518	12072518	G	C	hom		QUAL=12701;DP=104;AF=0.99;MQM=60;TRIO=HOM,104,0.99,HOM,139,1.00,HOM,171,1.00	MFN2	3'UTR	MFN2:NM_001127660.1:3'UTR:MODIFIER:exon18/18:c.*896G>C:,MFN2:NM_014874.3:3'UTR:MODIFIER:exon19/19:c.*896G>C:		rs3088064	0.5441	0	0	0										0.4015	0.4621	0.1364	64	72	n/a	n/a
chr1	16371067	16371067	G	T	het		QUAL=234;DP=4;AF=0.75;MQM=60;TRIO=HET,4,0.75,HOM,1,1.00,HOM,5,1.00	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon2/20:c.80G>T:p.Arg27Leu		rs2015352	0.5555	0.601	0.6422	0.3	-0.4670	P	T	P	B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];			COSM3750546	0.2576	0.1288	0.6136	155	165	n/a	n/a
chr1	16373124	16373124	A	G	hom		QUAL=22927;DP=177;AF=0.99;MQM=59;TRIO=HOM,177,0.99,HOM,243,1.00,HOM,303,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon4/20:c.324A>G:p.Ser108Ser		rs5257	0.7404	0.802	0.8117	0.3997						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.6515	0.3182	0.0303	292	141	n/a	n/a
chr1	16374533	16374533	G	C	hom		QUAL=383;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,5,1.00,HOM,3,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon5/20:c.492G>C:p.Gly164Gly		rs2014562	0.894	0.929	0.9364	0.7653						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.7879	0.0682	0.1439	370	55	n/a	n/a
chr1	16374994	16374994	C	T	hom		QUAL=18297;DP=147;AF=0.99;MQM=46;TRIO=HOM,147,0.99,HOM,198,1.00,HOM,243,1.00	CLCNKB	splice_region&intron	CLCNKB:NM_000085.4:splice_region&intron:LOW:exon6/19:c.577-5C>T:		rs1889788	0.7386	0.801	0	0						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.6515	0.3182	0.0303	288	138	n/a	n/a
chr1	16375063	16375063	C	G	hom		QUAL=17014;DP=182;AF=1.00;MQM=52;TRIO=HOM,182,1.00,HOM,170,1.00,HOM,213,1.00	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon7/20:c.641C>G:p.Ala214Gly		rs1889789	0.8273	0	0	0	-0.0370	P	T	B	B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.8561	0.1288	0.0152	377	69	n/a	n/a
chr1	16375064	16375064	A	C	hom		QUAL=17014;DP=182;AF=1.00;MQM=52;TRIO=HOM,182,1.00,HOM,170,1.00,HOM,213,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon7/20:c.642A>C:p.Ala214Ala		rs1889790	0.8273	0.9	0	0						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.8561	0.1288	0.0152	377	69	n/a	n/a
chr1	16375354	16375354	C	T	hom		QUAL=18854;DP=172;AF=1.00;MQM=59;TRIO=HOM,172,1.00,HOM,199,1.00,HOM,232,1.00	CLCNKB	5'UTR,intron	CLCNKB:NM_001165945.2:5'UTR:MODIFIER:exon1/13:c.-113C>T:,CLCNKB:NM_000085.4:intron:MODIFIER:exon7/19:c.656-261C>T:	MIR	rs9442227	0.7274	0	0	0						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.6439	0.3258	0.0303	94	51	n/a	n/a
chr1	16376191	16376191	C	T	hom		QUAL=26276;DP=165;AF=1.00;MQM=43;TRIO=HOM,165,1.00,HOM,303,1.00,HOM,394,1.00	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon9/20:c.860C>T:p.Ala287Val,CLCNKB:NM_001165945.2:missense:MODERATE:exon2/13:c.353C>T:p.Ala118Val		rs7367494	0.8299	0.909	0	0	-0.3350	P	T	B,B	B,B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];			COSM4142952	0.8788	0.1061	0.0152	366	57	n/a	n/a
chr1	16376319	16376319	T	C	hom		QUAL=33050;DP=190;AF=1.00;MQM=59;TRIO=HOM,190,1.00,HOM,359,1.00,HOM,481,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon10/20:c.876T>C:p.Cys292Cys,CLCNKB:NM_001165945.2:synonymous:LOW:exon3/13:c.369T>C:p.Cys123Cys		rs7368151	0.8301	0.911	0.9353	0.5803						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];			COSM4142954	0.8788	0.1061	0.0152	384	63	n/a	n/a
chr1	16380196	16380196	T	C	hom		QUAL=29134;DP=290;AF=1.00;MQM=51;TRIO=HOM,290,1.00,HOM,251,1.00,HOM,368,1.00	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon16/20:c.1685T>C:p.Met562Thr,CLCNKB:NM_001165945.2:missense:MODERATE:exon9/13:c.1178T>C:p.Met393Thr		rs5253	0.8383	0.931	0.9844	0.7006	-0.9230	P	T	B,B	B,B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.9697	0.0303	0	441	12	n/a	n/a
chr1	16380243	16380243	A	G	hom		QUAL=16363;DP=128;AF=1.00;MQM=48;TRIO=HOM,128,1.00,HET,232,0.42,HOM,309,0.99	CLCNKB	missense	CLCNKB:NM_000085.4:missense:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu,CLCNKB:NM_001165945.2:missense:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu		rs2275166	0.7017	0.658	0.6503	0.7994	0.8530	P	T	B,B	B,B	602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.4167	0.4924	0.0909	203	206	n/a	n/a
chr1	16380252	16380252	C	T	hom		QUAL=15213;DP=108;AF=1.00;MQM=48;TRIO=HOM,108,1.00,HET,216,0.44,HOM,300,1.00	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon16/20:c.1741C>T:p.Leu581Leu,CLCNKB:NM_001165945.2:synonymous:LOW:exon9/13:c.1234C>T:p.Leu412Leu		rs2275167	0.6136	0.621	0.6278	0.5792						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0.3788	0.5076	0.1136	192	207	n/a	n/a
chr1	16383402	16383402	C	T	het		QUAL=1369;DP=250;AF=0.24;MQM=34;TRIO=HET,250,0.24,WT,138,0.00,HET,143,0.07	CLCNKB	synonymous	CLCNKB:NM_000085.4:synonymous:LOW:exon20/20:c.2055C>T:p.Ala685Ala,CLCNKB:NM_001165945.2:synonymous:LOW:exon13/13:c.1545C>T:p.Ala515Ala		rs6698427	0	0.001	0	0						602023 [CLCNKB (confirmed) Bartter syndrome,type 3|Bartter syndrome,type 4b,digenic];				0	0.1515	0.8485	0	26	n/a	n/a
chr1	16383448	16383448	A	C	het		QUAL=18327;DP=211;AF=0.69;MQM=40;TRIO=HET,211,0.69,HOM,238,1.00,HET,285,0.89	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*37A>C:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*37A>C:		rs10803415	0.901	0.939	0	0										0.3333	0.6591	0.0076	164	107	n/a	n/a
chr1	16383574	16383574	A	T	het		QUAL=3082;DP=239;AF=0.13;MQM=33;TRIO=HET,239,0.13,WT,374,0.00,HET,609,0.20	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*163A>T:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*163A>T:		rs1057841	0	0	0	0										0	0.3258	0.6742	0	80	n/a	n/a
chr1	16383581	16383581	G	T	het		QUAL=25606;DP=238;AF=0.85;MQM=37;TRIO=HET,238,0.85,HET,376,0.51,HET,608,0.79	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*170G>T:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*170G>T:		rs1057844	0	0	0	0										0.2045	0.6288	0.1667	44	177	n/a	n/a
chr1	16383605	16383605	A	G	het		QUAL=26107;DP=194;AF=0.75;MQM=37;TRIO=HET,194,0.75,HET,399,0.52,HET,643,0.77	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*194A>G:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*194A>G:		rs1057845	0	0	0	0										0.1667	0.6288	0.2045	31	189	n/a	n/a
chr1	16383668	16383668	T	G	hom		QUAL=37774;DP=159;AF=1.00;MQM=41;TRIO=HOM,159,1.00,HOM,358,1.00,HOM,657,1.00	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*257T>G:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*257T>G:		rs6660218	1	0.999	0	0										1	0	0	256	0	n/a	n/a
chr1	16383682	16383682	G	C	het		QUAL=7864;DP=216;AF=0.19;MQM=41;TRIO=HET,216,0.19,WT,320,0.00,HET,647,0.36	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*271G>C:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*271G>C:		rs1057854	0	0.224	0	0	-3.2740	N	T					CR133355 [CLASS=DM? MUT=REF PHEN="Bartter syndrome 3" GENE=CLCNKB]; 		0	0.5455	0.4545	0	150	1	n/a
chr1	16383742	16383742	C	G	het		QUAL=20923;DP=330;AF=0.54;MQM=57;TRIO=HET,330,0.54,HOM,223,1.00,HET,514,0.53	CLCNKB	3'UTR	CLCNKB:NM_000085.4:3'UTR:MODIFIER:exon20/20:c.*331C>G:,CLCNKB:NM_001165945.2:3'UTR:MODIFIER:exon13/13:c.*331C>G:		rs1057857	0	0.585	0	0	-0.3020	P	T						COSM4142956	0.303	0.6894	0.0076	75	179	n/a	n/a
chr1	17312743	17312743	C	T	het		QUAL=809;DP=19;AF=0.42;MQM=60;TRIO=HET,19,0.42,HOM,16,0.94,HET,25,0.44	ATP13A2	missense,synonymous	ATP13A2:NM_001141974.2:missense:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr,ATP13A2:NM_022089.3:synonymous:LOW:exon29/29:c.3516G>A:p.Pro1172Pro,ATP13A2:NM_001141973.2:synonymous:LOW:exon29/29:c.3501G>A:p.Pro1167Pro		rs3170740	0.3313	0.455	0.5255	0.2168	-2.5480	P	T	B	B	610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116444.1 [benign]; 		COSM3750606	0.2348	0.4848	0.2803	197	370	n/a	n/a
chr1	17313343	17313343	G	A	het		QUAL=11696;DP=89;AF=0.45;MQM=60;TRIO=HET,89,0.45,HOM,198,1.00,HET,281,0.49	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon27/29:c.3192C>T:p.Ala1064Ala,ATP13A2:NM_001141973.2:synonymous:LOW:exon27/29:c.3177C>T:p.Ala1059Ala,ATP13A2:NM_001141974.2:synonymous:LOW:exon26/27:c.3060C>T:p.Ala1020Ala		rs9435659	0.3385	0.459	0.5234	0.2077						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116442.1 [benign]; 		COSM3747592	0.2652	0.4773	0.2576	196	379	n/a	n/a
chr1	17313454	17313454	G	A	het		QUAL=2875;DP=59;AF=0.44;MQM=60;TRIO=HET,59,0.44,WT,137,0.00,HET,171,0.43	ATP13A2	splice_region&intron	ATP13A2:NM_022089.3:splice_region&intron:LOW:exon26/28:c.3084-3C>T:,ATP13A2:NM_001141973.2:splice_region&intron:LOW:exon26/28:c.3069-3C>T:,ATP13A2:NM_001141974.2:splice_region&intron:LOW:exon25/26:c.2952-3C>T:		rs7531163	0.3065	0.273	0.2392	0.1686						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116440.1 [benign]; 			0.0833	0.3485	0.5682	54	321	n/a	n/a
chr1	17313654	17313654	C	T	het		QUAL=11564;DP=67;AF=0.48;MQM=60;TRIO=HET,67,0.48,HOM,241,1.00,HET,276,0.47	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon26/29:c.2970G>A:p.Val990Val,ATP13A2:NM_001141973.2:synonymous:LOW:exon26/29:c.2955G>A:p.Val985Val,ATP13A2:NM_001141974.2:synonymous:LOW:exon25/27:c.2838G>A:p.Val946Val		rs761421	0.3462	0.46	0.522	0.2374						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116439.1 [benign]; 		COSM3750608	0.2652	0.4773	0.2576	196	377	n/a	n/a
chr1	17314702	17314702	C	T	het		QUAL=13475;DP=277;AF=0.47;MQM=60;TRIO=HET,277,0.47,WT,493,0.01,HET,578,0.51	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon25/29:c.2790G>A:p.Ser930Ser,ATP13A2:NM_001141973.2:synonymous:LOW:exon25/29:c.2775G>A:p.Ser925Ser,ATP13A2:NM_001141974.2:synonymous:LOW:exon24/27:c.2658G>A:p.Ser886Ser		rs3738815	0.2909	0.241	0.1927	0.1496						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116437.1 [benign]; 		COSM3750610	0.0682	0.3182	0.6136	42	271	n/a	n/a
chr1	17314942	17314942	G	A	het		QUAL=15720;DP=290;AF=0.49;MQM=59;TRIO=HET,290,0.49,HOM,257,0.99,HET,319,0.45	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon24/29:c.2637C>T:p.Gly879Gly,ATP13A2:NM_001141973.2:synonymous:LOW:exon24/29:c.2622C>T:p.Gly874Gly,ATP13A2:NM_001141974.2:synonymous:LOW:exon23/27:c.2505C>T:p.Gly835Gly		rs9435662	0.3387	0.458	0.5222	0.207						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116435.1 [benign]; 		COSM3750612	0.2652	0.4773	0.2576	198	374	n/a	n/a
chr1	17319011	17319011	G	A	het		QUAL=7137;DP=77;AF=0.45;MQM=60;TRIO=HET,77,0.45,HOM,124,1.00,HET,151,0.48	ATP13A2	synonymous	ATP13A2:NM_022089.3:synonymous:LOW:exon17/29:c.1815C>T:p.Pro605Pro,ATP13A2:NM_001141973.2:synonymous:LOW:exon17/29:c.1800C>T:p.Pro600Pro,ATP13A2:NM_001141974.2:synonymous:LOW:exon17/27:c.1800C>T:p.Pro600Pro		rs2076603	0.4485	0.554	0.6323	0.4462						610513 [ATP13A2 (confirmed) Kufor-Rakeb syndrome|Ceroid lipofuscinosis,neuronal,12];	RCV000116434.1 [benign]; 		COSM3997075	0.3636	0.447	0.1894	277	361	n/a	n/a
chr1	19198064	19198064	T	G	het		QUAL=4244;DP=93;AF=0.53;MQM=60;TRIO=HET,93,0.53,WT,147,0.00,HET,185,0.47	ALDH4A1	3'UTR	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*1275A>C:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*1275A>C:,ALDH4A1:NM_170726.2:3'UTR:MODIFIER:exon16/16:c.*262A>C:		rs1138333	0.1793	0	0	0										0.0758	0.4242	0.5	13	63	n/a	n/a
chr1	19198100	19198100	C	G	het		QUAL=4158;DP=94;AF=0.54;MQM=60;TRIO=HET,94,0.54,WT,142,0.00,HET,165,0.50	ALDH4A1	3'UTR	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*1239G>C:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*1239G>C:,ALDH4A1:NM_170726.2:3'UTR:MODIFIER:exon16/16:c.*226G>C:		rs1138328	0.1651	0	0	0										0.0758	0.4242	0.5	13	63	n/a	n/a
chr1	19198141	19198141	T	C	het		QUAL=4117;DP=117;AF=0.51;MQM=60;TRIO=HET,117,0.51,WT,139,0.00,HET,145,0.48	ALDH4A1	3'UTR	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*1198A>G:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*1198A>G:,ALDH4A1:NM_170726.2:3'UTR:MODIFIER:exon16/16:c.*185A>G:		rs7366541	0.1799	0	0	0										0.0758	0.4242	0.5	13	63	n/a	n/a
chr1	19198414	19198414	G	A	het		QUAL=5103;DP=160;AF=0.48;MQM=60;TRIO=HET,160,0.48,WT,168,0.00,HET,192,0.48	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*925C>T:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*925C>T:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-130C>T:		rs1140477	0.1935	0	0	0										0.0758	0.4242	0.5	13	63	n/a	n/a
chr1	19198418	19198418	C	T	het		QUAL=5103;DP=160;AF=0.48;MQM=60;TRIO=HET,160,0.48,WT,168,0.00,HET,192,0.48	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*921G>A:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*921G>A:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-134G>A:		rs1138269	0.1933	0	0	0										0.0758	0.4242	0.5	13	63	n/a	n/a
chr1	19198576	19198576	A	G	hom		QUAL=29743;DP=363;AF=1.00;MQM=59;TRIO=HOM,363,1.00,HOM,238,1.00,HOM,311,0.99	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*763T>C:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*763T>C:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-292T>C:		rs1138267	0.6751	0	0	0										0.553	0.3561	0.0909	81	55	n/a	n/a
chr1	19198627	19198627	G	A	het		QUAL=7849;DP=280;AF=0.48;MQM=60;TRIO=HET,280,0.48,WT,200,0.01,HET,260,0.45	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*712C>T:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*712C>T:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-343C>T:		rs14311	0.1935	0	0	0										0.0758	0.4242	0.5	13	63	n/a	n/a
chr1	19198637	19198637	G	A	het		QUAL=13794;DP=232;AF=0.48;MQM=59;TRIO=HET,232,0.48,HOM,201,1.00,HET,253,0.53	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*702C>T:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*702C>T:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-353C>T:		rs3202002	0.4744	0	0	0										0.2045	0.4773	0.3182	29	70	n/a	n/a
chr1	19198682	19198682	C	-	het		QUAL=8628;DP=111;AF=0.42;MQM=60;TRIO=HET,111,0.42,HOM,167,0.98,HET,188,0.52	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*657delG:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*657delG:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*42-398delG:		rs11311839	0.4677	0	0	0										0.2045	0.4773	0.3182	29	71	n/a	n/a
chr1	19198895	19198895	A	G	het		QUAL=6342;DP=191;AF=0.49;MQM=59;TRIO=HET,191,0.49,WT,192,0.00,HET,245,0.44	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*444T>C:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*444T>C:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*41+403T>C:		rs9117	0.1102	0	0	0										0.0682	0.3864	0.5455	12	56	n/a	n/a
chr1	19199221	19199221	C	T	het		QUAL=22875;DP=211;AF=0.44;MQM=60;TRIO=HET,211,0.44,HOM,399,0.99,HET,484,0.47	ALDH4A1	3'UTR,intron	ALDH4A1:NM_003748.3:3'UTR:MODIFIER:exon15/15:c.*118G>A:,ALDH4A1:NM_001161504.1:3'UTR:MODIFIER:exon15/15:c.*118G>A:,ALDH4A1:NM_170726.2:intron:MODIFIER:exon15/15:c.*41+77G>A:		rs11740	0.4714	0	0	0										0.2045	0.4773	0.3182	30	69	n/a	n/a
chr1	19201956	19201956	A	G	hom		QUAL=18262;DP=308;AF=1.00;MQM=59;TRIO=HOM,308,1.00,HOM,131,1.00,HOM,137,1.00	ALDH4A1	synonymous	ALDH4A1:NM_003748.3:synonymous:LOW:exon13/15:c.1380T>C:p.Asp460Asp,ALDH4A1:NM_001161504.1:synonymous:LOW:exon13/15:c.1200T>C:p.Asp400Asp,ALDH4A1:NM_170726.2:synonymous:LOW:exon13/16:c.1380T>C:p.Asp460Asp		rs2230708	0.7372	0.73	0.714	0.6793						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];				0.5682	0.3561	0.0758	234	192	n/a	n/a
chr1	19202896	19202896	G	A	hom		QUAL=7490;DP=121;AF=1.00;MQM=60;TRIO=HOM,121,1.00,HET,72,0.33,HOM,96,0.99	ALDH4A1	synonymous	ALDH4A1:NM_003748.3:synonymous:LOW:exon12/15:c.1251C>T:p.Ala417Ala,ALDH4A1:NM_001161504.1:synonymous:LOW:exon12/15:c.1071C>T:p.Ala357Ala,ALDH4A1:NM_170726.2:synonymous:LOW:exon12/16:c.1251C>T:p.Ala417Ala		rs2230707	0.516	0.502	0.4648	0.4351						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];			COSM4143136	0.2424	0.553	0.2045	92	243	n/a	n/a
chr1	19202917	19202917	T	C	hom		QUAL=7592;DP=94;AF=1.00;MQM=59;TRIO=HOM,94,1.00,HOM,72,0.97,HOM,86,0.99	ALDH4A1	synonymous	ALDH4A1:NM_003748.3:synonymous:LOW:exon12/15:c.1230A>G:p.Ser410Ser,ALDH4A1:NM_001161504.1:synonymous:LOW:exon12/15:c.1050A>G:p.Ser350Ser,ALDH4A1:NM_170726.2:synonymous:LOW:exon12/16:c.1230A>G:p.Ser410Ser		rs7550938	0.6609	0.686	0.6938	0.4848						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];			COSM1337326	0.5076	0.4091	0.0833	214	202	n/a	n/a
chr1	19202926	19202926	T	C	hom		QUAL=6300;DP=61;AF=1.00;MQM=59;TRIO=HOM,61,1.00,HOM,71,0.99,HOM,87,0.99	ALDH4A1	synonymous	ALDH4A1:NM_003748.3:synonymous:LOW:exon12/15:c.1221A>G:p.Ala407Ala,ALDH4A1:NM_001161504.1:synonymous:LOW:exon12/15:c.1041A>G:p.Ala347Ala,ALDH4A1:NM_170726.2:synonymous:LOW:exon12/16:c.1221A>G:p.Ala407Ala		rs2230706	0.6601	0.684	0.6919	0.4837						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];			COSM1337328	0.5076	0.4091	0.0833	214	201	n/a	n/a
chr1	19203997	19203997	C	G	hom		QUAL=7615;DP=86;AF=0.98;MQM=59;TRIO=HOM,86,0.98,HOM,56,1.00,HOM,107,1.00	ALDH4A1	synonymous	ALDH4A1:NM_003748.3:synonymous:LOW:exon10/15:c.1050G>C:p.Ala350Ala,ALDH4A1:NM_001161504.1:synonymous:LOW:exon10/15:c.870G>C:p.Ala290Ala,ALDH4A1:NM_170726.2:synonymous:LOW:exon10/16:c.1050G>C:p.Ala350Ala		rs2230705	0.6416	0.683	0.7075	0.7193						606811 [ALDH4A1 (provisional) Hyperprolinemia,type II];			COSM424869	0.5303	0.3636	0.1061	197	202	n/a	n/a
chr1	21889635	21889635	T	C	hom		QUAL=5093;DP=28;AF=0.96;MQM=59;TRIO=HOM,28,0.96,HOM,89,1.00,HET,121,0.51	ALPL	synonymous	ALPL:NM_000478.4:synonymous:LOW:exon5/12:c.330T>C:p.Ser110Ser,ALPL:NM_001127501.2:synonymous:LOW:exon4/11:c.165T>C:p.Ser55Ser,ALPL:NM_001177520.1:synonymous:LOW:exon3/10:c.99T>C:p.Ser33Ser		rs1780316	0.9295	0.945	0.9493	0.8679						171760 [ALPL (confirmed) Hypophosphatasia,infantile|Hypophosphatasia,childhood|Odontohypophosphatasia|Hypophosphatasia,adult];			COSM3746801	0.8712	0.1212	0.0076	399	53	n/a	n/a
chr1	21904263	21904263	C	-	het		QUAL=5583;DP=176;AF=0.40;MQM=59;TRIO=HET,176,0.40,HET,235,0.50,WT,279,0.00	ALPL	3'UTR	ALPL:NM_000478.4:3'UTR:MODIFIER:exon12/12:c.*124delC:,ALPL:NM_001127501.2:3'UTR:MODIFIER:exon11/11:c.*124delC:,ALPL:NM_001177520.1:3'UTR:MODIFIER:exon10/10:c.*124delC:		rs140511985	0.0228	0	0	0										0.0076	0.1136	0.8788	1	20	n/a	n/a
chr1	21904267	21904267	A	G	hom		QUAL=22650;DP=184;AF=1.00;MQM=59;TRIO=HOM,184,1.00,HOM,239,0.98,HOM,293,1.00	ALPL	3'UTR	ALPL:NM_000478.4:3'UTR:MODIFIER:exon12/12:c.*126A>G:,ALPL:NM_001127501.2:3'UTR:MODIFIER:exon11/11:c.*126A>G:,ALPL:NM_001177520.1:3'UTR:MODIFIER:exon10/10:c.*126A>G:		rs1697406	0.8682	0	0	0										0.7576	0.197	0.0455	114	30	n/a	n/a
chr1	22149183	22149183	G	C	het		QUAL=1452;DP=23;AF=0.52;MQM=60;TRIO=HET,23,0.52,WT,27,0.00,HOM,41,1.00	LDLRAD2,HSPG2	3'UTR	LDLRAD2:NM_001013693.2:3'UTR:MODIFIER:exon5/5:c.*475G>C:,HSPG2:NM_001291860.1:3'UTR:MODIFIER:exon97/97:c.*626C>G:,HSPG2:NM_005529.6:3'UTR:MODIFIER:exon97/97:c.*626C>G:		rs1049644	0.3199	0	0	0										0.0985	0.3636	0.5379	14	61	n/a	n/a
chr1	22149935	22149935	T	C	hom		QUAL=15200;DP=112;AF=1.00;MQM=60;TRIO=HOM,112,1.00,HOM,144,1.00,HOM,230,1.00	HSPG2,LDLRAD2	synonymous,3'UTR	HSPG2:NM_001291860.1:synonymous:LOW:exon97/97:c.13053A>G:p.Ser4351Ser,HSPG2:NM_005529.6:synonymous:LOW:exon97/97:c.13050A>G:p.Ser4350Ser,LDLRAD2:NM_001013693.2:3'UTR:MODIFIER:exon5/5:c.*1227T>C:		rs897467	0.7804	0.797	0.8281	0.7223						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750884	0.6894	0.2652	0.0455	327	112	n/a	n/a
chr1	22150120	22150120	C	T	het		QUAL=7101;DP=146;AF=0.45;MQM=59;TRIO=HET,146,0.45,WT,207,0.01,HET,314,0.54	HSPG2,LDLRAD2	missense,3'UTR	HSPG2:NM_001291860.1:missense:MODERATE:exon96/97:c.12995G>A:p.Ser4332Asn,HSPG2:NM_005529.6:missense:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn,LDLRAD2:NM_001013693.2:3'UTR:MODIFIER:exon5/5:c.*1412C>T:		rs3736360	0.1761	0.184	0.1762	0.0869	0.0960	P	T	B	B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750886	0.0303	0.2879	0.6818	16	136	n/a	n/a
chr1	22150160	22150160	G	T	het		QUAL=9722;DP=284;AF=0.48;MQM=59;TRIO=HET,284,0.48,WT,205,0.01,HET,322,0.55	HSPG2,LDLRAD2	synonymous,3'UTR	HSPG2:NM_001291860.1:synonymous:LOW:exon96/97:c.12955C>A:p.Arg4319Arg,HSPG2:NM_005529.6:synonymous:LOW:exon96/97:c.12952C>A:p.Arg4318Arg,LDLRAD2:NM_001013693.2:3'UTR:MODIFIER:exon5/5:c.*1452G>T:		rs3736358	0	0.18	0.1755	0.0399						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750887	0.0303	0.2879	0.6818	16	135	n/a	n/a
chr1	22154845	22154845	A	G	het		QUAL=1408;DP=43;AF=0.35;MQM=60;TRIO=HET,43,0.35,WT,35,0.00,HOM,32,0.97	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon89/97:c.12315T>C:p.Asp4105Asp,HSPG2:NM_005529.6:synonymous:LOW:exon89/97:c.12312T>C:p.Asp4104Asp		rs2228347	0.2572	0.297	0.3063	0.1471						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3746805	0.1212	0.4015	0.4773	44	191	n/a	n/a
chr1	22159774	22159774	G	A	het		QUAL=5238;DP=136;AF=0.41;MQM=60;TRIO=HET,136,0.41,WT,202,0.00,HET,234,0.50	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon80/97:c.11085C>T:p.Pro3695Pro,HSPG2:NM_005529.6:synonymous:LOW:exon80/97:c.11082C>T:p.Pro3694Pro		rs2229486	0.0859	0.079	0.0767	0.1729						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1439	0.8561	1	66	n/a	n/a
chr1	22160043	22160043	C	T	het		QUAL=6580;DP=179;AF=0.41;MQM=60;TRIO=HET,179,0.41,WT,223,0.00,HET,286,0.49	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon79/97:c.10898G>A:p.Arg3633Gln,HSPG2:NM_005529.6:missense:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln		rs2229493	0.0859	0.079	0.0769	0.1732	-0.0650	P	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1439	0.8561	1	66	n/a	n/a
chr1	22163390	22163390	G	A	het		QUAL=6905;DP=170;AF=0.48;MQM=60;TRIO=HET,170,0.48,WT,227,0.00,HET,352,0.40	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon75/97:c.10263C>T:p.His3421His,HSPG2:NM_005529.6:synonymous:LOW:exon75/97:c.10260C>T:p.His3420His		rs35444472	0.0861	0.06	0.0737	0.1664						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750889	0	0.1439	0.8561	1	64	n/a	n/a
chr1	22165901	22165901	A	G	het		QUAL=3137;DP=79;AF=0.62;MQM=59;TRIO=HET,79,0.62,WT,38,0.00,HET,88,0.67	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon73/97:c.9855T>C:p.Ala3285Ala,HSPG2:NM_005529.6:synonymous:LOW:exon73/97:c.9852T>C:p.Ala3284Ala		rs2291826	0.346	0.287	0.2571	0.5311						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0.053	0.3636	0.5833	29	174	n/a	n/a
chr1	22167605	22167605	C	T	het		QUAL=2708;DP=50;AF=0.44;MQM=59;TRIO=HET,50,0.44,WT,164,0.00,HET,180,0.41	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon71/97:c.9505G>A:p.Ala3169Thr,HSPG2:NM_005529.6:missense:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr		rs2228349	0.0837	0.075	0.0755	0.1576	0.9110	P	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1439	0.8561	1	65	n/a	n/a
chr1	22168801	22168801	T	C	het		QUAL=1890;DP=58;AF=0.50;MQM=59;TRIO=HET,58,0.50,WT,75,0.00,HET,87,0.43	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon68/97:c.8986A>G:p.Ser2996Gly,HSPG2:NM_005529.6:missense:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly		rs2229491	0.0887	0.08	0.0767	0.1813	-0.0660	P	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1439	0.8561	1	67	n/a	n/a
chr1	22168845	22168845	A	T	het		QUAL=1232;DP=42;AF=0.55;MQM=60;TRIO=HET,42,0.55,WT,44,0.00,HET,56,0.38	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon68/97:c.8942T>A:p.Leu2981His,HSPG2:NM_005529.6:missense:MODERATE:exon68/97:c.8939T>A:p.Leu2980His		rs2229489	0.0343	0.05	0.0557	0.0091	1.8860	N	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM425370	0	0.1364	0.8636	0	52	n/a	n/a
chr1	22173990	22173990	A	G	het		QUAL=8871;DP=150;AF=0.54;MQM=59;TRIO=HET,150,0.54,WT,316,0.00,HET,425,0.49	HSPG2	splice_region&intron	HSPG2:NM_001291860.1:splice_region&intron:LOW:exon61/96:c.8029-5T>C:,HSPG2:NM_005529.6:splice_region&intron:LOW:exon61/96:c.8026-5T>C:		rs35917892	0.0347	0.05	0.0571	0.0093						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1364	0.8636	0	52	n/a	n/a
chr1	22174518	22174518	G	T	het		QUAL=9412;DP=275;AF=0.43;MQM=60;TRIO=HET,275,0.43,WT,356,0.00,HET,360,0.51	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon60/97:c.7809C>A:p.Val2603Val,HSPG2:NM_005529.6:synonymous:LOW:exon60/97:c.7806C>A:p.Val2602Val		rs12737091	0.0347	0.05	0.0571	0.0093						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1364	0.8636	0	52	n/a	n/a
chr1	22179244	22179244	C	T	het		QUAL=4416;DP=87;AF=0.43;MQM=59;TRIO=HET,87,0.43,WT,151,0.00,HET,203,0.52	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon52/97:c.6676G>A:p.Gly2226Ser,HSPG2:NM_005529.6:missense:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser		rs35669711	0.0347	0.05	0.0571	0.0095	-0.1820	N	T	B,B	B,B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1364	0.8636	0	52	n/a	n/a
chr1	22179451	22179451	C	T	het		QUAL=7279;DP=78;AF=0.45;MQM=59;TRIO=HET,78,0.45,WT,272,0.00,HET,433,0.46	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon51/97:c.6555G>A:p.Thr2185Thr,HSPG2:NM_005529.6:synonymous:LOW:exon51/97:c.6552G>A:p.Thr2184Thr		rs34443576	0.0345	0.05	0.0568	0.0095						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1364	0.8636	0	52	n/a	n/a
chr1	22180723	22180723	C	T	het		QUAL=3761;DP=79;AF=0.47;MQM=60;TRIO=HET,79,0.47,WT,143,0.00,HET,188,0.50	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon50/97:c.6405G>A:p.Val2135Val,HSPG2:NM_005529.6:synonymous:LOW:exon50/97:c.6402G>A:p.Val2134Val		rs12742444	0.0345	0.043	0.0547	0.0093						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1364	0.8636	0	52	n/a	n/a
chr1	22181895	22181895	C	T	het		QUAL=7034;DP=154;AF=0.47;MQM=60;TRIO=HET,154,0.47,WT,257,0.00,HET,307,0.53	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon47/97:c.5902G>A:p.Val1968Ile,HSPG2:NM_005529.6:missense:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile		rs2229475	0.0347	0.05	0.0565	0.0093	1.8290	D	T	D	D	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				0	0.1364	0.8636	0	52	n/a	n/a
chr1	22191454	22191454	G	A	het		QUAL=7364;DP=113;AF=0.38;MQM=60;TRIO=HET,113,0.38,HOM,205,1.00,WT,347,0.00	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon36/97:c.4511C>T:p.Ala1504Val,HSPG2:NM_005529.6:missense:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val		rs897471	0.6915	0.706	0.7396	0.6198	2.2600	P	T	D	D	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750893	0.5758	0.3409	0.0833	248	169	n/a	n/a
chr1	22199245	22199245	C	T	het		QUAL=3194;DP=44;AF=0.59;MQM=60;TRIO=HET,44,0.59,HOM,80,1.00,WT,75,0.01	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon32/97:c.3900G>A:p.Val1300Val,HSPG2:NM_005529.6:synonymous:LOW:exon32/97:c.3897G>A:p.Val1299Val		rs2229482	0.4249	0.543	0.6429	0.2941						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM425375	0.4015	0.4394	0.1591	191	197	n/a	n/a
chr1	22206649	22206649	T	C	hom		QUAL=22099;DP=192;AF=1.00;MQM=60;TRIO=HOM,192,1.00,HOM,238,1.00,HOM,254,1.00	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon17/97:c.2297A>G:p.Asn766Ser,HSPG2:NM_005529.6:missense:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser		rs989994	0.9299	0.981	0.9991	0.8105	0.8030	P	T	B	B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				1	0	0	453	1	n/a	n/a
chr1	22206942	22206942	G	A	hom		QUAL=8041;DP=123;AF=1.00;MQM=59;TRIO=HOM,123,1.00,HOM,60,1.00,HOM,74,1.00	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon16/97:c.2112C>T:p.Ala704Ala,HSPG2:NM_005529.6:synonymous:LOW:exon16/97:c.2109C>T:p.Ala703Ala		rs1874793	0.9299	0.981	0.9991	0.8105						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM4143367	1	0	0	453	1	n/a	n/a
chr1	22207235	22207235	T	C	hom		QUAL=11044;DP=153;AF=1.00;MQM=59;TRIO=HOM,153,1.00,HOM,73,1.00,HOM,129,1.00	HSPG2	missense	HSPG2:NM_001291860.1:missense:MODERATE:exon15/97:c.1915A>G:p.Met639Val,HSPG2:NM_005529.6:missense:MODERATE:exon15/97:c.1912A>G:p.Met638Val		rs1874792	0.9736	0.992	0.9994	0.9292	1.5550	P	T	B	B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				1	0	0	454	0	n/a	n/a
chr1	22214127	22214127	A	G	hom		QUAL=13276;DP=118;AF=1.00;MQM=60;TRIO=HOM,118,1.00,HET,181,0.50,HOM,214,1.00	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon8/97:c.744T>C:p.Leu248Leu,HSPG2:NM_005529.6:synonymous:LOW:exon8/97:c.744T>C:p.Leu248Leu		rs2229478	0.5363	0.417	0.3237	0.6296	-0.2600	P	T	B	B	142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];			COSM3750894	0.1212	0.4773	0.4015	54	205	n/a	n/a
chr1	22217108	22217108	G	A	hom		QUAL=25558;DP=203;AF=1.00;MQM=60;TRIO=HOM,203,1.00,HOM,275,1.00,HOM,330,1.00	HSPG2	synonymous	HSPG2:NM_001291860.1:synonymous:LOW:exon4/97:c.324C>T:p.Phe108Phe,HSPG2:NM_005529.6:synonymous:LOW:exon4/97:c.324C>T:p.Phe108Phe		rs2501260	0.9481	0.986	0.9991	0.8654						142461 [HSPG2 (confirmed) Schwartz-Jampel syndrome,type 1|Dyssegmental dysplasia,Silverman-Handmaker type];				1	0	0	453	1	n/a	n/a
chr1	22779159	22779159	T	C	hom		QUAL=28613;DP=264;AF=1.00;MQM=60;TRIO=HOM,264,1.00,HOM,252,1.00,HOM,390,1.00	ZBTB40	5'UTR,intron	ZBTB40:NM_001083621.1:5'UTR:MODIFIER:exon2/19:c.-350T>C:,ZBTB40:NM_014870.3:intron:MODIFIER:exon1/17:c.-70+662T>C:	MER58B	rs10737466	0.9698	0	0	0										1	0	0	150	0	n/a	n/a
chr1	22832743	22832743	A	T	hom		QUAL=15965;DP=209;AF=1.00;MQM=60;TRIO=HOM,209,1.00,HET,166,0.55,HOM,208,0.99	ZBTB40	splice_region&intron	ZBTB40:NM_001083621.1:splice_region&intron:LOW:exon7/18:c.1360+9A>T:,ZBTB40:NM_014870.3:splice_region&intron:LOW:exon6/17:c.1360+9A>T:		rs209732	0.7991	0.693	0.6164	0.8858									COSM3746831	0.4091	0.4773	0.1136	182	192	n/a	n/a
chr1	22835677	22835677	A	G	hom		QUAL=25518;DP=333;AF=1.00;MQM=60;TRIO=HOM,333,1.00,HET,272,0.53,HOM,302,1.00	ZBTB40	missense	ZBTB40:NM_001083621.1:missense:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys,ZBTB40:NM_014870.3:missense:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys		rs209729	0.8225	0.765	0.7192	0.904	0.2230	P	T	B,B	B,B				COSM3746832	0.5682	0.3864	0.0455	242	167	n/a	n/a
chr1	22846709	22846709	G	A	hom		QUAL=11968;DP=159;AF=1.00;MQM=60;TRIO=HOM,159,1.00,HOM,93,1.00,HOM,133,1.00	ZBTB40	missense	ZBTB40:NM_001083621.1:missense:MODERATE:exon15/19:c.2989G>A:p.Val997Met,ZBTB40:NM_014870.3:missense:MODERATE:exon14/18:c.2989G>A:p.Val997Met		rs209720	0.9984	0.997	0.9947	0.9989	2.3000	P	T	B,B	B,B					1	0	0	453	0	n/a	n/a
chr1	22852715	22852715	G	C	hom		QUAL=11077;DP=164;AF=0.99;MQM=60;TRIO=HOM,164,0.99,HET,108,0.46,HOM,139,0.99	ZBTB40	synonymous	ZBTB40:NM_001083621.1:synonymous:LOW:exon19/19:c.3546G>C:p.Pro1182Pro,ZBTB40:NM_014870.3:synonymous:LOW:exon18/18:c.3546G>C:p.Pro1182Pro		rs881646	0.3181	0.342	0.3688	0.1598									COSM3746849	0.1288	0.4848	0.3864	56	209	n/a	n/a
chr1	22853141	22853141	G	A	hom		QUAL=18025;DP=140;AF=1.00;MQM=59;TRIO=HOM,140,1.00,HET,230,0.50,HOM,315,1.00	ZBTB40	3'UTR	ZBTB40:NM_001083621.1:3'UTR:MODIFIER:exon19/19:c.*252G>A:,ZBTB40:NM_014870.3:3'UTR:MODIFIER:exon18/18:c.*252G>A:		rs2281354	0.2378	0	0	0										0.0985	0.4773	0.4242	15	72	n/a	n/a
chr1	22855194	22855194	-	T	het		QUAL=1144;DP=48;AF=0.31;MQM=59;TRIO=HET,48,0.31,HET,39,0.21,HET,46,0.46	ZBTB40	3'UTR	ZBTB40:NM_001083621.1:3'UTR:MODIFIER:exon19/19:c.*2320dupT:,ZBTB40:NM_014870.3:3'UTR:MODIFIER:exon18/18:c.*2320dupT:	AluJo	rs397979575	0	0	0	0										0.0152	0.1742	0.8106	2	25	n/a	n/a
chr1	22856601	22856601	T	C	hom		QUAL=19420;DP=217;AF=0.99;MQM=59;TRIO=HOM,217,0.99,HET,216,0.49,HOM,276,1.00	ZBTB40	3'UTR	ZBTB40:NM_001083621.1:3'UTR:MODIFIER:exon19/19:c.*3712T>C:,ZBTB40:NM_014870.3:3'UTR:MODIFIER:exon18/18:c.*3712T>C:		rs1062663	0.3295	0	0	0										0.1288	0.4848	0.3864	19	73	n/a	n/a
chr1	22965438	22965438	A	G	het		QUAL=374;DP=14;AF=0.64;MQM=60;TRIO=HET,14,0.64,HOM,2,1.00,HET,5,0.60	C1QA	synonymous	C1QA:NM_015991.2:synonymous:LOW:exon3/3:c.276A>G:p.Gly92Gly		rs172378	0.6164	0.468	0.3746	0.71	-0.2960	P	T			120550 [C1QA (confirmed) C1q deficiency];		CM035950 [CLASS=DP MUT=REF PHEN="Subacute cutaneous lupus erythematosus, association with" GENE=C1QA]; 	COSM3721050	0.1439	0.2652	0.5909	68	173	n/a	n/a
chr1	22974534	22974534	T	-	het		QUAL=1677;DP=51;AF=0.39;MQM=59;TRIO=HET,51,0.39,HET,36,0.22,HET,64,0.48	C1QC	3'UTR	C1QC:NM_001114101.1:3'UTR:MODIFIER:exon3/3:c.*273delT:,C1QC:NM_172369.3:3'UTR:MODIFIER:exon3/3:c.*273delT:		rs71020441	0	0	0	0										0	0.2197	0.7803	0	29	n/a	n/a
chr1	22974566	22974566	T	G	het	DP_low	QUAL=78;DP=36;AF=0.25;MQM=57;TRIO=HET,36,0.25,WT,38,0.00,WT,49,0.04	C1QC	3'UTR	C1QC:NM_001114101.1:3'UTR:MODIFIER:exon3/3:c.*290T>G:,C1QC:NM_172369.3:3'UTR:MODIFIER:exon3/3:c.*290T>G:			0	0	0	0										0	0.0682	0.9318	0	14	n/a	n/a
chr1	22987958	22987958	A	G	hom		QUAL=37623;DP=394;AF=1.00;MQM=59;TRIO=HOM,394,1.00,HOM,343,1.00,HOM,449,1.00	C1QB	3'UTR	C1QB:NM_000491.3:3'UTR:MODIFIER:exon3/3:c.*79A>G:		rs10580	0.9914	0	0	0										0.9394	0.0606	0	139	11	n/a	n/a
chr1	24128467	24128467	C	T	hom		QUAL=30743;DP=349;AF=1.00;MQM=59;TRIO=HOM,349,1.00,HET,343,0.50,HOM,428,1.00	HMGCL	3'UTR	HMGCL:NM_000191.2:3'UTR:MODIFIER:exon9/9:c.*486G>A:,HMGCL:NM_001166059.1:3'UTR:MODIFIER:exon7/7:c.*486G>A:		rs11714	0.8834	0	0	0										0.8561	0.1439	0	128	22	n/a	n/a
chr1	24134721	24134721	T	C	hom		QUAL=22317;DP=285;AF=1.00;MQM=60;TRIO=HOM,285,1.00,HET,224,0.53,HOM,284,1.00	HMGCL	synonymous	HMGCL:NM_000191.2:synonymous:LOW:exon7/9:c.654A>G:p.Leu218Leu,HMGCL:NM_001166059.1:synonymous:LOW:exon5/7:c.441A>G:p.Leu147Leu		rs719400	0.8874	0.904	0.9085	0.961	0.8730	P				613898 [HMGCL (provisional) HMG-CoA lyase deficiency];	RCV000078343.2 [benign]; RCV000125367.1 [benign]; 			0.8561	0.1439	0	385	67	n/a	n/a
chr1	24180962	24180962	T	C	het		QUAL=10446;DP=251;AF=0.50;MQM=60;TRIO=HET,251,0.50,WT,209,0.00,HOM,202,1.00	FUCA1	missense	FUCA1:NM_000147.4:missense:MODERATE:exon5/8:c.857A>G:p.Gln286Arg		rs13551	0.2113	0.279	0.3308	0.1459	0.6520	P	D	B	B	612280 [FUCA1 (confirmed) Fucosidosis];	RCV000000726.1 [benign]; 		COSM3746875	0.1061	0.4318	0.4621	31	192	n/a	n/a
chr1	24194770	24194770	C	G	het		QUAL=3360;DP=148;AF=0.48;MQM=59;TRIO=HET,148,0.48,HET,106,0.45,WT,111,0.00	FUCA1	missense	FUCA1:NM_000147.4:missense:MODERATE:exon1/8:c.7G>C:p.Ala3Pro		rs61996282	0.0134	0.0067	0.0025	0.0012	-2.4990	N	T	B	B	612280 [FUCA1 (confirmed) Fucosidosis];				0	0.0076	0.9924	0	8	n/a	n/a
chr1	26131654	26131654	G	A	hom		QUAL=16629;DP=150;AF=1.00;MQM=60;TRIO=HOM,150,1.00,HOM,218,1.00,HET,332,0.52	SEPN1	missense	SEPN1:NM_020451.2:missense:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr,SEPN1:NM_206926.1:missense:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr		rs7349185	0.8419	0.814	0	0	0.9620	P	T	B,B	B,B	606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1|Myopathy,congenital,with fiber-type disproportion];	RCV000082016.3 [benign]; 			0.6288	0.3409	0.0303	286	149	n/a	n/a
chr1	26138262	26138262	T	C	hom		QUAL=26336;DP=221;AF=1.00;MQM=59;TRIO=HOM,221,1.00,HOM,347,1.00,HET,486,0.51	SEPN1	synonymous	SEPN1:NM_020451.2:synonymous:LOW:exon9/13:c.1173T>C:p.Pro391Pro,SEPN1:NM_206926.1:synonymous:LOW:exon8/12:c.1071T>C:p.Pro357Pro		rs760597	0.7919	0.786	0.7881	0.6337						606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1|Myopathy,congenital,with fiber-type disproportion];	RCV000082009.3 [benign]; 		COSM1127046	0.6212	0.3409	0.0379	284	147	n/a	n/a
chr1	26140573	26140573	C	A	hom		QUAL=23036;DP=208;AF=1.00;MQM=60;TRIO=HOM,208,1.00,HOM,315,1.00,HET,434,0.50	SEPN1	missense	SEPN1:NM_020451.2:missense:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys,SEPN1:NM_206926.1:missense:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys		rs2294228	0.6975	0.773	0.7872	0.3241	0.1580	P	T	B,B	B,B	606210 [SEPN1 (confirmed) Muscular dystrophy,rigid spine,1|Myopathy,congenital,with fiber-type disproportion];	RCV000082012.3 [benign]; 		COSM4143697	0.6061	0.3485	0.0455	275	155	n/a	n/a
chr1	26143704	26143704	-	TTTTG	hom		QUAL=10753;DP=125;AF=0.85;MQM=58;TRIO=HOM,125,0.85,HOM,171,1.00,HET,222,0.41	SEPN1	3'UTR	SEPN1:NM_020451.2:3'UTR:MODIFIER:exon13/13:c.*1511_*1515dupTTTTG:,SEPN1:NM_206926.1:3'UTR:MODIFIER:exon12/12:c.*1511_*1515dupTTTTG:		rs397712756	0	0	0	0										0.5379	0.3485	0.1136	82	50	n/a	n/a
chr1	26143821	26143821	T	C	hom		QUAL=17405;DP=239;AF=1.00;MQM=54;TRIO=HOM,239,1.00,HOM,178,0.98,HET,264,0.46	SEPN1	3'UTR	SEPN1:NM_020451.2:3'UTR:MODIFIER:exon13/13:c.*1612T>C:,SEPN1:NM_206926.1:3'UTR:MODIFIER:exon12/12:c.*1612T>C:	AluSx	rs3203750	0.763	0	0	0										0.6136	0.3485	0.0379	95	50	n/a	n/a
chr1	26143931	26143931	T	C	hom		QUAL=23229;DP=327;AF=1.00;MQM=53;TRIO=HOM,327,1.00,HOM,227,1.00,HET,345,0.45	SEPN1	3'UTR	SEPN1:NM_020451.2:3'UTR:MODIFIER:exon13/13:c.*1722T>C:,SEPN1:NM_206926.1:3'UTR:MODIFIER:exon12/12:c.*1722T>C:	AluSx	rs4659383	0.8622	0	0	0										0.6212	0.3409	0.0379	96	49	n/a	n/a
chr1	26144438	26144438	C	-	hom		QUAL=4259;DP=59;AF=0.98;MQM=59;TRIO=HOM,59,0.98,HOM,68,1.00,HET,99,0.58	SEPN1	3'UTR	SEPN1:NM_020451.2:3'UTR:MODIFIER:exon13/13:c.*2236delC:,SEPN1:NM_206926.1:3'UTR:MODIFIER:exon12/12:c.*2236delC:		rs558875165	0	0	0	0										0.6136	0.3485	0.0379	95	50	n/a	n/a
chr1	33245802	33245802	C	G	het		QUAL=11347;DP=251;AF=0.53;MQM=60;TRIO=HET,251,0.53,HET,185,0.62,HET,249,0.45	YARS	synonymous	YARS:NM_003680.3:synonymous:LOW:exon11/13:c.1218G>C:p.Leu406Leu		rs699005	0.0875	0.098	0.1005	0.0956						603623 [YARS (confirmed) Charcot-Marie-Tooth disease,dominant intermediate C];				0	0.1742	0.8258	4	85	n/a	n/a
chr1	33283528	33283528	G	A	het		QUAL=43;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,NONE,0,0,WT,1,0.00	YARS,S100PBP	5'UTR,intron	YARS:NM_003680.3:5'UTR:MODIFIER:exon1/13:c.-683C>T:,S100PBP:NM_001256121.1:intron:MODIFIER:exon1/6:c.-120+328G>A:,S100PBP:NM_022753.3:intron:MODIFIER:exon1/6:c.-120+238G>A:		rs72654022	0.0603	0	0	0										0.0076	0.0076	0.9848	1	1	n/a	n/a
chr1	33475639	33475639	G	A	het		QUAL=4568;DP=707;AF=0.13;MQM=33;TRIO=HET,707,0.13,HET,550,0.23,HET,537,0.12	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*791C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*791C>T:		rs138902451	0	0.107	0	0										0	0.5909	0.4091	0	82	n/a	n/a
chr1	33475650	33475650	T	C	het		QUAL=4608;DP=665;AF=0.13;MQM=33;TRIO=HET,665,0.13,HET,543,0.24,HET,555,0.13	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*780A>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*780A>G:		rs141799861	0	0.124	0	0										0	0.5985	0.4015	0	84	n/a	n/a
chr1	33475687	33475687	C	G	het		QUAL=6456;DP=383;AF=0.11;MQM=33;TRIO=HET,383,0.11,HET,601,0.29,HET,579,0.16	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*743G>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*743G>C:		rs201444233	0	0.081	0	0										0	0.4318	0.5682	0	62	n/a	n/a
chr1	33475721	33475721	G	C	het		QUAL=8210;DP=332;AF=0.11;MQM=34;TRIO=HET,332,0.11,HET,605,0.31,HET,547,0.20	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*709C>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*709C>G:		rs139591926	0	0.13	0	0										0	0.4773	0.5227	0	70	n/a	n/a
chr1	33475750	33475750	A	G	het		QUAL=9108;DP=425;AF=0.12;MQM=39;TRIO=HET,425,0.12,HET,574,0.32,HET,527,0.22	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*680T>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*680T>C:		rs142975905	0	0.349	0	0										0	0.7727	0.2273	0	119	n/a	n/a
chr1	33475767	33475767	G	A	het		QUAL=9249;DP=511;AF=0.14;MQM=40;TRIO=HET,511,0.14,HET,537,0.33,HET,507,0.23	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*663C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*663C>T:		rs74066436	0	0.356	0	0										0	0.9242	0.0758	0	139	n/a	n/a
chr1	33475791	33475791	A	G	het		QUAL=13431;DP=522;AF=0.20;MQM=42;TRIO=HET,522,0.20,HET,603,0.36,HET,522,0.27	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*639T>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*639T>C:		rs6884	0	0.505	0	0										0.0909	0.9091	0	14	136	n/a	n/a
chr1	33475879	33475879	C	T	het		QUAL=13121;DP=574;AF=0.28;MQM=54;TRIO=HET,574,0.28,HET,396,0.41,HET,343,0.31	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*551G>A:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*551G>A:		rs61800917	0	0.374	0	0										0	1	0	1	149	n/a	n/a
chr1	33475967	33475967	G	A	het		QUAL=5004;DP=416;AF=0.23;MQM=48;TRIO=HET,416,0.23,HET,172,0.30,HET,190,0.23	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*463C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*463C>T:		rs74066437	0	0.31	0	0										0	0.9773	0.0227	0	147	n/a	n/a
chr1	33475977	33475977	G	A	het		QUAL=1595;DP=327;AF=0.12;MQM=41;TRIO=HET,327,0.12,HET,147,0.24,HET,153,0.16	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*453C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*453C>T:		rs115408325	0	0.308	0	0										0	0.6818	0.3182	0	105	n/a	n/a
chr1	33475979	33475979	A	G	het		QUAL=1595;DP=327;AF=0.12;MQM=41;TRIO=HET,327,0.12,HET,147,0.24,HET,153,0.16	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*451T>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*451T>C:		rs4045165	0	0.306	0	0										0	0.6591	0.3409	0	102	n/a	n/a
chr1	33475982	33475982	C	A	het		QUAL=1595;DP=327;AF=0.12;MQM=41;TRIO=HET,327,0.12,HET,147,0.24,HET,153,0.16	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*448G>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*448G>T:		rs114902220	0	0.304	0	0										0	0.6439	0.3561	0	100	n/a	n/a
chr1	33476032	33476032	T	C	het		QUAL=1300;DP=231;AF=0.11;MQM=35;TRIO=HET,231,0.11,HET,129,0.22,HET,154,0.16	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*398A>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*398A>G:		rs142912817	0	0.117	0	0										0	0.9167	0.0833	0	138	n/a	n/a
chr1	33476065	33476065	G	A	het		QUAL=2608;DP=321;AF=0.23;MQM=34;TRIO=HET,321,0.23,HET,112,0.21,HET,148,0.12	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*365C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*365C>T:		rs143947377	0	0.326	0	0										0	0.9848	0.0152	0	148	n/a	n/a
chr1	33476074	33476074	A	T	het		QUAL=2715;DP=336;AF=0.23;MQM=33;TRIO=HET,336,0.23,HET,118,0.19,HET,154,0.10	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*356T>A:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*356T>A:		rs199780633	0	0.324	0	0										0	0.9848	0.0152	1	147	n/a	n/a
chr1	33476090	33476090	T	C	het		QUAL=3274;DP=390;AF=0.25;MQM=33;TRIO=HET,390,0.25,HET,118,0.16,HET,154,0.12	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*340A>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*340A>G:		rs140167370	0	0.297	0	0										0	0.9848	0.0152	0	148	n/a	n/a
chr1	33476224	33476225	AC	-	het		QUAL=2633;DP=218;AF=0.27;MQM=46;TRIO=HET,218,0.27,HET,71,0.27,HET,71,0.31	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*205_*206delGT:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*205_*206delGT:		rs67829320	0.4665	0.12	0	0										0	0.9394	0.0606	0	141	n/a	n/a
chr1	33476239	33476239	T	C	het		QUAL=3976;DP=266;AF=0.30;MQM=47;TRIO=HET,266,0.30,HET,71,0.31,HET,77,0.38	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*191A>G:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*191A>G:		rs74066438	0	0.116	0	0										0	0.9697	0.0303	0	146	n/a	n/a
chr1	33476292	33476292	A	G	het		QUAL=6196;DP=266;AF=0.30;MQM=49;TRIO=HET,266,0.30,HET,136,0.49,HET,117,0.45	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*138T>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*138T>C:		rs74066439	0	0.327	0	0									COSN163035	0	0.7803	0.2197	0	117	n/a	n/a
chr1	33476353	33476353	C	T	het		QUAL=4045;DP=232;AF=0.17;MQM=47;TRIO=HET,232,0.17,HET,154,0.42,HET,142,0.32	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*77G>A:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*77G>A:		rs66599471	0	0.285	0	0										0	0.6439	0.3561	0	106	n/a	n/a
chr1	33476385	33476385	C	G	het		QUAL=2614;DP=224;AF=0.20;MQM=47;TRIO=HET,224,0.20,HET,134,0.34,HET,131,0.25	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*45G>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*45G>C:		rs76881767	0	0.196	0	0										0	0.6288	0.3712	0	119	n/a	n/a
chr1	33476387	33476387	C	T	het		QUAL=2614;DP=224;AF=0.20;MQM=47;TRIO=HET,224,0.20,HET,134,0.34,HET,131,0.25	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*43G>A:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*43G>A:		rs201842558	0	0.196	0	0										0	0.6061	0.3939	0	112	n/a	n/a
chr1	33476396	33476396	G	A	het		QUAL=2986;DP=226;AF=0.19;MQM=47;TRIO=HET,226,0.19,HET,132,0.35,HET,135,0.23	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*34C>T:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*34C>T:		rs79824855	0	0.166	0	0										0	0.6364	0.3636	0	113	n/a	n/a
chr1	33476404	33476404	T	G	het		QUAL=2634;DP=216;AF=0.21;MQM=47;TRIO=HET,216,0.21,HET,126,0.31,HET,132,0.23	AK2	3'UTR	AK2:NM_001199199.1:3'UTR:MODIFIER:exon7/7:c.*26A>C:,AK2:NM_013411.4:3'UTR:MODIFIER:exon7/7:c.*26A>C:		rs76230073	0	0.165	0	0										0	0.6515	0.3485	0	114	n/a	n/a
chr1	39492080	39492080	G	T	het		QUAL=4796;DP=84;AF=0.46;MQM=60;TRIO=HET,84,0.46,HOM,78,1.00,HET,107,0.45	NDUFS5	splice_region&intron	NDUFS5:NM_001184979.1:splice_region&intron:LOW:exon1/2:c.-3+10G>T:,NDUFS5:NM_004552.2:splice_region&intron:LOW:exon1/2:c.-3+6G>T:		rs1122472	0.5377	0	0	0										0.5985	0.3333	0.0682	97	54	n/a	n/a
chr1	40539076	40539076	C	T	hom		QUAL=19660;DP=384;AF=1.00;MQM=60;TRIO=HOM,384,1.00,HET,204,0.39,HET,252,0.50	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*657G>A:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*657G>A:		rs1126973	0.6673	0	0	0										0.5455	0.3788	0.0758	78	59	n/a	n/a
chr1	40539203	40539203	-	TGAT	hom		QUAL=19482;DP=296;AF=0.96;MQM=60;TRIO=HOM,296,0.96,HET,351,0.42,HET,442,0.45	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*526_*529dupATCA:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*526_*529dupATCA:		rs397730033	0.614	0	0	0										0.5455	0.3788	0.0758	77	60	n/a	n/a
chr1	40539228	40539228	G	C	hom		QUAL=32315;DP=525;AF=1.00;MQM=59;TRIO=HOM,525,1.00,HET,423,0.46,HET,536,0.48	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*505C>G:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*505C>G:		rs1126972	0.6607	0	0	0										0.5455	0.3788	0.0758	78	60	n/a	n/a
chr1	40539448	40539448	A	C	hom		QUAL=41422;DP=836;AF=1.00;MQM=60;TRIO=HOM,836,1.00,HET,414,0.53,HET,462,0.45	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*285T>G:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*285T>G:		rs1126970	0.6611	0	0	0										0.5455	0.3788	0.0758	78	60	n/a	n/a
chr1	40539572	40539572	A	G	het		QUAL=9331;DP=341;AF=0.46;MQM=60;TRIO=HET,341,0.46,WT,236,0.00,HET,266,0.47	PPT1	3'UTR	PPT1:NM_000310.3:3'UTR:MODIFIER:exon9/9:c.*161T>C:,PPT1:NM_001142604.1:3'UTR:MODIFIER:exon6/6:c.*161T>C:		rs11552578	0.1514	0	0	0										0.0076	0.1591	0.8333	1	24	n/a	n/a
chr1	40557033	40557033	A	G	het		QUAL=11554;DP=421;AF=0.44;MQM=59;TRIO=HET,421,0.44,WT,343,0.00,HET,348,0.49	PPT1	missense,intron	PPT1:NM_000310.3:missense:MODERATE:exon4/9:c.401T>C:p.Ile134Thr,PPT1:NM_001142604.1:intron:MODIFIER:exon1/5:c.125-1849T>C:		rs1800205	0.0739	0.066	0.0474	0.0104	0.5740	P	T	B,B	B,B	600722 [PPT1 (confirmed) Ceroid lipofuscinosis,neuronal,1];	RCV000118047.2 [likely benign]; RCV000127595.1 [benign]; 		COSM3751190	0.0076	0.0833	0.9091	2	46	n/a	n/a
chr1	40562993	40562993	T	C	hom		QUAL=5930;DP=33;AF=1.00;MQM=59;TRIO=HOM,33,1.00,HOM,62,1.00,HOM,100,1.00	PPT1	5'UTR	PPT1:NM_000310.3:5'UTR:MODIFIER:exon1/9:c.-83A>G:,PPT1:NM_001142604.1:5'UTR:MODIFIER:exon1/6:c.-83A>G:		rs6600313	0.8327	0	0	0										0.7803	0.197	0.0227	116	29	n/a	n/a
chr1	40563019	40563019	G	T	het		QUAL=1866;DP=29;AF=0.59;MQM=60;TRIO=HET,29,0.59,WT,50,0.02,HET,85,0.52	PPT1	5'UTR	PPT1:NM_000310.3:5'UTR:MODIFIER:exon1/9:c.-109C>A:,PPT1:NM_001142604.1:5'UTR:MODIFIER:exon1/6:c.-109C>A:		rs41301070	0.1138	0	0	0										0.0076	0.0833	0.9091	1	12	n/a	n/a
chr1	43199024	43199024	C	T	het		QUAL=8117;DP=211;AF=0.49;MQM=59;TRIO=HET,211,0.49,WT,251,0.00,HET,329,0.51	CLDN19	3'UTR	CLDN19:NM_148960.2:3'UTR:MODIFIER:exon5/5:c.*1733G>A:,CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*2515G>A:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*2409G>A:	AluSx1	rs112310775	0.1254	0	0	0										0.0152	0.2652	0.7197	2	41	n/a	n/a
chr1	43199115	43199115	A	G	het		QUAL=13338;DP=398;AF=0.48;MQM=60;TRIO=HET,398,0.48,WT,350,0.00,HET,441,0.50	CLDN19	3'UTR	CLDN19:NM_148960.2:3'UTR:MODIFIER:exon5/5:c.*1642T>C:,CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*2424T>C:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*2318T>C:		rs56345167	0.1907	0	0	0										0.0455	0.2955	0.6591	6	47	n/a	n/a
chr1	43200526	43200526	T	C	het		QUAL=6254;DP=134;AF=0.50;MQM=59;TRIO=HET,134,0.50,HET,127,0.43,HET,142,0.51	CLDN19	3'UTR	CLDN19:NM_148960.2:3'UTR:MODIFIER:exon5/5:c.*231A>G:,CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*1013A>G:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*907A>G:		rs912075	0.6068	0	0	0										0.3258	0.4773	0.197	50	73	n/a	n/a
chr1	43200855	43200855	G	A	het		QUAL=8917;DP=121;AF=0.52;MQM=59;TRIO=HET,121,0.52,HET,208,0.55,HET,246,0.46	CLDN19	3'UTR,intron	CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*684C>T:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*578C>T:,CLDN19:NM_148960.2:intron:MODIFIER:exon4/4:c.627-50C>T:		rs74885359	0.0387	0.096	0.1379	0.0302						610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement];				0.0076	0.2652	0.7273	1	43	n/a	n/a
chr1	43201216	43201216	A	C	het		QUAL=12983;DP=189;AF=0.47;MQM=60;TRIO=HET,189,0.47,HET,283,0.49,HET,353,0.49	CLDN19	3'UTR,intron	CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*323T>G:,CLDN19:NM_001185117.1:3'UTR:MODIFIER:exon3/3:c.*217T>G:,CLDN19:NM_148960.2:intron:MODIFIER:exon4/4:c.626+333T>G:	L2b	rs12141833	0.5569	0	0	0						610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement];				0.3258	0.4773	0.197	50	73	n/a	n/a
chr1	43201534	43201534	G	A	het		QUAL=4889;DP=82;AF=0.43;MQM=60;TRIO=HET,82,0.43,WT,174,0.01,HET,238,0.55	CLDN19	missense,splice_region&intron,3'UTR	CLDN19:NM_001185117.1:missense:MODERATE:exon3/3:c.556C>T:p.Arg186Cys,CLDN19:NM_148960.2:splice_region&intron:LOW:exon4/4:c.626+15C>T:,CLDN19:NM_001123395.1:3'UTR:MODIFIER:exon4/4:c.*5C>T:		rs4660658	0.1905	0.139	0.1608	0.2228	-1.1650	P	T	B	B	610036 [CLDN19 (confirmed) Hypomagnesemia 5,renal,with ocular involvement];			COSM3746967	0.0455	0.2955	0.6591	22	113	n/a	n/a
chr1	43212111	43212111	C	T	het		QUAL=11111;DP=301;AF=0.48;MQM=59;TRIO=HET,301,0.48,HET,178,0.54,HET,205,0.48	LEPRE1	3'UTR	LEPRE1:NM_001243246.1:3'UTR:MODIFIER:exon14/14:c.*472G>A:,LEPRE1:NM_001146289.1:3'UTR:MODIFIER:exon15/15:c.*393G>A:,LEPRE1:NM_022356.3:3'UTR:MODIFIER:exon15/15:c.*257G>A:		rs6882	0.6625	0	0	0										0.3939	0.4773	0.1288	62	70	n/a	n/a
chr1	43212431	43212431	A	G	hom		QUAL=23285;DP=215;AF=1.00;MQM=59;TRIO=HOM,215,1.00,HOM,208,1.00,HOM,339,1.00	LEPRE1	synonymous,3'UTR	LEPRE1:NM_022356.3:synonymous:LOW:exon15/15:c.2148T>C:p.Gly716Gly,LEPRE1:NM_001243246.1:3'UTR:MODIFIER:exon14/14:c.*152T>C:,LEPRE1:NM_001146289.1:3'UTR:MODIFIER:exon15/15:c.*73T>C:		rs4660662	1	0.999	0	0						610339 [LEPRE1 (confirmed) Osteogenesis imperfecta,type VIII];				1	0	0	454	0	n/a	n/a
chr1	43212869	43212869	A	T	het		QUAL=3666;DP=110;AF=0.48;MQM=60;TRIO=HET,110,0.48,WT,74,0.00,HET,126,0.50	LEPRE1	missense,intron	LEPRE1:NM_001243246.1:missense:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr,LEPRE1:NM_001146289.1:intron:MODIFIER:exon14/14:c.2074+55T>A:,LEPRE1:NM_022356.3:intron:MODIFIER:exon14/14:c.2055+74T>A:		rs3738496	0.121	0.123	0.1226	0.0715	-0.0100	P	D	B	B	610339 [LEPRE1 (confirmed) Osteogenesis imperfecta,type VIII];				0.0152	0.2652	0.7197	9	100	n/a	n/a
chr1	43408966	43408966	G	A	het		QUAL=9217;DP=287;AF=0.43;MQM=60;TRIO=HET,287,0.43,HET,344,0.52,WT,488,0.00	SLC2A1	synonymous	SLC2A1:NM_006516.2:synonymous:LOW:exon2/10:c.45C>T:p.Ala15Ala		rs1385129	0.2404	0.239	0.2155	0.1752						138140 [SLC2A1 (confirmed) GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 2|Epilepsy,idiopathic generalized,suscpetibility to,12|Dystonia 9];	RCV000081435.3 [benign]; 		COSM3751208	0.0455	0.3788	0.5758	41	300	n/a	n/a
chr1	44290530	44290530	A	G	het		QUAL=8913;DP=261;AF=0.45;MQM=60;TRIO=HET,261,0.45,HET,115,0.42,HOM,112,0.98	ST3GAL3	missense,intron	ST3GAL3:NM_174963.3:missense:MODERATE:exon5/13:c.382A>G:p.Thr128Ala,ST3GAL3:NM_174968.3:missense:MODERATE:exon5/13:c.337A>G:p.Thr113Ala,ST3GAL3:NM_174971.3:missense:MODERATE:exon4/12:c.289A>G:p.Thr97Ala,ST3GAL3:NM_001270459.1:intron:MODIFIER:exon4/11:c.209+9925A>G:,ST3GAL3:NM_001270460.1:intron:MODIFIER:exon4/10:c.209+9925A>G:,ST3GAL3:NM_001270461.1:intron:MODIFIER:exon3/8:c.161+9925A>G:,ST3GAL3:NM_001270462.1:intron:MODIFIER:exon3/7:c.161+9925A>G:,ST3GAL3:NM_001270463.1:intron:MODIFIER:exon3/7:c.206+9925A>G:,ST3GAL3:NM_001270464.1:intron:MODIFIER:exon3/7:c.161+9925A>G:,ST3GAL3:NM_001270465.1:intron:MODIFIER:exon3/7:c.206+9925A>G:,ST3GAL3:NM_001270466.1:intron:MODIFIER:exon3/4:c.161+9925A>G:,ST3GAL3:NM_006279.3:intron:MODIFIER:exon4/11:c.209+9925A>G:,ST3GAL3:NM_174964.2:intron:MODIFIER:exon4/11:c.254+9925A>G:,ST3GAL3:NM_174965.2:intron:MODIFIER:exon4/6:c.254+9925A>G:,ST3GAL3:NM_174966.2:intron:MODIFIER:exon4/9:c.209+9925A>G:,ST3GAL3:NM_174967.2:intron:MODIFIER:exon4/6:c.209+9925A>G:,ST3GAL3:NM_174969.2:intron:MODIFIER:exon3/10:c.161+9925A>G:,ST3GAL3:NM_174970.2:intron:MODIFIER:exon3/5:c.161+9925A>G:	MER5B	rs37458	0.2364	0.271	0.3486	0.3093	-0.1510	P	T	B,B,B	B,B,B	606494 [ST3GAL3 (provisional) Mental retardation,autosomal recessive 12|Epileptic encephalopathy,early infantile,15];	RCV000118418.2 [likely benign]; 		COSM3751230	0.1136	0.5606	0.3258	57	249	n/a	n/a
chr1	44396196	44396196	A	G	het		QUAL=4006;DP=156;AF=0.44;MQM=60;TRIO=HET,156,0.44,WT,74,0.00,HET,118,0.49	ST3GAL3	3'UTR	ST3GAL3:NM_174963.3:3'UTR:MODIFIER:exon13/13:c.*303A>G:,ST3GAL3:NM_001270459.1:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:NM_001270460.1:3'UTR:MODIFIER:exon11/11:c.*303A>G:,ST3GAL3:NM_001270461.1:3'UTR:MODIFIER:exon9/9:c.*303A>G:,ST3GAL3:NM_001270462.1:3'UTR:MODIFIER:exon8/8:c.*303A>G:,ST3GAL3:NM_001270463.1:3'UTR:MODIFIER:exon8/8:c.*341A>G:,ST3GAL3:NM_001270464.1:3'UTR:MODIFIER:exon8/8:c.*341A>G:,ST3GAL3:NM_001270465.1:3'UTR:MODIFIER:exon8/8:c.*415A>G:,ST3GAL3:NM_001270466.1:3'UTR:MODIFIER:exon5/5:c.*341A>G:,ST3GAL3:NM_006279.3:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:NM_174964.2:3'UTR:MODIFIER:exon12/12:c.*303A>G:,ST3GAL3:NM_174965.2:3'UTR:MODIFIER:exon7/7:c.*322A>G:,ST3GAL3:NM_174966.2:3'UTR:MODIFIER:exon10/10:c.*303A>G:,ST3GAL3:NM_174967.2:3'UTR:MODIFIER:exon7/7:c.*322A>G:,ST3GAL3:NM_174968.3:3'UTR:MODIFIER:exon13/13:c.*303A>G:,ST3GAL3:NM_174969.2:3'UTR:MODIFIER:exon11/11:c.*303A>G:,ST3GAL3:NM_174970.2:3'UTR:MODIFIER:exon6/6:c.*322A>G:,ST3GAL3:NM_174971.3:3'UTR:MODIFIER:exon12/12:c.*303A>G:		rs12561948	0.0507	0	0	0										0	0.1136	0.8864	0	17	n/a	n/a
chr1	44396646	44396646	C	G	het		QUAL=14957;DP=227;AF=0.48;MQM=59;TRIO=HET,227,0.48,HOM,220,1.00,HET,264,0.54	ST3GAL3	3'UTR	ST3GAL3:NM_174963.3:3'UTR:MODIFIER:exon13/13:c.*753C>G:,ST3GAL3:NM_001270459.1:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:NM_001270460.1:3'UTR:MODIFIER:exon11/11:c.*753C>G:,ST3GAL3:NM_001270461.1:3'UTR:MODIFIER:exon9/9:c.*753C>G:,ST3GAL3:NM_001270462.1:3'UTR:MODIFIER:exon8/8:c.*753C>G:,ST3GAL3:NM_001270463.1:3'UTR:MODIFIER:exon8/8:c.*791C>G:,ST3GAL3:NM_001270464.1:3'UTR:MODIFIER:exon8/8:c.*791C>G:,ST3GAL3:NM_001270465.1:3'UTR:MODIFIER:exon8/8:c.*865C>G:,ST3GAL3:NM_001270466.1:3'UTR:MODIFIER:exon5/5:c.*791C>G:,ST3GAL3:NM_006279.3:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:NM_174964.2:3'UTR:MODIFIER:exon12/12:c.*753C>G:,ST3GAL3:NM_174965.2:3'UTR:MODIFIER:exon7/7:c.*772C>G:,ST3GAL3:NM_174966.2:3'UTR:MODIFIER:exon10/10:c.*753C>G:,ST3GAL3:NM_174967.2:3'UTR:MODIFIER:exon7/7:c.*772C>G:,ST3GAL3:NM_174968.3:3'UTR:MODIFIER:exon13/13:c.*753C>G:,ST3GAL3:NM_174969.2:3'UTR:MODIFIER:exon11/11:c.*753C>G:,ST3GAL3:NM_174970.2:3'UTR:MODIFIER:exon6/6:c.*772C>G:,ST3GAL3:NM_174971.3:3'UTR:MODIFIER:exon12/12:c.*753C>G:		rs6801	0.5188	0	0	0										0.5379	0.4091	0.053	79	64	n/a	n/a
chr1	45285648	45285648	C	T	hom		QUAL=20920;DP=508;AF=1.00;MQM=59;TRIO=HOM,508,1.00,HET,164,0.54,HET,174,0.49	PTCH2	3'UTR	PTCH2:NM_001166292.1:3'UTR:MODIFIER:exon23/23:c.*713G>A:	U5	rs41269085	0.229	0	0	0										0.0303	0.2197	0.75	5	31	n/a	n/a
chr1	45292866	45292866	G	A	hom		QUAL=9784;DP=150;AF=0.99;MQM=59;TRIO=HOM,150,0.99,HET,146,0.50,HET,203,0.50	PTCH2	synonymous	PTCH2:NM_003738.4:synonymous:LOW:exon16/22:c.2487C>T:p.Asp829Asp,PTCH2:NM_001166292.1:synonymous:LOW:exon16/23:c.2487C>T:p.Asp829Asp		rs2295996	0.1478	0.161	0.167	0.0858						603673 [PTCH2 (provisional) Medulloblastoma|Basal cell carcinoma,somatic|Basal cell nevus syndrome];			COSM3751243	0.0303	0.2197	0.75	15	107	n/a	n/a
chr1	45293518	45293518	A	G	hom		QUAL=14820;DP=196;AF=0.99;MQM=60;TRIO=HOM,196,0.99,HET,265,0.48,HET,320,0.48	PTCH2	synonymous	PTCH2:NM_003738.4:synonymous:LOW:exon14/22:c.2055T>C:p.Ala685Ala,PTCH2:NM_001166292.1:synonymous:LOW:exon14/23:c.2055T>C:p.Ala685Ala		rs7525308	0.4455	0.383	0.3423	0.5847						603673 [PTCH2 (provisional) Medulloblastoma|Basal cell carcinoma,somatic|Basal cell nevus syndrome];			COSM3751244	0.1136	0.3939	0.4924	48	187	n/a	n/a
chr1	45340282	45340282	C	T	hom		QUAL=22331;DP=401;AF=1.00;MQM=60;TRIO=HOM,401,1.00,HET,251,0.48,HET,313,0.48	EIF2B3	3'UTR,intron	EIF2B3:NM_001166588.2:3'UTR:MODIFIER:exon10/10:c.*31G>A:,EIF2B3:NM_020365.4:intron:MODIFIER:exon10/11:c.1202+68G>A:,EIF2B3:NM_001261418.1:intron:MODIFIER:exon10/10:c.1202+68G>A:	HAL1	rs9988451	0.4517	0.395	0.3466	0.5882						606273 [EIF2B3 (provisional) Leukoencephalopathy with vanishing white matter];				0.1136	0.3939	0.4924	16	67	n/a	n/a
chr1	45452227	45452227	G	C	hom		QUAL=7678;DP=126;AF=1.00;MQM=60;TRIO=HOM,126,1.00,HET,106,0.42,HET,182,0.42	EIF2B3	5'UTR	EIF2B3:NM_020365.4:5'UTR:MODIFIER:exon1/12:c.-72C>G:,EIF2B3:NM_001261418.1:5'UTR:MODIFIER:exon1/11:c.-72C>G:,EIF2B3:NM_001166588.2:5'UTR:MODIFIER:exon1/10:c.-72C>G:		rs489676	0.4806	0	0	0										0.1894	0.4091	0.4015	30	62	n/a	n/a
chr1	46164399	46164399	T	C	het		QUAL=203;DP=8;AF=0.88;MQM=60;TRIO=HET,8,0.88,NONE,0,0,HOM,2,1.00	IPP	intron	IPP:NM_001145349.1:intron:MODIFIER:exon9/9:c.1651+1343A>G:	AluJb		0	0	0	0										0.0076	0.0455	0.947	1	6	n/a	n/a
chr1	46164846	46164846	A	T	hom		QUAL=21456;DP=301;AF=0.99;MQM=60;TRIO=HOM,301,0.99,HET,179,0.47,HOM,296,1.00	IPP	3'UTR,intron	IPP:NM_005897.2:3'UTR:MODIFIER:exon9/9:c.*792T>A:,IPP:NM_001145349.1:intron:MODIFIER:exon9/9:c.1651+896T>A:		rs10749856	0.3249	0	0	0										0.1061	0.4545	0.4394	16	70	n/a	n/a
chr1	46195375	46195375	T	C	hom		QUAL=10734;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HET,60,0.57,HOM,65,0.97	IPP	missense	IPP:NM_005897.2:missense:MODERATE:exon4/9:c.791A>G:p.Lys264Arg,IPP:NM_001145349.1:missense:MODERATE:exon4/10:c.791A>G:p.Lys264Arg		rs28375469	0.3149	0.304	0.296	0.2469	7.6230	P	D	B,B	B,B				COSM3751253	0.0985	0.4545	0.447	35	135	n/a	n/a
chr1	46655158	46655158	T	C	hom		QUAL=12679;DP=137;AF=1.00;MQM=60;TRIO=HOM,137,1.00,HOM,142,1.00,HOM,128,1.00	POMGNT1	missense&splice_region,missense	POMGNT1:NM_001243766.1:missense&splice_region:MODERATE:exon21/23:c.1867A>G:p.Met623Val,POMGNT1:NM_001290129.1:missense:MODERATE:exon20/22:c.1801A>G:p.Met601Val,POMGNT1:NM_001290130.1:missense:MODERATE:exon20/22:c.1438A>G:p.Met480Val,POMGNT1:NM_017739.3:missense:MODERATE:exon21/22:c.1867A>G:p.Met623Val		rs6659553	0.9425	0.984	0.9994	0.8277	5.7560	P	T	B,B,B	B,B,B	606822 [POMGNT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3];	RCV000153758.1 [benign]; 			1	0	0	454	0	n/a	n/a
chr1	46660295	46660295	T	C	hom		QUAL=18246;DP=249;AF=1.00;MQM=59;TRIO=HOM,249,1.00,HOM,199,0.99,HET,299,0.44	POMGNT1	synonymous	POMGNT1:NM_001243766.1:synonymous:LOW:exon8/23:c.681A>G:p.Lys227Lys,POMGNT1:NM_001290129.1:synonymous:LOW:exon7/22:c.615A>G:p.Lys205Lys,POMGNT1:NM_001290130.1:synonymous:LOW:exon7/22:c.252A>G:p.Lys84Lys,POMGNT1:NM_017739.3:synonymous:LOW:exon8/22:c.681A>G:p.Lys227Lys		rs2292487	0.3335	0.355	0.3488	0.3513	0.5750	P	T			606822 [POMGNT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3];	RCV000081805.4 [other]; 		COSM3751254	0.0985	0.5227	0.3788	66	203	n/a	n/a
chr1	47716041	47716042	AA	-	het		QUAL=5721;DP=244;AF=0.41;MQM=55;TRIO=HET,244,0.41,HET,173,0.48,WT,176,0.00	STIL	3'UTR	STIL:NM_001048166.1:3'UTR:MODIFIER:exon17/17:c.*766_*767delTT:,STIL:NM_001282936.1:3'UTR:MODIFIER:exon18/18:c.*766_*767delTT:,STIL:NM_001282937.1:3'UTR:MODIFIER:exon18/18:c.*766_*767delTT:,STIL:NM_001282938.1:3'UTR:MODIFIER:exon19/19:c.*766_*767delTT:,STIL:NM_001282939.1:3'UTR:MODIFIER:exon19/19:c.*766_*767delTT:,STIL:NM_003035.2:3'UTR:MODIFIER:exon17/17:c.*766_*767delTT:		rs398089260	0.3926	0	0	0										0.2955	0.4697	0.2348	48	70	n/a	n/a
chr1	47717189	47717189	A	G	het		QUAL=10309;DP=439;AF=0.49;MQM=60;TRIO=HET,439,0.49,HET,230,0.40,WT,305,0.01	STIL	synonymous	STIL:NM_001048166.1:synonymous:LOW:exon17/17:c.3486T>C:p.Pro1162Pro,STIL:NM_001282936.1:synonymous:LOW:exon18/18:c.3483T>C:p.Pro1161Pro,STIL:NM_001282937.1:synonymous:LOW:exon18/18:c.3432T>C:p.Pro1144Pro,STIL:NM_001282938.1:synonymous:LOW:exon19/19:c.3345T>C:p.Pro1115Pro,STIL:NM_001282939.1:synonymous:LOW:exon19/19:c.3291T>C:p.Pro1097Pro,STIL:NM_003035.2:synonymous:LOW:exon17/17:c.3483T>C:p.Pro1161Pro		rs2758735	0.3934	0.498	0.525	0.1811						181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive];	RCV000147697.1,RCV000080044.3 [benign,benign]; RCV000128291.1 [benign]; 			0.2955	0.4697	0.2348	120	229	n/a	n/a
chr1	47726087	47726087	T	C	het		QUAL=7901;DP=209;AF=0.51;MQM=60;TRIO=HET,209,0.51,HET,117,0.47,HET,175,0.47	STIL	missense	STIL:NM_001048166.1:missense:MODERATE:exon16/17:c.2954A>G:p.His985Arg,STIL:NM_001282936.1:missense:MODERATE:exon17/18:c.2951A>G:p.His984Arg,STIL:NM_001282937.1:missense:MODERATE:exon17/18:c.2900A>G:p.His967Arg,STIL:NM_001282938.1:missense:MODERATE:exon18/19:c.2813A>G:p.His938Arg,STIL:NM_001282939.1:missense:MODERATE:exon18/19:c.2759A>G:p.His920Arg,STIL:NM_003035.2:missense:MODERATE:exon16/17:c.2951A>G:p.His984Arg		rs13376679	0.1783	0.242	0.3151	0.2192	0.0410	P	T	B,B,B	B,B,B	181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive];	RCV000080043.3 [benign]; 		COSM4144058	0.0833	0.4773	0.4394	52	184	n/a	n/a
chr1	47767914	47767914	G	A	het		QUAL=15025;DP=244;AF=0.52;MQM=60;TRIO=HET,244,0.52,HET,185,0.54,HOM,257,0.99	STIL	missense	STIL:NM_001048166.1:missense:MODERATE:exon4/17:c.257C>T:p.Ala86Val,STIL:NM_001282936.1:missense:MODERATE:exon5/18:c.257C>T:p.Ala86Val,STIL:NM_001282937.1:missense:MODERATE:exon5/18:c.257C>T:p.Ala86Val,STIL:NM_001282938.1:missense:MODERATE:exon5/19:c.257C>T:p.Ala86Val,STIL:NM_001282939.1:missense:MODERATE:exon5/19:c.257C>T:p.Ala86Val,STIL:NM_003035.2:missense:MODERATE:exon4/17:c.257C>T:p.Ala86Val		rs3125630	0.6064	0.502	0.477	0.8198	5.1820	P	T	B,B,B,B	B,B,B,B	181590 [STIL (confirmed) Microcephaly 7,primary,autosomal recessive];	RCV000020526.1 [benign]; RCV000147687.1 [likely benign]; 			0.25	0.4545	0.2955	107	227	n/a	n/a
chr1	51066088	51066088	T	C	het		QUAL=4392;DP=166;AF=0.43;MQM=60;TRIO=HET,166,0.43,HET,136,0.48,WT,172,0.00	FAF1	intron	FAF1:NM_007051.2:intron:MODIFIER:exon8/18:c.745-4200A>G:	Charlie1a	rs6679854	0.1695	0	0	0										0.0682	0.4167	0.5152	12	63	n/a	n/a
chr1	53676448	53676448	G	A	het		QUAL=11736;DP=275;AF=0.51;MQM=60;TRIO=HET,275,0.51,WT,212,0.00,HOM,229,1.00	CPT2	missense	CPT2:NM_000098.2:missense:MODERATE:exon4/5:c.1102G>A:p.Val368Ile		rs1799821	0.4131	0.483	0.5416	0.2901	-0.0540	P	T	B	B	600650 [CPT2 (confirmed) Myopathy due to CPT II deficiency|CPT deficiency,hepatic,type II|CPT II deficiency,lethal neonatal|Encephalopathy,acute,infection-induced,4,susceptibility to];	RCV000023026.1 [other]; RCV000078116.2 [benign]; RCV000124601.1 [benign]; 	CM139511 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 2 deficiency" GENE=CPT2]; 	COSM3751293	0.3106	0.4167	0.2727	126	202	2	n/a
chr1	53679229	53679229	A	G	het		QUAL=7494;DP=260;AF=0.47;MQM=60;TRIO=HET,260,0.47,WT,177,0.00,HET,237,0.46	CPT2	missense	CPT2:NM_000098.2:missense:MODERATE:exon5/5:c.1939A>G:p.Met647Val		rs1799822	0.1004	0.162	0.2252	0.0545	7.4450	P	T	B	B	600650 [CPT2 (confirmed) Myopathy due to CPT II deficiency|CPT deficiency,hepatic,type II|CPT II deficiency,lethal neonatal|Encephalopathy,acute,infection-induced,4,susceptibility to];	RCV000078120.2 [benign]; RCV000124602.1 [benign]; 		COSM3751294	0.0379	0.3485	0.6136	22	142	n/a	n/a
chr1	55315351	55315351	T	C	hom		QUAL=17179;DP=246;AF=1.00;MQM=59;TRIO=HOM,246,1.00,HOM,128,1.00,HOM,157,1.00	DHCR24	3'UTR	DHCR24:NM_014762.3:3'UTR:MODIFIER:exon9/9:c.*2555A>G:		rs657688	0.9998	0	0	0										1	0	0	150	0	n/a	n/a
chr1	55315941	55315941	G	T	het		QUAL=12966;DP=442;AF=0.47;MQM=60;TRIO=HET,442,0.47,WT,313,0.00,HET,384,0.50	DHCR24	3'UTR	DHCR24:NM_014762.3:3'UTR:MODIFIER:exon9/9:c.*1965C>A:		rs11555500	0.0102	0	0	0										0	0.0606	0.9394	0	8	n/a	n/a
chr1	55316082	55316082	A	C	hom		QUAL=25091;DP=317;AF=1.00;MQM=60;TRIO=HOM,317,1.00,HOM,189,1.00,HOM,255,1.00	DHCR24	3'UTR	DHCR24:NM_014762.3:3'UTR:MODIFIER:exon9/9:c.*1824T>G:		rs654561	0.9832	0	0	0										1	0	0	150	0	n/a	n/a
chr1	55319902	55319902	A	G	hom		QUAL=601;DP=7;AF=1.00;MQM=60;TRIO=HOM,7,1.00,HOM,3,1.00,HOM,9,1.00	DHCR24	synonymous	DHCR24:NM_014762.3:synonymous:LOW:exon7/9:c.1026T>C:p.Ile342Ile		rs718265	0.6276	0.664	0.6933	0.6133						606418 [DHCR24 (confirmed) Desmosterolosis];			COSM4144102	0.4242	0.3485	0.2273	200	183	n/a	n/a
chr1	55464743	55464743	T	C	hom		QUAL=37304;DP=337;AF=0.99;MQM=59;TRIO=HOM,337,0.99,HOM,527,1.00,HET,645,0.49	BSND	5'UTR	BSND:NM_057176.2:5'UTR:MODIFIER:exon1/4:c.-117T>C:		rs2500340	0.5941	0	0	0										0.5909	0.3182	0.0909	88	50	n/a	n/a
chr1	55464790	55464790	C	G	hom		QUAL=39444;DP=318;AF=0.99;MQM=60;TRIO=HOM,318,0.99,HOM,565,1.00,HET,752,0.49	BSND	5'UTR_premature_start_codon_gain,5'UTR	BSND:NM_057176.2:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-70C>G:,BSND:NM_057176.2:5'UTR:MODIFIER:exon1/4:c.-70C>G:		rs2500341	0.595	0	0	0										0.5909	0.3182	0.0909	88	50	n/a	n/a
chr1	55474325	55474325	A	C	het		QUAL=19272;DP=298;AF=0.55;MQM=59;TRIO=HET,298,0.55,WT,322,0.01,HOM,449,1.00	BSND	3'UTR	BSND:NM_057176.2:3'UTR:MODIFIER:exon4/4:c.*24A>C:		rs6682884	0.3624	0.375	0.422	0.4943										0.1439	0.4015	0.4545	25	70	n/a	n/a
chr1	57340727	57340727	C	A	het		QUAL=6138;DP=133;AF=0.43;MQM=60;TRIO=HET,133,0.43,HOM,140,0.99,WT,209,0.00	C8A	missense	C8A:NM_000562.2:missense:MODERATE:exon3/11:c.277C>A:p.Gln93Lys		rs652785	0.3437	0.368	0.3766	0.2122	0.1090	P	T	B	B	120950 [C8A (confirmed) C8 deficiency,type I];	RCV000018567.1 [benign]; 			0.1818	0.4621	0.3561	87	206	n/a	n/a
chr1	57395020	57395020	A	G	het		QUAL=17300;DP=528;AF=0.52;MQM=60;TRIO=HET,528,0.52,HET,528,0.49,WT,777,0.00	C8B	3'UTR	C8B:NM_000066.3:3'UTR:MODIFIER:exon12/12:c.*57T>C:,C8B:NM_001278543.1:3'UTR:MODIFIER:exon13/13:c.*57T>C:,C8B:NM_001278544.1:3'UTR:MODIFIER:exon13/13:c.*57T>C:		rs2795	0.3672	0	0	0										0.1439	0.3939	0.4621	22	61	n/a	n/a
chr1	57422484	57422484	C	T	hom		QUAL=26219;DP=293;AF=1.00;MQM=60;TRIO=HOM,293,1.00,HOM,246,1.00,HOM,265,1.00	C8B	missense	C8B:NM_000066.3:missense:MODERATE:exon3/12:c.349G>A:p.Gly117Arg,C8B:NM_001278543.1:missense:MODERATE:exon4/13:c.193G>A:p.Gly65Arg,C8B:NM_001278544.1:missense:MODERATE:exon4/13:c.163G>A:p.Gly55Arg		rs1013579	0.9864	0.977	0.9672	0.9925	0.5350	P	T	B,B	B,B	120960 [C8B (confirmed) C8 deficiency,type II];				0.9924	0.0076	0	435	18	n/a	n/a
chr1	63881552	63881552	C	T	het		QUAL=8346;DP=250;AF=0.57;MQM=60;TRIO=HET,250,0.57,HET,64,0.44,HOM,87,1.00	ALG6	missense	ALG6:NM_013339.3:missense:MODERATE:exon11/15:c.911C>T:p.Ser304Phe		rs4630153	0.8305	0.75	0.6761	0.8558	0.9670	P	T	B	B	604566 [ALG6 (provisional) Congenital disorder of glycosylation,type Ic];	RCV000081560.4 [other]; 	CM001812 [CLASS=DFP MUT=REF PHEN="Congenital disorder of glycosylation 1c, mild" GENE=ALG6]; 		0.553	0.3864	0.0606	622	410	2	n/a
chr1	63903452	63903452	T	C	het		QUAL=2432;DP=96;AF=0.53;MQM=60;TRIO=HET,96,0.53,HET,14,0.57,HOM,21,1.00	ALG6	3'UTR	ALG6:NM_013339.3:3'UTR:MODIFIER:exon15/15:c.*761T>C:		rs3009572	0.6847	0	0	0										0.303	0.5227	0.1742	49	74	n/a	n/a
chr1	67465988	67465988	A	T	het		QUAL=1049;DP=62;AF=0.48;MQM=59;TRIO=HET,62,0.48,HET,9,0.78,HET,20,0.20	SLC35D1	3'UTR	SLC35D1:NM_015139.2:3'UTR:MODIFIER:exon12/12:c.*4035T>A:	AT_rich	rs7540819	0	0	0	0										0.053	0.5909	0.3561	8	83	n/a	n/a
chr1	67520060	67520061	CA	-	het		QUAL=518;DP=24;AF=0.42;MQM=59;TRIO=HET,24,0.42,HET,8,0.50,HOM,10,1.00	SLC35D1	5'UTR	SLC35D1:NM_015139.2:5'UTR:MODIFIER:exon1/12:c.-365_-364delTG:		rs397707349	0.6562	0	0	0										0.3409	0.3788	0.2803	54	54	n/a	n/a
chr1	67520083	67520083	C	T	het		QUAL=233;DP=11;AF=0.82;MQM=60;TRIO=HET,11,0.82,HET,6,0.50,WT,7,0.00					rs3806321	0.1567	0	0	0										0.0379	0.1818	0.7803	5	29	n/a	n/a
chr1	76190216	76190216	G	A	hom		QUAL=2820;DP=17;AF=0.94;MQM=60;TRIO=HOM,17,0.94,HET,76,0.49,HET,106,0.45	ACADM	5'UTR	ACADM:NM_001286043.1:5'UTR:MODIFIER:exon1/13:c.-257G>A:,ACADM:NM_000016.5:5'UTR:MODIFIER:exon1/12:c.-257G>A:,ACADM:NM_001127328.2:5'UTR:MODIFIER:exon1/12:c.-257G>A:,ACADM:NM_001286042.1:5'UTR:MODIFIER:exon1/11:c.-277G>A:,ACADM:NM_001286044.1:5'UTR:MODIFIER:exon1/9:c.-554G>A:		rs17848068	0.2043	0	0	0										0.1136	0.4015	0.4848	17	60	n/a	n/a
chr1	92940411	92940411	C	T	het		QUAL=7465;DP=277;AF=0.55;MQM=60;TRIO=HET,277,0.55,WT,118,0.00,HET,164,0.49	GFI1	3'UTR	GFI1:NM_001127215.1:3'UTR:MODIFIER:exon7/7:c.*1175G>A:,GFI1:NM_001127216.1:3'UTR:MODIFIER:exon7/7:c.*1175G>A:,GFI1:NM_005263.3:3'UTR:MODIFIER:exon7/7:c.*1175G>A:		rs41313373	0.0673	0	0	0										0.0076	0.2652	0.7273	1	38	n/a	n/a
chr1	92944327	92944332	AGAGAG	-	hom		QUAL=4702;DP=34;AF=0.00;MQM=60;TRIO=HOM,34,0.00,HET,85,0.21,HET,129,0.38	GFI1	splice_region&intron	GFI1:NM_001127215.1:splice_region&intron:LOW:exon5/6:c.925-22_925-17delCTCTCT:,GFI1:NM_001127216.1:splice_region&intron:LOW:exon5/6:c.925-22_925-17delCTCTCT:,GFI1:NM_005263.3:splice_region&intron:LOW:exon5/6:c.925-22_925-17delCTCTCT:	(GA)n		0	0	0	0						600871 [GFI1 (confirmed) Neutropenia,severe congenital 2,autosomal dominant|Neutropenia,nonimmune chronic idiopathic,of adults];				0.0152	0.197	0.7879	19	52	n/a	n/a
chr1	92948938	92948938	C	T	het		QUAL=4251;DP=85;AF=0.44;MQM=60;TRIO=HET,85,0.44,HET,265,0.45,WT,323,0.00	GFI1	missense	GFI1:NM_001127215.1:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn,GFI1:NM_001127216.1:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn,GFI1:NM_005263.3:missense:MODERATE:exon2/7:c.107G>A:p.Ser36Asn		rs34631763	0.0194	0.038	0.0545	0.0134	4.3840	N	T	B	B	600871 [GFI1 (confirmed) Neutropenia,severe congenital 2,autosomal dominant|Neutropenia,nonimmune chronic idiopathic,of adults];			COSM3747114	0.0076	0.0833	0.9091	2	38	n/a	n/a
chr1	97543752	97543752	G	A	het		QUAL=19606;DP=467;AF=0.48;MQM=60;TRIO=HET,467,0.48,HET,323,0.50,HET,437,0.48	DPYD	3'UTR	DPYD:NM_000110.3:3'UTR:MODIFIER:exon23/23:c.*780C>T:		rs291593	0.385	0	0	0							RCV000086445.1 [not provided]; 			0.053	0.3788	0.5682	10	55	n/a	n/a
chr1	97543764	97543764	C	T	het		QUAL=18997;DP=399;AF=0.49;MQM=60;TRIO=HET,399,0.49,HET,339,0.50,HET,457,0.47	DPYD	3'UTR	DPYD:NM_000110.3:3'UTR:MODIFIER:exon23/23:c.*768G>A:		rs291592	0.5775	0	0	0							RCV000086446.1 [not provided]; 			0.1364	0.5076	0.3561	21	74	n/a	n/a
chr1	97543959	97543959	C	T	het		QUAL=8601;DP=323;AF=0.53;MQM=60;TRIO=HET,323,0.53,HET,212,0.44,WT,284,0.00	DPYD	3'UTR	DPYD:NM_000110.3:3'UTR:MODIFIER:exon23/23:c.*573G>A:		rs1042482	0.0895	0	0	0							RCV000086448.1 [not provided]; 			0.0076	0.1212	0.8712	1	16	n/a	n/a
chr1	97915624	97915624	A	G	het		QUAL=5891;DP=196;AF=0.45;MQM=60;TRIO=HET,196,0.45,WT,148,0.00,HET,185,0.53	DPYD	synonymous	DPYD:NM_000110.3:synonymous:LOW:exon14/23:c.1896T>C:p.Phe632Phe		rs17376848	0.0521	0.047	0.045	0.0207						612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency|5-fluorouracil toxicity];	RCV000086470.1 [not provided]; 			0.0076	0.0985	0.8939	1	37	n/a	n/a
chr1	98185527	98185527	A	G	hom		QUAL=15733;DP=205;AF=1.00;MQM=60;TRIO=HOM,205,1.00,HOM,121,1.00,HOM,150,1.00	DPYD	3'UTR,intron	DPYD:NM_001160301.1:3'UTR:MODIFIER:exon6/6:c.*917T>C:,DPYD:NM_000110.3:intron:MODIFIER:exon5/22:c.483+1539T>C:		rs2151562	0.9978	0	0	0						612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency|5-fluorouracil toxicity];				1	0	0	150	0	n/a	n/a
chr1	98186077	98186077	T	C	hom		QUAL=20033;DP=278;AF=1.00;MQM=60;TRIO=HOM,278,1.00,HOM,137,1.00,HOM,192,1.00	DPYD	3'UTR,intron	DPYD:NM_001160301.1:3'UTR:MODIFIER:exon6/6:c.*367A>G:,DPYD:NM_000110.3:intron:MODIFIER:exon5/22:c.483+989A>G:		rs1333718	0.9978	0	0	0						612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency|5-fluorouracil toxicity];				1	0	0	150	0	n/a	n/a
chr1	98348885	98348885	G	A	hom		QUAL=15670;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,161,1.00,HET,213,0.52	DPYD	missense	DPYD:NM_000110.3:missense:MODERATE:exon2/23:c.85C>T:p.Arg29Cys,DPYD:NM_001160301.1:missense:MODERATE:exon2/6:c.85C>T:p.Arg29Cys		rs1801265	0.7398	0.765	0.7751	0.6003	2.2350	P	T	D	P	612779 [DPYD (confirmed) Dihydropyrimidine dehydrogenase deficiency|5-fluorouracil toxicity];	RCV000000464.1,RCV000086506.1 [pathogenic,not provided]; 	CM970421 [CLASS=DM? MUT=REF PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD]; 	COSM3735989	0.5455	0.4091	0.0455	266	162	2	n/a
chr1	98460060	98460060	A	C	het		QUAL=3662;DP=158;AF=0.48;MQM=60;TRIO=HET,158,0.48,WT,63,0.00,HET,88,0.51				AluSx		0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr1	98460106	98460106	G	A	hom		QUAL=9453;DP=165;AF=1.00;MQM=59;TRIO=HOM,165,1.00,HOM,83,1.00,HET,125,0.53				AluSx	rs9440288	0.8552	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98461132	98461132	G	C	hom		QUAL=23257;DP=262;AF=1.00;MQM=60;TRIO=HOM,262,1.00,HOM,279,1.00,HET,366,0.46				L2a	rs9324380	0.9267	0	0	0										0.8106	0.1894	0	119	31	n/a	n/a
chr1	98461257	98461257	-	TTGT	hom		QUAL=14939;DP=203;AF=0.97;MQM=60;TRIO=HOM,203,0.97,HOM,189,0.97,HET,262,0.41					rs10655213	0.8936	0	0	0										0.7121	0.2727	0.0152	105	43	n/a	n/a
chr1	98461443	98461443	C	T	het		QUAL=5997;DP=162;AF=0.52;MQM=60;TRIO=HET,162,0.52,HET,96,0.47,HET,103,0.52					rs9662365	0.4657	0	0	0										0.2045	0.5682	0.2273	32	85	n/a	n/a
chr1	98461954	98461954	T	C	hom		QUAL=6004;DP=148;AF=0.99;MQM=60;TRIO=HOM,148,0.99,HOM,26,1.00,HET,33,0.58					rs1938570	0.8936	0	0	0										0.7045	0.2727	0.0227	102	43	n/a	n/a
chr1	98462921	98462921	C	A	het		QUAL=6467;DP=250;AF=0.50;MQM=60;TRIO=HET,250,0.50,WT,156,0.00,HET,181,0.47					rs146033831	0.0176	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr1	98465528	98465528	G	A	hom		QUAL=23706;DP=307;AF=1.00;MQM=60;TRIO=HOM,307,1.00,HOM,252,1.00,HET,332,0.50					rs2154403	0.9034	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98465840	98465840	G	A	het		QUAL=7074;DP=280;AF=0.48;MQM=60;TRIO=HET,280,0.48,HET,220,0.41,WT,306,0.00				L2a	rs116319667	0.0046	0	0	0										0	0.0455	0.9545	0	6	n/a	n/a
chr1	98468539	98468540	TA	-	hom		QUAL=15675;DP=289;AF=0.95;MQM=60;TRIO=HOM,289,0.95,HOM,135,0.99,HET,202,0.51					rs560896765	0.892	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98469687	98469687	A	-	het		QUAL=7867;DP=223;AF=0.41;MQM=60;TRIO=HET,223,0.41,WT,251,0.00,HET,318,0.48					rs564190891	0.0036	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr1	98470051	98470051	-	AT	hom		QUAL=22520;DP=506;AF=0.96;MQM=60;TRIO=HOM,506,0.96,HOM,126,0.97,HET,225,0.45					rs141251091	0.8636	0	0	0										0.6439	0.3409	0.0152	96	52	n/a	n/a
chr1	98470605	98470605	A	G	hom		QUAL=6847;DP=178;AF=1.00;MQM=60;TRIO=HOM,178,1.00,HOM,20,1.00,HET,25,0.44					rs10747495	0.9022	0	0	0										0.7273	0.2576	0.0152	106	42	n/a	n/a
chr1	98472208	98472208	A	G	het		QUAL=3704;DP=166;AF=0.45;MQM=60;TRIO=HET,166,0.45,WT,75,0.00,HET,97,0.41					rs78878051	0.0633	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr1	98472879	98472879	C	T	hom		QUAL=21617;DP=322;AF=1.00;MQM=60;TRIO=HOM,322,1.00,HOM,190,1.00,HET,253,0.56					rs1938564	0.8137	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98472958	98472958	T	A	hom		QUAL=16301;DP=222;AF=1.00;MQM=60;TRIO=HOM,222,1.00,HOM,166,1.00,HET,183,0.55					rs1938563	0.9014	0	0	0										0.7197	0.2576	0.0227	105	42	n/a	n/a
chr1	98473716	98473716	T	A	hom		QUAL=19208;DP=394;AF=1.00;MQM=60;TRIO=HOM,394,1.00,HOM,116,1.00,HET,127,0.54					rs1938562	0.9014	0	0	0										0.7197	0.2576	0.0227	106	41	n/a	n/a
chr1	98474767	98474767	C	T	hom		QUAL=15708;DP=286;AF=1.00;MQM=60;TRIO=HOM,286,1.00,HOM,116,1.00,HET,162,0.49					rs2391902	0.8247	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98475522	98475522	T	C	hom		QUAL=16931;DP=305;AF=1.00;MQM=60;TRIO=HOM,305,1.00,HOM,118,1.00,HET,172,0.52					rs2154402	0.9255	0	0	0										0.8106	0.1894	0	119	31	n/a	n/a
chr1	98475913	98475913	G	A	hom		QUAL=14663;DP=296;AF=1.00;MQM=60;TRIO=HOM,296,1.00,HOM,87,1.00,HET,126,0.55					rs9324381	0.8606	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98476718	98476718	G	A	hom		QUAL=26751;DP=414;AF=1.00;MQM=60;TRIO=HOM,414,1.00,HOM,218,1.00,HET,278,0.59					rs1938561	0.9022	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98476950	98476950	T	C	hom		QUAL=26090;DP=337;AF=1.00;MQM=59;TRIO=HOM,337,1.00,HOM,267,1.00,HET,327,0.55				L2c	rs9440293	0.9024	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98476958	98476958	C	T	hom		QUAL=26430;DP=341;AF=1.00;MQM=59;TRIO=HOM,341,1.00,HOM,268,1.00,HET,336,0.55				L2c	rs9727941	0.8614	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98476966	98476966	G	C	hom		QUAL=26135;DP=338;AF=1.00;MQM=59;TRIO=HOM,338,1.00,HOM,262,1.00,HET,341,0.55				L2c	rs9724773	0.8614	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98478184	98478184	-	CA	het		QUAL=10604;DP=233;AF=0.73;MQM=59;TRIO=HET,233,0.73,HET,117,0.86,HET,163,0.47				(CA)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr1	98478544	98478544	A	T	hom		QUAL=30890;DP=401;AF=1.00;MQM=59;TRIO=HOM,401,1.00,HOM,331,1.00,HET,448,0.48				L2c	rs1938565	0.9024	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98478981	98478981	C	T	hom		QUAL=5410;DP=128;AF=1.00;MQM=60;TRIO=HOM,128,1.00,HOM,21,1.00,HET,28,0.43					rs1938566	0.8247	0	0	0										0.7045	0.2803	0.0152	102	45	n/a	n/a
chr1	98480128	98480128	T	C	hom		QUAL=22618;DP=398;AF=0.99;MQM=60;TRIO=HOM,398,0.99,HOM,193,1.00,HET,219,0.49				MER102b	rs1938567	0.8772	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98480212	98480212	C	T	het		QUAL=9529;DP=421;AF=0.53;MQM=60;TRIO=HET,421,0.53,HET,143,0.49,WT,200,0.01				MER102b	rs11165944	0.3331	0	0	0										0.1136	0.4848	0.4015	16	71	n/a	n/a
chr1	98480332	98480332	G	A	het		QUAL=426;DP=155;AF=0.21;MQM=51;TRIO=HET,155,0.21,WT,60,0.08,WT,91,0.08				(A)n		0	0	0	0										0	0.0227	0.9773	0	4	n/a	n/a
chr1	98480337	98480337	C	A	het		QUAL=596;DP=154;AF=0.25;MQM=51;TRIO=HET,154,0.25,WT,66,0.05,WT,101,0.06				(A)n		0	0	0	0										0	0.0152	0.9848	0	3	n/a	n/a
chr1	98481750	98481750	C	T	het		QUAL=8128;DP=328;AF=0.45;MQM=60;TRIO=HET,328,0.45,HET,216,0.47,WT,293,0.01					rs6683447	0.3187	0	0	0										0.1061	0.4394	0.4545	15	62	n/a	n/a
chr1	98482580	98482580	G	A	hom		QUAL=14705;DP=266;AF=1.00;MQM=60;TRIO=HOM,266,1.00,HOM,103,1.00,HET,171,0.50				L1MB1	rs2391903	0.9259	0	0	0										0.8106	0.1894	0	119	31	n/a	n/a
chr1	98482693	98482693	A	G	hom		QUAL=17556;DP=240;AF=1.00;MQM=60;TRIO=HOM,240,1.00,HOM,159,1.00,HET,246,0.54				L1MB1	rs1892549	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98482828	98482828	A	G	hom		QUAL=16215;DP=301;AF=1.00;MQM=60;TRIO=HOM,301,1.00,HOM,122,1.00,HET,138,0.44				L1MB1	rs1892550	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98482961	98482961	C	T	hom		QUAL=14510;DP=278;AF=1.00;MQM=60;TRIO=HOM,278,1.00,HOM,97,0.99,HET,134,0.45				L1MB1	rs1892551	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98483035	98483035	G	A	hom		QUAL=10007;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HOM,53,1.00,HET,75,0.48					rs1892552	0.871	0	0	0										0.7197	0.2652	0.0152	105	43	n/a	n/a
chr1	98483150	98483150	A	G	hom		QUAL=6233;DP=146;AF=1.00;MQM=60;TRIO=HOM,146,1.00,HOM,19,1.00,HET,34,0.62					rs2391904	0.871	0	0	0										0.7197	0.2652	0.0152	105	42	n/a	n/a
chr1	98483322	98483322	T	C	hom		QUAL=6725;DP=154;AF=1.00;MQM=60;TRIO=HOM,154,1.00,HOM,33,1.00,HET,48,0.31					rs9324382	0.8692	0	0	0										0.7045	0.2803	0.0152	103	44	n/a	n/a
chr1	98484152	98484152	T	C	hom		QUAL=8118;DP=165;AF=1.00;MQM=60;TRIO=HOM,165,1.00,HOM,51,1.00,HET,91,0.35					rs1938571	0.8157	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98484291	98484291	G	A	hom		QUAL=11430;DP=208;AF=1.00;MQM=60;TRIO=HOM,208,1.00,HOM,96,1.00,HET,108,0.36					rs4447033	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98484474	98484474	T	C	hom		QUAL=3516;DP=58;AF=1.00;MQM=57;TRIO=HOM,58,1.00,HOM,40,1.00,HET,39,0.36				AluSx1	rs1938572	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98484617	98484617	C	T	hom		QUAL=3301;DP=80;AF=1.00;MQM=59;TRIO=HOM,80,1.00,HOM,12,1.00,HET,26,0.42				AluSx1	rs1938573	0.8706	0	0	0										0.7121	0.2727	0.0152	105	43	n/a	n/a
chr1	98484954	98484954	G	T	hom		QUAL=19761;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,155,1.00,HET,222,0.47					rs1938558	0.8708	0	0	0										0.7197	0.2652	0.0152	105	43	n/a	n/a
chr1	98485102	98485102	G	A	hom		QUAL=14347;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HOM,126,1.00,HET,154,0.43				MIR	rs1938559	0.871	0	0	0										0.7197	0.2652	0.0152	105	43	n/a	n/a
chr1	98485192	98485192	C	T	hom		QUAL=22638;DP=508;AF=1.00;MQM=60;TRIO=HOM,508,1.00,HOM,106,1.00,HET,138,0.43				MIR	rs1938560	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98485573	98485573	C	T	hom		QUAL=9060;DP=148;AF=1.00;MQM=60;TRIO=HOM,148,1.00,HOM,87,1.00,HET,74,0.64					rs9324383	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98485698	98485698	C	T	het		QUAL=220;DP=35;AF=0.34;MQM=51;TRIO=HET,35,0.34,WT,8,0.00,HET,6,0.17					rs368715597	0	0	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr1	98485927	98485927	T	C	hom		QUAL=7407;DP=105;AF=1.00;MQM=58;TRIO=HOM,105,1.00,HOM,83,1.00,HET,108,0.44				AluSx1	rs9725319	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98485991	98485991	C	T	het		QUAL=3297;DP=109;AF=0.38;MQM=59;TRIO=HET,109,0.38,WT,136,0.00,HET,159,0.45				AluSx1	rs74829086	0.0527	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr1	98486162	98486162	T	C	hom		QUAL=7765;DP=148;AF=1.00;MQM=60;TRIO=HOM,148,1.00,HOM,66,1.00,HET,73,0.36					rs4477335	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98486242	98486242	-	A	hom		QUAL=3845;DP=126;AF=0.79;MQM=60;TRIO=HOM,126,0.79,HOM,19,0.95,HET,23,0.43					rs397709296	0.8678	0	0	0										0.7273	0.2576	0.0152	106	41	n/a	n/a
chr1	98486370	98486370	G	A	hom		QUAL=5101;DP=101;AF=1.00;MQM=60;TRIO=HOM,101,1.00,HOM,31,1.00,HET,42,0.48					rs4480407	0.8928	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98487333	98487333	A	G	hom		QUAL=21481;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,218,1.00,HET,280,0.57					rs9659624	0.871	0	0	0										0.7197	0.2652	0.0152	105	42	n/a	n/a
chr1	98487510	98487510	C	A	hom		QUAL=21210;DP=386;AF=1.00;MQM=60;TRIO=HOM,386,1.00,HOM,159,1.00,HET,198,0.54					rs5005705	0.869	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98487566	98487566	C	T	hom		QUAL=14214;DP=231;AF=1.00;MQM=60;TRIO=HOM,231,1.00,HOM,129,0.99,HET,144,0.53					rs9324384	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98487763	98487763	G	A	hom		QUAL=18676;DP=307;AF=1.00;MQM=60;TRIO=HOM,307,1.00,HOM,163,0.99,HET,181,0.50					rs4634961	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98487899	98487899	C	A	hom		QUAL=20668;DP=272;AF=1.00;MQM=60;TRIO=HOM,272,1.00,HOM,231,1.00,HET,261,0.52					rs9324385	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98487959	98487959	G	A	hom		QUAL=26996;DP=373;AF=1.00;MQM=60;TRIO=HOM,373,1.00,HOM,265,1.00,HET,325,0.50					rs9324386	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98488030	98488030	G	A	hom		QUAL=23457;DP=326;AF=1.00;MQM=60;TRIO=HOM,326,1.00,HOM,213,1.00,HET,327,0.50					rs9324387	0.8712	0	0	0										0.7197	0.2652	0.0152	105	42	n/a	n/a
chr1	98488155	98488155	G	A	hom		QUAL=18323;DP=280;AF=1.00;MQM=60;TRIO=HOM,280,1.00,HOM,169,1.00,HET,197,0.46					rs9324388	0.871	0	0	0										0.7197	0.2652	0.0152	105	43	n/a	n/a
chr1	98488863	98488863	A	G	hom		QUAL=17170;DP=323;AF=1.00;MQM=60;TRIO=HOM,323,1.00,HOM,126,1.00,HET,126,0.65					rs9659996	0.871	0	0	0										0.7121	0.2727	0.0152	104	44	n/a	n/a
chr1	98488895	98488895	C	T	hom		QUAL=10690;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,101,1.00,HET,91,0.58					rs9658841	0.871	0	0	0										0.7197	0.2652	0.0152	105	43	n/a	n/a
chr1	98489080	98489080	G	A	hom		QUAL=7400;DP=172;AF=1.00;MQM=60;TRIO=HOM,172,1.00,HOM,26,1.00,HET,38,0.61					rs9661157	0.871	0	0	0										0.7197	0.2652	0.0152	104	42	n/a	n/a
chr1	98489277	98489277	-	TACTT	het		QUAL=4358;DP=99;AF=0.75;MQM=60;TRIO=HET,99,0.75,HOM,49,0.94,HET,84,0.32					rs71071680	0.8708	0	0	0										0.697	0.2727	0.0303	102	44	n/a	n/a
chr1	98489330	98489330	C	T	hom		QUAL=9661;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,52,1.00,HET,81,0.31					rs10747496	0.871	0	0	0										0.7197	0.2652	0.0152	105	42	n/a	n/a
chr1	98489478	98489478	A	G	hom		QUAL=19959;DP=397;AF=1.00;MQM=60;TRIO=HOM,397,1.00,HOM,125,1.00,HET,163,0.42					rs4584446	0.871	0	0	0										0.7197	0.2652	0.0152	105	42	n/a	n/a
chr1	98489735	98489735	T	C	hom		QUAL=14967;DP=328;AF=1.00;MQM=60;TRIO=HOM,328,1.00,HOM,57,1.00,HET,130,0.51					rs2391905	0.871	0	0	0										0.7273	0.2576	0.0152	107	41	n/a	n/a
chr1	98490012	98490013	TT	-	hom		QUAL=9606;DP=245;AF=0.91;MQM=60;TRIO=HOM,245,0.91,HOM,67,0.94,HET,85,0.54				L2a	rs58960152	0.8706	0	0	0										0.75	0.2348	0.0152	111	37	n/a	n/a
chr1	98490165	98490165	C	T	hom		QUAL=8804;DP=179;AF=1.00;MQM=60;TRIO=HOM,179,1.00,HOM,46,1.00,HET,73,0.44					rs4950117	0.894	0	0	0										0.7121	0.2727	0.0152	105	43	n/a	n/a
chr1	98490358	98490358	G	T	hom		QUAL=16471;DP=258;AF=1.00;MQM=60;TRIO=HOM,258,1.00,HOM,153,0.99,HET,165,0.52					rs4950118	0.871	0	0	0										0.7121	0.2727	0.0152	105	43	n/a	n/a
chr1	98490636	98490636	T	C	hom		QUAL=18709;DP=370;AF=0.99;MQM=60;TRIO=HOM,370,0.99,HOM,120,1.00,HET,171,0.49					rs10783082	0.871	0	0	0										0.7197	0.2576	0.0227	106	41	n/a	n/a
chr1	98490770	98490770	-	TTAAGTAT	hom		QUAL=10868;DP=159;AF=0.89;MQM=60;TRIO=HOM,159,0.89,HOM,136,0.99,HET,141,0.52					rs397733292	0.871	0	0	0										0.6515	0.2652	0.0833	97	42	n/a	n/a
chr1	98491248	98491248	A	C	hom		QUAL=18896;DP=337;AF=1.00;MQM=60;TRIO=HOM,337,1.00,HOM,139,1.00,HET,192,0.45				MIR3	rs4950119	0.8682	0	0	0										0.6667	0.3106	0.0227	96	51	n/a	n/a
chr1	98491382	98491382	G	A	hom		QUAL=15008;DP=267;AF=1.00;MQM=60;TRIO=HOM,267,1.00,HOM,105,1.00,HET,175,0.44				MIRb	rs4950120	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98491473	98491473	A	C	hom		QUAL=18191;DP=350;AF=1.00;MQM=60;TRIO=HOM,350,1.00,HOM,116,0.99,HET,172,0.50				MIRb	rs4245673	0.871	0	0	0										0.7197	0.2652	0.0152	105	42	n/a	n/a
chr1	98491732	98491732	T	C	hom		QUAL=19137;DP=250;AF=1.00;MQM=60;TRIO=HOM,250,1.00,HOM,193,1.00,HET,285,0.49					rs1938568	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98492462	98492462	C	T	hom		QUAL=23156;DP=419;AF=1.00;MQM=60;TRIO=HOM,419,1.00,HOM,184,0.99,HET,197,0.47					rs9440393	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98492580	98492580	A	G	het		QUAL=16346;DP=470;AF=0.49;MQM=60;TRIO=HET,470,0.49,HET,260,0.48,HET,282,0.50					rs9440302	0.4575	0	0	0										0.2045	0.5682	0.2273	31	86	n/a	n/a
chr1	98492854	98492854	T	C	hom		QUAL=17181;DP=353;AF=1.00;MQM=60;TRIO=HOM,353,1.00,HOM,95,1.00,HET,113,0.50					rs9324389	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98493263	98493263	A	G	hom		QUAL=13960;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,123,1.00,HET,186,0.45					rs1938569	0.8706	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98493785	98493785	G	A	hom		QUAL=2306;DP=62;AF=0.98;MQM=60;TRIO=HOM,62,0.98,HOM,11,1.00,HET,14,0.36					rs2022864	0.8712	0	0	0										0.7197	0.25	0.0303	105	39	n/a	n/a
chr1	98493789	98493789	A	G	hom		QUAL=2306;DP=62;AF=0.98;MQM=60;TRIO=HOM,62,0.98,HOM,11,1.00,HET,14,0.36					rs2022865	0.8712	0	0	0										0.7197	0.2576	0.0227	105	40	n/a	n/a
chr1	98494185	98494185	G	A	hom		QUAL=13337;DP=214;AF=1.00;MQM=60;TRIO=HOM,214,1.00,HOM,104,0.99,HET,153,0.55					rs10875124	0.871	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98494200	98494200	A	C	hom		QUAL=12726;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,96,0.99,HET,139,0.53					rs10875125	0.871	0	0	0										0.7197	0.2652	0.0152	105	42	n/a	n/a
chr1	98494388	98494388	-	A	het		QUAL=7135;DP=175;AF=0.85;MQM=60;TRIO=HET,175,0.85,HOM,50,0.96,HET,81,0.40					rs398103064	0.87	0	0	0										0.6439	0.3333	0.0227	95	51	n/a	n/a
chr1	98494606	98494606	A	G	hom		QUAL=14962;DP=241;AF=1.00;MQM=60;TRIO=HOM,241,1.00,HOM,132,1.00,HET,151,0.44					rs1198574	0.8712	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98495513	98495513	T	C	hom		QUAL=10409;DP=153;AF=1.00;MQM=60;TRIO=HOM,153,1.00,HOM,94,1.00,HET,129,0.54					rs1198573	0.8708	0	0	0										0.7121	0.2652	0.0227	105	42	n/a	n/a
chr1	98496512	98496512	T	-	het		QUAL=4976;DP=213;AF=0.48;MQM=60;TRIO=HET,213,0.48,HET,105,0.60,WT,145,0.03					rs377025796	0	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr1	98497176	98497176	A	C	hom		QUAL=6061;DP=157;AF=1.00;MQM=60;TRIO=HOM,157,1.00,HOM,15,1.00,HET,15,0.67					rs1198572	0.8441	0	0	0										0.6515	0.3106	0.0379	94	51	n/a	n/a
chr1	98497355	98497355	A	G	het		QUAL=958;DP=52;AF=0.52;MQM=58;TRIO=HET,52,0.52,HET,13,0.62,WT,8,0.00					rs188465986	0.0022	0	0	0										0.0076	0.0227	0.9697	1	3	n/a	n/a
chr1	98497672	98497672	A	G	hom		QUAL=5064;DP=120;AF=1.00;MQM=60;TRIO=HOM,120,1.00,HOM,20,1.00,HET,35,0.37					rs1198571	0.8706	0	0	0										0.7273	0.25	0.0227	107	40	n/a	n/a
chr1	98498898	98498898	C	A	hom		QUAL=24781;DP=422;AF=1.00;MQM=60;TRIO=HOM,422,1.00,HOM,189,1.00,HET,268,0.47					rs1782815	0.8686	0	0	0										0.7045	0.2803	0.0152	104	44	n/a	n/a
chr1	98499590	98499590	A	-	het		QUAL=1426;DP=71;AF=0.49;MQM=59;TRIO=HET,71,0.49,WT,30,0.00,HET,31,0.48				A-rich	rs143336786	0	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr1	98499647	98499647	G	A	het		QUAL=448;DP=69;AF=0.22;MQM=54;TRIO=HET,69,0.22,HET,17,0.18,HET,14,0.21				A-rich	rs12405733	0	0	0	0										0	0.2803	0.7197	0	40	n/a	n/a
chr1	98499651	98499651	G	A	het		QUAL=401;DP=77;AF=0.14;MQM=49;TRIO=HET,77,0.14,HET,18,0.44,HET,14,0.07				A-rich	rs1782814	0	0	0	0										0	0.5303	0.4697	1	79	n/a	n/a
chr1	98499659	98499659	G	A	het		QUAL=1875;DP=82;AF=0.62;MQM=56;TRIO=HET,82,0.62,HET,13,0.77,HET,16,0.25				A-rich	rs58126792	0	0	0	0										0.0076	0.3939	0.5985	1	55	n/a	n/a
chr1	98499663	98499663	A	G	het		QUAL=1875;DP=82;AF=0.62;MQM=56;TRIO=HET,82,0.62,HET,13,0.77,HET,16,0.25				A-rich	rs60475427	0	0	0	0										0.0152	0.4394	0.5455	2	64	n/a	n/a
chr1	98499843	98499843	T	C	hom		QUAL=10521;DP=167;AF=0.99;MQM=60;TRIO=HOM,167,0.99,HOM,93,1.00,HET,158,0.46					rs1782813	0.889	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98500045	98500045	G	C	het		QUAL=8397;DP=389;AF=0.50;MQM=60;TRIO=HET,389,0.50,HET,132,0.45,WT,166,0.01					rs7554283	0.3195	0	0	0										0.1061	0.4394	0.4545	15	62	n/a	n/a
chr1	98501011	98501011	T	C	het		QUAL=8582;DP=314;AF=0.49;MQM=60;TRIO=HET,314,0.49,HET,201,0.53,WT,249,0.00					rs4950101	0.2772	0	0	0										0.0909	0.4167	0.4924	13	59	n/a	n/a
chr1	98501984	98501984	T	C	hom		QUAL=13997;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,83,1.00,HET,106,0.59					rs1702294	0.8401	0	0	0										0.6591	0.3182	0.0227	95	52	n/a	n/a
chr1	98502159	98502159	G	C	hom		QUAL=30288;DP=318;AF=1.00;MQM=60;TRIO=HOM,318,1.00,HOM,360,1.00,HET,438,0.51				Tigger3a	rs1702293	0.9257	0	0	0										0.8182	0.1818	0	120	30	n/a	n/a
chr1	98502340	98502340	G	A	hom		QUAL=19468;DP=238;AF=1.00;MQM=60;TRIO=HOM,238,1.00,HOM,229,1.00,HET,242,0.48				Tigger3a	rs1782810	0.7967	0	0	0										0.6515	0.3258	0.0227	92	55	n/a	n/a
chr1	98502410	98502410	A	C	hom		QUAL=22328;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,248,1.00,HET,294,0.51				Tigger3a	rs1782811	0.9026	0	0	0										0.7197	0.2652	0.0152	105	42	n/a	n/a
chr1	98502594	98502594	A	C	hom		QUAL=18744;DP=240;AF=1.00;MQM=59;TRIO=HOM,240,1.00,HOM,206,1.00,HET,268,0.49					rs1628294	0.9257	0	0	0										0.8106	0.1894	0	119	31	n/a	n/a
chr1	98502934	98502934	G	T	hom		QUAL=11034;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HOM,73,1.00,HET,106,0.38					rs1625579	0.7969	0	0	0										0.6515	0.3258	0.0227	94	53	n/a	n/a
chr1	98506631	98506631	-	ATTCATTC	het		QUAL=1378;DP=37;AF=0.59;MQM=60;TRIO=HET,37,0.76,WT,12,1.00,HET,35,0.46				(TTCA)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr1	98507696	98507696	A	G	hom		QUAL=6097;DP=151;AF=0.99;MQM=60;TRIO=HOM,151,0.99,HOM,15,1.00,HET,35,0.43					rs4292998	0.8129	0	0	0										0.6515	0.3258	0.0227	94	53	n/a	n/a
chr1	98507718	98507718	C	A	hom		QUAL=7288;DP=181;AF=1.00;MQM=60;TRIO=HOM,181,1.00,HOM,18,1.00,HET,38,0.45					rs4411173	0.8896	0	0	0										0.7197	0.2652	0.0152	106	42	n/a	n/a
chr1	98508258	98508258	C	T	hom		QUAL=40851;DP=569;AF=1.00;MQM=59;TRIO=HOM,569,1.00,HOM,409,1.00,HET,498,0.52					rs2802535	0.8097	0	0	0										0.6515	0.3258	0.0227	94	53	n/a	n/a
chr1	98508488	98508488	G	A	het		QUAL=10441;DP=416;AF=0.50;MQM=60;TRIO=HET,416,0.50,WT,172,0.00,HET,196,0.56					rs78924727	0.0527	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr1	98512127	98512127	G	T	hom		QUAL=34295;DP=401;AF=1.00;MQM=60;TRIO=HOM,401,1.00,HOM,411,1.00,HET,490,0.48					rs2660304	0.8468	0	0	0										0.6515	0.3258	0.0227	101	55	n/a	n/a
chr1	98513144	98513144	T	A	hom		QUAL=13523;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,115,1.00,HET,133,0.53				AT_rich	rs2660303	0.9259	0	0	0										0.8106	0.1894	0	119	31	n/a	n/a
chr1	98513845	98513845	G	A	hom		QUAL=13983;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,182,0.99,HET,259,0.47					rs61786696	0.9263	0	0	0										0.8106	0.1894	0	119	31	n/a	n/a
chr1	98513959	98513959	A	G	hom		QUAL=18778;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,207,1.00,HET,277,0.49					rs61786697	0.9261	0	0	0										0.8106	0.1894	0	119	31	n/a	n/a
chr1	100327026	100327026	C	T	het		QUAL=15458;DP=435;AF=0.53;MQM=60;TRIO=HET,435,0.53,HET,200,0.48,HET,299,0.45	AGL	5'UTR_premature_start_codon_gain,5'UTR,intron	AGL:NM_000645.2:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-2C>T:,AGL:NM_000645.2:5'UTR:MODIFIER:exon1/32:c.-2C>T:,AGL:NM_000028.2:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:NM_000642.2:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:NM_000643.2:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:NM_000644.2:intron:MODIFIER:exon2/33:c.83-33C>T:,AGL:NM_000646.2:intron:MODIFIER:exon2/33:c.35-33C>T:		rs2307129	0.2272	0.189	0.1707	0.3807						610860 [AGL (confirmed) Glycogen storage disease IIIa|Glycogen storage disease IIIb];				0.053	0.303	0.6439	25	151	n/a	n/a
chr1	100336361	100336361	C	T	het		QUAL=9930;DP=339;AF=0.42;MQM=60;TRIO=HET,339,0.42,HOM,98,1.00,HET,117,0.51	AGL	synonymous	AGL:NM_000028.2:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:NM_000642.2:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:NM_000643.2:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:NM_000644.2:synonymous:LOW:exon7/34:c.894C>T:p.Leu298Leu,AGL:NM_000646.2:synonymous:LOW:exon7/34:c.846C>T:p.Leu282Leu,AGL:NM_000645.2:synonymous:LOW:exon5/32:c.843C>T:p.Leu281Leu		rs2230306	0.7626	0.722	0.6957	0.9083						610860 [AGL (confirmed) Glycogen storage disease IIIa|Glycogen storage disease IIIb];				0.4924	0.4318	0.0758	239	180	n/a	n/a
chr1	100358103	100358103	C	T	het		QUAL=10272;DP=248;AF=0.48;MQM=60;TRIO=HET,248,0.48,HET,182,0.47,HET,222,0.51	AGL	missense	AGL:NM_000028.2:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:NM_000642.2:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:NM_000643.2:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:NM_000644.2:missense:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser,AGL:NM_000646.2:missense:MODERATE:exon24/34:c.3151C>T:p.Pro1051Ser,AGL:NM_000645.2:missense:MODERATE:exon22/32:c.3148C>T:p.Pro1050Ser		rs3753494	0.1106	0.136	0.1462	0.1264	7.2300	P	T	B,B,B	B,B,B	610860 [AGL (confirmed) Glycogen storage disease IIIa|Glycogen storage disease IIIb];				0.0379	0.2727	0.6894	17	133	n/a	n/a
chr1	100387939	100387939	C	T	het		QUAL=4929;DP=171;AF=0.49;MQM=59;TRIO=HET,171,0.49,HOM,41,1.00,HET,53,0.45	AGL	3'UTR	AGL:NM_000028.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000642.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000643.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000644.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000646.2:3'UTR:MODIFIER:exon34/34:c.*732C>T:,AGL:NM_000645.2:3'UTR:MODIFIER:exon32/32:c.*732C>T:		rs3766600	0.5905	0	0	0										0.3712	0.4848	0.1439	56	71	n/a	n/a
chr1	100654908	100654908	A	T	hom		QUAL=1139;DP=31;AF=1.00;MQM=58;TRIO=HOM,31,1.00,HOM,5,1.00,HOM,1,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6903T>A:	AluSz	rs10783125	0.9339	0	0	0										0.25	0.2424	0.5076	35	38	n/a	n/a
chr1	100654909	100654909	A	T	het		QUAL=248;DP=39;AF=0.23;MQM=57;TRIO=HET,39,0.23,HET,5,0.20,HET,3,0.67	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6902T>A:	AluSz	rs200943386	0	0	0	0										0.0076	0.0606	0.9318	1	8	n/a	n/a
chr1	100655583	100655583	T	A	hom		QUAL=4201;DP=99;AF=1.00;MQM=59;TRIO=HOM,99,1.00,HOM,15,1.00,HOM,12,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6228A>T:	MER3	rs4281338	0.7668	0	0	0										0.7576	0.2348	0.0076	110	37	n/a	n/a
chr1	100655696	100655697	AA	-	het		QUAL=3455;DP=167;AF=0.43;MQM=60;TRIO=HET,167,0.43,WT,57,0.02,HET,77,0.60	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*6114_*6115delTT:	MLT1J2	rs3081711	0	0	0	0										0.0455	0.4773	0.4773	9	66	n/a	n/a
chr1	100656265	100656265	C	T	hom		QUAL=13941;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HOM,105,1.00,HOM,140,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*5546G>A:		rs11166412	0.8007	0	0	0										0.7955	0.2045	0	117	32	n/a	n/a
chr1	100656661	100656661	T	C	hom		QUAL=23979;DP=358;AF=1.00;MQM=60;TRIO=HOM,358,1.00,HOM,156,1.00,HOM,206,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*5150A>G:		rs6701655	0.7696	0	0	0										0.7576	0.2348	0.0076	111	37	n/a	n/a
chr1	100657305	100657305	T	C	hom		QUAL=1510;DP=14;AF=0.86;MQM=55;TRIO=HOM,14,0.93,HET,21,1.00,HET,37,0.70	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*4506A>G:		rs112901689	0.7816	0	0	0										0.2879	0.1288	0.5833	38	19	n/a	n/a
chr1	100658578	100658578	G	A	hom		QUAL=34432;DP=325;AF=1.00;MQM=59;TRIO=HOM,325,1.00,HOM,313,1.00,HOM,465,1.00	DBT	3'UTR	DBT:NM_001918.3:3'UTR:MODIFIER:exon11/11:c.*3233C>T:		rs2784174	0.7696	0	0	0										0.7576	0.2348	0.0076	111	37	n/a	n/a
chr1	100672060	100672060	T	C	hom		QUAL=28828;DP=340;AF=1.00;MQM=60;TRIO=HOM,340,1.00,HOM,242,1.00,HOM,299,1.00	DBT	missense	DBT:NM_001918.3:missense:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly		rs12021720	0.8918	0.914	0.9024	0.7749	1.9050	P	T	B	B	248610 [DBT (confirmed) Maple syrup urine disease,type II];	RCV000012727.21,RCV000116865.3 [pathogenic,other]; 	CM983430 [CLASS=DM? MUT=REF PHEN="Maple syrup urine disease" GENE=DBT]; 		0.8485	0.1515	0	375	73	2	n/a
chr1	109771063	109771063	T	C	hom		QUAL=21655;DP=236;AF=1.00;MQM=60;TRIO=HOM,236,1.00,HOM,203,1.00,HOM,229,1.00	SARS	splice_region&intron	SARS:NM_006513.3:splice_region&intron:LOW:exon3/10:c.288+9T>C:		rs683182	0.6799	0.757	0.7957	0.4889									COSM3747471	0.6515	0.2879	0.0606	201	95	n/a	n/a
chr1	110709719	110709719	T	C	het		QUAL=19990;DP=257;AF=0.43;MQM=60;TRIO=HET,257,0.43,HET,328,0.54,HOM,377,1.00	SLC6A17	synonymous	SLC6A17:NM_001010898.2:synonymous:LOW:exon2/12:c.168T>C:p.Asp56Asp		rs7527375	0.393	0.457	0.5255	0.5125										0.25	0.5606	0.1894	96	160	n/a	n/a
chr1	110709720	110709720	G	A	het		QUAL=19990;DP=257;AF=0.43;MQM=59;TRIO=HET,257,0.43,WT,328,0.54,HOM,377,1.00	SLC6A17	missense	SLC6A17:NM_001010898.2:missense:MODERATE:exon2/12:c.169G>A:p.Ala57Thr		rs12737742	0.2502	0.371	0.4455	0.1083	0.5380	P	T	B	B					0.1894	0.553	0.2576	68	170	n/a	n/a
chr1	110738296	110738296	G	A	het		QUAL=19654;DP=282;AF=0.48;MQM=60;TRIO=HET,282,0.48,HET,379,0.53,HET,539,0.53	SLC6A17	synonymous	SLC6A17:NM_001010898.2:synonymous:LOW:exon10/12:c.1581G>A:p.Ser527Ser		rs2784140	0.2897	0.414	0.4972	0.1146									COSM146574	0.1667	0.4697	0.3636	54	155	n/a	n/a
chr1	110741081	110741081	C	G	het		QUAL=3218;DP=138;AF=0.49;MQM=59;TRIO=HET,138,0.49,HET,120,0.35,WT,150,0.01	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*15C>G:		rs2761446	0.017	0.037	0.0486	0.0084										0.0076	0.0455	0.947	1	8	n/a	n/a
chr1	110741349	110741349	G	T	het		QUAL=18976;DP=348;AF=0.46;MQM=60;TRIO=HET,348,0.46,HOM,265,1.00,HET,328,0.57	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*283G>T:		rs2603580	0.5425	0	0	0										0.2879	0.5	0.2121	45	71	n/a	n/a
chr1	110741583	110741583	C	G	het		QUAL=11121;DP=165;AF=0.38;MQM=60;TRIO=HET,165,0.38,HOM,177,1.00,HET,213,0.53	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*517C>G:		rs2784141	0.5447	0	0	0										0.2879	0.5	0.2121	45	71	n/a	n/a
chr1	110742085	110742085	T	C	het		QUAL=30105;DP=278;AF=0.44;MQM=59;TRIO=HET,278,0.44,HOM,498,1.00,HET,677,0.49	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*1019T>C:		rs2603579	0.5449	0	0	0										0.2879	0.5	0.2121	45	71	n/a	n/a
chr1	110742502	110742502	A	G	het		QUAL=2363;DP=161;AF=0.32;MQM=58;TRIO=HET,161,0.32,HET,78,0.24,HET,97,0.26	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*1436A>G:	(TGGA)n	rs2361044	0.2883	0	0	0										0.1591	0.4242	0.4167	25	63	n/a	n/a
chr1	110742615	110742615	A	G	het		QUAL=3341;DP=119;AF=0.45;MQM=60;TRIO=HET,119,0.45,HET,70,0.34,HET,103,0.43	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*1549A>G:	GA-rich	rs12133992	0.2867	0	0	0										0.1667	0.4091	0.4242	26	61	n/a	n/a
chr1	110742992	110742992	T	G	het		QUAL=8929;DP=168;AF=0.50;MQM=60;TRIO=HET,168,0.50,HET,180,0.52,HET,258,0.45	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*1926T>G:		rs2784142	0.3079	0	0	0										0.1667	0.4773	0.3561	26	70	n/a	n/a
chr1	110743588	110743588	G	C	het		QUAL=10131;DP=159;AF=0.52;MQM=60;TRIO=HET,159,0.52,WT,385,0.00,HET,472,0.51	SLC6A17	3'UTR	SLC6A17:NM_001010898.2:3'UTR:MODIFIER:exon12/12:c.*2522G>C:		rs151008748	0.0132	0	0	0										0	0.0606	0.9394	0	9	n/a	n/a
chr1	115259401	115259401	C	T	het		QUAL=4691;DP=182;AF=0.60;MQM=60;TRIO=HET,182,0.60,WT,117,0.00,HET,137,0.39	NRAS	5'UTR	NRAS:NM_002524.4:5'UTR:MODIFIER:exon1/7:c.-140G>A:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr1	115576023	115576023	A	G	hom		QUAL=17832;DP=255;AF=1.00;MQM=60;TRIO=HOM,255,1.00,HOM,134,1.00,HOM,149,1.00	TSHB	missense	TSHB:NM_000549.4:missense:MODERATE:exon2/3:c.40A>G:p.Thr14Ala		rs10776792	0.9836	0.971	0.9655	0.9943	0.2240	P	T	B	B	188540 [TSHB (confirmed) Hypothryoidism,congenital,nongoitrous 4];		CM991218 [CLASS=DM? MUT=REF PHEN="Hypothyroidism" GENE=TSHB]; 		0.9318	0.0682	0	420	32	2	n/a
chr1	115829313	115829313	G	A	hom		QUAL=20788;DP=177;AF=1.00;MQM=60;TRIO=HOM,177,1.00,HET,271,0.50,HOM,377,0.99	NGF	missense	NGF:NM_002506.2:missense:MODERATE:exon3/3:c.104C>T:p.Ala35Val		rs6330	0.2474	0.365	0.4523	0.2068	2.2980	P	D	B	B	162030 [NGF (confirmed) Neuropathy,hereditary sensory and autonomic,type V];		CM086294 [CLASS=DFP MUT=REF PHEN="Anxiety-related traits, gender-dependent, association with" GENE=NGF]; 	COSM3735921	0.1894	0.4697	0.3409	90	217	n/a	n/a
chr1	119965519	119965519	C	T	het		QUAL=13078;DP=464;AF=0.54;MQM=59;TRIO=HET,464,0.54,WT,297,0.00,HET,353,0.41	HSD3B2	3'UTR	HSD3B2:NM_000198.3:3'UTR:MODIFIER:exon4/4:c.*276C>T:,HSD3B2:NM_001166120.1:3'UTR:MODIFIER:exon4/4:c.*276C>T:		rs1819698	0.3101	0	0	0						613890 [HSD3B2 (confirmed) 3-beta-hydroxysteroid dehydrogenase,type II,deficiency];				0.0379	0.2121	0.75	5	32	n/a	n/a
chr1	119965564	119965564	C	G	het		QUAL=12922;DP=435;AF=0.54;MQM=60;TRIO=HET,435,0.54,WT,290,0.00,HET,354,0.42	HSD3B2	3'UTR	HSD3B2:NM_000198.3:3'UTR:MODIFIER:exon4/4:c.*321C>G:,HSD3B2:NM_001166120.1:3'UTR:MODIFIER:exon4/4:c.*321C>G:		rs1361530	0.256	0	0	0						613890 [HSD3B2 (confirmed) 3-beta-hydroxysteroid dehydrogenase,type II,deficiency];				0.0303	0.2121	0.7576	4	32	n/a	n/a
chr1	147228874	147228874	C	T	het		QUAL=7505;DP=263;AF=0.51;MQM=60;TRIO=HET,263,0.51,HET,191,0.54,WT,299,0.00	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*1396G>A:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*1396G>A:		rs11240121	0.4073	0	0	0										0.053	0.4015	0.5455	9	59	n/a	n/a
chr1	147229299	147229299	G	A	hom		QUAL=13227;DP=213;AF=1.00;MQM=59;TRIO=HOM,213,1.00,HOM,131,1.00,HET,161,0.50	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*971C>T:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*971C>T:		rs1043806	0.8662	0	0	0										0.6667	0.303	0.0303	99	45	n/a	n/a
chr1	147229382	147229382	G	A	hom		QUAL=22363;DP=233;AF=1.00;MQM=60;TRIO=HOM,233,1.00,HOM,194,1.00,HOM,277,1.00	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*888C>T:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*888C>T:		rs10900395	0.9886	0	0	0										1	0	0	150	0	n/a	n/a
chr1	147229563	147229563	G	A	het		QUAL=9357;DP=341;AF=0.41;MQM=60;TRIO=HET,341,0.41,HET,313,0.49,WT,374,0.00	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*707C>T:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*707C>T:		rs1043802	0.3191	0	0	0										0.0455	0.3864	0.5682	8	57	n/a	n/a
chr1	147230217	147230217	T	C	hom		QUAL=20390;DP=317;AF=1.00;MQM=60;TRIO=HOM,317,1.00,HOM,190,0.99,HET,233,0.54	GJA5	3'UTR	GJA5:NM_005266.6:3'UTR:MODIFIER:exon2/2:c.*53A>G:,GJA5:NM_181703.3:3'UTR:MODIFIER:exon2/2:c.*53A>G:		rs1692141	0.8804	0	0	0										0.6667	0.303	0.0303	99	45	n/a	n/a
chr1	147245474	147245474	G	C	hom		QUAL=20776;DP=214;AF=1.00;MQM=60;TRIO=HOM,214,1.00,HOM,182,1.00,HOM,274,1.00					rs791286	0.9748	0	0	0										1	0	0	150	0	n/a	n/a
chr1	150771703	150771703	T	C	hom		QUAL=34938;DP=353;AF=1.00;MQM=60;TRIO=HOM,353,1.00,HOM,338,1.00,HOM,361,1.00	CTSK	synonymous	CTSK:NM_000396.3:synonymous:LOW:exon7/8:c.831A>G:p.Ala277Ala		rs10788796	0.9633	0.989	0.9986	0.9374						601105 [CTSK (provisional) Pycnodysostosis];				0.9924	0.0076	0	451	3	n/a	n/a
chr1	151313774	151313774	A	G	het		QUAL=7331;DP=280;AF=0.48;MQM=60;TRIO=HET,280,0.48,HOM,89,1.00,WT,136,0.00	RFX5	3'UTR	RFX5:NM_000449.3:3'UTR:MODIFIER:exon11/11:c.*888T>C:,RFX5:NM_001025603.1:3'UTR:MODIFIER:exon11/11:c.*888T>C:		rs7552906	0.628	0	0	0										0.4242	0.4697	0.1061	62	74	n/a	n/a
chr1	151314379	151314379	T	C	het		QUAL=9317;DP=199;AF=0.56;MQM=60;TRIO=HET,199,0.56,HOM,111,1.00,HET,157,0.47	RFX5	3'UTR	RFX5:NM_000449.3:3'UTR:MODIFIER:exon11/11:c.*283A>G:,RFX5:NM_001025603.1:3'UTR:MODIFIER:exon11/11:c.*283A>G:	MLT1K	rs1752387	0.7644	0	0	0										0.6212	0.3561	0.0227	90	57	n/a	n/a
chr1	151315287	151315287	G	C	het		QUAL=3965;DP=120;AF=0.49;MQM=59;TRIO=HET,120,0.49,HET,137,0.50,WT,187,0.00	RFX5	missense	RFX5:NM_000449.3:missense:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg,RFX5:NM_001025603.1:missense:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg		rs2233854	0.0635	0.119	0.1619	0.035	1.7460	P	D	B,P	B,B	601863 [RFX5 (confirmed) Bare lymphocyte syndrome,type II,complementation group C|Bare lymphocyte syndrome,type II,complementation group E];			COSM3750354	0.0303	0.25	0.7197	13	116	n/a	n/a
chr1	151316161	151316161	G	A	hom		QUAL=13205;DP=186;AF=1.00;MQM=59;TRIO=HOM,186,1.00,HOM,92,1.00,HOM,132,1.00	RFX5	synonymous	RFX5:NM_000449.3:synonymous:LOW:exon9/11:c.753C>T:p.Leu251Leu,RFX5:NM_001025603.1:synonymous:LOW:exon9/11:c.753C>T:p.Leu251Leu		rs1752386	0.978	0.993	0.9998	0.9274						601863 [RFX5 (confirmed) Bare lymphocyte syndrome,type II,complementation group C|Bare lymphocyte syndrome,type II,complementation group E];				1	0	0	454	0	n/a	n/a
chr1	152274685	152274685	T	A	hom		QUAL=8569;DP=94;AF=1.00;MQM=60;TRIO=HOM,94,1.00,HOM,63,1.00,HOM,107,1.00	FLG	3'UTR	FLG:NM_002016.1:3'UTR:MODIFIER:exon3/3:c.*491A>T:		rs1933061	0.9994	0	0	0										0.9848	0.0152	0	148	2	n/a	n/a
chr1	152276149	152276149	C	T	het		QUAL=56112;DP=480;AF=0.51;MQM=58;TRIO=HET,480,0.51,HET,1295,0.51,HET,1840,0.51	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.11213G>A:p.Arg3738His		rs77422831	0.2869	0.229	0.1442	0.037	-2.2530	P	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996928	0.0303	0.3788	0.5909	11	99	n/a	n/a
chr1	152276459	152276459	C	T	het		QUAL=35237;DP=409;AF=0.10;MQM=30;TRIO=HET,409,0.10,HET,1542,0.22,HET,2191,0.38	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn		rs75448155	0	0.191	0.103	0.0268	1.6290	N	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142668	0	0.1288	0.8712	0	62	n/a	n/a
chr1	152276583	152276583	C	G	het		QUAL=19168;DP=343;AF=0.15;MQM=33;TRIO=HET,343,0.15,HET,890,0.19,HET,631,0.69	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp		rs12083389	0.3614	0.099	0.0319	0.3795	0.3080	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3734007	0.0379	0.1212	0.8409	12	31	n/a	n/a
chr1	152276598	152276598	G	A	het		QUAL=16864;DP=372;AF=0.07;MQM=31;TRIO=HET,372,0.07,HET,797,0.20,HOM,418,0.98	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10764C>T:p.His3588His		rs12742178	0.0887	0.056	0	0						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142669	0.053	0.0379	0.9091	14	14	n/a	n/a
chr1	152276626	152276626	G	C	het		QUAL=9108;DP=432;AF=0.12;MQM=32;TRIO=HET,432,0.12,HET,747,0.15,HOM,289,0.98	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg		rs3126075	0.4778	0.077	0.0174	0.2548	-5.4480	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142671	0.053	0.1439	0.803	17	30	n/a	n/a
chr1	152276671	152276671	C	T	het		QUAL=4723;DP=594;AF=0.10;MQM=45;TRIO=HET,594,0.10,HET,871,0.13,HET,477,0.27	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10691G>A:p.Arg3564His		rs7518080	0.2564	0.193	0	0	-1.3060	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142673	0	0.0758	0.9242	0	45	n/a	n/a
chr1	152276699	152276699	A	G	het		QUAL=15184;DP=504;AF=0.26;MQM=35;TRIO=HET,504,0.26,HET,875,0.14,HET,546,0.57	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg		rs12728605	0	0.19	0	0	-1.1810	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142674	0	0.2652	0.7348	0	59	n/a	n/a
chr1	152276772	152276772	C	A	het		QUAL=37850;DP=403;AF=0.43;MQM=56;TRIO=HET,403,0.43,HET,1136,0.44,HET,671,0.85	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser		rs72697000	0.2905	0.234	0.147	0.0365	-5.0060	P	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996929	0.0076	0.25	0.7424	7	81	n/a	n/a
chr1	152276871	152276871	A	G	het		QUAL=43489;DP=523;AF=0.41;MQM=58;TRIO=HET,523,0.41,HET,1117,0.47,HOM,637,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10491T>C:p.Asp3497Asp		rs3126066	0.4471	0.278	0.1485	0.463						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996930	0.053	0.2727	0.6742	17	87	n/a	n/a
chr1	152276889	152276889	A	G	het		QUAL=42929;DP=518;AF=0.41;MQM=58;TRIO=HET,518,0.41,HET,1135,0.46,HOM,626,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10473T>C:p.Asn3491Asn		rs3126067	0.5226	0.301	0.151	0.6891						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996931	0.053	0.2879	0.6591	18	92	n/a	n/a
chr1	152277055	152277055	C	G	het		QUAL=31930;DP=457;AF=0.40;MQM=53;TRIO=HET,457,0.40,HET,846,0.46,HET,547,0.88	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala		rs2065955	0.5142	0.299	0.1505	0.6847	-0.5970	P	T	P	P	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142675	0.0303	0.3712	0.5985	9	107	n/a	n/a
chr1	152277168	152277168	A	G	het		QUAL=50172;DP=481;AF=0.45;MQM=50;TRIO=HET,481,0.45,HET,1052,0.46,HOM,899,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10194T>C:p.Ser3398Ser		rs3091276	0.4736	0.284	0.1474	0.4877						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996932	0.053	0.3788	0.5682	17	104	n/a	n/a
chr1	152277345	152277345	C	T	het		QUAL=58497;DP=534;AF=0.45;MQM=58;TRIO=HET,534,0.45,HET,1327,0.48,HET,1975,0.48	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.10017G>A:p.Gln3339Gln		rs2065956	0.2875	0.229	0.1447	0.0365						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996933	0.0303	0.3712	0.5985	12	97	n/a	n/a
chr1	152277396	152277396	T	C	het		QUAL=86255;DP=497;AF=0.46;MQM=58;TRIO=HET,497,0.46,HET,1276,0.49,HOM,1858,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.9966A>G:p.Gln3322Gln		rs6681433	0.3411	0.261	0.1683	0.1321						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.053	0.3788	0.5682	16	104	n/a	n/a
chr1	152277717	152277717	C	A	het		QUAL=47818;DP=260;AF=0.30;MQM=48;TRIO=HET,260,0.30,HET,960,0.40,HOM,1104,1.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.9645G>T:p.Val3215Val		rs9436066	0.4696	0.299	0.1506	0.4489						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.053	0.2576	0.6894	18	87	n/a	n/a
chr1	152277822	152277822	T	C	het		QUAL=13564;DP=317;AF=0.17;MQM=38;TRIO=HET,317,0.17,HET,797,0.19,HOM,389,0.98	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.9540A>G:p.Ser3180Ser		rs3126069	0.2238	0.097	0	0						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.0455	0.2424	0.7121	14	48	n/a	n/a
chr1	152277826	152277826	A	C	het		QUAL=13564;DP=317;AF=0.17;MQM=38;TRIO=HET,317,0.17,HET,797,0.19,HOM,389,0.98	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly		rs2065957	0.3936	0.137	0.024	0.3928	-0.6040	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.053	0.2424	0.7045	17	50	n/a	n/a
chr1	152278434	152278434	T	G	het		QUAL=5321;DP=438;AF=0.23;MQM=39;TRIO=HET,438,0.23,HET,486,0.24,WT,546,0.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp		rs61816760	0.2873	0.288	0	0	-1.3040	P	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3801882	0	0.5379	0.4621	5	110	n/a	n/a
chr1	152278555	152278555	T	C	het		QUAL=37553;DP=431;AF=0.26;MQM=45;TRIO=HET,431,0.26,HET,1297,0.25,HET,1601,0.50	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly		rs80221306	0	0.208	0.0964	0.0734	-0.3860	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM1317676	0	0.3182	0.6818	0	93	n/a	n/a
chr1	152278689	152278689	C	A	het		QUAL=163651;DP=654;AF=0.55;MQM=50;TRIO=HET,654,0.55,HET,2465,0.54,HOM,3357,1.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.8673G>T:p.Val2891Val		rs57672167	0.3964	0.269	0.1669	0.2083						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.053	0.3788	0.5682	18	105	n/a	n/a
chr1	152278814	152278814	C	T	het		QUAL=36543;DP=1079;AF=0.09;MQM=37;TRIO=HET,1079,0.09,HET,2855,0.15,HET,4139,0.24	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser		rs2184952	0	0.085	0.0521	0.0768	-2.5340	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142676	0	0.0909	0.9091	0	31	n/a	n/a
chr1	152278856	152278856	T	G	het		QUAL=32725;DP=801;AF=0.22;MQM=50;TRIO=HET,801,0.22,HET,2604,0.21,HET,3895,0.18	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg		rs11582087	0	0.188	0.1107	0.0314		N	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.3939	0.6061	0	97	n/a	n/a
chr1	152279729	152279729	C	T	het		QUAL=76224;DP=556;AF=0.46;MQM=58;TRIO=HET,556,0.46,HET,1192,0.52,HOM,1532,0.99	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg		rs3126072	0.4748	0.297	0.1694	0.4995	-0.2430	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996934	0.053	0.3788	0.5682	17	108	n/a	n/a
chr1	152279841	152279841	G	C	het		QUAL=77509;DP=470;AF=0.48;MQM=58;TRIO=HET,470,0.48,HET,1183,0.51,HOM,1563,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7521C>G:p.His2507Gln		rs3126074	0.4623	0.294	0.1693	0.466	-7.9550	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.053	0.3788	0.5682	17	106	n/a	n/a
chr1	152279920	152279920	A	G	het		QUAL=80280;DP=448;AF=0.50;MQM=59;TRIO=HET,448,0.50,HET,1203,0.53,HOM,1652,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser		rs55650366	0.3425	0.261	0.1677	0.138	-1.3450	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996935	0.053	0.3788	0.5682	15	105	n/a	n/a
chr1	152280032	152280032	T	C	het		QUAL=88270;DP=543;AF=0.47;MQM=58;TRIO=HET,543,0.47,HET,1323,0.51,HOM,1828,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu		rs71625200	0.3431	0.261	0.1636	0.136	-0.8890	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996936	0.053	0.3788	0.5682	15	105	n/a	n/a
chr1	152280170	152280170	C	G	het		QUAL=62952;DP=429;AF=0.44;MQM=47;TRIO=HET,429,0.44,HET,1154,0.44,HOM,1433,0.97	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln		rs71625201	0.3305	0.258	0.1657	0.1326	-1.3100	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996937	0.0152	0.2727	0.7121	9	87	n/a	n/a
chr1	152280265	152280265	C	G	het		QUAL=44766;DP=489;AF=0.38;MQM=38;TRIO=HET,489,0.38,HET,1092,0.31,HET,1078,0.86	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr		rs71625202	0	0.206	0.1329	0.0348	0.0300	P	D	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3747555	0.0076	0.3182	0.6742	3	95	n/a	n/a
chr1	152280347	152280347	C	T	het		QUAL=40663;DP=462;AF=0.35;MQM=37;TRIO=HET,462,0.35,HET,1146,0.29,HET,1010,0.79	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn		rs139476473	0	0.141	0.0328	0.0185	1.6910	P	D	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM146618	0.0152	0.3712	0.6136	3	76	n/a	n/a
chr1	152280372	152280372	G	A	het		QUAL=51951;DP=496;AF=0.48;MQM=36;TRIO=HET,496,0.48,HET,1115,0.34,HOM,1030,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6990C>T:p.His2330His		rs142776569	0.4535	0.278	0	0						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996938	0.053	0.2652	0.6818	17	64	n/a	n/a
chr1	152280471	152280471	C	G	het		QUAL=22236;DP=640;AF=0.22;MQM=36;TRIO=HET,640,0.22,HET,1340,0.14,HET,1862,0.29	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp		rs78179835	0	0.208	0.1071	0.0915	-0.9250	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142679	0	0.303	0.697	1	95	n/a	n/a
chr1	152280736	152280736	T	C	het		QUAL=35459;DP=772;AF=0.31;MQM=53;TRIO=HET,772,0.31,HET,1489,0.18,HET,2372,0.33	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6626A>G:p.His2209Arg		rs66977240	0	0.235	0	0	-5.2630	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142690	0	0.4091	0.5909	0	97	n/a	n/a
chr1	152280759	152280759	A	G	het		QUAL=51219;DP=842;AF=0.34;MQM=53;TRIO=HET,842,0.34,HET,1539,0.23,HET,2649,0.40	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6603T>C:p.Asp2201Asp		rs2338554	0.3672	0.241	0.1099	0.3872						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142691	0	0.4167	0.5833	1	111	n/a	n/a
chr1	152280782	152280782	A	G	het		QUAL=140180;DP=858;AF=0.66;MQM=56;TRIO=HET,858,0.66,HET,1644,0.63,HOM,2776,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His		rs2184953	0.5397	0.317	0	0	-2.7490	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3927615	0.0606	0.3636	0.5758	19	107	n/a	n/a
chr1	152280788	152280788	T	G	het		QUAL=87055;DP=860;AF=0.32;MQM=54;TRIO=HET,860,0.32,HET,1649,0.27,HET,2815,0.73	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln		rs66954353	0	0.237	0.0952	0.2381	0.2450	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.3409	0.6591	0	107	n/a	n/a
chr1	152280864	152280864	A	G	het		QUAL=118858;DP=494;AF=0.61;MQM=54;TRIO=HET,494,0.61,HET,1492,0.66,HOM,2521,1.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6498T>C:p.Ser2166Ser		rs2184954	0.4637	0.294	0.169	0.4666						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.0606	0.3333	0.6061	18	100	n/a	n/a
chr1	152280900	152280900	T	G	het		QUAL=45393;DP=673;AF=0.32;MQM=51;TRIO=HET,673,0.32,HET,1464,0.30,HET,2360,0.36	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6462A>C:p.Gln2154His		rs74129452	0.3439	0.237	0	0	-3.3340	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.3182	0.6818	0	105	n/a	n/a
chr1	152281007	152281007	A	G	het		QUAL=40460;DP=797;AF=0.26;MQM=59;TRIO=HET,797,0.26,HET,1577,0.30,HET,2296,0.30	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His		rs7512553	0.3277	0.221	0.1266	0.3293	0.1210	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.3712	0.6288	0	110	n/a	n/a
chr1	152281008	152281008	A	G	het		QUAL=40460;DP=797;AF=0.26;MQM=59;TRIO=HET,797,0.26,HET,1577,0.30,HET,2296,0.30	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6354T>C:p.His2118His		rs7512554	0.3277	0.221	0.1259	0.3282						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.3712	0.6288	0	110	n/a	n/a
chr1	152281039	152281039	G	A	het		QUAL=46363;DP=917;AF=0.29;MQM=59;TRIO=HET,917,0.29,HET,1640,0.32,HET,2371,0.31	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val		rs7522925	0	0.221	0.1341	0.3568	-3.7960	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142692	0	0.3939	0.6061	0	113	n/a	n/a
chr1	152281228	152281228	C	G	het		QUAL=53314;DP=723;AF=0.25;MQM=53;TRIO=HET,723,0.25,HET,1954,0.34,HET,2607,0.33	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr		rs7546186	0	0.219	0.1311	0.328	1.5140	N	T	P	P	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.4091	0.5909	0	113	n/a	n/a
chr1	152281290	152281290	A	G	het		QUAL=50867;DP=657;AF=0.24;MQM=50;TRIO=HET,657,0.24,HET,1977,0.34,HET,2586,0.33	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.6072T>C:p.His2024His		rs80353812	0.3281	0.22	0.1262	0.2624						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142693	0	0.4015	0.5985	0	112	n/a	n/a
chr1	152281304	152281304	A	C	het		QUAL=52565;DP=659;AF=0.28;MQM=51;TRIO=HET,659,0.28,HET,1954,0.34,HET,2588,0.34	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala		rs7512857	0	0.218	0.1329	0.3268	0.3910	N	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142694	0	0.3939	0.6061	0	111	n/a	n/a
chr1	152281479	152281479	G	T	het		QUAL=115053;DP=864;AF=0.59;MQM=56;TRIO=HET,864,0.59,HET,1618,0.68,HOM,1990,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5883C>A:p.His1961Gln		rs3126079	0.5381	0.317	0.1721	0.6882	-4.7080	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142695	0.0606	0.303	0.6364	19	101	n/a	n/a
chr1	152281523	152281523	A	C	het		QUAL=33176;DP=794;AF=0.18;MQM=48;TRIO=HET,794,0.18,HET,1548,0.30,HET,1827,0.30	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly		rs80059102	0	0.22	0	0	-0.5530	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.2197	0.7803	0	70	n/a	n/a
chr1	152281534	152281534	A	T	het		QUAL=29307;DP=743;AF=0.17;MQM=48;TRIO=HET,743,0.17,HET,1506,0.28,HET,1768,0.28	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5828T>A:p.Leu1943His		rs113544881	0.3135	0	0	0	-2.7300	N	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.2197	0.7803	0	60	n/a	n/a
chr1	152281690	152281690	C	T	het		QUAL=50372;DP=518;AF=0.47;MQM=59;TRIO=HET,518,0.47,HET,1163,0.52,HET,1365,0.53	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln		rs12407748	0.2875	0.229	0.1444	0.0368	-4.0060	P	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996939	0.0455	0.3636	0.5909	13	99	n/a	n/a
chr1	152281948	152281948	G	A	het		QUAL=47503;DP=443;AF=0.48;MQM=58;TRIO=HET,443,0.48,HET,1103,0.51,HET,1940,0.39	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val		rs12405241	0.2875	0.229	0.1443	0.0365	-5.6230	P	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996940	0.0379	0.3712	0.5909	12	98	n/a	n/a
chr1	152282267	152282267	G	A	het		QUAL=45240;DP=396;AF=0.45;MQM=59;TRIO=HET,396,0.45,HET,1210,0.48,HET,1502,0.48	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys		rs12405278	0.2877	0.229	0.1442	0.0365	0.1370	P	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996941	0.0379	0.3712	0.5909	12	98	n/a	n/a
chr1	152282311	152282311	C	T	het		QUAL=48484;DP=501;AF=0.46;MQM=59;TRIO=HET,501,0.46,HET,1215,0.48,HET,1489,0.50	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.5051G>A:p.Arg1684His		rs12407807	0.2967	0.232	0.1443	0.0688	-2.4830	P	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.0379	0.3712	0.5909	12	100	n/a	n/a
chr1	152282917	152282917	G	T	het		QUAL=46964;DP=473;AF=0.49;MQM=59;TRIO=HET,473,0.49,HET,1064,0.49,HET,1503,0.50	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr		rs11204978	0.2871	0.229	0.1442	0.0365	0.2470	P	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996942	0.0303	0.3788	0.5909	11	99	n/a	n/a
chr1	152283236	152283236	T	C	het		QUAL=82024;DP=505;AF=0.48;MQM=55;TRIO=HET,505,0.48,HET,1297,0.48,HOM,1669,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly		rs11581433	0.3431	0.261	0.1671	0.1378	-2.3740	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.053	0.3788	0.5682	15	113	n/a	n/a
chr1	152283283	152283283	C	T	het		QUAL=50037;DP=499;AF=0.47;MQM=53;TRIO=HET,499,0.47,HET,1221,0.49,HET,1628,0.49	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.4079G>A:p.Arg1360His		rs11586631	0.2877	0.229	0.1439	0.037	-6.3060	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142696	0.0303	0.3788	0.5909	11	106	n/a	n/a
chr1	152283862	152283862	G	C	het		QUAL=70197;DP=524;AF=0.48;MQM=53;TRIO=HET,524,0.48,HET,1092,0.50,HOM,1440,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly		rs58001094	0.5341	0.306	0.1619	0.5996		P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM1600315	0.053	0.3788	0.5682	10	115	n/a	n/a
chr1	152283975	152283975	A	G	het		QUAL=81388;DP=541;AF=0.50;MQM=51;TRIO=HET,541,0.50,HET,1197,0.51,HOM,1682,1.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.3387T>C:p.Ser1129Ser		rs66831674	0.4631	0.294	0.1648	0.4564						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996943	0.053	0.3788	0.5682	17	106	n/a	n/a
chr1	152284377	152284377	G	A	het		QUAL=37675;DP=560;AF=0.52;MQM=55;TRIO=HET,560,0.52,WT,1312,0.02,HET,1613,0.55	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.2985C>T:p.His995His		rs373872833	0	0.0001	0	0						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0	0.0076	0.9924	0	3	n/a	n/a
chr1	152284854	152284854	A	G	het		QUAL=61226;DP=464;AF=0.47;MQM=58;TRIO=HET,464,0.47,HET,870,0.52,HOM,1237,0.99	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.2508T>C:p.Asp836Asp		rs3120653	0.4732	0.298	0.17	0.5011						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.053	0.3788	0.5682	17	108	n/a	n/a
chr1	152285099	152285099	C	T	het		QUAL=91934;DP=478;AF=0.52;MQM=59;TRIO=HET,478,0.52,HET,1417,0.50,HOM,1878,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys		rs74129461	0.3277	0.256	0.1678	0.0835	-0.3080	P	T	P	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996944	0.053	0.3788	0.5682	15	105	n/a	n/a
chr1	152285930	152285930	G	A	het		QUAL=74788;DP=496;AF=0.51;MQM=59;TRIO=HET,496,0.51,HET,1164,0.49,HOM,1550,0.99	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser		rs11584340	0.3446	0.261	0.1679	0.1396	-1.8930	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];		CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis, increased risk, association with" GENE=FLG]; 		0.053	0.3712	0.5758	15	104	n/a	n/a
chr1	152286002	152286002	T	C	het		QUAL=72932;DP=438;AF=0.48;MQM=59;TRIO=HET,438,0.48,HET,1142,0.49,HOM,1562,0.99	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala		rs2011331	0.4641	0.295	0.1699	0.4671	-2.8550	P	T	B	B	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM4142699	0.053	0.3712	0.5758	17	105	n/a	n/a
chr1	152286032	152286032	C	T	het		QUAL=50253;DP=552;AF=0.47;MQM=59;TRIO=HET,552,0.47,HET,1204,0.50,HET,1551,0.46	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg		rs11588170	0.2871	0.229	0.1443	0.0365	-0.6390	P	T	P	P	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM3996946	0.0303	0.3712	0.5985	11	98	n/a	n/a
chr1	152286126	152286126	A	G	het		QUAL=25185;DP=436;AF=0.49;MQM=60;TRIO=HET,436,0.49,HET,1192,0.50,WT,1496,0.00	FLG	synonymous	FLG:NM_002016.1:synonymous:LOW:exon3/3:c.1236T>C:p.Arg412Arg		rs11582620	0.0861	0.118	0.1166	0.0211						135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];			COSM146620	0.0076	0.2197	0.7727	9	63	n/a	n/a
chr1	152286367	152286367	C	A	het		QUAL=63412;DP=553;AF=0.50;MQM=59;TRIO=HET,553,0.50,HET,904,0.50,HOM,1264,1.00	FLG	missense	FLG:NM_002016.1:missense:MODERATE:exon3/3:c.995G>T:p.Gly332Val		rs41267154	0.3407	0.26	0.1679	0.1321	-1.0200	P	T	D	D	135940 [FLG (confirmed) Ichthyosis vulgaris|Dermatitis,atopic,susceptibility to,2];				0.053	0.3788	0.5682	15	105	n/a	n/a
chr1	154138283	154138283	G	A	het		QUAL=385;DP=135;AF=0.23;MQM=52;TRIO=HET,135,0.23,WT,60,0.07,HET,83,0.12	TPM3	3'UTR,intron	TPM3:NM_152263.3:3'UTR:MODIFIER:exon10/10:c.*2130C>T:,TPM3:NM_001278191.1:intron:MODIFIER:exon7/7:c.394+4593C>T:,TPM3:NM_001043351.1:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:NM_001043352.1:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:NM_001043353.1:intron:MODIFIER:exon7/7:c.664+4593C>T:,TPM3:NM_001278188.1:intron:MODIFIER:exon6/6:c.466+4593C>T:,TPM3:NM_001278189.1:intron:MODIFIER:exon8/8:c.743+3498C>T:,TPM3:NM_001278190.1:intron:MODIFIER:exon6/6:c.601+4593C>T:,TPM3:NM_153649.3:intron:MODIFIER:exon7/7:c.664+4593C>T:	AluSq	rs200411262	0	0	0	0						191030 [TPM3 (confirmed) Nemaline myopathy 1,autosomal dominant or recessive|CAP myopathy 1|Myopathy congenital,with fiber-type disproportion];				0	0.0303	0.9697	0	5	n/a	n/a
chr1	154548721	154548721	T	C	hom		QUAL=9171;DP=111;AF=0.98;MQM=59;TRIO=HOM,111,0.98,HOM,125,1.00,HET,108,0.51	CHRNB2	3'UTR	CHRNB2:NM_000748.2:3'UTR:MODIFIER:exon6/6:c.*313T>C:		rs2072660	0.6927	0	0	0										0.6439	0.3106	0.0455	96	47	n/a	n/a
chr1	154552010	154552010	C	G	het		QUAL=10205;DP=290;AF=0.56;MQM=60;TRIO=HET,290,0.56,HET,332,0.48,WT,411,0.00	CHRNB2	3'UTR	CHRNB2:NM_000748.2:3'UTR:MODIFIER:exon6/6:c.*3602C>G:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr1	156107534	156107534	C	T	het		QUAL=8044;DP=146;AF=0.60;MQM=59;TRIO=HET,146,0.60,WT,232,0.00,HET,321,0.56	LMNA	splice_region&synonymous,synonymous,intron	LMNA:NM_170707.3:splice_region&synonymous:LOW:exon10/12:c.1698C>T:p.His566His,LMNA:NM_001282626.1:splice_region&synonymous:LOW:exon10/12:c.1698C>T:p.His566His,LMNA:NM_001257374.2:splice_region&synonymous:LOW:exon10/13:c.1362C>T:p.His454His,LMNA:NM_001282625.1:synonymous:LOW:exon13/13:c.1698C>T:p.His566His,LMNA:NM_005572.3:synonymous:LOW:exon10/10:c.1698C>T:p.His566His,LMNA:NM_001282624.1:synonymous:LOW:exon11/11:c.1455C>T:p.His485His,LMNA:NM_170708.3:intron:MODIFIER:exon9/10:c.1608+511C>T:		rs4641	0.2202	0.162	0.2531	0.0881						150330 [LMNA (confirmed) Emery-Dreifuss muscular dystrophy 2,AD|Cardiomyopathy,dilated,1A|Lipodystrophy,familial partial,2|Emery-Dreifuss muscular dystrophy 3,AR|Charcot-Marie-Tooth disease,type 2B1|Muscular dystrophy,congenital|Muscular dystrophy,limb-girdle,type 1B|Mandibuloacral dysplasia|Hutchinson-Gilford progeria|Restrictive dermopathy,lethal|Heart-hand syndrome,Slovenian type|Malouf syndrome];	RCV000041327.4 [other]; RCV000057348.2 [benign]; 	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome, association with" GENE=LMNA]; 	COSM3750413	0.0682	0.3333	0.5985	37	194	n/a	n/a
chr1	156785617	156785617	G	A	hom		QUAL=22226;DP=189;AF=1.00;MQM=60;TRIO=HOM,189,1.00,HOM,210,1.00,HOM,294,1.00	NTRK1,SH2D2A	5'UTR,intron	NTRK1:NM_001007792.1:5'UTR:MODIFIER:exon1/17:c.-5G>A:,SH2D2A:NM_001161441.1:intron:MODIFIER:exon2/8:c.123+181C>T:,SH2D2A:NM_001161443.1:intron:MODIFIER:exon1/7:c.39+181C>T:,SH2D2A:NM_001161442.1:intron:MODIFIER:exon2/8:c.69+181C>T:,SH2D2A:NM_003975.3:intron:MODIFIER:exon2/8:c.123+181C>T:,SH2D2A:NM_001161444.1:intron:MODIFIER:exon2/7:c.123+181C>T:		rs1800601	0.637	0.668	0.6759	0.5041										0.4545	0.4242	0.1212	208	201	n/a	n/a
chr1	156846233	156846233	G	A	het		QUAL=6888;DP=152;AF=0.49;MQM=60;TRIO=HET,152,0.49,HOM,147,1.00,WT,146,0.00	NTRK1	synonymous	NTRK1:NM_002529.3:synonymous:LOW:exon14/17:c.1674G>A:p.Gln558Gln,NTRK1:NM_001007792.1:synonymous:LOW:exon14/17:c.1566G>A:p.Gln522Gln,NTRK1:NM_001012331.1:synonymous:LOW:exon13/16:c.1656G>A:p.Gln552Gln		rs6334	0.2129	0.219	0.2194	0.1432						191315 [NTRK1 (confirmed) Insensitivity to pain,congenital,with anhidrosis|Medullary thyroid carcinoma,familial];			COSM3750440	0.0606	0.2803	0.6591	32	141	n/a	n/a
chr1	156848995	156848995	C	T	het		QUAL=3957;DP=47;AF=0.30;MQM=59;TRIO=HET,47,0.30,WT,104,0.01,HOM,127,0.97	NTRK1	synonymous	NTRK1:NM_002529.3:synonymous:LOW:exon15/17:c.1887C>T:p.Ala629Ala,NTRK1:NM_001007792.1:synonymous:LOW:exon15/17:c.1779C>T:p.Ala593Ala,NTRK1:NM_001012331.1:synonymous:LOW:exon14/16:c.1869C>T:p.Ala623Ala		rs6337	0.3341	0.57	0.7262	0.2262						191315 [NTRK1 (confirmed) Insensitivity to pain,congenital,with anhidrosis|Medullary thyroid carcinoma,familial];	RCV000127264.1 [benign]; 		COSM4142851	0.4697	0.3939	0.1364	211	196	n/a	n/a
chr1	160009121	160009121	A	C	het		QUAL=3676;DP=170;AF=0.49;MQM=59;TRIO=HET,170,0.49,HET,67,0.45,WT,81,0.00	KCNJ10	3'UTR	KCNJ10:NM_002241.4:3'UTR:MODIFIER:exon2/2:c.*2062T>G:		rs1053074	0.481	0	0	0										0.1818	0.5152	0.303	26	77	n/a	n/a
chr1	160009143	160009143	G	C	hom		QUAL=8306;DP=137;AF=1.00;MQM=59;TRIO=HOM,137,1.00,HOM,56,0.96,HOM,66,1.00	KCNJ10	3'UTR	KCNJ10:NM_002241.4:3'UTR:MODIFIER:exon2/2:c.*2040C>G:		rs2486254	0.9982	0	0	0										1	0	0	150	0	n/a	n/a
chr1	160009419	160009419	A	C	hom		QUAL=31841;DP=364;AF=1.00;MQM=60;TRIO=HOM,364,1.00,HOM,261,1.00,HOM,343,1.00	KCNJ10	3'UTR	KCNJ10:NM_002241.4:3'UTR:MODIFIER:exon2/2:c.*1764T>G:		rs2486253	0.8628	0	0	0										0.7121	0.2576	0.0303	105	41	n/a	n/a
chr1	160247185	160247185	G	C	het		QUAL=11057;DP=283;AF=0.44;MQM=60;TRIO=HET,283,0.44,WT,166,0.01,HOM,216,1.00	PEX19	3'UTR	PEX19:NM_002857.3:3'UTR:MODIFIER:exon8/8:c.*2156C>G:,PEX19:NM_001193644.1:3'UTR:MODIFIER:exon8/8:c.*2164C>G:	Charlie10	rs10594	0.4523	0.496	0	0						615820 [DCAF8 (provisional) Giant axonal neuropathy 2,autosomal dominant];				0.2652	0.4773	0.2576	103	190	n/a	n/a
chr1	161140278	161140278	A	-	het		QUAL=7772;DP=225;AF=0.43;MQM=60;TRIO=HET,225,0.43,WT,328,0.00,HET,371,0.44	PPOX	frameshift	PPOX:NM_000309.3:frameshift:HIGH:exon10/13:c.1067delA:p.Gln356fs,PPOX:NM_001122764.1:frameshift:HIGH:exon10/13:c.1067delA:p.Gln356fs			0	0	0	0						600923 [PPOX (provisional) Porphyria variegata];				0	0.0076	0.9924	0	1	n/a	n/a
chr1	167399868	167399868	-	AG	hom		QUAL=14227;DP=173;AF=0.99;MQM=60;TRIO=HOM,173,0.99,HOM,133,1.00,HOM,169,0.98					rs397750029	0.987	0	0	0										1	0	0	150	0	n/a	n/a
chr1	167399962	167399962	T	C	hom		QUAL=39345;DP=380;AF=1.00;MQM=60;TRIO=HOM,380,1.00,HOM,371,1.00,HOM,456,1.00	CD247	3'UTR	CD247:NM_198053.2:3'UTR:MODIFIER:exon8/8:c.*956A>G:,CD247:NM_000734.3:3'UTR:MODIFIER:exon8/8:c.*956A>G:		rs947480	0.9874	0	0	0										1	0	0	150	0	n/a	n/a
chr1	167400074	167400074	T	A	hom		QUAL=45398;DP=397;AF=1.00;MQM=59;TRIO=HOM,397,1.00,HOM,431,1.00,HOM,587,1.00	CD247	3'UTR	CD247:NM_198053.2:3'UTR:MODIFIER:exon8/8:c.*844A>T:,CD247:NM_000734.3:3'UTR:MODIFIER:exon8/8:c.*844A>T:		rs1052231	0.8111	0	0	0										0.7348	0.2045	0.0606	108	34	n/a	n/a
chr1	179519880	179519880	T	C	hom		QUAL=27810;DP=264;AF=1.00;MQM=60;TRIO=HOM,264,1.00,HOM,270,1.00,HOM,326,1.00	NPHS2,AXDND1	3'UTR,intron	NPHS2:NM_014625.3:3'UTR:MODIFIER:exon8/8:c.*428A>G:,NPHS2:NM_001297575.1:3'UTR:MODIFIER:exon7/7:c.*428A>G:,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3767T>C:		rs1060775	0.9018	0	0	0										0.8636	0.1288	0.0076	129	20	n/a	n/a
chr1	179520050	179520050	T	C	het		QUAL=8889;DP=324;AF=0.46;MQM=60;TRIO=HET,324,0.46,HOM,120,1.00,WT,176,0.00	NPHS2,AXDND1	3'UTR,intron	NPHS2:NM_014625.3:3'UTR:MODIFIER:exon8/8:c.*258A>G:,NPHS2:NM_001297575.1:3'UTR:MODIFIER:exon7/7:c.*258A>G:,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3597T>C:		rs2274622	0.2831	0	0	0										0.0909	0.3333	0.5758	14	51	n/a	n/a
chr1	179520151	179520151	C	T	hom		QUAL=24034;DP=280;AF=1.00;MQM=60;TRIO=HOM,280,1.00,HOM,192,1.00,HOM,262,0.99	NPHS2,AXDND1	3'UTR,intron	NPHS2:NM_014625.3:3'UTR:MODIFIER:exon8/8:c.*157G>A:,NPHS2:NM_001297575.1:3'UTR:MODIFIER:exon7/7:c.*157G>A:,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3496C>T:		rs1410590	0.9052	0	0	0										0.8636	0.1288	0.0076	129	20	n/a	n/a
chr1	179520254	179520254	C	G	hom		QUAL=22001;DP=384;AF=0.99;MQM=59;TRIO=HOM,384,0.99,HOM,129,0.99,HOM,172,0.99	NPHS2,AXDND1	3'UTR,intron	NPHS2:NM_014625.3:3'UTR:MODIFIER:exon8/8:c.*54G>C:,NPHS2:NM_001297575.1:3'UTR:MODIFIER:exon7/7:c.*54G>C:,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3393C>G:		rs1410591	0.5879	0	0	0										0.3712	0.4545	0.1742	54	66	n/a	n/a
chr1	179520506	179520506	G	A	hom		QUAL=20539;DP=335;AF=0.99;MQM=60;TRIO=HOM,335,0.99,HOM,125,0.99,HOM,183,1.00	NPHS2,AXDND1	synonymous,intron	NPHS2:NM_014625.3:synonymous:LOW:exon8/8:c.954C>T:p.Ala318Ala,NPHS2:NM_001297575.1:synonymous:LOW:exon7/7:c.750C>T:p.Ala250Ala,AXDND1:NM_144696.5:intron:MODIFIER:exon25/25:c.3032-3141G>A:		rs1410592	0.5877	0.619	0.6262	0.5996						604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2];			COSM146700	0.3636	0.4545	0.1818	172	208	n/a	n/a
chr1	179544898	179544898	T	C	hom		QUAL=441;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HOM,3,1.00,HOM,13,1.00	NPHS2	synonymous	NPHS2:NM_014625.3:synonymous:LOW:exon1/8:c.102A>G:p.Gly34Gly,NPHS2:NM_001297575.1:synonymous:LOW:exon1/7:c.102A>G:p.Gly34Gly		rs1079292	0.9309	0.958	0.9933	0.9031						604766 [NPHS2 (confirmed) Nephrotic syndrome,type 2];			COSM3749013	0.8561	0.0152	0.1288	403	10	n/a	n/a
chr1	180235728	180235728	C	T	het		QUAL=2362;DP=74;AF=0.50;MQM=60;TRIO=HET,74,0.50,WT,91,0.00,HET,108,0.42	LHX4	splice_region&synonymous	LHX4:NM_033343.3:splice_region&synonymous:LOW:exon3/6:c.450C>T:p.Asn150Asn		rs16855642	0.0427	0.021	0.0134	0.0978						602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4];				0	0.0152	0.9848	0	11	n/a	n/a
chr1	180240510	180240510	T	C	het		QUAL=2014;DP=66;AF=0.52;MQM=60;TRIO=HET,66,0.52,HET,76,0.46,WT,112,0.00	LHX4	splice_region&intron	LHX4:NM_033343.3:splice_region&intron:LOW:exon3/5:c.452-5T>C:		rs2764449	0.0413	0.066	0.0803	0.0175						602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4];			COSM3997105	0	0.1667	0.8333	0	69	n/a	n/a
chr1	180243524	180243524	A	G	het		QUAL=9274;DP=204;AF=0.48;MQM=60;TRIO=HET,204,0.48,HET,154,0.49,HET,202,0.56	LHX4	missense	LHX4:NM_033343.3:missense:MODERATE:exon6/6:c.983A>G:p.Asn328Ser		rs7536561	0.4263	0.485	0.516	0.2049	2.5290	P	T	B	B	602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4];			COSM3746684	0.2273	0.5303	0.2424	123	219	n/a	n/a
chr1	183155305	183155305	G	A	het		QUAL=20740;DP=266;AF=0.51;MQM=60;TRIO=HET,266,0.51,WT,366,0.00,HOM,520,1.00	LAMC2	5'UTR	LAMC2:NM_005562.2:5'UTR:MODIFIER:exon1/23:c.-183G>A:,LAMC2:NM_018891.2:5'UTR:MODIFIER:exon1/22:c.-183G>A:		rs2276543	0.2989	0	0	0										0.053	0.4091	0.5379	7	63	n/a	n/a
chr1	183210381	183210381	A	-	het		QUAL=159;DP=14;AF=0.14;MQM=60;TRIO=HET,14,0.14,HET,11,0.64,WT,3,0.00	LAMC2	3'UTR,intron	LAMC2:NM_018891.2:3'UTR:MODIFIER:exon22/22:c.*862delA:,LAMC2:NM_005562.2:intron:MODIFIER:exon22/22:c.3328+870delA:	AluSx1	rs397864083	0	0	0	0						150292 [LAMC2 (confirmed) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,junctional,non-Herlitz type];				0.0379	0.053	0.9091	5	7	n/a	n/a
chr1	183524855	183524855	C	A	hom		QUAL=44273;DP=461;AF=1.00;MQM=59;TRIO=HOM,461,1.00,HOM,385,0.99,HOM,544,0.99	NCF2	3'UTR	NCF2:NM_000433.3:3'UTR:MODIFIER:exon15/15:c.*398G>T:,NCF2:NM_001190789.1:3'UTR:MODIFIER:exon13/13:c.*398G>T:,NCF2:NM_001190794.1:3'UTR:MODIFIER:exon14/14:c.*398G>T:,NCF2:NM_001127651.2:3'UTR:MODIFIER:exon16/16:c.*398G>T:		rs796860	0.9393	0	0	0										0.75	0.1515	0.0985	114	23	n/a	n/a
chr1	183542387	183542387	T	C	hom		QUAL=19064;DP=255;AF=0.99;MQM=60;TRIO=HOM,255,0.99,HOM,187,1.00,HET,266,0.54	NCF2	missense,intron	NCF2:NM_000433.3:missense:MODERATE:exon5/15:c.542A>G:p.Lys181Arg,NCF2:NM_001190794.1:missense:MODERATE:exon4/14:c.407A>G:p.Lys136Arg,NCF2:NM_001127651.2:missense:MODERATE:exon6/16:c.542A>G:p.Lys181Arg,NCF2:NM_001190789.1:intron:MODIFIER:exon3/12:c.367-2413A>G:		rs2274064	0.4916	0.489	0.4665	0.3588	0.5830	P	T	B,B	B,B	608515 [NCF2 (confirmed) Chronic granulomatous disease due to deficiency of NCF-2];			COSM3750690	0.2348	0.5076	0.2576	83	242	n/a	n/a
chr1	196654324	196654324	A	C	het		QUAL=11612;DP=283;AF=0.48;MQM=60;TRIO=HET,283,0.48,HET,208,0.48,HET,265,0.48	CFH	synonymous	CFH:NM_000186.3:synonymous:LOW:exon7/22:c.921A>C:p.Ala307Ala,CFH:NM_001014975.2:synonymous:LOW:exon7/10:c.921A>C:p.Ala307Ala		rs1061147	0.7131	0.667	0.6172	0.5903						134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1|Complement factor H deficiency|Macular degeneration,age-related,4|Basal laminar drusen];		CM057396 [CLASS=DP MUT=REF PHEN="Macular degeneration, age-related, association with" GENE=CFH]; 	COSM3750723	0.4394	0.4545	0.1061	199	214	n/a	n/a
chr1	196659237	196659237	C	T	het		QUAL=6675;DP=189;AF=0.57;MQM=56;TRIO=HET,189,0.57,HET,104,0.41,HET,108,0.49	CFH	missense	CFH:NM_000186.3:missense:MODERATE:exon9/22:c.1204C>T:p.His402Tyr,CFH:NM_001014975.2:missense:MODERATE:exon9/10:c.1204C>T:p.His402Tyr		rs1061170	0.7334	0.671	0.6177	0.6373	-6.7150	P	T	B,B	B,B	134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1|Complement factor H deficiency|Macular degeneration,age-related,4|Basal laminar drusen];	RCV000018015.2 [other]; RCV000018016.27 [pathogenic]; 	CM051020 [CLASS=DFP MUT=REF PHEN="Macular degeneration, age-related, association with" GENE=CFH]; 	COSM424915	0.4394	0.447	0.1136	198	208	2	n/a
chr1	196682947	196682947	G	A	het		QUAL=10701;DP=261;AF=0.42;MQM=60;TRIO=HET,261,0.42,HET,192,0.49,HET,255,0.48	CFH	synonymous	CFH:NM_000186.3:synonymous:LOW:exon10/22:c.1419G>A:p.Ala473Ala		rs2274700	0.479	0.442	0.4043	0.4689						134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1|Complement factor H deficiency|Macular degeneration,age-related,4|Basal laminar drusen];	RCV000018023.1 [other]; 	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis, association" GENE=CFH]; 	COSM3750724	0.1894	0.4924	0.3182	96	226	n/a	n/a
chr1	196709816	196709816	G	T	het		QUAL=8429;DP=284;AF=0.52;MQM=60;TRIO=HET,284,0.52,WT,183,0.00,HET,216,0.51	CFH	missense	CFH:NM_000186.3:missense:MODERATE:exon18/22:c.2850G>T:p.Gln950His		rs149474608	0.0016	0.0036	0.0062	0.0009	-0.2730	N	T	P	B	134370 [CFH (confirmed) Hemolytic uremic syndrome,atypical,susceptibility to,1|Complement factor H deficiency|Macular degeneration,age-related,4|Basal laminar drusen];		CM034428 [CLASS=DM MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH]; 		0	0.0152	0.9848	0	5	2	n/a
chr1	197053373	197053373	G	A	hom		QUAL=19063;DP=240;AF=1.00;MQM=60;TRIO=HOM,240,1.00,HOM,137,1.00,HOM,198,1.00	ASPM	3'UTR	ASPM:NM_018136.4:3'UTR:MODIFIER:exon28/28:c.*81C>T:,ASPM:NM_001206846.1:3'UTR:MODIFIER:exon27/27:c.*81C>T:		rs12677	0.7823	0	0	0										0.8788	0.1212	0	132	18	n/a	n/a
chr1	197055925	197055925	T	C	hom		QUAL=13650;DP=169;AF=1.00;MQM=60;TRIO=HOM,169,1.00,HOM,107,1.00,HOM,137,1.00	ASPM	splice_region&intron	ASPM:NM_018136.4:splice_region&intron:LOW:exon27/27:c.10331+8A>G:,ASPM:NM_001206846.1:splice_region&intron:LOW:exon26/26:c.5576+8A>G:		rs10754213	0.7827	0.878	0.9076	0.4575						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];				0.8788	0.1212	0	361	87	n/a	n/a
chr1	197070776	197070776	C	T	het		QUAL=10578;DP=223;AF=0.54;MQM=60;TRIO=HET,223,0.54,HET,188,0.46,HET,243,0.49	ASPM	synonymous,intron	ASPM:NM_018136.4:synonymous:LOW:exon18/28:c.7605G>A:p.Val2535Val,ASPM:NM_001206846.1:intron:MODIFIER:exon17/26:c.4066-5482G>A:		rs10922162	0.2949	0.239	0.151	0.0443						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020793.1 [benign]; RCV000123702.1 [benign]; RCV000145189.1 [benign]; 			0.053	0.2955	0.6515	19	120	n/a	n/a
chr1	197070815	197070815	T	C	hom		QUAL=19685;DP=237;AF=1.00;MQM=59;TRIO=HOM,237,1.00,HOM,154,1.00,HOM,197,1.00	ASPM	synonymous,intron	ASPM:NM_018136.4:synonymous:LOW:exon18/28:c.7566A>G:p.Leu2522Leu,ASPM:NM_001206846.1:intron:MODIFIER:exon17/26:c.4066-5521A>G:		rs1412640	0.8159	0.887	0.9077	0.5513						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020792.1 [benign]; RCV000145187.2 [other]; 			0.8788	0.1212	0	361	88	n/a	n/a
chr1	197070901	197070901	A	G	hom		QUAL=23141;DP=315;AF=1.00;MQM=60;TRIO=HOM,315,1.00,HOM,166,1.00,HOM,206,1.00	ASPM	missense,intron	ASPM:NM_018136.4:missense:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His,ASPM:NM_001206846.1:intron:MODIFIER:exon17/26:c.4066-5607T>C:		rs964201	0.9974	0.996	0.9941	0.9989	2.9990	P	T	B,B	B,B	605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020789.1 [benign]; RCV000123700.1 [benign]; RCV000145183.2 [benign]; 			0.9924	0.0076	0	451	3	n/a	n/a
chr1	197091537	197091537	A	T	hom		QUAL=24273;DP=309;AF=1.00;MQM=59;TRIO=HOM,309,1.00,HOM,197,1.00,HOM,248,1.00	ASPM	synonymous	ASPM:NM_018136.4:synonymous:LOW:exon14/28:c.3579T>A:p.Ser1193Ser,ASPM:NM_001206846.1:synonymous:LOW:exon14/27:c.3579T>A:p.Ser1193Ser		rs4915337	0.7825	0.878	0.9074	0.4567						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020768.1 [benign]; RCV000145113.1 [likely benign]; 			0.8788	0.1212	0	360	88	n/a	n/a
chr1	197094030	197094030	C	T	het		QUAL=11529;DP=391;AF=0.49;MQM=60;TRIO=HET,391,0.49,HET,151,0.48,HET,183,0.49	ASPM	synonymous	ASPM:NM_018136.4:synonymous:LOW:exon12/28:c.3138G>A:p.Arg1046Arg,ASPM:NM_001206846.1:synonymous:LOW:exon12/27:c.3138G>A:p.Arg1046Arg		rs6676084	0.2167	0.28	0.3181	0.1571						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020763.1 [benign]; RCV000145109.1 [benign]; 		COSM3750735	0.1364	0.5076	0.3561	52	197	n/a	n/a
chr1	197108946	197108946	A	G	het		QUAL=5147;DP=255;AF=0.42;MQM=60;TRIO=HET,255,0.42,HET,109,0.44,WT,143,0.00	ASPM	synonymous	ASPM:NM_018136.4:synonymous:LOW:exon4/28:c.1977T>C:p.Ile659Ile,ASPM:NM_001206846.1:synonymous:LOW:exon4/27:c.1977T>C:p.Ile659Ile		rs17550662	0.0192	0.045	0.0623	0.0113						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000020751.1 [benign]; RCV000145092.1 [benign]; 			0	0.1364	0.8636	1	48	n/a	n/a
chr1	197112533	197112533	G	A	hom		QUAL=7422;DP=110;AF=1.00;MQM=60;TRIO=HOM,110,1.00,HOM,61,0.98,HOM,52,1.00	ASPM	synonymous	ASPM:NM_018136.4:synonymous:LOW:exon3/28:c.849C>T:p.Ser283Ser,ASPM:NM_001206846.1:synonymous:LOW:exon3/27:c.849C>T:p.Ser283Ser		rs6677082	0.7556	0.869	0.9068	0.3872						605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive];	RCV000081938.3 [other]; 			0.8712	0.1212	0.0076	357	88	n/a	n/a
chr1	198661668	198661668	G	A	het		QUAL=962;DP=55;AF=0.45;MQM=60;TRIO=HET,55,0.45,HET,7,0.86,WT,5,0.00	PTPRC	intron	PTPRC:NM_002838.4:intron:MODIFIER:exon3/32:c.100+166G>A:,PTPRC:NM_001267798.1:intron:MODIFIER:exon3/3:c.100+166G>A:,PTPRC:NM_080921.3:intron:MODIFIER:exon3/29:c.100+166G>A:		rs115067628	0.004	0	0	0						151460 [PTPRC (confirmed) Hepatitic C virus,susceptibility to|Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive];				0	0.0227	0.9773	0	3	n/a	n/a
chr1	201012597	201012597	G	A	hom		QUAL=366;DP=10;AF=1.00;MQM=60;TRIO=HOM,10,1.00,WT,3,0.00,HOM,4,1.00	CACNA1S	synonymous	CACNA1S:NM_000069.2:synonymous:LOW:exon40/44:c.4860C>T:p.Pro1620Pro		rs41267497	0.0461	0.107	0.1621	0.0336						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];				0.0303	0	0.9697	12	59	n/a	n/a
chr1	201038687	201038687	A	G	het		QUAL=10060;DP=219;AF=0.48;MQM=60;TRIO=HET,219,0.48,WT,338,0.00,HET,423,0.51	CACNA1S	synonymous	CACNA1S:NM_000069.2:synonymous:LOW:exon18/44:c.2403T>C:p.Phe801Phe		rs7415038	0.2941	0.303	0.4502	0.5139						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];				0.1515	0.4697	0.3788	74	197	n/a	n/a
chr1	201044748	201044748	A	G	het		QUAL=11016;DP=150;AF=0.53;MQM=59;TRIO=HET,150,0.53,WT,258,0.00,HOM,277,1.00	CACNA1S	splice_region&intron	CACNA1S:NM_000069.2:splice_region&intron:LOW:exon12/43:c.1828-5T>C:		rs1998721	0.7596	0.781	0.777	0.5595						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];				0.6364	0.303	0.0606	274	150	n/a	n/a
chr1	201047062	201047062	G	A	hom		QUAL=15584;DP=132;AF=0.98;MQM=60;TRIO=HOM,132,0.98,HOM,259,1.00,HET,260,0.47	CACNA1S	synonymous	CACNA1S:NM_000069.2:synonymous:LOW:exon11/44:c.1564C>T:p.Leu522Leu		rs4915476	0.1909	0.207	0.2227	0.266						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];		CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis, association with" GENE=CACNA1S]; 	COSM3750745	0.0758	0.303	0.6212	37	141	n/a	n/a
chr1	201047075	201047075	A	G	hom		QUAL=18271;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HOM,268,1.00,HET,279,0.51	CACNA1S	synonymous	CACNA1S:NM_000069.2:synonymous:LOW:exon11/44:c.1551T>C:p.Gly517Gly		rs4915477	0.5711	0.584	0.6605	0.8836						114208 [CACNA1S (confirmed) Hypokalemic periodic paralysis,type 1|Malignant hyperthermia susceptibility 5|Thyrotoxic periodic paralysis,susceptibility to,1];		CM023569 [CLASS=DP MUT=REF PHEN="Hypokalaemic periodic paralysis, association with" GENE=CACNA1S]; 	COSM4143154	0.3864	0.4242	0.1894	190	192	n/a	n/a
chr1	209788213	209788213	T	C	hom		QUAL=5886;DP=148;AF=0.99;MQM=60;TRIO=HOM,148,0.99,HET,41,0.59,HET,72,0.46					rs926387	0.7748	0	0	0										0.3939	0.4394	0.1667	62	66	n/a	n/a
chr1	209788514	209788514	G	A	het		QUAL=6664;DP=183;AF=0.51;MQM=60;TRIO=HET,183,0.51,WT,239,0.00,HET,260,0.46	LAMB3	3'UTR	LAMB3:NM_000228.2:3'UTR:MODIFIER:exon23/23:c.*102C>T:,LAMB3:NM_001017402.1:3'UTR:MODIFIER:exon22/22:c.*102C>T:,LAMB3:NM_001127641.1:3'UTR:MODIFIER:exon23/23:c.*102C>T:		rs2566	0.2951	0	0	0								CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer, increased risk, association with" GENE=LAMB3]; 		0.053	0.303	0.6439	9	47	n/a	n/a
chr1	209799253	209799253	A	G	het		QUAL=23710;DP=287;AF=0.40;MQM=59;TRIO=HET,287,0.40,HOM,379,1.00,HET,543,0.50	LAMB3	synonymous	LAMB3:NM_000228.2:synonymous:LOW:exon14/23:c.1716T>C:p.Cys572Cys,LAMB3:NM_001017402.1:synonymous:LOW:exon13/22:c.1716T>C:p.Cys572Cys,LAMB3:NM_001127641.1:synonymous:LOW:exon14/23:c.1716T>C:p.Cys572Cys		rs2179402	0.765	0.754	0.735	0.7675						150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,junctional,non-Herlitz type];			COSM3746765	0.6591	0.2803	0.0606	265	150	n/a	n/a
chr1	209807972	209807972	G	A	hom		QUAL=5306;DP=28;AF=1.00;MQM=60;TRIO=HOM,28,1.00,HOM,58,1.00,HOM,90,1.00	LAMB3	synonymous	LAMB3:NM_000228.2:synonymous:LOW:exon6/23:c.384C>T:p.Pro128Pro,LAMB3:NM_001017402.1:synonymous:LOW:exon5/22:c.384C>T:p.Pro128Pro,LAMB3:NM_001127641.1:synonymous:LOW:exon6/23:c.384C>T:p.Pro128Pro		rs1130667	0.2454	0.344	0.3956	0.1539						150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,junctional,non-Herlitz type];			COSM3746766	0.1515	0.4167	0.4318	69	209	n/a	n/a
chr1	209811886	209811886	T	G	hom		QUAL=18786;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HOM,135,1.00,HOM,211,1.00	LAMB3	synonymous	LAMB3:NM_000228.2:synonymous:LOW:exon4/23:c.291A>C:p.Ser97Ser,LAMB3:NM_001017402.1:synonymous:LOW:exon3/22:c.291A>C:p.Ser97Ser,LAMB3:NM_001127641.1:synonymous:LOW:exon4/23:c.291A>C:p.Ser97Ser		rs2076356	0.4325	0.57	0.646	0.4351						150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,junctional,non-Herlitz type];			COSM146753	0.4924	0.3939	0.1136	206	196	n/a	n/a
chr1	209959614	209959614	G	T	het		QUAL=8532;DP=336;AF=0.54;MQM=57;TRIO=HET,336,0.54,WT,124,0.00,HET,183,0.50	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*2151C>A:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*2151C>A:		rs1044516	0.3099	0	0	0										0.053	0.2576	0.6894	7	36	n/a	n/a
chr1	209959872	209959872	G	A	hom		QUAL=19171;DP=310;AF=1.00;MQM=56;TRIO=HOM,310,1.00,HOM,124,0.99,HOM,149,0.99	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*1893C>T:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*1893C>T:		rs680331	0.8081	0	0	0										0.6515	0.2879	0.0606	99	42	n/a	n/a
chr1	209960436	209960436	G	A	het		QUAL=7809;DP=255;AF=0.46;MQM=59;TRIO=HET,255,0.46,WT,199,0.00,HET,248,0.50	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*1329C>T:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*1329C>T:	AluJo	rs2235372	0.2991	0	0	0										0.053	0.2576	0.6894	7	36	n/a	n/a
chr1	209960922	209960922	A	C	het		QUAL=3152;DP=118;AF=0.47;MQM=60;TRIO=HET,118,0.47,HOM,44,1.00,WT,110,0.00	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*843T>G:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*843T>G:		rs599021	0.3043	0	0	0										0.2197	0.5682	0.2121	36	82	n/a	n/a
chr1	209960925	209960925	T	C	het		QUAL=3758;DP=123;AF=0.52;MQM=60;TRIO=HET,123,0.52,WT,43,0.00,HET,124,0.45	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*840A>G:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*840A>G:		rs742214	0.2971	0	0	0										0.053	0.2576	0.6894	7	36	n/a	n/a
chr1	209961023	209961023	T	A	het		QUAL=2697;DP=95;AF=0.51;MQM=60;TRIO=HET,95,0.51,WT,51,0.02,HET,80,0.49	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*742A>T:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*742A>T:		rs742215	0.3037	0	0	0										0.053	0.2576	0.6894	7	36	n/a	n/a
chr1	209961314	209961314	T	C	het		QUAL=8053;DP=263;AF=0.51;MQM=60;TRIO=HET,263,0.51,WT,186,0.01,HET,240,0.47	IRF6	3'UTR	IRF6:NM_006147.3:3'UTR:MODIFIER:exon9/9:c.*451A>G:,IRF6:NM_001206696.1:3'UTR:MODIFIER:exon7/7:c.*451A>G:		rs17317411	0.0875	0	0	0										0.0303	0.2045	0.7652	4	28	n/a	n/a
chr1	209968684	209968684	C	A	het		QUAL=19377;DP=335;AF=0.45;MQM=60;TRIO=HET,335,0.45,WT,320,0.00,HOM,452,1.00	IRF6	synonymous	IRF6:NM_006147.3:synonymous:LOW:exon5/9:c.459G>T:p.Ser153Ser,IRF6:NM_001206696.1:synonymous:LOW:exon3/7:c.174G>T:p.Ser58Ser		rs2013162	0.4038	0.402	0.3685	0.2914						607199 [IRF6 (confirmed) van der Woude syndrome|Popliteal pterygium syndrome 1|Orofacial cleft 6];			COSM3746770	0.0909	0.4167	0.4924	41	210	n/a	n/a
chr1	209969902	209969902	G	C	het		QUAL=5382;DP=207;AF=0.47;MQM=60;TRIO=HET,207,0.47,WT,51,0.02,HOM,86,0.99	IRF6	splice_region&intron	IRF6:NM_006147.3:splice_region&intron:LOW:exon3/8:c.175-5C>G:,IRF6:NM_001206696.1:splice_region&intron:LOW:exon1/6:c.-111-5C>G:		rs7552506	0.271	0.324	0.3551	0.2826						607199 [IRF6 (confirmed) van der Woude syndrome|Popliteal pterygium syndrome 1|Orofacial cleft 6];				0.0758	0.3864	0.5379	39	182	n/a	n/a
chr1	209975386	209975386	A	G	het		QUAL=12725;DP=281;AF=0.48;MQM=60;TRIO=HET,281,0.48,HOM,262,1.00,WT,351,0.00	IRF6	splice_region,5'UTR,intron	IRF6:NM_006147.3:splice_region:LOW:exon2/9:c.-73T>C:,IRF6:NM_006147.3:5'UTR:MODIFIER:exon2/9:c.-73T>C:,IRF6:NM_001206696.1:intron:MODIFIER:exon1/6:c.-112+3906T>C:		rs861019	0.3864	0	0	0										0.2197	0.5682	0.2121	36	82	n/a	n/a
chr1	215796350	215796350	T	G	het		QUAL=14517;DP=349;AF=0.51;MQM=60;TRIO=HET,349,0.51,WT,177,0.00,HOM,266,1.00	USH2A	3'UTR	USH2A:NM_206933.2:3'UTR:MODIFIER:exon72/72:c.*2773A>C:		rs6667509	0.103	0	0	0										0.0227	0.1742	0.803	4	26	n/a	n/a
chr1	215798014	215798014	G	A	hom		QUAL=33474;DP=446;AF=1.00;MQM=60;TRIO=HOM,446,1.00,HOM,226,1.00,HOM,325,1.00	USH2A	3'UTR	USH2A:NM_206933.2:3'UTR:MODIFIER:exon72/72:c.*1109C>T:		rs2797255	0.9912	0	0	0										1	0	0	150	0	n/a	n/a
chr1	215808007	215808007	G	A	het		QUAL=4531;DP=172;AF=0.48;MQM=60;TRIO=HET,172,0.48,HET,134,0.50,WT,191,0.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp		rs56038610	0.006	0.016	0.0174	0.0039	3.0690	N	T	P	B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041778.2 [benign]; RCV000087008.2 [benign]; 			0	0.0379	0.9621	0	15	n/a	n/a
chr1	215848062	215848062	C	T	het		QUAL=9865;DP=364;AF=0.51;MQM=60;TRIO=HET,364,0.51,HET,246,0.50,WT,311,0.01	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon63/72:c.13191G>A:p.Glu4397Glu		rs2009923	0.2035	0.199	0.1866	0.0622						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041736.2 [benign]; RCV000126269.1 [benign]; 		COSM3746784	0.0303	0.2955	0.6742	13	138	n/a	n/a
chr1	215848641	215848641	T	C	het		QUAL=22725;DP=381;AF=0.49;MQM=60;TRIO=HET,381,0.49,HET,280,0.50,HOM,373,0.99	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon63/72:c.12612A>G:p.Thr4204Thr		rs2797235	0.6897	0.765	0.814	0.6382						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000126267.1 [benign]; RCV000152568.1,RCV000154669.1 [benign,benign]; 		COSM146765	0.6742	0.2879	0.0379	288	146	n/a	n/a
chr1	215901492	215901492	C	T	hom		QUAL=40924;DP=406;AF=0.99;MQM=59;TRIO=HOM,406,0.99,HET,539,0.42,HOM,637,0.99	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon61/72:c.11946G>A:p.Leu3982Leu		rs2820718	0.1188	0.156	0.1845	0.1714						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041709.2 [benign]; RCV000126265.1 [benign]; 			0.0379	0.3333	0.6288	15	127	n/a	n/a
chr1	215914751	215914751	G	T	het		QUAL=6562;DP=207;AF=0.54;MQM=60;TRIO=HET,207,0.54,HET,193,0.51,WT,253,0.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr		rs41303285	0.0062	0.017	0.0224	0.005	5.6550	D	T	D	D	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041701.2 [benign]; RCV000126262.1 [benign]; 			0	0.0455	0.9545	0	15	n/a	n/a
chr1	215960167	215960167	T	G	hom		QUAL=26796;DP=218;AF=1.00;MQM=59;TRIO=HOM,218,1.00,HOM,282,1.00,HOM,362,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala		rs10864198	0.5887	0.547	0.5188	0.6716	2.5980	P	T	B	B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000154357.1,RCV000041665.4 [benign,benign]; RCV000126257.1 [benign]; 		COSM3750863	0.3939	0.4091	0.197	139	207	n/a	n/a
chr1	216166454	216166454	T	G	het		QUAL=3381;DP=120;AF=0.48;MQM=60;TRIO=HET,120,0.48,HET,94,0.57,WT,98,0.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala		rs41277212	0.0076	0.022	0.0295	0.0059	4.8840	D	D	D	P	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041894.2 [benign]; RCV000087012.2 [benign]; 	CM140482 [CLASS=DM MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A]; 	COSM3750865	0	0.0227	0.9773	0	18	n/a	n/a
chr1	216172380	216172380	A	G	hom		QUAL=19042;DP=180;AF=0.99;MQM=60;TRIO=HOM,180,0.99,HOM,189,1.00,HOM,227,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr		rs10864219	0.5935	0.556	0.5027	0.4385	2.3950	P	T	B	B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041888.2 [benign]; RCV000126249.1 [benign]; 		COSM3750867	0.2955	0.4924	0.2121	129	213	n/a	n/a
chr1	216219781	216219781	A	G	het		QUAL=9746;DP=200;AF=0.49;MQM=60;TRIO=HET,200,0.49,HET,124,0.51,HOM,146,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr		rs6657250	0.5956	0.606	0.6695	0.7608	0.9880	P	T	B	B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000126248.1 [benign]; RCV000154356.1,RCV000154111.2 [benign,benign]; 		COSM146769	0.4848	0.3864	0.1288	208	188	n/a	n/a
chr1	216258194	216258194	G	T	het		QUAL=7315;DP=154;AF=0.49;MQM=60;TRIO=HET,154,0.49,HET,131,0.51,HET,174,0.52	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon25/72:c.5013C>A:p.Gly1671Gly		rs56110889	0.1058	0.135	0.1722	0.1916						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041853.4 [benign]; RCV000126247.1 [benign]; 		COSM3746787	0.0152	0.2803	0.7045	7	115	n/a	n/a
chr1	216347452	216347452	C	A	het		QUAL=4504;DP=216;AF=0.42;MQM=60;TRIO=HET,216,0.42,HET,106,0.45,WT,121,0.00	USH2A	3'UTR,intron	USH2A:NM_007123.5:3'UTR:MODIFIER:exon21/21:c.*1128G>T:,USH2A:NM_206933.2:intron:MODIFIER:exon21/71:c.4627+1142G>T:		rs401269	0.1945	0	0	0						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];				0.0379	0.3485	0.6136	5	51	n/a	n/a
chr1	216347556	216347556	A	G	het		QUAL=4532;DP=224;AF=0.48;MQM=60;TRIO=HET,224,0.48,HET,55,0.55,WT,55,0.00	USH2A	3'UTR,intron	USH2A:NM_007123.5:3'UTR:MODIFIER:exon21/21:c.*1024T>C:,USH2A:NM_206933.2:intron:MODIFIER:exon21/71:c.4627+1038T>C:		rs439940	0.1953	0	0	0						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];				0.0379	0.3485	0.6136	5	51	n/a	n/a
chr1	216348764	216348764	C	T	het		QUAL=32187;DP=475;AF=0.53;MQM=60;TRIO=HET,475,0.53,HET,452,0.49,HOM,505,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys,USH2A:NM_007123.5:missense:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys		rs1805049	0.6623	0.657	0.6117	0.596	-1.6250	P	T	B,B	B,B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000126245.1 [benign]; RCV000154339.1,RCV000154668.1 [benign,benign]; 		COSM3746788	0.3258	0.5682	0.1061	179	217	n/a	n/a
chr1	216371934	216371934	A	C	het		QUAL=4966;DP=222;AF=0.54;MQM=59;TRIO=HET,222,0.54,HET,82,0.55,WT,90,0.00	USH2A	splice_region&intron	USH2A:NM_206933.2:splice_region&intron:LOW:exon17/71:c.3812-8T>G:,USH2A:NM_007123.5:splice_region&intron:LOW:exon17/20:c.3812-8T>G:		rs646094	0.1977	0.212	0.2306	0.1673						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041834.2 [benign]; RCV000126241.1 [benign]; 			0.0379	0.3409	0.6212	19	139	n/a	n/a
chr1	216592003	216592003	T	C	hom		QUAL=18885;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HOM,185,1.00,HOM,254,1.00	USH2A	synonymous	USH2A:NM_206933.2:synonymous:LOW:exon3/72:c.504A>G:p.Thr168Thr,USH2A:NM_007123.5:synonymous:LOW:exon3/21:c.504A>G:p.Thr168Thr		rs4253963	0.6328	0.648	0.6431	0.505						608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041854.2 [benign]; RCV000126251.1 [benign]; 			0.3712	0.4773	0.1515	165	221	n/a	n/a
chr1	216595306	216595306	C	T	hom		QUAL=32927;DP=293;AF=1.00;MQM=60;TRIO=HOM,293,1.00,HOM,278,1.00,HOM,440,1.00	USH2A	missense	USH2A:NM_206933.2:missense:MODERATE:exon2/72:c.373G>A:p.Ala125Thr,USH2A:NM_007123.5:missense:MODERATE:exon2/21:c.373G>A:p.Ala125Thr		rs10779261	0.7612	0.729	0.6991	0.7578	0.3550	P	T	B,B	B,B	608400 [USH2A (confirmed) Usher syndrome,type 2A|Retinitis pigmentosa 39];	RCV000041833.2 [benign]; RCV000126239.1 [benign]; 			0.4621	0.4242	0.1136	209	196	n/a	n/a
chr1	220323449	220323449	T	-	het		QUAL=1622;DP=128;AF=0.27;MQM=59;TRIO=HET,128,0.27,HET,40,0.33,HET,46,0.22	RAB3GAP2	3'UTR	RAB3GAP2:NM_012414.3:3'UTR:MODIFIER:exon35/35:c.*1144delA:	FLAM_A	rs397861447	0	0	0	0										0.0227	0.2652	0.7121	3	36	n/a	n/a
chr1	220323794	220323794	T	-	het		QUAL=769;DP=48;AF=0.29;MQM=60;TRIO=HET,48,0.29,HET,14,0.43,HET,27,0.26	RAB3GAP2	3'UTR	RAB3GAP2:NM_012414.3:3'UTR:MODIFIER:exon35/35:c.*799delA:	(T)n	rs577626438	0.3638	0	0	0										0.0076	0.1667	0.8258	1	23	n/a	n/a
chr1	220324189	220324189	A	G	het		QUAL=11772;DP=414;AF=0.54;MQM=60;TRIO=HET,414,0.54,WT,215,0.00,HET,266,0.53	RAB3GAP2	3'UTR	RAB3GAP2:NM_012414.3:3'UTR:MODIFIER:exon35/35:c.*404T>C:		rs1059140	0.0627	0	0	0										0.0076	0.1894	0.803	2	27	n/a	n/a
chr1	220330672	220330672	C	T	het		QUAL=11408;DP=411;AF=0.54;MQM=60;TRIO=HET,411,0.54,WT,208,0.00,HET,288,0.48	RAB3GAP2	synonymous	RAB3GAP2:NM_012414.3:synonymous:LOW:exon31/35:c.3495G>A:p.Leu1165Leu		rs11547779	0.0605	0.088	0.0936	0.0216						609275 [RAB3GAP2 (provisional) Martsolf syndrome|Warburg micro syndrome 2];	RCV000118107.2 [likely benign]; RCV000127678.1 [benign]; 		COSM3750881	0.0076	0.1818	0.8106	8	76	n/a	n/a
chr1	220331205	220331205	C	G	het		QUAL=8062;DP=290;AF=0.45;MQM=60;TRIO=HET,290,0.45,WT,182,0.00,HET,248,0.46	RAB3GAP2	missense	RAB3GAP2:NM_012414.3:missense:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr		rs2289189	0.0603	0.087	0.0936	0.0216	7.4300	P	T	D,D	P,P	609275 [RAB3GAP2 (provisional) Martsolf syndrome|Warburg micro syndrome 2];	RCV000118106.2 [likely benign]; RCV000127677.1 [benign]; 		COSM3750882	0.0076	0.1818	0.8106	8	75	n/a	n/a
chr1	223178561	223178561	A	C	hom		QUAL=21452;DP=188;AF=1.00;MQM=60;TRIO=HOM,188,1.00,HOM,285,1.00,HET,370,0.53	DISP1	synonymous	DISP1:NM_032890.3:synonymous:LOW:exon10/10:c.3822A>C:p.Pro1274Pro		rs9441941	0.498	0.544	0.5767	0.4532									COSM146786	0.3409	0.4697	0.1894	152	220	n/a	n/a
chr1	225589473	225589473	C	T	het		QUAL=10335;DP=321;AF=0.50;MQM=60;TRIO=HET,321,0.50,WT,267,0.00,HET,351,0.44	LBR	3'UTR	LBR:NM_002296.3:3'UTR:MODIFIER:exon14/14:c.*1532G>A:,LBR:NM_194442.2:3'UTR:MODIFIER:exon14/14:c.*1532G>A:		rs7406	0.2726	0	0	0										0.0227	0.3106	0.6667	3	44	n/a	n/a
chr1	225590750	225590750	G	C	het		QUAL=5522;DP=310;AF=0.47;MQM=60;TRIO=HET,310,0.47,WT,47,0.00,HET,55,0.51	LBR	3'UTR	LBR:NM_002296.3:3'UTR:MODIFIER:exon14/14:c.*255C>G:,LBR:NM_194442.2:3'UTR:MODIFIER:exon14/14:c.*255C>G:		rs11551874	0.102	0	0	0										0.0227	0.2424	0.7348	3	35	n/a	n/a
chr1	225607144	225607144	C	T	het		QUAL=2142;DP=73;AF=0.38;MQM=60;TRIO=HET,73,0.38,HOM,20,1.00,HET,47,0.45	LBR	missense	LBR:NM_002296.3:missense:MODERATE:exon5/14:c.461G>A:p.Ser154Asn,LBR:NM_194442.2:missense:MODERATE:exon5/14:c.461G>A:p.Ser154Asn		rs2230419	0.7123	0.799	0.8397	0.4371	-0.1880	P	T	B,B	B,B	600024 [LBR (confirmed) Pelger-Huet anomaly|Greenberg skeletal dysplasia|Reynolds syndrome];				0.6667	0.3106	0.0227	307	126	n/a	n/a
chr1	225609884	225609884	A	G	het		QUAL=2589;DP=114;AF=0.57;MQM=60;TRIO=HET,114,0.57,HOM,12,1.00,HET,13,0.62	LBR	synonymous	LBR:NM_002296.3:synonymous:LOW:exon3/14:c.261T>C:p.Pro87Pro,LBR:NM_194442.2:synonymous:LOW:exon3/14:c.261T>C:p.Pro87Pro		rs1056608	0.6709	0.75	0.7909	0.402						600024 [LBR (confirmed) Pelger-Huet anomaly|Greenberg skeletal dysplasia|Reynolds syndrome];				0.5758	0.3712	0.053	278	153	n/a	n/a
chr1	225611661	225611661	C	T	het		QUAL=18817;DP=362;AF=0.53;MQM=60;TRIO=HET,362,0.53,HET,209,0.49,HOM,283,1.00	LBR	synonymous	LBR:NM_002296.3:synonymous:LOW:exon2/14:c.117G>A:p.Val39Val,LBR:NM_194442.2:synonymous:LOW:exon2/14:c.117G>A:p.Val39Val		rs1056607	0.6571	0.711	0.7313	0.636						600024 [LBR (confirmed) Pelger-Huet anomaly|Greenberg skeletal dysplasia|Reynolds syndrome];				0.5076	0.4167	0.0758	236	181	n/a	n/a
chr1	226555302	226555302	A	G	het		QUAL=7263;DP=187;AF=0.50;MQM=60;TRIO=HET,187,0.50,WT,213,0.00,HET,293,0.48	PARP1	missense	PARP1:NM_001618.3:missense:MODERATE:exon17/23:c.2285T>C:p.Val762Ala		rs1136410	0.1969	0.202	0.1594	0.0529	8.9570	P	T	P	P			CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer, susceptibility, association with" GENE=PARP1]; 	COSM3997295	0.0303	0.2576	0.7121	14	142	n/a	n/a
chr1	226570840	226570840	T	C	het		QUAL=5424;DP=92;AF=0.59;MQM=59;TRIO=HET,92,0.59,HOM,70,1.00,HET,92,0.51	PARP1	synonymous	PARP1:NM_001618.3:synonymous:LOW:exon8/23:c.1056A>G:p.Lys352Lys		rs1805415	0.7893	0.794	0.8408	0.8976									COSM3746819	0.7121	0.2576	0.0303	296	139	n/a	n/a
chr1	226573364	226573364	A	G	het		QUAL=5788;DP=146;AF=0.54;MQM=60;TRIO=HET,146,0.54,WT,206,0.00,HET,247,0.45	PARP1	synonymous	PARP1:NM_001618.3:synonymous:LOW:exon7/23:c.852T>C:p.Ala284Ala		rs1805414	0.5166	0.423	0.3415	0.537								CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma, association with" GENE=PARP1]; 	COSM4143411	0.1742	0.3409	0.4848	65	187	n/a	n/a
chr1	226589958	226589958	G	A	het		QUAL=11451;DP=288;AF=0.46;MQM=59;TRIO=HET,288,0.46,WT,297,0.00,HET,467,0.48	PARP1	synonymous	PARP1:NM_001618.3:synonymous:LOW:exon2/23:c.243C>T:p.Asp81Asp		rs1805404	0.2183	0.208	0.1591	0.1255									COSM3997296	0.0303	0.2576	0.7121	14	143	n/a	n/a
chr1	226595647	226595647	C	G	het		QUAL=2945;DP=39;AF=0.54;MQM=59;TRIO=HET,39,0.54,WT,145,0.00,HET,157,0.50	PARP1	5'UTR	PARP1:NM_001618.3:5'UTR:MODIFIER:exon1/23:c.-17G>C:		rs907187	0.1991	0.201	0.1548	0.0495									COSN392383	0.0303	0.2576	0.7121	6	47	n/a	n/a
chr1	227172290	227172290	C	T	het		QUAL=16779;DP=330;AF=0.47;MQM=60;TRIO=HET,330,0.47,HOM,381,0.98,WT,502,0.00	ADCK3	synonymous	ADCK3:NM_020247.4:synonymous:LOW:exon12/15:c.1440C>T:p.Phe480Phe		rs12593	0.2386	0.352	0.458	0.209						606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4];	RCV000116235.2 [likely benign]; 		COSM146800	0.1515	0.4015	0.447	211	502	n/a	n/a
chr1	227174145	227174145	T	C	het		QUAL=4379;DP=107;AF=0.54;MQM=60;TRIO=HET,107,0.54,HOM,86,1.00,WT,166,0.00	ADCK3	splice_region&intron	ADCK3:NM_020247.4:splice_region&intron:LOW:exon14/14:c.1660-9T>C:		rs7552783	0.3516	0.414	0.505	0.4185						606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4];				0.1667	0.5	0.3333	266	533	n/a	n/a
chr1	227174210	227174210	T	C	het		QUAL=5685;DP=155;AF=0.44;MQM=60;TRIO=HET,155,0.44,HOM,117,1.00,WT,184,0.00	ADCK3	synonymous	ADCK3:NM_020247.4:synonymous:LOW:exon15/15:c.1716T>C:p.Ser572Ser		rs3738725	0.3139	0.405	0.5053	0.3189						606980 [ADCK3 (confirmed) Coenzyme Q10 deficiency,primary,4];	RCV000116236.2 [likely benign]; 		COSM3997301	0.1667	0.5	0.3333	259	536	n/a	n/a
chr1	227174823	227174823	-	T	het		QUAL=13330;DP=233;AF=0.41;MQM=60;TRIO=HET,233,0.41,HOM,364,0.97,WT,479,0.00	ADCK3	3'UTR	ADCK3:NM_020247.4:3'UTR:MODIFIER:exon15/15:c.*389dupT:		rs11420839	0.2927	0	0	0										0.1591	0.5076	0.3333	24	80	n/a	n/a
chr1	227175245	227175245	-	T	het		QUAL=7666;DP=164;AF=0.37;MQM=60;TRIO=HET,164,0.37,HOM,216,0.94,WT,332,0.00	ADCK3	3'UTR	ADCK3:NM_020247.4:3'UTR:MODIFIER:exon15/15:c.*797_*798insT:		rs397803535	0.2548	0	0	0										0.1515	0.5152	0.3333	23	81	n/a	n/a
chr1	227175253	227175253	C	T	het		QUAL=8849;DP=159;AF=0.45;MQM=60;TRIO=HET,159,0.45,HOM,214,1.00,WT,323,0.00					rs10495274	0.4191	0	0	0										0.2955	0.5	0.2045	47	76	n/a	n/a
chr1	228346936	228346936	G	A	het		QUAL=2761;DP=44;AF=0.59;MQM=59;TRIO=HET,44,0.59,WT,92,0.00,HET,129,0.53	GJC2	3'UTR	GJC2:NM_020435.3:3'UTR:MODIFIER:exon2/2:c.*157G>A:		rs45491398	0.0234	0	0	0										0.0076	0.1061	0.8864	1	17	n/a	n/a
chr1	228347352	228347352	A	G	hom		QUAL=1566;DP=31;AF=1.00;MQM=59;TRIO=HOM,31,1.00,HOM,8,1.00,HOM,13,1.00	GJC2	3'UTR	GJC2:NM_020435.3:3'UTR:MODIFIER:exon2/2:c.*573A>G:		rs6668719	0.8043	0	0	0										0.8712	0.1136	0.0152	128	19	n/a	n/a
chr1	228612838	228612838	G	T	het		QUAL=20114;DP=275;AF=0.51;MQM=60;TRIO=HET,275,0.51,HET,285,0.46,HOM,380,1.00	HIST3H3	synonymous	HIST3H3:NM_003493.2:synonymous:LOW:exon1/1:c.189C>A:p.Ile63Ile		rs2230656	0.6903	0.821	0.8852	0.4172									COSM4143485	0.7803	0.2045	0.0152	341	105	n/a	n/a
chr1	229569803	229569803	A	G	het		QUAL=3702;DP=60;AF=0.53;MQM=60;TRIO=HET,60,0.53,HET,74,0.49,HET,107,0.55	ACTA1	5'UTR	ACTA1:NM_001100.3:5'UTR:MODIFIER:exon1/7:c.-65T>C:		rs605430	0.6302	0	0	0										0.3182	0.5379	0.1439	46	83	n/a	n/a
chr1	229569804	229569804	G	A	het		QUAL=3702;DP=60;AF=0.53;MQM=60;TRIO=HET,60,0.53,HET,74,0.49,HET,107,0.55	ACTA1	5'UTR	ACTA1:NM_001100.3:5'UTR:MODIFIER:exon1/7:c.-66C>T:		rs605428	0.6436	0	0	0										0.3182	0.5379	0.1439	46	83	n/a	n/a
chr1	231377081	231377081	C	T	hom		QUAL=19652;DP=271;AF=0.99;MQM=60;TRIO=HOM,271,0.99,HOM,246,0.99,HET,311,0.55	GNPAT	5'UTR	GNPAT:NM_014236.3:5'UTR:MODIFIER:exon1/16:c.-44C>T:		rs518686	0.5819	0.549	0.5383	0.5756										0.2727	0.553	0.1742	52	87	n/a	n/a
chr1	231401902	231401902	G	A	hom		QUAL=18894;DP=345;AF=1.00;MQM=60;TRIO=HOM,345,1.00,HET,200,0.49,HET,256,0.50	GNPAT	synonymous	GNPAT:NM_014236.3:synonymous:LOW:exon7/16:c.915G>A:p.Glu305Glu		rs574553	0.6286	0.568	0.5484	0.6854						602744 [GNPAT (provisional) Chondrodysplasia punctata,rhizomelic,type 2];			COSM3750988	0.2652	0.5909	0.1439	145	230	n/a	n/a
chr1	231500353	231500353	-	T	hom		QUAL=17172;DP=328;AF=0.92;MQM=60;TRIO=HOM,328,0.92,HET,163,0.43,HOM,180,0.97	EGLN1	3'UTR	EGLN1:NM_022051.2:3'UTR:MODIFIER:exon5/5:c.*1803dupA:		rs541569859	0	0	0	0										0.447	0.4242	0.1288	68	63	n/a	n/a
chr1	231557255	231557255	C	G	het		QUAL=210;DP=3;AF=0.67;MQM=60;TRIO=HET,3,0.67,HOM,9,1.00,WT,3,0.00	EGLN1	missense	EGLN1:NM_022051.2:missense:MODERATE:exon1/5:c.380G>C:p.Cys127Ser		rs12097901	0.2604	0.094	0	0	-0.0310	P	T	B	B	606425 [EGLN1 (confirmed) Erythrocytosis,familial,3];		CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1]; 	COSM4143508	0.0152	0.0833	0.9015	11	43	n/a	n/a
chr1	231559226	231559226	A	G	het		QUAL=5688;DP=198;AF=0.52;MQM=60;TRIO=HET,198,0.52,HOM,69,1.00,WT,82,0.02	EGLN1	5'UTR	EGLN1:NM_022051.2:5'UTR:MODIFIER:exon1/5:c.-1592T>C:		rs12406290	0.2915	0	0	0										0.0606	0.2879	0.6515	11	46	n/a	n/a
chr1	231560220	231560220	A	G	het		QUAL=17350;DP=594;AF=0.54;MQM=60;TRIO=HET,594,0.54,HOM,212,1.00,WT,205,0.00	EGLN1	5'UTR	EGLN1:NM_022051.2:5'UTR:MODIFIER:exon1/5:c.-2586T>C:		rs2153364	0.2939	0	0	0										0.0606	0.2879	0.6515	11	47	n/a	n/a
chr1	235825643	235825643	G	A	het		QUAL=3412;DP=205;AF=0.46;MQM=60;TRIO=HET,205,0.46,HET,30,0.33,WT,66,0.00	LYST	3'UTR	LYST:NM_000081.3:3'UTR:MODIFIER:exon53/53:c.*597C>T:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr1	235826383	235826383	A	-	hom		QUAL=14650;DP=200;AF=0.89;MQM=59;TRIO=HOM,200,0.89,HET,192,0.49,HOM,271,0.89	LYST	splice_region&intron	LYST:NM_000081.3:splice_region&intron:LOW:exon52/52:c.11268-5delT:		rs556428133	0	0	0	0						606897 [LYST (confirmed) Chediak-Higashi syndrome];				0.3182	0.4242	0.2576	113	132	1	n/a
chr1	235940450	235940450	C	T	hom		QUAL=18235;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HET,201,0.43,HOM,236,1.00	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon17/53:c.5373G>A:p.Lys1791Lys		rs2273584	0.3009	0.348	0.3993	0.5059						606897 [LYST (confirmed) Chediak-Higashi syndrome];			COSM3746866	0.2121	0.4773	0.3106	76	206	n/a	n/a
chr1	235945294	235945294	T	C	hom		QUAL=15929;DP=180;AF=0.99;MQM=60;TRIO=HOM,180,0.99,HET,149,0.51,HOM,234,1.00	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon15/53:c.4956A>G:p.Leu1652Leu		rs6696123	0.3035	0.349	0.3994	0.5077						606897 [LYST (confirmed) Chediak-Higashi syndrome];			COSM3746867	0.2121	0.4848	0.303	80	205	n/a	n/a
chr1	235971763	235971763	A	G	het		QUAL=10124;DP=200;AF=0.53;MQM=60;TRIO=HET,200,0.53,HET,184,0.51,HET,255,0.49	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon5/53:c.2355T>C:p.Leu785Leu		rs3768066	0.0707	0.103	0.1366	0.0772						606897 [LYST (confirmed) Chediak-Higashi syndrome];				0.0227	0.2424	0.7348	13	117	n/a	n/a
chr1	235972435	235972435	T	C	hom		QUAL=28307;DP=476;AF=1.00;MQM=60;TRIO=HOM,476,1.00,HET,193,0.52,HOM,284,1.00	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon5/53:c.1683A>G:p.Leu561Leu		rs3820553	0.3027	0.35	0.3997	0.5089						606897 [LYST (confirmed) Chediak-Higashi syndrome];			COSM3746868	0.2121	0.4848	0.303	78	206	n/a	n/a
chr1	235972867	235972867	T	C	hom		QUAL=28220;DP=447;AF=1.00;MQM=60;TRIO=HOM,447,1.00,HET,189,0.56,HOM,305,0.99	LYST	synonymous	LYST:NM_000081.3:synonymous:LOW:exon5/53:c.1251A>G:p.Gln417Gln		rs1063128	0.3033	0.35	0.3994	0.5089						606897 [LYST (confirmed) Chediak-Higashi syndrome];			COSM3746869	0.2121	0.4848	0.303	80	203	n/a	n/a
chr1	236557771	236557771	G	A	hom		QUAL=24351;DP=243;AF=1.00;MQM=60;TRIO=HOM,243,1.00,HOM,224,1.00,HOM,287,1.00	EDARADD	missense	EDARADD:NM_145861.2:missense:MODERATE:exon1/6:c.27G>A:p.Met9Ile		rs966365	0.7768	0.831	0.8398	0.5404	-0.0830	P	T	B	B	606603 [EDARADD (confirmed) Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive|Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type];			COSM3746871	0.7045	0.2652	0.0303	342	100	n/a	n/a
chr1	236647511	236647511	T	C	het		QUAL=14321;DP=272;AF=0.56;MQM=60;TRIO=HET,272,0.56,HET,142,0.49,HOM,223,1.00	EDARADD	3'UTR	EDARADD:NM_145861.2:3'UTR:MODIFIER:exon6/6:c.*1562T>C:,EDARADD:NM_080738.3:3'UTR:MODIFIER:exon6/6:c.*1562T>C:		rs7513402	0.254	0	0	0										0.1591	0.4242	0.4167	21	66	n/a	n/a
chr1	236647550	236647550	C	G	het		QUAL=15267;DP=323;AF=0.55;MQM=60;TRIO=HET,323,0.55,HET,126,0.53,HOM,224,1.00	EDARADD	3'UTR	EDARADD:NM_145861.2:3'UTR:MODIFIER:exon6/6:c.*1601C>G:,EDARADD:NM_080738.3:3'UTR:MODIFIER:exon6/6:c.*1601C>G:		rs3916983	0.2033	0	0	0										0.0909	0.3712	0.5379	12	56	n/a	n/a
chr1	236647736	236647736	C	T	het		QUAL=8001;DP=160;AF=0.54;MQM=59;TRIO=HET,160,0.54,HET,74,0.54,HOM,130,0.99	EDARADD	3'UTR	EDARADD:NM_145861.2:3'UTR:MODIFIER:exon6/6:c.*1787C>T:,EDARADD:NM_080738.3:3'UTR:MODIFIER:exon6/6:c.*1787C>T:		rs6428955	0.1378	0	0	0										0.0682	0.3485	0.5833	9	53	n/a	n/a
chr1	236648008	236648008	G	A	het		QUAL=31;DP=24;AF=0.25;MQM=57;TRIO=HET,24,0.25,HET,38,0.13,WT,45,0.02	EDARADD	splice_region,3'UTR	EDARADD:NM_145861.2:splice_region:LOW:exon6/6:c.*2059G>A:,EDARADD:NM_080738.3:splice_region:LOW:exon6/6:c.*2059G>A:,EDARADD:NM_145861.2:3'UTR:MODIFIER:exon6/6:c.*2059G>A:,EDARADD:NM_080738.3:3'UTR:MODIFIER:exon6/6:c.*2059G>A:	AluSc	rs200288312	0	0	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr1	237054569	237054569	A	G	het		QUAL=7781;DP=97;AF=0.56;MQM=60;TRIO=HET,97,0.56,HET,101,0.50,HOM,144,1.00	MTR	synonymous	MTR:NM_000254.2:synonymous:LOW:exon29/33:c.3144A>G:p.Ala1048Ala,MTR:NM_001291939.1:synonymous:LOW:exon28/32:c.2991A>G:p.Ala997Ala,MTR:NM_001291940.1:synonymous:LOW:exon28/32:c.1923A>G:p.Ala641Ala		rs2229276	0.3233	0.383	0.4134	0.1984						156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126869.1 [benign]; 		COSM3751028	0.1818	0.5	0.3182	67	224	n/a	n/a
chr1	237058744	237058744	C	A	het		QUAL=15882;DP=211;AF=0.51;MQM=60;TRIO=HET,211,0.51,HET,220,0.45,HOM,308,1.00	MTR	synonymous	MTR:NM_000254.2:synonymous:LOW:exon31/33:c.3492C>A:p.Arg1164Arg,MTR:NM_001291939.1:synonymous:LOW:exon30/32:c.3339C>A:p.Arg1113Arg,MTR:NM_001291940.1:synonymous:LOW:exon30/32:c.2271C>A:p.Arg757Arg		rs12070777	0.3215	0.363	0.4106	0.2072						156570 [MTR (confirmed) Homocystinuria-megaloblastic anemia,cblG complementation type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126862.1 [benign]; 		COSM3751029	0.1818	0.5	0.3182	67	224	n/a	n/a
chr1	237061056	237061056	A	C	het		QUAL=11822;DP=305;AF=0.54;MQM=60;TRIO=HET,305,0.54,HET,80,0.53,HOM,152,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*112A>C:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*112A>C:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*112A>C:		rs2853522	0.5401	0	0	0										0.3864	0.4697	0.1439	90	103	n/a	n/a
chr1	237061705	237061705	T	-	het		QUAL=2349;DP=101;AF=0.45;MQM=57;TRIO=HET,101,0.45,HET,29,0.52,HET,36,0.86	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*773delT:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*773delT:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*773delT:	AluY	rs57170329	0.4605	0	0	0										0.3106	0.3864	0.303	48	55	n/a	n/a
chr1	237061849	237061849	G	A	het		QUAL=1573;DP=78;AF=0.42;MQM=51;TRIO=HET,78,0.42,HET,34,0.59,WT,63,0.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*905G>A:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*905G>A:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*905G>A:	AluY	rs1131450	0.246	0	0	0										0.1136	0.4545	0.4318	22	64	n/a	n/a
chr1	237062198	237062198	A	C	het		QUAL=18307;DP=262;AF=0.54;MQM=60;TRIO=HET,262,0.54,HET,241,0.47,HOM,295,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*1254A>C:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*1254A>C:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*1254A>C:		rs2853523	0.7646	0	0	0										0.4167	0.4621	0.1212	66	64	n/a	n/a
chr1	237062305	237062305	A	G	het		QUAL=23931;DP=410;AF=0.52;MQM=60;TRIO=HET,410,0.52,HET,291,0.52,HOM,366,0.99	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*1361A>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*1361A>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*1361A>G:		rs1050993	0.7644	0	0	0										0.4167	0.4621	0.1212	65	64	n/a	n/a
chr1	237063335	237063335	G	C	het		QUAL=14170;DP=226;AF=0.50;MQM=60;TRIO=HET,226,0.50,HET,205,0.53,HOM,220,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*2391G>C:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*2391G>C:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*2391G>C:	L1ME3F	rs1050996	0.7328	0	0	0										0.4091	0.4697	0.1212	103	113	n/a	n/a
chr1	237063504	237063504	A	G	het		QUAL=13368;DP=378;AF=0.50;MQM=60;TRIO=HET,378,0.50,HET,106,0.54,HOM,148,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*2560A>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*2560A>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*2560A>G:	L1ME3F	rs9779	0.3219	0.291	0	0										0.1818	0.5	0.3182	40	122	n/a	n/a
chr1	237063709	237063709	-	A	het		QUAL=8814;DP=82;AF=0.80;MQM=59;TRIO=HET,82,0.80,HOM,61,0.92,HOM,183,0.93	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*2774dupA:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*2774dupA:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*2774dupA:	L1ME3F	rs561258037	0.6516	0	0	0										0.5909	0.0682	0.3409	100	9	n/a	n/a
chr1	237064626	237064626	T	G	het		QUAL=36456;DP=412;AF=0.50;MQM=60;TRIO=HET,412,0.50,HET,508,0.48,HOM,667,0.99	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*3682T>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*3682T>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*3682T>G:		rs6676866	0.5397	0	0	0										0.3864	0.4697	0.1439	61	66	n/a	n/a
chr1	237065326	237065326	C	T	het		QUAL=8337;DP=162;AF=0.52;MQM=60;TRIO=HET,162,0.52,HET,105,0.45,HOM,135,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*4382C>T:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*4382C>T:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*4382C>T:		rs4659746	0.5447	0	0	0										0.3939	0.4621	0.1439	62	64	n/a	n/a
chr1	237065583	237065583	G	T	het		QUAL=14214;DP=211;AF=0.51;MQM=59;TRIO=HET,211,0.51,HET,172,0.57,HOM,251,1.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*4639G>T:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*4639G>T:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*4639G>T:		rs10925264	0.7646	0	0	0										0.4167	0.4621	0.1212	66	64	n/a	n/a
chr1	237065810	237065810	T	G	het		QUAL=5730;DP=169;AF=0.52;MQM=60;TRIO=HET,169,0.52,WT,176,0.00,HET,170,0.55	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*4866T>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*4866T>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*4866T>G:	L2c	rs45563435	0.0076	0	0	0										0	0.1061	0.8939	0	16	n/a	n/a
chr1	237066114	237066114	A	G	het		QUAL=3805;DP=154;AF=0.47;MQM=59;TRIO=HET,154,0.47,HET,85,0.59,WT,112,0.00	MTR	3'UTR	MTR:NM_000254.2:3'UTR:MODIFIER:exon33/33:c.*5170A>G:,MTR:NM_001291939.1:3'UTR:MODIFIER:exon32/32:c.*5170A>G:,MTR:NM_001291940.1:3'UTR:MODIFIER:exon32/32:c.*5170A>G:		rs6680753	0.0104	0	0	0										0	0.053	0.947	0	7	n/a	n/a
chr1	240939104	240939104	G	A	het		QUAL=10069;DP=344;AF=0.48;MQM=60;TRIO=HET,344,0.48,HOM,143,0.99,WT,165,0.00	RGS7	3'UTR	RGS7:NM_002924.5:3'UTR:MODIFIER:exon18/18:c.*359C>T:,RGS7:NM_001282773.1:3'UTR:MODIFIER:exon16/16:c.*416C>T:,RGS7:NM_001282775.1:3'UTR:MODIFIER:exon18/18:c.*416C>T:,RGS7:NM_001282778.1:3'UTR:MODIFIER:exon17/17:c.*359C>T:		rs35557904	0.1727	0	0	0										0.0152	0.1818	0.803	2	25	n/a	n/a
chr1	240939152	240939152	A	G	het		QUAL=10318;DP=316;AF=0.44;MQM=59;TRIO=HET,316,0.44,HOM,178,0.99,WT,207,0.00	RGS7	3'UTR	RGS7:NM_002924.5:3'UTR:MODIFIER:exon18/18:c.*311T>C:,RGS7:NM_001282773.1:3'UTR:MODIFIER:exon16/16:c.*368T>C:,RGS7:NM_001282775.1:3'UTR:MODIFIER:exon18/18:c.*368T>C:,RGS7:NM_001282778.1:3'UTR:MODIFIER:exon17/17:c.*311T>C:		rs16840577	0.1727	0	0	0										0.0152	0.1818	0.803	2	25	n/a	n/a
chr1	240939391	240939391	C	T	het		QUAL=15847;DP=499;AF=0.46;MQM=60;TRIO=HET,499,0.46,HET,548,0.47,WT,686,0.00	RGS7	3'UTR	RGS7:NM_002924.5:3'UTR:MODIFIER:exon18/18:c.*72G>A:,RGS7:NM_001282773.1:3'UTR:MODIFIER:exon16/16:c.*129G>A:,RGS7:NM_001282775.1:3'UTR:MODIFIER:exon18/18:c.*129G>A:,RGS7:NM_001282778.1:3'UTR:MODIFIER:exon17/17:c.*72G>A:		rs12757054	0.0497	0	0.0918	0.0368										0	0.1591	0.8409	0	25	n/a	n/a
chr1	240975213	240975213	T	C	het		QUAL=11730;DP=251;AF=0.55;MQM=60;TRIO=HET,251,0.55,WT,200,0.01,HOM,233,1.00	RGS7	splice_region&intron	RGS7:NM_002924.5:splice_region&intron:LOW:exon14/17:c.1082+5A>G:,RGS7:NM_001282773.1:splice_region&intron:LOW:exon12/15:c.923+5A>G:,RGS7:NM_001282775.1:splice_region&intron:LOW:exon14/17:c.1082+5A>G:,RGS7:NM_001282778.1:splice_region&intron:LOW:exon14/16:c.1082+5A>G:		rs2275742	0.4046	0.505	0.5766	0.2724									COSM146839	0.3636	0.4318	0.2045	150	194	n/a	n/a
chr1	241519098	241519098	T	A	hom		QUAL=34780;DP=422;AF=1.00;MQM=60;TRIO=HOM,422,1.00,HOM,278,1.00,HOM,413,1.00	RGS7	5'UTR	RGS7:NM_002924.5:5'UTR:MODIFIER:exon2/18:c.-22A>T:,RGS7:NM_001282773.1:5'UTR:MODIFIER:exon2/16:c.-22A>T:,RGS7:NM_001282775.1:5'UTR:MODIFIER:exon2/18:c.-22A>T:,RGS7:NM_001282778.1:5'UTR:MODIFIER:exon2/17:c.-22A>T:		rs4659599	0.9483	0.978	0.9864	0.8822										0.9924	0.0076	0	164	2	n/a	n/a
chr1	247581560	247581560	A	T	het		QUAL=15253;DP=476;AF=0.51;MQM=60;TRIO=HET,476,0.51,WT,305,0.00,HET,430,0.55	NLRP3	5'UTR	NLRP3:NM_001079821.2:5'UTR:MODIFIER:exon2/11:c.-71A>T:,NLRP3:NM_001127461.2:5'UTR:MODIFIER:exon2/9:c.-537A>T:,NLRP3:NM_001127462.2:5'UTR:MODIFIER:exon1/8:c.-537A>T:,NLRP3:NM_001243133.1:5'UTR:MODIFIER:exon1/9:c.-543A>T:,NLRP3:NM_004895.4:5'UTR:MODIFIER:exon1/9:c.-537A>T:,NLRP3:NM_183395.2:5'UTR:MODIFIER:exon1/7:c.-537A>T:		rs116502550	0.003	0	0	0										0	0.053	0.947	0	9	n/a	n/a
chr1	247581692	247581692	T	C	hom		QUAL=17435;DP=257;AF=1.00;MQM=58;TRIO=HOM,257,1.00,HOM,158,1.00,HOM,162,1.00	NLRP3	5'UTR,intron	NLRP3:NM_001127461.2:5'UTR:MODIFIER:exon2/9:c.-405T>C:,NLRP3:NM_001127462.2:5'UTR:MODIFIER:exon1/8:c.-405T>C:,NLRP3:NM_001243133.1:5'UTR:MODIFIER:exon1/9:c.-411T>C:,NLRP3:NM_004895.4:5'UTR:MODIFIER:exon1/9:c.-405T>C:,NLRP3:NM_183395.2:5'UTR:MODIFIER:exon1/7:c.-405T>C:,NLRP3:NM_001079821.2:intron:MODIFIER:exon2/10:c.-39+100T>C:	AluSx1	rs7523422	0.9978	0	0	0										1	0	0	150	0	n/a	n/a
chr1	247581872	247581872	G	A	het		QUAL=6029;DP=208;AF=0.54;MQM=59;TRIO=HET,208,0.54,HET,67,0.55,HET,85,0.44	NLRP3	5'UTR,intron	NLRP3:NM_001127461.2:5'UTR:MODIFIER:exon2/9:c.-225G>A:,NLRP3:NM_001127462.2:5'UTR:MODIFIER:exon1/8:c.-225G>A:,NLRP3:NM_001243133.1:5'UTR:MODIFIER:exon1/9:c.-231G>A:,NLRP3:NM_004895.4:5'UTR:MODIFIER:exon1/9:c.-225G>A:,NLRP3:NM_183395.2:5'UTR:MODIFIER:exon1/7:c.-225G>A:,NLRP3:NM_001079821.2:intron:MODIFIER:exon2/10:c.-38-187G>A:	AluSx1	rs138900557	0.0158	0	0	0										0.0076	0.1212	0.8712	1	18	n/a	n/a
chr1	247582063	247582063	G	T	het		QUAL=12301;DP=323;AF=0.48;MQM=60;TRIO=HET,323,0.48,HET,230,0.41,HET,285,0.50	NLRP3	5'UTR	NLRP3:NM_001079821.2:5'UTR:MODIFIER:exon3/11:c.-34G>T:,NLRP3:NM_001127461.2:5'UTR:MODIFIER:exon2/9:c.-34G>T:,NLRP3:NM_001127462.2:5'UTR:MODIFIER:exon1/8:c.-34G>T:,NLRP3:NM_001243133.1:5'UTR:MODIFIER:exon1/9:c.-40G>T:,NLRP3:NM_004895.4:5'UTR:MODIFIER:exon1/9:c.-34G>T:,NLRP3:NM_183395.2:5'UTR:MODIFIER:exon1/7:c.-34G>T:		rs73136263	0.027	0.037	0.0469	0.032										0.0076	0.1364	0.8561	1	20	n/a	n/a
chr1	247587477	247587477	G	A	het		QUAL=7722;DP=162;AF=0.47;MQM=60;TRIO=HET,162,0.47,HET,151,0.41,HET,190,0.58	NLRP3	synonymous	NLRP3:NM_001079821.2:synonymous:LOW:exon5/11:c.732G>A:p.Ala244Ala,NLRP3:NM_001127461.2:synonymous:LOW:exon4/9:c.732G>A:p.Ala244Ala,NLRP3:NM_001127462.2:synonymous:LOW:exon3/8:c.732G>A:p.Ala244Ala,NLRP3:NM_001243133.1:synonymous:LOW:exon3/9:c.726G>A:p.Ala242Ala,NLRP3:NM_004895.4:synonymous:LOW:exon3/9:c.732G>A:p.Ala244Ala,NLRP3:NM_183395.2:synonymous:LOW:exon3/7:c.732G>A:p.Ala244Ala		rs3806268	0.3874	0.499	0.5526	0.1198						606416 [NLRP3 (confirmed) Cold-induced autoinflammatory syndrome,familial|Muckle-Wells syndrome|CINCA syndrome];	RCV000127218.1 [benign]; 		COSM146848	0.4167	0.4697	0.1136	165	214	n/a	n/a
chr1	247587531	247587531	A	G	hom		QUAL=14158;DP=157;AF=1.00;MQM=60;TRIO=HOM,157,1.00,HOM,119,1.00,HOM,160,1.00	NLRP3	synonymous	NLRP3:NM_001079821.2:synonymous:LOW:exon5/11:c.786A>G:p.Arg262Arg,NLRP3:NM_001127461.2:synonymous:LOW:exon4/9:c.786A>G:p.Arg262Arg,NLRP3:NM_001127462.2:synonymous:LOW:exon3/8:c.786A>G:p.Arg262Arg,NLRP3:NM_001243133.1:synonymous:LOW:exon3/9:c.780A>G:p.Arg260Arg,NLRP3:NM_004895.4:synonymous:LOW:exon3/9:c.786A>G:p.Arg262Arg,NLRP3:NM_183395.2:synonymous:LOW:exon3/7:c.786A>G:p.Arg262Arg		rs4925543	0.9199	0.943	0.9536	0.8509						606416 [NLRP3 (confirmed) Cold-induced autoinflammatory syndrome,familial|Muckle-Wells syndrome|CINCA syndrome];	RCV000127219.1 [benign]; 			0.9621	0.0379	0	417	35	n/a	n/a
chr1	247612036	247612036	G	C	hom		QUAL=50023;DP=689;AF=1.00;MQM=60;TRIO=HOM,689,1.00,HOM,381,1.00,HOM,499,1.00	NLRP3	3'UTR	NLRP3:NM_001079821.2:3'UTR:MODIFIER:exon11/11:c.*230G>C:,NLRP3:NM_001127461.2:3'UTR:MODIFIER:exon9/9:c.*230G>C:,NLRP3:NM_001127462.2:3'UTR:MODIFIER:exon8/8:c.*230G>C:,NLRP3:NM_001243133.1:3'UTR:MODIFIER:exon9/9:c.*230G>C:,NLRP3:NM_004895.4:3'UTR:MODIFIER:exon9/9:c.*230G>C:,NLRP3:NM_183395.2:3'UTR:MODIFIER:exon7/7:c.*230G>C:		rs10754558	0.6536	0	0	0								CR098789 [CLASS=DFP MUT=REF PHEN="Anaphylaxis, food-induced, association with" GENE=NLRP3]; 		0.2652	0.447	0.2879	41	69	n/a	n/a
chr2	1417244	1417244	A	G	het		QUAL=9948;DP=240;AF=0.54;MQM=60;TRIO=HET,240,0.54,WT,221,0.00,HET,351,0.52	TPO	5'UTR_premature_start_codon_gain,5'UTR	TPO:NM_000547.5:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-80A>G:,TPO:NM_001206744.1:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-75A>G:,TPO:NM_001206745.1:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-75A>G:,TPO:NM_175719.3:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-80A>G:,TPO:NM_000547.5:5'UTR:MODIFIER:exon1/17:c.-80A>G:,TPO:NM_001206744.1:5'UTR:MODIFIER:exon1/17:c.-75A>G:,TPO:NM_001206745.1:5'UTR:MODIFIER:exon1/16:c.-75A>G:,TPO:NM_175719.3:5'UTR:MODIFIER:exon1/16:c.-80A>G:		rs2071403	0.6324	0	0	0								CR146967 [CLASS=FP MUT=ALT PHEN="Decreased thyroid mRNA expression, association with" GENE=TPO]; 		0.1515	0.5455	0.303	22	83	n/a	n/a
chr2	1481155	1481155	G	T	het		QUAL=717;DP=10;AF=0.50;MQM=60;TRIO=HET,10,0.50,HOM,22,1.00,WT,21,0.00	TPO	missense,intron	TPO:NM_000547.5:missense:MODERATE:exon8/17:c.1117G>T:p.Ala373Ser,TPO:NM_001206744.1:missense:MODERATE:exon8/17:c.1117G>T:p.Ala373Ser,TPO:NM_001206745.1:missense:MODERATE:exon8/16:c.1117G>T:p.Ala373Ser,TPO:NM_175719.3:missense:MODERATE:exon8/16:c.1117G>T:p.Ala373Ser,TPO:NM_175721.3:missense:MODERATE:exon7/15:c.1117G>T:p.Ala373Ser,TPO:NM_175722.3:intron:MODIFIER:exon6/14:c.820-7213G>T:		rs2280132	0.4081	0.361	0.4479	0.3165	0.1730	P	T	B,B,B	B,B,B	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A];		CM146545 [CLASS=DFP MUT=ALT PHEN="Thyroid dyshormonogenesis" GENE=TPO]; 	COSM3749598	0.2424	0.4394	0.3182	92	176	n/a	n/a
chr2	1481231	1481231	G	C	hom		QUAL=289;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,8,1.00,WT,11,0.00	TPO	missense,intron	TPO:NM_000547.5:missense:MODERATE:exon8/17:c.1193G>C:p.Ser398Thr,TPO:NM_001206744.1:missense:MODERATE:exon8/17:c.1193G>C:p.Ser398Thr,TPO:NM_001206745.1:missense:MODERATE:exon8/16:c.1193G>C:p.Ser398Thr,TPO:NM_175719.3:missense:MODERATE:exon8/16:c.1193G>C:p.Ser398Thr,TPO:NM_175721.3:missense:MODERATE:exon7/15:c.1193G>C:p.Ser398Thr,TPO:NM_175722.3:intron:MODIFIER:exon6/14:c.820-7137G>C:		rs2175977	0.7103	0.469	0.7398	0.8638	1.2970	P,P	T,D	.,D,D,D	.,D,D,D	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A];			COSM3749599	0.4167	0.2727	0.3106	155	151	n/a	n/a
chr2	1520676	1520676	T	C	het		QUAL=10640;DP=233;AF=0.52;MQM=60;TRIO=HET,233,0.52,WT,211,0.00,HOM,223,1.00	TPO	missense	TPO:NM_000547.5:missense:MODERATE:exon15/17:c.2540T>C:p.Val847Ala,TPO:NM_001206744.1:missense:MODERATE:exon15/17:c.2540T>C:p.Val847Ala,TPO:NM_001206745.1:missense:MODERATE:exon14/16:c.2369T>C:p.Val790Ala,TPO:NM_175719.3:missense:MODERATE:exon14/16:c.2369T>C:p.Val790Ala,TPO:NM_175721.3:missense:MODERATE:exon13/15:c.2408T>C:p.Val803Ala,TPO:NM_175722.3:missense:MODERATE:exon13/15:c.2021T>C:p.Val674Ala		rs1126799	0.6639	0.589	0.5323	0.7712	0.6090	P,P	T,.	B,B,B,B,.	B,B,B,B,.	606765 [TPO (confirmed) Thyroid dyshormonogenesis 2A];			COSM148793	0.2424	0.5227	0.2348	131	214	n/a	n/a
chr2	1546327	1546327	C	G	het		QUAL=22495;DP=474;AF=0.44;MQM=60;TRIO=HET,474,0.44,HOM,497,1.00,WT,711,0.00	TPO	3'UTR	TPO:NM_000547.5:3'UTR:MODIFIER:exon17/17:c.*81C>G:,TPO:NM_001206744.1:3'UTR:MODIFIER:exon17/17:c.*81C>G:,TPO:NM_001206745.1:3'UTR:MODIFIER:exon16/16:c.*81C>G:,TPO:NM_175719.3:3'UTR:MODIFIER:exon16/16:c.*81C>G:,TPO:NM_175721.3:3'UTR:MODIFIER:exon15/15:c.*81C>G:,TPO:NM_175722.3:3'UTR:MODIFIER:exon15/15:c.*81C>G:		rs1042589	0.3526	0.389	0.4437	0.2384	-1.1970	P,P	T,.						COSM4001255	0.2652	0.5	0.2348	43	103	n/a	n/a
chr2	11911761	11911761	C	T	het		QUAL=18837;DP=251;AF=0.59;MQM=60;TRIO=HET,251,0.59,HOM,444,1.00,WT,573,0.00	LPIN1	synonymous	LPIN1:NM_001261428.1:synonymous:LOW:exon5/22:c.699C>T:p.Ile233Ile,LPIN1:NM_001261429.1:synonymous:LOW:exon5/10:c.570C>T:p.Ile190Ile,LPIN1:NM_001261427.1:synonymous:LOW:exon5/21:c.570C>T:p.Ile190Ile,LPIN1:NM_145693.2:synonymous:LOW:exon4/20:c.552C>T:p.Ile184Ile		rs11538448	0.0507	0.095	0.1405	0.0279						605518 [LPIN1 (provisional) Myoglobinuria,acute recurrent,autosomal recessive];	RCV000082649.2 [benign]; 			0.053	0.2879	0.6591	18	117	n/a	n/a
chr2	26413917	26413917	C	T	hom		QUAL=37198;DP=533;AF=1.00;MQM=59;TRIO=HOM,533,1.00,HOM,257,1.00,HOM,357,1.00	HADHA	3'UTR	HADHA:NM_000182.4:3'UTR:MODIFIER:exon20/20:c.*202G>A:		rs7260	0.7875	0	0	0										0.7348	0.2424	0.0227	109	37	n/a	n/a
chr2	26467666	26467666	G	A	hom		QUAL=5458;DP=40;AF=1.00;MQM=60;TRIO=HOM,40,1.00,HOM,59,1.00,HOM,94,1.00	HADHB	5'UTR	HADHB:NM_000183.2:5'UTR:MODIFIER:exon1/16:c.-201G>A:,HADHB:NM_001281512.1:5'UTR:MODIFIER:exon1/15:c.-201G>A:,HADHB:NM_001281513.1:5'UTR:MODIFIER:exon1/17:c.-350G>A:		rs3806516	0.4573	0	0	0										0.5455	0.3788	0.0758	81	57	n/a	n/a
chr2	26477125	26477125	-	ACT	het		QUAL=15168;DP=260;AF=0.85;MQM=60;TRIO=HET,260,0.85,HOM,108,0.98,HOM,178,0.96	HADHB	disruptive_inframe_insertion,5'UTR	HADHB:NM_000183.2:disruptive_inframe_insertion:MODERATE:exon2/16:c.5_7dupCTA:p.Thr2dup,HADHB:NM_001281512.1:disruptive_inframe_insertion:MODERATE:exon2/15:c.5_7dupCTA:p.Thr2dup,HADHB:NM_001281513.1:5'UTR:MODIFIER:exon2/17:c.-145_-143dupCTA:		rs147970487	0.7095	0.832	0.9296	0.8814						143450 [HADHB (confirmed) Trifunctional protein deficiency];	RCV000078340.2 [benign]; 			0.7121	0.2652	0.0227	358	90	n/a	n/a
chr2	26512957	26512957	G	C	hom		QUAL=38007;DP=467;AF=1.00;MQM=59;TRIO=HOM,467,1.00,HOM,298,1.00,HOM,366,1.00	HADHB	3'UTR	HADHB:NM_000183.2:3'UTR:MODIFIER:exon16/16:c.*136G>C:,HADHB:NM_001281512.1:3'UTR:MODIFIER:exon15/15:c.*136G>C:,HADHB:NM_001281513.1:3'UTR:MODIFIER:exon17/17:c.*136G>C:		rs1056471	0.7111	0	0	0										0.7803	0.197	0.0227	117	30	n/a	n/a
chr2	27589810	27589810	T	C	het		QUAL=19470;DP=326;AF=0.55;MQM=60;TRIO=HET,326,0.55,WT,283,0.00,HOM,412,1.00	EIF2B4	splice_region&intron	EIF2B4:NM_172195.3:splice_region&intron:LOW:exon9/11:c.1074-7A>G:,EIF2B4:NM_001034116.1:splice_region&intron:LOW:exon10/12:c.1014-7A>G:,EIF2B4:NM_015636.3:splice_region&intron:LOW:exon10/12:c.1011-7A>G:		rs2280737	0.3834	0.398	0.384	0.4782						606687 [EIF2B4 (provisional) Leukoencephaly with vanishing white matter|Ovarioleukodystrophy];	RCV000081778.2 [benign]; 			0.1061	0.4924	0.4015	134	508	n/a	n/a
chr2	31749714	31749714	C	T	het		QUAL=8583;DP=265;AF=0.49;MQM=60;TRIO=HET,265,0.49,WT,228,0.00,HET,258,0.55	SRD5A2	3'UTR	SRD5A2:NM_000348.3:3'UTR:MODIFIER:exon5/5:c.*1552G>A:		rs1042578	0.1669	0	0	0							RCV000083670.1 [not provided]; 			0.0455	0.2727	0.6818	6	41	n/a	n/a
chr2	31749910	31749910	T	G	het		QUAL=13347;DP=511;AF=0.53;MQM=60;TRIO=HET,511,0.53,WT,216,0.00,HET,274,0.48	SRD5A2	3'UTR	SRD5A2:NM_000348.3:3'UTR:MODIFIER:exon5/5:c.*1356A>C:		rs28383087	0.0046	0	0	0							RCV000083669.1 [not provided]; 			0	0.0227	0.9773	0	3	n/a	n/a
chr2	31751223	31751223	C	T	het		QUAL=6148;DP=260;AF=0.52;MQM=60;TRIO=HET,260,0.52,WT,95,0.00,HET,112,0.48	SRD5A2	3'UTR	SRD5A2:NM_000348.3:3'UTR:MODIFIER:exon5/5:c.*43G>A:		rs28383082	0.0034	0.0042	0.0106	0.0033										0	0.0227	0.9773	0	7	n/a	n/a
chr2	31805706	31805706	G	C	het		QUAL=13305;DP=117;AF=0.50;MQM=59;TRIO=HET,117,0.50,HET,307,0.51,HET,407,0.51	SRD5A2	synonymous	SRD5A2:NM_000348.3:synonymous:LOW:exon1/5:c.264C>G:p.Ala88Ala		rs523349	0.6522	0.637	0.71	0.7554						607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias];	RCV000083650.1 [not provided]; 			0.3485	0.5379	0.1136	223	224	n/a	n/a
chr2	31805880	31805880	-	G	het		QUAL=12582;DP=52;AF=0.73;MQM=60;TRIO=HET,52,0.73,HOM,180,0.92,HOM,251,0.97	SRD5A2	frameshift	SRD5A2:NM_000348.3:frameshift:HIGH:exon1/5:c.89dupC:p.Pro31fs		rs142200057	1	1	1	0.999						607306 [SRD5A2 (confirmed) Pseudovaginal perineoscrotal hypospadias];				0.9697	0.0303	0	494	12	0	n/a
chr2	31806031	31806031	C	G	het		QUAL=2015;DP=32;AF=0.47;MQM=60;TRIO=HET,32,0.47,HET,45,0.58,HET,51,0.59	SRD5A2	5'UTR	SRD5A2:NM_000348.3:5'UTR:MODIFIER:exon1/5:c.-62G>C:		rs632148	0.6404	0	0	0							RCV000083635.1 [not provided]; 			0.3409	0.5303	0.1288	107	111	n/a	n/a
chr2	32381110	32381110	T	G	het		QUAL=494;DP=33;AF=0.39;MQM=57;TRIO=HET,33,0.39,HOM,2,1.00,HET,9,0.44	SPAST	3'UTR	SPAST:NM_014946.3:3'UTR:MODIFIER:exon17/17:c.*1545T>G:,SPAST:NM_199436.1:3'UTR:MODIFIER:exon16/16:c.*1545T>G:	AluSp	rs9789593	0.3379	0	0	0										0.053	0.4167	0.5303	7	64	n/a	n/a
chr2	32381727	32381727	-	AGG	het		QUAL=10015;DP=306;AF=0.44;MQM=60;TRIO=HET,306,0.44,HOM,107,0.99,HET,139,0.55	SPAST	3'UTR	SPAST:NM_014946.3:3'UTR:MODIFIER:exon17/17:c.*2164_*2165insGAG:,SPAST:NM_199436.1:3'UTR:MODIFIER:exon16/16:c.*2164_*2165insGAG:		rs3040810	0.982	0	0	0										0.9621	0.0379	0	145	5	n/a	n/a
chr2	32381829	32381829	G	A	het		QUAL=7707;DP=233;AF=0.47;MQM=60;TRIO=HET,233,0.47,HET,112,0.52,HET,127,0.53	SPAST	3'UTR	SPAST:NM_014946.3:3'UTR:MODIFIER:exon17/17:c.*2264G>A:,SPAST:NM_199436.1:3'UTR:MODIFIER:exon16/16:c.*2264G>A:		rs3769602	0.48	0	0	0										0.25	0.4924	0.2576	34	77	n/a	n/a
chr2	39209047	39209047	A	G	hom		QUAL=20303;DP=279;AF=1.00;MQM=60;TRIO=HOM,279,1.00,HOM,141,1.00,HOM,189,1.00	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*3918T>C:		rs1043793	0.7476	0	0	0										0.8333	0.1591	0.0076	126	23	n/a	n/a
chr2	39209426	39209426	A	G	hom		QUAL=29090;DP=458;AF=1.00;MQM=60;TRIO=HOM,458,1.00,HOM,181,1.00,HOM,229,1.00	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*3539T>C:		rs1037495	0.7466	0	0	0										0.8333	0.1591	0.0076	126	23	n/a	n/a
chr2	39210398	39210398	A	T	hom		QUAL=29996;DP=333;AF=1.00;MQM=60;TRIO=HOM,333,1.00,HOM,252,1.00,HOM,318,1.00	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*2567T>A:		rs6704656	0.8996	0	0	0										0.8636	0.1288	0.0076	130	19	n/a	n/a
chr2	39210719	39210719	-	TA	het		QUAL=18164;DP=328;AF=0.91;MQM=60;TRIO=HET,328,0.91,HOM,137,0.96,HOM,173,0.93	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*2244_*2245dupTA:		rs397813136	0.7476	0	0	0										0.7197	0.2727	0.0076	109	40	n/a	n/a
chr2	39211121	39211121	T	C	hom		QUAL=32359;DP=434;AF=1.00;MQM=60;TRIO=HOM,434,1.00,HOM,237,1.00,HOM,290,1.00	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*1844A>G:		rs10166395	0.7622	0	0	0										0.8258	0.1667	0.0076	124	25	n/a	n/a
chr2	39211359	39211359	A	-	hom		QUAL=31766;DP=407;AF=0.98;MQM=60;TRIO=HOM,407,0.98,HOM,287,0.99,HOM,315,0.99	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*1606delT:		rs398080194	0.8976	0	0	0										0.8485	0.1439	0.0076	128	21	n/a	n/a
chr2	39212565	39212565	-	TG	het		QUAL=9872;DP=155;AF=0.85;MQM=60;TRIO=HET,155,0.85,HOM,97,0.95,HOM,123,0.93	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*399_*400insCA:		rs144104838	0.9026	0	0	0										0.7273	0.25	0.0227	111	36	n/a	n/a
chr2	39212637	39212637	T	C	het		QUAL=12954;DP=493;AF=0.52;MQM=60;TRIO=HET,493,0.52,HOM,143,1.00,WT,178,0.01	SOS1	3'UTR	SOS1:NM_005633.3:3'UTR:MODIFIER:exon23/23:c.*328A>G:		rs1059310	0.5234	0	0	0										0.4167	0.4924	0.0909	63	74	n/a	n/a
chr2	39262348	39262348	C	G	het		QUAL=3958;DP=159;AF=0.46;MQM=60;TRIO=HET,159,0.46,WT,92,0.00,HET,109,0.47	SOS1	splice_region&intron	SOS1:NM_005633.3:splice_region&intron:LOW:exon8/22:c.1074+5G>C:		rs145155424	0.0028	0.0078	0.0081	0.0014						182530 [SOS1 (confirmed) Fibromatosis,gingival|Noonan syndrome 4];	RCV000038508.5 [benign]; RCV000128195.2 [benign]; RCV000157008.1 [benign]; 			0	0.0076	0.9924	0	6	2	n/a
chr2	44114074	44114074	G	A	hom		QUAL=16520;DP=205;AF=1.00;MQM=59;TRIO=HOM,205,1.00,HOM,131,1.00,HOM,184,1.00	LRPPRC	3'UTR	LRPPRC:NM_133259.3:3'UTR:MODIFIER:exon38/38:c.*1665C>T:	AluSz6	rs1139250	0.6006	0	0	0										0.3485	0.4924	0.1591	53	73	n/a	n/a
chr2	44115183	44115183	T	A	het		QUAL=2731;DP=114;AF=0.53;MQM=60;TRIO=HET,114,0.53,WT,40,0.00,HET,56,0.48	LRPPRC	3'UTR	LRPPRC:NM_133259.3:3'UTR:MODIFIER:exon38/38:c.*556A>T:		rs1136998	0.0603	0	0	0										0.0076	0.1818	0.8106	1	27	n/a	n/a
chr2	44209477	44209477	C	T	hom		QUAL=8997;DP=162;AF=1.00;MQM=60;TRIO=HOM,162,1.00,HET,59,0.54,HOM,81,1.00	LRPPRC	synonymous	LRPPRC:NM_133259.3:synonymous:LOW:exon2/38:c.246G>A:p.Gln82Gln		rs6741066	0.504	0.624	0.7363	0.7009						607544 [LRPPRC (confirmed) Leigh syndrome,French-Canadian type];	RCV000117556.2 [likely benign]; 		COSM1408165	0.3864	0.4697	0.1439	211	194	n/a	n/a
chr2	45171842	45171842	A	G	hom		QUAL=10785;DP=38;AF=1.00;MQM=60;TRIO=HOM,38,1.00,HOM,128,1.00,HOM,183,1.00	SIX3	synonymous	SIX3:NM_005413.3:synonymous:LOW:exon2/2:c.942A>G:p.Ala314Ala		rs338074	0.9375	0.917	0.9204	0.969						603714 [SIX3 (confirmed) Holoprosencephaly-2|Schizencephaly];	RCV000153953.1 [benign]; 			0.8333	0.1515	0.0152	390	60	n/a	n/a
chr2	45172485	45172485	G	A	het		QUAL=693;DP=47;AF=0.45;MQM=53;TRIO=HET,47,0.45,HET,4,0.50,HET,8,0.38	SIX3	3'UTR	SIX3:NM_005413.3:3'UTR:MODIFIER:exon2/2:c.*586G>A:	A-rich	rs60528008	0	0	0	0										0.0379	0.3485	0.6136	7	51	n/a	n/a
chr2	45172557	45172557	T	-	het		QUAL=2642;DP=122;AF=0.48;MQM=60;TRIO=HET,122,0.48,HET,17,0.71,HET,26,0.54	SIX3	3'UTR	SIX3:NM_005413.3:3'UTR:MODIFIER:exon2/2:c.*666delT:	CT-rich	rs61475963	0.4643	0	0	0										0.0909	0.4318	0.4773	14	65	n/a	n/a
chr2	45172925	45172925	G	A	het		QUAL=10975;DP=285;AF=0.51;MQM=60;TRIO=HET,285,0.51,HET,171,0.53,HET,246,0.50	SIX3	3'UTR	SIX3:NM_005413.3:3'UTR:MODIFIER:exon2/2:c.*1026G>A:		rs13022334	0.2384	0	0	0										0.0455	0.3561	0.5985	7	50	n/a	n/a
chr2	46583281	46583281	C	T	het		QUAL=8293;DP=161;AF=0.43;MQM=59;TRIO=HET,161,0.43,HOM,211,1.00,WT,198,0.01	EPAS1	splice_region&intron	EPAS1:NM_001430.4:splice_region&intron:LOW:exon2/15:c.218-9C>T:		rs75984373	0.0663	0.392	0	0						603349 [EPAS1 (confirmed) Erythrocytosis,familial,4];				0.1061	0.1364	0.7576	27	52	n/a	n/a
chr2	46603671	46603671	C	G	het		QUAL=1076;DP=23;AF=0.52;MQM=60;TRIO=HET,23,0.52,WT,15,0.00,HOM,26,1.00	EPAS1	splice_region&intron	EPAS1:NM_001430.4:splice_region&intron:LOW:exon8/15:c.1035-7C>G:		rs7557402	0.3125	0.41	0.5028	0.2853						603349 [EPAS1 (confirmed) Erythrocytosis,familial,4];			COSM4001689	0.1818	0.4848	0.3333	99	229	n/a	n/a
chr2	46612327	46612328	TT	-	het		QUAL=2850;DP=121;AF=0.48;MQM=60;TRIO=HET,121,0.48,HET,38,0.08,HOM,46,0.96	EPAS1	3'UTR	EPAS1:NM_001430.4:3'UTR:MODIFIER:exon16/16:c.*539_*540delTT:		rs397984477	0.8858	0	0	0										0.6742	0.2727	0.053	99	44	n/a	n/a
chr2	46613038	46613038	A	G	het		QUAL=12782;DP=326;AF=0.50;MQM=60;TRIO=HET,326,0.50,WT,344,0.00,HET,475,0.50	EPAS1	3'UTR	EPAS1:NM_001430.4:3'UTR:MODIFIER:exon16/16:c.*1239A>G:		rs11539645	0.0172	0	0	0										0.0227	0.0985	0.8788	3	17	n/a	n/a
chr2	48914615	48914615	C	G	het		QUAL=4192;DP=213;AF=0.47;MQM=60;TRIO=HET,213,0.47,HET,49,0.57,WT,85,0.00	LHCGR,STON1-GTF2A1L	3'UTR,intron	LHCGR:NM_000233.3:3'UTR:MODIFIER:exon11/11:c.*221G>C:,STON1-GTF2A1L:NM_001198593.1:intron:MODIFIER:exon10/10:c.3441+15796C>G:	MER5C	rs62137532	0.1627	0	0	0										0.0379	0.2955	0.6667	5	43	n/a	n/a
chr2	48925746	48925746	C	T	het		QUAL=9006;DP=101;AF=0.55;MQM=60;TRIO=HET,101,0.55,HOM,120,1.00,HET,218,0.50	LHCGR,STON1-GTF2A1L	splice_region&intron,intron	LHCGR:NM_000233.3:splice_region&intron:LOW:exon9/10:c.866+8G>A:,STON1-GTF2A1L:NM_001198593.1:intron:MODIFIER:exon10/10:c.3441+26927C>T:		rs6755901	0.7374	0.765	0.8433	0.8702						152790 [LHCGR (provisional) Precocious puberty,male|Leydig cell hypoplasia with pseudohermaphroditism|Leydig cell hypoplasia with hypergonadotropic hypogonadism|Luteinizing hormone resistance,female|Leydig cell adenoma,somatic,with precocious puberty];			COSM4001691	0.7348	0.2652	0	320	129	n/a	n/a
chr2	58388696	58388696	A	G	het		QUAL=12662;DP=312;AF=0.46;MQM=60;TRIO=HET,312,0.46,HET,197,0.53,HET,259,0.54	FANCL	synonymous	FANCL:NM_001114636.1:synonymous:LOW:exon12/14:c.996T>C:p.Ser332Ser,FANCL:NM_018062.3:synonymous:LOW:exon12/14:c.981T>C:p.Ser327Ser		rs848291	0.7065	0.648	0.6035	0.9005						608111 [FANCL (provisional) Fanconi anemia,complementation group L];			COSM4001713	0.3485	0.5152	0.1364	161	231	n/a	n/a
chr2	61276263	61276263	G	A	hom		QUAL=13290;DP=229;AF=1.00;MQM=60;TRIO=HOM,229,1.00,HOM,70,1.00,HOM,103,1.00	PEX13	3'UTR	PEX13:NM_002618.3:3'UTR:MODIFIER:exon4/4:c.*358G>A:		rs1177230	0.9952	0	0	0										0.9848	0.0152	0	147	3	n/a	n/a
chr2	61276857	61276857	C	T	het		QUAL=1698;DP=55;AF=0.42;MQM=60;TRIO=HET,55,0.42,HET,62,0.58,WT,50,0.00	PEX13	3'UTR	PEX13:NM_002618.3:3'UTR:MODIFIER:exon4/4:c.*952C>T:	AluSp	rs56739127	0.3039	0	0	0										0.0758	0.447	0.4773	11	70	n/a	n/a
chr2	61277099	61277099	G	A	het		QUAL=2351;DP=119;AF=0.43;MQM=60;TRIO=HET,119,0.43,HET,46,0.54,WT,81,0.00	PEX13	3'UTR	PEX13:NM_002618.3:3'UTR:MODIFIER:exon4/4:c.*1194G>A:		rs75205376	0.0763	0	0	0										0.0379	0.3409	0.6212	5	54	n/a	n/a
chr2	61278052	61278052	A	G	hom		QUAL=6150;DP=98;AF=1.00;MQM=59;TRIO=HOM,98,1.00,HET,70,0.57,HOM,63,0.98	PEX13	3'UTR	PEX13:NM_002618.3:3'UTR:MODIFIER:exon4/4:c.*2147A>G:	AluY	rs2564097	0.616	0	0	0										0.3864	0.4924	0.1212	56	76	n/a	n/a
chr2	69547236	69547236	G	C	het		QUAL=9462;DP=233;AF=0.49;MQM=55;TRIO=HET,233,0.49,WT,225,0.00,HET,324,0.54	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*6085C>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*6085C>G:		rs7642	0.6554	0	0	0										0.3333	0.4318	0.2348	49	67	n/a	n/a
chr2	69548320	69548320	C	T	het		QUAL=8612;DP=370;AF=0.53;MQM=59;TRIO=HET,370,0.53,WT,107,0.00,HET,152,0.41	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*5001G>A:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*5001G>A:		rs13396883	0.6587	0	0	0										0.3333	0.4318	0.2348	49	67	n/a	n/a
chr2	69548591	69548591	C	T	het		QUAL=8016;DP=312;AF=0.54;MQM=60;TRIO=HET,312,0.54,WT,112,0.00,HET,131,0.53	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*4730G>A:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*4730G>A:		rs28694003	0.6386	0	0	0										0.3333	0.4318	0.2348	49	67	n/a	n/a
chr2	69549262	69549262	T	C	het		QUAL=6529;DP=251;AF=0.54;MQM=60;TRIO=HET,251,0.54,WT,107,0.00,HET,144,0.42	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*4059A>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*4059A>G:		rs13751	0.6476	0	0	0										0.3333	0.4318	0.2348	49	67	n/a	n/a
chr2	69550036	69550036	T	C	het		QUAL=18331;DP=566;AF=0.51;MQM=60;TRIO=HET,566,0.51,WT,404,0.00,HET,528,0.50	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*3285A>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*3285A>G:		rs7579532	0.6587	0	0	0										0.3333	0.4318	0.2348	49	67	n/a	n/a
chr2	69550230	69550230	T	G	het		QUAL=9107;DP=286;AF=0.52;MQM=60;TRIO=HET,286,0.52,WT,139,0.00,HET,207,0.60	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*3091A>C:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*3091A>C:		rs7582334	0.6476	0	0	0										0.3333	0.4318	0.2348	49	67	n/a	n/a
chr2	69550256	69550256	C	T	het		QUAL=9625;DP=300;AF=0.56;MQM=60;TRIO=HET,300,0.56,WT,120,0.00,HET,201,0.61	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*3065G>A:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*3065G>A:		rs7568296	0.6635	0	0	0										0.3333	0.4318	0.2348	49	67	n/a	n/a
chr2	69550652	69550652	G	A	het		QUAL=8872;DP=306;AF=0.49;MQM=59;TRIO=HET,306,0.49,WT,173,0.00,HET,262,0.49	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*2669C>T:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*2669C>T:	AluJb	rs10185336	0.6384	0	0	0										0.3333	0.4318	0.2348	49	67	n/a	n/a
chr2	69550811	69550811	T	-	het		QUAL=746;DP=82;AF=0.38;MQM=58;TRIO=HET,82,0.38,HET,15,0.13,HET,13,0.23	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*2510delA:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*2510delA:	AluJb:AluSc	rs370178312	0	0	0	0										0.0227	0.1591	0.8182	3	24	n/a	n/a
chr2	69551011	69551011	T	C	het		QUAL=478;DP=33;AF=0.52;MQM=46;TRIO=HET,33,0.52,WT,3,0.00,HET,5,0.20	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*2310A>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*2310A>G:	AluSc	rs10198150	0.6384	0	0	0										0.2879	0.3182	0.3939	44	49	n/a	n/a
chr2	69551052	69551052	T	C	het		QUAL=884;DP=53;AF=0.57;MQM=50;TRIO=HET,53,0.57,WT,2,0.00,HET,8,0.13	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*2269A>G:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*2269A>G:	AluSc	rs10198171	0.6494	0	0	0										0.3258	0.4015	0.2727	48	62	n/a	n/a
chr2	69552521	69552521	C	A	het		QUAL=11342;DP=467;AF=0.45;MQM=60;TRIO=HET,467,0.45,WT,182,0.00,HET,291,0.46	GFPT1	3'UTR	GFPT1:NM_001244710.1:3'UTR:MODIFIER:exon20/20:c.*800G>T:,GFPT1:NM_002056.3:3'UTR:MODIFIER:exon19/19:c.*800G>T:		rs2667	0.6382	0	0	0										0.3409	0.4242	0.2348	50	66	n/a	n/a
chr2	69553376	69553376	A	-	het		QUAL=1829;DP=81;AF=0.41;MQM=60;TRIO=HET,81,0.41,HET,52,0.13,HET,75,0.52	GFPT1	splice_region&intron	GFPT1:NM_001244710.1:splice_region&intron:LOW:exon19/19:c.2056-11delT:,GFPT1:NM_002056.3:splice_region&intron:LOW:exon18/18:c.2002-11delT:		rs201330278	0	0	0	0						138292 [GFPT1 (confirmed) Myasthenia,congenital,with tubular aggregates 1];				0.0606	0.3485	0.5909	29	82	n/a	n/a
chr2	69573029	69573029	T	C	het		QUAL=5754;DP=184;AF=0.51;MQM=60;TRIO=HET,184,0.51,WT,127,0.00,HET,178,0.49	GFPT1	splice_region&intron	GFPT1:NM_001244710.1:splice_region&intron:LOW:exon12/19:c.1105+7A>G:,GFPT1:NM_002056.3:splice_region&intron:LOW:exon11/18:c.1051+7A>G:		rs6722492	0.6472	0.595	0.5893	0.8436						138292 [GFPT1 (confirmed) Myasthenia,congenital,with tubular aggregates 1];	RCV000117140.1 [benign]; 			0.3333	0.4318	0.2348	170	204	n/a	n/a
chr2	71680950	71680950	C	A	het		QUAL=2414;DP=73;AF=0.48;MQM=60;TRIO=HET,73,0.48,HET,96,0.56,WT,121,0.00	DYSF	5'UTR	DYSF:NM_001130976.1:5'UTR:MODIFIER:exon1/54:c.-179C>A:,DYSF:NM_001130977.1:5'UTR:MODIFIER:exon1/55:c.-179C>A:,DYSF:NM_001130978.1:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:NM_001130979.1:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:NM_001130980.1:5'UTR:MODIFIER:exon1/55:c.-179C>A:,DYSF:NM_001130981.1:5'UTR:MODIFIER:exon1/56:c.-179C>A:,DYSF:NM_003494.3:5'UTR:MODIFIER:exon1/55:c.-179C>A:		rs6741336	0.2049	0	0	0										0.0152	0.197	0.7879	2	28	n/a	n/a
chr2	71780215	71780215	T	C	het		QUAL=24021;DP=283;AF=0.45;MQM=60;TRIO=HET,283,0.45,HOM,365,0.99,HET,543,0.50	DYSF	synonymous	DYSF:NM_001130987.1:synonymous:LOW:exon20/56:c.1881T>C:p.Asp627Asp,DYSF:NM_001130976.1:synonymous:LOW:exon19/54:c.1785T>C:p.Asp595Asp,DYSF:NM_001130977.1:synonymous:LOW:exon19/55:c.1785T>C:p.Asp595Asp,DYSF:NM_001130978.1:synonymous:LOW:exon20/56:c.1827T>C:p.Asp609Asp,DYSF:NM_001130979.1:synonymous:LOW:exon21/56:c.1920T>C:p.Asp640Asp,DYSF:NM_001130980.1:synonymous:LOW:exon20/55:c.1878T>C:p.Asp626Asp,DYSF:NM_001130981.1:synonymous:LOW:exon20/56:c.1878T>C:p.Asp626Asp,DYSF:NM_003494.3:synonymous:LOW:exon20/55:c.1827T>C:p.Asp609Asp,DYSF:NM_001130455.1:synonymous:LOW:exon20/55:c.1830T>C:p.Asp610Asp,DYSF:NM_001130982.1:synonymous:LOW:exon21/56:c.1923T>C:p.Asp641Asp,DYSF:NM_001130983.1:synonymous:LOW:exon20/56:c.1830T>C:p.Asp610Asp,DYSF:NM_001130984.1:synonymous:LOW:exon19/55:c.1788T>C:p.Asp596Asp,DYSF:NM_001130985.1:synonymous:LOW:exon20/55:c.1881T>C:p.Asp627Asp,DYSF:NM_001130986.1:synonymous:LOW:exon19/54:c.1788T>C:p.Asp596Asp		rs2303596	0.5755	0.643	0.7101	0.7833						603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B|Myopathy,distal,with anterior tibial onset|Miyoshi muscular dystrophy 1];	RCV000080244.4 [other]; 		COSM4001739	0.553	0.3636	0.0833	220	193	n/a	n/a
chr2	71795152	71795152	A	T	het		QUAL=1280;DP=32;AF=0.38;MQM=60;TRIO=HET,32,0.38,HOM,20,1.00,HET,33,0.45	DYSF	synonymous	DYSF:NM_001130987.1:synonymous:LOW:exon25/56:c.2637A>T:p.Ser879Ser,DYSF:NM_001130976.1:synonymous:LOW:exon24/54:c.2541A>T:p.Ser847Ser,DYSF:NM_001130977.1:synonymous:LOW:exon24/55:c.2541A>T:p.Ser847Ser,DYSF:NM_001130978.1:synonymous:LOW:exon25/56:c.2583A>T:p.Ser861Ser,DYSF:NM_001130979.1:synonymous:LOW:exon26/56:c.2676A>T:p.Ser892Ser,DYSF:NM_001130980.1:synonymous:LOW:exon25/55:c.2634A>T:p.Ser878Ser,DYSF:NM_001130981.1:synonymous:LOW:exon25/56:c.2634A>T:p.Ser878Ser,DYSF:NM_003494.3:synonymous:LOW:exon25/55:c.2583A>T:p.Ser861Ser,DYSF:NM_001130455.1:synonymous:LOW:exon25/55:c.2586A>T:p.Ser862Ser,DYSF:NM_001130982.1:synonymous:LOW:exon26/56:c.2679A>T:p.Ser893Ser,DYSF:NM_001130983.1:synonymous:LOW:exon25/56:c.2586A>T:p.Ser862Ser,DYSF:NM_001130984.1:synonymous:LOW:exon24/55:c.2544A>T:p.Ser848Ser,DYSF:NM_001130985.1:synonymous:LOW:exon25/55:c.2637A>T:p.Ser879Ser,DYSF:NM_001130986.1:synonymous:LOW:exon24/54:c.2544A>T:p.Ser848Ser		rs2288355	0.5505	0.604	0.6688	0.8087						603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B|Myopathy,distal,with anterior tibial onset|Miyoshi muscular dystrophy 1];	RCV000080254.4 [other]; 		COSM3766591	0.4091	0.4773	0.1136	182	223	n/a	n/a
chr2	71838597	71838597	C	A	het		QUAL=7229;DP=86;AF=0.50;MQM=60;TRIO=HET,86,0.50,HET,161,0.50,HET,265,0.44	DYSF	splice_region&synonymous	DYSF:NM_001130987.1:splice_region&synonymous:LOW:exon38/56:c.4062C>A:p.Ile1354Ile,DYSF:NM_001130976.1:splice_region&synonymous:LOW:exon37/54:c.3966C>A:p.Ile1322Ile,DYSF:NM_001130977.1:splice_region&synonymous:LOW:exon37/55:c.3966C>A:p.Ile1322Ile,DYSF:NM_001130978.1:splice_region&synonymous:LOW:exon38/56:c.4008C>A:p.Ile1336Ile,DYSF:NM_001130979.1:splice_region&synonymous:LOW:exon39/56:c.4101C>A:p.Ile1367Ile,DYSF:NM_001130980.1:splice_region&synonymous:LOW:exon38/55:c.4059C>A:p.Ile1353Ile,DYSF:NM_001130981.1:splice_region&synonymous:LOW:exon38/56:c.4059C>A:p.Ile1353Ile,DYSF:NM_003494.3:splice_region&synonymous:LOW:exon38/55:c.4008C>A:p.Ile1336Ile,DYSF:NM_001130455.1:splice_region&synonymous:LOW:exon38/55:c.4011C>A:p.Ile1337Ile,DYSF:NM_001130982.1:splice_region&synonymous:LOW:exon39/56:c.4104C>A:p.Ile1368Ile,DYSF:NM_001130983.1:splice_region&synonymous:LOW:exon38/56:c.4011C>A:p.Ile1337Ile,DYSF:NM_001130984.1:splice_region&synonymous:LOW:exon37/55:c.3969C>A:p.Ile1323Ile,DYSF:NM_001130985.1:splice_region&synonymous:LOW:exon38/55:c.4062C>A:p.Ile1354Ile,DYSF:NM_001130986.1:splice_region&synonymous:LOW:exon37/54:c.3969C>A:p.Ile1323Ile		rs2303606	0.4495	0.501	0.5107	0.3951						603009 [DYSF (confirmed) Muscular dystrophy,limb-girdle,type 2B|Myopathy,distal,with anterior tibial onset|Miyoshi muscular dystrophy 1];	RCV000080282.4 [other]; 			0.2955	0.4167	0.2879	129	202	n/a	n/a
chr2	73651967	73651967	C	T	het		QUAL=9626;DP=307;AF=0.45;MQM=60;TRIO=HET,307,0.45,WT,271,0.00,HET,311,0.51	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon5/23:c.1174C>T:p.Arg392Cys		rs3813227	0.3636	0.268	0.2375	0.7373	0.2600	P	T	B,B	B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				0.053	0.3788	0.5682	22	152	n/a	n/a
chr2	73675227	73675227	-	CTC	het		QUAL=14816;DP=157;AF=0.43;MQM=60;TRIO=HET,157,0.43,HOM,271,0.99,HET,312,0.45	ALMS1	disruptive_inframe_insertion	ALMS1:NM_015120.4:disruptive_inframe_insertion:MODERATE:exon8/23:c.1571_1573dupCTC:p.Ser524_Leu525insPro		rs587621330	0.6004	0.638	0.6367	0.3669						606844 [ALMS1 (confirmed) Alstrom syndrome];				0.4318	0.4394	0.1288	201	209	1	n/a
chr2	73675669	73675669	T	G	hom		QUAL=29274;DP=291;AF=1.00;MQM=59;TRIO=HOM,291,1.00,HOM,286,1.00,HOM,323,1.00	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.2012T>G:p.Val671Gly		rs2037814	0.8722	0.863	0.8705	0.9022	-0.5500	P	T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				0.7727	0.2197	0.0076	335	111	n/a	n/a
chr2	73675844	73675844	C	T	het		QUAL=16420;DP=247;AF=0.48;MQM=60;TRIO=HET,247,0.48,HOM,230,0.99,HET,324,0.50	ALMS1	synonymous	ALMS1:NM_015120.4:synonymous:LOW:exon8/23:c.2187C>T:p.Phe729Phe		rs7598901	0.5264	0	0.6244	0.2091						606844 [ALMS1 (confirmed) Alstrom syndrome];				0.4091	0.4621	0.1288	188	204	n/a	n/a
chr2	73677833	73677833	A	G	het		QUAL=10596;DP=173;AF=0.49;MQM=59;TRIO=HET,173,0.49,WT,355,0.01,HET,456,0.54	ALMS1	synonymous	ALMS1:NM_015120.4:synonymous:LOW:exon8/23:c.4176A>G:p.Gln1392Gln		rs6546836	0.3383	0.261	0.2364	0.6707						606844 [ALMS1 (confirmed) Alstrom syndrome];			COSM1409404	0.053	0.3788	0.5682	22	155	n/a	n/a
chr2	73677898	73677898	G	C	het		QUAL=10976;DP=213;AF=0.45;MQM=59;TRIO=HET,213,0.45,WT,334,0.00,HET,446,0.54	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.4241G>C:p.Gly1414Ala		rs6546837	0.3636	0.268	0.2379	0.7383	-2.3660	P	T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				0.053	0.3788	0.5682	23	154	n/a	n/a
chr2	73679280	73679280	A	G	het		QUAL=11555;DP=292;AF=0.52;MQM=60;TRIO=HET,292,0.52,WT,289,0.00,HET,377,0.54	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.5623A>G:p.Ile1875Val		rs6546838	0.3588	0.267	0.2385	0.7264	-0.1850	P	T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				0.053	0.3788	0.5682	23	154	n/a	n/a
chr2	73679866	73679866	T	C	het		QUAL=8249;DP=274;AF=0.50;MQM=60;TRIO=HET,274,0.50,WT,196,0.00,HET,236,0.46	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.6209T>C:p.Ile2070Thr		rs10496192	0.1036	0.142	0.1673	0.0804	-0.1900	P	T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				0.0303	0.3106	0.6591	11	118	n/a	n/a
chr2	73679990	73679990	T	A	het		QUAL=6521;DP=195;AF=0.47;MQM=60;TRIO=HET,195,0.47,WT,186,0.00,HET,220,0.49	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.6333T>A:p.Ser2111Arg		rs6724782	0.3638	0.269	0.239	0.7399	-0.2040	P	T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];			COSM4133927	0.053	0.3788	0.5682	24	156	n/a	n/a
chr2	73680508	73680508	G	C	het		QUAL=11793;DP=414;AF=0.50;MQM=60;TRIO=HET,414,0.50,WT,285,0.00,HET,269,0.55	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon8/23:c.6851G>C:p.Arg2284Pro		rs6546839	0.3644	0.269	0.2395	0.742	2.6600	P	T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				0.053	0.3788	0.5682	23	154	n/a	n/a
chr2	73717567	73717567	G	T	het		QUAL=7106;DP=233;AF=0.51;MQM=60;TRIO=HET,233,0.51,WT,135,0.01,HET,217,0.50	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon10/23:c.8478G>T:p.Arg2826Ser		rs2056486	0.3582	0.266	0.2368	0.7275	-0.0370	P	T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];			COSM4133929	0.053	0.3788	0.5682	23	152	n/a	n/a
chr2	73717656	73717656	A	G	het		QUAL=10474;DP=317;AF=0.52;MQM=60;TRIO=HET,317,0.52,WT,234,0.00,HET,313,0.48	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon10/23:c.8567A>G:p.Asn2856Ser		rs10193972	0.3582	0.266	0.2375	0.7245	-0.6910	P	T	B,B,B	B,B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];				0.053	0.3788	0.5682	23	153	n/a	n/a
chr2	73746923	73746923	C	T	het		QUAL=4254;DP=152;AF=0.49;MQM=60;TRIO=HET,152,0.49,WT,66,0.00,HET,100,0.61	ALMS1	synonymous	ALMS1:NM_015120.4:synonymous:LOW:exon11/23:c.9558C>T:p.Thr3186Thr		rs11884776	0.2568	0.217	0.2258	0.479						606844 [ALMS1 (confirmed) Alstrom syndrome];				0.053	0.3561	0.5909	22	144	n/a	n/a
chr2	73828538	73828538	G	A	het		QUAL=13698;DP=201;AF=0.54;MQM=60;TRIO=HET,201,0.54,HOM,195,1.00,HET,275,0.50	ALMS1	missense	ALMS1:NM_015120.4:missense:MODERATE:exon19/23:c.12086G>A:p.Arg4029Lys		rs1052161	0.5823	0.631	0.6371	0.3403	-1.7990	P	T	B,B	B,B	606844 [ALMS1 (confirmed) Alstrom syndrome];			COSM4133930	0.4318	0.4394	0.1288	192	200	n/a	n/a
chr2	73829372	73829372	C	T	het		QUAL=9982;DP=375;AF=0.49;MQM=59;TRIO=HET,375,0.49,WT,210,0.00,HET,272,0.50	ALMS1	synonymous	ALMS1:NM_015120.4:synonymous:LOW:exon20/23:c.12172C>T:p.Leu4058Leu		rs1052162	0.3417	0.264	0.2357	0.7018						606844 [ALMS1 (confirmed) Alstrom syndrome];				0.053	0.3788	0.5682	23	150	n/a	n/a
chr2	73837006	73837006	T	A	het		QUAL=10382;DP=211;AF=0.45;MQM=60;TRIO=HET,211,0.45,WT,176,0.00,HOM,229,1.00	ALMS1	3'UTR	ALMS1:NM_015120.4:3'UTR:MODIFIER:exon23/23:c.*267T>A:		rs62149804	0.1052	0	0	0										0.0379	0.3182	0.6439	5	48	n/a	n/a
chr2	74185876	74185876	A	T	hom		QUAL=10773;DP=106;AF=1.00;MQM=60;TRIO=HOM,106,1.00,HET,126,0.53,HOM,165,1.00	DGUOK	3'UTR	DGUOK:NM_080916.2:3'UTR:MODIFIER:exon7/7:c.*13A>T:,DGUOK:NM_080918.2:3'UTR:MODIFIER:exon5/5:c.*13A>T:		rs4777	0.5308	0	0.5945	0.5084										0.3409	0.5076	0.1515	73	97	n/a	n/a
chr2	84650707	84650707	A	G	hom		QUAL=17029;DP=226;AF=1.00;MQM=60;TRIO=HOM,226,1.00,HOM,158,1.00,HOM,146,1.00	SUCLG1	3'UTR	SUCLG1:NM_003849.3:3'UTR:MODIFIER:exon9/9:c.*163T>C:		rs2832	0.8021	0	0	0										0.8636	0.1212	0.0152	129	17	n/a	n/a
chr2	85894308	85894308	G	T	het		QUAL=4578;DP=157;AF=0.41;MQM=60;TRIO=HET,157,0.41,WT,113,0.00,HOM,87,1.00	SFTPB	splice_region&intron	SFTPB:NM_000542.3:splice_region&intron:LOW:exon3/11:c.232-8C>A:,SFTPB:NM_198843.2:splice_region&intron:LOW:exon3/11:c.232-8C>A:		rs3024798	0.2969	0.356	0.3752	0.1026						178640 [SFTPB (confirmed) Surfactant metabolism dysfunction,pulmonary,1];	RCV000151852.1 [benign]; 			0.1894	0.4697	0.3409	72	205	n/a	n/a
chr2	85895338	85895338	T	G	het		QUAL=5452;DP=112;AF=0.52;MQM=59;TRIO=HET,112,0.52,WT,101,0.01,HOM,117,1.00	SFTPB	missense	SFTPB:NM_000542.3:missense:MODERATE:exon2/12:c.5A>C:p.His2Pro,SFTPB:NM_198843.2:missense:MODERATE:exon2/12:c.5A>C:p.His2Pro		rs2077079	0.4185	0.309	0.3541	0.3454	0.8210	P		B	B	178640 [SFTPB (confirmed) Surfactant metabolism dysfunction,pulmonary,1];	RCV000151854.1 [benign]; 	CR077669 [CLASS=FP MUT=ALT PHEN="Increased promoter activity" GENE=SFTPB]; 	COSM3766592	0.1818	0.5	0.3182	70	198	n/a	n/a
chr2	86441303	86441303	A	C	hom		QUAL=26670;DP=391;AF=1.00;MQM=60;TRIO=HOM,391,1.00,HET,365,0.50,HET,499,0.46	REEP1	3'UTR	REEP1:NM_001164730.1:3'UTR:MODIFIER:exon7/7:c.*2920T>G:,REEP1:NM_001164731.1:3'UTR:MODIFIER:exon6/6:c.*2920T>G:,REEP1:NM_001164732.1:3'UTR:MODIFIER:exon5/5:c.*2859T>G:,REEP1:NM_022912.2:3'UTR:MODIFIER:exon7/7:c.*2920T>G:		rs708600	0.3736	0	0	0										0.1818	0.4091	0.4091	27	62	n/a	n/a
chr2	86441334	86441334	-	TGTT	hom		QUAL=18838;DP=236;AF=0.95;MQM=60;TRIO=HOM,236,0.95,HET,340,0.49,HET,480,0.45	REEP1	3'UTR	REEP1:NM_001164730.1:3'UTR:MODIFIER:exon7/7:c.*2885_*2888dupAACA:,REEP1:NM_001164731.1:3'UTR:MODIFIER:exon6/6:c.*2885_*2888dupAACA:,REEP1:NM_001164732.1:3'UTR:MODIFIER:exon5/5:c.*2824_*2827dupAACA:,REEP1:NM_022912.2:3'UTR:MODIFIER:exon7/7:c.*2885_*2888dupAACA:		rs397794472	0.373	0	0	0										0.1818	0.4091	0.4091	26	63	n/a	n/a
chr2	86442112	86442112	-	A	het		QUAL=2241;DP=99;AF=0.56;MQM=59;TRIO=HET,99,0.56,HET,31,0.29,HET,63,0.33	REEP1	3'UTR	REEP1:NM_001164730.1:3'UTR:MODIFIER:exon7/7:c.*2110dupT:,REEP1:NM_001164731.1:3'UTR:MODIFIER:exon6/6:c.*2110dupT:,REEP1:NM_001164732.1:3'UTR:MODIFIER:exon5/5:c.*2049dupT:,REEP1:NM_022912.2:3'UTR:MODIFIER:exon7/7:c.*2110dupT:		rs200132323	0.4267	0	0	0										0.1364	0.3333	0.5303	18	49	n/a	n/a
chr2	86481835	86481835	C	T	hom		QUAL=12507;DP=212;AF=0.99;MQM=60;TRIO=HOM,212,0.99,HET,156,0.55,HET,202,0.56	REEP1	synonymous,intron	REEP1:NM_001164730.1:synonymous:LOW:exon4/7:c.306G>A:p.Thr102Thr,REEP1:NM_001164731.1:synonymous:LOW:exon3/6:c.204G>A:p.Thr68Thr,REEP1:NM_022912.2:synonymous:LOW:exon4/7:c.285G>A:p.Thr95Thr,REEP1:NM_001164732.1:intron:MODIFIER:exon3/4:c.182+9253G>A:		rs2276625	0.4287	0.467	0.4423	0.2342						609139 [REEP1 (provisional) Spastic paraplegia 31,autosomal dominant|Neuronopathy,distal hereditary motor,type VB];	RCV000118136.2 [likely benign]; RCV000127760.1 [benign]; 		COSM3758400	0.2348	0.4545	0.3106	179	337	n/a	n/a
chr2	87012073	87012073	A	G	het		QUAL=11874;DP=297;AF=0.55;MQM=59;TRIO=HET,297,0.55,HET,153,0.54,HET,229,0.55	CD8A	3'UTR	CD8A:NM_001145873.1:3'UTR:MODIFIER:exon9/9:c.*970T>C:,CD8A:NM_001768.6:3'UTR:MODIFIER:exon6/6:c.*970T>C:,CD8A:NM_171827.3:3'UTR:MODIFIER:exon5/5:c.*970T>C:		rs1051386	0.1861	0.12	0	0										0.0076	0.2727	0.7197	8	82	n/a	n/a
chr2	87012293	87012293	A	G	het		QUAL=4648;DP=207;AF=0.55;MQM=60;TRIO=HET,207,0.55,HET,31,0.45,HET,40,0.45	CD8A	3'UTR	CD8A:NM_001145873.1:3'UTR:MODIFIER:exon9/9:c.*750T>C:,CD8A:NM_001768.6:3'UTR:MODIFIER:exon6/6:c.*750T>C:,CD8A:NM_171827.3:3'UTR:MODIFIER:exon5/5:c.*750T>C:		rs3020729	0.1861	0.121	0	0										0.0076	0.2727	0.7197	8	82	n/a	n/a
chr2	87012399	87012399	-	AA	het		QUAL=1275;DP=91;AF=0.31;MQM=60;TRIO=HET,91,0.31,HET,27,0.48,HET,21,0.24	CD8A	3'UTR	CD8A:NM_001145873.1:3'UTR:MODIFIER:exon9/9:c.*642_*643dupTT:,CD8A:NM_001768.6:3'UTR:MODIFIER:exon6/6:c.*642_*643dupTT:,CD8A:NM_171827.3:3'UTR:MODIFIER:exon5/5:c.*642_*643dupTT:		rs538181811	0.1723	0	0	0										0.0076	0.2576	0.7348	6	79	n/a	n/a
chr2	87016506	87016506	A	G	het		QUAL=9157;DP=118;AF=0.49;MQM=60;TRIO=HET,118,0.49,HET,210,0.45,HET,301,0.47	CD8A	synonymous,intron	CD8A:NM_001145873.1:synonymous:LOW:exon7/9:c.565T>C:p.Leu189Leu,CD8A:NM_001768.6:synonymous:LOW:exon4/6:c.565T>C:p.Leu189Leu,CD8A:NM_171827.3:intron:MODIFIER:exon3/4:c.514+257T>C:		rs3020726	0.0821	0.118	0.1644	0.0797						186910 [CD8A (confirmed) CD8 deficiency,familial];			COSM4001774	0	0.2576	0.7424	10	118	n/a	n/a
chr2	87018452	87018452	A	G	hom		QUAL=39186;DP=506;AF=1.00;MQM=59;TRIO=HOM,506,1.00,HOM,313,1.00,HOM,404,1.00	CD8A	5'UTR,intron	CD8A:NM_001768.6:5'UTR:MODIFIER:exon1/6:c.-504T>C:,CD8A:NM_171827.3:5'UTR:MODIFIER:exon1/5:c.-504T>C:,CD8A:NM_001145873.1:intron:MODIFIER:exon3/8:c.-270-234T>C:		rs6743139	0.6581	0	0	0										0.5379	0.3788	0.0833	80	58	n/a	n/a
chr2	87018547	87018547	A	G	het		QUAL=18743;DP=294;AF=0.51;MQM=59;TRIO=HET,294,0.51,HOM,281,1.00,HET,323,0.53	CD8A	5'UTR,intron	CD8A:NM_001768.6:5'UTR:MODIFIER:exon1/6:c.-599T>C:,CD8A:NM_171827.3:5'UTR:MODIFIER:exon1/5:c.-599T>C:,CD8A:NM_001145873.1:intron:MODIFIER:exon3/8:c.-270-329T>C:		rs3810831	0.1312	0	0	0										0.0303	0.3106	0.6591	5	47	n/a	n/a
chr2	88874891	88874891	C	A	hom		QUAL=36968;DP=387;AF=1.00;MQM=60;TRIO=HOM,387,1.00,HOM,326,1.00,HOM,409,1.00	EIF2AK3	missense	EIF2AK3:NM_004836.5:missense:MODERATE:exon13/17:c.2110G>T:p.Ala704Ser		rs1805165	0.7206	0.702	0.7299	0.9419	2.4940	P	T	B	B	604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome];	RCV000116968.2 [likely benign]; 			0.6061	0.3636	0.0303	269	162	n/a	n/a
chr2	88879131	88879131	T	C	het		QUAL=6188;DP=275;AF=0.48;MQM=60;TRIO=HET,275,0.48,WT,127,0.00,HET,115,0.50	EIF2AK3	synonymous	EIF2AK3:NM_004836.5:synonymous:LOW:exon11/17:c.1791A>G:p.Gln597Gln		rs1805164	0.2582	0.284	0.302	0.2167						604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome];	RCV000116967.2 [likely benign]; 		COSM3746551	0.0985	0.5076	0.3939	42	194	n/a	n/a
chr2	88895123	88895123	T	C	hom		QUAL=24575;DP=361;AF=1.00;MQM=60;TRIO=HOM,361,1.00,HOM,170,1.00,HOM,210,1.00	EIF2AK3	missense	EIF2AK3:NM_004836.5:missense:MODERATE:exon3/17:c.497A>G:p.Gln166Arg		rs13045	0.649	0.637	0.668	0.865	5.4970	P	T	B	B	604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome];	RCV000116970.2 [likely benign]; 	CM138802 [CLASS=R MUT=ALT PHEN="Wolcott-Rallison syndrome" GENE=EIF2AK3]; 	COSM4001781	0.5455	0.4091	0.0455	231	189	2	n/a
chr2	88926730	88926732	CAG	-	hom		QUAL=422;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HET,12,0.17,HOM,15,1.00	EIF2AK3	inframe_deletion	EIF2AK3:NM_004836.5:inframe_deletion:MODERATE:exon1/17:c.61_63delCTG:p.Leu21del	(CAG)n	rs72416210	0.7965	0	0	0						604032 [EIF2AK3 (confirmed) Wolcott-Rallison syndrome];				0.3864	0.4167	0.197	165	142	n/a	n/a
chr2	96778665	96778665	-	A	het		QUAL=2672;DP=123;AF=0.36;MQM=59;TRIO=HET,123,0.36,HET,87,0.52,HET,115,0.08	ADRA2B	3'UTR	ADRA2B:NM_000682.6:3'UTR:MODIFIER:exon1/1:c.*1879dupT:		rs11464083	0.628	0	0	0										0.197	0.4015	0.4015	26	57	n/a	n/a
chr2	96780122	96780122	G	T	het		QUAL=6749;DP=107;AF=0.50;MQM=59;TRIO=HET,107,0.50,WT,142,0.01,HOM,164,0.99	ADRA2B	3'UTR	ADRA2B:NM_000682.6:3'UTR:MODIFIER:exon1/1:c.*423C>A:		rs4907299	0.3335	0	0	0										0.0606	0.447	0.4924	8	69	n/a	n/a
chr2	96780185	96780185	G	T	het		QUAL=4652;DP=179;AF=0.46;MQM=60;TRIO=HET,179,0.46,HET,130,0.52,WT,147,0.00	ADRA2B	3'UTR	ADRA2B:NM_000682.6:3'UTR:MODIFIER:exon1/1:c.*360C>A:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr2	96780716	96780716	T	G	het		QUAL=14866;DP=345;AF=0.50;MQM=60;TRIO=HET,345,0.50,HOM,301,1.00,WT,441,0.01	ADRA2B	synonymous	ADRA2B:NM_000682.6:synonymous:LOW:exon1/1:c.1173A>C:p.Gly391Gly		rs2229169	0.7053	0.673	0.6826	0.7482										0.5076	0.447	0.0455	246	182	n/a	n/a
chr2	96780986	96780986	C	T	het		QUAL=5911;DP=160;AF=0.20;MQM=59;TRIO=HET,160,0.20,HET,136,0.24,WT,219,0.10	ADRA2B	synonymous	ADRA2B:NM_000682.6:synonymous:LOW:exon1/1:c.903G>A:p.Glu301Glu	(TCC)n	rs4426564	0.2486	0	0	0									COSM3749686	0	0.2803	0.7197	0	65	n/a	n/a
chr2	98330052	98330052	C	A	het		QUAL=4195;DP=147;AF=0.47;MQM=60;TRIO=HET,147,0.47,HET,56,0.46,HET,81,0.49	ZAP70	5'UTR	ZAP70:NM_001079.3:5'UTR:MODIFIER:exon1/14:c.-186C>A:		rs2276645	0.1935	0	0	0										0.1667	0.4394	0.3939	27	64	n/a	n/a
chr2	98354511	98354511	G	A	het		QUAL=15971;DP=275;AF=0.57;MQM=60;TRIO=HET,275,0.57,HET,290,0.52,HET,377,0.52	ZAP70	synonymous	ZAP70:NM_001079.3:synonymous:LOW:exon13/14:c.1677G>A:p.Glu559Glu,ZAP70:NM_207519.1:synonymous:LOW:exon5/6:c.756G>A:p.Glu252Glu		rs3192177	0.1484	0.27	0.3417	0.126						176947 [ZAP70 (confirmed) Selective T-cell defect];	RCV000126355.1 [benign]; 		COSM4134221	0.0833	0.4318	0.4848	48	174	n/a	n/a
chr2	98355990	98355990	G	A	het		QUAL=2476;DP=34;AF=0.53;MQM=60;TRIO=HET,34,0.53,HET,46,0.57,HET,70,0.60	ZAP70	3'UTR	ZAP70:NM_001079.3:3'UTR:MODIFIER:exon14/14:c.*29G>A:,ZAP70:NM_207519.1:3'UTR:MODIFIER:exon6/6:c.*29G>A:		rs11678558	0.1486	0.263	0.3403	0.1261										0.0833	0.4318	0.4848	19	67	n/a	n/a
chr2	98356250	98356250	G	C	het		QUAL=315;DP=19;AF=0.42;MQM=60;TRIO=HET,19,0.42,HET,17,0.35,WT,21,0.00	ZAP70	3'UTR	ZAP70:NM_001079.3:3'UTR:MODIFIER:exon14/14:c.*289G>C:,ZAP70:NM_207519.1:3'UTR:MODIFIER:exon6/6:c.*289G>C:		rs2278699	0.1488	0	0	0										0.0227	0.2879	0.6894	4	42	n/a	n/a
chr2	99172243	99172243	C	T	het		QUAL=3815;DP=130;AF=0.44;MQM=60;TRIO=HET,130,0.44,WT,129,0.02,HET,171,0.43	INPP4A	synonymous,intron	INPP4A:NM_001134224.1:synonymous:LOW:exon17/26:c.1809C>T:p.Ser603Ser,INPP4A:NM_001134225.1:synonymous:LOW:exon16/25:c.1794C>T:p.Ser598Ser,INPP4A:NM_001566.2:intron:MODIFIER:exon17/25:c.1720+89C>T:,INPP4A:NM_004027.2:intron:MODIFIER:exon17/25:c.1720+89C>T:		rs41486345	0.0254	0.056	0.0767	0.0087										0.0076	0.1136	0.8788	2	59	n/a	n/a
chr2	105977776	105977776	G	A	het		QUAL=12415;DP=563;AF=0.50;MQM=60;TRIO=HET,563,0.50,HET,211,0.55,WT,334,0.00	FHL2	synonymous	FHL2:NM_001039492.2:synonymous:LOW:exon7/7:c.804C>T:p.Asp268Asp,FHL2:NM_001450.3:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp,FHL2:NM_201555.1:synonymous:LOW:exon8/8:c.804C>T:p.Asp268Asp,FHL2:NM_201557.3:synonymous:LOW:exon6/6:c.804C>T:p.Asp268Asp		rs3087523	0.0517	0.091	0.127	0.0263							RCV000041652.3 [benign]; 		COSM1398595	0.0076	0.2424	0.75	7	98	n/a	n/a
chr2	106510191	106510191	-	AAAG	hom		QUAL=14131;DP=133;AF=0.96;MQM=59;TRIO=HOM,133,0.96,HOM,147,0.99,HOM,185,0.99	NCK2	3'UTR	NCK2:NM_001004720.2:3'UTR:MODIFIER:exon4/4:c.*562_*565dupAGAA:,NCK2:NM_001004722.3:3'UTR:MODIFIER:exon4/4:c.*731_*734dupAGAA:,NCK2:NM_003581.4:3'UTR:MODIFIER:exon5/5:c.*562_*565dupAGAA:		rs10645562	0.9591	0	0	0										0.8333	0.1136	0.053	125	18	n/a	n/a
chr2	106510455	106510455	-	CA	het		QUAL=1804;DP=62;AF=0.27;MQM=59;TRIO=HET,62,0.27,WT,19,0.00,HET,70,0.34	NCK2	3'UTR	NCK2:NM_001004720.2:3'UTR:MODIFIER:exon4/4:c.*843_*844dupAC:,NCK2:NM_001004722.3:3'UTR:MODIFIER:exon4/4:c.*1012_*1013dupAC:,NCK2:NM_003581.4:3'UTR:MODIFIER:exon5/5:c.*843_*844dupAC:	(CA)n	rs140853322	0	0	0	0										0.053	0.2348	0.7121	7	35	n/a	n/a
chr2	109389463	109389463	G	A	hom		QUAL=16221;DP=167;AF=1.00;MQM=60;TRIO=HOM,167,1.00,HOM,172,1.00,HOM,161,1.00	RANBP2	synonymous	RANBP2:NM_006267.4:synonymous:LOW:exon23/29:c.8253G>A:p.Glu2751Glu		rs826580	0.9872	0.996	0.9997	0.9539						601181 [RANBP2 (provisional) Encephalopathy,acute,infection-induced,3,susceptibility to];				1	0	0	454	0	n/a	n/a
chr2	109510933	109510937	TAATG	-	het		QUAL=2689;DP=66;AF=0.61;MQM=60;TRIO=HET,66,1.00,WT,11,1.00,HET,17,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*2426_*2430delCATTA:		rs555061424	0.0026	0	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr2	109510937	109510937	G	A	het		QUAL=2689;DP=66;AF=0.61;MQM=60;TRIO=HET,66,1.00,HOM,11,1.00,HET,17,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*2426C>T:		rs1478517	0.5317	0	0	0										0.553	0.3409	0.1061	77	55	n/a	n/a
chr2	109511765	109511765	A	G	hom		QUAL=23636;DP=398;AF=1.00;MQM=60;TRIO=HOM,398,1.00,HOM,130,0.99,HOM,186,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*1598T>C:		rs10865025	0.6699	0	0	0										0.7348	0.2273	0.0379	107	38	n/a	n/a
chr2	109512234	109512234	T	C	hom		QUAL=41700;DP=410;AF=1.00;MQM=59;TRIO=HOM,410,1.00,HOM,369,1.00,HOM,502,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*1129A>G:	MIR3	rs13001699	0.7208	0	0	0										0.7652	0.197	0.0379	112	33	n/a	n/a
chr2	109513321	109513321	C	A	hom		QUAL=20365;DP=232;AF=1.00;MQM=59;TRIO=HOM,232,1.00,HOM,161,1.00,HOM,239,1.00	EDAR	3'UTR	EDAR:NM_022336.3:3'UTR:MODIFIER:exon12/12:c.*42G>T:		rs7607563	0.883	0.896	0.9011	0.7767							RCV000143979.1 [other]; 			0.8788	0.1136	0.0076	144	21	n/a	n/a
chr2	109513654	109513654	G	A	hom		QUAL=23356;DP=231;AF=1.00;MQM=59;TRIO=HOM,231,1.00,HOM,205,1.00,HOM,311,1.00	EDAR	synonymous	EDAR:NM_022336.3:synonymous:LOW:exon12/12:c.1056C>T:p.Cys352Cys		rs12623957	0.7119	0.808	0.8305	0.4433						604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive|Hair morphology 1,hair thickness];	RCV000143982.1 [uncertain significance]; RCV000150610.1 [benign]; 			0.7348	0.2273	0.0379	324	112	n/a	n/a
chr2	109526969	109526969	G	A	hom		QUAL=24165;DP=236;AF=1.00;MQM=60;TRIO=HOM,236,1.00,HOM,195,1.00,HOM,305,1.00	EDAR	synonymous	EDAR:NM_022336.3:synonymous:LOW:exon9/12:c.750C>T:p.Ser250Ser		rs260632	0.9213	0.916	0.9022	0.8847						604095 [EDAR (confirmed) Ectodermal dysplasia 10A,hypohidrotic/hair/nail type,autosomal dominant|Ectodermal dysplasia 10B,hypohidrotic/hair/tooth type,autosomal recessive|Hair morphology 1,hair thickness];	RCV000143987.1 [uncertain significance]; RCV000150611.1 [benign]; 		COSM3766485	0.8788	0.1136	0.0076	392	60	n/a	n/a
chr2	110922703	110922703	C	T	hom		QUAL=12570;DP=216;AF=1.00;MQM=60;TRIO=HOM,216,1.00,HET,143,0.51,HET,191,0.52	NPHP1	synonymous	NPHP1:NM_000272.3:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu,NPHP1:NM_001128178.1:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu,NPHP1:NM_001128179.1:synonymous:LOW:exon5/18:c.468G>A:p.Glu156Glu,NPHP1:NM_207181.2:synonymous:LOW:exon7/20:c.654G>A:p.Glu218Glu		rs11675767	0.4744	0.379	0.3226	0.4887						607100 [NPHP1 (confirmed) Nephronophthisis 1,juvenile|Senior-Loken syndrome-1|Joubert syndrome 4];	RCV000078490.4 [other]; 			0.1136	0.4773	0.4091	142	495	n/a	n/a
chr2	113820476	113820476	T	C	het		QUAL=5011;DP=166;AF=0.48;MQM=60;TRIO=HET,166,0.48,HET,76,0.39,HET,117,0.41	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*222T>C:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*222T>C:		rs2515401	0.7153	0	0	0										0.3712	0.5076	0.1212	57	73	n/a	n/a
chr2	113820530	113820530	A	G	het		QUAL=5144;DP=166;AF=0.49;MQM=59;TRIO=HET,166,0.49,HET,81,0.33,HET,112,0.48	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*276A>G:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*276A>G:		rs1800930	0.7155	0	0	0										0.3712	0.5076	0.1212	57	73	n/a	n/a
chr2	113820580	113820580	C	A	het		QUAL=5529;DP=181;AF=0.41;MQM=60;TRIO=HET,181,0.41,HET,97,0.35,HET,150,0.47	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*326C>A:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*326C>A:		rs2515402	0.7155	0	0	0										0.3788	0.5	0.1212	58	72	n/a	n/a
chr2	113820655	113820655	A	T	het		QUAL=8913;DP=182;AF=0.48;MQM=60;TRIO=HET,182,0.48,HET,157,0.50,HET,238,0.53	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*401A>T:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*401A>T:		rs3180234	0.7151	0	0	0										0.3712	0.5076	0.1212	57	73	n/a	n/a
chr2	113820672	113820672	A	G	het		QUAL=10276;DP=214;AF=0.50;MQM=60;TRIO=HET,214,0.50,HET,174,0.47,HET,263,0.51	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*418A>G:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*418A>G:		rs3180235	0.7151	0	0	0										0.3712	0.5076	0.1212	57	73	n/a	n/a
chr2	113820732	113820732	T	C	het		QUAL=12303;DP=260;AF=0.44;MQM=59;TRIO=HET,260,0.44,HET,245,0.46,HET,308,0.53	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*478T>C:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*478T>C:		rs2515403	0.7153	0	0	0										0.3712	0.5076	0.1212	57	73	n/a	n/a
chr2	113820814	113820814	C	G	het		QUAL=9712;DP=222;AF=0.45;MQM=60;TRIO=HET,222,0.45,HET,201,0.45,HET,232,0.51	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*560C>G:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*560C>G:		rs2472188	0.7153	0	0	0										0.3712	0.5076	0.1212	57	73	n/a	n/a
chr2	113821117	113821117	C	T	het		QUAL=8407;DP=322;AF=0.44;MQM=60;TRIO=HET,322,0.44,HET,108,0.43,HET,139,0.52	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*863C>T:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*863C>T:	L1ME4a	rs2515404	0.8698	0	0	0										0.5	0.4167	0.0833	74	61	n/a	n/a
chr2	113821200	113821200	T	C	het		QUAL=6180;DP=161;AF=0.52;MQM=60;TRIO=HET,161,0.52,HET,104,0.40,HET,129,0.50	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*946T>C:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*946T>C:		rs957201	0.7153	0	0	0										0.3712	0.5076	0.1212	57	73	n/a	n/a
chr2	113821653	113821653	T	C	het		QUAL=15927;DP=359;AF=0.50;MQM=59;TRIO=HET,359,0.50,HET,275,0.46,HET,406,0.45	IL36RN	3'UTR	IL36RN:NM_012275.2:3'UTR:MODIFIER:exon5/5:c.*1399T>C:,IL36RN:NM_173170.1:3'UTR:MODIFIER:exon5/5:c.*1399T>C:	MLT1C	rs768627	0.7153	0	0	0										0.3712	0.5076	0.1212	57	73	n/a	n/a
chr2	113887207	113887207	T	C	het		QUAL=2559;DP=106;AF=0.48;MQM=60;TRIO=HET,106,0.48,HOM,29,1.00,WT,45,0.00	IL1RN	synonymous	IL1RN:NM_173841.2:synonymous:LOW:exon4/6:c.180T>C:p.Ala60Ala,IL1RN:NM_000577.4:synonymous:LOW:exon3/5:c.117T>C:p.Ala39Ala,IL1RN:NM_173843.2:synonymous:LOW:exon4/6:c.69T>C:p.Ala23Ala,IL1RN:NM_173842.2:synonymous:LOW:exon2/4:c.171T>C:p.Ala57Ala		rs419598	0.1917	0.249	0.2788	0.0642						147679 [IL1RN (confirmed) Gastric cancer risk after H. pylori infection|Microvascular complications of diabetes 4|Interleukin 1 receptor antagonist deficiency];		CM025329 [CLASS=DP MUT=ALT PHEN="Alopecia areata, association with" GENE=IL1RN]; 	COSM3766493	0.0985	0.4167	0.4848	46	157	n/a	n/a
chr2	113891412	113891412	G	A	hom		QUAL=13047;DP=134;AF=0.99;MQM=60;TRIO=HOM,134,0.99,HOM,169,0.99,HET,242,0.46	IL1RN	3'UTR	IL1RN:NM_173841.2:3'UTR:MODIFIER:exon6/6:c.*964G>A:,IL1RN:NM_000577.4:3'UTR:MODIFIER:exon5/5:c.*964G>A:,IL1RN:NM_173843.2:3'UTR:MODIFIER:exon6/6:c.*964G>A:,IL1RN:NM_173842.2:3'UTR:MODIFIER:exon4/4:c.*964G>A:	L2b	rs9005	0.3199	0	0	0										0.0985	0.447	0.4545	13	69	n/a	n/a
chr2	113975110	113975110	A	G	hom		QUAL=10376;DP=165;AF=1.00;MQM=60;TRIO=HOM,165,1.00,HET,135,0.50,HET,183,0.48	PAX8	3'UTR	PAX8:NM_003466.3:3'UTR:MODIFIER:exon12/12:c.*1000T>C:,PAX8:NM_013952.3:3'UTR:MODIFIER:exon12/12:c.*1077T>C:,PAX8:NM_013953.3:3'UTR:MODIFIER:exon10/10:c.*1077T>C:,PAX8:NM_013992.3:3'UTR:MODIFIER:exon9/9:c.*1077T>C:		rs1049137	0.146	0	0	0										0.0606	0.4242	0.5152	9	63	n/a	n/a
chr2	114036436	114036436	G	C	hom		QUAL=11728;DP=80;AF=0.99;MQM=60;TRIO=HOM,80,0.99,HOM,135,1.00,HOM,165,1.00	PAX8	5'UTR	PAX8:NM_003466.3:5'UTR:MODIFIER:exon1/12:c.-104C>G:,PAX8:NM_013952.3:5'UTR:MODIFIER:exon1/12:c.-104C>G:,PAX8:NM_013953.3:5'UTR:MODIFIER:exon1/10:c.-104C>G:,PAX8:NM_013992.3:5'UTR:MODIFIER:exon1/9:c.-104C>G:		rs2084163	0.9764	0	0	0										1	0	0	150	0	n/a	n/a
chr2	121726447	121726447	G	A	hom		QUAL=9231;DP=72;AF=1.00;MQM=60;TRIO=HOM,72,1.00,HOM,102,1.00,HOM,142,1.00	GLI2	synonymous	GLI2:NM_005270.4:synonymous:LOW:exon5/13:c.801G>A:p.Ser267Ser		rs2592595	0.8273	0.939	0.9838	0.4685	-5.5090	P	T	B	B	165230 [GLI2 (confirmed) Holoprosencephaly-9|Pallister-Hall syndrome 2];				0.9545	0.0455	0	429	22	n/a	n/a
chr2	121746956	121746956	G	T	hom		QUAL=16701;DP=75;AF=0.99;MQM=59;TRIO=HOM,75,0.99,HOM,173,1.00,HOM,294,1.00	GLI2	missense	GLI2:NM_005270.4:missense:MODERATE:exon13/13:c.3466G>T:p.Ala1156Ser		rs3738880	0.509	0.627	0.7307	0.4135	-0.3680	P		B,B	B,B	165230 [GLI2 (confirmed) Holoprosencephaly-9|Pallister-Hall syndrome 2];	RCV000081284.2 [benign]; 			0.4773	0.4394	0.0833	214	178	n/a	n/a
chr2	121747406	121747406	G	A	hom		QUAL=20922;DP=175;AF=1.00;MQM=59;TRIO=HOM,175,1.00,HOM,208,1.00,HOM,269,1.00	GLI2	missense	GLI2:NM_005270.4:missense:MODERATE:exon13/13:c.3916G>A:p.Asp1306Asn		rs12711538	0.5671	0.644	0.7283	0.5764	2.1560	P		B,B	B,B	165230 [GLI2 (confirmed) Holoprosencephaly-9|Pallister-Hall syndrome 2];	RCV000081285.2 [benign]; 		COSM3757603	0.4773	0.4394	0.0833	220	178	n/a	n/a
chr2	121747429	121747429	A	G	hom		QUAL=22489;DP=181;AF=1.00;MQM=60;TRIO=HOM,181,1.00,HOM,226,1.00,HOM,305,1.00	GLI2	synonymous	GLI2:NM_005270.4:synonymous:LOW:exon13/13:c.3939A>G:p.Pro1313Pro		rs10167980	0.5124	0.632	0.734	0.4094						165230 [GLI2 (confirmed) Holoprosencephaly-9|Pallister-Hall syndrome 2];	RCV000081286.2 [benign]; 		COSM3721935	0.4924	0.4318	0.0758	219	180	n/a	n/a
chr2	121749067	121749067	G	C	hom		QUAL=20056;DP=238;AF=1.00;MQM=60;TRIO=HOM,238,1.00,HOM,156,1.00,HOM,225,1.00	GLI2	3'UTR	GLI2:NM_005270.4:3'UTR:MODIFIER:exon13/13:c.*816G>C:		rs2278741	0.5078	0	0	0										0.4773	0.447	0.0758	76	63	n/a	n/a
chr2	127819777	127819777	C	T	het		QUAL=6342;DP=154;AF=0.42;MQM=59;TRIO=HET,154,0.42,WT,234,0.00,HET,311,0.46	BIN1	splice_region&intron	BIN1:NM_139343.2:splice_region&intron:LOW:exon9/18:c.775-4G>A:,BIN1:NM_004305.3:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:NM_139344.2:splice_region&intron:LOW:exon9/17:c.775-4G>A:,BIN1:NM_139345.2:splice_region&intron:LOW:exon9/15:c.775-4G>A:,BIN1:NM_139346.2:splice_region&intron:LOW:exon8/15:c.682-4G>A:,BIN1:NM_139347.2:splice_region&intron:LOW:exon8/15:c.682-4G>A:,BIN1:NM_139348.2:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:NM_139349.2:splice_region&intron:LOW:exon8/14:c.682-4G>A:,BIN1:NM_139350.2:splice_region&intron:LOW:exon8/13:c.682-4G>A:,BIN1:NM_139351.2:splice_region&intron:LOW:exon8/12:c.682-4G>A:		rs61748157	0.0972	0.108	0.1262	0.0652						601248 [BIN1 (provisional) Myopathy,centronuclear,autosomal recessive];				0.0152	0.2273	0.7576	9	116	n/a	n/a
chr2	135677471	135677471	-	GTTT	het		QUAL=6458;DP=198;AF=0.37;MQM=60;TRIO=HET,198,0.37,HET,133,0.43,HET,194,0.44	CCNT2	splice_region&intron	CCNT2:NM_058241.2:splice_region&intron:LOW:exon2/8:c.240+10_240+11insGTTT:,CCNT2:NM_001241.3:splice_region&intron:LOW:exon2/9:c.240+10_240+11insGTTT:		rs45507394	0.4173	0.333	0.2654	0.4327										0.0985	0.3712	0.5303	36	89	n/a	n/a
chr2	135711516	135711516	C	T	het		QUAL=17077;DP=354;AF=0.49;MQM=60;TRIO=HET,354,0.49,HET,189,0.54,HOM,249,1.00	CCNT2	synonymous	CCNT2:NM_058241.2:synonymous:LOW:exon9/9:c.1491C>T:p.Asp497Asp,CCNT2:NM_001241.3:synonymous:LOW:exon9/10:c.1491C>T:p.Asp497Asp		rs3814355	0.7328	0.589	0.47	0.7138										0.4318	0.4924	0.0758	141	114	n/a	n/a
chr2	135711657	135711657	G	A	het		QUAL=27593;DP=409;AF=0.48;MQM=59;TRIO=HET,409,0.48,HET,361,0.53,HOM,466,1.00	CCNT2	synonymous	CCNT2:NM_058241.2:synonymous:LOW:exon9/9:c.1632G>A:p.Lys544Lys,CCNT2:NM_001241.3:synonymous:LOW:exon9/10:c.1632G>A:p.Lys544Lys		rs3814354	0.7021	0.58	0.4683	0.6362									COSM1179790	0.4318	0.4924	0.0758	136	117	n/a	n/a
chr2	135713386	135713389	AAAA	-	het		QUAL=7799;DP=241;AF=0.43;MQM=60;TRIO=HET,241,0.43,HET,104,0.55,HET,165,0.50	CCNT2	3'UTR	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*1170_*1173delAAAA:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*1270_*1273delAAAA:		rs397897552	0	0	0	0										0.1212	0.4697	0.4091	19	68	n/a	n/a
chr2	135713703	135713703	G	A	het		QUAL=10261;DP=260;AF=0.52;MQM=60;TRIO=HET,260,0.52,HET,67,0.46,HOM,146,1.00	CCNT2	3'UTR	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*1485G>A:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*1585G>A:		rs3769023	0.7059	0	0	0										0.4318	0.4924	0.0758	65	70	n/a	n/a
chr2	135715175	135715175	C	-	het		QUAL=14183;DP=314;AF=0.50;MQM=60;TRIO=HET,314,0.50,HET,166,0.49,HOM,202,1.00	CCNT2	3'UTR	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*2957delC:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*3057delC:		rs10709967	0	0	0	0										0.4318	0.4924	0.0758	65	70	n/a	n/a
chr2	135715466	135715469	TAAT	-	het		QUAL=10380;DP=271;AF=0.42;MQM=60;TRIO=HET,271,0.42,HET,113,0.55,HOM,153,0.99	CCNT2	3'UTR	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*3252_*3255delTAAT:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*3352_*3355delTAAT:		rs570752784	0	0	0	0										0.4318	0.4924	0.0758	64	71	n/a	n/a
chr2	135715957	135715957	A	G	het		QUAL=13036;DP=409;AF=0.44;MQM=60;TRIO=HET,409,0.44,HET,175,0.43,HOM,145,1.00	CCNT2	3'UTR	CCNT2:NM_058241.2:3'UTR:MODIFIER:exon9/9:c.*3739A>G:,CCNT2:NM_001241.3:3'UTR:MODIFIER:exon10/10:c.*3839A>G:		rs1947112	0.7055	0	0	0										0.4318	0.4924	0.0758	65	70	n/a	n/a
chr2	145142173	145142173	T	-	het		QUAL=2850;DP=141;AF=0.45;MQM=60;TRIO=HET,141,0.45,WT,34,0.03,HET,69,0.45	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*4845delA:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*4845delA:		rs201661554	0.0885	0	0	0										0.0076	0.0758	0.9167	1	10	n/a	n/a
chr2	145143934	145143934	G	A	het		QUAL=3844;DP=172;AF=0.50;MQM=60;TRIO=HET,172,0.50,HOM,36,0.97,WT,49,0.00	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*3084C>T:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*3084C>T:		rs62169201	0.0397	0	0	0										0.0227	0.1818	0.7955	3	27	n/a	n/a
chr2	145144612	145144612	-	TA	het		QUAL=675;DP=30;AF=0.30;MQM=58;TRIO=HET,30,0.63,HET,27,0.19,HET,42,0.33	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*2404_*2405dupTA:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*2404_*2405dupTA:	(TA)n	rs143648355	0	0	0	0										0.0379	0.5379	0.4242	6	81	n/a	n/a
chr2	145144631	145144631	C	T	het		QUAL=675;DP=30;AF=0.30;MQM=60;TRIO=HET,30,0.63,WT,27,0.19,WT,42,0.33	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*2387G>A:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*2387G>A:	(TA)n	rs199966315	0	0	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr2	145145034	145145034	A	G	hom		QUAL=17111;DP=263;AF=1.00;MQM=60;TRIO=HOM,263,1.00,HOM,113,1.00,HOM,140,1.00	ZEB2	3'UTR	ZEB2:NM_014795.3:3'UTR:MODIFIER:exon10/10:c.*1984T>C:,ZEB2:NM_001171653.1:3'UTR:MODIFIER:exon9/9:c.*1984T>C:		rs10179925	0.9958	0	0	0										1	0	0	153	0	n/a	n/a
chr2	149270710	149270710	A	G	hom		QUAL=15961;DP=327;AF=0.99;MQM=60;TRIO=HOM,327,0.99,HET,157,0.50,HET,166,0.46	MBD5	3'UTR	MBD5:NM_018328.4:3'UTR:MODIFIER:exon15/15:c.*200A>G:		rs16828708	0.4491	0	0	0										0.0909	0.4545	0.4545	12	66	n/a	n/a
chr2	149881036	149881039	GTGT	-	het		QUAL=2536;DP=42;AF=0.29;MQM=59;TRIO=HET,42,0.76,HET,35,0.91,HET,65,0.78	KIF5C	3'UTR	KIF5C:NM_004522.2:3'UTR:MODIFIER:exon26/26:c.*1488_*1491delGTGT:	(TG)n		0	0	0	0										0.1439	0.4621	0.3939	22	67	n/a	n/a
chr2	149881076	149881076	A	G	het		QUAL=2536;DP=42;AF=0.29;MQM=54;TRIO=HET,42,0.76,WT,35,0.91,WT,65,0.78	KIF5C	3'UTR	KIF5C:NM_004522.2:3'UTR:MODIFIER:exon26/26:c.*1492A>G:	(TG)n	rs78917133	0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr2	152346553	152346553	G	A	het		QUAL=6190;DP=278;AF=0.44;MQM=60;TRIO=HET,278,0.44,HET,145,0.48,WT,227,0.00	NEB	stop_gained	NEB:NM_001271208.1:stop_gained:HIGH:exon182/183:c.25441C>T:p.Arg8481*,NEB:NM_001164507.1:stop_gained:HIGH:exon181/182:c.25336C>T:p.Arg8446*,NEB:NM_001164508.1:stop_gained:HIGH:exon181/182:c.25336C>T:p.Arg8446*,NEB:NM_004543.4:stop_gained:HIGH:exon148/149:c.19732C>T:p.Arg6578*		rs200731870	0	0.0001	0.0001	0	2.9000	A	T			161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];			COSM1007383	0	0.0076	0.9924	0	1	n/a	n/a
chr2	152346979	152346979	T	C	het		QUAL=13333;DP=285;AF=0.48;MQM=60;TRIO=HET,285,0.48,HET,236,0.49,HET,299,0.55	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon181/183:c.25309A>G:p.Ile8437Val,NEB:NM_001164507.1:missense:MODERATE:exon180/182:c.25204A>G:p.Ile8402Val,NEB:NM_001164508.1:missense:MODERATE:exon180/182:c.25204A>G:p.Ile8402Val,NEB:NM_004543.4:missense:MODERATE:exon147/149:c.19600A>G:p.Ile6534Val		rs1061305	0.3343	0.364	0.415	0.4266	-0.6960	P	T	B,B,B,B	B,B,B,B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081132.4 [other]; 			0.1667	0.4394	0.3939	73	205	n/a	n/a
chr2	152352843	152352843	C	G	hom		QUAL=34136;DP=322;AF=1.00;MQM=59;TRIO=HOM,322,1.00,HOM,320,1.00,HOM,413,1.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon174/183:c.24538G>C:p.Ala8180Pro,NEB:NM_001164507.1:missense:MODERATE:exon173/182:c.24433G>C:p.Ala8145Pro,NEB:NM_001164508.1:missense:MODERATE:exon173/182:c.24433G>C:p.Ala8145Pro,NEB:NM_004543.4:missense:MODERATE:exon140/149:c.18829G>C:p.Ala6277Pro		rs7575451	0.6278	0.639	0.6442	0.5948	3.0990	P,P,P	T,.,.	B,B,B,B,.,.	B,B,B,B,.,.	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081126.4 [other]; 		COSM4154531	0.4621	0.4091	0.1288	197	201	n/a	n/a
chr2	152354239	152354239	G	A	het		QUAL=5963;DP=186;AF=0.49;MQM=58;TRIO=HET,186,0.49,HET,221,0.43,WT,314,0.00	NEB	splice_region&intron,intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon171/182:c.24313-7C>T:,NEB:NM_001164507.1:splice_region&intron:LOW:exon170/181:c.24208-7C>T:,NEB:NM_001164508.1:splice_region&intron:LOW:exon170/181:c.24208-7C>T:,NEB:NM_004543.4:intron:MODIFIER:exon139/148:c.18790-1357C>T:		rs113048349	0.005	0.0072	0.0132	0.0014						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];				0	0.0076	0.9924	0	6	n/a	n/a
chr2	152387553	152387553	T	C	hom		QUAL=36066;DP=370;AF=1.00;MQM=60;TRIO=HOM,370,1.00,HOM,305,0.99,HOM,444,1.00	NEB	synonymous	NEB:NM_001271208.1:synonymous:LOW:exon146/183:c.21690A>G:p.Thr7230Thr,NEB:NM_001164507.1:synonymous:LOW:exon145/182:c.21585A>G:p.Thr7195Thr,NEB:NM_001164508.1:synonymous:LOW:exon145/182:c.21585A>G:p.Thr7195Thr,NEB:NM_004543.4:synonymous:LOW:exon117/149:c.16446A>G:p.Thr5482Thr		rs4664475	0.4916	0.577	0.622	0.4132						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081120.4 [other]; 			0.3788	0.4773	0.1439	173	212	n/a	n/a
chr2	152388416	152388416	T	-	hom		QUAL=17871;DP=178;AF=0.97;MQM=60;TRIO=HOM,178,0.97,HOM,148,0.98,HOM,253,0.98	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon144/182:c.21523-6delA:,NEB:NM_001164507.1:splice_region&intron:LOW:exon143/181:c.21418-6delA:,NEB:NM_001164508.1:splice_region&intron:LOW:exon143/181:c.21418-6delA:,NEB:NM_004543.4:splice_region&intron:LOW:exon115/148:c.16279-6delA:		rs398090759	0.4912	0.559	0.6176	0.3919						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081118.2 [benign]; 			0.3788	0.4773	0.1439	171	212	n/a	n/a
chr2	152402516	152402516	A	-	het		QUAL=2240;DP=109;AF=0.15;MQM=60;TRIO=HET,109,0.15,HET,70,0.16,HET,104,0.22	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon134/182:c.20467-4delT:,NEB:NM_001164507.1:splice_region&intron:LOW:exon134/181:c.20467-4delT:,NEB:NM_001164508.1:splice_region&intron:LOW:exon134/181:c.20467-4delT:,NEB:NM_004543.4:splice_region&intron:LOW:exon106/148:c.15328-4delT:			0	0	0	0						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];				0	0.053	0.947	0	8	n/a	n/a
chr2	152422076	152422076	C	G	het		QUAL=22108;DP=412;AF=0.47;MQM=60;TRIO=HET,412,0.47,HET,275,0.55,HOM,325,1.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon116/183:c.18305G>C:p.Arg6102Thr,NEB:NM_001164507.1:missense:MODERATE:exon116/182:c.18305G>C:p.Arg6102Thr,NEB:NM_001164508.1:missense:MODERATE:exon116/182:c.18305G>C:p.Arg6102Thr,NEB:NM_004543.4:missense:MODERATE:exon88/149:c.13166G>C:p.Arg4389Thr		rs2288210	0.6532	0.657	0.6633	0.6196	5.7170	P	T	B	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081115.4 [other]; 		COSM4154535	0.4848	0.4015	0.1136	204	200	n/a	n/a
chr2	152424933	152424933	-	A	het		QUAL=3668;DP=130;AF=0.25;MQM=59;TRIO=HET,130,0.25,HET,75,0.43,HET,87,0.75	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon111/182:c.17635-3_17635-2insT:,NEB:NM_001164507.1:splice_region&intron:LOW:exon111/181:c.17635-3_17635-2insT:,NEB:NM_001164508.1:splice_region&intron:LOW:exon111/181:c.17635-3_17635-2insT:,NEB:NM_004543.4:splice_region&intron:LOW:exon83/148:c.12496-3_12496-2insT:		rs539518038	0.5066	0	0	0						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];			COSM1613492	0.3636	0.3864	0.25	122	109	n/a	n/a
chr2	152432311	152432311	T	C	het		QUAL=5090;DP=218;AF=0.46;MQM=60;TRIO=HET,218,0.46,HET,116,0.48,WT,159,0.00	NEB	splice_region&synonymous	NEB:NM_001271208.1:splice_region&synonymous:LOW:exon107/183:c.16911A>G:p.Pro5637Pro,NEB:NM_001164507.1:splice_region&synonymous:LOW:exon107/182:c.16911A>G:p.Pro5637Pro,NEB:NM_001164508.1:splice_region&synonymous:LOW:exon107/182:c.16911A>G:p.Pro5637Pro,NEB:NM_004543.4:splice_region&synonymous:LOW:exon79/149:c.11772A>G:p.Pro3924Pro		rs33988153	0.1102	0.198	0.2531	0.0458						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081112.4 [other]; 		COSM3757670	0.053	0.3485	0.5985	23	172	n/a	n/a
chr2	152490458	152490458	A	G	hom		QUAL=45235;DP=398;AF=1.00;MQM=59;TRIO=HOM,398,1.00,HOM,429,1.00,HOM,601,1.00	NEB	missense,intron	NEB:NM_001271208.1:missense:MODERATE:exon65/183:c.9124T>C:p.Cys3042Arg,NEB:NM_001164507.1:missense:MODERATE:exon65/182:c.9124T>C:p.Cys3042Arg,NEB:NM_001164508.1:missense:MODERATE:exon65/182:c.9124T>C:p.Cys3042Arg,NEB:NM_004543.4:intron:MODIFIER:exon62/148:c.8854-3125T>C:		rs6710212	0.972	0.993	0.9991	0.922	1.6720	P	T			161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];				1	0	0	453	0	n/a	n/a
chr2	152496526	152496526	A	G	het		QUAL=9658;DP=174;AF=0.49;MQM=60;TRIO=HET,174,0.49,HET,199,0.48,HET,286,0.47	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon62/183:c.8734T>C:p.Ser2912Pro,NEB:NM_001164507.1:missense:MODERATE:exon62/182:c.8734T>C:p.Ser2912Pro,NEB:NM_001164508.1:missense:MODERATE:exon62/182:c.8734T>C:p.Ser2912Pro,NEB:NM_004543.4:missense:MODERATE:exon62/149:c.8734T>C:p.Ser2912Pro		rs6713162	0.4453	0.254	0.165	0.5978	5.5460	P	T	B	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117776.2 [likely benign]; 		COSM3757672	0.0455	0.3106	0.6439	17	148	n/a	n/a
chr2	152497088	152497088	G	A	het		QUAL=17170;DP=425;AF=0.47;MQM=52;TRIO=HET,425,0.47,HET,710,0.47,WT,898,0.00	NEB	synonymous	NEB:NM_001271208.1:synonymous:LOW:exon61/183:c.8466C>T:p.His2822His,NEB:NM_001164507.1:synonymous:LOW:exon61/182:c.8466C>T:p.His2822His,NEB:NM_001164508.1:synonymous:LOW:exon61/182:c.8466C>T:p.His2822His,NEB:NM_004543.4:synonymous:LOW:exon61/149:c.8466C>T:p.His2822His		rs61730771	0.0323	0.022	0.0181	0.0412						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117774.2 [likely benign]; 		COSM3694905	0	0.0303	0.9697	0	19	n/a	n/a
chr2	152499143	152499143	C	T	het		QUAL=8902;DP=241;AF=0.55;MQM=60;TRIO=HET,241,0.55,HET,273,0.51,WT,375,0.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon60/183:c.8318G>A:p.Arg2773Gln,NEB:NM_001164507.1:missense:MODERATE:exon60/182:c.8318G>A:p.Arg2773Gln,NEB:NM_001164508.1:missense:MODERATE:exon60/182:c.8318G>A:p.Arg2773Gln,NEB:NM_004543.4:missense:MODERATE:exon60/149:c.8318G>A:p.Arg2773Gln		rs35974308	0.0206	0.023	0.0285	0.0056	3.9180	D	T	D	D	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117773.2 [likely benign]; 		COSM3757675	0	0.0303	0.9697	0	19	n/a	n/a
chr2	152511778	152511778	A	C	het		QUAL=5265;DP=124;AF=0.58;MQM=60;TRIO=HET,124,0.58,HET,71,0.52,HET,85,0.62	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon51/182:c.6807+6T>G:,NEB:NM_001164507.1:splice_region&intron:LOW:exon51/181:c.6807+6T>G:,NEB:NM_001164508.1:splice_region&intron:LOW:exon51/181:c.6807+6T>G:,NEB:NM_004543.4:splice_region&intron:LOW:exon51/148:c.6807+6T>G:	AT_rich	rs10930723	0.4309	0.248	0.1674	0.5692						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117771.3 [other]; 			0.0455	0.3333	0.6212	16	149	n/a	n/a
chr2	152521096	152521096	C	T	het		QUAL=4402;DP=169;AF=0.44;MQM=60;TRIO=HET,169,0.44,HET,61,0.41,HET,85,0.46	NEB	synonymous	NEB:NM_001271208.1:synonymous:LOW:exon44/183:c.5370G>A:p.Glu1790Glu,NEB:NM_001164507.1:synonymous:LOW:exon44/182:c.5370G>A:p.Glu1790Glu,NEB:NM_001164508.1:synonymous:LOW:exon44/182:c.5370G>A:p.Glu1790Glu,NEB:NM_004543.4:synonymous:LOW:exon44/149:c.5370G>A:p.Glu1790Glu		rs10170273	0.4349	0.241	0.1662	0.5798						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117761.2 [likely benign]; 		COSM3757677	0.053	0.3258	0.6212	17	150	n/a	n/a
chr2	152527572	152527572	C	T	het		QUAL=17829;DP=300;AF=0.51;MQM=60;TRIO=HET,300,0.51,HET,311,0.54,HET,430,0.56	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon38/183:c.4471G>A:p.Val1491Met,NEB:NM_001164507.1:missense:MODERATE:exon38/182:c.4471G>A:p.Val1491Met,NEB:NM_001164508.1:missense:MODERATE:exon38/182:c.4471G>A:p.Val1491Met,NEB:NM_004543.4:missense:MODERATE:exon38/149:c.4471G>A:p.Val1491Met		rs7426114	0.5331	0.737	0.8325	0.3203	2.6960	P	D	P	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081137.4 [other]; 		COSM4001232	0.6212	0.3258	0.053	285	152	n/a	n/a
chr2	152527608	152527608	C	T	het		QUAL=17332;DP=322;AF=0.48;MQM=60;TRIO=HET,322,0.48,HET,366,0.45,HET,509,0.44	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon38/183:c.4435G>A:p.Val1479Ile,NEB:NM_001164507.1:missense:MODERATE:exon38/182:c.4435G>A:p.Val1479Ile,NEB:NM_001164508.1:missense:MODERATE:exon38/182:c.4435G>A:p.Val1479Ile,NEB:NM_004543.4:missense:MODERATE:exon38/149:c.4435G>A:p.Val1479Ile		rs34577613	0.3353	0.19	0.1088	0.3572	0.0190	P	T	B	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117759.2 [likely benign]; 		COSM148955	0.0227	0.2727	0.7045	9	114	n/a	n/a
chr2	152527636	152527636	C	G	het		QUAL=12637;DP=420;AF=0.47;MQM=60;TRIO=HET,420,0.47,HET,400,0.47,WT,540,0.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon38/183:c.4407G>C:p.Glu1469Asp,NEB:NM_001164507.1:missense:MODERATE:exon38/182:c.4407G>C:p.Glu1469Asp,NEB:NM_001164508.1:missense:MODERATE:exon38/182:c.4407G>C:p.Glu1469Asp,NEB:NM_004543.4:missense:MODERATE:exon38/149:c.4407G>C:p.Glu1469Asp		rs34800215	0.0272	0.02	0.0188	0.0479	0.3640	D	T	D	D	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117758.2 [likely benign]; 		COSM3694912	0	0.0303	0.9697	0	18	n/a	n/a
chr2	152531077	152531077	A	G	het		QUAL=8722;DP=255;AF=0.49;MQM=60;TRIO=HET,255,0.49,HET,146,0.43,HET,205,0.41	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon36/183:c.3901T>C:p.Tyr1301His,NEB:NM_001164507.1:missense:MODERATE:exon36/182:c.3901T>C:p.Tyr1301His,NEB:NM_001164508.1:missense:MODERATE:exon36/182:c.3901T>C:p.Tyr1301His,NEB:NM_004543.4:missense:MODERATE:exon36/149:c.3901T>C:p.Tyr1301His		rs6711382	0.7161	0.826	0.8924	0.6602	1.3400	P	T	B	B	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];			COSM4001234	0.7045	0.2727	0.0227	332	115	n/a	n/a
chr2	152536427	152536427	C	T	het		QUAL=10936;DP=289;AF=0.48;MQM=60;TRIO=HET,289,0.48,HET,396,0.52,WT,416,0.00	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon31/182:c.3147+5G>A:,NEB:NM_001164507.1:splice_region&intron:LOW:exon31/181:c.3147+5G>A:,NEB:NM_001164508.1:splice_region&intron:LOW:exon31/181:c.3147+5G>A:,NEB:NM_004543.4:splice_region&intron:LOW:exon31/148:c.3147+5G>A:		rs74859201	0.0114	0.016	0.0191	0.0045						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117754.1 [benign]; 			0	0.0303	0.9697	0	18	n/a	n/a
chr2	152536498	152536498	T	A	het		QUAL=25672;DP=389;AF=0.49;MQM=60;TRIO=HET,389,0.49,HET,364,0.48,HOM,416,1.00	NEB	missense	NEB:NM_001271208.1:missense:MODERATE:exon31/183:c.3081A>T:p.Lys1027Asn,NEB:NM_001164507.1:missense:MODERATE:exon31/182:c.3081A>T:p.Lys1027Asn,NEB:NM_001164508.1:missense:MODERATE:exon31/182:c.3081A>T:p.Lys1027Asn,NEB:NM_004543.4:missense:MODERATE:exon31/149:c.3081A>T:p.Lys1027Asn		rs6735208	0.5835	0.749	0.8265	0.427	-0.4180	P	T	D	P	161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081134.4 [other]; 			0.6288	0.3182	0.053	289	148	n/a	n/a
chr2	152573981	152573981	A	G	het		QUAL=16425;DP=351;AF=0.46;MQM=60;TRIO=HET,351,0.46,HET,181,0.48,HOM,252,1.00	NEB	synonymous	NEB:NM_001271208.1:synonymous:LOW:exon10/183:c.771T>C:p.Ala257Ala,NEB:NM_001164507.1:synonymous:LOW:exon10/182:c.771T>C:p.Ala257Ala,NEB:NM_001164508.1:synonymous:LOW:exon10/182:c.771T>C:p.Ala257Ala,NEB:NM_004543.4:synonymous:LOW:exon10/149:c.771T>C:p.Ala257Ala		rs4611637	0.5693	0.743	0.8271	0.3772						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000081142.4 [other]; 		COSM4001249	0.6439	0.3106	0.0455	290	144	n/a	n/a
chr2	152580766	152580766	A	G	het		QUAL=5724;DP=148;AF=0.41;MQM=60;TRIO=HET,148,0.41,HET,245,0.50,WT,378,0.00	NEB	splice_region&intron	NEB:NM_001271208.1:splice_region&intron:LOW:exon8/182:c.612+8T>C:,NEB:NM_001164507.1:splice_region&intron:LOW:exon8/181:c.612+8T>C:,NEB:NM_001164508.1:splice_region&intron:LOW:exon8/181:c.612+8T>C:,NEB:NM_004543.4:splice_region&intron:LOW:exon8/148:c.612+8T>C:		rs113095802	0.0254	0.019	0.0193	0.0372						161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive];	RCV000117768.2 [likely benign]; 			0	0.0379	0.9621	0	19	n/a	n/a
chr2	152690248	152690248	G	A	hom		QUAL=16455;DP=299;AF=1.00;MQM=60;TRIO=HOM,299,1.00,HOM,82,1.00,HOM,111,1.00	CACNB4	3'UTR	CACNB4:NM_000726.3:3'UTR:MODIFIER:exon14/14:c.*5385C>T:,CACNB4:NM_001005747.2:3'UTR:MODIFIER:exon13/13:c.*5385C>T:,CACNB4:NM_001005746.2:3'UTR:MODIFIER:exon14/14:c.*5385C>T:,CACNB4:NM_001145798.1:3'UTR:MODIFIER:exon13/13:c.*5385C>T:		rs1568673	0.8784	0	0	0										0.947	0.053	0	141	9	n/a	n/a
chr2	152691829	152691829	C	G	het		QUAL=7746;DP=339;AF=0.49;MQM=60;TRIO=HET,339,0.49,HET,122,0.55,WT,187,0.01	CACNB4	3'UTR	CACNB4:NM_000726.3:3'UTR:MODIFIER:exon14/14:c.*3804G>C:,CACNB4:NM_001005747.2:3'UTR:MODIFIER:exon13/13:c.*3804G>C:,CACNB4:NM_001005746.2:3'UTR:MODIFIER:exon14/14:c.*3804G>C:,CACNB4:NM_001145798.1:3'UTR:MODIFIER:exon13/13:c.*3804G>C:		rs2344734	0.4603	0	0	0										0.053	0.3485	0.5985	7	55	n/a	n/a
chr2	152693977	152693977	A	G	het		QUAL=7293;DP=311;AF=0.49;MQM=60;TRIO=HET,311,0.49,HET,134,0.50,WT,235,0.00	CACNB4	3'UTR	CACNB4:NM_000726.3:3'UTR:MODIFIER:exon14/14:c.*1656T>C:,CACNB4:NM_001005747.2:3'UTR:MODIFIER:exon13/13:c.*1656T>C:,CACNB4:NM_001005746.2:3'UTR:MODIFIER:exon14/14:c.*1656T>C:,CACNB4:NM_001145798.1:3'UTR:MODIFIER:exon13/13:c.*1656T>C:		rs62174451	0.0236	0	0	0										0	0.053	0.947	0	8	n/a	n/a
chr2	152695191	152695191	C	T	het		QUAL=3166;DP=160;AF=0.56;MQM=59;TRIO=HET,160,0.56,HET,25,0.52,WT,48,0.04	CACNB4	3'UTR	CACNB4:NM_000726.3:3'UTR:MODIFIER:exon14/14:c.*442G>A:,CACNB4:NM_001005747.2:3'UTR:MODIFIER:exon13/13:c.*442G>A:,CACNB4:NM_001005746.2:3'UTR:MODIFIER:exon14/14:c.*442G>A:,CACNB4:NM_001145798.1:3'UTR:MODIFIER:exon13/13:c.*442G>A:		rs7597215	0.4842	0	0	0										0.053	0.3636	0.5833	7	57	n/a	n/a
chr2	152717331	152717331	A	T	het		QUAL=5733;DP=221;AF=0.48;MQM=60;TRIO=HET,221,0.48,HET,181,0.52,WT,267,0.00	CACNB4	synonymous	CACNB4:NM_000726.3:synonymous:LOW:exon10/14:c.762T>A:p.Ile254Ile,CACNB4:NM_001005747.2:synonymous:LOW:exon9/13:c.660T>A:p.Ile220Ile,CACNB4:NM_001005746.2:synonymous:LOW:exon10/14:c.708T>A:p.Ile236Ile,CACNB4:NM_001145798.1:synonymous:LOW:exon10/13:c.762T>A:p.Ile254Ile		rs61736804	0.0503	0.033	0.0294	0.1212						601949 [CACNB4 (confirmed) Epilepsy,juvenile myoclonic,susceptibility to,6|Epilepsy,idiopathic generalized,susceptibility to,9|Episodic ataxia,type 5];	RCV000116535.2 [likely benign]; 		COSM3757682	0	0.053	0.947	1	46	n/a	n/a
chr2	166170127	166170127	T	C	hom		QUAL=20762;DP=188;AF=0.99;MQM=60;TRIO=HOM,188,0.99,HOM,189,1.00,HOM,270,1.00	SCN2A	splice_region&intron	SCN2A:NM_001040142.1:splice_region&intron:LOW:exon8/26:c.1035-3T>C:,SCN2A:NM_021007.2:splice_region&intron:LOW:exon8/26:c.1035-3T>C:,SCN2A:NM_001040143.1:splice_region&intron:LOW:exon7/25:c.1035-3T>C:		rs2121371	0.7724	0.802	0.841	0.8046						182390 [SCN2A (confirmed) Seizures,benign familial infantile,3|Epileptic encephalopathy,early infantile,11];	RCV000118252.1 [benign]; 			0.7045	0.2348	0.0606	288	141	n/a	n/a
chr2	166246710	166246710	A	C	het		QUAL=1426;DP=262;AF=0.35;MQM=59;TRIO=HET,262,0.35,WT,90,0.00,WT,150,0.00	SCN2A	3'UTR	SCN2A:NM_001040142.1:3'UTR:MODIFIER:exon27/27:c.*376A>C:,SCN2A:NM_021007.2:3'UTR:MODIFIER:exon27/27:c.*376A>C:,SCN2A:NM_001040143.1:3'UTR:MODIFIER:exon26/26:c.*376A>C:		rs376498111	0	0	0	0										0	0.0303	0.9697	0	7	n/a	n/a
chr2	166248047	166248047	G	A	het		QUAL=10414;DP=355;AF=0.48;MQM=60;TRIO=HET,355,0.48,HET,120,0.45,HET,174,0.55	SCN2A	3'UTR	SCN2A:NM_001040142.1:3'UTR:MODIFIER:exon27/27:c.*1713G>A:,SCN2A:NM_021007.2:3'UTR:MODIFIER:exon27/27:c.*1713G>A:,SCN2A:NM_001040143.1:3'UTR:MODIFIER:exon26/26:c.*1713G>A:		rs1007722	0.3834	0	0	0										0.1364	0.4848	0.3788	23	72	n/a	n/a
chr2	166847034	166847034	T	C	hom		QUAL=15742;DP=284;AF=1.00;MQM=60;TRIO=HOM,284,1.00,HOM,76,1.00,HOM,107,1.00	SCN1A	3'UTR	SCN1A:NM_001165963.1:3'UTR:MODIFIER:exon26/26:c.*721A>G:,SCN1A:NM_001165964.1:3'UTR:MODIFIER:exon26/26:c.*721A>G:,SCN1A:NM_006920.4:3'UTR:MODIFIER:exon26/26:c.*721A>G:,SCN1A:NM_001202435.1:3'UTR:MODIFIER:exon28/28:c.*721A>G:		rs4667859	0.9972	0	0	0										1	0	0	150	0	n/a	n/a
chr2	166892788	166892788	C	T	hom		QUAL=17625;DP=246;AF=1.00;MQM=60;TRIO=HOM,246,1.00,HET,188,0.46,HOM,210,1.00	SCN1A	missense	SCN1A:NM_001165963.1:missense:MODERATE:exon16/26:c.3199G>A:p.Ala1067Thr,SCN1A:NM_001165964.1:missense:MODERATE:exon16/26:c.3115G>A:p.Ala1039Thr,SCN1A:NM_006920.4:missense:MODERATE:exon16/26:c.3166G>A:p.Ala1056Thr,SCN1A:NM_001202435.1:missense:MODERATE:exon18/28:c.3199G>A:p.Ala1067Thr		rs2298771	0.7885	0.725	0.6755	0.8164	-0.5650	P	T	B,B,B	B,B,B	182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2|Dravet syndrome|Migraine,familial hemiplegic,3|Febrile seizures,familial,3A];	RCV000030432.1 [benign]; RCV000079572.4 [other]; RCV000127879.1 [benign]; 	CM144700 [CLASS=DP MUT=ALT PHEN="Epilepsy, symptomatic, reduced risk" GENE=SCN1A]; 	COSM3757725	0.3864	0.4545	0.1591	192	198	n/a	n/a
chr2	166897864	166897864	A	G	hom		QUAL=10383;DP=155;AF=1.00;MQM=60;TRIO=HOM,155,1.00,HET,78,0.62,HOM,118,0.99	SCN1A	synonymous	SCN1A:NM_001165963.1:synonymous:LOW:exon13/26:c.2292T>C:p.Val764Val,SCN1A:NM_001165964.1:synonymous:LOW:exon13/26:c.2208T>C:p.Val736Val,SCN1A:NM_006920.4:synonymous:LOW:exon13/26:c.2259T>C:p.Val753Val,SCN1A:NM_001202435.1:synonymous:LOW:exon15/28:c.2292T>C:p.Val764Val		rs6432860	0.7889	0.726	0.6756	0.8166						182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2|Dravet syndrome|Migraine,familial hemiplegic,3|Febrile seizures,familial,3A];	RCV000030431.1 [benign]; RCV000079565.4,RCV000127878.1 [other,benign]; 		COSM3757727	0.3864	0.4545	0.1591	192	198	n/a	n/a
chr2	166897989	166897989	G	A	het		QUAL=1189;DP=55;AF=0.49;MQM=58;TRIO=HET,55,0.49,HET,11,0.27,HET,26,0.19	SCN1A	splice_region&intron	SCN1A:NM_001165963.1:splice_region&intron:LOW:exon12/25:c.2177-10C>T:,SCN1A:NM_001165964.1:splice_region&intron:LOW:exon12/25:c.2093-10C>T:,SCN1A:NM_006920.4:splice_region&intron:LOW:exon12/25:c.2144-10C>T:,SCN1A:NM_001202435.1:splice_region&intron:LOW:exon14/27:c.2177-10C>T:		rs199507113	0	0	0	0						182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2|Dravet syndrome|Migraine,familial hemiplegic,3|Febrile seizures,familial,3A];				0	0.1061	0.8939	0	22	2	n/a
chr2	166903445	166903445	T	C	hom		QUAL=11693;DP=133;AF=1.00;MQM=59;TRIO=HOM,133,1.00,HET,144,0.53,HOM,158,0.99	SCN1A	synonymous	SCN1A:NM_001165963.1:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:NM_001165964.1:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:NM_006920.4:synonymous:LOW:exon9/26:c.1212A>G:p.Val404Val,SCN1A:NM_001202435.1:synonymous:LOW:exon11/28:c.1212A>G:p.Val404Val		rs7580482	0.7093	0.703	0.6752	0.5701						182389 [SCN1A (confirmed) Epilepsy,generalized,with febrile seizures plus,type 2|Dravet syndrome|Migraine,familial hemiplegic,3|Febrile seizures,familial,3A];	RCV000030430.1 [benign]; RCV000079554.4 [other]; 		COSM3757731	0.3864	0.4545	0.1591	192	198	n/a	n/a
chr2	167054934	167054934	-	AATC	het		QUAL=5475;DP=187;AF=0.44;MQM=60;TRIO=HET,187,0.44,HET,78,0.44,HET,121,0.50	SCN9A	3'UTR	SCN9A:NM_002977.3:3'UTR:MODIFIER:exon27/27:c.*244_*247dupGATT:		rs397744175	0.7458	0	0	0										0.5227	0.4167	0.0606	81	60	n/a	n/a
chr2	167060981	167060984	AAAC	-	het		QUAL=4606;DP=76;AF=0.37;MQM=60;TRIO=HET,76,0.37,HET,61,0.54,HOM,96,0.96	SCN9A	splice_region&intron	SCN9A:NM_002977.3:splice_region&intron:LOW:exon24/26:c.4366-10_4366-7delGTTT:		rs546230376	0.8988	0.88	0.863	0.9316						603415 [SCN9A (confirmed) Erythermalgia,primary|Insensitivity to pain,channelopathy-associated|Paroxysmal extreme pain disorder|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of];	RCV000153913.1 [benign]; 	CD072486 [CLASS=DM? MUT=ALT PHEN="Congenital indifference to pain" GENE=SCN9A]; 		0.7348	0.2348	0.0303	313	84	1	n/a
chr2	167099158	167099158	A	G	het		QUAL=13174;DP=225;AF=0.53;MQM=60;TRIO=HET,225,0.53,HET,177,0.51,HOM,200,1.00	SCN9A	missense	SCN9A:NM_002977.3:missense:MODERATE:exon19/27:c.3448T>C:p.Trp1150Arg		rs6746030	0.8872	0.852	0.8714	0.8906	0.9510	P	T	B	B	603415 [SCN9A (confirmed) Erythermalgia,primary|Insensitivity to pain,channelopathy-associated|Paroxysmal extreme pain disorder|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of];	RCV000020514.1 [benign]; 	CM051623 [CLASS=DFP MUT=REF PHEN="Erythermalgia, primary" GENE=SCN9A]; 		0.7348	0.2348	0.0303	341	105	n/a	n/a
chr2	167144974	167144974	A	T	het		QUAL=2098;DP=105;AF=0.51;MQM=60;TRIO=HET,105,0.51,HET,52,0.35,WT,81,0.00	SCN9A	synonymous	SCN9A:NM_002977.3:synonymous:LOW:exon10/27:c.1287T>A:p.Arg429Arg		rs6747673	0.5467	0.494	0.4774	0.7514						603415 [SCN9A (confirmed) Erythermalgia,primary|Insensitivity to pain,channelopathy-associated|Paroxysmal extreme pain disorder|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of];	RCV000118293.2 [likely benign]; 		COSM4001293	0.2121	0.4924	0.2955	104	208	n/a	n/a
chr2	167144995	167144995	T	C	het		QUAL=2950;DP=155;AF=0.48;MQM=60;TRIO=HET,155,0.48,HET,57,0.35,WT,96,0.01	SCN9A	synonymous	SCN9A:NM_002977.3:synonymous:LOW:exon10/27:c.1266A>G:p.Glu422Glu		rs13402180	0.3544	0.373	0.3889	0.3815						603415 [SCN9A (confirmed) Erythermalgia,primary|Insensitivity to pain,channelopathy-associated|Paroxysmal extreme pain disorder|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of];	RCV000118292.2 [likely benign]; 		COSM3757733	0.1439	0.4394	0.4167	69	203	n/a	n/a
chr2	167145142	167145142	A	G	het		QUAL=2339;DP=115;AF=0.51;MQM=60;TRIO=HET,115,0.51,HET,40,0.45,WT,56,0.00	SCN9A	synonymous	SCN9A:NM_002977.3:synonymous:LOW:exon10/27:c.1119T>C:p.Ala373Ala		rs13414203	0.3544	0.373	0.3879	0.379						603415 [SCN9A (confirmed) Erythermalgia,primary|Insensitivity to pain,channelopathy-associated|Paroxysmal extreme pain disorder|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of];	RCV000118290.2 [likely benign]; 			0.1364	0.447	0.4167	68	203	n/a	n/a
chr2	167163043	167163043	T	C	het		QUAL=7704;DP=239;AF=0.36;MQM=60;TRIO=HET,239,0.36,HET,137,0.55,HET,138,0.57	SCN9A	synonymous	SCN9A:NM_002977.3:synonymous:LOW:exon4/27:c.444A>G:p.Pro148Pro		rs9646771	0.6412	0.605	0.6571	0.8356						603415 [SCN9A (confirmed) Erythermalgia,primary|Insensitivity to pain,channelopathy-associated|Paroxysmal extreme pain disorder|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of];	RCV000118307.2 [likely benign]; 		COSM3933366	0.3939	0.447	0.1591	202	189	n/a	n/a
chr2	167168093	167168093	C	T	het		QUAL=13926;DP=288;AF=0.56;MQM=60;TRIO=HET,288,0.56,HET,255,0.53,HET,308,0.51	SCN9A	synonymous	SCN9A:NM_002977.3:synonymous:LOW:exon2/27:c.174G>A:p.Gln58Gln		rs6432901	0.5743	0.587	0.6369	0.7579						603415 [SCN9A (confirmed) Erythermalgia,primary|Insensitivity to pain,channelopathy-associated|Paroxysmal extreme pain disorder|Febrile seizures,familial,3B|Epilepsy,generalized,with febrile seizures plus,type 7|Small fiber neuropathy|Dravet syndrome,modifier of];	RCV000118295.2 [likely benign]; 			0.3712	0.4545	0.1742	175	205	n/a	n/a
chr2	169830328	169830328	A	G	het		QUAL=21523;DP=439;AF=0.52;MQM=60;TRIO=HET,439,0.52,HET,274,0.47,HOM,304,1.00	ABCB11	missense	ABCB11:NM_003742.2:missense:MODERATE:exon13/28:c.1331T>C:p.Val444Ala		rs2287622	0.5887	0.579	0.6004	0.5857	2.0330	P	T	B	B	603201 [ABCB11 (confirmed) Cholestasis,progressive familial intrahepatic 2|Cholestasis,benign recurrent intrahepatic,2];		CM071525 [CLASS=DFP MUT=ALT PHEN="Cholestasis, drug-induced, association with" GENE=ABCB11]; 		0.3409	0.5227	0.1364	170	217	n/a	n/a
chr2	169984262	169984262	-	T	het		QUAL=9990;DP=181;AF=0.75;MQM=59;TRIO=HET,181,0.75,HOM,114,0.86,HET,159,0.46	LRP2	3'UTR	LRP2:NM_004525.2:3'UTR:MODIFIER:exon79/79:c.*910dupA:		rs397941904	0.6619	0	0	0										0.4318	0.4318	0.1364	69	59	n/a	n/a
chr2	170003432	170003432	T	G	hom		QUAL=18168;DP=185;AF=1.00;MQM=60;TRIO=HOM,185,1.00,HOM,173,1.00,HOM,210,1.00	LRP2	missense	LRP2:NM_004525.2:missense:MODERATE:exon69/79:c.12628A>C:p.Ile4210Leu		rs4667591	0.5559	0.711	0.7901	0.2422	6.2840	P	D	D	D	600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117509.2 [likely benign]; 	CM065295 [CLASS=DP MUT=REF PHEN="Colorectal cancer, increased risk, association with" GENE=LRP2]; 	COSM1401028	0.6136	0.3561	0.0303	279	157	n/a	n/a
chr2	170010985	170010985	T	C	hom		QUAL=23300;DP=338;AF=1.00;MQM=60;TRIO=HOM,338,1.00,HOM,150,1.00,HOM,209,0.99	LRP2	missense	LRP2:NM_004525.2:missense:MODERATE:exon66/79:c.12280A>G:p.Lys4094Glu		rs2075252	0.778	0.762	0.7584	0.8852	4.7880	P	T	B	B	600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117508.2 [likely benign]; 		COSM4001308	0.5682	0.4091	0.0227	275	160	n/a	n/a
chr2	170025083	170025083	A	G	het		QUAL=12557;DP=420;AF=0.50;MQM=60;TRIO=HET,420,0.50,WT,249,0.00,HET,352,0.51	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon61/79:c.11601T>C:p.Cys3867Cys		rs2229268	0.1907	0.202	0.2085	0.0411	2.0780	P	T			600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117501.2 [likely benign]; 		COSM4133221	0.0227	0.3636	0.6136	11	169	n/a	n/a
chr2	170032989	170032989	C	T	het		QUAL=20791;DP=383;AF=0.45;MQM=60;TRIO=HET,383,0.45,HOM,295,1.00,HET,411,0.45	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon54/79:c.10503G>A:p.Gln3501Gln		rs2229265	0.3796	0.472	0.5176	0.3223						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117498.2 [likely benign]; 		COSM4133222	0.2727	0.5303	0.197	126	231	n/a	n/a
chr2	170092395	170092395	A	G	het		QUAL=10419;DP=161;AF=0.52;MQM=60;TRIO=HET,161,0.52,WT,309,0.00,HET,443,0.55	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon29/79:c.4875T>C:p.Cys1625Cys		rs2229267	0.4613	0.334	0.241	0.6453						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117534.2 [likely benign]; 		COSM4133227	0.0379	0.4167	0.5455	24	183	n/a	n/a
chr2	170099473	170099473	T	C	hom		QUAL=20614;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,258,1.00,HET,289,0.51	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon24/79:c.3660A>G:p.Ala1220Ala		rs831042	0.5819	0.523	0.4493	0.6085						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117527.2 [likely benign]; 			0.1591	0.5833	0.2576	86	242	n/a	n/a
chr2	170103336	170103336	T	C	hom		QUAL=32507;DP=408;AF=1.00;MQM=60;TRIO=HOM,408,1.00,HOM,364,0.99,HET,513,0.49	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon21/79:c.3069A>G:p.Thr1023Thr		rs831043	0.6186	0.538	0.4559	0.6916						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117524.2 [likely benign]; 			0.1818	0.5833	0.2348	93	242	n/a	n/a
chr2	170103351	170103351	G	T	hom		QUAL=31031;DP=354;AF=1.00;MQM=60;TRIO=HOM,354,1.00,HOM,379,1.00,HET,514,0.48	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon21/79:c.3054C>A:p.Thr1018Thr		rs2075249	0.4565	0.492	0.4588	0.2923						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117523.2 [likely benign]; 			0.1894	0.5455	0.2652	85	234	n/a	n/a
chr2	170115588	170115588	T	C	hom		QUAL=17301;DP=234;AF=1.00;MQM=60;TRIO=HOM,234,1.00,HOM,176,1.00,HET,241,0.50	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon17/79:c.2460A>G:p.Thr820Thr		rs2241190	0.6224	0.546	0.4677	0.6893						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117518.2 [likely benign]; 			0.1818	0.5985	0.2197	97	242	n/a	n/a
chr2	170129528	170129528	G	A	het		QUAL=16966;DP=303;AF=0.49;MQM=60;TRIO=HET,303,0.49,WT,293,0.00,HOM,390,1.00	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon15/79:c.2025C>T:p.Val675Val		rs830994	0.6096	0.624	0.6655	0.5166						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117515.2 [likely benign]; 			0.3939	0.4621	0.1439	192	201	n/a	n/a
chr2	170150671	170150671	G	A	het		QUAL=11953;DP=264;AF=0.56;MQM=60;TRIO=HET,264,0.56,HOM,226,1.00,WT,300,0.00	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon6/79:c.639C>T:p.Asp213Asp		rs2229266	0.3702	0.32	0.2617	0.3259						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117541.2 [likely benign]; 		COSM3757758	0.1439	0.3258	0.5303	49	164	n/a	n/a
chr2	170218847	170218847	C	G	hom		QUAL=6368;DP=48;AF=1.00;MQM=60;TRIO=HOM,48,1.00,HOM,66,1.00,HOM,104,1.00	LRP2	synonymous	LRP2:NM_004525.2:synonymous:LOW:exon1/79:c.63G>C:p.Ala21Ala		rs1559014	0.9846	0.996	0.9999	0.9682						600073 [LRP2 (confirmed) Donnai-Barrow syndrome];	RCV000117542.2 [likely benign]; 		COSM3749605	1	0	0	448	0	n/a	n/a
chr2	172291616	172291616	C	T	het		QUAL=10181;DP=293;AF=0.54;MQM=60;TRIO=HET,293,0.54,WT,211,0.00,HET,279,0.56	DCAF17	synonymous	DCAF17:NM_025000.3:synonymous:LOW:exon2/14:c.150C>T:p.Val50Val,DCAF17:NM_001164821.1:synonymous:LOW:exon2/12:c.150C>T:p.Val50Val		rs6751956	0.3067	0.272	0.2307	0.3729						612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome];	RCV000116869.2 [likely benign]; 			0.0303	0.3333	0.6364	23	164	n/a	n/a
chr2	172330393	172330393	A	G	het		QUAL=10192;DP=357;AF=0.43;MQM=60;TRIO=HET,357,0.43,WT,208,0.00,HET,310,0.50	DCAF17	synonymous,intron	DCAF17:NM_025000.3:synonymous:LOW:exon10/14:c.999A>G:p.Gln333Gln,DCAF17:NM_001164821.1:intron:MODIFIER:exon9/11:c.982-4104A>G:		rs3731983	0.2067	0.224	0.1999	0.1752	0.4960	P				612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome];	RCV000116872.2 [likely benign]; 		COSM4001323	0.0227	0.2879	0.6894	16	148	n/a	n/a
chr2	172336541	172336541	C	T	het		QUAL=7990;DP=262;AF=0.51;MQM=60;TRIO=HET,262,0.51,WT,150,0.01,HET,241,0.49	DCAF17	splice_region&intron	DCAF17:NM_025000.3:splice_region&intron:LOW:exon12/13:c.1267-7C>T:,DCAF17:NM_001164821.1:splice_region&intron:LOW:exon10/11:c.1066-7C>T:		rs3731981	0.2061	0.224	0.1991	0.1736						612515 [DCAF17 (provisional) Woodhouse-Sakati syndrome];	RCV000116867.2 [likely benign]; 		COSM4001324	0.0227	0.2879	0.6894	16	147	n/a	n/a
chr2	172338194	172338194	G	A	het		QUAL=8771;DP=342;AF=0.45;MQM=60;TRIO=HET,342,0.45,WT,130,0.00,HET,214,0.51	DCAF17	3'UTR	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*570G>A:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*570G>A:		rs3795998	0.2065	0.226	0	0										0.0227	0.2955	0.6818	11	93	n/a	n/a
chr2	172338300	172338300	T	G	het		QUAL=9071;DP=293;AF=0.49;MQM=60;TRIO=HET,293,0.49,WT,150,0.00,HET,230,0.57	DCAF17	3'UTR	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*676T>G:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*676T>G:		rs3821084	0.2061	0.224	0	0										0.0227	0.2955	0.6818	11	92	n/a	n/a
chr2	172339964	172339964	C	T	hom		QUAL=36552;DP=373;AF=1.00;MQM=60;TRIO=HOM,373,1.00,HOM,332,1.00,HOM,406,1.00	DCAF17	3'UTR	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*2340C>T:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*2340C>T:		rs888428	0.9774	0.994	0	0										1	0	0	290	0	n/a	n/a
chr2	172340049	172340049	T	A	het		QUAL=12069;DP=431;AF=0.52;MQM=60;TRIO=HET,431,0.52,WT,296,0.01,HET,345,0.52	DCAF17	3'UTR	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*2425T>A:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*2425T>A:		rs12151641	0.2065	0.228	0	0										0.0227	0.2955	0.6818	11	93	n/a	n/a
chr2	172340419	172340419	T	C	het		QUAL=11821;DP=396;AF=0.47;MQM=60;TRIO=HET,396,0.47,WT,236,0.00,HET,315,0.55	DCAF17	3'UTR	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*2795T>C:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*2795T>C:		rs17221346	0.2718	0.246	0	0										0.0303	0.3333	0.6364	14	101	n/a	n/a
chr2	172340736	172340736	C	G	het		QUAL=7164;DP=242;AF=0.50;MQM=60;TRIO=HET,242,0.50,WT,150,0.00,HET,185,0.54	DCAF17	3'UTR	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*3112C>G:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*3112C>G:		rs17221367	0.2065	0.227	0	0										0.0227	0.2955	0.6818	11	93	n/a	n/a
chr2	172341327	172341327	A	G	het		QUAL=6098;DP=164;AF=0.51;MQM=60;TRIO=HET,164,0.51,WT,130,0.00,HET,195,0.53	DCAF17	3'UTR	DCAF17:NM_025000.3:3'UTR:MODIFIER:exon14/14:c.*3703A>G:,DCAF17:NM_001164821.1:3'UTR:MODIFIER:exon12/12:c.*3703A>G:	L1ME2z	rs9789572	0.2065	0.223	0	0										0.0227	0.2955	0.6818	11	93	n/a	n/a
chr2	173339808	173339808	G	A	het		QUAL=14033;DP=226;AF=0.51;MQM=60;TRIO=HET,226,0.51,WT,275,0.00,HOM,318,1.00	ITGA6	missense	ITGA6:NM_001079818.1:missense:MODERATE:exon7/25:c.1138G>A:p.Ala380Thr,ITGA6:NM_000210.2:missense:MODERATE:exon7/26:c.1138G>A:p.Ala380Thr		rs11895564	0.2516	0.281	0.2977	0.3416	3.1200	P		P,B,P,P	B,B,P,P	147556 [ITGA6 (provisional) Epidermolysis bullosa,junctional,with pyloric stenosis];			COSM3757773	0.0606	0.4167	0.5227	36	181	n/a	n/a
chr2	173344474	173344474	A	G	het		QUAL=13689;DP=337;AF=0.47;MQM=59;TRIO=HET,337,0.47,WT,216,0.00,HOM,286,1.00	ITGA6	splice_region&intron	ITGA6:NM_001079818.1:splice_region&intron:LOW:exon10/24:c.1487+7A>G:,ITGA6:NM_000210.2:splice_region&intron:LOW:exon10/25:c.1487+7A>G:		rs1920979	0.4071	0.371	0.3513	0.5191						147556 [ITGA6 (provisional) Epidermolysis bullosa,junctional,with pyloric stenosis];			COSM4001325	0.0758	0.5379	0.3864	44	221	n/a	n/a
chr2	173369231	173369231	A	G	het		QUAL=10872;DP=261;AF=0.46;MQM=59;TRIO=HET,261,0.46,WT,161,0.00,HOM,219,1.00	ITGA6	3'UTR	ITGA6:NM_001079818.1:3'UTR:MODIFIER:exon25/25:c.*251A>G:,ITGA6:NM_000210.2:3'UTR:MODIFIER:exon26/26:c.*435A>G:		rs17664	0.634	0	0	0										0.1439	0.5455	0.3106	20	80	n/a	n/a
chr2	178404735	178404735	-	AAAG	hom		QUAL=1380;DP=35;AF=1.00;MQM=60;TRIO=HOM,35,1.00,HOM,5,1.00,HOM,9,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*1814_*1815insAGAA:		rs139584283	0.885	0	0	0										0.7348	0.2121	0.053	111	31	n/a	n/a
chr2	178404789	178404789	A	G	hom		QUAL=1362;DP=34;AF=1.00;MQM=59;TRIO=HOM,34,1.00,HOM,3,1.00,HOM,10,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*1866A>G:	(TA)n	rs10930795	0.8944	0	0	0										0.6742	0.1818	0.1439	103	27	n/a	n/a
chr2	178404802	178404805	TATA	-	hom		QUAL=780;DP=29;AF=0.72;MQM=60;TRIO=HOM,29,0.72,HOM,5,1.00,HET,11,0.64	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*1896_*1899delATAT:	(TA)n	rs72185133	0.9101	0	0	0										0.4167	0.3485	0.2348	63	50	n/a	n/a
chr2	178406481	178406481	C	T	hom		QUAL=14732;DP=308;AF=1.00;MQM=60;TRIO=HOM,308,1.00,HET,87,0.51,HOM,100,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*3558C>T:		rs8941	0.6967	0	0	0										0.5455	0.3864	0.0682	84	56	n/a	n/a
chr2	178406769	178406769	-	T	hom		QUAL=11323;DP=198;AF=0.94;MQM=60;TRIO=HOM,198,0.94,HOM,74,0.95,HOM,103,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*3854dupT:		rs397783598	0.8902	0	0	0										0.75	0.2121	0.0379	112	32	n/a	n/a
chr2	178407176	178407176	C	A	hom		QUAL=15460;DP=261;AF=1.00;MQM=60;TRIO=HOM,261,1.00,HOM,85,1.00,HOM,130,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*4253C>A:		rs10803912	0.877	0	0	0										0.75	0.2121	0.0379	112	33	n/a	n/a
chr2	178407897	178407897	T	C	hom		QUAL=22127;DP=254;AF=1.00;MQM=59;TRIO=HOM,254,1.00,HOM,175,1.00,HOM,274,1.00	AGPS	3'UTR	AGPS:NM_003659.3:3'UTR:MODIFIER:exon20/20:c.*4974T>C:		rs2293475	0.8764	0	0	0										0.75	0.2121	0.0379	112	33	n/a	n/a
chr2	179315444	179315444	T	G	het		QUAL=813;DP=38;AF=0.50;MQM=60;TRIO=HET,38,0.50,HET,16,0.50,HET,15,0.53	PRKRA	5'UTR,intron	PRKRA:NM_001139517.1:5'UTR:MODIFIER:exon1/7:c.-274A>C:,PRKRA:NM_003690.4:intron:MODIFIER:exon1/7:c.65+249A>C:		rs184658426	0.0088	0	0	0						603424 [PRKRA (confirmed) Dystonia 16];				0	0.0682	0.9318	1	9	n/a	n/a
chr2	179395554	179395554	G	A	het		QUAL=5469;DP=305;AF=0.43;MQM=60;TRIO=HET,305,0.43,HET,97,0.42,WT,169,0.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon358/363:c.105788C>T:p.Ala35263Val,TTN:NM_001256850.1:missense:MODERATE:exon308/313:c.100865C>T:p.Ala33622Val,TTN:NM_133437.4:missense:MODERATE:exon187/192:c.79169C>T:p.Ala26390Val,TTN:NM_003319.4:missense:MODERATE:exon186/191:c.78593C>T:p.Ala26198Val,TTN:NM_133378.4:missense:MODERATE:exon307/312:c.98084C>T:p.Ala32695Val,TTN:NM_133432.3:missense:MODERATE:exon187/192:c.78968C>T:p.Ala26323Val		rs66961115	0.0052	0.011	0.0143	0.0021	2.3280	N	D	B,B,B,B	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040971.4 [other]; RCV000125998.1 [benign]; 			0	0.0379	0.9621	0	14	n/a	n/a
chr2	179395555	179395555	C	A	het		QUAL=5469;DP=305;AF=0.43;MQM=60;TRIO=HET,305,0.43,HET,97,0.42,WT,169,0.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon358/363:c.105787G>T:p.Ala35263Ser,TTN:NM_001256850.1:missense:MODERATE:exon308/313:c.100864G>T:p.Ala33622Ser,TTN:NM_133437.4:missense:MODERATE:exon187/192:c.79168G>T:p.Ala26390Ser,TTN:NM_003319.4:missense:MODERATE:exon186/191:c.78592G>T:p.Ala26198Ser,TTN:NM_133378.4:missense:MODERATE:exon307/312:c.98083G>T:p.Ala32695Ser,TTN:NM_133432.3:missense:MODERATE:exon187/192:c.78967G>T:p.Ala26323Ser		rs67254537	0.0052	0.011	0.0143	0.0021	2.6440	N	D	B,B,B,B	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040970.4 [other]; RCV000125997.1 [benign]; 			0	0.0379	0.9621	0	14	n/a	n/a
chr2	179395573	179395573	C	T	het		QUAL=6397;DP=328;AF=0.48;MQM=60;TRIO=HET,328,0.48,HET,95,0.45,WT,172,0.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon358/363:c.105769G>A:p.Glu35257Lys,TTN:NM_001256850.1:missense:MODERATE:exon308/313:c.100846G>A:p.Glu33616Lys,TTN:NM_133437.4:missense:MODERATE:exon187/192:c.79150G>A:p.Glu26384Lys,TTN:NM_003319.4:missense:MODERATE:exon186/191:c.78574G>A:p.Glu26192Lys,TTN:NM_133378.4:missense:MODERATE:exon307/312:c.98065G>A:p.Glu32689Lys,TTN:NM_133432.3:missense:MODERATE:exon187/192:c.78949G>A:p.Glu26317Lys		rs56324595	0.0066	0.014	0.0175	0.0024	7.8180	D	D	D,D,D,D	D,D,D,D	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040968.4 [other]; RCV000125995.1 [benign]; 			0	0.0379	0.9621	0	15	n/a	n/a
chr2	179404498	179404498	G	C	het		QUAL=19364;DP=506;AF=0.51;MQM=60;TRIO=HET,506,0.51,WT,521,0.00,HET,645,0.51	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon352/363:c.98294C>G:p.Ala32765Gly,TTN:NM_001256850.1:missense:MODERATE:exon302/313:c.93371C>G:p.Ala31124Gly,TTN:NM_133437.4:missense:MODERATE:exon181/192:c.71675C>G:p.Ala23892Gly,TTN:NM_003319.4:missense:MODERATE:exon180/191:c.71099C>G:p.Ala23700Gly,TTN:NM_133378.4:missense:MODERATE:exon301/312:c.90590C>G:p.Ala30197Gly,TTN:NM_133432.3:missense:MODERATE:exon181/192:c.71474C>G:p.Ala23825Gly		rs72648273	0.001	0.0028	0.0041	0.0003	9.8690	D	D	D,D,D,D	D,D,D,D	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040867.2 [likely benign]; RCV000118794.1 [uncertain significance]; 			0	0.0152	0.9848	0	6	n/a	n/a
chr2	179432185	179432185	A	G	het		QUAL=22325;DP=494;AF=0.53;MQM=60;TRIO=HET,494,0.53,HOM,415,1.00,WT,543,0.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon326/363:c.78674T>C:p.Ile26225Thr,TTN:NM_001256850.1:missense:MODERATE:exon276/313:c.73751T>C:p.Ile24584Thr,TTN:NM_133437.4:missense:MODERATE:exon155/192:c.52055T>C:p.Ile17352Thr,TTN:NM_003319.4:missense:MODERATE:exon154/191:c.51479T>C:p.Ile17160Thr,TTN:NM_133378.4:missense:MODERATE:exon275/312:c.70970T>C:p.Ile23657Thr,TTN:NM_133432.3:missense:MODERATE:exon155/192:c.51854T>C:p.Ile17285Thr		rs12463674	0.13	0.236	0.303	0.0543	5.9890	P	D	P,P,P,P	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040637.5 [benign]; RCV000125894.1 [benign]; 			0.0833	0.3333	0.5833	51	199	n/a	n/a
chr2	179440029	179440029	G	A	het		QUAL=14221;DP=363;AF=0.50;MQM=59;TRIO=HET,363,0.50,HOM,283,0.99,WT,394,0.00	TTN	synonymous	TTN:NM_001267550.2:synonymous:LOW:exon326/363:c.70830C>T:p.Ser23610Ser,TTN:NM_001256850.1:synonymous:LOW:exon276/313:c.65907C>T:p.Ser21969Ser,TTN:NM_133437.4:synonymous:LOW:exon155/192:c.44211C>T:p.Ser14737Ser,TTN:NM_003319.4:synonymous:LOW:exon154/191:c.43635C>T:p.Ser14545Ser,TTN:NM_133378.4:synonymous:LOW:exon275/312:c.63126C>T:p.Ser21042Ser,TTN:NM_133432.3:synonymous:LOW:exon155/192:c.44010C>T:p.Ser14670Ser		rs12464787	0.1466	0.239	0.2975	0.1176						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040563.4 [benign]; RCV000125877.1 [benign]; 		COSM4133283	0.0758	0.3333	0.5909	52	202	n/a	n/a
chr2	179444768	179444768	C	G	hom		QUAL=59624;DP=514;AF=1.00;MQM=60;TRIO=HOM,514,1.00,HOM,555,1.00,HOM,768,1.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon318/363:c.67246G>C:p.Ala22416Pro,TTN:NM_001256850.1:missense:MODERATE:exon268/313:c.62323G>C:p.Ala20775Pro,TTN:NM_133437.4:missense:MODERATE:exon147/192:c.40627G>C:p.Ala13543Pro,TTN:NM_003319.4:missense:MODERATE:exon146/191:c.40051G>C:p.Ala13351Pro,TTN:NM_133378.4:missense:MODERATE:exon267/312:c.59542G>C:p.Ala19848Pro,TTN:NM_133432.3:missense:MODERATE:exon147/192:c.40426G>C:p.Ala13476Pro		rs4145333	0.9946	0.999	0.9999	0.9864	0.6560	P	D	B,B,B	B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040520.3 [benign]; RCV000125863.1 [benign]; 			1	0	0	507	0	n/a	n/a
chr2	179453796	179453796	C	T	het		QUAL=10144;DP=324;AF=0.56;MQM=60;TRIO=HET,324,0.56,WT,256,0.00,HET,297,0.44	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon304/363:c.62656G>A:p.Asp20886Asn,TTN:NM_001256850.1:missense:MODERATE:exon254/313:c.57733G>A:p.Asp19245Asn,TTN:NM_133437.4:missense:MODERATE:exon133/192:c.36037G>A:p.Asp12013Asn,TTN:NM_003319.4:missense:MODERATE:exon132/191:c.35461G>A:p.Asp11821Asn,TTN:NM_133378.4:missense:MODERATE:exon253/312:c.54952G>A:p.Asp18318Asn,TTN:NM_133432.3:missense:MODERATE:exon133/192:c.35836G>A:p.Asp11946Asn			0	0	0	0	7.8180	D	D	D,D,D,D	D,D,D,D	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];				0	0.0076	0.9924	0	1	n/a	n/a
chr2	179462494	179462494	A	G	het		QUAL=23935;DP=569;AF=0.47;MQM=60;TRIO=HET,569,0.47,HOM,459,0.99,WT,663,0.00	TTN	synonymous	TTN:NM_001267550.2:synonymous:LOW:exon294/363:c.57315T>C:p.His19105His,TTN:NM_001256850.1:synonymous:LOW:exon244/313:c.52392T>C:p.His17464His,TTN:NM_133437.4:synonymous:LOW:exon123/192:c.30696T>C:p.His10232His,TTN:NM_003319.4:synonymous:LOW:exon122/191:c.30120T>C:p.His10040His,TTN:NM_133378.4:synonymous:LOW:exon243/312:c.49611T>C:p.His16537His,TTN:NM_133432.3:synonymous:LOW:exon123/192:c.30495T>C:p.His10165His		rs35833641	0.127	0.234	0.3001	0.0525						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040390.3 [benign]; RCV000125830.1 [benign]; 		COSM4001389	0.0682	0.3409	0.5909	50	202	n/a	n/a
chr2	179542499	179542499	T	C	het		QUAL=5541;DP=290;AF=0.28;MQM=57;TRIO=HET,290,0.28,WT,656,0.00,HET,735,0.21	TTN	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon146/363:c.34140A>G:p.Glu11380Glu,TTN:NM_001256850.1:synonymous:LOW:exon144/313:c.33189A>G:p.Glu11063Glu,TTN:NM_133378.4:synonymous:LOW:exon143/312:c.30408A>G:p.Glu10136Glu,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13859-35455A>G:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13283-35455A>G:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13658-35455A>G:		rs147418835	0.003	0	0.0006	0.0003						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];				0	0.0076	0.9924	0	2	n/a	n/a
chr2	179545859	179545859	C	T	het		QUAL=9782;DP=342;AF=0.49;MQM=60;TRIO=HET,342,0.49,HOM,131,0.98,WT,225,0.00	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon138/363:c.33287G>A:p.Arg11096His,TTN:NM_001256850.1:missense:MODERATE:exon136/313:c.32336G>A:p.Arg10779His,TTN:NM_133378.4:missense:MODERATE:exon135/312:c.29555G>A:p.Arg9852His,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13859-38815G>A:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13283-38815G>A:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13658-38815G>A:		rs36051007	0.126	0.233	0.3031	0.0528	-0.5180	P	D	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040156.3 [benign]; RCV000125766.1 [benign]; 		COSM4001413	0.0682	0.3409	0.5909	53	195	n/a	n/a
chr2	179554305	179554305	C	T	het		QUAL=12697;DP=427;AF=0.45;MQM=60;TRIO=HET,427,0.45,HOM,196,1.00,WT,261,0.00	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon123/363:c.31864G>A:p.Gly10622Arg,TTN:NM_001256850.1:missense:MODERATE:exon121/313:c.30913G>A:p.Gly10305Arg,TTN:NM_133378.4:missense:MODERATE:exon120/312:c.28132G>A:p.Gly9378Arg,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13859-47261G>A:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13283-47261G>A:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13658-47261G>A:		rs2244492	0.4133	0.378	0.3605	0.5949	3.2520	P	D			188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040129.3 [benign]; RCV000125756.1 [benign]; 			0.1288	0.3864	0.4848	76	221	n/a	n/a
chr2	179569387	179569387	T	A	het		QUAL=9369;DP=322;AF=0.49;MQM=60;TRIO=HET,322,0.49,WT,160,0.00,HET,256,0.48	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon105/363:c.29812A>T:p.Thr9938Ser,TTN:NM_001256850.1:missense:MODERATE:exon103/313:c.28861A>T:p.Thr9621Ser,TTN:NM_133378.4:missense:MODERATE:exon102/312:c.26080A>T:p.Thr8694Ser,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13858+33422A>T:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13282+33422A>T:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13657+33422A>T:		rs72650006	0.0106	0.019	0.0266	0.0068	6.2960	D	D	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040096.3 [benign]; RCV000125744.1 [benign]; 			0	0.053	0.947	0	25	n/a	n/a
chr2	179585266	179585266	C	T	hom		QUAL=14760;DP=255;AF=1.00;MQM=60;TRIO=HOM,255,1.00,HOM,81,1.00,HOM,125,1.00	TTN	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon80/363:c.23223G>A:p.Gln7741Gln,TTN:NM_001256850.1:synonymous:LOW:exon78/313:c.22272G>A:p.Gln7424Gln,TTN:NM_133378.4:synonymous:LOW:exon77/312:c.19491G>A:p.Gln6497Gln,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13858+17543G>A:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13282+17543G>A:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13657+17543G>A:		rs2562831	0.982	0.995	0.9999	0.9401						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000039984.5 [benign]; RCV000126134.1 [benign]; 			1	0	0	511	0	n/a	n/a
chr2	179600563	179600563	G	A	hom		QUAL=21235;DP=287;AF=1.00;MQM=60;TRIO=HOM,287,1.00,HOM,122,1.00,HOM,232,1.00	TTN	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon50/363:c.14610C>T:p.Ser4870Ser,TTN:NM_001256850.1:synonymous:LOW:exon48/313:c.13659C>T:p.Ser4553Ser,TTN:NM_133378.4:synonymous:LOW:exon47/312:c.10878C>T:p.Ser3626Ser,TTN:NM_133437.4:intron:MODIFIER:exon47/191:c.13858+2246C>T:,TTN:NM_003319.4:intron:MODIFIER:exon46/190:c.13282+2246C>T:,TTN:NM_133432.3:intron:MODIFIER:exon47/191:c.13657+2246C>T:		rs2742348	0.9818	0.995	0.9999	0.9395						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000039860.5 [benign]; RCV000126094.1 [benign]; 			1	0	0	510	0	n/a	n/a
chr2	179610967	179610967	C	T	het		QUAL=10028;DP=390;AF=0.51;MQM=60;TRIO=HET,390,0.51,WT,171,0.01,HET,207,0.50	TTN	missense,intron	TTN:NM_133379.4:missense:MODERATE:exon46/46:c.16160G>A:p.Cys5387Tyr,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11312-4319G>A:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10361-4319G>A:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10799-4319G>A:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10223-4319G>A:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+6884G>A:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10598-4319G>A:		rs72648913	0.0012	0.0029	0.0041	0.0005	1.6850	D	D	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041064.2 [likely benign]; 			0	0.0152	0.9848	0	6	n/a	n/a
chr2	179614952	179614952	A	G	hom		QUAL=49076;DP=577;AF=1.00;MQM=60;TRIO=HOM,577,1.00,HOM,393,1.00,HOM,507,1.00	TTN	synonymous,intron	TTN:NM_133379.4:synonymous:LOW:exon46/46:c.12175T>C:p.Leu4059Leu,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+2899T>C:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+2899T>C:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+2899T>C:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+2899T>C:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+2899T>C:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+2899T>C:		rs10803917	0.975	0.993	0.9992	0.9206						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041012.2 [benign]; RCV000126063.1 [benign]; 			1	0	0	504	2	n/a	n/a
chr2	179615887	179615887	T	C	hom		QUAL=24405;DP=366;AF=1.00;MQM=60;TRIO=HOM,366,1.00,HOM,156,1.00,HOM,218,1.00	TTN	missense,intron	TTN:NM_133379.4:missense:MODERATE:exon46/46:c.11240A>G:p.Asp3747Gly,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+1964A>G:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+1964A>G:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+1964A>G:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+1964A>G:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+1964A>G:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+1964A>G:		rs922984	0.733	0.826	0.9303	0.5991	1.9380	P	T	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041005.2 [benign]; RCV000126060.1 [benign]; 			0.8561	0.1288	0.0152	454	53	n/a	n/a
chr2	179615931	179615931	C	G	hom		QUAL=19486;DP=271;AF=1.00;MQM=60;TRIO=HOM,271,1.00,HOM,135,1.00,HOM,179,1.00	TTN	missense,intron	TTN:NM_133379.4:missense:MODERATE:exon46/46:c.11196G>C:p.Leu3732Phe,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+1920G>C:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+1920G>C:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+1920G>C:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+1920G>C:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+1920G>C:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+1920G>C:		rs922985	0.975	0.993	0.9992	0.9203	-0.1470	P	D	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041004.2 [benign]; RCV000126059.1 [benign]; 			1	0	0	502	2	n/a	n/a
chr2	179615994	179615994	T	C	hom		QUAL=16774;DP=221;AF=1.00;MQM=60;TRIO=HOM,221,1.00,HOM,117,1.00,HOM,162,1.00	TTN	synonymous,intron	TTN:NM_133379.4:synonymous:LOW:exon46/46:c.11133A>G:p.Thr3711Thr,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+1857A>G:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+1857A>G:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+1857A>G:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+1857A>G:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+1857A>G:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+1857A>G:		rs922986	0.975	0.993	0.9992	0.9203						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041002.2 [benign]; RCV000126057.1 [benign]; 			0.9924	0	0.0076	511	2	n/a	n/a
chr2	179616771	179616771	A	-	het		QUAL=3072;DP=114;AF=0.71;MQM=59;TRIO=HET,114,0.71,HET,20,0.60,HET,37,0.46	TTN	splice_region&intron,intron	TTN:NM_133379.4:splice_region&intron:LOW:exon45/45:c.10361-6delT:,TTN:NM_001267550.2:intron:MODIFIER:exon47/362:c.11311+1079delT:,TTN:NM_001256850.1:intron:MODIFIER:exon45/312:c.10360+1079delT:,TTN:NM_133437.4:intron:MODIFIER:exon45/191:c.10798+1079delT:,TTN:NM_003319.4:intron:MODIFIER:exon44/190:c.10222+1079delT:,TTN:NM_133378.4:intron:MODIFIER:exon45/311:c.10360+1079delT:,TTN:NM_133432.3:intron:MODIFIER:exon45/191:c.10597+1079delT:			0	0	0	0						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];				0.2955	0.4091	0.2955	81	69	1	n/a
chr2	179620951	179620951	C	T	hom		QUAL=12406;DP=251;AF=1.00;MQM=59;TRIO=HOM,251,1.00,HOM,66,1.00,HOM,93,1.00	TTN	missense&splice_region,intron	TTN:NM_001267550.2:missense&splice_region:MODERATE:exon46/363:c.11252G>A:p.Gly3751Asp,TTN:NM_133437.4:missense&splice_region:MODERATE:exon44/192:c.10739G>A:p.Gly3580Asp,TTN:NM_001256850.1:intron:MODIFIER:exon44/312:c.10303+2760G>A:,TTN:NM_003319.4:intron:MODIFIER:exon43/190:c.10165+2760G>A:,TTN:NM_133378.4:intron:MODIFIER:exon44/311:c.10303+2760G>A:,TTN:NM_133432.3:intron:MODIFIER:exon44/191:c.10540+1318G>A:,TTN:NM_133379.4:intron:MODIFIER:exon44/45:c.10303+2760G>A:		rs7585334	0.8045	0.849	0.9321	0.8405	3.7080	P	D	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041121.2 [benign]; RCV000126054.1 [benign]; 			0.8561	0.1288	0.0152	459	53	n/a	n/a
chr2	179621184	179621184	G	A	het		QUAL=12807;DP=469;AF=0.49;MQM=60;TRIO=HET,469,0.49,HET,350,0.49,WT,486,0.00	TTN	synonymous,intron	TTN:NM_001267550.2:synonymous:LOW:exon46/363:c.11019C>T:p.Cys3673Cys,TTN:NM_133437.4:synonymous:LOW:exon44/192:c.10506C>T:p.Cys3502Cys,TTN:NM_001256850.1:intron:MODIFIER:exon44/312:c.10303+2527C>T:,TTN:NM_003319.4:intron:MODIFIER:exon43/190:c.10165+2527C>T:,TTN:NM_133378.4:intron:MODIFIER:exon44/311:c.10303+2527C>T:,TTN:NM_133432.3:intron:MODIFIER:exon44/191:c.10540+1085C>T:,TTN:NM_133379.4:intron:MODIFIER:exon44/45:c.10303+2527C>T:		rs72955212	0.0052	0.011	0.0146	0.0026						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041119.2 [benign]; RCV000126053.1 [benign]; 			0	0.0379	0.9621	0	14	n/a	n/a
chr2	179621477	179621477	C	T	hom		QUAL=13051;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,83,1.00,HOM,114,1.00	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon46/363:c.10726G>A:p.Ala3576Thr,TTN:NM_133437.4:missense:MODERATE:exon44/192:c.10213G>A:p.Ala3405Thr,TTN:NM_001256850.1:intron:MODIFIER:exon44/312:c.10303+2234G>A:,TTN:NM_003319.4:intron:MODIFIER:exon43/190:c.10165+2234G>A:,TTN:NM_133378.4:intron:MODIFIER:exon44/311:c.10303+2234G>A:,TTN:NM_133432.3:intron:MODIFIER:exon44/191:c.10540+792G>A:,TTN:NM_133379.4:intron:MODIFIER:exon44/45:c.10303+2234G>A:		rs6433728	0.999	1	1	0.9974	0.2260	P	D	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000155422.1,RCV000126050.1 [likely benign,benign]; RCV000152471.1 [not provided]; 			1	0	0	514	0	n/a	n/a
chr2	179621503	179621503	C	T	het		QUAL=3790;DP=206;AF=0.49;MQM=60;TRIO=HET,206,0.49,HET,67,0.51,WT,101,0.00	TTN	missense,intron	TTN:NM_001267550.2:missense:MODERATE:exon46/363:c.10700G>A:p.Ser3567Asn,TTN:NM_133437.4:missense:MODERATE:exon44/192:c.10187G>A:p.Ser3396Asn,TTN:NM_001256850.1:intron:MODIFIER:exon44/312:c.10303+2208G>A:,TTN:NM_003319.4:intron:MODIFIER:exon43/190:c.10165+2208G>A:,TTN:NM_133378.4:intron:MODIFIER:exon44/311:c.10303+2208G>A:,TTN:NM_133432.3:intron:MODIFIER:exon44/191:c.10540+766G>A:,TTN:NM_133379.4:intron:MODIFIER:exon44/45:c.10303+2208G>A:		rs72955213	0.0064	0.014	0.0176	0.0021	1.3030	D	D	B	B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000041115.2 [benign]; RCV000126049.1 [benign]; 			0	0.0379	0.9621	0	15	n/a	n/a
chr2	179623758	179623758	C	T	hom		QUAL=16191;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,115,1.00,HOM,136,1.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon44/363:c.10256G>A:p.Ser3419Asn,TTN:NM_001256850.1:missense:MODERATE:exon44/313:c.10256G>A:p.Ser3419Asn,TTN:NM_133437.4:missense:MODERATE:exon43/192:c.10118G>A:p.Ser3373Asn,TTN:NM_003319.4:missense:MODERATE:exon43/191:c.10118G>A:p.Ser3373Asn,TTN:NM_133378.4:missense:MODERATE:exon44/312:c.10256G>A:p.Ser3419Asn,TTN:NM_133432.3:missense:MODERATE:exon43/192:c.10118G>A:p.Ser3373Asn,TTN:NM_133379.4:missense:MODERATE:exon44/46:c.10256G>A:p.Ser3419Asn		rs2291310	0.8089	0.851	0.9324	0.8436	0.3980	P	D	B,B,B,B	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000039852.5 [benign]; RCV000126048.1 [benign]; 			0.8561	0.1288	0.0152	454	56	n/a	n/a
chr2	179629363	179629363	T	C	hom		QUAL=44757;DP=487;AF=1.00;MQM=60;TRIO=HOM,487,1.00,HOM,400,1.00,HOM,503,1.00	TTN	synonymous	TTN:NM_001267550.2:synonymous:LOW:exon42/363:c.9879A>G:p.Glu3293Glu,TTN:NM_001256850.1:synonymous:LOW:exon42/313:c.9879A>G:p.Glu3293Glu,TTN:NM_133437.4:synonymous:LOW:exon41/192:c.9741A>G:p.Glu3247Glu,TTN:NM_003319.4:synonymous:LOW:exon41/191:c.9741A>G:p.Glu3247Glu,TTN:NM_133378.4:synonymous:LOW:exon42/312:c.9879A>G:p.Glu3293Glu,TTN:NM_133432.3:synonymous:LOW:exon41/192:c.9741A>G:p.Glu3247Glu,TTN:NM_133379.4:synonymous:LOW:exon42/46:c.9879A>G:p.Glu3293Glu		rs4894043	0.9736	0.992	0.9992	0.914						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040976.5 [benign]; RCV000126043.1 [benign]; 			1	0	0	514	2	n/a	n/a
chr2	179629461	179629461	C	T	hom		QUAL=44786;DP=419;AF=1.00;MQM=59;TRIO=HOM,419,1.00,HOM,427,1.00,HOM,539,1.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon42/363:c.9781G>A:p.Val3261Met,TTN:NM_001256850.1:missense:MODERATE:exon42/313:c.9781G>A:p.Val3261Met,TTN:NM_133437.4:missense:MODERATE:exon41/192:c.9643G>A:p.Val3215Met,TTN:NM_003319.4:missense:MODERATE:exon41/191:c.9643G>A:p.Val3215Met,TTN:NM_133378.4:missense:MODERATE:exon42/312:c.9781G>A:p.Val3261Met,TTN:NM_133432.3:missense:MODERATE:exon41/192:c.9643G>A:p.Val3215Met,TTN:NM_133379.4:missense:MODERATE:exon42/46:c.9781G>A:p.Val3261Met		rs2291311	0.8049	0.85	0.9322	0.8268	1.0930	P	D	D,D,D,D	P,P,P,P	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040961.5 [benign]; RCV000126041.1 [benign]; 			0.8561	0.1288	0.0152	459	56	n/a	n/a
chr2	179634421	179634421	T	G	het		QUAL=182;DP=44;AF=0.39;MQM=59;TRIO=HET,44,0.39,WT,96,0.00,WT,129,0.00	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon37/363:c.8887A>C:p.Thr2963Pro,TTN:NM_001256850.1:missense:MODERATE:exon37/313:c.8887A>C:p.Thr2963Pro,TTN:NM_133437.4:missense:MODERATE:exon36/192:c.8749A>C:p.Thr2917Pro,TTN:NM_003319.4:missense:MODERATE:exon36/191:c.8749A>C:p.Thr2917Pro,TTN:NM_133378.4:missense:MODERATE:exon37/312:c.8887A>C:p.Thr2963Pro,TTN:NM_133432.3:missense:MODERATE:exon36/192:c.8749A>C:p.Thr2917Pro,TTN:NM_133379.4:missense:MODERATE:exon37/46:c.8887A>C:p.Thr2963Pro		rs200875815	0.2155	0.355	0	0	5.9120	D	D	D,D,D,D,D	D,D,D,D,D	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000126033.1 [benign]; 		COSM146061	0.0152	0.5152	0.4697	3	118	n/a	n/a
chr2	179642425	179642425	G	A	het		QUAL=5791;DP=171;AF=0.53;MQM=60;TRIO=HET,171,0.53,HOM,61,1.00,HET,64,0.47	TTN	splice_region&intron	TTN:NM_001267550.2:splice_region&intron:LOW:exon25/362:c.4480+6C>T:,TTN:NM_001256850.1:splice_region&intron:LOW:exon25/312:c.4480+6C>T:,TTN:NM_133437.4:splice_region&intron:LOW:exon24/191:c.4342+6C>T:,TTN:NM_003319.4:splice_region&intron:LOW:exon24/190:c.4342+6C>T:,TTN:NM_133378.4:splice_region&intron:LOW:exon25/311:c.4480+6C>T:,TTN:NM_133432.3:splice_region&intron:LOW:exon24/191:c.4342+6C>T:,TTN:NM_133379.4:splice_region&intron:LOW:exon25/45:c.4480+6C>T:		rs719201	0.9115	0.959	0.9914	0.8588						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040333.5 [benign]; RCV000126016.1 [benign]; 			0.947	0.053	0	500	15	n/a	n/a
chr2	179644035	179644035	G	A	het		QUAL=14808;DP=284;AF=0.52;MQM=60;TRIO=HET,284,0.52,HOM,183,1.00,HET,194,0.58	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon23/363:c.3884C>T:p.Ser1295Leu,TTN:NM_001256850.1:missense:MODERATE:exon23/313:c.3884C>T:p.Ser1295Leu,TTN:NM_133437.4:missense:MODERATE:exon22/192:c.3746C>T:p.Ser1249Leu,TTN:NM_003319.4:missense:MODERATE:exon22/191:c.3746C>T:p.Ser1249Leu,TTN:NM_133378.4:missense:MODERATE:exon23/312:c.3884C>T:p.Ser1295Leu,TTN:NM_133432.3:missense:MODERATE:exon22/192:c.3746C>T:p.Ser1249Leu,TTN:NM_133379.4:missense:MODERATE:exon23/46:c.3884C>T:p.Ser1295Leu		rs1552280	0.9201	0.96	0.9914	0.8718	6.2480	P	D	B,B,B,B	B,B,B,B	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040271.4 [benign]; RCV000126009.1 [benign]; 			0.947	0.053	0	489	18	n/a	n/a
chr2	179644855	179644855	T	C	het		QUAL=7125;DP=216;AF=0.50;MQM=60;TRIO=HET,216,0.50,HOM,65,1.00,HET,98,0.43	TTN	missense	TTN:NM_001267550.2:missense:MODERATE:exon22/363:c.3601A>G:p.Lys1201Glu,TTN:NM_001256850.1:missense:MODERATE:exon22/313:c.3601A>G:p.Lys1201Glu,TTN:NM_133437.4:missense:MODERATE:exon21/192:c.3463A>G:p.Lys1155Glu,TTN:NM_003319.4:missense:MODERATE:exon21/191:c.3463A>G:p.Lys1155Glu,TTN:NM_133378.4:missense:MODERATE:exon22/312:c.3601A>G:p.Lys1201Glu,TTN:NM_133432.3:missense:MODERATE:exon21/192:c.3463A>G:p.Lys1155Glu,TTN:NM_133379.4:missense:MODERATE:exon22/46:c.3601A>G:p.Lys1201Glu		rs10497520	0.5002	0.694	0.8702	0.4707	4.1160	P	D	B,B,B,B,P	B,B,B,B,P	188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040243.4 [benign]; RCV000126001.1 [benign]; 		COSM4001422	0.6212	0.3409	0.0379	386	116	n/a	n/a
chr2	179650701	179650701	C	T	het		QUAL=23821;DP=590;AF=0.55;MQM=60;TRIO=HET,590,0.55,HOM,469,1.00,WT,600,0.00	TTN	synonymous	TTN:NM_001267550.2:synonymous:LOW:exon14/363:c.2244G>A:p.Glu748Glu,TTN:NM_001256850.1:synonymous:LOW:exon14/313:c.2244G>A:p.Glu748Glu,TTN:NM_133437.4:synonymous:LOW:exon13/192:c.2106G>A:p.Glu702Glu,TTN:NM_003319.4:synonymous:LOW:exon13/191:c.2106G>A:p.Glu702Glu,TTN:NM_133378.4:synonymous:LOW:exon14/312:c.2244G>A:p.Glu748Glu,TTN:NM_133432.3:synonymous:LOW:exon13/192:c.2106G>A:p.Glu702Glu,TTN:NM_133379.4:synonymous:LOW:exon14/46:c.2244G>A:p.Glu748Glu		rs6715406	0.2047	0.319	0.4057	0.2						188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9|Cardiomyopathy,dilated,1G|Tibial muscular dystrophy,tardive|Muscular dystrophy,limb-girdle,type 2J|Myopathy,proximal,with early respiratory muscle involvement|Myopathy,early-onset,with fatal cardiomyopathy];	RCV000040044.3 [benign]; RCV000125846.1 [benign]; 		COSM4001427	0.1515	0.4015	0.447	101	215	n/a	n/a
chr2	190430177	190430177	A	G	hom		QUAL=30701;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HOM,275,1.00,HOM,392,1.00	SLC40A1	synonymous	SLC40A1:NM_014585.5:synonymous:LOW:exon6/8:c.663T>C:p.Val221Val		rs2304704	0.5501	0.614	0.6401	0.231						604653 [SLC40A1 (confirmed) Hemochromatosis,type 4];				0.4015	0.4697	0.1288	177	202	n/a	n/a
chr2	190445495	190445495	-	CCG	het		QUAL=1311;DP=11;AF=0.73;MQM=60;TRIO=HET,11,0.73,HET,30,0.50,HOM,37,0.95	SLC40A1	5'UTR	SLC40A1:NM_014585.5:5'UTR:MODIFIER:exon1/8:c.-312_-310dupCGG:		rs3833570	0.5335	0	0	0										0.303	0.4697	0.2273	48	66	n/a	n/a
chr2	191069434	191069434	G	A	het		QUAL=4101;DP=226;AF=0.45;MQM=60;TRIO=HET,226,0.45,WT,51,0.00,HET,69,0.49	HIBCH	3'UTR	HIBCH:NM_014362.3:3'UTR:MODIFIER:exon14/14:c.*409C>T:,HIBCH:NM_198047.2:3'UTR:MODIFIER:exon13/13:c.*519C>T:		rs1058230	0.3632	0	0	0										0.0758	0.4167	0.5076	14	60	n/a	n/a
chr2	191069476	191069476	C	T	het		QUAL=6734;DP=326;AF=0.47;MQM=60;TRIO=HET,326,0.47,WT,96,0.00,HET,126,0.49	HIBCH	3'UTR	HIBCH:NM_014362.3:3'UTR:MODIFIER:exon14/14:c.*367G>A:,HIBCH:NM_198047.2:3'UTR:MODIFIER:exon13/13:c.*477G>A:		rs1058227	0.3636	0	0	0										0.0833	0.4091	0.5076	15	59	n/a	n/a
chr2	191069689	191069689	T	A	het		QUAL=9944;DP=291;AF=0.46;MQM=59;TRIO=HET,291,0.46,WT,219,0.00,HET,326,0.52	HIBCH	3'UTR	HIBCH:NM_014362.3:3'UTR:MODIFIER:exon14/14:c.*154A>T:,HIBCH:NM_198047.2:3'UTR:MODIFIER:exon13/13:c.*264A>T:	MER58B	rs11542	0.348	0	0	0										0.0758	0.4167	0.5076	14	60	n/a	n/a
chr2	191110893	191110893	C	T	het		QUAL=4687;DP=217;AF=0.43;MQM=60;TRIO=HET,217,0.43,WT,47,0.00,HET,84,0.57	HIBCH	missense	HIBCH:NM_014362.3:missense:MODERATE:exon10/14:c.796G>A:p.Asp266Asn,HIBCH:NM_198047.2:missense:MODERATE:exon10/13:c.796G>A:p.Asp266Asn		rs144053672	0.0008	0.0025	0.0052	0.0011	2.5220	D	T	B,B	B,B	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency];				0	0.0076	0.9924	0	4	n/a	n/a
chr2	191161622	191161622	T	C	het		QUAL=16602;DP=310;AF=0.47;MQM=60;TRIO=HET,310,0.47,HOM,229,1.00,HET,277,0.50	HIBCH	missense	HIBCH:NM_014362.3:missense:MODERATE:exon3/14:c.136A>G:p.Thr46Ala,HIBCH:NM_198047.2:missense:MODERATE:exon3/13:c.136A>G:p.Thr46Ala		rs1058180	0.6843	0.739	0.7593	0.6557	2.9820	P	T	B,B	B,B	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency];				0.4848	0.4394	0.0758	234	180	n/a	n/a
chr2	191184475	191184475	A	G	het		QUAL=5797;DP=127;AF=0.47;MQM=60;TRIO=HET,127,0.47,HOM,86,1.00,HET,139,0.35	HIBCH	start_lost	HIBCH:NM_014362.3:start_lost:HIGH:exon1/14:c.2T>C:p.Met1?,HIBCH:NM_198047.2:start_lost:HIGH:exon1/13:c.2T>C:p.Met1?		rs291466	0.4317	0.519	0.6012	0.4557	1.2900	P	D	B,B	B,B	610690 [HIBCH (provisional) 3-hydroxyisobutryl-CoA hydrolase deficiency];		CM1311889 [CLASS=FTV MUT=ALT PHEN="Potential protein deficiency" GENE=HIBCH]; 		0.4015	0.4697	0.1288	165	220	n/a	n/a
chr2	191184524	191184524	C	T	hom		QUAL=16346;DP=229;AF=1.00;MQM=60;TRIO=HOM,229,1.00,HOM,118,1.00,HOM,182,1.00	HIBCH	5'UTR	HIBCH:NM_014362.3:5'UTR:MODIFIER:exon1/14:c.-48G>A:,HIBCH:NM_198047.2:5'UTR:MODIFIER:exon1/13:c.-48G>A:		rs3749022	0.5487	0.664	0.7855	0.4038									COSN166358	0.7727	0.197	0.0303	120	42	n/a	n/a
chr2	191841759	191841759	G	A	het		QUAL=6132;DP=228;AF=0.45;MQM=60;TRIO=HET,228,0.45,WT,115,0.00,HET,171,0.54	STAT1	splice_region&intron	STAT1:NM_007315.3:splice_region&intron:LOW:exon21/24:c.1874-8C>T:,STAT1:NM_139266.2:splice_region&intron:LOW:exon21/22:c.1874-8C>T:		rs2066804	0.2266	0.226	0.2397	0.1739						600555 [STAT1 (provisional) Mycobacterial infection,atypical,familial disseminated|Mycobacterial and viral infections,susceptibility to,autosomal recessive|Candidiasis,familial,7];				0.0379	0.3788	0.5833	22	186	n/a	n/a
chr2	198362018	198362018	T	C	hom		QUAL=32151;DP=442;AF=1.00;MQM=59;TRIO=HOM,442,1.00,HOM,238,1.00,HOM,306,1.00	HSPD1	synonymous	HSPD1:NM_002156.4:synonymous:LOW:exon3/12:c.273A>G:p.Lys91Lys,HSPD1:NM_199440.1:synonymous:LOW:exon3/12:c.273A>G:p.Lys91Lys		rs8539	0.6546	0.649	0.6842	0.7172						118190 [HSPD1 (confirmed) Spastic paraplegia 13,autosomal dominant|Leukodystrophy,hypomyelinating,4];	RCV000117240.2 [likely benign]; RCV000125392.1 [benign]; 		COSM3757862	0.553	0.3788	0.0682	384	309	n/a	n/a
chr2	198363504	198363504	A	G	het		QUAL=3671;DP=201;AF=0.46;MQM=56;TRIO=HET,201,0.46,HET,59,0.46,WT,84,0.01	HSPD1	synonymous	HSPD1:NM_002156.4:synonymous:LOW:exon2/12:c.69T>C:p.Thr23Thr,HSPD1:NM_199440.1:synonymous:LOW:exon2/12:c.69T>C:p.Thr23Thr		rs1050347	0.1581	0.165	0.1914	0.1117						118190 [HSPD1 (confirmed) Spastic paraplegia 13,autosomal dominant|Leukodystrophy,hypomyelinating,4];	RCV000117242.2 [likely benign]; RCV000125390.1 [benign]; 			0.0606	0.2879	0.6515	28	218	n/a	n/a
chr2	198364518	198364518	G	A	het		QUAL=1410;DP=19;AF=0.84;MQM=60;TRIO=HET,19,0.84,HET,52,0.71,WT,62,0.00	HSPD1	5'UTR_premature_start_codon_gain,5'UTR,intron	HSPD1:NM_002156.4:5'UTR_premature_start_codon_gain:LOW:exon1/12:c.-15C>T:,HSPD1:NM_002156.4:5'UTR:MODIFIER:exon1/12:c.-15C>T:,HSPD1:NM_199440.1:intron:MODIFIER:exon1/11:c.-3+366C>T:		rs13165	0.2332	0	0	0							RCV000125394.1 [benign]; 			0.0606	0.2727	0.6667	8	39	n/a	n/a
chr2	200134420	200134420	-	AA	hom		QUAL=1600;DP=79;AF=0.61;MQM=59;TRIO=HOM,79,0.61,HET,8,0.38,HOM,8,0.38	SATB2	3'UTR	SATB2:NM_001172509.1:3'UTR:MODIFIER:exon11/11:c.*2512_*2513dupTT:,SATB2:NM_001172517.1:3'UTR:MODIFIER:exon12/12:c.*2512_*2513dupTT:,SATB2:NM_015265.3:3'UTR:MODIFIER:exon12/12:c.*2512_*2513dupTT:		rs58333872	0	0	0	0										0.5379	0.3409	0.1212	80	51	n/a	n/a
chr2	200135233	200135233	-	A	het		QUAL=6171;DP=283;AF=0.39;MQM=59;TRIO=HET,283,0.39,HET,116,0.21,HET,163,0.44	SATB2	3'UTR	SATB2:NM_001172509.1:3'UTR:MODIFIER:exon11/11:c.*1700dupT:,SATB2:NM_001172517.1:3'UTR:MODIFIER:exon12/12:c.*1700dupT:,SATB2:NM_015265.3:3'UTR:MODIFIER:exon12/12:c.*1700dupT:		rs397987298	0.5377	0	0	0										0.0152	0.4167	0.5682	2	58	n/a	n/a
chr2	200136284	200136284	A	-	het		QUAL=2715;DP=95;AF=0.45;MQM=60;TRIO=HET,95,0.45,HET,73,0.58,HET,66,0.14	SATB2	3'UTR	SATB2:NM_001172509.1:3'UTR:MODIFIER:exon11/11:c.*650delT:,SATB2:NM_001172517.1:3'UTR:MODIFIER:exon12/12:c.*650delT:,SATB2:NM_015265.3:3'UTR:MODIFIER:exon12/12:c.*650delT:		rs397987299	0.4403	0	0	0										0.2273	0.4015	0.3712	37	60	n/a	n/a
chr2	200136583	200136583	T	A	hom		QUAL=16681;DP=199;AF=1.00;MQM=59;TRIO=HOM,199,1.00,HOM,120,1.00,HOM,198,1.00	SATB2	3'UTR	SATB2:NM_001172509.1:3'UTR:MODIFIER:exon11/11:c.*351A>T:,SATB2:NM_001172517.1:3'UTR:MODIFIER:exon12/12:c.*351A>T:,SATB2:NM_015265.3:3'UTR:MODIFIER:exon12/12:c.*351A>T:		rs6435006	0.9325	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr2	200173684	200173684	T	G	hom		QUAL=20724;DP=125;AF=1.00;MQM=60;TRIO=HOM,125,1.00,HOM,234,1.00,HOM,302,1.00	SATB2	splice_region&intron	SATB2:NM_001172509.1:splice_region&intron:LOW:exon9/10:c.1543-4A>C:,SATB2:NM_001172517.1:splice_region&intron:LOW:exon10/11:c.1543-4A>C:,SATB2:NM_015265.3:splice_region&intron:LOW:exon10/11:c.1543-4A>C:		rs10153730	0.9309	0.981	0.9995	0.8032						608148 [SATB2 (confirmed) Glass syndrome];				0.9924	0.0076	0	450	4	n/a	n/a
chr2	202565570	202565570	C	T	het		QUAL=5575;DP=239;AF=0.46;MQM=60;TRIO=HET,239,0.46,HET,138,0.45,WT,171,0.01	ALS2	3'UTR	ALS2:NM_020919.3:3'UTR:MODIFIER:exon34/34:c.*1004G>A:		rs11300	0.1024	0	0	0										0	0.1818	0.8182	0	26	n/a	n/a
chr2	202565681	202565681	G	A	het		QUAL=5602;DP=277;AF=0.47;MQM=60;TRIO=HET,277,0.47,HET,99,0.42,WT,169,0.01	ALS2	3'UTR	ALS2:NM_020919.3:3'UTR:MODIFIER:exon34/34:c.*893C>T:		rs3219174	0.0897	0	0	0										0	0.1439	0.8561	0	21	n/a	n/a
chr2	202575821	202575821	G	A	hom		QUAL=17054;DP=252;AF=1.00;MQM=60;TRIO=HOM,252,1.00,HOM,147,1.00,HET,193,0.61	ALS2	synonymous	ALS2:NM_020919.3:synonymous:LOW:exon26/34:c.4015C>T:p.Leu1339Leu		rs3219168	0.9054	0.923	0.9205	0.8226						606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile|Primary lateral sclerosis,juvenile|Spastic paralysis,infantile onset ascending];				0.8182	0.1667	0.0152	646	107	n/a	n/a
chr2	202593280	202593280	G	A	het		QUAL=9082;DP=335;AF=0.49;MQM=60;TRIO=HET,335,0.49,HET,239,0.50,WT,313,0.00	ALS2	synonymous	ALS2:NM_020919.3:synonymous:LOW:exon15/34:c.2796C>T:p.Ser932Ser		rs3219161	0.115	0.098	0.0841	0.06						606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile|Primary lateral sclerosis,juvenile|Spastic paralysis,infantile onset ascending];			COSM3757885	0	0.1818	0.8182	10	113	n/a	n/a
chr2	202598113	202598113	C	T	het		QUAL=6512;DP=188;AF=0.51;MQM=60;TRIO=HET,188,0.51,HET,88,0.52,HET,126,0.46	ALS2	synonymous	ALS2:NM_020919.3:synonymous:LOW:exon13/34:c.2466G>A:p.Val822Val		rs2276615	0.3724	0.527	0.6033	0.1634						606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile|Primary lateral sclerosis,juvenile|Spastic paralysis,infantile onset ascending];			COSM149044	0.4242	0.3939	0.1818	274	346	n/a	n/a
chr2	202625615	202625615	C	T	hom		QUAL=24633;DP=481;AF=1.00;MQM=60;TRIO=HOM,481,1.00,HOM,165,1.00,HET,250,0.45	ALS2	missense	ALS2:NM_020919.3:missense:MODERATE:exon4/34:c.1102G>A:p.Val368Met,ALS2:NM_001135745.1:missense:MODERATE:exon4/4:c.1102G>A:p.Val368Met		rs3219156	0.8966	0.91	0.8984	0.7817	-2.3570	P	T	B,B,B,B	B,B,B,B	606352 [ALS2 (confirmed) Amyotrophic lateral sclerosis 2,juvenile|Primary lateral sclerosis,juvenile|Spastic paralysis,infantile onset ascending];				0.7803	0.2121	0.0076	603	149	n/a	n/a
chr2	206988751	206988751	A	G	het		QUAL=6506;DP=278;AF=0.52;MQM=60;TRIO=HET,278,0.52,HET,96,0.52,WT,129,0.00	NDUFS1	3'UTR	NDUFS1:NM_001199984.1:3'UTR:MODIFIER:exon19/19:c.*158T>C:,NDUFS1:NM_001199981.1:3'UTR:MODIFIER:exon18/18:c.*158T>C:,NDUFS1:NM_001199982.1:3'UTR:MODIFIER:exon16/16:c.*158T>C:,NDUFS1:NM_001199983.1:3'UTR:MODIFIER:exon18/18:c.*158T>C:,NDUFS1:NM_005006.6:3'UTR:MODIFIER:exon19/19:c.*158T>C:		rs3770989	0.0256	0	0	0										0	0.0909	0.9091	0	12	n/a	n/a
chr2	206992537	206992537	A	C	het		QUAL=1851;DP=183;AF=0.48;MQM=60;TRIO=HET,183,0.48,WT,130,0.00,WT,161,0.00	NDUFS1	missense	NDUFS1:NM_001199984.1:missense:MODERATE:exon16/19:c.1910T>G:p.Ile637Arg,NDUFS1:NM_001199981.1:missense:MODERATE:exon15/18:c.1760T>G:p.Ile587Arg,NDUFS1:NM_001199982.1:missense:MODERATE:exon13/16:c.1535T>G:p.Ile512Arg,NDUFS1:NM_001199983.1:missense:MODERATE:exon15/18:c.1697T>G:p.Ile566Arg,NDUFS1:NM_005006.6:missense:MODERATE:exon16/19:c.1868T>G:p.Ile623Arg		rs201634181	0	0.0046	0	0	9.2840	D	D	D,P,P,P	D,P,P,P	157655 [NDUFS1 (provisional) Mitochondrial complex I deficiency];			COSM215852	0	0.2197	0.7803	0	50	n/a	n/a
chr2	207026131	207026131	G	A	het		QUAL=7658;DP=226;AF=0.46;MQM=55;TRIO=HET,226,0.46,HET,294,0.47,WT,378,0.00	EEF1B2	missense	EEF1B2:NM_001037663.1:missense:MODERATE:exon4/7:c.265G>A:p.Gly89Arg,EEF1B2:NM_001959.3:missense:MODERATE:exon3/6:c.265G>A:p.Gly89Arg,EEF1B2:NM_021121.3:missense:MODERATE:exon4/7:c.265G>A:p.Gly89Arg		rs11546386	0.0178	0.013	0.0076	0.0018	5.3110	D	T	B	B				COSM3695209	0	0.0152	0.9848	0	9	n/a	n/a
chr2	207657706	207657706	G	C	het		QUAL=5895;DP=190;AF=0.52;MQM=59;TRIO=HET,190,0.52,WT,126,0.00,HET,177,0.53	FASTKD2	3'UTR	FASTKD2:NM_001136193.1:3'UTR:MODIFIER:exon12/12:c.*1180G>C:,FASTKD2:NM_001136194.1:3'UTR:MODIFIER:exon12/12:c.*1180G>C:,FASTKD2:NM_014929.3:3'UTR:MODIFIER:exon12/12:c.*1180G>C:	AluSc8	rs114333222	0.0016	0	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr2	211421452	211421452	-	TCT	hom		QUAL=11090;DP=230;AF=0.84;MQM=60;TRIO=HOM,230,0.84,HET,163,0.48,HET,191,0.47	CPS1	inframe_insertion,5'UTR	CPS1:NM_001122633.2:inframe_insertion:MODERATE:exon2/39:c.15_16insTTC:p.Ile5_Lys6insPhe,CPS1:NM_001875.4:5'UTR:MODIFIER:exon1/38:c.-4_-3insTTC:		rs61509952	0.477	0.435	0.4015	0.5776						608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency|Pulmonary hypertension,neonatal,susceptibility to|Venoocclusive disease after bone marrow transplantation];				0.1818	0.5455	0.2727	84	218	1	n/a
chr2	211456637	211456637	A	G	hom		QUAL=15654;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,166,0.99,HET,253,0.51	CPS1	missense	CPS1:NM_001122633.2:missense:MODERATE:exon11/39:c.1048A>G:p.Thr350Ala,CPS1:NM_001875.4:missense:MODERATE:exon10/38:c.1030A>G:p.Thr344Ala		rs1047883	0	0.568	0.5676	0.6389	0.2530	P	D	B	B	608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency|Pulmonary hypertension,neonatal,susceptibility to|Venoocclusive disease after bone marrow transplantation];	RCV000116829.2 [likely benign]; RCV000124588.1 [benign]; 		COSM4133425	0.4167	0.4394	0.1439	161	206	n/a	n/a
chr2	211456639	211456639	C	T	hom		QUAL=15654;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,166,0.99,HET,253,0.51	CPS1	synonymous	CPS1:NM_001122633.2:synonymous:LOW:exon11/39:c.1050C>T:p.Thr350Thr,CPS1:NM_001875.4:synonymous:LOW:exon10/38:c.1032C>T:p.Thr344Thr		rs2229589	0.5913	0.572	0.5676	0.6562						608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency|Pulmonary hypertension,neonatal,susceptibility to|Venoocclusive disease after bone marrow transplantation];	RCV000116830.2 [likely benign]; RCV000124589.1 [benign]; 			0.4167	0.4394	0.1439	162	206	n/a	n/a
chr2	211481257	211481257	C	G	hom		QUAL=16421;DP=141;AF=1.00;MQM=60;TRIO=HOM,141,1.00,HOM,253,1.00,HET,291,0.42	CPS1	synonymous	CPS1:NM_001122633.2:synonymous:LOW:exon22/39:c.2697C>G:p.Gly899Gly,CPS1:NM_001875.4:synonymous:LOW:exon21/38:c.2679C>G:p.Gly893Gly,CPS1:NM_001122634.2:synonymous:LOW:exon11/28:c.1326C>G:p.Gly442Gly		rs2287599	0.6492	0.586	0.5616	0.8586						608307 [CPS1 (confirmed) Carbamoylphosphate synthetase I deficiency|Pulmonary hypertension,neonatal,susceptibility to|Venoocclusive disease after bone marrow transplantation];	RCV000116831.2 [likely benign]; RCV000124592.1 [benign]; 			0.4394	0.4167	0.1439	159	213	n/a	n/a
chr2	211543147	211543147	T	G	het		QUAL=9231;DP=270;AF=0.51;MQM=60;TRIO=HET,270,0.51,HET,92,0.63,HET,130,0.63	CPS1	3'UTR	CPS1:NM_001122633.2:3'UTR:MODIFIER:exon39/39:c.*438T>G:,CPS1:NM_001875.4:3'UTR:MODIFIER:exon38/38:c.*438T>G:,CPS1:NM_001122634.2:3'UTR:MODIFIER:exon28/28:c.*438T>G:		rs7684	0.269	0	0	0										0.1515	0.5	0.3485	22	74	n/a	n/a
chr2	215796302	215796302	-	ACAA	het		QUAL=6563;DP=204;AF=0.45;MQM=60;TRIO=HET,204,0.45,HOM,141,0.96,WT,281,0.00	ABCA12	3'UTR	ABCA12:NM_173076.2:3'UTR:MODIFIER:exon53/53:c.*1052_*1055dupTTGT:,ABCA12:NM_015657.3:3'UTR:MODIFIER:exon45/45:c.*1052_*1055dupTTGT:		rs57011945	0.3015	0	0	0										0.1591	0.4621	0.3788	26	65	n/a	n/a
chr2	215796568	215796568	T	C	hom		QUAL=19126;DP=222;AF=1.00;MQM=60;TRIO=HOM,222,1.00,HOM,158,1.00,HOM,203,1.00	ABCA12	3'UTR	ABCA12:NM_173076.2:3'UTR:MODIFIER:exon53/53:c.*790A>G:,ABCA12:NM_015657.3:3'UTR:MODIFIER:exon45/45:c.*790A>G:		rs12694349	0.5939	0	0	0										0.2727	0.4545	0.2727	41	65	n/a	n/a
chr2	215797332	215797332	C	T	hom		QUAL=15726;DP=319;AF=1.00;MQM=60;TRIO=HOM,319,1.00,HOM,82,1.00,HET,126,0.56	ABCA12	3'UTR	ABCA12:NM_173076.2:3'UTR:MODIFIER:exon53/53:c.*26G>A:,ABCA12:NM_015657.3:3'UTR:MODIFIER:exon45/45:c.*26G>A:		rs17426207	0.3982	0.419	0.4086	0.3459										0.1515	0.4621	0.3864	26	78	n/a	n/a
chr2	215820013	215820013	G	A	het		QUAL=14854;DP=322;AF=0.41;MQM=60;TRIO=HET,322,0.41,HOM,196,1.00,HET,264,0.49	ABCA12	synonymous	ABCA12:NM_173076.2:synonymous:LOW:exon43/53:c.6306C>T:p.Tyr2102Tyr,ABCA12:NM_015657.3:synonymous:LOW:exon35/45:c.5352C>T:p.Tyr1784Tyr		rs10498027	0.35	0.405	0.4165	0.3153						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];			COSM3757935	0.1894	0.4545	0.3561	84	205	n/a	n/a
chr2	215839570	215839570	C	T	het		QUAL=10767;DP=333;AF=0.49;MQM=60;TRIO=HET,333,0.49,WT,244,0.00,HET,338,0.48	ABCA12	synonymous	ABCA12:NM_173076.2:synonymous:LOW:exon35/53:c.5400G>A:p.Thr1800Thr,ABCA12:NM_015657.3:synonymous:LOW:exon27/45:c.4446G>A:p.Thr1482Thr		rs16853022	0.1196	0.048	0.0156	0.2696						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				0	0.0682	0.9318	0	37	n/a	n/a
chr2	215851303	215851303	A	G	hom		QUAL=15945;DP=175;AF=0.99;MQM=60;TRIO=HOM,175,0.99,HET,163,0.52,HOM,247,1.00	ABCA12	synonymous	ABCA12:NM_173076.2:synonymous:LOW:exon28/53:c.4126T>C:p.Leu1376Leu,ABCA12:NM_015657.3:synonymous:LOW:exon20/45:c.3172T>C:p.Leu1058Leu		rs34351934	0.2071	0.135	0.1013	0.3777						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				0.0379	0.2727	0.6894	12	113	n/a	n/a
chr2	215854156	215854156	C	T	het		QUAL=17604;DP=342;AF=0.49;MQM=60;TRIO=HET,342,0.49,HET,346,0.49,HET,455,0.46	ABCA12	synonymous	ABCA12:NM_173076.2:synonymous:LOW:exon26/53:c.3726G>A:p.Pro1242Pro,ABCA12:NM_015657.3:synonymous:LOW:exon18/45:c.2772G>A:p.Pro924Pro		rs71428357	0.0719	0.065	0.0595	0.0969						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				0.0152	0.1742	0.8106	2	60	n/a	n/a
chr2	215876166	215876166	A	T	hom		QUAL=15081;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HOM,124,1.00,HOM,161,1.00	ABCA12	missense	ABCA12:NM_173076.2:missense:MODERATE:exon17/53:c.2329T>A:p.Ser777Thr,ABCA12:NM_015657.3:missense:MODERATE:exon9/45:c.1375T>A:p.Ser459Thr		rs7560008	0.9984	0.999	1	0.9934	-1.4110	P	T	B,B	B,B	607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				1	0	0	449	2	n/a	n/a
chr2	215876371	215876371	T	C	hom		QUAL=11512;DP=184;AF=0.99;MQM=60;TRIO=HOM,184,0.99,HET,135,0.51,HET,211,0.51	ABCA12	splice_region&synonymous	ABCA12:NM_173076.2:splice_region&synonymous:LOW:exon17/53:c.2124A>G:p.Ala708Ala,ABCA12:NM_015657.3:splice_region&synonymous:LOW:exon9/45:c.1170A>G:p.Ala390Ala		rs10198064	0.2794	0.152	0.0913	0.5994						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];				0.0227	0.2727	0.7045	9	109	n/a	n/a
chr2	215901774	215901774	C	T	het		QUAL=9180;DP=316;AF=0.52;MQM=60;TRIO=HET,316,0.52,WT,202,0.00,HET,236,0.52	ABCA12	synonymous	ABCA12:NM_173076.2:synonymous:LOW:exon8/53:c.888G>A:p.Val296Val		rs17501837	0.2234	0.206	0.2105	0.1493						607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A|Ichthyosis,autosomal recessive 4B (harlequin)];			COSM50991	0.0152	0.2576	0.7273	18	127	n/a	n/a
chr2	216176807	216176807	T	G	het		QUAL=2989;DP=32;AF=0.53;MQM=60;TRIO=HET,32,0.53,WT,126,0.00,HET,172,0.52	ATIC	5'UTR	ATIC:NM_004044.6:5'UTR:MODIFIER:exon1/16:c.-59T>G:		rs4535042	0.2448	0	0	0										0.1742	0.4167	0.4091	26	61	n/a	n/a
chr2	216214492	216214492	T	G	het		QUAL=11294;DP=206;AF=0.52;MQM=60;TRIO=HET,206,0.52,HOM,163,1.00,HET,205,0.42	ATIC	3'UTR	ATIC:NM_004044.6:3'UTR:MODIFIER:exon16/16:c.*114T>G:		rs10498036	0.5952	0	0	0										0.2273	0.5152	0.2576	34	76	n/a	n/a
chr2	217277249	217277249	C	T	het		QUAL=8832;DP=100;AF=0.49;MQM=60;TRIO=HET,100,0.49,WT,169,0.00,HOM,248,1.00	SMARCAL1	5'UTR	SMARCAL1:NM_014140.3:5'UTR:MODIFIER:exon1/18:c.-218C>T:		rs3755141	0.2079	0	0	0										0.1136	0.3788	0.5076	15	55	n/a	n/a
chr2	219646547	219646547	-	C	het		QUAL=4169;DP=45;AF=0.89;MQM=59;TRIO=HET,45,0.89,HOM,58,0.91,HOM,58,0.98	CYP27A1	5'UTR	CYP27A1:NM_000784.3:5'UTR:MODIFIER:exon1/9:c.-357dupC:		rs397795841	0.9998	0	0	0										0.9621	0.0379	0	145	5	n/a	n/a
chr2	219940484	219940484	C	T	hom		QUAL=16672;DP=285;AF=1.00;MQM=59;TRIO=HOM,285,1.00,HOM,111,1.00,HOM,120,1.00	NHEJ1	3'UTR	NHEJ1:NM_024782.2:3'UTR:MODIFIER:exon8/8:c.*619G>A:		rs359960	0.9852	0	0	0										1	0	0	149	1	n/a	n/a
chr2	219941063	219941063	G	A	hom		QUAL=20561;DP=313;AF=1.00;MQM=60;TRIO=HOM,313,1.00,HET,196,0.45,HOM,234,1.00	NHEJ1	3'UTR	NHEJ1:NM_024782.2:3'UTR:MODIFIER:exon8/8:c.*40C>T:		rs897477	0.6384	0.71	0.7659	0.69									COSM4001506	0.5379	0.3636	0.0985	89	62	n/a	n/a
chr2	220283259	220283259	A	G	hom		QUAL=4742;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,58,1.00,HOM,98,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon1/9:c.75A>G:p.Pro25Pro		rs1318299	0.8862	0.958	0.9877	0.7178						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000154433.1,RCV000029660.1 [benign,benign]; RCV000037251.5 [benign]; RCV000124668.1 [benign]; 		COSM3757962	0.9015	0.0303	0.0682	447	7	n/a	n/a
chr2	220283277	220283277	T	C	hom		QUAL=5269;DP=6;AF=1.00;MQM=60;TRIO=HOM,6,1.00,HOM,67,1.00,HOM,100,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon1/9:c.93T>C:p.Ser31Ser		rs2017800	0.866	0.952	0.988	0.6692						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000154434.1,RCV000029661.1 [benign,benign]; RCV000037256.5 [benign]; RCV000124669.1 [benign]; 		COSM3749630	0.9015	0.0303	0.0682	455	9	n/a	n/a
chr2	220285309	220285309	C	T	hom		QUAL=37224;DP=370;AF=0.99;MQM=59;TRIO=HOM,370,0.99,HOM,367,0.99,HOM,447,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon4/9:c.828C>T:p.Asp276Asp		rs1058261	0.3375	0.336	0.3555	0.4412						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000037254.5 [benign]; 			0.0909	0.4697	0.4394	67	215	n/a	n/a
chr2	220285666	220285666	G	C	hom		QUAL=35199;DP=169;AF=1.00;MQM=60;TRIO=HOM,169,1.00,HOM,419,1.00,HOM,529,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon5/9:c.1014G>C:p.Leu338Leu		rs12920	0.3377	0.335	0.3551	0.448						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000037222.5 [benign]; 		COSM4133480	0.0909	0.4697	0.4394	67	215	n/a	n/a
chr2	220286142	220286142	G	A	hom		QUAL=29437;DP=195;AF=1.00;MQM=59;TRIO=HOM,195,1.00,HOM,310,1.00,HOM,454,1.00	DES	synonymous	DES:NM_001927.3:synonymous:LOW:exon6/9:c.1104G>A:p.Ala368Ala		rs1058284	0.3337	0.336	0.3552	0.4414						125660 [DES (confirmed) Myopathy,myofibrillar,1|Cardiomyopathy,dilated,1I|Scapuloperoneal syndrome,neurogenic,Kaeser type|Muscular dystrophy,limb-girdle,type 2R];	RCV000037225.5 [benign]; 		COSM4001515	0.0909	0.4697	0.4394	67	215	n/a	n/a
chr2	223158653	223158653	T	-	hom		QUAL=15506;DP=144;AF=0.86;MQM=60;TRIO=HOM,144,0.86,HOM,187,0.98,HOM,226,0.97	PAX3	3'UTR,intron	PAX3:NM_000438.5:3'UTR:MODIFIER:exon4/4:c.*171delA:,PAX3:NM_181459.3:intron:MODIFIER:exon4/9:c.586+233delA:,PAX3:NM_001127366.2:intron:MODIFIER:exon4/8:c.583+233delA:,PAX3:NM_181458.3:intron:MODIFIER:exon4/8:c.586+233delA:,PAX3:NM_181460.3:intron:MODIFIER:exon4/8:c.586+233delA:,PAX3:NM_181461.3:intron:MODIFIER:exon4/7:c.586+233delA:,PAX3:NM_181457.3:intron:MODIFIER:exon4/7:c.586+233delA:,PAX3:NM_013942.4:intron:MODIFIER:exon4/4:c.587-177delA:		rs397987956	1	0	0	0						606597 [PAX3 (confirmed) Waardenburg syndrome,type 1|Waardenburg syndrome,type 3|Craniofacial-deafness-hand syndrome|Rhabdomyosarcoma 2,alveolar];				0.9924	0.0076	0	149	1	n/a	n/a
chr2	223161889	223161889	A	G	hom		QUAL=8183;DP=48;AF=1.00;MQM=59;TRIO=HOM,48,1.00,HOM,117,1.00,HOM,127,1.00	PAX3	synonymous	PAX3:NM_181459.3:synonymous:LOW:exon2/10:c.129T>C:p.Gly43Gly,PAX3:NM_001127366.2:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:NM_181458.3:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:NM_181460.3:synonymous:LOW:exon2/9:c.129T>C:p.Gly43Gly,PAX3:NM_181461.3:synonymous:LOW:exon2/8:c.129T>C:p.Gly43Gly,PAX3:NM_181457.3:synonymous:LOW:exon2/8:c.129T>C:p.Gly43Gly,PAX3:NM_000438.5:synonymous:LOW:exon2/4:c.129T>C:p.Gly43Gly,PAX3:NM_013942.4:synonymous:LOW:exon2/5:c.129T>C:p.Gly43Gly		rs12623857	0.9044	0.87	0.8474	0.8449						606597 [PAX3 (confirmed) Waardenburg syndrome,type 1|Waardenburg syndrome,type 3|Craniofacial-deafness-hand syndrome|Rhabdomyosarcoma 2,alveolar];				0.7652	0.2121	0.0227	350	98	n/a	n/a
chr2	227867719	227867719	G	A	het		QUAL=8559;DP=384;AF=0.47;MQM=60;TRIO=HET,384,0.47,HET,151,0.52,WT,198,0.00	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*4322C>T:		rs1054413	0.5399	0	0	0										0.1742	0.5227	0.303	24	79	n/a	n/a
chr2	227868854	227868854	C	T	het		QUAL=6919;DP=279;AF=0.50;MQM=60;TRIO=HET,279,0.50,HET,146,0.53,WT,172,0.00	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*3187G>A:	L2c	rs56324594	0.4683	0	0	0										0.1667	0.5303	0.303	23	80	n/a	n/a
chr2	227869921	227869921	T	-	het		QUAL=4975;DP=299;AF=0.42;MQM=60;TRIO=HET,299,0.42,HET,90,0.37,HET,116,0.07	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*2120delA:		rs71821803	0.2871	0	0	0										0.1667	0.4848	0.3485	23	73	n/a	n/a
chr2	227871266	227871266	-	T	het		QUAL=5404;DP=245;AF=0.40;MQM=60;TRIO=HET,245,0.40,HET,180,0.43,WT,234,0.00	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*774dupA:		rs59918285	0.5154	0	0	0										0.1667	0.5303	0.303	23	80	n/a	n/a
chr2	227871475	227871475	T	-	het		QUAL=4179;DP=214;AF=0.44;MQM=60;TRIO=HET,214,0.44,HET,89,0.49,WT,101,0.00	COL4A4	3'UTR	COL4A4:NM_000092.4:3'UTR:MODIFIER:exon48/48:c.*566delA:		rs11314253	0.4806	0	0	0										0.1667	0.5303	0.303	23	80	n/a	n/a
chr2	227872182	227872182	G	A	het		QUAL=6508;DP=205;AF=0.55;MQM=60;TRIO=HET,205,0.55,HET,187,0.48,WT,198,0.02	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon48/48:c.4932C>T:p.Phe1644Phe		rs2228557	0.5144	0.466	0.407	0.5741						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757991	0.1667	0.5227	0.3106	77	225	n/a	n/a
chr2	227872995	227872995	T	C	het		QUAL=5171;DP=106;AF=0.51;MQM=60;TRIO=HET,106,0.51,HET,222,0.55,WT,223,0.00	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon47/48:c.4548A>G:p.Val1516Val		rs2228555	0.6406	0.56	0.5149	0.7272						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757992	0.25	0.5833	0.1667	120	228	n/a	n/a
chr2	227873028	227873028	A	G	het		QUAL=5294;DP=139;AF=0.55;MQM=59;TRIO=HET,139,0.55,HET,179,0.56,WT,175,0.00	COL4A4	splice_region&intron	COL4A4:NM_000092.4:splice_region&intron:LOW:exon46/47:c.4523-8T>C:		rs13419076	0.5156	0.464	0.3966	0.5722						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];				0.1667	0.5227	0.3106	78	224	n/a	n/a
chr2	227886773	227886773	A	G	het		QUAL=5764;DP=224;AF=0.49;MQM=60;TRIO=HET,224,0.49,HET,134,0.54,WT,200,0.00	COL4A4	missense	COL4A4:NM_000092.4:missense:MODERATE:exon44/48:c.4207T>C:p.Ser1403Pro		rs3752895	0.5262	0.476	0.4192	0.6076	3.4190	P	T	B	B	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757993	0.1894	0.5076	0.303	86	220	n/a	n/a
chr2	227892619	227892619	C	T	het		QUAL=5883;DP=251;AF=0.57;MQM=60;TRIO=HET,251,0.57,HET,69,0.71,WT,82,0.00	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon42/48:c.4080G>A:p.Pro1360Pro		rs2228556	0.4918	0.469	0.4223	0.5258						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM1752390	0.1894	0.5076	0.303	86	224	n/a	n/a
chr2	227892720	227892720	C	T	het		QUAL=4801;DP=159;AF=0.58;MQM=60;TRIO=HET,159,0.58,HET,96,0.66,WT,91,0.00	COL4A4	missense	COL4A4:NM_000092.4:missense:MODERATE:exon42/48:c.3979G>A:p.Val1327Met		rs2229813	0.493	0.461	0.4219	0.5281	-0.1400	P	T	B	B	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM1752392	0.1894	0.5076	0.303	86	222	n/a	n/a
chr2	227896652	227896652	C	G	het		QUAL=8300;DP=313;AF=0.50;MQM=60;TRIO=HET,313,0.50,HET,181,0.59,WT,266,0.00	COL4A4	splice_region&intron	COL4A4:NM_000092.4:splice_region&intron:LOW:exon40/47:c.3817+9G>C:		rs13423714	0.496	0.47	0.4201	0.518						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];				0.1894	0.5076	0.303	86	221	n/a	n/a
chr2	227896886	227896886	C	T	het		QUAL=4477;DP=207;AF=0.45;MQM=60;TRIO=HET,207,0.45,HET,97,0.46,WT,164,0.00	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon39/48:c.3684G>A:p.Lys1228Lys		rs2229812	0.4956	0.471	0.4218	0.5206						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757994	0.1894	0.5076	0.303	86	223	n/a	n/a
chr2	227896976	227896976	C	T	het		QUAL=4637;DP=281;AF=0.49;MQM=59;TRIO=HET,281,0.49,HET,40,0.53,WT,70,0.00	COL4A4	synonymous	COL4A4:NM_000092.4:synonymous:LOW:exon39/48:c.3594G>A:p.Gly1198Gly		rs10203363	0.495	0.469	0.4197	0.5211						120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757995	0.1818	0.5152	0.303	85	225	n/a	n/a
chr2	227915832	227915832	G	A	het		QUAL=9774;DP=309;AF=0.51;MQM=60;TRIO=HET,309,0.51,HET,263,0.56,WT,375,0.01	COL4A4	missense	COL4A4:NM_000092.4:missense:MODERATE:exon33/48:c.3011C>T:p.Pro1004Leu		rs1800517	0.5473	0.52	0.4893	0.5824	4.3580	P	D	P	B	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM4001525	0.2273	0.5833	0.1894	111	229	n/a	n/a
chr2	227954599	227954599	G	A	het		QUAL=3413;DP=137;AF=0.46;MQM=60;TRIO=HET,137,0.46,HET,112,0.44,WT,152,0.01	COL4A4	missense	COL4A4:NM_000092.4:missense:MODERATE:exon21/48:c.1444C>T:p.Pro482Ser		rs2229814	0.5485	0.534	0.5017	0.5251	0.6240	P	T	B	B	120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive|Hematuria,familial benign];			COSM3757996	0.2348	0.5303	0.2348	117	215	n/a	n/a
chr2	228111435	228111435	T	C	het		QUAL=10071;DP=290;AF=0.52;MQM=60;TRIO=HET,290,0.52,HET,124,0.54,HET,179,0.50	COL4A3	missense	COL4A3:NM_000091.4:missense:MODERATE:exon7/52:c.422T>C:p.Leu141Pro		rs10178458	0.7967	0.83	0.8277	0.6434	0.3960	P	T	B,B,B,B	B,B,B,B	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];				0.6515	0.3106	0.0379	304	130	n/a	n/a
chr2	228113175	228113175	A	G	het		QUAL=10345;DP=340;AF=0.49;MQM=60;TRIO=HET,340,0.49,HET,113,0.52,HET,180,0.52	COL4A3	missense	COL4A3:NM_000091.4:missense:MODERATE:exon9/52:c.485A>G:p.Glu162Gly		rs6436669	0.7963	0.83	0.828	0.6401	0.2100	P	T	B,B,B,B	B,B,B,B	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];				0.6515	0.3106	0.0379	304	130	n/a	n/a
chr2	228128540	228128540	C	T	hom		QUAL=9808;DP=140;AF=0.99;MQM=59;TRIO=HOM,140,0.99,HOM,68,1.00,HOM,101,1.00	COL4A3	synonymous	COL4A3:NM_000091.4:synonymous:LOW:exon21/52:c.1195C>T:p.Leu399Leu		rs10205042	0.7676	0.764	0.7341	0.6823						120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];				0.4848	0.3939	0.1212	225	185	n/a	n/a
chr2	228135631	228135631	C	T	hom		QUAL=9933;DP=189;AF=0.99;MQM=60;TRIO=HOM,189,0.99,HOM,75,1.00,HET,102,0.52	COL4A3	missense	COL4A3:NM_000091.4:missense:MODERATE:exon25/52:c.1721C>T:p.Pro574Leu		rs28381984	0.4	0.469	0.4702	0.2103	2.1930	P	D	D,D,D,D	D,D,D,D	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];			COSM3758001	0.197	0.5303	0.2727	110	210	n/a	n/a
chr2	228147093	228147093	A	G	het		QUAL=4540;DP=240;AF=0.48;MQM=60;TRIO=HET,240,0.48,WT,71,0.00,HET,77,0.52	COL4A3	missense	COL4A3:NM_000091.4:missense:MODERATE:exon32/52:c.2501A>G:p.Lys834Arg		rs56226424	0.0056	0.012	0.0147	0.0022	-0.2720	N	T	B,B,B,B	B,B,B,B	120070 [COL4A3 (confirmed) Alport syndrome,autosomal recessive|Hematuria,benign familial|Alport syndrome,autosomal dominant];				0	0.0379	0.9621	0	16	n/a	n/a
chr2	228176901	228176901	A	C	hom		QUAL=38824;DP=577;AF=1.00;MQM=60;TRIO=HOM,577,1.00,HOM,241,1.00,HOM,346,1.00	COL4A3	3'UTR	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*315A>C:		rs2070735	0.729	0	0	0										0.6894	0.2879	0.0227	107	40	n/a	n/a
chr2	228177479	228177479	C	T	hom		QUAL=27917;DP=409;AF=1.00;MQM=60;TRIO=HOM,409,1.00,HOM,179,1.00,HOM,253,1.00	COL4A3	3'UTR	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*893C>T:		rs7587228	0.8476	0	0	0										0.7576	0.2348	0.0076	116	33	n/a	n/a
chr2	228177643	228177643	A	-	het		QUAL=2268;DP=164;AF=0.09;MQM=60;TRIO=HET,164,0.09,HET,96,0.18,HET,120,0.52	COL4A3	3'UTR	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*1070delA:		rs11297279	0	0	0	0										0.2273	0.3485	0.4242	35	49	n/a	n/a
chr2	228177751	228177751	G	A	hom		QUAL=24932;DP=454;AF=0.99;MQM=60;TRIO=HOM,454,0.99,HOM,191,1.00,HET,248,0.45	COL4A3	3'UTR	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*1165G>A:		rs28554165	0.269	0	0	0										0.1364	0.4167	0.447	22	63	n/a	n/a
chr2	228177825	228177825	C	G	hom		QUAL=28550;DP=412;AF=1.00;MQM=60;TRIO=HOM,412,1.00,HOM,189,1.00,HOM,253,1.00	COL4A3	3'UTR	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*1239C>G:	L2a	rs10188531	0.9161	0	0	0										0.7879	0.2045	0.0076	122	27	n/a	n/a
chr2	228178645	228178645	C	G	hom		QUAL=19237;DP=299;AF=1.00;MQM=59;TRIO=HOM,299,1.00,HOM,118,1.00,HOM,166,1.00	COL4A3	3'UTR	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*2059C>G:	MER5A	rs4290648	0.9161	0	0	0										0.7879	0.2045	0.0076	122	27	n/a	n/a
chr2	228178780	228178780	A	C	hom		QUAL=18483;DP=315;AF=1.00;MQM=60;TRIO=HOM,315,1.00,HOM,109,1.00,HOM,126,1.00	COL4A3	3'UTR	COL4A3:NM_000091.4:3'UTR:MODIFIER:exon52/52:c.*2194A>C:		rs7567291	1	0	0	0										1	0	0	150	0	n/a	n/a
chr2	231050715	231050715	A	G	hom		QUAL=23036;DP=224;AF=1.00;MQM=60;TRIO=HOM,224,1.00,HOM,205,1.00,HOM,292,1.00	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon11/19:c.1274T>C:p.Leu425Ser,SP110:NM_004509.3:missense:MODERATE:exon11/18:c.1274T>C:p.Leu425Ser,SP110:NM_004510.3:missense:MODERATE:exon11/15:c.1274T>C:p.Leu425Ser,SP110:NM_001185015.1:missense:MODERATE:exon12/16:c.1292T>C:p.Leu431Ser		rs3948464	0.904	0.887	0.871	0.8463	-0.3640	P	T	B,B,B,B,B	B,B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];	RCV000005877.3 [other]; 	CM066604 [CLASS=DP MUT=REF PHEN="Tuberculosis, reduced susceptibility, association with" GENE=SP110]; 		0.7803	0.2045	0.0152	349	96	n/a	n/a
chr2	231072709	231072709	C	T	hom		QUAL=20463;DP=314;AF=1.00;MQM=60;TRIO=HOM,314,1.00,HOM,137,0.99,HOM,162,1.00	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon8/19:c.895G>A:p.Gly299Arg,SP110:NM_004509.3:missense:MODERATE:exon8/18:c.895G>A:p.Gly299Arg,SP110:NM_004510.3:missense:MODERATE:exon8/15:c.895G>A:p.Gly299Arg,SP110:NM_001185015.1:missense:MODERATE:exon9/16:c.913G>A:p.Gly305Arg		rs1365776	0.8025	0.665	0.6034	0.8953	-0.2260	P	T	B,B,B,B	B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];				0.4545	0.4091	0.1364	205	203	n/a	n/a
chr2	231077110	231077110	C	T	het		QUAL=9644;DP=291;AF=0.46;MQM=60;TRIO=HET,291,0.46,WT,344,0.00,HET,392,0.42	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon5/19:c.619G>A:p.Glu207Lys,SP110:NM_004509.3:missense:MODERATE:exon5/18:c.619G>A:p.Glu207Lys,SP110:NM_004510.3:missense:MODERATE:exon5/15:c.619G>A:p.Glu207Lys,SP110:NM_001185015.1:missense:MODERATE:exon6/16:c.637G>A:p.Glu213Lys		rs9061	0.1306	0.114	0.0938	0.0776	-0.4510	P	T	B,B,B,B	B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];		CM131316 [CLASS=DP MUT=ALT PHEN="Pulmonary tuberculosis, association with" GENE=SP110]; 	COSM3927760	0.0227	0.1742	0.803	10	90	n/a	n/a
chr2	231077112	231077112	G	A	het		QUAL=15514;DP=285;AF=0.52;MQM=60;TRIO=HET,285,0.52,HOM,339,1.00,WT,394,0.00	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon5/19:c.617C>T:p.Ala206Val,SP110:NM_004509.3:missense:MODERATE:exon5/18:c.617C>T:p.Ala206Val,SP110:NM_004510.3:missense:MODERATE:exon5/15:c.617C>T:p.Ala206Val,SP110:NM_001185015.1:missense:MODERATE:exon6/16:c.635C>T:p.Ala212Val		rs28930679	0.1591	0.211	0.2531	0.1414	-0.0850	P	T	B,B,B,B	B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];				0.1061	0.3258	0.5682	36	162	n/a	n/a
chr2	231077154	231077154	G	A	het		QUAL=12131;DP=200;AF=0.48;MQM=60;TRIO=HET,200,0.48,HOM,280,1.00,WT,332,0.00	SP110	splice_region&intron	SP110:NM_080424.2:splice_region&intron:LOW:exon4/18:c.584-9C>T:,SP110:NM_004509.3:splice_region&intron:LOW:exon4/17:c.584-9C>T:,SP110:NM_004510.3:splice_region&intron:LOW:exon4/14:c.584-9C>T:,SP110:NM_001185015.1:splice_region&intron:LOW:exon5/15:c.602-9C>T:		rs41309096	0.2288	0.238	0.2634	0.333						604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];				0.1288	0.3106	0.5606	42	172	n/a	n/a
chr2	231077676	231077676	G	A	het		QUAL=2616;DP=44;AF=0.50;MQM=60;TRIO=HET,44,0.50,WT,92,0.00,HET,123,0.54	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon4/19:c.383C>T:p.Ala128Val,SP110:NM_004509.3:missense:MODERATE:exon4/18:c.383C>T:p.Ala128Val,SP110:NM_004510.3:missense:MODERATE:exon4/15:c.383C>T:p.Ala128Val,SP110:NM_001185015.1:missense:MODERATE:exon5/16:c.401C>T:p.Ala134Val		rs11556887	0.0966	0.104	0.0936	0.0279	0.1220	N	T	P,P,D,D	B,B,P,D	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];			COSM3927761	0.0227	0.1818	0.7955	9	90	n/a	n/a
chr2	231077725	231077725	A	G	hom		QUAL=7938;DP=112;AF=1.00;MQM=60;TRIO=HOM,112,1.00,HOM,62,1.00,HOM,85,1.00	SP110	missense	SP110:NM_080424.2:missense:MODERATE:exon4/19:c.334T>C:p.Trp112Arg,SP110:NM_004509.3:missense:MODERATE:exon4/18:c.334T>C:p.Trp112Arg,SP110:NM_004510.3:missense:MODERATE:exon4/15:c.334T>C:p.Trp112Arg,SP110:NM_001185015.1:missense:MODERATE:exon5/16:c.352T>C:p.Trp118Arg		rs1129411	0.9511	0.909	0.8835	0.9759	-0.1940	P	T	B,B,B,B	B,B,B,B	604457 [SP110 (confirmed) Hepatic venoocclusive disease with immunodeficiency|Mycobacterium tuberculosis,susceptibility to];				0.803	0.1818	0.0152	368	76	n/a	n/a
chr2	233390937	233390937	A	G	hom		QUAL=479;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,6,0.67,HET,11,0.91	CHRND	synonymous	CHRND:NM_000751.2:synonymous:LOW:exon1/12:c.12A>G:p.Pro4Pro,CHRND:NM_001256657.1:synonymous:LOW:exon1/11:c.12A>G:p.Pro4Pro		rs2245601	0.4834	0.498	0.4837	0.3804						100720 [CHRND (confirmed) Myasthenic syndrome,slow-channel congenital|Myasthenic syndrome,fast-channel congenital|Multiple pterygium syndrome,lethal type];	RCV000116730.1 [benign]; 		COSM149097	0.2273	0.4091	0.3636	76	212	n/a	n/a
chr2	233400074	233400074	A	G	het		QUAL=7816;DP=161;AF=0.45;MQM=60;TRIO=HET,161,0.45,HET,169,0.51,HET,185,0.48	CHRND	3'UTR	CHRND:NM_000751.2:3'UTR:MODIFIER:exon12/12:c.*52A>G:,CHRND:NM_001256657.1:3'UTR:MODIFIER:exon11/11:c.*52A>G:		rs2767	0.4159	0.4	0.3686	0.2796										0.1136	0.4394	0.447	37	130	n/a	n/a
chr2	233400907	233400907	T	C	het		QUAL=10909;DP=257;AF=0.47;MQM=60;TRIO=HET,257,0.47,HET,184,0.51,HET,234,0.53	CHRND	3'UTR	CHRND:NM_000751.2:3'UTR:MODIFIER:exon12/12:c.*885T>C:,CHRND:NM_001256657.1:3'UTR:MODIFIER:exon11/11:c.*885T>C:	MLT1F	rs1004175	0.4159	0.35	0	0										0.1136	0.4394	0.447	37	130	n/a	n/a
chr2	238232752	238232752	C	A	het		QUAL=3751;DP=101;AF=0.54;MQM=59;TRIO=HET,101,0.54,HOM,43,1.00,HET,52,0.44	COL6A3	3'UTR	COL6A3:NM_004369.3:3'UTR:MODIFIER:exon44/44:c.*665G>T:,COL6A3:NM_057166.4:3'UTR:MODIFIER:exon41/41:c.*665G>T:,COL6A3:NM_057167.3:3'UTR:MODIFIER:exon43/43:c.*665G>T:		rs1050785	0.6879	0	0	0										0.3258	0.4848	0.1894	48	72	n/a	n/a
chr2	238232811	238232811	T	A	het		QUAL=5415;DP=271;AF=0.48;MQM=60;TRIO=HET,271,0.48,HET,92,0.41,WT,110,0.00	COL6A3	3'UTR	COL6A3:NM_004369.3:3'UTR:MODIFIER:exon44/44:c.*606A>T:,COL6A3:NM_057166.4:3'UTR:MODIFIER:exon41/41:c.*606A>T:,COL6A3:NM_057167.3:3'UTR:MODIFIER:exon43/43:c.*606A>T:		rs7436	0.1556	0	0	0										0	0.1439	0.8561	0	21	n/a	n/a
chr2	238233410	238233410	C	G	het		QUAL=9007;DP=356;AF=0.46;MQM=60;TRIO=HET,356,0.46,HET,263,0.47,WT,536,0.00	COL6A3	3'UTR	COL6A3:NM_004369.3:3'UTR:MODIFIER:exon44/44:c.*7G>C:,COL6A3:NM_057166.4:3'UTR:MODIFIER:exon41/41:c.*7G>C:,COL6A3:NM_057167.3:3'UTR:MODIFIER:exon43/43:c.*7G>C:		rs4663722	0.2099	0.141	0.0909	0.2306							RCV000080905.3 [benign]; 			0	0.1439	0.8561	3	93	n/a	n/a
chr2	238243285	238243285	G	A	het		QUAL=4290;DP=170;AF=0.53;MQM=60;TRIO=HET,170,0.53,HET,106,0.48,WT,138,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon41/44:c.9213C>T:p.His3071His,COL6A3:NM_057166.4:synonymous:LOW:exon38/41:c.7392C>T:p.His2464His,COL6A3:NM_057167.3:synonymous:LOW:exon40/43:c.8595C>T:p.His2865His		rs2270671	0.1004	0.105	0.1052	0.0897						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000081024.4 [other]; 			0	0.25	0.75	6	101	n/a	n/a
chr2	238243464	238243464	C	G	hom		QUAL=16923;DP=193;AF=1.00;MQM=59;TRIO=HOM,193,1.00,HOM,166,1.00,HOM,186,1.00	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon41/44:c.9034G>C:p.Ala3012Pro,COL6A3:NM_057166.4:missense:MODERATE:exon38/41:c.7213G>C:p.Ala2405Pro,COL6A3:NM_057167.3:missense:MODERATE:exon40/43:c.8416G>C:p.Ala2806Pro		rs2270669	0.7923	0.773	0.7784	0.9458	5.5020	P	T	B,B,B	B,B,B	120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000081019.3 [benign]; 			0.6061	0.3333	0.0606	304	134	n/a	n/a
chr2	238244963	238244963	A	G	het		QUAL=9576;DP=178;AF=0.57;MQM=59;TRIO=HET,178,0.57,HET,184,0.45,HET,253,0.52	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon40/44:c.8780T>C:p.Met2927Thr,COL6A3:NM_057166.4:missense:MODERATE:exon37/41:c.6959T>C:p.Met2320Thr,COL6A3:NM_057167.3:missense:MODERATE:exon39/43:c.8162T>C:p.Met2721Thr		rs6728818	0.6366	0.638	0.6538	0.7801	1.7470	P	T	B,B,B	B,B,B	120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000081013.3 [benign]; 			0.4394	0.4318	0.1288	223	186	n/a	n/a
chr2	238247734	238247734	C	G	het		QUAL=2939;DP=164;AF=0.34;MQM=60;TRIO=HET,164,0.34,HET,64,0.27,HET,84,0.32	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon39/44:c.8491G>C:p.Asp2831His,COL6A3:NM_057166.4:missense:MODERATE:exon36/41:c.6670G>C:p.Asp2224His,COL6A3:NM_057167.3:missense:MODERATE:exon38/43:c.7873G>C:p.Asp2625His		rs36104025	0.0325	0.067	0.0992	0.0188	5.4160	D	D	D,D,D	D,D,D	120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000081011.3 [benign]; 			0.0076	0.1894	0.803	3	73	n/a	n/a
chr2	238253065	238253065	C	T	het		QUAL=14957;DP=250;AF=0.48;MQM=60;TRIO=HET,250,0.48,HET,332,0.52,HET,455,0.47	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon36/44:c.7596G>A:p.Lys2532Lys,COL6A3:NM_057166.4:synonymous:LOW:exon33/41:c.5775G>A:p.Lys1925Lys,COL6A3:NM_057167.3:synonymous:LOW:exon35/43:c.6978G>A:p.Lys2326Lys		rs2291795	0.1548	0.129	0.115	0.1625						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080995.3 [benign]; 		COSM4001576	0.0152	0.2273	0.7576	10	85	n/a	n/a
chr2	238253149	238253149	G	A	het		QUAL=13244;DP=443;AF=0.43;MQM=59;TRIO=HET,443,0.43,HET,474,0.47,WT,663,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon36/44:c.7512C>T:p.Asn2504Asn,COL6A3:NM_057166.4:synonymous:LOW:exon33/41:c.5691C>T:p.Asn1897Asn,COL6A3:NM_057167.3:synonymous:LOW:exon35/43:c.6894C>T:p.Asn2298Asn		rs2646258	0.1084	0.108	0.1049	0.0917						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080994.4 [other]; 			0	0.25	0.75	6	104	n/a	n/a
chr2	238257013	238257013	G	A	het		QUAL=8938;DP=431;AF=0.44;MQM=60;TRIO=HET,431,0.44,HET,166,0.49,WT,200,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon30/44:c.6945C>T:p.Phe2315Phe,COL6A3:NM_057166.4:synonymous:LOW:exon27/41:c.5124C>T:p.Phe1708Phe,COL6A3:NM_057167.3:synonymous:LOW:exon29/43:c.6327C>T:p.Phe2109Phe		rs2646265	0.1064	0.11	0.1059	0.0817						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080980.4 [other]; 			0	0.25	0.75	6	105	n/a	n/a
chr2	238258814	238258814	C	G	het		QUAL=12564;DP=216;AF=0.47;MQM=60;TRIO=HET,216,0.47,HET,171,0.46,HOM,225,1.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon28/44:c.6855G>C:p.Gly2285Gly,COL6A3:NM_057166.4:synonymous:LOW:exon25/41:c.5034G>C:p.Gly1678Gly,COL6A3:NM_057167.3:synonymous:LOW:exon27/43:c.6237G>C:p.Gly2079Gly		rs3790993	0.5543	0.549	0.5495	0.5772						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080973.3 [benign]; 			0.2727	0.5606	0.1667	140	239	n/a	n/a
chr2	238267717	238267717	C	T	het		QUAL=13201;DP=483;AF=0.48;MQM=59;TRIO=HET,483,0.48,HET,391,0.48,WT,537,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon20/44:c.6369G>A:p.Leu2123Leu,COL6A3:NM_057166.4:synonymous:LOW:exon17/41:c.4548G>A:p.Leu1516Leu,COL6A3:NM_057167.3:synonymous:LOW:exon19/43:c.5751G>A:p.Leu1917Leu		rs2646254	0.3309	0.213	0.1358	0.4705						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080967.3 [benign]; 			0.0076	0.2955	0.697	12	135	n/a	n/a
chr2	238277573	238277573	C	A	het		QUAL=2924;DP=173;AF=0.45;MQM=60;TRIO=HET,173,0.45,HET,79,0.48,WT,95,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon10/44:c.4533G>T:p.Gly1511Gly,COL6A3:NM_057166.4:synonymous:LOW:exon7/41:c.2712G>T:p.Gly904Gly,COL6A3:NM_057167.3:synonymous:LOW:exon9/43:c.3915G>T:p.Gly1305Gly		rs2645774	0.2656	0.235	0.2121	0.2778						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080941.3 [benign]; 		COSM3758064	0.0303	0.3788	0.5909	17	165	n/a	n/a
chr2	238277795	238277795	A	G	het		QUAL=64;DP=12;AF=0.25;MQM=60;TRIO=HET,12,0.25,HOM,1,1.00,WT,1,0.00	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon10/44:c.4311T>C:p.Ile1437Ile,COL6A3:NM_057166.4:synonymous:LOW:exon7/41:c.2490T>C:p.Ile830Ile,COL6A3:NM_057167.3:synonymous:LOW:exon9/43:c.3693T>C:p.Ile1231Ile		rs2646260	0.3884	0.287	0.2341	0.5676						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000149961.1,RCV000080938.3 [uncertain significance,benign]; 		COSM3749639	0.0455	0.2045	0.75	24	153	n/a	n/a
chr2	238283605	238283605	G	A	hom		QUAL=2492;DP=57;AF=1.00;MQM=60;TRIO=HOM,57,1.00,HET,41,0.51,HET,43,0.42	COL6A3	synonymous	COL6A3:NM_004369.3:synonymous:LOW:exon8/44:c.3129C>T:p.Gly1043Gly,COL6A3:NM_057166.4:synonymous:LOW:exon5/41:c.1308C>T:p.Gly436Gly,COL6A3:NM_057167.3:synonymous:LOW:exon7/43:c.2511C>T:p.Gly837Gly,COL6A3:NM_057164.4:synonymous:LOW:exon6/7:c.1908C>T:p.Gly636Gly,COL6A3:NM_057165.4:synonymous:LOW:exon7/8:c.2511C>T:p.Gly837Gly		rs12622093	0.2159	0.231	0.2335	0.1289						120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080926.3 [benign]; 		COSM442555	0.053	0.3864	0.5606	20	180	n/a	n/a
chr2	238289980	238289980	G	C	het		QUAL=8233;DP=267;AF=0.46;MQM=60;TRIO=HET,267,0.46,HET,287,0.51,WT,375,0.00	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon5/44:c.1475C>G:p.Thr492Ser,COL6A3:NM_057166.4:missense:MODERATE:exon3/41:c.254C>G:p.Thr85Ser,COL6A3:NM_057167.3:missense:MODERATE:exon4/43:c.857C>G:p.Thr286Ser,COL6A3:NM_057164.4:missense:MODERATE:exon3/7:c.254C>G:p.Thr85Ser,COL6A3:NM_057165.4:missense:MODERATE:exon4/8:c.857C>G:p.Thr286Ser		rs113897824	0.0036	0.0075	0.0024	0.0011	0.2260	D	T	B,B,B,B,P,B	B,B,B,B,B,B	120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080913.2 [benign]; 			0	0.0227	0.9773	0	13	n/a	n/a
chr2	238289984	238289984	C	G	het		QUAL=8233;DP=267;AF=0.46;MQM=60;TRIO=HET,267,0.46,HET,287,0.51,WT,375,0.00	COL6A3	missense	COL6A3:NM_004369.3:missense:MODERATE:exon5/44:c.1471G>C:p.Asp491His,COL6A3:NM_057166.4:missense:MODERATE:exon3/41:c.250G>C:p.Asp84His,COL6A3:NM_057167.3:missense:MODERATE:exon4/43:c.853G>C:p.Asp285His,COL6A3:NM_057164.4:missense:MODERATE:exon3/7:c.250G>C:p.Asp84His,COL6A3:NM_057165.4:missense:MODERATE:exon4/8:c.853G>C:p.Asp285His		rs112010940	0.0036	0.0075	0.0021	0.0011	0.8220	D	T	B,P,B,B,P,B	B,P,B,B,P,B	120250 [COL6A3 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000080912.2 [benign]; 			0	0.0227	0.9773	0	13	n/a	n/a
chr2	238322712	238322712	C	T	het		QUAL=3190;DP=141;AF=0.48;MQM=60;TRIO=HET,141,0.48,HET,76,0.45,WT,92,0.00	COL6A3	5'UTR	COL6A3:NM_004369.3:5'UTR:MODIFIER:exon1/44:c.-147G>A:,COL6A3:NM_057166.4:5'UTR:MODIFIER:exon1/41:c.-147G>A:,COL6A3:NM_057167.3:5'UTR:MODIFIER:exon1/43:c.-147G>A:,COL6A3:NM_057164.4:5'UTR:MODIFIER:exon1/7:c.-147G>A:,COL6A3:NM_057165.4:5'UTR:MODIFIER:exon1/8:c.-147G>A:		rs113567254	0.0006	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr2	239969974	239969974	G	C	hom		QUAL=24832;DP=334;AF=0.99;MQM=59;TRIO=HOM,334,0.99,HET,352,0.52,HET,466,0.55	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*4819C>G:		rs1055333	0.2346	0	0	0										0.0152	0.3636	0.6212	2	51	n/a	n/a
chr2	239970266	239970266	-	AGATAGATAGAT	het		QUAL=8143;DP=16;AF=0.00;MQM=58;TRIO=HET,16,0.19,HET,142,0.93,WT,162,0.96	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*4515_*4526dupATCTATCTATCT:	(TAGA)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr2	239970360	239970360	A	C	hom		QUAL=16620;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HET,206,0.50,HET,284,0.49	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*4433T>G:		rs895808	0.3343	0	0	0										0.0682	0.4924	0.4394	10	72	n/a	n/a
chr2	239972883	239972883	C	T	het		QUAL=3340;DP=140;AF=0.50;MQM=60;TRIO=HET,140,0.50,HET,82,0.48,WT,142,0.01	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*1910G>A:		rs4852010	0.3361	0	0	0										0.0303	0.447	0.5227	5	71	n/a	n/a
chr2	239974241	239974241	-	C	het		QUAL=3289;DP=98;AF=0.43;MQM=59;TRIO=HET,98,0.43,WT,83,0.00,HOM,87,0.92	HDAC4	3'UTR	HDAC4:NM_006037.3:3'UTR:MODIFIER:exon27/27:c.*551dupG:		rs397972964	0	0	0	0										0.0303	0.2197	0.75	4	31	n/a	n/a
chr2	240003870	240003870	G	A	hom		QUAL=6103;DP=74;AF=0.99;MQM=60;TRIO=HOM,74,0.99,HOM,51,1.00,HOM,73,1.00	HDAC4	synonymous	HDAC4:NM_006037.3:synonymous:LOW:exon21/27:c.2565C>T:p.Pro855Pro		rs1063639	0.5952	0.533	0.4748	0.5672						605314 [HDAC4 (provisional) Brachydactyly-mental retardation syndrome];			COSM4133597	0.3561	0.3788	0.2652	132	208	n/a	n/a
chr2	240066417	240066417	A	G	hom		QUAL=8170;DP=65;AF=1.00;MQM=60;TRIO=HOM,65,1.00,HOM,92,0.99,HOM,103,1.00	HDAC4	splice_region&intron	HDAC4:NM_006037.3:splice_region&intron:LOW:exon7/26:c.734-7T>C:		rs2290087	0.8878	0.861	0.8597	0.9632						605314 [HDAC4 (provisional) Brachydactyly-mental retardation syndrome];				0.697	0.2576	0.0455	351	90	n/a	n/a
chr2	241531479	241531479	A	G	het		QUAL=1615;DP=37;AF=0.62;MQM=60;TRIO=HET,37,0.62,WT,26,0.00,HET,50,0.68	CAPN10	synonymous	CAPN10:NM_023083.3:synonymous:LOW:exon4/12:c.600A>G:p.Pro200Pro,CAPN10:NM_023085.3:synonymous:LOW:exon4/10:c.600A>G:p.Pro200Pro		rs3792269	0.1176	0.143	0.1615	0.052						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];				0.0152	0.2576	0.7273	8	106	n/a	n/a
chr2	241536126	241536126	A	G	het		QUAL=346;DP=20;AF=0.65;MQM=60;TRIO=HET,20,0.65,WT,5,0.00,HET,5,0.60	CAPN10	missense,intron	CAPN10:NM_023083.3:missense:MODERATE:exon9/12:c.1510A>G:p.Thr504Ala,CAPN10:NM_023085.3:intron:MODIFIER:exon7/9:c.1279-1179A>G:		rs7607759	0.1168	0.14	0.1557	0.0458	-0.3280	P	T	B,B	B,B	605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];		CM043260 [CLASS=DP MUT=ALT PHEN="Diabetes mellitus 2, association with" GENE=CAPN10]; 		0.0076	0.2424	0.75	8	103	n/a	n/a
chr2	241537421	241537421	G	A	het		QUAL=3104;DP=108;AF=0.50;MQM=60;TRIO=HET,108,0.50,HOM,50,1.00,WT,62,0.00	CAPN10	synonymous	CAPN10:NM_023083.3:synonymous:LOW:exon10/12:c.1860G>A:p.Ala620Ala,CAPN10:NM_023085.3:synonymous:LOW:exon8/10:c.1395G>A:p.Ala465Ala		rs3749166	0.5118	0.578	0.6191	0.3154						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];			COSM4133668	0.3485	0.5303	0.1212	168	222	n/a	n/a
chr2	241538061	241538061	T	C	het		QUAL=2453;DP=77;AF=0.56;MQM=60;TRIO=HET,77,0.56,WT,39,0.00,HET,65,0.57	CAPN10	splice_region&intron	CAPN10:NM_023083.3:splice_region&intron:LOW:exon11/11:c.1990-7T>C:,CAPN10:NM_023085.3:splice_region&intron:LOW:exon9/9:c.1525-7T>C:		rs55878652	0.1204	0.116	0.1504	0.0542						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];			COSM3766549	0.0076	0.2652	0.7273	7	107	n/a	n/a
chr2	241538074	241538074	A	G	hom		QUAL=5168;DP=82;AF=1.00;MQM=60;TRIO=HOM,82,1.00,HOM,34,1.00,HOM,52,0.96	CAPN10	missense	CAPN10:NM_023083.3:missense:MODERATE:exon12/12:c.1996A>G:p.Ile666Val,CAPN10:NM_023085.3:missense:MODERATE:exon10/10:c.1531A>G:p.Ile511Val		rs2975766	0.9898	0.974	0.9708	0.995	-0.9330	P	T	B,B,B	B,B,B	605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];				0.9394	0.0606	0	431	21	n/a	n/a
chr2	241538229	241538229	A	G	hom		QUAL=4614;DP=55;AF=1.00;MQM=60;TRIO=HOM,55,1.00,HOM,61,1.00,HET,79,0.51	CAPN10	3'UTR	CAPN10:NM_023083.3:3'UTR:MODIFIER:exon12/12:c.*132A>G:,CAPN10:NM_023085.3:3'UTR:MODIFIER:exon10/10:c.*132A>G:		rs2975767	0.7264	0	0	0						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];				0.697	0.2803	0.0227	102	43	n/a	n/a
chr2	241538531	241538531	T	C	het		QUAL=1143;DP=50;AF=0.50;MQM=60;TRIO=HET,50,0.50,WT,41,0.00,HET,53,0.38					rs17846983	0.0767	0	0	0						605286 [CAPN10 (confirmed) Diabetes mellitus,noninsulin-dependent 1];				0.0076	0.1818	0.8106	1	28	n/a	n/a
chr3	3191388	3191388	T	A	hom		QUAL=35056;DP=458;AF=1.00;MQM=60;TRIO=HOM,458,1.00,HOM,265,1.00,HOM,323,1.00	CRBN	3'UTR	CRBN:NM_016302.3:3'UTR:MODIFIER:exon11/11:c.*1161A>T:,CRBN:NM_001173482.1:3'UTR:MODIFIER:exon11/11:c.*1161A>T:		rs711628	0.9048	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr3	3191426	3191426	T	C	het		QUAL=16249;DP=376;AF=0.51;MQM=60;TRIO=HET,376,0.51,HET,252,0.52,HET,325,0.50	CRBN	3'UTR	CRBN:NM_016302.3:3'UTR:MODIFIER:exon11/11:c.*1123A>G:,CRBN:NM_001173482.1:3'UTR:MODIFIER:exon11/11:c.*1123A>G:		rs1045433	0.1292	0	0	0										0.0303	0.3485	0.6212	4	52	n/a	n/a
chr3	3191776	3191776	T	C	hom		QUAL=20029;DP=350;AF=1.00;MQM=60;TRIO=HOM,350,1.00,HOM,117,1.00,HOM,132,1.00	CRBN	3'UTR	CRBN:NM_016302.3:3'UTR:MODIFIER:exon11/11:c.*773A>G:,CRBN:NM_001173482.1:3'UTR:MODIFIER:exon11/11:c.*773A>G:		rs711627	0.9048	0	0	0										0.9924	0.0076	0	148	2	n/a	n/a
chr3	3192524	3192524	-	TAAC	het		QUAL=6939;DP=198;AF=0.37;MQM=60;TRIO=HET,198,0.37,HET,156,0.44,HET,198,0.40	CRBN	3'UTR	CRBN:NM_016302.3:3'UTR:MODIFIER:exon11/11:c.*21_*24dupGTTA:,CRBN:NM_001173482.1:3'UTR:MODIFIER:exon11/11:c.*21_*24dupGTTA:		rs397828468	0	0.531	0.6709	0.3425										0.2803	0.5833	0.1364	51	86	n/a	n/a
chr3	3215954	3215954	A	G	hom		QUAL=21493;DP=329;AF=1.00;MQM=60;TRIO=HOM,329,1.00,HOM,129,1.00,HOM,206,1.00	CRBN	splice_region&intron	CRBN:NM_016302.3:splice_region&intron:LOW:exon2/10:c.175-9T>C:,CRBN:NM_001173482.1:splice_region&intron:LOW:exon2/10:c.172-9T>C:		rs1669321	0.8838	0.967	0.9977	0.6562						609262 [CRBN (confirmed) Mental retardation,autosomal recessive 2];	RCV000116835.1 [benign]; 			0.9848	0.0152	0	448	5	n/a	n/a
chr3	4403357	4403357	A	C	hom		QUAL=15456;DP=226;AF=1.00;MQM=60;TRIO=HOM,226,1.00,HOM,102,1.00,HOM,138,0.99	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*471T>G:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*471T>G:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*471T>G:		rs2259818	0.8802	0	0	0										0.9621	0.0379	0	145	5	n/a	n/a
chr3	4403365	4403368	CTCA	-	hom		QUAL=10914;DP=167;AF=1.00;MQM=60;TRIO=HOM,167,1.00,HOM,80,1.00,HOM,104,1.00	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*460_*463delTGAG:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*460_*463delTGAG:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*460_*463delTGAG:		rs3835161	0.7047	0	0	0										0.3106	0.5152	0.1742	47	77	n/a	n/a
chr3	4403537	4403537	C	T	hom		QUAL=16008;DP=248;AF=1.00;MQM=59;TRIO=HOM,248,1.00,HOM,111,1.00,HOM,157,1.00	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*291G>A:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*291G>A:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*291G>A:	MIR3	rs4685744	0.4281	0	0	0										0.2576	0.5152	0.2273	39	77	n/a	n/a
chr3	4403767	4403767	A	G	hom		QUAL=19749;DP=286;AF=1.00;MQM=59;TRIO=HOM,286,1.00,HOM,150,1.00,HOM,171,1.00	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*61T>C:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*61T>C:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*61T>C:		rs2819561	0.7045	0	0	0										0.3106	0.5152	0.1742	47	77	n/a	n/a
chr3	4403817	4403817	T	A	hom		QUAL=17681;DP=173;AF=0.99;MQM=60;TRIO=HOM,173,0.99,HOM,185,0.99,HOM,224,0.99	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*11A>T:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*11A>T:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*11A>T:		rs2633851	0.7268	0.633	0.5265	0.7517							RCV000082713.2 [benign]; 			0.303	0.5227	0.1742	51	87	n/a	n/a
chr3	4403818	4403818	T	C	hom		QUAL=17681;DP=173;AF=0.99;MQM=60;TRIO=HOM,173,0.99,HOM,185,0.99,HOM,224,0.99	SUMF1	3'UTR	SUMF1:NM_182760.3:3'UTR:MODIFIER:exon9/9:c.*10A>G:,SUMF1:NM_001164674.1:3'UTR:MODIFIER:exon8/8:c.*10A>G:,SUMF1:NM_001164675.1:3'UTR:MODIFIER:exon8/8:c.*10A>G:		rs35083095	0.4321	0.494	0.4657	0.207							RCV000082712.2 [benign]; 			0.2576	0.5152	0.2273	115	195	n/a	n/a
chr3	4403837	4403837	A	G	hom		QUAL=21251;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HOM,222,1.00,HOM,268,1.00	SUMF1	synonymous	SUMF1:NM_182760.3:synonymous:LOW:exon9/9:c.1116T>C:p.Thr372Thr,SUMF1:NM_001164674.1:synonymous:LOW:exon8/8:c.1041T>C:p.Thr347Thr,SUMF1:NM_001164675.1:synonymous:LOW:exon8/8:c.1056T>C:p.Thr352Thr		rs2633852	0.7604	0.644	0.552	0.852						607939 [SUMF1 (provisional) Multiple sulfatase deficiency];	RCV000082714.2 [benign]; 		COSM3760098	0.3106	0.5152	0.1742	159	214	n/a	n/a
chr3	4508742	4508742	C	T	het		QUAL=950;DP=33;AF=0.52;MQM=60;TRIO=HET,33,0.52,HET,28,0.64,WT,27,0.00	SUMF1	missense	SUMF1:NM_182760.3:missense:MODERATE:exon1/9:c.188G>A:p.Ser63Asn,SUMF1:NM_001164674.1:missense:MODERATE:exon1/8:c.188G>A:p.Ser63Asn,SUMF1:NM_001164675.1:missense:MODERATE:exon1/8:c.188G>A:p.Ser63Asn		rs2819590	0.1166	0.175	0.2532	0.066	0.5130	P	T	D,P,P,P	P,P,P,B	607939 [SUMF1 (provisional) Multiple sulfatase deficiency];			COSM3760112	0.0833	0.3788	0.5379	28	161	n/a	n/a
chr3	4712413	4712413	G	A	het		QUAL=6593;DP=119;AF=0.46;MQM=60;TRIO=HET,119,0.46,HOM,161,1.00,WT,164,0.01	ITPR1	splice_region&synonymous	ITPR1:NM_001168272.1:splice_region&synonymous:LOW:exon19/61:c.1962G>A:p.Lys654Lys,ITPR1:NM_001099952.2:splice_region&synonymous:LOW:exon20/59:c.2007G>A:p.Lys669Lys,ITPR1:NM_002222.5:splice_region&synonymous:LOW:exon19/58:c.1962G>A:p.Lys654Lys		rs2306875	0.614	0.619	0.6722	0.7002						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117299.2 [likely benign]; 			0.4621	0.4621	0.0758	464	514	n/a	n/a
chr3	4716811	4716811	A	C	het		QUAL=6058;DP=220;AF=0.50;MQM=60;TRIO=HET,220,0.50,HET,172,0.45,WT,236,0.00	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon22/61:c.2613A>C:p.Leu871Leu,ITPR1:NM_001099952.2:synonymous:LOW:exon23/59:c.2658A>C:p.Leu886Leu,ITPR1:NM_002222.5:synonymous:LOW:exon22/58:c.2613A>C:p.Leu871Leu		rs2306877	0.3329	0.268	0.1757	0.3604						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117300.2 [likely benign]; 			0.0227	0.3485	0.6288	38	345	n/a	n/a
chr3	4767262	4767262	T	C	hom		QUAL=21504;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HOM,141,0.99,HOM,253,1.00	ITPR1	synonymous,intron	ITPR1:NM_001168272.1:synonymous:LOW:exon40/61:c.5124T>C:p.Thr1708Thr,ITPR1:NM_001099952.2:intron:MODIFIER:exon39/58:c.5077-7510T>C:,ITPR1:NM_002222.5:intron:MODIFIER:exon38/57:c.5032-7510T>C:		rs7613447	0.5122	0.687	0.8141	0.4812						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];				0.697	0.25	0.053	684	381	n/a	n/a
chr3	4817057	4817057	T	C	hom		QUAL=19446;DP=258;AF=1.00;MQM=60;TRIO=HOM,258,1.00,HOM,133,1.00,HOM,203,1.00	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon46/61:c.6066T>C:p.Asn2022Asn,ITPR1:NM_001099952.2:synonymous:LOW:exon44/59:c.5967T>C:p.Asn1989Asn,ITPR1:NM_002222.5:synonymous:LOW:exon43/58:c.5922T>C:p.Asn1974Asn		rs6442905	0.9627	0.97	0.9703	0.9542						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];				0.9545	0.0455	0	1065	58	n/a	n/a
chr3	4842231	4842231	C	T	het		QUAL=8496;DP=300;AF=0.46;MQM=59;TRIO=HET,300,0.46,WT,187,0.00,HET,264,0.49	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon53/61:c.7009C>T:p.Leu2337Leu,ITPR1:NM_001099952.2:synonymous:LOW:exon51/59:c.6910C>T:p.Leu2304Leu,ITPR1:NM_002222.5:synonymous:LOW:exon50/58:c.6865C>T:p.Leu2289Leu		rs2291862	0.2646	0.287	0.276	0.1348						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117303.2 [likely benign]; 		COSM3760146	0.0833	0.3333	0.5833	87	490	n/a	n/a
chr3	4856180	4856180	T	C	hom		QUAL=11620;DP=135;AF=0.99;MQM=59;TRIO=HOM,135,0.99,HOM,110,1.00,HOM,118,1.00	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon57/61:c.7590T>C:p.Thr2530Thr,ITPR1:NM_001099952.2:synonymous:LOW:exon55/59:c.7491T>C:p.Thr2497Thr,ITPR1:NM_002222.5:synonymous:LOW:exon54/58:c.7446T>C:p.Thr2482Thr		rs711631	0.7909	0.824	0.8399	0.7267						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117304.2 [likely benign]; 			0.7121	0.25	0.0379	748	336	n/a	n/a
chr3	4856234	4856234	G	A	het		QUAL=4624;DP=122;AF=0.45;MQM=60;TRIO=HET,122,0.45,HET,60,0.53,HOM,69,1.00	ITPR1	synonymous	ITPR1:NM_001168272.1:synonymous:LOW:exon57/61:c.7644G>A:p.Lys2548Lys,ITPR1:NM_001099952.2:synonymous:LOW:exon55/59:c.7545G>A:p.Lys2515Lys,ITPR1:NM_002222.5:synonymous:LOW:exon54/58:c.7500G>A:p.Lys2500Lys		rs901854	0.5875	0.604	0.6026	0.5807						147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15|Spinocerebellar ataxia 29,congenital nonprogressive];	RCV000117305.2 [likely benign]; 			0.4015	0.4394	0.1591	434	516	n/a	n/a
chr3	4889079	4889079	-	AA	het		QUAL=1591;DP=79;AF=0.20;MQM=60;TRIO=HET,79,0.20,WT,19,0.05,HET,17,0.29	ITPR1	3'UTR	ITPR1:NM_001168272.1:3'UTR:MODIFIER:exon61/61:c.*1183_*1184dupAA:,ITPR1:NM_001099952.2:3'UTR:MODIFIER:exon59/59:c.*1183_*1184dupAA:,ITPR1:NM_002222.5:3'UTR:MODIFIER:exon58/58:c.*1183_*1184dupAA:		rs71779262	0	0	0	0										0.2955	0.4924	0.2121	46	74	n/a	n/a
chr3	4889079	4889079	-	AAA	het		QUAL=1591;DP=79;AF=0.14;MQM=59;TRIO=HET,79,0.14,WT,19,0.58,HET,17,0.12	ITPR1	3'UTR	ITPR1:NM_001168272.1:3'UTR:MODIFIER:exon61/61:c.*1182_*1184dupAAA:,ITPR1:NM_001099952.2:3'UTR:MODIFIER:exon59/59:c.*1182_*1184dupAAA:,ITPR1:NM_002222.5:3'UTR:MODIFIER:exon58/58:c.*1182_*1184dupAAA:		rs36064013	0	0	0	0										0.053	0.3561	0.5909	8	51	n/a	n/a
chr3	8775589	8775589	C	T	hom		QUAL=23561;DP=256;AF=0.99;MQM=60;TRIO=HOM,256,0.99,HET,401,0.52,HET,525,0.52	CAV3	synonymous	CAV3:NM_001234.4:synonymous:LOW:exon1/3:c.27C>T:p.Leu9Leu,CAV3:NM_033337.2:synonymous:LOW:exon1/2:c.27C>T:p.Leu9Leu		rs1974763	0.0425	0.086	0.1248	0.0266						601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC|Rippling muscle disease|Creatine phosphokinase,elevated serum|Myopathy,distal,Tateyama type|Cardiomyopathy,familial hypertrophic|Long QT syndrome 9];	RCV000024400.1 [not provided]; RCV000039803.6 [other]; 			0.0076	0.2348	0.7576	5	95	n/a	n/a
chr3	8787220	8787220	T	C	het		QUAL=6084;DP=188;AF=0.46;MQM=60;TRIO=HET,188,0.46,HET,234,0.47,WT,308,0.00	CAV3	synonymous	CAV3:NM_001234.4:synonymous:LOW:exon2/3:c.123T>C:p.Phe41Phe,CAV3:NM_033337.2:synonymous:LOW:exon2/2:c.123T>C:p.Phe41Phe		rs13087941	0.153	0.188	0.241	0.2839						601253 [CAV3 (confirmed) Muscular dystrophy,limb-girdle,type IC|Rippling muscle disease|Creatine phosphokinase,elevated serum|Myopathy,distal,Tateyama type|Cardiomyopathy,familial hypertrophic|Long QT syndrome 9];	RCV000024401.3 [not provided]; RCV000039797.6 [other]; RCV000157708.1 [benign]; 		COSM1131343	0.0455	0.303	0.6515	24	147	n/a	n/a
chr3	8788096	8788096	T	C	het		QUAL=9923;DP=395;AF=0.53;MQM=60;TRIO=HET,395,0.53,HET,192,0.55,WT,264,0.00	CAV3	3'UTR	CAV3:NM_001234.4:3'UTR:MODIFIER:exon3/3:c.*447T>C:,CAV3:NM_033337.2:3'UTR:MODIFIER:exon2/2:c.*543T>C:		rs13093809	0.0503	0	0	0							RCV000024402.1 [not provided]; 			0.0152	0.2727	0.7121	4	40	n/a	n/a
chr3	8788198	8788198	A	T	het		QUAL=12061;DP=253;AF=0.53;MQM=60;TRIO=HET,253,0.53,HET,199,0.49,HET,268,0.53	CAV3	3'UTR	CAV3:NM_001234.4:3'UTR:MODIFIER:exon3/3:c.*549A>T:,CAV3:NM_033337.2:3'UTR:MODIFIER:exon2/2:c.*645A>T:		rs11476	0.3482	0	0	0							RCV000024384.1 [not provided]; 			0.1136	0.5606	0.3258	23	78	n/a	n/a
chr3	8788336	8788336	A	G	het		QUAL=13042;DP=307;AF=0.46;MQM=60;TRIO=HET,307,0.46,HET,234,0.48,HET,319,0.51	CAV3	3'UTR	CAV3:NM_001234.4:3'UTR:MODIFIER:exon3/3:c.*687A>G:,CAV3:NM_033337.2:3'UTR:MODIFIER:exon2/2:c.*783A>G:		rs7629329	0.2716	0	0	0							RCV000024404.1 [not provided]; 			0.0606	0.5379	0.4015	14	77	n/a	n/a
chr3	8788364	8788364	C	-	het		QUAL=14555;DP=381;AF=0.48;MQM=60;TRIO=HET,381,0.48,HET,248,0.51,WT,311,0.50	CAV3	3'UTR	CAV3:NM_001234.4:3'UTR:MODIFIER:exon3/3:c.*717delC:,CAV3:NM_033337.2:3'UTR:MODIFIER:exon2/2:c.*813delC:		rs66667169	0.0467	0	0	0										0.0076	0.2424	0.75	3	36	n/a	n/a
chr3	10085536	10085536	A	G	het		QUAL=11852;DP=410;AF=0.32;MQM=43;TRIO=HET,410,0.32,HET,374,0.30,HET,489,0.30	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:NM_001018115.1:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0	0.122	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM3759563	0	0.2652	0.7348	0	285	n/a	n/a
chr3	10088266	10088266	G	T	het		QUAL=6404;DP=252;AF=0.18;MQM=51;TRIO=HET,252,0.18,HET,201,0.20,HET,358,0.40	FANCD2	splice_region&synonymous	FANCD2:NM_033084.3:splice_region&synonymous:LOW:exon15/43:c.1137G>T:p.Val379Val,FANCD2:NM_001018115.1:splice_region&synonymous:LOW:exon15/44:c.1137G>T:p.Val379Val		rs72492997	0	0.35	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4157094	0	0.7955	0.2045	0	348	n/a	n/a
chr3	10088299	10088299	C	T	het		QUAL=8916;DP=329;AF=0.19;MQM=48;TRIO=HET,329,0.19,HET,244,0.23,HET,441,0.42	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon15/43:c.1170C>T:p.Ser390Ser,FANCD2:NM_001018115.1:synonymous:LOW:exon15/44:c.1170C>T:p.Ser390Ser		rs112887807	0	0.426	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0	0.5909	0.4091	0	384	n/a	n/a
chr3	10088308	10088308	T	C	het		QUAL=9750;DP=299;AF=0.21;MQM=48;TRIO=HET,299,0.21,HET,249,0.23,HET,460,0.43	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon15/43:c.1179T>C:p.Thr393Thr,FANCD2:NM_001018115.1:synonymous:LOW:exon15/44:c.1179T>C:p.Thr393Thr		rs72492998	0	0.429	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4152593	0	0.5682	0.4318	0	472	n/a	n/a
chr3	10088343	10088343	A	G	het		QUAL=9612;DP=418;AF=0.15;MQM=44;TRIO=HET,418,0.15,HET,256,0.23,HET,471,0.43	FANCD2	missense	FANCD2:NM_033084.3:missense:MODERATE:exon15/43:c.1214A>G:p.Asn405Ser,FANCD2:NM_001018115.1:missense:MODERATE:exon15/44:c.1214A>G:p.Asn405Ser		rs73126218	0	0.412	0	0	0.2110	N	T	B,B	B,B	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4152594	0	0.5758	0.4242	0	510	n/a	n/a
chr3	10089723	10089723	G	A	het		QUAL=12220;DP=275;AF=0.28;MQM=58;TRIO=HET,275,0.28,HET,253,0.36,HET,428,0.50	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon16/43:c.1401G>A:p.Thr467Thr,FANCD2:NM_001018115.1:synonymous:LOW:exon16/44:c.1401G>A:p.Thr467Thr		rs12330369	0	0.446	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4157099	0	0.8864	0.1136	0	753	n/a	n/a
chr3	10089738	10089738	A	G	het		QUAL=11133;DP=243;AF=0.26;MQM=57;TRIO=HET,243,0.26,HET,240,0.37,HET,407,0.51	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon16/42:c.1413+3A>G:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon16/43:c.1413+3A>G:		rs62245508	0	0.437	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0	0.8182	0.1818	0	739	1	n/a (1xTP)
chr3	10091049	10091049	C	T	het		QUAL=1656;DP=156;AF=0.35;MQM=38;TRIO=HET,156,0.35,HET,107,0.10,HET,149,0.07	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon16/42:c.1414-9C>T:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon16/43:c.1414-9C>T:		rs35557429	0	0.074	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0	0.2273	0.7727	2	70	n/a	n/a
chr3	10106532	10106532	C	T	het		QUAL=8769;DP=208;AF=0.39;MQM=43;TRIO=HET,208,0.39,HET,171,0.48,HET,239,0.48	FANCD2	missense	FANCD2:NM_033084.3:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:NM_001018115.1:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0	0.155	0	0	-0.1810	P	T	B,B	B,B	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];	RCV000120989.1 [not provided]; 			0.0152	0.2652	0.7197	19	271	n/a	n/a
chr3	10138069	10138069	T	G	het		QUAL=7290;DP=279;AF=0.47;MQM=60;TRIO=HET,279,0.47,HET,77,0.60,HET,112,0.44	FANCD2,FANCD2OS	synonymous,intron	FANCD2:NM_033084.3:synonymous:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:NM_001018115.1:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.187	0.1647	0.4714						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];		CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer, increased risk, association with" GENE=FANCD2]; 	COSM3759566	0.0227	0.2576	0.7197	23	282	n/a	n/a
chr3	10140671	10140671	G	A	het		QUAL=17484;DP=465;AF=0.42;MQM=59;TRIO=HET,465,0.42,HET,308,0.43,HET,451,0.46	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*37G>A:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+5211C>T:		rs7626117	0.3452	0.228	0.1874	0.7363						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0.0227	0.2879	0.6894	3	49	n/a	n/a
chr3	10140696	10140696	A	G	het		QUAL=18602;DP=504;AF=0.46;MQM=60;TRIO=HET,504,0.46,HET,289,0.46,HET,420,0.48	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*62A>G:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+197A>G:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+5186T>C:		rs7647987	0.2412	0	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0.0227	0.2576	0.7197	3	39	n/a	n/a
chr3	10141065	10141065	T	G	het		QUAL=5477;DP=156;AF=0.55;MQM=60;TRIO=HET,156,0.55,HET,82,0.61,HET,67,0.57	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*431T>G:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+566T>G:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+4817A>C:	FLAM_C	rs3826	0.242	0	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0.0227	0.2576	0.7197	3	39	n/a	n/a
chr3	10141184	10141184	C	T	het		QUAL=944;DP=53;AF=0.45;MQM=59;TRIO=HET,53,0.45,HET,16,0.31,HET,14,0.36	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*550C>T:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+685C>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+4698G>A:	AluSg	rs11716842	0.2061	0	0	0						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0.2197	0.4697	0.3106	32	68	n/a	n/a
chr3	10142949	10142949	C	T	het		QUAL=8286;DP=167;AF=0.47;MQM=60;TRIO=HET,167,0.47,HET,186,0.44,HET,219,0.48	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_001018115.1:3'UTR:MODIFIER:exon44/44:c.*3C>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+2933G>A:		rs3172417	0.2147	0.329	0.4197	0.0878									COSN166813	0.2197	0.4697	0.3106	180	454	n/a	n/a
chr3	10143274	10143274	C	T	het		QUAL=9253;DP=240;AF=0.50;MQM=59;TRIO=HET,240,0.50,HET,153,0.52,HET,215,0.47	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_001018115.1:3'UTR:MODIFIER:exon44/44:c.*328C>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+2608G>A:	AluSc8	rs58275763	0.1917	0	0	0										0.0227	0.2576	0.7197	3	39	n/a	n/a
chr3	10143328	10143328	A	T	het		QUAL=14150;DP=337;AF=0.52;MQM=58;TRIO=HET,337,0.52,HET,267,0.51,HET,314,0.46	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_001018115.1:3'UTR:MODIFIER:exon44/44:c.*382A>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+2554T>A:	AluSc8	rs59318799	0.1925	0	0	0										0.0227	0.2576	0.7197	3	39	n/a	n/a
chr3	12526006	12526006	G	A	het		QUAL=5460;DP=49;AF=0.39;MQM=60;TRIO=HET,49,0.39,HOM,181,0.99,WT,303,0.00	TSEN2	5'UTR	TSEN2:NM_001145393.1:5'UTR:MODIFIER:exon1/11:c.-28G>A:,TSEN2:NM_001145394.1:5'UTR:MODIFIER:exon1/13:c.-28G>A:		rs3806662	0.0791	0	0	0										0.0152	0.053	0.9318	3	9	n/a	n/a
chr3	12526188	12526188	G	T	het		QUAL=9017;DP=205;AF=0.50;MQM=60;TRIO=HET,205,0.50,WT,300,0.00,HET,355,0.54	TSEN2	5'UTR,intron	TSEN2:NM_001145395.1:5'UTR:MODIFIER:exon1/9:c.-209G>T:,TSEN2:NM_025265.3:5'UTR:MODIFIER:exon1/12:c.-209G>T:,TSEN2:NM_001145392.1:intron:MODIFIER:exon1/11:c.-18+61G>T:,TSEN2:NM_001145393.1:intron:MODIFIER:exon1/10:c.-18+172G>T:,TSEN2:NM_001145394.1:intron:MODIFIER:exon1/12:c.-18+172G>T:		rs709161	0.4545	0	0	0										0.2424	0.4773	0.2803	37	70	n/a	n/a
chr3	12544829	12544829	G	A	het		QUAL=7727;DP=132;AF=0.58;MQM=60;TRIO=HET,132,0.58,HOM,182,0.99,WT,241,0.00	TSEN2	missense	TSEN2:NM_001145392.1:missense:MODERATE:exon5/12:c.377G>A:p.Arg126His,TSEN2:NM_001145393.1:missense:MODERATE:exon5/11:c.377G>A:p.Arg126His,TSEN2:NM_001145394.1:missense:MODERATE:exon5/13:c.377G>A:p.Arg126His,TSEN2:NM_001145395.1:missense:MODERATE:exon5/9:c.377G>A:p.Arg126His,TSEN2:NM_025265.3:missense:MODERATE:exon5/12:c.377G>A:p.Arg126His		rs33955793	0.0587	0.078	0.0662	0.0608	-0.3930	N	T	B,B,B,B	B,B,B,B	608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B];	RCV000082253.3 [benign]; RCV000125708.1 [benign]; 			0.0152	0.053	0.9318	7	109	n/a	n/a
chr3	12571421	12571421	T	-	het		QUAL=6531;DP=229;AF=0.48;MQM=59;TRIO=HET,229,0.48,WT,157,0.05,HET,223,0.47	TSEN2	3'UTR,intron	TSEN2:NM_001145395.1:3'UTR:MODIFIER:exon9/9:c.*22delT:,TSEN2:NM_001145392.1:intron:MODIFIER:exon10/11:c.1248+61delT:,TSEN2:NM_001145393.1:intron:MODIFIER:exon9/10:c.1170+61delT:,TSEN2:NM_001145394.1:intron:MODIFIER:exon11/12:c.1071+61delT:,TSEN2:NM_025265.3:intron:MODIFIER:exon10/11:c.1248+61delT:		rs35445022	0	0	0	0						608753 [TSEN2 (provisional) Pontocerebellar hypoplasia type 2B];				0.0455	0.25	0.7045	29	133	n/a	n/a
chr3	12574512	12574512	G	T	het		QUAL=4382;DP=249;AF=0.47;MQM=60;TRIO=HET,249,0.47,WT,38,0.00,HET,41,0.41	TSEN2	3'UTR	TSEN2:NM_001145392.1:3'UTR:MODIFIER:exon12/12:c.*292G>T:,TSEN2:NM_001145393.1:3'UTR:MODIFIER:exon11/11:c.*292G>T:,TSEN2:NM_001145394.1:3'UTR:MODIFIER:exon13/13:c.*292G>T:,TSEN2:NM_025265.3:3'UTR:MODIFIER:exon12/12:c.*292G>T:		rs299643	0.4219	0	0	0										0.2424	0.4545	0.303	37	68	n/a	n/a
chr3	12625747	12625747	G	A	het		QUAL=23021;DP=445;AF=0.52;MQM=59;TRIO=HET,445,0.52,HOM,508,0.99,WT,695,0.00	RAF1	3'UTR	RAF1:NM_002880.3:3'UTR:MODIFIER:exon17/17:c.*266C>T:		rs1051208	0.1739	0	0	0										0.0227	0.2424	0.7348	4	38	n/a	n/a
chr3	14183410	14183410	T	C	het		QUAL=19477;DP=283;AF=0.48;MQM=59;TRIO=HET,283,0.48,HOM,334,0.99,HET,369,0.42	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*115T>C:		rs1043943	0.6891	0	0	0										0.3182	0.4091	0.2727	53	56	n/a	n/a
chr3	14183758	14183758	A	G	het		QUAL=13688;DP=362;AF=0.51;MQM=60;TRIO=HET,362,0.51,HOM,252,0.99,WT,322,0.00	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*463A>G:		rs1043953	0.0927	0	0	0										0.053	0.3106	0.6364	7	46	n/a	n/a
chr3	14184074	14184074	A	C	het		QUAL=13106;DP=393;AF=0.53;MQM=60;TRIO=HET,393,0.53,HOM,203,0.99,WT,285,0.00	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*779A>C:		rs13069	0.13	0	0	0										0.0606	0.3409	0.5985	8	52	n/a	n/a
chr3	14184669	14184669	T	C	het		QUAL=11500;DP=302;AF=0.48;MQM=60;TRIO=HET,302,0.48,HOM,207,1.00,WT,227,0.00	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*1374T>C:		rs8516	0.1048	0	0	0										0.053	0.3106	0.6364	7	46	n/a	n/a
chr3	14184719	14184719	T	C	het		QUAL=10664;DP=328;AF=0.46;MQM=60;TRIO=HET,328,0.46,HOM,171,1.00,WT,205,0.00	TMEM43	3'UTR	TMEM43:NM_024334.2:3'UTR:MODIFIER:exon12/12:c.*1424T>C:		rs10468	0.1306	0	0	0										0.0606	0.3409	0.5985	8	52	n/a	n/a
chr3	14186757	14186757	C	G	hom		QUAL=17921;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,130,1.00,HOM,157,1.00	XPC	3'UTR	XPC:NM_004628.4:3'UTR:MODIFIER:exon16/16:c.*684G>C:,XPC:NM_001145769.1:3'UTR:MODIFIER:exon16/16:c.*684G>C:		rs1126547	0.9189	0.883	0	0										0.7652	0.1818	0.053	221	60	n/a	n/a
chr3	14186823	14186823	T	C	het		QUAL=12471;DP=297;AF=0.51;MQM=60;TRIO=HET,297,0.51,HOM,244,0.98,WT,299,0.00	XPC	3'UTR	XPC:NM_004628.4:3'UTR:MODIFIER:exon16/16:c.*618A>G:,XPC:NM_001145769.1:3'UTR:MODIFIER:exon16/16:c.*618A>G:		rs2470458	0.1078	0.106	0	0										0.053	0.3106	0.6364	13	88	n/a	n/a
chr3	14186830	14186830	A	T	het		QUAL=13011;DP=290;AF=0.53;MQM=60;TRIO=HET,290,0.53,HOM,247,1.00,WT,311,0.00	XPC	3'UTR	XPC:NM_004628.4:3'UTR:MODIFIER:exon16/16:c.*611T>A:,XPC:NM_001145769.1:3'UTR:MODIFIER:exon16/16:c.*611T>A:		rs2470352	0.1082	0.104	0	0										0.053	0.3106	0.6364	13	88	n/a	n/a
chr3	14187345	14187345	G	C	het		QUAL=7093;DP=206;AF=0.46;MQM=59;TRIO=HET,206,0.46,HOM,136,0.99,WT,220,0.00	XPC	3'UTR	XPC:NM_004628.4:3'UTR:MODIFIER:exon16/16:c.*96C>G:,XPC:NM_001145769.1:3'UTR:MODIFIER:exon16/16:c.*96C>G:		rs2229090	0.255	0.225	0	0										0.1136	0.3258	0.5606	25	96	n/a	n/a
chr3	14187449	14187449	G	T	het		QUAL=15127;DP=289;AF=0.47;MQM=60;TRIO=HET,289,0.47,HOM,194,1.00,HET,329,0.45	XPC	missense	XPC:NM_004628.4:missense:MODERATE:exon16/16:c.2815C>A:p.Gln939Lys,XPC:NM_001145769.1:missense:MODERATE:exon16/16:c.2704C>A:p.Gln902Lys		rs2228001	0.6847	0.631	0.6015	0.7299	2.9050	P	T	B,B	B,B	613208 [XPC (confirmed) Xeroderma pigmentosum,group C];		CM070359 [CLASS=DFP MUT=REF PHEN="DNA repair rate, association with" GENE=XPC]; 	COSM4002478	0.3182	0.4015	0.2803	384	539	n/a	n/a
chr3	14190237	14190237	T	G	het		QUAL=16873;DP=192;AF=0.49;MQM=59;TRIO=HET,192,0.49,HOM,265,1.00,HET,360,0.54	XPC	splice_region&intron	XPC:NM_004628.4:splice_region&intron:LOW:exon12/15:c.2251-6A>C:,XPC:NM_001145769.1:splice_region&intron:LOW:exon12/15:c.2140-6A>C:		rs2279017	0.6797	0.63	0.6014	0.7032						613208 [XPC (confirmed) Xeroderma pigmentosum,group C];				0.3182	0.4015	0.2803	384	539	n/a	n/a
chr3	14197987	14197987	A	T	hom		QUAL=26333;DP=153;AF=1.00;MQM=60;TRIO=HOM,153,1.00,HOM,288,1.00,HOM,392,1.00	XPC	synonymous	XPC:NM_004628.4:synonymous:LOW:exon10/16:c.1881T>A:p.Ala627Ala,XPC:NM_001145769.1:synonymous:LOW:exon10/16:c.1770T>A:p.Ala590Ala		rs2958057	1	1	0	0						613208 [XPC (confirmed) Xeroderma pigmentosum,group C];				1	0	0	1162	0	n/a	n/a
chr3	14199887	14199887	G	A	het		QUAL=15032;DP=394;AF=0.50;MQM=60;TRIO=HET,394,0.50,HOM,298,0.99,WT,388,0.00	XPC	missense	XPC:NM_004628.4:missense:MODERATE:exon9/16:c.1496C>T:p.Ala499Val,XPC:NM_001145769.1:missense:MODERATE:exon9/16:c.1385C>T:p.Ala462Val		rs2228000	0.233	0.237	0.2482	0.0918		P	T	B,B	B,B	613208 [XPC (confirmed) Xeroderma pigmentosum,group C];	RCV000122343.1 [not provided]; 	CM057944 [CLASS=DP MUT=ALT PHEN="Lung cancer, association with" GENE=XPC]; 		0.0985	0.3258	0.5758	87	380	n/a	n/a
chr3	14220095	14220095	C	G	het		QUAL=10710;DP=106;AF=0.48;MQM=60;TRIO=HET,106,0.48,HOM,192,1.00,HET,211,0.51	XPC	5'UTR	XPC:NM_004628.4:5'UTR:MODIFIER:exon1/16:c.-27G>C:,XPC:NM_001145769.1:5'UTR:MODIFIER:exon1/16:c.-27G>C:		rs2607775	0.3279	0.414	0.4728	0.355										0.1818	0.4318	0.3864	62	134	n/a	n/a
chr3	15677019	15677019	G	A	het		QUAL=10412;DP=251;AF=0.49;MQM=60;TRIO=HET,251,0.49,WT,307,0.00,HET,390,0.54	BTD	missense	BTD:NM_001281723.1:missense:MODERATE:exon2/4:c.139G>A:p.Gly47Arg,BTD:NM_001281726.1:missense:MODERATE:exon2/3:c.133G>A:p.Gly45Arg,BTD:NM_000060.3:missense:MODERATE:exon2/4:c.133G>A:p.Gly45Arg,BTD:NM_001281724.1:missense:MODERATE:exon4/6:c.139G>A:p.Gly47Arg,BTD:NM_001281725.1:missense:MODERATE:exon2/4:c.73G>A:p.Gly25Arg		rs34885143	0.0038	0.01	0.0159	0.0018	-0.0370	N	T	B,B,B	B,B,B	609019 [BTD (provisional) Biotinidase deficiency];	RCV000021888.1 [pathogenic]; RCV000021889.1 [pathogenic]; RCV000021890.1 [pathogenic]; 	CM993540 [CLASS=DM MUT=ALT PHEN="Biotinidase deficiency" GENE=BTD]; 		0	0.0227	0.9773	0	22	2	n/a
chr3	24159008	24159008	G	A	het		QUAL=11963;DP=339;AF=0.45;MQM=60;TRIO=HET,339,0.45,WT,278,0.00,HET,424,0.49	THRB	3'UTR	THRB:NM_000461.4:3'UTR:MODIFIER:exon10/10:c.*5367C>T:,THRB:NM_001128176.2:3'UTR:MODIFIER:exon11/11:c.*5367C>T:,THRB:NM_001128177.1:3'UTR:MODIFIER:exon11/11:c.*5367C>T:,THRB:NM_001252634.1:3'UTR:MODIFIER:exon12/12:c.*5367C>T:	MLT1K	rs2167116	0.2145	0	0	0										0	0.1742	0.8258	0	27	n/a	n/a
chr3	24159023	24159023	G	A	het		QUAL=11469;DP=336;AF=0.47;MQM=60;TRIO=HET,336,0.47,WT,256,0.00,HET,383,0.50	THRB	3'UTR	THRB:NM_000461.4:3'UTR:MODIFIER:exon10/10:c.*5352C>T:,THRB:NM_001128176.2:3'UTR:MODIFIER:exon11/11:c.*5352C>T:,THRB:NM_001128177.1:3'UTR:MODIFIER:exon11/11:c.*5352C>T:,THRB:NM_001252634.1:3'UTR:MODIFIER:exon12/12:c.*5352C>T:	MLT1K	rs56204436	0.116	0	0	0										0	0.1212	0.8788	0	20	n/a	n/a
chr3	24159387	24159387	A	G	het		QUAL=19045;DP=233;AF=0.54;MQM=60;TRIO=HET,233,0.54,HOM,268,1.00,HET,353,0.52	THRB	3'UTR	THRB:NM_000461.4:3'UTR:MODIFIER:exon10/10:c.*4988T>C:,THRB:NM_001128176.2:3'UTR:MODIFIER:exon11/11:c.*4988T>C:,THRB:NM_001128177.1:3'UTR:MODIFIER:exon11/11:c.*4988T>C:,THRB:NM_001252634.1:3'UTR:MODIFIER:exon12/12:c.*4988T>C:		rs1349265	0.4802	0	0	0										0.4545	0.4091	0.1364	67	64	n/a	n/a
chr3	24168981	24168981	C	T	het		QUAL=457;DP=23;AF=0.48;MQM=60;TRIO=HET,23,0.48,HET,26,0.38,WT,54,0.00	THRB	splice_region&intron	THRB:NM_000461.4:splice_region&intron:LOW:exon9/9:c.1144+9G>A:,THRB:NM_001128176.2:splice_region&intron:LOW:exon10/10:c.1144+9G>A:,THRB:NM_001128177.1:splice_region&intron:LOW:exon10/10:c.1144+9G>A:,THRB:NM_001252634.1:splice_region&intron:LOW:exon11/11:c.1144+9G>A:		rs13063628	0.0629	0.11	0.1464	0.0735						190160 [THRB (confirmed) Thyroid hormone resistance|Thyroid hormone resistance,autosomal recessive|Thyroid hormone resistance,selective pituitary];				0	0.0985	0.9015	9	81	n/a	n/a
chr3	24270500	24270500	-	A	hom		QUAL=6570;DP=123;AF=0.94;MQM=60;TRIO=HOM,123,0.94,HET,91,0.47,HET,106,0.47	THRB	splice_region&intron	THRB:NM_000461.4:splice_region&intron:LOW:exon2/9:c.-42-9_-42-8insT:,THRB:NM_001128176.2:splice_region&intron:LOW:exon3/10:c.-42-9_-42-8insT:,THRB:NM_001128177.1:splice_region&intron:LOW:exon3/10:c.-42-9_-42-8insT:,THRB:NM_001252634.1:splice_region&intron:LOW:exon4/11:c.-42-9_-42-8insT:		rs397841135	0	0.322	0.2556	0.5499										0.1288	0.3788	0.4924	18	66	n/a	n/a
chr3	30735156	30735156	C	T	het		QUAL=10885;DP=392;AF=0.49;MQM=60;TRIO=HET,392,0.49,WT,222,0.00,HET,260,0.54	TGFBR2	3'UTR	TGFBR2:NM_001024847.2:3'UTR:MODIFIER:exon8/8:c.*2065C>T:,TGFBR2:NM_003242.5:3'UTR:MODIFIER:exon7/7:c.*2065C>T:		rs11466536	0.0232	0	0	0										0.0076	0.0758	0.9167	1	11	n/a	n/a
chr3	30735330	30735330	-	T	het		QUAL=4158;DP=212;AF=0.29;MQM=60;TRIO=HET,212,0.29,WT,158,0.00,HET,201,0.43	TGFBR2	3'UTR	TGFBR2:NM_001024847.2:3'UTR:MODIFIER:exon8/8:c.*2248dupT:,TGFBR2:NM_003242.5:3'UTR:MODIFIER:exon7/7:c.*2248dupT:		rs542768261	0.2065	0	0	0										0.0682	0.2803	0.6515	10	45	n/a	n/a
chr3	33055721	33055721	A	G	hom		QUAL=19907;DP=121;AF=1.00;MQM=59;TRIO=HOM,121,1.00,HOM,191,1.00,HOM,327,1.00	GLB1	missense	GLB1:NM_000404.2:missense:MODERATE:exon15/16:c.1561T>C:p.Cys521Arg,GLB1:NM_001079811.1:missense:MODERATE:exon15/16:c.1471T>C:p.Cys491Arg,GLB1:NM_001135602.1:missense:MODERATE:exon12/13:c.1168T>C:p.Cys390Arg		rs4302331	0.9271	0.98	0.9982	0.7976	0.3470	P	T	B	B	611458 [GLB1 (confirmed) GM1-gangliosidosis,type I|GM1-gangliosidosis,type II|GM1-gangliosidosis,type III|Mucopolysaccharidosis type IVB (Morquio)];	RCV000153326.1 [benign]; 	CM051080 [CLASS=DM? MUT=REF PHEN="Gangliosidosis GM1" GENE=GLB1]; 		1	0	0	1420	11	2	n/a
chr3	33138544	33138544	A	G	het		QUAL=3510;DP=17;AF=0.53;MQM=60;TRIO=HET,17,0.53,HOM,114,1.00,WT,199,0.01	GLB1	synonymous	GLB1:NM_000404.2:synonymous:LOW:exon1/16:c.34T>C:p.Leu12Leu,GLB1:NM_001135602.1:synonymous:LOW:exon1/13:c.34T>C:p.Leu12Leu		rs7614776	0.9277	0.904	0.8855	0.8764						611458 [GLB1 (confirmed) GM1-gangliosidosis,type I|GM1-gangliosidosis,type II|GM1-gangliosidosis,type III|Mucopolysaccharidosis type IVB (Morquio)];	RCV000078712.4 [other]; 		COSM4157973	0.8106	0.1667	0.0227	1101	199	n/a	n/a
chr3	33138549	33138549	G	A	het		QUAL=3129;DP=15;AF=0.40;MQM=60;TRIO=HET,15,0.40,HOM,112,0.97,WT,200,0.01	GLB1	missense	GLB1:NM_000404.2:missense:MODERATE:exon1/16:c.29C>T:p.Pro10Leu,GLB1:NM_001135602.1:missense:MODERATE:exon1/13:c.29C>T:p.Pro10Leu		rs7637099	0.4319	0.56	0.6236	0.1601	0.1970	P	T	B,B	B,B	611458 [GLB1 (confirmed) GM1-gangliosidosis,type I|GM1-gangliosidosis,type II|GM1-gangliosidosis,type III|Mucopolysaccharidosis type IVB (Morquio)];	RCV000078711.4 [other]; 	CM055955 [CLASS=R MUT=ALT PHEN="Gangliosidosis GM1" GENE=GLB1]; 	COSM4157975	0.3636	0.4545	0.1818	547	543	n/a	n/a
chr3	33174156	33174156	T	G	het		QUAL=10746;DP=202;AF=0.45;MQM=60;TRIO=HET,202,0.45,HOM,253,1.00,WT,337,0.00	CRTAP	synonymous	CRTAP:NM_006371.4:synonymous:LOW:exon5/7:c.1032T>G:p.Thr344Thr		rs1135127	0.2935	0.375	0.4455	0.2651						605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII];			COSM149349	0.2045	0.4697	0.3258	97	217	n/a	n/a
chr3	33174168	33174168	G	A	het		QUAL=9708;DP=168;AF=0.40;MQM=60;TRIO=HET,168,0.40,HOM,241,1.00,WT,321,0.00	CRTAP	synonymous	CRTAP:NM_006371.4:synonymous:LOW:exon5/7:c.1044G>A:p.Ser348Ser		rs1135128	0.2935	0.375	0.4453	0.2651						605497 [CRTAP (confirmed) Osteogenesis imperfecta,type VII];				0.2045	0.4697	0.3258	97	216	n/a	n/a
chr3	33185027	33185027	-	GAACTA	het		QUAL=5537;DP=242;AF=0.32;MQM=60;TRIO=HET,242,0.32,HOM,109,0.98,WT,159,0.00	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*1090_*1095dupACTAGA:	L2a	rs5847775	0.3387	0	0	0										0.3409	0.447	0.2121	49	66	n/a	n/a
chr3	33185407	33185407	G	A	het		QUAL=10999;DP=340;AF=0.48;MQM=60;TRIO=HET,340,0.48,WT,327,0.00,HET,415,0.49	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*1467G>A:	L2a	rs4678475	0.3019	0	0	0										0.0758	0.2879	0.6364	13	45	n/a	n/a
chr3	33185798	33185798	T	A	hom		QUAL=19319;DP=249;AF=1.00;MQM=60;TRIO=HOM,249,1.00,HOM,158,1.00,HOM,179,1.00	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*1858T>A:	L2a	rs4678476	0.896	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr3	33186356	33186356	T	C	het		QUAL=7130;DP=207;AF=0.54;MQM=60;TRIO=HET,207,0.54,WT,137,0.01,HET,231,0.46	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*2416T>C:	L2a	rs1127898	0.361	0	0	0										0.0606	0.2955	0.6439	11	44	n/a	n/a
chr3	33187425	33187425	G	A	het		QUAL=17005;DP=509;AF=0.49;MQM=60;TRIO=HET,509,0.49,HOM,279,0.99,WT,349,0.00	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*3485G>A:		rs1132392	0.3199	0	0	0										0.3939	0.447	0.1591	60	64	n/a	n/a
chr3	33187831	33187831	C	T	het		QUAL=10001;DP=175;AF=0.48;MQM=60;TRIO=HET,175,0.48,WT,357,0.00,HET,459,0.51	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*3891C>T:		rs4678478	0.3037	0	0	0										0.0606	0.303	0.6364	11	45	n/a	n/a
chr3	33189163	33189163	T	A	het		QUAL=3752;DP=172;AF=0.48;MQM=60;TRIO=HET,172,0.48,HET,71,0.51,WT,98,0.00	CRTAP	3'UTR	CRTAP:NM_006371.4:3'UTR:MODIFIER:exon7/7:c.*5223T>A:		rs192685869	0.0008	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr3	41241154	41241154	C	G	het		QUAL=2279;DP=86;AF=0.50;MQM=59;TRIO=HET,86,0.50,HET,96,0.42,WT,105,0.00	CTNNB1	5'UTR_premature_start_codon_gain,5'UTR	CTNNB1:NM_001098209.1:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-56C>G:,CTNNB1:NM_001098210.1:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-56C>G:,CTNNB1:NM_001904.3:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-56C>G:,CTNNB1:NM_001098209.1:5'UTR:MODIFIER:exon1/16:c.-56C>G:,CTNNB1:NM_001098210.1:5'UTR:MODIFIER:exon1/16:c.-56C>G:,CTNNB1:NM_001904.3:5'UTR:MODIFIER:exon1/15:c.-56C>G:		rs11564435	0.0032	0	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr3	41281388	41281388	T	G	het		QUAL=2489;DP=69;AF=0.43;MQM=60;TRIO=HET,69,0.43,HET,45,0.60,HET,59,0.53	CTNNB1	3'UTR	CTNNB1:NM_001098209.1:3'UTR:MODIFIER:exon16/16:c.*250T>G:,CTNNB1:NM_001098210.1:3'UTR:MODIFIER:exon16/16:c.*91T>G:,CTNNB1:NM_001904.3:3'UTR:MODIFIER:exon15/15:c.*555T>G:		rs2953	0.3652	0	0	0										0.2197	0.5379	0.2424	34	75	n/a	n/a
chr3	41281413	41281413	T	A	het		QUAL=1510;DP=97;AF=0.31;MQM=60;TRIO=HET,97,0.31,HET,33,0.39,HET,31,0.45	CTNNB1	3'UTR	CTNNB1:NM_001098209.1:3'UTR:MODIFIER:exon16/16:c.*275T>A:,CTNNB1:NM_001098210.1:3'UTR:MODIFIER:exon16/16:c.*116T>A:,CTNNB1:NM_001904.3:3'UTR:MODIFIER:exon15/15:c.*580T>A:	AT_rich	rs4135387	0.27	0	0	0										0.053	0.5985	0.3485	7	88	n/a	n/a
chr3	41281600	41281600	-	TAAT	het		QUAL=2039;DP=119;AF=0.44;MQM=60;TRIO=HET,119,0.44,HET,15,0.80,HET,13,0.31	CTNNB1	3'UTR	CTNNB1:NM_001098209.1:3'UTR:MODIFIER:exon16/16:c.*464_*467dupAATT:,CTNNB1:NM_001098210.1:3'UTR:MODIFIER:exon16/16:c.*305_*308dupAATT:,CTNNB1:NM_001904.3:3'UTR:MODIFIER:exon15/15:c.*769_*772dupAATT:		rs3834205	0.358	0	0	0										0.1742	0.5758	0.25	27	80	n/a	n/a
chr3	43761441	43761441	A	G	hom		QUAL=24840;DP=381;AF=1.00;MQM=60;TRIO=HOM,381,1.00,HET,220,0.44,HOM,262,1.00	ABHD5	3'UTR	ABHD5:NM_016006.4:3'UTR:MODIFIER:exon7/7:c.*1417A>G:		rs3733156	0.5487	0	0	0										0.4394	0.4621	0.0985	67	67	n/a	n/a
chr3	46944274	46944274	T	C	het		QUAL=25112;DP=350;AF=0.44;MQM=60;TRIO=HET,350,0.44,HOM,368,1.00,HET,470,0.54	PTH1R	synonymous	PTH1R:NM_000316.2:synonymous:LOW:exon15/16:c.1389T>C:p.Asn463Asn,PTH1R:NM_001184744.1:synonymous:LOW:exon14/15:c.1389T>C:p.Asn463Asn		rs1138518	0.6434	0.614	0.6186	0.7989						168468 [PTH1R (confirmed) Metaphyseal chondrodysplasia,Murk Jansen type|Chondrodysplasia,Blomstrand type|Eiken syndrome|Failure of tooth eruption,primary];			COSM149372	0.3636	0.4394	0.197	179	195	n/a	n/a
chr3	46945000	46945000	G	A	het		QUAL=4137;DP=138;AF=0.52;MQM=59;TRIO=HET,138,0.52,WT,104,0.00,HET,124,0.51	PTH1R	missense	PTH1R:NM_000316.2:missense:MODERATE:exon16/16:c.1636G>A:p.Glu546Lys,PTH1R:NM_001184744.1:missense:MODERATE:exon15/15:c.1636G>A:p.Glu546Lys		rs77048718	0.0086	0.017	0.0255	0.0041	1.8400	N	T	B	B	168468 [PTH1R (confirmed) Metaphyseal chondrodysplasia,Murk Jansen type|Chondrodysplasia,Blomstrand type|Eiken syndrome|Failure of tooth eruption,primary];				0	0.053	0.947	0	19	n/a	n/a
chr3	46945263	46945263	-	A	het		QUAL=994;DP=73;AF=0.30;MQM=60;TRIO=HET,73,0.30,HOM,33,0.85,WT,56,0.00	PTH1R	3'UTR	PTH1R:NM_000316.2:3'UTR:MODIFIER:exon16/16:c.*127dupA:,PTH1R:NM_001184744.1:3'UTR:MODIFIER:exon15/15:c.*127dupA:	(A)n	rs552713678	0.1532	0	0	0										0.0833	0.1742	0.7424	12	25	n/a	n/a
chr3	48508585	48508585	C	T	het		QUAL=7654;DP=277;AF=0.47;MQM=59;TRIO=HET,277,0.47,WT,185,0.01,HET,243,0.48	TREX1	synonymous	TREX1:NM_016381.5:synonymous:LOW:exon1/1:c.696C>T:p.Tyr232Tyr,TREX1:NM_007248.3:synonymous:LOW:exon2/2:c.501C>T:p.Tyr167Tyr,TREX1:NM_033629.4:synonymous:LOW:exon2/2:c.531C>T:p.Tyr177Tyr		rs11797	0.3133	0.37	0.4538	0.2746						606609 [TREX1 (confirmed) Aicardi-Goutieres syndrome 1,dominant and recessive|Chilblain lupus|Vasculopathy,retinal,with cerebral leukodystrophy|Systemic lupus erythematosus,susceptibility to];	RCV000082324.2 [benign]; 		COSM4002723	0.1894	0.5152	0.2955	84	221	n/a	n/a
chr3	48605076	48605076	A	-	het		QUAL=3044;DP=55;AF=0.45;MQM=60;TRIO=HET,55,0.45,HET,190,0.45,WT,265,0.00	COL7A1	splice_region&intron	COL7A1:NM_000094.3:splice_region&intron:LOW:exon107/117:c.7984-7delT:		rs397989501	0.0697	0.042	0.032	0.0725						120120 [COL7A1 (confirmed) Epidermolysis bullosa dystrophica,AD|Epidermolysis bullosa dystrophica,AR|Epidermolysis bullosa,pretibial|EBD,Bart type|EBD,localisata variant|Transient bullous of the newborn|Epidermolysis bullosa pruriginosa|Toenail dystrophy,isolated|EBD inversa];				0.0076	0.1212	0.8712	1	34	n/a	n/a
chr3	48625266	48625266	T	C	hom		QUAL=12049;DP=233;AF=0.99;MQM=59;TRIO=HOM,233,0.99,HET,134,0.52,HET,157,0.54	COL7A1	synonymous	COL7A1:NM_000094.3:synonymous:LOW:exon21/118:c.2817A>G:p.Pro939Pro		rs1264194	0.6811	0.678	0.7083	0.9013						120120 [COL7A1 (confirmed) Epidermolysis bullosa dystrophica,AD|Epidermolysis bullosa dystrophica,AR|Epidermolysis bullosa,pretibial|EBD,Bart type|EBD,localisata variant|Transient bullous of the newborn|Epidermolysis bullosa pruriginosa|Toenail dystrophy,isolated|EBD inversa];			COSM446657	0.447	0.4091	0.1439	215	186	n/a	n/a
chr3	49162040	49162040	T	G	het		QUAL=3002;DP=104;AF=0.43;MQM=60;TRIO=HET,104,0.43,HET,81,0.63,WT,101,0.00	LAMB2	missense	LAMB2:NM_002292.3:missense:MODERATE:exon22/32:c.3115A>C:p.Thr1039Pro			0	0	0	0	1.8160	D	T	P	B	150325 [LAMB2 (confirmed) Nephrotic syndrome,type 5,with or without ocular abnormalities|Pierson syndrome];				0	0.0076	0.9924	0	1	n/a	n/a
chr3	49506273	49506273	-	T	het		QUAL=1190;DP=43;AF=0.65;MQM=59;TRIO=HET,43,0.65,HET,12,0.67,HOM,10,0.90	DAG1	5'UTR	DAG1:NM_001177643.2:5'UTR:MODIFIER:exon1/3:c.-320dupT:	AluJb	rs71080520	0.6699	0	0	0										0.2197	0.2348	0.5455	33	35	n/a	n/a
chr3	49506299	49506299	C	T	hom		QUAL=1671;DP=36;AF=1.00;MQM=59;TRIO=HOM,36,1.00,HOM,14,1.00,HOM,10,1.00	DAG1	5'UTR	DAG1:NM_001177643.2:5'UTR:MODIFIER:exon1/3:c.-306C>T:	AluJb	rs6797164	0.9659	0	0	0										0.9697	0	0.0303	146	0	n/a	n/a
chr3	49507847	49507847	G	A	hom		QUAL=199;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,4,0.50,HET,4,0.75	DAG1	5'UTR,intron	DAG1:NM_001165928.3:5'UTR:MODIFIER:exon1/6:c.-497G>A:,DAG1:NM_001177634.2:5'UTR:MODIFIER:exon1/6:c.-440G>A:,DAG1:NM_001177636.2:5'UTR:MODIFIER:exon1/5:c.-418G>A:,DAG1:NM_001177637.2:5'UTR:MODIFIER:exon1/4:c.-256G>A:,DAG1:NM_001177638.2:5'UTR:MODIFIER:exon1/4:c.-287G>A:,DAG1:NM_001177640.2:5'UTR:MODIFIER:exon1/4:c.-193G>A:,DAG1:NM_001177641.2:5'UTR:MODIFIER:exon1/4:c.-283G>A:,DAG1:NM_001177642.2:5'UTR:MODIFIER:exon1/4:c.-188G>A:,DAG1:NM_001177644.2:5'UTR:MODIFIER:exon1/3:c.-276G>A:,DAG1:NM_004393.5:5'UTR:MODIFIER:exon1/3:c.-136G>A:,DAG1:NM_001177643.2:intron:MODIFIER:exon1/2:c.-117+1359G>A:,DAG1:NM_001177635.2:intron:MODIFIER:exon1/3:c.-169+140G>A:,DAG1:NM_001177639.2:intron:MODIFIER:exon1/2:c.-117+140G>A:		rs4855839	0.5829	0	0	0										0.1136	0.3561	0.5303	16	49	n/a	n/a
chr3	49548008	49548008	C	G	hom		QUAL=34962;DP=306;AF=1.00;MQM=60;TRIO=HOM,306,1.00,HOM,341,1.00,HOM,447,1.00	DAG1	missense	DAG1:NM_001165928.3:missense:MODERATE:exon5/6:c.41C>G:p.Ser14Trp,DAG1:NM_001177643.2:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:NM_001177634.2:missense:MODERATE:exon5/6:c.41C>G:p.Ser14Trp,DAG1:NM_001177635.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177636.2:missense:MODERATE:exon4/5:c.41C>G:p.Ser14Trp,DAG1:NM_001177637.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177638.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177639.2:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:NM_001177640.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177641.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177642.2:missense:MODERATE:exon3/4:c.41C>G:p.Ser14Trp,DAG1:NM_001177644.2:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp,DAG1:NM_004393.5:missense:MODERATE:exon2/3:c.41C>G:p.Ser14Trp		rs2131107	0.9659	0.992	0.9995	0.9212	2.0690	P	T	B	B	128239 [DAG1 (provisional) Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,9];	RCV000024443.1 [not provided]; 			1	0	0	453	1	n/a	n/a
chr3	49570882	49570882	T	C	hom		QUAL=6995;DP=168;AF=1.00;MQM=60;TRIO=HOM,168,1.00,HET,50,0.42,HET,60,0.52	DAG1	3'UTR	DAG1:NM_001165928.3:3'UTR:MODIFIER:exon6/6:c.*250T>C:,DAG1:NM_001177643.2:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:NM_001177634.2:3'UTR:MODIFIER:exon6/6:c.*250T>C:,DAG1:NM_001177635.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177636.2:3'UTR:MODIFIER:exon5/5:c.*250T>C:,DAG1:NM_001177637.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177638.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177639.2:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:NM_001177640.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177641.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177642.2:3'UTR:MODIFIER:exon4/4:c.*250T>C:,DAG1:NM_001177644.2:3'UTR:MODIFIER:exon3/3:c.*250T>C:,DAG1:NM_004393.5:3'UTR:MODIFIER:exon3/3:c.*250T>C:		rs1050088	0.5541	0.436	0	0							RCV000024448.1 [not provided]; 			0.1136	0.5606	0.3258	45	122	n/a	n/a
chr3	49572894	49572894	T	C	hom		QUAL=13078;DP=155;AF=1.00;MQM=59;TRIO=HOM,155,1.00,HOM,120,1.00,HOM,140,1.00	DAG1	3'UTR	DAG1:NM_001165928.3:3'UTR:MODIFIER:exon6/6:c.*2262T>C:,DAG1:NM_001177643.2:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:NM_001177634.2:3'UTR:MODIFIER:exon6/6:c.*2262T>C:,DAG1:NM_001177635.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177636.2:3'UTR:MODIFIER:exon5/5:c.*2262T>C:,DAG1:NM_001177637.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177638.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177639.2:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:NM_001177640.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177641.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177642.2:3'UTR:MODIFIER:exon4/4:c.*2262T>C:,DAG1:NM_001177644.2:3'UTR:MODIFIER:exon3/3:c.*2262T>C:,DAG1:NM_004393.5:3'UTR:MODIFIER:exon3/3:c.*2262T>C:		rs6446283	0.9758	0	0	0							RCV000024451.1 [not provided]; 			1	0	0	155	0	n/a	n/a
chr3	52017423	52017423	G	C	het		QUAL=332;DP=9;AF=0.67;MQM=60;TRIO=HET,9,0.67,HET,18,0.39,WT,36,0.00	ACY1	5'UTR	ACY1:NM_000666.2:5'UTR:MODIFIER:exon1/15:c.-201G>C:,ACY1:NM_001198895.1:5'UTR:MODIFIER:exon1/15:c.-196G>C:,ACY1:NM_001198896.1:5'UTR:MODIFIER:exon1/13:c.-201G>C:,ACY1:NM_001198897.1:5'UTR:MODIFIER:exon1/13:c.-201G>C:,ACY1:NM_001198898.1:5'UTR:MODIFIER:exon1/14:c.-201G>C:		rs554462231	0.0018	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr3	53122969	53122969	G	A	het		QUAL=1184;DP=71;AF=0.44;MQM=44;TRIO=HET,71,0.44,HET,19,0.42,WT,23,0.00	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2950C>T:	AluSx4	rs2082093	0.4904	0	0	0										0.2955	0.4318	0.2727	42	68	n/a	n/a
chr3	53123032	53123032	C	T	hom		QUAL=3423;DP=83;AF=0.99;MQM=47;TRIO=HOM,83,0.99,HET,36,0.47,HET,34,0.56	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2887G>A:	AluSx4	rs2099162	0.7185	0	0	0										0.447	0.4318	0.1212	66	65	n/a	n/a
chr3	53123079	53123079	A	T	het		QUAL=2511;DP=116;AF=0.46;MQM=57;TRIO=HET,116,0.46,WT,57,0.00,HET,65,0.54	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2840T>A:	AluSx4	rs9875573	0.1699	0	0	0										0.0076	0.2576	0.7348	1	39	n/a	n/a
chr3	53123273	53123273	A	G	het		QUAL=8148;DP=275;AF=0.53;MQM=60;TRIO=HET,275,0.53,HET,215,0.52,WT,313,0.00	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2646T>C:		rs891368	0.4904	0	0	0										0.303	0.4394	0.2576	43	69	n/a	n/a
chr3	53123486	53123486	G	A	het		QUAL=7655;DP=256;AF=0.47;MQM=60;TRIO=HET,256,0.47,HET,230,0.59,WT,323,0.00	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*2433C>T:		rs1078968	0.4904	0	0	0										0.303	0.4394	0.2576	43	69	n/a	n/a
chr3	53125297	53125297	G	C	het		QUAL=6453;DP=284;AF=0.45;MQM=60;TRIO=HET,284,0.45,WT,122,0.00,HET,136,0.53	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*622C>G:	L2b	rs7645611	0.1669	0	0	0										0.0152	0.25	0.7348	2	38	n/a	n/a
chr3	53125469	53125469	G	A	hom		QUAL=16511;DP=306;AF=1.00;MQM=60;TRIO=HOM,306,1.00,HET,195,0.43,HET,234,0.48	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*450C>T:		rs2564922	0.6508	0	0	0										0.4394	0.4394	0.1212	65	66	n/a	n/a
chr3	53125585	53125585	T	C	het		QUAL=6200;DP=294;AF=0.46;MQM=60;TRIO=HET,294,0.46,HET,103,0.50,WT,136,0.01	RFT1	3'UTR	RFT1:NM_052859.3:3'UTR:MODIFIER:exon13/13:c.*334A>G:		rs2564921	0.4904	0	0	0										0.303	0.4394	0.2576	43	69	n/a	n/a
chr3	53125922	53125922	T	C	het		QUAL=8360;DP=294;AF=0.46;MQM=59;TRIO=HET,294,0.46,HET,232,0.54,WT,260,0.00	RFT1	synonymous	RFT1:NM_052859.3:synonymous:LOW:exon13/13:c.1623A>G:p.Thr541Thr		rs11242	0.4904	0.55	0.5579	0.2549						611908 [RFT1 (confirmed) Congenital disorder of glycosylation,type In];	RCV000082329.2 [benign]; 			0.303	0.4394	0.2576	141	211	n/a	n/a
chr3	55499781	55499781	T	C	hom		QUAL=8053;DP=118;AF=0.99;MQM=60;TRIO=HOM,118,0.99,HET,115,0.57,HET,130,0.52	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*4339A>G:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*4339A>G:		rs1047898	0.484	0	0	0										0.1742	0.4773	0.3485	26	75	n/a	n/a
chr3	55500408	55500408	T	A	hom		QUAL=8711;DP=149;AF=1.00;MQM=60;TRIO=HOM,149,1.00,HET,100,0.51,HET,142,0.49	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*3712A>T:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*3712A>T:		rs10865994	0.4595	0	0	0										0.1742	0.4697	0.3561	26	72	n/a	n/a
chr3	55501002	55501002	G	C	hom		QUAL=17133;DP=261;AF=1.00;MQM=60;TRIO=HOM,261,1.00,HET,132,0.54,HOM,175,1.00	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*3118C>G:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*3118C>G:		rs669889	0.8095	0	0	0										0.5152	0.4091	0.0758	77	63	n/a	n/a
chr3	55501175	55501175	T	C	hom		QUAL=14139;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HET,160,0.46,HET,200,0.54	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*2945A>G:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*2945A>G:		rs1829556	0.4655	0	0	0										0.1742	0.4697	0.3561	26	73	n/a	n/a
chr3	55501393	55501393	T	-	het		QUAL=2635;DP=97;AF=0.62;MQM=59;TRIO=HET,97,0.62,HET,42,0.45,HET,48,0.31	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*2727delA:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*2727delA:		rs397874127	0	0	0	0										0.0227	0.2576	0.7197	3	36	n/a	n/a
chr3	55502185	55502185	G	A	het		QUAL=296;DP=81;AF=0.22;MQM=57;TRIO=HET,81,0.22,HET,43,0.09,HET,44,0.11	WNT5A	3'UTR	WNT5A:NM_003392.4:3'UTR:MODIFIER:exon5/5:c.*1935C>T:,WNT5A:NM_001256105.1:3'UTR:MODIFIER:exon5/5:c.*1935C>T:			0	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr3	58080583	58080583	A	G	het		QUAL=6700;DP=239;AF=0.46;MQM=60;TRIO=HET,239,0.46,HET,216,0.49,WT,285,0.00	FLNB	missense	FLNB:NM_001164317.1:missense:MODERATE:exon5/47:c.808A>G:p.Met270Val,FLNB:NM_001164318.1:missense:MODERATE:exon5/46:c.808A>G:p.Met270Val,FLNB:NM_001164319.1:missense:MODERATE:exon5/45:c.808A>G:p.Met270Val,FLNB:NM_001457.3:missense:MODERATE:exon5/46:c.808A>G:p.Met270Val		rs145036794	0.0002	0.0006	0.0014	0.0002	2.5940	D	T	B,B,B,B,B,B	B,B,B,B,B,B	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM1485423	0	0.0076	0.9924	0	3	3	n/a
chr3	58081888	58081888	T	C	het		QUAL=11126;DP=290;AF=0.46;MQM=59;TRIO=HET,290,0.46,WT,344,0.00,HET,447,0.48	FLNB	synonymous	FLNB:NM_001164317.1:synonymous:LOW:exon6/47:c.927T>C:p.Ser309Ser,FLNB:NM_001164318.1:synonymous:LOW:exon6/46:c.927T>C:p.Ser309Ser,FLNB:NM_001164319.1:synonymous:LOW:exon6/45:c.927T>C:p.Ser309Ser,FLNB:NM_001457.3:synonymous:LOW:exon6/46:c.927T>C:p.Ser309Ser		rs1522384	0.642	0.464	0.3244	0.5331						603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];				0.1212	0.4242	0.4545	50	194	n/a	n/a
chr3	58109162	58109162	G	A	het		QUAL=8270;DP=167;AF=0.52;MQM=60;TRIO=HET,167,0.52,WT,250,0.01,HET,362,0.51	FLNB	missense	FLNB:NM_001164317.1:missense:MODERATE:exon21/47:c.3469G>A:p.Asp1157Asn,FLNB:NM_001164318.1:missense:MODERATE:exon21/46:c.3469G>A:p.Asp1157Asn,FLNB:NM_001164319.1:missense:MODERATE:exon21/45:c.3469G>A:p.Asp1157Asn,FLNB:NM_001457.3:missense:MODERATE:exon21/46:c.3469G>A:p.Asp1157Asn		rs1131356	0.5461	0.372	0.2438	0.4115	9.8690	P	T	D,D,D,D,D,D	D,D,D,P,D,D	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM4158256	0.0833	0.3333	0.5833	34	152	n/a	n/a
chr3	58112440	58112440	A	G	het		QUAL=13684;DP=245;AF=0.53;MQM=60;TRIO=HET,245,0.53,HET,167,0.47,HOM,227,1.00	FLNB	synonymous	FLNB:NM_001164317.1:synonymous:LOW:exon24/47:c.4173A>G:p.Ala1391Ala,FLNB:NM_001164318.1:synonymous:LOW:exon24/46:c.4173A>G:p.Ala1391Ala,FLNB:NM_001164319.1:synonymous:LOW:exon24/45:c.4173A>G:p.Ala1391Ala,FLNB:NM_001457.3:synonymous:LOW:exon24/46:c.4173A>G:p.Ala1391Ala		rs2362903	0.8333	0.708	0.6417	0.8892						603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM4158261	0.3561	0.4697	0.1742	180	214	n/a	n/a
chr3	58112488	58112488	C	T	het		QUAL=5128;DP=165;AF=0.50;MQM=60;TRIO=HET,165,0.50,WT,123,0.00,HET,167,0.49	FLNB	splice_region&synonymous	FLNB:NM_001164317.1:splice_region&synonymous:LOW:exon24/47:c.4221C>T:p.Pro1407Pro,FLNB:NM_001164318.1:splice_region&synonymous:LOW:exon24/46:c.4221C>T:p.Pro1407Pro,FLNB:NM_001164319.1:splice_region&synonymous:LOW:exon24/45:c.4221C>T:p.Pro1407Pro,FLNB:NM_001457.3:splice_region&synonymous:LOW:exon24/46:c.4221C>T:p.Pro1407Pro		rs2362904	0.6486	0.408	0.2455	0.7088						603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM4158263	0.0833	0.3333	0.5833	35	157	n/a	n/a
chr3	58118555	58118555	G	A	het		QUAL=11479;DP=263;AF=0.45;MQM=60;TRIO=HET,263,0.45,WT,341,0.00,HET,482,0.49	FLNB	missense	FLNB:NM_001164317.1:missense:MODERATE:exon27/47:c.4504G>A:p.Val1502Met,FLNB:NM_001164318.1:missense:MODERATE:exon26/46:c.4411G>A:p.Val1471Met,FLNB:NM_001164319.1:missense:MODERATE:exon26/45:c.4411G>A:p.Val1471Met,FLNB:NM_001457.3:missense:MODERATE:exon26/46:c.4411G>A:p.Val1471Met		rs12632456	0.6082	0.395	0.2452	0.584	2.9510	P	T	P,P,B,B,P,P	B,B,B,B,B,B	603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];			COSM4158265	0.0833	0.3333	0.5833	35	155	n/a	n/a
chr3	58154327	58154327	C	T	het		QUAL=9587;DP=284;AF=0.49;MQM=60;TRIO=HET,284,0.49,WT,293,0.00,HET,371,0.47	FLNB	synonymous	FLNB:NM_001164317.1:synonymous:LOW:exon45/47:c.7452C>T:p.Ser2484Ser,FLNB:NM_001164318.1:synonymous:LOW:exon44/46:c.7326C>T:p.Ser2442Ser,FLNB:NM_001164319.1:synonymous:LOW:exon43/45:c.7287C>T:p.Ser2429Ser,FLNB:NM_001457.3:synonymous:LOW:exon44/46:c.7359C>T:p.Ser2453Ser		rs8640	0.5713	0.385	0.252	0.5023						603381 [FLNB (confirmed) Spondylocarpotarsal synostosis syndrome|Larsen syndrome|Atelosteogenesis,type I|Atelosteogenesis,type III|Boomerang dysplasia];				0.0758	0.3409	0.5833	40	152	n/a	n/a
chr3	58157519	58157519	G	C	het		QUAL=22135;DP=372;AF=0.48;MQM=60;TRIO=HET,372,0.48,HET,285,0.52,HOM,365,1.00	FLNB	3'UTR	FLNB:NM_001164317.1:3'UTR:MODIFIER:exon47/47:c.*1030G>C:,FLNB:NM_001164318.1:3'UTR:MODIFIER:exon46/46:c.*1030G>C:,FLNB:NM_001164319.1:3'UTR:MODIFIER:exon45/45:c.*1030G>C:,FLNB:NM_001457.3:3'UTR:MODIFIER:exon46/46:c.*1030G>C:		rs1131264	0.6931	0	0	0										0.1894	0.447	0.3636	26	70	n/a	n/a
chr3	58413405	58413405	T	C	het		QUAL=2561;DP=131;AF=0.40;MQM=60;TRIO=HET,131,0.40,WT,58,0.00,HET,74,0.50	PDHB	3'UTR	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*356A>G:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*356A>G:		rs1126737	0.3674	0.266	0	0										0.1061	0.3333	0.5606	23	110	n/a	n/a
chr3	58413408	58413408	A	G	het		QUAL=3968;DP=137;AF=0.59;MQM=60;TRIO=HET,137,0.59,HOM,59,1.00,WT,75,0.00	PDHB	3'UTR	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*353T>C:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*353T>C:		rs1126735	0.1847	0.241	0	0										0.1212	0.4773	0.4015	30	138	n/a	n/a
chr3	58413465	58413465	G	C	hom		QUAL=16741;DP=258;AF=1.00;MQM=60;TRIO=HOM,258,1.00,HOM,156,1.00,HET,192,0.53	PDHB	3'UTR	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*296C>G:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*296C>G:		rs7231	0.7418	0.726	0	0										0.6742	0.2955	0.0303	184	94	n/a	n/a
chr3	58413518	58413518	T	G	het		QUAL=11046;DP=206;AF=0.56;MQM=60;TRIO=HET,206,0.56,HOM,230,1.00,WT,273,0.00	PDHB	3'UTR	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*243A>C:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*243A>C:		rs1126722	0.2005	0.212	0	0										0.1212	0.4773	0.4015	31	138	n/a	n/a
chr3	58413662	58413662	G	A	het		QUAL=9983;DP=244;AF=0.41;MQM=60;TRIO=HET,244,0.41,WT,286,0.00,HET,376,0.56	PDHB	3'UTR	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*99C>T:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*99C>T:		rs7230	0.3672	0.272	0	0										0.1061	0.3333	0.5606	23	112	n/a	n/a
chr3	58413669	58413669	G	T	het		QUAL=13917;DP=274;AF=0.57;MQM=60;TRIO=HET,274,0.57,HOM,273,1.00,WT,372,0.01	PDHB	3'UTR	PDHB:NM_000925.3:3'UTR:MODIFIER:exon10/10:c.*92C>A:,PDHB:NM_001173468.1:3'UTR:MODIFIER:exon11/11:c.*92C>A:		rs4228	0.2047	0.245	0	0										0.1212	0.4773	0.4015	31	138	n/a	n/a
chr3	58416535	58416535	C	T	het		QUAL=30845;DP=278;AF=0.47;MQM=60;TRIO=HET,278,1.00,HOM,304,0.99,WT,405,1.00	PDHB	splice_region&intron,synonymous	PDHB:NM_001173468.1:splice_region&intron:LOW:exon6/10:c.404-20G>A:,PDHB:NM_000925.3:synonymous:LOW:exon6/10:c.438G>A:p.Gly146Gly		rs1126551	0.2047	0.283	0.0851	0.0288						179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency];	RCV000117898.2 [likely benign]; 		COSM3760211	0.1212	0.4848	0.3939	61	221	n/a	n/a
chr3	58416538	58416538	T	C	hom		QUAL=30845;DP=278;AF=0.47;MQM=60;TRIO=HOM,278,1.00,HOM,304,0.99,HOM,405,1.00	PDHB	synonymous,intron	PDHB:NM_000925.3:synonymous:LOW:exon6/10:c.435A>G:p.Arg145Arg,PDHB:NM_001173468.1:intron:MODIFIER:exon6/10:c.404-23A>G:		rs4264746	0.9848	0.995	0.9997	0.9408						179060 [PDHB (provisional) Pyruvate dehydrogenase E1-beta deficiency];	RCV000127406.1 [benign]; 			0.9848	0.0152	0	450	4	n/a	n/a
chr3	63850298	63850298	T	G	het		QUAL=13029;DP=288;AF=0.44;MQM=59;TRIO=HET,288,0.44,HET,163,0.46,HOM,243,1.00	ATXN7	5'UTR	ATXN7:NM_000333.3:5'UTR:MODIFIER:exon1/13:c.-488T>G:		rs6779372	0.7492	0	0	0										0.5682	0.3712	0.0606	84	57	n/a	n/a
chr3	63850299	63850299	G	C	het		QUAL=13029;DP=288;AF=0.44;MQM=59;TRIO=HET,288,0.44,HET,163,0.46,HOM,243,1.00	ATXN7	5'UTR	ATXN7:NM_000333.3:5'UTR:MODIFIER:exon1/13:c.-487G>C:		rs3733120	0.749	0	0	0										0.5682	0.3712	0.0606	84	57	n/a	n/a
chr3	63850660	63850660	C	G	het		QUAL=7442;DP=264;AF=0.52;MQM=60;TRIO=HET,264,0.52,WT,172,0.00,HET,222,0.50	ATXN7	5'UTR	ATXN7:NM_000333.3:5'UTR:MODIFIER:exon1/13:c.-126C>G:		rs3733121	0.1088	0	0	0										0.0076	0.2045	0.7879	1	30	n/a	n/a
chr3	63967900	63967900	A	G	het		QUAL=5950;DP=172;AF=0.48;MQM=60;TRIO=HET,172,0.48,WT,140,0.00,HET,202,0.53	ATXN7	missense	ATXN7:NM_001177387.1:missense:MODERATE:exon6/13:c.791A>G:p.Lys264Arg,ATXN7:NM_000333.3:missense:MODERATE:exon7/13:c.791A>G:p.Lys264Arg,ATXN7:NM_001128149.2:missense:MODERATE:exon3/9:c.356A>G:p.Lys119Arg		rs1053338	0.1146	0	0.1309	0.0351	4.0620	P	T	D,P,P	D,B,B	607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7];	RCV000116489.2 [likely benign]; 			0.0076	0.2121	0.7803	7	115	n/a	n/a
chr3	63981635	63981635	C	T	het		QUAL=8430;DP=267;AF=0.50;MQM=59;TRIO=HET,267,0.50,HET,252,0.56,WT,314,0.00	ATXN7	synonymous	ATXN7:NM_001177387.1:synonymous:LOW:exon11/13:c.2137C>T:p.Leu713Leu,ATXN7:NM_000333.3:synonymous:LOW:exon12/13:c.2137C>T:p.Leu713Leu,ATXN7:NM_001128149.2:synonymous:LOW:exon8/9:c.1702C>T:p.Leu568Leu		rs3733125	0.0905	0.096	0.1038	0.019						607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7];	RCV000116486.2 [likely benign]; 		COSM149408	0.0152	0.2045	0.7803	7	94	n/a	n/a
chr3	63982082	63982082	G	A	hom		QUAL=21813;DP=244;AF=0.99;MQM=60;TRIO=HOM,244,0.99,HET,208,0.55,HOM,315,1.00	ATXN7	missense	ATXN7:NM_001177387.1:missense:MODERATE:exon11/13:c.2584G>A:p.Val862Met,ATXN7:NM_000333.3:missense:MODERATE:exon12/13:c.2584G>A:p.Val862Met,ATXN7:NM_001128149.2:missense:MODERATE:exon8/9:c.2149G>A:p.Val717Met		rs3774729	0.4377	0.347	0.3071	0.5578	-0.2650	P	T	B,B,B	B,B,B	607640 [ATXN7 (confirmed) Spinocerebellar ataxia 7];	RCV000116488.2 [likely benign]; 		COSM1567156	0.0985	0.4394	0.4621	60	197	n/a	n/a
chr3	63986047	63986047	T	-	het		QUAL=5410;DP=193;AF=0.39;MQM=60;TRIO=HET,193,0.39,WT,65,0.00,HOM,110,0.91	ATXN7	3'UTR	ATXN7:NM_001177387.1:3'UTR:MODIFIER:exon13/13:c.*815delT:,ATXN7:NM_000333.3:3'UTR:MODIFIER:exon13/13:c.*907delT:,ATXN7:NM_001128149.2:3'UTR:MODIFIER:exon9/9:c.*907delT:		rs397841163	0.1999	0	0	0										0.0076	0.2955	0.697	1	43	n/a	n/a
chr3	63986170	63986170	A	G	hom		QUAL=23940;DP=386;AF=1.00;MQM=60;TRIO=HOM,386,1.00,HET,205,0.48,HOM,255,1.00	ATXN7	3'UTR	ATXN7:NM_001177387.1:3'UTR:MODIFIER:exon13/13:c.*935A>G:,ATXN7:NM_000333.3:3'UTR:MODIFIER:exon13/13:c.*1027A>G:,ATXN7:NM_001128149.2:3'UTR:MODIFIER:exon9/9:c.*1027A>G:		rs13272	0.5104	0	0	0										0.1136	0.4621	0.4242	16	73	n/a	n/a
chr3	63988171	63988171	C	T	het		QUAL=12810;DP=349;AF=0.47;MQM=60;TRIO=HET,349,0.47,WT,169,0.00,HOM,241,1.00	ATXN7	3'UTR	ATXN7:NM_001177387.1:3'UTR:MODIFIER:exon13/13:c.*2936C>T:,ATXN7:NM_000333.3:3'UTR:MODIFIER:exon13/13:c.*3028C>T:,ATXN7:NM_001128149.2:3'UTR:MODIFIER:exon9/9:c.*3028C>T:	(TG)n	rs3733126	0.1861	0	0	0										0.0076	0.2955	0.697	1	44	n/a	n/a
chr3	63988174	63988174	C	T	het		QUAL=7928;DP=351;AF=0.50;MQM=59;TRIO=HET,351,0.50,HET,164,0.42,WT,237,0.00	ATXN7	3'UTR	ATXN7:NM_001177387.1:3'UTR:MODIFIER:exon13/13:c.*2939C>T:,ATXN7:NM_000333.3:3'UTR:MODIFIER:exon13/13:c.*3031C>T:,ATXN7:NM_001128149.2:3'UTR:MODIFIER:exon9/9:c.*3031C>T:	(TG)n	rs3733127	0.2634	0	0	0										0.0152	0.2955	0.6894	3	44	n/a	n/a
chr3	81643167	81643167	T	C	hom		QUAL=27239;DP=327;AF=1.00;MQM=60;TRIO=HOM,327,1.00,HOM,222,1.00,HOM,278,1.00	GBE1	missense	GBE1:NM_000158.3:missense:MODERATE:exon8/16:c.1000A>G:p.Ile334Val		rs2172397	0.9836	0.969	0.9718	0.9961	5.5970	P	T	B,B	B,B	607839 [GBE1 (provisional) Glycogen storage disease IV|Polyglucosan body disease,adult form];				0.9394	0.0606	0	1052	70	n/a	n/a
chr3	81698130	81698130	T	C	het		QUAL=5923;DP=210;AF=0.48;MQM=60;TRIO=HET,210,0.48,WT,102,0.00,HET,155,0.52	GBE1	missense	GBE1:NM_000158.3:missense:MODERATE:exon5/16:c.568A>G:p.Arg190Gly		rs2229519	0.3215	0.307	0.3005	0.2766	3.4770	P	D	B,B	B,B	607839 [GBE1 (provisional) Glycogen storage disease IV|Polyglucosan body disease,adult form];	RCV000066196.2 [other]; 			0.1288	0.3939	0.4773	94	436	n/a	n/a
chr3	81810702	81810702	-	G	het		QUAL=1076;DP=23;AF=0.78;MQM=59;TRIO=HET,23,0.78,HOM,14,0.93,HET,14,0.86	GBE1	5'UTR	GBE1:NM_000158.3:5'UTR:MODIFIER:exon1/16:c.-35dupC:		rs11391701	0.9968	0.999	0.9714	0.9661										0.8485	0.1136	0.0379	670	16	n/a	n/a
chr3	81810725	81810725	C	T	het		QUAL=121;DP=9;AF=0.44;MQM=60;TRIO=HET,9,0.44,WT,10,0.00,HET,10,0.30	GBE1	5'UTR	GBE1:NM_000158.3:5'UTR:MODIFIER:exon1/16:c.-57G>A:		rs2290081	0.4209	0.329	0	0										0.1364	0.2955	0.5682	78	271	n/a	n/a
chr3	87308831	87308831	C	T	hom		QUAL=2143;DP=45;AF=1.00;MQM=60;TRIO=HOM,45,1.00,HOM,9,1.00,HOM,16,1.00	POU1F1	3'UTR	POU1F1:NM_001122757.2:3'UTR:MODIFIER:exon6/6:c.*213G>A:,POU1F1:NM_000306.3:3'UTR:MODIFIER:exon6/6:c.*213G>A:		rs6792500	1	0	0	0										1	0	0	150	0	n/a	n/a
chr3	87308904	87308904	T	A	het		QUAL=3974;DP=150;AF=0.57;MQM=60;TRIO=HET,150,0.57,HOM,43,1.00,WT,62,0.00	POU1F1	3'UTR	POU1F1:NM_001122757.2:3'UTR:MODIFIER:exon6/6:c.*140A>T:,POU1F1:NM_000306.3:3'UTR:MODIFIER:exon6/6:c.*140A>T:		rs33936108	0.2508	0	0	0										0.1818	0.4773	0.3409	28	72	n/a	n/a
chr3	101383562	101383562	G	A	het		QUAL=7147;DP=265;AF=0.49;MQM=60;TRIO=HET,265,0.49,WT,163,0.00,HET,201,0.43	ZBTB11	splice_region&intron	ZBTB11:NM_014415.3:splice_region&intron:LOW:exon4/10:c.1624-4C>T:		rs11712748	0.3307	0.323	0.3453	0.4294									COSM4002354	0.1136	0.4167	0.4697	30	143	n/a	n/a
chr3	121488995	121488995	C	G	hom		QUAL=17255;DP=306;AF=1.00;MQM=59;TRIO=HOM,306,1.00,HET,124,0.56,HOM,165,1.00	IQCB1	3'UTR	IQCB1:NM_001023570.2:3'UTR:MODIFIER:exon15/15:c.*197G>C:,IQCB1:NM_001023571.2:3'UTR:MODIFIER:exon12/12:c.*197G>C:		rs1135750	0.6212	0	0	0										0.3106	0.4773	0.2121	48	70	n/a	n/a
chr3	121500699	121500699	C	T	het		QUAL=3945;DP=194;AF=0.51;MQM=60;TRIO=HET,194,0.51,WT,56,0.00,HET,74,0.43	IQCB1	missense	IQCB1:NM_001023570.2:missense:MODERATE:exon13/15:c.1301G>A:p.Cys434Tyr,IQCB1:NM_001023571.2:missense:MODERATE:exon10/12:c.902G>A:p.Cys301Tyr		rs17849995	0.3027	0.289	0.2392	0.2329	2.8010	P	T	P,D	B,P	609237 [IQCB1 (provisional) Senior-Loken syndrome 5];				0.0758	0.4167	0.5076	31	180	n/a	n/a
chr3	121526204	121526204	G	A	hom		QUAL=18070;DP=306;AF=1.00;MQM=59;TRIO=HOM,306,1.00,HET,117,0.50,HOM,186,0.99	IQCB1	synonymous	IQCB1:NM_001023570.2:synonymous:LOW:exon7/15:c.574C>T:p.Leu192Leu,IQCB1:NM_001023571.2:synonymous:LOW:exon7/12:c.574C>T:p.Leu192Leu		rs4543051	0.62	0.627	0.6243	0.7074						609237 [IQCB1 (provisional) Senior-Loken syndrome 5];				0.3182	0.4848	0.197	170	201	n/a	n/a
chr3	121553853	121553858	CTCCCA	-	hom		QUAL=8437;DP=118;AF=0.99;MQM=59;TRIO=HOM,118,0.99,HET,132,0.43,HOM,135,1.00	IQCB1	5'UTR	IQCB1:NM_001023570.2:5'UTR:MODIFIER:exon1/15:c.-147_-142delTGGGAG:,IQCB1:NM_001023571.2:5'UTR:MODIFIER:exon1/12:c.-147_-142delTGGGAG:		rs72421117	0.6218	0	0	0										0.3182	0.4773	0.2045	49	69	n/a	n/a
chr3	121903266	121903266	G	A	hom		QUAL=3124;DP=10;AF=1.00;MQM=60;TRIO=HOM,10,1.00,HET,44,0.50,HOM,76,0.97	CASR	5'UTR,intron	CASR:NM_001178065.1:5'UTR:MODIFIER:exon1/7:c.-353G>A:,CASR:NM_000388.3:intron:MODIFIER:exon1/6:c.-243+607G>A:		rs9883981	0.2179	0	0	0										0.0606	0.3182	0.6212	8	51	n/a	n/a
chr3	122003045	122003045	G	C	hom		QUAL=35313;DP=317;AF=1.00;MQM=59;TRIO=HOM,317,1.00,HOM,360,1.00,HOM,411,1.00	CASR	synonymous	CASR:NM_001178065.1:synonymous:LOW:exon7/7:c.2274G>C:p.Pro758Pro,CASR:NM_000388.3:synonymous:LOW:exon7/7:c.2244G>C:p.Pro748Pro		rs2036400	0.9728	0.992	0.9994	0.9185						601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I|Hyperparathyroidism,neonatal|Hypocalcemia,autosomal dominant|Hypocalcemia,autosomal dominant,with Bartter syndrome|Epilepsy idiopathic generalized,susceptibility to,8|Hypercalciuric hypercalcemia|Calcium,serum level of];				0.9924	0.0076	0	449	2	n/a	n/a
chr3	122003832	122003832	G	C	het		QUAL=22065;DP=265;AF=0.49;MQM=59;TRIO=HET,265,0.49,HET,308,0.56,HOM,388,1.00	CASR	missense	CASR:NM_001178065.1:missense:MODERATE:exon7/7:c.3061G>C:p.Glu1021Gln,CASR:NM_000388.3:missense:MODERATE:exon7/7:c.3031G>C:p.Glu1011Gln		rs1801726	0.9241	0.945	0.9595	0.8364	1.1740	P	T	B	B	601199 [CASR (confirmed) Hypocalciuric hypercalcemia,type I|Hyperparathyroidism,neonatal|Hypocalcemia,autosomal dominant|Hypocalcemia,autosomal dominant,with Bartter syndrome|Epilepsy idiopathic generalized,susceptibility to,8|Hypercalciuric hypercalcemia|Calcium,serum level of];		CM045983 [CLASS=FP MUT=REF PHEN="Increased blood ionised calcium level" GENE=CASR]; 		0.9242	0.0758	0	420	34	n/a	n/a
chr3	122004098	122004098	A	T	het		QUAL=18414;DP=323;AF=0.47;MQM=60;TRIO=HET,323,0.47,HET,219,0.48,HOM,323,1.00	CASR	3'UTR	CASR:NM_001178065.1:3'UTR:MODIFIER:exon7/7:c.*60A>T:,CASR:NM_000388.3:3'UTR:MODIFIER:exon7/7:c.*60A>T:		rs4677948	0.9201	0	0	0										0.9242	0.0758	0	137	13	n/a	n/a
chr3	122004612	122004612	C	G	hom		QUAL=39976;DP=438;AF=1.00;MQM=59;TRIO=HOM,438,1.00,HOM,354,1.00,HOM,420,1.00	CASR	3'UTR	CASR:NM_001178065.1:3'UTR:MODIFIER:exon7/7:c.*574C>G:,CASR:NM_000388.3:3'UTR:MODIFIER:exon7/7:c.*574C>G:		rs6438718	0.9687	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr3	122005053	122005053	A	G	het		QUAL=7913;DP=227;AF=0.49;MQM=60;TRIO=HET,227,0.49,WT,218,0.00,HET,268,0.51	CASR	3'UTR	CASR:NM_001178065.1:3'UTR:MODIFIER:exon7/7:c.*1015A>G:,CASR:NM_000388.3:3'UTR:MODIFIER:exon7/7:c.*1015A>G:		rs9740	0.1815	0	0	0										0.0833	0.5227	0.3939	12	78	n/a	n/a
chr3	122005236	122005236	T	C	het		QUAL=7408;DP=315;AF=0.45;MQM=60;TRIO=HET,315,0.45,WT,104,0.01,HET,151,0.55	CASR	3'UTR	CASR:NM_001178065.1:3'UTR:MODIFIER:exon7/7:c.*1198T>C:,CASR:NM_000388.3:3'UTR:MODIFIER:exon7/7:c.*1198T>C:	MIRb	rs10190	0.5331	0	0	0										0.5303	0.4091	0.0606	77	62	n/a	n/a
chr3	128622922	128622922	G	A	het		QUAL=13839;DP=418;AF=0.46;MQM=60;TRIO=HET,418,0.46,WT,358,0.00,HET,517,0.47	ACAD9	missense	ACAD9:NM_014049.4:missense:MODERATE:exon10/18:c.976G>A:p.Ala326Thr		rs115532916	0.0078	0.018	0.0219	0.0023	6.9770	D	D	D,D	D,D	611103 [ACAD9 (confirmed) ACAD9 deficiency];	RCV000123467.1,RCV000023868.1 [benign,pathogenic]; 			0	0.1136	0.8864	1	31	2	n/a
chr3	128887147	128887147	C	T	hom		QUAL=27979;DP=304;AF=1.00;MQM=59;TRIO=HOM,304,1.00,HOM,231,1.00,HOM,313,1.00	CNBP	3'UTR	CNBP:NM_001127192.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_001127193.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_001127194.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_001127195.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_001127196.1:3'UTR:MODIFIER:exon5/5:c.*2149G>A:,CNBP:NM_003418.4:3'UTR:MODIFIER:exon5/5:c.*2149G>A:		rs9880375	0.978	0	0	0										0.9394	0.0606	0	139	10	n/a	n/a
chr3	128887527	128887527	A	G	hom		QUAL=7080;DP=135;AF=1.00;MQM=60;TRIO=HOM,135,1.00,HOM,44,1.00,HOM,37,1.00	CNBP	3'UTR	CNBP:NM_001127192.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_001127193.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_001127194.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_001127195.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_001127196.1:3'UTR:MODIFIER:exon5/5:c.*1769T>C:,CNBP:NM_003418.4:3'UTR:MODIFIER:exon5/5:c.*1769T>C:	AluSx	rs12633752	0.8764	0	0	0										0.9318	0.0682	0	138	11	n/a	n/a
chr3	128887783	128887783	-	A	het		QUAL=141;DP=7;AF=0.71;MQM=52;TRIO=HET,7,0.71,WT,1,0.00,HOM,3,1.00	CNBP	3'UTR	CNBP:NM_001127192.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_001127193.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_001127194.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_001127195.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_001127196.1:3'UTR:MODIFIER:exon5/5:c.*1512dupT:,CNBP:NM_003418.4:3'UTR:MODIFIER:exon5/5:c.*1512dupT:	AluY	rs11401192	0.8157	0	0	0										0.2197	0.0455	0.7348	36	7	n/a	n/a
chr3	128887862	128887862	A	G	hom		QUAL=309;DP=10;AF=1.00;MQM=43;TRIO=HOM,10,1.00,NONE,0,0,NONE,0,0	CNBP	3'UTR	CNBP:NM_001127192.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_001127193.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_001127194.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_001127195.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_001127196.1:3'UTR:MODIFIER:exon5/5:c.*1434T>C:,CNBP:NM_003418.4:3'UTR:MODIFIER:exon5/5:c.*1434T>C:	AluY	rs6792159	0.9687	0	0	0										0.4167	0.0303	0.553	67	7	n/a	n/a
chr3	128890350	128890350	G	A	hom		QUAL=36950;DP=380;AF=1.00;MQM=60;TRIO=HOM,380,1.00,HOM,336,1.00,HOM,405,1.00	CNBP	synonymous	CNBP:NM_001127192.1:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp,CNBP:NM_001127193.1:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp,CNBP:NM_001127194.1:synonymous:LOW:exon3/5:c.135C>T:p.Asp45Asp,CNBP:NM_001127195.1:synonymous:LOW:exon3/5:c.135C>T:p.Asp45Asp,CNBP:NM_001127196.1:synonymous:LOW:exon3/5:c.135C>T:p.Asp45Asp,CNBP:NM_003418.4:synonymous:LOW:exon3/5:c.156C>T:p.Asp52Asp		rs4303883	0.7572	0.89	0.9695	0.4433						116955 [CNBP (confirmed) Myotonic dystrophy 2];				0.9242	0.0758	0	399	52	n/a	n/a
chr3	142168331	142168331	C	T	het		QUAL=25891;DP=517;AF=0.44;MQM=60;TRIO=HET,517,0.44,HET,316,0.50,HOM,403,1.00	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon47/47:c.7875G>A:p.Gln2625Gln		rs1802904	0.9163	0.865	0.8614	0.9689						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079601.3 [other]; 			0.6288	0.2955	0.0758	730	238	n/a	n/a
chr3	142178144	142178144	C	T	het		QUAL=12545;DP=394;AF=0.44;MQM=60;TRIO=HET,394,0.44,HET,178,0.48,HET,270,0.45	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln		rs2229032	0.1022	0.132	0.1578	0.0881	0.0440	P	T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000123787.1 [benign]; RCV000145330.1 [benign]; 		COSM149485	0.0303	0.2348	0.7348	29	262	n/a	n/a
chr3	142277575	142277575	A	T	het		QUAL=9539;DP=160;AF=0.53;MQM=60;TRIO=HET,160,0.53,HET,171,0.52,HET,218,0.56	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon8/47:c.1776T>A:p.Gly592Gly		rs2227930	0.598	0.553	0.595	0.7957						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145291.2 [other]; 		COSM149486	0.303	0.4697	0.2273	346	453	n/a	n/a
chr3	142281612	142281612	A	G	het		QUAL=9974;DP=255;AF=0.49;MQM=60;TRIO=HET,255,0.49,HET,163,0.49,HET,202,0.51	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon4/47:c.632T>C:p.Met211Thr		rs2227928	0.5974	0.552	0.5955	0.7928	1.2730	P	T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079600.3 [other]; 		COSM149487	0.303	0.4697	0.2273	345	452	n/a	n/a
chr3	150644247	150644247	C	T	het		QUAL=9313;DP=291;AF=0.51;MQM=60;TRIO=HET,291,0.51,HOM,150,1.00,WT,158,0.01	CLRN1	3'UTR	CLRN1:NM_052995.2:3'UTR:MODIFIER:exon4/4:c.*392G>A:		rs3796239	0.6408	0	0	0						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				0.4167	0.4545	0.1288	65	66	n/a	n/a
chr3	150645351	150645351	G	A	het		QUAL=5884;DP=248;AF=0.43;MQM=60;TRIO=HET,248,0.43,HOM,71,1.00,WT,146,0.00	CLRN1	3'UTR,intron	CLRN1:NM_001195794.1:3'UTR:MODIFIER:exon4/4:c.*372C>T:,CLRN1:NM_001256819.1:3'UTR:MODIFIER:exon4/4:c.*685C>T:,CLRN1:NM_174878.2:3'UTR:MODIFIER:exon3/3:c.*372C>T:,CLRN1:NM_052995.2:intron:MODIFIER:exon3/3:c.342+501C>T:		rs4680058	0.7778	0.578	0	0						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				0.6061	0.303	0.0909	155	104	n/a	n/a
chr3	150645408	150645408	G	A	het		QUAL=6316;DP=235;AF=0.50;MQM=60;TRIO=HET,235,0.50,HOM,76,1.00,WT,117,0.00	CLRN1	3'UTR,intron	CLRN1:NM_001195794.1:3'UTR:MODIFIER:exon4/4:c.*315C>T:,CLRN1:NM_001256819.1:3'UTR:MODIFIER:exon4/4:c.*628C>T:,CLRN1:NM_174878.2:3'UTR:MODIFIER:exon3/3:c.*315C>T:,CLRN1:NM_052995.2:intron:MODIFIER:exon3/3:c.342+444C>T:		rs1456138	0.7768	0.55	0	0						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				0.6061	0.303	0.0909	156	103	n/a	n/a
chr3	150645442	150645443	CA	-	het		QUAL=3288;DP=186;AF=0.35;MQM=59;TRIO=HET,186,0.35,HOM,57,0.74,WT,95,0.03	CLRN1	3'UTR,intron	CLRN1:NM_001195794.1:3'UTR:MODIFIER:exon4/4:c.*280_*281delTG:,CLRN1:NM_001256819.1:3'UTR:MODIFIER:exon4/4:c.*593_*594delTG:,CLRN1:NM_174878.2:3'UTR:MODIFIER:exon3/3:c.*280_*281delTG:,CLRN1:NM_052995.2:intron:MODIFIER:exon3/3:c.342+409_342+410delTG:	(CA)n		0	0	0	0						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				0	0	1	0	0	n/a	n/a
chr3	150661842	150661842	T	G	het		QUAL=12378;DP=406;AF=0.49;MQM=59;TRIO=HET,406,0.49,WT,336,0.00,HET,438,0.42	CLRN1	5'UTR,intron	CLRN1:NM_052995.2:5'UTR:MODIFIER:exon1/4:c.-211A>C:,CLRN1:NM_001195794.1:intron:MODIFIER:exon1/3:c.254-2294A>C:,CLRN1:NM_001256819.1:intron:MODIFIER:exon1/3:c.254-64A>C:,CLRN1:NM_174878.2:intron:MODIFIER:exon1/2:c.254-2294A>C:	L2a	rs11914988	0.272	0	0	0						606397 [CLRN1 (confirmed) Usher syndrome,type 3A|Retinitis pigmentosa 61];				0.0227	0.3182	0.6591	5	50	n/a	n/a
chr3	150690566	150690566	T	C	het		QUAL=30805;DP=410;AF=0.52;MQM=59;TRIO=HET,410,0.52,HOM,464,1.00,HET,593,0.50	CLRN1	5'UTR	CLRN1:NM_001195794.1:5'UTR:MODIFIER:exon1/4:c.-71A>G:,CLRN1:NM_001256819.1:5'UTR:MODIFIER:exon1/4:c.-71A>G:,CLRN1:NM_174878.2:5'UTR:MODIFIER:exon1/3:c.-71A>G:		rs3796240	0.4692	0.512	0	0										0.3409	0.4924	0.1667	100	139	n/a	n/a
chr3	155572067	155572067	G	A	het		QUAL=3135;DP=59;AF=0.56;MQM=60;TRIO=HET,59,0.56,HET,136,0.52,WT,175,0.00	SLC33A1	5'UTR	SLC33A1:NM_001190992.1:5'UTR:MODIFIER:exon1/7:c.-281C>T:,SLC33A1:NM_004733.3:5'UTR:MODIFIER:exon1/6:c.-281C>T:		rs560777515	0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr3	158362391	158362391	C	T	hom		QUAL=10373;DP=136;AF=1.00;MQM=59;TRIO=HOM,136,1.00,HOM,123,1.00,HET,209,0.45	GFM1	5'UTR	GFM1:NM_024996.5:5'UTR:MODIFIER:exon1/18:c.-33C>T:		rs28372852	0.1474	0.11	0.1833	0.1004										0.053	0.3636	0.5833	11	55	n/a	n/a
chr3	158362441	158362441	T	C	hom		QUAL=12308;DP=216;AF=1.00;MQM=60;TRIO=HOM,216,1.00,HOM,110,1.00,HET,206,0.46	GFM1	synonymous	GFM1:NM_024996.5:synonymous:LOW:exon1/18:c.18T>C:p.Ala6Ala		rs1864507	0.5831	0.494	0.5389	0.7166						606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1];			COSM3721924	0.3939	0.447	0.1591	160	211	n/a	n/a
chr3	158366900	158366900	G	A	hom		QUAL=13242;DP=237;AF=0.99;MQM=60;TRIO=HOM,237,0.99,HOM,114,1.00,HET,140,0.36	GFM1	missense	GFM1:NM_024996.5:missense:MODERATE:exon5/18:c.643G>A:p.Val215Ile		rs2303909	0.5833	0.547	0.5388	0.7147	3.3150	P	T	B,B,B	B,B,B	606639 [GFM1 (confirmed) Combined oxidative phosphorylation deficiency 1];			COSM4002505	0.3939	0.447	0.1591	161	213	n/a	n/a
chr3	158409262	158409262	C	T	hom		QUAL=17802;DP=293;AF=1.00;MQM=60;TRIO=HOM,293,1.00,HOM,142,1.00,HET,235,0.49	GFM1	3'UTR	GFM1:NM_024996.5:3'UTR:MODIFIER:exon18/18:c.*6C>T:		rs1047355	0.4091	0.366	0.3747	0.5942										0.1894	0.4545	0.3561	80	200	n/a	n/a
chr3	158409482	158409482	C	T	hom		QUAL=3309;DP=88;AF=1.00;MQM=60;TRIO=HOM,88,1.00,HOM,7,1.00,HET,6,0.50	GFM1	3'UTR	GFM1:NM_024996.5:3'UTR:MODIFIER:exon18/18:c.*226C>T:		rs1047366	0.5833	0	0	0										0.3864	0.447	0.1667	56	66	n/a	n/a
chr3	158409708	158409710	TTG	-	hom		QUAL=8195;DP=149;AF=0.99;MQM=60;TRIO=HOM,149,0.99,HOM,78,0.99,HET,86,0.38	GFM1	3'UTR	GFM1:NM_024996.5:3'UTR:MODIFIER:exon18/18:c.*454_*456delGTT:		rs367730845	0.1472	0	0	0										0.053	0.3636	0.5833	7	52	n/a	n/a
chr3	158409947	158409947	T	A	hom		QUAL=10072;DP=150;AF=0.99;MQM=60;TRIO=HOM,150,0.99,HOM,93,1.00,HET,133,0.53	GFM1	3'UTR	GFM1:NM_024996.5:3'UTR:MODIFIER:exon18/18:c.*691T>A:		rs8650	0.4091	0	0	0										0.1894	0.4545	0.3561	27	67	n/a	n/a
chr3	182755209	182755209	T	G	hom		QUAL=12353;DP=186;AF=0.99;MQM=60;TRIO=HOM,186,0.99,HET,201,0.50,HET,240,0.47	MCCC1	missense	MCCC1:NM_020166.4:missense:MODERATE:exon13/19:c.1391A>C:p.His464Pro,MCCC1:NM_001293273.1:missense:MODERATE:exon11/17:c.1040A>C:p.His347Pro		rs2270968	0.4649	0.623	0.7371	0.2876	1.1180	P	T	B,B,B	B,B,B	609010 [MCCC1 (confirmed) 3-Methylcrotonyl-CoA carboxylase 1 deficiency];	RCV000081992.2 [benign]; 		COSM4002526	0.4773	0.4015	0.1212	351	293	n/a	n/a
chr3	182790249	182790249	G	A	hom		QUAL=16214;DP=183;AF=1.00;MQM=60;TRIO=HOM,183,1.00,HOM,116,1.00,HOM,200,1.00	MCCC1	synonymous,intron	MCCC1:NM_020166.4:synonymous:LOW:exon5/19:c.396C>T:p.Leu132Leu,MCCC1:NM_001293273.1:intron:MODIFIER:exon3/16:c.141-1104C>T:		rs7622479	0.9155	0.929	0.9308	0.7966						609010 [MCCC1 (confirmed) 3-Methylcrotonyl-CoA carboxylase 1 deficiency];	RCV000081994.2 [benign]; 			0.8333	0.1591	0.0076	601	105	n/a	n/a
chr3	182817328	182817328	C	G	hom		QUAL=16285;DP=67;AF=1.00;MQM=59;TRIO=HOM,67,1.00,HOM,203,1.00,HOM,263,1.00	MCCC1	5'UTR	MCCC1:NM_020166.4:5'UTR:MODIFIER:exon1/19:c.-100G>C:,MCCC1:NM_001293273.1:5'UTR:MODIFIER:exon1/17:c.-192G>C:		rs937652	0.5449	0	0	0										0.5455	0.3939	0.0606	81	58	n/a	n/a
chr3	190023552	190023552	T	C	hom		QUAL=12511;DP=223;AF=0.98;MQM=60;TRIO=HOM,223,0.98,HOM,87,1.00,HET,139,0.52	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*2514A>G:		rs8298	0.7212	0	0	0										0.3258	0.4773	0.197	50	72	n/a	n/a
chr3	190023837	190023837	A	G	hom		QUAL=22128;DP=384;AF=0.99;MQM=60;TRIO=HOM,384,0.99,HOM,175,0.99,HET,248,0.46	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*2229T>C:		rs8798	0.7143	0	0	0										0.3258	0.4773	0.197	50	72	n/a	n/a
chr3	190024057	190024057	C	T	hom		QUAL=35392;DP=634;AF=1.00;MQM=60;TRIO=HOM,634,1.00,HOM,261,1.00,HET,333,0.50	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*2009G>A:		rs1364722	0.7005	0	0	0										0.3258	0.4773	0.197	50	72	n/a	n/a
chr3	190024103	190024103	T	C	hom		QUAL=31558;DP=547;AF=1.00;MQM=60;TRIO=HOM,547,1.00,HOM,248,1.00,HET,293,0.50	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*1963A>G:		rs1895708	0.7021	0	0	0										0.3258	0.4773	0.197	50	72	n/a	n/a
chr3	190024188	190024188	G	A	hom		QUAL=25659;DP=471;AF=1.00;MQM=60;TRIO=HOM,471,1.00,HOM,192,1.00,HET,240,0.48	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*1878C>T:		rs2204226	0.6969	0	0	0										0.3258	0.4773	0.197	51	71	n/a	n/a
chr3	190024457	190024457	A	G	hom		QUAL=38588;DP=544;AF=0.99;MQM=60;TRIO=HOM,544,0.99,HOM,399,1.00,HET,533,0.45	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*1609T>C:	MIRc	rs9290928	0.7011	0	0	0										0.3258	0.4773	0.197	51	71	n/a	n/a
chr3	190024643	190024643	G	T	hom		QUAL=58135;DP=693;AF=0.99;MQM=59;TRIO=HOM,693,0.99,HOM,698,1.00,HET,982,0.47	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*1423C>A:		rs1060680	0.1166	0	0	0										0.0227	0.2955	0.6818	3	46	n/a	n/a
chr3	190025617	190025617	T	A	hom		QUAL=16217;DP=233;AF=0.99;MQM=60;TRIO=HOM,233,0.99,HOM,162,1.00,HET,199,0.54	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*449A>T:		rs9825098	0.6975	0	0	0										0.3182	0.4848	0.197	50	72	n/a	n/a
chr3	190025618	190025618	A	G	hom		QUAL=16217;DP=233;AF=0.99;MQM=60;TRIO=HOM,233,0.99,HOM,162,1.00,HET,199,0.54	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*448T>C:		rs9842576	0.6969	0	0	0										0.3182	0.4848	0.197	50	72	n/a	n/a
chr3	190025805	190025805	G	T	hom		QUAL=10120;DP=208;AF=0.99;MQM=60;TRIO=HOM,208,0.99,HOM,59,1.00,HET,83,0.51	CLDN1	3'UTR	CLDN1:NM_021101.4:3'UTR:MODIFIER:exon4/4:c.*261C>A:		rs1043747	0.7007	0	0	0										0.3258	0.4773	0.197	51	71	n/a	n/a
chr3	190030680	190030680	A	G	hom		QUAL=16433;DP=126;AF=1.00;MQM=60;TRIO=HOM,126,1.00,HOM,171,1.00,HOM,235,1.00	CLDN1	synonymous	CLDN1:NM_021101.4:synonymous:LOW:exon2/4:c.369T>C:p.Gly123Gly		rs9869263	0.8111	0.833	0.8478	0.7696						603718 [CLDN1 (confirmed) Ichthyosis,leukocyte vacuoles,alopecia,and sclerosing cholangitis];				0.697	0.2803	0.0227	333	111	n/a	n/a
chr3	190040008	190040008	C	G	het		QUAL=5850;DP=183;AF=0.46;MQM=59;TRIO=HET,183,0.46,HET,219,0.53,WT,286,0.00	CLDN1	5'UTR	CLDN1:NM_021101.4:5'UTR:MODIFIER:exon1/4:c.-13G>C:		rs17429833	0.0509	0.065	0.0849	0.0309										0.0076	0.1212	0.8712	1	17	n/a	n/a
chr3	190040207	190040207	C	A	het		QUAL=5866;DP=262;AF=0.54;MQM=60;TRIO=HET,262,0.54,HOM,37,1.00,HET,61,0.52	CLDN1	5'UTR	CLDN1:NM_021101.4:5'UTR:MODIFIER:exon1/4:c.-212G>T:		rs12696600	0.6625	0	0	0										0.1894	0.4773	0.3333	32	72	n/a	n/a
chr3	193355074	193355074	T	C	hom		QUAL=11234;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HET,105,0.42,HOM,149,0.99	OPA1	splice_region&intron	OPA1:NM_130837.2:splice_region&intron:LOW:exon10/30:c.1035+4T>C:,OPA1:NM_015560.2:splice_region&intron:LOW:exon8/28:c.870+4T>C:,OPA1:NM_130831.2:splice_region&intron:LOW:exon7/27:c.762+4T>C:,OPA1:NM_130832.2:splice_region&intron:LOW:exon8/28:c.816+4T>C:,OPA1:NM_130833.2:splice_region&intron:LOW:exon8/28:c.873+4T>C:,OPA1:NM_130834.2:splice_region&intron:LOW:exon9/29:c.924+4T>C:,OPA1:NM_130835.2:splice_region&intron:LOW:exon9/29:c.927+4T>C:,OPA1:NM_130836.2:splice_region&intron:LOW:exon9/29:c.981+4T>C:		rs166850	0.9229	0.872	0.8263	0.9594						605290 [OPA1 (confirmed) Optic atrophy 1|Glaucoma,normal tension,susceptibility to|Optic atrophy plus syndrome];	RCV000081773.2 [benign]; RCV000127276.1 [benign]; 			0.6364	0.3258	0.0379	1013	370	n/a	n/a
chr3	193412672	193412672	A	G	het		QUAL=13896;DP=322;AF=0.54;MQM=60;TRIO=HET,322,0.54,WT,228,0.01,HOM,251,1.00	OPA1	3'UTR	OPA1:NM_130837.2:3'UTR:MODIFIER:exon31/31:c.*283A>G:,OPA1:NM_015560.2:3'UTR:MODIFIER:exon29/29:c.*283A>G:,OPA1:NM_130831.2:3'UTR:MODIFIER:exon28/28:c.*283A>G:,OPA1:NM_130832.2:3'UTR:MODIFIER:exon29/29:c.*283A>G:,OPA1:NM_130833.2:3'UTR:MODIFIER:exon29/29:c.*283A>G:,OPA1:NM_130834.2:3'UTR:MODIFIER:exon30/30:c.*283A>G:,OPA1:NM_130835.2:3'UTR:MODIFIER:exon30/30:c.*283A>G:,OPA1:NM_130836.2:3'UTR:MODIFIER:exon30/30:c.*283A>G:		rs1061648	0.6412	0	0	0										0.3788	0.4621	0.1591	58	66	n/a	n/a
chr3	193412949	193412949	T	C	hom		QUAL=20515;DP=331;AF=0.99;MQM=60;TRIO=HOM,331,0.99,HET,186,0.50,HOM,191,1.00	OPA1	3'UTR	OPA1:NM_130837.2:3'UTR:MODIFIER:exon31/31:c.*560T>C:,OPA1:NM_015560.2:3'UTR:MODIFIER:exon29/29:c.*560T>C:,OPA1:NM_130831.2:3'UTR:MODIFIER:exon28/28:c.*560T>C:,OPA1:NM_130832.2:3'UTR:MODIFIER:exon29/29:c.*560T>C:,OPA1:NM_130833.2:3'UTR:MODIFIER:exon29/29:c.*560T>C:,OPA1:NM_130834.2:3'UTR:MODIFIER:exon30/30:c.*560T>C:,OPA1:NM_130835.2:3'UTR:MODIFIER:exon30/30:c.*560T>C:,OPA1:NM_130836.2:3'UTR:MODIFIER:exon30/30:c.*560T>C:		rs7643844	0.9137	0	0	0										0.6818	0.2879	0.0303	104	41	n/a	n/a
chr3	193413502	193413502	C	T	het		QUAL=9372;DP=275;AF=0.53;MQM=60;TRIO=HET,275,0.53,WT,126,0.00,HOM,135,1.00	OPA1	3'UTR	OPA1:NM_130837.2:3'UTR:MODIFIER:exon31/31:c.*1113C>T:,OPA1:NM_015560.2:3'UTR:MODIFIER:exon29/29:c.*1113C>T:,OPA1:NM_130831.2:3'UTR:MODIFIER:exon28/28:c.*1113C>T:,OPA1:NM_130832.2:3'UTR:MODIFIER:exon29/29:c.*1113C>T:,OPA1:NM_130833.2:3'UTR:MODIFIER:exon29/29:c.*1113C>T:,OPA1:NM_130834.2:3'UTR:MODIFIER:exon30/30:c.*1113C>T:,OPA1:NM_130835.2:3'UTR:MODIFIER:exon30/30:c.*1113C>T:,OPA1:NM_130836.2:3'UTR:MODIFIER:exon30/30:c.*1113C>T:		rs12630	0.5958	0	0	0										0.2576	0.4394	0.303	41	62	n/a	n/a
chr3	193413732	193413732	A	G	het		QUAL=14212;DP=330;AF=0.50;MQM=60;TRIO=HET,330,0.50,WT,212,0.00,HOM,263,1.00	OPA1	3'UTR	OPA1:NM_130837.2:3'UTR:MODIFIER:exon31/31:c.*1343A>G:,OPA1:NM_015560.2:3'UTR:MODIFIER:exon29/29:c.*1343A>G:,OPA1:NM_130831.2:3'UTR:MODIFIER:exon28/28:c.*1343A>G:,OPA1:NM_130832.2:3'UTR:MODIFIER:exon29/29:c.*1343A>G:,OPA1:NM_130833.2:3'UTR:MODIFIER:exon29/29:c.*1343A>G:,OPA1:NM_130834.2:3'UTR:MODIFIER:exon30/30:c.*1343A>G:,OPA1:NM_130835.2:3'UTR:MODIFIER:exon30/30:c.*1343A>G:,OPA1:NM_130836.2:3'UTR:MODIFIER:exon30/30:c.*1343A>G:		rs1056366	0.6963	0	0	0										0.3864	0.4545	0.1591	59	65	n/a	n/a
chr3	196769762	196769762	-	T	hom		QUAL=12699;DP=199;AF=0.97;MQM=60;TRIO=HOM,199,0.97,HOM,113,0.97,HOM,91,0.99	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*1731dupA:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*1731dupA:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*1731dupA:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*1731dupA:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*1731dupA:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*1731dupA:		rs386399009	0	0	0	0										0.553	0.4167	0.0303	84	58	n/a	n/a
chr3	196769797	196769797	A	G	hom		QUAL=15347;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,102,1.00,HOM,103,1.00	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*1697T>C:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*1697T>C:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*1697T>C:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*1697T>C:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*1697T>C:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*1697T>C:		rs7753	0.6174	0	0	0										0.3485	0.5227	0.1288	56	73	n/a	n/a
chr3	196769982	196769982	C	G	het		QUAL=12945;DP=363;AF=0.47;MQM=60;TRIO=HET,363,0.47,HOM,129,1.00,HET,174,0.50	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*1512G>C:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*1512G>C:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*1512G>C:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*1512G>C:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*1512G>C:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*1512G>C:		rs7641	0.3636	0	0	0										0.1591	0.4545	0.3864	26	66	n/a	n/a
chr3	196770356	196770359	AAGG	-	hom		QUAL=8073;DP=119;AF=0.99;MQM=60;TRIO=HOM,119,0.99,HOM,57,1.00,HOM,88,1.00	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*1135_*1138delCCTT:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*1135_*1138delCCTT:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*1135_*1138delCCTT:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*1135_*1138delCCTT:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*1135_*1138delCCTT:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*1135_*1138delCCTT:		rs569151903	0.7562	0	0	0										0.5303	0.4394	0.0303	81	61	n/a	n/a
chr3	196771245	196771245	G	A	hom		QUAL=33855;DP=490;AF=1.00;MQM=60;TRIO=HOM,490,1.00,HOM,254,1.00,HOM,280,1.00	DLG1	3'UTR	DLG1:NM_004087.2:3'UTR:MODIFIER:exon26/26:c.*249C>T:,DLG1:NM_001204387.1:3'UTR:MODIFIER:exon22/22:c.*249C>T:,DLG1:NM_001204388.1:3'UTR:MODIFIER:exon21/21:c.*249C>T:,DLG1:NM_001098424.1:3'UTR:MODIFIER:exon26/26:c.*249C>T:,DLG1:NM_001204386.1:3'UTR:MODIFIER:exon25/25:c.*249C>T:,DLG1:NM_001290983.1:3'UTR:MODIFIER:exon26/26:c.*249C>T:		rs4916600	0.7478	0	0	0										0.5455	0.4242	0.0303	83	59	n/a	n/a
chr3	196865242	196865242	C	T	het		QUAL=3163;DP=146;AF=0.46;MQM=60;TRIO=HET,146,0.46,WT,55,0.00,HET,72,0.54	DLG1	missense	DLG1:NM_004087.2:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln,DLG1:NM_001204387.1:missense:MODERATE:exon5/22:c.485G>A:p.Arg162Gln,DLG1:NM_001204388.1:missense:MODERATE:exon5/21:c.485G>A:p.Arg162Gln,DLG1:NM_001098424.1:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln,DLG1:NM_001204386.1:missense:MODERATE:exon9/25:c.734G>A:p.Arg245Gln,DLG1:NM_001290983.1:missense:MODERATE:exon10/26:c.833G>A:p.Arg278Gln		rs1134986	0.128	0.155	0.1473	0.0252	7.4450	P	T	P,P,D,D,D,P,D	B,B,D,D,D,P,D			CM146495 [CLASS=DM? MUT=ALT PHEN="Crohn's disease, susceptibility to" GENE=DLG1]; 		0.0379	0.2348	0.7273	11	75	n/a	n/a
chr4	1807894	1807894	G	A	hom		QUAL=33538;DP=120;AF=1.00;MQM=60;TRIO=HOM,120,1.00,HOM,404,1.00,HOM,563,1.00	FGFR3	synonymous	FGFR3:NM_001163213.1:synonymous:LOW:exon14/18:c.1959G>A:p.Thr653Thr,FGFR3:NM_000142.4:synonymous:LOW:exon14/18:c.1953G>A:p.Thr651Thr,FGFR3:NM_022965.3:synonymous:LOW:exon12/16:c.1617G>A:p.Thr539Thr		rs7688609	0.9561	0.987	0.9992	0.869						134934 [FGFR3 (confirmed) Achondroplasia|Hypochondroplasia|Thanatophoric dysplasia,type I|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Bladder cancer,somatic|Colorectal cancer,somatic|Cervical cancer,somatic|LADD syndrome|CATSHL syndrome|Nevus,epidermal,somatic|Thanatophoric dysplasia,type II|Spermatocytic seminoma,somatic];				1	0	0	500	1	n/a	n/a
chr4	1809128	1809129	GT	-	hom		QUAL=6316;DP=43;AF=0.91;MQM=60;TRIO=HOM,43,0.91,HOM,90,0.90,HOM,110,0.92	FGFR3	3'UTR	FGFR3:NM_001163213.1:3'UTR:MODIFIER:exon18/18:c.*156_*157delTG:,FGFR3:NM_000142.4:3'UTR:MODIFIER:exon18/18:c.*156_*157delTG:,FGFR3:NM_022965.3:3'UTR:MODIFIER:exon16/16:c.*156_*157delTG:	(TG)n	rs397821865	0	0	0	0									COSN504965	0.803	0.1136	0.0833	216	30	n/a	n/a
chr4	1809787	1809787	C	T	hom		QUAL=9127;DP=156;AF=1.00;MQM=60;TRIO=HOM,156,1.00,HOM,69,0.99,HOM,82,1.00	FGFR3	3'UTR	FGFR3:NM_001163213.1:3'UTR:MODIFIER:exon18/18:c.*798C>T:,FGFR3:NM_000142.4:3'UTR:MODIFIER:exon18/18:c.*798C>T:,FGFR3:NM_022965.3:3'UTR:MODIFIER:exon16/16:c.*798C>T:		rs3135904	0.8982	0	0	0										0.9924	0.0076	0	169	1	n/a	n/a
chr4	1981229	1981229	G	T	het		QUAL=7806;DP=255;AF=0.52;MQM=59;TRIO=HET,255,0.52,HET,235,0.48,WT,285,0.00	WHSC1	3'UTR	WHSC1:NM_001042424.2:3'UTR:MODIFIER:exon22/22:c.*593G>T:,WHSC1:NM_133330.2:3'UTR:MODIFIER:exon24/24:c.*593G>T:,WHSC1:NM_133331.2:3'UTR:MODIFIER:exon23/23:c.*593G>T:,WHSC1:NM_133335.3:3'UTR:MODIFIER:exon22/22:c.*593G>T:		rs73202837	0.0443	0	0	0										0	0.1061	0.8939	0	15	n/a	n/a
chr4	3475252	3475252	T	C	hom		QUAL=7587;DP=58;AF=1.00;MQM=60;TRIO=HOM,58,1.00,HOM,59,1.00,HOM,132,1.00	DOK7	synonymous	DOK7:NM_001301071.1:synonymous:LOW:exon3/10:c.220T>C:p.Leu74Leu,DOK7:NM_001164673.1:synonymous:LOW:exon3/7:c.220T>C:p.Leu74Leu,DOK7:NM_173660.4:synonymous:LOW:exon3/7:c.220T>C:p.Leu74Leu		rs4325970	1	1	0	0						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];				1	0	0	463	0	n/a	n/a
chr4	3494600	3494600	A	G	hom		QUAL=7730;DP=87;AF=0.99;MQM=60;TRIO=HOM,87,0.99,HET,156,0.52,HET,203,0.47	DOK7	missense,5'UTR,3'UTR	DOK7:NM_001301071.1:missense:MODERATE:exon7/10:c.887A>G:p.Gln296Arg,DOK7:NM_173660.4:missense:MODERATE:exon7/7:c.887A>G:p.Gln296Arg,DOK7:NM_001256896.1:5'UTR:MODIFIER:exon4/4:c.-44A>G:,DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*108A>G:		rs6811423	0.2181	0.218	0.2067	0.0555	1.6510	P	T	P,B	B,B	610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];	RCV000116896.1 [benign]; 		COSM447809	0.0758	0.3939	0.5303	21	142	n/a	n/a
chr4	3494826	3494826	A	C	hom		QUAL=1460;DP=20;AF=1.00;MQM=60;TRIO=HOM,20,1.00,HET,35,0.40,HET,40,0.48	DOK7	synonymous,3'UTR	DOK7:NM_001301071.1:synonymous:LOW:exon7/10:c.1113A>C:p.Ser371Ser,DOK7:NM_173660.4:synonymous:LOW:exon7/7:c.1113A>C:p.Ser371Ser,DOK7:NM_001256896.1:synonymous:LOW:exon4/4:c.183A>C:p.Ser61Ser,DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*334A>C:		rs6811856	0.2169	0.198	0.1926	0.0534						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];	RCV000116884.1 [benign]; 		COSM3760589	0.0682	0.3712	0.5606	20	136	n/a	n/a
chr4	3494847	3494847	G	A	hom		QUAL=1276;DP=16;AF=1.00;MQM=60;TRIO=HOM,16,1.00,HET,28,0.54,HET,35,0.46	DOK7	synonymous,3'UTR	DOK7:NM_001301071.1:synonymous:LOW:exon7/10:c.1134G>A:p.Ala378Ala,DOK7:NM_173660.4:synonymous:LOW:exon7/7:c.1134G>A:p.Ala378Ala,DOK7:NM_001256896.1:synonymous:LOW:exon4/4:c.204G>A:p.Ala68Ala,DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*355G>A:		rs6831659	0.2149	0.198	0.1702	0.0477						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];	RCV000116885.1 [benign]; 		COSM3749874	0.0682	0.3561	0.5758	20	126	n/a	n/a
chr4	3494898	3494898	C	T	hom		QUAL=2203;DP=46;AF=1.00;MQM=59;TRIO=HOM,46,1.00,HET,24,0.58,HET,35,0.46	DOK7	synonymous,3'UTR	DOK7:NM_001301071.1:synonymous:LOW:exon7/10:c.1185C>T:p.Tyr395Tyr,DOK7:NM_173660.4:synonymous:LOW:exon7/7:c.1185C>T:p.Tyr395Tyr,DOK7:NM_001256896.1:synonymous:LOW:exon4/4:c.255C>T:p.Tyr85Tyr,DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*406C>T:		rs6850908	0.2196	0.218	0.2074	0.0664						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];	RCV000116887.1 [benign]; 		COSM447810	0.0682	0.3939	0.5379	20	140	n/a	n/a
chr4	3495446	3495446	C	T	hom		QUAL=10758;DP=100;AF=1.00;MQM=59;TRIO=HOM,100,1.00,HET,152,0.43,HOM,183,0.99	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*954C>T:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*218C>T:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*218C>T:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+236C>T:		rs10022432	0.6342	0	0	0						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];				0.3636	0.4773	0.1591	55	71	n/a	n/a
chr4	3495477	3495477	T	C	hom		QUAL=16685;DP=132;AF=1.00;MQM=60;TRIO=HOM,132,1.00,HOM,174,1.00,HOM,223,1.00	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*985T>C:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*249T>C:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*249T>C:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+267T>C:		rs2858030	0.7406	0	0	0						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];				0.5227	0.4091	0.0682	80	59	n/a	n/a
chr4	3495941	3495941	T	C	hom		QUAL=5781;DP=90;AF=0.99;MQM=59;TRIO=HOM,90,0.99,HET,93,0.43,HET,113,0.50	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*1449T>C:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*713T>C:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*713T>C:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+731T>C:		rs1054661	0.4367	0	0	0						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];				0.2197	0.4394	0.3409	33	64	n/a	n/a
chr4	3496150	3496150	A	G	hom		QUAL=23890;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HET,290,0.44,HOM,377,1.00	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*1658A>G:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*922A>G:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*922A>G:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+940A>G:		rs1054662	0.6554	0	0	0						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];				0.3636	0.4697	0.1667	55	70	n/a	n/a
chr4	3496205	3496205	C	T	hom		QUAL=23042;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HOM,259,1.00,HOM,327,1.00	DOK7	3'UTR,intron	DOK7:NM_001164673.1:3'UTR:MODIFIER:exon7/7:c.*1713C>T:,DOK7:NM_173660.4:3'UTR:MODIFIER:exon7/7:c.*977C>T:,DOK7:NM_001256896.1:3'UTR:MODIFIER:exon4/4:c.*977C>T:,DOK7:NM_001301071.1:intron:MODIFIER:exon7/9:c.1497+995C>T:		rs2105849	0.739	0	0	0						610285 [DOK7 (confirmed) Myasthenia,limb-girdle,familial|Fetal akinesia deformation sequence];				0.5227	0.4015	0.0758	80	58	n/a	n/a
chr4	5564191	5564191	A	T	hom		QUAL=15471;DP=262;AF=1.00;MQM=60;TRIO=HOM,262,1.00,HOM,105,1.00,HOM,126,1.00	EVC2	3'UTR	EVC2:NM_147127.4:3'UTR:MODIFIER:exon22/22:c.*384T>A:,EVC2:NM_001166136.1:3'UTR:MODIFIER:exon22/22:c.*384T>A:		rs2287576	0.5409	0	0	0										0.5606	0.3788	0.0606	82	58	n/a	n/a
chr4	5570221	5570221	G	A	het		QUAL=5357;DP=84;AF=0.49;MQM=60;TRIO=HET,84,0.49,HET,61,0.49,HOM,106,1.00	EVC2	synonymous	EVC2:NM_147127.4:synonymous:LOW:exon20/22:c.3507C>T:p.His1169His,EVC2:NM_001166136.1:synonymous:LOW:exon20/22:c.3267C>T:p.His1089His		rs12511039	0.4409	0.362	0.3005	0.1701						607261 [EVC2 (confirmed) Ellis-van Creveld syndrome];			COSM330193	0.1439	0.4697	0.3864	65	187	n/a	n/a
chr4	5710647	5710647	A	G	het		QUAL=5396;DP=109;AF=0.50;MQM=60;TRIO=HET,109,0.50,WT,191,0.02,HET,242,0.49	EVC2	5'UTR	EVC2:NM_001166136.1:5'UTR:MODIFIER:exon1/22:c.-104T>C:		rs2013183	0.38	0	0	0										0.2197	0.4545	0.3258	31	67	n/a	n/a
chr4	5710856	5710856	G	A	het		QUAL=867;DP=49;AF=0.47;MQM=60;TRIO=HET,49,0.47,HET,16,0.56,WT,40,0.00	EVC2	5'UTR	EVC2:NM_001166136.1:5'UTR:MODIFIER:exon1/22:c.-313C>T:		rs3755842	0.2133	0	0	0										0.0833	0.3485	0.5682	11	57	n/a	n/a
chr4	5710988	5710990	AGG	-	het		QUAL=639;DP=59;AF=0.31;MQM=60;TRIO=HET,59,0.31,HET,20,0.35,WT,31,0.00	EVC2	5'UTR	EVC2:NM_001166136.1:5'UTR:MODIFIER:exon1/22:c.-447_-445delCCT:		rs67550450	0.2274	0	0	0										0.0985	0.3485	0.553	13	58	n/a	n/a
chr4	5711095	5711095	G	A	het		QUAL=4089;DP=103;AF=0.49;MQM=60;TRIO=HET,103,0.49,HET,96,0.46,HET,104,0.48	EVC2	5'UTR	EVC2:NM_001166136.1:5'UTR:MODIFIER:exon1/22:c.-552C>T:		rs10000314	0.4625	0	0	0										0.2424	0.3864	0.3712	39	59	n/a	n/a
chr4	5721049	5721049	A	G	het		QUAL=12010;DP=297;AF=0.45;MQM=60;TRIO=HET,297,0.45,WT,402,0.00,HET,465,0.50	EVC	synonymous	EVC:NM_153717.2:synonymous:LOW:exon2/21:c.249A>G:p.Ser83Ser		rs35870680	0.0695	0.115	0.1495	0.0306						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];			COSM3760673	0.0379	0.2348	0.7273	13	129	n/a	n/a
chr4	5743509	5743509	C	T	hom		QUAL=15471;DP=275;AF=1.00;MQM=60;TRIO=HOM,275,1.00,HOM,83,1.00,HOM,130,1.00	EVC	synonymous	EVC:NM_153717.2:synonymous:LOW:exon6/21:c.769C>T:p.Leu257Leu		rs6446393	0.9667	0.945	0.9374	0.9891						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				0.8636	0.1364	0	390	62	n/a	n/a
chr4	5743512	5743512	T	C	hom		QUAL=15471;DP=275;AF=1.00;MQM=60;TRIO=HOM,275,1.00,HET,83,1.00,HET,130,1.00	EVC	missense	EVC:NM_153717.2:missense:MODERATE:exon6/21:c.772T>C:p.Tyr258His		rs6414624	0.7448	0.794	0.8035	0.5186	1.9260	P	T	B	B	604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				0.5682	0.4015	0.0303	259	175	n/a	n/a
chr4	5747072	5747072	C	T	het		QUAL=1590;DP=35;AF=0.60;MQM=60;TRIO=HET,35,0.60,HOM,22,0.95,HET,32,0.34	EVC	splice_region&intron	EVC:NM_153717.2:splice_region&intron:LOW:exon7/20:c.939+4C>T:		rs2286343	0.4093	0.373	0.3085	0.2946						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				0.0909	0.4318	0.4773	47	192	n/a	n/a
chr4	5747078	5747078	A	G	het		QUAL=918;DP=32;AF=0.41;MQM=60;TRIO=HET,32,0.41,WT,22,0.05,HET,30,0.67	EVC	splice_region&intron	EVC:NM_153717.2:splice_region&intron:LOW:exon7/20:c.939+10A>G:		rs2286342	0.5931	0.629	0.696	0.7084						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				0.4545	0.4091	0.1364	216	185	n/a	n/a
chr4	5750003	5750003	A	G	het		QUAL=8269;DP=245;AF=0.54;MQM=60;TRIO=HET,245,0.54,WT,175,0.00,HET,217,0.59	EVC	synonymous	EVC:NM_153717.2:synonymous:LOW:exon8/21:c.1068A>G:p.Leu356Leu		rs33929747	0.2175	0.292	0.3583	0.1089						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				0.1212	0.4924	0.3864	59	217	n/a	n/a
chr4	5755542	5755542	C	A	het		QUAL=19534;DP=152;AF=0.57;MQM=60;TRIO=HET,152,0.57,HET,284,0.54,HOM,379,1.00	EVC	missense	EVC:NM_153717.2:missense:MODERATE:exon10/21:c.1346C>A:p.Thr449Lys		rs2302075	0.8446	0.796	0.8007	0.9539	0.3130	P	T	B	B	604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];	RCV000153204.1 [benign]; 			0.5985	0.3409	0.0606	293	137	n/a	n/a
chr4	5785442	5785442	G	A	hom		QUAL=10625;DP=128;AF=1.00;MQM=60;TRIO=HOM,128,1.00,HET,197,0.48,HET,225,0.53	EVC	missense	EVC:NM_153717.2:missense:MODERATE:exon12/21:c.1727G>A:p.Arg576Gln		rs1383180	0.3015	0.339	0.3645	0.1977	4.5440	P	T	D	D	604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];			COSM3760684	0.1364	0.5227	0.3409	62	235	n/a	n/a
chr4	5803669	5803669	T	C	het		QUAL=3381;DP=82;AF=0.49;MQM=60;TRIO=HET,82,0.49,HOM,45,1.00,HET,53,0.47	EVC	splice_region&intron	EVC:NM_153717.2:splice_region&intron:LOW:exon15/20:c.2305-8T>C:		rs1031919	0.6905	0.723	0.7221	0.7211						604831 [EVC (provisional) Ellis-van Creveld syndrome|Weyers acrodental dysostosis];				0.4545	0.447	0.0985	224	181	n/a	n/a
chr4	5812778	5812778	G	A	het		QUAL=17540;DP=243;AF=0.47;MQM=60;TRIO=HET,243,0.47,HOM,274,1.00,HET,341,0.48	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*14G>A:		rs2291151	0.5337	0.575	0.6053	0.6273									COSN167150	0.3182	0.5379	0.1439	70	104	n/a	n/a
chr4	5812974	5812974	C	A	het		QUAL=8502;DP=369;AF=0.47;MQM=60;TRIO=HET,369,0.47,HET,203,0.42,WT,338,0.01	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*210C>A:		rs16837692	0.0885	0	0	0										0.0076	0.1439	0.8485	1	26	n/a	n/a
chr4	5813512	5813512	T	C	het		QUAL=4536;DP=231;AF=0.13;MQM=45;TRIO=HET,231,0.13,HET,494,0.32,WT,837,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*748T>C:		rs62297707	0.1498	0	0	0										0.0227	0.2955	0.6818	4	45	n/a	n/a
chr4	5813523	5813523	T	G	het		QUAL=3951;DP=214;AF=0.09;MQM=43;TRIO=HET,214,0.09,HET,438,0.32,WT,761,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*759T>G:		rs75700009	0	0	0	0										0	0.1136	0.8864	0	17	n/a	n/a
chr4	5813560	5813560	G	T	het		QUAL=2563;DP=369;AF=0.13;MQM=48;TRIO=HET,369,0.13,HET,411,0.25,WT,765,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*796G>T:			0	0	0	0										0.0076	0.1515	0.8409	1	23	n/a	n/a
chr4	5813562	5813562	T	G	het		QUAL=2563;DP=369;AF=0.13;MQM=48;TRIO=HET,369,0.13,HET,411,0.25,WT,765,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*798T>G:		rs13101313	0	0	0	0										0.0076	0.1439	0.8485	1	23	n/a	n/a
chr4	5813695	5813695	T	C	het		QUAL=40235;DP=451;AF=0.55;MQM=59;TRIO=HET,451,0.55,HOM,651,1.00,HET,745,0.53	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*931T>C:		rs6840435	0.4369	0	0	0										0.2197	0.5227	0.2576	34	78	n/a	n/a
chr4	5813824	5813824	A	C	het		QUAL=8214;DP=366;AF=0.23;MQM=53;TRIO=HET,366,0.23,HET,593,0.39,WT,994,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1060A>C:		rs71599848	0.1168	0	0	0										0	0.1894	0.8106	0	31	n/a	n/a
chr4	5813847	5813847	T	G	het		QUAL=6444;DP=222;AF=0.10;MQM=53;TRIO=HET,222,0.10,HET,535,0.41,WT,860,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1083T>G:		rs71599850	0.0966	0	0	0										0	0.1212	0.8788	0	17	n/a	n/a
chr4	5813876	5813876	T	C	het		QUAL=7121;DP=297;AF=0.15;MQM=52;TRIO=HET,297,0.15,HET,432,0.50,WT,616,0.01	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1112T>C:		rs28460555	0	0	0	0										0.0152	0.3106	0.6742	2	46	n/a	n/a
chr4	5813887	5813887	A	G	het		QUAL=9581;DP=409;AF=0.23;MQM=52;TRIO=HET,409,0.23,HET,497,0.48,WT,701,0.01	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1123A>G:		rs112378896	0	0	0	0										0	0.1894	0.8106	0	32	n/a	n/a
chr4	5814608	5814608	T	-	het		QUAL=21908;DP=392;AF=0.44;MQM=60;TRIO=HET,392,0.44,HOM,328,0.99,HET,455,0.46	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*1845delT:		rs397690241	0.3748	0	0	0										0.1515	0.4924	0.3561	25	73	n/a	n/a
chr4	5815181	5815181	T	C	het		QUAL=5578;DP=221;AF=0.49;MQM=59;TRIO=HET,221,0.49,HOM,45,1.00,HET,63,0.40	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2417T>C:	AluSx3	rs6848370	0.723	0	0	0										0.447	0.4773	0.0758	69	71	n/a	n/a
chr4	5815381	5815381	G	A	het		QUAL=10891;DP=210;AF=0.38;MQM=60;TRIO=HET,210,0.38,HOM,147,1.00,HET,237,0.49	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2617G>A:	L3	rs3733186	0.3876	0	0	0										0.1515	0.4924	0.3561	25	74	n/a	n/a
chr4	5815444	5815444	G	A	het		QUAL=3683;DP=173;AF=0.45;MQM=59;TRIO=HET,173,0.45,HET,113,0.46,WT,198,0.01	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2680G>A:		rs3733187	0.0745	0	0	0										0.0076	0.1818	0.8106	1	31	n/a	n/a
chr4	5815477	5815477	C	T	het		QUAL=10496;DP=189;AF=0.49;MQM=60;TRIO=HET,189,0.49,HOM,136,1.00,HET,190,0.52	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2713C>T:		rs3733188	0.3852	0	0	0										0.1515	0.4924	0.3561	25	74	n/a	n/a
chr4	5815635	5815635	C	T	het		QUAL=8025;DP=275;AF=0.46;MQM=59;TRIO=HET,275,0.46,HET,286,0.47,WT,317,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*2871C>T:		rs3733189	0.0731	0	0	0										0.0076	0.1818	0.8106	1	31	n/a	n/a
chr4	5815929	5815929	T	C	het		QUAL=9842;DP=242;AF=0.48;MQM=60;TRIO=HET,242,0.48,HET,400,0.48,WT,488,0.00	EVC	3'UTR	EVC:NM_153717.2:3'UTR:MODIFIER:exon21/21:c.*3165T>C:	LTR89	rs3755847	0.0815	0	0	0										0.0076	0.1818	0.8106	1	31	n/a	n/a
chr4	6292915	6292915	A	G	het		QUAL=3797;DP=64;AF=0.42;MQM=60;TRIO=HET,64,0.42,HET,204,0.50,WT,244,0.00	WFS1	splice_region&intron	WFS1:NM_001145853.1:splice_region&intron:LOW:exon4/7:c.461-9A>G:,WFS1:NM_006005.3:splice_region&intron:LOW:exon4/7:c.461-9A>G:		rs10010131	0.7288	0.655	0.6091	0.6573						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000004785.4 [other]; RCV000038664.4 [other]; 			0.3939	0.4015	0.2045	426	519	n/a	n/a
chr4	6293696	6293696	C	G	het		QUAL=2530;DP=57;AF=0.51;MQM=59;TRIO=HET,57,0.51,HOM,52,1.00,WT,66,0.05	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon6/8:c.684C>G:p.Arg228Arg,WFS1:NM_006005.3:synonymous:LOW:exon6/8:c.684C>G:p.Arg228Arg		rs1801213	0.7564	0.703	0.6827	0.6689	-0.0970	P				606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038665.4 [other]; 		COSM448012	0.4924	0.3636	0.1439	546	450	n/a	n/a
chr4	6302519	6302519	G	A	het		QUAL=22925;DP=386;AF=0.51;MQM=60;TRIO=HET,386,0.51,HOM,523,0.99,WT,654,0.00	WFS1	missense	WFS1:NM_001145853.1:missense:MODERATE:exon8/8:c.997G>A:p.Val333Ile,WFS1:NM_006005.3:missense:MODERATE:exon8/8:c.997G>A:p.Val333Ile		rs1801212	0.8844	0.782	0.7237	0.9469	3.7380	P	T	B	B	606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038668.5,RCV000155337.1 [benign,benign]; 	CM115388 [CLASS=DP MUT=ALT PHEN="Wolframin variant" GENE=WFS1]; 		0.5455	0.3409	0.1136	622	421	n/a	n/a
chr4	6302707	6302707	C	T	het		QUAL=11379;DP=269;AF=0.51;MQM=60;TRIO=HET,269,0.51,HET,431,0.52,WT,556,0.00	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon8/8:c.1185C>T:p.Val395Val,WFS1:NM_006005.3:synonymous:LOW:exon8/8:c.1185C>T:p.Val395Val		rs1801206	0.6416	0.624	0.5983	0.4648						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038635.6 [other]; 	CM021362 [CLASS=DP MUT=REF PHEN="Diabetes, type 1, association with" GENE=WFS1]; 		0.3788	0.4167	0.2045	399	533	n/a	n/a
chr4	6303022	6303022	C	T	het		QUAL=8801;DP=219;AF=0.48;MQM=60;TRIO=HET,219,0.48,HET,320,0.53,WT,343,0.01	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon8/8:c.1500C>T:p.Asn500Asn,WFS1:NM_006005.3:synonymous:LOW:exon8/8:c.1500C>T:p.Asn500Asn		rs1801214	0.7294	0.659	0.6098	0.6764						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038641.6 [other]; 			0.3939	0.4015	0.2045	422	526	n/a	n/a
chr4	6303354	6303354	G	A	het		QUAL=5760;DP=248;AF=0.48;MQM=60;TRIO=HET,248,0.48,HET,143,0.50,WT,199,0.01	WFS1	missense	WFS1:NM_001145853.1:missense:MODERATE:exon8/8:c.1832G>A:p.Arg611His,WFS1:NM_006005.3:missense:MODERATE:exon8/8:c.1832G>A:p.Arg611His		rs734312	0.4692	0.536	0.5469	0.1169	4.7040	P	T	B	B	606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038646.6 [other]; 	CM000447 [CLASS=DP MUT=REF PHEN="Diabetes, type 1, association with" GENE=WFS1]; 	COSM149634	0.3106	0.4242	0.2652	317	545	n/a	n/a
chr4	6303955	6303955	G	A	het		QUAL=6513;DP=181;AF=0.49;MQM=59;TRIO=HET,181,0.49,HET,248,0.49,WT,313,0.00	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon8/8:c.2433G>A:p.Lys811Lys,WFS1:NM_006005.3:synonymous:LOW:exon8/8:c.2433G>A:p.Lys811Lys		rs1046314	0.6532	0.626	0.5966	0.5059						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038659.6 [other]; 	CM021365 [CLASS=DP MUT=REF PHEN="Diabetes, type 1, association with" GENE=WFS1]; 	COSM3760688	0.3788	0.4167	0.2045	399	538	n/a	n/a
chr4	6304087	6304087	A	G	het		QUAL=10444;DP=188;AF=0.52;MQM=60;TRIO=HET,188,0.52,HOM,244,1.00,WT,282,0.01	WFS1	synonymous	WFS1:NM_001145853.1:synonymous:LOW:exon8/8:c.2565A>G:p.Ser855Ser,WFS1:NM_006005.3:synonymous:LOW:exon8/8:c.2565A>G:p.Ser855Ser		rs1046316	0.78	0.721	0.687	0.7601						606201 [WFS1 (confirmed) Wolfram syndrome|Deafness,autosomal dominant 6/14/38|Wolfram-like syndrome,autosomal dominant|Diabetes mellitus,noninsulin-dependent,association with|Cataract 41];	RCV000038660.6 [other]; 	CM021366 [CLASS=DP MUT=REF PHEN="Diabetes, type 1, association with" GENE=WFS1]; 	COSM448013	0.5	0.3636	0.1364	547	460	n/a	n/a
chr4	6304242	6304242	T	C	het		QUAL=14230;DP=170;AF=0.60;MQM=59;TRIO=HET,170,0.60,HOM,354,1.00,WT,474,0.01	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*47T>C:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*47T>C:		rs1046317	0.7837	0.72	0.6861	0.7795										0.5	0.3636	0.1364	82	58	n/a	n/a
chr4	6304286	6304286	C	T	het		QUAL=15368;DP=206;AF=0.58;MQM=60;TRIO=HET,206,0.58,HOM,383,1.00,WT,518,0.00	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*91C>T:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*91C>T:		rs1046319	0.848	0	0	0										0.5455	0.3409	0.1136	82	50	n/a	n/a
chr4	6304344	6304344	G	A	het		QUAL=12660;DP=244;AF=0.53;MQM=60;TRIO=HET,244,0.53,HET,519,0.51,WT,670,0.00	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*149G>A:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*149G>A:		rs1046320	0.6066	0	0	0										0.3864	0.3939	0.2197	57	59	n/a	n/a
chr4	6304762	6304762	C	G	het		QUAL=5718;DP=186;AF=0.49;MQM=60;TRIO=HET,186,0.49,WT,141,0.00,HET,158,0.58	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*567C>G:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*567C>G:		rs12508118	0.0114	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr4	6304799	6304799	G	C	het		QUAL=5048;DP=189;AF=0.48;MQM=59;TRIO=HET,189,0.48,HET,126,0.53,WT,147,0.01	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*604G>C:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*604G>C:		rs9457	0.6262	0	0	0										0.3561	0.4015	0.2424	54	58	n/a	n/a
chr4	6304878	6304878	C	T	het		QUAL=4405;DP=169;AF=0.55;MQM=60;TRIO=HET,169,0.55,HET,129,0.47,WT,176,0.01	WFS1	3'UTR	WFS1:NM_001145853.1:3'UTR:MODIFIER:exon8/8:c.*683C>T:,WFS1:NM_006005.3:3'UTR:MODIFIER:exon8/8:c.*683C>T:		rs3200	0.6476	0	0	0										0.3636	0.4167	0.2197	55	60	n/a	n/a
chr4	15568992	15568992	T	C	hom		QUAL=20604;DP=233;AF=1.00;MQM=60;TRIO=HOM,233,1.00,HOM,229,1.00,HET,326,0.53	CC2D2A	splice_region&intron	CC2D2A:NM_001080522.2:splice_region&intron:LOW:exon25/37:c.3183-8T>C:		rs13121363	0.6625	0.706	0.723	0.6556						612013 [CC2D2A (confirmed) Joubert syndrome 9|Meckel syndrome 6|COACH syndrome];	RCV000114172.2 [likely benign]; 			0.5227	0.4015	0.0758	590	453	n/a	n/a
chr4	15603069	15603069	G	C	hom		QUAL=22113;DP=295;AF=1.00;MQM=60;TRIO=HOM,295,1.00,HOM,229,1.00,HET,295,0.46	CC2D2A	3'UTR	CC2D2A:NM_001080522.2:3'UTR:MODIFIER:exon38/38:c.*21G>C:		rs1134634	0.5669	0.525	0.5952	0.5488										0.2879	0.5758	0.1364	283	365	n/a	n/a
chr4	17488064	17488064	T	C	hom		QUAL=31255;DP=284;AF=1.00;MQM=60;TRIO=HOM,284,1.00,HOM,305,1.00,HOM,360,0.99	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*690A>G:		rs1031326	0.626	0	0	0										0.4242	0.3939	0.1818	64	59	n/a	n/a
chr4	17488072	17488072	T	C	hom		QUAL=33704;DP=337;AF=1.00;MQM=59;TRIO=HOM,337,1.00,HOM,311,1.00,HOM,372,1.00	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*682A>G:		rs699459	0.6595	0	0	0										0.5076	0.3409	0.1515	76	52	n/a	n/a
chr4	17488132	17488132	A	G	hom		QUAL=20920;DP=352;AF=0.99;MQM=60;TRIO=HOM,352,0.99,HET,272,0.46,HET,355,0.45	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*622T>C:		rs10604	0.2324	0	0	0										0.1212	0.4242	0.4545	17	64	n/a	n/a
chr4	17488244	17488244	G	A	hom		QUAL=20046;DP=294;AF=1.00;MQM=60;TRIO=HOM,294,1.00,HOM,147,0.99,HOM,174,0.99	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*510C>T:		rs1031327	0.6585	0	0	0										0.5076	0.3409	0.1515	76	52	n/a	n/a
chr4	17488286	17488286	T	G	hom		QUAL=17383;DP=239;AF=1.00;MQM=60;TRIO=HOM,239,1.00,HOM,135,0.99,HOM,153,1.00	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*468A>C:		rs699460	0.6591	0	0	0										0.5076	0.3409	0.1515	76	52	n/a	n/a
chr4	17488508	17488508	C	-	hom		QUAL=24243;DP=428;AF=0.95;MQM=60;TRIO=HOM,428,0.95,HET,350,0.49,HET,457,0.46	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*246delG:		rs71810044	0.1877	0	0	0										0.0909	0.4167	0.4924	12	64	n/a	n/a
chr4	17488533	17488533	C	T	hom		QUAL=38098;DP=423;AF=1.00;MQM=60;TRIO=HOM,423,1.00,HOM,325,1.00,HOM,427,1.00	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*221G>A:		rs1049582	0.6589	0	0	0										0.5076	0.3409	0.1515	76	52	n/a	n/a
chr4	17488534	17488534	A	G	hom		QUAL=38098;DP=423;AF=1.00;MQM=60;TRIO=HOM,423,1.00,HOM,325,1.00,HOM,427,1.00	QDPR	3'UTR	QDPR:NM_000320.2:3'UTR:MODIFIER:exon7/7:c.*220T>C:		rs1049581	0.6593	0	0	0										0.5076	0.3409	0.1515	76	52	n/a	n/a
chr4	17503382	17503382	C	T	hom		QUAL=13928;DP=302;AF=1.00;MQM=60;TRIO=HOM,302,1.00,HET,115,0.55,HET,199,0.44	QDPR	synonymous	QDPR:NM_000320.2:synonymous:LOW:exon4/7:c.396G>A:p.Leu132Leu		rs2597775	0.2324	0.288	0.3327	0.2324						612676 [QDPR (confirmed) Hyperphenylalaninemia,BH4-deficient,C];				0.1364	0.4242	0.4394	59	209	n/a	n/a
chr4	52888026	52888026	A	C	hom		QUAL=10035;DP=168;AF=1.00;MQM=60;TRIO=HOM,168,1.00,HOM,60,1.00,HOM,86,0.99	SGCB	3'UTR	SGCB:NM_000232.4:3'UTR:MODIFIER:exon6/6:c.*2097T>G:		rs170424	0.4786	0	0	0										0.5303	0.4167	0.053	80	63	n/a	n/a
chr4	56236328	56236328	C	T	het		QUAL=9877;DP=396;AF=0.48;MQM=59;TRIO=HET,396,0.48,HET,266,0.44,WT,324,0.01	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*70C>T:		rs2538	0.2676	0	0	0										0.0833	0.3561	0.5606	14	52	n/a	n/a
chr4	56236568	56236575	AACCGAAA	-	het		QUAL=8576;DP=187;AF=0.47;MQM=59;TRIO=HET,187,1.00,HET,76,0.61,WT,80,0.60	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*319_*326delACCGAAAA:		rs375142797	0.2678	0	0	0										0.0758	0.3561	0.5682	12	52	n/a	n/a
chr4	56236579	56236579	C	T	het		QUAL=8576;DP=187;AF=0.47;MQM=60;TRIO=HET,187,1.00,WT,76,0.61,HET,80,0.60	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*321C>T:		rs13149568	0.3592	0	0	0										0.1212	0.4015	0.4773	18	58	n/a	n/a
chr4	56236606	56236607	AC	-	het		QUAL=2552;DP=35;AF=0.37;MQM=59;TRIO=HET,35,0.37,WT,52,0.23,HET,60,0.40	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*381_*382delCA:	(CA)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr4	56236613	56236624	CACACACACACA	-	het		QUAL=2552;DP=35;AF=0.46;MQM=59;TRIO=HET,35,0.83,HET,52,0.85,WT,60,0.40	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*371_*382delCACACACACACA:	(CA)n		0	0	0	0										0.0833	0.2576	0.6591	15	37	n/a	n/a
chr4	56236804	56236804	G	A	het		QUAL=4241;DP=170;AF=0.50;MQM=59;TRIO=HET,170,0.50,HET,93,0.54,WT,109,0.00	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*546G>A:	AluJb	rs573960	0.2676	0	0	0										0.0833	0.3561	0.5606	14	52	n/a	n/a
chr4	56237137	56237137	C	T	het		QUAL=2429;DP=120;AF=0.57;MQM=60;TRIO=HET,120,0.57,HET,22,0.41,WT,29,0.00	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*879C>T:		rs576732	0.2674	0	0	0										0.0833	0.3561	0.5606	14	52	n/a	n/a
chr4	56237327	56237327	G	A	hom		QUAL=10911;DP=233;AF=1.00;MQM=59;TRIO=HOM,233,1.00,HET,78,0.41,HET,128,0.48	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*1069G>A:		rs501679	0.6887	0	0	0										0.3485	0.4773	0.1742	51	73	n/a	n/a
chr4	56238263	56238263	T	C	het		QUAL=5047;DP=209;AF=0.54;MQM=60;TRIO=HET,209,0.54,HET,100,0.39,WT,146,0.01	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2005T>C:		rs819269	0.2692	0	0	0										0.0833	0.3561	0.5606	14	52	n/a	n/a
chr4	56238321	56238321	G	A	het		QUAL=6367;DP=313;AF=0.49;MQM=60;TRIO=HET,313,0.49,HET,97,0.43,WT,148,0.01	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2063G>A:		rs73236134	0.0162	0	0	0										0	0.1439	0.8561	0	20	n/a	n/a
chr4	56238626	56238626	G	A	het		QUAL=12476;DP=462;AF=0.48;MQM=60;TRIO=HET,462,0.48,HET,318,0.49,WT,466,0.01	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2368G>A:		rs819270	0.2676	0	0	0										0.0833	0.3561	0.5606	14	52	n/a	n/a
chr4	56238847	56238847	G	A	hom		QUAL=17125;DP=330;AF=0.99;MQM=60;TRIO=HOM,330,0.99,HET,173,0.46,HET,241,0.51	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2589G>A:		rs819271	0.75	0	0	0										0.3485	0.4773	0.1742	51	73	n/a	n/a
chr4	56239103	56239103	A	-	het		QUAL=1770;DP=82;AF=0.60;MQM=60;TRIO=HET,82,0.60,HET,21,0.29,HET,25,0.36	SRD5A3	3'UTR	SRD5A3:NM_024592.4:3'UTR:MODIFIER:exon5/5:c.*2858delA:		rs397993423	0	0	0	0										0.2727	0.3636	0.3636	41	52	n/a	n/a
chr4	68603535	68603535	C	A	het		QUAL=7401;DP=242;AF=0.39;MQM=60;TRIO=HET,242,0.39,HET,83,0.53,HET,134,0.63	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2663G>T:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2772G>T:		rs1038426	0.3452	0	0	0								CR113071 [CLASS=DFP MUT=ALT PHEN="Polycystic ovary syndrome, association with" GENE=GNRHR]; 		0.2273	0.5227	0.25	34	77	n/a	n/a
chr4	68603702	68603702	C	T	het		QUAL=2633;DP=133;AF=0.39;MQM=60;TRIO=HET,133,0.39,HET,32,0.38,HET,32,0.50	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2496G>A:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2605G>A:		rs1038427	0.3452	0	0	0										0.2273	0.5152	0.2576	34	76	n/a	n/a
chr4	68603757	68603757	A	G	het		QUAL=2896;DP=110;AF=0.56;MQM=60;TRIO=HET,110,0.56,WT,23,0.00,HET,46,0.65	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2441T>C:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2550T>C:	AT_rich	rs2319657	0.0421	0	0	0										0.0227	0.1288	0.8485	3	19	n/a	n/a
chr4	68604032	68604032	C	T	het		QUAL=2856;DP=153;AF=0.42;MQM=60;TRIO=HET,153,0.42,HET,20,0.40,HET,37,0.43	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2166G>A:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2275G>A:	Charlie4a	rs7666201	0.3492	0	0	0										0.2273	0.5227	0.25	34	78	n/a	n/a
chr4	68604143	68604143	C	T	het		QUAL=5252;DP=180;AF=0.46;MQM=60;TRIO=HET,180,0.46,HET,76,0.47,HET,100,0.44	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*2055G>A:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2164G>A:		rs17635749	0.1773	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr4	68604307	68604307	A	C	het		QUAL=7807;DP=230;AF=0.52;MQM=60;TRIO=HET,230,0.52,HET,105,0.43,HET,137,0.52	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*1891T>G:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*2000T>G:		rs12508464	0.1855	0	0	0										0.0682	0.4773	0.4545	11	72	n/a	n/a
chr4	68604938	68604938	C	A	het		QUAL=12229;DP=283;AF=0.52;MQM=60;TRIO=HET,283,0.52,HET,196,0.47,HET,252,0.54	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*1260G>T:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*1369G>T:		rs13150734	0.1855	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr4	68605369	68605369	A	G	het		QUAL=9348;DP=362;AF=0.51;MQM=60;TRIO=HET,362,0.51,HET,92,0.45,HET,127,0.44	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*829T>C:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*938T>C:		rs17635850	0.3492	0	0	0										0.2273	0.5227	0.25	34	78	n/a	n/a
chr4	68605389	68605389	G	A	het		QUAL=8819;DP=328;AF=0.49;MQM=60;TRIO=HET,328,0.49,HET,100,0.44,HET,122,0.47	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*809C>T:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*918C>T:		rs35683646	0.1859	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr4	68605396	68605396	C	G	het		QUAL=9039;DP=331;AF=0.49;MQM=60;TRIO=HET,331,0.49,HET,109,0.47,HET,124,0.46	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*802G>C:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*911G>C:		rs35610027	0.1859	0	0	0										0.0682	0.4773	0.4545	11	72	n/a	n/a
chr4	68605615	68605615	T	C	het		QUAL=8932;DP=256;AF=0.48;MQM=60;TRIO=HET,256,0.48,HET,151,0.53,HET,183,0.41	GNRHR	3'UTR	GNRHR:NM_000406.2:3'UTR:MODIFIER:exon3/3:c.*583A>G:,GNRHR:NM_001012763.1:3'UTR:MODIFIER:exon3/3:c.*692A>G:		rs35845954	0.1855	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr4	68620277	68620277	T	C	hom		QUAL=15696;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HOM,84,1.00,HOM,114,1.00	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-224A>G:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-224A>G:		rs2627260	0.981	0	0	0										1	0	0	150	0	n/a	n/a
chr4	68620957	68620957	T	C	het		QUAL=6301;DP=194;AF=0.65;MQM=60;TRIO=HET,194,0.65,WT,87,0.00,HET,137,0.49	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-904A>G:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-904A>G:		rs6552113	0.4663	0	0	0										0.2803	0.4394	0.2803	40	71	n/a	n/a
chr4	68621197	68621197	A	G	het		QUAL=4858;DP=160;AF=0.61;MQM=60;TRIO=HET,160,0.61,WT,49,0.00,HET,76,0.71	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1144T>C:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1144T>C:	L2a	rs2062303	0.4417	0	0	0										0.2803	0.4394	0.2803	40	70	n/a	n/a
chr4	68621308	68621308	A	G	het		QUAL=5771;DP=200;AF=0.51;MQM=60;TRIO=HET,200,0.51,WT,123,0.01,HET,149,0.52	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1255T>C:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1255T>C:		rs2062302	0.4669	0	0	0										0.2803	0.4394	0.2803	40	71	n/a	n/a
chr4	68621332	68621332	C	T	het		QUAL=8134;DP=248;AF=0.59;MQM=60;TRIO=HET,248,0.59,WT,148,0.01,HET,194,0.54	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1279G>A:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1279G>A:	LTR16D	rs2062301	0.4659	0	0	0										0.2803	0.4394	0.2803	40	71	n/a	n/a
chr4	68621550	68621550	G	A	het		QUAL=5663;DP=228;AF=0.55;MQM=60;TRIO=HET,228,0.55,WT,54,0.00,HET,92,0.51	GNRHR	5'UTR_premature_start_codon_gain,5'UTR	GNRHR:NM_000406.2:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-1497C>T:,GNRHR:NM_001012763.1:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-1497C>T:,GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1497C>T:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1497C>T:		rs13138607	0.4661	0	0	0										0.2803	0.4394	0.2803	40	71	n/a	n/a
chr4	68621586	68621586	A	-	het		QUAL=5545;DP=241;AF=0.52;MQM=60;TRIO=HET,241,0.52,WT,49,0.04,HET,83,0.57	GNRHR	5'UTR	GNRHR:NM_000406.2:5'UTR:MODIFIER:exon1/3:c.-1533delT:,GNRHR:NM_001012763.1:5'UTR:MODIFIER:exon1/3:c.-1533delT:		rs34993359	0.4675	0	0	0										0.2879	0.4318	0.2803	41	69	n/a	n/a
chr4	72425863	72425863	C	T	hom		QUAL=26998;DP=235;AF=1.00;MQM=60;TRIO=HOM,235,1.00,HOM,254,1.00,HOM,331,1.00	SLC4A4	synonymous	SLC4A4:NM_001134742.1:synonymous:LOW:exon23/25:c.2991C>T:p.His997His,SLC4A4:NM_001098484.2:synonymous:LOW:exon23/26:c.2991C>T:p.His997His,SLC4A4:NM_003759.3:synonymous:LOW:exon20/23:c.2859C>T:p.His953His		rs1453458	0.7823	0.889	0.9555	0.6648						603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities];				0.8106	0.1894	0	382	69	n/a	n/a
chr4	72433759	72433759	C	T	hom		QUAL=21905;DP=296;AF=1.00;MQM=60;TRIO=HOM,296,1.00,HOM,148,1.00,HOM,216,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*149C>T:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*291C>T:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*291C>T:		rs1453453	0.9115	0	0	0										0.947	0.053	0	143	7	n/a	n/a
chr4	72433879	72433879	G	C	hom		QUAL=35217;DP=495;AF=1.00;MQM=59;TRIO=HOM,495,1.00,HOM,248,1.00,HOM,310,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*269G>C:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*411G>C:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*411G>C:		rs1453452	0.8882	0	0	0										0.947	0.053	0	143	7	n/a	n/a
chr4	72434457	72434457	T	A	het		QUAL=7975;DP=254;AF=0.46;MQM=60;TRIO=HET,254,0.46,WT,182,0.00,HET,245,0.51	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*847T>A:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*989T>A:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*989T>A:		rs34921070	0.0286	0	0	0										0.0152	0.1061	0.8788	2	17	n/a	n/a
chr4	72435944	72435973	TAACTCATCATTTCAGCCTCTGAGTAGAGG	-	hom		QUAL=6854;DP=23;AF=0.96;MQM=60;TRIO=HOM,23,0.96,HOM,89,1.00,HOM,128,0.99	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*2337_*2366delCTCATCATTTCAGCCTCTGAGTAGAGGTAA:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*2479_*2508delCTCATCATTTCAGCCTCTGAGTAGAGGTAA:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*2479_*2508delCTCATCATTTCAGCCTCTGAGTAGAGGTAA:		rs71822971	0.3185	0	0	0										0.2576	0.3712	0.3712	38	56	n/a	n/a
chr4	72436235	72436235	A	G	hom		QUAL=31067;DP=425;AF=1.00;MQM=60;TRIO=HOM,425,1.00,HOM,214,1.00,HOM,288,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*2625A>G:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*2767A>G:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*2767A>G:		rs1043218	0.6206	0	0	0										0.5606	0.3636	0.0758	81	56	n/a	n/a
chr4	72436498	72436498	G	A	hom		QUAL=29639;DP=318;AF=1.00;MQM=60;TRIO=HOM,318,1.00,HOM,250,1.00,HOM,337,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*2888G>A:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*3030G>A:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*3030G>A:		rs9997127	0.9191	0	0	0										0.947	0.053	0	143	7	n/a	n/a
chr4	72436804	72436804	G	A	hom		QUAL=27531;DP=422;AF=1.00;MQM=60;TRIO=HOM,422,1.00,HOM,168,1.00,HOM,231,1.00	SLC4A4	3'UTR	SLC4A4:NM_001134742.1:3'UTR:MODIFIER:exon25/25:c.*3194G>A:,SLC4A4:NM_001098484.2:3'UTR:MODIFIER:exon26/26:c.*3336G>A:,SLC4A4:NM_003759.3:3'UTR:MODIFIER:exon23/23:c.*3336G>A:		rs9997398	0.9191	0	0	0										0.947	0.053	0	143	7	n/a	n/a
chr4	79186171	79186171	G	A	hom		QUAL=26785;DP=350;AF=1.00;MQM=60;TRIO=HOM,350,1.00,HOM,209,1.00,HOM,275,1.00	FRAS1	splice_region&intron	FRAS1:NM_025074.6:splice_region&intron:LOW:exon6/73:c.604-8G>A:,FRAS1:NM_001166133.1:splice_region&intron:LOW:exon6/41:c.604-8G>A:		rs2867014	0.9221	0.973	0.9942	0.8113						607830 [FRAS1 (provisional) Fraser syndrome];			COSM4003161	0.9697	0.0303	0	446	8	n/a	n/a
chr4	79188595	79188595	C	T	het		QUAL=8109;DP=168;AF=0.50;MQM=60;TRIO=HET,168,0.50,WT,316,0.00,HET,402,0.46	FRAS1	splice_region&intron	FRAS1:NM_025074.6:splice_region&intron:LOW:exon9/73:c.981+9C>T:,FRAS1:NM_001166133.1:splice_region&intron:LOW:exon9/41:c.981+9C>T:		rs112081709	0.0092	0.019	0.0258	0.0047						607830 [FRAS1 (provisional) Fraser syndrome];				0	0.0682	0.9318	0	16	n/a	n/a
chr4	79205699	79205699	T	A	het		QUAL=13515;DP=205;AF=0.47;MQM=60;TRIO=HET,205,0.47,HET,289,0.47,HET,408,0.48	FRAS1	missense	FRAS1:NM_025074.6:missense:MODERATE:exon13/74:c.1396T>A:p.Leu466Ile,FRAS1:NM_001166133.1:missense:MODERATE:exon13/42:c.1396T>A:p.Leu466Ile		rs12504081	0.3211	0.349	0.3485	0.186	0.9550	P,P	.,T	.,P,P,D,D	.,P,P,D,D	607830 [FRAS1 (provisional) Fraser syndrome];			COSM4003165	0.0909	0.553	0.3561	54	199	n/a	n/a
chr4	79238649	79238649	T	C	het		QUAL=10212;DP=186;AF=0.45;MQM=60;TRIO=HET,186,0.45,HET,147,0.41,HOM,192,1.00	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon17/74:c.1947T>C:p.His649His,FRAS1:NM_001166133.1:synonymous:LOW:exon17/42:c.1947T>C:p.His649His		rs345514	0	0.742	0.7656	0.8646	-2.4890	P,P				607830 [FRAS1 (provisional) Fraser syndrome];			COSM4159209	0.4545	0.5076	0.0379	218	198	n/a	n/a
chr4	79240063	79240063	A	G	het		QUAL=10688;DP=257;AF=0.56;MQM=59;TRIO=HET,257,0.56,HET,174,0.45,HET,213,0.53	FRAS1	missense	FRAS1:NM_025074.6:missense:MODERATE:exon18/74:c.2060A>G:p.Asp687Gly,FRAS1:NM_001166133.1:missense:MODERATE:exon18/42:c.2060A>G:p.Asp687Gly		rs345513	0.4343	0.41	0.3829	0.4714	0.4320	P,P,P	T,.,.	B,B,B,.,.	B,B,B,.,.	607830 [FRAS1 (provisional) Fraser syndrome];			COSM4003169	0.1818	0.5379	0.2803	78	208	n/a	n/a
chr4	79372930	79372930	C	T	hom		QUAL=18789;DP=169;AF=0.99;MQM=60;TRIO=HOM,169,0.99,HOM,171,1.00,HOM,241,1.00	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon46/74:c.6468C>T:p.His2156His		rs753752	0.5795	0.672	0.7411	0.562	-2.3510	P				607830 [FRAS1 (provisional) Fraser syndrome];			COSM1131035	0.5	0.3939	0.1061	224	169	n/a	n/a
chr4	79385632	79385632	C	T	het		QUAL=12055;DP=349;AF=0.55;MQM=60;TRIO=HET,349,0.55,WT,253,0.00,HET,342,0.54	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon49/74:c.6924C>T:p.Val2308Val		rs13123710	0.0244	0.058	0.0806	0.0167	2.6800	D				607830 [FRAS1 (provisional) Fraser syndrome];				0.0152	0.0909	0.8939	2	46	n/a	n/a
chr4	79385719	79385719	G	A	het		QUAL=13524;DP=277;AF=0.55;MQM=60;TRIO=HET,277,0.55,HET,230,0.46,HET,321,0.51	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon49/74:c.7011G>A:p.Ala2337Ala		rs6851427	0.2975	0.365	0.3781	0.1743	-2.2490	P				607830 [FRAS1 (provisional) Fraser syndrome];			COSM3760770	0.1439	0.4167	0.4394	70	184	n/a	n/a
chr4	79387442	79387442	C	T	het		QUAL=17351;DP=347;AF=0.45;MQM=59;TRIO=HET,347,0.45,HET,343,0.46,HET,534,0.44	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon50/74:c.7110C>T:p.His2370His		rs7660664	0.3221	0.317	0.3554	0.4763	-0.0540	P				607830 [FRAS1 (provisional) Fraser syndrome];			COSM1131032	0.0909	0.5076	0.4015	43	212	n/a	n/a
chr4	79387464	79387464	A	G	hom		QUAL=42502;DP=425;AF=1.00;MQM=60;TRIO=HOM,425,1.00,HOM,349,1.00,HOM,534,1.00	FRAS1	missense	FRAS1:NM_025074.6:missense:MODERATE:exon50/74:c.7132A>G:p.Lys2378Glu		rs7684722	0.9677	0.99	0.9971	0.915	7.6740	P,P	.,T	.,B	.,B	607830 [FRAS1 (provisional) Fraser syndrome];				1	0	0	452	1	n/a	n/a
chr4	79400868	79400868	C	T	het		QUAL=9602;DP=301;AF=0.49;MQM=60;TRIO=HET,301,0.49,HET,166,0.43,HET,220,0.48	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon56/74:c.8439C>T:p.Asp2813Asp		rs11098194	0.2913	0.358	0.3771	0.1759	1.3810	P				607830 [FRAS1 (provisional) Fraser syndrome];			COSM3760773	0.1288	0.4318	0.4394	70	183	n/a	n/a
chr4	79420869	79420869	C	T	het		QUAL=3564;DP=167;AF=0.40;MQM=60;TRIO=HET,167,0.40,HET,95,0.56,WT,143,0.00	FRAS1	splice_region&intron	FRAS1:NM_025074.6:splice_region&intron:LOW:exon60/73:c.9116-6C>T:		rs76630865	0.1725	0.179	0.139	0.1439						607830 [FRAS1 (provisional) Fraser syndrome];				0.0455	0.3106	0.6439	16	133	n/a	n/a
chr4	79420870	79420870	C	G	het		QUAL=3564;DP=167;AF=0.40;MQM=60;TRIO=HET,167,0.40,HET,95,0.56,WT,143,0.00	FRAS1	splice_region&intron	FRAS1:NM_025074.6:splice_region&intron:LOW:exon60/73:c.9116-5C>G:		rs7695038	0.5917	0.507	0.4179	0.617						607830 [FRAS1 (provisional) Fraser syndrome];				0.2955	0.4167	0.2879	133	184	n/a	n/a
chr4	79437155	79437155	C	T	het		QUAL=5441;DP=202;AF=0.43;MQM=60;TRIO=HET,202,0.43,HET,216,0.45,WT,305,0.00	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon66/74:c.10377C>T:p.Thr3459Thr		rs3749487	0.1765	0.18	0.1818	0.1781	-1.6450	P				607830 [FRAS1 (provisional) Fraser syndrome];			COSM1131029	0.0455	0.3106	0.6439	18	139	n/a	n/a
chr4	79447763	79447763	T	C	het		QUAL=8908;DP=389;AF=0.47;MQM=60;TRIO=HET,389,0.47,HET,168,0.55,WT,233,0.00	FRAS1	missense	FRAS1:NM_025074.6:missense:MODERATE:exon70/74:c.10877T>C:p.Val3626Ala		rs34670941	0.1454	0.116	0.0998	0.1635	0.3720	P	T	B	B	607830 [FRAS1 (provisional) Fraser syndrome];				0	0.2045	0.7955	5	74	n/a	n/a
chr4	79455714	79455714	C	G	het		QUAL=10967;DP=464;AF=0.47;MQM=60;TRIO=HET,464,0.47,HET,268,0.45,WT,365,0.01	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon71/74:c.11037C>G:p.Pro3679Pro		rs4975070	0.515	0.488	0.4359	0.3376	0.4930	P				607830 [FRAS1 (provisional) Fraser syndrome];			COSM4005805	0.3106	0.4167	0.2727	119	198	n/a	n/a
chr4	79455733	79455733	C	T	het		QUAL=9488;DP=404;AF=0.47;MQM=60;TRIO=HET,404,0.47,HET,249,0.43,WT,334,0.01	FRAS1	synonymous	FRAS1:NM_025074.6:synonymous:LOW:exon71/74:c.11056C>T:p.Leu3686Leu		rs4975139	0.515	0.488	0.4359	0.3379	1.1260	P				607830 [FRAS1 (provisional) Fraser syndrome];			COSM4005808	0.3106	0.4167	0.2727	119	198	n/a	n/a
chr4	79462311	79462311	T	A	het		QUAL=7241;DP=258;AF=0.48;MQM=60;TRIO=HET,258,0.48,HET,94,0.44,HET,141,0.44	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*33T>A:		rs72659058	0.1056	0.154	0.2309	0.1039										0.0303	0.3333	0.6364	5	50	n/a	n/a
chr4	79462560	79462560	A	T	het		QUAL=17868;DP=474;AF=0.50;MQM=60;TRIO=HET,474,0.50,HET,263,0.50,HET,343,0.50	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*282A>T:		rs3749485	0.2023	0	0	0										0.0758	0.4318	0.4924	13	60	n/a	n/a
chr4	79464432	79464432	C	T	het		QUAL=18861;DP=368;AF=0.49;MQM=60;TRIO=HET,368,0.49,HET,352,0.47,HET,446,0.52	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*2154C>T:		rs3811747	0.6617	0	0	0										0.5	0.3939	0.1061	76	56	n/a	n/a
chr4	79464767	79464767	T	C	het		QUAL=21668;DP=416;AF=0.55;MQM=60;TRIO=HET,416,0.55,HET,389,0.57,HET,410,0.50	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*2489T>C:		rs11098227	0.6617	0	0	0										0.5152	0.3864	0.0985	77	56	n/a	n/a
chr4	79464978	79464978	G	A	het		QUAL=12925;DP=311;AF=0.45;MQM=60;TRIO=HET,311,0.45,HET,210,0.54,HET,266,0.50	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*2700G>A:		rs11098228	0.6404	0	0	0										0.4394	0.4318	0.1288	67	62	n/a	n/a
chr4	79465100	79465100	-	TTTT	het		QUAL=12835;DP=391;AF=0.40;MQM=60;TRIO=HET,391,0.40,HET,221,0.48,HET,316,0.47	FRAS1	3'UTR	FRAS1:NM_025074.6:3'UTR:MODIFIER:exon74/74:c.*2824_*2825insTTTT:		rs397724155	0.6406	0	0	0										0.4394	0.4318	0.1288	66	63	n/a	n/a
chr4	80823880	80823880	-	T	het		QUAL=4577;DP=131;AF=0.64;MQM=59;TRIO=HET,131,0.64,HET,67,0.33,HET,82,0.72	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*4702dupA:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*4702dupA:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*4702dupA:		rs397702828	0.5996	0	0	0										0.3636	0.3258	0.3106	53	49	n/a	n/a
chr4	80824302	80824302	-	A	het		QUAL=10898;DP=155;AF=0.72;MQM=58;TRIO=HET,155,0.91,HET,110,0.93,HET,149,0.94	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*4280dupT:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*4280dupT:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*4280dupT:	AluSz6	rs373264816	0	0	0	0										0	0.197	0.803	0	29	n/a	n/a
chr4	80824311	80824311	G	A	hom		QUAL=10898;DP=155;AF=0.72;MQM=58;TRIO=HOM,155,0.91,HOM,110,0.93,HOM,149,0.94	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*4272C>T:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*4272C>T:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*4272C>T:	AluSz6	rs56708107	0.4858	0	0	0										0.3333	0.447	0.2197	51	66	n/a	n/a
chr4	80824527	80824527	A	T	het		QUAL=15909;DP=351;AF=0.86;MQM=59;TRIO=HET,351,0.86,HET,139,0.45,HOM,170,0.95	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*4056T>A:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*4056T>A:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*4056T>A:		rs11946205	0.2516	0	0	0										0.0606	0.5909	0.3485	9	89	n/a	n/a
chr4	80824888	80824888	A	G	hom		QUAL=19131;DP=303;AF=1.00;MQM=60;TRIO=HOM,303,1.00,HOM,123,1.00,HOM,162,1.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*3695T>C:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*3695T>C:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*3695T>C:		rs4611863	0.9798	0	0	0										1	0	0	150	0	n/a	n/a
chr4	80825271	80825271	A	-	hom		QUAL=8981;DP=195;AF=0.96;MQM=60;TRIO=HOM,195,0.96,HOM,41,1.00,HOM,52,0.92	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*3312delT:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*3312delT:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*3312delT:		rs11292255	0.4858	0	0	0										0.3485	0.4621	0.1894	53	67	n/a	n/a
chr4	80826920	80826920	C	T	het		QUAL=6226;DP=316;AF=0.44;MQM=60;TRIO=HET,316,0.44,HET,117,0.45,WT,146,0.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*1663G>A:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*1663G>A:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*1663G>A:		rs113322831	0.02	0	0	0										0.0076	0.1212	0.8712	1	17	n/a	n/a
chr4	80827062	80827062	T	C	hom		QUAL=23492;DP=250;AF=1.00;MQM=60;TRIO=HOM,250,1.00,HOM,194,1.00,HOM,279,1.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*1521A>G:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*1521A>G:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*1521A>G:		rs7747	0.8516	0	0	0										0.6439	0.3106	0.0455	97	46	n/a	n/a
chr4	80827798	80827798	A	G	hom		QUAL=33280;DP=450;AF=1.00;MQM=60;TRIO=HOM,450,1.00,HOM,245,1.00,HOM,325,1.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*785T>C:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*785T>C:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*785T>C:		rs63539261	0.8492	0	0	0										0.6439	0.3106	0.0455	96	47	n/a	n/a
chr4	80827799	80827799	A	C	hom		QUAL=33280;DP=450;AF=1.00;MQM=60;TRIO=HOM,450,1.00,HOM,245,1.00,HOM,325,1.00	ANTXR2	3'UTR	ANTXR2:NM_001286781.1:3'UTR:MODIFIER:exon17/17:c.*784T>G:,ANTXR2:NM_058172.5:3'UTR:MODIFIER:exon17/17:c.*784T>G:,ANTXR2:NM_001286780.1:3'UTR:MODIFIER:exon17/17:c.*784T>G:		rs1139638	0.8494	0	0	0										0.6439	0.3106	0.0455	96	47	n/a	n/a
chr4	80905990	80905990	C	G	hom		QUAL=5104;DP=87;AF=0.99;MQM=60;TRIO=HOM,87,0.99,HET,52,0.44,HOM,49,1.00	ANTXR2	missense	ANTXR2:NM_001145794.1:missense:MODERATE:exon13/16:c.1069G>C:p.Ala357Pro,ANTXR2:NM_001286781.1:missense:MODERATE:exon13/17:c.838G>C:p.Ala280Pro,ANTXR2:NM_058172.5:missense:MODERATE:exon13/17:c.1069G>C:p.Ala357Pro,ANTXR2:NM_001286780.1:missense:MODERATE:exon13/17:c.838G>C:p.Ala280Pro		rs12647691	0.8027	0.767	0.7074	0.7166	2.2410	P	T	B,B,B	B,B,B	608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome];		CM121492 [CLASS=DFP MUT=ALT PHEN="Anthrax toxin sensitivity, association with" GENE=ANTXR2]; 	COSM3760782	0.6061	0.3409	0.053	253	163	n/a	n/a
chr4	80977078	80977078	T	G	hom		QUAL=9912;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HET,80,0.51,HOM,84,1.00	ANTXR2	splice_region&intron	ANTXR2:NM_001145794.1:splice_region&intron:LOW:exon4/15:c.378+8A>C:,ANTXR2:NM_001286781.1:splice_region&intron:LOW:exon4/16:c.147+8A>C:,ANTXR2:NM_058172.5:splice_region&intron:LOW:exon4/16:c.378+8A>C:,ANTXR2:NM_001286780.1:splice_region&intron:LOW:exon4/16:c.147+8A>C:		rs4594664	0.6973	0.626	0.6151	0.5252						608041 [ANTXR2 (provisional) Hyaline fibromatosis syndrome];				0.447	0.4015	0.1515	181	199	n/a	n/a
chr4	84188850	84188850	G	A	het		QUAL=3325;DP=137;AF=0.44;MQM=59;TRIO=HET,137,0.44,WT,116,0.00,HET,110,0.45	COQ2	synonymous	COQ2:NM_015697.7:synonymous:LOW:exon6/7:c.990C>T:p.Ser330Ser		rs1129617	0.2103	0.169	0.2722	0.1145						609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1|Multiple system atrophy,susceptibility to];	RCV000116809.2 [likely benign]; RCV000124535.1 [benign]; 			0.0606	0.4167	0.5227	68	357	n/a	n/a
chr4	84191031	84191031	A	G	het		QUAL=12090;DP=215;AF=0.51;MQM=60;TRIO=HET,215,0.51,HOM,171,1.00,HET,206,0.50	COQ2	synonymous	COQ2:NM_015697.7:synonymous:LOW:exon5/7:c.894T>C:p.Asp298Asp		rs6535454	0.7782	0.734	0.7025	0.8141						609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1|Multiple system atrophy,susceptibility to];	RCV000116808.2 [likely benign]; RCV000124533.1 [benign]; 			0.5455	0.3939	0.0606	433	372	n/a	n/a
chr4	84205872	84205872	C	A	hom		QUAL=683;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,10,1.00,HOM,9,1.00	COQ2	missense	COQ2:NM_015697.7:missense:MODERATE:exon1/7:c.196G>T:p.Val66Leu		rs6818847	0.6498	0.614	0.746	0.549	-1.9210	P	T	B	B	609825 [COQ2 (provisional) Coenzyme Q10 deficiency,primary,1|Multiple system atrophy,susceptibility to];	RCV000116807.2 [likely benign]; RCV000124541.1 [benign]; 			0.4924	0.2879	0.2197	314	191	n/a	n/a
chr4	87684031	87684031	A	G	het		QUAL=12234;DP=325;AF=0.44;MQM=60;TRIO=HET,325,0.44,HOM,244,1.00,WT,387,0.00	PTPN13	synonymous	PTPN13:NM_080685.2:synonymous:LOW:exon24/48:c.3705A>G:p.Pro1235Pro,PTPN13:NM_006264.2:synonymous:LOW:exon23/47:c.3648A>G:p.Pro1216Pro,PTPN13:NM_080683.2:synonymous:LOW:exon24/48:c.3705A>G:p.Pro1235Pro,PTPN13:NM_080684.2:synonymous:LOW:exon21/45:c.3132A>G:p.Pro1044Pro		rs710832	0.7109	0.711	0.7314	0.8398										0.4545	0.4394	0.1061	231	185	n/a	n/a
chr4	87685796	87685796	T	G	het		QUAL=7584;DP=261;AF=0.48;MQM=60;TRIO=HET,261,0.48,HET,177,0.62,WT,196,0.01	PTPN13	missense	PTPN13:NM_080685.2:missense:MODERATE:exon25/48:c.4068T>G:p.Phe1356Leu,PTPN13:NM_006264.2:missense:MODERATE:exon24/47:c.4011T>G:p.Phe1337Leu,PTPN13:NM_080683.2:missense:MODERATE:exon25/48:c.4068T>G:p.Phe1356Leu,PTPN13:NM_080684.2:missense:MODERATE:exon22/45:c.3495T>G:p.Phe1165Leu		rs10033029	0.0521	0.076	0.1196	0.0534	2.6660	P	T	B,B,B,B	B,B,B,B					0	0.1818	0.8182	6	86	n/a	n/a
chr4	87692393	87692393	G	A	het		QUAL=12123;DP=462;AF=0.48;MQM=60;TRIO=HET,462,0.48,HET,312,0.50,WT,412,0.00	PTPN13	missense	PTPN13:NM_080685.2:missense:MODERATE:exon31/48:c.4888G>A:p.Glu1630Lys,PTPN13:NM_006264.2:missense:MODERATE:exon30/47:c.4816G>A:p.Glu1606Lys,PTPN13:NM_080683.2:missense:MODERATE:exon31/48:c.4873G>A:p.Glu1625Lys,PTPN13:NM_080684.2:missense:MODERATE:exon28/45:c.4300G>A:p.Glu1434Lys		rs12500797	0.0443	0.078	0.1202	0.0301	5.2760	P	T	P,B,B,B	B,B,B,B			CM067710 [CLASS=DP MUT=ALT PHEN="Lung cancer, susceptibility to, association with" GENE=PTPN13]; 		0	0.1818	0.8182	3	91	n/a	n/a
chr4	87696470	87696470	A	G	het		QUAL=5622;DP=264;AF=0.50;MQM=60;TRIO=HET,264,0.50,HET,82,0.50,WT,112,0.00	PTPN13	synonymous	PTPN13:NM_080685.2:synonymous:LOW:exon34/48:c.5670A>G:p.Thr1890Thr,PTPN13:NM_006264.2:synonymous:LOW:exon33/47:c.5598A>G:p.Thr1866Thr,PTPN13:NM_080683.2:synonymous:LOW:exon34/48:c.5655A>G:p.Thr1885Thr,PTPN13:NM_080684.2:synonymous:LOW:exon31/45:c.5082A>G:p.Thr1694Thr		rs12507034	0.0705	0.085	0.1212	0.0996										0	0.1818	0.8182	3	91	n/a	n/a
chr4	87696476	87696476	G	A	het		QUAL=5351;DP=253;AF=0.47;MQM=60;TRIO=HET,253,0.47,HET,84,0.51,WT,114,0.00	PTPN13	synonymous	PTPN13:NM_080685.2:synonymous:LOW:exon34/48:c.5676G>A:p.Thr1892Thr,PTPN13:NM_006264.2:synonymous:LOW:exon33/47:c.5604G>A:p.Thr1868Thr,PTPN13:NM_080683.2:synonymous:LOW:exon34/48:c.5661G>A:p.Thr1887Thr,PTPN13:NM_080684.2:synonymous:LOW:exon31/45:c.5088G>A:p.Thr1696Thr		rs12499471	0.0705	0.085	0.1218	0.1										0	0.1818	0.8182	3	92	n/a	n/a
chr4	87736307	87736307	A	C	het		QUAL=5708;DP=247;AF=0.41;MQM=60;TRIO=HET,247,0.41,HET,147,0.48,WT,178,0.00	PTPN13	3'UTR	PTPN13:NM_080685.2:3'UTR:MODIFIER:exon48/48:c.*603A>C:,PTPN13:NM_006264.2:3'UTR:MODIFIER:exon47/47:c.*603A>C:,PTPN13:NM_080683.2:3'UTR:MODIFIER:exon48/48:c.*603A>C:,PTPN13:NM_080684.2:3'UTR:MODIFIER:exon45/45:c.*603A>C:		rs17750575	0.0657	0	0	0										0	0.1742	0.8258	0	27	n/a	n/a
chr4	88584148	88584148	C	T	het		QUAL=9536;DP=268;AF=0.47;MQM=60;TRIO=HET,268,0.47,WT,298,0.01,HET,378,0.46	DMP1	synonymous	DMP1:NM_004407.3:synonymous:LOW:exon6/6:c.1218C>T:p.Ser406Ser,DMP1:NM_001079911.2:synonymous:LOW:exon5/5:c.1170C>T:p.Ser390Ser		rs2615498	0.1757	0.191	0.1914	0.0731						600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR];			COSM3760817	0.0455	0.3333	0.6212	19	147	n/a	n/a
chr4	88584160	88584160	G	A	het		QUAL=10131;DP=279;AF=0.49;MQM=60;TRIO=HET,279,0.49,WT,273,0.01,HET,367,0.47	DMP1	synonymous	DMP1:NM_004407.3:synonymous:LOW:exon6/6:c.1230G>A:p.Glu410Glu,DMP1:NM_001079911.2:synonymous:LOW:exon5/5:c.1182G>A:p.Glu394Glu		rs2615497	0.3213	0.259	0.2244	0.3976						600980 [DMP1 (confirmed) Hypophosphatemic rickets,AR];			COSM3760818	0.0758	0.3864	0.5379	34	168	n/a	n/a
chr4	88584507	88584507	G	A	het		QUAL=10313;DP=303;AF=0.50;MQM=60;TRIO=HET,303,0.50,WT,260,0.00,HET,318,0.49	DMP1	3'UTR	DMP1:NM_004407.3:3'UTR:MODIFIER:exon6/6:c.*35G>A:,DMP1:NM_001079911.2:3'UTR:MODIFIER:exon5/5:c.*35G>A:		rs2627724	0.3213	0.259	0.2159	0.3838										0.0758	0.3864	0.5379	13	60	n/a	n/a
chr4	88585079	88585079	A	G	het		QUAL=9840;DP=436;AF=0.53;MQM=60;TRIO=HET,436,0.53,WT,122,0.01,HET,137,0.48	DMP1	3'UTR	DMP1:NM_004407.3:3'UTR:MODIFIER:exon6/6:c.*607A>G:,DMP1:NM_001079911.2:3'UTR:MODIFIER:exon5/5:c.*607A>G:	L2c	rs2627725	0.6661	0	0	0										0.2727	0.4697	0.2576	38	74	n/a	n/a
chr4	88585218	88585218	T	-	het		QUAL=13773;DP=204;AF=0.43;MQM=60;TRIO=HET,204,0.43,HET,143,0.36,HET,168,0.40	DMP1	3'UTR	DMP1:NM_004407.3:3'UTR:MODIFIER:exon6/6:c.*758delT:,DMP1:NM_001079911.2:3'UTR:MODIFIER:exon5/5:c.*758delT:			0.4824	0	0	0										0.1515	0.3258	0.5227	21	48	n/a	n/a
chr4	88585218	88585219	TT	-	het		QUAL=13773;DP=204;AF=0.50;MQM=60;TRIO=HET,204,0.50,HET,143,0.53,HET,168,0.48	DMP1	3'UTR	DMP1:NM_004407.3:3'UTR:MODIFIER:exon6/6:c.*757_*758delTT:,DMP1:NM_001079911.2:3'UTR:MODIFIER:exon5/5:c.*757_*758delTT:		rs35239689	0.3486	0	0	0										0.2879	0.3106	0.4015	42	48	n/a	n/a
chr4	103611845	103611845	C	T	hom		QUAL=9350;DP=146;AF=0.99;MQM=60;TRIO=HOM,146,0.99,HET,135,0.50,HET,162,0.50	MANBA	missense	MANBA:NM_005908.3:missense:MODERATE:exon6/17:c.757G>A:p.Val253Ile		rs227368	0.3766	0.442	0.4745	0.2108	-0.2430	P	T	B,B	B,B	609489 [MANBA (confirmed) Mannosidosis,beta];			COSM4155100	0.2045	0.4621	0.3333	111	223	n/a	n/a
chr4	107270027	107270027	G	A	het		QUAL=10570;DP=361;AF=0.48;MQM=60;TRIO=HET,361,0.48,WT,225,0.00,HET,261,0.55	AIMP1	3'UTR	AIMP1:NM_001142416.1:3'UTR:MODIFIER:exon7/7:c.*1178G>A:,AIMP1:NM_001142415.1:3'UTR:MODIFIER:exon7/7:c.*1178G>A:,AIMP1:NM_004757.3:3'UTR:MODIFIER:exon7/7:c.*1178G>A:		rs13534	0.1785	0	0	0										0.0682	0.4091	0.5227	11	60	n/a	n/a
chr4	108931039	108931039	T	C	hom		QUAL=21957;DP=351;AF=1.00;MQM=60;TRIO=HOM,351,1.00,HOM,151,0.99,HOM,187,1.00	HADH	missense	HADH:NM_001184705.2:missense:MODERATE:exon2/9:c.257T>C:p.Leu86Pro,HADH:NM_005327.4:missense:MODERATE:exon2/8:c.257T>C:p.Leu86Pro		rs4956145	0.869	0.915	0.9237	0.7045	4.8010	P	T	B,B,B	B,B,B	601609 [HADH (confirmed) 3-hydroxyacyl-CoA dehydrogenase deficiency|Hyperinsulinemic hypoglycemia,familial,4];	RCV000153344.1 [benign]; 			0.8864	0.1136	0	391	60	n/a	n/a
chr4	110661937	110661937	G	A	hom		QUAL=13135;DP=250;AF=1.00;MQM=60;TRIO=HOM,250,1.00,HOM,74,1.00,HOM,85,1.00	CFI	3'UTR	CFI:NM_000204.3:3'UTR:MODIFIER:exon13/13:c.*112C>T:		rs551	0.9537	0.983	0	0										1	0	0	150	0	n/a	n/a
chr4	110678925	110678925	T	C	hom		QUAL=8960;DP=165;AF=1.00;MQM=60;TRIO=HOM,165,1.00,HOM,44,1.00,HOM,61,1.00	CFI	missense	CFI:NM_000204.3:missense:MODERATE:exon7/13:c.898A>G:p.Thr300Ala		rs11098044	0.9669	0.989	0.9991	0.8948	-0.2530	P	T	B,B	B,B	217030 [CFI (confirmed) Complement factor I deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,3|Macular degeneration,age-related,13,susceptibility to];				1	0	0	451	2	n/a	n/a
chr4	113565887	113565889	AAG	-	het		QUAL=2974;DP=102;AF=0.50;MQM=60;TRIO=HET,102,0.50,HET,100,0.47,WT,121,0.00	LARP7	disruptive_inframe_deletion	LARP7:NM_001267039.1:disruptive_inframe_deletion:MODERATE:exon4/15:c.86_88delAAG:p.Glu29del,LARP7:NM_016648.3:disruptive_inframe_deletion:MODERATE:exon2/13:c.65_67delAAG:p.Glu22del,LARP7:NM_015454.2:disruptive_inframe_deletion:MODERATE:exon2/13:c.65_67delAAG:p.Glu22del		rs570445594	0.0012	0.0026	0.0125	0.0063						612026 [LARP7 (provisional) Alazami syndrome];				0	0.0076	0.9924	0	4	n/a	n/a
chr4	119201532	119201533	TT	-	het		QUAL=7472;DP=269;AF=0.47;MQM=60;TRIO=HET,269,0.47,HOM,116,0.97,WT,161,0.00	PRSS12	3'UTR	PRSS12:NM_003619.3:3'UTR:MODIFIER:exon13/13:c.*1558_*1559delAA:		rs397839202	0.2312	0	0	0										0.1061	0.3864	0.5076	15	59	n/a	n/a
chr4	119201587	119201587	C	T	het		QUAL=9311;DP=362;AF=0.45;MQM=60;TRIO=HET,362,0.45,WT,182,0.00,HET,236,0.49	PRSS12	3'UTR	PRSS12:NM_003619.3:3'UTR:MODIFIER:exon13/13:c.*1504G>A:		rs1045817	0.0958	0	0	0										0.0606	0.3106	0.6288	9	46	n/a	n/a
chr4	119219909	119219909	C	A	het		QUAL=10016;DP=243;AF=0.54;MQM=60;TRIO=HET,243,0.54,WT,269,0.00,HET,355,0.53	PRSS12	missense	PRSS12:NM_003619.3:missense:MODERATE:exon9/13:c.1816G>T:p.Ala606Ser		rs28661939	0.1246	0.148	0.1499	0.1241	0.8120	P	T	B	B	606709 [PRSS12 (provisional) Mental retardation,autosomal recessive 1];	RCV000118070.2 [likely benign]; 			0.0606	0.3106	0.6288	14	119	n/a	n/a
chr4	119237348	119237348	T	C	het		QUAL=11172;DP=218;AF=0.52;MQM=60;TRIO=HET,218,0.52,WT,169,0.01,HOM,232,1.00	PRSS12	synonymous	PRSS12:NM_003619.3:synonymous:LOW:exon6/13:c.1281A>G:p.Gln427Gln		rs2292597	0.5453	0.554	0.5495	0.4739						606709 [PRSS12 (provisional) Mental retardation,autosomal recessive 1];	RCV000118068.2 [likely benign]; 		COSM149728	0.3864	0.4697	0.1439	147	224	n/a	n/a
chr4	122742217	122742217	T	C	hom		QUAL=18124;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HOM,103,1.00,HOM,199,1.00	CCNA2	missense	CCNA2:NM_001237.3:missense:MODERATE:exon3/8:c.487A>G:p.Ile163Val		rs769242	0.9687	0.963	0.9606	0.9857	1.1430	P	T	B	B					0.9697	0.0303	0	437	15	n/a	n/a
chr4	122744942	122744942	G	A	hom		QUAL=10874;DP=52;AF=0.98;MQM=60;TRIO=HOM,52,0.98,HOM,184,1.00,HET,211,0.54	CCNA2	5'UTR_premature_start_codon_gain,5'UTR	CCNA2:NM_001237.3:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-159C>T:,CCNA2:NM_001237.3:5'UTR:MODIFIER:exon1/8:c.-159C>T:		rs769238	0.2494	0	0	0										0.1742	0.4091	0.4167	25	62	n/a	n/a
chr4	122744979	122744979	G	A	het		QUAL=2721;DP=46;AF=0.41;MQM=60;TRIO=HET,46,0.41,HET,141,0.53,WT,191,0.00	CCNA2	5'UTR_premature_start_codon_gain,5'UTR	CCNA2:NM_001237.3:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-196C>T:,CCNA2:NM_001237.3:5'UTR:MODIFIER:exon1/8:c.-196C>T:		rs769237	0.0208	0	0	0										0	0.0833	0.9167	0	12	n/a	n/a
chr4	122745729	122745729	C	T	hom		QUAL=11991;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,113,1.00,HET,136,0.43	BBS7	3'UTR	BBS7:NM_176824.2:3'UTR:MODIFIER:exon19/19:c.*1286G>A:		rs1507996	0.1723	0	0	0										0.1364	0.3485	0.5152	20	51	n/a	n/a
chr4	122746325	122746325	A	G	hom		QUAL=22818;DP=410;AF=1.00;MQM=60;TRIO=HOM,410,1.00,HOM,159,0.99,HET,216,0.54	BBS7	3'UTR	BBS7:NM_176824.2:3'UTR:MODIFIER:exon19/19:c.*690T>C:		rs3217753	0.2494	0	0	0										0.1742	0.4091	0.4167	25	62	n/a	n/a
chr4	145701128	145701128	T	G	hom		QUAL=25768;DP=362;AF=1.00;MQM=60;TRIO=HOM,362,1.00,HOM,173,1.00,HOM,236,1.00					rs4835188	0.9589	0	0	0										1	0	0	150	0	n/a	n/a
chr4	146579194	146579194	T	C	het		QUAL=7332;DP=277;AF=0.48;MQM=60;TRIO=HET,277,0.48,HET,77,0.45,HET,131,0.46	MMAA	3'UTR	MMAA:NM_172250.2:3'UTR:MODIFIER:exon7/7:c.*2608T>C:	MSTB	rs7699187	0.5657	0	0	0										0.2121	0.4924	0.2955	31	75	n/a	n/a
chr4	146579354	146579354	A	T	het		QUAL=5196;DP=144;AF=0.44;MQM=60;TRIO=HET,144,0.44,HET,86,0.49,HET,127,0.44	MMAA	3'UTR	MMAA:NM_172250.2:3'UTR:MODIFIER:exon7/7:c.*2768A>T:	MSTB	rs7699166	0.5657	0	0	0										0.2121	0.4924	0.2955	31	75	n/a	n/a
chr4	146579452	146579452	A	G	het		QUAL=9288;DP=417;AF=0.45;MQM=60;TRIO=HET,417,0.45,WT,102,0.00,HET,179,0.50	MMAA	3'UTR	MMAA:NM_172250.2:3'UTR:MODIFIER:exon7/7:c.*2866A>G:	MIR	rs17020500	0.2742	0	0	0										0.0379	0.4091	0.553	6	61	n/a	n/a
chr4	146579844	146579844	A	-	het		QUAL=3100;DP=251;AF=0.27;MQM=59;TRIO=HET,251,0.27,HET,69,0.36,HET,91,0.18	MMAA	3'UTR	MMAA:NM_172250.2:3'UTR:MODIFIER:exon7/7:c.*3274delA:		rs33978754	0.2766	0	0	0										0.0152	0.3258	0.6591	2	44	n/a	n/a
chr4	149000024	149000024	C	T	hom		QUAL=21207;DP=396;AF=0.99;MQM=60;TRIO=HOM,396,0.99,HOM,114,1.00,HOM,160,0.99	NR3C2	3'UTR	NR3C2:NM_000901.4:3'UTR:MODIFIER:exon9/9:c.*2471G>A:,NR3C2:NM_001166104.1:3'UTR:MODIFIER:exon8/8:c.*2471G>A:		rs2871	0.7163	0	0	0										0.4167	0.447	0.1364	66	64	n/a	n/a
chr4	149001085	149001085	T	C	hom		QUAL=20575;DP=322;AF=1.00;MQM=60;TRIO=HOM,322,1.00,HOM,167,1.00,HET,256,0.54	NR3C2	3'UTR	NR3C2:NM_000901.4:3'UTR:MODIFIER:exon9/9:c.*1410A>G:,NR3C2:NM_001166104.1:3'UTR:MODIFIER:exon8/8:c.*1410A>G:		rs5534	0.5535	0	0	0								CR1111313 [CLASS=DFP MUT=REF PHEN="Myocardial infarction, increased risk, association with" GENE=NR3C2]; 		0.2652	0.4621	0.2727	45	67	n/a	n/a
chr4	149002017	149002017	T	-	hom		QUAL=5610;DP=110;AF=1.00;MQM=60;TRIO=HOM,110,1.00,HOM,30,1.00,HOM,35,1.00	NR3C2	3'UTR	NR3C2:NM_000901.4:3'UTR:MODIFIER:exon9/9:c.*478delA:,NR3C2:NM_001166104.1:3'UTR:MODIFIER:exon8/8:c.*478delA:	AT_rich	rs397779293	0	0	0	0										0.3939	0.4545	0.1515	107	106	n/a	n/a
chr4	149356516	149356516	A	G	hom		QUAL=33389;DP=390;AF=1.00;MQM=60;TRIO=HOM,390,1.00,HOM,262,1.00,HOM,367,1.00	NR3C2	synonymous	NR3C2:NM_000901.4:synonymous:LOW:exon2/9:c.1497T>C:p.Asp499Asp,NR3C2:NM_001166104.1:synonymous:LOW:exon2/8:c.1497T>C:p.Asp499Asp		rs5525	0.892	0.882	0.8909	0.9122						600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy];				0.8561	0.1364	0.0076	379	72	n/a	n/a
chr4	149357475	149357475	C	T	hom		QUAL=27497;DP=358;AF=1.00;MQM=60;TRIO=HOM,358,1.00,HOM,233,1.00,HOM,246,1.00	NR3C2	missense	NR3C2:NM_000901.4:missense:MODERATE:exon2/9:c.538G>A:p.Val180Ile,NR3C2:NM_001166104.1:missense:MODERATE:exon2/8:c.538G>A:p.Val180Ile		rs5522	0.892	0.881	0.8902	0.9119	-0.3800	P		B,B	B,B	600983 [NR3C2 (confirmed) Pseudohypoaldosteronism type I,autosomal dominant|Hypertension,early-onset,autosomal dominant,with exacerbation in pregnancy];		CM030066 [CLASS=DFP MUT=REF PHEN="Reduced expression" GENE=NR3C2]; 		0.8561	0.1364	0.0076	378	73	n/a	n/a
chr4	149358014	149358014	G	C	hom		QUAL=19344;DP=307;AF=1.00;MQM=60;TRIO=HOM,307,1.00,HET,249,0.54,HET,316,0.51	NR3C2	splice_region,5'UTR	NR3C2:NM_000901.4:splice_region:LOW:exon2/9:c.-2C>G:,NR3C2:NM_001166104.1:splice_region:LOW:exon2/8:c.-2C>G:,NR3C2:NM_000901.4:5'UTR:MODIFIER:exon2/9:c.-2C>G:,NR3C2:NM_001166104.1:5'UTR:MODIFIER:exon2/8:c.-2C>G:		rs2070951	0.5008	0.518	0.4744	0.2472								CR030126 [CLASS=DFP MUT=REF PHEN="Increased blood pressure, association with" GENE=NR3C2]; 		0.3333	0.4773	0.1894	138	190	n/a	n/a
chr4	159601676	159601676	C	T	hom		QUAL=25328;DP=257;AF=1.00;MQM=60;TRIO=HOM,257,1.00,HOM,227,1.00,HOM,271,1.00	ETFDH	missense,intron	ETFDH:NM_004453.3:missense:MODERATE:exon2/13:c.92C>T:p.Thr31Ile,ETFDH:NM_001281737.1:intron:MODIFIER:exon1/11:c.35-1671C>T:		rs11559290	0.6727	0.812	0.86	0.2596	1.1210	P	T	B	B	231675 [ETFDH (confirmed) Glutaric acidemia IIC];	RCV000081080.2 [benign]; 		COSM4158888	0.7879	0.197	0.0152	342	103	n/a	n/a
chr4	178352679	178352679	T	G	hom		QUAL=11539;DP=224;AF=1.00;MQM=60;TRIO=HOM,224,1.00,HOM,45,1.00,HOM,76,1.00	AGA	3'UTR	AGA:NM_000027.3:3'UTR:MODIFIER:exon9/9:c.*183A>C:,AGA:NM_001171988.1:3'UTR:MODIFIER:exon9/9:c.*183A>C:		rs1061814	0.4569	0.475	0	0										0.3333	0.4621	0.2045	121	121	n/a	n/a
chr4	178359960	178359960	G	C	hom		QUAL=19274;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,153,1.00,HOM,202,1.00	AGA	missense	AGA:NM_000027.3:missense:MODERATE:exon4/9:c.446C>G:p.Thr149Ser,AGA:NM_001171988.1:missense:MODERATE:exon4/9:c.446C>G:p.Thr149Ser		rs2228119	0.9209	0.978	0.999	0.7814	-0.1550	P,P	.,T	.,B	.,B	613228 [AGA (confirmed) Aspartylglucosaminuria];	RCV000077944.2 [benign]; 			1	0	0	451	2	n/a	n/a
chr4	184369040	184369040	G	A	hom		QUAL=12848;DP=286;AF=1.00;MQM=60;TRIO=HOM,286,1.00,HET,98,0.55,HET,140,0.42	CDKN2AIP	3'UTR	CDKN2AIP:NM_017632.2:3'UTR:MODIFIER:exon3/3:c.*460G>A:		rs3187025	0.0719	0	0	0										0.0303	0.1818	0.7879	4	28	n/a	n/a
chr4	186068637	186068637	A	G	hom		QUAL=14495;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HOM,122,1.00,HOM,119,1.00	SLC25A4	3'UTR	SLC25A4:NM_001151.3:3'UTR:MODIFIER:exon4/4:c.*512A>G:		rs7660552	0.9365	0	0	0										0.8106	0.1591	0.0303	121	24	n/a	n/a
chr4	186069178	186069178	T	C	hom		QUAL=10738;DP=152;AF=1.00;MQM=60;TRIO=HOM,152,1.00,HET,99,0.48,HOM,136,0.99	SLC25A4	3'UTR	SLC25A4:NM_001151.3:3'UTR:MODIFIER:exon4/4:c.*1053T>C:	MLT1A0	rs55905558	0.4399	0	0	0										0.2879	0.4091	0.303	41	59	n/a	n/a
chr4	186070432	186070432	T	C	hom		QUAL=39912;DP=452;AF=1.00;MQM=59;TRIO=HOM,452,1.00,HET,443,0.50,HOM,563,1.00	SLC25A4	3'UTR	SLC25A4:NM_001151.3:3'UTR:MODIFIER:exon4/4:c.*2307T>C:		rs2046535	0.4687	0	0	0										0.2879	0.4091	0.303	42	58	n/a	n/a
chr4	186071068	186071068	G	A	hom		QUAL=22771;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HET,193,0.46,HOM,260,1.00	SLC25A4	3'UTR	SLC25A4:NM_001151.3:3'UTR:MODIFIER:exon4/4:c.*2943G>A:		rs7675110	0.4305	0	0	0										0.2955	0.4167	0.2879	42	59	n/a	n/a
chr4	186997767	186997767	C	A	het		QUAL=10461;DP=252;AF=0.48;MQM=60;TRIO=HET,252,0.48,HET,136,0.49,HOM,160,0.99	TLR3	splice_region,5'UTR	TLR3:NM_003265.2:splice_region:LOW:exon2/5:c.-7C>A:,TLR3:NM_003265.2:5'UTR:MODIFIER:exon2/5:c.-7C>A:		rs3775296	0.1817	0.182	0.1951	0.1596										0.0227	0.2652	0.7121	16	119	n/a	n/a
chr4	187004074	187004074	C	T	het		QUAL=9352;DP=353;AF=0.49;MQM=60;TRIO=HET,353,0.49,HET,231,0.48,WT,294,0.01	TLR3	missense	TLR3:NM_003265.2:missense:MODERATE:exon4/5:c.1234C>T:p.Leu412Phe		rs3775291	0.2318	0.271	0.2902	0.071	4.0310	P	D	D	D	603029 [TLR3 (provisional) Herpes simplex encephalitis,susceptibility to,2 613002|HIV1 infection,resistance to];	RCV000034357.2 [pathogenic]; 	CM073380 [CLASS=DFP MUT=ALT PHEN="Altered activity, association with" GENE=TLR3]; 	COSM149771	0.0606	0.4167	0.5227	31	191	1	n/a
chr4	187004217	187004217	C	T	het		QUAL=20846;DP=452;AF=0.51;MQM=60;TRIO=HET,452,0.51,HET,238,0.49,HOM,290,1.00	TLR3	synonymous	TLR3:NM_003265.2:synonymous:LOW:exon4/5:c.1377C>T:p.Phe459Phe		rs3775290	0.2722	0.3	0.3094	0.1972						603029 [TLR3 (provisional) Herpes simplex encephalitis,susceptibility to,2 613002|HIV1 infection,resistance to];			COSM1428947	0.0758	0.3788	0.5455	40	167	n/a	n/a
chr4	187158034	187158034	G	A	het		QUAL=20308;DP=369;AF=0.49;MQM=60;TRIO=HET,369,0.49,HOM,278,1.00,HET,381,0.44	KLKB1	missense	KLKB1:NM_000892.3:missense:MODERATE:exon5/15:c.428G>A:p.Ser143Asn		rs3733402	0.6046	0.536	0.5066	0.7365	3.7480	P,P	T,.	B,.	B,.	229000 [KLKB1 (provisional) Fletcher factor deficiency];	RCV000012817.23 [pathogenic]; 	CM073166 [CLASS=DFP MUT=REF PHEN="Prekallikrein deficiency" GENE=KLKB1]; 	COSM149774	0.1894	0.5227	0.2879	111	214	2	n/a
chr4	187179210	187179210	T	C	het		QUAL=14496;DP=181;AF=0.49;MQM=60;TRIO=HET,181,0.49,HOM,236,0.98,HET,295,0.50	KLKB1	synonymous	KLKB1:NM_000892.3:synonymous:LOW:exon15/15:c.1761T>C:p.Asn587Asn		rs925453	0.6581	0.668	0.687	0.6614	-3.8940	P,P	.,T	.,B	.,B	229000 [KLKB1 (provisional) Fletcher factor deficiency];				0.4394	0.4015	0.1591	205	184	n/a	n/a
chr4	187179486	187179486	A	G	het		QUAL=16488;DP=308;AF=0.50;MQM=60;TRIO=HET,308,0.50,HOM,224,1.00,HET,291,0.52	KLKB1	3'UTR	KLKB1:NM_000892.3:3'UTR:MODIFIER:exon15/15:c.*120A>G:	MIRb	rs3087505	0.9185	0	0	0										0.7424	0.2348	0.0227	112	35	n/a	n/a
chr4	190874234	190874234	C	T	het		QUAL=5049;DP=196;AF=0.16;MQM=41;TRIO=HET,196,0.16,HET,165,0.33,HET,237,0.36	FRG1	missense	FRG1:NM_004477.2:missense:MODERATE:exon4/9:c.271C>T:p.Pro91Ser		rs200620299	0	0.314	0	0	7.0600	D	D	D	D		RCV000066382.2 [other]; 			0	0.6818	0.3182	0	269	n/a	n/a
chr4	190876242	190876242	G	A	het		QUAL=15587;DP=275;AF=0.08;MQM=41;TRIO=HET,275,0.08,HET,300,0.55,HET,504,0.64	FRG1	missense	FRG1:NM_004477.2:missense:MODERATE:exon5/9:c.368G>A:p.Gly123Glu		rs1061653	0	0.488	0	0	7.4130	D	T	B	B					0	0.7197	0.2803	0	397	n/a	n/a
chr4	190878597	190878597	C	T	het		QUAL=23448;DP=535;AF=0.44;MQM=34;TRIO=HET,535,0.44,HET,471,0.45,HET,641,0.51	FRG1	synonymous	FRG1:NM_004477.2:synonymous:LOW:exon6/9:c.477C>T:p.Cys159Cys		rs62345290	0	0.462	0	0									COSM4158962	0	0.9091	0.0909	0	440	n/a	n/a
chr4	190878654	190878654	C	G	het		QUAL=10657;DP=484;AF=0.21;MQM=33;TRIO=HET,484,0.21,HET,475,0.26,HET,637,0.26	FRG1	missense	FRG1:NM_004477.2:missense:MODERATE:exon6/9:c.534C>G:p.Ile178Met		rs78653319	0	0.446	0	0	0.0290	D	T	B	P				COSM4158963	0	0.4848	0.5152	0	350	n/a	n/a
chr4	190878661	190878661	A	T	het		QUAL=21807;DP=470;AF=0.41;MQM=34;TRIO=HET,470,0.41,HET,476,0.42,HET,633,0.48	FRG1	splice_region&intron	FRG1:NM_004477.2:splice_region&intron:LOW:exon6/8:c.537+4A>T:		rs62345291	0	0.491	0	0										0	1	0	0	461	n/a	n/a
chr5	231111	231111	T	C	hom		QUAL=11190;DP=107;AF=1.00;MQM=56;TRIO=HOM,107,1.00,HOM,113,1.00,HOM,142,1.00	SDHA	synonymous	SDHA:NM_004168.3:synonymous:LOW:exon7/15:c.891T>C:p.Pro297Pro,SDHA:NM_001294332.1:synonymous:LOW:exon6/14:c.747T>C:p.Pro249Pro		rs1126417	0.6534	0.707	0.7582	0.7892						600857 [SDHA (confirmed) Leigh syndrome|Mitochondrial respiratory chain complex II deficiency|Cardiomyopathy,dilated,1GG|Paragangliomas 5];	RCV000118321.2 [likely benign]; 		COSM4159838	0.4697	0.4697	0.0606	232	224	n/a	n/a
chr5	256472	256472	G	A	het		QUAL=3686;DP=392;AF=0.08;MQM=51;TRIO=HET,392,0.08,HET,242,0.50,WT,274,0.00	SDHA	synonymous	SDHA:NM_004168.3:synonymous:LOW:exon15/15:c.1932G>A:p.Val644Val,SDHA:NM_001294332.1:synonymous:LOW:exon14/14:c.1788G>A:p.Val596Val		rs6961	0.3353	0.171	0.1436	0.5411						600857 [SDHA (confirmed) Leigh syndrome|Mitochondrial respiratory chain complex II deficiency|Cardiomyopathy,dilated,1GG|Paragangliomas 5];	RCV000118316.2 [likely benign]; 			0.0152	0.3712	0.6136	8	210	n/a	n/a
chr5	1393588	1393590	TGT	-	het		QUAL=7535;DP=305;AF=0.43;MQM=59;TRIO=HET,305,0.43,HET,251,0.49,WT,347,0.00	SLC6A3	3'UTR	SLC6A3:NM_001044.4:3'UTR:MODIFIER:exon15/15:c.*1260_*1262delACA:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr5	6599493	6599493	G	-	het		QUAL=4021;DP=124;AF=0.41;MQM=58;TRIO=HET,124,0.41,HET,51,0.47,HET,111,0.50	NSUN2	3'UTR	NSUN2:NM_017755.5:3'UTR:MODIFIER:exon19/19:c.*546delC:,NSUN2:NM_001193455.1:3'UTR:MODIFIER:exon18/18:c.*546delC:		rs200230801	0.0248	0	0	0										0	0.1288	0.8712	0	22	n/a	n/a
chr5	6599940	6599940	C	T	het		QUAL=10504;DP=350;AF=0.46;MQM=59;TRIO=HET,350,0.46,HET,296,0.56,WT,469,0.00	NSUN2	3'UTR	NSUN2:NM_017755.5:3'UTR:MODIFIER:exon19/19:c.*99G>A:,NSUN2:NM_001193455.1:3'UTR:MODIFIER:exon18/18:c.*99G>A:		rs3776448	0.1462	0	0	0										0	0.1818	0.8182	0	30	n/a	n/a
chr5	6600064	6600064	G	T	het		QUAL=20547;DP=380;AF=0.50;MQM=59;TRIO=HET,380,0.50,HET,368,0.49,HET,568,0.52	NSUN2	missense	NSUN2:NM_017755.5:missense:MODERATE:exon19/19:c.2279C>A:p.Pro760Gln,NSUN2:NM_001193455.1:missense:MODERATE:exon18/18:c.2174C>A:p.Pro725Gln		rs61744358	0.0551	0.059	0.0693	0.0592	0.6020	N	T	B,B,B	B,B,B	610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5];	RCV000117858.2 [likely benign]; 			0.0076	0.2045	0.7879	6	75	n/a	n/a
chr5	6600150	6600150	G	A	het		QUAL=15514;DP=431;AF=0.47;MQM=60;TRIO=HET,431,0.47,HET,594,0.49,WT,844,0.00	NSUN2	synonymous	NSUN2:NM_017755.5:synonymous:LOW:exon19/19:c.2193C>T:p.Asp731Asp,NSUN2:NM_001193455.1:synonymous:LOW:exon18/18:c.2088C>T:p.Asp696Asp		rs3822434	0.1735	0.174	0.1487	0.0933						610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5];	RCV000117856.2 [likely benign]; 		COSM1438254	0.0152	0.2197	0.7652	12	102	n/a	n/a
chr5	6622122	6622122	T	A	het		QUAL=12027;DP=248;AF=0.47;MQM=60;TRIO=HET,248,0.47,HET,246,0.48,HET,299,0.47	NSUN2	splice_region&intron	NSUN2:NM_017755.5:splice_region&intron:LOW:exon6/18:c.622+7A>T:,NSUN2:NM_001193455.1:splice_region&intron:LOW:exon5/17:c.517+7A>T:		rs16877704	0.016	0.038	0.0598	0.0102						610916 [NSUN2 (provisional) Mental retardation,autosomal recessive 5];	RCV000117861.2 [likely benign]; 			0	0.1212	0.8788	0	42	n/a	n/a
chr5	7869235	7869235	T	C	het		QUAL=5784;DP=47;AF=0.38;MQM=60;TRIO=HET,47,0.38,HET,131,0.52,HET,223,0.48	MTRR	5'UTR	MTRR:NM_024010.2:5'UTR:MODIFIER:exon1/15:c.-12T>C:,MTRR:NM_002454.2:5'UTR:MODIFIER:exon1/15:c.-119T>C:		rs72716536	0.229	0.158	0.1048	0.3157							RCV000126883.1 [benign]; 			0.0076	0.1742	0.8182	2	31	n/a	n/a
chr5	7878192	7878192	T	C	het		QUAL=14919;DP=500;AF=0.48;MQM=59;TRIO=HET,500,0.48,HET,427,0.49,WT,611,0.00	MTRR	synonymous	MTRR:NM_024010.2:synonymous:LOW:exon5/15:c.618T>C:p.Leu206Leu,MTRR:NM_002454.2:synonymous:LOW:exon5/15:c.537T>C:p.Leu179Leu		rs161870	0.253	0.171	0.1184	0.3777	-3.7990	P				602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126885.1 [benign]; 			0.0152	0.1515	0.8333	13	100	n/a	n/a
chr5	7885959	7885959	A	G	het		QUAL=6055;DP=137;AF=0.55;MQM=60;TRIO=HET,137,0.55,HET,235,0.50,WT,343,0.00	MTRR	missense	MTRR:NM_024010.2:missense:MODERATE:exon7/15:c.1130A>G:p.Lys377Arg,MTRR:NM_002454.2:missense:MODERATE:exon7/15:c.1049A>G:p.Lys350Arg		rs162036	0.2532	0.171	0.1185	0.3772	1.2300	P	T	B	B	602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126870.1 [benign]; RCV000144925.1 [uncertain significance]; 			0.0152	0.1515	0.8333	13	100	n/a	n/a
chr5	7897191	7897191	C	T	het		QUAL=8067;DP=257;AF=0.51;MQM=60;TRIO=HET,257,0.51,HET,222,0.51,WT,253,0.00	MTRR	missense	MTRR:NM_024010.2:missense:MODERATE:exon14/15:c.1864C>T:p.His622Tyr,MTRR:NM_002454.2:missense:MODERATE:exon14/15:c.1783C>T:p.His595Tyr		rs10380	0.2194	0.151	0.0978	0.32	0.5320	P	D	B	B	602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126880.1 [benign]; RCV000144924.1 [uncertain significance]; 	CM083724 [CLASS=DFP MUT=ALT PHEN="Pancreatic cancer, increased risk, association with" GENE=MTRR]; 		0.0076	0.1439	0.8485	9	83	n/a	n/a
chr5	7897283	7897283	G	A	het		QUAL=10212;DP=361;AF=0.48;MQM=60;TRIO=HET,361,0.48,HET,293,0.51,WT,322,0.00	MTRR	synonymous	MTRR:NM_024010.2:synonymous:LOW:exon14/15:c.1956G>A:p.Val652Val,MTRR:NM_002454.2:synonymous:LOW:exon14/15:c.1875G>A:p.Val625Val		rs12347	0.2438	0.168	0.1173	0.3704						602568 [MTRR (provisional) Homocystinuria-megaloblastic anemia,cbl E type|Neural tube defects,folate-sensitive,susceptibility to];	RCV000126881.1 [benign]; 			0.0152	0.1439	0.8409	14	98	n/a	n/a
chr5	7900712	7900712	G	A	het		QUAL=3196;DP=213;AF=0.40;MQM=60;TRIO=HET,213,0.40,HET,27,0.44,WT,34,0.00	MTRR	3'UTR	MTRR:NM_024010.2:3'UTR:MODIFIER:exon15/15:c.*541G>A:,MTRR:NM_002454.2:3'UTR:MODIFIER:exon15/15:c.*541G>A:		rs9332	0.2472	0	0	0										0.0152	0.1515	0.8333	2	21	n/a	n/a
chr5	10250430	10250430	G	A	hom		QUAL=4821;DP=44;AF=1.00;MQM=60;TRIO=HOM,44,1.00,HOM,51,1.00,HOM,64,1.00	CCT5	5'UTR	CCT5:NM_012073.3:5'UTR:MODIFIER:exon1/11:c.-23G>A:		rs2548546	0.6853	0.789	0.85	0.4455										0.7273	0.2424	0.0303	317	133	n/a	n/a
chr5	10250443	10250443	T	C	hom		QUAL=4766;DP=42;AF=1.00;MQM=60;TRIO=HOM,42,1.00,HOM,51,1.00,HOM,63,1.00	CCT5	5'UTR_premature_start_codon_gain,5'UTR	CCT5:NM_012073.3:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-10T>C:,CCT5:NM_012073.3:5'UTR:MODIFIER:exon1/11:c.-10T>C:		rs2578618	0.6853	0.789	0.8544	0.4519										0.7273	0.2424	0.0303	512	214	n/a	n/a
chr5	10254817	10254817	A	G	hom		QUAL=16276;DP=156;AF=1.00;MQM=59;TRIO=HOM,156,1.00,HOM,164,1.00,HOM,192,1.00	CCT5	synonymous	CCT5:NM_012073.3:synonymous:LOW:exon3/11:c.198A>G:p.Gly66Gly		rs2578617	0.6859	0.789	0.8549	0.4528						610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia];				0.7273	0.2424	0.0303	518	218	n/a	n/a
chr5	10256161	10256161	T	C	hom		QUAL=16032;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,103,1.00,HOM,122,1.00	CCT5	synonymous	CCT5:NM_012073.3:synonymous:LOW:exon4/11:c.426T>C:p.Arg142Arg		rs1042392	0.6925	0.794	0.8624	0.4637						610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia];				0.7348	0.2348	0.0303	526	210	n/a	n/a
chr5	10262740	10262740	C	A	hom		QUAL=11730;DP=83;AF=0.99;MQM=60;TRIO=HOM,83,0.99,HOM,112,1.00,HOM,184,1.00	CCT5	splice_region&intron	CCT5:NM_012073.3:splice_region&intron:LOW:exon9/10:c.1317+10C>A:		rs2578642	0.6859	0.789	0.8549	0.4528						610150 [CCT5 (provisional) Neuropathy,hereditary sensory,with spastic paraplegia];				0.7273	0.2424	0.0303	518	217	n/a	n/a
chr5	10264962	10264962	A	G	hom		QUAL=18676;DP=257;AF=1.00;MQM=60;TRIO=HOM,257,1.00,HOM,134,1.00,HOM,175,1.00	CCT5	3'UTR	CCT5:NM_012073.3:3'UTR:MODIFIER:exon11/11:c.*67A>G:		rs544	0.6857	0	0	0										0.7273	0.2424	0.0303	106	40	n/a	n/a
chr5	10265076	10265076	C	T	hom		QUAL=13392;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,83,1.00,HOM,107,1.00	CCT5	3'UTR	CCT5:NM_012073.3:3'UTR:MODIFIER:exon11/11:c.*181C>T:		rs699113	0.6859	0	0	0										0.7273	0.2424	0.0303	105	41	n/a	n/a
chr5	10265278	10265278	A	G	hom		QUAL=21596;DP=370;AF=1.00;MQM=60;TRIO=HOM,370,1.00,HOM,141,1.00,HOM,166,1.00	CCT5	3'UTR	CCT5:NM_012073.3:3'UTR:MODIFIER:exon11/11:c.*383A>G:		rs2662533	0.6859	0	0	0										0.7197	0.25	0.0303	104	42	n/a	n/a
chr5	10265462	10265462	G	A	hom		QUAL=24098;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HOM,245,1.00,HOM,309,1.00	CCT5	3'UTR	CCT5:NM_012073.3:3'UTR:MODIFIER:exon11/11:c.*567G>A:		rs2607286	0	0	0	0										0.7273	0.2424	0.0303	106	40	n/a	n/a
chr5	10265488	10265488	A	G	hom		QUAL=22446;DP=221;AF=1.00;MQM=60;TRIO=HOM,221,1.00,HOM,218,1.00,HOM,263,1.00	CCT5	3'UTR	CCT5:NM_012073.3:3'UTR:MODIFIER:exon11/11:c.*593A>G:		rs2578640	0.6861	0	0	0										0.7273	0.2424	0.0303	105	41	n/a	n/a
chr5	10265719	10265719	C	G	hom		QUAL=31386;DP=538;AF=1.00;MQM=59;TRIO=HOM,538,1.00,HOM,196,1.00,HOM,228,1.00	CCT5	3'UTR	CCT5:NM_012073.3:3'UTR:MODIFIER:exon11/11:c.*824C>G:		rs2578639	0.6631	0	0	0										0.7273	0.2424	0.0303	106	40	n/a	n/a
chr5	10265886	10265886	-	TCTAT	hom		QUAL=13098;DP=210;AF=0.95;MQM=60;TRIO=HOM,210,0.95,HOM,122,0.93,HOM,119,0.97	CCT5	3'UTR	CCT5:NM_012073.3:3'UTR:MODIFIER:exon11/11:c.*994_*995insATTCT:	MIR	rs112586209	0.6809	0	0	0										0.7273	0.2424	0.0303	106	40	n/a	n/a
chr5	10266067	10266067	G	T	hom		QUAL=36390;DP=431;AF=1.00;MQM=60;TRIO=HOM,431,1.00,HOM,295,1.00,HOM,376,1.00	CCT5	3'UTR	CCT5:NM_012073.3:3'UTR:MODIFIER:exon11/11:c.*1172G>T:		rs2578638	0.888	0	0	0										0.8333	0.1515	0.0152	123	25	n/a	n/a
chr5	10972889	10972889	T	-	het		QUAL=1682;DP=170;AF=0.11;MQM=59;TRIO=HET,170,0.11,HET,94,0.43,HET,119,0.14	CTNND2	3'UTR	CTNND2:NM_001332.3:3'UTR:MODIFIER:exon22/22:c.*676delA:,CTNND2:NM_001288715.1:3'UTR:MODIFIER:exon21/21:c.*676delA:,CTNND2:NM_001288716.1:3'UTR:MODIFIER:exon19/19:c.*676delA:,CTNND2:NM_001288717.1:3'UTR:MODIFIER:exon21/21:c.*676delA:		rs397996790	0	0	0	0										0.0076	0.0909	0.9015	1	13	n/a	n/a
chr5	11117583	11117583	C	T	het		QUAL=11346;DP=380;AF=0.52;MQM=60;TRIO=HET,380,0.52,WT,206,0.00,HET,338,0.51	CTNND2	synonymous	CTNND2:NM_001332.3:synonymous:LOW:exon13/22:c.2256G>A:p.Gly752Gly,CTNND2:NM_001288715.1:synonymous:LOW:exon12/21:c.1983G>A:p.Gly661Gly,CTNND2:NM_001288716.1:synonymous:LOW:exon10/19:c.1245G>A:p.Gly415Gly,CTNND2:NM_001288717.1:synonymous:LOW:exon12/21:c.957G>A:p.Gly319Gly		rs2285975	0.2236	0.118	0.0583	0.1872									COSM4003253	0	0.1288	0.8712	0	32	n/a	n/a
chr5	16474795	16474795	C	T	het		QUAL=948;DP=113;AF=0.12;MQM=57;TRIO=HET,113,0.50,WT,29,0.34,WT,37,0.38	FAM134B	3'UTR	FAM134B:NM_001034850.2:3'UTR:MODIFIER:exon9/9:c.*55G>A:,FAM134B:NM_019000.4:3'UTR:MODIFIER:exon7/7:c.*55G>A:	(T)n		0	0	0	0										0	0.0455	0.9545	0	7	n/a	n/a
chr5	16478200	16478200	G	A	hom		QUAL=12408;DP=201;AF=1.00;MQM=60;TRIO=HOM,201,1.00,HOM,74,1.00,HOM,103,1.00	FAM134B	synonymous	FAM134B:NM_001034850.2:synonymous:LOW:exon7/9:c.816C>T:p.Asp272Asp,FAM134B:NM_019000.4:synonymous:LOW:exon5/7:c.393C>T:p.Asp131Asp		rs162848	0.6775	0.659	0.6984	0.803						613114 [FAM134B (provisional) Neuropathy,hereditary sensory and autonomic,type IIB];				0.5379	0.3636	0.0985	232	174	n/a	n/a
chr5	16508898	16508898	T	C	het		QUAL=7349;DP=255;AF=0.45;MQM=60;TRIO=HET,255,0.45,HET,223,0.50,WT,303,0.00	FAM134B	5'UTR,intron	FAM134B:NM_019000.4:5'UTR:MODIFIER:exon1/7:c.-177A>G:,FAM134B:NM_001034850.2:intron:MODIFIER:exon3/8:c.459-25317A>G:		rs33684	0.5431	0	0	0						613114 [FAM134B (provisional) Neuropathy,hereditary sensory and autonomic,type IIB];				0.4167	0.447	0.1364	66	65	n/a	n/a
chr5	33988581	33988581	C	A	het		QUAL=8909;DP=318;AF=0.44;MQM=60;TRIO=HET,318,0.44,WT,218,0.00,HET,243,0.56	AMACR	3'UTR,intron	AMACR:NM_014324.5:3'UTR:MODIFIER:exon5/5:c.*617G>T:,AMACR:NM_203382.2:3'UTR:MODIFIER:exon4/4:c.*1008G>T:,AMACR:NM_001167595.1:intron:MODIFIER:exon5/5:c.1132-115G>T:		rs12659370	0.0749	0	0	0						604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency|Bile acid synthesis defect,congenital,4];				0	0.1212	0.8788	0	19	n/a	n/a
chr5	33989518	33989518	C	T	hom		QUAL=27216;DP=333;AF=0.99;MQM=60;TRIO=HOM,333,0.99,HET,253,0.49,HOM,382,1.00	AMACR	missense,3'UTR	AMACR:NM_001167595.1:missense:MODERATE:exon5/6:c.829G>A:p.Glu277Lys,AMACR:NM_014324.5:missense:MODERATE:exon5/5:c.829G>A:p.Glu277Lys,AMACR:NM_203382.2:3'UTR:MODIFIER:exon4/4:c.*71G>A:		rs2278008	0.6961	0.701	0.7465	0.7837	2.0460	P	T	B,B,B	B,B,B	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency|Bile acid synthesis defect,congenital,4];	RCV000116324.2 [likely benign]; 	CM078460 [CLASS=DP MUT=REF PHEN="Advanced distal colorectal adenoma, increased risk, association" GENE=AMACR]; 	COSM3761202	0.5303	0.3636	0.1061	611	414	n/a	n/a
chr5	33998768	33998768	C	A	het		QUAL=8080;DP=204;AF=0.49;MQM=60;TRIO=HET,204,0.49,HET,138,0.50,HET,166,0.57	AMACR	missense	AMACR:NM_001167595.1:missense:MODERATE:exon4/6:c.717G>T:p.Gln239His,AMACR:NM_014324.5:missense:MODERATE:exon4/5:c.717G>T:p.Gln239His,AMACR:NM_203382.2:missense:MODERATE:exon3/4:c.556G>T:p.Val186Phe		rs34677	0.1144	0.126	0.1453	0.0704	1.8670	P,P	D,T	P,P,P,P,D,D	B,B,B,B,D,P	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency|Bile acid synthesis defect,congenital,4];	RCV000116323.2 [likely benign]; 		COSM149809	0	0.25	0.75	11	260	n/a	n/a
chr5	33998883	33998883	A	G	hom		QUAL=16339;DP=234;AF=1.00;MQM=60;TRIO=HOM,234,1.00,HET,150,0.59,HOM,177,1.00	AMACR	missense,synonymous	AMACR:NM_001167595.1:missense:MODERATE:exon4/6:c.602T>C:p.Leu201Ser,AMACR:NM_014324.5:missense:MODERATE:exon4/5:c.602T>C:p.Leu201Ser,AMACR:NM_203382.2:synonymous:LOW:exon3/4:c.441T>C:p.Ile147Ile		rs2287939	0.7149	0.699	0.7138	0.8166	-0.7150	P	T	B,B,B	B,B,B	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency|Bile acid synthesis defect,congenital,4];	RCV000116322.2 [likely benign]; 	CM078459 [CLASS=DP MUT=REF PHEN="Advanced distal colorectal adenoma, increased risk, association" GENE=AMACR]; 		0.4848	0.3409	0.1742	562	448	n/a	n/a
chr5	38475507	38475507	G	A	het		QUAL=5755;DP=118;AF=0.50;MQM=60;TRIO=HET,118,0.50,HET,92,0.60,HET,129,0.51	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*6190C>T:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*6190C>T:		rs1046224	0.3728	0	0	0										0.1591	0.4394	0.4015	23	65	n/a	n/a
chr5	38476027	38476027	T	C	het		QUAL=11790;DP=308;AF=0.50;MQM=60;TRIO=HET,308,0.50,HET,144,0.57,HET,227,0.54	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*5670A>G:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*5670A>G:		rs3822425	0.3255	0	0	0										0.1667	0.4394	0.3939	24	64	n/a	n/a
chr5	38476624	38476624	-	T	het		QUAL=4726;DP=273;AF=0.31;MQM=60;TRIO=HET,273,0.31,HET,92,0.38,HET,129,0.36	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*5072dupA:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*5072dupA:		rs397997444	0.3107	0	0	0										0.1364	0.4242	0.4394	20	61	n/a	n/a
chr5	38477863	38477863	G	C	het		QUAL=10793;DP=292;AF=0.49;MQM=60;TRIO=HET,292,0.49,HET,159,0.51,HET,194,0.53	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*3834C>G:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*3834C>G:		rs34130318	0.3223	0	0	0										0.1515	0.447	0.4015	22	65	n/a	n/a
chr5	38480227	38480227	A	C	het		QUAL=7388;DP=257;AF=0.52;MQM=60;TRIO=HET,257,0.52,HET,66,0.55,HET,110,0.50	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*1470T>G:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*1470T>G:		rs13156520	0.3181	0	0	0										0.1515	0.4545	0.3939	22	67	n/a	n/a
chr5	38481271	38481271	C	T	het		QUAL=9185;DP=428;AF=0.44;MQM=60;TRIO=HET,428,0.44,HET,199,0.49,WT,240,0.00	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*426G>A:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*426G>A:		rs116625329	0.0048	0	0	0										0	0.053	0.947	0	7	n/a	n/a
chr5	38481335	38481335	C	T	het		QUAL=16685;DP=464;AF=0.48;MQM=60;TRIO=HET,464,0.48,HET,258,0.49,HET,319,0.50	LIFR	3'UTR	LIFR:NM_001127671.1:3'UTR:MODIFIER:exon20/20:c.*362G>A:,LIFR:NM_002310.5:3'UTR:MODIFIER:exon20/20:c.*362G>A:		rs1005017	0.729	0	0	0										0.4318	0.4621	0.1061	65	67	n/a	n/a
chr5	38482731	38482731	T	C	het		QUAL=1765;DP=93;AF=0.54;MQM=60;TRIO=HET,93,0.54,HET,13,0.38,WT,16,0.00	LIFR	missense	LIFR:NM_001127671.1:missense:MODERATE:exon19/20:c.2630A>G:p.Glu877Gly,LIFR:NM_002310.5:missense:MODERATE:exon19/20:c.2630A>G:p.Glu877Gly			0	0	0	0	3.9330	D	T	D	D	151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome];				0	0.0076	0.9924	0	1	n/a	n/a
chr5	38528975	38528976	CA	-	het		QUAL=3446;DP=20;AF=0.65;MQM=60;TRIO=HET,20,0.85,HET,51,0.94,HET,73,0.89	LIFR	intron	LIFR:NM_001127671.1:intron:MODIFIER:exon2/19:c.143-34_143-33delTG:,LIFR:NM_002310.5:intron:MODIFIER:exon2/19:c.143-34_143-33delTG:	(CA)n		0	0	0	0						151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome];				0	0	1	0	0	n/a	n/a
chr5	38528976	38528979	ACAC	-	het		QUAL=3446;DP=20;AF=0.65;MQM=60;TRIO=HET,20,0.85,HET,51,0.94,HET,73,0.89	LIFR	intron	LIFR:NM_001127671.1:intron:MODIFIER:exon2/19:c.143-37_143-34delGTGT:,LIFR:NM_002310.5:intron:MODIFIER:exon2/19:c.143-37_143-34delGTGT:	(CA)n		0	0	0	0						151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome];				0	0.2955	0.7045	3	89	n/a	n/a
chr5	38919158	38919158	G	A	het		QUAL=5241;DP=151;AF=0.52;MQM=60;TRIO=HET,151,0.52,WT,148,0.00,HET,175,0.51	OSMR	missense	OSMR:NM_003999.2:missense:MODERATE:exon11/18:c.1579G>A:p.Glu527Lys		rs10941412	0.1464	0.154	0.1679	0.2401	2.3480	P	T	D	P	601743 [OSMR (confirmed) Amyloidosis,primary localized cutaneous,1];				0.0152	0.2879	0.697	12	101	n/a	n/a
chr5	38933749	38933749	C	T	hom		QUAL=18625;DP=282;AF=0.99;MQM=60;TRIO=HOM,282,0.99,HET,313,0.49,HET,304,0.46	OSMR	3'UTR	OSMR:NM_003999.2:3'UTR:MODIFIER:exon18/18:c.*203C>T:		rs1239344	0.4491	0	0	0										0.1742	0.5303	0.2955	26	77	n/a	n/a
chr5	38935101	38935101	G	C	hom		QUAL=12125;DP=174;AF=0.99;MQM=54;TRIO=HOM,174,0.99,HET,184,0.51,HET,227,0.51	OSMR	3'UTR	OSMR:NM_003999.2:3'UTR:MODIFIER:exon18/18:c.*1555G>C:	AluSq2	rs357252	0.6404	0	0	0										0.3561	0.4773	0.1667	55	70	n/a	n/a
chr5	38935412	38935414	CAA	-	hom		QUAL=24364;DP=286;AF=0.99;MQM=60;TRIO=HOM,286,0.99,HET,475,0.48,HET,605,0.47	OSMR	3'UTR	OSMR:NM_003999.2:3'UTR:MODIFIER:exon18/18:c.*1870_*1872delAAC:		rs16351	0.6432	0	0	0										0.3561	0.4773	0.1667	55	70	n/a	n/a
chr5	38935682	38935682	C	T	hom		QUAL=6419;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HET,27,0.63,HET,51,0.25	OSMR	3'UTR	OSMR:NM_003999.2:3'UTR:MODIFIER:exon18/18:c.*2136C>T:		rs7318	0.362	0	0	0										0.1439	0.5152	0.3409	21	76	n/a	n/a
chr5	39285139	39285139	T	A	hom		QUAL=24078;DP=389;AF=0.99;MQM=59;TRIO=HOM,389,0.99,HOM,151,0.98,HOM,204,0.99	C9	3'UTR	C9:NM_001737.3:3'UTR:MODIFIER:exon11/11:c.*162A>T:	AT_rich	rs261738	0.8067	0	0	0										0.8409	0.1591	0	127	23	n/a	n/a
chr5	39342308	39342308	C	T	het		QUAL=8992;DP=264;AF=0.50;MQM=60;TRIO=HET,264,0.50,HOM,149,1.00,WT,199,0.00	C9	splice_region&intron	C9:NM_001737.3:splice_region&intron:LOW:exon1/10:c.78-10G>A:		rs476569	0.6278	0.535	0.504	0.8062						120940 [C9 (confirmed) C9 deficiency|Macular degeneration,age-related,15,suscepbitility to];				0.2273	0.4621	0.3106	144	194	n/a	n/a
chr5	40949997	40949997	C	T	hom		QUAL=17654;DP=146;AF=1.00;MQM=60;TRIO=HOM,146,1.00,HOM,189,1.00,HOM,212,1.00	C7	splice_region&intron	C7:NM_000587.2:splice_region&intron:LOW:exon8/17:c.983-9C>T:		rs1450656	0.6585	0.605	0.646	0.7361						217070 [C7 (confirmed) C7 deficiency];				0.4394	0.4621	0.0985	204	193	n/a	n/a
chr5	40955561	40955561	G	C	hom		QUAL=32124;DP=354;AF=1.00;MQM=60;TRIO=HOM,354,1.00,HOM,278,1.00,HOM,357,1.00	C7	missense	C7:NM_000587.2:missense:MODERATE:exon10/18:c.1166G>C:p.Ser389Thr		rs1063499	0.4812	0.57	0.6132	0.3449	1.3790	P	T	P	P	217070 [C7 (confirmed) C7 deficiency];			COSM3761227	0.4091	0.4545	0.1364	177	209	n/a	n/a
chr5	40981769	40981771	CTT	-	het		QUAL=10064;DP=318;AF=0.37;MQM=59;TRIO=HET,318,0.37,HET,423,0.51,WT,544,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*99_*101delTCT:		rs35249475	0.3009	0	0	0										0.053	0.4318	0.5152	8	64	n/a	n/a
chr5	40982175	40982175	T	C	het		QUAL=6894;DP=240;AF=0.52;MQM=60;TRIO=HET,240,0.52,HET,188,0.51,WT,242,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*500T>C:		rs16870568	0.3015	0	0	0										0.053	0.4318	0.5152	8	64	n/a	n/a
chr5	40982460	40982460	C	T	het		QUAL=1383;DP=91;AF=0.47;MQM=54;TRIO=HET,91,0.47,HET,11,0.36,WT,15,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*785C>T:	AluSx1	rs12153342	0.224	0	0	0										0.053	0.4242	0.5227	8	63	n/a	n/a
chr5	40982620	40982620	G	T	het		QUAL=2724;DP=149;AF=0.45;MQM=60;TRIO=HET,149,0.45,HET,60,0.45,WT,88,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*945G>T:		rs1061442	0.2238	0	0	0										0.053	0.4318	0.5152	8	63	n/a	n/a
chr5	40982622	40982622	G	T	het		QUAL=2724;DP=149;AF=0.45;MQM=60;TRIO=HET,149,0.45,HET,60,0.45,WT,88,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*947G>T:		rs1061443	0.2113	0	0	0										0.053	0.4318	0.5152	8	63	n/a	n/a
chr5	40982977	40982977	A	G	het		QUAL=2355;DP=162;AF=0.38;MQM=60;TRIO=HET,162,0.38,HET,26,0.46,WT,23,0.00	C7	3'UTR	C7:NM_000587.2:3'UTR:MODIFIER:exon18/18:c.*1302A>G:		rs14190	0.2115	0	0	0										0.053	0.4318	0.5152	8	63	n/a	n/a
chr5	41142573	41142573	G	T	het		QUAL=6127;DP=299;AF=0.44;MQM=60;TRIO=HET,299,0.44,HET,112,0.45,WT,149,0.00	C6	3'UTR	C6:NM_000065.3:3'UTR:MODIFIER:exon18/18:c.*354C>A:,C6:NM_001115131.2:3'UTR:MODIFIER:exon18/18:c.*354C>A:		rs10067242	0.0172	0	0	0										0	0.0985	0.9015	0	14	n/a	n/a
chr5	41142606	41142606	C	T	het		QUAL=7539;DP=371;AF=0.47;MQM=60;TRIO=HET,371,0.47,HET,132,0.44,WT,200,0.00	C6	3'UTR	C6:NM_000065.3:3'UTR:MODIFIER:exon18/18:c.*321G>A:,C6:NM_001115131.2:3'UTR:MODIFIER:exon18/18:c.*321G>A:		rs9200	0.6707	0	0	0										0.303	0.4848	0.2121	41	73	n/a	n/a
chr5	41158863	41158863	G	A	hom		QUAL=25817;DP=240;AF=1.00;MQM=60;TRIO=HOM,240,1.00,HOM,248,1.00,HOM,297,1.00	C6	synonymous	C6:NM_000065.3:synonymous:LOW:exon13/18:c.1881C>T:p.Asp627Asp,C6:NM_001115131.2:synonymous:LOW:exon13/18:c.1881C>T:p.Asp627Asp		rs6866352	0.9982	1	0	0						217050 [C6 (confirmed) C6 deficiency|Combined C6/C7 deficiency];				1	0	0	454	0	n/a	n/a
chr5	41199959	41199959	G	T	het		QUAL=12934;DP=250;AF=0.52;MQM=60;TRIO=HET,250,0.52,HET,259,0.47,HET,311,0.47	C6	missense	C6:NM_000065.3:missense:MODERATE:exon4/18:c.356C>A:p.Ala119Glu,C6:NM_001115131.2:missense:MODERATE:exon4/18:c.356C>A:p.Ala119Glu		rs1801033	0.5539	0.593	0.6308	0.5647	2.5510	P	T	B	B	217050 [C6 (confirmed) C6 deficiency|Combined C6/C7 deficiency];			COSM4159876	0.3939	0.5	0.1061	169	223	n/a	n/a
chr5	52394019	52394019	C	-	het		QUAL=1462;DP=67;AF=0.46;MQM=60;TRIO=HET,67,0.46,HET,20,0.50,HET,24,0.46	MOCS2	3'UTR	MOCS2:NM_004531.4:3'UTR:MODIFIER:exon7/7:c.*413delG:,MOCS2:NM_176806.3:3'UTR:MODIFIER:exon7/7:c.*900delG:		rs3839261	0.152	0	0	0										0.0227	0.2803	0.697	3	41	n/a	n/a
chr5	52397311	52397311	T	C	het		QUAL=4546;DP=186;AF=0.52;MQM=60;TRIO=HET,186,0.52,HET,81,0.57,WT,113,0.00	MOCS2	synonymous,3'UTR	MOCS2:NM_004531.4:synonymous:LOW:exon5/7:c.255A>G:p.Lys85Lys,MOCS2:NM_176806.3:3'UTR:MODIFIER:exon5/7:c.*175A>G:		rs2233216	0.0363	0.038	0.0347	0.0202						603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B];				0.0076	0.0985	0.8939	1	33	n/a	n/a
chr5	52398005	52398005	T	C	het		QUAL=7868;DP=304;AF=0.45;MQM=60;TRIO=HET,304,0.45,HET,178,0.60,WT,276,0.00	MOCS2	missense,3'UTR	MOCS2:NM_004531.4:missense:MODERATE:exon4/7:c.148A>G:p.Thr50Ala,MOCS2:NM_176806.3:3'UTR:MODIFIER:exon4/7:c.*68A>G:		rs2233213	0.0363	0.038	0.0376	0.0213	4.5420	D	T	P	B	603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B];				0.0076	0.0985	0.8939	1	39	n/a	n/a
chr5	52405174	52405174	C	A	het		QUAL=7653;DP=120;AF=0.58;MQM=60;TRIO=HET,120,0.58,HET,119,0.60,HET,201,0.50	MOCS2	5'UTR_premature_start_codon_gain,5'UTR,intron	MOCS2:NM_004531.4:5'UTR_premature_start_codon_gain:LOW:exon1/7:c.-263G>T:,MOCS2:NM_004531.4:5'UTR:MODIFIER:exon1/7:c.-263G>T:,MOCS2:NM_176806.3:intron:MODIFIER:exon1/6:c.18+368G>T:		rs77585010	0	0	0	0						603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B];				0.0227	0.2727	0.7045	3	40	n/a	n/a
chr5	52942083	52942083	A	C	hom		QUAL=17158;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,124,1.00,HOM,205,1.00	NDUFS4	synonymous	NDUFS4:NM_002495.2:synonymous:LOW:exon3/5:c.198A>C:p.Gly66Gly		rs31304	0.9435	0.955	0.9655	0.9753						602694 [NDUFS4 (provisional) Leigh syndrome|Mitochondrial complex I deficiency];	RCV000117714.2 [likely benign]; 			0.9242	0.0758	0	416	37	n/a	n/a
chr5	52942197	52942197	A	G	het		QUAL=9543;DP=396;AF=0.52;MQM=60;TRIO=HET,396,0.52,HET,187,0.47,WT,294,0.00	NDUFS4	synonymous	NDUFS4:NM_002495.2:synonymous:LOW:exon3/5:c.312A>G:p.Arg104Arg		rs31303	0.8001	0.773	0.7623	0.8513						602694 [NDUFS4 (provisional) Leigh syndrome|Mitochondrial complex I deficiency];	RCV000117715.2 [likely benign]; 		COSM4159887	0.553	0.3788	0.0682	244	173	n/a	n/a
chr5	52979097	52979097	G	A	het		QUAL=7205;DP=294;AF=0.51;MQM=60;TRIO=HET,294,0.51,HET,138,0.50,WT,174,0.01	NDUFS4	3'UTR	NDUFS4:NM_002495.2:3'UTR:MODIFIER:exon5/5:c.*46G>A:		rs567	0.3786	0.446	0.487	0.2878										0.2045	0.4697	0.3258	29	79	n/a	n/a
chr5	55660603	55660603	T	G	het		QUAL=10047;DP=290;AF=0.47;MQM=60;TRIO=HET,290,0.47,HET,152,0.49,HET,210,0.47				L2c	rs1900155	0.3728	0	0	0										0.1364	0.5833	0.2803	23	81	n/a	n/a
chr5	60170337	60170337	A	G	het		QUAL=6545;DP=202;AF=0.52;MQM=60;TRIO=HET,202,0.52,HOM,52,0.98,HET,79,0.53	ERCC8	3'UTR	ERCC8:NM_000082.3:3'UTR:MODIFIER:exon12/12:c.*105T>C:,ERCC8:NM_001007233.2:3'UTR:MODIFIER:exon13/13:c.*105T>C:,ERCC8:NM_001290285.1:3'UTR:MODIFIER:exon11/11:c.*105T>C:		rs3117	0.3067	0	0	0										0.1136	0.5	0.3864	19	74	n/a	n/a
chr5	60240986	60240986	A	G	het		QUAL=9229;DP=263;AF=0.48;MQM=59;TRIO=HET,263,0.48,WT,252,0.00,HET,356,0.49	NDUFAF2	5'UTR	NDUFAF2:NM_174889.4:5'UTR:MODIFIER:exon1/4:c.-97A>G:		rs158922	0.7242	0	0	0										0.447	0.4924	0.0606	65	74	n/a	n/a
chr5	60241142	60241142	G	A	het		QUAL=9746;DP=228;AF=0.50;MQM=55;TRIO=HET,228,0.50,WT,333,0.00,HET,413,0.48	NDUFAF2	synonymous	NDUFAF2:NM_174889.4:synonymous:LOW:exon1/4:c.60G>A:p.Lys20Lys		rs158921	0.6929	0.642	0	0						609653 [NDUFAF2 (provisional) Mitochondrial complex I deficiency|Leigh syndrome];	RCV000117705.2 [likely benign]; 		COSM3761271	0.3864	0.4924	0.1212	143	252	n/a	n/a
chr5	68788261	68788261	G	A	hom		QUAL=10045;DP=44;AF=1.00;MQM=59;TRIO=HOM,44,1.00,HOM,129,1.00,HOM,159,0.99	OCLN	5'UTR	OCLN:NM_002538.3:5'UTR:MODIFIER:exon1/9:c.-294G>A:		rs3733742	0.8516	0	0	0										0.7652	0.2121	0.0227	113	34	n/a	n/a
chr5	68850922	68850922	G	C	het		QUAL=583;DP=45;AF=0.38;MQM=28;TRIO=HET,45,0.38,HOM,6,1.00,WT,11,0.00	OCLN	3'UTR	OCLN:NM_001205254.1:3'UTR:MODIFIER:exon9/9:c.*1424G>C:,OCLN:NM_002538.3:3'UTR:MODIFIER:exon9/9:c.*1424G>C:,OCLN:NM_001205255.1:3'UTR:MODIFIER:exon7/7:c.*1424G>C:	AluSx4	rs76123058	0.5627	0	0	0										0.4924	0.1818	0.3258	74	29	n/a	n/a
chr5	68853877	68853877	C	T	het		QUAL=11811;DP=339;AF=0.33;MQM=28;TRIO=HET,339,0.33,WT,197,0.01,HET,383,0.65	OCLN	3'UTR	OCLN:NM_001205254.1:3'UTR:MODIFIER:exon9/9:c.*4379C>T:,OCLN:NM_002538.3:3'UTR:MODIFIER:exon9/9:c.*4379C>T:,OCLN:NM_001205255.1:3'UTR:MODIFIER:exon7/7:c.*4379C>T:		rs200773462	0	0	0	0										0.0152	0.2727	0.7121	2	41	n/a	n/a
chr5	70883136	70883136	A	G	het		QUAL=1217;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,HOM,28,1.00,HET,33,0.36	MCCC2	5'UTR	MCCC2:NM_022132.4:5'UTR:MODIFIER:exon1/17:c.-117A>G:		rs11746722	0	0	0	0										0.6515	0.25	0.0985	95	35	n/a	n/a
chr5	70945075	70945075	A	G	hom		QUAL=24638;DP=221;AF=0.99;MQM=60;TRIO=HOM,221,0.99,HOM,251,1.00,HOM,301,1.00	MCCC2	synonymous	MCCC2:NM_022132.4:synonymous:LOW:exon14/17:c.1368A>G:p.Ala456Ala		rs10064079	0.8514	0.878	0.8679	0.7065						609014 [MCCC2 (confirmed) 3-Methylcrotonyl-CoA carboxylase 2 deficiency];	RCV000082093.2 [benign]; 			0.75	0.2197	0.0303	342	102	n/a	n/a
chr5	70952934	70952934	C	T	hom		QUAL=21865;DP=373;AF=1.00;MQM=60;TRIO=HOM,373,1.00,HOM,124,1.00,HOM,149,1.00	MCCC2	3'UTR	MCCC2:NM_022132.4:3'UTR:MODIFIER:exon17/17:c.*247C>T:	MIR	rs1135667	0.8111	0	0	0										0.7348	0.2273	0.0379	110	35	n/a	n/a
chr5	70953280	70953280	G	T	het		QUAL=5641;DP=195;AF=0.53;MQM=59;TRIO=HET,195,0.53,WT,133,0.00,HET,238,0.36	MCCC2	3'UTR	MCCC2:NM_022132.4:3'UTR:MODIFIER:exon17/17:c.*593G>T:	AluSz	rs60069076	0.1154	0	0	0										0.0076	0.1742	0.8182	1	26	n/a	n/a
chr5	70953930	70953930	G	C	hom		QUAL=38683;DP=411;AF=1.00;MQM=60;TRIO=HOM,411,1.00,HOM,290,1.00,HOM,477,1.00	MCCC2	3'UTR	MCCC2:NM_022132.4:3'UTR:MODIFIER:exon17/17:c.*1243G>C:	L2c	rs7731970	0	0	0	0										0.7348	0.2273	0.0379	110	35	n/a	n/a
chr5	73981270	73981270	T	C	hom		QUAL=4794;DP=16;AF=1.00;MQM=60;TRIO=HOM,16,1.00,HOM,84,1.00,HET,144,0.40	HEXB	missense,intron	HEXB:NM_000521.3:missense:MODERATE:exon1/14:c.185T>C:p.Leu62Ser,HEXB:NM_001292004.1:intron:MODIFIER:exon1/13:c.-376-3883T>C:		rs820878	0.9814	0.97	0.9587	0.9902	0.9630	P	T			606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms];	RCV000004086.1,RCV000153357.1 [pathogenic,benign]; 	CM952225 [CLASS=DM? MUT=REF PHEN="Sandhoff disease" GENE=HEXB]; 	COSM450042	0.9318	0.0606	0.0076	1059	79	2	n/a
chr5	73985215	73985215	A	G	het		QUAL=11480;DP=362;AF=0.49;MQM=60;TRIO=HET,362,0.49,WT,299,0.00,HET,342,0.51	HEXB	missense,5'UTR	HEXB:NM_000521.3:missense:MODERATE:exon2/14:c.362A>G:p.Lys121Arg,HEXB:NM_001292004.1:5'UTR:MODIFIER:exon2/14:c.-314A>G:		rs11556045	0.2226	0.199	0.1688	0.259	-0.9130	P	T	B	B	606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms];	RCV000004078.1 [benign]; RCV000079063.2 [benign]; 		COSM149850	0.0379	0.2955	0.6667	54	330	n/a	n/a
chr5	74009327	74009327	A	G	het		QUAL=6377;DP=170;AF=0.50;MQM=60;TRIO=HET,170,0.50,HET,203,0.58,WT,247,0.00	HEXB	splice_region&intron	HEXB:NM_000521.3:splice_region&intron:LOW:exon6/13:c.772-4A>G:,HEXB:NM_001292004.1:splice_region&intron:LOW:exon6/13:c.97-4A>G:		rs17561000	0.0395	0.073	0.0987	0.0184						606873 [HEXB (confirmed) Sandhoff disease,infantile,juvenile,and adult forms];	RCV000079066.2 [benign]; 			0	0.1591	0.8409	4	179	n/a	n/a
chr5	76704849	76704849	T	C	hom		QUAL=23292;DP=235;AF=1.00;MQM=60;TRIO=HOM,235,1.00,HOM,207,1.00,HOM,281,1.00	PDE8B	synonymous,intron	PDE8B:NM_003719.3:synonymous:LOW:exon14/22:c.1497T>C:p.Pro499Pro,PDE8B:NM_001029851.2:synonymous:LOW:exon11/19:c.1206T>C:p.Pro402Pro,PDE8B:NM_001029853.2:synonymous:LOW:exon13/21:c.1437T>C:p.Pro479Pro,PDE8B:NM_001029854.2:synonymous:LOW:exon13/21:c.1356T>C:p.Pro452Pro,PDE8B:NM_001029852.2:intron:MODIFIER:exon13/20:c.1365+1567T>C:		rs186753	0	1	0	0						603390 [PDE8B (confirmed) Pigmented nodular adrenocortical disease,primary,3|Striatal degeneration,autosomal dominant];				1	0	0	454	0	n/a	n/a
chr5	76722442	76722442	C	T	het		QUAL=9045;DP=343;AF=0.54;MQM=60;TRIO=HET,343,0.54,HET,150,0.61,WT,177,0.00	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*63C>T:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*63C>T:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*63C>T:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*63C>T:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*63C>T:		rs62362531	0.1098	0	0	0										0.0152	0.2803	0.7045	3	41	n/a	n/a
chr5	76722443	76722443	G	A	het		QUAL=12740;DP=340;AF=0.45;MQM=59;TRIO=HET,340,0.45,HET,150,0.39,HOM,176,1.00	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*64G>A:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*64G>A:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*64G>A:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*64G>A:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*64G>A:		rs40594	0.6611	0	0	0										0.2652	0.5	0.2348	40	74	n/a	n/a
chr5	76722877	76722877	C	-	het		QUAL=8355;DP=286;AF=0.36;MQM=60;TRIO=HET,286,0.47,WT,91,0.55,HET,123,1.00	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*498delC:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*498delC:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*498delC:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*498delC:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*498delC:		rs567378113	0	0	0	0										0.0152	0.0606	0.9242	2	10	n/a	n/a
chr5	76722891	76722891	T	C	het		QUAL=10629;DP=292;AF=0.50;MQM=59;TRIO=HET,292,0.50,HET,93,0.53,HOM,138,1.00	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*512T>C:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*512T>C:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*512T>C:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*512T>C:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*512T>C:		rs460267	0.4455	0	0	0										0.2273	0.4697	0.303	34	70	n/a	n/a
chr5	76723227	76723228	AA	-	hom		QUAL=1058;DP=33;AF=0.73;MQM=60;TRIO=HOM,33,0.73,HOM,3,1.00,HOM,12,0.83	PDE8B	3'UTR	PDE8B:NM_003719.3:3'UTR:MODIFIER:exon22/22:c.*863_*864delAA:,PDE8B:NM_001029851.2:3'UTR:MODIFIER:exon19/19:c.*863_*864delAA:,PDE8B:NM_001029852.2:3'UTR:MODIFIER:exon21/21:c.*863_*864delAA:,PDE8B:NM_001029853.2:3'UTR:MODIFIER:exon21/21:c.*863_*864delAA:,PDE8B:NM_001029854.2:3'UTR:MODIFIER:exon21/21:c.*863_*864delAA:	AT_rich	rs397998241	0.6236	0	0	0										0.3182	0.197	0.4848	46	31	n/a	n/a
chr5	77425028	77425028	A	T	hom		QUAL=12839;DP=222;AF=1.00;MQM=60;TRIO=HOM,222,1.00,HOM,97,1.00,HET,157,0.45	AP3B1	missense	AP3B1:NM_003664.4:missense:MODERATE:exon16/27:c.1754T>A:p.Val585Glu,AP3B1:NM_001271769.1:missense:MODERATE:exon16/27:c.1607T>A:p.Val536Glu		rs6453373	0	0.863	0.9238	0.9503	6.3070	P	T	B	B	603401 [AP3B1 (provisional) Hermansky-Pudlak syndrome 2];	RCV000150163.1 [benign]; 			0.8561	0.1364	0.0076	392	59	n/a	n/a
chr5	78073245	78073245	C	A	hom		QUAL=8540;DP=103;AF=1.00;MQM=60;TRIO=HOM,103,1.00,HOM,69,1.00,HOM,87,1.00	ARSB	3'UTR	ARSB:NM_000046.3:3'UTR:MODIFIER:exon8/8:c.*2975G>T:	L1MB5	rs3088247	0.7374	0	0	0										0.5606	0.3333	0.1061	85	51	n/a	n/a
chr5	78074198	78074198	A	C	het		QUAL=19965;DP=413;AF=0.48;MQM=60;TRIO=HET,413,0.48,WT,299,0.00,HOM,404,1.00	ARSB	3'UTR	ARSB:NM_000046.3:3'UTR:MODIFIER:exon8/8:c.*2022T>G:		rs7704939	0.4467	0	0	0										0.2121	0.4848	0.303	32	70	n/a	n/a
chr5	78074751	78074751	G	A	het		QUAL=2881;DP=162;AF=0.50;MQM=59;TRIO=HET,162,0.50,WT,22,0.00,HET,25,0.48	ARSB	3'UTR	ARSB:NM_000046.3:3'UTR:MODIFIER:exon8/8:c.*1469C>T:	AluJo	rs55710452	0.0427	0	0	0										0.0227	0.1818	0.7955	4	28	n/a	n/a
chr5	78074918	78074918	C	A	het		QUAL=5163;DP=146;AF=0.53;MQM=60;TRIO=HET,146,0.53,HET,48,0.60,HOM,61,1.00	ARSB	3'UTR	ARSB:NM_000046.3:3'UTR:MODIFIER:exon8/8:c.*1302G>T:		rs754566	0.5026	0	0	0										0.2879	0.4545	0.2576	45	69	n/a	n/a
chr5	78135201	78135201	C	T	het		QUAL=2983;DP=158;AF=0.38;MQM=60;TRIO=HET,158,0.38,HET,70,0.51,WT,122,0.00	ARSB	synonymous	ARSB:NM_000046.3:synonymous:LOW:exon6/8:c.1191G>A:p.Pro397Pro,ARSB:NM_198709.2:synonymous:LOW:exon7/8:c.1191G>A:p.Pro397Pro		rs25413	0.2592	0.201	0.1869	0.4966						611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy)];	RCV000078001.2 [benign]; 		COSM3761330	0.0606	0.3409	0.5985	32	149	n/a	n/a
chr5	78181477	78181477	C	T	het		QUAL=12687;DP=278;AF=0.54;MQM=59;TRIO=HET,278,0.54,HET,210,0.52,HET,297,0.49	ARSB	missense	ARSB:NM_000046.3:missense:MODERATE:exon5/8:c.1072G>A:p.Val358Met,ARSB:NM_198709.2:missense:MODERATE:exon6/8:c.1072G>A:p.Val358Met		rs1065757	0.2855	0.391	0.4324	0.1144	3.9850	P	T	D,D	D,D	611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy)];	RCV000077997.2 [benign]; 	CM088428 [CLASS=FP MUT=ALT PHEN="Reduced activity" GENE=ARSB]; 		0.1591	0.5076	0.3333	80	208	n/a	n/a
chr5	78181577	78181577	T	C	het		QUAL=6074;DP=153;AF=0.49;MQM=60;TRIO=HET,153,0.49,WT,187,0.00,HET,250,0.50	ARSB	synonymous	ARSB:NM_000046.3:synonymous:LOW:exon5/8:c.972A>G:p.Gly324Gly,ARSB:NM_198709.2:synonymous:LOW:exon6/8:c.972A>G:p.Gly324Gly		rs72762973	0.0266	0.053	0.0715	0.015						611542 [ARSB (confirmed) Mucopolysaccharidosis type VI (Maroteaux-Lamy)];	RCV000078006.2 [benign]; 			0.0076	0.1515	0.8409	2	36	n/a	n/a
chr5	78281373	78281373	T	C	hom		QUAL=13189;DP=244;AF=1.00;MQM=60;TRIO=HOM,244,1.00,HOM,79,1.00,HOM,95,1.00	ARSB	5'UTR	ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-302A>G:,ARSB:NM_198709.2:5'UTR:MODIFIER:exon2/8:c.-302A>G:		rs163127	0.9052	0	0	0										0.9697	0.0303	0	146	4	n/a	n/a
chr5	78281635	78281635	T	C	het		QUAL=8980;DP=332;AF=0.54;MQM=60;TRIO=HET,332,0.54,HET,215,0.52,WT,232,0.00	ARSB	5'UTR,intron	ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-564A>G:,ARSB:NM_198709.2:intron:MODIFIER:exon1/7:c.-311+87A>G:		rs59558132	0.1719	0	0	0										0.053	0.3106	0.6364	9	46	n/a	n/a
chr5	78281909	78281909	-	TG	hom		QUAL=28002;DP=290;AF=0.95;MQM=60;TRIO=HOM,290,0.95,HOM,249,0.99,HOM,359,0.98	ARSB	5'UTR	ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-840_-839dupCA:		rs397805372	0.9519	0	0	0										0.9697	0.0303	0	146	4	n/a	n/a
chr5	78281977	78281977	G	C	het		QUAL=13971;DP=521;AF=0.49;MQM=60;TRIO=HET,521,0.49,HET,305,0.54,WT,400,0.00	ARSB	5'UTR_premature_start_codon_gain,5'UTR	ARSB:NM_000046.3:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-906C>G:,ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-906C>G:		rs62377914	0.1456	0	0	0										0.0455	0.3106	0.6439	8	46	n/a	n/a
chr5	78282029	78282029	T	C	het		QUAL=13325;DP=548;AF=0.48;MQM=60;TRIO=HET,548,0.48,HET,259,0.54,WT,359,0.00	ARSB	5'UTR	ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-958A>G:		rs57586329	0.1629	0	0	0										0.053	0.3106	0.6364	9	46	n/a	n/a
chr5	78282249	78282249	T	C	het		QUAL=12975;DP=290;AF=0.55;MQM=60;TRIO=HET,290,0.55,HET,130,0.54,HOM,169,1.00	ARSB	5'UTR_premature_start_codon_gain,5'UTR	ARSB:NM_000046.3:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-1178A>G:,ARSB:NM_000046.3:5'UTR:MODIFIER:exon1/8:c.-1178A>G:	LTR37A	rs163126	0.8163	0	0	0										0.6136	0.3258	0.0606	92	48	n/a	n/a
chr5	88015545	88015545	A	C	hom		QUAL=15616;DP=316;AF=0.00;MQM=60;TRIO=HOM,316,0.00,HET,94,0.36,HET,115,0.00	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*2876T>G:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*2876T>G:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*2876T>G:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*2876T>G:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*2876T>G:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*2876T>G:		rs34316	0.4824	0	0	0										0.303	0.5152	0.1818	45	81	n/a	n/a
chr5	88016008	88016008	A	G	hom		QUAL=32118;DP=446;AF=1.00;MQM=60;TRIO=HOM,446,1.00,HOM,311,1.00,HET,452,0.48	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*2413T>C:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*2413T>C:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*2413T>C:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*2413T>C:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*2413T>C:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*2413T>C:		rs34317	0.7013	0	0	0										0.5076	0.4015	0.0909	75	63	n/a	n/a
chr5	88016153	88016153	-	T	het		QUAL=6611;DP=193;AF=0.77;MQM=60;TRIO=HET,193,0.77,HET,60,0.75,HET,93,0.38	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*2267dupA:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*2267dupA:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*2267dupA:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*2267dupA:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*2267dupA:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*2267dupA:	AT_rich	rs398109145	0.6384	0	0	0										0.3788	0.4394	0.1818	56	64	n/a	n/a
chr5	88016605	88016605	T	-	hom		QUAL=9682;DP=273;AF=0.99;MQM=60;TRIO=HOM,273,0.99,HOM,29,1.00,HET,34,0.59	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*1816delA:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*1816delA:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*1816delA:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*1816delA:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*1816delA:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*1816delA:	AT_rich	rs398084276	0.4828	0	0	0										0.3106	0.5	0.1894	47	78	n/a	n/a
chr5	88018389	88018389	A	-	het		QUAL=3184;DP=254;AF=0.18;MQM=60;TRIO=HET,254,0.18,HET,107,0.07,HET,173,0.42	MEF2C	3'UTR	MEF2C:NM_001193347.1:3'UTR:MODIFIER:exon12/12:c.*32delT:,MEF2C:NM_001193348.1:3'UTR:MODIFIER:exon8/8:c.*32delT:,MEF2C:NM_001193349.1:3'UTR:MODIFIER:exon9/9:c.*32delT:,MEF2C:NM_001193350.1:3'UTR:MODIFIER:exon11/11:c.*32delT:,MEF2C:NM_002397.4:3'UTR:MODIFIER:exon11/11:c.*32delT:,MEF2C:NM_001131005.2:3'UTR:MODIFIER:exon11/11:c.*32delT:		rs373455781	0	0	0	0										0	0.1894	0.8106	0	28	n/a	n/a
chr5	88179070	88179070	A	G	het		QUAL=167;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,WT,17,0.00,HET,16,0.44	MEF2C	5'UTR,intron	MEF2C:NM_001193350.1:5'UTR:MODIFIER:exon1/11:c.-438T>C:,MEF2C:NM_002397.4:5'UTR:MODIFIER:exon1/11:c.-441T>C:,MEF2C:NM_001193347.1:intron:MODIFIER:exon2/11:c.-143+4249T>C:,MEF2C:NM_001131005.2:intron:MODIFIER:exon2/10:c.-143+4249T>C:	(CG)n		0	0	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr5	90107108	90107108	A	G	hom		QUAL=14018;DP=169;AF=1.00;MQM=60;TRIO=HOM,169,1.00,HOM,101,1.00,HOM,153,1.00	GPR98	missense	GPR98:NM_032119.3:missense:MODERATE:exon74/90:c.16031A>G:p.Glu5344Gly		rs2438374	0.9461	0.968	0.9734	0.8544	1.3490	P		B,B,B	B,B,B	602851 [GPR98 (confirmed) Febrile seizures,familial,4|Usher syndrome,type 2C|Usher syndrome,type 2C,GPR98/PDZD7 digenic];	RCV000039538.5 [other]; 			0.947	0.053	0	431	23	n/a	n/a
chr5	90119324	90119324	G	A	hom		QUAL=34611;DP=387;AF=1.00;MQM=60;TRIO=HOM,387,1.00,HOM,296,1.00,HOM,377,1.00	GPR98	missense	GPR98:NM_032119.3:missense:MODERATE:exon76/90:c.16279G>A:p.Val5427Met		rs2438378	0.9722	0.992	0.9993	0.914	-0.0070	P		B,B,B	B,B,B	602851 [GPR98 (confirmed) Febrile seizures,familial,4|Usher syndrome,type 2C|Usher syndrome,type 2C,GPR98/PDZD7 digenic];	RCV000039541.3 [other]; 			1	0	0	452	2	n/a	n/a
chr5	90151589	90151589	G	A	het		QUAL=7132;DP=242;AF=0.46;MQM=60;TRIO=HET,242,0.46,HOM,119,0.99,WT,155,0.00	GPR98	missense	GPR98:NM_032119.3:missense:MODERATE:exon82/90:c.17626G>A:p.Val5876Ile		rs2247870	0.4591	0.536	0.5472	0.1952	2.8990	P		B,P,B	B,B,B	602851 [GPR98 (confirmed) Febrile seizures,familial,4|Usher syndrome,type 2C|Usher syndrome,type 2C,GPR98/PDZD7 digenic];	RCV000039547.3 [other]; 		COSM149886	0.2652	0.3864	0.3485	129	195	n/a	n/a
chr5	90449031	90449031	T	C	hom		QUAL=13960;DP=177;AF=1.00;MQM=60;TRIO=HOM,177,1.00,HOM,115,1.00,HOM,148,1.00	GPR98	splice_region&intron	GPR98:NM_032119.3:splice_region&intron:LOW:exon88/89:c.18625-7T>C:		rs7726023	0.8984	0.918	0.9378	0.8707						602851 [GPR98 (confirmed) Febrile seizures,familial,4|Usher syndrome,type 2C|Usher syndrome,type 2C,GPR98/PDZD7 digenic];	RCV000154372.1,RCV000039555.3 [benign,other]; 			0.9091	0.0833	0.0076	395	53	n/a	n/a
chr5	118788196	118788196	C	G	het		QUAL=9866;DP=167;AF=0.54;MQM=59;TRIO=HET,167,0.54,WT,164,0.01,HOM,239,1.00	HSD17B4	5'UTR	HSD17B4:NM_001199291.2:5'UTR:MODIFIER:exon1/25:c.-253C>G:,HSD17B4:NM_000414.3:5'UTR:MODIFIER:exon1/24:c.-75C>G:,HSD17B4:NM_001199292.1:5'UTR:MODIFIER:exon1/23:c.-75C>G:,HSD17B4:NM_001292027.1:5'UTR:MODIFIER:exon1/25:c.-212C>G:,HSD17B4:NM_001292028.1:5'UTR:MODIFIER:exon1/24:c.-674C>G:		rs26180	0.4064	0	0	0										0.3106	0.4924	0.197	46	76	n/a	n/a
chr5	118811533	118811533	G	A	het		QUAL=12722;DP=382;AF=0.51;MQM=60;TRIO=HET,382,0.51,WT,139,0.00,HOM,189,1.00	HSD17B4	missense,5'UTR	HSD17B4:NM_001199291.2:missense:MODERATE:exon7/25:c.392G>A:p.Arg131His,HSD17B4:NM_000414.3:missense:MODERATE:exon6/24:c.317G>A:p.Arg106His,HSD17B4:NM_001199292.1:missense:MODERATE:exon5/23:c.263G>A:p.Arg88His,HSD17B4:NM_001292027.1:missense:MODERATE:exon7/25:c.245G>A:p.Arg82His,HSD17B4:NM_001292028.1:5'UTR:MODIFIER:exon6/24:c.-95G>A:		rs25640	0.3626	0.44	0.46	0.1762	7.6330	P	D	D,D,D,D	P,B,P,B	601860 [HSD17B4 (provisional) D-bifunctional protein deficiency|Perrault syndrome 1];	RCV000008096.1 [pathogenic]; 		COSM1432658	0.2727	0.5	0.2273	173	352	2	n/a
chr5	118861713	118861713	A	G	het		QUAL=13489;DP=282;AF=0.45;MQM=60;TRIO=HET,282,0.45,WT,229,0.00,HOM,283,1.00	HSD17B4	missense	HSD17B4:NM_001199291.2:missense:MODERATE:exon20/25:c.1750A>G:p.Ile584Val,HSD17B4:NM_000414.3:missense:MODERATE:exon19/24:c.1675A>G:p.Ile559Val,HSD17B4:NM_001199292.1:missense:MODERATE:exon18/23:c.1621A>G:p.Ile541Val,HSD17B4:NM_001292027.1:missense:MODERATE:exon20/25:c.1603A>G:p.Ile535Val,HSD17B4:NM_001292028.1:missense:MODERATE:exon19/24:c.1255A>G:p.Ile419Val		rs11205	0.4002	0.411	0.4091	0.3953	3.8360	P	T	P,B,B,B,B	B,B,B,B,B	601860 [HSD17B4 (provisional) D-bifunctional protein deficiency|Perrault syndrome 1];			COSM1130959	0.2424	0.5152	0.2424	134	354	n/a	n/a
chr5	118877933	118877933	-	A	het		QUAL=6023;DP=267;AF=0.42;MQM=59;TRIO=HET,267,0.42,WT,76,0.01,HOM,86,0.94	HSD17B4	3'UTR	HSD17B4:NM_001199291.2:3'UTR:MODIFIER:exon25/25:c.*250dupA:,HSD17B4:NM_000414.3:3'UTR:MODIFIER:exon24/24:c.*250dupA:,HSD17B4:NM_001199292.1:3'UTR:MODIFIER:exon23/23:c.*250dupA:,HSD17B4:NM_001292027.1:3'UTR:MODIFIER:exon25/25:c.*250dupA:,HSD17B4:NM_001292028.1:3'UTR:MODIFIER:exon24/24:c.*250dupA:		rs149778406	0.5639	0	0	0										0.3864	0.4545	0.1591	57	69	n/a	n/a
chr5	125877635	125877635	A	G	hom		QUAL=3855;DP=76;AF=1.00;MQM=60;TRIO=HOM,76,1.00,HET,32,0.59,HOM,29,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*3022T>C:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*3022T>C:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*3022T>C:		rs2035471	0.4718	0	0	0										0.303	0.4545	0.2424	44	70	n/a	n/a
chr5	125877659	125877659	-	A	het		QUAL=2387;DP=53;AF=0.72;MQM=60;TRIO=HET,53,0.72,HOM,29,0.69,HET,32,0.81	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*2997dupT:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*2997dupT:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*2997dupT:		rs397760043	0.9625	0	0	0										0.4697	0.197	0.3333	66	29	n/a	n/a
chr5	125878158	125878158	C	T	hom		QUAL=18906;DP=276;AF=0.99;MQM=59;TRIO=HOM,276,0.99,HET,174,0.47,HOM,228,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*2499G>A:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*2499G>A:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*2499G>A:	AluJr	rs7715516	0.4856	0	0	0										0.303	0.4545	0.2424	44	70	n/a	n/a
chr5	125878908	125878908	C	A	hom		QUAL=21082;DP=379;AF=0.99;MQM=60;TRIO=HOM,379,0.99,HET,223,0.53,HET,327,0.49	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*1749G>T:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*1749G>T:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*1749G>T:		rs744722	0.3732	0	0	0										0.1515	0.4848	0.3636	21	72	n/a	n/a
chr5	125878909	125878909	A	T	hom		QUAL=21082;DP=379;AF=0.99;MQM=60;TRIO=HOM,379,0.99,HET,223,0.53,HET,327,0.49	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*1748T>A:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*1748T>A:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*1748T>A:		rs744721	0.3732	0	0	0										0.1515	0.4848	0.3636	21	72	n/a	n/a
chr5	125878955	125878955	A	-	hom		QUAL=21874;DP=391;AF=0.93;MQM=60;TRIO=HOM,391,0.93,HET,151,0.54,HOM,225,0.98	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*1702delT:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*1702delT:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*1702delT:		rs5871218	0.5705	0	0	0										0.303	0.447	0.25	43	70	n/a	n/a
chr5	125879549	125879549	C	T	hom		QUAL=12274;DP=240;AF=1.00;MQM=60;TRIO=HOM,240,1.00,HET,94,0.47,HOM,101,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*1108G>A:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*1108G>A:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*1108G>A:		rs1483780	0.4916	0	0	0										0.2955	0.4545	0.25	42	71	n/a	n/a
chr5	125879677	125879677	G	T	het		QUAL=380;DP=131;AF=0.14;MQM=60;TRIO=HET,131,0.14,HET,39,0.13,HET,53,0.26	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*980C>A:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*980C>A:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*980C>A:	AluSx1	rs74892068	0	0	0	0										0	0.0606	0.9394	0	8	n/a	n/a
chr5	125879850	125879850	G	C	hom		QUAL=2009;DP=64;AF=1.00;MQM=59;TRIO=HOM,64,1.00,HET,3,0.33,HOM,5,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*807C>G:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*807C>G:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*807C>G:	AluSx1	rs1807	0.5759	0	0	0										0.303	0.3636	0.3333	43	58	n/a	n/a
chr5	125879981	125879981	G	A	hom		QUAL=4832;DP=85;AF=1.00;MQM=59;TRIO=HOM,85,1.00,HOM,32,1.00,HOM,35,1.00	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*676C>T:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*676C>T:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*676C>T:		rs7447380	0.9974	0	0	0										1	0	0	150	0	n/a	n/a
chr5	125880589	125880589	T	C	hom		QUAL=11669;DP=208;AF=1.00;MQM=58;TRIO=HOM,208,1.00,HET,127,0.45,HET,161,0.57	ALDH7A1	3'UTR	ALDH7A1:NM_001182.4:3'UTR:MODIFIER:exon18/18:c.*68A>G:,ALDH7A1:NM_001201377.1:3'UTR:MODIFIER:exon18/18:c.*68A>G:,ALDH7A1:NM_001202404.1:3'UTR:MODIFIER:exon16/16:c.*68A>G:		rs2775	0.3606	0	0.4833	0.3215										0.1591	0.4773	0.3636	26	76	n/a	n/a
chr5	125931022	125931022	T	G	hom		QUAL=1437;DP=22;AF=1.00;MQM=59;TRIO=HOM,22,1.00,HET,30,0.40,HET,33,0.52	ALDH7A1	5'UTR	ALDH7A1:NM_001182.4:5'UTR:MODIFIER:exon1/18:c.-132A>C:,ALDH7A1:NM_001201377.1:5'UTR:MODIFIER:exon1/18:c.-216A>C:,ALDH7A1:NM_001202404.1:5'UTR:MODIFIER:exon1/16:c.-51A>C:		rs900641	0.2464	0	0	0										0	0.1818	0.8182	0	26	n/a	n/a
chr5	126112580	126112580	T	C	het		QUAL=635;DP=31;AF=0.45;MQM=60;TRIO=HET,31,0.45,HET,29,0.38,WT,41,0.00	LMNB1	5'UTR	LMNB1:NM_005573.3:5'UTR:MODIFIER:exon1/11:c.-621T>C:		rs35091677	0.2324	0	0	0										0.053	0.2955	0.6515	7	46	n/a	n/a
chr5	126171999	126171999	T	C	hom		QUAL=17425;DP=214;AF=1.00;MQM=60;TRIO=HOM,214,1.00,HOM,116,1.00,HOM,196,1.00	LMNB1	3'UTR	LMNB1:NM_005573.3:3'UTR:MODIFIER:exon11/11:c.*43T>C:,LMNB1:NM_001198557.1:3'UTR:MODIFIER:exon11/11:c.*43T>C:		rs1051643	0.6727	0.675	0.6448	0.6677										0.4621	0.3939	0.1439	70	69	n/a	n/a
chr5	126172195	126172195	C	T	het		QUAL=4235;DP=123;AF=0.50;MQM=60;TRIO=HET,123,0.50,HOM,45,1.00,HET,54,0.44	LMNB1	3'UTR	LMNB1:NM_005573.3:3'UTR:MODIFIER:exon11/11:c.*239C>T:,LMNB1:NM_001198557.1:3'UTR:MODIFIER:exon11/11:c.*239C>T:		rs1051644	0.4479	0	0	0										0.2273	0.5152	0.2576	36	74	n/a	n/a
chr5	127594512	127594512	T	C	hom		QUAL=18555;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,134,1.00,HOM,183,1.00	FBN2	3'UTR	FBN2:NM_001999.3:3'UTR:MODIFIER:exon65/65:c.*635A>G:		rs27858	0.9856	0	0	0										0.9394	0.053	0.0076	140	9	n/a	n/a
chr5	127638759	127638759	A	G	het		QUAL=4930;DP=263;AF=0.45;MQM=60;TRIO=HET,263,0.45,HET,68,0.54,WT,128,0.00	FBN2	synonymous	FBN2:NM_001999.3:synonymous:LOW:exon46/65:c.5823T>C:p.His1941His		rs11955288	0.0929	0.095	0.1033	0.1058						612570 [FBN2 (provisional) Contractural arachnodactyly,congenital];	RCV000117025.1 [benign]; RCV000125065.1 [benign]; 		COSM4159389	0.0152	0.2121	0.7727	11	66	n/a	n/a
chr5	127640783	127640783	G	A	het		QUAL=9094;DP=178;AF=0.47;MQM=60;TRIO=HET,178,0.47,HET,147,0.50,HET,246,0.53	FBN2	splice_region&intron	FBN2:NM_001999.3:splice_region&intron:LOW:exon44/64:c.5675-9C>T:		rs27713	0.7344	0.711	0	0						612570 [FBN2 (provisional) Contractural arachnodactyly,congenital];	RCV000117024.2 [likely benign]; RCV000125064.1 [benign]; 			0.5303	0.4015	0.0682	236	174	n/a	n/a
chr5	127685135	127685135	C	T	hom		QUAL=16601;DP=295;AF=1.00;MQM=60;TRIO=HOM,295,1.00,HET,204,0.42,HET,273,0.48	FBN2	missense	FBN2:NM_001999.3:missense:MODERATE:exon23/65:c.2893G>A:p.Val965Ile		rs154001	0.731	0.723	0.6798	0.6278	3.8840	P	T	B,B	B,B	612570 [FBN2 (provisional) Contractural arachnodactyly,congenital];	RCV000117020.1 [benign]; RCV000125040.1 [benign]; 			0.5379	0.3788	0.0833	217	182	n/a	n/a
chr5	127873094	127873094	G	A	het		QUAL=2406;DP=43;AF=0.60;MQM=60;TRIO=HET,43,0.60,HET,128,0.49,WT,186,0.00	FBN2	missense	FBN2:NM_001999.3:missense:MODERATE:exon1/65:c.203C>T:p.Ala68Val		rs62390671	0.0148	0.03	0.0466	0.0139	1.9370	N	T	B,B,B,B	B,B,B,B	612570 [FBN2 (provisional) Contractural arachnodactyly,congenital];	RCV000079963.4 [other]; RCV000125030.1 [benign]; 			0.0076	0.053	0.9394	1	33	n/a	n/a
chr5	127873605	127873605	T	C	het		QUAL=3100;DP=68;AF=0.38;MQM=60;TRIO=HET,68,0.38,HET,58,0.62,HET,68,0.57	FBN2	5'UTR	FBN2:NM_001999.3:5'UTR:MODIFIER:exon1/65:c.-309A>G:		rs7732639	0.4375	0	0	0										0.0379	0.3636	0.5985	8	55	n/a	n/a
chr5	131705458	131705458	C	G	het		QUAL=160;DP=6;AF=0.83;MQM=60;TRIO=HET,6,0.83,WT,4,0.00,HET,8,0.38	SLC22A5	5'UTR	SLC22A5:NM_003060.3:5'UTR:MODIFIER:exon1/10:c.-207C>G:		rs2631367	0.733	0	0	0								CR041140 [CLASS=DFP MUT=REF PHEN="Crohn's disease, susceptibility, association with" GENE=SLC22A5]; 		0.2045	0.4242	0.3712	31	58	n/a	n/a
chr5	131705949	131705949	T	C	het		QUAL=4094;DP=30;AF=0.33;MQM=57;TRIO=HET,30,0.33,WT,214,0.00,HET,308,0.44	SLC22A5	synonymous	SLC22A5:NM_003060.3:synonymous:LOW:exon1/10:c.285T>C:p.Leu95Leu		rs2631365	0.4862	0.388	0.366	0.3172						603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary];	RCV000080053.2 [benign]; 		COSM4005840	0.1364	0.4848	0.3788	65	204	n/a	n/a
chr5	131706028	131706028	G	T	het		QUAL=8845;DP=166;AF=0.39;MQM=59;TRIO=HET,166,0.39,WT,353,0.00,HET,456,0.49	SLC22A5	missense	SLC22A5:NM_003060.3:missense:MODERATE:exon1/10:c.364G>T:p.Asp122Tyr		rs201082652	0	0.0003	0.0003	0	6.0270	D	D	D,D	D,D	603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary];	RCV000022318.2 [not provided]; 	CM104584 [CLASS=DM MUT=ALT PHEN="Carnitine deficiency, systemic primary" GENE=SLC22A5]; 		0	0.0076	0.9924	0	1	n/a	n/a
chr5	131719999	131719999	A	G	hom		QUAL=28739;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,289,1.00,HOM,403,1.00	SLC22A5	splice_region&intron	SLC22A5:NM_003060.3:splice_region&intron:LOW:exon3/9:c.652+6A>G:		rs4551059	1	1	0	0						603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary];	RCV000022335.2 [not provided]; RCV000080057.2 [benign]; RCV000128067.1 [benign]; 			1	0	0	454	0	n/a	n/a
chr5	131721174	131721174	A	G	het		QUAL=11144;DP=416;AF=0.51;MQM=60;TRIO=HET,416,0.51,WT,233,0.00,HET,305,0.49	SLC22A5	synonymous	SLC22A5:NM_003060.3:synonymous:LOW:exon4/10:c.807A>G:p.Leu269Leu		rs274558	0.4862	0.439	0.3913	0.3529						603377 [SLC22A5 (confirmed) Carnitine deficiency,systemic primary];	RCV000022346.2,RCV000080060.2 [not provided,benign]; 		COSM3760913	0.1364	0.4924	0.3712	66	224	n/a	n/a
chr5	131730011	131730011	C	T	het		QUAL=14638;DP=467;AF=0.47;MQM=60;TRIO=HET,467,0.47,WT,325,0.00,HET,437,0.52	SLC22A5	3'UTR	SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*47C>T:		rs1045020	0.0517	0.103	0.1217	0.0229							RCV000022391.2 [not provided]; 			0	0.1818	0.8182	0	35	n/a	n/a
chr5	131730053	131730053	A	-	het		QUAL=26565;DP=297;AF=0.74;MQM=60;TRIO=HET,297,0.74,HOM,287,0.98,HOM,386,0.94	SLC22A5	3'UTR	SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*92delA:		rs398084481	0.7552	0	0	0										0.6136	0.3561	0.0303	95	51	n/a	n/a
chr5	131730056	131730056	A	G	het		QUAL=1487;DP=313;AF=0.22;MQM=60;TRIO=HET,313,0.22,WT,295,0.00,WT,387,0.03	SLC22A5	3'UTR	SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*92A>G:		rs113943881	0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr5	131730807	131730807	T	C	hom		QUAL=20547;DP=402;AF=1.00;MQM=60;TRIO=HOM,402,1.00,HOM,99,0.99,HOM,115,1.00	SLC22A5	3'UTR	SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*843T>C:		rs274548	0.7442	0	0	0										0.6515	0.3182	0.0303	100	46	n/a	n/a
chr5	131730923	131730923	-	C	het		QUAL=10881;DP=304;AF=0.75;MQM=59;TRIO=HET,304,0.75,HET,69,0.65,HET,105,0.69	SLC22A5	3'UTR	SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*959_*960insC:	AT_rich	rs144261584	0.7674	0	0	0										0.5455	0.4091	0.0455	83	60	n/a	n/a
chr5	131730923	131730923	A	C	het		QUAL=10881;DP=304;AF=0.18;MQM=59;TRIO=HET,304,0.18,HET,69,0.33,HET,105,0.27	SLC22A5	3'UTR	SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*959A>C:	AT_rich	rs14701	0	0	0	0										0	0.4091	0.5909	0	62	n/a	n/a
chr5	131731304	131731304	A	T	hom		QUAL=10641;DP=226;AF=1.00;MQM=60;TRIO=HOM,226,1.00,HOM,41,1.00,HOM,66,1.00	SLC22A5	splice_region,3'UTR	SLC22A5:NM_003060.3:splice_region:LOW:exon10/10:c.*1340A>T:,SLC22A5:NM_003060.3:3'UTR:MODIFIER:exon10/10:c.*1340A>T:		rs274547	0.7442	0	0	0										0.6515	0.3182	0.0303	100	46	n/a	n/a
chr5	131892979	131892979	G	A	hom		QUAL=13457;DP=168;AF=1.00;MQM=60;TRIO=HOM,168,1.00,HOM,101,1.00,HOM,158,1.00	RAD50	5'UTR	RAD50:NM_005732.3:5'UTR:MODIFIER:exon1/25:c.-38G>A:		rs4526098	0.9249	0.975	0.9977	0.7646							RCV000160912.1 [benign]; 			0.9924	0.0076	0	165	1	n/a	n/a
chr5	132203997	132203997	A	G	het		QUAL=20720;DP=401;AF=0.48;MQM=59;TRIO=HET,401,0.48,WT,326,0.00,HOM,434,1.00	UQCRQ	3'UTR	UQCRQ:NM_014402.4:3'UTR:MODIFIER:exon3/3:c.*723A>G:	MIR	rs17166297	0.1707	0	0	0										0.0606	0.3333	0.6061	10	48	n/a	n/a
chr5	132204031	132204031	G	A	het		QUAL=17653;DP=369;AF=0.49;MQM=60;TRIO=HET,369,0.49,WT,299,0.00,HOM,366,0.99	UQCRQ	3'UTR	UQCRQ:NM_014402.4:3'UTR:MODIFIER:exon3/3:c.*757G>A:	MIR	rs17624157	0.0479	0	0	0										0.053	0.2727	0.6742	8	41	n/a	n/a
chr5	132204448	132204448	G	-	het		QUAL=14480;DP=396;AF=0.45;MQM=60;TRIO=HET,396,0.45,HOM,285,0.99,WT,361,0.00	UQCRQ	3'UTR	UQCRQ:NM_014402.4:3'UTR:MODIFIER:exon3/3:c.*1175delG:		rs67367845	0.4253	0	0	0										0.2424	0.5303	0.2273	35	75	n/a	n/a
chr5	132204467	132204467	A	G	het		QUAL=16937;DP=486;AF=0.49;MQM=60;TRIO=HET,486,0.49,HOM,290,1.00,WT,368,0.00	UQCRQ	3'UTR	UQCRQ:NM_014402.4:3'UTR:MODIFIER:exon3/3:c.*1193A>G:		rs254284	0	0	0	0										0.2424	0.5303	0.2273	35	75	n/a	n/a
chr5	137206560	137206560	A	C	hom		QUAL=21624;DP=177;AF=1.00;MQM=59;TRIO=HOM,177,1.00,HOM,242,1.00,HOM,261,1.00	MYOT	missense,splice_region&intron,intron	MYOT:NM_006790.2:missense:MODERATE:exon2/10:c.220A>C:p.Lys74Gln,MYOT:NM_001300911.1:splice_region&intron:LOW:exon2/10:c.-120-6A>C:,MYOT:NM_001135940.1:intron:MODIFIER:exon2/9:c.-197+346A>C:		rs6890689	0	0.996	1	0.9562	2.8090	P	T	B	B	604103 [MYOT (confirmed) Muscular dystrophy,limb-girdle,type 1A|Myopathy,myofibrillar,3|Myopathy,spheroid body];	RCV000153527.1 [benign]; 	CM056011 [CLASS=DM MUT=REF PHEN="Myotilinopathy" GENE=MYOT]; 		1	0	0	452	1	2	n/a
chr5	138456815	138456815	T	C	het		QUAL=16978;DP=237;AF=0.51;MQM=60;TRIO=HET,237,0.51,WT,294,0.00,HOM,405,1.00	SIL1	synonymous	SIL1:NM_001037633.1:synonymous:LOW:exon4/11:c.153A>G:p.Thr51Thr,SIL1:NM_022464.4:synonymous:LOW:exon3/10:c.153A>G:p.Thr51Thr		rs3088052	0.4269	0.435	0.4308	0.677						608005 [SIL1 (confirmed) Marinesco-Sjogren syndrome];	RCV000082151.4 [other]; 			0.1742	0.5152	0.3106	307	685	n/a	n/a
chr5	138609609	138609609	C	G	het		QUAL=6502;DP=228;AF=0.50;MQM=60;TRIO=HET,228,0.50,WT,194,0.00,HET,236,0.44	MATR3	5'UTR	MATR3:NM_001194954.1:5'UTR:MODIFIER:exon1/17:c.-528C>G:,MATR3:NM_001282278.1:5'UTR:MODIFIER:exon1/17:c.-535C>G:,MATR3:NM_199189.2:5'UTR:MODIFIER:exon1/18:c.-610C>G:		rs11242456	0.4203	0.559	0	0										0.3788	0.5152	0.1061	124	142	n/a	n/a
chr5	138642997	138642997	-	T	het		QUAL=6893;DP=226;AF=0.45;MQM=59;TRIO=HET,226,0.45,WT,72,0.00,HOM,113,0.99	MATR3	5'UTR,intron	MATR3:NM_001194954.1:5'UTR:MODIFIER:exon4/17:c.-103dupT:,MATR3:NM_199189.2:5'UTR:MODIFIER:exon5/18:c.-103dupT:,MATR3:NM_018834.5:5'UTR:MODIFIER:exon2/15:c.-103dupT:,MATR3:NM_001194955.1:5'UTR:MODIFIER:exon2/15:c.-103dupT:,MATR3:NM_001282278.1:intron:MODIFIER:exon4/16:c.-102-7362dupT:,MATR3:NM_001194956.1:intron:MODIFIER:exon1/13:c.49-7362dupT:		rs112107315	0.4317	0	0	0						164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21];				0.3864	0.5379	0.0758	59	78	n/a	n/a
chr5	138643062	138643062	T	A	het		QUAL=6702;DP=177;AF=0.55;MQM=59;TRIO=HET,177,0.55,WT,84,0.00,HOM,119,1.00	MATR3	5'UTR,intron	MATR3:NM_001194954.1:5'UTR:MODIFIER:exon4/17:c.-43T>A:,MATR3:NM_199189.2:5'UTR:MODIFIER:exon5/18:c.-43T>A:,MATR3:NM_018834.5:5'UTR:MODIFIER:exon2/15:c.-43T>A:,MATR3:NM_001194955.1:5'UTR:MODIFIER:exon2/15:c.-43T>A:,MATR3:NM_001282278.1:intron:MODIFIER:exon4/16:c.-102-7302T>A:,MATR3:NM_001194956.1:intron:MODIFIER:exon1/13:c.49-7302T>A:	AT_rich	rs12153162	0.4465	0.626	0.6757	0.2758						164015 [MATR3 (provisional) Amyotrophic lateral sclerosis 21];				0.4545	0.4924	0.053	69	71	n/a	n/a
chr5	138665756	138665756	G	A	het		QUAL=7987;DP=290;AF=0.50;MQM=59;TRIO=HET,290,0.50,WT,71,0.00,HOM,94,1.00	MATR3	3'UTR	MATR3:NM_001194954.1:3'UTR:MODIFIER:exon17/17:c.*672G>A:,MATR3:NM_001282278.1:3'UTR:MODIFIER:exon17/17:c.*672G>A:,MATR3:NM_199189.2:3'UTR:MODIFIER:exon18/18:c.*672G>A:,MATR3:NM_018834.5:3'UTR:MODIFIER:exon15/15:c.*672G>A:,MATR3:NM_001194955.1:3'UTR:MODIFIER:exon15/15:c.*672G>A:,MATR3:NM_001194956.1:3'UTR:MODIFIER:exon14/14:c.*672G>A:		rs7305	0	0.589	0	0										0.3712	0.553	0.0758	116	145	n/a	n/a
chr5	138666372	138666372	T	G	het		QUAL=6070;DP=255;AF=0.44;MQM=60;TRIO=HET,255,0.44,WT,42,0.00,HOM,72,1.00	MATR3	3'UTR	MATR3:NM_001194954.1:3'UTR:MODIFIER:exon17/17:c.*1288T>G:,MATR3:NM_001282278.1:3'UTR:MODIFIER:exon17/17:c.*1288T>G:,MATR3:NM_199189.2:3'UTR:MODIFIER:exon18/18:c.*1288T>G:,MATR3:NM_018834.5:3'UTR:MODIFIER:exon15/15:c.*1288T>G:,MATR3:NM_001194955.1:3'UTR:MODIFIER:exon15/15:c.*1288T>G:,MATR3:NM_001194956.1:3'UTR:MODIFIER:exon14/14:c.*1288T>G:		rs10515507	0.4	0.615	0	0										0.3864	0.5379	0.0758	124	136	n/a	n/a
chr5	140027216	140027216	T	C	het		QUAL=5993;DP=153;AF=0.50;MQM=60;TRIO=HET,153,0.50,WT,236,0.00,HET,255,0.45	NDUFA2	5'UTR	NDUFA2:NM_002488.4:5'UTR:MODIFIER:exon1/3:c.-48A>G:,NDUFA2:NM_001185012.1:5'UTR:MODIFIER:exon1/3:c.-48A>G:		rs778593	0.3778	0.398	0.4112	0.2853										0.1439	0.4697	0.3864	46	141	n/a	n/a
chr5	140027304	140027304	T	C	het		QUAL=4165;DP=177;AF=0.44;MQM=60;TRIO=HET,177,0.44,WT,123,0.00,HET,145,0.44	NDUFA2	5'UTR_premature_start_codon_gain,5'UTR	NDUFA2:NM_002488.4:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-136A>G:,NDUFA2:NM_001185012.1:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-136A>G:,NDUFA2:NM_002488.4:5'UTR:MODIFIER:exon1/3:c.-136A>G:,NDUFA2:NM_001185012.1:5'UTR:MODIFIER:exon1/3:c.-136A>G:		rs778594	0.3776	0.364	0	0										0.1515	0.4697	0.3788	42	134	n/a	n/a
chr5	146435580	146435580	A	G	het		QUAL=11662;DP=276;AF=0.41;MQM=60;TRIO=HET,276,0.41,HET,154,0.53,HOM,185,1.00	PPP2R2B	5'UTR,intron	PPP2R2B:NM_181674.2:5'UTR:MODIFIER:exon1/10:c.-279T>C:,PPP2R2B:NM_181676.2:5'UTR:MODIFIER:exon1/9:c.-274T>C:,PPP2R2B:NM_001271899.1:intron:MODIFIER:exon2/9:c.88+25042T>C:,PPP2R2B:NM_001271900.1:intron:MODIFIER:exon2/10:c.50+25042T>C:,PPP2R2B:NM_181677.2:intron:MODIFIER:exon2/10:c.-62-20777T>C:,PPP2R2B:NM_181678.2:intron:MODIFIER:exon2/10:c.-49+25042T>C:		rs1480153	0.6585	0	0	0						604325 [PPP2R2B (provisional) Spinocerebellar ataxia 12];				0.4091	0.5455	0.0455	63	78	n/a	n/a
chr5	147469113	147469113	G	A	het		QUAL=13052;DP=383;AF=0.46;MQM=60;TRIO=HET,383,0.46,HET,486,0.47,WT,632,0.00	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon7/34:c.531G>A:p.Arg177Arg,SPINK5:NM_001127699.1:synonymous:LOW:exon7/28:c.531G>A:p.Arg177Arg,SPINK5:NM_006846.3:synonymous:LOW:exon7/33:c.531G>A:p.Arg177Arg		rs35121983	0.0469	0.034	0.0199	0.0444						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128216.1 [benign]; 		COSM149969	0	0.0606	0.9394	1	22	n/a	n/a
chr5	147475386	147475386	A	G	het		QUAL=9330;DP=245;AF=0.51;MQM=60;TRIO=HET,245,0.51,HET,138,0.47,HET,207,0.46	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon10/34:c.800A>G:p.Gln267Arg,SPINK5:NM_001127699.1:missense:MODERATE:exon10/28:c.800A>G:p.Gln267Arg,SPINK5:NM_006846.3:missense:MODERATE:exon10/33:c.800A>G:p.Gln267Arg		rs6892205	0.509	0.521	0.5081	0.4605	-4.0170	P	T	B,B,B	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128217.1 [benign]; 		COSM4003378	0.3106	0.4848	0.2045	144	205	n/a	n/a
chr5	147477551	147477551	C	T	het		QUAL=8963;DP=197;AF=0.49;MQM=60;TRIO=HET,197,0.49,HET,168,0.53,HET,199,0.48	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon11/34:c.1004C>T:p.Ala335Val,SPINK5:NM_001127699.1:missense:MODERATE:exon11/28:c.1004C>T:p.Ala335Val,SPINK5:NM_006846.3:missense:MODERATE:exon11/33:c.1004C>T:p.Ala335Val		rs34482796	0.4465	0.507	0.506	0.2976	0.0650	P	T	B,B,B	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128218.1 [benign]; 			0.3106	0.4848	0.2045	141	209	n/a	n/a
chr5	147480027	147480027	G	A	het		QUAL=14783;DP=194;AF=0.53;MQM=60;TRIO=HET,194,0.53,HET,264,0.57,HET,374,0.56	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon13/34:c.1103G>A:p.Ser368Asn,SPINK5:NM_001127699.1:missense:MODERATE:exon13/28:c.1103G>A:p.Ser368Asn,SPINK5:NM_006846.3:missense:MODERATE:exon13/33:c.1103G>A:p.Ser368Asn		rs2303063	0.4315	0.506	0.511	0.2512	0.0360	P	T	B,B,B	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];		CM013814 [CLASS=DP MUT=ALT PHEN="Atopy, maternally inherited, association with" GENE=SPINK5]; 	COSM4003380	0.3182	0.4773	0.2045	144	207	n/a	n/a
chr5	147480080	147480080	G	A	het		QUAL=16301;DP=384;AF=0.47;MQM=60;TRIO=HET,384,0.47,HET,311,0.45,HET,429,0.43	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon13/34:c.1156G>A:p.Asp386Asn,SPINK5:NM_001127699.1:missense:MODERATE:exon13/28:c.1156G>A:p.Asp386Asn,SPINK5:NM_006846.3:missense:MODERATE:exon13/33:c.1156G>A:p.Asp386Asn		rs2303064	0.3482	0.212	0.1251	0.4585	1.8960	P	T	P,P,P,B	B,B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128219.1 [benign]; 			0.0455	0.2576	0.697	16	97	n/a	n/a
chr5	147480112	147480112	T	C	het		QUAL=17626;DP=288;AF=0.53;MQM=60;TRIO=HET,288,0.53,HET,301,0.56,HET,396,0.58	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon13/34:c.1188T>C:p.His396His,SPINK5:NM_001127699.1:synonymous:LOW:exon13/28:c.1188T>C:p.His396His,SPINK5:NM_006846.3:synonymous:LOW:exon13/33:c.1188T>C:p.His396His		rs2303065	0.4329	0.507	0.5108	0.2501						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128220.1 [benign]; 		COSM4003381	0.3182	0.4773	0.2045	144	207	n/a	n/a
chr5	147480955	147480955	A	G	het		QUAL=11190;DP=205;AF=0.49;MQM=60;TRIO=HET,205,0.49,HET,238,0.51,HET,286,0.47	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon14/34:c.1258A>G:p.Lys420Glu,SPINK5:NM_001127699.1:missense:MODERATE:exon14/28:c.1258A>G:p.Lys420Glu,SPINK5:NM_006846.3:missense:MODERATE:exon14/33:c.1258A>G:p.Lys420Glu		rs2303067	0.4331	0.507	0.5133	0.2555	0.1530	P	T	B,B,B	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000005585.1 [other]; RCV000005586.1 [other]; RCV000005587.1 [other]; 	CM013815 [CLASS=DFP MUT=REF PHEN="Atopy, maternally inherited, association with" GENE=SPINK5]; 	COSM4003383	0.3182	0.4773	0.2045	144	207	n/a	n/a
chr5	147481430	147481430	A	G	het		QUAL=14759;DP=306;AF=0.51;MQM=59;TRIO=HET,306,0.51,HET,286,0.49,HET,337,0.49	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon15/34:c.1389A>G:p.Gly463Gly,SPINK5:NM_001127699.1:synonymous:LOW:exon15/28:c.1389A>G:p.Gly463Gly,SPINK5:NM_006846.3:synonymous:LOW:exon15/33:c.1389A>G:p.Gly463Gly		rs6896303	0.4329	0.507	0.5124	0.2526						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM149971	0.3182	0.4773	0.2045	144	206	n/a	n/a
chr5	147486677	147486677	C	A	het		QUAL=18366;DP=329;AF=0.51;MQM=60;TRIO=HET,329,0.51,HET,344,0.46,HET,505,0.48	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon17/34:c.1557C>A:p.Gly519Gly,SPINK5:NM_001127699.1:synonymous:LOW:exon17/28:c.1557C>A:p.Gly519Gly,SPINK5:NM_006846.3:synonymous:LOW:exon17/33:c.1557C>A:p.Gly519Gly		rs880687	0.4293	0.505	0.5111	0.2378						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM149972	0.3182	0.4773	0.2045	143	208	n/a	n/a
chr5	147488367	147488367	C	T	het		QUAL=10323;DP=290;AF=0.39;MQM=60;TRIO=HET,290,0.39,HET,200,0.46,HET,234,0.47	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon18/34:c.1659C>T:p.Val553Val,SPINK5:NM_001127699.1:synonymous:LOW:exon18/28:c.1659C>T:p.Val553Val,SPINK5:NM_006846.3:synonymous:LOW:exon18/33:c.1659C>T:p.Val553Val	GA-rich	rs2303071	0.602	0.552	0.5195	0.7632						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM449063	0.3182	0.4697	0.2121	148	208	n/a	n/a
chr5	147498019	147498019	G	A	het		QUAL=14405;DP=288;AF=0.52;MQM=60;TRIO=HET,288,0.52,HET,235,0.47,HET,392,0.47	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon23/34:c.2132G>A:p.Arg711Gln,SPINK5:NM_001127699.1:missense:MODERATE:exon23/28:c.2132G>A:p.Arg711Gln,SPINK5:NM_006846.3:missense:MODERATE:exon23/33:c.2132G>A:p.Arg711Gln		rs3777134	0.4884	0.583	0.6165	0.381	0.4400	P	T	P,B,P	B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM149974	0.4091	0.447	0.1439	184	200	n/a	n/a
chr5	147499616	147499616	C	T	het		QUAL=14276;DP=345;AF=0.50;MQM=60;TRIO=HET,345,0.50,HET,224,0.52,HET,312,0.47	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon25/34:c.2358C>T:p.Leu786Leu,SPINK5:NM_001127699.1:synonymous:LOW:exon25/28:c.2358C>T:p.Leu786Leu,SPINK5:NM_006846.3:synonymous:LOW:exon25/33:c.2358C>T:p.Leu786Leu		rs17704908	0.4874	0.582	0.6154	0.3733						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM4003387	0.4091	0.447	0.1439	185	198	n/a	n/a
chr5	147499670	147499670	C	T	het		QUAL=13839;DP=348;AF=0.47;MQM=60;TRIO=HET,348,0.47,HET,244,0.47,HET,338,0.46	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon25/34:c.2412C>T:p.Gly804Gly,SPINK5:NM_001127699.1:synonymous:LOW:exon25/28:c.2412C>T:p.Gly804Gly,SPINK5:NM_006846.3:synonymous:LOW:exon25/33:c.2412C>T:p.Gly804Gly		rs33920397	0.4884	0.582	0.6156	0.3733						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM149975	0.4091	0.447	0.1439	185	199	n/a	n/a
chr5	147499891	147499891	G	T	het		QUAL=10313;DP=316;AF=0.46;MQM=60;TRIO=HET,316,0.46,HET,352,0.51,WT,414,0.00	SPINK5	missense	SPINK5:NM_001127698.1:missense:MODERATE:exon26/34:c.2475G>T:p.Glu825Asp,SPINK5:NM_001127699.1:missense:MODERATE:exon26/28:c.2475G>T:p.Glu825Asp,SPINK5:NM_006846.3:missense:MODERATE:exon26/33:c.2475G>T:p.Glu825Asp		rs2303070	0.1745	0.128	0.095	0.1067	-0.6140	P	T	B,B,B,B	B,B,B,B	605010 [SPINK5 (provisional) Netherton syndrome|Atopy];	RCV000128223.1 [benign]; 			0.0303	0.1894	0.7803	10	73	n/a	n/a
chr5	147505116	147505116	G	A	het		QUAL=19691;DP=469;AF=0.45;MQM=60;TRIO=HET,469,0.45,HET,319,0.48,HET,454,0.51	SPINK5	synonymous,intron	SPINK5:NM_001127698.1:synonymous:LOW:exon29/34:c.2769G>A:p.Ala923Ala,SPINK5:NM_006846.3:intron:MODIFIER:exon28/32:c.2740-170G>A:		rs3764930	0.4533	0.572	0.6132	0.2628						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM4003390	0.4091	0.447	0.1439	182	201	n/a	n/a
chr5	147510866	147510866	T	C	het		QUAL=12133;DP=262;AF=0.47;MQM=60;TRIO=HET,262,0.47,HET,235,0.48,HET,286,0.47	SPINK5	synonymous	SPINK5:NM_001127698.1:synonymous:LOW:exon32/34:c.3099T>C:p.Gly1033Gly,SPINK5:NM_006846.3:synonymous:LOW:exon31/33:c.3009T>C:p.Gly1003Gly		rs2400478	0.5092	0.589	0.617	0.4387						605010 [SPINK5 (provisional) Netherton syndrome|Atopy];			COSM149977	0.4167	0.4394	0.1439	186	198	n/a	n/a
chr5	147516598	147516598	T	C	het		QUAL=10064;DP=211;AF=0.54;MQM=60;TRIO=HET,211,0.54,HET,158,0.57,HET,225,0.49	SPINK5	3'UTR	SPINK5:NM_001127698.1:3'UTR:MODIFIER:exon34/34:c.*44T>C:,SPINK5:NM_006846.3:3'UTR:MODIFIER:exon33/33:c.*44T>C:		rs4349706	0.491	0.411	0.3841	0.57										0.1439	0.447	0.4091	29	83	n/a	n/a
chr5	147516762	147516762	C	G	het		QUAL=19884;DP=540;AF=0.43;MQM=60;TRIO=HET,540,0.43,HET,295,0.55,HET,421,0.50	SPINK5	3'UTR	SPINK5:NM_001127698.1:3'UTR:MODIFIER:exon34/34:c.*208C>G:,SPINK5:NM_006846.3:3'UTR:MODIFIER:exon33/33:c.*208C>G:		rs3088193	0.491	0	0	0										0.1439	0.447	0.4091	23	64	n/a	n/a
chr5	147516884	147516884	T	C	het		QUAL=6268;DP=250;AF=0.45;MQM=60;TRIO=HET,250,0.45,HET,165,0.54,WT,199,0.00	SPINK5	3'UTR	SPINK5:NM_001127698.1:3'UTR:MODIFIER:exon34/34:c.*330T>C:,SPINK5:NM_006846.3:3'UTR:MODIFIER:exon33/33:c.*330T>C:		rs72660265	0.1743	0	0	0										0.0303	0.1894	0.7803	4	27	n/a	n/a
chr5	147516914	147516914	-	CTC	het		QUAL=4163;DP=207;AF=0.31;MQM=60;TRIO=HET,207,0.31,HET,83,0.39,HET,128,0.48	SPINK5	3'UTR	SPINK5:NM_001127698.1:3'UTR:MODIFIER:exon34/34:c.*361_*363dupCTC:,SPINK5:NM_006846.3:3'UTR:MODIFIER:exon33/33:c.*361_*363dupCTC:		rs397704765	0.491	0	0	0										0.1439	0.447	0.4091	23	64	n/a	n/a
chr5	148361720	148361720	-	T	het		QUAL=8099;DP=94;AF=0.83;MQM=60;TRIO=HET,94,0.83,HOM,93,0.95,HET,129,0.91	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*22553dupA:		rs397725504	0.481	0	0	0										0.3106	0.2803	0.4091	46	39	n/a	n/a
chr5	148364355	148364355	A	G	hom		QUAL=34777;DP=454;AF=1.00;MQM=60;TRIO=HOM,454,1.00,HOM,263,0.99,HOM,331,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*19919T>C:		rs2217638	0.8023	0	0	0										0.6364	0.2879	0.0758	97	42	n/a	n/a
chr5	148364701	148364701	C	T	hom		QUAL=13995;DP=221;AF=1.00;MQM=59;TRIO=HOM,221,1.00,HOM,104,1.00,HOM,143,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*19573G>A:		rs4560536	0.4716	0	0	0										0.3712	0.447	0.1818	55	67	n/a	n/a
chr5	148364709	148364709	-	A	het		QUAL=6727;DP=197;AF=0.65;MQM=59;TRIO=HET,197,0.65,HET,80,0.71,HET,94,0.77	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*19564dupT:		rs398109536	0.6817	0	0	0										0.3864	0.3712	0.2424	60	53	n/a	n/a
chr5	148365234	148365234	T	C	hom		QUAL=27048;DP=441;AF=0.99;MQM=60;TRIO=HOM,441,0.99,HOM,173,1.00,HOM,197,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*19040A>G:	L1ME1	rs930205	0.5092	0	0	0										0.3712	0.447	0.1818	55	67	n/a	n/a
chr5	148365720	148365720	C	A	hom		QUAL=30718;DP=374;AF=1.00;MQM=60;TRIO=HOM,374,1.00,HOM,233,1.00,HOM,313,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*18554G>T:	MIR	rs10040598	0.7973	0	0	0										0.6364	0.2879	0.0758	95	42	n/a	n/a
chr5	148366571	148366571	T	C	hom		QUAL=19449;DP=374;AF=1.00;MQM=60;TRIO=HOM,374,1.00,HOM,93,1.00,HOM,130,0.99	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*17703A>G:		rs4235739	0.6234	0	0	0										0.3939	0.4318	0.1742	59	65	n/a	n/a
chr5	148367324	148367324	A	G	hom		QUAL=22889;DP=412;AF=1.00;MQM=59;TRIO=HOM,412,1.00,HOM,98,1.00,HOM,185,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*16950T>C:		rs10040798	0.7881	0	0	0										0.6364	0.2879	0.0758	95	42	n/a	n/a
chr5	148367643	148367643	C	T	hom		QUAL=20606;DP=327;AF=1.00;MQM=60;TRIO=HOM,327,1.00,HOM,183,1.00,HET,256,0.46	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*16631G>A:		rs4705303	0.4613	0	0	0										0.3333	0.4621	0.2045	50	69	n/a	n/a
chr5	148368254	148368254	T	G	hom		QUAL=19275;DP=255;AF=1.00;MQM=60;TRIO=HOM,255,1.00,HOM,148,0.99,HOM,207,0.99	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*16020A>C:	MLT1F	rs4543254	0.618	0	0	0										0.3939	0.4318	0.1742	60	65	n/a	n/a
chr5	148368451	148368451	A	G	hom		QUAL=26366;DP=484;AF=1.00;MQM=60;TRIO=HOM,484,1.00,HOM,140,1.00,HOM,183,1.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*15823T>C:		rs4562031	0.7981	0	0	0										0.6364	0.2879	0.0758	95	42	n/a	n/a
chr5	148373306	148373306	C	T	het		QUAL=7118;DP=199;AF=0.54;MQM=60;TRIO=HET,199,0.54,HOM,116,1.00,WT,148,0.00	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*10968G>A:		rs13166730	0.0723	0	0	0										0.0303	0.2727	0.697	5	41	n/a	n/a
chr5	148374164	148374167	TGGT	-	hom		QUAL=5202;DP=33;AF=0.91;MQM=60;TRIO=HOM,33,0.91,HOM,98,0.99,HET,144,0.42	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*10107_*10110delACCA:	(TTGG)n	rs72253703	0	0	0	0										0.1742	0.0833	0.7424	25	11	n/a	n/a
chr5	148381138	148381138	C	T	hom		QUAL=25291;DP=500;AF=1.00;MQM=60;TRIO=HOM,500,1.00,HOM,180,1.00,HET,189,0.50	SH3TC2	3'UTR	SH3TC2:NM_024577.3:3'UTR:MODIFIER:exon17/17:c.*3136G>A:		rs1019927	0.9904	0	0	0										0.9394	0.0606	0	140	10	n/a	n/a
chr5	148407708	148407708	A	C	hom		QUAL=19925;DP=206;AF=1.00;MQM=59;TRIO=HOM,206,1.00,HOM,276,1.00,HET,358,0.44	SH3TC2	synonymous	SH3TC2:NM_024577.3:synonymous:LOW:exon11/17:c.1587T>G:p.Arg529Arg		rs1432794	0.9906	0.978	0.9691	0.9946						608206 [SH3TC2 (provisional) Charcot-Marie-Tooth disease,type 4C|Mononeuropathy of the median nerve,mild];	RCV000118336.2 [likely benign]; 			0.9394	0.0606	0	435	18	n/a	n/a
chr5	149360877	149360877	T	C	hom		QUAL=30863;DP=359;AF=1.00;MQM=60;TRIO=HOM,359,1.00,HOM,255,1.00,HOM,324,1.00	SLC26A2	missense	SLC26A2:NM_000112.3:missense:MODERATE:exon3/3:c.1721T>C:p.Ile574Thr		rs30832	0	0.993	0.9908	0.998	1.6390	P	T	B	B	606718 [SLC26A2 (confirmed) Diastrophic dysplasia|Atelosteogenesis II|Achondrogenesis Ib|Epiphyseal dysplasia,multiple,4|Diastrophic dysplasia,broad bone-platyspondylic variant|De la Chapelle dysplasia];		CM016008 [CLASS=DM? MUT=REF PHEN="Diastrophic dysplasia" GENE=SLC26A2]; 		1	0	0	451	3	2	n/a
chr5	149362400	149362400	T	G	het		QUAL=14268;DP=392;AF=0.48;MQM=60;TRIO=HET,392,0.48,WT,193,0.01,HOM,240,1.00	SLC26A2	3'UTR	SLC26A2:NM_000112.3:3'UTR:MODIFIER:exon3/3:c.*1024T>G:		rs8073	0.274	0	0	0										0.0758	0.3485	0.5758	10	54	n/a	n/a
chr5	149364780	149364780	C	T	hom		QUAL=34912;DP=491;AF=1.00;MQM=60;TRIO=HOM,491,1.00,HET,297,0.56,HOM,434,1.00	SLC26A2	3'UTR	SLC26A2:NM_000112.3:3'UTR:MODIFIER:exon3/3:c.*3404C>T:		rs30833	0.992	0	0	0										0.9773	0.0227	0	146	4	n/a	n/a
chr5	149365837	149365837	T	-	het		QUAL=2118;DP=96;AF=0.51;MQM=60;TRIO=HET,96,0.51,WT,21,0.00,HOM,21,1.00	SLC26A2	3'UTR	SLC26A2:NM_000112.3:3'UTR:MODIFIER:exon3/3:c.*4469delT:		rs397883627	0.4681	0	0	0										0.1515	0.4773	0.3712	21	72	n/a	n/a
chr5	149907533	149907533	T	G	hom		QUAL=32416;DP=398;AF=1.00;MQM=60;TRIO=HOM,398,1.00,HET,548,0.52,HET,757,0.47	NDST1	synonymous	NDST1:NM_001543.4:synonymous:LOW:exon3/15:c.681T>G:p.Val227Val,NDST1:NM_001301063.1:synonymous:LOW:exon3/14:c.681T>G:p.Val227Val		rs2273235	0.3658	0.45	0.468	0.2978									COSM4159647	0.1894	0.4924	0.3182	84	216	n/a	n/a
chr5	149907602	149907602	A	G	hom		QUAL=27112;DP=265;AF=0.99;MQM=59;TRIO=HOM,265,0.99,HET,533,0.52,HET,707,0.49	NDST1	synonymous	NDST1:NM_001543.4:synonymous:LOW:exon3/15:c.750A>G:p.Pro250Pro,NDST1:NM_001301063.1:synonymous:LOW:exon3/14:c.750A>G:p.Pro250Pro		rs2273234	0.2995	0.418	0.4657	0.1757										0.1742	0.5076	0.3182	80	220	n/a	n/a
chr5	149919739	149919739	G	C	hom		QUAL=19762;DP=275;AF=0.99;MQM=59;TRIO=HOM,275,0.99,HET,204,0.53,HOM,247,1.00	NDST1	synonymous	NDST1:NM_001543.4:synonymous:LOW:exon8/15:c.1662G>C:p.Thr554Thr,NDST1:NM_001301063.1:synonymous:LOW:exon8/14:c.1662G>C:p.Thr554Thr		rs1290147	0.8069	0.715	0.6547	0.9228										0.4167	0.4848	0.0985	181	211	n/a	n/a
chr5	149933899	149933899	A	T	het		QUAL=202;DP=18;AF=0.50;MQM=60;TRIO=HET,18,0.50,HET,6,0.17,WT,6,0.00	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*1005A>T:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*1005A>T:	(TA)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr5	149935171	149935171	T	C	hom		QUAL=27883;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,375,1.00,HET,497,0.52	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*2277T>C:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*2277T>C:		rs13181064	0.5735	0	0	0										0.6288	0.3258	0.0455	94	50	n/a	n/a
chr5	149935680	149935680	A	G	hom		QUAL=25223;DP=437;AF=0.99;MQM=59;TRIO=HOM,437,0.99,HET,280,0.47,HET,410,0.51	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*2786A>G:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*2786A>G:	MamRep137	rs11542921	0.243	0	0	0										0.1364	0.5152	0.3485	20	76	n/a	n/a
chr5	149937496	149937496	A	-	hom		QUAL=12714;DP=214;AF=0.95;MQM=59;TRIO=HOM,214,0.95,HET,194,0.47,HET,290,0.43	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*4602delA:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*4602delA:		rs36071594	0.2426	0	0	0										0.1364	0.5152	0.3485	20	76	n/a	n/a
chr5	149937739	149937739	G	A	hom		QUAL=14010;DP=219;AF=1.00;MQM=60;TRIO=HOM,219,1.00,HET,213,0.49,HET,255,0.47	NDST1	3'UTR	NDST1:NM_001543.4:3'UTR:MODIFIER:exon15/15:c.*4845G>A:,NDST1:NM_001301063.1:3'UTR:MODIFIER:exon14/14:c.*4845G>A:		rs11994	0.3131	0	0	0										0.1439	0.5076	0.3485	21	75	n/a	n/a
chr5	155754192	155754192	C	G	het		QUAL=14615;DP=211;AF=0.47;MQM=60;TRIO=HET,211,0.47,HOM,231,1.00,HET,286,0.55	SGCD	5'UTR	SGCD:NM_000337.5:5'UTR:MODIFIER:exon1/9:c.-94C>G:,SGCD:NM_172244.2:5'UTR:MODIFIER:exon1/8:c.-94C>G:,SGCD:NM_001128209.1:5'UTR:MODIFIER:exon1/8:c.-51C>G:		rs13170573	0.4605	0	0	0							RCV000041400.2 [benign]; 			0.1894	0.5	0.3106	40	100	n/a	n/a
chr5	155771579	155771579	T	C	het		QUAL=8553;DP=177;AF=0.53;MQM=59;TRIO=HET,177,0.53,HOM,103,1.00,HET,138,0.49	SGCD	synonymous	SGCD:NM_000337.5:synonymous:LOW:exon3/9:c.84T>C:p.Tyr28Tyr,SGCD:NM_172244.2:synonymous:LOW:exon3/8:c.84T>C:p.Tyr28Tyr,SGCD:NM_001128209.1:synonymous:LOW:exon2/8:c.81T>C:p.Tyr27Tyr		rs1801193	0.4854	0.466	0.4316	0.2638						601411 [SGCD (confirmed) Muscular dystrophy,limb-girdle,type 2F|Cardiomyopathy,dilated,1L];	RCV000041413.5 [benign]; RCV000128029.1 [benign]; 		COSM4159671	0.2273	0.4924	0.2803	106	250	n/a	n/a
chr5	156187928	156187928	C	T	het		QUAL=16949;DP=502;AF=0.47;MQM=60;TRIO=HET,502,0.47,HET,253,0.51,HET,319,0.49	SGCD	3'UTR	SGCD:NM_000337.5:3'UTR:MODIFIER:exon9/9:c.*1527C>T:,SGCD:NM_001128209.1:3'UTR:MODIFIER:exon8/8:c.*1527C>T:		rs284445	0.2073	0	0	0										0.1288	0.3485	0.5227	19	51	n/a	n/a
chr5	156193118	156193118	G	A	hom		QUAL=22787;DP=368;AF=1.00;MQM=60;TRIO=HOM,368,1.00,HOM,123,1.00,HOM,194,1.00	SGCD	3'UTR	SGCD:NM_000337.5:3'UTR:MODIFIER:exon9/9:c.*6717G>A:,SGCD:NM_001128209.1:3'UTR:MODIFIER:exon8/8:c.*6717G>A:		rs1827368	0.9271	0	0	0										0.7955	0.197	0.0076	120	28	n/a	n/a
chr5	156680685	156680685	A	G	hom		QUAL=28982;DP=346;AF=0.99;MQM=60;TRIO=HOM,346,0.99,HOM,229,1.00,HOM,323,1.00	ITK	3'UTR	ITK:NM_005546.3:3'UTR:MODIFIER:exon17/17:c.*997A>G:		rs27988	0.8335	0	0	0										0.803	0.1742	0.0227	117	30	n/a	n/a
chr5	158742014	158742014	G	T	hom		QUAL=23638;DP=155;AF=1.00;MQM=60;TRIO=HOM,155,1.00,HOM,272,1.00,HOM,331,1.00	IL12B	3'UTR	IL12B:NM_002187.2:3'UTR:MODIFIER:exon8/8:c.*1095C>A:		rs1368439	0.9203	0	0	0										0.7197	0.2576	0.0227	105	41	n/a	n/a
chr5	161324898	161324898	A	G	hom		QUAL=9520;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,52,1.00,HET,70,0.63	GABRA1	3'UTR	GABRA1:NM_000806.5:3'UTR:MODIFIER:exon11/11:c.*470A>G:,GABRA1:NM_001127643.1:3'UTR:MODIFIER:exon11/11:c.*470A>G:,GABRA1:NM_001127644.1:3'UTR:MODIFIER:exon10/10:c.*470A>G:,GABRA1:NM_001127645.1:3'UTR:MODIFIER:exon10/10:c.*470A>G:,GABRA1:NM_001127648.1:3'UTR:MODIFIER:exon9/9:c.*470A>G:		rs2290732	0.5811	0	0	0										0.3333	0.5	0.1667	49	75	n/a	n/a
chr5	161325934	161325934	A	C	hom		QUAL=16761;DP=288;AF=1.00;MQM=60;TRIO=HOM,288,1.00,HOM,100,1.00,HET,166,0.64	GABRA1	3'UTR	GABRA1:NM_000806.5:3'UTR:MODIFIER:exon11/11:c.*1506A>C:,GABRA1:NM_001127643.1:3'UTR:MODIFIER:exon11/11:c.*1506A>C:,GABRA1:NM_001127644.1:3'UTR:MODIFIER:exon10/10:c.*1506A>C:,GABRA1:NM_001127645.1:3'UTR:MODIFIER:exon10/10:c.*1506A>C:,GABRA1:NM_001127648.1:3'UTR:MODIFIER:exon9/9:c.*1506A>C:		rs998754	0.5805	0	0	0										0.3409	0.4924	0.1667	50	74	n/a	n/a
chr5	161494852	161494852	C	T	het		QUAL=9130;DP=251;AF=0.47;MQM=60;TRIO=HET,251,0.47,WT,274,0.00,HET,377,0.44	GABRG2	5'UTR	GABRG2:NM_198903.2:5'UTR:MODIFIER:exon1/11:c.-154C>T:,GABRG2:NM_000816.3:5'UTR:MODIFIER:exon1/9:c.-154C>T:,GABRG2:NM_198904.2:5'UTR:MODIFIER:exon1/10:c.-154C>T:		rs3219203	0.0361	0	0	0										0	0.1212	0.8788	0	17	n/a	n/a
chr5	161529571	161529571	A	G	hom		QUAL=2379;DP=31;AF=1.00;MQM=60;TRIO=HOM,31,1.00,HOM,20,1.00,HOM,26,1.00	GABRG2	missense,intron	GABRG2:NM_198903.2:missense:MODERATE:exon6/11:c.643A>G:p.Ile215Val,GABRG2:NM_000816.3:intron:MODIFIER:exon5/8:c.631+1248A>G:,GABRG2:NM_198904.2:intron:MODIFIER:exon5/9:c.631+1248A>G:	AluJb	rs211035	0.8213	0.793	0	0		P	T	B	B	137164 [GABRG2 (confirmed) Epilepsy,generalized,with febrile seizures plus,type 3|Epilepsy,childhood absence,susceptibility to,2|Febrile seizures,familial,8];				0.6591	0.2955	0.0455	237	107	n/a	n/a
chr5	172659511	172659511	C	A	hom		QUAL=5625;DP=32;AF=0.97;MQM=60;TRIO=HOM,32,0.97,HOM,112,0.99,HET,96,0.53	NKX2-5	3'UTR	NKX2-5:NM_004387.3:3'UTR:MODIFIER:exon2/2:c.*61G>T:,NKX2-5:NM_001166175.1:3'UTR:MODIFIER:exon2/2:c.*989G>T:,NKX2-5:NM_001166176.1:3'UTR:MODIFIER:exon2/2:c.*835G>T:		rs703752	0.2556	0	0	0										0.1364	0.4242	0.4394	20	66	n/a	n/a
chr5	176636882	176636882	C	T	het		QUAL=6988;DP=211;AF=0.52;MQM=60;TRIO=HET,211,0.52,HOM,108,0.99,WT,119,0.00	NSD1	synonymous	NSD1:NM_022455.4:synonymous:LOW:exon5/23:c.1482C>T:p.Cys494Cys,NSD1:NM_172349.2:synonymous:LOW:exon6/24:c.675C>T:p.Cys225Cys		rs1363405	0.4681	0.3	0.1901	0.6743						606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082100.3 [benign]; 			0.0379	0.2727	0.6894	31	152	n/a	n/a
chr5	176637149	176637149	G	A	het		QUAL=9330;DP=300;AF=0.44;MQM=60;TRIO=HET,300,0.44,HOM,163,0.99,WT,232,0.00	NSD1	synonymous	NSD1:NM_022455.4:synonymous:LOW:exon5/23:c.1749G>A:p.Glu583Glu,NSD1:NM_172349.2:synonymous:LOW:exon6/24:c.942G>A:p.Glu314Glu		rs3733874	0	0.175	0.1133	0.0753						606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082103.3 [benign]; 			0.0227	0.1591	0.8182	14	87	n/a	n/a
chr5	176637240	176637240	G	T	het		QUAL=13852;DP=512;AF=0.44;MQM=60;TRIO=HET,512,0.44,HOM,201,0.99,WT,305,0.00	NSD1	missense	NSD1:NM_022455.4:missense:MODERATE:exon5/23:c.1840G>T:p.Val614Leu,NSD1:NM_172349.2:missense:MODERATE:exon6/24:c.1033G>T:p.Val345Leu		rs3733875	0.2286	0.174	0.1142	0.0704	-0.3010	P		B,B,B	B,B,B	606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082107.3 [benign]; 			0.0227	0.1591	0.8182	14	87	n/a	n/a
chr5	176637576	176637576	T	C	het		QUAL=14133;DP=590;AF=0.47;MQM=60;TRIO=HET,590,0.47,HOM,151,1.00,WT,266,0.00	NSD1	missense	NSD1:NM_022455.4:missense:MODERATE:exon5/23:c.2176T>C:p.Ser726Pro,NSD1:NM_172349.2:missense:MODERATE:exon6/24:c.1369T>C:p.Ser457Pro		rs28932178	0.2496	0.199	0.1385	0.1026	0.3970	P		D,D,D	D,P,P	606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082108.3 [benign]; 			0.0303	0.197	0.7727	20	109	n/a	n/a
chr5	176721198	176721198	T	C	het		QUAL=12527;DP=366;AF=0.51;MQM=59;TRIO=HET,366,0.51,WT,149,0.00,HOM,209,1.00	NSD1	synonymous	NSD1:NM_022455.4:synonymous:LOW:exon23/23:c.6829T>C:p.Leu2277Leu,NSD1:NM_172349.2:synonymous:LOW:exon24/24:c.6022T>C:p.Leu2008Leu		rs28580074	0.7714	0.824	0.8848	0.9267						606681 [NSD1 (confirmed) Sotos syndrome 1|Leukemia,acute myeloid|Beckwith-Wiedemann syndrome];	RCV000082138.3 [other]; RCV000127260.1 [benign]; 		COSM150019	0.8182	0.1591	0.0227	393	88	n/a	n/a
chr5	176726002	176726002	T	C	het		QUAL=14991;DP=452;AF=0.48;MQM=60;TRIO=HET,452,0.48,WT,253,0.00,HOM,245,1.00	NSD1	3'UTR	NSD1:NM_022455.4:3'UTR:MODIFIER:exon23/23:c.*3542T>C:,NSD1:NM_172349.2:3'UTR:MODIFIER:exon24/24:c.*3542T>C:		rs4976682	0.764	0	0	0										0.8182	0.1591	0.0227	124	23	n/a	n/a
chr5	176727059	176727059	C	-	het		QUAL=435;DP=10;AF=0.20;MQM=60;TRIO=HET,10,0.90,WT,7,0.57,HET,24,0.67	NSD1	3'UTR	NSD1:NM_022455.4:3'UTR:MODIFIER:exon23/23:c.*4611delC:,NSD1:NM_172349.2:3'UTR:MODIFIER:exon24/24:c.*4611delC:	GC_rich	rs543827810	0.5549	0	0	0										0.0455	0.2273	0.7273	6	31	n/a	n/a
chr5	176727072	176727072	G	C	het		QUAL=435;DP=10;AF=0.20;MQM=57;TRIO=HET,10,0.90,HET,7,0.57,HET,24,0.67	NSD1	3'UTR	NSD1:NM_022455.4:3'UTR:MODIFIER:exon23/23:c.*4612G>C:,NSD1:NM_172349.2:3'UTR:MODIFIER:exon24/24:c.*4612G>C:	GC_rich		0	0	0	0										0	0.0758	0.9242	0	10	n/a	n/a
chr5	177031348	177031348	T	C	het		QUAL=4967;DP=45;AF=0.40;MQM=59;TRIO=HET,45,0.40,HOM,113,0.99,HET,106,0.41	B4GALT7	synonymous	B4GALT7:NM_007255.2:synonymous:LOW:exon2/6:c.219T>C:p.Arg73Arg		rs11537644	0.6613	0.649	0.6218	0.6539						604327 [B4GALT7 (confirmed) Ehlers-Danlos syndrome,progeroid type,1];			COSM3761139	0.3485	0.4924	0.1591	164	213	n/a	n/a
chr5	177035964	177035964	T	C	het		QUAL=13786;DP=181;AF=0.50;MQM=59;TRIO=HET,181,0.50,HOM,213,1.00,HET,261,0.52	B4GALT7	synonymous	B4GALT7:NM_007255.2:synonymous:LOW:exon5/6:c.777T>C:p.His259His		rs729459	0.605	0.59	0.554	0.6155						604327 [B4GALT7 (confirmed) Ehlers-Danlos syndrome,progeroid type,1];			COSM3761140	0.2424	0.5152	0.2424	146	204	n/a	n/a
chr5	177422876	177422876	T	C	hom		QUAL=17113;DP=163;AF=1.00;MQM=59;TRIO=HOM,163,1.00,HOM,176,1.00,HOM,246,1.00	PROP1	missense	PROP1:NM_006261.4:missense:MODERATE:exon1/3:c.59A>G:p.Asn20Ser		rs7445271	0.9994	1	1	0.9991	-0.4890	P	T	B	B	601538 [PROP1 (provisional) Pituitary hormone deficiency,combined,2];				1	0	0	454	0	n/a	n/a
chr5	177422908	177422908	A	G	hom		QUAL=16313;DP=135;AF=0.99;MQM=60;TRIO=HOM,135,0.99,HET,230,0.48,HOM,301,1.00	PROP1	synonymous	PROP1:NM_006261.4:synonymous:LOW:exon1/3:c.27T>C:p.Ala9Ala		rs1135320	0.4477	0.476	0.4477	0.2864						601538 [PROP1 (provisional) Pituitary hormone deficiency,combined,2];			COSM4159781	0.303	0.4394	0.2576	115	205	n/a	n/a
chr5	177423144	177423144	T	G	hom		QUAL=32997;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HET,402,0.46,HOM,528,1.00	PROP1	5'UTR	PROP1:NM_006261.4:5'UTR:MODIFIER:exon1/3:c.-210A>C:		rs13187293	0.3303	0	0	0										0.1894	0.4091	0.4015	28	61	n/a	n/a
chr6	3224825	3224825	A	-	hom		QUAL=40653;DP=355;AF=0.99;MQM=60;TRIO=HOM,355,0.99,HOM,411,0.99,HOM,533,0.98	TUBB2B	3'UTR	TUBB2B:NM_178012.4:3'UTR:MODIFIER:exon4/4:c.*160delT:		rs398000197	0	0	0	0										0.8485	0.1515	0	129	21	n/a	n/a
chr6	7542148	7542148	-	A	het		QUAL=2192;DP=57;AF=0.49;MQM=59;TRIO=HET,57,0.49,HET,114,0.42,WT,121,0.01	DSP	frameshift&start_lost	DSP:NM_004415.2:frameshift&start_lost:HIGH:exon1/24:c.1dupA:p.Met1fs,DSP:NM_001008844.1:frameshift&start_lost:HIGH:exon1/24:c.1dupA:p.Met1fs		rs606231377	0.1997	0.158	0.1456	0.207							RCV000029674.1 [likely benign]; RCV000037982.2 [benign]; 			0.0152	0.2727	0.7121	19	121	2	n/a
chr6	7542274	7542274	T	C	het		QUAL=1321;DP=17;AF=0.24;MQM=60;TRIO=HET,17,0.24,WT,60,0.00,HET,71,0.61	DSP	synonymous	DSP:NM_004415.2:synonymous:LOW:exon1/24:c.126T>C:p.Tyr42Tyr,DSP:NM_001008844.1:synonymous:LOW:exon1/24:c.126T>C:p.Tyr42Tyr		rs36087964	0.0609	0.045	0.0524	0.0945						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic];	RCV000037988.2 [benign]; 		COSM451787	0	0.1061	0.8939	6	57	n/a	n/a
chr6	7563983	7563983	T	G	hom		QUAL=32445;DP=448;AF=1.00;MQM=60;TRIO=HOM,448,1.00,HOM,230,1.00,HOM,314,1.00	DSP	synonymous	DSP:NM_004415.2:synonymous:LOW:exon6/24:c.741T>G:p.Ala247Ala,DSP:NM_001008844.1:synonymous:LOW:exon6/24:c.741T>G:p.Ala247Ala		rs2806234	1	0.999	0.9981	0.9993						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic];	RCV000154388.1,RCV000038087.1 [likely benign,likely benign]; RCV000124814.1,RCV000038088.2 [benign,likely benign]; 			1	0	0	506	0	n/a	n/a
chr6	7565727	7565727	A	T	het		QUAL=9041;DP=220;AF=0.49;MQM=60;TRIO=HET,220,0.49,WT,276,0.00,HET,397,0.48	DSP	missense	DSP:NM_004415.2:missense:MODERATE:exon7/24:c.913A>T:p.Ile305Phe,DSP:NM_001008844.1:missense:MODERATE:exon7/24:c.913A>T:p.Ile305Phe		rs17604693	0.0184	0.03	0.0419	0.0059	9.2100	D	D	D,D	P,P	125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic];	RCV000029686.1 [likely benign]; RCV000038119.2 [benign]; RCV000143884.1 [uncertain significance]; 		COSM1685467	0	0.0909	0.9091	1	42	n/a	n/a
chr6	7572262	7572262	A	G	hom		QUAL=14072;DP=196;AF=1.00;MQM=60;TRIO=HOM,196,1.00,HOM,98,1.00,HOM,146,1.00	DSP	synonymous	DSP:NM_004415.2:synonymous:LOW:exon15/24:c.2091A>G:p.Gly697Gly,DSP:NM_001008844.1:synonymous:LOW:exon15/24:c.2091A>G:p.Gly697Gly		rs2076304	0.7744	0.761	0.7795	0.7982						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic];	RCV000154389.1,RCV000038004.2 [benign,benign]; 			0.6364	0.3409	0.0227	308	183	n/a	n/a
chr6	7576527	7576527	G	A	hom		QUAL=10060;DP=177;AF=1.00;MQM=60;TRIO=HOM,177,1.00,HOM,55,1.00,HOM,86,1.00	DSP	splice_region&synonymous	DSP:NM_004415.2:splice_region&synonymous:LOW:exon19/24:c.2631G>A:p.Arg877Arg,DSP:NM_001008844.1:splice_region&synonymous:LOW:exon19/24:c.2631G>A:p.Arg877Arg		rs1016835	0.7354	0.771	0.8024	0.6421						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic];	RCV000154390.1,RCV000038011.2 [benign,benign]; 			0.6894	0.2727	0.0379	343	144	n/a	n/a
chr6	7584617	7584617	C	T	hom		QUAL=23272;DP=425;AF=1.00;MQM=59;TRIO=HOM,425,1.00,HET,161,0.51,HOM,220,0.99	DSP	synonymous	DSP:NM_004415.2:synonymous:LOW:exon24/24:c.7122C>T:p.Thr2374Thr,DSP:NM_001008844.1:synonymous:LOW:exon24/24:c.5325C>T:p.Thr1775Thr		rs2076300	0.2117	0.288	0.369	0.172						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic];	RCV000038083.2 [benign]; 		COSM150043	0.197	0.4773	0.3258	87	224	n/a	n/a
chr6	7585967	7585967	G	C	hom		QUAL=18298;DP=246;AF=1.00;MQM=60;TRIO=HOM,246,1.00,HET,176,0.49,HOM,256,0.99	DSP	synonymous	DSP:NM_004415.2:synonymous:LOW:exon24/24:c.8472G>C:p.Gly2824Gly,DSP:NM_001008844.1:synonymous:LOW:exon24/24:c.6675G>C:p.Gly2225Gly		rs2744380	0.7095	0	0.7173	0.631						125647 [DSP (confirmed) Keratosis palmoplantaris striata II|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|Skin fragility-woolly hair syndrome|Epidermolysis bullosa,lethal acantholytic];	RCV000154391.1,RCV000038104.2 [benign,benign]; 			0.5606	0.3409	0.0985	266	184	n/a	n/a
chr6	16327615	16327615	A	G	het		QUAL=5674;DP=100;AF=0.44;MQM=59;TRIO=HET,100,0.44,HET,145,0.40,HET,184,0.45	ATXN1	synonymous	ATXN1:NM_000332.3:synonymous:LOW:exon8/9:c.927T>C:p.Ala309Ala,ATXN1:NM_001128164.1:synonymous:LOW:exon7/8:c.927T>C:p.Ala309Ala		rs179990	0.7802	0.732	0.6651	0.7896						601556 [ATXN1 (confirmed) Spinocerebellar ataxia 1];	RCV000116476.2,RCV000116475.2 [likely benign,likely benign]; 		COSM3761638	0.4091	0.5	0.0909	192	203	n/a	n/a
chr6	18122506	18122506	G	A	het		QUAL=2382;DP=43;AF=0.49;MQM=59;TRIO=HET,43,0.49,WT,90,0.00,HET,106,0.62	NHLRC1	missense	NHLRC1:NM_198586.2:missense:MODERATE:exon1/1:c.332C>T:p.Pro111Leu		rs10949483	0.3429	0.386	0.385	0.2431	1.4920	P	T	B	B	608072 [NHLRC1 (confirmed) Epilepsy,progressive myoclonic 2B (Lafora)];	RCV000117782.2 [benign]; RCV000127205.1 [benign]; 	CM065338 [CLASS=DM? MUT=ALT PHEN="Myoclonic epilepsy of Lafora" GENE=NHLRC1]; 	COSM3749962	0.1212	0.5152	0.3636	157	574	2	n/a
chr6	24532392	24532392	T	C	het		QUAL=7330;DP=266;AF=0.46;MQM=60;TRIO=HET,266,0.46,HET,197,0.53,WT,303,0.00	ALDH5A1	synonymous	ALDH5A1:NM_170740.1:synonymous:LOW:exon10/11:c.1428T>C:p.Asp476Asp,ALDH5A1:NM_001080.3:synonymous:LOW:exon9/10:c.1389T>C:p.Asp463Asp		rs58747567	0.0026	0.0062	0.0131	0.0018						610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency];				0	0.0076	0.9924	0	7	n/a	n/a
chr6	24532412	24532412	G	A	het		QUAL=5783;DP=200;AF=0.43;MQM=60;TRIO=HET,200,0.43,HET,191,0.52,WT,286,0.00	ALDH5A1	splice_region&intron	ALDH5A1:NM_170740.1:splice_region&intron:LOW:exon10/10:c.1441+7G>A:,ALDH5A1:NM_001080.3:splice_region&intron:LOW:exon9/9:c.1402+7G>A:		rs12211574	0.0507	0.081	0.104	0.0277						610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency];				0.0076	0.1364	0.8561	4	61	n/a	n/a
chr6	24535179	24535179	T	G	het		QUAL=10290;DP=382;AF=0.48;MQM=60;TRIO=HET,382,0.48,HET,229,0.60,WT,261,0.00	ALDH5A1	3'UTR	ALDH5A1:NM_170740.1:3'UTR:MODIFIER:exon11/11:c.*1239T>G:,ALDH5A1:NM_001080.3:3'UTR:MODIFIER:exon10/10:c.*1239T>G:		rs191960134	0.0026	0	0	0										0	0.0076	0.9924	0	2	n/a	n/a
chr6	24535817	24535817	A	G	het		QUAL=4008;DP=211;AF=0.40;MQM=56;TRIO=HET,211,0.40,HET,117,0.37,WT,140,0.01	ALDH5A1	3'UTR	ALDH5A1:NM_170740.1:3'UTR:MODIFIER:exon11/11:c.*1877A>G:,ALDH5A1:NM_001080.3:3'UTR:MODIFIER:exon10/10:c.*1877A>G:	AluY	rs41271787	0.0026	0	0	0										0	0.0076	0.9924	0	2	n/a	n/a
chr6	26027135	26027135	G	A	het		QUAL=3713;DP=138;AF=0.47;MQM=60;TRIO=HET,138,0.47,HET,120,0.53,WT,164,0.01	HIST1H4B	3'UTR	HIST1H4B:NM_003544.2:3'UTR:MODIFIER:exon1/1:c.*34C>T:		rs3752420	0.3918	0.395	0.4036	0.1916										0.1667	0.4697	0.3636	27	69	n/a	n/a
chr6	26027433	26027433	G	A	het		QUAL=4871;DP=167;AF=0.46;MQM=60;TRIO=HET,167,0.46,HET,193,0.49,WT,229,0.00	HIST1H4B	synonymous	HIST1H4B:NM_003544.2:synonymous:LOW:exon1/1:c.48C>T:p.Ala16Ala		rs3752419	0.3944	0.404	0.4051	0.1922									COSM4160437	0.1667	0.4697	0.3636	47	129	n/a	n/a
chr6	35423662	35423662	A	C	het		QUAL=3047;DP=62;AF=0.53;MQM=60;TRIO=HET,62,0.53,HET,72,0.44,HET,69,0.54	FANCE	synonymous	FANCE:NM_021922.2:synonymous:LOW:exon2/10:c.387A>C:p.Pro129Pro		rs4713867	0.778	0.721	0.6717	0.8604						613976 [FANCE (provisional) Fanconi anemia,complementation group E];				0.3636	0.4924	0.1439	447	431	n/a	n/a
chr6	42931628	42931631	TTTA	-	het		QUAL=517;DP=7;AF=0.29;MQM=60;TRIO=HET,7,0.29,WT,16,0.00,HOM,18,1.00	PEX6	3'UTR	PEX6:NM_000287.3:3'UTR:MODIFIER:exon17/17:c.*442_*445delTAAA:		rs398001342	0.6474	0	0	0										0.3333	0.2348	0.4318	52	33	n/a	n/a
chr6	42932200	42932200	G	T	het		QUAL=2972;DP=96;AF=0.46;MQM=60;TRIO=HET,96,0.46,WT,68,0.00,HET,71,0.97	PEX6	missense	PEX6:NM_000287.3:missense:MODERATE:exon17/17:c.2816C>A:p.Pro939Gln		rs1129187	0.3315	0.39	0.4456	0.3904	0.2320	P	T	B	B	601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder 4B];	RCV000078574.2 [benign]; 		COSM1444600	0.197	0.4621	0.3409	91	215	n/a	n/a
chr6	42932202	42932202	C	T	het		QUAL=2972;DP=96;AF=0.46;MQM=60;TRIO=HET,96,0.46,WT,68,0.00,HOM,71,0.97	PEX6	synonymous	PEX6:NM_000287.3:synonymous:LOW:exon17/17:c.2814G>A:p.Glu938Glu		rs1129186	0.4936	0.49	0.5291	0.7313						601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder 4B];	RCV000078573.2 [benign]; 		COSM1444601	0.3485	0.4091	0.2424	134	212	n/a	n/a
chr6	42942779	42942779	A	G	het		QUAL=8674;DP=185;AF=0.50;MQM=60;TRIO=HET,185,0.50,WT,241,0.00,HET,339,0.54	PEX6	splice_region&intron	PEX6:NM_000287.3:splice_region&intron:LOW:exon1/16:c.883-3T>C:		rs9986447	0.2897	0.377	0.4467	0.2399						601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder 4B];	RCV000078578.2 [benign]; 			0.197	0.4697	0.3333	92	211	n/a	n/a
chr6	42946490	42946490	C	A	het		QUAL=2105;DP=61;AF=0.46;MQM=59;TRIO=HET,61,0.46,WT,67,0.01,HET,88,0.57	PEX6	synonymous	PEX6:NM_000287.3:synonymous:LOW:exon1/17:c.399G>T:p.Val133Val		rs9462858	0.3319	0.285	0.3987	0.3251						601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder 4B];	RCV000078576.2 [benign]; 		COSM3749975	0.197	0.4697	0.3333	92	193	n/a	n/a
chr6	42946943	42946943	G	A	het		QUAL=7495;DP=207;AF=0.41;MQM=60;TRIO=HET,207,0.41,WT,221,0.00,HET,342,0.48	PEX6	5'UTR	PEX6:NM_000287.3:5'UTR:MODIFIER:exon1/17:c.-55C>T:		rs9462859	0.3339	0	0	0										0.197	0.4697	0.3333	29	71	n/a	n/a
chr6	43583386	43583386	A	-	het		QUAL=218;DP=100;AF=0.13;MQM=60;TRIO=HET,100,0.13,HET,15,0.20,WT,22,0.00	POLH	3'UTR	POLH:NM_006502.2:3'UTR:MODIFIER:exon11/11:c.*1103delA:,POLH:NM_001291969.1:3'UTR:MODIFIER:exon9/9:c.*1103delA:,POLH:NM_001291970.1:3'UTR:MODIFIER:exon11/11:c.*1929delA:			0	0	0	0										0	0.1136	0.8864	0	17	n/a	n/a
chr6	43584323	43584323	-	A	het		QUAL=3550;DP=168;AF=0.30;MQM=59;TRIO=HET,168,0.30,HET,104,0.09,HET,134,0.52	POLH	3'UTR	POLH:NM_006502.2:3'UTR:MODIFIER:exon11/11:c.*2043dupA:,POLH:NM_001291969.1:3'UTR:MODIFIER:exon9/9:c.*2043dupA:,POLH:NM_001291970.1:3'UTR:MODIFIER:exon11/11:c.*2869dupA:	AluSg4	rs368089629	0.1971	0	0	0										0.0152	0.1591	0.8258	2	22	n/a	n/a
chr6	49398861	49398861	T	C	hom		QUAL=16454;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,174,0.99,HET,192,0.51	MUT	3'UTR	MUT:NM_000255.3:3'UTR:MODIFIER:exon13/13:c.*580A>G:		rs11757098	0.1136	0	0	0										0.0455	0.3182	0.6364	6	50	n/a	n/a
chr6	49399315	49399315	T	C	het		QUAL=4336;DP=211;AF=0.47;MQM=60;TRIO=HET,211,0.47,HET,86,0.40,WT,104,0.00	MUT	3'UTR	MUT:NM_000255.3:3'UTR:MODIFIER:exon13/13:c.*126A>G:		rs192605776	0.0014	0	0	0										0	0.0076	0.9924	0	2	n/a	n/a
chr6	49403282	49403282	T	C	hom		QUAL=18724;DP=306;AF=1.00;MQM=60;TRIO=HOM,306,1.00,HOM,172,1.00,HET,232,0.44	MUT	missense	MUT:NM_000255.3:missense:MODERATE:exon12/13:c.2011A>G:p.Ile671Val		rs8589	0.5495	0.574	0.6167	0.5878	3.8290	P	T	B	B	609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type];	RCV000078444.2 [benign]; 		COSM4004063	0.4545	0.4394	0.1061	175	207	n/a	n/a
chr6	49425521	49425521	C	T	hom		QUAL=29552;DP=565;AF=0.99;MQM=60;TRIO=HOM,565,0.99,HOM,229,1.00,HET,323,0.46	MUT	synonymous	MUT:NM_000255.3:synonymous:LOW:exon3/13:c.636G>A:p.Lys212Lys		rs2229384	0.5515	0.573	0.6164	0.5726						609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type];	RCV000078447.2 [benign]; RCV000126887.1 [benign]; 			0.4545	0.4394	0.1061	174	207	n/a	n/a
chr6	51480486	51480486	G	T	hom		QUAL=16418;DP=204;AF=1.00;MQM=60;TRIO=HOM,204,1.00,HET,172,0.55,HOM,212,1.00	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*3393C>A:		rs2784198	0.6867	0	0	0										0.3712	0.4773	0.1515	53	68	n/a	n/a
chr6	51480853	51480853	T	C	hom		QUAL=10243;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HET,55,0.47,HOM,90,0.98	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*3026A>G:		rs2784199	0.7548	0	0	0										0.4167	0.4545	0.1288	61	64	n/a	n/a
chr6	51481315	51481315	T	C	hom		QUAL=16064;DP=291;AF=1.00;MQM=59;TRIO=HOM,291,1.00,HET,122,0.52,HOM,151,1.00	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*2564A>G:		rs1414504	0.8834	0	0	0										0.7576	0.2121	0.0303	111	33	n/a	n/a
chr6	51481325	51481325	-	T	het		QUAL=1740;DP=140;AF=0.23;MQM=60;TRIO=HET,140,0.23,HET,103,0.06,HET,115,0.28	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*2553dupA:		rs113144792	0	0	0	0										0.0076	0.0985	0.8939	1	14	n/a	n/a
chr6	51481671	51481671	T	C	het		QUAL=7723;DP=345;AF=0.48;MQM=60;TRIO=HET,345,0.48,WT,104,0.00,HET,151,0.47	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*2208A>G:	L2	rs2784200	0.1316	0	0	0										0.0152	0.1818	0.803	3	28	n/a	n/a
chr6	51483505	51483505	A	G	hom		QUAL=63717;DP=853;AF=1.00;MQM=60;TRIO=HOM,853,1.00,HOM,467,1.00,HOM,584,1.00	PKHD1	3'UTR	PKHD1:NM_138694.3:3'UTR:MODIFIER:exon67/67:c.*374T>C:		rs2784201	0.9968	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr6	51483961	51483961	T	C	het		QUAL=13571;DP=418;AF=0.50;MQM=60;TRIO=HET,418,0.50,HET,167,0.54,HET,235,0.50	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon67/67:c.12143A>G:p.Gln4048Arg		rs9381994	0.5657	0.563	0.5487	0.4812	0.4300	P	T	B	B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082526.2 [benign]; 		COSM1445058	0.2652	0.5152	0.2197	133	235	n/a	n/a
chr6	51491884	51491884	T	C	het		QUAL=9111;DP=217;AF=0.46;MQM=60;TRIO=HET,217,0.46,HET,171,0.54,HET,212,0.45	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon66/67:c.11696A>G:p.Gln3899Arg		rs4715227	0.5533	0.555	0.5453	0.4812	1.9650	P	D	B	B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082522.2 [benign]; 		COSM4004068	0.25	0.5227	0.2273	126	241	n/a	n/a
chr6	51586771	51586771	G	A	hom		QUAL=18188;DP=303;AF=0.47;MQM=60;TRIO=HOM,303,0.99,HET,215,0.53,HET,295,0.51	PKHD1	3'UTR,intron	PKHD1:NM_170724.2:3'UTR:MODIFIER:exon61/61:c.*13C>T:,PKHD1:NM_138694.3:intron:MODIFIER:exon60/66:c.10156+22412C>T:		rs9349593	0.766	0.65	0.5338	0.773						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];				0.3182	0.4621	0.2197	60	107	n/a	n/a
chr6	51586772	51586772	C	T	het		QUAL=18188;DP=303;AF=0.47;MQM=59;TRIO=HET,303,0.99,HET,215,0.53,WT,295,0.51	PKHD1	3'UTR,intron	PKHD1:NM_170724.2:3'UTR:MODIFIER:exon61/61:c.*12G>A:,PKHD1:NM_138694.3:intron:MODIFIER:exon60/66:c.10156+22411G>A:		rs45451196	0.2194	0.169	0.1502	0.3677						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];			COSN167788	0.0227	0.25	0.7273	3	52	n/a	n/a
chr6	51613177	51613177	C	T	het		QUAL=9291;DP=217;AF=0.53;MQM=59;TRIO=HET,217,0.53,WT,260,0.00,HET,329,0.53	PKHD1	synonymous	PKHD1:NM_138694.3:synonymous:LOW:exon58/67:c.9237G>A:p.Ala3079Ala,PKHD1:NM_170724.2:synonymous:LOW:exon58/61:c.9237G>A:p.Ala3079Ala		rs765525	0.386	0.404	0.3619	0.1026						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082591.2 [benign]; 			0.1439	0.4167	0.4394	62	218	n/a	n/a
chr6	51732807	51732807	C	T	hom		QUAL=20983;DP=258;AF=1.00;MQM=60;TRIO=HOM,258,1.00,HOM,157,1.00,HOM,224,1.00	PKHD1	synonymous	PKHD1:NM_138694.3:synonymous:LOW:exon48/67:c.7587G>A:p.Gly2529Gly,PKHD1:NM_170724.2:synonymous:LOW:exon48/61:c.7587G>A:p.Gly2529Gly		rs12210295	0.3676	0.506	0.6315	0.3479						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082571.2 [benign]; 		COSM1179827	0.4167	0.4167	0.1667	179	234	n/a	n/a
chr6	51875250	51875250	A	C	hom		QUAL=24030;DP=188;AF=1.00;MQM=60;TRIO=HOM,188,1.00,HOM,229,1.00,HOM,333,1.00	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon35/67:c.5608T>G:p.Leu1870Val,PKHD1:NM_170724.2:missense:MODERATE:exon35/61:c.5608T>G:p.Leu1870Val		rs2435322	0.9559	0.987	0.9991	0.8656	5.0500	P	T	B,B	B,B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082560.2 [benign]; 			0.9848	0.0152	0	470	3	n/a	n/a
chr6	51890823	51890823	G	A	hom		QUAL=16401;DP=227;AF=1.00;MQM=60;TRIO=HOM,227,1.00,HET,154,0.55,HOM,225,0.99	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon32/67:c.3785C>T:p.Ala1262Val,PKHD1:NM_170724.2:missense:MODERATE:exon32/61:c.3785C>T:p.Ala1262Val		rs9296669	0.3546	0.468	0.5166	0.1498	0.2650	P	T	B,B	B,B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082549.2 [benign]; 		COSM4004072	0.25	0.4621	0.2879	119	229	n/a	n/a
chr6	51890852	51890852	C	G	het		QUAL=7763;DP=202;AF=0.51;MQM=60;TRIO=HET,202,0.51,WT,172,0.00,HET,283,0.51	PKHD1	synonymous	PKHD1:NM_138694.3:synonymous:LOW:exon32/67:c.3756G>C:p.Leu1252Leu,PKHD1:NM_170724.2:synonymous:LOW:exon32/61:c.3756G>C:p.Leu1252Leu		rs9689306	0.0186	0.038	0.0592	0.0132						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000153717.1 [benign]; 		COSM3762127	0	0.0227	0.9773	1	31	n/a	n/a
chr6	51893107	51893107	T	C	het		QUAL=6791;DP=281;AF=0.49;MQM=60;TRIO=HET,281,0.49,HET,152,0.53,WT,187,0.00	PKHD1	missense	PKHD1:NM_138694.3:missense:MODERATE:exon30/67:c.3407A>G:p.Tyr1136Cys,PKHD1:NM_170724.2:missense:MODERATE:exon30/61:c.3407A>G:p.Tyr1136Cys		rs41273726	0.0026	0.0079	0.0102	0.0007	-0.0620	N	T	D,D	P,P	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000153718.1 [benign]; 	CM051142 [CLASS=DM? MUT=ALT PHEN="Polycystic kidney disease" GENE=PKHD1]; 		0	0.0303	0.9697	0	14	n/a	n/a
chr6	51914956	51914956	G	A	hom		QUAL=5253;DP=93;AF=1.00;MQM=60;TRIO=HOM,93,1.00,HET,51,0.43,HOM,58,1.00	PKHD1	missense&splice_region	PKHD1:NM_138694.3:missense&splice_region:MODERATE:exon22/67:c.2278C>T:p.Arg760Cys,PKHD1:NM_170724.2:missense&splice_region:MODERATE:exon22/61:c.2278C>T:p.Arg760Cys		rs9370096	0.3558	0.465	0.5102	0.1514	-0.4870	P	T	B,B	B,B	606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082536.2 [benign]; 			0.25	0.4697	0.2803	118	230	n/a	n/a
chr6	51924774	51924774	A	G	hom		QUAL=25571;DP=324;AF=1.00;MQM=60;TRIO=HOM,324,1.00,HOM,188,1.00,HOM,269,1.00	PKHD1	synonymous	PKHD1:NM_138694.3:synonymous:LOW:exon15/67:c.1185T>C:p.Asp395Asp,PKHD1:NM_170724.2:synonymous:LOW:exon15/61:c.1185T>C:p.Asp395Asp		rs1896976	0.9583	0.988	0.9991	0.8813						606702 [PKHD1 (confirmed) Polycystic kidney and hepatic disease];	RCV000082524.2 [benign]; 			0.9697	0.0303	0	469	4	n/a	n/a
chr6	52357260	52357260	C	A	hom		QUAL=14670;DP=199;AF=1.00;MQM=60;TRIO=HOM,199,1.00,HOM,127,1.00,HOM,137,1.00	EFHC1	3'UTR	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*121C>A:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*121C>A:		rs7757370	0.9	0.862	0	0						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				0.7348	0.2121	0.053	216	64	n/a	n/a
chr6	52358010	52358010	C	G	het		QUAL=6204;DP=138;AF=0.45;MQM=60;TRIO=HET,138,0.45,HOM,136,1.00,WT,168,0.00	EFHC1	3'UTR	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*871C>G:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*871C>G:	MLT2B4	rs78956562	0.1721	0.144	0	0						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				0.0379	0.25	0.7121	8	73	n/a	n/a
chr6	52358020	52358020	A	T	hom		QUAL=13153;DP=127;AF=1.00;MQM=60;TRIO=HOM,127,1.00,HOM,136,1.00,HOM,157,1.00	EFHC1	3'UTR	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*881A>T:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*881A>T:	MLT2B4	rs6926242	0.9331	0.885	0	0						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				0.75	0.197	0.053	219	62	n/a	n/a
chr6	52358319	52358319	G	A	hom		QUAL=5753;DP=98;AF=1.00;MQM=59;TRIO=HOM,98,1.00,HOM,46,1.00,HOM,49,1.00	EFHC1	3'UTR	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*1180G>A:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*1180G>A:	AluSx	rs4455668	0.9	0.879	0	0						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				0.7348	0.2121	0.053	214	65	n/a	n/a
chr6	52358453	52358453	-	A	het		QUAL=5112;DP=209;AF=0.39;MQM=59;TRIO=HET,209,0.39,HET,114,0.82,WT,168,0.01	EFHC1	3'UTR	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*1325dupA:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*1325dupA:	AluSx	rs539728759	0.2278	0	0	0						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				0.0379	0.1742	0.7879	6	38	n/a	n/a
chr6	52358887	52358887	-	CA	het		QUAL=16021;DP=268;AF=0.86;MQM=60;TRIO=HET,268,0.86,HOM,154,0.95,HET,200,0.92	EFHC1	3'UTR	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*1749_*1750insAC:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*1749_*1750insAC:		rs77236493	0.8996	0.879	0	0						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				0.6515	0.2955	0.053	190	89	n/a	n/a
chr6	52360283	52360283	T	A	hom		QUAL=21618;DP=317;AF=1.00;MQM=60;TRIO=HOM,317,1.00,HOM,214,1.00,HET,283,0.47	EFHC1	3'UTR	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*3144T>A:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*3144T>A:	LTR78	rs3789772	0.6991	0.621	0	0						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				0.4697	0.3939	0.1364	143	110	n/a	n/a
chr6	52360545	52360545	T	C	het		QUAL=12437;DP=429;AF=0.49;MQM=59;TRIO=HET,429,0.49,WT,257,0.00,HET,363,0.47	EFHC1	3'UTR	EFHC1:NM_018100.3:3'UTR:MODIFIER:exon11/11:c.*3406T>C:,EFHC1:NM_001172420.1:3'UTR:MODIFIER:exon12/12:c.*3406T>C:		rs6919266	0.2794	0.231	0	0						608815 [EFHC1 (confirmed) Myoclonic epilepsy,juvenile,susceptibility to,1|Epilepsy,juvenile absence,susceptibility to,1];				0.25	0.3333	0.4167	62	120	n/a	n/a
chr6	81053642	81053642	G	A	hom		QUAL=28900;DP=446;AF=1.00;MQM=60;TRIO=HOM,446,1.00,HOM,276,1.00,HET,341,0.47	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*121G>A:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+113G>A:		rs926733	0.7151	0	0	0										0.7121	0.2348	0.053	108	35	n/a	n/a
chr6	81053717	81053719	TTG	-	hom		QUAL=8470;DP=185;AF=1.00;MQM=59;TRIO=HOM,185,1.00,HOM,71,1.00,HET,88,0.40	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*210_*212delGTT:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+202_*8+204delGTT:	AluSx1	rs146478934	0	0	0	0										0.7121	0.2348	0.053	107	36	n/a	n/a
chr6	81053814	81053814	T	C	hom		QUAL=5012;DP=89;AF=1.00;MQM=57;TRIO=HOM,89,1.00,HOM,52,1.00,HET,56,0.41	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*293T>C:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+285T>C:	AluSx1	rs926732	0.7155	0	0	0										0.7121	0.2348	0.053	107	36	n/a	n/a
chr6	81053825	81053825	G	A	hom		QUAL=4533;DP=74;AF=1.00;MQM=55;TRIO=HOM,74,1.00,HOM,50,1.00,HET,50,0.46	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*304G>A:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+296G>A:	AluSx1	rs926731	0.7159	0	0	0										0.7121	0.2348	0.053	107	36	n/a	n/a
chr6	81053866	81053866	C	T	hom		QUAL=5432;DP=138;AF=0.99;MQM=55;TRIO=HOM,138,0.99,HOM,34,1.00,HET,29,0.38	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*345C>T:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+337C>T:	AluSx1	rs1811844	0.5899	0	0	0										0.7045	0.2424	0.053	106	37	n/a	n/a
chr6	81053916	81053916	G	T	hom		QUAL=4827;DP=144;AF=1.00;MQM=59;TRIO=HOM,144,1.00,HOM,12,1.00,HET,15,0.33	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*395G>T:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+387G>T:	AluSx1	rs4706116	0.9585	0	0	0										0.8788	0.1136	0.0076	132	17	n/a	n/a
chr6	81054066	81054067	TT	-	het		QUAL=191;DP=9;AF=0.78;MQM=58;TRIO=HET,9,0.78,NONE,0,0,HOM,2,1.00	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*559_*560delTT:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+551_*8+552delTT:	AluSc	rs71649498	0.893	0	0	0										0.4091	0.0833	0.5076	64	15	n/a	n/a
chr6	81054148	81054148	T	C	hom		QUAL=2419;DP=69;AF=1.00;MQM=57;TRIO=HOM,69,1.00,HOM,5,1.00,HET,19,0.53	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*627T>C:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+619T>C:	AluSc	rs4706838	0.7153	0	0	0										0.697	0.2424	0.0606	106	36	n/a	n/a
chr6	81054252	81054252	C	T	hom		QUAL=5212;DP=90;AF=1.00;MQM=51;TRIO=HOM,90,1.00,HOM,57,1.00,HET,66,0.44	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*731C>T:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+723C>T:	AluSc	rs4706117	0.3998	0	0	0										0.2803	0.4924	0.2273	40	72	n/a	n/a
chr6	81054310	81054310	C	T	hom		QUAL=8391;DP=122;AF=1.00;MQM=57;TRIO=HOM,122,1.00,HOM,95,1.00,HET,137,0.43	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*789C>T:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+781C>T:	AluSc	rs4706118	0.7155	0	0	0										0.7121	0.2348	0.053	107	36	n/a	n/a
chr6	81054326	81054326	T	C	hom		QUAL=8958;DP=110;AF=1.00;MQM=59;TRIO=HOM,110,1.00,HOM,110,1.00,HET,153,0.46	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*805T>C:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+797T>C:	AluSc	rs4706839	0.7155	0	0	0										0.7121	0.2348	0.053	107	36	n/a	n/a
chr6	81054515	81054515	G	A	hom		QUAL=20555;DP=332;AF=1.00;MQM=60;TRIO=HOM,332,1.00,HOM,166,1.00,HET,252,0.47	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*994G>A:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*8+986G>A:		rs4502885	0.7153	0	0	0										0.7121	0.2348	0.053	108	35	n/a	n/a
chr6	81054663	81054663	C	G	hom		QUAL=15244;DP=224;AF=1.00;MQM=60;TRIO=HOM,224,1.00,HOM,138,1.00,HET,178,0.53	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*1142C>G:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*9-1029C>G:		rs1042367	0.6887	0	0	0										0.7121	0.2348	0.053	108	35	n/a	n/a
chr6	81054762	81054762	A	G	hom		QUAL=16493;DP=264;AF=1.00;MQM=60;TRIO=HOM,264,1.00,HOM,134,1.00,HET,186,0.53	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*1241A>G:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*9-930A>G:		rs1042368	0.7153	0	0	0										0.7121	0.2348	0.053	108	35	n/a	n/a
chr6	81054965	81054965	T	C	hom		QUAL=12955;DP=304;AF=1.00;MQM=60;TRIO=HOM,304,1.00,HOM,42,1.00,HET,79,0.57	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*1444T>C:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*9-727T>C:		rs3805848	0.7153	0	0	0										0.7121	0.2348	0.053	107	36	n/a	n/a
chr6	81055299	81055299	A	G	hom		QUAL=23115;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HOM,234,1.00,HET,308,0.51	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*1778A>G:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*9-393A>G:		rs7758761	0.7149	0	0	0										0.7121	0.2348	0.053	107	36	n/a	n/a
chr6	81055331	81055331	T	C	hom		QUAL=24110;DP=351;AF=1.00;MQM=60;TRIO=HOM,351,1.00,HOM,228,1.00,HET,322,0.46	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*1810T>C:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*9-361T>C:		rs7740932	0.7153	0	0	0										0.7121	0.2348	0.053	107	35	n/a	n/a
chr6	81055396	81055396	G	A	hom		QUAL=26765;DP=380;AF=1.00;MQM=60;TRIO=HOM,380,1.00,HOM,260,1.00,HET,396,0.48	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*1875G>A:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*9-296G>A:		rs7759304	0.7153	0	0	0										0.7121	0.2348	0.053	108	35	n/a	n/a
chr6	81055413	81055413	T	C	hom		QUAL=28880;DP=408;AF=1.00;MQM=59;TRIO=HOM,408,1.00,HOM,280,1.00,HET,411,0.49	BCKDHB	3'UTR,intron	BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*1892T>C:,BCKDHB:NM_000056.3:intron:MODIFIER:exon10/10:c.*9-279T>C:		rs7740958	0.7153	0	0	0										0.7121	0.2348	0.053	108	35	n/a	n/a
chr6	81055792	81055792	G	A	hom		QUAL=8305;DP=179;AF=1.00;MQM=60;TRIO=HOM,179,1.00,HOM,46,0.98,HET,49,0.45	BCKDHB	3'UTR	BCKDHB:NM_000056.3:3'UTR:MODIFIER:exon11/11:c.*109G>A:,BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*2271G>A:		rs15062	0.7159	0	0	0										0.7121	0.2348	0.053	108	35	n/a	n/a
chr6	81055803	81055803	C	T	hom		QUAL=8240;DP=173;AF=1.00;MQM=60;TRIO=HOM,173,1.00,HOM,51,0.98,HET,49,0.41	BCKDHB	3'UTR	BCKDHB:NM_000056.3:3'UTR:MODIFIER:exon11/11:c.*120C>T:,BCKDHB:NM_183050.2:3'UTR:MODIFIER:exon10/10:c.*2282C>T:		rs10864	0.7157	0	0	0										0.7121	0.2348	0.053	108	35	n/a	n/a
chr6	88221391	88221391	C	T	het		QUAL=14310;DP=529;AF=0.48;MQM=60;TRIO=HET,529,0.48,HET,353,0.50,WT,458,0.00	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*147C>T:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*147C>T:		rs55960393	0.023	0	0	0										0	0.0379	0.9621	0	6	n/a	n/a
chr6	88221546	88221546	A	G	hom		QUAL=22665;DP=463;AF=1.00;MQM=60;TRIO=HOM,463,1.00,HET,174,0.51,HET,242,0.52	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*302A>G:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*302A>G:		rs1051131	0.6392	0	0	0										0.2121	0.4697	0.3182	30	73	n/a	n/a
chr6	88221763	88221763	-	TGAA	het		QUAL=12989;DP=236;AF=0.92;MQM=60;TRIO=HET,236,0.92,HET,174,0.51,HET,291,0.44	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*521_*522insAATG:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*521_*522insAATG:		rs10681831	0.6556	0	0	0										0.1667	0.4242	0.4091	24	66	n/a	n/a
chr6	88221767	88221767	-	TAAC	het		QUAL=6867;DP=240;AF=0.40;MQM=60;TRIO=HET,240,0.40,WT,178,0.00,HET,280,0.45	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*525_*528dupAACT:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*525_*528dupAACT:			0	0	0	0										0.0227	0.1515	0.8258	3	23	n/a	n/a
chr6	88221892	88221892	T	G	hom		QUAL=13289;DP=301;AF=1.00;MQM=60;TRIO=HOM,301,1.00,HET,83,0.55,HET,108,0.46	SLC35A1	3'UTR	SLC35A1:NM_006416.4:3'UTR:MODIFIER:exon8/8:c.*648T>G:,SLC35A1:NM_001168398.1:3'UTR:MODIFIER:exon7/7:c.*648T>G:		rs1051148	0.6386	0	0	0										0.2121	0.4697	0.3182	30	73	n/a	n/a
chr6	88240570	88240570	C	T	het		QUAL=9623;DP=334;AF=0.49;MQM=59;TRIO=HET,334,0.49,WT,195,0.00,HET,271,0.48	RARS2	missense	RARS2:NM_020320.3:missense:MODERATE:exon9/20:c.703G>A:p.Val235Met		rs35862137	0.0206	0.032	0.0435	0.0111	-1.0730	N	D	B	B	611524 [RARS2 (confirmed) Pontocerebellar hypoplasia,type 6];	RCV000118126.1 [benign]; RCV000127725.1 [benign]; 			0	0.0227	0.9773	2	43	n/a	n/a
chr6	89883013	89883013	A	T	het		QUAL=9761;DP=161;AF=0.53;MQM=60;TRIO=HET,161,0.53,HET,91,0.45,HOM,177,0.99					rs9353650	0.1625	0	0	0										0.0682	0.3636	0.5682	10	54	n/a	n/a
chr6	97337537	97337537	C	T	hom		QUAL=26538;DP=441;AF=1.00;MQM=59;TRIO=HOM,441,1.00,HET,319,0.46,HET,430,0.50	NDUFAF4	3'UTR	NDUFAF4:NM_014165.3:3'UTR:MODIFIER:exon3/3:c.*1443G>A:		rs7758762	0.2748	0	0	0										0.0909	0.3636	0.5455	17	53	n/a	n/a
chr6	97338598	97338598	A	T	hom		QUAL=38286;DP=453;AF=1.00;MQM=59;TRIO=HOM,453,1.00,HOM,307,1.00,HOM,421,1.00	NDUFAF4	3'UTR	NDUFAF4:NM_014165.3:3'UTR:MODIFIER:exon3/3:c.*382T>A:		rs1971475	0.9341	0	0	0										0.7576	0.2273	0.0152	114	34	n/a	n/a
chr6	97338679	97338679	A	T	hom		QUAL=19054;DP=328;AF=0.99;MQM=60;TRIO=HOM,328,0.99,HET,197,0.50,HET,280,0.49	NDUFAF4	3'UTR	NDUFAF4:NM_014165.3:3'UTR:MODIFIER:exon3/3:c.*301T>A:		rs1854268	0.275	0	0	0										0.0909	0.3636	0.5455	17	53	n/a	n/a
chr6	97339078	97339078	A	G	hom		QUAL=13492;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HET,97,0.59,HOM,109,0.99	NDUFAF4	synonymous	NDUFAF4:NM_014165.3:synonymous:LOW:exon3/3:c.430T>C:p.Leu144Leu		rs6684	0.515	0.518	0.5092	0.3912						611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency];	RCV000117707.2 [likely benign]; 		COSM3762230	0.2727	0.447	0.2803	123	212	n/a	n/a
chr6	97339088	97339088	C	T	hom		QUAL=15487;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HOM,99,1.00,HOM,114,1.00	NDUFAF4	synonymous	NDUFAF4:NM_014165.3:synonymous:LOW:exon3/3:c.420G>A:p.Gln140Gln		rs11402	0.9339	0.894	0.8635	0.9482						611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency];	RCV000117706.2 [likely benign]; 			0.7576	0.2273	0.0152	340	106	n/a	n/a
chr6	97339275	97339275	-	A	het		QUAL=4125;DP=111;AF=0.62;MQM=60;TRIO=HET,111,0.86,HET,50,0.88,HET,50,0.80	NDUFAF4	splice_region&intron	NDUFAF4:NM_014165.3:splice_region&intron:LOW:exon2/2:c.241-9_241-8insT:		rs397799265	0.6701	0	0	0						611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency];				0.4924	0.25	0.2576	241	109	n/a	n/a
chr6	97339286	97339286	G	A	het		QUAL=4125;DP=111;AF=0.62;MQM=60;TRIO=HET,111,0.86,WT,50,0.88,WT,50,0.80	NDUFAF4	splice_region&intron	NDUFAF4:NM_014165.3:splice_region&intron:LOW:exon2/2:c.241-19C>T:			0	0	0	0						611776 [NDUFAF4 (confirmed) Mitochondrial complex I deficiency];				0	0	1	0	0	n/a	n/a
chr6	100837889	100837889	T	A	het		QUAL=17618;DP=411;AF=0.48;MQM=60;TRIO=HET,411,0.48,HET,266,0.53,HET,352,0.52	SIM1	3'UTR	SIM1:NM_005068.2:3'UTR:MODIFIER:exon11/11:c.*348A>T:		rs1395119	0.3988	0	0	0										0.1894	0.5	0.3106	27	76	n/a	n/a
chr6	101094554	101094554	A	G	hom		QUAL=20399;DP=307;AF=0.99;MQM=60;TRIO=HOM,307,0.99,HET,208,0.52,HOM,209,1.00	ASCC3	synonymous	ASCC3:NM_006828.3:synonymous:LOW:exon22/42:c.3570T>C:p.Pro1190Pro		rs239239	0.5713	0.542	0.5279	0.5906									COSM3761400	0.2727	0.4773	0.25	124	217	n/a	n/a
chr6	101215224	101215224	A	-	hom		QUAL=11416;DP=169;AF=0.92;MQM=60;TRIO=HOM,169,0.92,HOM,113,0.96,HOM,127,0.94	ASCC3	splice_region&intron	ASCC3:NM_006828.3:splice_region&intron:LOW:exon8/41:c.1396-3delT:,ASCC3:NM_001284271.1:splice_region&intron:LOW:exon8/12:c.1396-3delT:		rs397888735	0.9696	0	0	0										0.9924	0	0.0076	462	5	n/a	n/a
chr6	101296389	101296389	G	A	het		QUAL=13264;DP=422;AF=0.49;MQM=60;TRIO=HET,422,0.49,WT,167,0.01,HOM,187,1.00	ASCC3	missense	ASCC3:NM_006828.3:missense:MODERATE:exon4/42:c.436C>T:p.Leu146Phe,ASCC3:NM_001284271.1:missense:MODERATE:exon4/13:c.436C>T:p.Leu146Phe		rs9390698	0.2454	0.365	0.4558	0.1448	2.5230	P	T	B,B,B	B,B,B				COSM150148	0.1742	0.4848	0.3409	76	216	n/a	n/a
chr6	101304332	101304332	T	C	het		QUAL=8265;DP=284;AF=0.53;MQM=60;TRIO=HET,284,0.53,WT,119,0.01,HET,200,0.49	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*2652A>G:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+7608A>G:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+7608A>G:		rs78942177	0.0395	0	0	0										0	0.1364	0.8636	0	19	n/a	n/a
chr6	101304644	101304644	C	T	het		QUAL=8810;DP=333;AF=0.51;MQM=60;TRIO=HET,333,0.51,WT,172,0.00,HET,204,0.48	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*2340G>A:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+7296G>A:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+7296G>A:	L1ME3	rs80004866	0.0058	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr6	101304829	101304829	C	T	het		QUAL=9967;DP=315;AF=0.43;MQM=60;TRIO=HET,315,0.43,WT,146,0.01,HOM,170,1.00	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*2155G>A:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+7111G>A:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+7111G>A:	L1ME3	rs705599	0.6667	0	0	0										0.5076	0.3788	0.1136	74	59	n/a	n/a
chr6	101305757	101305757	-	AC	het		QUAL=3920;DP=166;AF=0.17;MQM=59;TRIO=HET,166,0.17,WT,121,0.00,HET,152,0.78	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*1225_*1226dupGT:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+6181_241+6182dupGT:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+6181_241+6182dupGT:	(CA)n	rs398110480	0	0	0	0										0.0303	0.5985	0.3712	4	93	n/a	n/a
chr6	101305983	101305983	A	T	hom		QUAL=5707;DP=141;AF=1.00;MQM=60;TRIO=HOM,141,1.00,HOM,8,1.00,HOM,18,1.00	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*1001T>A:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+5957T>A:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+5957T>A:	L1ME3	rs846793	0.9471	0	0	0										0.8561	0.1288	0.0152	128	20	n/a	n/a
chr6	101306006	101306010	TAAAT	-	het		QUAL=1871;DP=118;AF=0.45;MQM=60;TRIO=HET,118,0.45,WT,8,0.00,HET,17,0.47	ASCC3	3'UTR,intron	ASCC3:NM_022091.4:3'UTR:MODIFIER:exon4/4:c.*974_*978delATTTA:,ASCC3:NM_006828.3:intron:MODIFIER:exon3/41:c.241+5930_241+5934delATTTA:,ASCC3:NM_001284271.1:intron:MODIFIER:exon3/12:c.241+5930_241+5934delATTTA:	L1ME3	rs67936868	0.1601	0	0	0										0.0833	0.3939	0.5227	12	58	n/a	n/a
chr6	101312097	101312097	C	T	hom		QUAL=12426;DP=162;AF=1.00;MQM=60;TRIO=HOM,162,1.00,HOM,82,1.00,HOM,135,1.00	ASCC3	splice_region&intron	ASCC3:NM_006828.3:splice_region&intron:LOW:exon2/41:c.91-7G>A:,ASCC3:NM_001284271.1:splice_region&intron:LOW:exon2/12:c.91-7G>A:,ASCC3:NM_022091.4:splice_region&intron:LOW:exon2/3:c.91-7G>A:		rs846791	0.98	0.96	0.9533	0.9907										0.8712	0.1288	0	409	42	n/a	n/a
chr6	101329173	101329173	A	C	het		QUAL=22386;DP=171;AF=0.50;MQM=60;TRIO=HET,171,0.50,WT,496,0.00,HOM,648,0.99	ASCC3	5'UTR_premature_start_codon_gain,5'UTR	ASCC3:NM_006828.3:5'UTR_premature_start_codon_gain:LOW:exon1/42:c.-278T>G:,ASCC3:NM_001284271.1:5'UTR_premature_start_codon_gain:LOW:exon1/13:c.-278T>G:,ASCC3:NM_022091.4:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-278T>G:,ASCC3:NM_006828.3:5'UTR:MODIFIER:exon1/42:c.-278T>G:,ASCC3:NM_001284271.1:5'UTR:MODIFIER:exon1/13:c.-278T>G:,ASCC3:NM_022091.4:5'UTR:MODIFIER:exon1/4:c.-278T>G:		rs12530388	0.5194	0	0	0										0.2803	0.4621	0.2576	41	74	n/a	n/a
chr6	102376517	102376517	G	A	het		QUAL=6178;DP=193;AF=0.52;MQM=60;TRIO=HET,193,0.52,WT,170,0.00,HET,189,0.52	GRIK2	splice_region&intron	GRIK2:NM_021956.4:splice_region&intron:LOW:exon13/15:c.2085+10G>A:,GRIK2:NM_001166247.1:splice_region&intron:LOW:exon13/16:c.2085+10G>A:,GRIK2:NM_175768.3:splice_region&intron:LOW:exon13/16:c.2085+10G>A:		rs2243355	0.1705	0.274	0.3347	0.0624						138244 [GRIK2 (confirmed) Mental retardation,autosomal recessive,6];	RCV000117160.2 [likely benign]; 			0.1061	0.447	0.447	44	194	n/a	n/a
chr6	102503317	102503317	G	A	het		QUAL=1908;DP=52;AF=0.50;MQM=60;TRIO=HET,52,0.50,HOM,17,1.00,HET,34,0.56	GRIK2	synonymous	GRIK2:NM_021956.4:synonymous:LOW:exon15/16:c.2424G>A:p.Glu808Glu,GRIK2:NM_001166247.1:synonymous:LOW:exon15/17:c.2424G>A:p.Glu808Glu,GRIK2:NM_175768.3:synonymous:LOW:exon15/17:c.2424G>A:p.Glu808Glu		rs2227283	0.3275	0.391	0.4406	0.2808						138244 [GRIK2 (confirmed) Mental retardation,autosomal recessive,6];	RCV000117164.2 [likely benign]; 		COSM3761403	0.1818	0.4242	0.3939	84	218	n/a	n/a
chr6	107475278	107475278	-	A	het		QUAL=2984;DP=187;AF=0.33;MQM=60;TRIO=HET,187,0.33,HET,96,0.44,WT,132,0.02	PDSS2	3'UTR	PDSS2:NM_020381.3:3'UTR:MODIFIER:exon8/8:c.*544dupT:	AluSq2	rs397807908	0.1815	0	0	0										0.053	0.4015	0.5455	8	59	n/a	n/a
chr6	107475512	107475512	C	T	het		QUAL=7818;DP=215;AF=0.49;MQM=60;TRIO=HET,215,0.49,WT,204,0.00,HET,266,0.50	PDSS2	3'UTR	PDSS2:NM_020381.3:3'UTR:MODIFIER:exon8/8:c.*311G>A:		rs41292442	0.0333	0	0	0										0	0.1515	0.8485	0	23	n/a	n/a
chr6	108363619	108363619	T	-	het		QUAL=649;DP=36;AF=0.33;MQM=57;TRIO=HET,36,0.33,HET,9,0.33,HET,16,0.38	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2369delA:	AluJb		0	0	0	0										0	0.1061	0.8939	0	16	n/a	n/a
chr6	108363645	108363645	G	C	het		QUAL=2012;DP=73;AF=0.68;MQM=59;TRIO=HET,73,0.68,WT,29,0.00,HET,37,0.65	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2344C>G:	AluJb	rs113263335	0.1392	0	0	0										0	0.0909	0.9091	0	13	n/a	n/a
chr6	108363660	108363660	C	A	het		QUAL=1964;DP=75;AF=0.67;MQM=59;TRIO=HET,75,0.67,WT,35,0.00,HET,46,0.57	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2329G>T:	AluJb	rs112792700	0.1392	0	0	0										0	0.0909	0.9091	0	13	n/a	n/a
chr6	108363688	108363688	T	C	het		QUAL=3029;DP=116;AF=0.57;MQM=59;TRIO=HET,116,0.57,WT,46,0.00,HET,61,0.54	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2301A>G:	AluJb	rs9386700	0.3441	0	0	0										0.0682	0.4167	0.5152	10	61	n/a	n/a
chr6	108363706	108363706	A	G	het		QUAL=3471;DP=137;AF=0.55;MQM=59;TRIO=HET,137,0.55,WT,51,0.02,HET,65,0.60	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2283T>C:	AluJb	rs112283202	0.1392	0	0	0										0	0.0909	0.9091	0	13	n/a	n/a
chr6	108363936	108363936	G	A	het		QUAL=12696;DP=451;AF=0.52;MQM=60;TRIO=HET,451,0.52,WT,230,0.00,HET,279,0.53	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*2053C>T:		rs17069215	0.0757	0	0	0										0	0.0833	0.9167	0	12	n/a	n/a
chr6	108364106	108364106	A	G	het		QUAL=10643;DP=426;AF=0.56;MQM=60;TRIO=HET,426,0.56,WT,127,0.00,HET,166,0.47	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*1883T>C:		rs7662	0.3441	0	0	0										0.0682	0.4167	0.5152	10	61	n/a	n/a
chr6	108364548	108364548	T	-	het		QUAL=8268;DP=296;AF=0.42;MQM=60;TRIO=HET,296,0.42,WT,184,0.00,HET,286,0.49	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*1441delA:		rs140320992	0.1256	0	0	0										0	0.0909	0.9091	0	13	n/a	n/a
chr6	108364637	108364637	T	C	het		QUAL=7562;DP=317;AF=0.56;MQM=60;TRIO=HET,317,0.56,WT,78,0.00,HET,124,0.53	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*1352A>G:		rs9372179	0.0757	0	0	0										0	0.0833	0.9167	0	12	n/a	n/a
chr6	108364655	108364655	A	G	het		QUAL=6251;DP=248;AF=0.57;MQM=60;TRIO=HET,248,0.57,WT,59,0.00,HET,108,0.49	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*1334T>C:		rs9374008	0.0757	0	0	0										0	0.0833	0.9167	0	12	n/a	n/a
chr6	108365658	108365658	T	C	het		QUAL=3506;DP=144;AF=0.55;MQM=60;TRIO=HET,144,0.55,WT,50,0.00,HET,55,0.53	OSTM1	3'UTR	OSTM1:NM_014028.3:3'UTR:MODIFIER:exon6/6:c.*331A>G:		rs9320250	0.4764	0	0	0										0.0985	0.4242	0.4773	14	63	n/a	n/a
chr6	110106234	110106234	A	G	hom		QUAL=21777;DP=315;AF=0.99;MQM=60;TRIO=HOM,315,0.99,HOM,132,1.00,HOM,229,0.98	FIG4	splice_region&intron	FIG4:NM_014845.5:splice_region&intron:LOW:exon17/22:c.1948+3A>G:		rs10499054	0.3588	0.526	0.6689	0.2124						609390 [FIG4 (provisional) Charcot-Marie-Tooth disease,type 4J|Amyotrophic lateral sclerosis 11|Yunis-Varon syndrome];				0.3409	0.5303	0.1288	319	351	n/a	n/a
chr6	110146303	110146303	G	A	hom		QUAL=21230;DP=274;AF=0.99;MQM=60;TRIO=HOM,274,0.99,HOM,224,1.00,HET,331,0.53	FIG4	synonymous	FIG4:NM_014845.5:synonymous:LOW:exon23/23:c.2559G>A:p.Ser853Ser		rs1127771	0.3958	0.429	0.4103	0.148						609390 [FIG4 (provisional) Charcot-Marie-Tooth disease,type 4J|Amyotrophic lateral sclerosis 11|Yunis-Varon syndrome];				0.1742	0.4848	0.3409	148	367	n/a	n/a
chr6	110146588	110146588	C	T	hom		QUAL=23923;DP=272;AF=0.99;MQM=59;TRIO=HOM,272,0.99,HOM,295,1.00,HET,379,0.48	FIG4	3'UTR	FIG4:NM_014845.5:3'UTR:MODIFIER:exon23/23:c.*120C>T:		rs1127775	0.4483	0	0	0										0.2121	0.5	0.2879	32	74	n/a	n/a
chr6	129381026	129381026	C	A	hom		QUAL=20154;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,193,1.00,HOM,218,1.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon3/65:c.381C>A:p.Thr127Thr,LAMA2:NM_001079823.1:synonymous:LOW:exon3/64:c.381C>A:p.Thr127Thr		rs4404787	0.9367	0.958	0.9699	0.9033						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078766.3 [benign]; 			0.9773	0.0227	0	433	21	n/a	n/a
chr6	129571330	129571330	G	A	het		QUAL=10092;DP=345;AF=0.46;MQM=60;TRIO=HET,345,0.46,WT,247,0.00,HET,329,0.46	LAMA2	missense	LAMA2:NM_000426.3:missense:MODERATE:exon13/65:c.1856G>A:p.Arg619His,LAMA2:NM_001079823.1:missense:MODERATE:exon13/64:c.1856G>A:p.Arg619His		rs3816665	0.271	0.183	0.14	0.5229	-1.5750	P	T	B,B	B,B	156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078752.3 [benign]; 			0.0303	0.2955	0.6742	16	124	n/a	n/a
chr6	129612808	129612808	A	G	het		QUAL=8628;DP=284;AF=0.54;MQM=60;TRIO=HET,284,0.54,WT,131,0.00,HET,199,0.57	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon20/65:c.2799A>G:p.Gln933Gln,LAMA2:NM_001079823.1:synonymous:LOW:exon20/64:c.2799A>G:p.Gln933Gln		rs1027199	0.3139	0.268	0.2272	0.3193						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078759.3 [benign]; 		COSM3761478	0.0758	0.4015	0.5227	27	183	n/a	n/a
chr6	129691132	129691132	C	G	hom		QUAL=16207;DP=295;AF=0.99;MQM=60;TRIO=HOM,295,0.99,HET,189,0.46,HET,256,0.47	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon34/65:c.4956C>G:p.Thr1652Thr,LAMA2:NM_001079823.1:synonymous:LOW:exon34/64:c.4956C>G:p.Thr1652Thr		rs17057184	0.0966	0.085	0.0615	0.113						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078774.3 [benign]; 			0	0.1288	0.8712	3	72	n/a	n/a
chr6	129722389	129722389	A	G	het		QUAL=15561;DP=319;AF=0.50;MQM=60;TRIO=HET,319,0.50,HOM,324,1.00,WT,431,0.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon38/65:c.5466A>G:p.Glu1822Glu,LAMA2:NM_001079823.1:synonymous:LOW:exon38/64:c.5466A>G:p.Glu1822Glu		rs3749877	0.5445	0.498	0.4653	0.6151						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078777.3 [benign]; 			0.2576	0.4394	0.303	100	230	n/a	n/a
chr6	129722425	129722425	G	A	het		QUAL=20305;DP=527;AF=0.47;MQM=60;TRIO=HET,527,0.47,HOM,374,1.00,WT,482,0.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon38/65:c.5502G>A:p.Glu1834Glu,LAMA2:NM_001079823.1:synonymous:LOW:exon38/64:c.5502G>A:p.Glu1834Glu		rs3749878	0.5433	0.496	0.4641	0.6144						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078778.3 [benign]; 		COSM4160174	0.2576	0.4318	0.3106	100	228	n/a	n/a
chr6	129762112	129762112	G	A	het		QUAL=9585;DP=286;AF=0.50;MQM=60;TRIO=HET,286,0.50,WT,283,0.00,HET,320,0.50	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon43/65:c.6237G>A:p.Thr2079Thr,LAMA2:NM_001079823.1:synonymous:LOW:exon43/64:c.6237G>A:p.Thr2079Thr		rs2297738	0.1825	0.168	0.1457	0.126						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078786.3 [benign]; 		COSM3761479	0.0076	0.2348	0.7576	10	117	n/a	n/a
chr6	129807629	129807629	C	T	het		QUAL=4981;DP=199;AF=0.49;MQM=60;TRIO=HET,199,0.49,HET,143,0.45,WT,199,0.00	LAMA2	missense	LAMA2:NM_000426.3:missense:MODERATE:exon56/65:c.7760C>T:p.Ala2587Val,LAMA2:NM_001079823.1:missense:MODERATE:exon55/64:c.7748C>T:p.Ala2583Val		rs2229848	0.5839	0.667	0.7265	0.4671	4.4990	P		D,D	D,D	156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000153440.1 [benign]; 	CM023406 [CLASS=DP MUT=REF PHEN="Tuberculoid leprosy, association with" GENE=LAMA2]; 	COSM1440401	0.6136	0.3258	0.0606	233	178	n/a	n/a
chr6	129807699	129807699	G	C	het		QUAL=7785;DP=336;AF=0.48;MQM=60;TRIO=HET,336,0.48,HET,176,0.44,WT,248,0.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon56/65:c.7830G>C:p.Val2610Val,LAMA2:NM_001079823.1:synonymous:LOW:exon55/64:c.7818G>C:p.Val2606Val		rs2229849	0.5843	0.668	0.7266	0.4709						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078800.3 [benign]; 			0.6136	0.3258	0.0606	233	179	n/a	n/a
chr6	129807714	129807714	G	A	het		QUAL=17257;DP=326;AF=0.55;MQM=60;TRIO=HET,326,0.55,HET,179,0.56,HOM,249,1.00	LAMA2	synonymous	LAMA2:NM_000426.3:synonymous:LOW:exon56/65:c.7845G>A:p.Pro2615Pro,LAMA2:NM_001079823.1:synonymous:LOW:exon55/64:c.7833G>A:p.Pro2611Pro		rs2229850	0.4038	0.308	0.2488	0.5245						156225 [LAMA2 (confirmed) Muscular dystrophy,congenital merosin-deficient|Muscular dystrophy,congenital,due to partial LAMA2 deficiency];	RCV000078801.3 [benign]; 			0.0379	0.2955	0.6667	36	160	n/a	n/a
chr6	129837681	129837683	AAT	-	hom		QUAL=7153;DP=180;AF=0.96;MQM=60;TRIO=HOM,180,0.96,HET,33,0.67,HOM,45,1.00	LAMA2	3'UTR	LAMA2:NM_000426.3:3'UTR:MODIFIER:exon65/65:c.*193_*195delATA:,LAMA2:NM_001079823.1:3'UTR:MODIFIER:exon64/64:c.*193_*195delATA:		rs371188338	0.7051	0	0	0										0.5909	0.3712	0.0379	90	55	n/a	n/a
chr6	135715915	135715915	G	A	het		QUAL=309;DP=22;AF=0.55;MQM=60;TRIO=HET,22,0.55,WT,2,0.00,WT,11,0.00	AHI1	splice_region&synonymous	AHI1:NM_001134830.1:splice_region&synonymous:LOW:exon21/27:c.3108C>T:p.Thr1036Thr,AHI1:NM_001134831.1:splice_region&synonymous:LOW:exon23/29:c.3108C>T:p.Thr1036Thr,AHI1:NM_017651.4:splice_region&synonymous:LOW:exon22/28:c.3108C>T:p.Thr1036Thr,AHI1:NM_001134832.1:splice_region&synonymous:LOW:exon22/23:c.3108C>T:p.Thr1036Thr			0	0	0	0	-3.5700	D				608894 [AHI1 (confirmed) Joubert syndrome-3];				0	0	1	0	0	n/a	n/a
chr6	135818897	135818897	C	A	het		QUAL=5032;DP=9;AF=0.44;MQM=60;TRIO=HET,9,0.44,HOM,107,1.00,HET,159,0.46	AHI1	5'UTR	AHI1:NM_001134830.1:5'UTR:MODIFIER:exon1/27:c.-231G>T:,AHI1:NM_001134831.1:5'UTR:MODIFIER:exon1/29:c.-378G>T:,AHI1:NM_017651.4:5'UTR:MODIFIER:exon1/28:c.-293G>T:,AHI1:NM_001134832.1:5'UTR:MODIFIER:exon1/23:c.-293G>T:		rs13197384	0.3011	0.157	0	0										0.1136	0.4848	0.4015	16	70	n/a	n/a
chr6	137166790	137166790	A	C	het		QUAL=9996;DP=362;AF=0.49;MQM=60;TRIO=HET,362,0.49,WT,202,0.00,HET,267,0.46	PEX7	missense	PEX7:NM_000288.3:missense:MODERATE:exon4/10:c.377A>C:p.Gln126Pro		rs113268723	0.0014	0.0038	0.004	0.0014	5.5310	D	T	P	P	601757 [PEX7 (provisional) Rhizomelic chondrodysplasia punctata,type 1|Peroxisome biogenesis disorder 9B];				0	0.0152	0.9848	0	9	3	n/a
chr6	137234919	137234919	-	GTA	het		QUAL=6604;DP=267;AF=0.49;MQM=60;TRIO=HET,267,0.49,HOM,86,1.00,WT,110,0.00	PEX7	3'UTR	PEX7:NM_000288.3:3'UTR:MODIFIER:exon10/10:c.*257_*258insAGT:		rs1801001	0.523	0	0	0										0.2803	0.5152	0.2045	43	77	n/a	n/a
chr6	137234970	137234970	T	G	het		QUAL=4374;DP=186;AF=0.48;MQM=60;TRIO=HET,186,0.48,HOM,56,1.00,WT,61,0.00	PEX7	3'UTR	PEX7:NM_000288.3:3'UTR:MODIFIER:exon10/10:c.*306T>G:		rs1050803	0.5206	0	0	0										0.2803	0.5152	0.2045	42	77	n/a	n/a
chr6	143810682	143810682	A	T	het		QUAL=159;DP=12;AF=0.50;MQM=60;TRIO=HET,12,0.50,HOM,2,1.00,WT,3,0.00	PEX3	3'UTR	PEX3:NM_003630.2:3'UTR:MODIFIER:exon12/12:c.*319A>T:	AT_rich	rs223234	0.7927	0	0	0										0.4545	0.2121	0.3333	69	31	n/a	n/a
chr6	143810909	143810909	A	G	het		QUAL=1173;DP=61;AF=0.48;MQM=60;TRIO=HET,61,0.48,HET,15,0.53,WT,18,0.00	PEX3	3'UTR	PEX3:NM_003630.2:3'UTR:MODIFIER:exon12/12:c.*546A>G:		rs10809	0.129	0	0	0										0.0152	0.3636	0.6212	3	56	n/a	n/a
chr6	144509845	144509845	-	A	het		QUAL=1095;DP=33;AF=0.79;MQM=58;TRIO=HET,33,0.79,HET,12,0.75,HET,23,0.26	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*1221dupA:		rs397725572	0.5583	0	0	0										0.1667	0.4621	0.3712	25	70	n/a	n/a
chr6	144509855	144509855	C	T	het		QUAL=91;DP=37;AF=0.30;MQM=39;TRIO=HET,37,0.30,WT,9,0.00,WT,13,0.00	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*1227C>T:	AluSc8	rs148087652	0	0	0	0										0	0.0758	0.9242	0	15	n/a	n/a
chr6	144510421	144510421	A	C	het		QUAL=7016;DP=169;AF=0.50;MQM=59;TRIO=HET,169,0.50,HET,100,0.57,HET,143,0.54	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*1793A>C:	AluJo	rs4896705	0.273	0	0	0										0.1212	0.4697	0.4091	18	71	n/a	n/a
chr6	144510926	144510926	C	T	het		QUAL=11089;DP=349;AF=0.49;MQM=60;TRIO=HET,349,0.49,HET,179,0.50,HET,188,0.40	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*2298C>T:		rs3734227	0.267	0	0	0										0.1061	0.4545	0.4394	16	68	n/a	n/a
chr6	144512671	144512671	-	A	het		QUAL=9263;DP=254;AF=0.83;MQM=60;TRIO=HET,254,0.83,HET,69,0.78,HET,67,0.73	STX11	3'UTR	STX11:NM_003764.3:3'UTR:MODIFIER:exon2/2:c.*4054dupA:		rs397795966	0.9277	0	0	0										0.8409	0.1515	0.0076	126	23	n/a	n/a
chr6	145947080	145947080	C	T	hom		QUAL=29570;DP=380;AF=1.00;MQM=60;TRIO=HOM,380,1.00,HOM,204,0.99,HOM,307,0.99	EPM2A	3'UTR,intron	EPM2A:NM_005670.3:3'UTR:MODIFIER:exon4/4:c.*1472G>A:,EPM2A:NM_001018041.1:intron:MODIFIER:exon4/4:c.925-220G>A:	MIRb	rs1045820	0.4471	0	0	0						607566 [EPM2A (confirmed) Epilepsy,progressive myoclonic 2A (Lafora)];				0.2424	0.4848	0.2727	57	125	n/a	n/a
chr6	146056848	146056848	T	C	het		QUAL=100;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,NONE,0,0,HOM,2,1.00	EPM2A	5'UTR_premature_start_codon_gain,5'UTR	EPM2A:NM_005670.3:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-214A>G:,EPM2A:NM_001018041.1:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-214A>G:,EPM2A:NM_005670.3:5'UTR:MODIFIER:exon1/4:c.-214A>G:,EPM2A:NM_001018041.1:5'UTR:MODIFIER:exon1/5:c.-214A>G:		rs2235481	0.7352	0	0	0										0.0455	0.0152	0.9394	7	2	n/a	n/a
chr6	152443468	152443468	G	T	het		QUAL=16318;DP=518;AF=0.48;MQM=59;TRIO=HET,518,0.48,HET,479,0.54,WT,725,0.00	SYNE1	3'UTR	SYNE1:NM_182961.3:3'UTR:MODIFIER:exon146/146:c.*103C>A:,SYNE1:NM_033071.3:3'UTR:MODIFIER:exon146/146:c.*103C>A:		rs2250122	0.2452	0	0	0										0.0606	0.3409	0.5985	9	52	n/a	n/a
chr6	152464839	152464839	A	G	het		QUAL=16436;DP=422;AF=0.52;MQM=60;TRIO=HET,422,0.52,HOM,290,1.00,WT,383,0.01	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon138/146:c.25038T>C:p.Arg8346Arg,SYNE1:NM_033071.3:synonymous:LOW:exon138/146:c.24894T>C:p.Arg8298Arg		rs2256135	0.6897	0.611	0.5564	0.7544						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118470.2 [likely benign]; 			0.2803	0.5076	0.2121	372	535	n/a	n/a
chr6	152466674	152466674	T	C	het		QUAL=8868;DP=313;AF=0.49;MQM=60;TRIO=HET,313,0.49,HET,244,0.52,WT,295,0.00	SYNE1	synonymous,intron	SYNE1:NM_033071.3:synonymous:LOW:exon137/146:c.24780A>G:p.Glu8260Glu,SYNE1:NM_182961.3:intron:MODIFIER:exon137/145:c.24977-1774A>G:		rs2747662	0.3662	0.345	0.3301	0.3473						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118469.1 [benign]; 		COSM3761562	0.0833	0.4545	0.4621	146	509	n/a	n/a
chr6	152469188	152469188	C	G	het		QUAL=4562;DP=165;AF=0.47;MQM=60;TRIO=HET,165,0.47,HET,131,0.55,WT,207,0.00	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon137/146:c.24968G>C:p.Gly8323Ala,SYNE1:NM_033071.3:missense:MODERATE:exon136/146:c.24755G>C:p.Gly8252Ala		rs2252755	0.3994	0.358	0.3373	0.4444	2.6650	P	T	P,P,B,B,B	B,B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118468.2 [likely benign]; 			0.0833	0.4621	0.4545	150	513	n/a	n/a
chr6	152469204	152469204	G	A	het		QUAL=4752;DP=176;AF=0.43;MQM=60;TRIO=HET,176,0.43,HET,153,0.55,WT,226,0.00	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon137/146:c.24952C>T:p.Leu8318Phe,SYNE1:NM_033071.3:missense:MODERATE:exon136/146:c.24739C>T:p.Leu8247Phe		rs141716975	0.0022	0.0053	0.0056	0.0007	6.9680	N	T	P,P,P,P,P	B,B,P,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];				0	0.0076	0.9924	1	11	3	n/a
chr6	152469331	152469331	C	T	het		QUAL=7045;DP=222;AF=0.47;MQM=60;TRIO=HET,222,0.47,HET,255,0.49,WT,372,0.00	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon137/146:c.24825G>A:p.Pro8275Pro,SYNE1:NM_033071.3:synonymous:LOW:exon136/146:c.24612G>A:p.Pro8204Pro		rs2252748	0.3395	0.313	0.2944	0.3137						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118467.2 [likely benign]; 		COSM3761565	0.0682	0.3864	0.5455	117	472	1	n/a
chr6	152532702	152532702	T	C	het		QUAL=8824;DP=339;AF=0.50;MQM=60;TRIO=HET,339,0.50,WT,145,0.00,HET,234,0.42	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon124/146:c.22516A>G:p.Ser7506Gly,SYNE1:NM_033071.3:missense:MODERATE:exon123/146:c.22303A>G:p.Ser7435Gly		rs35763277	0.0046	0.014	0.0171	0.0041	7.9410	D	T	D,D,D,D	D,D,D,D	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118462.2 [likely benign]; 			0	0.0379	0.9621	0	26	n/a	n/a
chr6	152534768	152534768	C	T	het		QUAL=9084;DP=291;AF=0.48;MQM=60;TRIO=HET,291,0.48,WT,212,0.00,HET,274,0.50	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon123/146:c.22473G>A:p.Leu7491Leu,SYNE1:NM_033071.3:synonymous:LOW:exon122/146:c.22260G>A:p.Leu7420Leu		rs34891041	0.0206	0.026	0.0271	0.0438						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118461.2 [likely benign]; 			0	0.0606	0.9394	1	50	n/a	n/a
chr6	152540278	152540278	A	C	hom		QUAL=26055;DP=306;AF=1.00;MQM=59;TRIO=HOM,306,1.00,HOM,213,1.00,HOM,278,1.00	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon120/146:c.21904T>G:p.Phe7302Val,SYNE1:NM_033071.3:missense:MODERATE:exon119/146:c.21691T>G:p.Phe7231Val		rs2147377	0.9956	0.992	0.9901	0.9989	1.3490	P	T	B,B,B,B	B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118459.2 [likely benign]; 			0.9924	0.0076	0	1126	19	1	n/a (12xTP)
chr6	152615200	152615200	G	A	hom		QUAL=20342;DP=357;AF=1.00;MQM=60;TRIO=HOM,357,1.00,HET,242,0.57,HET,295,0.48	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon94/146:c.17745C>T:p.His5915His,SYNE1:NM_033071.3:synonymous:LOW:exon93/146:c.17532C>T:p.His5844His		rs12664753	0.1478	0.187	0.1917	0.0465						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118454.2 [likely benign]; 			0.0303	0.2955	0.6742	44	317	1	n/a (2xTP)
chr6	152629773	152629773	A	-	het		QUAL=1212;DP=147;AF=0.15;MQM=60;TRIO=HET,147,0.15,HET,68,0.46,HET,80,0.14	SYNE1	splice_region&intron	SYNE1:NM_182961.3:splice_region&intron:LOW:exon90/145:c.17203-6delT:,SYNE1:NM_033071.3:splice_region&intron:LOW:exon89/145:c.16994-10delT:		rs535229755	0	0	0	0						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];				0.0152	0.3182	0.6667	103	222	n/a	n/a
chr6	152647681	152647681	A	T	het		QUAL=19947;DP=457;AF=0.51;MQM=60;TRIO=HET,457,0.51,HET,322,0.53,HET,423,0.51	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon79/146:c.15043T>A:p.Leu5015Met,SYNE1:NM_033071.3:missense:MODERATE:exon78/146:c.14830T>A:p.Leu4944Met		rs2306916	0.8147	0.779	0.7494	0.9296	2.9340	P	T	B,B,B,B	B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118448.2 [likely benign]; 			0.5909	0.3409	0.0682	614	447	n/a	n/a
chr6	152652034	152652034	A	T	het		QUAL=11300;DP=188;AF=0.58;MQM=60;TRIO=HET,188,0.58,HET,187,0.56,HET,254,0.57	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon78/146:c.13786T>A:p.Ser4596Thr,SYNE1:NM_033071.3:missense:MODERATE:exon77/146:c.13573T>A:p.Ser4525Thr		rs6911096	0.8033	0.776	0.749	0.8874	-2.5130	P	T	B,B,B,B	B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118444.2 [likely benign]; 		COSM1487365	0.5909	0.3409	0.0682	615	448	n/a	n/a
chr6	152658062	152658062	C	G	het		QUAL=9632;DP=311;AF=0.44;MQM=60;TRIO=HET,311,0.44,WT,172,0.01,HET,310,0.50	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon76/146:c.12442G>C:p.Asp4148His,SYNE1:NM_033071.3:missense:MODERATE:exon75/146:c.12229G>C:p.Asp4077His		rs117501809	0.0124	0.027	0.0326	0.0068	7.8150	D	D	D,D,D,D	D,D,D,D	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118441.2 [likely benign]; 			0.0076	0.0455	0.947	3	77	n/a	n/a
chr6	152658142	152658142	T	C	het		QUAL=8661;DP=154;AF=0.51;MQM=60;TRIO=HET,154,0.51,HET,133,0.50,HET,245,0.53	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon76/146:c.12362A>G:p.Lys4121Arg,SYNE1:NM_033071.3:missense:MODERATE:exon75/146:c.12149A>G:p.Lys4050Arg		rs9479297	0.7931	0.751	0.7194	0.9224	1.4310	P	T	B,B,B,B	B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118439.2 [likely benign]; 			0.5833	0.3561	0.0606	596	455	n/a	n/a
chr6	152697675	152697675	G	T	het		QUAL=5447;DP=227;AF=0.49;MQM=60;TRIO=HET,227,0.49,HET,132,0.44,WT,217,0.00	SYNE1	synonymous	SYNE1:NM_182961.3:synonymous:LOW:exon58/146:c.9165C>A:p.Ser3055Ser,SYNE1:NM_033071.3:synonymous:LOW:exon58/146:c.9186C>A:p.Ser3062Ser		rs117020413	0.0068	0.013	0.0121	0.0043	1.2490	D				608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];				0	0.0227	0.9773	0	36	n/a	n/a
chr6	152772264	152772264	A	G	hom		QUAL=19409;DP=341;AF=1.00;MQM=60;TRIO=HOM,341,1.00,HET,198,0.47,HET,276,0.54	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon26/146:c.3104T>C:p.Val1035Ala,SYNE1:NM_033071.3:missense:MODERATE:exon26/146:c.3125T>C:p.Val1042Ala		rs214976	0.6072	0.481	0.4295	0.7335	8.6440	P	T	B,B,B,B,B,P	B,B,B,B,B,B	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118478.2 [likely benign]; 			0.1136	0.5	0.3864	236	555	1	n/a
chr6	152774753	152774753	C	T	het		QUAL=5908;DP=241;AF=0.50;MQM=59;TRIO=HET,241,0.50,HET,120,0.58,WT,142,0.00	SYNE1	missense	SYNE1:NM_182961.3:missense:MODERATE:exon25/146:c.2995G>A:p.Glu999Lys,SYNE1:NM_033071.3:missense:MODERATE:exon25/146:c.3016G>A:p.Glu1006Lys		rs148346599	0.002	0.0034	0.0023	0	7.3880	D	T	D,D,D,D,D,D,D	P,P,P,D,D,P,D	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];			COSM231094	0	0.0076	0.9924	0	4	n/a	n/a
chr6	152809527	152809527	A	T	hom		QUAL=9458;DP=177;AF=1.00;MQM=60;TRIO=HOM,177,1.00,HET,88,0.56,HET,136,0.45	SYNE1	splice_region&intron	SYNE1:NM_182961.3:splice_region&intron:LOW:exon12/145:c.1047+4T>A:,SYNE1:NM_033071.3:splice_region&intron:LOW:exon12/145:c.1068+4T>A:		rs9397106	0.5893	0.476	0.4328	0.6523						608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4,autosomal dominant];	RCV000118432.2 [likely benign]; 			0.1212	0.5227	0.3561	243	557	1	n/a (6xTP)
chr6	152958461	152958461	G	A	het		QUAL=1626;DP=47;AF=0.49;MQM=60;TRIO=HET,47,0.49,WT,84,0.00,HET,102,0.36	SYNE1	5'UTR	SYNE1:NM_182961.3:5'UTR:MODIFIER:exon1/146:c.-529C>T:		rs9478345	0.3301	0	0	0										0.1136	0.4848	0.4015	15	73	n/a	n/a
chr6	157522360	157522360	G	A	het		QUAL=8025;DP=194;AF=0.55;MQM=60;TRIO=HET,194,0.55,HET,308,0.49,WT,418,0.00	ARID1B	synonymous	ARID1B:NM_020732.3:synonymous:LOW:exon18/20:c.4632G>A:p.Pro1544Pro,ARID1B:NM_017519.2:synonymous:LOW:exon17/19:c.4593G>A:p.Pro1531Pro		rs61738955	0.0184	0.027	0.0405	0.0077						614556 [ARID1B (confirmed) Mental retardation,autosomal dominant 12];	RCV000114277.1 [benign]; 			0.0076	0.053	0.9394	3	24	n/a	n/a
chr6	157529844	157529844	C	T	het		QUAL=357;DP=76;AF=0.32;MQM=54;TRIO=HET,76,0.32,WT,32,0.03,HET,39,0.15	ARID1B	3'UTR	ARID1B:NM_020732.3:3'UTR:MODIFIER:exon20/20:c.*819C>T:,ARID1B:NM_017519.2:3'UTR:MODIFIER:exon19/19:c.*819C>T:	(T)n		0	0	0	0										0	0.0985	0.9015	0	15	n/a	n/a
chr6	157529849	157529849	C	T	het		QUAL=554;DP=54;AF=0.59;MQM=53;TRIO=HET,54,0.59,HET,23,0.13,HET,24,0.21	ARID1B	3'UTR	ARID1B:NM_020732.3:3'UTR:MODIFIER:exon20/20:c.*824C>T:,ARID1B:NM_017519.2:3'UTR:MODIFIER:exon19/19:c.*824C>T:	(T)n	rs139366986	0	0	0	0										0	0.2273	0.7727	0	32	n/a	n/a
chr6	158613375	158613375	A	-	het		QUAL=2041;DP=218;AF=0.18;MQM=59;TRIO=HET,218,0.18,HET,65,0.54,HET,86,0.08	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*198delA:		rs3841147	0.3193	0	0	0										0.0303	0.25	0.7197	4	37	n/a	n/a
chr6	158613603	158613603	A	C	het		QUAL=14834;DP=324;AF=0.49;MQM=60;TRIO=HET,324,0.49,HET,271,0.45,HET,315,0.56	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*414A>C:		rs4425618	0.4239	0	0	0										0.0758	0.4773	0.447	13	71	n/a	n/a
chr6	158613910	158613910	G	A	het		QUAL=3813;DP=130;AF=0.54;MQM=60;TRIO=HET,130,0.54,HET,47,0.66,HET,59,0.46	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*721G>A:	AluJr	rs9457163	0.4239	0	0	0										0.0758	0.4773	0.447	13	71	n/a	n/a
chr6	158614528	158614528	G	A	het		QUAL=9135;DP=333;AF=0.49;MQM=59;TRIO=HET,333,0.49,WT,181,0.00,HET,237,0.48	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*1339G>A:		rs35508045	0.0935	0	0	0										0.0152	0.3258	0.6591	4	48	n/a	n/a
chr6	158615926	158615926	A	T	het		QUAL=13688;DP=388;AF=0.50;MQM=60;TRIO=HET,388,0.50,HET,202,0.47,HET,248,0.49	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*2737A>T:		rs1019682	0.7798	0	0	0										0.5	0.4318	0.0682	78	63	n/a	n/a
chr6	158616335	158616335	A	C	het		QUAL=5228;DP=202;AF=0.57;MQM=60;TRIO=HET,202,0.57,HET,35,0.46,HET,50,0.52	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*3146A>C:		rs10946159	0.3722	0	0	0										0.0606	0.4924	0.447	10	74	n/a	n/a
chr6	158616727	158616727	C	T	het		QUAL=13635;DP=440;AF=0.50;MQM=58;TRIO=HET,440,0.50,HET,151,0.54,HET,231,0.47	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*3538C>T:		rs1047876	0.4233	0	0	0										0.0758	0.4773	0.447	13	71	n/a	n/a
chr6	158616876	158616876	A	C	het		QUAL=8630;DP=310;AF=0.54;MQM=55;TRIO=HET,310,0.54,WT,133,0.00,HET,220,0.43	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*3687A>C:		rs4354181	0.0986	0	0	0										0.0152	0.3182	0.6667	4	47	n/a	n/a
chr6	158617694	158617694	A	T	het		QUAL=6537;DP=297;AF=0.49;MQM=60;TRIO=HET,297,0.49,WT,102,0.00,HET,135,0.44	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*4505A>T:	HSMAR2	rs144679213	0.0126	0	0	0										0.0076	0.0909	0.9015	1	13	n/a	n/a
chr6	158619409	158619409	G	A	hom		QUAL=31900;DP=461;AF=1.00;MQM=59;TRIO=HOM,461,1.00,HOM,213,1.00,HOM,283,1.00	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*6220G>A:		rs599345	0.8912	0	0	0										0.5833	0.3636	0.053	86	55	n/a	n/a
chr6	158619713	158619713	C	G	hom		QUAL=13385;DP=261;AF=0.99;MQM=59;TRIO=HOM,261,0.99,HOM,99,1.00,HET,149,0.37	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*6524C>G:	AluSz	rs615107	0.5677	0	0	0										0.3258	0.4848	0.1894	48	74	n/a	n/a
chr6	158619948	158619948	G	C	het		QUAL=5793;DP=299;AF=0.48;MQM=60;TRIO=HET,299,0.48,WT,91,0.01,HET,96,0.34	GTF2H5	3'UTR	GTF2H5:NM_207118.2:3'UTR:MODIFIER:exon3/3:c.*6759G>C:		rs71563797	0.1032	0	0	0										0.0152	0.3182	0.6667	4	47	n/a	n/a
chr6	161132146	161132146	C	T	het		QUAL=7861;DP=228;AF=0.47;MQM=55;TRIO=HET,228,0.47,HET,309,0.48,WT,366,0.00	PLG	synonymous	PLG:NM_000301.3:synonymous:LOW:exon4/19:c.330C>T:p.Asn110Asn,PLG:NM_001168338.1:synonymous:LOW:exon4/4:c.330C>T:p.Asn110Asn		rs4757	0.2494	0.263	0.3156	0.473						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0.1136	0.5152	0.3712	62	206	n/a	n/a
chr6	161132417	161132417	T	G	het		QUAL=8317;DP=318;AF=0.47;MQM=48;TRIO=HET,318,0.47,HET,209,0.47,WT,280,0.00	PLG	3'UTR,intron	PLG:NM_001168338.1:3'UTR:MODIFIER:exon4/4:c.*190T>G:,PLG:NM_000301.3:intron:MODIFIER:exon4/18:c.407+194T>G:	MER2	rs4252082	0.2486	0	0	0						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0.1136	0.5152	0.3712	17	72	n/a	n/a
chr6	161132725	161132725	T	C	het		QUAL=7541;DP=256;AF=0.52;MQM=57;TRIO=HET,256,0.52,HET,159,0.58,WT,198,0.00	PLG	3'UTR,intron	PLG:NM_001168338.1:3'UTR:MODIFIER:exon4/4:c.*498T>C:,PLG:NM_000301.3:intron:MODIFIER:exon4/18:c.407+502T>C:		rs4252086	0.2486	0	0	0						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0.1136	0.5152	0.3712	17	72	n/a	n/a
chr6	161132804	161132804	T	C	het		QUAL=8820;DP=284;AF=0.53;MQM=56;TRIO=HET,284,0.53,HET,211,0.55,WT,315,0.00	PLG	3'UTR,intron	PLG:NM_001168338.1:3'UTR:MODIFIER:exon4/4:c.*577T>C:,PLG:NM_000301.3:intron:MODIFIER:exon4/18:c.407+581T>C:		rs1853018	0.2486	0	0	0						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0.1136	0.5076	0.3788	17	71	n/a	n/a
chr6	161132830	161132830	G	A	hom		QUAL=30616;DP=343;AF=1.00;MQM=58;TRIO=HOM,343,1.00,HOM,239,1.00,HOM,330,1.00	PLG	3'UTR,intron	PLG:NM_001168338.1:3'UTR:MODIFIER:exon4/4:c.*603G>A:,PLG:NM_000301.3:intron:MODIFIER:exon4/18:c.407+607G>A:		rs1830519	0.6066	0	0	0						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0.5909	0.3561	0.053	89	54	n/a	n/a
chr6	161137779	161137779	T	C	het		QUAL=6189;DP=131;AF=0.56;MQM=60;TRIO=HET,131,0.56,HET,55,0.58,HOM,97,0.99	PLG	synonymous	PLG:NM_000301.3:synonymous:LOW:exon7/19:c.771T>C:p.Cys257Cys		rs14224	0.4499	0.422	0.418	0.5222						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0.1667	0.5076	0.3258	87	237	n/a	n/a
chr6	161137790	161137790	G	A	het		QUAL=1838;DP=110;AF=0.41;MQM=60;TRIO=HET,110,0.41,HET,51,0.41,WT,84,0.00	PLG	missense	PLG:NM_000301.3:missense:MODERATE:exon7/19:c.782G>A:p.Arg261His		rs4252187	0.0008	0.0031	0.0036	0.0014	4.4140	D	D	D	P	173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0	0.0152	0.9848	0	5	n/a	n/a
chr6	161139480	161139480	C	T	het		QUAL=12131;DP=309;AF=0.52;MQM=60;TRIO=HET,309,0.52,HET,113,0.50,HOM,182,1.00	PLG	synonymous	PLG:NM_000301.3:synonymous:LOW:exon8/19:c.942C>T:p.Phe314Phe		rs1130656	0.3498	0.378	0.403	0.2669						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];			COSM1131985	0.1288	0.4924	0.3788	69	218	n/a	n/a
chr6	161139857	161139857	A	G	het		QUAL=6100;DP=210;AF=0.41;MQM=60;TRIO=HET,210,0.41,HET,185,0.58,WT,253,0.00	PLG	synonymous	PLG:NM_000301.3:synonymous:LOW:exon9/19:c.1083A>G:p.Gln361Gln		rs13231	0.1364	0.215	0.3008	0.1764						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0.0833	0.4924	0.4242	37	203	n/a	n/a
chr6	161143608	161143608	T	C	het		QUAL=4743;DP=189;AF=0.43;MQM=60;TRIO=HET,189,0.43,HET,152,0.48,WT,187,0.01	PLG	splice_region&intron	PLG:NM_000301.3:splice_region&intron:LOW:exon10/18:c.1256+9T>C:		rs4252120	0.14	0.217	0.303	0.1825						173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];				0.0833	0.4924	0.4242	36	202	n/a	n/a
chr6	161152240	161152240	G	A	het		QUAL=5389;DP=212;AF=0.48;MQM=60;TRIO=HET,212,0.48,HET,153,0.51,WT,198,0.00	PLG	missense	PLG:NM_000301.3:missense:MODERATE:exon11/19:c.1414G>A:p.Asp472Asn		rs4252125	0.1398	0.217	0.3028	0.1825	0.0580	P	T	B	B	173350 [PLG (confirmed) Plasminogen Tochigi disease|Thrombophilia,dysplasminogenemic|Plasminogen deficiency,types I and II|Conjunctivitis,ligneous];		CM043559 [CLASS=DFP MUT=ALT PHEN="Invasive aspergillosis, susceptibility" GENE=PLG]; 		0.0833	0.4848	0.4318	36	201	n/a	n/a
chr6	161174658	161174658	G	A	het		QUAL=12998;DP=235;AF=0.51;MQM=46;TRIO=HET,235,0.51,HOM,179,1.00,HET,197,0.50	PLG	3'UTR	PLG:NM_000301.3:3'UTR:MODIFIER:exon19/19:c.*565G>A:		rs783167	0.8738	0	0	0										0.697	0.2955	0.0076	102	46	n/a	n/a
chr6	161174933	161174933	C	T	het		QUAL=17428;DP=451;AF=0.47;MQM=60;TRIO=HET,451,0.47,WT,536,0.00,HET,653,0.49	PLG	3'UTR	PLG:NM_000301.3:3'UTR:MODIFIER:exon19/19:c.*840C>T:		rs4252199	0.011	0	0	0										0	0.0455	0.9545	1	7	n/a	n/a
chr6	161175004	161175004	C	T	het		QUAL=17473;DP=531;AF=0.51;MQM=55;TRIO=HET,531,0.51,HET,538,0.48,WT,650,0.00	PLG	3'UTR	PLG:NM_000301.3:3'UTR:MODIFIER:exon19/19:c.*911C>T:		rs4252181	0.1126	0	0	0										0.0758	0.4773	0.447	11	67	n/a	n/a
chr6	161768651	161768651	G	T	het		QUAL=311;DP=35;AF=0.34;MQM=54;TRIO=HET,35,0.34,NONE,0,0,HOM,2,1.00	PARK2	3'UTR	PARK2:NM_004562.2:3'UTR:MODIFIER:exon12/12:c.*2480C>A:,PARK2:NM_013987.2:3'UTR:MODIFIER:exon11/11:c.*2480C>A:,PARK2:NM_013988.2:3'UTR:MODIFIER:exon9/9:c.*2480C>A:	AluSg4	rs68121389	0.499	0	0	0										0.053	0.0606	0.8864	12	16	n/a	n/a
chr6	161769835	161769835	T	C	het		QUAL=13632;DP=410;AF=0.53;MQM=60;TRIO=HET,410,0.53,WT,355,0.00,HET,439,0.48	PARK2	3'UTR	PARK2:NM_004562.2:3'UTR:MODIFIER:exon12/12:c.*1296A>G:,PARK2:NM_013987.2:3'UTR:MODIFIER:exon11/11:c.*1296A>G:,PARK2:NM_013988.2:3'UTR:MODIFIER:exon9/9:c.*1296A>G:		rs3734464	0.0577	0	0	0										0	0.2045	0.7955	0	31	n/a	n/a
chr6	167369897	167369897	C	A	het		QUAL=1442;DP=15;AF=0.60;MQM=59;TRIO=HET,15,0.60,WT,60,0.02,HET,84,0.51	RNASET2	5'UTR	RNASET2:NM_003730.4:5'UTR:MODIFIER:exon1/9:c.-227G>T:		rs1044059	0.6737	0	0	0										0.2652	0.447	0.2879	39	66	n/a	n/a
chr6	167369992	167369992	A	G	het		QUAL=708;DP=8;AF=0.75;MQM=60;TRIO=HET,8,0.75,WT,26,0.00,HET,37,0.59	RNASET2	5'UTR	RNASET2:NM_003730.4:5'UTR:MODIFIER:exon1/9:c.-322T>C:		rs2247325	0.6396	0	0	0										0.1288	0.3485	0.5227	18	50	n/a	n/a
chr6	170871037	170871037	-	CAG	het		QUAL=9321;DP=15;AF=0.27;MQM=59;TRIO=HET,15,0.27,HET,357,0.33,HET,350,0.59	TBP	disruptive_inframe_insertion	TBP:NM_003194.4:disruptive_inframe_insertion:MODERATE:exon3/8:c.213_215dupGCA:p.Gln72dup,TBP:NM_001172085.1:disruptive_inframe_insertion:MODERATE:exon2/7:c.153_155dupGCA:p.Gln52dup	(CAG)n		0	0	0	0						600075 [TBP (confirmed) Spinocerebellar ataxia 17|Parkinson disease,susceptibility to];				0.5985	0.2727	0.1288	565	182	n/a	n/a
chr6	170878793	170878793	T	C	hom		QUAL=19289;DP=304;AF=1.00;MQM=59;TRIO=HOM,304,1.00,HET,248,0.49,HET,337,0.47	TBP	synonymous	TBP:NM_003194.4:synonymous:LOW:exon6/8:c.771T>C:p.Asn257Asn,TBP:NM_001172085.1:synonymous:LOW:exon5/7:c.711T>C:p.Asn237Asn		rs1042327	0.6146	0.531	0.5007	0.6568	0.3870	P				600075 [TBP (confirmed) Spinocerebellar ataxia 17|Parkinson disease,susceptibility to];	RCV000118601.2 [likely benign]; 			0.2652	0.5152	0.2197	146	235	n/a	n/a
chr7	286402	286402	A	G	het		QUAL=5744;DP=155;AF=0.34;MQM=60;TRIO=HET,155,0.34,HOM,143,0.99,WT,310,0.00	FAM20C	synonymous	FAM20C:NM_020223.3:synonymous:LOW:exon4/10:c.885A>G:p.Thr295Thr		rs141256626	0.2883	0.234	0.2319	0.5159						611061 [FAM20C (confirmed) Raine syndrome];			COSM4162129	0.0455	0.3333	0.6212	20	141	n/a	n/a
chr7	4831675	4831675	G	A	het		QUAL=2411;DP=59;AF=0.47;MQM=60;TRIO=HET,59,0.47,HET,113,0.47,WT,150,0.00	AP5Z1	3'UTR	AP5Z1:NM_014855.2:3'UTR:MODIFIER:exon17/17:c.*659G>A:		rs140612456	0.0136	0	0	0										0	0.1364	0.8636	0	19	n/a	n/a
chr7	6026775	6026775	T	C	hom		QUAL=32402;DP=189;AF=0.99;MQM=56;TRIO=HOM,189,0.99,HOM,323,1.00,HOM,484,1.00	PMS2	missense	PMS2:NM_000535.5:missense:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu		rs2228006	0.8832	0.851	0.8457	0.9185	1.4430	P	T	B,B,B	B,B,B	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000030365.2 [benign]; RCV000034619.2 [benign]; 	BM1497492 [CLASS=DM? MUT=REF PHEN="Colorectal cancer, non-polyposis" GENE=PMS2]; 	COSM4162329	0.7576	0.2197	0.0227	731	242	n/a	n/a
chr7	6026959	6026959	G	C	het		QUAL=4878;DP=165;AF=0.36;MQM=48;TRIO=HET,165,0.36,WT,120,0.00,HET,198,0.51	PMS2	missense	PMS2:NM_000535.5:missense:MODERATE:exon11/15:c.1437C>G:p.His479Gln		rs63750685	0.0028	0.0045	0.0028	0.0098	0.1820	N	T	B,B,B	B,B,B	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000034615.2 [benign]; RCV000076809.2 [uncertain significance]; RCV000121844.1 [not provided]; 			0	0.0076	0.9924	0	7	n/a	n/a
chr7	6026988	6026988	G	A	hom		QUAL=10427;DP=202;AF=1.00;MQM=52;TRIO=HOM,202,1.00,HET,100,0.47,HET,165,0.48	PMS2	missense	PMS2:NM_000535.5:missense:MODERATE:exon11/15:c.1408C>T:p.Pro470Ser		rs1805321	0.3582	0.385	0.4209	0.2819	0.2650	P	T	B,B,B	B,B,B	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000030364.2 [benign]; RCV000034614.1 [benign]; RCV000079103.3 [benign]; RCV000130721.1 [benign]; RCV000144645.1 [benign]; 		COSM3736445	0.1742	0.4924	0.3333	166	485	1	n/a
chr7	6036980	6036980	G	C	hom		QUAL=7004;DP=124;AF=1.00;MQM=60;TRIO=HOM,124,1.00,HOM,46,1.00,HOM,40,1.00	PMS2	synonymous	PMS2:NM_000535.5:synonymous:LOW:exon7/15:c.780C>G:p.Ser260Ser		rs1805319	0.8313	0.809	0.8148	0.8414						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000030372.2 [benign]; RCV000079112.2 [benign]; RCV000131484.1 [benign]; 		COSM4162330	0.697	0.2424	0.0606	659	293	n/a	n/a
chr7	6037058	6037058	A	-	het		QUAL=559;DP=12;AF=0.58;MQM=60;TRIO=HET,12,0.58,HET,27,0.44,HET,26,0.23	PMS2	splice_region&intron	PMS2:NM_000535.5:splice_region&intron:LOW:exon6/14:c.706-4delT:		rs549793612	0	0	0	0						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];				0.0303	0.2727	0.697	25	124	n/a	n/a
chr7	22980929	22980929	-	AC	het		QUAL=4671;DP=133;AF=0.42;MQM=60;TRIO=HET,133,0.42,WT,66,0.00,HOM,98,0.97	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*4278_*4279insGT:		rs35708583	0.4275	0	0	0										0.1667	0.4394	0.3939	24	65	n/a	n/a
chr7	22981404	22981404	T	G	het		QUAL=5255;DP=148;AF=0.40;MQM=59;TRIO=HET,148,0.40,HOM,102,1.00,WT,127,0.01	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*3804A>C:		rs34683819	0.225	0	0	0										0.1591	0.3561	0.4848	24	55	n/a	n/a
chr7	22981528	22981528	T	C	het		QUAL=8594;DP=202;AF=0.50;MQM=59;TRIO=HET,202,0.50,WT,85,0.00,HOM,166,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*3680A>G:		rs3815348	0.4275	0	0	0										0.1742	0.4318	0.3939	25	64	n/a	n/a
chr7	22982207	22982207	T	C	het		QUAL=9068;DP=256;AF=0.55;MQM=60;TRIO=HET,256,0.55,WT,94,0.00,HOM,137,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*3001A>G:		rs2286495	0.4277	0	0	0										0.1742	0.4318	0.3939	25	64	n/a	n/a
chr7	22982547	22982547	G	A	het		QUAL=6625;DP=272;AF=0.47;MQM=60;TRIO=HET,272,0.47,HOM,79,0.96,WT,152,0.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*2661C>T:		rs13222017	0.2206	0	0	0										0.1515	0.3561	0.4924	22	57	n/a	n/a
chr7	22982826	22982827	AT	-	het		QUAL=7454;DP=278;AF=0.46;MQM=60;TRIO=HET,278,0.46,WT,99,0.00,HOM,108,0.98	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*2381_*2382delAT:		rs143367578	0.1086	0	0	0										0.0303	0.2727	0.697	4	41	n/a	n/a
chr7	22983600	22983600	T	C	het		QUAL=11982;DP=424;AF=0.48;MQM=60;TRIO=HET,424,0.48,HOM,156,1.00,WT,211,0.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*1608A>G:		rs10488277	0.225	0	0	0										0.1515	0.3561	0.4924	22	58	n/a	n/a
chr7	22983702	22983702	A	T	hom		QUAL=32100;DP=472;AF=1.00;MQM=60;TRIO=HOM,472,1.00,HOM,236,1.00,HOM,304,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*1506T>A:		rs4607514	0.6671	0	0	0										0.5303	0.3788	0.0909	80	57	n/a	n/a
chr7	22983890	22983890	T	C	hom		QUAL=30163;DP=335;AF=1.00;MQM=60;TRIO=HOM,335,1.00,HOM,226,1.00,HOM,347,1.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*1318A>G:		rs1583511	0.6721	0	0	0										0.5303	0.3864	0.0833	81	57	n/a	n/a
chr7	22984772	22984772	A	C	het		QUAL=18613;DP=503;AF=0.46;MQM=60;TRIO=HET,503,0.46,WT,264,0.00,HOM,344,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*436T>G:		rs10085448	0.4301	0	0	0										0.1742	0.4318	0.3939	25	65	n/a	n/a
chr7	22984773	22984773	G	A	het		QUAL=18613;DP=503;AF=0.46;MQM=60;TRIO=HET,503,0.46,WT,264,0.00,HOM,344,0.99	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*435C>T:		rs10085739	0.4273	0	0	0										0.1742	0.4318	0.3939	25	65	n/a	n/a
chr7	22984824	22984824	T	C	hom		QUAL=37087;DP=582;AF=1.00;MQM=60;TRIO=HOM,582,1.00,HOM,244,1.00,HOM,299,1.00	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*384A>G:		rs2286494	0.653	0	0	0										0.5303	0.3788	0.0909	80	57	n/a	n/a
chr7	22984967	22984967	A	G	het		QUAL=8210;DP=285;AF=0.47;MQM=60;TRIO=HET,285,0.47,HOM,116,0.99,WT,154,0.02	FAM126A	3'UTR	FAM126A:NM_032581.3:3'UTR:MODIFIER:exon11/11:c.*241T>C:		rs2286493	0.2025	0	0	0										0.1515	0.3561	0.4924	22	58	n/a	n/a
chr7	23015831	23015831	T	C	het		QUAL=11987;DP=268;AF=0.53;MQM=60;TRIO=HET,268,0.53,WT,202,0.00,HOM,225,1.00	FAM126A	splice_region&synonymous	FAM126A:NM_032581.3:splice_region&synonymous:LOW:exon7/11:c.624A>G:p.Ser208Ser		rs3735231	0.3748	0.372	0.345	0.3436	1.6430	P				610531 [FAM126A (provisional) Leukodystrophy,hypomyelinating,5];	RCV000020929.2 [benign]; 			0.1515	0.4091	0.4394	86	322	1	n/a
chr7	30634661	30634661	C	G	hom		QUAL=3700;DP=16;AF=1.00;MQM=59;TRIO=HOM,16,1.00,HOM,43,1.00,HOM,71,1.00	GARS	missense	GARS:NM_002047.2:missense:MODERATE:exon1/17:c.124C>G:p.Pro42Ala		rs1049402	0.6494	0.659	0.7921	0.6315	-0.6710	P	T	B	B	600287 [GARS (confirmed) Charcot-Marie-Tooth disease,type 2D|Neuropathy,distal hereditary motor,type VA];			COSM3762627	0.6136	0.25	0.1364	425	254	n/a	n/a
chr7	30673345	30673345	C	T	hom		QUAL=20032;DP=204;AF=1.00;MQM=60;TRIO=HOM,204,1.00,HOM,184,1.00,HOM,240,1.00	GARS	splice_region&intron	GARS:NM_002047.2:splice_region&intron:LOW:exon16/16:c.2095-6C>T:		rs2240401	0.4042	0.552	0.64	0.1645						600287 [GARS (confirmed) Charcot-Marie-Tooth disease,type 2D|Neuropathy,distal hereditary motor,type VA];			COSM4004448	0.447	0.4015	0.1515	278	345	n/a	n/a
chr7	30673513	30673513	A	-	het		QUAL=10523;DP=212;AF=0.59;MQM=59;TRIO=HET,212,0.59,HET,174,0.71,HET,218,0.71	GARS	3'UTR	GARS:NM_002047.2:3'UTR:MODIFIER:exon17/17:c.*51delA:		rs70983380	0	0	0	0										0.3636	0.3788	0.2576	53	53	n/a	n/a
chr7	42003662	42003662	-	T	het		QUAL=391;DP=76;AF=0.13;MQM=60;TRIO=HET,76,0.13,HET,3,0.33,HOM,11,0.73	GLI3	3'UTR	GLI3:NM_000168.5:3'UTR:MODIFIER:exon15/15:c.*265dupA:		rs550264781	0.3918	0	0	0										0.0076	0.0833	0.9091	1	12	n/a	n/a
chr7	44184403	44184403	C	T	het		QUAL=2734;DP=107;AF=0.51;MQM=59;TRIO=HET,107,0.51,HET,74,0.51,WT,119,0.00	GCK	3'UTR	GCK:NM_033507.1:3'UTR:MODIFIER:exon10/10:c.*332G>A:,GCK:NM_033508.1:3'UTR:MODIFIER:exon11/11:c.*332G>A:,GCK:NM_000162.3:3'UTR:MODIFIER:exon10/10:c.*332G>A:		rs13306388	0.152	0	0	0										0.0758	0.4015	0.5227	11	60	n/a	n/a
chr7	47865325	47865325	C	A	hom		QUAL=19172;DP=308;AF=1.00;MQM=60;TRIO=HOM,308,1.00,HOM,142,1.00,HOM,150,1.00	PKD1L1	intron	PKD1L1:NM_138295.3:intron:MODIFIER:exon45/56:c.6854+1623G>T:	L1M2	rs4720618	0.9802	0	0	0										1	0	0	150	0	n/a	n/a
chr7	50611735	50611735	T	C	hom		QUAL=33149;DP=228;AF=1.00;MQM=59;TRIO=HOM,228,1.00,HOM,342,1.00,HOM,463,1.00	DDC	missense	DDC:NM_000790.3:missense:MODERATE:exon2/15:c.49A>G:p.Met17Val,DDC:NM_001242886.1:missense:MODERATE:exon2/14:c.49A>G:p.Met17Val,DDC:NM_001242887.1:missense:MODERATE:exon2/14:c.49A>G:p.Met17Val,DDC:NM_001242888.1:missense:MODERATE:exon2/13:c.49A>G:p.Met17Val,DDC:NM_001242889.1:missense:MODERATE:exon2/13:c.49A>G:p.Met17Val,DDC:NM_001082971.1:missense:MODERATE:exon2/15:c.49A>G:p.Met17Val,DDC:NM_001242890.1:missense:MODERATE:exon2/10:c.49A>G:p.Met17Val		rs6264	0.9932	0.998	1	0.9803	-0.6030	P	T	B	B	107930 [DDC (confirmed) Aromatic L-amino acid decarboxylase deficiency];				1	0	0	454	0	n/a	n/a
chr7	50628740	50628743	CTCT	-	het		QUAL=7677;DP=223;AF=0.39;MQM=60;TRIO=HET,223,0.39,WT,216,0.00,HOM,171,0.99	DDC	5'UTR,intron	DDC:NM_000790.3:5'UTR:MODIFIER:exon1/15:c.-61_-58delAGAG:,DDC:NM_001242886.1:5'UTR:MODIFIER:exon1/14:c.-61_-58delAGAG:,DDC:NM_001242887.1:5'UTR:MODIFIER:exon1/14:c.-61_-58delAGAG:,DDC:NM_001242888.1:5'UTR:MODIFIER:exon1/13:c.-61_-58delAGAG:,DDC:NM_001242889.1:5'UTR:MODIFIER:exon1/13:c.-61_-58delAGAG:,DDC:NM_001242890.1:5'UTR:MODIFIER:exon1/10:c.-61_-58delAGAG:,DDC:NM_001082971.1:intron:MODIFIER:exon1/14:c.-29+4239_-29+4242delAGAG:		rs398095073	0.2929	0	0	0										0.0909	0.3712	0.5379	15	53	n/a	n/a
chr7	65425894	65425894	A	G	hom		QUAL=35798;DP=457;AF=0.99;MQM=60;TRIO=HOM,457,0.99,HET,585,0.50,HET,752,0.48	GUSB	missense	GUSB:NM_000181.3:missense:MODERATE:exon12/12:c.1946T>C:p.Leu649Pro,GUSB:NM_001284290.1:missense:MODERATE:exon10/10:c.1508T>C:p.Leu503Pro,GUSB:NM_001293104.1:missense:MODERATE:exon11/11:c.1376T>C:p.Leu459Pro,GUSB:NM_001293105.1:missense:MODERATE:exon10/10:c.1289T>C:p.Leu430Pro		rs9530	0.5807	0.58	0.553	0.3695	-0.0470	P	T	B,B	B,B	611499 [GUSB (confirmed) Mucopolysaccharidosis VII];	RCV000078327.2 [benign]; 			0.3939	0.5152	0.0909	162	216	n/a	n/a
chr7	65447242	65447242	C	A	het		QUAL=504;DP=21;AF=0.52;MQM=60;TRIO=HET,21,0.52,HET,14,0.71,WT,22,0.00	GUSB	5'UTR	GUSB:NM_000181.3:5'UTR:MODIFIER:exon1/12:c.-72G>T:,GUSB:NM_001284290.1:5'UTR:MODIFIER:exon1/10:c.-72G>T:,GUSB:NM_001293104.1:5'UTR:MODIFIER:exon1/11:c.-457G>T:,GUSB:NM_001293105.1:5'UTR:MODIFIER:exon1/10:c.-401G>T:		rs2279904	0.0377	0	0	0										0.0076	0.1136	0.8788	1	17	n/a	n/a
chr7	66104909	66104909	G	C	het		QUAL=6580;DP=238;AF=0.50;MQM=60;TRIO=HET,238,0.50,HET,183,0.50,WT,215,0.00	KCTD7	3'UTR,intron	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*690G>C:,KCTD7:NM_001167961.2:intron:MODIFIER:exon4/4:c.867-472G>C:		rs4718382	0.0407	0	0	0						611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions];				0	0.1439	0.8561	0	22	n/a	n/a
chr7	66105163	66105163	C	G	het		QUAL=20213;DP=338;AF=0.51;MQM=59;TRIO=HET,338,0.51,HOM,271,1.00,HET,332,0.56	KCTD7	3'UTR,intron	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*944C>G:,KCTD7:NM_001167961.2:intron:MODIFIER:exon4/4:c.867-218C>G:		rs9791712	0.6238	0	0	0						611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions];				0.3106	0.5379	0.1515	45	85	n/a	n/a
chr7	66105198	66105198	C	A	het		QUAL=16489;DP=240;AF=0.50;MQM=60;TRIO=HET,240,0.50,HOM,237,1.00,HET,292,0.55	KCTD7	3'UTR,intron	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*979C>A:,KCTD7:NM_001167961.2:intron:MODIFIER:exon4/4:c.867-183C>A:		rs9791713	0.6236	0	0	0						611725 [KCTD7 (provisional) Epilepsy,progressive myoclonic 3,with or without intracellular inclusions];				0.3106	0.5379	0.1515	45	85	n/a	n/a
chr7	66105946	66105946	G	C	het		QUAL=7871;DP=296;AF=0.43;MQM=60;TRIO=HET,296,0.43,HET,248,0.49,WT,315,0.00	KCTD7	3'UTR	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*1727G>C:,KCTD7:NM_001167961.2:3'UTR:MODIFIER:exon5/5:c.*565G>C:		rs17229513	0.0371	0	0	0										0	0.1439	0.8561	0	22	n/a	n/a
chr7	66106875	66106875	A	G	het		QUAL=23085;DP=366;AF=0.53;MQM=60;TRIO=HET,366,0.53,HOM,328,1.00,HET,350,0.54	KCTD7	3'UTR	KCTD7:NM_153033.4:3'UTR:MODIFIER:exon4/4:c.*2656A>G:,KCTD7:NM_001167961.2:3'UTR:MODIFIER:exon5/5:c.*1494A>G:		rs1860469	0.6234	0	0	0										0.3106	0.5379	0.1515	45	85	n/a	n/a
chr7	73442480	73442480	C	T	het		QUAL=165;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,WT,8,0.00,HET,11,0.45	ELN	5'UTR_premature_start_codon_gain,5'UTR	ELN:NM_001278939.1:5'UTR_premature_start_codon_gain:LOW:exon1/34:c.-38C>T:,ELN:NM_000501.3:5'UTR_premature_start_codon_gain:LOW:exon1/33:c.-38C>T:,ELN:NM_001081752.2:5'UTR_premature_start_codon_gain:LOW:exon1/30:c.-38C>T:,ELN:NM_001081753.2:5'UTR_premature_start_codon_gain:LOW:exon1/31:c.-38C>T:,ELN:NM_001081754.2:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:NM_001081755.2:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:NM_001278912.1:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:NM_001278913.1:5'UTR_premature_start_codon_gain:LOW:exon1/29:c.-38C>T:,ELN:NM_001278914.1:5'UTR_premature_start_codon_gain:LOW:exon1/31:c.-38C>T:,ELN:NM_001278915.1:5'UTR_premature_start_codon_gain:LOW:exon1/33:c.-38C>T:,ELN:NM_001278916.1:5'UTR_premature_start_codon_gain:LOW:exon1/29:c.-38C>T:,ELN:NM_001278917.1:5'UTR_premature_start_codon_gain:LOW:exon1/32:c.-38C>T:,ELN:NM_001278918.1:5'UTR_premature_start_codon_gain:LOW:exon1/28:c.-38C>T:,ELN:NM_001278939.1:5'UTR:MODIFIER:exon1/34:c.-38C>T:,ELN:NM_000501.3:5'UTR:MODIFIER:exon1/33:c.-38C>T:,ELN:NM_001081752.2:5'UTR:MODIFIER:exon1/30:c.-38C>T:,ELN:NM_001081753.2:5'UTR:MODIFIER:exon1/31:c.-38C>T:,ELN:NM_001081754.2:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:NM_001081755.2:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:NM_001278912.1:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:NM_001278913.1:5'UTR:MODIFIER:exon1/29:c.-38C>T:,ELN:NM_001278914.1:5'UTR:MODIFIER:exon1/31:c.-38C>T:,ELN:NM_001278915.1:5'UTR:MODIFIER:exon1/33:c.-38C>T:,ELN:NM_001278916.1:5'UTR:MODIFIER:exon1/29:c.-38C>T:,ELN:NM_001278917.1:5'UTR:MODIFIER:exon1/32:c.-38C>T:,ELN:NM_001278918.1:5'UTR:MODIFIER:exon1/28:c.-38C>T:		rs41410045	0.026	0.019	0.0087	0.0016										0	0.0379	0.9621	0	5	n/a	n/a
chr7	73483531	73483531	-	A	het		QUAL=5495;DP=135;AF=0.46;MQM=60;TRIO=HET,135,0.46,WT,180,0.00,HET,244,0.49	ELN	3'UTR	ELN:NM_001278939.1:3'UTR:MODIFIER:exon34/34:c.*501_*502insA:,ELN:NM_000501.3:3'UTR:MODIFIER:exon33/33:c.*501_*502insA:,ELN:NM_001081752.2:3'UTR:MODIFIER:exon30/30:c.*501_*502insA:,ELN:NM_001081753.2:3'UTR:MODIFIER:exon31/31:c.*501_*502insA:,ELN:NM_001081754.2:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:NM_001081755.2:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:NM_001278912.1:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:NM_001278913.1:3'UTR:MODIFIER:exon29/29:c.*501_*502insA:,ELN:NM_001278914.1:3'UTR:MODIFIER:exon31/31:c.*501_*502insA:,ELN:NM_001278915.1:3'UTR:MODIFIER:exon33/33:c.*501_*502insA:,ELN:NM_001278916.1:3'UTR:MODIFIER:exon29/29:c.*501_*502insA:,ELN:NM_001278917.1:3'UTR:MODIFIER:exon32/32:c.*501_*502insA:,ELN:NM_001278918.1:3'UTR:MODIFIER:exon28/28:c.*501_*502insA:		rs34208922	0.2901	0	0	0										0.0303	0.3939	0.5758	6	60	n/a	n/a
chr7	74193668	74193668	G	A	het		QUAL=16679;DP=14;AF=0.71;MQM=36;TRIO=HET,14,0.71,HET,272,0.79,HET,535,0.59	NCF1	missense	NCF1:NM_000265.5:missense:MODERATE:exon4/11:c.295G>A:p.Gly99Ser		rs17295741	0.6312	0.535	0	0	0.5180	P	T	B,B	B,B	608512 [NCF1 (provisional) Chronic granulomatous disease due to deficiency of NCF-1];			COSM4162428	0.3561	0.5	0.1439	175	253	n/a	n/a
chr7	75163169	75163169	A	G	hom		QUAL=28221;DP=237;AF=1.00;MQM=59;TRIO=HOM,237,1.00,HOM,281,1.00,HOM,347,1.00	HIP1	3'UTR	HIP1:NM_005338.6:3'UTR:MODIFIER:exon31/31:c.*4324T>C:,HIP1:NM_001243198.2:3'UTR:MODIFIER:exon29/29:c.*4324T>C:		rs1167827	0.528	0	0	0										0.3333	0.5152	0.1515	49	78	n/a	n/a
chr7	75163761	75163761	T	-	het		QUAL=53;DP=49;AF=0.08;MQM=60;TRIO=HET,49,0.08,WT,5,0.00,HET,10,0.50	HIP1	3'UTR	HIP1:NM_005338.6:3'UTR:MODIFIER:exon31/31:c.*3732delA:,HIP1:NM_001243198.2:3'UTR:MODIFIER:exon29/29:c.*3732delA:	AluSx1		0	0	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr7	75166401	75166401	C	T	hom		QUAL=30709;DP=294;AF=0.99;MQM=59;TRIO=HOM,294,0.99,HOM,312,0.99,HOM,375,1.00	HIP1	3'UTR	HIP1:NM_005338.6:3'UTR:MODIFIER:exon31/31:c.*1092G>A:,HIP1:NM_001243198.2:3'UTR:MODIFIER:exon29/29:c.*1092G>A:		rs1167830	0.3758	0	0	0										0.1667	0.4848	0.3485	26	69	n/a	n/a
chr7	75166426	75166426	C	T	hom		QUAL=22098;DP=210;AF=0.99;MQM=60;TRIO=HOM,210,0.99,HET,284,0.50,HOM,342,1.00	HIP1	3'UTR	HIP1:NM_005338.6:3'UTR:MODIFIER:exon31/31:c.*1067G>A:,HIP1:NM_001243198.2:3'UTR:MODIFIER:exon29/29:c.*1067G>A:		rs55859405	0.094	0	0	0										0.0076	0.0985	0.8939	1	17	n/a	n/a
chr7	75183403	75183403	A	G	hom		QUAL=14584;DP=165;AF=1.00;MQM=59;TRIO=HOM,165,1.00,HOM,130,0.98,HOM,177,1.00	HIP1	splice_region&intron	HIP1:NM_005338.6:splice_region&intron:LOW:exon21/30:c.2158+9T>C:,HIP1:NM_001243198.2:splice_region&intron:LOW:exon21/28:c.2158+9T>C:		rs1167807	0.6759	0.612	0.561	0.8053						601767 [HIP1 (confirmed) Prostate cancer,progression of];			COSM3950799	0.3485	0.4621	0.1894	141	221	n/a	n/a
chr7	75513062	75513062	A	G	hom		QUAL=25852;DP=228;AF=1.00;MQM=59;TRIO=HOM,228,1.00,HOM,259,1.00,HOM,328,1.00	RHBDD2	synonymous	RHBDD2:NM_001040456.1:synonymous:LOW:exon3/4:c.633A>G:p.Ala211Ala,RHBDD2:NM_001040457.1:synonymous:LOW:exon4/5:c.210A>G:p.Ala70Ala		rs42183	0.9866	0.968	0.9611	0.994	-2.5140	P								0.8939	0.1061	0	291	24	n/a	n/a
chr7	75544455	75544455	A	C	hom		QUAL=480;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HET,26,0.38,HET,31,0.19	POR	5'UTR	POR:NM_000941.2:5'UTR:MODIFIER:exon1/16:c.-47A>C:		rs3823884	0.4836	0	0	0										0.0682	0.3258	0.6061	18	82	n/a	n/a
chr7	75583325	75583325	A	G	het		QUAL=5078;DP=121;AF=0.46;MQM=60;TRIO=HET,121,0.46,HET,248,0.46,WT,317,0.00	POR	synonymous	POR:NM_000941.2:synonymous:LOW:exon2/16:c.15A>G:p.Gly5Gly		rs10262966	0.1046	0.035	0.0044	0.2429						124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome P450 oxidoreductase];				0	0.0152	0.9848	0	11	n/a	n/a
chr7	75609677	75609677	A	G	het		QUAL=9726;DP=123;AF=0.53;MQM=60;TRIO=HET,123,0.53,HET,205,0.47,HET,293,0.52	POR	synonymous	POR:NM_000941.2:synonymous:LOW:exon5/16:c.387A>G:p.Pro129Pro		rs1135612	0.2494	0.264	0.2512	0.0763	-5.4830	P				124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome P450 oxidoreductase];			COSM453393	0.0227	0.3561	0.6212	32	186	n/a	n/a
chr7	75614953	75614953	T	C	hom		QUAL=5335;DP=59;AF=1.00;MQM=59;TRIO=HOM,59,1.00,HOM,61,1.00,HOM,58,1.00	POR	synonymous	POR:NM_000941.2:synonymous:LOW:exon13/16:c.1455T>C:p.Ala485Ala		rs2228104	0.8353	0.911	0.9664	0.6843	-6.5840	P				124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome P450 oxidoreductase];	RCV000127583.1 [benign]; 		COSM4162445	0.9318	0.0682	0	438	33	n/a	n/a
chr7	75615287	75615287	G	A	het		QUAL=7249;DP=184;AF=0.45;MQM=59;TRIO=HET,184,0.45,HET,283,0.55,WT,383,0.01	POR	synonymous	POR:NM_000941.2:synonymous:LOW:exon14/16:c.1716G>A:p.Ser572Ser		rs1057870	0.1953	0.247	0.3481	0.1548	-2.3900	P				124015 [POR (confirmed) Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome P450 oxidoreductase];			COSM3762836	0.0909	0.447	0.4621	55	200	n/a	n/a
chr7	75615875	75615875	G	A	het		QUAL=4353;DP=144;AF=0.49;MQM=60;TRIO=HET,144,0.49,HET,123,0.59,WT,142,0.00	POR	3'UTR	POR:NM_000941.2:3'UTR:MODIFIER:exon16/16:c.*76G>A:		rs55909219	0	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr7	82993252	82993252	G	A	het		QUAL=471;DP=20;AF=0.65;MQM=40;TRIO=HET,20,0.65,WT,10,0.00,HOM,9,1.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*3650C>T:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*3650C>T:	AluYb9	rs111864994	0.0747	0	0	0										0.0227	0.1667	0.8106	3	23	n/a	n/a
chr7	82993432	82993432	G	A	het		QUAL=4768;DP=184;AF=0.48;MQM=43;TRIO=HET,184,0.48,WT,102,0.00,HET,151,0.50	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*3470C>T:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*3470C>T:	AluYb9	rs181922588	0.0096	0	0	0										0	0.0682	0.9318	0	9	n/a	n/a
chr7	82993568	82993568	T	C	het		QUAL=14699;DP=373;AF=0.53;MQM=60;TRIO=HET,373,0.53,WT,240,0.00,HOM,265,0.98	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*3334A>G:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*3334A>G:		rs112935076	0.1008	0	0	0										0.0152	0.2121	0.7727	2	29	n/a	n/a
chr7	82994067	82994067	C	G	het		QUAL=13098;DP=338;AF=0.46;MQM=60;TRIO=HET,338,0.46,WT,204,0.00,HOM,241,1.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*2835G>C:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*2835G>C:		rs73709849	0.1008	0	0	0										0.0152	0.2121	0.7727	2	29	n/a	n/a
chr7	82995006	82995006	T	A	het		QUAL=5855;DP=152;AF=0.51;MQM=60;TRIO=HET,152,0.51,HOM,100,1.00,WT,141,0.02	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*1896A>T:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*1896A>T:		rs2723017	0.6384	0	0	0										0.4697	0.4697	0.0606	78	64	n/a	n/a
chr7	82995443	82995443	A	G	het		QUAL=3310;DP=169;AF=0.41;MQM=60;TRIO=HET,169,0.41,HET,49,0.61,WT,65,0.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*1459T>C:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*1459T>C:		rs571661220	0	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr7	82995774	82995774	A	-	het		QUAL=5089;DP=193;AF=0.52;MQM=60;TRIO=HET,193,0.52,WT,48,0.02,HOM,58,1.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*1128delT:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*1128delT:		rs146062755	0.101	0	0	0										0.0152	0.2121	0.7727	2	29	n/a	n/a
chr7	82996706	82996706	A	T	het		QUAL=8992;DP=359;AF=0.53;MQM=60;TRIO=HET,359,0.53,WT,69,0.00,HOM,80,1.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*196T>A:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*196T>A:	AT_rich	rs3801661	0.0907	0	0	0										0.0152	0.2121	0.7727	2	29	n/a	n/a
chr7	82996831	82996831	A	T	het		QUAL=3514;DP=196;AF=0.46;MQM=60;TRIO=HET,196,0.46,HET,37,0.59,WT,37,0.00	SEMA3E	3'UTR	SEMA3E:NM_012431.2:3'UTR:MODIFIER:exon17/17:c.*71T>A:,SEMA3E:NM_001178129.1:3'UTR:MODIFIER:exon17/17:c.*71T>A:		rs75164403	0.1046	0	0	0										0.0076	0.2727	0.7197	1	41	n/a	n/a
chr7	83029438	83029438	C	T	het		QUAL=10093;DP=236;AF=0.55;MQM=60;TRIO=HET,236,0.55,HOM,183,0.99,WT,282,0.00	SEMA3E	synonymous	SEMA3E:NM_012431.2:synonymous:LOW:exon11/17:c.1272G>A:p.Leu424Leu,SEMA3E:NM_001178129.1:synonymous:LOW:exon11/17:c.1092G>A:p.Leu364Leu		rs2722974	0.3395	0.422	0.4453	0.1287						608166 [SEMA3E (provisional) CHARGE syndrome];				0.2348	0.5076	0.2576	90	225	n/a	n/a
chr7	83037731	83037731	C	G	het		QUAL=9099;DP=225;AF=0.48;MQM=60;TRIO=HET,225,0.48,WT,126,0.00,HOM,181,1.00	SEMA3E	missense	SEMA3E:NM_012431.2:missense:MODERATE:exon6/17:c.623G>C:p.Arg208Pro,SEMA3E:NM_001178129.1:missense:MODERATE:exon6/17:c.443G>C:p.Arg148Pro		rs61729612	0.0976	0.113	0.1286	0.0785	1.1470	P	T	B	B	608166 [SEMA3E (provisional) CHARGE syndrome];			COSM4162479	0.0227	0.1742	0.803	5	83	n/a	n/a
chr7	83037751	83037751	C	A	het		QUAL=7622;DP=197;AF=0.51;MQM=60;TRIO=HET,197,0.51,HOM,139,1.00,WT,190,0.00	SEMA3E	synonymous	SEMA3E:NM_012431.2:synonymous:LOW:exon6/17:c.603G>T:p.Ala201Ala,SEMA3E:NM_001178129.1:synonymous:LOW:exon6/17:c.423G>T:p.Ala141Ala		rs2722985	0.5563	0.607	0.5877	0.2156						608166 [SEMA3E (provisional) CHARGE syndrome];			COSM3762861	0.3939	0.4697	0.1364	158	219	n/a	n/a
chr7	83278227	83278227	C	A	het		QUAL=4094;DP=226;AF=0.38;MQM=58;TRIO=HET,226,0.38,HOM,51,1.00,WT,149,0.00	SEMA3E	5'UTR	SEMA3E:NM_012431.2:5'UTR:MODIFIER:exon1/17:c.-369G>T:	(A)n	rs302114	0.7534	0	0	0										0.4242	0.4394	0.1364	65	64	n/a	n/a
chr7	87079406	87079406	T	A	het		QUAL=7229;DP=247;AF=0.51;MQM=60;TRIO=HET,247,0.51,WT,177,0.00,HET,207,0.49	ABCB4	splice_region&synonymous	ABCB4:NM_018849.2:splice_region&synonymous:LOW:exon8/28:c.711A>T:p.Ile237Ile,ABCB4:NM_000443.3:splice_region&synonymous:LOW:exon8/28:c.711A>T:p.Ile237Ile,ABCB4:NM_018850.2:splice_region&synonymous:LOW:exon8/27:c.711A>T:p.Ile237Ile		rs2109505	0.2614	0.21	0.1827	0.3073						171060 [ABCB4 (confirmed) Cholestasis,progressive familial intrahepatic 3|Cholestasis,intrahepatic,of pregnancy,3|Gallbladder disease 1];		CM031116 [CLASS=DP MUT=ALT PHEN="Intrahepatic cholestasis of pregnancy, association" GENE=ABCB4]; 	COSM3982275	0.0379	0.2576	0.7045	13	146	n/a	n/a
chr7	87092185	87092185	G	A	het		QUAL=1919;DP=86;AF=0.48;MQM=60;TRIO=HET,86,0.48,WT,38,0.00,HET,48,0.46	ABCB4	synonymous	ABCB4:NM_018849.2:synonymous:LOW:exon4/28:c.175C>T:p.Leu59Leu,ABCB4:NM_000443.3:synonymous:LOW:exon4/28:c.175C>T:p.Leu59Leu,ABCB4:NM_018850.2:synonymous:LOW:exon4/27:c.175C>T:p.Leu59Leu		rs2302387	0.2524	0.175	0.147	0.4276						171060 [ABCB4 (confirmed) Cholestasis,progressive familial intrahepatic 3|Cholestasis,intrahepatic,of pregnancy,3|Gallbladder disease 1];				0.0303	0.2197	0.75	10	122	n/a	n/a
chr7	92129162	92129162	A	-	hom		QUAL=9671;DP=158;AF=0.89;MQM=60;TRIO=HOM,158,0.89,HOM,106,0.84,HOM,147,0.86	PEX1	splice_region&intron	PEX1:NM_000466.2:splice_region&intron:LOW:exon15/23:c.2584-10delT:,PEX1:NM_001282677.1:splice_region&intron:LOW:exon14/22:c.2413-10delT:,PEX1:NM_001282678.1:splice_region&intron:LOW:exon15/23:c.1960-10delT:		rs5885806	0	0	0	0						602136 [PEX1 (confirmed) Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B (NALD/IRD)];				0.447	0.1818	0.3712	190	77	n/a	n/a
chr7	92131289	92131289	G	T	hom		QUAL=23081;DP=409;AF=1.00;MQM=60;TRIO=HOM,409,1.00,HOM,111,1.00,HOM,201,1.00	PEX1	synonymous	PEX1:NM_000466.2:synonymous:LOW:exon14/24:c.2331C>A:p.Gly777Gly,PEX1:NM_001282677.1:synonymous:LOW:exon13/23:c.2160C>A:p.Gly720Gly,PEX1:NM_001282678.1:synonymous:LOW:exon14/24:c.1707C>A:p.Gly569Gly		rs10278857	0.9499	0.922	0.9124	0.9694						602136 [PEX1 (confirmed) Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder 1B (NALD/IRD)];	RCV000078920.4 [other]; 			0.8258	0.1591	0.0152	381	66	n/a	n/a
chr7	94039032	94039032	C	T	het		QUAL=15949;DP=330;AF=0.56;MQM=60;TRIO=HET,330,0.56,HET,295,0.47,HET,350,0.50	COL1A2	splice_region&intron	COL1A2:NM_000089.3:splice_region&intron:LOW:exon18/51:c.937-3C>T:		rs42519	0.8243	0.774	0.7567	0.8965						120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB|Osteogenesis imperfecta,type IV|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type II|Osteoporosis,postmenopausal|Ehlers-Danlos syndrome,cardiac valvular form];				0.553	0.3864	0.0606	243	172	n/a	n/a
chr7	94041937	94041937	A	C	het		QUAL=10774;DP=227;AF=0.53;MQM=60;TRIO=HET,227,0.53,HET,182,0.48,HET,233,0.58	COL1A2	synonymous	COL1A2:NM_000089.3:synonymous:LOW:exon25/52:c.1446A>C:p.Pro482Pro		rs412777	0.3273	0.344	0.3707	0.3423						120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB|Osteogenesis imperfecta,type IV|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type II|Osteoporosis,postmenopausal|Ehlers-Danlos syndrome,cardiac valvular form];			COSM1452968	0.1591	0.4394	0.4015	69	212	n/a	n/a
chr7	94043239	94043239	C	G	het		QUAL=23441;DP=615;AF=0.47;MQM=60;TRIO=HET,615,0.47,HET,391,0.49,HET,495,0.49	COL1A2	missense	COL1A2:NM_000089.3:missense:MODERATE:exon28/52:c.1645C>G:p.Pro549Ala		rs42524	0.8217	0.769	0.7488	0.8831	1.2480	P	T	B	B	120160 [COL1A2 (confirmed) Ehlers-Danlos syndrome,type VIIB|Osteogenesis imperfecta,type IV|Osteogenesis imperfecta,type III|Osteogenesis imperfecta,type II|Osteoporosis,postmenopausal|Ehlers-Danlos syndrome,cardiac valvular form];		CM040403 [CLASS=DP MUT=REF PHEN="Intracranial aneurysm, susceptibility, association with" GENE=COL1A2]; 	COSM3762900	0.5455	0.3939	0.0606	238	173	n/a	n/a
chr7	99699169	99699169	A	T	het		QUAL=548;DP=16;AF=0.44;MQM=60;TRIO=HET,16,0.44,WT,24,0.04,HET,29,0.55	MCM7,AP4M1	5'UTR	MCM7:NM_005916.4:5'UTR:MODIFIER:exon1/15:c.-252T>A:,AP4M1:NM_004722.3:5'UTR:MODIFIER:exon1/15:c.-169A>T:,MCM7:NM_001278595.1:5'UTR:MODIFIER:exon1/14:c.-855T>A:		rs1534310	0.2772	0	0	0										0.0758	0.3864	0.5379	11	54	n/a	n/a
chr7	99704796	99704796	A	T	hom		QUAL=6266;DP=120;AF=1.00;MQM=59;TRIO=HOM,120,1.00,HOM,48,0.98,HOM,53,1.00	AP4M1,TAF6	3'UTR	AP4M1:NM_004722.3:3'UTR:MODIFIER:exon15/15:c.*291A>T:,TAF6:NM_001190415.1:3'UTR:MODIFIER:exon15/15:c.*73T>A:,TAF6:NM_005641.3:3'UTR:MODIFIER:exon15/15:c.*73T>A:,TAF6:NM_139315.2:3'UTR:MODIFIER:exon15/15:c.*73T>A:		rs13309	0.6352	0	0	0										0.3106	0.5455	0.1439	48	81	n/a	n/a
chr7	103112862	103112862	C	T	hom		QUAL=19818;DP=376;AF=1.00;MQM=60;TRIO=HOM,376,1.00,HOM,87,1.00,HOM,118,1.00	RELN	3'UTR	RELN:NM_005045.3:3'UTR:MODIFIER:exon65/65:c.*397G>A:,RELN:NM_173054.2:3'UTR:MODIFIER:exon64/64:c.*397G>A:		rs7811262	0.9984	0	0	0										1	0	0	150	0	n/a	n/a
chr7	103138517	103138517	C	G	hom		QUAL=23424;DP=202;AF=1.00;MQM=59;TRIO=HOM,202,1.00,HOM,217,1.00,HOM,298,1.00	RELN	splice_region&intron	RELN:NM_005045.3:splice_region&intron:LOW:exon54/64:c.8843+7G>C:,RELN:NM_173054.2:splice_region&intron:LOW:exon54/63:c.8843+7G>C:		rs2711885	0.9956	0.987	0.9871	0.9984						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)];	RCV000081246.4 [other]; 			0.9773	0.0227	0	1096	28	n/a	n/a
chr7	103155705	103155705	A	G	het		QUAL=4169;DP=130;AF=0.49;MQM=59;TRIO=HET,130,0.49,HOM,75,0.97,WT,64,0.00	RELN	synonymous	RELN:NM_005045.3:synonymous:LOW:exon50/65:c.8046T>C:p.His2682His,RELN:NM_173054.2:synonymous:LOW:exon50/64:c.8046T>C:p.His2682His		rs2229864	0.6484	0.471	0.3608	0.7583						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)];	RCV000081242.4 [other]; 			0.1364	0.4848	0.3788	194	518	n/a	n/a
chr7	103155864	103155864	A	G	het		QUAL=2105;DP=76;AF=0.34;MQM=60;TRIO=HET,76,0.34,HOM,49,0.96,WT,42,0.00	RELN	synonymous	RELN:NM_005045.3:synonymous:LOW:exon50/65:c.7887T>C:p.Pro2629Pro,RELN:NM_173054.2:synonymous:LOW:exon50/64:c.7887T>C:p.Pro2629Pro		rs56345626	0.1749	0.181	0.191	0.1271						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)];	RCV000118171.2 [likely benign]; 		COSM3762300	0.0303	0.2879	0.6818	53	339	n/a	n/a
chr7	103206001	103206001	-	A	het		QUAL=5003;DP=129;AF=0.73;MQM=60;TRIO=HET,129,0.73,HET,119,0.40,HET,142,0.39	RELN	splice_region&intron	RELN:NM_005045.3:splice_region&intron:LOW:exon33/64:c.4937-4_4937-3insT:,RELN:NM_173054.2:splice_region&intron:LOW:exon33/63:c.4937-4_4937-3insT:		rs397763920	0.2508	0	0	0						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)];				0.0379	0.2576	0.7045	33	302	n/a	n/a
chr7	103389954	103389954	A	G	het		QUAL=9714;DP=286;AF=0.52;MQM=60;TRIO=HET,286,0.52,WT,213,0.00,HET,286,0.50	RELN	splice_region&intron	RELN:NM_005045.3:splice_region&intron:LOW:exon5/64:c.578-3T>C:,RELN:NM_173054.2:splice_region&intron:LOW:exon5/63:c.578-3T>C:		rs607755	0.4655	0.496	0.5455	0.443						600514 [RELN (confirmed) Lissencephaly 2 (Norman-Roberts type)];	RCV000081236.4 [other]; 			0.2803	0.5076	0.2121	312	561	n/a	n/a
chr7	107545799	107545799	T	C	het		QUAL=11893;DP=244;AF=0.52;MQM=60;TRIO=HET,244,0.52,HET,117,0.53,HOM,178,0.99	DLD	splice_region&intron,intron	DLD:NM_000108.4:splice_region&intron:LOW:exon6/13:c.439-7T>C:,DLD:NM_001289750.1:splice_region&intron:LOW:exon4/11:c.142-7T>C:,DLD:NM_001289751.1:splice_region&intron:LOW:exon5/12:c.370-7T>C:,DLD:NM_001289752.1:intron:MODIFIER:exon6/12:c.438+296T>C:		rs10263341	0.7161	0.616	0.5784	0.7854						238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency];	RCV000124689.1 [benign]; 			0.4697	0.4242	0.1061	182	198	n/a	n/a
chr7	107559502	107559502	A	C	het		QUAL=10368;DP=354;AF=0.49;MQM=60;TRIO=HET,354,0.49,WT,198,0.00,HET,292,0.48	DLD	synonymous	DLD:NM_000108.4:synonymous:LOW:exon13/14:c.1422A>C:p.Gly474Gly,DLD:NM_001289750.1:synonymous:LOW:exon11/12:c.1125A>C:p.Gly375Gly,DLD:NM_001289751.1:synonymous:LOW:exon12/13:c.1353A>C:p.Gly451Gly,DLD:NM_001289752.1:synonymous:LOW:exon12/13:c.1278A>C:p.Gly426Gly		rs34453495	0.0048	0.0088	0.013	0.0025						238331 [DLD (confirmed) Dihydrolipoamide dehydrogenase deficiency];	RCV000124696.1 [benign]; 			0	0.0303	0.9697	0	15	n/a	n/a
chr7	107559722	107559722	A	T	het		QUAL=4430;DP=197;AF=0.50;MQM=60;TRIO=HET,197,0.50,HET,15,0.33,HET,46,0.67	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*18A>T:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*18A>T:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*18A>T:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*18A>T:		rs8721	0.2758	0.356	0.3847	0.1182										0.2348	0.5076	0.2576	39	74	n/a	n/a
chr7	107559911	107559911	G	A	het		QUAL=8489;DP=267;AF=0.48;MQM=60;TRIO=HET,267,0.48,HET,55,0.62,HOM,93,1.00	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*207G>A:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*207G>A:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*207G>A:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*207G>A:		rs4564	0.7107	0	0	0										0.4697	0.4318	0.0985	74	60	n/a	n/a
chr7	107560191	107560191	C	T	het		QUAL=14161;DP=253;AF=0.53;MQM=60;TRIO=HET,253,0.53,HET,157,0.41,HOM,223,1.00	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*487C>T:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*487C>T:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*487C>T:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*487C>T:		rs4518	0.7145	0	0	0										0.4773	0.4242	0.0985	75	61	n/a	n/a
chr7	107560651	107560651	G	T	het		QUAL=13042;DP=341;AF=0.45;MQM=60;TRIO=HET,341,0.45,HET,216,0.50,HET,304,0.45	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*947G>T:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*947G>T:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*947G>T:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*947G>T:		rs7777259	0.2724	0	0	0										0.2273	0.5152	0.2576	35	75	n/a	n/a
chr7	107560682	107560682	T	C	het		QUAL=21427;DP=477;AF=0.47;MQM=59;TRIO=HET,477,0.47,HET,259,0.42,HOM,322,1.00	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*978T>C:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*978T>C:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*978T>C:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*978T>C:		rs2158835	0.7147	0	0	0										0.4697	0.4318	0.0985	74	60	n/a	n/a
chr7	107561155	107561155	T	C	het		QUAL=14604;DP=357;AF=0.49;MQM=60;TRIO=HET,357,0.49,HET,138,0.54,HOM,198,1.00	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*1451T>C:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*1451T>C:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*1451T>C:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*1451T>C:	L1MEb	rs2108223	0.7153	0	0	0										0.4773	0.4242	0.0985	75	59	n/a	n/a
chr7	107561392	107561392	G	A	het		QUAL=14994;DP=441;AF=0.47;MQM=60;TRIO=HET,441,0.47,HET,169,0.56,HET,266,0.55	DLD	3'UTR	DLD:NM_000108.4:3'UTR:MODIFIER:exon14/14:c.*1688G>A:,DLD:NM_001289750.1:3'UTR:MODIFIER:exon12/12:c.*1688G>A:,DLD:NM_001289751.1:3'UTR:MODIFIER:exon13/13:c.*1688G>A:,DLD:NM_001289752.1:3'UTR:MODIFIER:exon13/13:c.*1688G>A:	L1MEb	rs8440	0.2722	0	0	0										0.2273	0.5152	0.2576	35	75	n/a	n/a
chr7	112092211	112092211	T	-	het		QUAL=14515;DP=230;AF=0.76;MQM=59;TRIO=HET,230,0.76,HET,209,0.48,HET,284,0.82	IFRD1	5'UTR,intron	IFRD1:NM_001197079.1:5'UTR:MODIFIER:exon1/12:c.-400delT:,IFRD1:NM_001007245.2:intron:MODIFIER:exon2/12:c.94+1386delT:,IFRD1:NM_001197080.1:intron:MODIFIER:exon1/11:c.-56-3595delT:,IFRD1:NM_001550.3:intron:MODIFIER:exon1/11:c.94+1386delT:	AluJr	rs11299789	0.8345	0	0	0										0.4394	0.3485	0.2121	69	48	n/a	n/a
chr7	112092347	112092347	C	T	het		QUAL=7447;DP=245;AF=0.51;MQM=60;TRIO=HET,245,0.51,WT,198,0.00,HET,231,0.47	IFRD1	5'UTR,intron	IFRD1:NM_001197079.1:5'UTR:MODIFIER:exon1/12:c.-276C>T:,IFRD1:NM_001007245.2:intron:MODIFIER:exon2/12:c.94+1510C>T:,IFRD1:NM_001197080.1:intron:MODIFIER:exon1/11:c.-56-3471C>T:,IFRD1:NM_001550.3:intron:MODIFIER:exon1/11:c.94+1510C>T:	AluJr	rs4727771	0.2087	0	0	0										0.0303	0.1818	0.7879	4	27	n/a	n/a
chr7	112112892	112112892	G	A	het		QUAL=7516;DP=249;AF=0.50;MQM=60;TRIO=HET,249,0.50,HET,225,0.47,WT,304,0.00	IFRD1	synonymous	IFRD1:NM_001007245.2:synonymous:LOW:exon12/13:c.1242G>A:p.Thr414Thr,IFRD1:NM_001197080.1:synonymous:LOW:exon11/12:c.1092G>A:p.Thr364Thr,IFRD1:NM_001550.3:synonymous:LOW:exon11/12:c.1242G>A:p.Thr414Thr,IFRD1:NM_001197079.1:synonymous:LOW:exon11/12:c.1092G>A:p.Thr364Thr		rs11542468	0.0453	0.065	0.0814	0.0343									COSM3762331	0	0.1439	0.8561	0	59	n/a	n/a
chr7	112115658	112115658	C	T	het		QUAL=4690;DP=235;AF=0.47;MQM=60;TRIO=HET,235,0.47,WT,69,0.00,HET,65,0.49	IFRD1	3'UTR	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*84C>T:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*84C>T:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*84C>T:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*84C>T:		rs7817	0.393	0	0	0								CR092300 [CLASS=DFP MUT=ALT PHEN="Severity in cystic fibrosis, association with" GENE=IFRD1]; 		0.2121	0.5	0.2879	30	74	n/a	n/a
chr7	112116198	112116198	G	A	het		QUAL=18152;DP=409;AF=0.57;MQM=60;TRIO=HET,409,0.57,HOM,311,1.00,WT,435,0.00	IFRD1	3'UTR	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*624G>A:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*624G>A:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*624G>A:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*624G>A:		rs7467	0.2851	0	0	0										0.0833	0.4318	0.4848	14	66	n/a	n/a
chr7	112116537	112116537	A	C	het		QUAL=9625;DP=307;AF=0.47;MQM=59;TRIO=HET,307,0.47,WT,287,0.00,HET,386,0.44	IFRD1	3'UTR	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*963A>C:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*963A>C:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*963A>C:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*963A>C:	AluJo	rs2190587	0.399	0	0	0										0.2197	0.5	0.2803	31	74	n/a	n/a
chr7	112116659	112116659	T	C	hom		QUAL=26467;DP=363;AF=1.00;MQM=59;TRIO=HOM,363,1.00,HOM,261,1.00,HET,425,0.48	IFRD1	3'UTR	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*1085T>C:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*1085T>C:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*1085T>C:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*1085T>C:	AluJo	rs2190588	0.7049	0	0	0										0.5909	0.3636	0.0455	88	55	n/a	n/a
chr7	112116685	112116685	C	T	het		QUAL=10608;DP=347;AF=0.45;MQM=59;TRIO=HET,347,0.45,WT,239,0.00,HET,376,0.47	IFRD1	3'UTR	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*1111C>T:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*1111C>T:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*1111C>T:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*1111C>T:	AluJo	rs12532656	0.1034	0	0	0										0.0076	0.1212	0.8712	1	18	n/a	n/a
chr7	112116980	112116980	C	T	het		QUAL=8469;DP=294;AF=0.48;MQM=60;TRIO=HET,294,0.48,WT,175,0.00,HET,245,0.49	IFRD1	3'UTR	IFRD1:NM_001007245.2:3'UTR:MODIFIER:exon13/13:c.*1406C>T:,IFRD1:NM_001197080.1:3'UTR:MODIFIER:exon12/12:c.*1406C>T:,IFRD1:NM_001550.3:3'UTR:MODIFIER:exon12/12:c.*1406C>T:,IFRD1:NM_001197079.1:3'UTR:MODIFIER:exon12/12:c.*1406C>T:		rs1054043	0.3994	0	0	0										0.2197	0.5	0.2803	31	74	n/a	n/a
chr7	114331999	114331999	A	-	het		QUAL=2382;DP=215;AF=0.26;MQM=59;TRIO=HET,215,0.26,HET,55,0.38,HET,93,0.27	FOXP2	3'UTR	FOXP2:NM_148898.3:3'UTR:MODIFIER:exon18/18:c.*2030delA:,FOXP2:NM_001172766.2:3'UTR:MODIFIER:exon17/17:c.*2030delA:,FOXP2:NM_014491.3:3'UTR:MODIFIER:exon17/17:c.*2030delA:,FOXP2:NM_148900.3:3'UTR:MODIFIER:exon18/18:c.*2030delA:	(A)n	rs58804519	0.243	0	0	0										0.1136	0.4621	0.4242	37	86	n/a	n/a
chr7	114332246	114332246	G	T	het		QUAL=13452;DP=433;AF=0.50;MQM=60;TRIO=HET,433,0.50,HET,189,0.48,HET,193,0.52	FOXP2	3'UTR	FOXP2:NM_148898.3:3'UTR:MODIFIER:exon18/18:c.*2265G>T:,FOXP2:NM_001172766.2:3'UTR:MODIFIER:exon17/17:c.*2265G>T:,FOXP2:NM_014491.3:3'UTR:MODIFIER:exon17/17:c.*2265G>T:,FOXP2:NM_148900.3:3'UTR:MODIFIER:exon18/18:c.*2265G>T:		rs12705977	0.223	0.289	0	0										0.1591	0.4697	0.3712	44	131	n/a	n/a
chr7	117188736	117188736	C	A	het		QUAL=1857;DP=174;AF=0.32;MQM=32;TRIO=HET,174,0.32,HET,94,0.16,HET,145,0.07	CFTR	missense	CFTR:NM_000492.3:missense:MODERATE:exon10/27:c.1251C>A:p.Asn417Lys		rs4727853	0	0.019	0	0	-0.0310	N	T	B	B	602421 [CFTR (confirmed) Cystic fibrosis|Congenital bilateral absence of vas deferens|Sweat chloride elevation without CF|Pancreatitis,idiopathic|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of];			COSM4161731	0	0.9697	0.0303	0	203	n/a	n/a
chr7	117188750	117188750	C	T	het		QUAL=911;DP=190;AF=0.20;MQM=33;TRIO=HET,190,0.20,HET,111,0.10,WT,151,0.05	CFTR	missense	CFTR:NM_000492.3:missense:MODERATE:exon10/27:c.1265C>T:p.Ser422Phe		rs201880593	0	0.0032	0	0	3.1910	N	D	P	B	602421 [CFTR (confirmed) Cystic fibrosis|Congenital bilateral absence of vas deferens|Sweat chloride elevation without CF|Pancreatitis,idiopathic|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of];	RCV000067592.2 [other]; 		COSM1284105	0	0.3636	0.6364	0	75	n/a	n/a
chr7	117199533	117199533	G	A	het		QUAL=9199;DP=224;AF=0.50;MQM=60;TRIO=HET,224,0.50,HOM,100,1.00,HET,157,0.55	CFTR	missense	CFTR:NM_000492.3:missense:MODERATE:exon11/27:c.1408G>A:p.Val470Met		rs213950	0.5821	0.483	0.4681	0.8504	2.6080	P	T	B	B	602421 [CFTR (confirmed) Cystic fibrosis|Congenital bilateral absence of vas deferens|Sweat chloride elevation without CF|Pancreatitis,idiopathic|Hypertrypsinemia,neonatal|Bronchiectasis with or without elevated sweat chloride 1,modifier of];	RCV000007550.1 [benign]; RCV000036517.6 [other]; 	CM034388 [CLASS=DFP MUT=REF PHEN="Respiratory/pancreatic disease, association with" GENE=CFTR]; 	COSM3762337	0.1061	0.5152	0.3788	67	229	n/a	n/a
chr7	121714653	121714653	C	T	het		QUAL=5478;DP=158;AF=0.49;MQM=60;TRIO=HET,158,0.49,WT,88,0.00,HOM,85,1.00	AASS	3'UTR	AASS:NM_005763.3:3'UTR:MODIFIER:exon24/24:c.*1890G>A:	L1MB8	rs12217	0.6697	0	0	0										0.3182	0.4394	0.2424	50	65	n/a	n/a
chr7	121715965	121715965	C	T	het		QUAL=4488;DP=146;AF=0.51;MQM=60;TRIO=HET,146,0.51,WT,46,0.00,HOM,65,1.00	AASS	3'UTR	AASS:NM_005763.3:3'UTR:MODIFIER:exon24/24:c.*578G>A:		rs1206380	0.6673	0	0	0										0.3182	0.4394	0.2424	50	65	n/a	n/a
chr7	127950724	127950724	C	T	het		QUAL=11796;DP=351;AF=0.46;MQM=60;TRIO=HET,351,0.46,WT,328,0.00,HET,440,0.47	RBM28	3'UTR	RBM28:NM_018077.2:3'UTR:MODIFIER:exon19/19:c.*126G>A:,RBM28:NM_001166135.1:3'UTR:MODIFIER:exon15/15:c.*126G>A:		rs141043380	0.0126	0	0	0										0.0076	0.0985	0.8939	1	17	n/a	n/a
chr7	127950725	127950725	G	A	het		QUAL=23830;DP=350;AF=0.51;MQM=60;TRIO=HET,350,0.51,HOM,326,1.00,HET,444,0.53	RBM28	3'UTR	RBM28:NM_018077.2:3'UTR:MODIFIER:exon19/19:c.*125C>T:,RBM28:NM_001166135.1:3'UTR:MODIFIER:exon15/15:c.*125C>T:		rs12850	0.3399	0	0	0										0.1364	0.4318	0.4318	21	66	n/a	n/a
chr7	128470482	128470482	G	A	hom		QUAL=1003;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HOM,16,1.00,HOM,25,1.00					rs2639138	1	0	0	0										0.8485	0	0.1515	121	0	n/a	n/a
chr7	128487866	128487866	T	C	hom		QUAL=6045;DP=46;AF=1.00;MQM=60;TRIO=HOM,46,1.00,HOM,68,1.00,HOM,78,1.00	FLNC	synonymous	FLNC:NM_001458.4:synonymous:LOW:exon25/48:c.4404T>C:p.Asp1468Asp,FLNC:NM_001127487.1:synonymous:LOW:exon25/47:c.4404T>C:p.Asp1468Asp		rs2249128	0.9906	0.997	1	0.9726						102565 [FLNC (confirmed) Myopathy,myofibrillar,5|Myopathy,distal,4];				1	0	0	454	0	n/a	n/a
chr7	128489228	128489228	T	C	het		QUAL=4132;DP=155;AF=0.50;MQM=59;TRIO=HET,155,0.50,WT,92,0.01,HET,138,0.48	FLNC	splice_region&intron	FLNC:NM_001458.4:splice_region&intron:LOW:exon28/47:c.4928-7T>C:,FLNC:NM_001127487.1:splice_region&intron:LOW:exon28/46:c.4928-7T>C:		rs201957008	0.004	0.0046	0.0049	0.0003						102565 [FLNC (confirmed) Myopathy,myofibrillar,5|Myopathy,distal,4];				0	0.0076	0.9924	0	1	n/a	n/a
chr7	139784641	139784641	A	G	hom		QUAL=1485;DP=38;AF=1.00;MQM=60;TRIO=HOM,38,1.00,HOM,5,1.00,HOM,7,1.00	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*6253T>C:		rs12703525	0.996	0	0	0										0.9621	0.0076	0.0303	144	1	n/a	n/a
chr7	139785024	139785024	C	A	het		QUAL=9121;DP=251;AF=0.37;MQM=60;TRIO=HET,251,0.38,HET,180,0.49,HET,235,0.49	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*5870G>T:		rs10984	0.3596	0	0	0										0.2727	0.4242	0.303	43	62	n/a	n/a
chr7	139785028	139785030	AAG	-	het		QUAL=9121;DP=251;AF=0.37;MQM=60;TRIO=HET,251,0.38,WT,180,0.49,HET,235,0.49	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*5864_*5866delCTT:		rs371560827	0.1991	0	0	0										0.0682	0.3409	0.5909	13	49	n/a	n/a
chr7	139786186	139786186	G	A	het		QUAL=3791;DP=164;AF=0.51;MQM=60;TRIO=HET,164,0.51,HET,26,0.42,HET,52,0.38	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*4708C>T:		rs11972958	0.3712	0	0	0										0.2803	0.4318	0.2879	44	63	n/a	n/a
chr7	139787189	139787189	G	A	het		QUAL=11928;DP=529;AF=0.46;MQM=60;TRIO=HET,529,0.46,WT,190,0.02,HET,223,0.50	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*3705C>T:		rs1476619	0.1687	0	0	0										0.1439	0.3939	0.4621	24	56	n/a	n/a
chr7	139787853	139787853	A	-	het		QUAL=9552;DP=254;AF=0.50;MQM=60;TRIO=HET,254,0.50,HET,162,0.50,HET,177,0.50	KDM7A	3'UTR	KDM7A:NM_030647.1:3'UTR:MODIFIER:exon20/20:c.*3041delT:		rs398006590	0.3598	0	0	0										0.2727	0.4394	0.2879	42	64	n/a	n/a
chr7	139797431	139797431	G	T	het		QUAL=7261;DP=289;AF=0.49;MQM=60;TRIO=HET,289,0.49,WT,171,0.00,HET,192,0.44	KDM7A	missense	KDM7A:NM_030647.1:missense:MODERATE:exon15/20:c.1930C>A:p.Arg644Ser		rs6950119	0.3275	0.32	0.3398	0.3826	2.4720	P	T	B	B				COSM321080	0.2121	0.4242	0.3636	62	127	n/a	n/a
chr7	139801777	139801777	T	G	het		QUAL=7819;DP=193;AF=0.52;MQM=60;TRIO=HET,193,0.52,WT,220,0.00,HET,298,0.48	KDM7A	synonymous	KDM7A:NM_030647.1:synonymous:LOW:exon12/20:c.1612A>C:p.Arg538Arg		rs1062277	0.3335	0.322	0.3402	0.3861									COSM3762429	0.2121	0.4318	0.3561	62	128	n/a	n/a
chr7	143016928	143016928	C	T	het		QUAL=7501;DP=240;AF=0.50;MQM=60;TRIO=HET,240,0.50,HET,244,0.47,WT,322,0.00	CLCN1	synonymous	CLCN1:NM_000083.2:synonymous:LOW:exon2/23:c.261C>T:p.Thr87Thr		rs6962852	0.3229	0.297	0.3258	0.5683						118425 [CLCN1 (provisional) Myotonia congenita,recessive|Myotonia congenita,dominant|Myotonia levior,recessive];			COSM3762451	0.1591	0.4773	0.3636	80	202	n/a	n/a
chr7	143017807	143017807	G	T	hom		QUAL=22869;DP=229;AF=1.00;MQM=60;TRIO=HOM,229,1.00,HOM,178,1.00,HOM,302,1.00	CLCN1	missense	CLCN1:NM_000083.2:missense:MODERATE:exon3/23:c.352G>T:p.Gly118Trp		rs10282312	0.9936	0.986	0.975	0.9952	5.9710	P	T	B	B	118425 [CLCN1 (provisional) Myotonia congenita,recessive|Myotonia congenita,dominant|Myotonia levior,recessive];		CM127929 [CLASS=DM? MUT=REF PHEN="Myotonia" GENE=CLCN1]; 		0.9773	0.0227	0	446	8	2	n/a
chr7	143036337	143036337	C	T	het		QUAL=9177;DP=324;AF=0.41;MQM=60;TRIO=HET,324,0.41,HET,130,0.52,HET,195,0.47	CLCN1	splice_region&intron	CLCN1:NM_000083.2:splice_region&intron:LOW:exon12/22:c.1402-9C>T:		rs2272252	0.4143	0.411	0.4262	0.5626						118425 [CLCN1 (provisional) Myotonia congenita,recessive|Myotonia congenita,dominant|Myotonia levior,recessive];			COSM4004350	0.197	0.4848	0.3182	91	220	n/a	n/a
chr7	143043240	143043240	C	T	het		QUAL=11276;DP=117;AF=0.47;MQM=60;TRIO=HET,117,0.47,HET,269,0.47,HET,367,0.47	CLCN1	missense	CLCN1:NM_000083.2:missense:MODERATE:exon18/23:c.2180C>T:p.Pro727Leu		rs13438232	0.3694	0.397	0.4262	0.4176	0.8500	P	D	P	B	118425 [CLCN1 (provisional) Myotonia congenita,recessive|Myotonia congenita,dominant|Myotonia levior,recessive];			COSM3737851	0.197	0.4848	0.3182	93	219	n/a	n/a
chr7	145813854	145813854	G	A	hom		QUAL=1160;DP=22;AF=1.00;MQM=60;TRIO=HOM,22,1.00,HET,16,0.38,HET,24,0.58	CNTNAP2	5'UTR	CNTNAP2:NM_014141.5:5'UTR:MODIFIER:exon1/24:c.-115G>A:		rs2462603	0.512	0	0	0										0.3182	0.4697	0.2121	53	66	n/a	n/a
chr7	147092861	147092861	G	A	het		QUAL=7149;DP=187;AF=0.53;MQM=59;TRIO=HET,187,0.53,HET,252,0.50,WT,309,0.00	CNTNAP2	synonymous	CNTNAP2:NM_014141.5:synonymous:LOW:exon10/24:c.1659G>A:p.Ala553Ala		rs34592169	0.0937	0.187	0.2349	0.0558						604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome|Autism susceptibility 15|Pitt-Hopkins like syndrome 1];	RCV000081587.4 [other]; 		COSM3762462	0.0227	0.3106	0.6667	13	142	n/a	n/a
chr7	148106477	148106477	C	G	het		QUAL=12573;DP=228;AF=0.46;MQM=60;TRIO=HET,228,0.46,HOM,182,0.98,HET,234,0.45	CNTNAP2	splice_region&intron	CNTNAP2:NM_014141.5:splice_region&intron:LOW:exon22/23:c.3716-6C>G:		rs77025884	0	0.0062	0	0						604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome|Autism susceptibility 15|Pitt-Hopkins like syndrome 1];	RCV000081603.3 [benign]; RCV000124385.1 [benign]; 		COSM3785030	0.2727	0.3712	0.3561	124	102	n/a	n/a
chr7	148106490	148106490	G	A	het		QUAL=14500;DP=260;AF=0.46;MQM=60;TRIO=HET,260,0.46,HOM,210,1.00,HET,265,0.46	CNTNAP2	synonymous	CNTNAP2:NM_014141.5:synonymous:LOW:exon23/24:c.3723G>A:p.Ala1241Ala		rs9648691	0.5491	0.536	0.5497	0.6541						604569 [CNTNAP2 (confirmed) Cortical dysplasia-focal epilepsy syndrome|Autism susceptibility 15|Pitt-Hopkins like syndrome 1];	RCV000081604.4 [other]; 		COSM3762466	0.3485	0.4545	0.197	158	200	n/a	n/a
chr7	148112872	148112872	-	A	het		QUAL=3655;DP=136;AF=0.61;MQM=60;TRIO=HET,136,0.61,HET,39,0.28,HET,51,0.86	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*175dupA:		rs397763623	0.5226	0	0	0										0.2803	0.5076	0.2121	44	75	n/a	n/a
chr7	148112987	148112987	C	A	het		QUAL=7207;DP=229;AF=0.52;MQM=60;TRIO=HET,229,0.52,HET,85,0.53,HET,128,0.48	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*279C>A:		rs987456	0.6607	0	0	0										0.6667	0.2879	0.0455	102	42	n/a	n/a
chr7	148113624	148113628	TAGTT	-	hom		QUAL=18445;DP=294;AF=1.00;MQM=59;TRIO=HOM,294,1.00,HOM,136,1.00,HOM,154,1.00	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*921_*925delTAGTT:		rs569195865	0.9844	0	0	0										0.9924	0	0.0076	149	0	n/a	n/a
chr7	148113895	148113895	G	A	het		QUAL=11310;DP=352;AF=0.51;MQM=60;TRIO=HET,352,0.51,WT,263,0.00,HET,336,0.49	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*1187G>A:		rs2530312	0.3746	0	0	0										0.1742	0.4848	0.3409	27	71	n/a	n/a
chr7	148114265	148114265	A	C	het		QUAL=10017;DP=329;AF=0.49;MQM=60;TRIO=HET,329,0.49,WT,186,0.01,HET,294,0.48	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*1557A>C:		rs3194	0.3944	0	0	0										0.1818	0.4848	0.3333	28	72	n/a	n/a
chr7	148114865	148114865	A	G	het		QUAL=8064;DP=362;AF=0.49;MQM=60;TRIO=HET,362,0.49,WT,113,0.00,HET,156,0.44	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*2157A>G:		rs1062072	0.5371	0	0	0										0.2045	0.4848	0.3106	31	72	n/a	n/a
chr7	148115639	148115640	AA	-	het		QUAL=11804;DP=271;AF=0.54;MQM=60;TRIO=HET,271,0.54,HET,223,0.45,HET,257,0.47	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*2935_*2936delAA:		rs544152145	0.7817	0	0	0										0.6667	0.2803	0.053	99	44	n/a	n/a
chr7	148116450	148116450	A	G	het		QUAL=9687;DP=306;AF=0.57;MQM=60;TRIO=HET,306,0.57,WT,186,0.00,HET,240,0.53	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*3742A>G:		rs2530311	0.521	0	0	0										0.197	0.4924	0.3106	30	73	n/a	n/a
chr7	148116692	148116692	-	T	het		QUAL=1482;DP=54;AF=0.22;MQM=57;TRIO=HET,54,0.22,HET,67,0.30,HET,75,0.29	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*3999dupT:	AluSx1	rs397890079	0.5571	0	0	0										0.1288	0.3333	0.5379	19	48	n/a	n/a
chr7	148117505	148117505	G	C	het		QUAL=15092;DP=348;AF=0.45;MQM=60;TRIO=HET,348,0.45,HET,256,0.50,HET,344,0.52	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*4797G>C:		rs2717829	0.7935	0	0	0										0.6667	0.2879	0.0455	99	45	n/a	n/a
chr7	148117642	148117642	C	T	het		QUAL=8073;DP=292;AF=0.47;MQM=60;TRIO=HET,292,0.47,WT,157,0.01,HET,228,0.47	CNTNAP2	3'UTR	CNTNAP2:NM_014141.5:3'UTR:MODIFIER:exon24/24:c.*4934C>T:		rs2530310	0.386	0	0	0										0.1742	0.5	0.3258	26	74	n/a	n/a
chr8	1729217	1729217	C	T	hom		QUAL=20736;DP=256;AF=1.00;MQM=59;TRIO=HOM,256,1.00,HOM,165,0.99,HOM,235,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*484C>T:		rs11778824	0.8097	0	0	0										0.7652	0.2273	0.0076	115	34	n/a	n/a
chr8	1729514	1729514	A	G	hom		QUAL=8734;DP=109;AF=1.00;MQM=56;TRIO=HOM,109,1.00,HOM,69,1.00,HOM,103,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*781A>G:	AluSz	rs1137514	0.622	0	0	0										0.4394	0.4545	0.1061	68	68	n/a	n/a
chr8	1729582	1729582	-	TGG	hom		QUAL=11801;DP=137;AF=0.96;MQM=60;TRIO=HOM,137,0.96,HOM,103,1.00,HOM,159,0.99	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*853_*855dupTGG:		rs397698661	0.619	0	0	0										0.4394	0.4545	0.1061	67	68	n/a	n/a
chr8	1730140	1730140	-	GT	het		QUAL=7821;DP=72;AF=0.65;MQM=60;TRIO=HET,72,0.65,HET,101,0.88,HET,174,0.86	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*1413_*1414dupTG:	(TG)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr8	1732224	1732224	G	C	hom		QUAL=17448;DP=221;AF=1.00;MQM=55;TRIO=HOM,221,1.00,HOM,165,0.99,HOM,172,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*3491G>C:	AluSz	rs10089222	0.7123	0	0	0										0.553	0.3939	0.053	86	57	n/a	n/a
chr8	1732580	1732580	C	G	hom		QUAL=29086;DP=305;AF=1.00;MQM=60;TRIO=HOM,305,1.00,HOM,281,1.00,HOM,312,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*3847C>G:	MLT1A1	rs7827009	0.8079	0	0	0										0.7727	0.2197	0.0076	116	33	n/a	n/a
chr8	1732756	1732756	C	A	hom		QUAL=31871;DP=281;AF=1.00;MQM=59;TRIO=HOM,281,1.00,HOM,285,1.00,HOM,430,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*4023C>A:		rs7827285	0.8057	0	0	0										0.7652	0.2273	0.0076	115	34	n/a	n/a
chr8	1734452	1734452	C	G	hom		QUAL=6608;DP=126;AF=1.00;MQM=60;TRIO=HOM,126,1.00,HOM,32,1.00,HOM,52,1.00	CLN8	3'UTR	CLN8:NM_018941.3:3'UTR:MODIFIER:exon3/3:c.*5719C>G:		rs3812477	0.6983	0	0	0										0.5606	0.3864	0.053	87	56	n/a	n/a
chr8	1857548	1857548	T	C	het		QUAL=5301;DP=170;AF=0.51;MQM=59;TRIO=HET,170,0.51,HET,51,0.63,HET,123,0.41	ARHGEF10	synonymous	ARHGEF10:NM_014629.2:synonymous:LOW:exon18/29:c.2055T>C:p.Tyr685Tyr		rs2294038	0.1569	0.153	0.1544	0.1298						608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD];			COSM3982452	0.0227	0.2424	0.7348	13	109	n/a	n/a
chr8	1876631	1876631	C	T	het		QUAL=3743;DP=142;AF=0.54;MQM=60;TRIO=HET,142,0.54,HET,107,0.42,WT,162,0.00	ARHGEF10	synonymous	ARHGEF10:NM_014629.2:synonymous:LOW:exon24/29:c.2736C>T:p.Ile912Ile		rs2272611	0.1444	0.156	0.1445	0.121						608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD];			COSM1455921	0.0379	0.2121	0.75	13	94	n/a	n/a
chr8	1900911	1900911	C	T	het		QUAL=3753;DP=126;AF=0.51;MQM=60;TRIO=HET,126,0.51,HET,122,0.49,WT,147,0.00	ARHGEF10	synonymous	ARHGEF10:NM_014629.2:synonymous:LOW:exon28/29:c.3438C>T:p.His1146His		rs2272608	0.2151	0.161	0.1252	0.2985						608136 [ARHGEF10 (confirmed) Slowed nerve conduction velocity,AD];			COSM3982455	0.0455	0.2121	0.7424	16	85	n/a	n/a
chr8	1905615	1905615	G	A	het		QUAL=10924;DP=342;AF=0.47;MQM=60;TRIO=HET,342,0.47,WT,284,0.00,HET,355,0.49	ARHGEF10	3'UTR	ARHGEF10:NM_014629.2:3'UTR:MODIFIER:exon29/29:c.*186G>A:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr8	1905728	1905728	G	A	hom		QUAL=16104;DP=189;AF=1.00;MQM=60;TRIO=HOM,189,1.00,HOM,146,1.00,HOM,158,1.00	ARHGEF10	3'UTR	ARHGEF10:NM_014629.2:3'UTR:MODIFIER:exon29/29:c.*299G>A:		rs6558566	0.9453	0	0	0										0.9242	0.0758	0	140	10	n/a	n/a
chr8	1905823	1905823	A	G	het		QUAL=3442;DP=162;AF=0.48;MQM=60;TRIO=HET,162,0.48,HET,54,0.48,WT,53,0.02	ARHGEF10	3'UTR	ARHGEF10:NM_014629.2:3'UTR:MODIFIER:exon29/29:c.*394A>G:		rs6991392	0.397	0	0	0										0.2045	0.4924	0.303	29	75	n/a	n/a
chr8	1906630	1906630	G	T	hom		QUAL=52197;DP=407;AF=1.00;MQM=59;TRIO=HOM,407,1.00,HOM,549,1.00,HOM,661,1.00	ARHGEF10	3'UTR	ARHGEF10:NM_014629.2:3'UTR:MODIFIER:exon29/29:c.*1201G>T:		rs14375	0.9519	0	0	0										0.9242	0.0758	0	140	10	n/a	n/a
chr8	6264130	6264130	G	C	het		QUAL=2345;DP=11;AF=0.27;MQM=60;TRIO=HET,11,0.27,HOM,48,1.00,HET,54,0.59	MCPH1	5'UTR	MCPH1:NM_024596.3:5'UTR:MODIFIER:exon1/14:c.-59G>C:,MCPH1:NM_001172574.1:5'UTR:MODIFIER:exon1/8:c.-59G>C:,MCPH1:NM_001172575.1:5'UTR:MODIFIER:exon1/7:c.-59G>C:		rs2305023	0.5387	0	0.7976	0.3849										0.5227	0.3788	0.0985	91	59	n/a	n/a
chr8	6272399	6272399	G	T	het		QUAL=6672;DP=203;AF=0.48;MQM=60;TRIO=HET,203,0.48,HOM,69,1.00,HET,81,0.51	MCPH1	synonymous	MCPH1:NM_024596.3:synonymous:LOW:exon3/14:c.228G>T:p.Val76Val,MCPH1:NM_001172574.1:synonymous:LOW:exon3/8:c.228G>T:p.Val76Val,MCPH1:NM_001172575.1:synonymous:LOW:exon3/7:c.228G>T:p.Val76Val		rs2305022	0.6781	0.772	0.8016	0.4673						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000146307.1 [likely benign]; 			0.5606	0.4015	0.0379	257	171	n/a	n/a
chr8	6296550	6296550	G	T	hom		QUAL=24265;DP=272;AF=1.00;MQM=60;TRIO=HOM,272,1.00,HOM,198,1.00,HOM,268,1.00	MCPH1	missense,intron	MCPH1:NM_024596.3:missense:MODERATE:exon6/14:c.513G>T:p.Arg171Ser,MCPH1:NM_001172574.1:missense:MODERATE:exon6/8:c.513G>T:p.Arg171Ser,MCPH1:NM_001172575.1:intron:MODIFIER:exon5/6:c.436+2867G>T:		rs2442513	0.9169	0.966	0.9834	0.7975	-0.2920	P	T	B,B	B,B	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000126703.1 [benign]; 			0.9924	0.0076	0	439	15	n/a	n/a
chr8	6302106	6302106	C	A	het		QUAL=12231;DP=366;AF=0.54;MQM=60;TRIO=HET,366,0.54,WT,229,0.00,HET,348,0.50	MCPH1	missense	MCPH1:NM_024596.3:missense:MODERATE:exon8/14:c.863C>A:p.Pro288His,MCPH1:NM_001172574.1:missense:MODERATE:exon8/8:c.863C>A:p.Pro288His,MCPH1:NM_001172575.1:missense:MODERATE:exon7/7:c.719C>A:p.Pro240His		rs35590577	0.0693	0.029	0.0109	0.1858	2.1950	P	T	D,D,D	D,D,D	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000146333.1 [benign]; 			0	0.0303	0.9697	1	17	n/a	n/a
chr8	6302183	6302183	G	C	het		QUAL=23159;DP=432;AF=0.50;MQM=60;TRIO=HET,432,0.50,HOM,284,1.00,HET,386,0.55	MCPH1	missense	MCPH1:NM_024596.3:missense:MODERATE:exon8/14:c.940G>C:p.Asp314His,MCPH1:NM_001172574.1:missense:MODERATE:exon8/8:c.940G>C:p.Asp314His,MCPH1:NM_001172575.1:missense:MODERATE:exon7/7:c.796G>C:p.Asp266His		rs930557	0.6448	0.77	0.8141	0.3736	0.3110	P	T	D,D,D	D,D,D	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000020903.1 [benign]; RCV000146337.1 [likely benign]; 			0.6288	0.3258	0.0455	275	154	n/a	n/a
chr8	6302418	6302418	A	G	hom		QUAL=29784;DP=265;AF=1.00;MQM=60;TRIO=HOM,265,1.00,HOM,308,1.00,HOM,357,1.00	MCPH1	missense	MCPH1:NM_024596.3:missense:MODERATE:exon8/14:c.1175A>G:p.Asp392Gly,MCPH1:NM_001172574.1:missense:MODERATE:exon8/8:c.1175A>G:p.Asp392Gly,MCPH1:NM_001172575.1:missense:MODERATE:exon7/7:c.1031A>G:p.Asp344Gly		rs2515569	0.9944	0.998	0.9999	0.9777	-3.5300	P	T	B,B,B	B,B,B	607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000082198.3 [other]; 			1	0	0	453	1	n/a	n/a
chr8	6302671	6302671	C	T	het		QUAL=9899;DP=275;AF=0.53;MQM=60;TRIO=HET,275,0.53,WT,210,0.00,HET,278,0.56	MCPH1	synonymous	MCPH1:NM_024596.3:synonymous:LOW:exon8/14:c.1428C>T:p.Phe476Phe,MCPH1:NM_001172574.1:synonymous:LOW:exon8/8:c.1428C>T:p.Phe476Phe,MCPH1:NM_001172575.1:synonymous:LOW:exon7/7:c.1284C>T:p.Phe428Phe		rs2920676	0.2081	0.085	0.018	0.3931						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000082200.3 [benign]; 			0	0.0758	0.9242	0	36	n/a	n/a
chr8	6303025	6303025	G	A	het		QUAL=22302;DP=462;AF=0.50;MQM=60;TRIO=HET,462,0.50,HOM,295,1.00,HET,315,0.50	MCPH1	synonymous	MCPH1:NM_024596.3:synonymous:LOW:exon8/14:c.1782G>A:p.Thr594Thr,MCPH1:NM_001172574.1:synonymous:LOW:exon8/8:c.1782G>A:p.Thr594Thr,MCPH1:NM_001172575.1:synonymous:LOW:exon7/7:c.1638G>A:p.Thr546Thr		rs2584	0.1322	0.257	0.3297	0.0663						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];	RCV000146282.1 [benign]; 			0.0758	0.4167	0.5076	35	161	n/a	n/a
chr8	6303409	6303409	T	G	het		QUAL=7810;DP=330;AF=0.47;MQM=60;TRIO=HET,330,0.47,WT,169,0.00,HET,210,0.40	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*333T>G:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*333T>G:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+341T>G:		rs2916750	0.2935	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.0379	0.3333	0.6288	5	51	n/a	n/a
chr8	6303434	6303434	T	A	het		QUAL=11361;DP=233;AF=0.50;MQM=60;TRIO=HET,233,0.50,HOM,139,1.00,HET,167,0.61	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*358T>A:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*358T>A:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+366T>A:		rs2515570	0.6536	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3258	0.0455	94	50	n/a	n/a
chr8	6303511	6303511	T	A	het		QUAL=6850;DP=186;AF=0.53;MQM=60;TRIO=HET,186,0.53,HOM,66,1.00,HET,77,0.61	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*435T>A:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*435T>A:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+443T>A:		rs1054073	0.6691	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3258	0.0455	94	50	n/a	n/a
chr8	6303614	6303614	A	C	het		QUAL=4038;DP=148;AF=0.53;MQM=60;TRIO=HET,148,0.53,HOM,20,1.00,HET,43,0.51	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*538A>C:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*538A>C:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+546A>C:		rs1054074	0.6609	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6212	0.3333	0.0455	93	51	n/a	n/a
chr8	6303846	6303846	A	G	het		QUAL=5295;DP=132;AF=0.49;MQM=60;TRIO=HET,132,0.49,WT,125,0.01,HET,205,0.49	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*770A>G:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*770A>G:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+778A>G:		rs79010412	0.0705	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0	0.0303	0.9697	0	4	n/a	n/a
chr8	6303859	6303859	C	T	het		QUAL=10146;DP=121;AF=0.50;MQM=60;TRIO=HET,121,0.50,HOM,135,0.99,HET,236,0.53	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*783C>T:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*783C>T:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+791C>T:		rs2440415	0.6442	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3258	0.0455	94	50	n/a	n/a
chr8	6304259	6304259	G	A	het		QUAL=6026;DP=152;AF=0.43;MQM=60;TRIO=HET,152,0.43,HOM,77,1.00,HET,89,0.53	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1183G>A:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1183G>A:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1191G>A:		rs2515571	0.6534	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3258	0.0455	94	50	n/a	n/a
chr8	6304348	6304348	C	T	het		QUAL=8358;DP=178;AF=0.48;MQM=60;TRIO=HET,178,0.48,HOM,107,1.00,HET,138,0.49	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1272C>T:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1272C>T:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1280C>T:		rs2166006	0.6725	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3333	0.0379	94	51	n/a	n/a
chr8	6304522	6304535	CAGGCAGGGGTGTC	-	het		QUAL=6178;DP=134;AF=0.34;MQM=60;TRIO=HET,134,0.34,HOM,109,1.00,HET,215,0.33	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1455_*1468delGTGTCCAGGCAGGG:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1455_*1468delGTGTCCAGGCAGGG:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1463_1825+1476delGTGTCCAGGCAGGG:		rs370636933	0.6482	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3333	0.0379	94	51	n/a	n/a
chr8	6304694	6304694	A	G	het		QUAL=15296;DP=242;AF=0.52;MQM=60;TRIO=HET,242,0.52,HOM,204,1.00,HET,281,0.51	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1618A>G:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1618A>G:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1626A>G:		rs1129703	0.6573	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3333	0.0379	94	51	n/a	n/a
chr8	6304730	6304730	A	C	het		QUAL=14007;DP=271;AF=0.48;MQM=60;TRIO=HET,271,0.48,HOM,171,1.00,HET,246,0.50	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1654A>C:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1654A>C:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1662A>C:		rs1129704	0.6492	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3333	0.0379	94	51	n/a	n/a
chr8	6304814	6304814	A	G	het		QUAL=16202;DP=244;AF=0.49;MQM=60;TRIO=HET,244,0.49,HOM,224,1.00,HET,288,0.52	MCPH1	3'UTR,intron	MCPH1:NM_001172574.1:3'UTR:MODIFIER:exon8/8:c.*1738A>G:,MCPH1:NM_001172575.1:3'UTR:MODIFIER:exon7/7:c.*1738A>G:,MCPH1:NM_024596.3:intron:MODIFIER:exon8/13:c.1825+1746A>G:		rs1129706	0.6573	0	0	0						607117 [MCPH1 (confirmed) Microcephaly 1,primary,autosomal recessive];				0.6288	0.3333	0.0379	94	51	n/a	n/a
chr8	8559832	8559832	G	A	het		QUAL=1709;DP=34;AF=0.50;MQM=59;TRIO=HET,34,0.50,HOM,46,1.00,WT,79,0.00	CLDN23	5'UTR	CLDN23:NM_194284.2:5'UTR:MODIFIER:exon1/1:c.-77G>A:		rs9644774	0.2163	0	0	0										0.1136	0.4318	0.4545	19	61	n/a	n/a
chr8	10581882	10581882	A	C	hom		QUAL=20868;DP=314;AF=1.00;MQM=60;TRIO=HOM,314,1.00,HOM,156,1.00,HOM,205,1.00	SOX7	3'UTR	SOX7:NM_031439.3:3'UTR:MODIFIER:exon2/2:c.*1366T>G:		rs11250064	0.6781	0	0	0										0.4697	0.3939	0.1364	71	61	n/a	n/a
chr8	10582523	10582523	T	G	het		QUAL=1280;DP=74;AF=0.49;MQM=58;TRIO=HET,74,0.49,WT,11,0.00,HET,15,0.47	SOX7	3'UTR	SOX7:NM_031439.3:3'UTR:MODIFIER:exon2/2:c.*725A>C:	AluSq2	rs145522498	0.0296	0	0	0										0	0.0758	0.9242	0	12	n/a	n/a
chr8	10583203	10583203	A	G	hom		QUAL=26802;DP=211;AF=1.00;MQM=59;TRIO=HOM,211,1.00,HOM,293,1.00,HOM,339,1.00	SOX7	3'UTR	SOX7:NM_031439.3:3'UTR:MODIFIER:exon2/2:c.*45T>C:		rs10110624	0.65	0.646	0.6789	0.8224										0.4848	0.3864	0.1288	79	69	n/a	n/a
chr8	10583506	10583506	A	G	het		QUAL=2901;DP=67;AF=0.51;MQM=60;TRIO=HET,67,0.51,HOM,64,1.00,WT,72,0.00	SOX7	synonymous	SOX7:NM_031439.3:synonymous:LOW:exon2/2:c.909T>C:p.Leu303Leu		rs4841432	0.4327	0.362	0.3683	0.7385										0.0833	0.4924	0.4242	30	157	n/a	n/a
chr8	22021933	22021933	C	T	het		QUAL=2962;DP=145;AF=0.53;MQM=59;TRIO=HET,145,0.53,WT,61,0.00,HET,60,0.62	SFTPC	3'UTR	SFTPC:NM_001172410.1:3'UTR:MODIFIER:exon6/6:c.*165C>T:,SFTPC:NM_001172357.1:3'UTR:MODIFIER:exon5/5:c.*379C>T:,SFTPC:NM_003018.3:3'UTR:MODIFIER:exon6/6:c.*173C>T:		rs1126931	0.1044	0.135	0	0	-1.7130	P	D			178620 [SFTPC (confirmed) Surfactant metabolism dysfunction,pulmonary,2];				0.0303	0.303	0.6667	10	68	n/a	n/a
chr8	24809067	24809067	C	T	hom		QUAL=28981;DP=386;AF=1.00;MQM=60;TRIO=HOM,386,1.00,HOM,209,1.00,HOM,282,1.00	NEFL	3'UTR	NEFL:NM_006158.4:3'UTR:MODIFIER:exon5/5:c.*1256G>A:		rs2979704	0.7196	0	0	0										0.6364	0.3258	0.0379	93	50	n/a	n/a
chr8	24809636	24809636	C	G	hom		QUAL=19047;DP=238;AF=1.00;MQM=60;TRIO=HOM,238,1.00,HOM,146,1.00,HOM,200,1.00	NEFL	3'UTR	NEFL:NM_006158.4:3'UTR:MODIFIER:exon5/5:c.*687G>C:		rs2976439	0.5427	0	0	0										0.3106	0.4697	0.2197	44	73	n/a	n/a
chr8	24810088	24810088	T	A	hom		QUAL=32912;DP=377;AF=1.00;MQM=60;TRIO=HOM,377,1.00,HOM,297,1.00,HOM,342,1.00	NEFL	3'UTR	NEFL:NM_006158.4:3'UTR:MODIFIER:exon5/5:c.*235A>T:		rs1059111	0.7208	0	0	0										0.6364	0.3258	0.0379	124	53	n/a	n/a
chr8	24811065	24811065	G	-	hom		QUAL=32666;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HOM,365,1.00,HOM,540,1.00	NEFL	splice_acceptor&splice_donor	NEFL:NM_006158.4:splice_acceptor&splice_donor:HIGH:exon3/4:c.1413+1delC:		rs397788090	1	1	1	0.9992						162280 [NEFL (confirmed) Charcot-Marie-Tooth disease,type 2E|Charcot-Marie-Tooth disease,type 1F];				1	0	0	454	0	n/a	n/a
chr8	27317337	27317337	A	G	hom		QUAL=41455;DP=274;AF=1.00;MQM=59;TRIO=HOM,274,1.00,HOM,414,0.99,HOM,597,1.00	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*1809T>C:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*1809T>C:		rs2280375	0.8057	0	0	0										0.75	0.2121	0.0379	111	33	n/a	n/a
chr8	27317445	27317445	G	T	het		QUAL=22205;DP=176;AF=0.56;MQM=60;TRIO=HET,176,0.56,HOM,353,1.00,HET,564,0.51	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*1701C>A:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*1701C>A:		rs1057137	0.4052	0	0	0										0.1364	0.4773	0.3864	20	74	n/a	n/a
chr8	27317762	27317762	G	A	het		QUAL=5890;DP=163;AF=0.50;MQM=60;TRIO=HET,163,0.50,WT,166,0.00,HET,229,0.48	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*1384C>T:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*1384C>T:		rs2280376	0.2218	0	0	0										0.0682	0.4091	0.5227	10	60	n/a	n/a
chr8	27317987	27317987	A	G	het		QUAL=9574;DP=273;AF=0.50;MQM=59;TRIO=HET,273,0.50,WT,278,0.00,HET,384,0.45	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*1159T>C:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*1159T>C:		rs1560344	0.3654	0	0	0										0.2197	0.5227	0.2576	31	79	n/a	n/a
chr8	27318391	27318391	C	T	het		QUAL=8502;DP=263;AF=0.49;MQM=60;TRIO=HET,263,0.49,WT,218,0.00,HET,300,0.48	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*755G>A:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*755G>A:		rs2292974	0.3614	0	0	0										0.2121	0.5303	0.2576	30	80	n/a	n/a
chr8	27318425	27318425	C	A	het		QUAL=8780;DP=282;AF=0.50;MQM=60;TRIO=HET,282,0.50,WT,205,0.00,HET,264,0.49	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*721G>T:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*721G>T:		rs2292975	0.359	0	0	0										0.2121	0.5303	0.2576	30	80	n/a	n/a
chr8	27318544	27318544	A	G	hom		QUAL=26301;DP=228;AF=1.00;MQM=60;TRIO=HOM,228,1.00,HOM,270,1.00,HOM,326,1.00	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*602T>C:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*602T>C:		rs2292976	0.7867	0	0	0										0.75	0.2121	0.0379	111	33	n/a	n/a
chr8	27318635	27318635	C	G	hom		QUAL=27404;DP=280;AF=0.99;MQM=59;TRIO=HOM,280,0.99,HOM,262,1.00,HOM,324,1.00	CHRNA2	3'UTR	CHRNA2:NM_000742.3:3'UTR:MODIFIER:exon7/7:c.*511G>C:,CHRNA2:NM_001282455.1:3'UTR:MODIFIER:exon7/7:c.*511G>C:		rs2292977	0.7819	0	0	0										0.7197	0.2424	0.0379	107	37	n/a	n/a
chr8	27324822	27324822	T	C	hom		QUAL=15863;DP=220;AF=1.00;MQM=60;TRIO=HOM,220,1.00,HET,229,0.50,HET,313,0.50	CHRNA2	missense	CHRNA2:NM_000742.3:missense:MODERATE:exon5/7:c.373A>G:p.Thr125Ala,CHRNA2:NM_001282455.1:missense:MODERATE:exon5/7:c.328A>G:p.Thr110Ala		rs891398	0.6102	0.531	0.4871	0.7617	0.6030	P	T	B	B	118502 [CHRNA2 (confirmed) Epilepsy,nocturnal frontal lobe,type 4];	RCV000116712.2 [likely benign]; RCV000124271.1 [benign]; 	CM144682 [CLASS=DP MUT=ALT PHEN="Nicotine dependence, association with" GENE=CHRNA2]; 		0.25	0.4773	0.2727	119	214	n/a	n/a
chr8	27336446	27336446	T	G	het		QUAL=318;DP=99;AF=0.25;MQM=58;TRIO=HET,99,0.25,WT,120,0.01,WT,175,0.01	CHRNA2	5'UTR	CHRNA2:NM_000742.3:5'UTR:MODIFIER:exon1/7:c.-242A>C:,CHRNA2:NM_001282455.1:5'UTR:MODIFIER:exon1/7:c.-242A>C:		rs368160505	0	0	0	0										0	0.1061	0.8939	0	15	n/a	n/a
chr8	27661066	27661066	-	AC	het		QUAL=7808;DP=171;AF=0.42;MQM=60;TRIO=HET,171,0.71,HET,72,0.46,HET,124,0.87	ESCO2	3'UTR	ESCO2:NM_001017420.2:3'UTR:MODIFIER:exon11/11:c.*128_*129dupAC:	(CA)n	rs56062620	0	0	0	0										0.1212	0.4242	0.4545	19	63	n/a	n/a
chr8	27661085	27661085	G	A	het		QUAL=7808;DP=171;AF=0.42;MQM=52;TRIO=HET,171,0.84,HET,72,0.83,WT,124,0.87	ESCO2	3'UTR	ESCO2:NM_001017420.2:3'UTR:MODIFIER:exon11/11:c.*130G>A:	(CA)n	rs62498042	0.497	0	0	0										0.1439	0.2955	0.5606	20	42	n/a	n/a
chr8	33356562	33356562	G	-	het		QUAL=13395;DP=326;AF=0.42;MQM=60;TRIO=HET,326,0.42,HOM,175,0.98,HET,221,0.48	MAK16,TTI2	3'UTR	MAK16:NM_032509.3:3'UTR:MODIFIER:exon10/10:c.*416delG:,TTI2:NM_001102401.2:3'UTR:MODIFIER:exon8/8:c.*129delC:,TTI2:NM_001265581.1:3'UTR:MODIFIER:exon8/8:c.*129delC:,TTI2:NM_025115.3:3'UTR:MODIFIER:exon7/7:c.*129delC:		rs397698667	0.5815	0	0	0										0.4015	0.4773	0.1212	61	71	n/a	n/a
chr8	33369944	33369944	T	C	het		QUAL=15506;DP=278;AF=0.49;MQM=59;TRIO=HET,278,0.49,HOM,186,1.00,HET,301,0.52	TTI2	missense	TTI2:NM_001102401.2:missense:MODERATE:exon2/8:c.188A>G:p.Glu63Gly,TTI2:NM_001265581.1:missense:MODERATE:exon2/8:c.188A>G:p.Glu63Gly,TTI2:NM_025115.3:missense:MODERATE:exon1/7:c.188A>G:p.Glu63Gly		rs2304748	0.5068	0.561	0.6177	0.4612	0.7680	P	T	P,B,B	B,B,B	614426 [TTI2 (provisional) Mental retardation,autosomal recessive 39];				0.3712	0.4924	0.1364	155	222	n/a	n/a
chr8	33369994	33369994	A	G	het		QUAL=17484;DP=405;AF=0.48;MQM=59;TRIO=HET,405,0.48,HOM,188,1.00,HET,320,0.52	TTI2	synonymous	TTI2:NM_001102401.2:synonymous:LOW:exon2/8:c.138T>C:p.Asn46Asn,TTI2:NM_001265581.1:synonymous:LOW:exon2/8:c.138T>C:p.Asn46Asn,TTI2:NM_025115.3:synonymous:LOW:exon1/7:c.138T>C:p.Asn46Asn		rs3098657	0.5789	0.601	0.6486	0.6707						614426 [TTI2 (provisional) Mental retardation,autosomal recessive 39];				0.4015	0.4773	0.1212	169	222	n/a	n/a
chr8	33370261	33370261	G	A	het		QUAL=2111;DP=107;AF=0.43;MQM=60;TRIO=HET,107,0.43,HOM,14,1.00,HET,30,0.33	TTI2	5'UTR,intron	TTI2:NM_025115.3:5'UTR:MODIFIER:exon1/7:c.-130C>T:,TTI2:NM_001102401.2:intron:MODIFIER:exon1/7:c.-99-31C>T:,TTI2:NM_001265581.1:intron:MODIFIER:exon1/7:c.-99-31C>T:		rs34226219	0.2206	0	0	0										0.1515	0.5606	0.2879	24	81	n/a	n/a
chr8	38000267	38000267	T	C	hom		QUAL=27598;DP=281;AF=1.00;MQM=59;TRIO=HOM,281,1.00,HOM,252,1.00,HOM,343,1.00	STAR	3'UTR	STAR:NM_000349.2:3'UTR:MODIFIER:exon7/7:c.*1524A>G:	AluSx	rs3990403	0.5505	0	0	0										0.7273	0.2652	0.0076	110	38	n/a	n/a
chr8	38000824	38000824	T	-	het		QUAL=1983;DP=35;AF=0.37;MQM=60;TRIO=HET,35,0.37,HET,27,0.52,HET,48,0.46	STAR	3'UTR	STAR:NM_000349.2:3'UTR:MODIFIER:exon7/7:c.*966delA:	AluSc8		0	0	0	0										0.0227	0.2879	0.6894	3	40	n/a	n/a
chr8	38000824	38000825	TT	-	het		QUAL=1983;DP=35;AF=0.34;MQM=59;TRIO=HET,35,0.34,HET,27,0.26,HET,48,0.27	STAR	3'UTR	STAR:NM_000349.2:3'UTR:MODIFIER:exon7/7:c.*966_*967delAA:	AluSc8		0	0	0	0										0.2652	0.4394	0.2955	42	65	n/a	n/a
chr8	38005835	38005835	T	C	hom		QUAL=13357;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HOM,137,1.00,HOM,155,1.00	STAR	synonymous	STAR:NM_000349.2:synonymous:LOW:exon3/7:c.189A>G:p.Leu63Leu		rs2229620	0.9954	0.999	1	0.9889		P				600617 [STAR (provisional) Lipoid adrenal hyperplasia];			COSM4162974	1	0	0	453	0	n/a	n/a
chr8	38326046	38326046	G	A	het		QUAL=682;DP=7;AF=0.57;MQM=60;TRIO=HET,7,0.57,HET,11,0.27,HOM,20,1.00	FGFR1	5'UTR_premature_start_codon_gain,5'UTR	FGFR1:NM_001174063.1:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:NM_001174064.1:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-728C>T:,FGFR1:NM_015850.3:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:NM_023105.2:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-636C>T:,FGFR1:NM_023106.2:5'UTR_premature_start_codon_gain:LOW:exon1/17:c.-636C>T:,FGFR1:NM_023110.2:5'UTR_premature_start_codon_gain:LOW:exon1/18:c.-636C>T:,FGFR1:NM_001174063.1:5'UTR:MODIFIER:exon1/18:c.-636C>T:,FGFR1:NM_001174064.1:5'UTR:MODIFIER:exon1/19:c.-728C>T:,FGFR1:NM_015850.3:5'UTR:MODIFIER:exon1/18:c.-636C>T:,FGFR1:NM_023105.2:5'UTR:MODIFIER:exon1/17:c.-636C>T:,FGFR1:NM_023106.2:5'UTR:MODIFIER:exon1/17:c.-636C>T:,FGFR1:NM_023110.2:5'UTR:MODIFIER:exon1/18:c.-636C>T:		rs3213849	0.3407	0	0	0										0.1288	0.2955	0.5758	18	40	n/a	n/a
chr8	38326161	38326161	G	A	hom		QUAL=2152;DP=42;AF=1.00;MQM=60;TRIO=HOM,42,1.00,HOM,22,1.00,HOM,25,1.00	FGFR1	5'UTR	FGFR1:NM_001174063.1:5'UTR:MODIFIER:exon1/18:c.-751C>T:,FGFR1:NM_001174064.1:5'UTR:MODIFIER:exon1/19:c.-843C>T:,FGFR1:NM_015850.3:5'UTR:MODIFIER:exon1/18:c.-751C>T:,FGFR1:NM_023105.2:5'UTR:MODIFIER:exon1/17:c.-751C>T:,FGFR1:NM_023106.2:5'UTR:MODIFIER:exon1/17:c.-751C>T:,FGFR1:NM_023110.2:5'UTR:MODIFIER:exon1/18:c.-751C>T:		rs2445003	0.9569	0	0	0										1	0	0	150	0	n/a	n/a
chr8	43054553	43054553	T	C	hom		QUAL=30390;DP=399;AF=1.00;MQM=60;TRIO=HOM,399,1.00,HOM,229,1.00,HOM,302,1.00	HGSNAT	synonymous	HGSNAT:NM_152419.2:synonymous:LOW:exon18/18:c.1749T>C:p.Tyr583Tyr		rs1126058	0.9916	0.996	0.9997	0.9731						610453 [HGSNAT (confirmed) Mucopolysaccharidosis type IIIC (Sanfilippo C)];	RCV000082655.2 [benign]; 			1	0	0	452	2	n/a	n/a
chr8	43056513	43056513	T	C	hom		QUAL=32780;DP=207;AF=1.00;MQM=59;TRIO=HOM,207,1.00,HOM,424,1.00,HOM,433,1.00	HGSNAT	3'UTR	HGSNAT:NM_152419.2:3'UTR:MODIFIER:exon18/18:c.*1801T>C:	L2c	rs3739431	0.8219	0	0	0										0.9545	0.0455	0	143	7	n/a	n/a
chr8	48805816	48805816	-	G	hom		QUAL=16247;DP=174;AF=0.94;MQM=60;TRIO=HOM,174,0.94,HOM,173,0.99,HOM,221,0.95	PRKDC	frameshift	PRKDC:NM_006904.6:frameshift:HIGH:exon31/86:c.3729dupC:p.Phe1244fs,PRKDC:NM_001081640.1:frameshift:HIGH:exon31/85:c.3729dupC:p.Phe1244fs		rs397814002	1	1	0.9996	0.9984										1	0	0	490	0	1	n/a
chr8	48846519	48846519	T	C	hom		QUAL=18377;DP=256;AF=1.00;MQM=60;TRIO=HOM,256,1.00,HOM,189,1.00,HET,242,0.55	PRKDC	splice_region&intron	PRKDC:NM_006904.6:splice_region&intron:LOW:exon15/85:c.1623+6A>G:,PRKDC:NM_001081640.1:splice_region&intron:LOW:exon15/84:c.1623+6A>G:		rs1231202	0.9836	0.96	0.9489	0.9911										0.9091	0.0909	0	421	43	n/a	n/a
chr8	61102553	61102553	A	-	het		QUAL=1585;DP=79;AF=0.22;MQM=60;TRIO=HET,79,0.22,HET,70,0.26,HET,93,0.35	CA8	splice_region&intron	CA8:NM_004056.4:splice_region&intron:LOW:exon8/8:c.*36-9delT:		rs57677078	0	0	0	0										0	0.3106	0.6894	0	44	n/a	n/a
chr8	61178574	61178574	T	C	hom		QUAL=19300;DP=279;AF=1.00;MQM=60;TRIO=HOM,279,1.00,HOM,188,1.00,HET,232,0.50	CA8	synonymous	CA8:NM_004056.4:synonymous:LOW:exon3/9:c.327A>G:p.Glu109Glu		rs7464181	0.501	0.427	0.4097	0.7596						114815 [CA8 (provisional) Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3];	RCV000116510.2 [likely benign]; 		COSM3763364	0.197	0.4545	0.3485	206	539	n/a	n/a
chr8	61193760	61193760	T	G	hom		QUAL=13594;DP=45;AF=1.00;MQM=59;TRIO=HOM,45,1.00,HOM,263,1.00,HET,395,0.36	CA8	5'UTR	CA8:NM_004056.4:5'UTR:MODIFIER:exon1/9:c.-54A>C:		rs10101374	0.6266	0	0	0										0.3561	0.4242	0.2197	52	65	n/a	n/a
chr8	61193809	61193809	A	G	hom		QUAL=15458;DP=83;AF=1.00;MQM=59;TRIO=HOM,83,1.00,HOM,279,1.00,HET,407,0.38	CA8	5'UTR	CA8:NM_004056.4:5'UTR:MODIFIER:exon1/9:c.-103T>C:		rs10086341	0.6258	0	0	0										0.3561	0.4318	0.2121	52	66	n/a	n/a
chr8	61193828	61193828	A	G	hom		QUAL=15970;DP=80;AF=1.00;MQM=60;TRIO=HOM,80,1.00,HOM,292,1.00,HET,421,0.38	CA8	5'UTR	CA8:NM_004056.4:5'UTR:MODIFIER:exon1/9:c.-122T>C:		rs10086352	0.4329	0	0	0										0.1818	0.447	0.3712	25	67	n/a	n/a
chr8	61193843	61193843	C	G	hom		QUAL=16399;DP=85;AF=1.00;MQM=59;TRIO=HOM,85,1.00,HOM,286,1.00,HET,423,0.38	CA8	5'UTR	CA8:NM_004056.4:5'UTR:MODIFIER:exon1/9:c.-137G>C:		rs10086449	0.4329	0	0	0										0.1818	0.447	0.3712	25	67	n/a	n/a
chr8	61779681	61779681	A	C	het		QUAL=17337;DP=495;AF=0.51;MQM=60;TRIO=HET,495,0.51,HOM,163,1.00,HET,224,0.49	CHD7	3'UTR	CHD7:NM_017780.3:3'UTR:MODIFIER:exon38/38:c.*1189A>C:		rs4738834	0.5004	0	0	0										0.3788	0.4167	0.2045	56	63	n/a	n/a
chr8	61779936	61779936	T	G	het		QUAL=18319;DP=520;AF=0.51;MQM=60;TRIO=HET,520,0.51,HOM,188,0.99,HET,288,0.43	CHD7	3'UTR	CHD7:NM_017780.3:3'UTR:MODIFIER:exon38/38:c.*1444T>G:		rs4237040	0.4958	0	0	0										0.3788	0.4091	0.2121	56	62	n/a	n/a
chr8	61780220	61780220	T	C	het		QUAL=14913;DP=403;AF=0.53;MQM=60;TRIO=HET,403,0.53,HOM,141,1.00,HET,233,0.50	CHD7	3'UTR	CHD7:NM_017780.3:3'UTR:MODIFIER:exon38/38:c.*1728T>C:		rs2280917	0.7376	0	0	0										0.4773	0.3788	0.1439	72	56	n/a	n/a
chr8	61780289	61780289	C	T	het		QUAL=13639;DP=351;AF=0.46;MQM=60;TRIO=HET,351,0.46,HOM,151,1.00,HET,217,0.50	CHD7	3'UTR	CHD7:NM_017780.3:3'UTR:MODIFIER:exon38/38:c.*1797C>T:		rs6985168	0.4962	0	0	0										0.3864	0.4091	0.2045	57	62	n/a	n/a
chr8	62562872	62562872	C	T	het		QUAL=24899;DP=427;AF=0.52;MQM=60;TRIO=HET,427,0.52,HET,304,0.51,HOM,382,1.00	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon5/24:c.490+737G>A:,ASPH:NM_001164750.1:intron:MODIFIER:exon5/24:c.403+737G>A:,ASPH:NM_001164751.1:intron:MODIFIER:exon6/14:c.448+737G>A:,ASPH:NM_001164752.1:intron:MODIFIER:exon6/13:c.448+737G>A:,ASPH:NM_001164753.1:intron:MODIFIER:exon6/13:c.448+737G>A:,ASPH:NM_032468.4:intron:MODIFIER:exon6/14:c.448+737G>A:,ASPH:NM_001164754.1:intron:MODIFIER:exon5/12:c.490+737G>A:,ASPH:NM_001164755.1:intron:MODIFIER:exon5/12:c.490+737G>A:,ASPH:NM_032466.3:intron:MODIFIER:exon5/13:c.490+737G>A:		rs2350590	0.8045	0	0	0						600582 [ASPH (confirmed) Traboulsi syndrome];				0.697	0.2652	0.0379	105	40	n/a	n/a
chr8	62563764	62563764	A	G	het		QUAL=13302;DP=259;AF=0.54;MQM=60;TRIO=HET,259,0.54,HET,146,0.49,HOM,203,1.00	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon4/24:c.416-81T>C:,ASPH:NM_001164750.1:intron:MODIFIER:exon4/24:c.329-81T>C:,ASPH:NM_001164751.1:intron:MODIFIER:exon5/14:c.374-81T>C:,ASPH:NM_001164752.1:intron:MODIFIER:exon5/13:c.374-81T>C:,ASPH:NM_001164753.1:intron:MODIFIER:exon5/13:c.374-81T>C:,ASPH:NM_032468.4:intron:MODIFIER:exon5/14:c.374-81T>C:,ASPH:NM_001164754.1:intron:MODIFIER:exon4/12:c.416-81T>C:,ASPH:NM_001164755.1:intron:MODIFIER:exon4/12:c.416-81T>C:,ASPH:NM_032466.3:intron:MODIFIER:exon4/13:c.416-81T>C:		rs7016141	0.8051	0	0	0						600582 [ASPH (confirmed) Traboulsi syndrome];				0.697	0.2652	0.0379	105	40	n/a	n/a
chr8	62565897	62565897	G	A	het		QUAL=21116;DP=583;AF=0.47;MQM=60;TRIO=HET,583,0.47,WT,242,0.00,HOM,359,1.00	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon4/24:c.415+230C>T:,ASPH:NM_001164750.1:intron:MODIFIER:exon4/24:c.328+230C>T:,ASPH:NM_001164751.1:intron:MODIFIER:exon5/14:c.373+230C>T:,ASPH:NM_001164752.1:intron:MODIFIER:exon5/13:c.373+230C>T:,ASPH:NM_001164753.1:intron:MODIFIER:exon5/13:c.373+230C>T:,ASPH:NM_032468.4:intron:MODIFIER:exon5/14:c.373+230C>T:,ASPH:NM_001164754.1:intron:MODIFIER:exon4/12:c.415+230C>T:,ASPH:NM_001164755.1:intron:MODIFIER:exon4/12:c.415+230C>T:,ASPH:NM_032466.3:intron:MODIFIER:exon4/13:c.415+230C>T:	MIRc	rs949761	0.1034	0	0	0						600582 [ASPH (confirmed) Traboulsi syndrome];				0.0152	0.2197	0.7652	2	33	n/a	n/a
chr8	62567097	62567097	C	T	het		QUAL=21275;DP=672;AF=0.45;MQM=60;TRIO=HET,672,0.45,WT,242,0.00,HOM,340,0.99	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon3/24:c.323-878G>A:,ASPH:NM_001164750.1:intron:MODIFIER:exon3/24:c.236-878G>A:,ASPH:NM_001164751.1:intron:MODIFIER:exon4/14:c.281-878G>A:,ASPH:NM_001164752.1:intron:MODIFIER:exon4/13:c.281-878G>A:,ASPH:NM_001164753.1:intron:MODIFIER:exon4/13:c.281-878G>A:,ASPH:NM_032468.4:intron:MODIFIER:exon4/14:c.281-878G>A:,ASPH:NM_001164754.1:intron:MODIFIER:exon3/12:c.323-878G>A:,ASPH:NM_001164755.1:intron:MODIFIER:exon3/12:c.323-878G>A:,ASPH:NM_032466.3:intron:MODIFIER:exon3/13:c.323-878G>A:		rs10504331	0.1034	0	0	0						600582 [ASPH (confirmed) Traboulsi syndrome];				0.0152	0.2197	0.7652	2	33	n/a	n/a
chr8	62567214	62567214	G	C	het		QUAL=21826;DP=386;AF=0.52;MQM=60;TRIO=HET,386,0.52,HET,250,0.46,HOM,347,1.00	ASPH	intron	ASPH:NM_004318.3:intron:MODIFIER:exon3/24:c.323-995C>G:,ASPH:NM_001164750.1:intron:MODIFIER:exon3/24:c.236-995C>G:,ASPH:NM_001164751.1:intron:MODIFIER:exon4/14:c.281-995C>G:,ASPH:NM_001164752.1:intron:MODIFIER:exon4/13:c.281-995C>G:,ASPH:NM_001164753.1:intron:MODIFIER:exon4/13:c.281-995C>G:,ASPH:NM_032468.4:intron:MODIFIER:exon4/14:c.281-995C>G:,ASPH:NM_001164754.1:intron:MODIFIER:exon3/12:c.323-995C>G:,ASPH:NM_001164755.1:intron:MODIFIER:exon3/12:c.323-995C>G:,ASPH:NM_032466.3:intron:MODIFIER:exon3/13:c.323-995C>G:		rs9283975	0.7829	0	0	0						600582 [ASPH (confirmed) Traboulsi syndrome];				0.6894	0.2727	0.0379	104	41	n/a	n/a
chr8	63972324	63972324	C	T	het		QUAL=365;DP=20;AF=0.55;MQM=60;TRIO=HET,20,0.55,HET,4,0.50,HOM,2,1.00	TTPA	3'UTR	TTPA:NM_000370.3:3'UTR:MODIFIER:exon5/5:c.*1487G>A:		rs6472068	0.5284	0	0	0										0.2273	0.303	0.4697	32	47	n/a	n/a
chr8	63972718	63972718	C	T	het		QUAL=16502;DP=360;AF=0.47;MQM=60;TRIO=HET,360,0.47,HOM,184,0.99,HET,300,0.51	TTPA	3'UTR	TTPA:NM_000370.3:3'UTR:MODIFIER:exon5/5:c.*1093G>A:		rs4587328	0.6755	0	0	0										0.2955	0.447	0.2576	43	66	n/a	n/a
chr8	63973233	63973235	AAA	-	het		QUAL=4097;DP=125;AF=0.41;MQM=59;TRIO=HET,125,0.41,HOM,70,0.83,HET,62,0.47	TTPA	3'UTR	TTPA:NM_000370.3:3'UTR:MODIFIER:exon5/5:c.*576_*578delTTT:	AluSz6	rs35504965	0.6747	0	0	0										0.3788	0.3636	0.2576	55	54	n/a	n/a
chr8	63978659	63978659	A	-	hom		QUAL=14481;DP=178;AF=1.00;MQM=60;TRIO=HOM,178,1.00,HOM,120,0.99,HOM,168,0.99	TTPA	splice_region&intron	TTPA:NM_000370.3:splice_region&intron:LOW:exon2/4:c.359-3delT:		rs398008072	1	1	0.9999	1						600415 [TTPA (confirmed) Ataxia with isolated vitamin E deficiency];	RCV000078673.2 [benign]; 			1	0	0	1122	0	n/a	n/a
chr8	75262798	75262798	G	C	hom		QUAL=36258;DP=265;AF=1.00;MQM=59;TRIO=HOM,265,1.00,HOM,357,1.00,HOM,495,1.00	GDAP1	synonymous,intron	GDAP1:NM_018972.2:synonymous:LOW:exon1/6:c.102G>C:p.Ser34Ser,GDAP1:NM_001040875.2:intron:MODIFIER:exon1/5:c.-64+91G>C:		rs7828201	0.9956	0.997	0	0						606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis|Charcot-Marie-Tooth disease,axonal,type 2K|Charcot-Marie-Tooth disease,recessive intermediate,A];			COSM4163063	1	0	0	454	0	n/a	n/a
chr8	75274141	75274141	T	G	het		QUAL=14344;DP=289;AF=0.47;MQM=60;TRIO=HET,289,0.47,WT,248,0.01,HOM,313,0.99	GDAP1	synonymous	GDAP1:NM_018972.2:synonymous:LOW:exon4/6:c.507T>G:p.Ser169Ser,GDAP1:NM_001040875.2:synonymous:LOW:exon4/6:c.303T>G:p.Ser101Ser		rs11554166	0.2192	0.277	0.3181	0.128						606598 [GDAP1 (confirmed) Charcot-Marie-Tooth disease,type 4A|Charcot-Marie-Tooth disease,axonal,with vocal cord paresis|Charcot-Marie-Tooth disease,axonal,type 2K|Charcot-Marie-Tooth disease,recessive intermediate,A];			COSM3763403	0.0985	0.4242	0.4773	43	192	n/a	n/a
chr8	75277399	75277399	A	G	hom		QUAL=19978;DP=261;AF=1.00;MQM=60;TRIO=HOM,261,1.00,HOM,155,1.00,HOM,190,1.00	GDAP1	3'UTR	GDAP1:NM_018972.2:3'UTR:MODIFIER:exon6/6:c.*797A>G:,GDAP1:NM_001040875.2:3'UTR:MODIFIER:exon6/6:c.*797A>G:		rs7007283	0.9898	0.988	0	0										0.9924	0.0076	0	289	1	n/a	n/a
chr8	75278457	75278457	A	G	het		QUAL=20878;DP=765;AF=0.53;MQM=60;TRIO=HET,765,0.53,WT,160,0.00,HOM,235,1.00	GDAP1	3'UTR	GDAP1:NM_018972.2:3'UTR:MODIFIER:exon6/6:c.*1855A>G:,GDAP1:NM_001040875.2:3'UTR:MODIFIER:exon6/6:c.*1855A>G:		rs6472842	0.2668	0.226	0	0										0.0985	0.4242	0.4773	29	122	n/a	n/a
chr8	75278816	75278816	A	G	het		QUAL=14001;DP=401;AF=0.52;MQM=60;TRIO=HET,401,0.52,WT,139,0.00,HOM,214,1.00	GDAP1	3'UTR	GDAP1:NM_018972.2:3'UTR:MODIFIER:exon6/6:c.*2214A>G:,GDAP1:NM_001040875.2:3'UTR:MODIFIER:exon6/6:c.*2214A>G:		rs10504580	0.2294	0.209	0	0										0.0985	0.4242	0.4773	29	122	n/a	n/a
chr8	77892834	77892834	A	T	het		QUAL=10949;DP=232;AF=0.56;MQM=60;TRIO=HET,232,0.56,HET,185,0.44,HET,250,0.50	PEX2	3'UTR	PEX2:NM_000318.2:3'UTR:MODIFIER:exon4/4:c.*2663T>A:,PEX2:NM_001079867.1:3'UTR:MODIFIER:exon3/3:c.*2663T>A:,PEX2:NM_001172086.1:3'UTR:MODIFIER:exon5/5:c.*2663T>A:,PEX2:NM_001172087.1:3'UTR:MODIFIER:exon3/3:c.*2663T>A:	MLT1K	rs28435921	0.518	0	0	0										0.3788	0.447	0.1742	54	70	n/a	n/a
chr8	77893120	77893120	T	C	hom		QUAL=29404;DP=427;AF=1.00;MQM=60;TRIO=HOM,427,1.00,HOM,211,1.00,HOM,236,1.00	PEX2	3'UTR	PEX2:NM_000318.2:3'UTR:MODIFIER:exon4/4:c.*2377A>G:,PEX2:NM_001079867.1:3'UTR:MODIFIER:exon3/3:c.*2377A>G:,PEX2:NM_001172086.1:3'UTR:MODIFIER:exon5/5:c.*2377A>G:,PEX2:NM_001172087.1:3'UTR:MODIFIER:exon3/3:c.*2377A>G:		rs4388434	0.9543	0	0	0										0.9773	0.0227	0	147	3	n/a	n/a
chr8	77894303	77894303	T	C	hom		QUAL=15654;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HOM,111,1.00,HOM,113,1.00	PEX2	3'UTR	PEX2:NM_000318.2:3'UTR:MODIFIER:exon4/4:c.*1194A>G:,PEX2:NM_001079867.1:3'UTR:MODIFIER:exon3/3:c.*1194A>G:,PEX2:NM_001172086.1:3'UTR:MODIFIER:exon5/5:c.*1194A>G:,PEX2:NM_001172087.1:3'UTR:MODIFIER:exon3/3:c.*1194A>G:		rs4311633	0.9858	0	0	0										0.9773	0.0227	0	147	3	n/a	n/a
chr8	77894770	77894770	A	G	hom		QUAL=19570;DP=324;AF=0.99;MQM=59;TRIO=HOM,324,0.99,HOM,110,1.00,HOM,169,1.00	PEX2	3'UTR	PEX2:NM_000318.2:3'UTR:MODIFIER:exon4/4:c.*727T>C:,PEX2:NM_001079867.1:3'UTR:MODIFIER:exon3/3:c.*727T>C:,PEX2:NM_001172086.1:3'UTR:MODIFIER:exon5/5:c.*727T>C:,PEX2:NM_001172087.1:3'UTR:MODIFIER:exon3/3:c.*727T>C:	AluSc8	rs4610720	0.9543	0	0	0										0.9773	0.0227	0	147	3	n/a	n/a
chr8	77895865	77895865	A	G	hom		QUAL=21992;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HOM,159,1.00,HOM,216,1.00	PEX2	missense	PEX2:NM_000318.2:missense:MODERATE:exon4/4:c.550T>C:p.Cys184Arg,PEX2:NM_001079867.1:missense:MODERATE:exon3/3:c.550T>C:p.Cys184Arg,PEX2:NM_001172086.1:missense:MODERATE:exon5/5:c.550T>C:p.Cys184Arg,PEX2:NM_001172087.1:missense:MODERATE:exon3/3:c.550T>C:p.Cys184Arg		rs10087163	0.9962	0.988	0.9851	0.997	6.1730	P	T	B	B	170993 [PEX2 (confirmed) Peroxisome biogenesis disorder 5A (Zellweger)|Peroxisome biogenesis disorder 5B];				0.9924	0.0076	0	1093	31	n/a	n/a
chr8	77912230	77912230	G	T	het		QUAL=5450;DP=144;AF=0.51;MQM=60;TRIO=HET,144,0.51,WT,155,0.00,HET,203,0.50	PEX2	5'UTR	PEX2:NM_000318.2:5'UTR:MODIFIER:exon1/4:c.-164C>A:,PEX2:NM_001079867.1:5'UTR:MODIFIER:exon1/3:c.-132C>A:,PEX2:NM_001172086.1:5'UTR:MODIFIER:exon2/5:c.-164C>A:,PEX2:NM_001172087.1:5'UTR:MODIFIER:exon2/3:c.-22C>A:		rs12718	0.2778	0.214	0	0										0.0379	0.2727	0.6894	10	64	n/a	n/a
chr8	77912424	77912424	T	G	hom		QUAL=34963;DP=416;AF=1.00;MQM=59;TRIO=HOM,416,1.00,HOM,293,1.00,HOM,388,1.00	PEX2	5'UTR,intron	PEX2:NM_000318.2:5'UTR:MODIFIER:exon1/4:c.-358A>C:,PEX2:NM_001079867.1:5'UTR:MODIFIER:exon1/3:c.-326A>C:,PEX2:NM_001172086.1:intron:MODIFIER:exon1/4:c.-302-56A>C:,PEX2:NM_001172087.1:intron:MODIFIER:exon1/2:c.-160-56A>C:		rs10081480	0.9655	0	0	0										0.9773	0.0227	0	168	3	n/a	n/a
chr8	86376130	86376130	A	T	hom		QUAL=1172;DP=14;AF=1.00;MQM=59;TRIO=HOM,14,1.00,HOM,16,1.00,HOM,13,1.00					rs11261477	0.9988	0	0	0										0.8788	0.0303	0.0909	130	4	n/a	n/a
chr8	86389403	86389403	T	C	hom		QUAL=36493;DP=398;AF=1.00;MQM=60;TRIO=HOM,398,1.00,HOM,328,0.99,HOM,397,1.00	CA2	synonymous	CA2:NM_000067.2:synonymous:LOW:exon6/7:c.562T>C:p.Leu188Leu,CA2:NM_001293675.1:synonymous:LOW:exon5/6:c.259T>C:p.Leu87Leu		rs703	0.5777	0.589	0.6151	0.6977						611492 [CA2 (confirmed) Osteopetrosis,autosomal recessive 3,with renal tubular acidosis];			COSM3982612	0.447	0.447	0.1061	196	194	n/a	n/a
chr8	90946056	90946056	A	G	het		QUAL=6028;DP=211;AF=0.52;MQM=60;TRIO=HET,211,0.52,WT,48,0.00,HOM,71,1.00	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*1754T>C:	L1MEf	rs9995	0.3355	0	0	0										0.0985	0.4015	0.5	13	59	n/a	n/a
chr8	90946601	90946601	T	G	het		QUAL=22064;DP=525;AF=0.50;MQM=60;TRIO=HET,525,0.50,WT,326,0.00,HOM,403,1.00	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*1209A>C:	LTR67B	rs1063054	0.3353	0	0	0										0.0985	0.4015	0.5	13	59	n/a	n/a
chr8	90947269	90947269	C	G	het		QUAL=6782;DP=221;AF=0.51;MQM=60;TRIO=HET,221,0.51,WT,68,0.00,HOM,98,0.99	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*541G>C:		rs2735383	0.3303	0	0	0								CR121123 [CLASS=DFP MUT=ALT PHEN="Lung cancer, increased risk, association with" GENE=NBN]; 		0.0985	0.4015	0.5	13	59	n/a	n/a
chr8	90947409	90947409	G	C	het		QUAL=4578;DP=197;AF=0.51;MQM=60;TRIO=HET,197,0.51,HET,60,0.63,WT,89,0.00	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*401C>G:	L1ME4b	rs104895030	0.0012	0	0	0							RCV000114873.1 [not provided]; 			0	0.0152	0.9848	0	2	n/a	n/a
chr8	90947537	90947537	C	T	het		QUAL=7308;DP=196;AF=0.48;MQM=60;TRIO=HET,196,0.48,WT,104,0.00,HOM,129,1.00	NBN	3'UTR	NBN:NM_002485.4:3'UTR:MODIFIER:exon16/16:c.*273G>A:	L1ME4b	rs1063053	0.3219	0	0	0										0.0985	0.3939	0.5076	13	58	n/a	n/a
chr8	90958422	90958422	T	C	het		QUAL=9649;DP=281;AF=0.48;MQM=60;TRIO=HET,281,0.48,WT,95,0.01,HOM,161,1.00	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon13/16:c.2016A>G:p.Pro672Pro		rs1061302	0.3528	0.345	0.3132	0.2276						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];			COSM3763441	0.0833	0.4318	0.4848	95	450	n/a	n/a
chr8	90958530	90958530	T	C	het		QUAL=8941;DP=284;AF=0.50;MQM=60;TRIO=HET,284,0.50,WT,102,0.01,HOM,136,0.99	NBN	splice_region&intron	NBN:NM_002485.4:splice_region&intron:LOW:exon12/15:c.1915-7A>G:		rs2308962	0.379	0.353	0.3144	0.3107						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];				0.0833	0.4242	0.4924	95	450	n/a	n/a
chr8	90967711	90967711	A	G	het		QUAL=6386;DP=173;AF=0.50;MQM=60;TRIO=HET,173,0.50,WT,97,0.00,HOM,115,0.98	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon10/16:c.1197T>C:p.Asp399Asp		rs709816	0.6086	0.467	0.3559	0.7527						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];			COSM3763442	0.1288	0.4242	0.447	123	478	n/a	n/a
chr8	90990479	90990479	C	G	het		QUAL=11307;DP=282;AF=0.45;MQM=60;TRIO=HET,282,0.45,WT,138,0.00,HOM,217,1.00	NBN	missense	NBN:NM_002485.4:missense:MODERATE:exon5/16:c.553G>C:p.Glu185Gln		rs1805794	0.357	0.345	0.3136	0.2338	2.1330	P	T	B	B	602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000121620.1 [not provided]; 	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer, association with" GENE=NBN]; 	COSM3763443	0.0833	0.4318	0.4848	95	449	n/a	n/a
chr8	90995019	90995019	C	T	het		QUAL=14735;DP=406;AF=0.43;MQM=60;TRIO=HET,406,0.43,WT,209,0.00,HOM,269,1.00	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon2/16:c.102G>A:p.Leu34Leu		rs1063045	0.3792	0.353	0.3147	0.3103						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];			COSM3763444	0.0833	0.4318	0.4848	93	427	n/a	n/a
chr8	94794620	94794620	C	T	het		QUAL=5834;DP=134;AF=0.49;MQM=60;TRIO=HET,134,0.49,HOM,116,1.00,WT,142,0.01	TMEM67	splice_region&intron	TMEM67:NM_153704.5:splice_region&intron:LOW:exon10/27:c.1066-3C>T:,TMEM67:NM_001142301.1:splice_region&intron:LOW:exon11/28:c.823-3C>T:		rs3097427	0.7151	0.631	0.5749	0.7631						609884 [TMEM67 (confirmed) Meckel syndrome 3|Joubert syndrome 6|Bardet-Biedl syndrome 14,modifier of|COACH syndrome|Nephronophthisis 11];	RCV000082681.4 [other]; 			0.2652	0.4545	0.2803	346	397	n/a	n/a
chr8	94808165	94808165	A	G	het		QUAL=5100;DP=220;AF=0.45;MQM=60;TRIO=HET,220,0.45,HOM,58,1.00,WT,93,0.00	TMEM67	missense	TMEM67:NM_153704.5:missense:MODERATE:exon18/28:c.1810A>G:p.Ile604Val,TMEM67:NM_001142301.1:missense:MODERATE:exon19/29:c.1567A>G:p.Ile523Val		rs3134031	0.6929	0.637	0.595	0.7291	0.3570	P	T	B,B	B,B	609884 [TMEM67 (confirmed) Meckel syndrome 3|Joubert syndrome 6|Bardet-Biedl syndrome 14,modifier of|COACH syndrome|Nephronophthisis 11];	RCV000114244.2 [likely benign]; 		COSM3763456	0.2955	0.4318	0.2727	417	531	n/a	n/a
chr8	94929079	94929079	T	A	hom		QUAL=391;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HOM,7,1.00,HET,11,0.55					rs4469422	0.4966	0	0	0										0.1061	0.1591	0.7348	30	42	n/a	n/a
chr8	94935937	94935937	T	C	het		QUAL=19122;DP=548;AF=0.45;MQM=60;TRIO=HET,548,0.45,HOM,202,1.00,HET,278,0.48	PDP1	3'UTR	PDP1:NM_001161779.1:3'UTR:MODIFIER:exon3/3:c.*36T>C:,PDP1:NM_018444.3:3'UTR:MODIFIER:exon2/2:c.*36T>C:,PDP1:NM_001161780.1:3'UTR:MODIFIER:exon3/3:c.*36T>C:,PDP1:NM_001161781.1:3'UTR:MODIFIER:exon2/2:c.*36T>C:		rs4735258	0.4952	0.466	0.4067	0.4011										0.1364	0.4621	0.4015	21	76	n/a	n/a
chr8	94936532	94936532	G	C	het		QUAL=11471;DP=298;AF=0.52;MQM=60;TRIO=HET,298,0.52,HOM,110,1.00,HET,167,0.49	PDP1	3'UTR	PDP1:NM_001161779.1:3'UTR:MODIFIER:exon3/3:c.*631G>C:,PDP1:NM_018444.3:3'UTR:MODIFIER:exon2/2:c.*631G>C:,PDP1:NM_001161780.1:3'UTR:MODIFIER:exon3/3:c.*631G>C:,PDP1:NM_001161781.1:3'UTR:MODIFIER:exon2/2:c.*631G>C:		rs911	0.5939	0	0	0										0.1364	0.4621	0.4015	20	69	n/a	n/a
chr8	96047806	96047806	-	A	het		QUAL=2678;DP=80;AF=0.70;MQM=60;TRIO=HET,80,0.70,HET,35,0.80,HET,33,0.88	NDUFAF6	splice_region&intron	NDUFAF6:NM_152416.3:splice_region&intron:LOW:exon3/8:c.420+2_420+3insA:		rs397749867	0.6376	0	0	0						612392 [NDUFAF6 (provisional) Leigh syndrome due to mitochondrial complex I deficiency];				0.6818	0.3106	0.0076	221	144	1	n/a
chr8	96070181	96070181	T	C	hom		QUAL=8755;DP=96;AF=1.00;MQM=60;TRIO=HOM,96,1.00,HOM,83,1.00,HOM,93,1.00	NDUFAF6	3'UTR	NDUFAF6:NM_152416.3:3'UTR:MODIFIER:exon9/9:c.*16T>C:		rs2678832	0.9265	0.941	0.9469	0.8507										0.8939	0.0985	0.0076	148	14	n/a	n/a
chr8	97239126	97239126	T	C	hom		QUAL=11092;DP=236;AF=1.00;MQM=60;TRIO=HOM,236,1.00,HOM,60,1.00,HET,82,0.60	UQCRB	3'UTR	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*4207A>G:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*4157A>G:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*4157A>G:		rs7827095	0.51	0.451	0	0										0.3409	0.4015	0.2576	82	129	n/a	n/a
chr8	97239613	97239613	A	C	hom		QUAL=17536;DP=179;AF=1.00;MQM=57;TRIO=HOM,179,1.00,HOM,229,1.00,HET,278,0.53	UQCRB	3'UTR	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*3720T>G:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*3670T>G:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*3670T>G:		rs2292836	0.3664	0.376	0	0										0.3333	0.4015	0.2652	80	128	n/a	n/a
chr8	97240129	97240129	C	T	hom		QUAL=15238;DP=310;AF=0.99;MQM=50;TRIO=HOM,310,0.99,HOM,86,1.00,HET,123,0.59	UQCRB	3'UTR	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*3204G>A:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*3154G>A:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*3154G>A:		rs10504961	0.3664	0.381	0	0										0.3333	0.4015	0.2652	80	129	n/a	n/a
chr8	97240847	97240847	A	G	hom		QUAL=28388;DP=341;AF=1.00;MQM=59;TRIO=HOM,341,1.00,HOM,301,1.00,HET,406,0.53	UQCRB	3'UTR	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*2486T>C:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*2436T>C:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*2436T>C:	MIR	rs13253635	0.3666	0.387	0	0										0.3333	0.4015	0.2652	80	130	n/a	n/a
chr8	97242124	97242124	G	A	hom		QUAL=19795;DP=304;AF=1.00;MQM=59;TRIO=HOM,304,1.00,HOM,185,0.99,HET,229,0.53	UQCRB	3'UTR	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*1209C>T:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*1159C>T:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*1159C>T:		rs7002575	0.3658	0.383	0	0										0.3333	0.4015	0.2652	80	130	n/a	n/a
chr8	97242134	97242135	CT	-	hom		QUAL=18377;DP=291;AF=0.98;MQM=59;TRIO=HOM,291,0.98,HOM,188,0.98,HET,242,0.52	UQCRB	3'UTR	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*1198_*1199delAG:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*1148_*1149delAG:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*1148_*1149delAG:		rs35954659	0.233	0.301	0	0										0.2424	0.3788	0.3788	58	125	n/a	n/a
chr8	97242849	97242849	C	T	hom		QUAL=13468;DP=244;AF=1.00;MQM=59;TRIO=HOM,244,1.00,HOM,88,1.00,HET,139,0.49	UQCRB	3'UTR	UQCRB:NM_001254752.1:3'UTR:MODIFIER:exon5/5:c.*484G>A:,UQCRB:NM_001199975.2:3'UTR:MODIFIER:exon5/5:c.*434G>A:,UQCRB:NM_006294.4:3'UTR:MODIFIER:exon4/4:c.*434G>A:		rs7836698	0.2336	0.283	0	0										0.2424	0.3788	0.3788	58	125	n/a	n/a
chr8	97243720	97243720	G	A	hom		QUAL=19652;DP=281;AF=0.99;MQM=60;TRIO=HOM,281,0.99,HOM,174,1.00,HET,279,0.54	UQCRB	synonymous,intron	UQCRB:NM_001254752.1:synonymous:LOW:exon4/5:c.282C>T:p.His94His,UQCRB:NM_001199975.2:intron:MODIFIER:exon4/4:c.162+282C>T:,UQCRB:NM_006294.4:intron:MODIFIER:exon3/3:c.258+282C>T:	MIR3	rs2292835	0.2334	0.204	0	0						191330 [UQCRB (provisional) Mitochondrial complex III deficiency,nuclear type 3];				0.2424	0.3788	0.3788	76	176	n/a	n/a
chr8	100133706	100133706	T	G	het		QUAL=21456;DP=354;AF=0.50;MQM=60;TRIO=HET,354,0.50,HOM,280,1.00,HET,366,0.53	VPS13B	stop_gained,intron	VPS13B:NM_181661.2:stop_gained:HIGH:exon8/8:c.1239T>G:p.Tyr413*,VPS13B:NM_017890.4:intron:MODIFIER:exon8/61:c.1206+33T>G:,VPS13B:NM_015243.2:intron:MODIFIER:exon8/17:c.1206+33T>G:,VPS13B:NM_152564.4:intron:MODIFIER:exon8/61:c.1206+33T>G:		rs7460625	0.7051	0.749	0.7938	0.6811	0.0410	P				607817 [VPS13B (confirmed) Cohen syndrome];		CM1310452 [CLASS=FTV MUT=ALT PHEN="Potential protein deficiency" GENE=VPS13B]; 		0.6591	0.2727	0.0682	300	131	2	n/a
chr8	100844595	100844595	A	T	het		QUAL=321;DP=100;AF=0.21;MQM=54;TRIO=HET,100,0.21,WT,83,0.04,HET,94,0.13	VPS13B	splice_acceptor	VPS13B:NM_017890.4:splice_acceptor:HIGH:exon51/61:c.9406-2A>T:,VPS13B:NM_152564.4:splice_acceptor:HIGH:exon51/61:c.9331-2A>T:		rs74485751	0.3738	0.0045	0	0	6.2810	D				607817 [VPS13B (confirmed) Cohen syndrome];				0	0.0152	0.9848	0	3	0	n/a
chr8	100844758	100844758	T	C	het		QUAL=11508;DP=334;AF=0.52;MQM=60;TRIO=HET,334,0.52,WT,283,0.00,HET,380,0.49	VPS13B	synonymous	VPS13B:NM_017890.4:synonymous:LOW:exon52/62:c.9567T>C:p.Ser3189Ser,VPS13B:NM_152564.4:synonymous:LOW:exon52/62:c.9492T>C:p.Ser3164Ser		rs36074608	0.1971	0.192	0.1736	0.0826						607817 [VPS13B (confirmed) Cohen syndrome];	RCV000081923.4 [other]; 		COSM3982313	0.0303	0.2955	0.6742	9	109	n/a	n/a
chr8	100888323	100888325	TAT	-	hom		QUAL=9400;DP=158;AF=0.99;MQM=60;TRIO=HOM,158,0.99,HET,126,0.52,HET,134,0.60	VPS13B	3'UTR	VPS13B:NM_017890.4:3'UTR:MODIFIER:exon62/62:c.*434_*436delTTA:,VPS13B:NM_152564.4:3'UTR:MODIFIER:exon62/62:c.*434_*436delTTA:		rs397696753	0.5519	0	0	0										0.2121	0.4848	0.303	29	80	n/a	n/a
chr8	103218466	103218466	-	A	het		QUAL=3824;DP=154;AF=0.40;MQM=60;TRIO=HET,154,0.40,WT,83,0.00,HET,125,0.47	RRM2B	3'UTR	RRM2B:NM_001172477.1:3'UTR:MODIFIER:exon9/9:c.*1894dupT:,RRM2B:NM_001172478.1:3'UTR:MODIFIER:exon8/8:c.*1894dupT:,RRM2B:NM_015713.4:3'UTR:MODIFIER:exon9/9:c.*1894dupT:		rs150629554	0.0853	0	0	0										0.0152	0.1818	0.803	3	25	n/a	n/a
chr8	103218873	103218873	C	G	het		QUAL=6568;DP=288;AF=0.47;MQM=60;TRIO=HET,288,0.47,WT,125,0.00,HET,139,0.42	RRM2B	3'UTR	RRM2B:NM_001172477.1:3'UTR:MODIFIER:exon9/9:c.*1488G>C:,RRM2B:NM_001172478.1:3'UTR:MODIFIER:exon8/8:c.*1488G>C:,RRM2B:NM_015713.4:3'UTR:MODIFIER:exon9/9:c.*1488G>C:		rs1265116	0.0777	0	0	0										0.0152	0.1439	0.8409	2	21	n/a	n/a
chr8	103220351	103220351	A	G	hom		QUAL=18446;DP=305;AF=1.00;MQM=60;TRIO=HOM,305,1.00,HOM,108,1.00,HOM,147,1.00	RRM2B	3'UTR	RRM2B:NM_001172477.1:3'UTR:MODIFIER:exon9/9:c.*10T>C:,RRM2B:NM_001172478.1:3'UTR:MODIFIER:exon8/8:c.*10T>C:,RRM2B:NM_015713.4:3'UTR:MODIFIER:exon9/9:c.*10T>C:		rs1265117	1	1	1	0.9998										1	0	0	1017	0	n/a	n/a
chr8	105440271	105440271	G	C	het		QUAL=5394;DP=229;AF=0.55;MQM=60;TRIO=HET,229,0.55,HET,68,0.65,WT,86,0.00	DPYS	synonymous	DPYS:NM_001385.2:synonymous:LOW:exon6/10:c.1029C>G:p.Thr343Thr		rs117104587	0.0046	0.011	0.013	0.0016						613326 [DPYS (provisional) Dihydropyrimidinuria];	RCV000086522.1 [not provided]; 			0	0.0455	0.9545	0	9	n/a	n/a
chr8	105479149	105479149	A	G	het		QUAL=955;DP=6;AF=0.50;MQM=60;TRIO=HET,6,0.50,WT,37,0.00,HOM,35,1.00	DPYS	5'UTR	DPYS:NM_001385.2:5'UTR:MODIFIER:exon1/10:c.-1T>C:		rs2959023	0.6362	0.487	0.6946	0.7484							RCV000086534.1 [not provided]; 			0.3864	0.3485	0.2652	163	160	n/a	n/a
chr8	119936246	119936246	C	T	het		QUAL=5800;DP=299;AF=0.52;MQM=60;TRIO=HET,299,0.52,WT,54,0.00,HET,61,0.43	TNFRSF11B	3'UTR	TNFRSF11B:NM_002546.3:3'UTR:MODIFIER:exon5/5:c.*367G>A:		rs7815884	0.0887	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr8	119936330	119936330	-	T	het		QUAL=3349;DP=193;AF=0.36;MQM=59;TRIO=HET,193,0.36,WT,86,0.05,HET,113,0.37	TNFRSF11B	3'UTR	TNFRSF11B:NM_002546.3:3'UTR:MODIFIER:exon5/5:c.*282dupA:		rs112977670	0	0	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr8	119936669	119936669	A	G	het		QUAL=11494;DP=356;AF=0.51;MQM=59;TRIO=HET,356,0.51,WT,263,0.00,HET,379,0.45	TNFRSF11B	synonymous	TNFRSF11B:NM_002546.3:synonymous:LOW:exon5/5:c.1150T>C:p.Leu384Leu		rs1804854	0.0881	0.026	0.0012	0.2649						602643 [TNFRSF11B (confirmed) Paget disease,juvenile];				0	0.0152	0.9848	0	3	n/a	n/a
chr8	119941173	119941173	A	G	hom		QUAL=17156;DP=242;AF=1.00;MQM=60;TRIO=HOM,242,1.00,HET,181,0.44,HOM,219,1.00	TNFRSF11B	splice_region&intron	TNFRSF11B:NM_002546.3:splice_region&intron:LOW:exon2/4:c.401-5T>C:		rs3134046	0.9237	0.934	0.9455	0.9194						602643 [TNFRSF11B (confirmed) Paget disease,juvenile];				0.8788	0.1136	0.0076	402	46	n/a	n/a
chr8	119964052	119964052	G	C	hom		QUAL=3024;DP=28;AF=1.00;MQM=60;TRIO=HOM,28,1.00,HOM,47,0.98,HET,78,0.41	TNFRSF11B	missense	TNFRSF11B:NM_002546.3:missense:MODERATE:exon1/5:c.9C>G:p.Asn3Lys		rs2073618	0.6667	0.497	0.4504	0.86	0.6450	P		B	B	602643 [TNFRSF11B (confirmed) Paget disease,juvenile];		CM045665 [CLASS=DP MUT=ALT PHEN="Osteoporotic fractures, association with" GENE=TNFRSF11B]; 	COSM1488949	0.2576	0.4924	0.25	124	225	n/a	n/a
chr8	119964283	119964283	G	A	hom		QUAL=2923;DP=51;AF=1.00;MQM=60;TRIO=HOM,51,1.00,HET,50,0.44,HET,67,0.43	TNFRSF11B	5'UTR	TNFRSF11B:NM_002546.3:5'UTR:MODIFIER:exon1/5:c.-223C>T:		rs2073617	0.6216	0	0	0								CR021403 [CLASS=DFP MUT=REF PHEN="Increased intima-media thickness, association" GENE=TNFRSF11B]; 		0.2803	0.4924	0.2273	40	73	n/a	n/a
chr8	120803637	120803637	C	G	het		QUAL=14090;DP=335;AF=0.43;MQM=60;TRIO=HET,335,0.43,HET,236,0.50,HET,292,0.56	TAF2	missense	TAF2:NM_003184.3:missense:MODERATE:exon11/26:c.1340G>C:p.Ser447Thr		rs9297605	0.6583	0.685	0.6983	0.769	4.7700	P,P	T,.	B,.	B,.	604912 [TAF2 (provisional) Mental retardation,autosomal recessive 40];			COSM150523	0.553	0.3939	0.053	237	174	n/a	n/a
chr8	133133361	133133361	C	T	het		QUAL=13564;DP=357;AF=0.47;MQM=60;TRIO=HET,357,0.47,HOM,144,0.99,HET,218,0.46	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*8148G>A:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*8148G>A:		rs1437822	0.1352	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr8	133134003	133134003	G	A	het		QUAL=2427;DP=76;AF=0.57;MQM=60;TRIO=HET,76,0.57,WT,47,0.00,HET,66,0.58	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7506C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7506C>T:		rs11785257	0.1222	0	0	0										0.0152	0.3636	0.6212	2	54	n/a	n/a
chr8	133134288	133134288	G	A	het		QUAL=17320;DP=278;AF=0.43;MQM=60;TRIO=HET,278,0.43,HOM,264,1.00,HET,341,0.46	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7221C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7221C>T:		rs2436124	0.1352	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr8	133134366	133134366	T	C	het		QUAL=15770;DP=385;AF=0.46;MQM=60;TRIO=HET,385,0.46,HOM,192,1.00,HET,260,0.44	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7143A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7143A>G:	MIRb	rs2436125	0.1352	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr8	133134390	133134390	G	A	het		QUAL=16846;DP=379;AF=0.46;MQM=60;TRIO=HET,379,0.46,HOM,208,1.00,HET,299,0.44	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7119C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7119C>T:	MIRb	rs2436126	0.1352	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr8	133134434	133134434	T	C	het		QUAL=18038;DP=411;AF=0.48;MQM=60;TRIO=HET,411,0.48,HOM,225,1.00,HET,315,0.44	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7075A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7075A>G:	MIRb	rs2436127	0.1348	0	0	0										0.0682	0.4848	0.447	11	72	n/a	n/a
chr8	133134476	133134476	A	G	het		QUAL=20900;DP=512;AF=0.46;MQM=60;TRIO=HET,512,0.46,HOM,237,1.00,HET,363,0.48	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*7033T>C:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*7033T>C:	MIRb	rs2436128	0.1348	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr8	133134553	133134553	T	C	het		QUAL=16346;DP=366;AF=0.45;MQM=60;TRIO=HET,366,0.45,HOM,199,0.99,HET,312,0.48	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*6956A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*6956A>G:		rs2469630	0.136	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr8	133134635	133134635	G	C	het		QUAL=13766;DP=376;AF=0.44;MQM=60;TRIO=HET,376,0.44,HOM,155,1.00,HET,214,0.46	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*6874C>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*6874C>G:	L4_C_Mam	rs2436129	0.1348	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr8	133135169	133135169	C	T	het		QUAL=12389;DP=307;AF=0.50;MQM=60;TRIO=HET,307,0.50,HOM,127,0.99,HET,185,0.51	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*6340G>A:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*6340G>A:		rs2469629	0.1392	0	0	0										0.0682	0.4848	0.447	11	72	n/a	n/a
chr8	133135577	133135577	T	G	het		QUAL=17083;DP=308;AF=0.51;MQM=59;TRIO=HET,308,0.51,HOM,243,1.00,HET,290,0.46	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*5932A>C:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*5932A>C:		rs2436130	0.1352	0	0	0										0.0682	0.4848	0.447	11	73	n/a	n/a
chr8	133135790	133135790	G	A	het		QUAL=9650;DP=313;AF=0.47;MQM=60;TRIO=HET,313,0.47,WT,207,0.01,HET,296,0.49	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*5719C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*5719C>T:		rs11786417	0.1222	0	0	0										0.0152	0.3636	0.6212	2	54	n/a	n/a
chr8	133136551	133136551	T	C	hom		QUAL=20780;DP=260;AF=1.00;MQM=60;TRIO=HOM,260,1.00,HOM,145,1.00,HOM,221,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*4958A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*4958A>G:		rs1437824	0.7228	0	0	0										0.7045	0.2879	0.0076	105	44	n/a	n/a
chr8	133136762	133136762	-	CTGT	hom		QUAL=18741;DP=157;AF=0.97;MQM=60;TRIO=HOM,157,0.97,HOM,192,0.99,HOM,262,0.98	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*4746_*4747insACAG:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*4746_*4747insACAG:		rs112550767	0.2863	0	0	0										0.2652	0.5227	0.2121	42	74	n/a	n/a
chr8	133137266	133137266	T	A	hom		QUAL=26577;DP=377;AF=0.99;MQM=60;TRIO=HOM,377,0.99,HOM,205,1.00,HOM,220,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*4243A>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*4243A>T:		rs2436131	0.2863	0	0	0										0.2727	0.5227	0.2045	43	75	n/a	n/a
chr8	133137532	133137532	C	T	hom		QUAL=16147;DP=280;AF=1.00;MQM=59;TRIO=HOM,280,1.00,HOM,92,1.00,HOM,119,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*3977G>A:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*3977G>A:		rs2469628	0.3109	0	0	0										0.2727	0.5227	0.2045	43	75	n/a	n/a
chr8	133137912	133137912	C	T	hom		QUAL=15927;DP=303;AF=1.00;MQM=60;TRIO=HOM,303,1.00,HOM,76,1.00,HOM,87,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*3597G>A:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*3597G>A:		rs1025436	0.7208	0	0	0										0.6894	0.303	0.0076	103	46	n/a	n/a
chr8	133138474	133138474	T	C	het		QUAL=17881;DP=243;AF=0.48;MQM=60;TRIO=HET,243,0.99,HOM,136,1.00,HET,179,0.99	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*3035A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*3035A>G:		rs2469627	0.1432	0	0	0										0.0909	0.4848	0.4242	14	73	n/a	n/a
chr8	133138477	133138477	T	C	hom		QUAL=17881;DP=243;AF=0.48;MQM=60;TRIO=HOM,243,0.99,HOM,136,1.00,HOM,179,0.99	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*3032A>G:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*3032A>G:		rs2469626	0.2931	0	0	0										0.303	0.5076	0.1894	47	73	n/a	n/a
chr8	133139755	133139755	G	A	hom		QUAL=43581;DP=566;AF=0.99;MQM=60;TRIO=HOM,566,0.99,HOM,342,0.99,HOM,418,1.00	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*1754C>T:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*1754C>T:		rs977939	0.2686	0	0	0										0.2576	0.5455	0.197	40	79	n/a	n/a
chr8	133140767	133140772	TGTGTG	-	het		QUAL=2616;DP=64;AF=0.42;MQM=59;TRIO=HET,64,0.50,WT,48,0.63,HET,88,0.69	KCNQ3	3'UTR	KCNQ3:NM_004519.3:3'UTR:MODIFIER:exon15/15:c.*737_*742delCACACA:,KCNQ3:NM_001204824.1:3'UTR:MODIFIER:exon15/15:c.*737_*742delCACACA:	(TG)n		0	0	0	0										0.0303	0.2197	0.75	5	33	n/a	n/a
chr8	133883671	133883671	C	T	het		QUAL=12560;DP=319;AF=0.42;MQM=59;TRIO=HET,319,0.42,WT,318,0.00,HET,508,0.52	TG	missense	TG:NM_003235.4:missense:MODERATE:exon4/48:c.353C>T:p.Pro118Leu		rs114322847	0.0058	0	0.0224	0.0061	5.2540	D	D	D	D	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];				0	0.0303	0.9697	0	14	n/a	n/a
chr8	133900252	133900252	T	G	het		QUAL=2288;DP=97;AF=0.44;MQM=60;TRIO=HET,97,0.44,HET,70,0.54,WT,70,0.00	TG	missense	TG:NM_003235.4:missense:MODERATE:exon10/48:c.2200T>G:p.Ser734Ala		rs180223	0.6763	0.583	0.5172	0.7299	6.0760	P	T	B	B	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];	RCV000013534.1 [other]; 		COSM4162675	0.2955	0.4848	0.2197	131	228	n/a	n/a
chr8	133900386	133900386	T	C	het		QUAL=7728;DP=274;AF=0.57;MQM=59;TRIO=HET,274,0.57,HET,209,0.46,WT,279,0.00	TG	synonymous	TG:NM_003235.4:synonymous:LOW:exon10/48:c.2334T>C:p.Pro778Pro		rs2069550	0.6727	0.582	0.5176	0.7211						188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];				0.2955	0.4848	0.2197	132	227	n/a	n/a
chr8	133909974	133909974	A	G	het		QUAL=10686;DP=422;AF=0.50;MQM=60;TRIO=HET,422,0.50,HET,244,0.50,WT,343,0.01	TG	missense	TG:NM_003235.4:missense:MODERATE:exon12/48:c.3082A>G:p.Met1028Val		rs853326	0.6749	0.584	0.5176	0.7274	-0.4530	P	T	B	B	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];	RCV000013535.1 [other]; 		COSM4162676	0.2955	0.4848	0.2197	132	225	n/a	n/a
chr8	133920518	133920518	A	G	hom		QUAL=15642;DP=226;AF=1.00;MQM=60;TRIO=HOM,226,1.00,HOM,159,1.00,HET,196,0.50	TG	missense	TG:NM_003235.4:missense:MODERATE:exon18/48:c.3935A>G:p.Asp1312Gly		rs2069556	0.3988	0.569	0.6151	0.1621	4.2890	P	T	B	B	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];			COSM1454960	0.3106	0.4318	0.2576	159	200	n/a	n/a
chr8	133931748	133931748	T	C	hom		QUAL=19205;DP=350;AF=1.00;MQM=60;TRIO=HOM,350,1.00,HOM,152,0.99,HET,216,0.49	TG	synonymous	TG:NM_003235.4:synonymous:LOW:exon21/48:c.4506T>C:p.Ala1502Ala		rs853304	0.4738	0.591	0.6129	0.3974	-0.6180	P				188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];			COSM150549	0.3106	0.4924	0.197	160	207	n/a	n/a
chr8	133975283	133975283	G	A	hom		QUAL=14695;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,139,1.00,HET,202,0.52	TG	missense	TG:NM_003235.4:missense:MODERATE:exon29/48:c.5512G>A:p.Asp1838Asn		rs2069561	0.3468	0.485	0.5114	0.1203	0.5280	P,P	T,.	B,B,.	B,B,.	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];			COSM150550	0.2045	0.4545	0.3409	119	197	n/a	n/a
chr8	133984058	133984058	C	T	het		QUAL=10227;DP=305;AF=0.48;MQM=59;TRIO=HET,305,0.48,WT,290,0.00,HET,317,0.55	TG	missense	TG:NM_003235.4:missense:MODERATE:exon33/48:c.5995C>T:p.Arg1999Trp		rs2076740	0.3325	0.323	0.3373	0.498	0.0500	P,P	T,.	B,B,B,.	B,B,B,.	188450 [TG (confirmed) Thyroid dyshormonogenesis 3|Autoimmune thyroid disease,susceptibility to,3];	RCV000013533.1 [other]; 	CM035973 [CLASS=DP MUT=ALT PHEN="Autoimmune thyroid disease, association with" GENE=TG]; 	COSM3982409	0.0909	0.4697	0.4394	60	199	n/a	n/a
chr8	134250165	134250165	A	G	het		QUAL=5922;DP=208;AF=0.48;MQM=60;TRIO=HET,208,0.48,HET,169,0.54,WT,212,0.00	NDRG1	3'UTR	NDRG1:NM_001135242.1:3'UTR:MODIFIER:exon16/16:c.*956T>C:,NDRG1:NM_001258432.1:3'UTR:MODIFIER:exon14/14:c.*956T>C:,NDRG1:NM_001258433.1:3'UTR:MODIFIER:exon15/15:c.*956T>C:,NDRG1:NM_006096.3:3'UTR:MODIFIER:exon16/16:c.*956T>C:		rs1049697	0.8303	0	0	0										0.6136	0.3409	0.0455	93	50	n/a	n/a
chr8	134250430	134250430	C	T	het		QUAL=9337;DP=335;AF=0.50;MQM=60;TRIO=HET,335,0.50,HET,254,0.48,WT,363,0.00	NDRG1	3'UTR	NDRG1:NM_001135242.1:3'UTR:MODIFIER:exon16/16:c.*691G>A:,NDRG1:NM_001258432.1:3'UTR:MODIFIER:exon14/14:c.*691G>A:,NDRG1:NM_001258433.1:3'UTR:MODIFIER:exon15/15:c.*691G>A:,NDRG1:NM_006096.3:3'UTR:MODIFIER:exon16/16:c.*691G>A:		rs1049694	0.2718	0	0	0										0.0833	0.4318	0.4848	11	69	n/a	n/a
chr8	134292516	134292516	A	G	hom		QUAL=24459;DP=295;AF=1.00;MQM=60;TRIO=HOM,295,1.00,HET,245,0.56,HOM,327,0.99	NDRG1	splice_region&intron,intron	NDRG1:NM_001135242.1:splice_region&intron:LOW:exon2/15:c.64-6T>C:,NDRG1:NM_001258433.1:splice_region&intron:LOW:exon2/14:c.-74-6T>C:,NDRG1:NM_006096.3:splice_region&intron:LOW:exon2/15:c.64-6T>C:,NDRG1:NM_001258432.1:intron:MODIFIER:exon1/13:c.-99-15621T>C:		rs2272653	0.6134	0.563	0.5722	0.8545						605262 [NDRG1 (provisional) Charcot-Marie-Tooth disease,type 4D];				0.3106	0.4621	0.2273	150	205	n/a	n/a
chr8	134309134	134309134	G	A	het		QUAL=1705;DP=54;AF=0.52;MQM=60;TRIO=HET,54,0.52,HET,57,0.58,WT,97,0.00	NDRG1	5'UTR,intron	NDRG1:NM_001135242.1:5'UTR:MODIFIER:exon1/16:c.-173C>T:,NDRG1:NM_001258432.1:intron:MODIFIER:exon1/13:c.-100+243C>T:,NDRG1:NM_001258433.1:intron:MODIFIER:exon1/14:c.-156+243C>T:,NDRG1:NM_006096.3:intron:MODIFIER:exon1/15:c.-19+243C>T:		rs10108354	0.0847	0	0	0										0.0379	0.2045	0.7576	5	29	n/a	n/a
chr8	140624798	140624798	-	G	hom		QUAL=26216;DP=209;AF=0.98;MQM=60;TRIO=HOM,209,0.98,HOM,279,1.00,HOM,363,0.98					rs386414214	1	0	0	0										1	0	0	150	0	n/a	n/a
chr8	140743200	140743200	G	A	hom		QUAL=7152;DP=81;AF=1.00;MQM=59;TRIO=HOM,81,1.00,HET,127,0.54,HET,159,0.60	TRAPPC9	3'UTR	TRAPPC9:NM_031466.6:3'UTR:MODIFIER:exon23/23:c.*104C>T:,TRAPPC9:NM_001160372.2:3'UTR:MODIFIER:exon23/23:c.*104C>T:		rs199226	0.2007	0	0	0										0.0227	0.2955	0.6818	3	44	n/a	n/a
chr8	141310644	141310644	G	A	het		QUAL=13527;DP=353;AF=0.48;MQM=60;TRIO=HET,353,0.48,HET,538,0.47,WT,674,0.00	TRAPPC9	synonymous	TRAPPC9:NM_031466.6:synonymous:LOW:exon11/23:c.1986C>T:p.Asn662Asn,TRAPPC9:NM_001160372.2:synonymous:LOW:exon11/23:c.1692C>T:p.Asn564Asn		rs12549048	0.3558	0.268	0.1763	0.2292	0.2020	P				611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];	RCV000118668.2 [likely benign]; 			0.0227	0.3106	0.6667	15	134	n/a	n/a
chr8	141445350	141445370	AGAAAACAAAAAACAAAAACC	-	het		QUAL=6123;DP=82;AF=0.17;MQM=60;TRIO=HET,82,0.17,HET,145,0.68,HET,168,0.69	TRAPPC9	splice_region&intron	TRAPPC9:NM_031466.6:splice_region&intron:LOW:exon3/22:c.1025-31_1025-11delGGTTTTTGTTTTTTGTTTTCT:,TRAPPC9:NM_001160372.2:splice_region&intron:LOW:exon3/22:c.731-31_731-11delGGTTTTTGTTTTTTGTTTTCT:		rs398010085	0.7768	0.74	0.668	0.587						611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];				0.0833	0.2879	0.6288	40	90	n/a	n/a
chr8	141461062	141461062	G	A	het		QUAL=18117;DP=318;AF=0.44;MQM=60;TRIO=HET,318,0.44,HET,238,0.55,HOM,297,1.00	TRAPPC9	synonymous	TRAPPC9:NM_031466.6:synonymous:LOW:exon2/23:c.705C>T:p.Asn235Asn,TRAPPC9:NM_001160372.2:synonymous:LOW:exon2/23:c.411C>T:p.Asn137Asn		rs3735803	0.4667	0.468	0.486	0.4187						611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];	RCV000118685.2 [likely benign]; 			0.2803	0.4242	0.2955	98	215	n/a	n/a
chr8	141461185	141461185	A	G	het		QUAL=14348;DP=181;AF=0.49;MQM=60;TRIO=HET,181,0.49,HET,214,0.46,HOM,269,0.99	TRAPPC9	synonymous	TRAPPC9:NM_031466.6:synonymous:LOW:exon2/23:c.582T>C:p.Phe194Phe,TRAPPC9:NM_001160372.2:synonymous:LOW:exon2/23:c.288T>C:p.Phe96Phe		rs3735802	0.5389	0.544	0.5706	0.5565						611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];	RCV000118681.2 [likely benign]; 			0.3939	0.3939	0.2121	138	213	n/a	n/a
chr8	141461266	141461266	A	G	het		QUAL=11422;DP=212;AF=0.47;MQM=60;TRIO=HET,212,0.47,HET,167,0.45,HOM,202,1.00	TRAPPC9	synonymous	TRAPPC9:NM_031466.6:synonymous:LOW:exon2/23:c.501T>C:p.Gly167Gly,TRAPPC9:NM_001160372.2:synonymous:LOW:exon2/23:c.207T>C:p.Gly69Gly		rs3735801	0.5379	0.544	0.5705	0.5565						611966 [TRAPPC9 (provisional) Mental retardation,autosomal recessive 13];	RCV000118680.2 [likely benign]; 			0.3939	0.3939	0.2121	138	215	n/a	n/a
chr8	143953937	143953937	A	C	het		QUAL=14630;DP=423;AF=0.53;MQM=60;TRIO=HET,423,0.53,HET,191,0.47,HET,269,0.49	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1852T>G:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1852T>G:	MLT1A0-int	rs4736312	0.6963	0	0	0										0.3939	0.4773	0.1288	60	71	n/a	n/a
chr8	143954223	143954223	C	A	het		QUAL=15291;DP=394;AF=0.53;MQM=60;TRIO=HET,394,0.53,HET,238,0.61,HET,269,0.47	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1566G>T:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1566G>T:	MLT1A0	rs1134096	0.6961	0	0	0										0.3939	0.4773	0.1288	60	71	n/a	n/a
chr8	143954290	143954290	G	A	het		QUAL=17408;DP=434;AF=0.48;MQM=60;TRIO=HET,434,0.48,HET,303,0.56,HET,338,0.46	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1499C>T:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1499C>T:	MLT1A0	rs1134095	0.6941	0	0	0										0.3939	0.4773	0.1288	59	72	n/a	n/a
chr8	143954747	143954747	T	C	het		QUAL=15534;DP=373;AF=0.52;MQM=59;TRIO=HET,373,0.52,HET,261,0.49,HET,302,0.52	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1042A>G:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1042A>G:		rs7003319	0.6957	0	0	0										0.3939	0.4773	0.1288	60	71	n/a	n/a
chr8	143954769	143954769	G	A	het		QUAL=14895;DP=376;AF=0.45;MQM=57;TRIO=HET,376,0.45,HET,267,0.48,HET,312,0.51	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*1020C>T:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*1020C>T:		rs5017238	0.6957	0	0	0										0.3939	0.4773	0.1288	60	71	n/a	n/a
chr8	143955051	143955051	C	T	het		QUAL=26181;DP=292;AF=0.41;MQM=59;TRIO=HET,292,0.41,HET,623,0.50,HET,777,0.50	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*738G>A:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*738G>A:		rs5304	0.6957	0	0	0										0.3939	0.4773	0.1288	60	71	n/a	n/a
chr8	143955095	143955095	A	G	het		QUAL=23421;DP=349;AF=0.48;MQM=59;TRIO=HET,349,0.48,HET,533,0.49,HET,647,0.49	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*694T>C:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*694T>C:		rs5303	0.7462	0	0	0										0.3939	0.4773	0.1288	60	71	n/a	n/a
chr8	143955273	143955273	T	C	het		QUAL=24708;DP=414;AF=0.51;MQM=59;TRIO=HET,414,0.51,HET,505,0.53,HET,637,0.46	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*516A>G:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*516A>G:		rs5301	0.5745	0	0	0										0.2879	0.4848	0.2273	41	75	n/a	n/a
chr8	143955318	143955318	T	G	het		QUAL=21874;DP=358;AF=0.44;MQM=59;TRIO=HET,358,0.44,HET,495,0.52,HET,593,0.46	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*471A>C:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*471A>C:		rs12543598	0.7512	0	0	0										0.3939	0.4773	0.1288	60	71	n/a	n/a
chr8	143955471	143955471	T	C	het		QUAL=15280;DP=292;AF=0.50;MQM=59;TRIO=HET,292,0.50,HET,286,0.49,HET,374,0.52	CYP11B1	3'UTR	CYP11B1:NM_000497.3:3'UTR:MODIFIER:exon9/9:c.*318A>G:,CYP11B1:NM_001026213.1:3'UTR:MODIFIER:exon8/8:c.*318A>G:		rs5299	0.6957	0	0	0										0.3939	0.4773	0.1288	60	71	n/a	n/a
chr8	143960597	143960597	G	A	het		QUAL=12732;DP=123;AF=0.54;MQM=59;TRIO=HET,123,0.54,HET,296,0.53,HET,406,0.50	CYP11B1	synonymous	CYP11B1:NM_000497.3:synonymous:LOW:exon2/9:c.246C>T:p.Asp82Asp,CYP11B1:NM_001026213.1:synonymous:LOW:exon2/8:c.246C>T:p.Asp82Asp		rs5283	0.3027	0.398	0.4393	0.1117						610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency|Aldosteronism,glucocorticoid-remediable];			COSM4162721	0.2273	0.5076	0.2652	94	215	n/a	n/a
chr8	143961005	143961005	T	C	het		QUAL=9702;DP=173;AF=0.49;MQM=59;TRIO=HET,173,0.49,HET,235,0.51,HET,240,0.45	CYP11B1	synonymous	CYP11B1:NM_000497.3:synonymous:LOW:exon1/9:c.225A>G:p.Leu75Leu,CYP11B1:NM_001026213.1:synonymous:LOW:exon1/8:c.225A>G:p.Leu75Leu		rs6410	0.5841	0.572	0.5412	0.4424						610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency|Aldosteronism,glucocorticoid-remediable];				0.3712	0.4848	0.1439	158	217	n/a	n/a
chr8	143992218	143992218	A	G	het		QUAL=20351;DP=390;AF=0.50;MQM=60;TRIO=HET,390,0.50,HET,397,0.52,HET,474,0.47	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*1178T>C:		rs3802228	0.5988	0	0	0										0.3636	0.5	0.1364	56	74	n/a	n/a
chr8	143992661	143992661	C	T	het		QUAL=25829;DP=343;AF=0.46;MQM=59;TRIO=HET,343,0.46,HET,690,0.48,HET,760,0.43	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*735G>A:		rs28491316	0.3099	0	0	0										0.2121	0.5303	0.2576	31	81	n/a	n/a
chr8	143992864	143992864	C	A	het		QUAL=25833;DP=449;AF=0.41;MQM=59;TRIO=HET,449,0.41,HET,565,0.50,HET,683,0.50	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*532G>T:		rs3802230	0.5958	0	0	0										0.3636	0.5	0.1364	56	74	n/a	n/a
chr8	143993101	143993101	-	GGA	het		QUAL=9585;DP=233;AF=0.36;MQM=60;TRIO=HET,233,0.36,HET,225,0.46,HET,262,0.48	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*292_*294dupTCC:		rs377036717	0.7748	0	0	0										0.3409	0.5303	0.1288	52	79	n/a	n/a
chr8	143993157	143993157	A	G	hom		QUAL=22484;DP=210;AF=1.00;MQM=59;TRIO=HOM,210,1.00,HOM,260,1.00,HOM,245,1.00	CYP11B2	3'UTR	CYP11B2:NM_000498.3:3'UTR:MODIFIER:exon9/9:c.*239T>C:		rs9297975	0.999	0	0	0										1	0	0	150	0	n/a	n/a
chr8	143994702	143994702	G	T	het		QUAL=5543;DP=60;AF=0.52;MQM=50;TRIO=HET,60,0.52,HET,138,0.52,HET,163,0.50	CYP11B2	splice_region&synonymous	CYP11B2:NM_000498.3:splice_region&synonymous:LOW:exon6/9:c.1120C>A:p.Arg374Arg		rs4538	0.6076	0.589	0.556	0.4916						124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency|Hypoaldosteronism,congenital,due to CMO I deficiency|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];			COSM454129	0.3788	0.4621	0.1591	171	203	n/a	n/a
chr8	143995761	143995761	C	T	hom		QUAL=34309;DP=241;AF=1.00;MQM=59;TRIO=HOM,241,1.00,HOM,340,1.00,HOM,489,1.00	CYP11B2	synonymous	CYP11B2:NM_000498.3:synonymous:LOW:exon5/9:c.873G>A:p.Ala291Ala		rs4536	0.8235	0.909	0.9793	0.9498						124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency|Hypoaldosteronism,congenital,due to CMO I deficiency|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];				0.9394	0.0606	0	437	16	n/a	n/a
chr8	143996539	143996539	T	C	het		QUAL=13631;DP=150;AF=0.47;MQM=54;TRIO=HET,150,0.47,HET,318,0.48,HET,419,0.49	CYP11B2	missense	CYP11B2:NM_000498.3:missense:MODERATE:exon3/9:c.518A>G:p.Lys173Arg		rs4539	0.3464	0.417	0.4489	0.2356	-0.6680	P	T	B	B	124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency|Hypoaldosteronism,congenital,due to CMO I deficiency|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];		CM962423 [CLASS=DP MUT=ALT PHEN="Low renin hypertension, association with" GENE=CYP11B2]; 	COSM4006860	0.2045	0.5152	0.2803	103	212	n/a	n/a
chr8	143996553	143996553	G	A	het		QUAL=14150;DP=182;AF=0.46;MQM=55;TRIO=HET,182,0.46,HET,313,0.48,HET,416,0.51	CYP11B2	synonymous	CYP11B2:NM_000498.3:synonymous:LOW:exon3/9:c.504C>T:p.Phe168Phe		rs4546	0.3454	0.416	0.4492	0.2317						124080 [CYP11B2 (confirmed) Hypoaldosteronism,congenital,due to CMO II deficiency|Hypoaldosteronism,congenital,due to CMO I deficiency|Low renin hypertension,susceptibility to|Aldosterone to renin ratio raised];			COSM1569160	0.2045	0.5152	0.2803	104	210	n/a	n/a
chr8	144989452	144989452	T	C	het		QUAL=1447;DP=23;AF=0.48;MQM=60;TRIO=HET,23,0.48,WT,52,0.00,HET,66,0.56	PLEC	3'UTR	PLEC:NM_201380.3:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201384.2:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201383.2:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201382.3:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201381.2:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201379.2:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_201378.3:3'UTR:MODIFIER:exon32/32:c.*893A>G:,PLEC:NM_000445.4:3'UTR:MODIFIER:exon33/33:c.*893A>G:		rs189205952	0.0006	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr8	144995964	144995964	G	A	het		QUAL=5214;DP=129;AF=0.52;MQM=59;TRIO=HET,129,0.52,WT,208,0.00,HET,258,0.44	PLEC	synonymous	PLEC:NM_201380.3:synonymous:LOW:exon32/32:c.8436C>T:p.Gly2812Gly,PLEC:NM_201384.2:synonymous:LOW:exon32/32:c.8025C>T:p.Gly2675Gly,PLEC:NM_201383.2:synonymous:LOW:exon32/32:c.8037C>T:p.Gly2679Gly,PLEC:NM_201382.3:synonymous:LOW:exon32/32:c.8025C>T:p.Gly2675Gly,PLEC:NM_201381.2:synonymous:LOW:exon32/32:c.7929C>T:p.Gly2643Gly,PLEC:NM_201379.2:synonymous:LOW:exon32/32:c.7959C>T:p.Gly2653Gly,PLEC:NM_201378.3:synonymous:LOW:exon32/32:c.7983C>T:p.Gly2661Gly,PLEC:NM_000445.4:synonymous:LOW:exon33/33:c.8106C>T:p.Gly2702Gly		rs35139934	0.0276	0.057	0.0771	0.0116						601282 [PLEC (confirmed) Muscular dystrophy with epidermolysis bullosa simplex|Epidermolysis bullosa simplex,Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Muscular dystrophy,limb-girdle,type 2Q];	RCV000117978.2 [likely benign]; 		COSM4162788	0.0227	0.2424	0.7348	7	89	n/a	n/a
chr8	144997503	144997503	G	A	het		QUAL=4179;DP=97;AF=0.40;MQM=60;TRIO=HET,97,0.40,HET,210,0.48,WT,257,0.00	PLEC	synonymous	PLEC:NM_201380.3:synonymous:LOW:exon31/32:c.7005C>T:p.Thr2335Thr,PLEC:NM_201384.2:synonymous:LOW:exon31/32:c.6594C>T:p.Thr2198Thr,PLEC:NM_201383.2:synonymous:LOW:exon31/32:c.6606C>T:p.Thr2202Thr,PLEC:NM_201382.3:synonymous:LOW:exon31/32:c.6594C>T:p.Thr2198Thr,PLEC:NM_201381.2:synonymous:LOW:exon31/32:c.6498C>T:p.Thr2166Thr,PLEC:NM_201379.2:synonymous:LOW:exon31/32:c.6528C>T:p.Thr2176Thr,PLEC:NM_201378.3:synonymous:LOW:exon31/32:c.6552C>T:p.Thr2184Thr,PLEC:NM_000445.4:synonymous:LOW:exon32/33:c.6675C>T:p.Thr2225Thr		rs144242254	0.0016	0.0012	0.0009	0						601282 [PLEC (confirmed) Muscular dystrophy with epidermolysis bullosa simplex|Epidermolysis bullosa simplex,Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Muscular dystrophy,limb-girdle,type 2Q];				0	0.0379	0.9621	0	7	n/a	n/a
chr8	145004546	145004546	G	A	hom		QUAL=1004;DP=14;AF=1.00;MQM=60;TRIO=HOM,14,1.00,HOM,11,1.00,HOM,12,1.00	PLEC	splice_region&intron	PLEC:NM_201380.3:splice_region&intron:LOW:exon20/31:c.2868+6C>T:,PLEC:NM_201384.2:splice_region&intron:LOW:exon20/31:c.2457+6C>T:,PLEC:NM_201383.2:splice_region&intron:LOW:exon20/31:c.2469+6C>T:,PLEC:NM_201382.3:splice_region&intron:LOW:exon20/31:c.2457+6C>T:,PLEC:NM_201381.2:splice_region&intron:LOW:exon20/31:c.2361+6C>T:,PLEC:NM_201379.2:splice_region&intron:LOW:exon20/31:c.2391+6C>T:,PLEC:NM_201378.3:splice_region&intron:LOW:exon20/31:c.2415+6C>T:,PLEC:NM_000445.4:splice_region&intron:LOW:exon21/32:c.2538+6C>T:		rs11780911	0.5719	0.68	0.8186	0.4537						601282 [PLEC (confirmed) Muscular dystrophy with epidermolysis bullosa simplex|Epidermolysis bullosa simplex,Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Muscular dystrophy,limb-girdle,type 2Q];	RCV000117959.3 [other]; 			0.5985	0.2424	0.1591	284	120	n/a	n/a
chr8	145024450	145024450	C	T	het		QUAL=5610;DP=97;AF=0.48;MQM=60;TRIO=HET,97,0.48,HET,258,0.53,WT,329,0.00	PLEC	missense,intron	PLEC:NM_201380.3:missense:MODERATE:exon1/32:c.425G>A:p.Arg142Gln,PLEC:NM_201379.2:intron:MODIFIER:exon1/31:c.46+3444G>A:,PLEC:NM_201378.3:intron:MODIFIER:exon1/31:c.71-11590G>A:,PLEC:NM_000445.4:intron:MODIFIER:exon2/32:c.194-11590G>A:		rs558227477	0	0	0	0	2.5110	D	T	B	B	601282 [PLEC (confirmed) Muscular dystrophy with epidermolysis bullosa simplex|Epidermolysis bullosa simplex,Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Muscular dystrophy,limb-girdle,type 2Q];				0	0.0076	0.9924	0	1	n/a	n/a
chr8	145699382	145699384	CTC	-	het		QUAL=8375;DP=242;AF=0.45;MQM=59;TRIO=HET,242,0.45,HET,353,0.49,WT,458,0.00	KIFC2,FOXH1	3'UTR	KIFC2:NM_145754.2:3'UTR:MODIFIER:exon17/17:c.*551_*553delCCT:,FOXH1:NM_003923.2:3'UTR:MODIFIER:exon3/3:c.*237_*239delGAG:		rs550365735	0.0012	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr8	145699601	145699601	T	C	hom		QUAL=16933;DP=147;AF=1.00;MQM=59;TRIO=HOM,147,1.00,HOM,183,0.99,HOM,216,1.00	FOXH1	3'UTR	FOXH1:NM_003923.2:3'UTR:MODIFIER:exon3/3:c.*20A>G:		rs2721176	0.9457	0.97	0.9989	0.9896										0.9848	0.0152	0	164	2	n/a	n/a
chr8	145700346	145700346	T	A	het		QUAL=2146;DP=52;AF=0.46;MQM=60;TRIO=HET,52,0.46,WT,110,0.00,HET,111,0.51	FOXH1	missense	FOXH1:NM_003923.2:missense:MODERATE:exon3/3:c.373A>T:p.Thr125Ser		rs112028242	0.0266	0.0068	0.0009	0.0733	2.3370	D	T	D	D					0	0.0076	0.9924	0	1	n/a	n/a
chr8	145701453	145701453	A	C	hom		QUAL=2870;DP=44;AF=0.98;MQM=59;TRIO=HOM,44,0.98,HOM,17,0.94,HOM,33,1.00	FOXH1	5'UTR_premature_start_codon_gain,5'UTR	FOXH1:NM_003923.2:5'UTR_premature_start_codon_gain:LOW:exon1/3:c.-314T>G:,FOXH1:NM_003923.2:5'UTR:MODIFIER:exon1/3:c.-314T>G:		rs750472	0.4443	0	0	0										0.2273	0.5	0.2727	34	75	n/a	n/a
chr9	271638	271638	C	T	het		QUAL=15350;DP=348;AF=0.52;MQM=60;TRIO=HET,348,0.52,HOM,299,1.00,WT,321,0.00	DOCK8	missense	DOCK8:NM_203447.3:missense:MODERATE:exon2/48:c.65C>T:p.Ala22Val		rs506121	0.3077	0.309	0.3303	0.2926	1.4180	P	D	B	B	611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150504.1 [benign]; 		COSM3982814	0.1591	0.3636	0.4773	55	186	n/a	n/a
chr9	286491	286491	G	A	het		QUAL=9131;DP=178;AF=0.46;MQM=60;TRIO=HET,178,0.46,HET,189,0.46,HET,272,0.48	DOCK8	missense,5'UTR	DOCK8:NM_203447.3:missense:MODERATE:exon3/48:c.187G>A:p.Asp63Asn,DOCK8:NM_001190458.1:5'UTR:MODIFIER:exon2/46:c.-18G>A:,DOCK8:NM_001193536.1:5'UTR:MODIFIER:exon2/47:c.-18G>A:		rs3209441	0.0701	0.123	0.1759	0.0315	9.4790	P	T	D	D	611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000124785.1 [benign]; RCV000150505.1 [benign]; 			0.0227	0.2803	0.697	17	112	n/a	n/a
chr9	286593	286593	C	A	het		QUAL=14152;DP=271;AF=0.49;MQM=60;TRIO=HET,271,0.49,HET,226,0.58,HET,317,0.59	DOCK8	missense	DOCK8:NM_203447.3:missense:MODERATE:exon3/48:c.289C>A:p.Pro97Thr,DOCK8:NM_001190458.1:missense:MODERATE:exon2/46:c.85C>A:p.Pro29Thr,DOCK8:NM_001193536.1:missense:MODERATE:exon2/47:c.85C>A:p.Pro29Thr		rs529208	0.5298	0.52	0.4899	0.4142	3.1490	P	D	D,D,P	D,P,P	611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000155526.1 [benign]; 		COSM3763874	0.3106	0.4621	0.2273	124	212	n/a	n/a
chr9	312124	312124	T	C	het		QUAL=10867;DP=136;AF=0.52;MQM=59;TRIO=HET,136,0.52,HET,262,0.52,HET,277,0.52	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon6/48:c.699T>C:p.Asn233Asn,DOCK8:NM_001190458.1:synonymous:LOW:exon5/46:c.495T>C:p.Asn165Asn,DOCK8:NM_001193536.1:synonymous:LOW:exon5/47:c.495T>C:p.Asn165Asn		rs2039045	0.1643	0.168	0.1987	0.2519						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000124786.1 [benign]; RCV000150506.1 [benign]; 			0.0227	0.3258	0.6515	16	136	n/a	n/a
chr9	334337	334337	A	G	het		QUAL=10334;DP=204;AF=0.48;MQM=60;TRIO=HET,204,0.48,HOM,147,1.00,HET,187,0.45	DOCK8	missense	DOCK8:NM_203447.3:missense:MODERATE:exon11/48:c.1238A>G:p.Asn413Ser,DOCK8:NM_001190458.1:missense:MODERATE:exon10/46:c.1034A>G:p.Asn345Ser,DOCK8:NM_001193536.1:missense:MODERATE:exon10/47:c.1034A>G:p.Asn345Ser		rs10970979	0.1997	0.249	0.3092	0.229	0.4170	P	T	B,B	B,B	611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150508.1 [benign]; 		COSM3765451	0.1136	0.447	0.4394	48	196	n/a	n/a
chr9	370244	370244	A	G	het		QUAL=22463;DP=396;AF=0.44;MQM=60;TRIO=HET,396,0.44,HOM,300,0.99,HET,406,0.51	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon16/48:c.1812A>G:p.Lys604Lys,DOCK8:NM_001190458.1:synonymous:LOW:exon15/46:c.1608A>G:p.Lys536Lys,DOCK8:NM_001193536.1:synonymous:LOW:exon15/47:c.1608A>G:p.Lys536Lys		rs913703	0.2159	0.223	0.2431	0.2687						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000124766.1 [benign]; RCV000155528.1 [benign]; 		COSM3763925	0.0455	0.4167	0.5379	24	177	n/a	n/a
chr9	377111	377111	G	C	het		QUAL=6328;DP=159;AF=0.42;MQM=60;TRIO=HET,159,0.42,HOM,93,0.99,HET,128,0.44	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon20/48:c.2340G>C:p.Leu780Leu,DOCK8:NM_001190458.1:synonymous:LOW:exon19/46:c.2136G>C:p.Leu712Leu,DOCK8:NM_001193536.1:synonymous:LOW:exon19/47:c.2136G>C:p.Leu712Leu		rs10814431	0.2286	0.229	0.2553	0.2885						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000124768.1 [benign]; RCV000150510.1 [benign]; 		COSM3763935	0.053	0.4167	0.5303	26	177	n/a	n/a
chr9	390512	390512	C	T	het		QUAL=22082;DP=320;AF=0.53;MQM=60;TRIO=HET,320,0.53,HOM,320,1.00,HET,371,0.50	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon24/48:c.2916C>T:p.Thr972Thr,DOCK8:NM_001190458.1:synonymous:LOW:exon22/46:c.2616C>T:p.Thr872Thr,DOCK8:NM_001193536.1:synonymous:LOW:exon23/47:c.2712C>T:p.Thr904Thr		rs2297075	0.255	0.234	0.2459	0.3613						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000124770.1 [benign]; RCV000155529.1 [benign]; 		COSM1179613	0.053	0.3788	0.5682	26	172	n/a	n/a
chr9	429719	429719	T	C	hom		QUAL=26354;DP=291;AF=1.00;MQM=60;TRIO=HOM,291,1.00,HOM,218,1.00,HOM,303,1.00	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon36/48:c.4491T>C:p.Phe1497Phe,DOCK8:NM_001190458.1:synonymous:LOW:exon34/46:c.4191T>C:p.Phe1397Phe,DOCK8:NM_001193536.1:synonymous:LOW:exon35/47:c.4287T>C:p.Phe1429Phe		rs7854035	0.9994	0.998	0.9956	0.9991						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000155534.1 [benign]; 			0.9924	0.0076	0	452	2	n/a	n/a
chr9	432330	432330	C	G	hom		QUAL=17576;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HET,192,0.49,HOM,254,1.00	DOCK8	splice_region&intron	DOCK8:NM_203447.3:splice_region&intron:LOW:exon37/47:c.4785+6C>G:,DOCK8:NM_001190458.1:splice_region&intron:LOW:exon35/45:c.4485+6C>G:,DOCK8:NM_001193536.1:splice_region&intron:LOW:exon36/46:c.4581+6C>G:		rs7036567	0.7143	0.758	0.7597	0.4927						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150514.1 [benign]; 			0.5682	0.3333	0.0985	265	146	n/a	n/a
chr9	433978	433978	A	G	hom		QUAL=21008;DP=254;AF=1.00;MQM=60;TRIO=HOM,254,1.00,HET,213,0.52,HOM,296,1.00	DOCK8	splice_region&intron	DOCK8:NM_203447.3:splice_region&intron:LOW:exon38/47:c.4886+3A>G:,DOCK8:NM_001190458.1:splice_region&intron:LOW:exon36/45:c.4586+3A>G:,DOCK8:NM_001193536.1:splice_region&intron:LOW:exon37/46:c.4682+3A>G:		rs2360712	0.721	0.759	0.7566	0.5154						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000150515.1 [benign]; 			0.5606	0.3409	0.0985	260	152	n/a	n/a
chr9	441952	441952	G	A	het		QUAL=10328;DP=275;AF=0.44;MQM=60;TRIO=HET,275,0.44,WT,161,0.01,HOM,198,1.00	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon42/48:c.5433G>A:p.Glu1811Glu,DOCK8:NM_001190458.1:synonymous:LOW:exon40/46:c.5133G>A:p.Glu1711Glu,DOCK8:NM_001193536.1:synonymous:LOW:exon41/47:c.5229G>A:p.Glu1743Glu		rs1887957	0.8039	0.82	0.8153	0.6015						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000155535.1 [benign]; 		COSM4163899	0.6212	0.3333	0.0455	305	128	n/a	n/a
chr9	449798	449798	G	A	het		QUAL=5360;DP=156;AF=0.49;MQM=60;TRIO=HET,156,0.49,WT,125,0.00,HET,209,0.44	DOCK8	synonymous	DOCK8:NM_203447.3:synonymous:LOW:exon45/48:c.5832G>A:p.Pro1944Pro,DOCK8:NM_001190458.1:synonymous:LOW:exon43/46:c.5532G>A:p.Pro1844Pro,DOCK8:NM_001193536.1:synonymous:LOW:exon44/47:c.5628G>A:p.Pro1876Pro		rs10491684	0.0717	0.07	0.0734	0.1537						611432 [DOCK8 (provisional) Mental retardation,autosomal dominant 2|Hyper-IgE recurrent infection syndrome,autosomal recessive];	RCV000124782.1 [benign]; RCV000150517.1 [benign]; 			0	0.1212	0.8788	2	56	n/a	n/a
chr9	464920	464920	G	A	het		QUAL=13405;DP=436;AF=0.44;MQM=60;TRIO=HET,436,0.44,WT,163,0.00,HOM,210,1.00	DOCK8	3'UTR	DOCK8:NM_203447.3:3'UTR:MODIFIER:exon48/48:c.*701G>A:,DOCK8:NM_001190458.1:3'UTR:MODIFIER:exon46/46:c.*701G>A:,DOCK8:NM_001193536.1:3'UTR:MODIFIER:exon47/47:c.*701G>A:		rs3780338	0.856	0	0	0										0.6061	0.3485	0.0455	89	54	n/a	n/a
chr9	470302	470302	T	C	het		QUAL=5151;DP=247;AF=0.57;MQM=59;TRIO=HET,247,0.57,WT,80,0.01,HET,109,0.44	KANK1	5'UTR	KANK1:NM_001256876.1:5'UTR:MODIFIER:exon1/16:c.-641T>C:		rs151242444	0.013	0	0	0										0	0.0152	0.9848	0	3	n/a	n/a
chr9	707077	707077	C	T	hom		QUAL=16480;DP=171;AF=0.99;MQM=60;TRIO=HOM,171,0.99,HOM,218,0.99,HET,326,0.50	KANK1	5'UTR_premature_start_codon_gain,5'UTR,intron	KANK1:NM_153186.4:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-608C>T:,KANK1:NM_153186.4:5'UTR:MODIFIER:exon1/11:c.-608C>T:,KANK1:NM_001256876.1:intron:MODIFIER:exon6/15:c.38-3727C>T:,KANK1:NM_001256877.1:intron:MODIFIER:exon3/12:c.38-3727C>T:,KANK1:NM_015158.3:intron:MODIFIER:exon2/11:c.38-3727C>T:		rs7871551	0.3676	0	0	0						607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2];				0.2652	0.4545	0.2803	38	70	n/a	n/a
chr9	712060	712060	G	C	hom		QUAL=20674;DP=299;AF=1.00;MQM=59;TRIO=HOM,299,1.00,HET,289,0.44,HET,446,0.48	KANK1	missense	KANK1:NM_001256876.1:missense:MODERATE:exon7/16:c.1294G>C:p.Glu432Gln,KANK1:NM_001256877.1:missense:MODERATE:exon4/13:c.1294G>C:p.Glu432Gln,KANK1:NM_015158.3:missense:MODERATE:exon3/12:c.1294G>C:p.Glu432Gln,KANK1:NM_153186.4:missense:MODERATE:exon2/11:c.820G>C:p.Glu274Gln		rs4465020	0.2352	0.339	0.3945	0.0801	2.0530	P	T	B,B	B,B	607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2];			COSM1132465	0.1212	0.4924	0.3864	75	205	n/a	n/a
chr9	712599	712599	C	T	hom		QUAL=40920;DP=526;AF=1.00;MQM=60;TRIO=HOM,526,1.00,HET,585,0.52,HET,809,0.54	KANK1	synonymous	KANK1:NM_001256876.1:synonymous:LOW:exon7/16:c.1833C>T:p.Asn611Asn,KANK1:NM_001256877.1:synonymous:LOW:exon4/13:c.1833C>T:p.Asn611Asn,KANK1:NM_015158.3:synonymous:LOW:exon3/12:c.1833C>T:p.Asn611Asn,KANK1:NM_153186.4:synonymous:LOW:exon2/11:c.1359C>T:p.Asn453Asn		rs11789987	0.253	0.348	0.4021	0.1375						607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2];			COSM1462714	0.1212	0.5	0.3788	78	208	n/a	n/a
chr9	742342	742342	A	G	hom		QUAL=2864;DP=37;AF=1.00;MQM=60;TRIO=HOM,37,1.00,HOM,17,1.00,HOM,40,1.00	KANK1	synonymous	KANK1:NM_001256876.1:synonymous:LOW:exon14/16:c.3834A>G:p.Gly1278Gly,KANK1:NM_001256877.1:synonymous:LOW:exon11/13:c.3834A>G:p.Gly1278Gly,KANK1:NM_015158.3:synonymous:LOW:exon10/12:c.3834A>G:p.Gly1278Gly,KANK1:NM_153186.4:synonymous:LOW:exon9/11:c.3360A>G:p.Gly1120Gly		rs10733535	0.9976	0.995	0.991	0.998						607704 [KANK1 (confirmed) Cerebral palsy,spastic quadriplegic,2];			COSM3763985	0.9924	0.0076	0	450	3	n/a	n/a
chr9	2039793	2039793	A	C	het		QUAL=5713;DP=55;AF=0.93;MQM=59;TRIO=HET,55,0.93,HET,123,0.54,HET,149,0.54	SMARCA2	missense	SMARCA2:NM_001289396.1:missense:MODERATE:exon4/34:c.683A>C:p.Gln228Pro,SMARCA2:NM_001289397.1:missense:MODERATE:exon4/33:c.683A>C:p.Gln228Pro,SMARCA2:NM_003070.4:missense:MODERATE:exon4/34:c.683A>C:p.Gln228Pro,SMARCA2:NM_139045.3:missense:MODERATE:exon4/33:c.683A>C:p.Gln228Pro	(CAG)n	rs62534884	0.0292	0.035	0	0	0.7910	D	T	B,B	B,B	600014 [SMARCA2 (provisional) Nicolaides-Baraitser syndrome];	RCV000114294.1 [benign]; 		COSM1461690	0.0076	0.1136	0.8788	3	50	n/a	n/a
chr9	2116037	2116037	G	A	het		QUAL=3480;DP=68;AF=0.53;MQM=60;TRIO=HET,68,0.53,WT,115,0.00,HET,164,0.47	SMARCA2	synonymous	SMARCA2:NM_001289396.1:synonymous:LOW:exon25/34:c.3672G>A:p.Glu1224Glu,SMARCA2:NM_001289397.1:synonymous:LOW:exon25/33:c.3498G>A:p.Glu1166Glu,SMARCA2:NM_003070.4:synonymous:LOW:exon25/34:c.3672G>A:p.Glu1224Glu,SMARCA2:NM_139045.3:synonymous:LOW:exon25/33:c.3672G>A:p.Glu1224Glu		rs6601	0.2354	0.132	0.1074	0.5815						600014 [SMARCA2 (provisional) Nicolaides-Baraitser syndrome];	RCV000114289.2 [likely benign]; 		COSM3763856	0	0.197	0.803	4	84	n/a	n/a
chr9	2622121	2622121	A	G	hom		QUAL=2082;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HOM,33,1.00,HOM,36,1.00	VLDLR	5'UTR	VLDLR:NM_003383.3:5'UTR:MODIFIER:exon1/19:c.-69A>G:,VLDLR:NM_001018056.1:5'UTR:MODIFIER:exon1/18:c.-69A>G:		rs12379259	0.8123	0	0	0										0.5985	0.1591	0.2424	155	60	n/a	n/a
chr9	2622170	2622170	-	CGG	hom		QUAL=335;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HET,25,0.20,HET,25,0.44	VLDLR	5'UTR	VLDLR:NM_003383.3:5'UTR:MODIFIER:exon1/19:c.-21_-19dupGGC:,VLDLR:NM_001018056.1:5'UTR:MODIFIER:exon1/18:c.-21_-19dupGGC:	(CGG)n		0	0	0	0										0.0379	0.1591	0.803	20	46	n/a	n/a
chr9	6532477	6532477	G	A	het		QUAL=2227;DP=76;AF=0.51;MQM=58;TRIO=HET,76,0.51,HOM,21,1.00,HET,24,0.63	GLDC	3'UTR	GLDC:NM_000170.2:3'UTR:MODIFIER:exon25/25:c.*540C>T:		rs7848919	0.7712	0	0	0										0.5076	0.4091	0.0833	76	59	n/a	n/a
chr9	6532511	6532512	AA	-	het		QUAL=1402;DP=57;AF=0.07;MQM=46;TRIO=HET,57,0.07,HET,25,0.00,WT,33,0.45	GLDC	3'UTR	GLDC:NM_000170.2:3'UTR:MODIFIER:exon25/25:c.*505_*506delTT:		rs145481724	0	0	0	0										0.0833	0.1742	0.7424	13	24	n/a	n/a
chr9	6532544	6532544	G	A	het		QUAL=4460;DP=128;AF=0.48;MQM=41;TRIO=HET,128,0.48,HOM,50,1.00,HET,59,0.56	GLDC	3'UTR	GLDC:NM_000170.2:3'UTR:MODIFIER:exon25/25:c.*473C>T:		rs1061407	0.7516	0	0	0										0.4545	0.4621	0.0833	67	68	n/a	n/a
chr9	6533010	6533010	C	G	het		QUAL=18789;DP=270;AF=0.50;MQM=56;TRIO=HET,270,0.50,HOM,290,1.00,HET,362,0.48	GLDC	3'UTR	GLDC:NM_000170.2:3'UTR:MODIFIER:exon25/25:c.*7G>C:		rs2228098	0.7552	0.686	0.6177	0.7188										0.447	0.4394	0.1136	177	202	n/a	n/a
chr9	32986031	32986031	A	-	het		QUAL=2557;DP=73;AF=0.64;MQM=60;TRIO=HET,73,0.89,HET,15,0.93,HET,24,0.88	APTX	splice_region&intron	APTX:NM_001195248.1:splice_region&intron:LOW:exon4/7:c.526-3delT:,APTX:NM_001195249.1:splice_region&intron:LOW:exon4/7:c.484-3delT:,APTX:NM_001195254.1:splice_region&intron:LOW:exon3/6:c.322-3delT:,APTX:NM_001195250.1:splice_region&intron:LOW:exon3/6:c.364-3delT:,APTX:NM_001195251.1:splice_region&intron:LOW:exon5/8:c.484-3delT:,APTX:NM_001195252.1:splice_region&intron:LOW:exon4/7:c.310-3delT:,APTX:NM_175069.2:splice_region&intron:LOW:exon4/7:c.526-3delT:,APTX:NM_175073.2:splice_region&intron:LOW:exon5/8:c.484-3delT:	(A)n	rs373304582	0	0	0	0						606350 [APTX (confirmed) Ataxia,early-onset,with oculomotor apraxia and hypoalbuminemia];				0.0682	0.2955	0.6364	29	94	n/a	n/a
chr9	32986040	32986040	A	C	het		QUAL=2557;DP=73;AF=0.64;MQM=60;TRIO=HET,73,0.89,HET,15,0.93,HET,24,0.88	APTX	splice_region&intron	APTX:NM_001195248.1:splice_region&intron:LOW:exon4/7:c.526-12T>G:,APTX:NM_001195249.1:splice_region&intron:LOW:exon4/7:c.484-12T>G:,APTX:NM_001195254.1:splice_region&intron:LOW:exon3/6:c.322-12T>G:,APTX:NM_001195250.1:splice_region&intron:LOW:exon3/6:c.364-12T>G:,APTX:NM_001195251.1:splice_region&intron:LOW:exon5/8:c.484-12T>G:,APTX:NM_001195252.1:splice_region&intron:LOW:exon4/7:c.310-12T>G:,APTX:NM_175069.2:splice_region&intron:LOW:exon4/7:c.526-12T>G:,APTX:NM_175073.2:splice_region&intron:LOW:exon5/8:c.484-12T>G:	(A)n	rs1981011	0	0	0	0						606350 [APTX (confirmed) Ataxia,early-onset,with oculomotor apraxia and hypoalbuminemia];				0	0.2424	0.7576	45	346	n/a	n/a
chr9	32986041	32986041	C	A	het		QUAL=2557;DP=73;AF=0.64;MQM=60;TRIO=HET,73,0.89,HET,15,0.93,HET,24,0.88	APTX	splice_region&intron	APTX:NM_001195248.1:splice_region&intron:LOW:exon4/7:c.526-13G>T:,APTX:NM_001195249.1:splice_region&intron:LOW:exon4/7:c.484-13G>T:,APTX:NM_001195254.1:splice_region&intron:LOW:exon3/6:c.322-13G>T:,APTX:NM_001195250.1:splice_region&intron:LOW:exon3/6:c.364-13G>T:,APTX:NM_001195251.1:splice_region&intron:LOW:exon5/8:c.484-13G>T:,APTX:NM_001195252.1:splice_region&intron:LOW:exon4/7:c.310-13G>T:,APTX:NM_175069.2:splice_region&intron:LOW:exon4/7:c.526-13G>T:,APTX:NM_175073.2:splice_region&intron:LOW:exon5/8:c.484-13G>T:	(A)n	rs10123944	0	0	0	0						606350 [APTX (confirmed) Ataxia,early-onset,with oculomotor apraxia and hypoalbuminemia];	RCV000123681.1 [benign]; 			0	0.303	0.697	146	277	n/a	n/a
chr9	33112715	33112718	TTCT	-	het		QUAL=5602;DP=266;AF=0.42;MQM=60;TRIO=HET,266,0.42,WT,110,0.00,HET,148,0.47	B4GALT1	3'UTR	B4GALT1:NM_001497.3:3'UTR:MODIFIER:exon6/6:c.*734_*737delAGAA:		rs537888935	0.0046	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr9	33113196	33113196	G	T	hom		QUAL=15388;DP=236;AF=1.00;MQM=60;TRIO=HOM,236,1.00,HOM,114,0.98,HOM,125,1.00	B4GALT1	3'UTR	B4GALT1:NM_001497.3:3'UTR:MODIFIER:exon6/6:c.*256C>A:		rs7019896	0.9485	0	0	0										0.8864	0.1136	0	134	16	n/a	n/a
chr9	35060302	35060302	T	C	het		QUAL=4483;DP=151;AF=0.52;MQM=60;TRIO=HET,151,0.52,HET,53,0.47,HET,66,0.64	VCP	splice_region&intron	VCP:NM_007126.3:splice_region&intron:LOW:exon13/16:c.1695+8A>G:		rs684562	0.4087	0.585	0.7058	0.2814						601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia];				0.3485	0.5455	0.1061	164	230	n/a	n/a
chr9	35061693	35061693	-	ACAGTACACAA	het		QUAL=5387;DP=95;AF=0.23;MQM=60;TRIO=HET,95,0.23,HET,164,0.44,HET,211,0.46	VCP	splice_region&intron	VCP:NM_007126.3:splice_region&intron:LOW:exon9/16:c.1082-8_1082-7insTTGTGTACTGT:		rs11272867	0.4083	0.581	0	0						601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia];				0.2955	0.553	0.1515	139	222	n/a	n/a
chr9	35062972	35062972	C	T	het		QUAL=16142;DP=306;AF=0.48;MQM=60;TRIO=HET,306,0.48,HET,309,0.48,HET,390,0.53	VCP	splice_region&intron	VCP:NM_007126.3:splice_region&intron:LOW:exon7/16:c.811+3G>A:		rs514492	0.7011	0.744	0.7738	0.7313						601023 [VCP (confirmed) Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1|Amyotrophic lateral sclerosis 14,with or without frontotemporal dementia];			COSM150600	0.5152	0.4318	0.053	246	179	n/a	n/a
chr9	35074917	35074917	T	C	het		QUAL=9179;DP=200;AF=0.53;MQM=59;TRIO=HET,200,0.53,HET,137,0.58,HET,221,0.48	FANCG	splice_region&intron	FANCG:NM_004629.1:splice_region&intron:LOW:exon12/13:c.1636+7A>G:		rs587118	0.2202	0.396	0.4993	0.0944						602956 [FANCG (confirmed) Fanconi anemia,complementation group G];				0.1212	0.553	0.3258	212	506	n/a	n/a
chr9	35657741	35657741	A	G	het		QUAL=1598;DP=52;AF=0.50;MQM=60;TRIO=HET,52,0.50,HET,69,0.49,WT,73,0.00					rs71521283	0.1558	0.175	0	0										0.0985	0.3636	0.5379	24	112	n/a	n/a
chr9	71650752	71650752	A	G	hom		QUAL=4434;DP=22;AF=1.00;MQM=60;TRIO=HOM,22,1.00,HOM,57,1.00,HOM,78,1.00	FXN	synonymous	FXN:NM_000144.4:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro,FXN:NM_181425.2:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro,FXN:NM_001161706.1:synonymous:LOW:exon1/5:c.54A>G:p.Pro18Pro		rs2481598	0.9848	0.989	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];	RCV000117105.2 [likely benign]; 			0.9773	0	0.0227	1357	2	n/a	n/a
chr9	71688476	71688476	T	G	het		QUAL=25624;DP=769;AF=0.51;MQM=59;TRIO=HET,769,0.51,HET,332,0.56,HET,411,0.50	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*798T>G:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*848T>G:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+8525T>G:		rs11145043	0.3281	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];		CR132641 [CLASS=FP MUT=REF PHEN="Altered expression" GENE=FXN]; 		0.197	0.447	0.3561	31	69	n/a	n/a
chr9	71689436	71689436	A	-	het		QUAL=2292;DP=96;AF=0.47;MQM=59;TRIO=HET,96,0.47,HET,45,0.60,HET,65,0.17	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*1771delA:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*1821delA:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+9498delA:	AluSx	rs34933249	0	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				0.0227	0.053	0.9242	3	7	n/a	n/a
chr9	71690150	71690150	T	G	hom		QUAL=13369;DP=206;AF=1.00;MQM=52;TRIO=HOM,206,1.00,HOM,76,1.00,HOM,129,1.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*2472T>G:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*2522T>G:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10199T>G:	AluSx	rs7875272	0.9916	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				1	0	0	150	0	n/a	n/a
chr9	71690452	71690452	T	A	het		QUAL=15092;DP=387;AF=0.50;MQM=60;TRIO=HET,387,0.50,HET,254,0.44,HET,350,0.46	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*2774T>A:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*2824T>A:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10501T>A:		rs7875693	0.6617	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				0.3561	0.447	0.197	50	69	n/a	n/a
chr9	71690482	71690482	T	G	het		QUAL=14303;DP=334;AF=0.49;MQM=60;TRIO=HET,334,0.49,HET,273,0.43,HET,378,0.47	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*2804T>G:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*2854T>G:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10531T>G:		rs7849347	0.6643	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				0.3561	0.447	0.197	50	69	n/a	n/a
chr9	71690684	71690684	G	T	hom		QUAL=24776;DP=288;AF=1.00;MQM=59;TRIO=HOM,288,1.00,HOM,213,1.00,HOM,272,1.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*3006G>T:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*3056G>T:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10733G>T:	AluJb	rs6560541	0.9898	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				1	0	0	150	0	n/a	n/a
chr9	71690872	71690872	C	T	het		QUAL=6430;DP=287;AF=0.53;MQM=59;TRIO=HET,287,0.53,HET,95,0.49,WT,125,0.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*3194C>T:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*3244C>T:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+10921C>T:	AluJb	rs188391059	0.001	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				0	0.0076	0.9924	0	1	n/a	n/a
chr9	71691134	71691134	T	-	het		QUAL=3432;DP=132;AF=0.45;MQM=60;TRIO=HET,132,0.45,HET,48,0.44,HET,69,0.52	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*3469delT:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*3519delT:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+11196delT:	MIRb	rs11310316	0.7163	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				0.1515	0.2273	0.6212	23	33	n/a	n/a
chr9	71692705	71692705	C	G	hom		QUAL=8766;DP=114;AF=1.00;MQM=54;TRIO=HOM,114,1.00,HOM,68,1.00,HOM,102,1.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*5027C>G:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*5077C>G:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+12754C>G:	AluSq2	rs7848466	0.9898	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				1	0	0	150	0	n/a	n/a
chr9	71693128	71693128	G	C	hom		QUAL=35107;DP=419;AF=1.00;MQM=60;TRIO=HOM,419,1.00,HOM,277,1.00,HOM,360,1.00	FXN	3'UTR,intron	FXN:NM_000144.4:3'UTR:MODIFIER:exon5/5:c.*5450G>C:,FXN:NM_181425.2:3'UTR:MODIFIER:exon5/5:c.*5500G>C:,FXN:NM_001161706.1:intron:MODIFIER:exon4/4:c.482+13177G>C:	MER91C	rs7866579	0.992	0	0	0						606829 [FXN (confirmed) Friedreich ataxia|Friedreich ataxia with retained reflexes];				1	0	0	150	0	n/a	n/a
chr9	79792440	79792440	G	A	het		QUAL=234;DP=10;AF=0.30;MQM=60;TRIO=HET,10,0.30,WT,10,0.00,HET,15,0.60	VPS13A	5'UTR	VPS13A:NM_033305.2:5'UTR:MODIFIER:exon1/72:c.-181G>A:,VPS13A:NM_001018038.2:5'UTR:MODIFIER:exon1/69:c.-181G>A:,VPS13A:NM_015186.3:5'UTR:MODIFIER:exon1/69:c.-181G>A:,VPS13A:NM_001018037.1:5'UTR:MODIFIER:exon1/71:c.-181G>A:		rs117488726	0.0759	0	0	0										0.0227	0.1667	0.8106	4	25	n/a	n/a
chr9	79936415	79936415	A	G	het		QUAL=6158;DP=229;AF=0.52;MQM=60;TRIO=HET,229,0.52,WT,116,0.00,HET,134,0.54	VPS13A	synonymous	VPS13A:NM_033305.2:synonymous:LOW:exon44/72:c.5583A>G:p.Thr1861Thr,VPS13A:NM_001018038.2:synonymous:LOW:exon44/69:c.5583A>G:p.Thr1861Thr,VPS13A:NM_015186.3:synonymous:LOW:exon44/69:c.5583A>G:p.Thr1861Thr,VPS13A:NM_001018037.1:synonymous:LOW:exon43/71:c.5466A>G:p.Thr1822Thr		rs17423984	0.0487	0.075	0.088	0.0204	0.1070	P				605978 [VPS13A (confirmed) Choreoacanthocytosis];			COSM3764010	0	0.1288	0.8712	13	167	n/a	n/a
chr9	79954545	79954545	T	C	het		QUAL=12346;DP=318;AF=0.44;MQM=60;TRIO=HET,318,0.44,HET,227,0.48,HET,284,0.49	VPS13A	synonymous	VPS13A:NM_033305.2:synonymous:LOW:exon48/72:c.6492T>C:p.Asp2164Asp,VPS13A:NM_001018038.2:synonymous:LOW:exon48/69:c.6492T>C:p.Asp2164Asp,VPS13A:NM_015186.3:synonymous:LOW:exon48/69:c.6492T>C:p.Asp2164Asp,VPS13A:NM_001018037.1:synonymous:LOW:exon47/71:c.6375T>C:p.Asp2125Asp		rs7025532	0.1627	0.175	0.2008	0.2242						605978 [VPS13A (confirmed) Choreoacanthocytosis];			COSM3764015	0.0152	0.3258	0.6591	60	358	n/a	n/a
chr9	79984232	79984232	T	C	het		QUAL=10695;DP=341;AF=0.49;MQM=60;TRIO=HET,341,0.49,WT,162,0.00,HET,280,0.56	VPS13A	synonymous	VPS13A:NM_033305.2:synonymous:LOW:exon63/72:c.8571T>C:p.Tyr2857Tyr,VPS13A:NM_001018038.2:synonymous:LOW:exon63/69:c.8571T>C:p.Tyr2857Tyr,VPS13A:NM_015186.3:synonymous:LOW:exon63/69:c.8571T>C:p.Tyr2857Tyr,VPS13A:NM_001018037.1:synonymous:LOW:exon62/71:c.8454T>C:p.Tyr2818Tyr		rs17340192	0.0517	0.076	0.0884	0.0295						605978 [VPS13A (confirmed) Choreoacanthocytosis];			COSM3764018	0	0.1288	0.8712	13	126	n/a	n/a
chr9	79986057	79986057	A	G	het		QUAL=18511;DP=393;AF=0.52;MQM=59;TRIO=HET,393,0.52,HET,296,0.54,HET,414,0.50	VPS13A	synonymous	VPS13A:NM_033305.2:synonymous:LOW:exon67/72:c.9069A>G:p.Gly3023Gly,VPS13A:NM_001018038.2:synonymous:LOW:exon67/69:c.9069A>G:p.Gly3023Gly,VPS13A:NM_015186.3:synonymous:LOW:exon67/69:c.9069A>G:p.Gly3023Gly,VPS13A:NM_001018037.1:synonymous:LOW:exon66/71:c.8952A>G:p.Gly2984Gly		rs3737289	0.4151	0.449	0.4349	0.325						605978 [VPS13A (confirmed) Choreoacanthocytosis];				0.1364	0.5379	0.3258	213	578	n/a	n/a
chr9	79997881	79997881	T	C	het		QUAL=13927;DP=367;AF=0.46;MQM=60;TRIO=HET,367,0.46,HET,197,0.51,HET,275,0.53	VPS13A	3'UTR,intron	VPS13A:NM_001018038.2:3'UTR:MODIFIER:exon69/69:c.*666T>C:,VPS13A:NM_033305.2:intron:MODIFIER:exon68/71:c.9189+878T>C:,VPS13A:NM_015186.3:intron:MODIFIER:exon68/68:c.9189+878T>C:,VPS13A:NM_001018037.1:intron:MODIFIER:exon67/70:c.9072+878T>C:		rs10869921	0.3844	0	0	0						605978 [VPS13A (confirmed) Choreoacanthocytosis];				0.1212	0.5227	0.3561	25	81	n/a	n/a
chr9	79999824	79999824	T	C	het		QUAL=6028;DP=213;AF=0.50;MQM=60;TRIO=HET,213,0.50,WT,105,0.00,HET,162,0.45	VPS13A	3'UTR,intron	VPS13A:NM_015186.3:3'UTR:MODIFIER:exon69/69:c.*225T>C:,VPS13A:NM_033305.2:intron:MODIFIER:exon68/71:c.9189+2821T>C:,VPS13A:NM_001018037.1:intron:MODIFIER:exon67/70:c.9072+2821T>C:		rs7872010	0.0731	0	0	0						605978 [VPS13A (confirmed) Choreoacanthocytosis];				0	0.1439	0.8561	0	25	n/a	n/a
chr9	80031144	80031144	G	A	het		QUAL=5024;DP=168;AF=0.51;MQM=60;TRIO=HET,168,0.51,HET,58,0.50,HET,67,0.55	VPS13A	3'UTR	VPS13A:NM_033305.2:3'UTR:MODIFIER:exon72/72:c.*222G>A:,VPS13A:NM_001018037.1:3'UTR:MODIFIER:exon71/71:c.*222G>A:		rs12343797	0.1653	0	0	0										0.0303	0.3485	0.6212	4	60	n/a	n/a
chr9	80031946	80031946	C	T	het		QUAL=9713;DP=243;AF=0.48;MQM=60;TRIO=HET,243,0.48,HET,151,0.50,HET,192,0.53	VPS13A	3'UTR	VPS13A:NM_033305.2:3'UTR:MODIFIER:exon72/72:c.*1024C>T:,VPS13A:NM_001018037.1:3'UTR:MODIFIER:exon71/71:c.*1024C>T:		rs9186	0.5757	0	0	0										0.2197	0.553	0.2273	35	90	n/a	n/a
chr9	80032300	80032300	C	A	het		QUAL=13672;DP=374;AF=0.48;MQM=60;TRIO=HET,374,0.48,HET,203,0.44,HET,293,0.49	VPS13A	3'UTR	VPS13A:NM_033305.2:3'UTR:MODIFIER:exon72/72:c.*1378C>A:,VPS13A:NM_001018037.1:3'UTR:MODIFIER:exon71/71:c.*1378C>A:		rs13286867	0.2494	0	0	0										0.1364	0.4697	0.3939	20	80	n/a	n/a
chr9	94087622	94087622	T	G	het		QUAL=8408;DP=325;AF=0.56;MQM=60;TRIO=HET,325,0.56,WT,126,0.00,HET,154,0.47	AUH	synonymous	AUH:NM_001698.2:synonymous:LOW:exon4/10:c.483A>C:p.Ile161Ile		rs7874056	0.0895	0.087	0.105	0.1813						600529 [AUH (provisional) 3-methylglutaconic aciduria,type I];	RCV000116490.2 [likely benign]; 		COSM3764058	0.0152	0.1818	0.803	10	116	n/a	n/a
chr9	94830356	94830356	C	A	het		QUAL=8139;DP=320;AF=0.51;MQM=60;TRIO=HET,320,0.51,WT,112,0.00,HET,183,0.50	SPTLC1	missense	SPTLC1:NM_001281303.1:missense:MODERATE:exon6/15:c.452G>T:p.Arg151Leu,SPTLC1:NM_006415.3:missense:MODERATE:exon6/15:c.452G>T:p.Arg151Leu		rs45461899	0.0116	0.022	0.0291	0.0041	3.9190	D	D	B,B	B,B	605712 [SPTLC1 (provisional) Neuropathy,hereditary sensory and autonomic,type IA];				0	0.0606	0.9394	0	21	n/a	n/a
chr9	97862118	97862118	C	T	het		QUAL=15638;DP=281;AF=0.47;MQM=60;TRIO=HET,281,0.47,HET,359,0.47,HET,407,0.49	FANCC	3'UTR	FANCC:NM_000136.2:3'UTR:MODIFIER:exon15/15:c.*1871G>A:,FANCC:NM_001243743.1:3'UTR:MODIFIER:exon15/15:c.*1871G>A:		rs4647558	0.4135	0	0	0										0.1515	0.5076	0.3409	22	75	n/a	n/a
chr9	97862701	97862701	A	G	het		QUAL=14591;DP=348;AF=0.51;MQM=60;TRIO=HET,348,0.51,HET,241,0.54,HET,254,0.54	FANCC	3'UTR	FANCC:NM_000136.2:3'UTR:MODIFIER:exon15/15:c.*1288T>C:,FANCC:NM_001243743.1:3'UTR:MODIFIER:exon15/15:c.*1288T>C:		rs4647554	0.5028	0	0	0										0.1591	0.5152	0.3258	23	76	n/a	n/a
chr9	97872712	97872712	C	T	hom		QUAL=10883;DP=214;AF=1.00;MQM=60;TRIO=HOM,214,1.00,HOM,55,1.00,HOM,64,1.00	FANCC	3'UTR,intron	FANCC:NM_001243744.1:3'UTR:MODIFIER:exon14/14:c.*766G>A:,FANCC:NM_000136.2:intron:MODIFIER:exon13/14:c.1329+1033G>A:,FANCC:NM_001243743.1:intron:MODIFIER:exon13/14:c.1329+1033G>A:		rs10429619	0.998	0	0	0						613899 [FANCC (confirmed) Fanconi anemia,complementation group C];				0.9924	0.0076	0	149	1	n/a	n/a
chr9	97873004	97873007	TAAC	-	het		QUAL=4750;DP=173;AF=0.44;MQM=60;TRIO=HET,173,0.44,WT,129,0.01,HET,186,0.42	FANCC	3'UTR,intron	FANCC:NM_001243744.1:3'UTR:MODIFIER:exon14/14:c.*471_*474delGTTA:,FANCC:NM_000136.2:intron:MODIFIER:exon13/14:c.1329+738_1329+741delGTTA:,FANCC:NM_001243743.1:intron:MODIFIER:exon13/14:c.1329+738_1329+741delGTTA:		rs71934724	0.135	0	0	0						613899 [FANCC (confirmed) Fanconi anemia,complementation group C];				0.0455	0.3106	0.6439	9	46	n/a	n/a
chr9	97873339	97873339	G	A	het		QUAL=9299;DP=153;AF=0.46;MQM=60;TRIO=HET,153,0.46,HET,198,0.53,HET,253,0.51	FANCC	3'UTR,intron	FANCC:NM_001243744.1:3'UTR:MODIFIER:exon14/14:c.*139C>T:,FANCC:NM_000136.2:intron:MODIFIER:exon13/14:c.1329+406C>T:,FANCC:NM_001243743.1:intron:MODIFIER:exon13/14:c.1329+406C>T:		rs879492	0.4167	0	0	0						613899 [FANCC (confirmed) Fanconi anemia,complementation group C];				0.1364	0.5227	0.3409	20	77	n/a	n/a
chr9	97873435	97873435	G	A	het		QUAL=7725;DP=166;AF=0.51;MQM=60;TRIO=HET,166,0.51,HET,132,0.56,HET,169,0.53	FANCC	3'UTR,intron	FANCC:NM_001243744.1:3'UTR:MODIFIER:exon14/14:c.*43C>T:,FANCC:NM_000136.2:intron:MODIFIER:exon13/14:c.1329+310C>T:,FANCC:NM_001243743.1:intron:MODIFIER:exon13/14:c.1329+310C>T:		rs2404457	0.4111	0.209	0	0						613899 [FANCC (confirmed) Fanconi anemia,complementation group C];				0.1364	0.5303	0.3333	20	78	n/a	n/a
chr9	98229389	98229389	C	G	hom		QUAL=8460;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,58,1.00,HOM,71,1.00	PTCH1	splice_region&intron	PTCH1:NM_000264.3:splice_region&intron:LOW:exon15/23:c.2560+9G>C:,PTCH1:NM_001083607.1:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:NM_001083606.1:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:NM_001083604.1:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:NM_001083605.1:splice_region&intron:LOW:exon15/23:c.2107+9G>C:,PTCH1:NM_001083602.1:splice_region&intron:LOW:exon15/23:c.2362+9G>C:,PTCH1:NM_001083603.1:splice_region&intron:LOW:exon15/23:c.2557+9G>C:		rs2066829	0.3906	0.358	0.3645	0.6285						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				0.1212	0.4318	0.447	132	470	n/a	n/a
chr9	98238358	98238358	G	A	hom		QUAL=14188;DP=204;AF=0.99;MQM=59;TRIO=HOM,204,0.99,HOM,85,0.99,HOM,169,0.99	PTCH1	synonymous	PTCH1:NM_000264.3:synonymous:LOW:exon12/24:c.1686C>T:p.Ala562Ala,PTCH1:NM_001083607.1:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:NM_001083606.1:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:NM_001083604.1:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:NM_001083605.1:synonymous:LOW:exon12/24:c.1233C>T:p.Ala411Ala,PTCH1:NM_001083602.1:synonymous:LOW:exon12/24:c.1488C>T:p.Ala496Ala,PTCH1:NM_001083603.1:synonymous:LOW:exon12/24:c.1683C>T:p.Ala561Ala		rs2066836	0.0919	0.171	0.2213	0.0331						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];			COSM1756287	0.0455	0.2727	0.6818	50	339	n/a	n/a
chr9	98269419	98269419	G	-	hom		QUAL=18877;DP=152;AF=0.99;MQM=59;TRIO=HOM,152,0.99,HOM,209,0.99,HOM,289,0.98	PTCH1	5'UTR,intron	PTCH1:NM_001083607.1:5'UTR:MODIFIER:exon1/24:c.-453delC:,PTCH1:NM_000264.3:intron:MODIFIER:exon1/23:c.202-538delC:,PTCH1:NM_001083606.1:intron:MODIFIER:exon1/23:c.-253+92delC:,PTCH1:NM_001083604.1:intron:MODIFIER:exon1/23:c.-252-538delC:,PTCH1:NM_001083605.1:intron:MODIFIER:exon1/23:c.-252-538delC:,PTCH1:NM_001083602.1:intron:MODIFIER:exon1/23:c.4-538delC:,PTCH1:NM_001083603.1:intron:MODIFIER:exon1/23:c.199-538delC:		rs397728992	0.2228	0	0	0						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				0.0606	0.3106	0.6288	9	49	n/a	n/a
chr9	98270321	98270328	GTGAGTGT	-	het		QUAL=13908;DP=55;AF=0.73;MQM=59;TRIO=HET,55,1.00,HET,201,0.99,HET,304,0.99	PTCH1	5'UTR,intron,transcript	PTCH1:NM_001083604.1:5'UTR:MODIFIER:exon1/24:c.-360_-358delACACTCAC:,PTCH1:NM_001083605.1:5'UTR:MODIFIER:exon1/24:c.-343_-341delACACTCAC:,PTCH1:NM_000264.3:intron:MODIFIER:exon1/23:c.201+115_201+122delACACTCAC:,PTCH1:NM_001083602.1:intron:MODIFIER:exon1/23:c.4-1447_4-1440delACACTCAC:,PTCH1:NM_001083603.1:intron:MODIFIER:exon1/23:c.199-1447_199-1440delACACTCAC:,PTCH1:NM_001083604.1:transcript:MODIFIER::c.-360_-358delACACTCAC:,PTCH1:NM_001083605.1:transcript:MODIFIER::c.-343_-341delACACTCAC:	(TG)n	rs148507954	0	0	0	0						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				0.0682	0.2727	0.6591	9	42	n/a	n/a
chr9	98270324	98270324	A	T	het		QUAL=13908;DP=55;AF=0.73;MQM=60;TRIO=HET,55,1.00,HET,201,0.99,HET,304,0.99	PTCH1	intron	PTCH1:NM_000264.3:intron:MODIFIER:exon1/23:c.201+119T>A:,PTCH1:NM_001083602.1:intron:MODIFIER:exon1/23:c.4-1443T>A:,PTCH1:NM_001083603.1:intron:MODIFIER:exon1/23:c.199-1443T>A:	(TG)n	rs28475503	0.0417	0	0	0						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				0	0.0455	0.9545	0	8	n/a	n/a
chr9	100459578	100459578	T	C	hom		QUAL=6849;DP=59;AF=0.98;MQM=59;TRIO=HOM,59,0.98,HET,99,0.29,HOM,144,1.00	XPA	5'UTR	XPA:NM_000380.3:5'UTR:MODIFIER:exon1/6:c.-4A>G:		rs1800975	0.6464	0.628	0.7098	0.824								CR044772 [CLASS=DP MUT=ALT PHEN="Lung adenocarcinoma, risk, association with" GENE=XPA]; 		0.4848	0.4167	0.0985	515	453	n/a	n/a
chr9	100615553	100615553	A	G	het		QUAL=1157;DP=4;AF=0.75;MQM=59;TRIO=HET,4,0.75,WT,48,0.00,HET,84,0.52	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-644A>G:		rs13302470	0.6859	0	0	0										0.303	0.3712	0.3258	42	52	n/a	n/a
chr9	100615572	100615572	G	A	het		QUAL=1374;DP=6;AF=0.33;MQM=59;TRIO=HET,6,0.33,WT,62,0.00,HET,103,0.52	FOXE1	5'UTR_premature_start_codon_gain,5'UTR	FOXE1:NM_004473.3:5'UTR_premature_start_codon_gain:LOW:exon1/1:c.-625G>A:,FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-625G>A:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr9	100615660	100615660	G	C	hom		QUAL=5937;DP=29;AF=1.00;MQM=59;TRIO=HOM,29,1.00,HET,151,0.53,HET,188,0.49	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-537G>C:		rs7849497	0.883	0	0	0										0.5606	0.3485	0.0909	80	54	n/a	n/a
chr9	100615914	100615914	A	G	het		QUAL=863;DP=19;AF=0.53;MQM=60;TRIO=HET,19,0.53,WT,25,0.00,HET,49,0.47	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-283A>G:		rs1867277	0.6859	0	0	0								CR095675 [CLASS=DFP MUT=REF PHEN="Thyroid cancer susceptibility, association with" GENE=FOXE1]; 		0.3409	0.4697	0.1894	48	70	n/a	n/a
chr9	100615949	100615949	C	A	het		QUAL=1940;DP=26;AF=0.42;MQM=60;TRIO=HET,26,0.42,WT,108,0.00,HET,153,0.45	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-248C>A:		rs1867278	0.6859	0	0	0										0.3409	0.4773	0.1818	48	72	n/a	n/a
chr9	100616041	100616041	T	C	hom		QUAL=1573;DP=11;AF=1.00;MQM=60;TRIO=HOM,11,1.00,HET,42,0.48,HET,56,0.52	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-156T>C:		rs1867279	0.883	0	0	0										0.5227	0.3258	0.1515	75	49	n/a	n/a
chr9	100616066	100616066	G	C	het		QUAL=498;DP=10;AF=0.60;MQM=60;TRIO=HET,10,0.60,WT,25,0.00,HET,29,0.52	FOXE1	5'UTR	FOXE1:NM_004473.3:5'UTR:MODIFIER:exon1/1:c.-131G>C:		rs1867280	0.6861	0	0	0										0.303	0.4167	0.2803	42	58	n/a	n/a
chr9	100616583	100616583	T	C	hom		QUAL=2834;DP=38;AF=1.00;MQM=60;TRIO=HOM,38,1.00,HET,56,0.59,HET,75,0.52	FOXE1	synonymous	FOXE1:NM_004473.3:synonymous:LOW:exon1/1:c.387T>C:p.Leu129Leu		rs3021523	0.8828	0.799	0.7378	0.9295						602617 [FOXE1 (confirmed) Bamforth-Lazarus syndrome];	RCV000081101.2 [benign]; 		COSM4163149	0.553	0.3485	0.0985	251	161	n/a	n/a
chr9	100617375	100617375	T	C	hom		QUAL=20493;DP=241;AF=0.99;MQM=60;TRIO=HOM,241,0.99,HET,414,0.49,HET,502,0.45	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*57T>C:		rs7046645	0.8828	0	0	0										0.553	0.3561	0.0909	79	56	n/a	n/a
chr9	100617433	100617433	A	C	het		QUAL=8107;DP=146;AF=0.53;MQM=59;TRIO=HET,146,0.53,HET,383,0.49,WT,456,0.00	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*115A>C:		rs7043516	0.1813	0	0	0										0.0303	0.2424	0.7273	4	38	n/a	n/a
chr9	100617479	100617479	G	T	het		QUAL=7992;DP=162;AF=0.51;MQM=59;TRIO=HET,162,0.51,WT,299,0.00,HET,413,0.43	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*161G>T:		rs1443434	0.6861	0	0	0										0.3409	0.4773	0.1818	48	72	n/a	n/a
chr9	100617583	100617583	T	C	het		QUAL=10456;DP=281;AF=0.48;MQM=60;TRIO=HET,281,0.48,WT,307,0.01,HET,423,0.46	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*265T>C:		rs1443435	0.6861	0	0	0										0.3409	0.4773	0.1818	48	72	n/a	n/a
chr9	100617649	100617649	A	G	het		QUAL=11137;DP=352;AF=0.51;MQM=60;TRIO=HET,352,0.51,WT,279,0.00,HET,359,0.48	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*331A>G:		rs41274258	0.0152	0	0	0										0	0.0758	0.9242	0	10	n/a	n/a
chr9	100618660	100618660	G	A	het		QUAL=4909;DP=221;AF=0.47;MQM=60;TRIO=HET,221,0.47,HET,78,0.62,WT,146,0.00	FOXE1	3'UTR	FOXE1:NM_004473.3:3'UTR:MODIFIER:exon1/1:c.*1342G>A:		rs10984009	0.0956	0	0	0										0.0076	0.1894	0.803	1	26	n/a	n/a
chr9	101913690	101913690	T	G	het		QUAL=1784;DP=99;AF=0.51;MQM=59;TRIO=HET,99,0.51,HET,3,0.33,HOM,12,1.00	TGFBR1	3'UTR	TGFBR1:NM_004612.2:3'UTR:MODIFIER:exon9/9:c.*2103T>G:,TGFBR1:NM_001130916.1:3'UTR:MODIFIER:exon8/8:c.*2103T>G:	(T)n	rs7871490	0	0	0	0										0.0152	0.2424	0.7424	2	34	n/a	n/a
chr9	103015184	103015184	T	C	het		QUAL=5177;DP=121;AF=0.57;MQM=60;TRIO=HET,121,0.57,HOM,100,1.00,WT,142,0.00	INVS	splice_region&intron	INVS:NM_014425.3:splice_region&intron:LOW:exon9/16:c.1235-5T>C:,INVS:NM_183245.2:splice_region&intron:LOW:exon9/17:c.1235-5T>C:		rs2245216	0.2105	0.312	0.3967	0.1398						243305 [INVS (confirmed) Nephronophthisis 2,infantile];	RCV000081626.2 [benign]; 		COSM150650	0.1818	0.4621	0.3561	73	228	n/a	n/a
chr9	103054951	103054951	T	C	het		QUAL=17271;DP=219;AF=0.49;MQM=60;TRIO=HET,219,0.49,HOM,286,1.00,HET,339,0.47	INVS	synonymous,intron	INVS:NM_014425.3:synonymous:LOW:exon14/17:c.2412T>C:p.Ser804Ser,INVS:NM_183245.2:intron:MODIFIER:exon14/17:c.2179+233T>C:		rs2787374	0.4073	0.467	0.568	0.5853						243305 [INVS (confirmed) Nephronophthisis 2,infantile];	RCV000081629.2 [benign]; 		COSM3763490	0.3106	0.4621	0.2273	135	235	n/a	n/a
chr9	103063434	103063437	CACA	-	hom		QUAL=337;DP=12;AF=0.75;MQM=60;TRIO=HOM,12,0.75,HET,12,0.92,WT,3,0.00				(CA)n		0	0	0	0										0.0152	0.0758	0.9091	2	11	n/a	n/a
chr9	104183194	104183194	C	T	het		QUAL=13830;DP=420;AF=0.48;MQM=60;TRIO=HET,420,0.48,HOM,224,0.99,WT,359,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*897G>A:	HAL1ME	rs17772839	0.0625	0	0	0										0.0379	0.1818	0.7803	5	27	n/a	n/a
chr9	104183479	104183479	T	C	het		QUAL=8550;DP=235;AF=0.52;MQM=60;TRIO=HET,235,0.52,HOM,144,0.98,WT,129,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*612A>G:	MER5B	rs41296049	0.0625	0	0	0										0.0379	0.1818	0.7803	5	27	n/a	n/a
chr9	104183539	104183539	A	T	het		QUAL=12193;DP=419;AF=0.48;MQM=59;TRIO=HET,419,0.48,HOM,190,0.98,WT,230,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*552T>A:	MER5B	rs41308902	0.0627	0	0	0										0.0379	0.1818	0.7803	5	27	n/a	n/a
chr9	104183586	104183586	G	T	het		QUAL=13166;DP=459;AF=0.46;MQM=60;TRIO=HET,459,0.46,HOM,191,0.98,WT,254,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*505C>A:		rs17772845	0.0625	0	0	0										0.0379	0.1818	0.7803	5	27	n/a	n/a
chr9	104183885	104183885	G	T	het		QUAL=9406;DP=354;AF=0.44;MQM=60;TRIO=HET,354,0.44,HOM,126,1.00,WT,162,0.01	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*206C>A:		rs17772869	0.0561	0	0	0										0.0379	0.1818	0.7803	5	27	n/a	n/a
chr9	104183969	104183969	C	T	het		QUAL=6018;DP=192;AF=0.47;MQM=60;TRIO=HET,192,0.47,HOM,96,1.00,WT,119,0.00	ALDOB	3'UTR	ALDOB:NM_000035.3:3'UTR:MODIFIER:exon9/9:c.*122G>A:		rs41310087	0.0397	0	0	0										0.0227	0.1742	0.803	3	25	n/a	n/a
chr9	108398678	108398678	A	G	het		QUAL=16450;DP=247;AF=0.53;MQM=60;TRIO=HET,247,0.53,HET,325,0.55,HET,393,0.51	FKTN	3'UTR,intron	FKTN:NM_001079802.1:3'UTR:MODIFIER:exon11/11:c.*1133A>G:,FKTN:NM_006731.2:3'UTR:MODIFIER:exon10/10:c.*1133A>G:,FKTN:NM_001198963.1:intron:MODIFIER:exon11/11:c.1270+1249A>G:		rs2768282	0.1354	0	0	0						607440 [FKTN (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,4|Muscular dystrophy-dystroglycanopathy (congenital without mental retardation),type B,4|Cardiomyopathy,dilated,1X|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,4];				0.0227	0.3258	0.6515	4	49	n/a	n/a
chr9	108399825	108399825	T	C	het		QUAL=21439;DP=575;AF=0.53;MQM=60;TRIO=HET,575,0.53,HET,308,0.42,HET,421,0.50	FKTN	3'UTR,intron	FKTN:NM_001079802.1:3'UTR:MODIFIER:exon11/11:c.*2280T>C:,FKTN:NM_006731.2:3'UTR:MODIFIER:exon10/10:c.*2280T>C:,FKTN:NM_001198963.1:intron:MODIFIER:exon11/11:c.1270+2396T>C:		rs1024366	0.1342	0	0	0						607440 [FKTN (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,4|Muscular dystrophy-dystroglycanopathy (congenital without mental retardation),type B,4|Cardiomyopathy,dilated,1X|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,4];				0.0227	0.3182	0.6591	4	48	n/a	n/a
chr9	108402805	108402805	G	T	het		QUAL=1872;DP=87;AF=0.48;MQM=58;TRIO=HET,87,0.48,HET,16,0.38,HET,25,0.64	FKTN	3'UTR	FKTN:NM_001079802.1:3'UTR:MODIFIER:exon11/11:c.*5260G>T:,FKTN:NM_001198963.1:3'UTR:MODIFIER:exon12/12:c.*401G>T:,FKTN:NM_006731.2:3'UTR:MODIFIER:exon10/10:c.*5260G>T:	AluSz	rs2010861	0.1318	0	0	0										0.0227	0.3106	0.6667	4	47	n/a	n/a
chr9	111653574	111653574	C	G	hom		QUAL=14796;DP=250;AF=1.00;MQM=60;TRIO=HOM,250,1.00,HET,197,0.39,HET,280,0.47	IKBKAP	synonymous	IKBKAP:NM_003640.3:synonymous:LOW:exon28/37:c.3069G>C:p.Leu1023Leu		rs1063110	0.3155	0.391	0.4551	0.1121						603722 [IKBKAP (confirmed) Dysautonomia,familial];			COSM3763506	0.1818	0.4924	0.3258	76	235	n/a	n/a
chr9	111696389	111696389	G	C	het		QUAL=1990;DP=39;AF=0.46;MQM=60;TRIO=HET,39,0.46,HET,105,0.48,WT,166,0.00	IKBKAP	5'UTR	IKBKAP:NM_003640.3:5'UTR:MODIFIER:exon1/37:c.-301C>G:		rs2275641	0.352	0	0	0										0.1364	0.4015	0.4621	20	62	n/a	n/a
chr9	113457726	113457726	G	A	het		QUAL=10048;DP=220;AF=0.49;MQM=60;TRIO=HET,220,0.49,HET,169,0.49,HET,233,0.52	MUSK	synonymous	MUSK:NM_005592.3:synonymous:LOW:exon4/14:c.402G>A:p.Glu134Glu,MUSK:NM_001166280.1:synonymous:LOW:exon4/13:c.402G>A:p.Glu134Glu,MUSK:NM_001166281.1:synonymous:LOW:exon4/12:c.402G>A:p.Glu134Glu		rs10980531	0.1701	0.133	0.1697	0.1205						601296 [MUSK (confirmed) Myasthenic syndrome,congenital,associated with acetylcholine receptor deficiency];	RCV000117647.1 [benign]; 			0.0455	0.3258	0.6288	14	142	n/a	n/a
chr9	116023498	116023498	C	T	het		QUAL=6992;DP=220;AF=0.52;MQM=53;TRIO=HET,220,0.52,WT,172,0.00,HET,229,0.51	SLC31A1	3'UTR	SLC31A1:NM_001859.3:3'UTR:MODIFIER:exon5/5:c.*745C>T:	AluSq2	rs139028783	0.0096	0	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr9	116023979	116023979	A	C	het		QUAL=9585;DP=257;AF=0.56;MQM=60;TRIO=HET,257,0.56,WT,183,0.01,HET,279,0.53	SLC31A1	3'UTR	SLC31A1:NM_001859.3:3'UTR:MODIFIER:exon5/5:c.*1226A>C:	MER5A	rs41280225	0.1384	0	0	0										0.0076	0.1742	0.8182	1	29	n/a	n/a
chr9	116025024	116025024	A	C	het		QUAL=10733;DP=424;AF=0.50;MQM=60;TRIO=HET,424,0.50,HET,233,0.49,WT,266,0.00	SLC31A1	3'UTR	SLC31A1:NM_001859.3:3'UTR:MODIFIER:exon5/5:c.*2271A>C:		rs10759637	0.5092	0	0	0										0.1515	0.5152	0.3333	23	77	n/a	n/a
chr9	116026255	116026255	G	C	het		QUAL=9351;DP=348;AF=0.53;MQM=59;TRIO=HET,348,0.53,HET,187,0.53,WT,247,0.00	SLC31A1	3'UTR	SLC31A1:NM_001859.3:3'UTR:MODIFIER:exon5/5:c.*3502G>C:		rs1143245	0.3185	0	0	0										0.0152	0.3106	0.6742	3	48	n/a	n/a
chr9	119462112	119462112	C	T	hom		QUAL=27298;DP=356;AF=1.00;MQM=60;TRIO=HOM,356,1.00,HOM,215,1.00,HOM,254,1.00	TRIM32,ASTN2	3'UTR,intron	TRIM32:NM_001099679.1:3'UTR:MODIFIER:exon2/2:c.*129C>T:,TRIM32:NM_012210.3:3'UTR:MODIFIER:exon2/2:c.*129C>T:,ASTN2:NM_014010.4:intron:MODIFIER:exon15/21:c.2653+25938G>A:		rs3019	0.9491	0	0	0										0.9091	0.0833	0.0076	137	12	n/a	n/a
chr9	119463189	119463189	T	C	het		QUAL=11982;DP=352;AF=0.54;MQM=60;TRIO=HET,352,0.54,WT,325,0.00,HET,325,0.54	TRIM32,ASTN2	3'UTR,intron	TRIM32:NM_001099679.1:3'UTR:MODIFIER:exon2/2:c.*1206T>C:,TRIM32:NM_012210.3:3'UTR:MODIFIER:exon2/2:c.*1206T>C:,ASTN2:NM_014010.4:intron:MODIFIER:exon15/21:c.2653+24861A>G:		rs2281627	0.268	0	0	0										0.1288	0.4697	0.4015	18	74	n/a	n/a
chr9	123170733	123170733	C	G	hom		QUAL=29488;DP=339;AF=1.00;MQM=59;TRIO=HOM,339,1.00,HOM,273,1.00,HOM,336,1.00	CDK5RAP2	missense	CDK5RAP2:NM_018249.5:missense:MODERATE:exon31/38:c.4618G>C:p.Val1540Leu,CDK5RAP2:NM_001011649.2:missense:MODERATE:exon31/37:c.4618G>C:p.Val1540Leu,CDK5RAP2:NM_001272039.1:missense:MODERATE:exon28/35:c.3928G>C:p.Val1310Leu		rs4837768	0.7532	0.769	0.7527	0.5842	-0.0830	P	T	B,B,B,B,B	B,B,B,B,B	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive];	RCV000020841.1 [benign]; RCV000145488.1 [likely benign]; 			0.6591	0.2955	0.0455	274	164	n/a	n/a
chr9	123215872	123215872	G	C	het		QUAL=12100;DP=378;AF=0.47;MQM=60;TRIO=HET,378,0.47,WT,324,0.00,HET,402,0.50	CDK5RAP2	missense,intron	CDK5RAP2:NM_018249.5:missense:MODERATE:exon21/38:c.2655C>G:p.Phe885Leu,CDK5RAP2:NM_001011649.2:missense:MODERATE:exon21/37:c.2655C>G:p.Phe885Leu,CDK5RAP2:NM_001272039.1:intron:MODIFIER:exon18/34:c.2104-5468C>G:		rs112600265	0.0014	0.004	0.0037	0.0014	0.5100	N	T	B,B,B,B	B,B,B,B	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive];				0	0.0076	0.9924	0	7	3	n/a
chr9	123291036	123291036	C	G	hom		QUAL=34515;DP=324;AF=1.00;MQM=60;TRIO=HOM,324,1.00,HOM,332,1.00,HOM,382,1.00	CDK5RAP2	missense	CDK5RAP2:NM_018249.5:missense:MODERATE:exon9/38:c.865G>C:p.Glu289Gln,CDK5RAP2:NM_001011649.2:missense:MODERATE:exon9/37:c.865G>C:p.Glu289Gln,CDK5RAP2:NM_001272039.1:missense:MODERATE:exon9/35:c.865G>C:p.Glu289Gln		rs4836822	0.8011	0.877	0.928	0.6929	2.5270	P	T	P,B,P	P,B,P	608201 [CDK5RAP2 (confirmed) Microcephaly 3,primary,autosomal recessive];	RCV000020847.1 [benign]; RCV000145507.1 [likely benign]; 			0.8182	0.1667	0.0152	382	69	n/a	n/a
chr9	123342259	123342259	C	A	hom		QUAL=6018;DP=88;AF=1.00;MQM=60;TRIO=HOM,88,1.00,HOM,38,1.00,HOM,67,1.00	CDK5RAP2	5'UTR	CDK5RAP2:NM_018249.5:5'UTR:MODIFIER:exon1/38:c.-3G>T:,CDK5RAP2:NM_001011649.2:5'UTR:MODIFIER:exon1/37:c.-3G>T:,CDK5RAP2:NM_001272039.1:5'UTR:MODIFIER:exon1/35:c.-3G>T:		rs932975	0.9804	0.992	0.999	0.9246							RCV000081944.3 [benign]; 			1	0	0	446	0	n/a	n/a
chr9	123342275	123342275	A	G	hom		QUAL=5113;DP=71;AF=1.00;MQM=60;TRIO=HOM,71,1.00,HOM,40,1.00,HOM,62,1.00	CDK5RAP2	5'UTR	CDK5RAP2:NM_018249.5:5'UTR:MODIFIER:exon1/38:c.-19T>C:,CDK5RAP2:NM_001011649.2:5'UTR:MODIFIER:exon1/37:c.-19T>C:,CDK5RAP2:NM_001272039.1:5'UTR:MODIFIER:exon1/35:c.-19T>C:		rs932974	0.9655	0.987	0.9986	0.8811							RCV000081943.2 [benign]; 			1	0	0	201	0	n/a	n/a
chr9	123714876	123714876	C	T	het		QUAL=8891;DP=309;AF=0.48;MQM=60;TRIO=HET,309,0.48,HET,231,0.57,WT,333,0.00	C5	3'UTR	C5:NM_001735.2:3'UTR:MODIFIER:exon41/41:c.*141G>A:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr9	123769200	123769200	C	T	hom		QUAL=23854;DP=279;AF=1.00;MQM=60;TRIO=HOM,279,1.00,HOM,185,1.00,HOM,250,1.00	C5	missense	C5:NM_001735.2:missense:MODERATE:exon19/41:c.2404G>A:p.Val802Ile		rs17611	0.4048	0.459	0.4452	0.0899	0.1000	P	T	B	B	120900 [C5 (confirmed) C5 deficiency|Eculizumab,poor response to];		CM093430 [CLASS=DP MUT=ALT PHEN="Ischemic stroke, association with" GENE=C5]; 		0.2197	0.4394	0.3409	109	220	n/a	n/a
chr9	123780005	123780005	G	A	hom		QUAL=28123;DP=393;AF=0.99;MQM=60;TRIO=HOM,393,0.99,HOM,201,1.00,HOM,246,1.00	C5	synonymous	C5:NM_001735.2:synonymous:LOW:exon13/41:c.1632C>T:p.Tyr544Tyr		rs25681	0.4058	0.457	0.445	0.0894						120900 [C5 (confirmed) C5 deficiency|Eculizumab,poor response to];			COSM1459729	0.2197	0.4394	0.3409	108	220	n/a	n/a
chr9	124083614	124083614	C	T	het		QUAL=7218;DP=249;AF=0.46;MQM=60;TRIO=HET,249,0.46,HET,293,0.45,WT,409,0.00	GSN	synonymous	GSN:NM_000177.4:synonymous:LOW:exon10/17:c.1413C>T:p.Gly471Gly,GSN:NM_001127662.1:synonymous:LOW:exon10/17:c.1260C>T:p.Gly420Gly,GSN:NM_001127663.1:synonymous:LOW:exon12/19:c.1368C>T:p.Gly456Gly,GSN:NM_001127664.1:synonymous:LOW:exon12/19:c.1260C>T:p.Gly420Gly,GSN:NM_001127665.1:synonymous:LOW:exon12/19:c.1260C>T:p.Gly420Gly,GSN:NM_001127666.1:synonymous:LOW:exon12/19:c.1293C>T:p.Gly431Gly,GSN:NM_001127667.1:synonymous:LOW:exon12/19:c.1293C>T:p.Gly431Gly,GSN:NM_198252.2:synonymous:LOW:exon11/18:c.1260C>T:p.Gly420Gly,GSN:NM_001258029.1:synonymous:LOW:exon10/17:c.1311C>T:p.Gly437Gly,GSN:NM_001258030.1:synonymous:LOW:exon10/17:c.1284C>T:p.Gly428Gly		rs2304393	0.0855	0.062	0.04	0.079						137350 [GSN (provisional) Amyloidosis,Finnish type];				0	0.1515	0.8485	2	66	n/a	n/a
chr9	129453229	129453229	A	G	hom		QUAL=9129;DP=103;AF=1.00;MQM=59;TRIO=HOM,103,1.00,HET,104,0.55,HOM,130,1.00	LMX1B	synonymous	LMX1B:NM_001174146.1:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu,LMX1B:NM_001174147.1:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu,LMX1B:NM_002316.3:synonymous:LOW:exon3/8:c.441A>G:p.Glu147Glu		rs2277158	0.48	0.445	0.4307	0.5247						602575 [LMX1B (confirmed) Nail-patella syndrome];			COSM3763641	0.1818	0.5076	0.3106	95	223	n/a	n/a
chr9	129455587	129455587	G	C	hom		QUAL=9383;DP=81;AF=1.00;MQM=59;TRIO=HOM,81,1.00,HET,126,0.40,HOM,172,0.99	LMX1B	synonymous	LMX1B:NM_001174146.1:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser,LMX1B:NM_001174147.1:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser,LMX1B:NM_002316.3:synonymous:LOW:exon4/8:c.726G>C:p.Ser242Ser		rs13295990	0.4393	0.416	0.4295	0.3943						602575 [LMX1B (confirmed) Nail-patella syndrome];				0.2045	0.4924	0.303	97	220	n/a	n/a
chr9	129459181	129459181	C	T	het		QUAL=5995;DP=104;AF=0.49;MQM=60;TRIO=HET,104,0.49,WT,250,0.00,HET,301,0.48	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*451C>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*451C>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*451C>T:		rs71497630	0.1516	0	0	0										0.0152	0.2348	0.75	2	34	n/a	n/a
chr9	129459314	129459314	C	T	het		QUAL=16499;DP=309;AF=0.44;MQM=59;TRIO=HET,309,0.44,HET,375,0.47,HET,489,0.44	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*584C>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*584C>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*584C>T:		rs34200683	0.2181	0	0	0										0.0682	0.5076	0.4242	13	78	n/a	n/a
chr9	129459438	129459438	G	A	het		QUAL=10595;DP=155;AF=0.46;MQM=60;TRIO=HET,155,0.46,HET,275,0.45,HET,359,0.40	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*708G>A:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*708G>A:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*708G>A:		rs10987413	0.2057	0	0	0										0.0455	0.5152	0.4394	10	78	n/a	n/a
chr9	129459478	129459478	C	T	het		QUAL=9026;DP=189;AF=0.47;MQM=60;TRIO=HET,189,0.47,HET,207,0.43,HET,313,0.38	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*748C>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*748C>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*748C>T:		rs10987414	0.234	0	0	0										0.0682	0.5076	0.4242	13	78	n/a	n/a
chr9	129459662	129459662	G	T	het		QUAL=11240;DP=438;AF=0.47;MQM=60;TRIO=HET,438,0.47,WT,226,0.00,HET,263,0.56	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*932G>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*932G>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*932G>T:		rs28687510	0.2298	0	0	0										0.0152	0.2348	0.75	2	34	n/a	n/a
chr9	129459985	129459985	A	G	het		QUAL=7149;DP=219;AF=0.49;MQM=60;TRIO=HET,219,0.49,WT,243,0.00,HET,249,0.49	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1255A>G:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1255A>G:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1255A>G:	L3b	rs16929236	0.2302	0	0	0										0.0152	0.2348	0.75	2	34	n/a	n/a
chr9	129460117	129460121	TGTTT	-	het		QUAL=2964;DP=21;AF=0.43;MQM=59;TRIO=HET,21,1.00,HET,85,0.36,HET,61,0.93	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1437_*1441delTGTTT:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1437_*1441delTGTTT:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1437_*1441delTGTTT:	L3b:AluSp	rs535437948	0	0	0	0										0.1591	0.2121	0.6288	23	31	n/a	n/a
chr9	129460119	129460119	T	G	het		QUAL=2964;DP=21;AF=0.43;MQM=56;TRIO=HET,21,1.00,WT,85,0.36,HET,61,0.93	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1389T>G:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1389T>G:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1389T>G:	AluSp	rs13300385	0.1641	0	0	0										0.0152	0.1591	0.8258	2	22	n/a	n/a
chr9	129460123	129460123	G	T	het		QUAL=2964;DP=21;AF=0.43;MQM=56;TRIO=HET,21,1.00,WT,85,0.36,HET,61,0.93	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1393G>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1393G>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1393G>T:	AluSp	rs13299451	0.1613	0	0	0										0.0152	0.2197	0.7652	2	31	n/a	n/a
chr9	129460203	129460203	G	A	het		QUAL=2818;DP=129;AF=0.45;MQM=49;TRIO=HET,129,0.45,WT,130,0.00,HET,97,0.35	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1473G>A:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1473G>A:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1473G>A:	AluSp	rs13299609	0.1508	0	0	0										0.0152	0.2348	0.75	2	34	n/a	n/a
chr9	129460312	129460312	A	G	hom		QUAL=11833;DP=161;AF=0.99;MQM=56;TRIO=HOM,161,0.99,HET,138,0.44,HOM,165,0.99	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1582A>G:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1582A>G:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1582A>G:	AluSp	rs10987415	0.4103	0	0	0										0.197	0.5076	0.2955	31	78	n/a	n/a
chr9	129460396	129460396	C	T	het		QUAL=13843;DP=235;AF=0.52;MQM=56;TRIO=HET,235,0.52,HET,285,0.46,HET,366,0.54	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1666C>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1666C>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1666C>T:	AluSp	rs10987416	0.2169	0	0	0										0.0455	0.5076	0.447	10	77	n/a	n/a
chr9	129460722	129460722	T	C	hom		QUAL=23065;DP=408;AF=1.00;MQM=59;TRIO=HOM,408,1.00,HET,243,0.49,HET,352,0.53	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1992T>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1992T>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1992T>C:	L3b	rs34776870	0.1955	0	0	0										0.0152	0.2424	0.7424	2	35	n/a	n/a
chr9	129460727	129460727	G	A	hom		QUAL=22136;DP=392;AF=0.99;MQM=59;TRIO=HOM,392,0.99,HET,251,0.48,HET,349,0.52	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*1997G>A:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*1997G>A:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*1997G>A:	L3b	rs35632228	0.1953	0	0	0										0.0152	0.2424	0.7424	2	35	n/a	n/a
chr9	129461123	129461123	T	C	hom		QUAL=8552;DP=151;AF=0.57;MQM=59;TRIO=HOM,151,1.00,HOM,59,1.00,HOM,61,1.00	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*2393T>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*2393T>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*2393T>C:		rs10120414	0.8714	0	0	0										0.8864	0.1136	0	134	16	n/a	n/a
chr9	129461124	129461124	G	C	het		QUAL=8552;DP=151;AF=0.57;MQM=59;TRIO=HET,151,1.00,WT,59,1.00,HET,61,1.00	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*2394G>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*2394G>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*2394G>C:		rs10760451	0.4089	0	0	0										0.1439	0.4773	0.3788	21	71	n/a	n/a
chr9	129461319	129461320	TT	-	het		QUAL=4418;DP=159;AF=0.39;MQM=60;TRIO=HET,159,0.39,HET,142,0.23,HET,169,0.36	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*2590_*2591delTT:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*2590_*2591delTT:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*2590_*2591delTT:		rs560251761	0.3754	0	0	0										0.1439	0.4545	0.4015	21	67	n/a	n/a
chr9	129462501	129462501	G	T	het		QUAL=14855;DP=307;AF=0.53;MQM=60;TRIO=HET,307,0.53,HET,270,0.46,HET,371,0.49	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*3771G>T:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*3771G>T:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*3771G>T:		rs10987417	0.5407	0	0	0										0.2348	0.5152	0.25	36	75	n/a	n/a
chr9	129462563	129462563	A	G	het		QUAL=16636;DP=297;AF=0.48;MQM=60;TRIO=HET,297,0.48,HET,343,0.45,HET,459,0.50	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*3833A>G:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*3833A>G:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*3833A>G:		rs10987418	0.5481	0	0	0										0.2424	0.5227	0.2348	37	76	n/a	n/a
chr9	129462594	129462594	T	C	het		QUAL=17775;DP=266;AF=0.49;MQM=59;TRIO=HET,266,0.49,HET,390,0.46,HET,524,0.51	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*3864T>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*3864T>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*3864T>C:		rs10987419	0.5483	0	0	0										0.2424	0.5227	0.2348	37	76	n/a	n/a
chr9	129462687	129462687	C	A	het		QUAL=21536;DP=313;AF=0.49;MQM=60;TRIO=HET,313,0.49,HET,467,0.49,HET,622,0.49	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*3957C>A:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*3957C>A:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*3957C>A:		rs10987422	0.5323	0	0	0										0.2424	0.5227	0.2348	37	76	n/a	n/a
chr9	129462901	129462901	T	C	hom		QUAL=22028;DP=216;AF=1.00;MQM=59;TRIO=HOM,216,1.00,HET,279,0.46,HOM,358,1.00	LMX1B	3'UTR	LMX1B:NM_001174146.1:3'UTR:MODIFIER:exon8/8:c.*4171T>C:,LMX1B:NM_001174147.1:3'UTR:MODIFIER:exon8/8:c.*4171T>C:,LMX1B:NM_002316.3:3'UTR:MODIFIER:exon8/8:c.*4171T>C:		rs3814119	0.5511	0	0	0										0.25	0.5303	0.2197	38	77	n/a	n/a
chr9	130629139	130629139	T	G	hom		QUAL=5397;DP=59;AF=1.00;MQM=60;TRIO=HOM,59,1.00,HOM,34,1.00,HOM,74,1.00	AK1	3'UTR	AK1:NM_000476.2:3'UTR:MODIFIER:exon7/7:c.*1148A>C:	LFSINE_Vert	rs913987	0.7087	0	0	0										0.6288	0.3333	0.0379	96	49	n/a	n/a
chr9	130629527	130629527	G	T	hom		QUAL=7714;DP=78;AF=1.00;MQM=57;TRIO=HOM,78,1.00,HOM,76,1.00,HOM,101,1.00	AK1	3'UTR	AK1:NM_000476.2:3'UTR:MODIFIER:exon7/7:c.*760C>A:	AluSx	rs2249308	0.9181	0	0	0										0.8182	0.1818	0	123	27	n/a	n/a
chr9	130630233	130630233	G	T	hom		QUAL=38973;DP=165;AF=1.00;MQM=59;TRIO=HOM,165,1.00,HOM,475,1.00,HOM,611,1.00	AK1	3'UTR	AK1:NM_000476.2:3'UTR:MODIFIER:exon7/7:c.*54C>A:		rs4226	0.6817	0	0.7976	0.4155										0.6212	0.3333	0.0455	102	57	n/a	n/a
chr9	130630639	130630639	A	G	hom		QUAL=24223;DP=246;AF=1.00;MQM=60;TRIO=HOM,246,1.00,HOM,247,1.00,HOM,270,1.00	AK1	synonymous	AK1:NM_000476.2:synonymous:LOW:exon6/7:c.477T>C:p.Pro159Pro		rs913986	0.9982	0.999	0.9999	0.9948	-4.9500	P				103000 [AK1 (confirmed) Hemolytic anemia due to adenylate kinase deficiency];				1	0	0	454	0	n/a	n/a
chr9	130698029	130698029	G	C	hom		QUAL=35623;DP=358;AF=1.00;MQM=59;TRIO=HOM,358,1.00,HOM,305,1.00,HOM,417,1.00	DPM2	missense	DPM2:NM_003863.3:missense:MODERATE:exon4/4:c.227C>G:p.Thr76Ser		rs7997	0.6835	0.787	0.8681	0.68	0.1410	P	T	B	B	603564 [DPM2 (provisional) Congenital disorder of glycosylation,type Iu];	RCV000116901.1 [benign]; 		COSM3982740	0.803	0.1742	0.0227	228	77	n/a	n/a
chr9	130698043	130698043	A	G	hom		QUAL=33634;DP=328;AF=1.00;MQM=60;TRIO=HOM,328,1.00,HOM,307,1.00,HOM,390,1.00	DPM2	synonymous	DPM2:NM_003863.3:synonymous:LOW:exon4/4:c.213T>C:p.Tyr71Tyr		rs6781	0.731	0.814	0.8695	0.6811						603564 [DPM2 (provisional) Congenital disorder of glycosylation,type Iu];	RCV000116900.2 [benign]; 			0.8182	0.1591	0.0227	234	72	n/a	n/a
chr9	130700251	130700251	T	C	hom		QUAL=35668;DP=413;AF=1.00;MQM=59;TRIO=HOM,413,1.00,HOM,325,1.00,HOM,409,1.00	DPM2	5'UTR	DPM2:NM_003863.3:5'UTR:MODIFIER:exon1/4:c.-152A>G:		rs6478802	0.6839	0	0	0										0.8106	0.1667	0.0227	121	25	n/a	n/a
chr9	130700727	130700727	T	C	hom		QUAL=23121;DP=248;AF=1.00;MQM=59;TRIO=HOM,248,1.00,HOM,209,1.00,HOM,267,1.00	DPM2	5'UTR	DPM2:NM_003863.3:5'UTR:MODIFIER:exon1/4:c.-628A>G:		rs3758327	0.6839	0	0	0										0.803	0.1742	0.0227	120	26	n/a	n/a
chr9	131285955	131285955	A	G	het		QUAL=957;DP=59;AF=0.44;MQM=60;TRIO=HET,59,0.44,HET,24,0.33,WT,56,0.00	GLE1	missense	GLE1:NM_001003722.1:missense:MODERATE:exon6/16:c.727A>G:p.Ile243Val,GLE1:NM_001499.2:missense:MODERATE:exon6/14:c.727A>G:p.Ile243Val		rs2275260	0.3474	0.267	0.2014	0.3883	1.7440	P	T	B,B	B,B	603371 [GLE1 (confirmed) Lethal congenital contracture syndrome 1|Arthrogryposis,lethal,with anterior horn cell disease];		CM1310812 [CLASS=DM? MUT=ALT PHEN="Arthrogryposis & hypoplasia" GENE=GLE1]; 		0.0682	0.4091	0.5227	30	174	2	n/a
chr9	131303522	131303522	G	A	het		QUAL=5442;DP=190;AF=0.49;MQM=60;TRIO=HET,190,0.49,HET,154,0.49,WT,163,0.01	GLE1	3'UTR	GLE1:NM_001003722.1:3'UTR:MODIFIER:exon16/16:c.*73G>A:		rs10760563	0.266	0	0	0										0.0682	0.3939	0.5379	10	56	n/a	n/a
chr9	131346218	131346218	A	C	hom		QUAL=36853;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,393,1.00,HOM,530,1.00	SPTAN1	synonymous	SPTAN1:NM_001130438.2:synonymous:LOW:exon16/57:c.2163A>C:p.Ala721Ala,SPTAN1:NM_001195532.1:synonymous:LOW:exon16/55:c.2163A>C:p.Ala721Ala,SPTAN1:NM_003127.3:synonymous:LOW:exon16/56:c.2163A>C:p.Ala721Ala		rs10760566	0.9698	0.991	0.9997	0.9124						182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5];	RCV000128236.1 [benign]; 			1	0	0	453	1	n/a	n/a
chr9	131360750	131360750	C	T	hom		QUAL=16574;DP=222;AF=1.00;MQM=59;TRIO=HOM,222,1.00,HOM,131,1.00,HOM,159,1.00	SPTAN1	synonymous	SPTAN1:NM_001130438.2:synonymous:LOW:exon25/57:c.3486C>T:p.Leu1162Leu,SPTAN1:NM_001195532.1:synonymous:LOW:exon24/55:c.3426C>T:p.Leu1142Leu,SPTAN1:NM_003127.3:synonymous:LOW:exon25/56:c.3486C>T:p.Leu1162Leu		rs2227864	0.6428	0.797	0.9017	0.4846						182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5];	RCV000147625.1,RCV000147626.1 [benign,benign]; 			0.8561	0.1364	0.0076	378	73	n/a	n/a
chr9	131375701	131375701	A	G	hom		QUAL=27035;DP=259;AF=1.00;MQM=60;TRIO=HOM,259,1.00,HOM,232,1.00,HOM,329,1.00	SPTAN1	synonymous	SPTAN1:NM_001130438.2:synonymous:LOW:exon40/57:c.5085A>G:p.Leu1695Leu,SPTAN1:NM_001195532.1:synonymous:LOW:exon38/55:c.5010A>G:p.Leu1670Leu,SPTAN1:NM_003127.3:synonymous:LOW:exon39/56:c.5070A>G:p.Leu1690Leu		rs1415568	0.9848	0.996	0.9998	0.9573						182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5];	RCV000128256.1 [benign]; 			1	0	0	453	1	n/a	n/a
chr9	131379967	131379967	C	T	hom		QUAL=28045;DP=261;AF=1.00;MQM=59;TRIO=HOM,261,1.00,HOM,250,1.00,HOM,375,1.00	SPTAN1	synonymous	SPTAN1:NM_001130438.2:synonymous:LOW:exon42/57:c.5406C>T:p.Thr1802Thr,SPTAN1:NM_001195532.1:synonymous:LOW:exon40/55:c.5331C>T:p.Thr1777Thr,SPTAN1:NM_003127.3:synonymous:LOW:exon41/56:c.5391C>T:p.Thr1797Thr		rs2227862	0.617	0.791	0.9036	0.3995						182810 [SPTAN1 (confirmed) Epileptic encephalopathy,early infantile,5];	RCV000147635.1,RCV000128258.1 [benign,benign]; RCV000147636.1 [benign]; 		COSM4163386	0.8333	0.1591	0.0076	373	78	n/a	n/a
chr9	131670919	131670919	T	C	hom		QUAL=24124;DP=237;AF=1.00;MQM=59;TRIO=HOM,237,1.00,HOM,311,0.99,HET,413,0.54	LRRC8A	synonymous	LRRC8A:NM_001127244.1:synonymous:LOW:exon3/4:c.1476T>C:p.Arg492Arg,LRRC8A:NM_001127245.1:synonymous:LOW:exon2/3:c.1476T>C:p.Arg492Arg,LRRC8A:NM_019594.3:synonymous:LOW:exon3/4:c.1476T>C:p.Arg492Arg		rs3750319	0.5711	0.688	0.7248	0.3143						608360 [LRRC8A (confirmed) Agammaglobulinemia 5];				0.5379	0.3712	0.0909	231	171	n/a	n/a
chr9	131679892	131679892	C	T	hom		QUAL=12060;DP=122;AF=0.99;MQM=60;TRIO=HOM,122,0.99,HOM,168,1.00,HET,178,0.54	LRRC8A	3'UTR	LRRC8A:NM_001127244.1:3'UTR:MODIFIER:exon4/4:c.*1242C>T:,LRRC8A:NM_001127245.1:3'UTR:MODIFIER:exon3/3:c.*1242C>T:,LRRC8A:NM_019594.3:3'UTR:MODIFIER:exon4/4:c.*1242C>T:		rs9031	0.5118	0	0	0										0.5152	0.3939	0.0909	75	62	n/a	n/a
chr9	131679897	131679897	A	G	hom		QUAL=14919;DP=123;AF=1.00;MQM=60;TRIO=HOM,123,1.00,HOM,170,1.00,HOM,179,1.00	LRRC8A	3'UTR	LRRC8A:NM_001127244.1:3'UTR:MODIFIER:exon4/4:c.*1247A>G:,LRRC8A:NM_001127245.1:3'UTR:MODIFIER:exon3/3:c.*1247A>G:,LRRC8A:NM_019594.3:3'UTR:MODIFIER:exon4/4:c.*1247A>G:		rs10819453	0.9974	0	0	0										1	0	0	150	0	n/a	n/a
chr9	131680177	131680177	G	T	het		QUAL=9887;DP=293;AF=0.49;MQM=60;TRIO=HET,293,0.49,HET,333,0.50,WT,429,0.00	LRRC8A	3'UTR	LRRC8A:NM_001127244.1:3'UTR:MODIFIER:exon4/4:c.*1527G>T:,LRRC8A:NM_001127245.1:3'UTR:MODIFIER:exon3/3:c.*1527G>T:,LRRC8A:NM_019594.3:3'UTR:MODIFIER:exon4/4:c.*1527G>T:		rs11542344	0.0262	0	0	0										0.0227	0.0682	0.9091	3	10	n/a	n/a
chr9	132575797	132575797	A	T	het		QUAL=6945;DP=246;AF=0.47;MQM=60;TRIO=HET,246,0.47,WT,165,0.00,HET,210,0.47	TOR1A	3'UTR	TOR1A:NM_000113.2:3'UTR:MODIFIER:exon5/5:c.*454T>A:		rs1045441	0.0681	0	0	0										0.0076	0.0909	0.9015	1	15	n/a	n/a
chr9	132575828	132575828	A	-	het		QUAL=5277;DP=244;AF=0.48;MQM=60;TRIO=HET,244,0.48,HET,131,0.48,WT,161,0.01	TOR1A	3'UTR	TOR1A:NM_000113.2:3'UTR:MODIFIER:exon5/5:c.*423delT:		rs573629050	0.0136	0	0	0										0	0.0758	0.9242	0	10	n/a	n/a
chr9	132576037	132576037	G	C	het		QUAL=3651;DP=132;AF=0.49;MQM=60;TRIO=HET,132,0.49,WT,62,0.00,HET,103,0.50	TOR1A	3'UTR	TOR1A:NM_000113.2:3'UTR:MODIFIER:exon5/5:c.*214C>G:		rs1183	0.0681	0	0	0										0.0076	0.0909	0.9015	1	15	n/a	n/a
chr9	132585058	132585058	G	A	het		QUAL=7311;DP=252;AF=0.47;MQM=60;TRIO=HET,252,0.47,HET,285,0.41,WT,365,0.00	TOR1A	synonymous	TOR1A:NM_000113.2:synonymous:LOW:exon2/5:c.246C>T:p.Ala82Ala		rs2296793	0.2262	0.227	0.2402	0.2227						605204 [TOR1A (confirmed) Dystonia-1,torsion|Dystonia,early-onset atypical,with myoclonic features|Dystonia-1,modifier of];			COSM150726	0.0682	0.3712	0.5606	29	193	n/a	n/a
chr9	133364757	133364757	T	C	het		QUAL=6551;DP=129;AF=0.47;MQM=57;TRIO=HET,129,0.47,WT,227,0.00,HET,261,0.56	ASS1	synonymous	ASS1:NM_000050.4:synonymous:LOW:exon13/16:c.876T>C:p.His292His,ASS1:NM_054012.3:synonymous:LOW:exon12/15:c.876T>C:p.His292His		rs1057484	0.0767	0.094	0.0985	0.1114						603470 [ASS1 (confirmed) Citrullinemia];	RCV000078028.2 [benign]; RCV000123707.1 [benign]; 			0.0152	0.2652	0.7197	6	97	n/a	n/a
chr9	133376678	133376689	GTGTGTGTGTGT	-	het		QUAL=560;DP=5;AF=0.40;MQM=60;TRIO=HET,5,0.80,HET,14,0.86,WT,17,0.82				(TG)n		0	0	0	0										0.0076	0.0833	0.9091	1	13	n/a	n/a
chr9	133376679	133376692	TGTGTGTGTGTGTG	-	het		QUAL=560;DP=5;AF=0.40;MQM=60;TRIO=HET,5,0.80,HET,14,0.86,HET,17,0.82				(TG)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr9	134385436	134385436	A	G	hom		QUAL=23088;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HET,309,0.48,HOM,375,1.00	POMT1	missense,intron	POMT1:NM_007171.3:missense:MODERATE:exon8/20:c.752A>G:p.Gln251Arg,POMT1:NM_001077365.1:intron:MODIFIER:exon8/19:c.699+53A>G:,POMT1:NM_001077366.1:intron:MODIFIER:exon7/18:c.537+53A>G:,POMT1:NM_001136113.1:intron:MODIFIER:exon8/19:c.699+53A>G:,POMT1:NM_001136114.1:intron:MODIFIER:exon6/17:c.348+53A>G:		rs2296949	0.8706	0.923	0.9515	0.7383	1.3280	P		B	B	607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1];	RCV000081493.2 [benign]; 			0.8939	0.1061	0	405	47	n/a	n/a
chr9	134386744	134386744	T	C	hom		QUAL=10988;DP=127;AF=1.00;MQM=59;TRIO=HOM,127,1.00,HET,101,0.50,HOM,166,1.00	POMT1	synonymous	POMT1:NM_007171.3:synonymous:LOW:exon10/20:c.942T>C:p.Thr314Thr,POMT1:NM_001077365.1:synonymous:LOW:exon10/20:c.876T>C:p.Thr292Thr,POMT1:NM_001077366.1:synonymous:LOW:exon9/19:c.714T>C:p.Thr238Thr,POMT1:NM_001136113.1:synonymous:LOW:exon10/20:c.876T>C:p.Thr292Thr,POMT1:NM_001136114.1:synonymous:LOW:exon8/18:c.525T>C:p.Thr175Thr		rs10901065	0.8708	0.923	0.9522	0.7406	-1.7260	P	D			607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1];	RCV000153752.1 [benign]; 			0.8939	0.1061	0	407	45	n/a	n/a
chr9	134387488	134387488	T	C	hom		QUAL=23048;DP=281;AF=1.00;MQM=60;TRIO=HOM,281,1.00,HET,258,0.53,HOM,294,1.00	POMT1	synonymous	POMT1:NM_007171.3:synonymous:LOW:exon11/20:c.1113T>C:p.Asp371Asp,POMT1:NM_001077365.1:synonymous:LOW:exon11/20:c.1047T>C:p.Asp349Asp,POMT1:NM_001077366.1:synonymous:LOW:exon10/19:c.885T>C:p.Asp295Asp,POMT1:NM_001136113.1:synonymous:LOW:exon11/20:c.1047T>C:p.Asp349Asp,POMT1:NM_001136114.1:synonymous:LOW:exon9/18:c.696T>C:p.Asp232Asp		rs3739494	0.8708	0.923	0.9522	0.7406						607423 [POMT1 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,1|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,1|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,1];	RCV000153753.1 [benign]; 			0.8939	0.1061	0	407	45	n/a	n/a
chr9	134398534	134398534	T	C	hom		QUAL=21862;DP=140;AF=1.00;MQM=59;TRIO=HOM,140,1.00,HET,297,0.55,HOM,399,1.00	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*41T>C:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*41T>C:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*41T>C:		rs3739495	0.8704	0.92	0.9521	0.7363										0.8939	0.1061	0	163	22	n/a	n/a
chr9	134398719	134398719	T	C	hom		QUAL=29351;DP=351;AF=1.00;MQM=60;TRIO=HOM,351,1.00,HET,309,0.52,HOM,413,0.99	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*226T>C:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*226T>C:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*226T>C:		rs3824395	0.8708	0	0	0										0.8939	0.1061	0	131	17	n/a	n/a
chr9	134398771	134398771	T	C	hom		QUAL=28850;DP=275;AF=1.00;MQM=59;TRIO=HOM,275,1.00,HET,330,0.53,HOM,443,1.00	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*278T>C:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*278T>C:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*278T>C:		rs10793885	0.8712	0	0	0										0.9015	0.0985	0	132	16	n/a	n/a
chr9	134398778	134398778	A	G	hom		QUAL=33015;DP=252;AF=1.00;MQM=59;TRIO=HOM,252,1.00,HOM,330,1.00,HOM,440,1.00	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*285A>G:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*285A>G:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*285A>G:		rs4740259	0.9812	0	0	0										1	0	0	149	1	n/a	n/a
chr9	134398841	134398841	C	T	hom		QUAL=21019;DP=172;AF=1.00;MQM=59;TRIO=HOM,172,1.00,HET,255,0.49,HOM,365,1.00	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*348C>T:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*348C>T:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*348C>T:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*348C>T:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*348C>T:		rs7857419	0.8664	0	0	0										0.8788	0.1212	0	127	21	n/a	n/a
chr9	134398946	134398946	T	C	hom		QUAL=12617;DP=150;AF=1.00;MQM=59;TRIO=HOM,150,1.00,HET,197,0.55,HET,266,0.52	POMT1	3'UTR	POMT1:NM_007171.3:3'UTR:MODIFIER:exon20/20:c.*453T>C:,POMT1:NM_001077365.1:3'UTR:MODIFIER:exon20/20:c.*453T>C:,POMT1:NM_001077366.1:3'UTR:MODIFIER:exon19/19:c.*453T>C:,POMT1:NM_001136113.1:3'UTR:MODIFIER:exon20/20:c.*453T>C:,POMT1:NM_001136114.1:3'UTR:MODIFIER:exon18/18:c.*453T>C:		rs11005	0.749	0	0	0										0.5909	0.3864	0.0227	87	58	n/a	n/a
chr9	135202829	135202829	T	C	hom		QUAL=23205;DP=322;AF=1.00;MQM=60;TRIO=HOM,322,1.00,HOM,171,1.00,HOM,202,1.00	SETX	missense	SETX:NM_015046.5:missense:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val		rs543573	0.5561	0.725	0.8457	0.3972	-0.6580	P	T	B,B,B	B,B,B	608465 [SETX (confirmed) Ataxia-ocular apraxia-2|Amyotrophic lateral sclerosis 4,juvenile];	RCV000081696.4 [other]; 		COSM150732	0.6061	0.3258	0.0682	978	396	n/a	n/a
chr9	135203231	135203231	C	T	hom		QUAL=14696;DP=199;AF=0.99;MQM=60;TRIO=HOM,199,0.99,HOM,96,0.98,HOM,162,1.00	SETX	missense	SETX:NM_015046.5:missense:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg		rs1183768	0.5561	0.725	0.845	0.3965	0.4900	P	T	P,P,P	B,B,B	608465 [SETX (confirmed) Ataxia-ocular apraxia-2|Amyotrophic lateral sclerosis 4,juvenile];	RCV000081695.4 [other]; 		COSM150733	0.6061	0.3258	0.0682	988	392	n/a	n/a
chr9	135203409	135203409	A	C	hom		QUAL=15382;DP=319;AF=1.00;MQM=60;TRIO=HOM,319,1.00,HOM,61,1.00,HOM,83,0.99	SETX	missense	SETX:NM_015046.5:missense:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu		rs1185193	0.6406	0.763	0.8617	0.6586	-0.9950	P	T	B,B,B	B,B,B	608465 [SETX (confirmed) Ataxia-ocular apraxia-2|Amyotrophic lateral sclerosis 4,juvenile];	RCV000081694.4 [other]; 			0.7045	0.2424	0.053	1023	357	n/a	n/a
chr9	135206460	135206460	A	G	hom		QUAL=29133;DP=513;AF=1.00;MQM=60;TRIO=HOM,513,1.00,HOM,171,0.99,HOM,190,1.00	SETX	synonymous	SETX:NM_015046.5:synonymous:LOW:exon9/26:c.1077T>C:p.Tyr359Tyr		rs9411449	0.6266	0.747	0.8466	0.6366						608465 [SETX (confirmed) Ataxia-ocular apraxia-2|Amyotrophic lateral sclerosis 4,juvenile];	RCV000081691.4 [other]; 		COSM4163458	0.6136	0.3258	0.0606	985	392	n/a	n/a
chr9	135767185	135767185	C	T	het		QUAL=10877;DP=401;AF=0.44;MQM=60;TRIO=HET,401,0.44,WT,310,0.00,HET,370,0.42	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*4437G>A:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*4437G>A:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*4437G>A:		rs11553763	0.1034	0	0	0										0.0076	0.0758	0.9167	1	13	n/a	n/a
chr9	135770115	135770115	C	T	hom		QUAL=14515;DP=253;AF=1.00;MQM=59;TRIO=HOM,253,1.00,HOM,93,1.00,HOM,105,1.00	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1507G>A:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1507G>A:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1507G>A:		rs739441	0.7734	0	0	0										0.553	0.3939	0.053	81	59	n/a	n/a
chr9	135770134	135770134	G	A	het		QUAL=8349;DP=296;AF=0.48;MQM=59;TRIO=HET,296,0.48,WT,106,0.00,HOM,126,1.00	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1488C>T:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1488C>T:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1488C>T:		rs739442	0.4507	0	0	0										0.2197	0.5076	0.2727	33	73	n/a	n/a
chr9	135770250	135770250	A	C	het		QUAL=12830;DP=262;AF=0.45;MQM=59;TRIO=HET,262,0.45,HET,228,0.55,HET,322,0.52	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1372T>G:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1372T>G:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1372T>G:		rs58612431	0.2196	0	0	0										0.0227	0.2424	0.7348	3	38	n/a	n/a
chr9	135770300	135770300	G	A	het		QUAL=21392;DP=384;AF=0.45;MQM=60;TRIO=HET,384,0.45,HET,258,0.52,HOM,352,1.00	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1322C>T:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1322C>T:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1322C>T:		rs2809243	0.5521	0	0	0										0.2803	0.5303	0.1894	44	74	n/a	n/a
chr9	135770347	135770347	A	C	hom		QUAL=32054;DP=345;AF=1.00;MQM=60;TRIO=HOM,345,1.00,HOM,274,0.99,HOM,372,1.00	TSC1	3'UTR	TSC1:NM_000368.4:3'UTR:MODIFIER:exon23/23:c.*1275T>G:,TSC1:NM_001162426.1:3'UTR:MODIFIER:exon23/23:c.*1275T>G:,TSC1:NM_001162427.1:3'UTR:MODIFIER:exon22/22:c.*1275T>G:		rs2809244	0.7482	0	0	0										0.4697	0.4015	0.1288	72	59	n/a	n/a
chr9	135772717	135772717	G	A	het		QUAL=13529;DP=282;AF=0.48;MQM=60;TRIO=HET,282,0.48,HET,245,0.58,HET,266,0.53	TSC1	synonymous	TSC1:NM_000368.4:synonymous:LOW:exon22/23:c.2829C>T:p.Ala943Ala,TSC1:NM_001162426.1:synonymous:LOW:exon22/23:c.2826C>T:p.Ala942Ala,TSC1:NM_001162427.1:synonymous:LOW:exon21/22:c.2676C>T:p.Ala892Ala		rs4962081	0.0621	0.076	0.0819	0.0906						605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];	RCV000042257.2 [not provided]; RCV000054906.1 [not provided]; RCV000055028.1 [not provided]; RCV000055028.1 [not provided]; RCV000118693.3 [other]; RCV000125634.1 [benign]; 			0.0076	0.0985	0.8939	2	65	n/a	n/a
chr9	135773000	135773000	G	A	het		QUAL=579;DP=41;AF=0.34;MQM=57;TRIO=HET,41,0.61,WT,19,0.26,HET,30,0.33	TSC1	splice_region&intron	TSC1:NM_000368.4:splice_region&intron:LOW:exon20/22:c.2626-3C>T:,TSC1:NM_001162426.1:splice_region&intron:LOW:exon20/22:c.2623-3C>T:,TSC1:NM_001162427.1:splice_region&intron:LOW:exon19/21:c.2473-3C>T:			0	0	0	0						605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];				0	0.0152	0.9848	0	5	n/a	n/a
chr9	135773001	135773001	A	-	het		QUAL=579;DP=41;AF=0.00;MQM=60;TRIO=HET,41,0.27,WT,19,0.32,WT,30,0.53	TSC1	splice_region&intron	TSC1:NM_000368.4:splice_region&intron:LOW:exon20/22:c.2626-4delT:,TSC1:NM_001162426.1:splice_region&intron:LOW:exon20/22:c.2623-4delT:,TSC1:NM_001162427.1:splice_region&intron:LOW:exon19/21:c.2473-4delT:		rs118203716	0.3427	0	0	0						605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];	RCV000042234.2 [not provided]; 			0	0.0985	0.9015	0	18	n/a	n/a
chr9	135782221	135782221	T	C	het		QUAL=4412;DP=175;AF=0.52;MQM=60;TRIO=HET,175,0.52,HET,99,0.47,WT,140,0.00	TSC1	splice_region&synonymous	TSC1:NM_000368.4:splice_region&synonymous:LOW:exon14/23:c.1335A>G:p.Glu445Glu,TSC1:NM_001162426.1:splice_region&synonymous:LOW:exon14/23:c.1332A>G:p.Glu444Glu,TSC1:NM_001162427.1:splice_region&synonymous:LOW:exon13/22:c.1182A>G:p.Glu394Glu		rs7862221	0.1386	0.136	0.1463	0.219						605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];	RCV000042015.2 [not provided]; RCV000118690.3 [other]; RCV000125625.1 [benign]; 		COSM3763712	0.0303	0.2803	0.6894	13	127	n/a	n/a
chr9	135786904	135786904	A	G	het		QUAL=7588;DP=317;AF=0.45;MQM=60;TRIO=HET,317,0.45,HET,190,0.51,WT,215,0.00	TSC1	missense	TSC1:NM_000368.4:missense:MODERATE:exon10/23:c.965T>C:p.Met322Thr,TSC1:NM_001162426.1:missense:MODERATE:exon10/23:c.965T>C:p.Met322Thr,TSC1:NM_001162427.1:missense:MODERATE:exon9/22:c.812T>C:p.Met271Thr		rs1073123	0.1352	0.129	0.1378	0.2195	1.3780	P	T	B,B,B,B,B,B	B,B,B,B,B,B	605284 [TSC1 (confirmed) Tuberous sclerosis-1|Lymphangioleiomyomatosis|Focal cortical dysplasia,Taylor balloon cell type];	RCV000034613.4 [benign]; RCV000054853.1 [not provided]; RCV000054992.1 [not provided]; RCV000054997.1 [not provided]; RCV000054997.1 [not provided]; RCV000118695.4 [other]; 	CM131323 [CLASS=DP MUT=ALT PHEN="Respiratory disease, aspirin-exacerbated, association with" GENE=TSC1]; 	COSM3763713	0.0303	0.2727	0.697	13	119	n/a	n/a
chr9	135974079	135974079	G	C	het		QUAL=14185;DP=227;AF=0.41;MQM=60;TRIO=HET,227,0.41,HOM,199,1.00,HET,322,0.46	RALGDS	synonymous	RALGDS:NM_006266.3:synonymous:LOW:exon18/18:c.2640C>G:p.Leu880Leu,RALGDS:NM_001271776.1:synonymous:LOW:exon18/18:c.2604C>G:p.Leu868Leu,RALGDS:NM_001271775.1:synonymous:LOW:exon18/18:c.2637C>G:p.Leu879Leu,RALGDS:NM_001271774.1:synonymous:LOW:exon18/18:c.2553C>G:p.Leu851Leu,RALGDS:NM_001042368.2:synonymous:LOW:exon18/18:c.2475C>G:p.Leu825Leu		rs1062356	0.8275	0.841	0.8529	0.8559										0.8182	0.1818	0	330	115	n/a	n/a
chr9	135974100	135974100	G	A	het		QUAL=6146;DP=213;AF=0.40;MQM=60;TRIO=HET,213,0.40,HET,214,0.51,WT,334,0.00	RALGDS	synonymous	RALGDS:NM_006266.3:synonymous:LOW:exon18/18:c.2619C>T:p.Thr873Thr,RALGDS:NM_001271776.1:synonymous:LOW:exon18/18:c.2583C>T:p.Thr861Thr,RALGDS:NM_001271775.1:synonymous:LOW:exon18/18:c.2616C>T:p.Thr872Thr,RALGDS:NM_001271774.1:synonymous:LOW:exon18/18:c.2532C>T:p.Thr844Thr,RALGDS:NM_001042368.2:synonymous:LOW:exon18/18:c.2454C>T:p.Thr818Thr		rs886017	0.4916	0.542	0.5295	0.2932										0.3788	0.4167	0.2045	132	229	n/a	n/a
chr9	135985796	135985796	C	T	het		QUAL=4847;DP=149;AF=0.49;MQM=60;TRIO=HET,149,0.49,HET,199,0.48,WT,270,0.00	RALGDS	synonymous	RALGDS:NM_006266.3:synonymous:LOW:exon3/18:c.375G>A:p.Val125Val,RALGDS:NM_001271776.1:synonymous:LOW:exon3/18:c.375G>A:p.Val125Val,RALGDS:NM_001271775.1:synonymous:LOW:exon3/18:c.372G>A:p.Val124Val,RALGDS:NM_001271774.1:synonymous:LOW:exon3/18:c.324G>A:p.Val108Val,RALGDS:NM_001042368.2:synonymous:LOW:exon3/18:c.210G>A:p.Val70Val		rs3761824	0.2486	0.284	0.308	0.156									COSM4163478	0.1136	0.4242	0.4621	42	199	n/a	n/a
chr9	136223366	136223366	G	A	hom		QUAL=175;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HOM,1,1.00,HOM,2,1.00					rs523304	0.512	0.379	0	0							RCV000128344.1 [benign]; 			0	0.0076	0.9924	1	1	n/a	n/a
chr9	136291063	136291063	C	T	hom		QUAL=31731;DP=321;AF=1.00;MQM=59;TRIO=HOM,321,1.00,HOM,319,0.99,HOM,382,1.00	ADAMTS13	synonymous	ADAMTS13:NM_139025.4:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala,ADAMTS13:NM_139026.4:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala,ADAMTS13:NM_139027.4:synonymous:LOW:exon5/29:c.420C>T:p.Ala140Ala		rs3118667	0.5819	0.55	0.5336	0.483						604134 [ADAMTS13 (provisional) Thrombotic thrombocytopenic purpura,familial];			COSM1460807	0.3561	0.4545	0.1894	145	215	n/a	n/a
chr9	136304497	136304497	A	G	hom		QUAL=31621;DP=265;AF=1.00;MQM=59;TRIO=HOM,265,1.00,HOM,333,1.00,HOM,387,1.00	ADAMTS13	synonymous	ADAMTS13:NM_139025.4:synonymous:LOW:exon15/29:c.1716A>G:p.Thr572Thr,ADAMTS13:NM_139026.4:synonymous:LOW:exon15/29:c.1623A>G:p.Thr541Thr,ADAMTS13:NM_139027.4:synonymous:LOW:exon15/29:c.1716A>G:p.Thr572Thr		rs3124768	0.516	0.472	0.4449	0.3579						604134 [ADAMTS13 (provisional) Thrombotic thrombocytopenic purpura,familial];		CM1213383 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=ADAMTS13]; 	COSM4163494	0.2652	0.4621	0.2727	110	216	n/a	n/a
chr9	136412170	136412170	C	T	hom		QUAL=24579;DP=133;AF=1.00;MQM=60;TRIO=HOM,133,1.00,HET,369,0.54,HOM,475,1.00	ADAMTSL2	synonymous	ADAMTSL2:NM_001145320.1:synonymous:LOW:exon9/19:c.774C>T:p.Asp258Asp,ADAMTSL2:NM_014694.3:synonymous:LOW:exon9/19:c.774C>T:p.Asp258Asp		rs2073874	0.724	0.819	0.9169	0.7944						612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1];				0.7348	0.2424	0.0227	352	94	n/a	n/a
chr9	136412236	136412236	A	T	hom		QUAL=38023;DP=296;AF=0.99;MQM=59;TRIO=HOM,296,0.99,HET,514,0.50,HOM,633,1.00	ADAMTSL2	synonymous	ADAMTSL2:NM_001145320.1:synonymous:LOW:exon9/19:c.840A>T:p.Ala280Ala,ADAMTSL2:NM_014694.3:synonymous:LOW:exon9/19:c.840A>T:p.Ala280Ala		rs2073875	0.7246	0.819	0.9172	0.7941						612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1];				0.7348	0.2424	0.0227	353	95	n/a	n/a
chr9	136412255	136412255	A	C	hom		QUAL=37860;DP=271;AF=1.00;MQM=59;TRIO=HOM,271,1.00,HET,514,0.52,HOM,636,1.00	ADAMTSL2	synonymous	ADAMTSL2:NM_001145320.1:synonymous:LOW:exon9/19:c.859A>C:p.Arg287Arg,ADAMTSL2:NM_014694.3:synonymous:LOW:exon9/19:c.859A>C:p.Arg287Arg		rs2073876	0.7246	0.819	0.9172	0.7944						612277 [ADAMTSL2 (provisional) Geleophysic dysplasia 1];				0.7348	0.2424	0.0227	353	95	n/a	n/a
chr9	136440144	136440144	G	A	hom		QUAL=5383;DP=63;AF=1.00;MQM=46;TRIO=HOM,63,1.00,HET,75,0.37,HOM,91,0.99	ADAMTSL2	3'UTR	ADAMTSL2:NM_001145320.1:3'UTR:MODIFIER:exon19/19:c.*158G>A:,ADAMTSL2:NM_014694.3:3'UTR:MODIFIER:exon19/19:c.*158G>A:		rs1105952	0.4637	0	0	0										0.2955	0.447	0.2576	43	68	n/a	n/a
chr9	139323201	139323201	A	G	het		QUAL=6905;DP=249;AF=0.57;MQM=60;TRIO=HET,249,0.57,HET,136,0.57,WT,159,0.00	INPP5E	3'UTR	INPP5E:NM_019892.4:3'UTR:MODIFIER:exon10/10:c.*926T>C:		rs1128877	0.1278	0	0	0										0.0152	0.25	0.7348	2	37	n/a	n/a
chr9	139323311	139323311	T	C	het		QUAL=12280;DP=181;AF=0.61;MQM=59;TRIO=HET,181,0.61,HOM,187,0.99,HET,233,0.48	INPP5E	3'UTR	INPP5E:NM_019892.4:3'UTR:MODIFIER:exon10/10:c.*816A>G:		rs8413	0.3658	0	0	0										0.2045	0.4924	0.303	31	74	n/a	n/a
chr9	139323424	139323424	T	C	het		QUAL=9444;DP=155;AF=0.55;MQM=59;TRIO=HET,155,0.55,HOM,138,0.98,HET,144,0.51	INPP5E	3'UTR	INPP5E:NM_019892.4:3'UTR:MODIFIER:exon10/10:c.*703A>G:		rs1128874	0.3776	0	0	0										0.2273	0.4773	0.2955	34	72	n/a	n/a
chr9	139323497	139323497	C	T	het		QUAL=4020;DP=128;AF=0.48;MQM=59;TRIO=HET,128,0.48,HET,125,0.57,WT,140,0.00	INPP5E	3'UTR	INPP5E:NM_019892.4:3'UTR:MODIFIER:exon10/10:c.*630G>A:		rs539039743	0.0004	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr9	139323799	139323799	A	G	het		QUAL=10608;DP=129;AF=0.58;MQM=59;TRIO=HET,129,0.58,HOM,181,0.99,HET,220,0.44	INPP5E	3'UTR	INPP5E:NM_019892.4:3'UTR:MODIFIER:exon10/10:c.*328T>C:		rs35763810	0.3828	0	0	0										0.2197	0.4848	0.2955	32	74	n/a	n/a
chr9	139324740	139324740	C	T	het		QUAL=4597;DP=102;AF=0.56;MQM=60;TRIO=HET,102,0.56,HET,195,0.51,WT,273,0.00	INPP5E	synonymous	INPP5E:NM_019892.4:synonymous:LOW:exon9/10:c.1791G>A:p.Pro597Pro		rs10870182	0.1284	0.075	0.1239	0.0492						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117270.1,RCV000117269.2 [benign,likely benign]; RCV000125420.1 [benign]; 			0.0152	0.25	0.7348	19	248	n/a	n/a
chr9	139326304	139326304	G	A	het		QUAL=1001;DP=36;AF=0.36;MQM=59;TRIO=HET,36,0.36,HET,54,0.52,WT,55,0.00	INPP5E	synonymous	INPP5E:NM_019892.4:synonymous:LOW:exon7/10:c.1521C>T:p.His507His		rs10870188	0.1214	0.135	0.1334	0.0383						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117267.2 [likely benign]; RCV000125424.1 [benign]; 		COSM1162712	0.0152	0.25	0.7348	20	244	n/a	n/a
chr9	139327034	139327034	A	G	het		QUAL=8379;DP=100;AF=0.55;MQM=59;TRIO=HET,100,0.55,HOM,131,1.00,HET,143,0.61	INPP5E	synonymous	INPP5E:NM_019892.4:synonymous:LOW:exon6/10:c.1284T>C:p.Gly428Gly		rs10870194	0.3778	0.258	0.4253	0.3724						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117265.2 [likely benign]; 		COSM3722170	0.2273	0.4773	0.2955	205	537	n/a	n/a
chr9	139327439	139327439	A	G	het		QUAL=35703;DP=265;AF=0.52;MQM=59;TRIO=HET,265,0.52,HOM,653,0.99,HET,829,0.42	INPP5E	synonymous	INPP5E:NM_019892.4:synonymous:LOW:exon5/10:c.1248T>C:p.Thr416Thr		rs10781542	0.3784	0.414	0.4562	0.3967						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117264.2 [likely benign]; 			0.2273	0.4773	0.2955	208	549	n/a	n/a
chr9	139328551	139328551	T	C	het		QUAL=2949;DP=88;AF=0.50;MQM=60;TRIO=HET,88,0.50,HET,128,0.41,WT,163,0.00	INPP5E	synonymous	INPP5E:NM_019892.4:synonymous:LOW:exon3/10:c.972A>G:p.Pro324Pro		rs10870199	0.1238	0.137	0.1365	0.0307						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];	RCV000117276.2 [likely benign]; RCV000125422.1 [benign]; 		COSM3763772	0.0152	0.2576	0.7273	19	253	n/a	n/a
chr9	139333053	139333053	T	G	het		QUAL=84;DP=4;AF=0.50;MQM=60;TRIO=HET,4,0.50,HET,5,0.80,WT,2,0.00	INPP5E	splice_region&intron	INPP5E:NM_019892.4:splice_region&intron:LOW:exon1/9:c.812+7A>C:			0	0	0	0						613037 [INPP5E (provisional) Mental retardation,truncal obesity,retinal dystrophy,and micropenis|Joubert syndrome 1];				0.0076	0.0682	0.9242	3	24	n/a	n/a
chr9	139726239	139726239	A	G	hom		QUAL=26218;DP=195;AF=1.00;MQM=59;TRIO=HOM,195,1.00,HOM,273,1.00,HOM,354,1.00	RABL6	synonymous	RABL6:NM_001173988.1:synonymous:LOW:exon6/15:c.525A>G:p.Gly175Gly,RABL6:NM_001173989.2:synonymous:LOW:exon6/8:c.525A>G:p.Gly175Gly,RABL6:NM_024718.4:synonymous:LOW:exon6/15:c.525A>G:p.Gly175Gly		rs2811748	0.8167	0.847	0.8641	0.8897	-1.1310	P							COSM4163584	0.7727	0.197	0.0303	342	101	n/a	n/a
chr9	139731969	139731969	C	T	hom		QUAL=838;DP=5;AF=1.00;MQM=57;TRIO=HOM,5,1.00,HOM,12,1.00,HOM,13,1.00	RABL6	synonymous	RABL6:NM_001173988.1:synonymous:LOW:exon9/15:c.984C>T:p.Ala328Ala,RABL6:NM_024718.4:synonymous:LOW:exon9/15:c.981C>T:p.Ala327Ala		rs2811742	0.7666	0.727	0.8229	0.7522									COSM455621	0.5379	0.1212	0.3409	262	87	n/a	n/a
chr9	139732331	139732331	G	C	hom		QUAL=12733;DP=94;AF=1.00;MQM=59;TRIO=HOM,94,1.00,HOM,152,1.00,HOM,180,1.00	RABL6	missense	RABL6:NM_001173988.1:missense:MODERATE:exon10/15:c.1147G>C:p.Glu383Gln,RABL6:NM_024718.4:missense:MODERATE:exon10/15:c.1144G>C:p.Glu382Gln		rs2811741	0.8055	0.727	0.8207	0.8258	3.6890	P	T	D,D,D	D,D,P					0.6742	0.2879	0.0379	303	138	n/a	n/a
chr9	139981627	139981627	A	G	hom		QUAL=17934;DP=54;AF=1.00;MQM=60;TRIO=HOM,54,1.00,HOM,226,1.00,HOM,310,1.00	MAN1B1	missense	MAN1B1:NM_016219.4:missense:MODERATE:exon1/13:c.176A>G:p.Asn59Ser		rs968733	0.9054	0.97	0.9974	0.7518	0.9110	P	T	B	B	604346 [MAN1B1 (provisional) Mental retardation,autosomal recessive 15];	RCV000117582.2 [likely benign]; 		COSM4163617	1	0	0	467	3	n/a	n/a
chr9	140002989	140002989	T	C	hom		QUAL=21358;DP=151;AF=0.99;MQM=59;TRIO=HOM,151,0.99,HOM,341,1.00,HET,438,0.43	MAN1B1	synonymous	MAN1B1:NM_016219.4:synonymous:LOW:exon13/13:c.2046T>C:p.Asp682Asp		rs4880091	0.8099	0.766	0.7555	0.9435	1.0730	P,P				604346 [MAN1B1 (provisional) Mental retardation,autosomal recessive 15];	RCV000117585.2 [likely benign]; 		COSM4138895	0.6136	0.3106	0.0758	260	163	n/a	n/a
chr9	140003427	140003427	A	G	hom		QUAL=9070;DP=134;AF=0.99;MQM=59;TRIO=HOM,134,0.99,HOM,102,1.00,HET,105,0.49	MAN1B1	3'UTR	MAN1B1:NM_016219.4:3'UTR:MODIFIER:exon13/13:c.*384A>G:		rs4567	0.5519	0.43	0	0	-3.1640	P						CR094058 [CLASS=DFP MUT=REF PHEN="End-stage liver disease, early onset, association with" GENE=MAN1B1]; 		0.2424	0.4773	0.2803	65	150	n/a	n/a
chr9	140003640	140003640	G	A	hom		QUAL=15921;DP=184;AF=0.98;MQM=60;TRIO=HOM,184,0.98,HOM,208,1.00,HET,243,0.53					rs7853336	0.404	0.252	0	0										0.0682	0.3485	0.5833	17	116	n/a	n/a
chr9	140729844	140729844	G	C	het		QUAL=5192;DP=185;AF=0.45;MQM=60;TRIO=HET,185,0.45,HET,161,0.52,WT,236,0.00	EHMT1	3'UTR	EHMT1:NM_024757.4:3'UTR:MODIFIER:exon27/27:c.*439G>C:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr10	6053374	6053374	A	G	het		QUAL=28457;DP=556;AF=0.50;MQM=59;TRIO=HET,556,0.50,HOM,618,0.99,WT,816,0.00	IL2RA	3'UTR	IL2RA:NM_000417.2:3'UTR:MODIFIER:exon8/8:c.*1461T>C:	MER5A	rs12244380	0.3548	0	0	0										0.1667	0.5152	0.3182	24	76	n/a	n/a
chr10	6053568	6053568	C	T	hom		QUAL=30937;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HET,385,0.45,HOM,492,1.00	IL2RA	3'UTR	IL2RA:NM_000417.2:3'UTR:MODIFIER:exon8/8:c.*1267G>A:	AluJr	rs1570538	0.376	0	0	0										0.2197	0.5833	0.197	36	84	n/a	n/a
chr10	6066200	6066200	C	G	hom		QUAL=14237;DP=101;AF=1.00;MQM=60;TRIO=HOM,101,1.00,HET,312,0.50,HET,397,0.50	IL2RA	splice_region&intron	IL2RA:NM_000417.2:splice_region&intron:LOW:exon3/7:c.367+7G>C:		rs11256369	0.1793	0.212	0.2227	0.0831						147730 [IL2RA (confirmed) Interleukin-2 receptor,alpha chain,deficiency of|Diabetes,mellitus,insulin-dependent,susceptibility to,10];				0.0455	0.3182	0.6364	24	146	n/a	n/a
chr10	14949856	14949856	C	T	het		QUAL=825;DP=56;AF=0.59;MQM=42;TRIO=HET,56,0.59,HET,35,0.17,HET,53,0.26	DCLRE1C	3'UTR	DCLRE1C:NM_001033855.2:3'UTR:MODIFIER:exon14/14:c.*551G>A:,DCLRE1C:NM_001033857.2:3'UTR:MODIFIER:exon15/15:c.*551G>A:,DCLRE1C:NM_001033858.2:3'UTR:MODIFIER:exon16/16:c.*551G>A:,DCLRE1C:NM_001289076.1:3'UTR:MODIFIER:exon12/12:c.*551G>A:,DCLRE1C:NM_001289077.1:3'UTR:MODIFIER:exon15/15:c.*551G>A:,DCLRE1C:NM_001289078.1:3'UTR:MODIFIER:exon12/12:c.*551G>A:,DCLRE1C:NM_001289079.1:3'UTR:MODIFIER:exon16/16:c.*551G>A:,DCLRE1C:NM_022487.3:3'UTR:MODIFIER:exon13/13:c.*551G>A:	AluSp	rs373280996	0	0	0	0						605988 [DCLRE1C (confirmed) Severe combined immunodeficiency,Athabascan type|Omenn syndrome];				0	0.3258	0.6742	0	45	n/a	n/a
chr10	26993598	26993598	T	-	het		QUAL=2961;DP=82;AF=0.46;MQM=60;TRIO=HET,82,0.46,HOM,31,1.00,HET,43,0.58	PDSS1	splice_region&intron	PDSS1:NM_014317.3:splice_region&intron:LOW:exon2/11:c.163-8delT:		rs34296355	0.2374	0.304	0.3479	0.0994						607429 [PDSS1 (provisional) Coenzyme Q10 deficiency,primary,2];				0.1439	0.4545	0.4015	150	496	n/a	n/a
chr10	38344700	38344700	C	G	het		QUAL=19197;DP=368;AF=0.49;MQM=57;TRIO=HET,368,0.49,HET,347,0.50,HET,420,0.55	ZNF33A	missense	ZNF33A:NM_001278177.1:missense:MODERATE:exon5/5:c.1711C>G:p.Gln571Glu,ZNF33A:NM_001278170.1:missense:MODERATE:exon4/4:c.1666C>G:p.Gln556Glu,ZNF33A:NM_001278171.1:missense:MODERATE:exon6/6:c.1312C>G:p.Gln438Glu,ZNF33A:NM_001278173.1:missense:MODERATE:exon6/6:c.1702C>G:p.Gln568Glu,ZNF33A:NM_001278174.1:missense:MODERATE:exon6/6:c.1312C>G:p.Gln438Glu,ZNF33A:NM_001278175.1:missense:MODERATE:exon6/6:c.1414C>G:p.Gln472Glu,ZNF33A:NM_001278176.1:missense:MODERATE:exon6/6:c.1519C>G:p.Gln507Glu,ZNF33A:NM_001278178.1:missense:MODERATE:exon5/5:c.1312C>G:p.Gln438Glu,ZNF33A:NM_001278179.1:missense:MODERATE:exon6/6:c.1312C>G:p.Gln438Glu,ZNF33A:NM_006954.1:missense:MODERATE:exon5/5:c.1648C>G:p.Gln550Glu,ZNF33A:NM_006974.2:missense:MODERATE:exon5/5:c.1645C>G:p.Gln549Glu		rs2505232	0.477	0.446	0.4771	0.5148	4.3420	P	T	B,B,B	B,B,B					0.2652	0.4697	0.2652	83	149	n/a	n/a
chr10	38346092	38346092	C	T	het		QUAL=7556;DP=299;AF=0.50;MQM=60;TRIO=HET,299,0.50,HET,153,0.52,WT,213,0.00	ZNF33A	3'UTR	ZNF33A:NM_001278177.1:3'UTR:MODIFIER:exon5/5:c.*604C>T:,ZNF33A:NM_001278170.1:3'UTR:MODIFIER:exon4/4:c.*604C>T:,ZNF33A:NM_001278171.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278173.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278174.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278175.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278176.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_001278178.1:3'UTR:MODIFIER:exon5/5:c.*604C>T:,ZNF33A:NM_001278179.1:3'UTR:MODIFIER:exon6/6:c.*604C>T:,ZNF33A:NM_006954.1:3'UTR:MODIFIER:exon5/5:c.*604C>T:,ZNF33A:NM_006974.2:3'UTR:MODIFIER:exon5/5:c.*604C>T:		rs2142349	0.0128	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr10	43595968	43595968	A	G	het		QUAL=1731;DP=29;AF=0.48;MQM=60;TRIO=HET,29,0.48,HET,71,0.68,WT,96,0.00	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon2/20:c.135A>G:p.Ala45Ala,RET:NM_020630.4:synonymous:LOW:exon2/19:c.135A>G:p.Ala45Ala		rs1800858	0.7536	0.736	0.7394	0.9453						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000014967.1 [other]; RCV000127776.1,RCV000153833.2 [benign,benign]; 	CM020759 [CLASS=DP MUT=REF PHEN="Hirschsprung disease, association with" GENE=RET]; 	COSM4144678	0.5379	0.3636	0.0985	550	377	1	n/a
chr10	43606687	43606687	A	G	hom		QUAL=9809;DP=66;AF=1.00;MQM=60;TRIO=HOM,66,1.00,HOM,127,0.98,HOM,128,1.00	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon7/20:c.1296A>G:p.Ala432Ala,RET:NM_020630.4:synonymous:LOW:exon7/19:c.1296A>G:p.Ala432Ala		rs1800860	0.7752	0.706	0.6902	0.8625						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000082048.2 [benign]; RCV000127778.1 [benign]; RCV000131068.1 [benign]; 	CM033447 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease, association with" GENE=RET]; 		0.5379	0.4167	0.0455	494	429	n/a	n/a
chr10	43613843	43613843	G	T	het		QUAL=7111;DP=182;AF=0.48;MQM=60;TRIO=HET,182,0.48,HOM,92,1.00,HET,110,0.46	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:NM_020630.4:synonymous:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.742	0.7653	0.8754						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000021844.1 [benign]; RCV000127779.1 [benign]; RCV000154625.1,RCV000153835.2 [benign,benign]; 	CM014825 [CLASS=DP MUT=REF PHEN="Hirschsprung disease, association with" GENE=RET]; 		0.553	0.3485	0.0985	580	402	n/a	n/a
chr10	43622217	43622217	T	C	het		QUAL=12543;DP=196;AF=0.57;MQM=59;TRIO=HET,196,0.57,HOM,157,1.00,HET,255,0.49	RET	3'UTR,intron	RET:NM_020630.4:3'UTR:MODIFIER:exon19/19:c.*15T>C:,RET:NM_020975.4:intron:MODIFIER:exon19/19:c.3187+47T>C:		rs2075912	0.755	0.787	0.8253	0.908						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000151742.1 [benign]; 	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease, association with" GENE=RET]; 		0.6515	0.303	0.0455	113	54	n/a	n/a
chr10	43622368	43622368	T	A	het		QUAL=5016;DP=160;AF=0.50;MQM=60;TRIO=HET,160,0.50,HOM,52,1.00,HET,59,0.41	RET	3'UTR,intron	RET:NM_020630.4:3'UTR:MODIFIER:exon19/19:c.*166T>A:,RET:NM_020975.4:intron:MODIFIER:exon19/19:c.3187+198T>A:		rs2075913	0.6607	0	0	0						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];				0.5606	0.3409	0.0985	84	52	n/a	n/a
chr10	43622933	43622933	T	C	het		QUAL=29544;DP=408;AF=0.50;MQM=60;TRIO=HET,408,0.50,HOM,438,1.00,HET,524,0.52	RET	3'UTR,intron	RET:NM_020630.4:3'UTR:MODIFIER:exon19/19:c.*731T>C:,RET:NM_020975.4:intron:MODIFIER:exon19/19:c.3188-627T>C:		rs2565200	0.7654	0	0	0						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];				0.6515	0.303	0.0455	99	43	n/a	n/a
chr10	43623812	43623812	C	T	het		QUAL=14578;DP=293;AF=0.51;MQM=60;TRIO=HET,293,0.51,HOM,190,1.00,HET,232,0.47	RET	3'UTR	RET:NM_020975.4:3'UTR:MODIFIER:exon20/20:c.*95C>T:		rs17028	0.1366	0	0	0										0.0303	0.3561	0.6136	4	54	n/a	n/a
chr10	43624317	43624317	A	T	het		QUAL=7128;DP=179;AF=0.46;MQM=60;TRIO=HET,179,0.46,HOM,81,1.00,HET,114,0.50	RET	3'UTR	RET:NM_020975.4:3'UTR:MODIFIER:exon20/20:c.*600A>T:		rs2742240	0.7524	0	0	0										0.6439	0.3106	0.0455	98	45	n/a	n/a
chr10	43624833	43624833	T	C	het		QUAL=21821;DP=360;AF=0.48;MQM=60;TRIO=HET,360,0.48,HOM,345,0.99,HET,337,0.47	RET	3'UTR	RET:NM_020975.4:3'UTR:MODIFIER:exon20/20:c.*1116T>C:		rs2435355	0.1899	0	0	0										0.0606	0.3712	0.5682	8	58	n/a	n/a
chr10	43625223	43625223	G	A	het		QUAL=20283;DP=412;AF=0.53;MQM=60;TRIO=HET,412,0.53,HOM,223,1.00,HET,388,0.46	RET	3'UTR	RET:NM_020975.4:3'UTR:MODIFIER:exon20/20:c.*1506G>A:		rs2742241	0.7472	0	0	0								CR032442 [CLASS=DP MUT=REF PHEN="Hirschsprung disease, association with" GENE=RET]; 		0.6439	0.3106	0.0455	98	45	n/a	n/a
chr10	50664895	50664897	AAT	-	het		QUAL=7170;DP=283;AF=0.46;MQM=60;TRIO=HET,283,0.46,HET,263,0.43,WT,338,0.00	ERCC6	3'UTR	ERCC6:NM_000124.3:3'UTR:MODIFIER:exon21/21:c.*1964_*1966delATT:		rs147228327	0.0349	0	0	0										0.0303	0.1515	0.8182	5	20	n/a	n/a
chr10	50667105	50667105	T	C	het		QUAL=17168;DP=238;AF=0.50;MQM=60;TRIO=HET,238,0.50,HET,228,0.50,HOM,298,1.00	ERCC6	missense	ERCC6:NM_000124.3:missense:MODERATE:exon21/21:c.4238A>G:p.Gln1413Arg		rs2228529	0.1789	0.218	0.2167	0.1353	0.1010	P	T	B	B	609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000117001.2 [likely benign]; 		COSM427630	0.0682	0.3409	0.5909	28	161	n/a	n/a
chr10	50678369	50678369	T	C	het		QUAL=13713;DP=229;AF=0.56;MQM=59;TRIO=HET,229,0.56,HET,199,0.49,HOM,207,0.99	ERCC6	missense	ERCC6:NM_000124.3:missense:MODERATE:exon18/21:c.3637A>G:p.Arg1213Gly		rs2228527	0.1847	0.22	0.2174	0.1562	1.7160	P	T	P	B	609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000116998.2 [likely benign]; 	CM980633 [CLASS=DP MUT=ALT PHEN="Colorectal cancer, increased risk, association with" GENE=ERCC6]; 	COSM3751836	0.0682	0.3409	0.5909	31	159	n/a	n/a
chr10	50678717	50678717	T	C	het		QUAL=31544;DP=469;AF=0.49;MQM=60;TRIO=HET,469,0.49,HET,353,0.59,HOM,521,1.00	ERCC6	missense	ERCC6:NM_000124.3:missense:MODERATE:exon18/21:c.3289A>G:p.Met1097Val		rs2228526	0.1825	0.219	0.2167	0.1405	-0.2110	P	T	B	B	609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000116997.2 [likely benign]; 	CM076169 [CLASS=DP MUT=ALT PHEN="Reduced chromosomal damage in coke oven workers, association with" GENE=ERCC6]; 	COSM3751837	0.0682	0.3409	0.5909	29	160	n/a	n/a
chr10	50701156	50701156	G	A	het		QUAL=11516;DP=204;AF=0.49;MQM=60;TRIO=HET,204,0.49,HET,146,0.49,HOM,190,1.00	ERCC6	splice_region&intron	ERCC6:NM_000124.3:splice_region&intron:LOW:exon8/20:c.1821+7C>T:		rs4253132	0.877	0.888	0.8819	0.7354						609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];				0.75	0.2197	0.0303	349	92	n/a	n/a
chr10	50740876	50740876	G	C	het		QUAL=14214;DP=166;AF=0.49;MQM=60;TRIO=HET,166,0.49,HET,226,0.47,HOM,276,1.00	ERCC6,ERCC6-PGBD3	synonymous	ERCC6:NM_000124.3:synonymous:LOW:exon2/21:c.135C>G:p.Leu45Leu,ERCC6-PGBD3:NM_001277058.1:synonymous:LOW:exon2/6:c.135C>G:p.Leu45Leu,ERCC6-PGBD3:NM_001277059.1:synonymous:LOW:exon2/6:c.135C>G:p.Leu45Leu		rs2228524	0.5909	0.694	0.7419	0.4044						609413 [ERCC6 (confirmed) Cockayne syndrome,type B|Cerebrooculofacioskeletal syndrome 1|De Sanctis-Cacchione syndrome|Macular degeneration,age-related,susceptibility to 5|UV-sensitive syndrome 1|Lung cancer,susceptibility to];	RCV000116995.2 [likely benign]; 			0.6136	0.303	0.0833	255	158	n/a	n/a
chr10	50821191	50821191	G	T	het		QUAL=13264;DP=238;AF=0.47;MQM=60;TRIO=HET,238,0.47,HET,282,0.53,HET,323,0.49	CHAT	5'UTR,intron	CHAT:NM_020985.3:5'UTR:MODIFIER:exon1/16:c.-298G>T:,CHAT:NM_020986.3:5'UTR:MODIFIER:exon1/15:c.-126G>T:,CHAT:NM_020984.3:intron:MODIFIER:exon1/14:c.-68-3357G>T:		rs3729496	0.4307	0	0	0										0.5	0.4318	0.0682	77	63	n/a	n/a
chr10	50863147	50863147	T	C	hom		QUAL=14306;DP=218;AF=1.00;MQM=59;TRIO=HOM,218,1.00,HOM,118,1.00,HOM,128,1.00	CHAT	synonymous	CHAT:NM_020549.4:synonymous:LOW:exon12/15:c.1641T>C:p.His547His,CHAT:NM_020984.3:synonymous:LOW:exon12/15:c.1287T>C:p.His429His,CHAT:NM_020985.3:synonymous:LOW:exon13/16:c.1287T>C:p.His429His,CHAT:NM_020986.3:synonymous:LOW:exon12/15:c.1287T>C:p.His429His,CHAT:NM_001142929.1:synonymous:LOW:exon12/15:c.1287T>C:p.His429His,CHAT:NM_001142933.1:synonymous:LOW:exon13/16:c.1395T>C:p.His465His,CHAT:NM_001142934.1:synonymous:LOW:exon13/16:c.1287T>C:p.His429His		rs8178992	0.7935	0.849	0.9117	0.6995						118490 [CHAT (confirmed) Myasthenic syndrome,congenital,associated with episodic apnea];	RCV000116692.1 [benign]; 		COSM4144746	0.7727	0.2045	0.0227	366	78	n/a	n/a
chr10	64572038	64572038	T	-	hom		QUAL=15677;DP=169;AF=1.00;MQM=60;TRIO=HOM,169,1.00,HOM,156,1.00,HOM,174,1.00	EGR2	3'UTR	EGR2:NM_000399.3:3'UTR:MODIFIER:exon2/2:c.*929delA:,EGR2:NM_001136177.1:3'UTR:MODIFIER:exon3/3:c.*929delA:,EGR2:NM_001136179.1:3'UTR:MODIFIER:exon3/3:c.*929delA:,EGR2:NM_001136178.1:3'UTR:MODIFIER:exon4/4:c.*929delA:		rs398013782	0.9944	0	0	0										1	0	0	150	0	n/a	n/a
chr10	64573771	64573771	C	T	hom		QUAL=35714;DP=163;AF=1.00;MQM=59;TRIO=HOM,163,1.00,HOM,460,1.00,HOM,553,1.00	EGR2	synonymous	EGR2:NM_000399.3:synonymous:LOW:exon2/2:c.627G>A:p.Pro209Pro,EGR2:NM_001136177.1:synonymous:LOW:exon3/3:c.627G>A:p.Pro209Pro,EGR2:NM_001136179.1:synonymous:LOW:exon3/3:c.477G>A:p.Pro159Pro,EGR2:NM_001136178.1:synonymous:LOW:exon4/4:c.627G>A:p.Pro209Pro		rs224083	0.986	0.995	0.9998	0.9478						129010 [EGR2 (provisional) Neuropathy,congenital hypomyelinating,1|Charcot-Marie-Tooth disease,type 1D|Dejerine-Sottas disease];				1	0	0	454	0	n/a	n/a
chr10	70748784	70748784	G	A	het		QUAL=8502;DP=170;AF=0.46;MQM=59;TRIO=HET,170,0.46,HET,185,0.49,HET,250,0.48	KIAA1279	missense	KIAA1279:NM_015634.3:missense:MODERATE:exon1/7:c.196G>A:p.Gly66Ser		rs2255607	0.3538	0.41	0.4832	0.342	0.2110	P	T	B	B	609367 [KIAA1279 (provisional) Goldberg-Shprintzen megacolon syndrome];	RCV000146132.1 [benign]; 		COSM3751905	0.1667	0.5227	0.3106	94	225	n/a	n/a
chr10	70776594	70776594	A	C	het		QUAL=5824;DP=201;AF=0.54;MQM=60;TRIO=HET,201,0.54,HET,38,0.58,HET,76,0.59	KIAA1279	3'UTR	KIAA1279:NM_015634.3:3'UTR:MODIFIER:exon7/7:c.*422A>C:		rs6864	0.3638	0	0	0										0.1667	0.5303	0.303	24	79	n/a	n/a
chr10	71332204	71332204	A	G	hom		QUAL=10567;DP=94;AF=1.00;MQM=59;TRIO=HOM,94,1.00,HOM,99,1.00,HOM,141,1.00	NEUROG3	missense	NEUROG3:NM_020999.3:missense:MODERATE:exon2/2:c.596T>C:p.Phe199Ser		rs4536103	0.4299	0.534	0.6787	0.3946	1.4960	P	T	B	B	604882 [NEUROG3 (provisional) Diarrhea 4,malabsorptive,congenital];	RCV000117780.2 [likely benign]; 	CM068025 [CLASS=DP MUT=ALT PHEN="Diabetes, type 2, association with" GENE=NEUROG3]; 	COSM3749111	0.4091	0.4242	0.1667	185	183	n/a	n/a
chr10	72357600	72357600	A	-	het		QUAL=3898;DP=99;AF=0.42;MQM=59;TRIO=HET,99,0.42,HET,98,0.65,HET,120,0.23	PRF1	3'UTR	PRF1:NM_001083116.1:3'UTR:MODIFIER:exon3/3:c.*208delT:,PRF1:NM_005041.4:3'UTR:MODIFIER:exon3/3:c.*208delT:	MER30		0	0	0	0										0.0379	0.3258	0.6364	5	45	n/a	n/a
chr10	72357713	72357713	C	T	hom		QUAL=37632;DP=515;AF=1.00;MQM=59;TRIO=HOM,515,1.00,HOM,291,0.99,HOM,402,1.00	PRF1	3'UTR	PRF1:NM_001083116.1:3'UTR:MODIFIER:exon3/3:c.*96G>A:,PRF1:NM_005041.4:3'UTR:MODIFIER:exon3/3:c.*96G>A:	MER30	rs1889490	0.5779	0	0	0										0.1515	0.3788	0.4697	20	61	n/a	n/a
chr10	72358577	72358577	G	A	hom		QUAL=27330;DP=191;AF=1.00;MQM=59;TRIO=HOM,191,1.00,HOM,309,1.00,HOM,395,1.00	PRF1	synonymous	PRF1:NM_001083116.1:synonymous:LOW:exon3/3:c.900C>T:p.His300His,PRF1:NM_005041.4:synonymous:LOW:exon3/3:c.900C>T:p.His300His		rs885822	0.6959	0.635	0.5943	0.7953						170280 [PRF1 (confirmed) Hemophagocytic lymphohistiocytosis,familial,2|Lymphoma,non-Hodgkin];			COSM3765513	0.2879	0.4394	0.2727	156	226	n/a	n/a
chr10	73270906	73270906	T	C	hom		QUAL=40370;DP=317;AF=0.99;MQM=60;TRIO=HOM,317,0.99,HOM,411,1.00,HOM,539,1.00	CDH23	synonymous	CDH23:NM_022124.5:synonymous:LOW:exon6/68:c.366T>C:p.Val122Val,CDH23:NM_001171932.1:synonymous:LOW:exon6/11:c.366T>C:p.Val122Val,CDH23:NM_052836.3:synonymous:LOW:exon6/13:c.366T>C:p.Val122Val,CDH23:NM_001171931.1:synonymous:LOW:exon6/25:c.366T>C:p.Val122Val,CDH23:NM_001171930.1:synonymous:LOW:exon6/31:c.366T>C:p.Val122Val		rs3802720	0.7346	0.672	0.6609	0.933						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000150270.1,RCV000039162.2 [benign,benign]; 		COSM4144827	0.4697	0.3788	0.1515	196	213	n/a	n/a
chr10	73377314	73377314	C	G	hom		QUAL=25104;DP=229;AF=1.00;MQM=60;TRIO=HOM,229,1.00,HOM,242,1.00,HOM,342,0.99	CDH23	3'UTR,intron	CDH23:NM_001171932.1:3'UTR:MODIFIER:exon11/11:c.*77C>G:,CDH23:NM_022124.5:intron:MODIFIER:exon11/67:c.1134+164C>G:,CDH23:NM_052836.3:intron:MODIFIER:exon11/12:c.1134+164C>G:,CDH23:NM_001171931.1:intron:MODIFIER:exon11/24:c.1134+164C>G:,CDH23:NM_001171930.1:intron:MODIFIER:exon11/30:c.1134+164C>G:	Charlie7a	rs7903772	0.5495	0	0	0						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];				0.5303	0.4091	0.0606	79	62	n/a	n/a
chr10	73406599	73406599	G	A	het		QUAL=12979;DP=204;AF=0.53;MQM=60;TRIO=HET,204,0.53,HET,241,0.49,HET,354,0.51	CDH23	3'UTR,intron	CDH23:NM_052836.3:3'UTR:MODIFIER:exon13/13:c.*81G>A:,CDH23:NM_022124.5:intron:MODIFIER:exon13/67:c.1449+225G>A:,CDH23:NM_001171931.1:intron:MODIFIER:exon13/24:c.1449+225G>A:,CDH23:NM_001171930.1:intron:MODIFIER:exon13/30:c.1449+225G>A:		rs2305210	0.2592	0	0	0						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];				0.0682	0.3182	0.6136	10	48	n/a	n/a
chr10	73406636	73406636	C	T	het		QUAL=9756;DP=208;AF=0.43;MQM=60;TRIO=HET,208,0.43,HET,194,0.48,HET,270,0.47	CDH23	3'UTR,intron	CDH23:NM_052836.3:3'UTR:MODIFIER:exon13/13:c.*118C>T:,CDH23:NM_022124.5:intron:MODIFIER:exon13/67:c.1449+262C>T:,CDH23:NM_001171931.1:intron:MODIFIER:exon13/24:c.1449+262C>T:,CDH23:NM_001171930.1:intron:MODIFIER:exon13/30:c.1449+262C>T:		rs11598249	0.2368	0	0	0						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];				0.1061	0.447	0.447	17	66	n/a	n/a
chr10	73407220	73407220	A	-	hom		QUAL=228;DP=11;AF=0.91;MQM=56;TRIO=HOM,11,0.91,HOM,1,1.00,NONE,0,0	CDH23	intron	CDH23:NM_022124.5:intron:MODIFIER:exon13/67:c.1449+846delA:,CDH23:NM_001171931.1:intron:MODIFIER:exon13/24:c.1449+846delA:,CDH23:NM_001171930.1:intron:MODIFIER:exon13/30:c.1449+846delA:	AluSz6	rs113373333	0.8317	0	0	0						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];				0.1439	0.0379	0.8182	22	6	n/a	n/a
chr10	73434906	73434906	G	A	hom		QUAL=26152;DP=384;AF=1.00;MQM=60;TRIO=HOM,384,1.00,HOM,252,0.99,HET,381,0.48	CDH23	missense	CDH23:NM_022124.5:missense:MODERATE:exon14/68:c.1487G>A:p.Ser496Asn,CDH23:NM_001171931.1:missense:MODERATE:exon14/25:c.1487G>A:p.Ser496Asn,CDH23:NM_001171930.1:missense:MODERATE:exon14/31:c.1487G>A:p.Ser496Asn		rs10999947	0.2524	0.272	0.2595	0.2304	0.4000	P	T	B,B,B	B,B,B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000039108.2 [benign]; 			0.0758	0.3636	0.5606	29	162	n/a	n/a
chr10	73492079	73492079	A	G	het		QUAL=20724;DP=193;AF=0.41;MQM=59;TRIO=HET,193,0.41,HET,347,0.54,HOM,395,1.00	CDH23,C10orf105	missense,intron	CDH23:NM_022124.5:missense:MODERATE:exon31/68:c.4051A>G:p.Asn1351Asp,CDH23:NM_001171930.1:missense:MODERATE:exon31/31:c.4051A>G:p.Asn1351Asp,C10orf105:NM_001168390.1:intron:MODIFIER:exon1/1:c.-6+5406T>C:		rs1227065	0.7821	0.794	0.8237	0.7911	7.6660	P	T	B	B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000154336.1,RCV000039171.4 [benign,benign]; 			0.6667	0.2955	0.0379	320	117	n/a	n/a
chr10	73501556	73501556	G	A	het		QUAL=26257;DP=331;AF=0.52;MQM=60;TRIO=HET,331,0.52,HET,383,0.52,HOM,488,1.00	CDH23	missense	CDH23:NM_022124.5:missense:MODERATE:exon36/68:c.4723G>A:p.Ala1575Thr		rs1227051	0.7288	0.767	0.796	0.6339	6.2020	P	T	B	B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000154337.1,RCV000039189.2 [benign,benign]; 			0.5833	0.3636	0.053	288	143	n/a	n/a
chr10	73537614	73537614	G	A	het		QUAL=1155;DP=45;AF=0.51;MQM=60;TRIO=HET,45,0.51,HET,40,0.43,WT,56,0.00	CDH23	missense	CDH23:NM_022124.5:missense:MODERATE:exon37/68:c.5023G>A:p.Val1675Ile		rs17712523	0.1322	0.178	0.1932	0.039	0.1020	P	T	B	B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000039194.2 [benign]; RCV000086975.1 [not provided]; 		COSM146951	0.053	0.2879	0.6591	19	137	n/a	n/a
chr10	73550117	73550117	C	G	het		QUAL=9293;DP=148;AF=0.43;MQM=60;TRIO=HET,148,0.43,HET,231,0.42,HET,310,0.44	CDH23	missense	CDH23:NM_022124.5:missense:MODERATE:exon44/68:c.5996C>G:p.Thr1999Ser		rs11592462	0.3452	0.426	0.4861	0.2702	1.6610	P	T	B	B	605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000039232.4 [benign]; 		COSM3751946	0.25	0.4621	0.2879	98	214	n/a	n/a
chr10	73569749	73569749	C	T	het		QUAL=12061;DP=242;AF=0.50;MQM=60;TRIO=HET,242,0.50,WT,453,0.00,HET,581,0.46	CDH23	synonymous	CDH23:NM_022124.5:synonymous:LOW:exon59/68:c.8895C>T:p.Pro2965Pro,CDH23:NM_001171933.1:synonymous:LOW:exon14/23:c.2175C>T:p.Pro725Pro,CDH23:NM_001171934.1:synonymous:LOW:exon14/22:c.2175C>T:p.Pro725Pro		rs11000009	0.0809	0.113	0.1274	0.0932						605516 [CDH23 (confirmed) Usher syndrome,type 1D|Deafness,autosomal recessive 12|Usher syndrome,type 1D/F digenic];	RCV000039294.3 [benign]; 			0.0227	0.25	0.7273	13	121	n/a	n/a
chr10	73575384	73575384	A	G	het		QUAL=13239;DP=175;AF=0.47;MQM=60;TRIO=HET,175,0.47,HOM,223,1.00,HET,242,0.54	CDH23	3'UTR	CDH23:NM_022124.5:3'UTR:MODIFIER:exon68/68:c.*349A>G:,CDH23:NM_001171933.1:3'UTR:MODIFIER:exon23/23:c.*349A>G:,CDH23:NM_001171934.1:3'UTR:MODIFIER:exon22/22:c.*349A>G:,CDH23:NM_001171935.1:3'UTR:MODIFIER:exon5/5:c.*349A>G:,CDH23:NM_001171936.1:3'UTR:MODIFIER:exon4/4:c.*349A>G:		rs1867978	0.7893	0	0	0										0.4924	0.447	0.0606	74	67	n/a	n/a
chr10	75009977	75009977	A	-	het		QUAL=367;DP=30;AF=0.30;MQM=53;TRIO=HET,30,0.30,HOM,4,1.00,HET,5,0.40	MRPS16	3'UTR	MRPS16:NM_016065.3:3'UTR:MODIFIER:exon3/3:c.*633delT:	AluY	rs555061429	0	0	0	0										0.0076	0.0606	0.9318	1	10	n/a	n/a
chr10	75936611	75936611	C	T	hom		QUAL=5486;DP=24;AF=1.00;MQM=59;TRIO=HOM,24,1.00,HET,106,0.51,HOM,112,0.99	ADK	5'UTR_premature_start_codon_gain,5'UTR,intron	ADK:NM_001123.3:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-20C>T:,ADK:NM_001202449.1:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-20C>T:,ADK:NM_001123.3:5'UTR:MODIFIER:exon1/11:c.-20C>T:,ADK:NM_001202449.1:5'UTR:MODIFIER:exon1/10:c.-20C>T:,ADK:NM_006721.3:intron:MODIFIER:exon1/10:c.66-23911C>T:,ADK:NM_001202450.1:intron:MODIFIER:exon1/9:c.66-23911C>T:		rs10824095	0.6302	0.678	0.7635	0.7933						102750 [ADK (confirmed) Hypermethioninemia due to adenosine kinase deficiency];				0.6288	0.3258	0.0455	119	70	n/a	n/a
chr10	76468851	76468851	C	T	het		QUAL=4523;DP=181;AF=0.52;MQM=60;TRIO=HET,181,0.52,HOM,46,0.98,WT,96,0.00	ADK	3'UTR	ADK:NM_006721.3:3'UTR:MODIFIER:exon11/11:c.*648C>T:,ADK:NM_001202450.1:3'UTR:MODIFIER:exon10/10:c.*648C>T:,ADK:NM_001123.3:3'UTR:MODIFIER:exon11/11:c.*648C>T:,ADK:NM_001202449.1:3'UTR:MODIFIER:exon10/10:c.*648C>T:		rs1189553	0.85	0	0	0										0.5682	0.3864	0.0455	88	56	n/a	n/a
chr10	82031937	82031937	-	CCAGCCTGAA	het		QUAL=2988;DP=165;AF=0.22;MQM=60;TRIO=HET,165,0.22,HET,181,0.43,WT,316,0.00	MAT1A	3'UTR	MAT1A:NM_000429.2:3'UTR:MODIFIER:exon9/9:c.*1599_*1600insTTCAGGCTGG:		rs145159688	0.49	0	0	0										0.1136	0.4621	0.4242	16	71	n/a	n/a
chr10	82032240	82032240	A	G	het		QUAL=10134;DP=252;AF=0.48;MQM=60;TRIO=HET,252,0.48,HOM,227,0.99,WT,277,0.00	MAT1A	3'UTR	MAT1A:NM_000429.2:3'UTR:MODIFIER:exon9/9:c.*1297T>C:		rs1985908	0.4982	0	0	0										0.1136	0.3788	0.5076	18	59	n/a	n/a
chr10	82033594	82033594	G	A	het		QUAL=23105;DP=470;AF=0.48;MQM=60;TRIO=HET,470,0.48,HET,418,0.51,HET,541,0.50	MAT1A	synonymous	MAT1A:NM_000429.2:synonymous:LOW:exon9/9:c.1131C>T:p.Tyr377Tyr		rs2993763	0.5869	0.512	0.443	0.7231						610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency|Methionine adenosyltransferase deficiency,autosomal recessive];			COSM3751998	0.2348	0.4848	0.2803	94	212	n/a	n/a
chr10	82034842	82034842	A	G	het		QUAL=4296;DP=169;AF=0.48;MQM=59;TRIO=HET,169,0.48,HOM,29,1.00,HET,79,0.35	MAT1A	synonymous	MAT1A:NM_000429.2:synonymous:LOW:exon7/9:c.882T>C:p.Ala294Ala		rs10887711	0.8405	0.703	0.6236	0.8699						610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency|Methionine adenosyltransferase deficiency,autosomal recessive];			COSM428025	0.3939	0.447	0.1591	188	193	n/a	n/a
chr10	82034854	82034854	T	C	het		QUAL=3919;DP=142;AF=0.49;MQM=59;TRIO=HET,142,0.49,HOM,30,1.00,HET,75,0.40	MAT1A	synonymous	MAT1A:NM_000429.2:synonymous:LOW:exon7/9:c.870A>G:p.Val290Val		rs10788546	0.8409	0.712	0.6258	0.8726						610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency|Methionine adenosyltransferase deficiency,autosomal recessive];				0.3939	0.447	0.1591	189	192	n/a	n/a
chr10	82040052	82040052	A	G	hom		QUAL=21475;DP=162;AF=0.99;MQM=60;TRIO=HOM,162,0.99,HOM,238,1.00,HOM,293,0.99	MAT1A	synonymous	MAT1A:NM_000429.2:synonymous:LOW:exon5/9:c.426T>C:p.Ala142Ala		rs1143694	0.8634	0.754	0.66	0.921						610550 [MAT1A (provisional) Hypermethioninemia,persistent,autosomal dominant,due to methionine adenosyltransferase I/III deficiency|Methionine adenosyltransferase deficiency,autosomal recessive];			COSM4144914	0.4621	0.4015	0.1364	214	184	n/a	n/a
chr10	82049251	82049251	-	TTCTTC	het		QUAL=10256;DP=92;AF=0.80;MQM=59;TRIO=HET,92,0.80,HOM,153,0.87,HET,190,0.49	MAT1A	5'UTR	MAT1A:NM_000429.2:5'UTR:MODIFIER:exon1/9:c.-78_-73dupGAAGAA:	(TTC)n	rs145126070	0.7696	0	0	0										0.2879	0.4015	0.3106	43	60	n/a	n/a
chr10	83637775	83637775	C	G	het		QUAL=9223;DP=278;AF=0.47;MQM=60;TRIO=HET,278,0.47,WT,134,0.00,HOM,165,0.99	NRG3	missense&splice_region,intron	NRG3:NM_001165973.1:missense&splice_region:MODERATE:exon1/11:c.59C>G:p.Thr20Arg,NRG3:NM_001010848.3:intron:MODIFIER:exon1/8:c.823+1856C>G:,NRG3:NM_001165972.1:intron:MODIFIER:exon1/8:c.823+1856C>G:		rs1884282	0.1394	0.126	0.1251	0.1662	-0.8040	P	D	B	B				COSM146979	0.0152	0.1894	0.7955	7	82	n/a	n/a
chr10	84746576	84746576	C	T	hom		QUAL=24548;DP=279;AF=1.00;MQM=60;TRIO=HOM,279,1.00,HOM,206,1.00,HOM,253,1.00	NRG3	3'UTR	NRG3:NM_001010848.3:3'UTR:MODIFIER:exon9/9:c.*1215C>T:,NRG3:NM_001165972.1:3'UTR:MODIFIER:exon9/9:c.*1215C>T:,NRG3:NM_001165973.1:3'UTR:MODIFIER:exon11/11:c.*1215C>T:		rs3763704	0.9307	0	0	0										0.8712	0.1212	0.0076	133	16	n/a	n/a
chr10	84746621	84746621	A	G	hom		QUAL=24221;DP=373;AF=1.00;MQM=60;TRIO=HOM,373,1.00,HOM,218,1.00,HET,263,0.50	NRG3	3'UTR	NRG3:NM_001010848.3:3'UTR:MODIFIER:exon9/9:c.*1260A>G:,NRG3:NM_001165972.1:3'UTR:MODIFIER:exon9/9:c.*1260A>G:,NRG3:NM_001165973.1:3'UTR:MODIFIER:exon11/11:c.*1260A>G:		rs8421	0.3464	0	0	0										0.3333	0.4848	0.1818	49	77	n/a	n/a
chr10	87359561	87359561	T	A	het		QUAL=156;DP=6;AF=0.67;MQM=60;TRIO=HET,6,0.67,NONE,0,0,HET,8,0.50	GRID1	3'UTR	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2469A>T:	AT_rich	rs200266031	0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr10	87359563	87359563	T	A	het		QUAL=156;DP=6;AF=0.67;MQM=60;TRIO=HET,6,0.67,NONE,0,0,WT,8,0.50	GRID1	3'UTR	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2467A>T:	AT_rich		0	0	0	0										0	0	1	0	0	n/a	n/a
chr10	87359676	87359676	T	A	het		QUAL=1688;DP=39;AF=0.10;MQM=56;TRIO=HET,39,0.56,HET,36,0.31,WT,53,0.42	GRID1	3'UTR	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2354A>T:	(TC)n	rs12253218	0	0	0	0										0.0076	0.1818	0.8106	1	25	n/a	n/a
chr10	87359697	87359697	A	C	het		QUAL=1688;DP=39;AF=0.10;MQM=55;TRIO=HET,39,0.85,WT,36,0.61,WT,53,0.64	GRID1	3'UTR	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2333T>G:	(CA)n	rs201962779	0	0	0	0										0	0.1061	0.8939	0	14	n/a	n/a
chr10	87359826	87359826	A	G	hom		QUAL=12762;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HOM,121,1.00,HET,176,0.59	GRID1	3'UTR	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*2204T>C:		rs2664405	0.65	0	0	0										0.3333	0.5227	0.1439	51	78	n/a	n/a
chr10	87360712	87360712	G	C	hom		QUAL=21122;DP=272;AF=0.99;MQM=59;TRIO=HOM,272,0.99,HOM,224,0.99,HET,350,0.51	GRID1	3'UTR	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*1318C>G:		rs2616672	0.6506	0	0	0										0.3333	0.5227	0.1439	51	78	n/a	n/a
chr10	87360723	87360723	A	G	hom		QUAL=21761;DP=271;AF=0.99;MQM=59;TRIO=HOM,271,0.99,HOM,237,1.00,HET,350,0.52	GRID1	3'UTR	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*1307T>C:		rs2664404	0.6506	0	0	0										0.3333	0.5227	0.1439	51	78	n/a	n/a
chr10	87361961	87361961	G	A	hom		QUAL=2178;DP=44;AF=1.00;MQM=59;TRIO=HOM,44,1.00,HET,31,0.48,HET,39,0.51	GRID1	3'UTR	GRID1:NM_017551.2:3'UTR:MODIFIER:exon16/16:c.*69C>T:		rs1054979	0.3618	0	0	0										0.0833	0.5076	0.4091	15	74	n/a	n/a
chr10	87898729	87898729	G	A	hom		QUAL=18138;DP=191;AF=0.98;MQM=60;TRIO=HOM,191,0.98,HET,362,0.49,HET,457,0.48	GRID1	synonymous	GRID1:NM_017551.2:synonymous:LOW:exon4/16:c.573C>T:p.Asp191Asp		rs17106320	0.1809	0.148	0.1451	0.2497										0.0152	0.303	0.6818	13	132	n/a	n/a
chr10	88428303	88428303	G	A	het		QUAL=9226;DP=219;AF=0.53;MQM=59;TRIO=HET,219,0.53,WT,268,0.00,HET,357,0.53	LDB3	5'UTR	LDB3:NM_001171610.1:5'UTR:MODIFIER:exon1/14:c.-48G>A:		rs2803556	0.0597	0	0	0							RCV000126610.1 [benign]; 			0.0076	0.2121	0.7803	1	31	n/a	n/a
chr10	88428335	88428335	T	C	hom		QUAL=25803;DP=136;AF=1.00;MQM=60;TRIO=HOM,136,1.00,HOM,320,1.00,HOM,385,0.99	LDB3	splice_region&intron,5'UTR	LDB3:NM_001171610.1:splice_region&intron:LOW:exon1/13:c.-24+8T>C:,LDB3:NM_001080116.1:5'UTR:MODIFIER:exon1/8:c.-114T>C:		rs2803558	0.7522	0	0	0							RCV000126612.1 [benign]; 			0.4773	0.4015	0.1212	81	60	n/a	n/a
chr10	88494752	88494752	A	-	het		QUAL=2415;DP=78;AF=0.65;MQM=60;TRIO=HET,78,0.65,HOM,24,0.75,HET,39,0.79	LDB3	3'UTR	LDB3:NM_001171610.1:3'UTR:MODIFIER:exon14/14:c.*2033delA:,LDB3:NM_001080114.1:3'UTR:MODIFIER:exon13/13:c.*2033delA:,LDB3:NM_007078.2:3'UTR:MODIFIER:exon13/13:c.*2033delA:		rs571839799	0.8584	0	0	0										0.1818	0.4167	0.4015	28	57	n/a	n/a
chr10	89623716	89623716	G	A	het		QUAL=141;DP=3;AF=0.33;MQM=60;TRIO=HET,3,0.33,WT,10,0.00,HET,10,0.60	PTEN	5'UTR	PTEN:NM_000314.4:5'UTR:MODIFIER:exon1/9:c.-511G>A:		rs12573787	0.1603	0	0	0										0.0152	0.0985	0.8864	2	15	n/a	n/a
chr10	89623861	89623861	T	-	hom		QUAL=1130;DP=4;AF=1.00;MQM=58;TRIO=HOM,4,1.00,HOM,16,0.94,HOM,19,1.00	PTEN	5'UTR	PTEN:NM_000314.4:5'UTR:MODIFIER:exon1/9:c.-366delT:		rs71022512	1	0	0	0										0.8636	0	0.1364	129	0	n/a	n/a
chr10	89623901	89623901	G	C	hom		QUAL=1769;DP=20;AF=1.00;MQM=51;TRIO=HOM,20,1.00,HOM,16,1.00,HOM,22,1.00	PTEN	5'UTR	PTEN:NM_000314.4:5'UTR:MODIFIER:exon1/9:c.-326G>C:	GC_rich	rs2943772	1	0	0	0										0.9621	0	0.0379	145	0	n/a	n/a
chr10	90771829	90771829	T	C	het		QUAL=10378;DP=297;AF=0.56;MQM=60;TRIO=HET,297,0.56,HOM,152,0.98,WT,232,0.01	FAS	synonymous	FAS:NM_000043.4:synonymous:LOW:exon7/9:c.642T>C:p.Thr214Thr,FAS:NM_152871.2:synonymous:LOW:exon6/8:c.579T>C:p.Thr193Thr,FAS:NM_152872.2:synonymous:LOW:exon7/8:c.642T>C:p.Thr214Thr		rs2234978	0.7754	0.756	0.7002	0.6854						134637 [FAS (confirmed) Autoimmune lymphoproliferative syndrome|Squamous cell carcinoma,burn scar-related,somatic|Autoimmune lymphoproliferative syndrome,type IA];		CM045201 [CLASS=DP MUT=REF PHEN="Thyroid carcinoma, association with" GENE=FAS]; 		0.5152	0.3712	0.1136	225	184	n/a	n/a
chr10	95552653	95552653	T	C	hom		QUAL=20534;DP=261;AF=1.00;MQM=60;TRIO=HOM,261,1.00,HOM,165,1.00,HOM,212,1.00	LGI1	synonymous	LGI1:NM_005097.2:synonymous:LOW:exon6/8:c.657T>C:p.Phe219Phe		rs1111820	0.9774	0.993	0.9983	0.9353						604619 [LGI1 (confirmed) Epilepsy,familial temporal lobe,1];				1	0	0	450	2	n/a	n/a
chr10	95892129	95892129	T	A	het		QUAL=18502;DP=585;AF=0.48;MQM=60;TRIO=HET,585,0.48,HET,644,0.49,WT,751,0.00	PLCE1	missense	PLCE1:NM_016341.3:missense:MODERATE:exon3/33:c.1405T>A:p.Ser469Thr,PLCE1:NM_001288989.1:missense:MODERATE:exon3/33:c.1405T>A:p.Ser469Thr,PLCE1:NM_001165979.2:missense:MODERATE:exon2/32:c.481T>A:p.Ser161Thr		rs17508082	0.0172	0.031	0.0424	0.0056	3.4920	N	D	P,P,P	B,B,B	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];				0	0.1439	0.8561	2	60	n/a	n/a
chr10	96039597	96039597	G	C	het		QUAL=9186;DP=285;AF=0.49;MQM=60;TRIO=HET,285,0.49,HET,332,0.46,WT,483,0.00	PLCE1	missense	PLCE1:NM_016341.3:missense:MODERATE:exon20/33:c.4724G>C:p.Arg1575Pro,PLCE1:NM_001288989.1:missense:MODERATE:exon20/33:c.4676G>C:p.Arg1559Pro,PLCE1:NM_001165979.2:missense:MODERATE:exon19/32:c.3800G>C:p.Arg1267Pro		rs2274224	0.4862	0.437	0.4439	0.5454	0.7950	P	T	B,B,B	B,B,B	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];		CM1314035 [CLASS=DP MUT=REF PHEN="Oesophageal squamous cell carcinoma, reduced risk" GENE=PLCE1]; 		0.2652	0.4545	0.2803	106	221	n/a	n/a
chr10	96058298	96058298	C	T	het		QUAL=10477;DP=393;AF=0.47;MQM=60;TRIO=HET,393,0.47,HET,301,0.54,WT,396,0.00	PLCE1	missense	PLCE1:NM_016341.3:missense:MODERATE:exon24/33:c.5330C>T:p.Thr1777Ile,PLCE1:NM_001288989.1:missense:MODERATE:exon24/33:c.5282C>T:p.Thr1761Ile,PLCE1:NM_001165979.2:missense:MODERATE:exon23/32:c.4406C>T:p.Thr1469Ile		rs3765524	0.3079	0.271	0.2857	0.3935	5.1480	P	T	B,B,B	B,B,B	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];		CM105437 [CLASS=DP MUT=ALT PHEN="Gastric adenocarcinoma and oesophageal SCC, association with" GENE=PLCE1]; 		0.1136	0.4091	0.4773	51	197	n/a	n/a
chr10	96058433	96058433	G	A	het		QUAL=6960;DP=220;AF=0.47;MQM=60;TRIO=HET,220,0.47,HET,236,0.53,WT,298,0.00	PLCE1	splice_region&intron	PLCE1:NM_016341.3:splice_region&intron:LOW:exon24/32:c.5458+7G>A:,PLCE1:NM_001288989.1:splice_region&intron:LOW:exon24/32:c.5410+7G>A:,PLCE1:NM_001165979.2:splice_region&intron:LOW:exon23/31:c.4534+7G>A:		rs17516758	0.1068	0.137	0.1554	0.0946						608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];				0.0379	0.3106	0.6515	12	143	n/a	n/a
chr10	96066341	96066341	A	G	het		QUAL=10283;DP=347;AF=0.53;MQM=60;TRIO=HET,347,0.53,HET,277,0.49,WT,358,0.00	PLCE1	missense	PLCE1:NM_016341.3:missense:MODERATE:exon26/33:c.5780A>G:p.His1927Arg,PLCE1:NM_001288989.1:missense:MODERATE:exon26/33:c.5732A>G:p.His1911Arg,PLCE1:NM_001165979.2:missense:MODERATE:exon25/32:c.4856A>G:p.His1619Arg		rs2274223	0.2985	0.284	0.3111	0.3341	3.0200	P	T	B,B,B	B,B,B	608414 [PLCE1 (confirmed) Nephrotic syndrome,type 3];		CM105436 [CLASS=DP MUT=ALT PHEN="Gastric adenocarcinoma and oesophageal SCC, association with" GENE=PLCE1]; 		0.1364	0.4545	0.4091	58	209	n/a	n/a
chr10	96087728	96087728	A	G	het		QUAL=4834;DP=241;AF=0.51;MQM=60;TRIO=HET,241,0.51,HET,76,0.53,WT,95,0.00	PLCE1	3'UTR	PLCE1:NM_016341.3:3'UTR:MODIFIER:exon33/33:c.*28A>G:,PLCE1:NM_001288989.1:3'UTR:MODIFIER:exon33/33:c.*28A>G:,PLCE1:NM_001165979.2:3'UTR:MODIFIER:exon32/32:c.*28A>G:		rs3203713	0.1054	0.134	0.158	0.0965	2.1340	P	D							0.0379	0.3106	0.6515	6	82	n/a	n/a
chr10	97365820	97365820	G	A	het		QUAL=6604;DP=216;AF=0.53;MQM=60;TRIO=HET,216,0.53,HET,73,0.53,HET,107,0.50	ALDH18A1	3'UTR	ALDH18A1:NM_002860.3:3'UTR:MODIFIER:exon18/18:c.*699C>T:,ALDH18A1:NM_001017423.1:3'UTR:MODIFIER:exon18/18:c.*699C>T:		rs4037	0.2005	0	0	0										0.0833	0.4242	0.4924	15	62	n/a	n/a
chr10	97366364	97366364	C	T	het		QUAL=6846;DP=202;AF=0.50;MQM=60;TRIO=HET,202,0.50,HET,63,0.54,HOM,84,1.00	ALDH18A1	3'UTR	ALDH18A1:NM_002860.3:3'UTR:MODIFIER:exon18/18:c.*155G>A:,ALDH18A1:NM_001017423.1:3'UTR:MODIFIER:exon18/18:c.*155G>A:		rs1053905	0.2979	0	0	0										0.2424	0.5682	0.1894	38	84	n/a	n/a
chr10	97388162	97388162	G	A	het		QUAL=12754;DP=276;AF=0.48;MQM=60;TRIO=HET,276,0.48,WT,226,0.00,HOM,263,1.00	ALDH18A1	missense	ALDH18A1:NM_002860.3:missense:MODERATE:exon8/18:c.896C>T:p.Thr299Ile,ALDH18A1:NM_001017423.1:missense:MODERATE:exon8/18:c.890C>T:p.Thr297Ile		rs2275272	0.0717	0.103	0.126	0.0527	6.1520	P	D	B,B	B,B	138250 [ALDH18A1 (confirmed) Cutis laxa,autosomal recessive,type IIIA];				0.0455	0.2727	0.6818	13	112	n/a	n/a
chr10	97515949	97515949	G	T	het		QUAL=9065;DP=351;AF=0.48;MQM=60;TRIO=HET,351,0.48,WT,204,0.00,HET,241,0.51	ENTPD1	5'UTR_premature_start_codon_gain,5'UTR,intron	ENTPD1:NM_001164179.1:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-48G>T:,ENTPD1:NM_001164182.1:5'UTR_premature_start_codon_gain:LOW:exon1/9:c.-311G>T:,ENTPD1:NM_001164183.1:5'UTR_premature_start_codon_gain:LOW:exon1/8:c.-193G>T:,ENTPD1:NM_001776.5:5'UTR_premature_start_codon_gain:LOW:exon1/10:c.-48G>T:,ENTPD1:NM_001164179.1:5'UTR:MODIFIER:exon1/10:c.-48G>T:,ENTPD1:NM_001164182.1:5'UTR:MODIFIER:exon1/9:c.-311G>T:,ENTPD1:NM_001164183.1:5'UTR:MODIFIER:exon1/8:c.-193G>T:,ENTPD1:NM_001776.5:5'UTR:MODIFIER:exon1/10:c.-48G>T:,ENTPD1:NM_001164178.1:intron:MODIFIER:exon1/9:c.52+426G>T:,ENTPD1:NM_001098175.1:intron:MODIFIER:exon1/9:c.37+44199G>T:,ENTPD1:NM_001164181.1:intron:MODIFIER:exon1/8:c.-181+426G>T:		rs200451742	0.0004	0.0005	0	0						601752 [ENTPD1 (provisional) Spastic paraplegia 64];				0	0.0076	0.9924	0	2	n/a	n/a
chr10	97628170	97628170	T	C	het		QUAL=20294;DP=463;AF=0.50;MQM=59;TRIO=HET,463,0.50,WT,286,0.00,HOM,381,1.00	ENTPD1	3'UTR	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*2030T>C:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*2030T>C:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*2030T>C:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*2030T>C:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*2030T>C:		rs3181115	0.0499	0	0	0										0.0303	0.2273	0.7424	4	34	n/a	n/a
chr10	97630523	97630523	C	T	het		QUAL=20820;DP=396;AF=0.47;MQM=60;TRIO=HET,396,0.47,HET,249,0.49,HOM,331,1.00	ENTPD1	3'UTR	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*4383C>T:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*4383C>T:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*4383C>T:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*4383C>T:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*4383C>T:		rs10736094	0.5841	0	0	0										0.3864	0.4545	0.1591	56	68	n/a	n/a
chr10	97631051	97631051	T	C	het		QUAL=14463;DP=406;AF=0.48;MQM=59;TRIO=HET,406,0.48,HET,128,0.57,HOM,170,0.98	ENTPD1	3'UTR	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*4911T>C:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*4911T>C:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*4911T>C:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*4911T>C:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*4911T>C:		rs2153914	0.5865	0	0	0										0.3864	0.4621	0.1515	56	68	n/a	n/a
chr10	97631172	97631172	A	C	het		QUAL=12233;DP=342;AF=0.50;MQM=60;TRIO=HET,342,0.50,WT,149,0.00,HOM,206,0.99	ENTPD1	3'UTR	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*5032A>C:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*5032A>C:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*5032A>C:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*5032A>C:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*5032A>C:		rs34630379	0.0541	0	0	0										0.0303	0.2273	0.7424	4	34	n/a	n/a
chr10	97633021	97633021	C	T	het		QUAL=19984;DP=326;AF=0.50;MQM=59;TRIO=HET,326,0.50,HET,257,0.40,HOM,344,1.00	ENTPD1	3'UTR	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*6881C>T:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*6881C>T:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*6881C>T:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*6881C>T:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*6881C>T:	L3	rs11188513	0.5839	0	0	0										0.3864	0.4545	0.1591	56	68	n/a	n/a
chr10	97633470	97633470	T	C	het		QUAL=13739;DP=304;AF=0.53;MQM=59;TRIO=HET,304,0.53,WT,236,0.00,HOM,260,1.00	ENTPD1	3'UTR	ENTPD1:NM_001164178.1:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1:NM_001098175.1:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1:NM_001164181.1:3'UTR:MODIFIER:exon9/9:c.*7330T>C:,ENTPD1:NM_001164179.1:3'UTR:MODIFIER:exon10/10:c.*7330T>C:,ENTPD1:NM_001164182.1:3'UTR:MODIFIER:exon9/9:c.*7330T>C:,ENTPD1:NM_001164183.1:3'UTR:MODIFIER:exon8/8:c.*7330T>C:,ENTPD1:NM_001776.5:3'UTR:MODIFIER:exon10/10:c.*7330T>C:	THE1A	rs11592937	0.0497	0	0	0										0.0303	0.2273	0.7424	4	34	n/a	n/a
chr10	97990583	97990583	A	G	hom		QUAL=14975;DP=196;AF=1.00;MQM=60;TRIO=HOM,196,1.00,HOM,156,1.00,HET,197,0.54	BLNK	synonymous	BLNK:NM_013314.3:synonymous:LOW:exon4/17:c.171T>C:p.Pro57Pro,BLNK:NM_001258440.1:synonymous:LOW:exon4/16:c.171T>C:p.Pro57Pro,BLNK:NM_001258441.1:synonymous:LOW:exon4/15:c.171T>C:p.Pro57Pro,BLNK:NM_001258442.1:synonymous:LOW:exon4/14:c.171T>C:p.Pro57Pro,BLNK:NM_001114094.1:synonymous:LOW:exon4/16:c.171T>C:p.Pro57Pro		rs727852	0.4613	0.621	0.7193	0.2438						604515 [BLNK (provisional) Agammaglobulinemia 4];			COSM147002	0.5227	0.4167	0.0606	236	176	n/a	n/a
chr10	101469605	101469605	G	A	hom		QUAL=40052;DP=515;AF=1.00;MQM=60;TRIO=HOM,515,1.00,HET,399,0.43,HOM,506,1.00	ENTPD7,COX15	3'UTR	ENTPD7:NM_020354.3:3'UTR:MODIFIER:exon13/13:c.*5165G>A:,COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*4739C>T:,COX15:NM_004376.5:3'UTR:MODIFIER:exon9/9:c.*3566C>T:		rs2300983	0.8263	0	0	0										0.7424	0.2348	0.0227	111	35	n/a	n/a
chr10	101470858	101470858	-	A	hom		QUAL=9034;DP=239;AF=0.76;MQM=60;TRIO=HOM,239,0.76,HET,54,0.43,HOM,77,0.97	ENTPD7,COX15	3'UTR	ENTPD7:NM_020354.3:3'UTR:MODIFIER:exon13/13:c.*6426dupA:,COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*3485dupT:,COX15:NM_004376.5:3'UTR:MODIFIER:exon9/9:c.*2312dupT:		rs397764905	0.8227	0	0	0										0.7424	0.2348	0.0227	111	35	n/a	n/a
chr10	101470927	101470927	A	G	hom		QUAL=11045;DP=260;AF=1.00;MQM=60;TRIO=HOM,260,1.00,HET,77,0.49,HET,91,0.43	ENTPD7,COX15	3'UTR	ENTPD7:NM_020354.3:3'UTR:MODIFIER:exon13/13:c.*6487A>G:,COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*3417T>C:,COX15:NM_004376.5:3'UTR:MODIFIER:exon9/9:c.*2244T>C:		rs10883407	0.1264	0	0	0										0.0152	0.1591	0.8258	2	25	n/a	n/a
chr10	101473218	101473218	A	G	hom		QUAL=18808;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HET,182,0.49,HOM,231,1.00	COX15	missense,3'UTR	COX15:NM_004376.5:missense:MODERATE:exon9/9:c.1120T>C:p.Phe374Leu,COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*1126T>C:	L3	rs2231687	0.8271	0.86	0.8733	0.7599	0.2480	P	D	B	B	603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2];	RCV000116814.2 [likely benign]; 			0.7424	0.2348	0.0227	355	109	n/a	n/a
chr10	101473535	101473535	C	T	hom		QUAL=18066;DP=290;AF=1.00;MQM=56;TRIO=HOM,290,1.00,HET,140,0.53,HOM,193,1.00	COX15	3'UTR,intron	COX15:NM_078470.4:3'UTR:MODIFIER:exon9/9:c.*809G>A:,COX15:NM_004376.5:intron:MODIFIER:exon8/8:c.1102-299G>A:	AluSq2	rs7073616	0.8518	0	0	0						603646 [COX15 (confirmed) Leigh syndrome due to cytochrome c oxidase deficiency|Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 2];				0.7424	0.2348	0.0227	111	35	n/a	n/a
chr10	102747363	102747363	G	T	het		QUAL=19702;DP=498;AF=0.49;MQM=60;TRIO=HET,498,0.49,HET,365,0.50,HET,477,0.49	C10orf2	5'UTR	C10orf2:NM_021830.4:5'UTR:MODIFIER:exon1/5:c.-605G>T:,C10orf2:NM_001163812.1:5'UTR:MODIFIER:exon1/5:c.-605G>T:,C10orf2:NM_001163813.1:5'UTR:MODIFIER:exon1/5:c.-127G>T:,C10orf2:NM_001163814.1:5'UTR:MODIFIER:exon1/5:c.-127G>T:		rs3740484	0.4121	0	0	0							RCV000124045.1 [benign]; 			0.1061	0.3939	0.5	17	67	n/a	n/a
chr10	102750621	102750621	C	T	het		QUAL=6756;DP=277;AF=0.47;MQM=60;TRIO=HET,277,0.47,HET,218,0.45,WT,297,0.00	C10orf2	splice_region&intron	C10orf2:NM_021830.4:splice_region&intron:LOW:exon3/4:c.1593-5C>T:,C10orf2:NM_001163812.1:splice_region&intron:LOW:exon3/4:c.1593-5C>T:,C10orf2:NM_001163813.1:splice_region&intron:LOW:exon3/4:c.231-5C>T:,C10orf2:NM_001163814.1:splice_region&intron:LOW:exon3/4:c.231-5C>T:		rs3740485	0.376	0	0.1824	0.406						606075 [C10orf2 (confirmed) Progressive external ophthalmoplegia,autosomal dominant,3|Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)];	RCV000124041.1 [benign]; 			0.0455	0.303	0.6515	49	347	n/a	n/a
chr10	102750623	102750623	T	C	het		QUAL=6756;DP=277;AF=0.47;MQM=60;TRIO=HET,277,0.47,HET,218,0.45,WT,297,0.00	C10orf2	splice_region&intron	C10orf2:NM_021830.4:splice_region&intron:LOW:exon3/4:c.1593-3T>C:,C10orf2:NM_001163812.1:splice_region&intron:LOW:exon3/4:c.1593-3T>C:,C10orf2:NM_001163813.1:splice_region&intron:LOW:exon3/4:c.231-3T>C:,C10orf2:NM_001163814.1:splice_region&intron:LOW:exon3/4:c.231-3T>C:		rs3740486	0.376	0.275	0.1809	0.4017						606075 [C10orf2 (confirmed) Progressive external ophthalmoplegia,autosomal dominant,3|Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)];	RCV000124042.1 [benign]; 			0.0455	0.303	0.6515	47	349	n/a	n/a
chr10	102750783	102750783	C	A	het		QUAL=7662;DP=210;AF=0.52;MQM=60;TRIO=HET,210,0.52,HET,276,0.49,WT,339,0.00	C10orf2	splice_region&intron,3'UTR	C10orf2:NM_021830.4:splice_region&intron:LOW:exon4/4:c.1734+16C>A:,C10orf2:NM_001163813.1:splice_region&intron:LOW:exon4/4:c.372+16C>A:,C10orf2:NM_001163812.1:3'UTR:MODIFIER:exon4/5:c.*1C>A:,C10orf2:NM_001163814.1:3'UTR:MODIFIER:exon4/5:c.*1C>A:		rs3740487	0.3758	0.275	0.2081	0.4353						606075 [C10orf2 (confirmed) Progressive external ophthalmoplegia,autosomal dominant,3|Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)];	RCV000124043.1 [benign]; 			0.0455	0.303	0.6515	49	349	n/a	n/a
chr10	102754033	102754033	A	T	het		QUAL=9756;DP=324;AF=0.53;MQM=60;TRIO=HET,324,0.53,HET,267,0.53,WT,387,0.00	C10orf2	3'UTR	C10orf2:NM_021830.4:3'UTR:MODIFIER:exon5/5:c.*766A>T:,C10orf2:NM_001163812.1:3'UTR:MODIFIER:exon5/5:c.*1116A>T:,C10orf2:NM_001163813.1:3'UTR:MODIFIER:exon5/5:c.*766A>T:,C10orf2:NM_001163814.1:3'UTR:MODIFIER:exon5/5:c.*1116A>T:		rs3740488	0.3748	0	0	0										0.0455	0.3106	0.6439	9	52	n/a	n/a
chr10	104596924	104596924	C	A	hom		QUAL=4776;DP=84;AF=1.00;MQM=60;TRIO=HOM,84,1.00,HET,60,0.48,HOM,54,1.00	CYP17A1	synonymous	CYP17A1:NM_000102.3:synonymous:LOW:exon1/8:c.195G>T:p.Ser65Ser		rs6163	0.4103	0.397	0.3944	0.3616						609300 [CYP17A1 (confirmed) 17-alpha-hydroxylase/17,20-lyase deficiency|17,20-lyase deficiency,isolated];			COSM3751499	0.2045	0.3864	0.4091	86	197	n/a	n/a
chr10	104596981	104596981	G	A	hom		QUAL=8709;DP=139;AF=0.99;MQM=59;TRIO=HOM,139,0.99,HET,102,0.43,HOM,110,1.00	CYP17A1	synonymous	CYP17A1:NM_000102.3:synonymous:LOW:exon1/8:c.138C>T:p.His46His		rs6162	0.4425	0.425	0.4105	0.3645						609300 [CYP17A1 (confirmed) 17-alpha-hydroxylase/17,20-lyase deficiency|17,20-lyase deficiency,isolated];			COSM3751500	0.25	0.3712	0.3788	101	201	n/a	n/a
chr10	104597152	104597152	A	G	hom		QUAL=19056;DP=242;AF=1.00;MQM=59;TRIO=HOM,242,1.00,HET,210,0.52,HOM,242,1.00	CYP17A1	5'UTR	CYP17A1:NM_000102.3:5'UTR:MODIFIER:exon1/8:c.-34T>C:		rs743572	0.4105	0.396	0.3934	0.3608								CR942079 [CLASS=DP MUT=ALT PHEN="Polycystic ovaries, association with" GENE=CYP17A1]; 		0.2045	0.3864	0.4091	30	60	n/a	n/a
chr10	105791355	105791355	C	T	het		QUAL=12202;DP=366;AF=0.48;MQM=60;TRIO=HET,366,0.48,HET,157,0.47,HET,230,0.50	COL17A1	3'UTR	COL17A1:NM_000494.3:3'UTR:MODIFIER:exon56/56:c.*638G>A:		rs9425	0.1885	0	0	0										0.053	0.25	0.697	7	38	n/a	n/a
chr10	105791630	105791630	A	-	het		QUAL=16390;DP=327;AF=0.49;MQM=60;TRIO=HET,327,0.49,HET,321,0.48,HET,421,0.48	COL17A1	3'UTR	COL17A1:NM_000494.3:3'UTR:MODIFIER:exon56/56:c.*363delT:		rs113786874	0.2466	0	0	0										0.0833	0.2576	0.6591	11	39	n/a	n/a
chr10	105791929	105791929	C	G	het		QUAL=14702;DP=354;AF=0.52;MQM=60;TRIO=HET,354,0.52,HET,236,0.51,HET,353,0.42	COL17A1	3'UTR	COL17A1:NM_000494.3:3'UTR:MODIFIER:exon56/56:c.*64G>C:		rs805687	0.2288	0	0.1703	0.3736										0.053	0.2576	0.6894	7	43	n/a	n/a
chr10	105796399	105796399	G	C	het		QUAL=4783;DP=65;AF=0.42;MQM=60;TRIO=HET,65,0.42,HET,93,0.55,HET,138,0.59	COL17A1	splice_region&intron	COL17A1:NM_000494.3:splice_region&intron:LOW:exon47/55:c.3278-9C>G:		rs2274098	0.6915	0.779	0.833	0.5079						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];				0.6515	0.25	0.0985	309	122	n/a	n/a
chr10	105796819	105796819	A	G	hom		QUAL=32025;DP=234;AF=1.00;MQM=60;TRIO=HOM,234,1.00,HOM,335,1.00,HOM,430,1.00	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon47/56:c.3261T>C:p.Ile1087Ile		rs2476958	0.986	0.996	1	0.9594						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];				1	0	0	450	0	n/a	n/a
chr10	105798872	105798872	T	C	het		QUAL=15467;DP=389;AF=0.45;MQM=60;TRIO=HET,389,0.45,HET,328,0.34,HET,404,0.48	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon44/56:c.2904A>G:p.Pro968Pro		rs2274100	0.6815	0.777	0.8329	0.507						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];			COSM3751514	0.6515	0.25	0.0985	312	123	n/a	n/a
chr10	105799216	105799216	G	T	het		QUAL=11305;DP=238;AF=0.52;MQM=59;TRIO=HET,238,0.52,HET,198,0.48,HET,263,0.52	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon43/56:c.2883C>A:p.Pro961Pro		rs2296219	0.6835	0.777	0.8316	0.4877						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];			COSM3751515	0.6515	0.25	0.0985	311	122	n/a	n/a
chr10	105801253	105801253	G	A	het		QUAL=5981;DP=134;AF=0.44;MQM=59;TRIO=HET,134,0.44,HET,111,0.49,HET,136,0.63	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon37/56:c.2595C>T:p.Arg865Arg		rs4918079	0.6739	0.769	0.8287	0.5023						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];		CM144867 [CLASS=DP MUT=ALT PHEN="Ossification of posterior longitudinal ligament, association with" GENE=COL17A1]; 	COSM3751516	0.6439	0.2576	0.0985	310	122	n/a	n/a
chr10	105810400	105810400	T	C	het		QUAL=31209;DP=420;AF=0.51;MQM=60;TRIO=HET,420,0.51,HOM,456,1.00,HET,583,0.50	COL17A1	missense	COL17A1:NM_000494.3:missense:MODERATE:exon27/56:c.2107A>G:p.Met703Val		rs805722	0.6937	0.78	0.8185	0.525	-0.2220	P	T	B	B	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];			COSM1178415	0.5909	0.3409	0.0682	288	147	n/a	n/a
chr10	105816916	105816916	C	T	hom		QUAL=24758;DP=105;AF=0.99;MQM=59;TRIO=HOM,105,0.99,HOM,290,1.00,HOM,368,1.00	COL17A1	missense	COL17A1:NM_000494.3:missense:MODERATE:exon17/56:c.1282G>A:p.Gly428Ser		rs805698	0.8185	0.934	0.9929	0.5675	0.8810	P	T	B,B	B,B	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];		CM144866 [CLASS=DP MUT=ALT PHEN="Ossification of posterior longitudinal ligament, association with" GENE=COL17A1]; 		0.9848	0.0152	0	440	11	n/a	n/a
chr10	105819956	105819956	G	A	het		QUAL=30337;DP=404;AF=0.51;MQM=60;TRIO=HET,404,0.51,HOM,463,1.00,HET,569,0.47	COL17A1	synonymous	COL17A1:NM_000494.3:synonymous:LOW:exon14/56:c.1062C>T:p.Ala354Ala		rs805701	0.5525	0.647	0.674	0.3234						113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];				0.3864	0.4545	0.1591	195	207	n/a	n/a
chr10	105824333	105824333	G	A	het		QUAL=2187;DP=50;AF=0.48;MQM=60;TRIO=HET,50,0.48,HOM,39,0.97,HET,23,0.48	COL17A1	missense	COL17A1:NM_000494.3:missense:MODERATE:exon10/56:c.629C>T:p.Thr210Met		rs805708	0.5649	0.666	0.703	0.355	6.8340	P	T	D,D,D	D,D,P	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type];				0.4015	0.4318	0.1667	211	193	n/a	n/a
chr10	112361870	112361870	A	G	hom		QUAL=17449;DP=228;AF=1.00;MQM=58;TRIO=HOM,228,1.00,HOM,129,1.00,HOM,169,1.00	SMC3	synonymous	SMC3:NM_005445.3:synonymous:LOW:exon25/29:c.3039A>G:p.Ser1013Ser		rs2419565	0.9868	0.996	0.9993	0.9714						606062 [SMC3 (provisional) Cornelia de Lange syndrome 3];	RCV000147595.1 [benign]; 			1	0	0	453	1	n/a	n/a
chr10	112773063	112773063	G	-	het		QUAL=3043;DP=197;AF=0.38;MQM=60;TRIO=HET,197,0.38,WT,44,0.00,HET,78,0.28	SHOC2	3'UTR	SHOC2:NM_007373.3:3'UTR:MODIFIER:exon9/9:c.*1487delG:,SHOC2:NM_001269039.1:3'UTR:MODIFIER:exon7/7:c.*1487delG:		rs143768227	0.0525	0	0	0										0	0.1212	0.8788	0	19	n/a	n/a
chr10	119302341	119302341	-	T	het		QUAL=2454;DP=49;AF=0.43;MQM=60;TRIO=HET,49,0.43,HET,57,0.63,HET,107,0.54	EMX2	5'UTR	EMX2:NM_004098.3:5'UTR:MODIFIER:exon1/3:c.-424dupT:,EMX2:NM_001165924.1:5'UTR:MODIFIER:exon1/2:c.-424dupT:		rs534695537	0.5284	0	0	0										0.1515	0.303	0.5455	23	43	n/a	n/a
chr10	119302449	119302449	G	A	het		QUAL=364;DP=65;AF=0.26;MQM=49;TRIO=HET,65,0.26,HET,16,0.31,HET,20,0.10	EMX2	5'UTR	EMX2:NM_004098.3:5'UTR:MODIFIER:exon1/3:c.-330G>A:,EMX2:NM_001165924.1:5'UTR:MODIFIER:exon1/2:c.-330G>A:	(A)n		0	0	0	0										0	0.0606	0.9394	0	10	n/a	n/a
chr10	119308060	119308063	AGAG	-	hom		QUAL=10011;DP=67;AF=0.96;MQM=59;TRIO=HOM,67,0.96,HOM,126,0.93,HOM,173,0.97	EMX2	3'UTR	EMX2:NM_004098.3:3'UTR:MODIFIER:exon3/3:c.*338_*341delGAGA:,EMX2:NM_001165924.1:3'UTR:MODIFIER:exon2/2:c.*402_*405delGAGA:	(GA)n	rs66710107	0.9497	0	0	0										0.8409	0.1288	0.0303	125	21	n/a	n/a
chr10	121436362	121436362	A	G	het		QUAL=11967;DP=357;AF=0.52;MQM=60;TRIO=HET,357,0.52,HET,147,0.54,HET,230,0.49	BAG3	synonymous	BAG3:NM_004281.3:synonymous:LOW:exon4/4:c.1296A>G:p.Val432Val		rs196295	0.7065	0.741	0.7792	0.7531						603883 [BAG3 (provisional) Myopathy,myofibrillar,6|Cardiomyopathy,dilated,1HH];	RCV000037886.4 [benign]; RCV000123817.1 [benign]; 			0.6061	0.3485	0.0455	288	150	n/a	n/a
chr10	121437032	121437034	TTG	-	het		QUAL=10541;DP=354;AF=0.44;MQM=60;TRIO=HET,354,0.44,WT,276,0.00,HET,374,0.48	BAG3	3'UTR	BAG3:NM_004281.3:3'UTR:MODIFIER:exon4/4:c.*243_*245delGTT:		rs71758126	0.4585	0	0	0										0.3636	0.4697	0.1667	56	69	n/a	n/a
chr10	123239112	123239112	G	A	het		QUAL=14368;DP=197;AF=0.49;MQM=59;TRIO=HET,197,0.49,HOM,237,1.00,HET,288,0.42	FGFR2	synonymous,3'UTR	FGFR2:NM_001144915.1:synonymous:LOW:exon17/17:c.2107C>T:p.Leu703Leu,FGFR2:NM_022970.3:3'UTR:MODIFIER:exon18/18:c.*259C>T:,FGFR2:NM_001144914.1:3'UTR:MODIFIER:exon15/15:c.*259C>T:,FGFR2:NM_023029.2:3'UTR:MODIFIER:exon16/16:c.*259C>T:,FGFR2:NM_001144916.1:3'UTR:MODIFIER:exon15/15:c.*259C>T:,FGFR2:NM_000141.4:3'UTR:MODIFIER:exon18/18:c.*259C>T:,FGFR2:NM_001144917.1:3'UTR:MODIFIER:exon16/16:c.*259C>T:,FGFR2:NM_001144918.1:3'UTR:MODIFIER:exon16/16:c.*259C>T:		rs1047057	0.4143	0.365	0.549	0.1712						176943 [FGFR2 (confirmed) Crouzon syndrome|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Apert syndrome|Saethre-Chotzen syndrome|Craniosynostosis,nonspecific|Gastric cancer,somatic|Craniofacial-skeletal-dermatologic dysplasia|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome|Scaphocephaly,maxillary retrusion,and mental retardation|Bent bone dysplasia syndrome];			COSM147070	0.2955	0.4773	0.2273	137	230	n/a	n/a
chr10	123298158	123298158	T	C	hom		QUAL=41674;DP=407;AF=1.00;MQM=59;TRIO=HOM,407,1.00,HET,467,0.55,HOM,615,1.00	FGFR2	synonymous	FGFR2:NM_022970.3:synonymous:LOW:exon6/18:c.696A>G:p.Val232Val,FGFR2:NM_001144914.1:synonymous:LOW:exon5/15:c.696A>G:p.Val232Val,FGFR2:NM_023029.2:synonymous:LOW:exon4/16:c.429A>G:p.Val143Val,FGFR2:NM_001144916.1:synonymous:LOW:exon3/15:c.351A>G:p.Val117Val,FGFR2:NM_001144915.1:synonymous:LOW:exon5/17:c.429A>G:p.Val143Val,FGFR2:NM_000141.4:synonymous:LOW:exon6/18:c.696A>G:p.Val232Val,FGFR2:NM_001144917.1:synonymous:LOW:exon6/16:c.696A>G:p.Val232Val,FGFR2:NM_001144918.1:synonymous:LOW:exon4/16:c.351A>G:p.Val117Val,FGFR2:NM_001144913.1:synonymous:LOW:exon5/17:c.696A>G:p.Val232Val,FGFR2:NM_001144919.1:synonymous:LOW:exon5/17:c.429A>G:p.Val143Val		rs1047100	0.7953	0.78	0.7764	0.7478						176943 [FGFR2 (confirmed) Crouzon syndrome|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Apert syndrome|Saethre-Chotzen syndrome|Craniosynostosis,nonspecific|Gastric cancer,somatic|Craniofacial-skeletal-dermatologic dysplasia|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome|Scaphocephaly,maxillary retrusion,and mental retardation|Bent bone dysplasia syndrome];				0.6515	0.303	0.0455	294	157	n/a	n/a
chr10	123357561	123357561	C	T	hom		QUAL=1942;DP=10;AF=1.00;MQM=60;TRIO=HOM,10,1.00,HET,29,0.55,HOM,51,1.00	FGFR2	5'UTR	FGFR2:NM_022970.3:5'UTR:MODIFIER:exon1/18:c.-236G>A:,FGFR2:NM_000141.4:5'UTR:MODIFIER:exon1/18:c.-236G>A:,FGFR2:NM_001144917.1:5'UTR:MODIFIER:exon1/16:c.-236G>A:,FGFR2:NM_001144918.1:5'UTR:MODIFIER:exon1/16:c.-236G>A:,FGFR2:NM_001144919.1:5'UTR:MODIFIER:exon1/17:c.-236G>A:		rs1047111	0.7103	0	0	0										0.6515	0.2727	0.0758	100	37	n/a	n/a
chr10	126107506	126107506	A	C	het		QUAL=8961;DP=136;AF=0.61;MQM=60;TRIO=HET,136,0.61,HOM,125,1.00,HET,184,0.49	OAT	5'UTR	OAT:NM_000274.3:5'UTR:MODIFIER:exon1/10:c.-94T>G:,OAT:NM_001171814.1:5'UTR:MODIFIER:exon1/9:c.-280T>G:		rs4144117	0.863	0	0	0										0.6667	0.3258	0.0076	96	51	n/a	n/a
chr11	791462	791462	G	A	het		QUAL=5012;DP=124;AF=0.46;MQM=60;TRIO=HET,124,0.46,WT,117,0.00,HET,208,0.51	SLC25A22	3'UTR	SLC25A22:NM_001191060.1:3'UTR:MODIFIER:exon10/10:c.*453C>T:,SLC25A22:NM_024698.5:3'UTR:MODIFIER:exon10/10:c.*453C>T:,SLC25A22:NM_001191061.1:3'UTR:MODIFIER:exon10/10:c.*453C>T:		rs4963153	0.2993	0	0	0										0.1439	0.5227	0.3333	25	78	n/a	n/a
chr11	1861760	1861760	T	C	hom		QUAL=21143;DP=154;AF=0.99;MQM=59;TRIO=HOM,154,0.99,HOM,225,1.00,HOM,318,1.00	TNNI2	splice_region&synonymous	TNNI2:NM_001145829.1:splice_region&synonymous:LOW:exon4/7:c.60T>C:p.Ser20Ser,TNNI2:NM_003282.3:splice_region&synonymous:LOW:exon4/7:c.60T>C:p.Ser20Ser,TNNI2:NM_001145841.1:splice_region&synonymous:LOW:exon3/6:c.60T>C:p.Ser20Ser		rs907610	0.8277	0.871	0.8721	0.6686						191043 [TNNI2 (confirmed) Arthrogryposis multiplex congenita,distal,type 2B];	RCV000080081.4 [other]; RCV000128669.1 [not provided]; 		COSM4145619	0.7348	0.2576	0.0076	352	98	n/a	n/a
chr11	1959707	1959707	C	T	het		QUAL=1053;DP=29;AF=0.45;MQM=60;TRIO=HET,29,0.45,HET,26,0.50,HET,41,0.37	TNNT3	synonymous	TNNT3:NM_006757.3:synonymous:LOW:exon16/16:c.762C>T:p.Gly254Gly,TNNT3:NM_001042780.2:synonymous:LOW:exon15/15:c.738C>T:p.Gly246Gly,TNNT3:NM_001042781.2:synonymous:LOW:exon16/16:c.756C>T:p.Gly252Gly,TNNT3:NM_001042782.2:synonymous:LOW:exon15/15:c.738C>T:p.Gly246Gly,TNNT3:NM_001297646.1:synonymous:LOW:exon16/16:c.738C>T:p.Gly246Gly		rs4727	0.137	0.144	0.1545	0.0363						600692 [TNNT3 (confirmed) Arthyrgryposis,distal,type 2B];	RCV000024568.1 [not provided]; RCV000118647.1 [benign]; 		COSM3752284	0.0227	0.3333	0.6439	18	126	n/a	n/a
chr11	2187855	2187855	G	C	het		QUAL=2641;DP=14;AF=0.57;MQM=60;TRIO=HET,14,0.57,WT,126,0.00,HET,157,0.53	TH	splice_region&intron	TH:NM_199292.2:splice_region&intron:LOW:exon9/13:c.1070+8C>G:,TH:NM_000360.3:splice_region&intron:LOW:exon8/12:c.977+8C>G:,TH:NM_199293.2:splice_region&intron:LOW:exon9/13:c.1058+8C>G:		rs12419447	0.1799	0.243	0.3307	0.1257						191290 [TH (confirmed) Segawa syndrome,recessive];				0.1061	0.4318	0.4621	83	360	n/a	n/a
chr11	2188238	2188238	C	T	het		QUAL=1840;DP=35;AF=0.43;MQM=60;TRIO=HET,35,0.43,WT,72,0.00,HET,94,0.51	TH	synonymous	TH:NM_199292.2:synonymous:LOW:exon8/14:c.813G>A:p.Lys271Lys,TH:NM_000360.3:synonymous:LOW:exon7/13:c.720G>A:p.Lys240Lys,TH:NM_199293.2:synonymous:LOW:exon8/14:c.801G>A:p.Lys267Lys		rs6357	0.1546	0.207	0.3089	0.1256						191290 [TH (confirmed) Segawa syndrome,recessive];			COSM3752293	0.0833	0.3864	0.5303	50	346	n/a	n/a
chr11	3877114	3877118	TCTCT	-	het		QUAL=2791;DP=60;AF=0.30;MQM=59;TRIO=HET,60,0.30,HET,70,0.26,HOM,68,0.97	STIM1	5'UTR	STIM1:NM_001277961.1:5'UTR:MODIFIER:exon1/12:c.-370_-366delTCTTC:,STIM1:NM_001277962.1:5'UTR:MODIFIER:exon1/13:c.-370_-366delTCTTC:,STIM1:NM_003156.3:5'UTR:MODIFIER:exon1/12:c.-370_-366delTCTTC:	(TTCTC)n	rs147711952	0.2688	0	0	0										0.0909	0.4621	0.447	13	68	n/a	n/a
chr11	4103524	4103524	A	G	hom		QUAL=16921;DP=212;AF=0.99;MQM=60;TRIO=HOM,212,0.99,HET,177,0.44,HOM,241,1.00	STIM1	synonymous	STIM1:NM_001277961.1:synonymous:LOW:exon8/12:c.1080A>G:p.Gln360Gln,STIM1:NM_001277962.1:synonymous:LOW:exon8/13:c.1080A>G:p.Gln360Gln,STIM1:NM_003156.3:synonymous:LOW:exon8/12:c.1080A>G:p.Gln360Gln		rs2304891	0.389	0.496	0.5745	0.1738	1.7940	P				605921 [STIM1 (provisional) Immunodeficiency 10|Myopathy,tubular aggregate,1 160565|Stormorken syndrome];			COSM428967	0.2879	0.4773	0.2348	127	218	n/a	n/a
chr11	4113395	4113395	G	A	hom		QUAL=23032;DP=300;AF=1.00;MQM=59;TRIO=HOM,300,1.00,HET,250,0.50,HOM,287,1.00	STIM1	3'UTR	STIM1:NM_001277961.1:3'UTR:MODIFIER:exon12/12:c.*367G>A:,STIM1:NM_001277962.1:3'UTR:MODIFIER:exon13/13:c.*839G>A:,STIM1:NM_003156.3:3'UTR:MODIFIER:exon12/12:c.*367G>A:		rs1561876	0.6941	0	0	0										0.7424	0.197	0.0606	112	30	n/a	n/a
chr11	4113471	4113471	G	A	het		QUAL=16432;DP=350;AF=0.52;MQM=60;TRIO=HET,350,0.52,HET,301,0.52,HET,356,0.48	STIM1	3'UTR	STIM1:NM_001277961.1:3'UTR:MODIFIER:exon12/12:c.*443G>A:,STIM1:NM_001277962.1:3'UTR:MODIFIER:exon13/13:c.*915G>A:,STIM1:NM_003156.3:3'UTR:MODIFIER:exon12/12:c.*443G>A:		rs76833585	0.0397	0	0	0										0.0076	0.1364	0.8561	1	19	n/a	n/a
chr11	5248243	5248243	A	G	het		QUAL=25417;DP=396;AF=0.48;MQM=59;TRIO=HET,396,0.48,HET,366,0.47,HOM,420,1.00	HBB	synonymous	HBB:NM_000518.4:synonymous:LOW:exon1/3:c.9T>C:p.His3His		rs713040	0.7143	0.767	0.8409	0.8639						141900 [HBB (confirmed) Sickle cell anemia|Thalassemias,beta-|Erythremias,beta-|Methemoglobinemias,beta-|Heinz body anemias,beta-|Thalassemia-beta,dominant inclusion-body|Hereditary persistence of fetal hemoglobin|Delta-beta thalassemia|Malaria,resistance to];	RCV000016529.1 [other]; 			0.6515	0.3258	0.0227	302	135	n/a	n/a
chr11	6411935	6411935	T	C	het		QUAL=2988;DP=31;AF=0.68;MQM=60;TRIO=HET,31,0.97,WT,28,1.00,HOM,47,1.00	SMPD1	missense	SMPD1:NM_000543.4:missense:MODERATE:exon1/6:c.107T>C:p.Val36Ala,SMPD1:NM_001007593.2:missense:MODERATE:exon1/6:c.107T>C:p.Val36Ala		rs1050228	0.5613	0	0.5649	0.2405	0.5000	P	T	B,B	B,B	607608 [SMPD1 (confirmed) Niemann-Pick disease,type A|Niemann-Pick disease,type B];	RCV000079189.2 [benign]; 		COSM1561695	0.303	0.3712	0.3258	117	150	n/a	n/a
chr11	6411954	6411959	GCTGGC	-	het		QUAL=2988;DP=31;AF=0.68;MQM=60;TRIO=HET,31,0.97,HOM,28,1.00,WT,47,1.00	SMPD1	disruptive_inframe_deletion	SMPD1:NM_000543.4:disruptive_inframe_deletion:MODERATE:exon1/6:c.138_143delGCTGGC:p.Leu47_Ala48del,SMPD1:NM_001007593.2:disruptive_inframe_deletion:MODERATE:exon1/6:c.138_143delGCTGGC:p.Leu47_Ala48del			0	0	0	0						607608 [SMPD1 (confirmed) Niemann-Pick disease,type A|Niemann-Pick disease,type B];				0.1742	0.4015	0.4242	69	174	n/a	n/a
chr11	6415463	6415463	G	A	het		QUAL=14055;DP=348;AF=0.50;MQM=59;TRIO=HET,348,0.50,HOM,262,0.99,WT,341,0.00	SMPD1	missense	SMPD1:NM_000543.4:missense:MODERATE:exon6/6:c.1522G>A:p.Gly508Arg,SMPD1:NM_001007593.2:missense:MODERATE:exon6/6:c.1519G>A:p.Gly507Arg		rs1050239	0.15	0.192	0.2293	0.1372	6.2260	P	T	D,D,D	P,P,P	607608 [SMPD1 (confirmed) Niemann-Pick disease,type A|Niemann-Pick disease,type B];	RCV000079195.2 [benign]; 		COSM3752609	0.0379	0.3712	0.5909	12	141	n/a	n/a
chr11	6634149	6634149	C	T	het		QUAL=22102;DP=349;AF=0.49;MQM=60;TRIO=HET,349,0.49,HOM,312,1.00,HET,394,0.52	TPP1	3'UTR	TPP1:NM_000391.3:3'UTR:MODIFIER:exon13/13:c.*1628G>A:	L2c	rs7488	0.8103	0	0	0										0.5909	0.3636	0.0455	91	54	n/a	n/a
chr11	6634189	6634189	G	A	het		QUAL=17223;DP=433;AF=0.49;MQM=60;TRIO=HET,433,0.49,HET,286,0.52,HET,337,0.51	TPP1	3'UTR	TPP1:NM_000391.3:3'UTR:MODIFIER:exon13/13:c.*1588C>T:	L2c	rs7487	0.4489	0	0	0										0.3258	0.4697	0.2045	52	68	n/a	n/a
chr11	9800601	9800601	G	A	het		QUAL=7315;DP=188;AF=0.51;MQM=60;TRIO=HET,188,0.51,HET,66,0.61,HOM,87,1.00	SBF2	3'UTR	SBF2:NM_030962.3:3'UTR:MODIFIER:exon40/40:c.*1364C>T:		rs10118	0.6108	0	0	0										0.4242	0.5076	0.0682	68	73	n/a	n/a
chr11	9801925	9801925	T	G	het		QUAL=22073;DP=268;AF=0.47;MQM=60;TRIO=HET,268,0.47,HET,298,0.46,HOM,414,1.00	SBF2	3'UTR	SBF2:NM_030962.3:3'UTR:MODIFIER:exon40/40:c.*40A>C:		rs3751000	0.3275	0.301	0.2507	0.3144										0.0833	0.5076	0.4091	15	80	n/a	n/a
chr11	9812236	9812236	G	A	hom		QUAL=9379;DP=144;AF=1.00;MQM=59;TRIO=HOM,144,1.00,HOM,58,1.00,HOM,82,1.00	SBF2	splice_region&intron	SBF2:NM_030962.3:splice_region&intron:LOW:exon33/39:c.4571-6C>T:		rs2645029	0.8027	0.858	0.9	0.8565						607697 [SBF2 (confirmed) Charcot-Marie-Tooth disease,type 4B2];				0.8258	0.1591	0.0152	341	74	n/a	n/a
chr11	13514417	13514417	C	T	het		QUAL=10330;DP=232;AF=0.50;MQM=60;TRIO=HET,232,0.50,HET,133,0.49,HOM,138,1.00	PTH	splice_region&intron	PTH:NM_000315.2:splice_region&intron:LOW:exon1/2:c.-5-10G>A:		rs694	0.4177	0.549	0.6413	0.2647										0.4167	0.4621	0.1212	84	99	n/a	n/a
chr11	17408025	17408025	A	G	het		QUAL=5581;DP=161;AF=0.52;MQM=60;TRIO=HET,161,0.52,HET,230,0.42,WT,265,0.00	KCNJ11	3'UTR	KCNJ11:NM_000525.3:3'UTR:MODIFIER:exon1/1:c.*441T>C:,KCNJ11:NM_001166290.1:3'UTR:MODIFIER:exon2/2:c.*441T>C:		rs2285676	0.4689	0	0	0										0.0758	0.5606	0.3636	12	83	n/a	n/a
chr11	17408251	17408251	G	A	het		QUAL=7389;DP=250;AF=0.47;MQM=59;TRIO=HET,250,0.47,HET,297,0.44,WT,419,0.00	KCNJ11	3'UTR	KCNJ11:NM_000525.3:3'UTR:MODIFIER:exon1/1:c.*215C>T:,KCNJ11:NM_001166290.1:3'UTR:MODIFIER:exon2/2:c.*215C>T:		rs5210	0.4677	0	0	0								CS035715 [CLASS=DFP MUT=ALT PHEN="Diabetes, type 2, association with" GENE=KCNJ11]; 		0.0758	0.5606	0.3636	12	83	n/a	n/a
chr11	17408404	17408404	C	T	hom		QUAL=28788;DP=196;AF=0.99;MQM=59;TRIO=HOM,196,0.99,HOM,445,0.99,HET,614,0.50	KCNJ11	3'UTR	KCNJ11:NM_000525.3:3'UTR:MODIFIER:exon1/1:c.*62G>A:,KCNJ11:NM_001166290.1:3'UTR:MODIFIER:exon2/2:c.*62G>A:		rs5213	0.7358	0	0	0										0.4242	0.4848	0.0909	65	72	n/a	n/a
chr11	17408630	17408630	C	T	hom		QUAL=40942;DP=319;AF=0.99;MQM=59;TRIO=HOM,319,0.99,HOM,610,1.00,HET,756,0.48	KCNJ11	missense	KCNJ11:NM_000525.3:missense:MODERATE:exon1/1:c.1009G>A:p.Val337Ile,KCNJ11:NM_001166290.1:missense:MODERATE:exon2/2:c.748G>A:p.Val250Ile		rs5215	0.7306	0.645	0.6392	0.9132	-0.1400	P	T	B	B	600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2|Diabetes,permanent neonatal|Diabetes mellitus,permanent neonatal,with neurologic features|Diabetes mellitus,type 2,susceptibility to|Diabetes mellitus,transient neonatal,3];	RCV000146099.1 [benign]; 	CM078157 [CLASS=DP MUT=REF PHEN="Diabetes mellitus 2, association with" GENE=KCNJ11]; 		0.4167	0.5	0.0833	183	222	n/a	n/a
chr11	17408838	17408838	G	C	het		QUAL=12049;DP=270;AF=0.47;MQM=59;TRIO=HET,270,0.47,WT,410,0.00,HET,492,0.51	KCNJ11	synonymous	KCNJ11:NM_000525.3:synonymous:LOW:exon1/1:c.801C>G:p.Leu267Leu,KCNJ11:NM_001166290.1:synonymous:LOW:exon2/2:c.540C>G:p.Leu180Leu		rs5216	0.0134	0.017	0.0204	0.0055						600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2|Diabetes,permanent neonatal|Diabetes mellitus,permanent neonatal,with neurologic features|Diabetes mellitus,type 2,susceptibility to|Diabetes mellitus,transient neonatal,3];	RCV000146118.1 [benign]; 			0	0.0682	0.9318	0	23	n/a	n/a
chr11	17409069	17409069	G	A	het		QUAL=7713;DP=204;AF=0.49;MQM=60;TRIO=HET,204,0.49,HET,308,0.50,WT,378,0.00	KCNJ11	synonymous	KCNJ11:NM_000525.3:synonymous:LOW:exon1/1:c.570C>T:p.Ala190Ala,KCNJ11:NM_001166290.1:synonymous:LOW:exon2/2:c.309C>T:p.Ala103Ala		rs5218	0.2274	0.256	0.2985	0.0752						600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2|Diabetes,permanent neonatal|Diabetes mellitus,permanent neonatal,with neurologic features|Diabetes mellitus,type 2,susceptibility to|Diabetes mellitus,transient neonatal,3];	RCV000146111.1 [benign]; 	CM035697 [CLASS=DFP MUT=REF PHEN="Diabetes, type 2, association with" GENE=KCNJ11]; 	COSM3752262	0.0455	0.4167	0.5379	26	170	n/a	n/a
chr11	17409572	17409572	T	C	hom		QUAL=23302;DP=212;AF=1.00;MQM=59;TRIO=HOM,212,1.00,HOM,371,0.99,HET,427,0.48	KCNJ11	missense,intron	KCNJ11:NM_000525.3:missense:MODERATE:exon1/1:c.67A>G:p.Lys23Glu,KCNJ11:NM_001166290.1:intron:MODIFIER:exon1/1:c.-16-179A>G:		rs5219	0.737	0.647	0.6394	0.9307	2.0650	P	T	B	B	600937 [KCNJ11 (confirmed) Hyperinsulinemic hypoglycemia,familial,2|Diabetes,permanent neonatal|Diabetes mellitus,permanent neonatal,with neurologic features|Diabetes mellitus,type 2,susceptibility to|Diabetes mellitus,transient neonatal,3];	RCV000009214.1 [other]; RCV000009215.1 [drug response]; RCV000020356.1 [benign]; RCV000146116.1 [benign]; 	CM981121 [CLASS=DFP MUT=REF PHEN="Diabetes mellitus 2, association with" GENE=KCNJ11]; 	COSM3765554	0.4167	0.5	0.0833	183	221	n/a	n/a
chr11	17410136	17410136	A	G	het		QUAL=845;DP=56;AF=0.50;MQM=54;TRIO=HET,56,0.50,WT,24,0.00,HET,39,0.18	KCNJ11	5'UTR,intron	KCNJ11:NM_000525.3:5'UTR:MODIFIER:exon1/1:c.-498T>C:,KCNJ11:NM_001166290.1:intron:MODIFIER:exon1/1:c.-17+585T>C:	AluSg	rs529946415	0.003	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr11	17410145	17410145	A	-	het		QUAL=691;DP=38;AF=0.39;MQM=57;TRIO=HET,38,0.39,HET,17,0.59,WT,31,0.00	KCNJ11	5'UTR,intron	KCNJ11:NM_000525.3:5'UTR:MODIFIER:exon1/1:c.-507delT:,KCNJ11:NM_001166290.1:intron:MODIFIER:exon1/1:c.-17+576delT:	AluSg	rs397808534	0	0	0	0										0.0758	0.4621	0.4621	12	65	n/a	n/a
chr11	17418477	17418477	C	A	hom		QUAL=12723;DP=102;AF=0.99;MQM=60;TRIO=HOM,102,0.99,HOM,192,0.99,HET,326,0.46	ABCC8	missense	ABCC8:NM_001287174.1:missense:MODERATE:exon33/39:c.4108G>T:p.Ala1370Ser,ABCC8:NM_000352.4:missense:MODERATE:exon33/39:c.4105G>T:p.Ala1369Ser		rs757110	0.7264	0.643	0.6394	0.932	0.1700	P,P	T,.	B,.	B,.	600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1|Hypoglycemia of infancy,leucine-sensitive|Diabetes mellitus,transient neonatal 2, 610374|Diabetes mellitus,noninsulin-dependent|Diabetes mellitus,permanent neonatal];	RCV000144996.1 [likely benign]; 	CM004821 [CLASS=DFP MUT=REF PHEN="Enhanced insulin secretion in pregnancy, association" GENE=ABCC8]; 		0.4015	0.5152	0.0833	176	226	n/a	n/a
chr11	17419279	17419279	C	T	het		QUAL=6114;DP=121;AF=0.58;MQM=59;TRIO=HET,121,0.58,WT,130,0.00,HET,215,0.61	ABCC8	synonymous	ABCC8:NM_001287174.1:synonymous:LOW:exon31/39:c.3822G>A:p.Arg1274Arg,ABCC8:NM_000352.4:synonymous:LOW:exon31/39:c.3819G>A:p.Arg1273Arg		rs1799859	0.391	0.295	0.2695	0.6832	0.3110	P				600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1|Hypoglycemia of infancy,leucine-sensitive|Diabetes mellitus,transient neonatal 2, 610374|Diabetes mellitus,noninsulin-dependent|Diabetes mellitus,permanent neonatal];	RCV000144994.1 [likely benign]; 	CM981881 [CLASS=DP MUT=ALT PHEN="Hyperinsulinaemia, association with" GENE=ABCC8]; 	COSM3752264	0.0682	0.4697	0.4621	37	191	n/a	n/a
chr11	17448704	17448704	G	A	het		QUAL=4458;DP=138;AF=0.44;MQM=60;TRIO=HET,138,0.44,HET,221,0.44,WT,338,0.00	ABCC8	splice_region&intron	ABCC8:NM_001287174.1:splice_region&intron:LOW:exon15/38:c.2117-3C>T:,ABCC8:NM_000352.4:splice_region&intron:LOW:exon15/38:c.2117-3C>T:		rs1799854	0.3684	0.428	0.4429	0.1793						600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1|Hypoglycemia of infancy,leucine-sensitive|Diabetes mellitus,transient neonatal 2, 610374|Diabetes mellitus,noninsulin-dependent|Diabetes mellitus,permanent neonatal];		CS991507 [CLASS=DP MUT=ALT PHEN="Diabetes mellitus 2, association with" GENE=ABCC8]; 		0.2576	0.4015	0.3409	100	207	n/a	n/a
chr11	17496516	17496516	A	G	het		QUAL=11124;DP=311;AF=0.52;MQM=60;TRIO=HET,311,0.52,HET,404,0.45,WT,531,0.00	ABCC8	synonymous	ABCC8:NM_001287174.1:synonymous:LOW:exon2/39:c.207T>C:p.Pro69Pro,ABCC8:NM_000352.4:synonymous:LOW:exon2/39:c.207T>C:p.Pro69Pro		rs1048099	0.4393	0.474	0.5102	0.4116						600509 [ABCC8 (confirmed) Hyperinsulinemic hypoglycemia,familial,1|Hypoglycemia of infancy,leucine-sensitive|Diabetes mellitus,transient neonatal 2, 610374|Diabetes mellitus,noninsulin-dependent|Diabetes mellitus,permanent neonatal];	RCV000144982.1 [likely benign]; 	CM129527 [CLASS=DFP MUT=ALT PHEN="Diabetes mellitus, protection against" GENE=ABCC8]; 	COSM3752266	0.2424	0.5076	0.25	127	224	n/a	n/a
chr11	17515459	17515459	-	TGTT	het		QUAL=5211;DP=122;AF=0.86;MQM=60;TRIO=HET,122,0.86,HOM,55,0.98,HET,77,0.44	USH1C	3'UTR	USH1C:NM_153676.3:3'UTR:MODIFIER:exon27/27:c.*419_*420insAACA:,USH1C:NM_001297764.1:3'UTR:MODIFIER:exon20/20:c.*451_*452insAACA:,USH1C:NM_005709.3:3'UTR:MODIFIER:exon21/21:c.*451_*452insAACA:		rs10649542	0.9453	0	0	0										0.803	0.197	0	122	28	n/a	n/a
chr11	17515668	17515668	T	C	het		QUAL=10997;DP=312;AF=0.47;MQM=59;TRIO=HET,312,0.47,HET,425,0.47,WT,569,0.00	USH1C	3'UTR	USH1C:NM_153676.3:3'UTR:MODIFIER:exon27/27:c.*211A>G:,USH1C:NM_001297764.1:3'UTR:MODIFIER:exon20/20:c.*243A>G:,USH1C:NM_005709.3:3'UTR:MODIFIER:exon21/21:c.*243A>G:		rs1055581	0.3826	0	0	0										0.25	0.4848	0.2652	42	71	n/a	n/a
chr11	17515693	17515693	G	A	het		QUAL=11102;DP=313;AF=0.47;MQM=59;TRIO=HET,313,0.47,HET,428,0.48,WT,583,0.00	USH1C	3'UTR	USH1C:NM_153676.3:3'UTR:MODIFIER:exon27/27:c.*186C>T:,USH1C:NM_001297764.1:3'UTR:MODIFIER:exon20/20:c.*218C>T:,USH1C:NM_005709.3:3'UTR:MODIFIER:exon21/21:c.*218C>T:		rs1055577	0.3666	0	0	0										0.2424	0.4848	0.2727	41	71	n/a	n/a
chr11	17515833	17515833	A	G	het		QUAL=8986;DP=275;AF=0.53;MQM=60;TRIO=HET,275,0.53,HET,304,0.49,WT,434,0.00	USH1C	3'UTR	USH1C:NM_153676.3:3'UTR:MODIFIER:exon27/27:c.*46T>C:,USH1C:NM_001297764.1:3'UTR:MODIFIER:exon20/20:c.*78T>C:,USH1C:NM_005709.3:3'UTR:MODIFIER:exon21/21:c.*78T>C:		rs1055574	0.3704	0.407	0.4718	0.4145										0.25	0.4848	0.2652	43	83	n/a	n/a
chr11	17519742	17519742	C	G	het		QUAL=10825;DP=360;AF=0.47;MQM=59;TRIO=HET,360,0.47,HET,363,0.49,WT,580,0.00	USH1C	missense	USH1C:NM_153676.3:missense:MODERATE:exon24/27:c.2457G>C:p.Glu819Asp,USH1C:NM_001297764.1:missense:MODERATE:exon18/20:c.1500G>C:p.Glu500Asp,USH1C:NM_005709.3:missense:MODERATE:exon19/21:c.1557G>C:p.Glu519Asp		rs1064074	0.4209	0.487	0.5594	0.4286	0.6000	P	T	B,B,B	B,B,B	605242 [USH1C (confirmed) Usher syndrome,type 1C|Deafness,autosomal recessive 18A];	RCV000041279.2 [benign]; 		COSM3736035	0.3258	0.4848	0.1894	150	210	n/a	n/a
chr11	17542439	17542439	T	C	hom		QUAL=21425;DP=204;AF=0.99;MQM=60;TRIO=HOM,204,0.99,HET,252,0.50,HOM,347,0.99	USH1C	synonymous	USH1C:NM_153676.3:synonymous:LOW:exon14/27:c.1188A>G:p.Pro396Pro,USH1C:NM_001297764.1:synonymous:LOW:exon13/20:c.1131A>G:p.Pro377Pro,USH1C:NM_005709.3:synonymous:LOW:exon14/21:c.1188A>G:p.Pro396Pro		rs2240487	0.5164	0.569	0.5795	0.3566						605242 [USH1C (confirmed) Usher syndrome,type 1C|Deafness,autosomal recessive 18A];	RCV000041251.2 [benign]; 		COSM4145599	0.2879	0.4318	0.2803	142	213	n/a	n/a
chr11	22214903	22214903	G	C	het		QUAL=8288;DP=56;AF=0.38;MQM=59;TRIO=HET,56,0.38,WT,285,0.00,HOM,264,1.00	ANO5	5'UTR	ANO5:NM_213599.2:5'UTR:MODIFIER:exon1/22:c.-136G>C:,ANO5:NM_001142649.1:5'UTR:MODIFIER:exon1/22:c.-136G>C:		rs12792259	0.7899	0	0	0							RCV000128763.1 [not provided]; 			0.7197	0.2348	0.0455	109	35	n/a	n/a
chr11	22242729	22242729	T	C	het		QUAL=14483;DP=365;AF=0.57;MQM=60;TRIO=HET,365,0.57,WT,201,0.01,HOM,229,1.00	ANO5	synonymous	ANO5:NM_213599.2:synonymous:LOW:exon5/22:c.267T>C:p.Asp89Asp,ANO5:NM_001142649.1:synonymous:LOW:exon5/22:c.264T>C:p.Asp88Asp		rs4312063	0.7899	0.776	0.7996	0.9319						608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia|Muscular dystrophy,limb-girdle,type 2L|Miyoshi muscular dystrophy 3];	RCV000082848.3 [benign]; RCV000128783.1 [not provided]; 		COSM3998372	0.7045	0.2576	0.0379	293	146	n/a	n/a
chr11	22271870	22271870	A	T	het		QUAL=8125;DP=188;AF=0.46;MQM=60;TRIO=HET,188,0.46,WT,146,0.00,HOM,161,0.99	ANO5	missense	ANO5:NM_213599.2:missense:MODERATE:exon10/22:c.966A>T:p.Leu322Phe,ANO5:NM_001142649.1:missense:MODERATE:exon10/22:c.963A>T:p.Leu321Phe		rs7481951	0	0.48	0.5862	0.1802	-0.0010	P	T	B	B	608662 [ANO5 (confirmed) Gnathodiaphyseal dysplasia|Muscular dystrophy,limb-girdle,type 2L|Miyoshi muscular dystrophy 3];	RCV000082855.3 [benign]; RCV000128791.1 [not provided]; 		COSM3998373	0.3712	0.4773	0.1515	151	233	n/a	n/a
chr11	22301411	22301411	T	-	het		QUAL=3523;DP=99;AF=0.35;MQM=60;TRIO=HET,99,0.35,HOM,26,0.88,WT,36,0.03	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*113delT:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*113delT:	(T)n		0	0	0	0										0.0758	0.3333	0.5909	12	47	n/a	n/a
chr11	22301411	22301412	TT	-	het		QUAL=3523;DP=99;AF=0.43;MQM=60;TRIO=HET,99,0.43,WT,26,0.00,HOM,36,0.81	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*112_*113delTT:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*112_*113delTT:	(T)n	rs398015551	0	0	0	0										0.7045	0.2045	0.0909	104	30	n/a	n/a
chr11	22301807	22301807	A	G	het		QUAL=12003;DP=317;AF=0.56;MQM=60;TRIO=HET,317,0.56,WT,136,0.00,HOM,182,1.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*496A>G:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*496A>G:		rs10766930	0.4441	0	0	0										0.4167	0.4924	0.0909	61	73	n/a	n/a
chr11	22302597	22302597	G	T	het		QUAL=8105;DP=222;AF=0.47;MQM=60;TRIO=HET,222,0.47,WT,114,0.01,HOM,144,1.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*1286G>T:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*1286G>T:		rs7925081	0.5675	0	0	0										0.447	0.4621	0.0909	64	70	n/a	n/a
chr11	22303068	22303068	A	-	het		QUAL=12925;DP=237;AF=0.48;MQM=60;TRIO=HET,237,0.48,WT,225,0.00,HOM,291,0.99	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*1762delA:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*1762delA:		rs398015552	0.4702	0	0	0										0.4242	0.4848	0.0909	61	74	n/a	n/a
chr11	22303201	22303204	AAGA	-	het		QUAL=13136;DP=245;AF=0.50;MQM=60;TRIO=HET,245,0.50,WT,225,0.00,HOM,288,1.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*1894_*1897delAAGA:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*1894_*1897delAAGA:		rs397786204	0.4527	0	0	0										0.4242	0.4848	0.0909	61	74	n/a	n/a
chr11	22303406	22303406	G	A	het		QUAL=9381;DP=397;AF=0.51;MQM=60;TRIO=HET,397,0.51,HOM,76,1.00,WT,119,0.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*2095G>A:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*2095G>A:		rs142192440	0.0052	0	0	0										0.0076	0.0303	0.9621	1	6	n/a	n/a
chr11	22304489	22304489	C	G	het		QUAL=8393;DP=217;AF=0.50;MQM=60;TRIO=HET,217,0.50,WT,94,0.00,HOM,147,1.00	ANO5	3'UTR	ANO5:NM_213599.2:3'UTR:MODIFIER:exon22/22:c.*3178C>G:,ANO5:NM_001142649.1:3'UTR:MODIFIER:exon22/22:c.*3178C>G:		rs6483841	0.6929	0	0	0										0.5076	0.4091	0.0833	72	64	n/a	n/a
chr11	22644893	22644893	-	T	hom		QUAL=7163;DP=164;AF=0.99;MQM=60;TRIO=HOM,164,0.99,HOM,30,1.00,HOM,27,1.00	FANCF	3'UTR	FANCF:NM_022725.3:3'UTR:MODIFIER:exon1/1:c.*1338dupA:		rs66534067	0	0	0	0										1	0	0	150	0	n/a	n/a
chr11	22645413	22645413	G	A	hom		QUAL=5576;DP=81;AF=1.00;MQM=59;TRIO=HOM,81,1.00,HOM,55,1.00,HOM,58,1.00	FANCF	3'UTR	FANCF:NM_022725.3:3'UTR:MODIFIER:exon1/1:c.*819C>T:	AluSx3	rs450946	0.9491	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr11	22645600	22645600	C	T	hom		QUAL=9052;DP=173;AF=1.00;MQM=60;TRIO=HOM,173,1.00,HOM,46,1.00,HOM,63,1.00	FANCF	3'UTR	FANCF:NM_022725.3:3'UTR:MODIFIER:exon1/1:c.*632G>A:		rs444923	0.9714	0	0	0										1	0	0	150	0	n/a	n/a
chr11	22646025	22646025	G	A	hom		QUAL=26222;DP=379;AF=0.99;MQM=60;TRIO=HOM,379,0.99,HOM,194,1.00,HOM,214,1.00	FANCF	3'UTR	FANCF:NM_022725.3:3'UTR:MODIFIER:exon1/1:c.*207C>T:		rs4447177	0.7037	0	0	0										0.6894	0.2803	0.0303	104	39	n/a	n/a
chr11	30352473	30352473	-	AG	hom		QUAL=12736;DP=206;AF=0.98;MQM=60;TRIO=HOM,206,0.98,HOM,98,0.95,HOM,124,0.98	ARL14EP	5'UTR	ARL14EP:NM_152316.1:5'UTR:MODIFIER:exon2/4:c.-23_-22insAG:		rs35824273	0	0.686	0	0										0.4621	0.4167	0.1212	70	75	n/a	n/a
chr11	30358475	30358475	A	T	hom		QUAL=18992;DP=313;AF=1.00;MQM=59;TRIO=HOM,313,1.00,HOM,126,1.00,HOM,134,1.00	ARL14EP	3'UTR	ARL14EP:NM_152316.1:3'UTR:MODIFIER:exon4/4:c.*133A>T:		rs1222206	1	0	0	0										1	0	0	150	0	n/a	n/a
chr11	31807524	31807524	C	T	hom		QUAL=19697;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,130,1.00,HOM,182,1.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*3958G>A:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*3958G>A:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*3958G>A:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*3958G>A:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*3958G>A:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*3958G>A:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*3958G>A:		rs3026401	0.6432	0	0	0										0.5833	0.3182	0.0985	88	48	n/a	n/a
chr11	31808235	31808235	-	AAAA	het		QUAL=13320;DP=190;AF=0.85;MQM=59;TRIO=HET,190,0.85,HET,141,0.89,HET,179,0.92	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*3246_*3247insTTTT:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*3246_*3247insTTTT:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*3246_*3247insTTTT:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*3246_*3247insTTTT:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*3246_*3247insTTTT:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*3246_*3247insTTTT:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*3246_*3247insTTTT:		rs397768344	0.4946	0	0	0										0.4621	0.4394	0.0985	70	65	n/a	n/a
chr11	31808280	31808280	C	T	hom		QUAL=18147;DP=220;AF=1.00;MQM=60;TRIO=HOM,220,1.00,HOM,150,1.00,HOM,181,1.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*3202G>A:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*3202G>A:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*3202G>A:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*3202G>A:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*3202G>A:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*3202G>A:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*3202G>A:		rs608293	0.8498	0	0	0										0.7197	0.2652	0.0152	111	36	n/a	n/a
chr11	31808585	31808585	-	AAAT	hom		QUAL=12960;DP=201;AF=0.96;MQM=59;TRIO=HOM,201,0.96,HOM,99,0.98,HOM,142,0.94	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*2893_*2896dupATTT:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*2893_*2896dupATTT:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*2893_*2896dupATTT:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*2893_*2896dupATTT:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*2893_*2896dupATTT:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*2893_*2896dupATTT:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*2893_*2896dupATTT:	AT_rich	rs397795797	0.8478	0	0	0										0.7197	0.2652	0.0152	110	37	n/a	n/a
chr11	31808775	31808775	G	A	het		QUAL=11889;DP=289;AF=0.50;MQM=59;TRIO=HET,289,0.50,HOM,240,0.99,WT,284,0.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*2707C>T:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*2707C>T:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*2707C>T:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*2707C>T:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*2707C>T:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*2707C>T:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*2707C>T:		rs3026398	0.154	0	0	0										0.0833	0.3409	0.5758	15	53	n/a	n/a
chr11	31809322	31809322	C	T	het		QUAL=11434;DP=272;AF=0.52;MQM=60;TRIO=HET,272,0.52,WT,164,0.01,HOM,207,1.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*2160G>A:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*2160G>A:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*2160G>A:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*2160G>A:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*2160G>A:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*2160G>A:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*2160G>A:		rs12421026	0.4479	0	0	0										0.2576	0.4621	0.2803	38	69	n/a	n/a
chr11	31810298	31810298	T	A	hom		QUAL=28805;DP=393;AF=1.00;MQM=60;TRIO=HOM,393,1.00,HOM,201,1.00,HOM,277,1.00	PAX6	3'UTR	PAX6:NM_001258462.1:3'UTR:MODIFIER:exon14/14:c.*1184A>T:,PAX6:NM_001258465.1:3'UTR:MODIFIER:exon12/12:c.*1184A>T:,PAX6:NM_000280.4:3'UTR:MODIFIER:exon13/13:c.*1184A>T:,PAX6:NM_001258464.1:3'UTR:MODIFIER:exon13/13:c.*1184A>T:,PAX6:NM_001604.5:3'UTR:MODIFIER:exon14/14:c.*1184A>T:,PAX6:NM_001258463.1:3'UTR:MODIFIER:exon14/14:c.*1184A>T:,PAX6:NM_001127612.1:3'UTR:MODIFIER:exon13/13:c.*1184A>T:		rs1506	0.6609	0	0	0										0.6061	0.3182	0.0758	91	48	n/a	n/a
chr11	32409565	32409566	CA	-	het		QUAL=745;DP=77;AF=0.00;MQM=60;TRIO=HET,77,0.00,HET,58,0.02,WT,53,0.26	WT1	3'UTR	WT1:NM_024426.4:3'UTR:MODIFIER:exon10/10:c.*1038_*1039delTG:,WT1:NM_001198551.1:3'UTR:MODIFIER:exon10/10:c.*1038_*1039delTG:,WT1:NM_001198552.1:3'UTR:MODIFIER:exon9/9:c.*1038_*1039delTG:,WT1:NM_000378.4:3'UTR:MODIFIER:exon9/9:c.*1038_*1039delTG:,WT1:NM_024424.3:3'UTR:MODIFIER:exon10/10:c.*1038_*1039delTG:	(CA)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr11	32456298	32456298	G	A	het		QUAL=3068;DP=71;AF=0.35;MQM=60;TRIO=HET,71,0.35,HET,166,0.48,WT,233,0.00	WT1	synonymous	WT1:NM_024426.4:synonymous:LOW:exon1/10:c.594C>T:p.Asn198Asn,WT1:NM_000378.4:synonymous:LOW:exon1/9:c.594C>T:p.Asn198Asn,WT1:NM_024424.3:synonymous:LOW:exon1/10:c.594C>T:p.Asn198Asn		rs2234583	0.1212	0.078	0.0668	0.2645						607102 [WT1 (confirmed) Wilms tumor,type 1|Denys-Drash syndrome|Nephrotic syndrome,type 4|Frasier syndrome|Meacham syndrome|Mesothelioma,somatic];				0.0076	0.2121	0.7803	5	104	n/a	n/a
chr11	32456694	32456694	C	A	het		QUAL=233;DP=8;AF=0.63;MQM=60;TRIO=HET,8,0.63,HET,11,0.55,WT,10,0.00	WT1	synonymous	WT1:NM_024426.4:synonymous:LOW:exon1/10:c.198G>T:p.Pro66Pro,WT1:NM_000378.4:synonymous:LOW:exon1/9:c.198G>T:p.Pro66Pro,WT1:NM_024424.3:synonymous:LOW:exon1/10:c.198G>T:p.Pro66Pro		rs2234582	0.3017	0.127	0.1961	0.4748						607102 [WT1 (confirmed) Wilms tumor,type 1|Denys-Drash syndrome|Nephrotic syndrome,type 4|Frasier syndrome|Meacham syndrome|Mesothelioma,somatic];			COSM4145655	0.0985	0.2045	0.697	39	135	n/a	n/a
chr11	33724780	33724780	T	C	hom		QUAL=19834;DP=354;AF=0.99;MQM=60;TRIO=HOM,354,0.99,HET,209,0.51,HET,287,0.50	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*6892A>G:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*6892A>G:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*6892A>G:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*6892A>G:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*6892A>G:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*6892A>G:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*6892A>G:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*6892A>G:		rs704697	0.5096	0	0	0										0.3106	0.5076	0.1818	45	74	n/a	n/a
chr11	33724992	33724992	T	C	hom		QUAL=18371;DP=325;AF=0.98;MQM=60;TRIO=HOM,325,0.98,HET,219,0.50,HET,288,0.48	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*6680A>G:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*6680A>G:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*6680A>G:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*6680A>G:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*6680A>G:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*6680A>G:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*6680A>G:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*6680A>G:		rs1047581	0.2103	0	0	0										0.1061	0.4167	0.4773	16	63	n/a	n/a
chr11	33726222	33726222	G	A	hom		QUAL=20212;DP=367;AF=0.99;MQM=60;TRIO=HOM,367,0.99,HET,243,0.49,HET,304,0.52	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*5450C>T:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*5450C>T:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*5450C>T:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*5450C>T:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*5450C>T:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*5450C>T:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*5450C>T:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*5450C>T:	MIR	rs1546727	0.1589	0	0	0										0.1061	0.4167	0.4773	16	63	n/a	n/a
chr11	33726290	33726290	C	A	hom		QUAL=14232;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HET,203,0.50,HET,263,0.51	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*5382G>T:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*5382G>T:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*5382G>T:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*5382G>T:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*5382G>T:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*5382G>T:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*5382G>T:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*5382G>T:		rs36093484	0.1863	0	0	0										0.1061	0.4091	0.4848	16	62	n/a	n/a
chr11	33726544	33726544	C	G	hom		QUAL=13708;DP=254;AF=1.00;MQM=60;TRIO=HOM,254,1.00,HET,142,0.49,HET,177,0.53	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*5128G>C:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*5128G>C:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*5128G>C:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*5128G>C:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*5128G>C:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*5128G>C:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*5128G>C:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*5128G>C:		rs12364970	0.1571	0	0	0										0.1061	0.4167	0.4773	16	63	n/a	n/a
chr11	33726980	33726980	A	G	hom		QUAL=23880;DP=339;AF=1.00;MQM=59;TRIO=HOM,339,1.00,HOM,231,0.99,HET,336,0.51	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*4692T>C:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*4692T>C:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*4692T>C:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*4692T>C:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*4692T>C:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*4692T>C:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*4692T>C:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*4692T>C:		rs7046	0.641	0	0	0										0.3939	0.4545	0.1515	57	66	n/a	n/a
chr11	33728614	33728614	T	G	hom		QUAL=16573;DP=354;AF=0.99;MQM=60;TRIO=HOM,354,0.99,HET,146,0.48,HET,197,0.44	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*3058A>C:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*3058A>C:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*3058A>C:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*3058A>C:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*3058A>C:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*3058A>C:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*3058A>C:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*3058A>C:		rs831618	0.5092	0	0	0										0.3182	0.5	0.1818	46	73	n/a	n/a
chr11	33730060	33730060	A	C	hom		QUAL=4301;DP=92;AF=0.98;MQM=60;TRIO=HOM,92,0.98,HET,45,0.69,HET,50,0.50	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*1612T>G:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*1612T>G:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*1612T>G:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*1612T>G:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*1612T>G:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*1612T>G:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*1612T>G:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*1612T>G:		rs11032350	0.1583	0	0	0										0.1061	0.3939	0.5	16	60	n/a	n/a
chr11	33730261	33730261	G	T	hom		QUAL=15406;DP=194;AF=0.98;MQM=60;TRIO=HOM,194,0.98,HET,240,0.58,HET,313,0.47	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*1411C>A:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*1411C>A:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*1411C>A:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*1411C>A:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*1411C>A:		rs7357	0.1867	0	0	0										0.1061	0.4167	0.4773	16	62	n/a	n/a
chr11	33731406	33731406	C	T	hom		QUAL=14749;DP=265;AF=1.00;MQM=60;TRIO=HOM,265,1.00,HET,169,0.47,HET,215,0.48	CD59	3'UTR	CD59:NM_000611.5:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:NM_001127223.1:3'UTR:MODIFIER:exon3/3:c.*266G>A:,CD59:NM_001127225.1:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:NM_001127226.1:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:NM_001127227.1:3'UTR:MODIFIER:exon4/4:c.*266G>A:,CD59:NM_203329.2:3'UTR:MODIFIER:exon5/5:c.*266G>A:,CD59:NM_203330.2:3'UTR:MODIFIER:exon6/6:c.*266G>A:,CD59:NM_203331.2:3'UTR:MODIFIER:exon5/5:c.*266G>A:		rs842	0.1863	0	0	0										0.1061	0.4167	0.4773	16	63	n/a	n/a
chr11	33757941	33757941	A	G	hom		QUAL=4730;DP=31;AF=1.00;MQM=60;TRIO=HOM,31,1.00,HOM,75,1.00,HET,104,0.52	CD59	5'UTR_premature_start_codon_gain,5'UTR	CD59:NM_000611.5:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-32T>C:,CD59:NM_203329.2:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-148T>C:,CD59:NM_203330.2:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-193T>C:,CD59:NM_203331.2:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-77T>C:,CD59:NM_000611.5:5'UTR:MODIFIER:exon1/4:c.-32T>C:,CD59:NM_203329.2:5'UTR:MODIFIER:exon1/5:c.-148T>C:,CD59:NM_203330.2:5'UTR:MODIFIER:exon1/6:c.-193T>C:,CD59:NM_203331.2:5'UTR:MODIFIER:exon1/5:c.-77T>C:		rs13614	0.6468	0	0	0										0.4242	0.4621	0.1136	63	68	n/a	n/a
chr11	34937697	34937697	T	C	hom		QUAL=2143;DP=24;AF=0.38;MQM=59;TRIO=HOM,24,1.00,HET,41,0.56,HOM,33,1.00	PDHX,APIP	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-506T>C:,PDHX:NM_001135024.1:5'UTR:MODIFIER:exon1/11:c.-222T>C:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-506T>C:,APIP:NM_015957.3:intron:MODIFIER:exon1/6:c.57+78A>G:		rs2016814	0.7722	0	0	0										0.5909	0.3409	0.0682	84	53	n/a	n/a
chr11	34937698	34937698	G	A	het		QUAL=2143;DP=24;AF=0.38;MQM=59;TRIO=HET,24,1.00,WT,41,0.56,HOM,33,1.00	PDHX,APIP	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-505G>A:,PDHX:NM_001135024.1:5'UTR:MODIFIER:exon1/11:c.-221G>A:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-505G>A:,APIP:NM_015957.3:intron:MODIFIER:exon1/6:c.57+77C>T:		rs16926448	0.1927	0	0	0										0.053	0.1667	0.7803	7	24	n/a	n/a
chr11	34937901	34937901	A	G	hom		QUAL=3982;DP=40;AF=1.00;MQM=59;TRIO=HOM,40,1.00,HET,54,0.54,HOM,64,1.00	PDHX,APIP	5'UTR_premature_start_codon_gain,5'UTR	PDHX:NM_003477.2:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-302A>G:,PDHX:NM_001135024.1:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-18A>G:,PDHX:NM_001166158.1:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-302A>G:,APIP:NM_015957.3:5'UTR:MODIFIER:exon1/7:c.-70T>C:,PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-302A>G:,PDHX:NM_001135024.1:5'UTR:MODIFIER:exon1/11:c.-18A>G:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-302A>G:		rs2956112	0.7626	0.751	0.8082	0.7829										0.6212	0.3182	0.0606	511	222	n/a	n/a
chr11	34938001	34938001	A	G	het		QUAL=1131;DP=15;AF=0.67;MQM=60;TRIO=HET,15,0.67,WT,17,0.00,HOM,29,1.00	PDHX	missense,5'UTR	PDHX:NM_001135024.1:missense:MODERATE:exon1/11:c.83A>G:p.Glu28Gly,PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-202A>G:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-202A>G:		rs113073242	0.1927	0.041	0	0	0.1540	P	T	B	B	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];			COSM3749158	0.0606	0.1591	0.7803	27	218	n/a	n/a
chr11	34938072	34938074	GGC	-	het		QUAL=1309;DP=16;AF=0.38;MQM=60;TRIO=HET,16,1.00,WT,14,0.29,HOM,42,0.81	PDHX	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-129_-127delCGG:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-129_-127delCGG:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+41_115+43delCGG:		rs371074122	0	0.048	0.1017	0.3331						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				0.053	0.1667	0.7803	8	26	n/a	n/a
chr11	34938074	34938074	C	T	het		QUAL=1309;DP=16;AF=0.38;MQM=60;TRIO=HET,16,1.00,HET,14,0.29,WT,42,0.81	PDHX	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-129C>T:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-129C>T:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+41C>T:		rs112032820	0.1206	0	0	0						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				0.1136	0.2879	0.5985	18	41	n/a	n/a
chr11	34938079	34938079	G	C	het		QUAL=1142;DP=34;AF=0.41;MQM=60;TRIO=HET,34,0.41,WT,27,0.00,HOM,33,0.97	PDHX	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-124G>C:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-124G>C:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+46G>C:		rs375130125	0.1925	0.042	0	0						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				0.0455	0.0909	0.8636	6	14	n/a	n/a
chr11	34938115	34938115	C	A	het		QUAL=2336;DP=120;AF=0.45;MQM=60;TRIO=HET,120,0.45,HET,65,0.49,WT,81,0.01	PDHX	5'UTR_premature_start_codon_gain,5'UTR,intron	PDHX:NM_003477.2:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-88C>A:,PDHX:NM_001166158.1:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-88C>A:,PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-88C>A:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-88C>A:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+82C>A:		rs2956110	0.5719	0	0	0						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				0.4318	0.4394	0.1288	62	68	n/a	n/a
chr11	34938199	34938199	C	G	het		QUAL=6957;DP=104;AF=0.64;MQM=59;TRIO=HET,104,0.64,WT,123,0.00,HOM,171,0.99	PDHX	5'UTR,intron	PDHX:NM_003477.2:5'UTR:MODIFIER:exon1/11:c.-4C>G:,PDHX:NM_001166158.1:5'UTR:MODIFIER:exon1/6:c.-4C>G:,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+166C>G:		rs3818401	0.1925	0.135	0.1105	0.394						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				0.0606	0.1591	0.7803	28	238	n/a	n/a
chr11	34938265	34938265	C	T	hom		QUAL=9708;DP=67;AF=0.49;MQM=60;TRIO=HOM,67,1.00,HET,132,0.51,HOM,197,0.99	PDHX	synonymous,intron	PDHX:NM_003477.2:synonymous:LOW:exon1/11:c.63C>T:p.Pro21Pro,PDHX:NM_001166158.1:synonymous:LOW:exon1/6:c.63C>T:p.Pro21Pro,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+232C>T:		rs2956109	0.7646	0.771	0.8023	0.7859						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				0.6212	0.3333	0.0455	730	334	n/a	n/a
chr11	34938269	34938269	C	T	het		QUAL=9708;DP=67;AF=0.49;MQM=60;TRIO=HET,67,1.00,WT,132,0.51,HOM,197,0.99	PDHX	missense,intron	PDHX:NM_003477.2:missense:MODERATE:exon1/11:c.67C>T:p.Arg23Cys,PDHX:NM_001166158.1:missense:MODERATE:exon1/6:c.67C>T:p.Arg23Cys,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+236C>T:		rs1049306	0.1925	0.134	0.1102	0.3921	-0.0800	P	T	B,B	B,B	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				0.0606	0.1591	0.7803	27	242	n/a	n/a
chr11	34938310	34938310	T	C	het		QUAL=9130;DP=135;AF=0.52;MQM=60;TRIO=HET,135,0.52,WT,158,0.01,HOM,226,1.00	PDHX	synonymous,intron	PDHX:NM_003477.2:synonymous:LOW:exon1/11:c.108T>C:p.Ser36Ser,PDHX:NM_001166158.1:synonymous:LOW:exon1/6:c.108T>C:p.Ser36Ser,PDHX:NM_001135024.1:intron:MODIFIER:exon1/10:c.115+277T>C:		rs1049307	0.1927	0.13	0.1101	0.3905						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];				0.0606	0.1591	0.7803	27	242	n/a	n/a
chr11	34969112	34969112	A	G	het		QUAL=6427;DP=231;AF=0.49;MQM=60;TRIO=HET,231,0.49,HET,160,0.53,WT,238,0.00	PDHX	missense	PDHX:NM_003477.2:missense:MODERATE:exon3/11:c.301A>G:p.Thr101Ala,PDHX:NM_001135024.1:missense:MODERATE:exon3/11:c.256A>G:p.Thr86Ala,PDHX:NM_001166158.1:missense:MODERATE:exon3/6:c.301A>G:p.Thr101Ala		rs11539202	0.1088	0.22	0.3215	0.0865	8.1290	P	T	D,P,B	D,B,B	608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];			COSM3752346	0.0606	0.3409	0.5985	90	445	n/a	n/a
chr11	34991727	34991727	T	C	het		QUAL=7009;DP=246;AF=0.50;MQM=60;TRIO=HET,246,0.50,HET,184,0.53,WT,195,0.00	PDHX	synonymous,intron	PDHX:NM_003477.2:synonymous:LOW:exon7/11:c.858T>C:p.Val286Val,PDHX:NM_001135024.1:synonymous:LOW:exon7/11:c.813T>C:p.Val271Val,PDHX:NM_001166158.1:intron:MODIFIER:exon3/5:c.343-14390T>C:		rs497582	0.5705	0.643	0.7049	0.3871						608769 [PDHX (confirmed) Lacticacidemia due to PDX1 deficiency];			COSM4145674	0.4242	0.4394	0.1364	513	488	n/a	n/a
chr11	35017205	35017205	G	T	het		QUAL=9558;DP=356;AF=0.53;MQM=60;TRIO=HET,356,0.53,HET,200,0.49,WT,237,0.00	PDHX	3'UTR	PDHX:NM_003477.2:3'UTR:MODIFIER:exon11/11:c.*486G>T:,PDHX:NM_001135024.1:3'UTR:MODIFIER:exon11/11:c.*486G>T:,PDHX:NM_001166158.1:3'UTR:MODIFIER:exon6/6:c.*486G>T:		rs9326	0.6248	0	0	0										0.4318	0.4394	0.1288	62	68	n/a	n/a
chr11	35017363	35017363	C	A	hom		QUAL=22864;DP=435;AF=1.00;MQM=59;TRIO=HOM,435,1.00,HET,175,0.41,HOM,180,0.99	PDHX	3'UTR	PDHX:NM_003477.2:3'UTR:MODIFIER:exon11/11:c.*644C>A:,PDHX:NM_001135024.1:3'UTR:MODIFIER:exon11/11:c.*644C>A:,PDHX:NM_001166158.1:3'UTR:MODIFIER:exon6/6:c.*644C>A:		rs7808	0.7816	0	0	0										0.6212	0.3258	0.053	88	54	n/a	n/a
chr11	36595600	36595600	A	G	het		QUAL=9114;DP=276;AF=0.50;MQM=60;TRIO=HET,276,0.50,WT,256,0.00,HET,310,0.45	RAG1	missense	RAG1:NM_000448.2:missense:MODERATE:exon2/2:c.746A>G:p.His249Arg		rs3740955	0.6134	0.447	0.336	0.7266	0.1690	P	T	B	B	179615 [RAG1 (confirmed) Severe combined immunodeficiency,B cell-negative|Omenn syndrome, 603554|Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion,severe cytomegalovirus infection,and autoimmunity|Combined cellular and humoral immune defects with granulomas];	RCV000127709.1 [benign]; 	CM122460 [CLASS=DM? MUT=ALT PHEN="Immunodeficiency, severe combined" GENE=RAG1]; 		0.1515	0.4697	0.3788	75	205	2	n/a
chr11	36601170	36601170	G	A	het		QUAL=3087;DP=169;AF=0.43;MQM=60;TRIO=HET,169,0.43,WT,28,0.00,HET,51,0.49	RAG1	3'UTR	RAG1:NM_000448.2:3'UTR:MODIFIER:exon2/2:c.*3184G>A:		rs1056403	0.6126	0	0	0										0.1515	0.4697	0.3788	23	70	n/a	n/a
chr11	36613807	36613807	T	C	het		QUAL=5895;DP=210;AF=0.52;MQM=60;TRIO=HET,210,0.52,WT,114,0.00,HET,130,0.55	RAG2	3'UTR	RAG2:NM_000536.3:3'UTR:MODIFIER:exon2/2:c.*328A>G:,RAG2:NM_001243785.1:3'UTR:MODIFIER:exon3/3:c.*328A>G:,RAG2:NM_001243786.1:3'UTR:MODIFIER:exon3/3:c.*328A>G:		rs10836573	0.6132	0	0	0										0.1515	0.4697	0.3788	21	71	n/a	n/a
chr11	44117102	44117102	T	C	het		QUAL=13901;DP=428;AF=0.57;MQM=60;TRIO=HET,428,0.57,HOM,202,0.99,WT,290,0.00	EXT2	5'UTR	EXT2:NM_001178083.1:5'UTR:MODIFIER:exon1/15:c.-331T>C:,EXT2:NM_207122.1:5'UTR:MODIFIER:exon1/14:c.-331T>C:		rs10458911	0.3061	0	0	0						608210 [EXT2 (confirmed) Exostoses,multiple,type 2];				0.0606	0.3561	0.5833	9	54	n/a	n/a
chr11	44117122	44117122	G	A	hom		QUAL=21485;DP=381;AF=1.00;MQM=59;TRIO=HOM,381,1.00,HOM,193,0.99,HET,290,0.51	EXT2	5'UTR	EXT2:NM_001178083.1:5'UTR:MODIFIER:exon1/15:c.-311G>A:,EXT2:NM_207122.1:5'UTR:MODIFIER:exon1/14:c.-311G>A:		rs3923808	0.5208	0	0	0						608210 [EXT2 (confirmed) Exostoses,multiple,type 2];				0.2803	0.5227	0.197	40	80	n/a	n/a
chr11	44283297	44283297	T	C	hom		QUAL=43639;DP=297;AF=1.00;MQM=60;TRIO=HOM,297,1.00,HOM,445,1.00,HOM,604,1.00	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*3107A>G:		rs4755239	0.9073	0	0	0										0.7348	0.2273	0.0379	114	31	n/a	n/a
chr11	44283722	44283722	G	A	het		QUAL=22407;DP=283;AF=0.51;MQM=60;TRIO=HET,283,0.51,HOM,349,1.00,HET,433,0.48	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*2682C>T:		rs897005	0.7326	0	0	0										0.3864	0.5	0.1136	61	73	n/a	n/a
chr11	44284294	44284294	T	C	hom		QUAL=17648;DP=283;AF=1.00;MQM=59;TRIO=HOM,283,1.00,HOM,113,1.00,HOM,144,1.00	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*2110A>G:		rs7105993	0.9918	0	0	0										1	0	0	150	0	n/a	n/a
chr11	44285857	44285857	T	C	hom		QUAL=21550;DP=138;AF=0.99;MQM=60;TRIO=HOM,138,0.99,HOM,250,1.00,HOM,314,1.00	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*547A>G:		rs4755796	0.8848	0	0	0										0.6591	0.3182	0.0227	100	47	n/a	n/a
chr11	44285887	44285887	G	A	hom		QUAL=22977;DP=148;AF=0.99;MQM=59;TRIO=HOM,148,0.99,HOM,261,1.00,HOM,320,1.00	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*517C>T:		rs4755797	0.756	0	0	0										0.4924	0.4091	0.0985	76	61	n/a	n/a
chr11	44286176	44286176	G	A	hom		QUAL=7023;DP=70;AF=1.00;MQM=60;TRIO=HOM,70,1.00,HET,141,0.46,HET,177,0.56	ALX4	3'UTR	ALX4:NM_021926.3:3'UTR:MODIFIER:exon4/4:c.*228C>T:		rs4755798	0.1991	0	0	0										0.0606	0.447	0.4924	10	65	n/a	n/a
chr11	44289071	44289071	G	A	hom		QUAL=8961;DP=117;AF=1.00;MQM=60;TRIO=HOM,117,1.00,HET,131,0.51,HET,195,0.55	ALX4	synonymous	ALX4:NM_021926.3:synonymous:LOW:exon3/4:c.879C>T:p.Leu293Leu		rs12419361	0.1036	0.11	0.1047	0.0572						605420 [ALX4 (provisional) Parietal foramina 2|Frontonasal dysplasia 2|Craniosynostosis 5,susceptibility to];				0.0227	0.1439	0.8333	10	90	n/a	n/a
chr11	44297054	44297054	T	C	hom		QUAL=8538;DP=55;AF=1.00;MQM=60;TRIO=HOM,55,1.00,HOM,106,1.00,HOM,110,1.00	ALX4	synonymous	ALX4:NM_021926.3:synonymous:LOW:exon2/4:c.621A>G:p.Ser207Ser		rs10769028	0.9916	0.998	0.9998	0.9746						605420 [ALX4 (provisional) Parietal foramina 2|Frontonasal dysplasia 2|Craniosynostosis 5,susceptibility to];			COSM4145711	1	0	0	453	1	n/a	n/a
chr11	44331309	44331309	G	A	het		QUAL=2081;DP=4;AF=0.25;MQM=60;TRIO=HET,4,0.25,HET,61,0.44,HET,85,0.54	ALX4	missense	ALX4:NM_021926.3:missense:MODERATE:exon1/4:c.304C>T:p.Pro102Ser		rs12421995	0.372	0.4	0	0		P	T	B	B	605420 [ALX4 (provisional) Parietal foramina 2|Frontonasal dysplasia 2|Craniosynostosis 5,susceptibility to];			COSM3749161	0.2121	0.4242	0.3636	85	194	n/a	n/a
chr11	44331509	44331509	C	G	het		QUAL=7104;DP=55;AF=0.49;MQM=60;TRIO=HET,55,0.49,HET,185,0.53,HET,235,0.45	ALX4	missense	ALX4:NM_021926.3:missense:MODERATE:exon1/4:c.104G>C:p.Arg35Thr		rs3824915	0.4726	0.482	0.4873	0.3009	5.2690	P	D	B	B	605420 [ALX4 (provisional) Parietal foramina 2|Frontonasal dysplasia 2|Craniosynostosis 5,susceptibility to];			COSM3752366	0.2652	0.5076	0.2273	105	233	n/a	n/a
chr11	45832935	45832935	G	A	hom		QUAL=17172;DP=171;AF=0.99;MQM=59;TRIO=HOM,171,0.99,HET,291,0.55,HET,422,0.56	SLC35C1	3'UTR	SLC35C1:NM_018389.4:3'UTR:MODIFIER:exon2/2:c.*49G>A:,SLC35C1:NM_001145265.1:3'UTR:MODIFIER:exon3/3:c.*49G>A:,SLC35C1:NM_001145266.1:3'UTR:MODIFIER:exon3/3:c.*49G>A:		rs1139266	0.4513	0.557	0.7916	0.3286										0.5152	0.4394	0.0455	115	88	n/a	n/a
chr11	45834044	45834044	C	T	hom		QUAL=18457;DP=191;AF=1.00;MQM=60;TRIO=HOM,191,1.00,HOM,184,1.00,HOM,218,1.00	SLC35C1	3'UTR	SLC35C1:NM_018389.4:3'UTR:MODIFIER:exon2/2:c.*1158C>T:,SLC35C1:NM_001145265.1:3'UTR:MODIFIER:exon3/3:c.*1158C>T:,SLC35C1:NM_001145266.1:3'UTR:MODIFIER:exon3/3:c.*1158C>T:	MLT1A0	rs4756027	0.7206	0	0	0										0.6667	0.303	0.0303	182	67	n/a	n/a
chr11	45834198	45834198	T	C	hom		QUAL=18687;DP=226;AF=1.00;MQM=59;TRIO=HOM,226,1.00,HOM,156,1.00,HOM,210,1.00	SLC35C1	3'UTR	SLC35C1:NM_018389.4:3'UTR:MODIFIER:exon2/2:c.*1312T>C:,SLC35C1:NM_001145265.1:3'UTR:MODIFIER:exon3/3:c.*1312T>C:,SLC35C1:NM_001145266.1:3'UTR:MODIFIER:exon3/3:c.*1312T>C:	MLT1A0	rs7943306	0.6538	0.748	0	0										0.6591	0.3106	0.0303	178	71	n/a	n/a
chr11	45931502	45931502	G	A	hom		QUAL=19755;DP=160;AF=0.99;MQM=60;TRIO=HOM,160,0.99,HET,244,0.48,HOM,358,1.00	PEX16	3'UTR	PEX16:NM_057174.2:3'UTR:MODIFIER:exon11/11:c.*138C>T:,PEX16:NM_004813.2:3'UTR:MODIFIER:exon11/11:c.*303C>T:		rs10838529	0.3936	0	0	0										0.4924	0.3864	0.1212	76	57	n/a	n/a
chr11	45935384	45935384	A	G	hom		QUAL=21605;DP=178;AF=1.00;MQM=60;TRIO=HOM,178,1.00,HET,251,0.47,HOM,390,1.00	PEX16	synonymous	PEX16:NM_057174.2:synonymous:LOW:exon9/11:c.873T>C:p.Tyr291Tyr,PEX16:NM_004813.2:synonymous:LOW:exon9/11:c.873T>C:p.Tyr291Tyr		rs1132349	0.6891	0.815	0.9191	0.6012						603360 [PEX16 (provisional) Peroxisome biogenesis disorder 8A,(Zellweger)|Peroxisome biogenesis disorder 8B];			COSM4145721	0.7273	0.25	0.0227	348	98	n/a	n/a
chr11	45937267	45937267	C	T	hom		QUAL=29886;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,301,1.00,HOM,445,1.00	PEX16	missense	PEX16:NM_057174.2:missense:MODERATE:exon4/11:c.346G>A:p.Val116Ile,PEX16:NM_004813.2:missense:MODERATE:exon4/11:c.346G>A:p.Val116Ile		rs10742772	1	1	0	0	3.7850	P	T	B,B	B,B	603360 [PEX16 (provisional) Peroxisome biogenesis disorder 8A,(Zellweger)|Peroxisome biogenesis disorder 8B];				1	0	0	454	0	n/a	n/a
chr11	47238522	47238522	T	C	hom		QUAL=1243;DP=20;AF=1.00;MQM=60;TRIO=HOM,20,1.00,HOM,10,1.00,HOM,10,1.00	DDB2	synonymous	DDB2:NM_000107.2:synonymous:LOW:exon3/10:c.378T>C:p.Thr126Thr,DDB2:NM_001300734.1:synonymous:LOW:exon3/6:c.378T>C:p.Thr126Thr		rs326212	0.9942	0.999	1	0.9861						600811 [DDB2 (provisional) Xeroderma pigmentosum,group E,DDB-negative subtype];				0.9697	0	0.0303	1155	1	n/a	n/a
chr11	47460306	47460306	A	G	hom		QUAL=1645;DP=17;AF=1.00;MQM=60;TRIO=HOM,17,1.00,HET,21,0.57,HOM,27,1.00	RAPSN	synonymous	RAPSN:NM_005055.4:synonymous:LOW:exon7/8:c.1143T>C:p.Pro381Pro,RAPSN:NM_032645.4:synonymous:LOW:exon5/6:c.966T>C:p.Pro322Pro		rs7126210	0.6248	0.611	0.7095	0.4229						601592 [RAPSN (provisional) Myasthenic syndrome,congenital,associated with acetylcholine receptor deficiency|Myasthenic syndrome,congenital,associated with facial dysmorphism and acetylcholine receptor deficiency|Fetal akinesia deformation sequence];	RCV000118117.2 [likely benign]; 		COSM3931321	0.5682	0.3106	0.1212	255	158	n/a	n/a
chr11	47463484	47463484	G	-	hom		QUAL=2251;DP=19;AF=0.95;MQM=59;TRIO=HOM,19,0.95,HET,47,0.28,HOM,52,1.00	RAPSN	splice_region&intron	RAPSN:NM_005055.4:splice_region&intron:LOW:exon3/7:c.691-11delC:,RAPSN:NM_032645.4:splice_region&intron:LOW:exon3/5:c.691-11delC:		rs397825047	0.6108	0.628	0.7161	0.3888						601592 [RAPSN (provisional) Myasthenic syndrome,congenital,associated with acetylcholine receptor deficiency|Myasthenic syndrome,congenital,associated with facial dysmorphism and acetylcholine receptor deficiency|Fetal akinesia deformation sequence];				0.3561	0.2273	0.4167	112	60	n/a	n/a
chr11	47469439	47469439	A	G	hom		QUAL=30188;DP=271;AF=1.00;MQM=60;TRIO=HOM,271,1.00,HET,419,0.45,HOM,518,1.00	RAPSN	synonymous	RAPSN:NM_005055.4:synonymous:LOW:exon2/8:c.456T>C:p.Tyr152Tyr,RAPSN:NM_032645.4:synonymous:LOW:exon2/6:c.456T>C:p.Tyr152Tyr		rs7111873	0.6256	0.679	0.7191	0.4269						601592 [RAPSN (provisional) Myasthenic syndrome,congenital,associated with acetylcholine receptor deficiency|Myasthenic syndrome,congenital,associated with facial dysmorphism and acetylcholine receptor deficiency|Fetal akinesia deformation sequence];	RCV000118119.2 [likely benign]; 			0.553	0.3333	0.1136	255	161	n/a	n/a
chr11	60236272	60236272	A	G	het		QUAL=14535;DP=345;AF=0.54;MQM=60;TRIO=HET,345,0.54,HOM,266,1.00,WT,323,0.01	MS4A1	3'UTR	MS4A1:NM_021950.3:3'UTR:MODIFIER:exon7/7:c.*331A>G:,MS4A1:NM_152866.2:3'UTR:MODIFIER:exon8/8:c.*331A>G:		rs1051756	0.638	0	0	0										0.3409	0.4773	0.1818	52	69	n/a	n/a
chr11	60237234	60237234	T	C	het		QUAL=6082;DP=236;AF=0.51;MQM=60;TRIO=HET,236,0.51,HET,140,0.49,WT,186,0.00	MS4A1	3'UTR	MS4A1:NM_021950.3:3'UTR:MODIFIER:exon7/7:c.*1293T>C:,MS4A1:NM_152866.2:3'UTR:MODIFIER:exon8/8:c.*1293T>C:		rs1051461	0.2228	0	0	0										0.0985	0.4394	0.4621	16	63	n/a	n/a
chr11	60237991	60237991	T	C	het		QUAL=8871;DP=350;AF=0.52;MQM=60;TRIO=HET,350,0.52,HOM,81,1.00,WT,105,0.00	MS4A1	3'UTR	MS4A1:NM_021950.3:3'UTR:MODIFIER:exon7/7:c.*2050T>C:,MS4A1:NM_152866.2:3'UTR:MODIFIER:exon8/8:c.*2050T>C:		rs1051593	0.4756	0	0	0										0.2273	0.5152	0.2576	36	75	n/a	n/a
chr11	60238054	60238054	C	T	het		QUAL=7476;DP=269;AF=0.49;MQM=60;TRIO=HET,269,0.49,HOM,94,1.00,WT,122,0.00	MS4A1	3'UTR	MS4A1:NM_021950.3:3'UTR:MODIFIER:exon7/7:c.*2113C>T:,MS4A1:NM_152866.2:3'UTR:MODIFIER:exon8/8:c.*2113C>T:		rs1051594	0.4742	0	0	0										0.2273	0.5227	0.25	35	77	n/a	n/a
chr11	61165280	61165280	G	A	het		QUAL=5021;DP=134;AF=0.44;MQM=60;TRIO=HET,134,0.44,HET,64,0.44,HOM,81,1.00	TMEM216	synonymous	TMEM216:NM_001173991.2:synonymous:LOW:exon4/5:c.264G>A:p.Pro88Pro,TMEM216:NM_001173990.2:synonymous:LOW:exon4/5:c.264G>A:p.Pro88Pro,TMEM216:NM_016499.5:synonymous:LOW:exon4/5:c.81G>A:p.Pro27Pro		rs3741265	0.8558	0.865	0.861	0.774						613277 [TMEM216 (confirmed) Joubert syndrome 2|Meckel syndrome 2];	RCV000114238.2 [likely benign]; 			0.8258	0.1591	0.0152	875	228	n/a	n/a
chr11	61165731	61165731	-	A	het		QUAL=8160;DP=181;AF=0.51;MQM=60;TRIO=HET,181,0.51,HET,103,0.54,HOM,128,0.95	TMEM216	splice_acceptor,splice_region&intron	TMEM216:NM_001173991.2:splice_acceptor:HIGH:exon4/4:c.432-2_432-1insA:,TMEM216:NM_016499.5:splice_acceptor:HIGH:exon4/4:c.249-2_249-1insA:,TMEM216:NM_001173990.2:splice_region&intron:LOW:exon4/4:c.432-11_432-10insA:		rs11382548	0.8558	0.858	0.8589	0.7614						613277 [TMEM216 (confirmed) Joubert syndrome 2|Meckel syndrome 2];				0.8258	0.1591	0.0152	751	178	n/a	n/a
chr11	61165741	61165741	G	C	het		QUAL=9487;DP=184;AF=0.55;MQM=60;TRIO=HET,184,0.55,HET,119,0.54,HOM,143,0.99	TMEM216	splice_acceptor,missense	TMEM216:NM_001173990.2:splice_acceptor:HIGH:exon4/4:c.432-1G>C:,TMEM216:NM_001173991.2:missense:MODERATE:exon5/5:c.440G>C:p.Arg147Thr,TMEM216:NM_016499.5:missense:MODERATE:exon5/5:c.257G>C:p.Arg86Thr		rs10897158	0.7196	0.813	0.85	0.392	0.7930	P,P	.,T			613277 [TMEM216 (confirmed) Joubert syndrome 2|Meckel syndrome 2];	RCV000114239.2 [benign]; 		COSM1582850	0.8182	0.1667	0.0152	865	244	n/a	n/a
chr11	61166306	61166306	G	A	het		QUAL=1223;DP=111;AF=0.34;MQM=60;TRIO=HET,111,0.34,WT,4,0.00,HOM,7,1.00	TMEM216	3'UTR	TMEM216:NM_001173991.2:3'UTR:MODIFIER:exon5/5:c.*558G>A:,TMEM216:NM_001173990.2:3'UTR:MODIFIER:exon5/5:c.*558G>A:,TMEM216:NM_016499.5:3'UTR:MODIFIER:exon5/5:c.*558G>A:		rs7607	0.7196	0	0	0										0.8106	0.1591	0.0303	123	23	n/a	n/a
chr11	61717607	61717607	C	T	het		QUAL=9506;DP=279;AF=0.47;MQM=60;TRIO=HET,279,0.47,WT,344,0.00,HET,391,0.47	BEST1	5'UTR	BEST1:NM_001139443.1:5'UTR:MODIFIER:exon1/9:c.-321C>T:,BEST1:NM_001300786.1:5'UTR:MODIFIER:exon1/9:c.-321C>T:,BEST1:NM_001300787.1:5'UTR:MODIFIER:exon1/10:c.-321C>T:,BEST1:NM_004183.3:5'UTR:MODIFIER:exon1/11:c.-329C>T:		rs972354	0.349	0	0	0										0.0227	0.1894	0.7879	3	26	n/a	n/a
chr11	61717715	61717715	T	C	het		QUAL=14787;DP=337;AF=0.51;MQM=60;TRIO=HET,337,0.51,HET,281,0.51,HET,309,0.47	BEST1	5'UTR	BEST1:NM_001139443.1:5'UTR:MODIFIER:exon1/9:c.-213T>C:,BEST1:NM_001300786.1:5'UTR:MODIFIER:exon1/9:c.-213T>C:,BEST1:NM_001300787.1:5'UTR:MODIFIER:exon1/10:c.-213T>C:,BEST1:NM_004183.3:5'UTR:MODIFIER:exon1/11:c.-221T>C:		rs972353	0.6793	0	0	0										0.1061	0.4394	0.4545	15	70	n/a	n/a
chr11	61719387	61719387	T	C	het		QUAL=594;DP=34;AF=0.50;MQM=60;TRIO=HET,34,0.50,HET,8,0.13,HET,12,0.50	BEST1	synonymous,intron	BEST1:NM_004183.3:synonymous:LOW:exon2/11:c.109T>C:p.Leu37Leu,BEST1:NM_001139443.1:intron:MODIFIER:exon1/8:c.-29+1488T>C:,BEST1:NM_001300786.1:intron:MODIFIER:exon1/8:c.-29+1488T>C:,BEST1:NM_001300787.1:intron:MODIFIER:exon1/9:c.-29+1488T>C:		rs1800007	0.6805	0.485	0.3097	0.7159						607854 [BEST1 (confirmed) Best macular dystrophy|Maculopathy,bull's-eye|Vitelliform macular dystrophy,adult-onset|Bestrophinopathy|Vitreoretinochoroidopathy|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma|Retinitis pigmentosa-50|Retinitis pigmentosa,concentric];	RCV000086084.1 [not provided]; RCV000152861.1 [benign]; 		COSM3752558	0.1061	0.3712	0.5227	51	190	n/a	n/a
chr11	61727438	61727438	C	T	het		QUAL=7456;DP=234;AF=0.50;MQM=60;TRIO=HET,234,0.50,WT,161,0.01,HET,246,0.50	BEST1	synonymous	BEST1:NM_001139443.1:synonymous:LOW:exon8/9:c.843C>T:p.Pro281Pro,BEST1:NM_001300786.1:synonymous:LOW:exon7/9:c.762C>T:p.Pro254Pro,BEST1:NM_001300787.1:synonymous:LOW:exon8/10:c.843C>T:p.Pro281Pro,BEST1:NM_004183.3:synonymous:LOW:exon9/11:c.1023C>T:p.Pro341Pro		rs1801390	0.014	0.022	0.0217	0.0334	-3.4650	D	D	B,B	B,B	607854 [BEST1 (confirmed) Best macular dystrophy|Maculopathy,bull's-eye|Vitelliform macular dystrophy,adult-onset|Bestrophinopathy|Vitreoretinochoroidopathy|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma|Retinitis pigmentosa-50|Retinitis pigmentosa,concentric];	RCV000086082.1 [not provided]; 			0	0.0379	0.9621	0	28	n/a	n/a
chr11	61730036	61730036	G	A	het		QUAL=10406;DP=271;AF=0.53;MQM=59;TRIO=HET,271,0.53,HET,203,0.51,HET,245,0.44	BEST1	synonymous	BEST1:NM_001139443.1:synonymous:LOW:exon9/9:c.1230G>A:p.Thr410Thr,BEST1:NM_001300786.1:synonymous:LOW:exon8/9:c.1149G>A:p.Thr383Thr,BEST1:NM_001300787.1:synonymous:LOW:exon9/10:c.1230G>A:p.Thr410Thr,BEST1:NM_004183.3:synonymous:LOW:exon10/11:c.1410G>A:p.Thr470Thr		rs149698	0.1122	0.227	0.3103	0.0858						607854 [BEST1 (confirmed) Best macular dystrophy|Maculopathy,bull's-eye|Vitelliform macular dystrophy,adult-onset|Bestrophinopathy|Vitreoretinochoroidopathy|Microcornea,rod-cone dystrophy,cataract,and posterior staphyloma|Retinitis pigmentosa-50|Retinitis pigmentosa,concentric];			COSM3752560	0.1061	0.4091	0.4848	44	184	n/a	n/a
chr11	63990997	63990997	C	-	het		QUAL=6793;DP=136;AF=0.38;MQM=59;TRIO=HET,136,0.38,HET,161,0.48,HET,228,0.46	FERMT3	3'UTR	FERMT3:NM_178443.2:3'UTR:MODIFIER:exon15/15:c.*35delC:,FERMT3:NM_031471.5:3'UTR:MODIFIER:exon15/15:c.*35delC:		rs5792315	0	0.444	0.4248	0.7458										0.1136	0.4924	0.3939	22	76	n/a	n/a
chr11	65485727	65485727	T	G	hom		QUAL=31477;DP=368;AF=1.00;MQM=59;TRIO=HOM,368,1.00,HET,344,0.49,HOM,441,0.99	RNASEH2C,KAT5	3'UTR,intron	RNASEH2C:NM_032193.3:3'UTR:MODIFIER:exon4/4:c.*1527A>C:,KAT5:NM_182710.2:intron:MODIFIER:exon10/12:c.1265-334T>G:,KAT5:NM_001206833.1:intron:MODIFIER:exon9/11:c.1109-334T>G:,KAT5:NM_006388.3:intron:MODIFIER:exon11/13:c.1166-334T>G:,KAT5:NM_182709.2:intron:MODIFIER:exon10/12:c.1010-334T>G:		rs521678	0.8249	0	0	0										0.8864	0.1136	0	130	19	n/a	n/a
chr11	65636053	65636053	T	C	hom		QUAL=27064;DP=321;AF=1.00;MQM=59;TRIO=HOM,321,1.00,HOM,241,1.00,HOM,301,1.00	EFEMP2	missense	EFEMP2:NM_016938.4:missense:MODERATE:exon8/11:c.775A>G:p.Ile259Val		rs601314	0.8946	0.969	0.9985	0.6915	0.5430	P	T	B,B	B,B	604633 [EFEMP2 (provisional) Cutis laxa,autosomal recessive,type IB];	RCV000032273.1 [benign]; RCV000155538.1 [benign]; 			1	0	0	449	5	n/a	n/a
chr11	65638719	65638719	G	A	hom		QUAL=16305;DP=93;AF=1.00;MQM=60;TRIO=HOM,93,1.00,HET,260,0.50,HOM,323,1.00	EFEMP2	synonymous	EFEMP2:NM_016938.4:synonymous:LOW:exon4/11:c.276C>T:p.His92His		rs633800	0.3211	0.45	0.518	0.1597						604633 [EFEMP2 (provisional) Cutis laxa,autosomal recessive,type IB];	RCV000150612.1 [benign]; 		COSM3752644	0.2955	0.5379	0.1667	124	229	n/a	n/a
chr11	66282095	66282095	G	A	het		QUAL=6787;DP=130;AF=0.49;MQM=60;TRIO=HET,130,0.49,WT,94,0.00,HOM,164,1.00	BBS1	synonymous	BBS1:NM_024649.4:synonymous:LOW:exon4/17:c.378G>A:p.Leu126Leu		rs2298806	0.2117	0.223	0.2306	0.1332	1.1130	P	T			209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1];			COSM3998544	0.0379	0.4015	0.5606	13	166	n/a	n/a
chr11	66288733	66288733	G	C	het		QUAL=4500;DP=102;AF=0.53;MQM=60;TRIO=HET,102,0.53,WT,68,0.00,HOM,99,0.98	BBS1	splice_region&intron	BBS1:NM_024649.4:splice_region&intron:LOW:exon8/16:c.724-8G>C:		rs10896125	0.2426	0.232	0.2311	0.2266						209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1];	RCV000082204.2 [benign]; 		COSM147275	0.0379	0.4015	0.5606	13	166	n/a	n/a
chr11	66297363	66297363	C	T	het		QUAL=11510;DP=195;AF=0.50;MQM=60;TRIO=HET,195,0.50,WT,187,0.00,HOM,270,1.00	BBS1	synonymous	BBS1:NM_024649.4:synonymous:LOW:exon14/17:c.1413C>T:p.Leu471Leu		rs3816492	0.1434	0.203	0.2303	0.048						209901 [BBS1 (confirmed) Bardet-Biedl syndrome 1];			COSM3752662	0.0379	0.3939	0.5682	13	163	n/a	n/a
chr11	66299515	66299515	A	G	hom		QUAL=11369;DP=162;AF=0.99;MQM=59;TRIO=HOM,162,0.99,HET,103,0.54,HOM,152,1.00	BBS1	3'UTR	BBS1:NM_024649.4:3'UTR:MODIFIER:exon17/17:c.*7A>G:		rs8432	0.6128	0.54	0.5914	0.8429										0.3788	0.4167	0.2045	142	211	n/a	n/a
chr11	66300348	66300348	A	G	het		QUAL=2066;DP=57;AF=0.49;MQM=60;TRIO=HET,57,0.49,WT,33,0.00,HOM,42,0.98	BBS1	3'UTR	BBS1:NM_024649.4:3'UTR:MODIFIER:exon17/17:c.*840A>G:		rs3741360	0.2358	0	0	0										0.0379	0.4015	0.5606	5	56	n/a	n/a
chr11	66458980	66458980	G	A	het		QUAL=7441;DP=84;AF=0.55;MQM=59;TRIO=HET,84,0.55,WT,115,0.00,HOM,202,1.00	SPTBN2	synonymous	SPTBN2:NM_006946.2:synonymous:LOW:exon26/37:c.5340C>T:p.Asn1780Asn		rs623022	0.0631	0.065	0.0497	0.0105						604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];				0.0076	0.0985	0.8939	3	113	n/a	n/a
chr11	66460527	66460527	C	T	het		QUAL=4570;DP=91;AF=0.57;MQM=60;TRIO=HET,91,0.57,WT,73,0.01,HOM,97,0.98	SPTBN2	synonymous	SPTBN2:NM_006946.2:synonymous:LOW:exon24/37:c.4899G>A:p.Leu1633Leu		rs639938	0.0777	0.069	0.0499	0.0509						604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];			COSM3998547	0.0076	0.0985	0.8939	2	114	n/a	n/a
chr11	66468469	66468469	A	G	het		QUAL=4890;DP=91;AF=0.46;MQM=60;TRIO=HET,91,0.46,WT,125,0.01,HOM,118,0.98	SPTBN2	missense	SPTBN2:NM_006946.2:missense:MODERATE:exon16/37:c.3101T>C:p.Val1034Ala		rs506028	0.2057	0.131	0.0924	0.2607	-0.1020	P	T	B	B	604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];	RCV000118411.2 [likely benign]; 		COSM3752673	0.0076	0.2197	0.7727	12	230	n/a	n/a
chr11	66472274	66472274	T	C	hom		QUAL=5397;DP=28;AF=1.00;MQM=60;TRIO=HOM,28,1.00,HOM,73,1.00,HOM,71,1.00	SPTBN2	missense	SPTBN2:NM_006946.2:missense:MODERATE:exon14/37:c.2473A>G:p.Ser825Gly		rs4930388	0.9878	0.996	0.9996	0.9656	2.0170	P	T	B	B	604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];			COSM3752674	1	0	0	1132	3	n/a	n/a
chr11	66481633	66481633	G	A	het		QUAL=15087;DP=409;AF=0.52;MQM=60;TRIO=HET,409,0.52,HET,524,0.48,WT,632,0.00	SPTBN2	synonymous	SPTBN2:NM_006946.2:synonymous:LOW:exon6/37:c.585C>T:p.Asn195Asn		rs34775878	0.0407	0.082	0.1191	0.023						604985 [SPTBN2 (confirmed) Spinocerebellar ataxia 5|Spinocerebellar ataxia,autosomal recessive 14];	RCV000118412.2 [likely benign]; 			0.0152	0.2348	0.75	16	234	n/a	n/a
chr11	67758895	67758895	G	C	het		QUAL=334;DP=14;AF=0.71;MQM=43;TRIO=HET,14,0.71,HOM,7,1.00,WT,13,0.00	UNC93B1	3'UTR	UNC93B1:NM_030930.3:3'UTR:MODIFIER:exon11/11:c.*122C>G:		rs7932	0.2302	0	0	0										0.0909	0.3182	0.5909	13	46	n/a	n/a
chr11	67759196	67759196	A	C	het		QUAL=297;DP=15;AF=0.07;MQM=29;TRIO=HET,15,0.07,HET,49,0.24,HET,49,0.14	UNC93B1	missense	UNC93B1:NM_030930.3:missense:MODERATE:exon11/11:c.1612T>G:p.Tyr538Asp		rs2375178	0	0.0004	0	0	8.0290	D		D	D	608204 [UNC93B1 (confirmed) Herpes simplex encephalitis,susceptibility to,1];			COSM132779	0	0.4167	0.5833	0	70	n/a	n/a
chr11	67759254	67759254	G	C	het		QUAL=2697;DP=22;AF=0.27;MQM=35;TRIO=HET,22,0.27,HOM,78,0.99,HET,91,0.21	UNC93B1	synonymous	UNC93B1:NM_030930.3:synonymous:LOW:exon11/11:c.1554C>G:p.Arg518Arg		rs7149	0.2566	0.013	0	0						608204 [UNC93B1 (confirmed) Herpes simplex encephalitis,susceptibility to,1];			COSM1288831	0.0909	0.4318	0.4773	22	134	n/a	n/a
chr11	67765163	67765163	-	G	hom		QUAL=13577;DP=60;AF=0.93;MQM=60;TRIO=HOM,60,0.93,HOM,169,0.97,HOM,242,0.97	UNC93B1	frameshift	UNC93B1:NM_030930.3:frameshift:HIGH:exon7/11:c.887dupC:p.Ser297fs		rs5792426	1	1	0.9995	0.9985						608204 [UNC93B1 (confirmed) Herpes simplex encephalitis,susceptibility to,1];			COSM1356479	1	0	0	470	0	n/a	n/a
chr11	67804074	67804074	C	T	het		QUAL=12662;DP=177;AF=0.49;MQM=59;TRIO=HET,177,0.49,HOM,331,1.00,WT,381,0.00	NDUFS8	3'UTR	NDUFS8:NM_002496.3:3'UTR:MODIFIER:exon7/7:c.*14C>T:		rs1051806	0.1699	0.153	0.1751	0.2249										0.053	0.2197	0.7273	8	39	n/a	n/a
chr11	67814979	67814979	G	C	hom		QUAL=18791;DP=139;AF=1.00;MQM=59;TRIO=HOM,139,1.00,HOM,198,1.00,HOM,261,1.00	TCIRG1	synonymous	TCIRG1:NM_006019.3:synonymous:LOW:exon11/20:c.1245G>C:p.Leu415Leu,TCIRG1:NM_006053.3:synonymous:LOW:exon6/15:c.597G>C:p.Leu199Leu		rs2471829	0.9698	0.993	0.9995	0.927	0.4660	P				604592 [TCIRG1 (confirmed) Osteopetrosis,autosomal recessive 1];				1	0	0	453	1	n/a	n/a
chr11	68133035	68133035	T	C	het		QUAL=2576;DP=54;AF=0.59;MQM=57;TRIO=HET,54,0.59,HET,132,0.45,WT,199,0.00	LRP5	splice_region&intron	LRP5:NM_002335.3:splice_region&intron:LOW:exon4/22:c.884-4T>C:,LRP5:NM_001291902.1:splice_region&intron:LOW:exon4/22:c.-882-4T>C:		rs314776	0.4032	0.376	0.4082	0.6795						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];			COSM3765595	0.1136	0.5076	0.3788	72	236	n/a	n/a
chr11	68171013	68171013	T	C	hom		QUAL=7226;DP=63;AF=1.00;MQM=59;TRIO=HOM,63,1.00,HOM,75,1.00,HOM,91,1.00	LRP5	synonymous,5'UTR	LRP5:NM_002335.3:synonymous:LOW:exon8/23:c.1647T>C:p.Phe549Phe,LRP5:NM_001291902.1:5'UTR:MODIFIER:exon7/23:c.-291T>C:		rs545382	0.8415	0.9	0.907	0.6366						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];			COSM4146219	0.8258	0.1667	0.0076	362	88	n/a	n/a
chr11	68174122	68174122	G	A	het		QUAL=11872;DP=278;AF=0.50;MQM=59;TRIO=HET,278,0.50,HET,437,0.55,WT,540,0.00	LRP5	synonymous	LRP5:NM_002335.3:synonymous:LOW:exon9/23:c.1932G>A:p.Glu644Glu,LRP5:NM_001291902.1:synonymous:LOW:exon9/23:c.189G>A:p.Glu63Glu		rs2277268	0.0559	0.06	0.0694	0.0698						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];				0	0.1364	0.8636	0	57	n/a	n/a
chr11	68177614	68177614	T	C	het		QUAL=4298;DP=144;AF=0.46;MQM=59;TRIO=HET,144,0.46,HET,183,0.45,WT,225,0.00	LRP5	splice_region&intron	LRP5:NM_002335.3:splice_region&intron:LOW:exon10/22:c.2318+6T>C:,LRP5:NM_001291902.1:splice_region&intron:LOW:exon10/22:c.575+6T>C:		rs4988322	0.0559	0.06	0.0702	0.0703						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];				0	0.1364	0.8636	0	57	n/a	n/a
chr11	68192690	68192690	G	A	het		QUAL=9378;DP=178;AF=0.49;MQM=60;TRIO=HET,178,0.49,WT,167,0.00,HOM,217,1.00	LRP5	synonymous	LRP5:NM_002335.3:synonymous:LOW:exon15/23:c.3357G>A:p.Val1119Val,LRP5:NM_001291902.1:synonymous:LOW:exon15/23:c.1614G>A:p.Val538Val		rs556442	0.5793	0.675	0.673	0.2405						603506 [LRP5 (confirmed) Osteoporosis-pseudoglioma syndrome|Bone mineral density variability 1|Hyperostosis,endosteal|van Buchem disease,type 2|Osteosclerosis|Osteoporosis|Exudative vitreoretinopathy 4|Osteopetrosis,autosomal dominant 1];			COSM3752692	0.4318	0.4545	0.1136	189	207	n/a	n/a
chr11	68522216	68522216	T	C	het		QUAL=13147;DP=485;AF=0.50;MQM=60;TRIO=HET,485,0.50,HET,311,0.50,WT,392,0.00	CPT1A	3'UTR	CPT1A:NM_001031847.2:3'UTR:MODIFIER:exon19/19:c.*68A>G:		rs75022915	0.0104	0	0.0387	0.0079										0	0.1136	0.8864	0	16	n/a	n/a
chr11	68523179	68523179	T	-	het		QUAL=170;DP=33;AF=0.03;MQM=59;TRIO=HET,33,0.03,HET,16,0.06,WT,9,0.33	CPT1A	3'UTR,intron	CPT1A:NM_001876.3:3'UTR:MODIFIER:exon19/19:c.*1933delA:,CPT1A:NM_001031847.2:intron:MODIFIER:exon18/18:c.2236-860delA:	T-rich		0	0	0	0						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];				0.0076	0.053	0.9394	1	7	n/a	n/a
chr11	68523910	68523910	T	C	het		QUAL=11991;DP=278;AF=0.55;MQM=59;TRIO=HET,278,0.55,HET,134,0.60,HOM,138,0.99	CPT1A	3'UTR,intron	CPT1A:NM_001876.3:3'UTR:MODIFIER:exon19/19:c.*1202A>G:,CPT1A:NM_001031847.2:intron:MODIFIER:exon18/18:c.2236-1591A>G:		rs2278908	0.6488	0	0	0						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];				0.4394	0.447	0.1136	63	72	n/a	n/a
chr11	68524053	68524053	G	A	het		QUAL=4698;DP=141;AF=0.53;MQM=59;TRIO=HET,141,0.53,HET,52,0.50,HOM,55,1.00	CPT1A	3'UTR,intron	CPT1A:NM_001876.3:3'UTR:MODIFIER:exon19/19:c.*1059C>T:,CPT1A:NM_001031847.2:intron:MODIFIER:exon18/18:c.2236-1734C>T:		rs2278907	0.5625	0	0	0						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];				0.2803	0.553	0.1667	41	90	n/a	n/a
chr11	68549340	68549340	A	G	hom		QUAL=37384;DP=323;AF=1.00;MQM=60;TRIO=HOM,323,1.00,HOM,341,1.00,HOM,488,1.00	CPT1A	synonymous	CPT1A:NM_001876.3:synonymous:LOW:exon11/19:c.1251T>C:p.Phe417Phe,CPT1A:NM_001031847.2:synonymous:LOW:exon11/19:c.1251T>C:p.Phe417Phe	L3	rs2228502	0.8926	0.931	0.9453	0.847						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];	RCV000124600.1,RCV000153103.1 [benign,benign]; 			0.7879	0.2121	0	390	56	n/a	n/a
chr11	68560787	68560787	C	T	het		QUAL=3925;DP=136;AF=0.54;MQM=60;TRIO=HET,136,0.54,HET,93,0.60,WT,109,0.00	CPT1A	synonymous	CPT1A:NM_001876.3:synonymous:LOW:exon9/19:c.963G>A:p.Glu321Glu,CPT1A:NM_001031847.2:synonymous:LOW:exon9/19:c.963G>A:p.Glu321Glu		rs2229737	0.0509	0.089	0.106	0.038						600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];	RCV000079919.2 [benign]; RCV000124598.1 [benign]; 		COSM3752695	0.0152	0.2273	0.7576	8	87	n/a	n/a
chr11	68562328	68562328	C	T	het		QUAL=12067;DP=407;AF=0.49;MQM=60;TRIO=HET,407,0.49,WT,337,0.00,HET,390,0.52	CPT1A	missense	CPT1A:NM_001876.3:missense:MODERATE:exon8/19:c.823G>A:p.Ala275Thr,CPT1A:NM_001031847.2:missense:MODERATE:exon8/19:c.823G>A:p.Ala275Thr		rs2229738	0.0238	0.065	0.077	0.0143	0.2480	N	T	B,B,B	B,B,B	600528 [CPT1A (confirmed) CPT deficiency,hepatic,type IA];	RCV000055868.1 [pathogenic]; RCV000124597.1 [benign]; 	CM033597 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 1 deficiency" GENE=CPT1A]; 		0	0.1515	0.8485	4	60	2	n/a
chr11	68671419	68671419	C	T	het		QUAL=1758;DP=58;AF=0.47;MQM=60;TRIO=HET,58,0.47,HOM,45,0.98,WT,102,0.00	IGHMBP2	5'UTR	IGHMBP2:NM_002180.2:5'UTR:MODIFIER:exon1/15:c.-2C>T:		rs4930624	0.116	0.157	0.2448	0.0992										0.0606	0.4621	0.4773	22	177	n/a	n/a
chr11	68671477	68671477	T	C	het		QUAL=2642;DP=16;AF=0.50;MQM=60;TRIO=HET,16,0.50,HOM,49,1.00,HET,84,0.43	IGHMBP2	synonymous	IGHMBP2:NM_002180.2:synonymous:LOW:exon1/15:c.57T>C:p.Leu19Leu		rs1249463	0.6751	0.674	0.854	0.6579						600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI];				0.5833	0.3788	0.0379	300	144	n/a	n/a
chr11	68678962	68678962	T	C	het		QUAL=20577;DP=263;AF=0.50;MQM=60;TRIO=HET,263,0.50,HOM,314,1.00,HET,450,0.44	IGHMBP2	missense	IGHMBP2:NM_002180.2:missense:MODERATE:exon5/15:c.602T>C:p.Leu201Ser		rs560096	0.6805	0.771	0.8442	0.6505	-0.0700	P	T	B	B	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI];			COSM4146225	0.5833	0.3788	0.0379	301	146	n/a	n/a
chr11	68682402	68682402	A	G	het		QUAL=5472;DP=158;AF=0.53;MQM=60;TRIO=HET,158,0.53,HOM,96,0.99,WT,111,0.00	IGHMBP2	missense	IGHMBP2:NM_002180.2:missense:MODERATE:exon6/15:c.823A>G:p.Ile275Val		rs10896380	0.1198	0.182	0.2477	0.1239	1.5760	P	T	B	B	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI];			COSM1178425	0.0606	0.4621	0.4773	23	182	n/a	n/a
chr11	68701948	68701948	C	T	het		QUAL=12960;DP=195;AF=0.50;MQM=60;TRIO=HET,195,0.50,HOM,322,0.99,WT,448,0.00	IGHMBP2	synonymous	IGHMBP2:NM_002180.2:synonymous:LOW:exon11/15:c.1554C>T:p.Val518Val		rs11228413	0.1328	0.184	0.2477	0.1739						600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI];			COSM429749	0.0606	0.4621	0.4773	23	182	n/a	n/a
chr11	68704028	68704028	C	T	het		QUAL=5832;DP=109;AF=0.39;MQM=59;TRIO=HET,109,0.39,HOM,149,0.99,WT,169,0.01	IGHMBP2	missense	IGHMBP2:NM_002180.2:missense:MODERATE:exon13/15:c.2080C>T:p.Arg694Trp		rs2236654	0.133	0.187	0.2481	0.1741	0.1980	P	D	B	B	600502 [IGHMBP2 (provisional) Neuronopathy,distal hereditary motor,type VI];			COSM3722147	0.0606	0.4621	0.4773	23	180	n/a	n/a
chr11	68707454	68707454	T	C	het		QUAL=3951;DP=111;AF=0.48;MQM=60;TRIO=HET,111,0.48,HOM,44,1.00,HET,71,0.51	IGHMBP2	3'UTR	IGHMBP2:NM_002180.2:3'UTR:MODIFIER:exon15/15:c.*255T>C:		rs564244	0.6709	0	0	0										0.5758	0.3864	0.0379	90	55	n/a	n/a
chr11	68707880	68707880	T	C	het		QUAL=5281;DP=138;AF=0.51;MQM=60;TRIO=HET,138,0.51,HOM,102,0.99,WT,118,0.00	IGHMBP2	3'UTR	IGHMBP2:NM_002180.2:3'UTR:MODIFIER:exon15/15:c.*681T>C:		rs9095	0.1536	0	0	0										0.0606	0.4697	0.4697	8	68	n/a	n/a
chr11	70049523	70049523	A	G	het		QUAL=1261;DP=15;AF=0.47;MQM=60;TRIO=HET,15,0.47,HOM,38,1.00,WT,53,0.02	FADD	5'UTR	FADD:NM_003824.3:5'UTR:MODIFIER:exon1/2:c.-43A>G:		rs1131677	0.5327	0.387	0.6105	0.6198										0.3409	0.4697	0.1894	52	67	n/a	n/a
chr11	70053123	70053123	-	TGT	het		QUAL=2374;DP=71;AF=0.46;MQM=59;TRIO=HET,71,0.46,HOM,59,0.93,WT,96,0.00	FADD	3'UTR	FADD:NM_003824.3:3'UTR:MODIFIER:exon2/2:c.*545_*547dupTGT:		rs397720848	0.4653	0	0	0										0.2576	0.5303	0.2121	40	78	n/a	n/a
chr11	70053487	70053487	C	T	het		QUAL=11044;DP=324;AF=0.42;MQM=60;TRIO=HET,324,0.42,HOM,202,1.00,WT,276,0.00	FADD	3'UTR	FADD:NM_003824.3:3'UTR:MODIFIER:exon2/2:c.*908C>T:		rs1131715	0.5405	0	0	0										0.2879	0.5227	0.1894	44	77	n/a	n/a
chr11	70314597	70314597	T	A	hom		QUAL=29294;DP=380;AF=1.00;MQM=60;TRIO=HOM,380,1.00,HOM,213,1.00,HOM,297,1.00	SHANK2	3'UTR	SHANK2:NM_012309.4:3'UTR:MODIFIER:exon23/23:c.*4377A>T:,SHANK2:NM_133266.4:3'UTR:MODIFIER:exon11/11:c.*4377A>T:		rs513996	0.9635	0	0	0										1	0	0	150	1	n/a	n/a
chr11	70316391	70316391	A	G	het		QUAL=18983;DP=393;AF=0.47;MQM=60;TRIO=HET,393,0.47,HET,278,0.47,HOM,271,1.00	SHANK2	3'UTR	SHANK2:NM_012309.4:3'UTR:MODIFIER:exon23/23:c.*2583T>C:,SHANK2:NM_133266.4:3'UTR:MODIFIER:exon11/11:c.*2583T>C:		rs55678639	0.2173	0	0	0										0.0606	0.5	0.4394	9	77	n/a	n/a
chr11	70318714	70318714	A	G	hom		QUAL=25763;DP=240;AF=1.00;MQM=60;TRIO=HOM,240,1.00,HOM,258,1.00,HOM,303,1.00	SHANK2	3'UTR	SHANK2:NM_012309.4:3'UTR:MODIFIER:exon23/23:c.*260T>C:,SHANK2:NM_133266.4:3'UTR:MODIFIER:exon11/11:c.*260T>C:		rs578657	0.9683	0	0	0										1	0	0	185	1	n/a	n/a
chr11	70666765	70666765	C	T	het		QUAL=590;DP=18;AF=0.33;MQM=60;TRIO=HET,18,0.33,HET,32,0.53,WT,52,0.00	SHANK2	synonymous	SHANK2:NM_012309.4:synonymous:LOW:exon9/23:c.1005G>A:p.Ala335Ala		rs11237599	0.0931	0.083	0	0						603290 [SHANK2 (provisional) Autism susceptibility 17];				0.0152	0.2803	0.7045	10	114	n/a	n/a
chr11	70935766	70935766	T	C	het		QUAL=17887;DP=306;AF=0.46;MQM=60;TRIO=HET,306,0.46,HOM,260,1.00,HET,369,0.43	SHANK2	5'UTR	SHANK2:NM_012309.4:5'UTR:MODIFIER:exon1/23:c.-36A>G:		rs3020047	0.7468	0	0	0										0.2348	0.4773	0.2879	36	66	n/a	n/a
chr11	71145687	71145687	T	C	hom		QUAL=18446;DP=204;AF=1.00;MQM=59;TRIO=HOM,204,1.00,HOM,163,1.00,HOM,199,1.00	DHCR7	3'UTR	DHCR7:NM_001163817.1:3'UTR:MODIFIER:exon9/9:c.*734A>G:,DHCR7:NM_001360.2:3'UTR:MODIFIER:exon9/9:c.*734A>G:	LTR41B	rs7690	0.7736	0	0	0										0.9242	0.0758	0	141	12	n/a	n/a
chr11	71145778	71145778	G	A	hom		QUAL=22668;DP=189;AF=0.99;MQM=59;TRIO=HOM,189,0.99,HOM,231,1.00,HOM,293,1.00	DHCR7	3'UTR	DHCR7:NM_001163817.1:3'UTR:MODIFIER:exon9/9:c.*643C>T:,DHCR7:NM_001360.2:3'UTR:MODIFIER:exon9/9:c.*643C>T:		rs1044535	0.7436	0	0	0										0.9242	0.0758	0	140	12	n/a	n/a
chr11	71145941	71145941	G	A	het		QUAL=18804;DP=191;AF=0.44;MQM=60;TRIO=HET,191,0.44,HET,289,0.49,HOM,387,0.99	DHCR7	3'UTR	DHCR7:NM_001163817.1:3'UTR:MODIFIER:exon9/9:c.*480C>T:,DHCR7:NM_001360.2:3'UTR:MODIFIER:exon9/9:c.*480C>T:	LTR41B	rs1790345	0.3594	0	0	0										0.0303	0.3561	0.6136	9	59	n/a	n/a
chr11	71146249	71146260	AGCAAGGAACAG	-	het		QUAL=17053;DP=167;AF=0.26;MQM=60;TRIO=HET,167,0.26,HET,336,0.45,HOM,388,1.00	DHCR7	3'UTR	DHCR7:NM_001163817.1:3'UTR:MODIFIER:exon9/9:c.*161_*172delCTGTTCCTTGCT:,DHCR7:NM_001360.2:3'UTR:MODIFIER:exon9/9:c.*161_*172delCTGTTCCTTGCT:		rs368755383	0.3544	0.225	0	0										0.0303	0.3561	0.6136	13	89	n/a	n/a
chr11	71146577	71146577	G	A	het		QUAL=4425;DP=99;AF=0.45;MQM=60;TRIO=HET,99,0.45,HET,279,0.43,WT,423,0.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon9/9:c.1272C>T:p.Gly424Gly,DHCR7:NM_001360.2:synonymous:LOW:exon9/9:c.1272C>T:p.Gly424Gly		rs909217	0.382	0.547	0.7388	0.3366						602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079641.2 [benign]; 		COSM329305	0.5758	0.3561	0.0682	231	173	n/a	n/a
chr11	71146691	71146691	A	G	hom		QUAL=12990;DP=97;AF=1.00;MQM=59;TRIO=HOM,97,1.00,HOM,171,1.00,HOM,170,1.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon9/9:c.1158T>C:p.Asp386Asp,DHCR7:NM_001360.2:synonymous:LOW:exon9/9:c.1158T>C:p.Asp386Asp		rs760241	0.7564	0.853	0.946	0.7252	-0.7980	P	D			602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079639.2 [benign]; 		COSM1475860	0.9242	0.0758	0	395	56	n/a	n/a
chr11	71152461	71152461	A	G	hom		QUAL=31058;DP=247;AF=1.00;MQM=60;TRIO=HOM,247,1.00,HOM,307,1.00,HOM,432,1.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon6/9:c.438T>C:p.Asn146Asn,DHCR7:NM_001360.2:synonymous:LOW:exon6/9:c.438T>C:p.Asn146Asn		rs949177	0.8073	0.872	0.9476	0.8366						602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079654.2 [benign]; 			0.9242	0.0758	0	397	54	n/a	n/a
chr11	71155153	71155153	A	G	hom		QUAL=28155;DP=234;AF=1.00;MQM=59;TRIO=HOM,234,1.00,HOM,268,1.00,HOM,367,1.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon4/9:c.207T>C:p.Thr69Thr,DHCR7:NM_001360.2:synonymous:LOW:exon4/9:c.207T>C:p.Thr69Thr		rs1790334	0.8101	0.871	0.9476	0.8452						602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079649.2 [benign]; 		COSM4146260	0.9242	0.0758	0	397	54	n/a	n/a
chr11	71155171	71155171	C	T	het		QUAL=8152;DP=245;AF=0.54;MQM=59;TRIO=HET,245,0.54,HET,283,0.46,WT,371,0.00	DHCR7	synonymous	DHCR7:NM_001163817.1:synonymous:LOW:exon4/9:c.189G>A:p.Gln63Gln,DHCR7:NM_001360.2:synonymous:LOW:exon4/9:c.189G>A:p.Gln63Gln		rs1044482	0.401	0.55	0.7355	0.415						602858 [DHCR7 (confirmed) Smith-Lemli-Opitz syndrome];	RCV000079647.2 [benign]; 		COSM3931426	0.5758	0.3561	0.0682	231	171	n/a	n/a
chr11	71159429	71159429	G	A	hom		QUAL=3950;DP=35;AF=0.97;MQM=60;TRIO=HOM,35,0.97,HET,79,0.56,HET,97,0.60	DHCR7	5'UTR	DHCR7:NM_001163817.1:5'UTR:MODIFIER:exon1/9:c.-202C>T:,DHCR7:NM_001360.2:5'UTR:MODIFIER:exon1/9:c.-225C>T:		rs4944946	0.3534	0	0	0										0.5758	0.3561	0.0682	83	57	n/a	n/a
chr11	74165954	74165954	G	C	het		QUAL=12474;DP=406;AF=0.45;MQM=60;TRIO=HET,406,0.45,HET,406,0.48,WT,499,0.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*2343C>G:		rs34315739	0.1677	0	0	0										0.0227	0.25	0.7273	3	37	n/a	n/a
chr11	74166278	74166278	G	A	hom		QUAL=19000;DP=317;AF=1.00;MQM=60;TRIO=HOM,317,1.00,HOM,112,1.00,HOM,141,1.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*2019C>T:		rs9516	0.596	0	0	0										0.2424	0.5682	0.1894	36	84	n/a	n/a
chr11	74166320	74166320	T	G	hom		QUAL=20830;DP=281;AF=0.99;MQM=60;TRIO=HOM,281,0.99,HOM,153,1.00,HOM,199,1.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1977A>C:		rs7789	0.4247	0	0	0										0.1894	0.5076	0.303	27	77	n/a	n/a
chr11	74166781	74166781	-	T	het		QUAL=2972;DP=184;AF=0.39;MQM=56;TRIO=HET,184,0.39,HET,96,0.40,WT,139,0.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1515dupA:	AluSx1	rs141878274	0.2863	0	0	0										0.0303	0.2879	0.6818	4	43	n/a	n/a
chr11	74166859	74166859	A	G	hom		QUAL=11534;DP=166;AF=0.99;MQM=51;TRIO=HOM,166,0.99,HOM,84,0.99,HOM,123,0.99	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1438T>C:	AluSx1	rs35833816	0.5956	0	0	0										0.2197	0.5303	0.25	32	81	n/a	n/a
chr11	74166866	74166866	G	A	hom		QUAL=11649;DP=160;AF=0.99;MQM=52;TRIO=HOM,160,0.99,HOM,86,0.99,HOM,121,0.99	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*1431C>T:	AluSx1	rs28705219	0.5671	0	0	0										0.2197	0.5227	0.2576	32	78	n/a	n/a
chr11	74167388	74167388	G	A	het		QUAL=6356;DP=155;AF=0.43;MQM=56;TRIO=HET,155,0.60,HET,91,0.57,HET,138,0.91	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*909C>T:	AluSx	rs41258394	0	0	0	0										0	0.1288	0.8712	0	19	n/a	n/a
chr11	74167409	74167409	T	C	hom		QUAL=15570;DP=186;AF=1.00;MQM=59;TRIO=HOM,186,1.00,HOM,124,0.99,HOM,203,1.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*888A>G:		rs12272502	0.5667	0	0	0										0.2197	0.5152	0.2652	32	77	n/a	n/a
chr11	74167630	74167630	A	G	hom		QUAL=22375;DP=237;AF=1.00;MQM=60;TRIO=HOM,237,1.00,HOM,192,1.00,HOM,245,1.00	KCNE3	3'UTR	KCNE3:NM_005472.4:3'UTR:MODIFIER:exon3/3:c.*667T>C:	Arthur1B	rs12271177	0.5733	0	0	0										0.2197	0.5152	0.2652	32	77	n/a	n/a
chr11	74168411	74168411	A	G	het		QUAL=4934;DP=156;AF=0.46;MQM=60;TRIO=HET,156,0.46,HET,157,0.55,WT,267,0.00	KCNE3	synonymous	KCNE3:NM_005472.4:synonymous:LOW:exon3/3:c.198T>C:p.Phe66Phe		rs2270676	0.1412	0.133	0.1084	0.1252						604433 [KCNE3 (provisional) Brugada syndrome 6];		CM057459 [CLASS=DP MUT=ALT PHEN="Meniere's disease, association with" GENE=KCNE3]; 		0.0227	0.2576	0.7197	8	87	n/a	n/a
chr11	76853783	76853783	T	C	het		QUAL=10189;DP=132;AF=0.52;MQM=59;TRIO=HET,132,0.52,WT,135,0.01,HOM,262,1.00	MYO7A	missense	MYO7A:NM_000260.3:missense:MODERATE:exon3/49:c.47T>C:p.Leu16Ser,MYO7A:NM_001127179.2:missense:MODERATE:exon3/27:c.47T>C:p.Leu16Ser,MYO7A:NM_001127180.1:missense:MODERATE:exon3/49:c.47T>C:p.Leu16Ser		rs1052030	0.5136	0.399	0.3423	0.7236	4.4690	P	T	B,B,B	B,B,B	276903 [MYO7A (confirmed) Usher syndrome,type 1B|Deafness,autosomal recessive 2|Deafness,autosomal dominant 11];	RCV000036163.2 [benign]; RCV000132571.1 [likely benign]; 		COSM4146342	0.2045	0.4621	0.3333	81	199	n/a	n/a
chr11	76868392	76868392	A	G	het		QUAL=10637;DP=260;AF=0.51;MQM=60;TRIO=HET,260,0.51,WT,283,0.00,HET,363,0.54	MYO7A	missense	MYO7A:NM_000260.3:missense:MODERATE:exon8/49:c.803A>G:p.Lys268Arg,MYO7A:NM_001127179.2:missense:MODERATE:exon8/27:c.803A>G:p.Lys268Arg,MYO7A:NM_001127180.1:missense:MODERATE:exon8/49:c.803A>G:p.Lys268Arg		rs184866544	0.0006	0.0009	0.0016	0.0005	0.6210	D	T	B,B,B	B,B,B	276903 [MYO7A (confirmed) Usher syndrome,type 1B|Deafness,autosomal recessive 2|Deafness,autosomal dominant 11];	RCV000155225.1 [likely benign]; 	CM112920 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=MYO7A]; 		0	0.0076	0.9924	0	1	n/a	n/a
chr11	76895855	76895855	C	G	het		QUAL=12901;DP=338;AF=0.54;MQM=60;TRIO=HET,338,0.54,HET,462,0.48,WT,546,0.00	MYO7A	3'UTR,intron	MYO7A:NM_001127179.2:3'UTR:MODIFIER:exon27/27:c.*61C>G:,MYO7A:NM_000260.3:intron:MODIFIER:exon27/48:c.3503+95C>G:,MYO7A:NM_001127180.1:intron:MODIFIER:exon27/48:c.3503+95C>G:	MIRb	rs576982361	0.001	0.0014	0	0	-0.0160	N				276903 [MYO7A (confirmed) Usher syndrome,type 1B|Deafness,autosomal recessive 2|Deafness,autosomal dominant 11];				0	0.0076	0.9924	0	2	n/a	n/a
chr11	76926245	76926245	C	T	het		QUAL=8497;DP=260;AF=0.53;MQM=60;TRIO=HET,260,0.53,HET,134,0.50,HET,172,0.52	MYO7A	3'UTR	MYO7A:NM_000260.3:3'UTR:MODIFIER:exon49/49:c.*504C>T:,MYO7A:NM_001127180.1:3'UTR:MODIFIER:exon49/49:c.*504C>T:		rs34765389	0.0339	0	0	0										0	0.1667	0.8333	0	25	n/a	n/a
chr11	77811990	77811990	T	C	hom		QUAL=14735;DP=119;AF=1.00;MQM=60;TRIO=HOM,119,1.00,HOM,154,1.00,HOM,187,1.00	ALG8	splice_region,3'UTR	ALG8:NM_024079.4:splice_region:LOW:exon13/13:c.*20A>G:,ALG8:NM_001007027.2:splice_region:LOW:exon14/14:c.*272A>G:,ALG8:NM_024079.4:3'UTR:MODIFIER:exon13/13:c.*20A>G:,ALG8:NM_001007027.2:3'UTR:MODIFIER:exon14/14:c.*272A>G:		rs1263505	0.8327	0.832	0.8515	0.9368							RCV000082154.2 [benign]; 			0.7955	0.1894	0.0152	128	32	n/a	n/a
chr11	77825320	77825320	T	C	hom		QUAL=20425;DP=247;AF=0.99;MQM=60;TRIO=HOM,247,0.99,HOM,223,1.00,HET,347,0.45	ALG8	missense	ALG8:NM_024079.4:missense:MODERATE:exon6/13:c.665A>G:p.Asn222Ser,ALG8:NM_001007027.2:missense:MODERATE:exon6/14:c.665A>G:p.Asn222Ser		rs665278	0.1464	0.199	0.2291	0.0739	0.5410	P,P	.,T	.,B,B,B	.,B,B,B	608103 [ALG8 (provisional) Congenital disorder of glycosylation,type Ih];	RCV000082158.2 [benign]; 		COSM3752755	0.0909	0.3485	0.5606	39	158	n/a	n/a
chr11	87013438	87013438	G	A	hom		QUAL=19866;DP=225;AF=1.00;MQM=60;TRIO=HOM,225,1.00,HOM,143,1.00,HOM,233,1.00	TMEM135	missense	TMEM135:NM_022918.3:missense:MODERATE:exon8/15:c.652G>A:p.Gly218Arg,TMEM135:NM_001168724.1:missense:MODERATE:exon7/14:c.586G>A:p.Gly196Arg		rs2276102	0.5829	0.624	0.6943	0.604	2.4950	P		B,B	B,B					0.447	0.4773	0.0758	215	194	n/a	n/a
chr11	87036784	87036784	T	C	hom		QUAL=23543;DP=344;AF=1.00;MQM=60;TRIO=HOM,344,1.00,HOM,167,0.99,HOM,202,0.99	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*4409T>C:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*4409T>C:		rs10898669	0.2306	0.293	0	0										0.1212	0.5076	0.3712	40	138	n/a	n/a
chr11	87037139	87037139	T	A	het		QUAL=9274;DP=354;AF=0.50;MQM=60;TRIO=HET,354,0.50,WT,161,0.00,HET,228,0.50	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*4764T>A:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*4764T>A:		rs551809652	0.0006	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr11	87037202	87037202	T	C	hom		QUAL=23896;DP=289;AF=1.00;MQM=60;TRIO=HOM,289,1.00,HOM,173,1.00,HOM,280,1.00	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*4827T>C:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*4827T>C:		rs12276145	0.2151	0.273	0	0										0.1212	0.5076	0.3712	40	137	n/a	n/a
chr11	87037565	87037565	T	C	hom		QUAL=34905;DP=473;AF=1.00;MQM=60;TRIO=HOM,473,1.00,HOM,227,0.99,HOM,348,1.00	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5190T>C:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5190T>C:		rs7926724	0.4461	0.531	0	0										0.3788	0.5227	0.0985	115	135	n/a	n/a
chr11	87037680	87037680	A	G	hom		QUAL=14154;DP=190;AF=1.00;MQM=60;TRIO=HOM,190,1.00,HOM,111,1.00,HOM,165,1.00	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5305A>G:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5305A>G:		rs12282551	0.3502	0.423	0	0										0.2576	0.5455	0.197	83	147	n/a	n/a
chr11	87037743	87037743	G	A	hom		QUAL=13831;DP=191;AF=0.99;MQM=60;TRIO=HOM,191,0.99,HOM,105,1.00,HOM,121,1.00	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5368G>A:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5368G>A:		rs10898670	0.3385	0.43	0	0										0.2576	0.5455	0.197	83	147	n/a	n/a
chr11	87037954	87037955	TT	-	het		QUAL=2673;DP=50;AF=0.38;MQM=60;TRIO=HET,50,0.38,HET,37,0.59,HET,35,0.37	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5596_*5597delTT:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5596_*5597delTT:			0	0	0	0										0.2121	0.3939	0.3939	63	64	n/a	n/a
chr11	87037954	87037956	TTT	-	het		QUAL=2673;DP=50;AF=0.26;MQM=60;TRIO=HET,50,0.26,HET,37,0.32,HET,35,0.40	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*5595_*5597delTTT:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*5595_*5597delTTT:			0	0	0	0										0.0909	0.3712	0.5379	31	87	n/a	n/a
chr11	87039402	87039402	G	A	hom		QUAL=19204;DP=276;AF=1.00;MQM=59;TRIO=HOM,276,1.00,HOM,133,0.99,HOM,182,1.00	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*7027G>A:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*7027G>A:		rs4480563	0.3411	0.422	0	0										0.2576	0.5455	0.197	82	148	n/a	n/a
chr11	87039467	87039467	T	G	hom		QUAL=20620;DP=295;AF=1.00;MQM=58;TRIO=HOM,295,1.00,HOM,143,1.00,HOM,173,1.00	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*7092T>G:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*7092T>G:	L1PB3	rs4644661	0.3413	0.418	0	0										0.2576	0.5455	0.197	83	146	n/a	n/a
chr11	87039532	87039532	C	T	hom		QUAL=20993;DP=290;AF=1.00;MQM=60;TRIO=HOM,290,1.00,HOM,148,0.99,HOM,196,1.00	TMEM135	3'UTR	TMEM135:NM_022918.3:3'UTR:MODIFIER:exon15/15:c.*7157C>T:,TMEM135:NM_001168724.1:3'UTR:MODIFIER:exon14/14:c.*7157C>T:	L1PB3	rs4318005	0.3411	0.418	0	0										0.2576	0.5455	0.197	83	147	n/a	n/a
chr11	88045583	88045583	A	G	het		QUAL=13761;DP=245;AF=0.49;MQM=60;TRIO=HET,245,0.49,HOM,208,1.00,HET,254,0.40	CTSC	missense	CTSC:NM_001814.4:missense:MODERATE:exon3/7:c.458T>C:p.Ile153Thr		rs217086	0.9309	0.886	0.8398	0.9114	-0.6170	P,P		B,.	B,.	602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];		CM002936 [CLASS=DM? MUT=REF PHEN="Papillon-Lefevre syndrome" GENE=CTSC]; 	COSM3752799	0.7045	0.2879	0.0076	326	121	2	n/a
chr11	88053979	88053979	T	C	het		QUAL=6547;DP=130;AF=0.58;MQM=60;TRIO=HET,130,0.58,HOM,76,1.00,HET,106,0.55	CTSC	intron	CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-8257A>G:		rs217053	0.8239	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.6364	0.3485	0.0152	95	52	n/a	n/a
chr11	88054346	88054346	G	C	het		QUAL=1132;DP=57;AF=0.49;MQM=60;TRIO=HET,57,0.49,HOM,7,1.00,HET,9,0.44	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*5199C>G:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*5255C>G:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-8624C>G:	L1PA10	rs217054	0.8516	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.6136	0.3485	0.0379	92	52	n/a	n/a
chr11	88054571	88054571	G	A	het		QUAL=979;DP=46;AF=0.43;MQM=59;TRIO=HET,46,0.43,HOM,7,1.00,HET,12,0.50	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*4974C>T:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*5030C>T:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-8849C>T:	L1PA10	rs10830669	0.1861	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.197	0.4394	0.3636	31	66	n/a	n/a
chr11	88055089	88055089	C	T	het		QUAL=7043;DP=206;AF=0.50;MQM=60;TRIO=HET,206,0.50,HOM,74,1.00,HET,77,0.53	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*4456G>A:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*4512G>A:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-9367G>A:	L1PA10	rs217055	0.9311	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.7045	0.2879	0.0076	104	44	n/a	n/a
chr11	88055170	88055170	G	A	het		QUAL=4942;DP=110;AF=0.52;MQM=60;TRIO=HET,110,0.52,HOM,68,1.00,HET,55,0.49	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*4375C>T:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*4431C>T:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-9448C>T:	L1PA10	rs596261	0.3456	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.303	0.5227	0.1742	47	76	n/a	n/a
chr11	88055291	88055291	T	C	het		QUAL=3402;DP=141;AF=0.48;MQM=60;TRIO=HET,141,0.48,HOM,27,1.00,HET,29,0.52	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*4254A>G:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*4310A>G:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-9569A>G:	L1PA10	rs12288615	0.2037	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.2045	0.4697	0.3258	32	70	n/a	n/a
chr11	88055789	88055789	A	T	het		QUAL=1836;DP=68;AF=0.54;MQM=53;TRIO=HET,68,0.54,HOM,12,1.00,HET,14,0.71	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*3756T>A:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*3812T>A:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-10067T>A:	L1P3	rs452648	0.865	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.6212	0.3182	0.0606	93	48	n/a	n/a
chr11	88055794	88055794	A	G	het		QUAL=1965;DP=69;AF=0.55;MQM=53;TRIO=HET,69,0.55,HOM,12,1.00,HET,15,0.67	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*3751T>C:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*3807T>C:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-10072T>C:	L1P3	rs442528	0.865	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.6061	0.3106	0.0833	91	47	n/a	n/a
chr11	88056130	88056130	A	G	het		QUAL=2109;DP=70;AF=0.51;MQM=58;TRIO=HET,70,0.51,HOM,17,1.00,HET,27,0.59	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*3415T>C:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*3471T>C:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-10408T>C:	L1P3	rs217056	0.7899	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.553	0.4091	0.0379	84	60	n/a	n/a
chr11	88056396	88056396	T	G	het		QUAL=1531;DP=47;AF=0.62;MQM=59;TRIO=HET,47,0.62,HOM,15,1.00,HET,12,0.33	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*3149A>C:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*3205A>C:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.319-10674A>C:	L1P3	rs217057	0.7895	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.553	0.3864	0.0606	84	57	n/a	n/a
chr11	88056942	88056942	G	A	het		QUAL=373;DP=19;AF=0.37;MQM=59;TRIO=HET,19,0.37,HOM,5,1.00,HET,7,0.29	CTSC	3'UTR,intron	CTSC:NM_001114173.1:3'UTR:MODIFIER:exon4/4:c.*2603C>T:,CTSC:NM_148170.3:3'UTR:MODIFIER:exon4/4:c.*2659C>T:,CTSC:NM_001814.4:intron:MODIFIER:exon2/6:c.318+11163C>T:	L1P3	rs217058	0.9083	0	0	0						602365 [CTSC (confirmed) Papillon-Lefevre syndrome|Haim-Munk syndrome|Periodontitis 1,juvenile];				0.5303	0.1212	0.3485	80	17	n/a	n/a
chr11	94151547	94151547	-	T	het		QUAL=4416;DP=225;AF=0.34;MQM=59;TRIO=HET,225,0.34,HET,186,0.38,WT,265,0.06	MRE11A	3'UTR	MRE11A:NM_005591.3:3'UTR:MODIFIER:exon20/20:c.*1743dupA:,MRE11A:NM_005590.3:3'UTR:MODIFIER:exon19/19:c.*1743dupA:		rs200848216	0.127	0	0	0										0.0606	0.3106	0.6288	8	45	n/a	n/a
chr11	94152631	94152631	G	A	het		QUAL=1469;DP=57;AF=0.33;MQM=56;TRIO=HET,57,0.65,HET,18,0.61,HET,35,0.66	MRE11A	3'UTR	MRE11A:NM_005591.3:3'UTR:MODIFIER:exon20/20:c.*660C>T:,MRE11A:NM_005590.3:3'UTR:MODIFIER:exon19/19:c.*660C>T:	(GA)n	rs591959	0	0	0	0										0	0.0455	0.9545	0	6	n/a	n/a
chr11	94152649	94152649	-	GAGA	het		QUAL=1469;DP=57;AF=0.33;MQM=59;TRIO=HET,57,0.65,HET,18,0.61,HET,35,0.66	MRE11A	3'UTR	MRE11A:NM_005591.3:3'UTR:MODIFIER:exon20/20:c.*638_*641dupTCTC:,MRE11A:NM_005590.3:3'UTR:MODIFIER:exon19/19:c.*638_*641dupTCTC:	(GA)n		0	0	0	0										0.0455	0.2045	0.75	6	32	n/a	n/a
chr11	94212048	94212048	C	T	het		QUAL=7631;DP=155;AF=0.46;MQM=60;TRIO=HET,155,0.46,WT,148,0.00,HOM,172,0.99	MRE11A	splice_region&intron	MRE11A:NM_005591.3:splice_region&intron:LOW:exon5/19:c.403-6G>A:,MRE11A:NM_005590.3:splice_region&intron:LOW:exon5/18:c.403-6G>A:		rs535801	0.3131	0.325	0.3011	0.2081						600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder];	RCV000117634.2 [likely benign]; 			0.1364	0.447	0.4167	198	701	n/a	n/a
chr11	95566048	95566048	G	A	het		QUAL=3572;DP=144;AF=0.55;MQM=60;TRIO=HET,144,0.55,HET,72,0.57,WT,135,0.00	MTMR2	3'UTR	MTMR2:NM_016156.5:3'UTR:MODIFIER:exon15/15:c.*2406C>T:,MTMR2:NM_001243571.1:3'UTR:MODIFIER:exon18/18:c.*2406C>T:,MTMR2:NM_201278.2:3'UTR:MODIFIER:exon17/17:c.*2406C>T:,MTMR2:NM_201281.2:3'UTR:MODIFIER:exon16/16:c.*2406C>T:		rs16922613	0.0298	0	0	0										0	0.0455	0.9545	0	7	n/a	n/a
chr11	102980324	102980324	C	T	hom		QUAL=14068;DP=197;AF=0.99;MQM=60;TRIO=HOM,197,0.99,HET,230,0.44,HET,349,0.47	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon1/90:c.21C>T:p.Asp7Asp,DYNC2H1:NM_001377.2:synonymous:LOW:exon1/89:c.21C>T:p.Asp7Asp		rs17301028	0.0411	0.074	0.096	0.019						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				0.0076	0.2273	0.7652	7	78	n/a	n/a
chr11	103029516	103029516	A	G	hom		QUAL=9779;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HOM,47,1.00,HOM,72,1.00	DYNC2H1	missense	DYNC2H1:NM_001080463.1:missense:MODERATE:exon27/90:c.4238A>G:p.Lys1413Arg,DYNC2H1:NM_001377.2:missense:MODERATE:exon27/89:c.4238A>G:p.Lys1413Arg		rs688906	0.6683	0.655	0.7417	0.5133	4.1300	P	T	B,P	B,B	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				0.6136	0.3485	0.0379	272	157	n/a	n/a
chr11	103047007	103047007	C	A	hom		QUAL=12886;DP=190;AF=1.00;MQM=60;TRIO=HOM,190,1.00,HOM,76,1.00,HOM,127,1.00	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon37/90:c.5718C>A:p.Thr1906Thr,DYNC2H1:NM_001377.2:synonymous:LOW:exon37/89:c.5718C>A:p.Thr1906Thr		rs585692	0.9313	0.905	0.9273	0.9834						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];	RCV000153168.1 [benign]; 			0.8333	0.1591	0.0076	375	74	n/a	n/a
chr11	103057048	103057048	A	G	hom		QUAL=19986;DP=224;AF=1.00;MQM=60;TRIO=HOM,224,1.00,HOM,181,1.00,HOM,223,1.00	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon42/90:c.6711A>G:p.Arg2237Arg,DYNC2H1:NM_001377.2:synonymous:LOW:exon42/89:c.6711A>G:p.Arg2237Arg		rs658804	0.5715	0.62	0.6269	0.533						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				0.4394	0.4621	0.0985	201	199	n/a	n/a
chr11	103058126	103058126	C	T	hom		QUAL=14014;DP=197;AF=1.00;MQM=60;TRIO=HOM,197,1.00,HOM,102,1.00,HOM,137,1.00	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon43/90:c.6951C>T:p.His2317His,DYNC2H1:NM_001377.2:synonymous:LOW:exon43/89:c.6951C>T:p.His2317His		rs586592	0.617	0.632	0.6292	0.6739						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];	RCV000079444.2 [benign]; 			0.4394	0.4621	0.0985	204	196	n/a	n/a
chr11	103082590	103082590	G	A	hom		QUAL=13989;DP=230;AF=1.00;MQM=60;TRIO=HOM,230,1.00,HOM,83,1.00,HOM,104,1.00	DYNC2H1	missense	DYNC2H1:NM_001080463.1:missense:MODERATE:exon54/90:c.8612G>A:p.Arg2871Gln,DYNC2H1:NM_001377.2:missense:MODERATE:exon54/89:c.8612G>A:p.Arg2871Gln		rs589623	0.7384	0.741	0.81	0.63	4.3360	P	T	P,B	B,B	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];			COSM147316	0.75	0.2273	0.0227	315	123	n/a	n/a
chr11	103153788	103153788	C	A	het		QUAL=6397;DP=313;AF=0.47;MQM=60;TRIO=HET,313,0.47,HET,93,0.52,WT,162,0.00	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon74/90:c.10885C>A:p.Arg3629Arg,DYNC2H1:NM_001377.2:synonymous:LOW:exon73/89:c.10864C>A:p.Arg3622Arg		rs117178504	0.0042	0.0069	0.0119	0.0035						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				0	0.0076	0.9924	0	5	n/a	n/a
chr11	103158278	103158278	C	T	het		QUAL=7683;DP=283;AF=0.46;MQM=60;TRIO=HET,283,0.46,WT,159,0.00,HET,227,0.50	DYNC2H1	missense	DYNC2H1:NM_001080463.1:missense:MODERATE:exon76/90:c.11060C>T:p.Ala3687Val,DYNC2H1:NM_001377.2:missense:MODERATE:exon75/89:c.11039C>T:p.Ala3680Val		rs10895391	0.2863	0.325	0.3521	0.2035	6.1230	P	T	P,P	B,B	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				0.0682	0.4167	0.5152	48	183	n/a	n/a
chr11	103229027	103229027	T	C	het		QUAL=11656;DP=253;AF=0.53;MQM=60;TRIO=HET,253,0.53,HOM,141,1.00,HET,166,0.47	DYNC2H1	synonymous	DYNC2H1:NM_001080463.1:synonymous:LOW:exon84/90:c.12117T>C:p.Asp4039Asp,DYNC2H1:NM_001377.2:synonymous:LOW:exon83/89:c.12096T>C:p.Asp4032Asp		rs2566913	0.495	0.591	0.6656	0.3184						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				0.4545	0.5	0.0455	205	204	n/a	n/a
chr11	103270607	103270607	G	A	het		QUAL=6198;DP=158;AF=0.46;MQM=60;TRIO=HET,158,0.46,WT,76,0.00,HOM,123,1.00	DYNC2H1	splice_region&intron	DYNC2H1:NM_001080463.1:splice_region&intron:LOW:exon85/89:c.12387+7G>A:,DYNC2H1:NM_001377.2:splice_region&intron:LOW:exon84/88:c.12366+7G>A:		rs10895417	0.5377	0.489	0.4518	0.6212						603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly];				0.1667	0.4545	0.3788	79	237	n/a	n/a
chr11	107992312	107992312	C	G	het		QUAL=2886;DP=75;AF=0.60;MQM=60;TRIO=HET,75,0.60,HET,102,0.48,WT,109,0.00	ACAT1	5'UTR	ACAT1:NM_000019.3:5'UTR:MODIFIER:exon1/12:c.-22C>G:		rs3741054	0.0954	0.095	0.1527	0.0849										0.0076	0.2727	0.7197	1	54	n/a	n/a
chr11	107992325	107992325	T	A	het		QUAL=4609;DP=125;AF=0.38;MQM=59;TRIO=HET,125,0.38,WT,95,0.00,HOM,107,1.00	ACAT1	5'UTR	ACAT1:NM_000019.3:5'UTR:MODIFIER:exon1/12:c.-9T>A:		rs3741055	0.3137	0.186	0.2582	0.0792							RCV000077928.2 [benign]; 			0.2273	0.4015	0.3712	75	183	n/a	n/a
chr11	107992346	107992346	G	C	het		QUAL=4273;DP=120;AF=0.35;MQM=60;TRIO=HET,120,0.35,WT,85,0.00,HOM,99,1.00	ACAT1	missense	ACAT1:NM_000019.3:missense:MODERATE:exon1/12:c.13G>C:p.Ala5Pro		rs3741056	0.3319	0.197	0.2544	0.1224	-0.1180	P	D	P,P	B,B	607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria];	RCV000077929.2 [benign]; 		COSM3752118	0.2273	0.4015	0.3712	75	184	n/a	n/a
chr11	108009660	108009660	C	A	het		QUAL=7018;DP=198;AF=0.41;MQM=60;TRIO=HET,198,0.41,HET,306,0.45,WT,392,0.00	ACAT1	synonymous	ACAT1:NM_000019.3:synonymous:LOW:exon6/12:c.471C>A:p.Ser157Ser		rs35188041	0.127	0.156	0.1746	0.1958	0.1580	P				607809 [ACAT1 (confirmed) Alpha-methylacetoacetic aciduria];	RCV000077930.2 [benign]; 		COSM1350699	0.0076	0.2879	0.7045	7	112	n/a	n/a
chr11	108018894	108018897	AATT	-	het		QUAL=5852;DP=227;AF=0.39;MQM=60;TRIO=HET,227,0.39,HET,197,0.55,WT,270,0.00					rs577109182	0.2039	0	0	0										0.1212	0.3712	0.5076	19	57	n/a	n/a
chr11	108093833	108093833	G	A	het		QUAL=17746;DP=315;AF=0.44;MQM=60;TRIO=HET,315,0.44,WT,391,0.00,HOM,477,0.99	ATM	5'UTR	ATM:NM_000051.3:5'UTR:MODIFIER:exon1/63:c.-111G>A:		rs189037	0.476	0	0	0								CR109394 [CLASS=DFP MUT=ALT PHEN="Longevity, association with" GENE=ATM]; 		0.4242	0.4318	0.1439	66	63	n/a	n/a
chr11	108183167	108183167	A	G	hom		QUAL=14922;DP=212;AF=1.00;MQM=60;TRIO=HOM,212,1.00,HOM,91,1.00,HOM,141,1.00	ATM	missense	ATM:NM_000051.3:missense:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser		rs659243	1	1	0	0	-1.0580	P	T	B,B	B,B	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000128947.1 [benign]; 			1	0	0	1765	0	n/a	n/a
chr11	108236783	108236783	G	T	het		QUAL=1670;DP=67;AF=0.48;MQM=58;TRIO=HET,67,0.48,WT,19,0.00,HOM,25,1.00	ATM	3'UTR	ATM:NM_000051.3:3'UTR:MODIFIER:exon63/63:c.*548G>T:		rs227092	0.5184	0	0	0										0.4167	0.4394	0.1439	64	65	n/a	n/a
chr11	108237839	108237839	C	T	het		QUAL=1948;DP=92;AF=0.33;MQM=52;TRIO=HET,92,0.33,WT,37,0.03,HOM,34,1.00	ATM	3'UTR	ATM:NM_000051.3:3'UTR:MODIFIER:exon63/63:c.*1604C>T:	AluSc8	rs227091	0.5182	0	0	0										0.4242	0.4318	0.1439	66	63	n/a	n/a
chr11	108239016	108239016	A	-	het		QUAL=1112;DP=81;AF=0.27;MQM=58;TRIO=HET,81,0.27,HET,20,0.30,HET,34,0.32	ATM	3'UTR	ATM:NM_000051.3:3'UTR:MODIFIER:exon63/63:c.*2797delA:	AluSz6		0	0	0	0										0	0.1894	0.8106	0	25	n/a	n/a
chr11	108239628	108239628	G	T	het		QUAL=8066;DP=328;AF=0.52;MQM=60;TRIO=HET,328,0.52,WT,88,0.01,HOM,83,1.00	ATM	3'UTR	ATM:NM_000051.3:3'UTR:MODIFIER:exon63/63:c.*3393G>T:		rs4585	0.5345	0	0	0										0.4242	0.4318	0.1439	66	63	n/a	n/a
chr11	111654621	111654625	TATAT	-	het		QUAL=2960;DP=164;AF=0.47;MQM=59;TRIO=HET,164,0.47,HET,70,0.39,WT,125,0.00	ALG9	3'UTR	ALG9:NM_024740.2:3'UTR:MODIFIER:exon16/16:c.*2496_*2500delATATA:,ALG9:NM_001077691.1:3'UTR:MODIFIER:exon15/15:c.*2496_*2500delATATA:,ALG9:NM_001077692.1:3'UTR:MODIFIER:exon15/15:c.*2496_*2500delATATA:,ALG9:NM_001077690.1:3'UTR:MODIFIER:exon16/16:c.*2496_*2500delATATA:		rs66517706	0.2372	0	0	0										0.0985	0.4091	0.4924	15	63	n/a	n/a
chr11	111654648	111654648	T	A	het		QUAL=8537;DP=259;AF=0.83;MQM=58;TRIO=HET,259,0.83,HET,63,0.76,HET,82,0.43	ALG9	3'UTR	ALG9:NM_024740.2:3'UTR:MODIFIER:exon16/16:c.*2473A>T:,ALG9:NM_001077691.1:3'UTR:MODIFIER:exon15/15:c.*2473A>T:,ALG9:NM_001077692.1:3'UTR:MODIFIER:exon15/15:c.*2473A>T:,ALG9:NM_001077690.1:3'UTR:MODIFIER:exon16/16:c.*2473A>T:	AT_rich	rs2554994	0	0	0	0										0.1439	0.6288	0.2273	21	97	n/a	n/a
chr11	111654670	111654678	GACAAAACA	-	het		QUAL=2374;DP=175;AF=0.34;MQM=57;TRIO=HET,175,0.34,HET,53,0.47,WT,67,0.00	ALG9	3'UTR	ALG9:NM_024740.2:3'UTR:MODIFIER:exon16/16:c.*2443_*2451delTGTTTTGTC:,ALG9:NM_001077691.1:3'UTR:MODIFIER:exon15/15:c.*2443_*2451delTGTTTTGTC:,ALG9:NM_001077692.1:3'UTR:MODIFIER:exon15/15:c.*2443_*2451delTGTTTTGTC:,ALG9:NM_001077690.1:3'UTR:MODIFIER:exon16/16:c.*2443_*2451delTGTTTTGTC:		rs72428193	0	0	0	0										0.0985	0.4091	0.4924	15	63	n/a	n/a
chr11	111724133	111724133	C	T	het		QUAL=11482;DP=315;AF=0.47;MQM=60;TRIO=HET,315,0.47,HET,222,0.49,HET,251,0.39	ALG9	missense	ALG9:NM_024740.2:missense:MODERATE:exon9/16:c.865G>A:p.Val289Ile,ALG9:NM_001077691.1:missense:MODERATE:exon8/15:c.352G>A:p.Val118Ile,ALG9:NM_001077692.1:missense:MODERATE:exon8/15:c.352G>A:p.Val118Ile,ALG9:NM_001077690.1:missense:MODERATE:exon9/16:c.865G>A:p.Val289Ile		rs10502151	0.3265	0.35	0.3221	0.1364	6.0710	P	T	D,B,D	P,B,P	606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il];			COSM3998223	0.1061	0.4167	0.4773	48	194	n/a	n/a
chr11	111742146	111742146	G	-	hom		QUAL=10224;DP=24;AF=1.00;MQM=59;TRIO=HOM,24,1.00,HOM,120,1.00,HOM,209,1.00	ALG9	splice_acceptor&splice_donor	ALG9:NM_024740.2:splice_acceptor&splice_donor:HIGH:exon1/15:c.60+1delC:,ALG9:NM_001077690.1:splice_acceptor&splice_donor:HIGH:exon1/15:c.60+1delC:		rs10708475	1	1	1	0.9986						606941 [ALG9 (confirmed) Congenital disorder of glycosylation,type Il];				1	0	0	439	0	n/a	n/a
chr11	111781047	111781047	A	C	het		QUAL=5974;DP=212;AF=0.49;MQM=60;TRIO=HET,212,0.49,HET,182,0.47,WT,263,0.00	CRYAB	splice_region&intron	CRYAB:NM_001289807.1:splice_region&intron:LOW:exon3/3:c.324+4T>G:,CRYAB:NM_001289808.1:splice_region&intron:LOW:exon2/2:c.324+4T>G:,CRYAB:NM_001885.2:splice_region&intron:LOW:exon3/3:c.324+4T>G:		rs11603779	0.2398	0.269	0.3	0.2185		P	D	B	B	123590 [CRYAB (confirmed) Myopathy,myofibrillar,2|Cataract 16,multiple types|Myopathy,myofibrillar,fatal infantile hypertrophy,alpha-B crystallin-related|Cardiomyopathy,dilated,1II];	RCV000037213.2 [benign]; RCV000124611.1 [benign]; 		COSM3998232	0.1061	0.4167	0.4773	55	202	n/a	n/a
chr11	118175439	118175439	G	A	het		QUAL=4922;DP=204;AF=0.42;MQM=60;TRIO=HET,204,0.42,HET,61,0.48,HET,84,0.52	CD3E	5'UTR	CD3E:NM_000733.3:5'UTR:MODIFIER:exon1/9:c.-112G>A:		rs2231440	0.229	0	0	0										0.053	0.4697	0.4773	8	68	n/a	n/a
chr11	118178007	118178007	C	T	het		QUAL=5673;DP=148;AF=0.47;MQM=60;TRIO=HET,148,0.47,HET,105,0.48,HET,123,0.55	CD3E	synonymous	CD3E:NM_000733.3:synonymous:LOW:exon3/9:c.54C>T:p.Gly18Gly		rs1126924	0.2254	0.306	0.3194	0.0868						186830 [CD3E (provisional) Immunodeficiency 18|Immunodeficiency 18,SCID variant];			COSM147335	0.053	0.4848	0.4621	36	197	n/a	n/a
chr11	118215076	118215079	GGCT	-	het		QUAL=4392;DP=127;AF=0.43;MQM=60;TRIO=HET,127,0.43,HET,183,0.53,WT,240,0.00	CD3G	5'UTR	CD3G:NM_000073.2:5'UTR:MODIFIER:exon1/7:c.-46_-43delGCTG:	(GCTG)n	rs398045642	0.4026	0	0.2875	0.299										0.0985	0.4545	0.447	16	78	n/a	n/a
chr11	118221349	118221349	T	C	het		QUAL=989;DP=68;AF=0.34;MQM=60;TRIO=HET,68,0.34,HET,24,0.50,WT,47,0.00	CD3G	synonymous	CD3G:NM_000073.2:synonymous:LOW:exon4/7:c.390T>C:p.Ala130Ala		rs3753059	0.2963	0	0.0024	0.0027						186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient];			COSM3998253	0.0606	0.2727	0.6667	18	149	n/a	n/a
chr11	118221350	118221350	G	T	het		QUAL=989;DP=68;AF=0.34;MQM=60;TRIO=HET,68,0.34,HET,24,0.50,WT,47,0.00	CD3G	missense	CD3G:NM_000073.2:missense:MODERATE:exon4/7:c.391G>T:p.Val131Phe		rs3753058	0.2975	0.219	0.0044	0.0043	0.3220	P	T	D	P	186740 [CD3G (confirmed) Immunodeficiency 17,CD3 gamma deficient];			COSM3931231	0.0606	0.2727	0.6667	18	149	n/a	n/a
chr11	118224059	118224059	A	G	het		QUAL=4964;DP=251;AF=0.51;MQM=60;TRIO=HET,251,0.51,WT,20,0.00,HET,48,0.54	CD3G	3'UTR	CD3G:NM_000073.2:3'UTR:MODIFIER:exon7/7:c.*244A>G:		rs45508093	0.0721	0	0	0										0.0227	0.3106	0.6667	3	48	n/a	n/a
chr11	118224268	118224268	G	T	het		QUAL=1505;DP=116;AF=0.39;MQM=53;TRIO=HET,116,0.39,HET,17,0.65,HET,24,0.08	CD3G	3'UTR	CD3G:NM_000073.2:3'UTR:MODIFIER:exon7/7:c.*453G>T:	AluSz	rs45477194	0.2977	0	0	0										0.0606	0.2197	0.7197	8	36	n/a	n/a
chr11	118898436	118898436	C	-	hom		QUAL=52585;DP=261;AF=0.99;MQM=60;TRIO=HOM,261,0.99,HOM,646,0.99,HOM,813,1.00	SLC37A4	splice_acceptor&splice_donor	SLC37A4:NM_001164278.1:splice_acceptor&splice_donor:HIGH:exon5/11:c.527+1delG:,SLC37A4:NM_001164280.1:splice_acceptor&splice_donor:HIGH:exon3/8:c.527+1delG:,SLC37A4:NM_001164277.1:splice_acceptor&splice_donor:HIGH:exon5/10:c.527+1delG:,SLC37A4:NM_001164279.1:splice_acceptor&splice_donor:HIGH:exon5/10:c.308+1delG:,SLC37A4:NM_001467.5:splice_acceptor&splice_donor:HIGH:exon4/9:c.527+1delG:		rs547203028	1	1	0	0						602671 [SLC37A4 (confirmed) Glycogen storage disease Ib|Glycogen storage disease Ic];				1	0	0	454	0	n/a	n/a
chr11	118901166	118901166	C	G	het		QUAL=8097;DP=83;AF=0.36;MQM=59;TRIO=HET,83,0.36,HET,122,0.52,HOM,176,0.99	SLC37A4	5'UTR_premature_start_codon_gain,5'UTR,intron	SLC37A4:NM_001164277.1:5'UTR_premature_start_codon_gain:LOW:exon2/11:c.-420G>C:,SLC37A4:NM_001164277.1:5'UTR:MODIFIER:exon2/11:c.-420G>C:,SLC37A4:NM_001164278.1:intron:MODIFIER:exon2/11:c.-196+92G>C:,SLC37A4:NM_001164279.1:intron:MODIFIER:exon1/10:c.-345+393G>C:,SLC37A4:NM_001467.5:intron:MODIFIER:exon1/9:c.-196+393G>C:		rs2846281	0.8496	0	0	0										0.6894	0.303	0.0076	103	46	n/a	n/a
chr11	118967524	118967524	C	T	het		QUAL=18788;DP=242;AF=0.46;MQM=60;TRIO=HET,242,0.46,HET,270,0.51,HOM,336,1.00	DPAGT1	3'UTR	DPAGT1:NM_001382.3:3'UTR:MODIFIER:exon9/9:c.*184G>A:		rs8551	0.4367	0	0	0										0.2348	0.3939	0.3712	34	63	n/a	n/a
chr11	118967758	118967758	T	C	het		QUAL=22055;DP=355;AF=0.52;MQM=60;TRIO=HET,355,0.52,HET,270,0.52,HOM,350,1.00	DPAGT1	missense	DPAGT1:NM_001382.3:missense:MODERATE:exon9/9:c.1177A>G:p.Ile393Val		rs643788	0.4333	0.421	0.4334	0.297	-0.3200	P	T	B,B	B,B	191350 [DPAGT1 (confirmed) Congenital disorder of glycosylation,type Ij|Myasthenic syndrome,congenital,with tubular aggregates 2];	RCV000079665.3 [benign]; 			0.2273	0.4015	0.3712	82	218	n/a	n/a
chr11	119209979	119209979	T	A	het		QUAL=3646;DP=120;AF=0.48;MQM=60;TRIO=HET,120,0.48,HET,160,0.44,WT,240,0.00	C1QTNF5,MFRP	3'UTR	C1QTNF5:NM_001278431.1:3'UTR:MODIFIER:exon3/3:c.*62A>T:,MFRP:NM_031433.3:3'UTR:MODIFIER:exon15/15:c.*1690A>T:,C1QTNF5:NM_015645.4:3'UTR:MODIFIER:exon15/15:c.*62A>T:		rs9640	0.1378	0	0	0								CR080754 [CLASS=DP MUT=REF PHEN="Increased BMI, association with" GENE=C1QTNF5]; 		0.0076	0.2045	0.7879	1	31	n/a	n/a
chr11	119216231	119216231	A	G	hom		QUAL=6360;DP=99;AF=1.00;MQM=60;TRIO=HOM,99,1.00,HOM,43,1.00,HOM,55,1.00	MFRP,C1QTNF5	synonymous,5'UTR	MFRP:NM_031433.3:synonymous:LOW:exon5/15:c.540T>C:p.His180His,C1QTNF5:NM_015645.4:5'UTR:MODIFIER:exon5/15:c.-2097T>C:		rs2510143	0.902	0.936	0.9556	0.8731						606227 [MFRP (provisional) Microphthalmia,isolated 5|Nanophthalmos 2];	RCV000153496.1 [benign]; 		COSM4145393	0.9091	0.0833	0.0076	427	25	n/a	n/a
chr11	119216504	119216504	C	T	het		QUAL=1812;DP=82;AF=0.44;MQM=59;TRIO=HET,82,0.44,HOM,24,1.00,WT,38,0.03	MFRP,C1QTNF5	missense,5'UTR_premature_start_codon_gain,5'UTR	MFRP:NM_031433.3:missense:MODERATE:exon4/15:c.406G>A:p.Val136Met,C1QTNF5:NM_015645.4:5'UTR_premature_start_codon_gain:LOW:exon4/15:c.-2231G>A:,C1QTNF5:NM_015645.4:5'UTR:MODIFIER:exon4/15:c.-2231G>A:		rs3814762	0.1821	0.265	0.3226	0.0975	-1.8680	P	T	B,B	B,B	606227 [MFRP (provisional) Microphthalmia,isolated 5|Nanophthalmos 2];	RCV000153499.1 [benign]; 			0.1439	0.447	0.4091	47	196	n/a	n/a
chr11	119217254	119217254	C	T	het		QUAL=10089;DP=246;AF=0.48;MQM=60;TRIO=HET,246,0.48,HOM,204,1.00,WT,318,0.00	MFRP,C1QTNF5	5'UTR	MFRP:NM_031433.3:5'UTR:MODIFIER:exon1/15:c.-31G>A:,C1QTNF5:NM_015645.4:5'UTR:MODIFIER:exon1/15:c.-2667G>A:		rs883247	0.6356	0.594	0.5809	0.5407										0.4091	0.4773	0.1136	84	96	n/a	n/a
chr11	119217311	119217311	G	A	het		QUAL=8289;DP=188;AF=0.53;MQM=60;TRIO=HET,188,0.53,HOM,171,1.00,WT,275,0.01	MFRP,C1QTNF5	5'UTR_premature_start_codon_gain,5'UTR	MFRP:NM_031433.3:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-88C>T:,C1QTNF5:NM_015645.4:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-2724C>T:,MFRP:NM_031433.3:5'UTR:MODIFIER:exon1/15:c.-88C>T:,C1QTNF5:NM_015645.4:5'UTR:MODIFIER:exon1/15:c.-2724C>T:		rs883245	0.5839	0	0	0										0.3712	0.447	0.1818	56	65	n/a	n/a
chr11	119510644	119510644	A	C	hom		QUAL=22992;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,193,1.00,HOM,311,1.00	PVRL1	missense	PVRL1:NM_203285.1:missense:MODERATE:exon6/8:c.1082T>G:p.Val361Gly		rs7940667	0.8728	0.916	0.9307	0.7333	0.0680	P	T	B	B	600644 [PVRL1 (confirmed) Cleft lip/palate-ectodermal dysplasia syndrome|Orofacial cleft 7];		CM066206 [CLASS=DP MUT=ALT PHEN="Cleft lip / palate, association with" GENE=PVRL1]; 		0.9394	0.0606	0	398	54	n/a	n/a
chr11	119545224	119545224	-	G	het		QUAL=4080;DP=108;AF=0.39;MQM=60;TRIO=HET,108,0.39,HOM,111,0.95,WT,155,0.00	PVRL1	3'UTR,intron	PVRL1:NM_203286.1:3'UTR:MODIFIER:exon6/6:c.*77dupC:,PVRL1:NM_002855.4:intron:MODIFIER:exon5/5:c.1003+644dupC:,PVRL1:NM_203285.1:intron:MODIFIER:exon5/7:c.1003+644dupC:		rs534319501	0	0	0	0						600644 [PVRL1 (confirmed) Cleft lip/palate-ectodermal dysplasia syndrome|Orofacial cleft 7];				0.0076	0.1364	0.8561	1	19	n/a	n/a
chr11	121178302	121178302	A	C	het		QUAL=16166;DP=272;AF=0.54;MQM=60;TRIO=HET,272,0.54,HET,193,0.45,HOM,270,1.00	SC5D	3'UTR	SC5D:NM_001024956.2:3'UTR:MODIFIER:exon5/5:c.*81A>C:,SC5D:NM_006918.4:3'UTR:MODIFIER:exon5/5:c.*81A>C:		rs1061332	0.7246	0	0	0										0.4848	0.4167	0.0985	70	63	n/a	n/a
chr11	121179847	121179847	A	T	het		QUAL=19758;DP=315;AF=0.53;MQM=60;TRIO=HET,315,0.53,HET,234,0.51,HOM,319,1.00	SC5D	3'UTR	SC5D:NM_001024956.2:3'UTR:MODIFIER:exon5/5:c.*1626A>T:,SC5D:NM_006918.4:3'UTR:MODIFIER:exon5/5:c.*1626A>T:	MLT1J2	rs2060008	0.4221	0	0	0										0.2576	0.5379	0.2045	40	75	n/a	n/a
chr11	121183145	121183145	T	C	het		QUAL=7161;DP=191;AF=0.49;MQM=59;TRIO=HET,191,0.49,HET,69,0.61,HOM,80,1.00	SC5D	3'UTR	SC5D:NM_001024956.2:3'UTR:MODIFIER:exon5/5:c.*4924T>C:,SC5D:NM_006918.4:3'UTR:MODIFIER:exon5/5:c.*4924T>C:		rs35288685	0.3934	0	0	0										0.2576	0.5303	0.2121	40	74	n/a	n/a
chr11	126139100	126139100	T	C	hom		QUAL=24749;DP=173;AF=1.00;MQM=60;TRIO=HOM,173,1.00,HOM,283,1.00,HOM,342,1.00	FOXRED1	5'UTR	FOXRED1:NM_017547.3:5'UTR:MODIFIER:exon1/11:c.-2T>C:		rs1786702	0.7861	0.788	0.7599	0.5679										0.6364	0.3258	0.0379	264	157	n/a	n/a
chr11	126146290	126146290	T	G	het		QUAL=208;DP=26;AF=0.50;MQM=59;TRIO=HET,26,0.50,WT,45,0.07,WT,55,0.05	FOXRED1	missense&splice_region	FOXRED1:NM_017547.3:missense&splice_region:MODERATE:exon9/11:c.973T>G:p.Tyr325Asp		rs201062084	0.2644	0.36	0	0	7.1660	D	D	B,D,B	B,P,B	613622 [FOXRED1 (provisional) Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial complex I deficiency];			COSM3746238	0.0076	0.4394	0.553	1	110	n/a	n/a
chr11	126147697	126147697	G	A	het		QUAL=7667;DP=190;AF=0.40;MQM=60;TRIO=HET,190,0.40,HET,157,0.45,HET,223,0.48	FOXRED1	3'UTR	FOXRED1:NM_017547.3:3'UTR:MODIFIER:exon11/11:c.*113G>A:		rs667627	0.1314	0.179	0	0										0.0606	0.3636	0.5758	16	101	n/a	n/a
chr11	126293799	126293799	C	G	het		QUAL=2245;DP=71;AF=0.41;MQM=60;TRIO=HET,71,0.41,HOM,48,1.00,WT,60,0.00	KIRREL3	3'UTR	KIRREL3:NM_032531.3:3'UTR:MODIFIER:exon17/17:c.*676G>C:,KIRREL3:NM_001301097.1:3'UTR:MODIFIER:exon16/16:c.*676G>C:		rs948053	0.5783	0	0	0										0.2576	0.5227	0.2197	40	78	n/a	n/a
chr11	126294080	126294080	C	G	hom		QUAL=12651;DP=127;AF=1.00;MQM=59;TRIO=HOM,127,1.00,HOM,124,0.98,HOM,147,0.99	KIRREL3	3'UTR	KIRREL3:NM_032531.3:3'UTR:MODIFIER:exon17/17:c.*395G>C:,KIRREL3:NM_001301097.1:3'UTR:MODIFIER:exon16/16:c.*395G>C:		rs7113456	0.7179	0	0	0										0.3561	0.5379	0.1061	53	82	n/a	n/a
chr11	126294237	126294237	G	A	het		QUAL=4676;DP=132;AF=0.45;MQM=59;TRIO=HET,132,0.45,WT,157,0.01,HET,197,0.49	KIRREL3	3'UTR	KIRREL3:NM_032531.3:3'UTR:MODIFIER:exon17/17:c.*238C>T:,KIRREL3:NM_001301097.1:3'UTR:MODIFIER:exon16/16:c.*238C>T:		rs34642230	0.119	0	0	0										0	0.2273	0.7727	0	35	n/a	n/a
chr11	126294261	126294261	T	C	het		QUAL=9337;DP=161;AF=0.48;MQM=60;TRIO=HET,161,0.48,WT,179,0.00,HOM,229,0.99	KIRREL3	3'UTR	KIRREL3:NM_032531.3:3'UTR:MODIFIER:exon17/17:c.*214A>G:,KIRREL3:NM_001301097.1:3'UTR:MODIFIER:exon16/16:c.*214A>G:		rs3802815	0.3874	0	0	0										0.1894	0.3106	0.5	27	50	n/a	n/a
chr11	126294817	126294817	G	A	hom		QUAL=10176;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HOM,144,0.99,HOM,183,1.00	KIRREL3	synonymous	KIRREL3:NM_032531.3:synonymous:LOW:exon17/17:c.1995C>T:p.Gly665Gly,KIRREL3:NM_001301097.1:synonymous:LOW:exon16/16:c.1959C>T:p.Gly653Gly		rs948052	0.7037	0.664	0.6335	0.727						607761 [KIRREL3 (provisional) Mental retardation,autosomal dominant 4];	RCV000117432.2 [likely benign]; 			0.3939	0.4697	0.1364	203	199	n/a	n/a
chr11	128708423	128708423	G	A	het		QUAL=10029;DP=414;AF=0.49;MQM=60;TRIO=HET,414,0.49,HET,230,0.45,WT,268,0.00	KCNJ1	3'UTR	KCNJ1:NM_000220.4:3'UTR:MODIFIER:exon2/2:c.*597C>T:,KCNJ1:NM_153764.2:3'UTR:MODIFIER:exon2/2:c.*597C>T:,KCNJ1:NM_153765.2:3'UTR:MODIFIER:exon3/3:c.*597C>T:,KCNJ1:NM_153766.2:3'UTR:MODIFIER:exon3/3:c.*597C>T:,KCNJ1:NM_153767.3:3'UTR:MODIFIER:exon4/4:c.*597C>T:		rs117189807	0.0108	0	0	0										0	0.0303	0.9697	0	5	n/a	n/a
chr11	128737188	128737188	A	G	hom		QUAL=30833;DP=373;AF=1.00;MQM=60;TRIO=HOM,373,1.00,HOM,220,1.00,HOM,338,1.00	KCNJ1	5'UTR	KCNJ1:NM_153764.2:5'UTR:MODIFIER:exon1/2:c.-142T>C:,KCNJ1:NM_153765.2:5'UTR:MODIFIER:exon1/3:c.-224T>C:,KCNJ1:NM_153766.2:5'UTR:MODIFIER:exon1/3:c.-312T>C:,KCNJ1:NM_153767.3:5'UTR:MODIFIER:exon1/4:c.-445T>C:		rs2855790	0.8185	0	0	0										0.6818	0.2879	0.0303	106	40	n/a	n/a
chr12	431586	431586	T	A	het		QUAL=3718;DP=103;AF=0.55;MQM=60;TRIO=HET,103,0.55,WT,110,0.00,HET,153,0.43	KDM5A	missense	KDM5A:NM_001042603.2:missense:MODERATE:exon17/28:c.2423A>T:p.His808Leu		rs74894801	0.0084	0.016	0.0257	0.0101	5.8510	D	D	B,B,B	B,B,B					0	0.0152	0.9848	1	12	n/a	n/a
chr12	862641	862641	T	G	het		QUAL=1591;DP=33;AF=0.64;MQM=59;TRIO=HET,33,0.64,WT,67,0.00,HET,78,0.47	WNK1	5'UTR	WNK1:NM_001184985.1:5'UTR:MODIFIER:exon1/28:c.-91T>G:,WNK1:NM_014823.2:5'UTR:MODIFIER:exon1/26:c.-91T>G:,WNK1:NM_018979.3:5'UTR:MODIFIER:exon1/28:c.-91T>G:,WNK1:NM_213655.4:5'UTR:MODIFIER:exon1/28:c.-91T>G:		rs3088353	0.3399	0	0	0										0.197	0.4848	0.3182	26	72	n/a	n/a
chr12	862989	862989	T	C	hom		QUAL=10194;DP=110;AF=1.00;MQM=60;TRIO=HOM,110,1.00,HOM,97,1.00,HOM,116,1.00	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon1/28:c.258T>C:p.Cys86Cys,WNK1:NM_014823.2:synonymous:LOW:exon1/26:c.258T>C:p.Cys86Cys,WNK1:NM_018979.3:synonymous:LOW:exon1/28:c.258T>C:p.Cys86Cys,WNK1:NM_213655.4:synonymous:LOW:exon1/28:c.258T>C:p.Cys86Cys		rs3168640	0.9756	0.992	0.9999	0.9187						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				1	0	0	454	0	n/a	n/a
chr12	863152	863152	G	A	het		QUAL=4679;DP=141;AF=0.53;MQM=59;TRIO=HET,141,0.53,WT,109,0.00,HET,201,0.45	WNK1	missense	WNK1:NM_001184985.1:missense:MODERATE:exon1/28:c.421G>A:p.Ala141Thr,WNK1:NM_014823.2:missense:MODERATE:exon1/26:c.421G>A:p.Ala141Thr,WNK1:NM_018979.3:missense:MODERATE:exon1/28:c.421G>A:p.Ala141Thr,WNK1:NM_213655.4:missense:MODERATE:exon1/28:c.421G>A:p.Ala141Thr		rs11554421	0.0745	0.107	0.1079	0.0255	2.0540	P	T	B,B,B	B,B,B	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000126341.1 [benign]; 		COSM3753516	0.0227	0.197	0.7803	11	100	n/a	n/a
chr12	939302	939302	A	G	hom		QUAL=33776;DP=252;AF=1.00;MQM=60;TRIO=HOM,252,1.00,HOM,393,1.00,HOM,408,1.00	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala,WNK1:NM_014823.2:synonymous:LOW:exon4/26:c.1287A>G:p.Ala429Ala,WNK1:NM_018979.3:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala,WNK1:NM_213655.4:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala		rs10774466	0.6935	0.745	0.749	0.5617						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];			COSM3753538	0.5076	0.4318	0.0606	246	177	n/a	n/a
chr12	968489	968489	T	C	het		QUAL=5865;DP=244;AF=0.37;MQM=60;TRIO=HET,244,0.37,WT,171,0.00,HET,210,0.45	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon6/28:c.1479T>C:p.Asp493Asp,WNK1:NM_014823.2:synonymous:LOW:exon6/26:c.1479T>C:p.Asp493Asp,WNK1:NM_018979.3:synonymous:LOW:exon6/28:c.1479T>C:p.Asp493Asp,WNK1:NM_213655.4:synonymous:LOW:exon6/28:c.1479T>C:p.Asp493Asp		rs2286006	0.0935	0.148	0.1503	0.0474						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000126337.1 [benign]; 		COSM3753546	0.0303	0.2652	0.7045	16	122	n/a	n/a
chr12	974355	974355	-	C	hom		QUAL=10471;DP=149;AF=0.91;MQM=60;TRIO=HOM,149,0.91,HET,123,0.49,HOM,183,0.96	WNK1	frameshift,intron	WNK1:NM_213655.4:frameshift:HIGH:exon9/28:c.2220dupC:p.Phe741fs,WNK1:NM_001184985.1:intron:MODIFIER:exon8/27:c.2140-2676dupC:,WNK1:NM_014823.2:intron:MODIFIER:exon8/25:c.2139+2920dupC:,WNK1:NM_018979.3:intron:MODIFIER:exon8/27:c.2139+2920dupC:		rs397768556	0.5184	0.481	0	0						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				0.3258	0.4394	0.2348	136	192	2	n/a
chr12	974404	974404	T	C	hom		QUAL=18948;DP=222;AF=1.00;MQM=60;TRIO=HOM,222,1.00,HOM,226,1.00,HET,353,0.44	WNK1	synonymous,intron	WNK1:NM_213655.4:synonymous:LOW:exon9/28:c.2268T>C:p.Pro756Pro,WNK1:NM_001184985.1:intron:MODIFIER:exon8/27:c.2140-2628T>C:,WNK1:NM_014823.2:intron:MODIFIER:exon8/25:c.2139+2968T>C:,WNK1:NM_018979.3:intron:MODIFIER:exon8/27:c.2139+2968T>C:		rs7300829	0.654	0.554	0	0						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				0.3409	0.4394	0.2197	125	190	n/a	n/a
chr12	987482	987482	G	A	hom		QUAL=10650;DP=170;AF=0.99;MQM=60;TRIO=HOM,170,0.99,HOM,66,1.00,HOM,101,1.00	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon11/28:c.3567G>A:p.Gln1189Gln,WNK1:NM_014823.2:synonymous:LOW:exon10/26:c.2325G>A:p.Gln775Gln,WNK1:NM_018979.3:synonymous:LOW:exon10/28:c.2328G>A:p.Gln776Gln,WNK1:NM_213655.4:synonymous:LOW:exon12/28:c.3822G>A:p.Gln1274Gln		rs1012729	0.6795	0.734	0.7406	0.5604	-0.8680	P				605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];			COSM3753548	0.4924	0.447	0.0606	236	184	n/a	n/a
chr12	987533	987533	-	T	het		QUAL=1818;DP=93;AF=0.47;MQM=60;TRIO=HET,93,0.47,HET,21,0.76,HET,36,0.58	WNK1	splice_region&intron	WNK1:NM_001184985.1:splice_region&intron:LOW:exon11/27:c.3612+6_3612+7insT:,WNK1:NM_014823.2:splice_region&intron:LOW:exon10/25:c.2370+6_2370+7insT:,WNK1:NM_018979.3:splice_region&intron:LOW:exon10/27:c.2373+6_2373+7insT:,WNK1:NM_213655.4:splice_region&intron:LOW:exon12/27:c.3867+6_3867+7insT:		rs5795952	0	0	0	0						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				0.0076	0.3712	0.6212	61	87	n/a	n/a
chr12	990912	990912	A	C	het		QUAL=21939;DP=396;AF=0.50;MQM=60;TRIO=HET,396,0.50,HOM,281,1.00,HET,366,0.53	WNK1	missense	WNK1:NM_001184985.1:missense:MODERATE:exon13/28:c.3946A>C:p.Thr1316Pro,WNK1:NM_014823.2:missense:MODERATE:exon11/26:c.2425A>C:p.Thr809Pro,WNK1:NM_018979.3:missense:MODERATE:exon13/28:c.3166A>C:p.Thr1056Pro,WNK1:NM_213655.4:missense:MODERATE:exon13/28:c.3922A>C:p.Thr1308Pro		rs956868	0.8528	0.831	0.8513	0.8552	0.0100	P,P	.,T	.,B,B,B	.,B,B,B	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];		CM065520 [CLASS=DP MUT=REF PHEN="Colorectal cancer, increased risk, association with" GENE=WNK1]; 		0.6591	0.303	0.0379	315	124	n/a	n/a
chr12	993930	993930	C	T	het		QUAL=15809;DP=310;AF=0.51;MQM=60;TRIO=HET,310,0.51,HOM,212,1.00,HET,259,0.47	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon19/28:c.4740C>T:p.Asn1580Asn,WNK1:NM_014823.2:synonymous:LOW:exon17/26:c.3219C>T:p.Asn1073Asn,WNK1:NM_018979.3:synonymous:LOW:exon19/28:c.3960C>T:p.Asn1320Asn,WNK1:NM_213655.4:synonymous:LOW:exon19/28:c.4716C>T:p.Asn1572Asn		rs7300444	0.399	0.419	0.4403	0.2966						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000126339.1 [benign]; 		COSM3753554	0.1288	0.5152	0.3561	83	203	n/a	n/a
chr12	994014	994014	C	T	het		QUAL=7233;DP=242;AF=0.50;MQM=59;TRIO=HET,242,0.50,WT,175,0.00,HET,223,0.47	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon19/28:c.4824C>T:p.Thr1608Thr,WNK1:NM_014823.2:synonymous:LOW:exon17/26:c.3303C>T:p.Thr1101Thr,WNK1:NM_018979.3:synonymous:LOW:exon19/28:c.4044C>T:p.Thr1348Thr,WNK1:NM_213655.4:synonymous:LOW:exon19/28:c.4800C>T:p.Thr1600Thr		rs10849577	0.1158	0.155	0.1421	0.0527						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];	RCV000126340.1 [benign]; 		COSM3998996	0.0379	0.2955	0.6667	15	120	n/a	n/a
chr12	994487	994487	G	C	hom		QUAL=29911;DP=460;AF=1.00;MQM=59;TRIO=HOM,460,1.00,HOM,187,1.00,HOM,249,1.00	WNK1	missense	WNK1:NM_001184985.1:missense:MODERATE:exon19/28:c.5297G>C:p.Cys1766Ser,WNK1:NM_014823.2:missense:MODERATE:exon17/26:c.3776G>C:p.Cys1259Ser,WNK1:NM_018979.3:missense:MODERATE:exon19/28:c.4517G>C:p.Cys1506Ser,WNK1:NM_213655.4:missense:MODERATE:exon19/28:c.5273G>C:p.Cys1758Ser		rs7955371	0.9868	0.996	1	0.9589	0.1530	P	T	B,B,B	B,B,B	605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];				1	0	0	454	0	n/a	n/a
chr12	1017197	1017197	C	T	hom		QUAL=26513;DP=200;AF=1.00;MQM=60;TRIO=HOM,200,1.00,HOM,270,1.00,HOM,369,1.00	WNK1	synonymous	WNK1:NM_001184985.1:synonymous:LOW:exon27/28:c.7608C>T:p.Tyr2536Tyr,WNK1:NM_014823.2:synonymous:LOW:exon25/26:c.6084C>T:p.Tyr2028Tyr,WNK1:NM_018979.3:synonymous:LOW:exon27/28:c.6828C>T:p.Tyr2276Tyr,WNK1:NM_213655.4:synonymous:LOW:exon27/28:c.7584C>T:p.Tyr2528Tyr		rs4766334	0.987	0.996	1	0.9591						605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC|Neuropathy,hereditary sensory and autonomic,type II];			COSM4146469	1	0	0	454	0	n/a	n/a
chr12	1019453	1019453	-	ATC	het		QUAL=12644;DP=330;AF=0.39;MQM=60;TRIO=HET,330,0.39,HOM,145,0.99,HET,234,0.51	WNK1	3'UTR	WNK1:NM_001184985.1:3'UTR:MODIFIER:exon28/28:c.*1496_*1498dupATC:,WNK1:NM_014823.2:3'UTR:MODIFIER:exon26/26:c.*1496_*1498dupATC:,WNK1:NM_018979.3:3'UTR:MODIFIER:exon28/28:c.*1496_*1498dupATC:,WNK1:NM_213655.4:3'UTR:MODIFIER:exon28/28:c.*1496_*1498dupATC:		rs397783428	0	0	0	0										0.0758	0.4091	0.5152	12	60	n/a	n/a
chr12	1019944	1019944	G	A	hom		QUAL=25645;DP=331;AF=1.00;MQM=60;TRIO=HOM,331,1.00,HOM,202,1.00,HOM,242,1.00	WNK1	3'UTR	WNK1:NM_001184985.1:3'UTR:MODIFIER:exon28/28:c.*1986G>A:,WNK1:NM_014823.2:3'UTR:MODIFIER:exon26/26:c.*1986G>A:,WNK1:NM_018979.3:3'UTR:MODIFIER:exon28/28:c.*1986G>A:,WNK1:NM_213655.4:3'UTR:MODIFIER:exon28/28:c.*1986G>A:		rs2023944	0.9872	0	0	0										1	0	0	150	0	n/a	n/a
chr12	1020266	1020266	T	C	het		QUAL=9787;DP=386;AF=0.47;MQM=60;TRIO=HET,386,0.47,WT,148,0.00,HET,213,0.56	WNK1	3'UTR	WNK1:NM_001184985.1:3'UTR:MODIFIER:exon28/28:c.*2308T>C:,WNK1:NM_014823.2:3'UTR:MODIFIER:exon26/26:c.*2308T>C:,WNK1:NM_018979.3:3'UTR:MODIFIER:exon28/28:c.*2308T>C:,WNK1:NM_213655.4:3'UTR:MODIFIER:exon28/28:c.*2308T>C:		rs1060499	0.1192	0	0	0										0.0379	0.3106	0.6515	5	48	n/a	n/a
chr12	5020435	5020435	G	A	het		QUAL=1233;DP=52;AF=0.42;MQM=60;TRIO=HET,52,0.42,HET,48,0.50,WT,86,0.00	KCNA1	5'UTR	KCNA1:NM_000217.2:5'UTR:MODIFIER:exon2/2:c.-110G>A:		rs35678382	0.1583	0	0	0										0.0379	0.2273	0.7348	5	34	n/a	n/a
chr12	5021984	5021984	T	A	het		QUAL=15668;DP=254;AF=0.57;MQM=60;TRIO=HET,254,0.57,HOM,358,1.00,WT,427,0.00	KCNA1	synonymous	KCNA1:NM_000217.2:synonymous:LOW:exon2/2:c.1440T>A:p.Thr480Thr		rs4766309	0.8205	0.738	0.6843	0.8561						176260 [KCNA1 (confirmed) Episodic ataxia/myokymia syndrome];	RCV000117314.2 [likely benign]; 			0.4621	0.4621	0.0758	512	497	1	n/a (2xTP)
chr12	5026471	5026471	C	T	het		QUAL=14357;DP=347;AF=0.50;MQM=60;TRIO=HET,347,0.50,HOM,268,0.99,WT,338,0.00	KCNA1	3'UTR	KCNA1:NM_000217.2:3'UTR:MODIFIER:exon2/2:c.*4439C>T:		rs12424292	0.2438	0	0	0										0.053	0.3409	0.6061	7	50	n/a	n/a
chr12	6457062	6457062	T	C	hom		QUAL=8426;DP=99;AF=1.00;MQM=59;TRIO=HOM,99,1.00,HOM,112,1.00,HET,124,0.48	SCNN1A	missense	SCNN1A:NM_001159576.1:missense:MODERATE:exon12/12:c.2164A>G:p.Thr722Ala,SCNN1A:NM_001038.5:missense:MODERATE:exon13/13:c.1987A>G:p.Thr663Ala,SCNN1A:NM_001159575.1:missense:MODERATE:exon13/13:c.2056A>G:p.Thr686Ala		rs2228576	0.7406	0.68	0.6929	0.9	-0.5860	P	T	B,B,B	B,B,B	600228 [SCNN1A (confirmed) Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 2];	RCV000151811.1 [benign]; 	CM994637 [CLASS=DFP MUT=ALT PHEN="Hypertension, reduced risk, association with" GENE=SCNN1A]; 	COSM1747194	0.447	0.4848	0.0682	222	155	n/a	n/a
chr12	6484709	6484709	T	C	het		QUAL=1132;DP=19;AF=0.63;MQM=60;TRIO=HET,19,0.63,WT,25,0.00,HOM,27,1.00	SCNN1A,LTBR	5'UTR,intron	SCNN1A:NM_001038.5:5'UTR:MODIFIER:exon1/13:c.-93A>G:,LTBR:NM_001270987.1:5'UTR:MODIFIER:exon1/10:c.-13T>C:,SCNN1A:NM_001159575.1:intron:MODIFIER:exon1/12:c.16-706A>G:		rs10849447	0.7568	0.456	0	0						600228 [SCNN1A (confirmed) Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 2];				0.2045	0.5152	0.2803	30	80	n/a	n/a
chr12	7045178	7045178	G	A	het		QUAL=1141;DP=29;AF=0.66;MQM=60;TRIO=HET,29,0.66,HET,55,0.38,WT,68,0.00	ATN1	missense	ATN1:NM_001007026.1:missense:MODERATE:exon5/10:c.748G>A:p.Gly250Ser,ATN1:NM_001940.3:missense:MODERATE:exon5/10:c.748G>A:p.Gly250Ser		rs148694613	0.003	0.0062	0.0105	0.0023	2.6350	N	T	B,B	B,B	607462 [ATN1 (confirmed) Dentatorubro-pallidoluysian atrophy];				0	0.0152	0.9848	0	10	n/a	n/a
chr12	7045898	7045900	CAG	-	het		QUAL=3747;DP=3;AF=0.00;MQM=60;TRIO=HET,3,0.67,HET,140,0.95,WT,234,0.06	ATN1	disruptive_inframe_deletion	ATN1:NM_001007026.1:disruptive_inframe_deletion:MODERATE:exon5/10:c.1506_1508delGCA:p.Gln502del,ATN1:NM_001940.3:disruptive_inframe_deletion:MODERATE:exon5/10:c.1506_1508delGCA:p.Gln502del	(CAG)n		0	0	0	0						607462 [ATN1 (confirmed) Dentatorubro-pallidoluysian atrophy];				0.0152	0.0606	0.9242	5	37	n/a	n/a
chr12	7048292	7048292	C	T	het		QUAL=2790;DP=207;AF=0.45;MQM=60;TRIO=HET,207,0.45,WT,301,0.00,WT,415,0.00	ATN1	missense	ATN1:NM_001007026.1:missense:MODERATE:exon7/10:c.3166C>T:p.His1056Tyr,ATN1:NM_001940.3:missense:MODERATE:exon7/10:c.3166C>T:p.His1056Tyr			0	0	0	0	7.6510	D	D	P	P	607462 [ATN1 (confirmed) Dentatorubro-pallidoluysian atrophy];				0	0	1	0	0	n/a	n/a
chr12	7242204	7242204	C	T	het		QUAL=3292;DP=116;AF=0.40;MQM=60;TRIO=HET,116,0.40,HOM,67,0.96,WT,93,0.00	C1R	missense	C1R:NM_001733.4:missense:MODERATE:exon4/9:c.550G>A:p.Glu184Lys		rs1126605	0.1749	0.117	0.0833	0.1402	-0.4440	P	T	B,B,B	B,B,B	613785 [C1R (confirmed) C1r/C1s deficiency,combined];				0.0152	0.1212	0.8636	6	69	n/a	n/a
chr12	7242299	7242299	G	A	het		QUAL=2769;DP=120;AF=0.53;MQM=59;TRIO=HET,120,0.53,WT,60,0.02,HET,72,0.39	C1R	missense	C1R:NM_001733.4:missense:MODERATE:exon4/9:c.455C>T:p.Ser152Leu		rs1801046	0.2392	0.232	0.2315	0.1658	0.0160	P	T	B,B,B	B,B,B	613785 [C1R (confirmed) C1r/C1s deficiency,combined];				0.0455	0.4091	0.5455	16	162	n/a	n/a
chr12	7363574	7363574	C	G	het		QUAL=12518;DP=275;AF=0.51;MQM=59;TRIO=HET,275,0.51,HOM,257,1.00,WT,266,0.00	PEX5	3'UTR,intron	PEX5:NM_001300789.1:3'UTR:MODIFIER:exon16/16:c.*755C>G:,PEX5:NM_001131023.1:3'UTR:MODIFIER:exon16/16:c.*755C>G:,PEX5:NM_001131024.1:3'UTR:MODIFIER:exon15/15:c.*755C>G:,PEX5:NM_001131025.1:3'UTR:MODIFIER:exon16/16:c.*755C>G:,PEX5:NM_000319.4:3'UTR:MODIFIER:exon15/15:c.*755C>G:,PEX5:NM_001131026.1:intron:MODIFIER:exon17/17:c.*19+736C>G:		rs1057225	0.4321	0	0	0										0.2424	0.4848	0.2727	39	69	n/a	n/a
chr12	8755758	8755758	G	T	het		QUAL=174;DP=52;AF=0.23;MQM=56;TRIO=HET,52,0.23,WT,38,0.03,WT,50,0.06	AICDA	3'UTR	AICDA:NM_020661.2:3'UTR:MODIFIER:exon5/5:c.*1122C>A:	FLAM_A		0	0	0	0										0	0.0076	0.9924	0	2	n/a	n/a
chr12	8757481	8757481	G	A	het		QUAL=3580;DP=194;AF=0.42;MQM=60;TRIO=HET,194,0.42,HET,30,0.47,HET,67,0.31	AICDA	synonymous	AICDA:NM_020661.2:synonymous:LOW:exon4/5:c.465C>T:p.His155His		rs2028373	0.4842	0.589	0.6431	0.3363	-0.1680	P				605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2];				0.3561	0.5303	0.1136	184	201	n/a	n/a
chr12	8757522	8757522	-	A	het		QUAL=848;DP=43;AF=0.26;MQM=60;TRIO=HET,43,0.26,HET,9,0.89,HET,28,0.64	AICDA	splice_region&intron	AICDA:NM_020661.2:splice_region&intron:LOW:exon3/4:c.428-5_428-4insT:		rs397718057	0.6424	0	0	0						605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2];				0.4848	0.303	0.2121	197	94	1	n/a
chr12	8765447	8765447	T	C	hom		QUAL=34759;DP=378;AF=1.00;MQM=60;TRIO=HOM,378,1.00,HOM,281,1.00,HOM,412,1.00					rs1345004	0.9954	0	0.9997	0.9841										1	0	0	166	0	n/a	n/a
chr12	13714729	13714729	T	C	hom		QUAL=28662;DP=399;AF=1.00;MQM=60;TRIO=HOM,399,1.00,HOM,200,1.00,HOM,268,1.00	GRIN2B	3'UTR	GRIN2B:NM_000834.3:3'UTR:MODIFIER:exon13/13:c.*988A>G:		rs1805477	0.8914	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr12	13715308	13715308	A	C	het		QUAL=9925;DP=406;AF=0.49;MQM=60;TRIO=HET,406,0.49,HET,202,0.50,WT,306,0.01	GRIN2B	3'UTR	GRIN2B:NM_000834.3:3'UTR:MODIFIER:exon13/13:c.*409T>G:		rs890	0.275	0	0	0										0.2045	0.5985	0.197	28	93	n/a	n/a
chr12	13716638	13716638	G	A	het		QUAL=8128;DP=229;AF=0.40;MQM=59;TRIO=HET,229,0.40,WT,306,0.00,HET,349,0.48	GRIN2B	synonymous	GRIN2B:NM_000834.3:synonymous:LOW:exon13/13:c.3534C>T:p.His1178His		rs1806191	0.2476	0.391	0.4998	0.2097						138252 [GRIN2B (provisional) Mental retardation,autosomal dominant 6];	RCV000117197.2 [likely benign]; 		COSM4146926	0.197	0.5833	0.2197	93	247	n/a	n/a
chr12	14019157	14019157	C	T	het		QUAL=1702;DP=76;AF=0.42;MQM=60;TRIO=HET,76,0.42,WT,47,0.00,HET,54,0.54	GRIN2B	5'UTR	GRIN2B:NM_000834.3:5'UTR:MODIFIER:exon2/13:c.-15G>A:		rs12818068	0.0379	0.079	0.1097	0.0179							RCV000125318.1 [benign]; 			0.0227	0.1742	0.803	3	29	n/a	n/a
chr12	25358650	25358650	A	T	hom		QUAL=11191;DP=263;AF=1.00;MQM=57;TRIO=HOM,263,1.00,HOM,46,1.00,HET,63,0.51	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*4200T>A:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*4079T>A:		rs12245	0.5483	0	0	0										0.2576	0.5076	0.2348	40	75	n/a	n/a
chr12	25358663	25358664	TT	-	hom		QUAL=7331;DP=183;AF=1.00;MQM=55;TRIO=HOM,183,1.00,HOM,35,1.00,HET,51,0.49	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*4186_*4187delAA:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*4065_*4066delAA:		rs57698689	0.5435	0	0	0										0.2576	0.5076	0.2348	39	75	n/a	n/a
chr12	25358828	25358828	T	G	hom		QUAL=8154;DP=143;AF=1.00;MQM=60;TRIO=HOM,143,1.00,HOM,61,1.00,HET,74,0.54	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*4022A>C:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3901A>C:		rs12587	0.5483	0	0	0										0.2576	0.5076	0.2348	37	76	n/a	n/a
chr12	25358943	25358943	T	C	hom		QUAL=15897;DP=364;AF=0.99;MQM=60;TRIO=HOM,364,0.99,HOM,76,1.00,HET,99,0.46	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3907A>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3786A>G:		rs8720	0.5485	0	0	0										0.2576	0.5076	0.2348	37	76	n/a	n/a
chr12	25358969	25358969	T	G	hom		QUAL=13131;DP=296;AF=0.99;MQM=60;TRIO=HOM,296,0.99,HOM,63,1.00,HET,92,0.49	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3881A>C:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3760A>C:		rs1137196	0.4333	0	0	0										0.2045	0.4545	0.3409	29	67	n/a	n/a
chr12	25359328	25359328	A	T	hom		QUAL=11876;DP=196;AF=0.99;MQM=59;TRIO=HOM,196,0.99,HOM,93,1.00,HET,152,0.43	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3522T>A:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3401T>A:		rs1137189	0.5481	0	0	0										0.2576	0.5076	0.2348	37	76	n/a	n/a
chr12	25359352	25359352	G	A	hom		QUAL=11997;DP=221;AF=1.00;MQM=59;TRIO=HOM,221,1.00,HOM,75,1.00,HET,136,0.44	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3498C>T:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3377C>T:		rs1137188	0.5485	0	0	0										0.2576	0.5076	0.2348	37	76	n/a	n/a
chr12	25359465	25359465	A	-	hom		QUAL=14918;DP=300;AF=0.99;MQM=59;TRIO=HOM,300,0.99,HOM,102,0.96,HET,167,0.45	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3385delT:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*3264delT:		rs34176876	0.5485	0	0	0										0.2576	0.5076	0.2348	37	76	n/a	n/a
chr12	25359841	25359841	T	C	hom		QUAL=6898;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HOM,18,1.00,HET,38,0.55	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*3009A>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*2888A>G:		rs13096	0.5256	0	0	0										0.2424	0.5076	0.25	35	75	n/a	n/a
chr12	25360138	25360138	T	C	hom		QUAL=31359;DP=307;AF=0.99;MQM=59;TRIO=HOM,307,0.99,HOM,259,1.00,HOM,405,1.00	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*2712A>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*2591A>G:	L2a	rs4963858	0.9886	0	0	0										1	0	0	150	0	n/a	n/a
chr12	25360449	25360449	-	A	het		QUAL=4229;DP=130;AF=0.67;MQM=60;TRIO=HET,130,0.67,HET,37,0.78,HET,41,0.76	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*2400dupT:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*2279dupT:	AluSz	rs397747594	0.8788	0	0	0										0.5758	0.2955	0.1288	88	42	n/a	n/a
chr12	25361091	25361091	T	C	hom		QUAL=17384;DP=275;AF=1.00;MQM=59;TRIO=HOM,275,1.00,HOM,119,1.00,HOM,152,1.00	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*1759A>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*1638A>G:		rs4597149	0.9974	0	0	0										1	0	0	150	0	n/a	n/a
chr12	25361101	25361101	-	A	het		QUAL=8244;DP=226;AF=0.69;MQM=59;TRIO=HET,226,0.69,HET,94,0.83,HET,126,0.41	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*1748dupT:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*1627dupT:		rs398116239	0.5711	0	0	0										0.303	0.5152	0.1818	46	75	n/a	n/a
chr12	25362217	25362217	A	G	hom		QUAL=14481;DP=262;AF=1.00;MQM=60;TRIO=HOM,262,1.00,HOM,100,1.00,HET,149,0.48	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*633T>C:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*512T>C:		rs9266	0.5491	0.524	0	0										0.2576	0.5076	0.2348	74	128	n/a	n/a
chr12	25362465	25362465	G	A	hom		QUAL=18986;DP=322;AF=1.00;MQM=58;TRIO=HOM,322,1.00,HOM,111,1.00,HOM,160,1.00	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*385C>T:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*264C>T:		rs4285970	0.9972	0	0	0										1	0	0	180	0	n/a	n/a
chr12	25362552	25362552	A	C	hom		QUAL=15052;DP=264;AF=0.99;MQM=60;TRIO=HOM,264,0.99,HOM,107,1.00,HET,170,0.51	KRAS	3'UTR	KRAS:NM_033360.3:3'UTR:MODIFIER:exon6/6:c.*298T>G:,KRAS:NM_004985.4:3'UTR:MODIFIER:exon5/5:c.*177T>G:		rs712	0.5206	0	0	0										0.25	0.5076	0.2424	39	78	n/a	n/a
chr12	25368462	25368462	C	T	hom		QUAL=14290;DP=204;AF=1.00;MQM=60;TRIO=HOM,204,1.00,HOM,92,1.00,HOM,144,1.00	KRAS	synonymous,intron	KRAS:NM_033360.3:synonymous:LOW:exon5/6:c.483G>A:p.Arg161Arg,KRAS:NM_004985.4:intron:MODIFIER:exon4/4:c.451-5617G>A:		rs4362222	0.9976	1	1	0.9957						190070 [KRAS (confirmed) Lung cancer,somatic|Bladder cancer,somatic|Pancreatic carcinoma,somatic|Gastric cancer,somatic|Leukemia,acute myelogenous|Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|Breast cancer,somatic|SFM syndrome,somatic mosaic];	RCV000150886.1,RCV000039808.2 [benign,benign]; RCV000149847.2 [benign]; 			1	0	0	477	0	n/a	n/a
chr12	31256995	31256995	G	A	hom		QUAL=12977;DP=161;AF=1.00;MQM=50;TRIO=HOM,161,1.00,HOM,139,1.00,HET,194,0.53	DDX11	3'UTR	DDX11:NM_001257144.1:3'UTR:MODIFIER:exon27/27:c.*28G>A:,DDX11:NM_001257145.1:3'UTR:MODIFIER:exon27/27:c.*225G>A:,DDX11:NM_004399.2:3'UTR:MODIFIER:exon26/26:c.*225G>A:,DDX11:NM_030653.3:3'UTR:MODIFIER:exon27/27:c.*225G>A:,DDX11:NM_152438.1:3'UTR:MODIFIER:exon27/27:c.*28G>A:		rs11545332	0.1546	0.143	0.2539	0.0543										0.0227	0.303	0.6742	4	51	n/a	n/a
chr12	32735236	32735236	C	T	het		QUAL=14636;DP=524;AF=0.44;MQM=60;TRIO=HET,524,0.44,WT,341,0.00,HET,453,0.50	FGD4	synonymous	FGD4:NM_139241.2:synonymous:LOW:exon4/17:c.435C>T:p.Asp145Asp		rs904582	0.4671	0.411	0.4021	0.6879						611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H];				0.197	0.4242	0.3788	95	196	n/a	n/a
chr12	32778581	32778581	T	C	het		QUAL=5559;DP=182;AF=0.49;MQM=60;TRIO=HET,182,0.49,WT,109,0.00,HET,173,0.50	FGD4	splice_region&intron	FGD4:NM_139241.2:splice_region&intron:LOW:exon13/16:c.1636-7T>C:		rs11052113	0.1402	0.13	0.1083	0.1802						611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H];				0.0303	0.2045	0.7652	7	115	n/a	n/a
chr12	32794600	32794600	A	C	het		QUAL=7410;DP=288;AF=0.47;MQM=60;TRIO=HET,288,0.47,WT,166,0.00,HET,184,0.48	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*1133A>C:		rs10844268	0.3616	0	0	0										0.1515	0.4091	0.4394	21	61	n/a	n/a
chr12	32794921	32794921	A	G	het		QUAL=7694;DP=291;AF=0.54;MQM=60;TRIO=HET,291,0.54,WT,118,0.00,HET,131,0.58	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*1454A>G:		rs7964947	0.3171	0	0	0										0.1364	0.3864	0.4773	19	58	n/a	n/a
chr12	32794959	32794959	T	G	het		QUAL=7458;DP=275;AF=0.50;MQM=60;TRIO=HET,275,0.50,WT,143,0.00,HET,152,0.57	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*1492T>G:		rs7980205	0.3618	0	0	0										0.1515	0.4091	0.4394	21	61	n/a	n/a
chr12	32795421	32795421	A	G	het		QUAL=2974;DP=149;AF=0.50;MQM=60;TRIO=HET,149,0.50,WT,16,0.00,HET,32,0.59	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*1954A>G:		rs1239829	0.7418	0	0	0										0.3182	0.3712	0.3106	45	59	n/a	n/a
chr12	32796604	32796604	T	-	het		QUAL=2737;DP=148;AF=0.49;MQM=60;TRIO=HET,148,0.49,WT,27,0.04,HET,28,0.61	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*3148delT:		rs57501047	0.3351	0	0	0										0.1515	0.3788	0.4697	21	56	n/a	n/a
chr12	32797237	32797237	G	T	het		QUAL=6045;DP=236;AF=0.44;MQM=60;TRIO=HET,236,0.44,WT,133,0.00,HET,167,0.49	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*3770G>T:		rs11052123	0.4337	0	0	0										0.2652	0.4015	0.3333	38	63	n/a	n/a
chr12	32797822	32797822	-	A	het		QUAL=2029;DP=186;AF=0.24;MQM=59;TRIO=HET,186,0.24,WT,78,0.04,HET,78,0.33	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*4369dupA:		rs59282238	0.2957	0	0	0										0.0227	0.1515	0.8258	3	21	n/a	n/a
chr12	32797905	32797905	A	G	het		QUAL=7632;DP=310;AF=0.50;MQM=60;TRIO=HET,310,0.50,WT,133,0.00,HET,148,0.50	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*4438A>G:		rs11052124	0.4966	0	0	0										0.2727	0.3939	0.3333	38	63	n/a	n/a
chr12	32798458	32798458	A	G	hom		QUAL=6441;DP=142;AF=1.00;MQM=59;TRIO=HOM,142,1.00,HOM,24,1.00,HOM,32,1.00	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*4991A>G:	AluSg	rs1239830	0.9902	0	0	0										1	0	0	150	0	n/a	n/a
chr12	32798665	32798665	G	A	het		QUAL=4694;DP=157;AF=0.50;MQM=56;TRIO=HET,157,0.50,WT,114,0.02,HET,165,0.44	FGD4	3'UTR	FGD4:NM_139241.2:3'UTR:MODIFIER:exon17/17:c.*5198G>A:	AluSg	rs1133509	0.4677	0	0	0										0.2652	0.4015	0.3333	37	64	n/a	n/a
chr12	32899495	32899495	C	T	het		QUAL=306;DP=27;AF=0.33;MQM=60;TRIO=HET,27,0.33,WT,11,0.00,HET,10,0.40	YARS2	3'UTR	YARS2:NM_001040436.2:3'UTR:MODIFIER:exon5/5:c.*643G>A:	AluSz6	rs11052214	0.1266	0	0	0										0.0606	0.25	0.6894	8	35	n/a	n/a
chr12	32899929	32899929	C	G	het		QUAL=7078;DP=288;AF=0.48;MQM=60;TRIO=HET,288,0.48,WT,124,0.01,HET,181,0.48	YARS2	3'UTR	YARS2:NM_001040436.2:3'UTR:MODIFIER:exon5/5:c.*209G>C:		rs10844337	0.1438	0	0	0										0.0606	0.2576	0.6818	8	36	n/a	n/a
chr12	32908237	32908237	C	A	het		QUAL=4542;DP=217;AF=0.46;MQM=59;TRIO=HET,217,0.46,WT,104,0.00,HET,150,0.47	YARS2	missense	YARS2:NM_001040436.2:missense:MODERATE:exon1/5:c.572G>T:p.Gly191Val		rs11539445	0.1266	0.126	0.1431	0.1621	4.2110	P	D	P	B	610957 [YARS2 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 2];	RCV000088672.1 [pathogenic]; 	CM1312757 [CLASS=FP MUT=ALT PHEN="MLASA syndrome" GENE=YARS2]; 	COSM3753192	0.0606	0.25	0.6894	22	105	n/a	n/a
chr12	32908518	32908518	G	A	het		QUAL=11543;DP=381;AF=0.55;MQM=59;TRIO=HET,381,0.55,WT,275,0.00,HET,368,0.46	YARS2	synonymous	YARS2:NM_001040436.2:synonymous:LOW:exon1/5:c.291C>T:p.Gly97Gly		rs11539444	0.127	0.126	0.1452	0.1643						610957 [YARS2 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 2];	RCV000126351.1 [benign]; 		COSM3753193	0.0606	0.25	0.6894	22	105	n/a	n/a
chr12	44182706	44182706	A	G	het		QUAL=4773;DP=178;AF=0.53;MQM=60;TRIO=HET,178,0.53,HET,106,0.54,WT,149,0.00	IRAK4	3'UTR	IRAK4:NM_001114182.2:3'UTR:MODIFIER:exon13/13:c.*2188A>G:,IRAK4:NM_001145256.1:3'UTR:MODIFIER:exon12/12:c.*2188A>G:,IRAK4:NM_001145257.1:3'UTR:MODIFIER:exon11/11:c.*2188A>G:,IRAK4:NM_001145258.1:3'UTR:MODIFIER:exon10/10:c.*2188A>G:,IRAK4:NM_016123.3:3'UTR:MODIFIER:exon12/12:c.*2188A>G:	MSTB-int	rs1141168	0.4225	0	0	0										0.2576	0.5833	0.1591	43	81	n/a	n/a
chr12	48236386	48236386	T	A	het		QUAL=1466;DP=67;AF=0.46;MQM=49;TRIO=HET,67,0.46,HOM,18,1.00,WT,26,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*2143A>T:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*2143A>T:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*2143A>T:	AluSp	rs2853562	0.5433	0	0	0										0.2879	0.5	0.2121	44	72	n/a	n/a
chr12	48236407	48236412	TTTTTT	-	het		QUAL=328;DP=15;AF=0.00;MQM=48;TRIO=HET,15,0.00,HET,9,0.44,WT,5,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*2117_*2122delAAAAAA:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*2117_*2122delAAAAAA:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*2117_*2122delAAAAAA:	AluSp	rs541331784	0.7738	0	0	0										0.25	0.1818	0.5682	35	29	n/a	n/a
chr12	48236550	48236550	G	C	hom		QUAL=22607;DP=322;AF=1.00;MQM=59;TRIO=HOM,322,1.00,HOM,204,1.00,HOM,206,1.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*1979C>G:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*1979C>G:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*1979C>G:	AluSp	rs2544043	0.9782	0	0	0										0.8636	0.1364	0	128	22	n/a	n/a
chr12	48236623	48236623	G	T	het		QUAL=14677;DP=233;AF=0.60;MQM=60;TRIO=HET,233,0.60,HOM,313,1.00,WT,304,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*1906C>A:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*1906C>A:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*1906C>A:	MIRc	rs9729	0.5026	0	0	0										0.2803	0.5076	0.2121	43	73	n/a	n/a
chr12	48237736	48237736	A	-	het		QUAL=7787;DP=204;AF=0.44;MQM=59;TRIO=HET,204,0.49,HET,196,1.00,WT,283,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*793delT:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*793delT:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*793delT:		rs78783628	0	0	0	0										0.2576	0.5152	0.2273	39	74	n/a	n/a
chr12	48238221	48238221	G	T	het		QUAL=6880;DP=189;AF=0.58;MQM=59;TRIO=HET,189,0.58,HOM,119,0.99,WT,126,0.00	VDR	3'UTR	VDR:NM_001017536.1:3'UTR:MODIFIER:exon10/10:c.*308C>A:,VDR:NM_000376.2:3'UTR:MODIFIER:exon10/10:c.*308C>A:,VDR:NM_001017535.1:3'UTR:MODIFIER:exon11/11:c.*308C>A:		rs739837	0.4942	0	0	0										0.2803	0.5076	0.2121	43	73	n/a	n/a
chr12	48238757	48238757	A	G	het		QUAL=14661;DP=239;AF=0.48;MQM=60;TRIO=HET,239,0.48,HOM,384,0.99,WT,529,0.00	VDR	synonymous	VDR:NM_001017536.1:synonymous:LOW:exon10/10:c.1206T>C:p.Ile402Ile,VDR:NM_000376.2:synonymous:LOW:exon10/10:c.1056T>C:p.Ile352Ile,VDR:NM_001017535.1:synonymous:LOW:exon11/11:c.1056T>C:p.Ile352Ile		rs731236	0.2766	0.334	0.3944	0.2792						601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA|Osteoporosis,involutional];			COSM3753247	0.1439	0.4545	0.4015	74	217	n/a	n/a
chr12	48272895	48272895	A	G	hom		QUAL=4360;DP=48;AF=1.00;MQM=60;TRIO=HOM,48,1.00,HOM,47,1.00,HOM,48,1.00	VDR	start_lost,missense	VDR:NM_000376.2:start_lost:HIGH:exon3/10:c.2T>C:p.Met1?,VDR:NM_001017535.1:start_lost:HIGH:exon4/11:c.2T>C:p.Met1?,VDR:NM_001017536.1:missense:MODERATE:exon3/10:c.152T>C:p.Met51Thr		rs2228570	0.6715	0.637	0.6141	0.7885	4.2980	P	D	B,D	B,P	601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA|Osteoporosis,involutional];		CM972826 [CLASS=DFP MUT=ALT PHEN="Higher bone mineral density, association with" GENE=VDR]; 	COSM3753248	0.3788	0.4545	0.1667	214	182	n/a	n/a
chr12	48293716	48293716	G	T	het		QUAL=17584;DP=298;AF=0.50;MQM=60;TRIO=HET,298,0.50,WT,338,0.00,HOM,404,1.00	VDR	5'UTR,intron	VDR:NM_001017535.1:5'UTR:MODIFIER:exon2/11:c.-180C>A:,VDR:NM_001017536.1:intron:MODIFIER:exon1/9:c.67+4631C>A:,VDR:NM_000376.2:intron:MODIFIER:exon1/9:c.-84+5022C>A:		rs11168293	0.1661	0	0	0						601769 [VDR (provisional) Rickets,vitamin D-resistant,type IIA|Osteoporosis,involutional];				0.1212	0.3712	0.5076	17	56	n/a	n/a
chr12	48375568	48375568	A	G	het		QUAL=23059;DP=217;AF=0.41;MQM=59;TRIO=HET,217,0.41,HOM,394,0.99,HET,523,0.50	COL2A1	synonymous	COL2A1:NM_001844.4:synonymous:LOW:exon36/54:c.2400T>C:p.Asn800Asn,COL2A1:NM_033150.2:synonymous:LOW:exon35/53:c.2193T>C:p.Asn731Asn		rs1635553	0.4828	0.335	0.4558	0.4469						120140 [COL2A1 (confirmed) Stickler syndrome,type I|Kniest dysplasia|Achondrogenesis,type II or hypochondrogenesis|SED congenita|SMED Strudwick type|Epiphyseal dysplasia,multiple,with myopia and deafness|Spondyloperipheral dysplasia|SED,Namaqualand type|Osteoarthritis with mild chondrodysplasia|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type|Otospondylomegaepiphyseal dysplasia|Avascular necrosis of the femoral head|Legg-Calve-Perthes disease|Stickler sydrome,type I,nonsyndromic ocular|Czech dysplasia];	RCV000079724.2 [benign]; 		COSM1606168	0.1364	0.5682	0.2955	92	232	n/a	n/a
chr12	48376291	48376291	G	A	het		QUAL=17088;DP=269;AF=0.46;MQM=60;TRIO=HET,269,0.46,HOM,255,1.00,HET,307,0.58	COL2A1	synonymous	COL2A1:NM_001844.4:synonymous:LOW:exon34/54:c.2295C>T:p.Gly765Gly,COL2A1:NM_033150.2:synonymous:LOW:exon33/53:c.2088C>T:p.Gly696Gly		rs2276454	0.4297	0.393	0.4065	0.3484						120140 [COL2A1 (confirmed) Stickler syndrome,type I|Kniest dysplasia|Achondrogenesis,type II or hypochondrogenesis|SED congenita|SMED Strudwick type|Epiphyseal dysplasia,multiple,with myopia and deafness|Spondyloperipheral dysplasia|SED,Namaqualand type|Osteoarthritis with mild chondrodysplasia|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type|Otospondylomegaepiphyseal dysplasia|Avascular necrosis of the femoral head|Legg-Calve-Perthes disease|Stickler sydrome,type I,nonsyndromic ocular|Czech dysplasia];				0.1136	0.553	0.3333	73	232	n/a	n/a
chr12	48391416	48391416	G	T	het		QUAL=8195;DP=178;AF=0.53;MQM=60;TRIO=HET,178,0.53,HOM,193,0.98,WT,245,0.00	COL2A1	synonymous	COL2A1:NM_001844.4:synonymous:LOW:exon7/54:c.504C>A:p.Gly168Gly,COL2A1:NM_033150.2:synonymous:LOW:exon6/53:c.297C>A:p.Gly99Gly		rs3737548	0.2192	0.204	0.2241	0.1573						120140 [COL2A1 (confirmed) Stickler syndrome,type I|Kniest dysplasia|Achondrogenesis,type II or hypochondrogenesis|SED congenita|SMED Strudwick type|Epiphyseal dysplasia,multiple,with myopia and deafness|Spondyloperipheral dysplasia|SED,Namaqualand type|Osteoarthritis with mild chondrodysplasia|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type|Otospondylomegaepiphyseal dysplasia|Avascular necrosis of the femoral head|Legg-Calve-Perthes disease|Stickler sydrome,type I,nonsyndromic ocular|Czech dysplasia];			COSM3753255	0.0303	0.2727	0.697	13	153	n/a	n/a
chr12	48391657	48391657	T	A	het		QUAL=13526;DP=485;AF=0.52;MQM=60;TRIO=HET,485,0.52,HET,361,0.48,WT,478,0.00	COL2A1	missense	COL2A1:NM_001844.4:missense:MODERATE:exon6/54:c.426A>T:p.Glu142Asp,COL2A1:NM_033150.2:missense:MODERATE:exon5/53:c.219A>T:p.Glu73Asp		rs34392760	0.018	0.038	0.053	0.0082	0.5040	D	T	B,B	B,B	120140 [COL2A1 (confirmed) Stickler syndrome,type I|Kniest dysplasia|Achondrogenesis,type II or hypochondrogenesis|SED congenita|SMED Strudwick type|Epiphyseal dysplasia,multiple,with myopia and deafness|Spondyloperipheral dysplasia|SED,Namaqualand type|Osteoarthritis with mild chondrodysplasia|Vitreoretinopathy with phalangeal epiphyseal dysplasia|Platyspondylic skeletal dysplasia,Torrance type|Otospondylomegaepiphyseal dysplasia|Avascular necrosis of the femoral head|Legg-Calve-Perthes disease|Stickler sydrome,type I,nonsyndromic ocular|Czech dysplasia];				0	0.0682	0.9318	2	40	n/a	n/a
chr12	49418435	49418435	A	C	het		QUAL=3101;DP=110;AF=0.51;MQM=60;TRIO=HET,110,0.51,HET,106,0.45,WT,143,0.00	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon50/54:c.15978T>G:p.Leu5326Leu		rs55776396	0.0174	0.027	0.0326	0.0056						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080152.3 [benign]; 			0	0.0758	0.9242	0	27	n/a	n/a
chr12	49424534	49424534	G	A	het		QUAL=2176;DP=81;AF=0.52;MQM=60;TRIO=HET,81,0.52,WT,53,0.00,HET,65,0.54	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon41/54:c.13689C>T:p.Pro4563Pro		rs11168830	0.1228	0.093	0.033	0.049						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080132.3 [benign]; 		COSM3753292	0	0.0455	0.9545	4	22	n/a	n/a
chr12	49426460	49426460	A	G	het		QUAL=8545;DP=205;AF=0.42;MQM=59;TRIO=HET,205,0.42,HET,356,0.53,WT,449,0.00	KMT2D	missense	KMT2D:NM_003482.3:missense:MODERATE:exon39/54:c.12028T>C:p.Ser4010Pro		rs80132640	0.0172	0.026	0.03	0.0046	1.4120	N	D	B	B	602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080117.4 [benign]; 			0	0.0758	0.9242	0	27	n/a	n/a
chr12	49427652	49427652	C	T	het		QUAL=17102;DP=293;AF=0.44;MQM=59;TRIO=HET,293,0.44,HET,380,0.48,HET,501,0.51	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon39/54:c.10836G>A:p.Gln3612Gln	(CTG)n	rs3782357	0.4435	0.337	0.3671	0.5285						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080105.3 [benign]; 		COSM431203	0.1288	0.4318	0.4394	59	195	n/a	n/a
chr12	49434074	49434074	C	A	het		QUAL=762;DP=21;AF=0.38;MQM=60;TRIO=HET,21,0.38,HET,19,0.63,HET,24,0.46	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon31/54:c.7479G>T:p.Gly2493Gly		rs10747559	0.4355	0.409	0.3966	0.4602						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080211.3 [benign]; 		COSM3722551	0.2045	0.447	0.3485	81	202	n/a	n/a
chr12	49442562	49442563	AG	-	het		QUAL=8559;DP=269;AF=0.45;MQM=60;TRIO=HET,269,0.45,HET,324,0.47,WT,432,0.00	KMT2D	splice_region&intron	KMT2D:NM_003482.3:splice_region&intron:LOW:exon12/53:c.4021-11_4021-10delCT:		rs55776244	0.0539	0.038	0.0325	0.1312						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080177.2 [benign]; 			0	0.0758	0.9242	0	29	n/a	n/a
chr12	49444545	49444545	G	A	het		QUAL=1324;DP=50;AF=0.44;MQM=59;TRIO=HET,50,0.44,HET,25,0.40,HET,25,0.52	KMT2D	synonymous	KMT2D:NM_003482.3:synonymous:LOW:exon11/54:c.2826C>T:p.Ile942Ile		rs2241726	0.4036	0.377	0.3703	0.4176						602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080169.3 [benign]; 		COSM3753294	0.1288	0.4318	0.4394	60	199	n/a	n/a
chr12	49448463	49448463	C	T	het		QUAL=3423;DP=125;AF=0.50;MQM=60;TRIO=HET,125,0.50,HET,100,0.50,WT,132,0.00	KMT2D	missense	KMT2D:NM_003482.3:missense:MODERATE:exon3/54:c.248G>A:p.Arg83Gln		rs55865069	0.0164	0.026	0.0309	0.0055	0.6130	N	D	B	B	602113 [KMT2D (provisional) Kabuki syndrome 1];	RCV000080166.4 [benign]; 		COSM3773644	0	0.0758	0.9242	0	27	n/a	n/a
chr12	51135275	51135275	T	C	hom		QUAL=47502;DP=452;AF=1.00;MQM=60;TRIO=HOM,452,1.00,HOM,464,1.00,HOM,545,1.00	DIP2B	synonymous	DIP2B:NM_173602.2:synonymous:LOW:exon37/38:c.4431T>C:p.Ile1477Ile		rs1866422	0.9599	0.988	0.9995	0.8797						611379 [DIP2B (provisional) Mental retardation,FRA12A type];				1	0	0	453	1	n/a	n/a
chr12	51139279	51139279	A	G	hom		QUAL=11736;DP=179;AF=0.99;MQM=60;TRIO=HOM,179,0.99,HET,146,0.49,HET,209,0.57	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*657A>G:		rs4768914	0.2905	0	0	0										0.0606	0.4545	0.4848	8	68	n/a	n/a
chr12	51139692	51139692	T	G	hom		QUAL=13169;DP=305;AF=0.99;MQM=60;TRIO=HOM,305,0.99,HET,97,0.43,HET,132,0.45	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*1070T>G:		rs35845404	0.2907	0	0	0										0.0606	0.4545	0.4848	8	69	n/a	n/a
chr12	51139803	51139803	C	A	hom		QUAL=10495;DP=194;AF=1.00;MQM=60;TRIO=HOM,194,1.00,HET,107,0.46,HET,170,0.44	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*1181C>A:		rs3742063	0.2534	0	0	0										0.0606	0.4545	0.4848	8	69	n/a	n/a
chr12	51139892	51139892	C	T	hom		QUAL=13169;DP=256;AF=1.00;MQM=60;TRIO=HOM,256,1.00,HET,146,0.40,HET,212,0.43	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*1270C>T:		rs3742064	0.274	0	0	0										0.0606	0.4545	0.4848	8	68	n/a	n/a
chr12	51140410	51140410	C	G	hom		QUAL=28578;DP=386;AF=1.00;MQM=60;TRIO=HOM,386,1.00,HOM,222,1.00,HOM,270,1.00	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*1788C>G:		rs7303202	0.8389	0	0	0										0.9242	0.0758	0	138	12	n/a	n/a
chr12	51141883	51141883	A	G	hom		QUAL=29850;DP=366;AF=1.00;MQM=60;TRIO=HOM,366,1.00,HOM,253,1.00,HOM,305,1.00	DIP2B	3'UTR	DIP2B:NM_173602.2:3'UTR:MODIFIER:exon38/38:c.*3261A>G:		rs4768915	0.7953	0	0	0										0.9242	0.0758	0	138	12	n/a	n/a
chr12	53703021	53703021	G	A	hom		QUAL=9521;DP=142;AF=1.00;MQM=60;TRIO=HOM,142,1.00,HOM,69,1.00,HOM,98,1.00	AAAS	synonymous	AAAS:NM_015665.5:synonymous:LOW:exon9/16:c.855C>T:p.Phe285Phe,AAAS:NM_001173466.1:synonymous:LOW:exon8/15:c.756C>T:p.Phe252Phe		rs1546808	0.9153	0.974	0.9985	0.7263						605378 [AAAS (confirmed) Achalasia-addisonianism-alacrimia syndrome];	RCV000116212.2 [likely benign]; 			1	0	0	452	2	n/a	n/a
chr12	56082025	56082025	G	C	het		QUAL=18074;DP=599;AF=0.52;MQM=60;TRIO=HET,599,0.52,HET,493,0.50,WT,648,0.00	ITGA7	synonymous	ITGA7:NM_001144996.1:synonymous:LOW:exon23/25:c.3030C>G:p.Ser1010Ser,ITGA7:NM_002206.2:synonymous:LOW:exon23/25:c.3018C>G:p.Ser1006Ser,ITGA7:NM_001144997.1:synonymous:LOW:exon23/25:c.2739C>G:p.Ser913Ser		rs17117883	0.0443	0.042	0.0464	0.0642						600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency];	RCV000117295.2 [likely benign]; 		COSM1128539	0	0.1818	0.8182	2	75	n/a	n/a
chr12	56089344	56089344	A	G	het		QUAL=2993;DP=99;AF=0.42;MQM=60;TRIO=HET,99,0.42,WT,117,0.00,HET,129,0.47	ITGA7	synonymous	ITGA7:NM_001144996.1:synonymous:LOW:exon14/25:c.1977T>C:p.Cys659Cys,ITGA7:NM_002206.2:synonymous:LOW:exon14/25:c.1965T>C:p.Cys655Cys,ITGA7:NM_001144997.1:synonymous:LOW:exon14/25:c.1686T>C:p.Cys562Cys		rs7971022	0.0098	0.016	0.0257	0.0043						600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency];	RCV000079980.4 [other]; 			0	0.0606	0.9394	0	18	n/a	n/a
chr12	56089357	56089357	C	T	het		QUAL=8256;DP=161;AF=0.38;MQM=59;TRIO=HET,161,0.38,HET,139,0.54,HOM,145,1.00	ITGA7	missense	ITGA7:NM_001144996.1:missense:MODERATE:exon14/25:c.1964G>A:p.Arg655His,ITGA7:NM_002206.2:missense:MODERATE:exon14/25:c.1952G>A:p.Arg651His,ITGA7:NM_001144997.1:missense:MODERATE:exon14/25:c.1673G>A:p.Arg558His		rs1800974	0.5994	0.585	0.5085	0.3398	0.2040	P	T	B,B,B,B	B,B,B,B	600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency];	RCV000079979.3 [benign]; 	CM067685 [CLASS=DP MUT=ALT PHEN="Lung cancer, susceptibility to, association with" GENE=ITGA7]; 	COSM4147275	0.2955	0.5076	0.197	115	225	n/a	n/a
chr12	56398454	56398454	G	C	hom		QUAL=23216;DP=255;AF=1.00;MQM=60;TRIO=HOM,255,1.00,HOM,200,1.00,HOM,280,1.00	SUOX	synonymous	SUOX:NM_000456.2:synonymous:LOW:exon6/6:c.1281G>C:p.Ser427Ser,SUOX:NM_001032386.1:synonymous:LOW:exon5/5:c.1281G>C:p.Ser427Ser,SUOX:NM_001032387.1:synonymous:LOW:exon4/4:c.1281G>C:p.Ser427Ser		rs773115	0.7522	0.873	0.9198	0.3768						606887 [SUOX (provisional) Sulfite oxidase deficiency];	RCV000118423.2 [likely benign]; 			0.8788	0.1212	0	388	63	n/a	n/a
chr12	56473808	56473808	T	C	het		QUAL=1729;DP=31;AF=0.58;MQM=60;TRIO=HET,31,0.58,HET,35,0.60,HET,50,0.46					rs7297175	0.6508	0	0	0										0.4242	0.4773	0.0985	66	69	n/a	n/a
chr12	56477694	56477694	A	T	het		QUAL=15256;DP=195;AF=0.45;MQM=60;TRIO=HET,195,0.45,HET,352,0.49,HET,472,0.52	ERBB3	splice_region&intron	ERBB3:NM_001982.3:splice_region&intron:LOW:exon2/27:c.234+8A>T:,ERBB3:NM_001005915.1:splice_region&intron:LOW:exon2/2:c.234+8A>T:		rs2271194	0.5923	0.617	0.5859	0.3191						190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2];				0.4394	0.4773	0.0833	187	229	n/a	n/a
chr12	56493822	56493822	A	C	het		QUAL=19440;DP=409;AF=0.49;MQM=60;TRIO=HET,409,0.49,HET,339,0.52,HET,438,0.52	ERBB3	splice_region&intron	ERBB3:NM_001982.3:splice_region&intron:LOW:exon25/27:c.3129+9A>C:		rs2292238	0.2951	0.361	0.4063	0.1979						190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2];			COSM3998887	0.0909	0.447	0.4621	67	219	n/a	n/a
chr12	56494991	56494991	G	A	het		QUAL=9696;DP=187;AF=0.51;MQM=60;TRIO=HET,187,0.51,HET,197,0.51,HET,251,0.48	ERBB3	synonymous	ERBB3:NM_001982.3:synonymous:LOW:exon27/28:c.3348G>A:p.Arg1116Arg		rs2271189	0.2522	0.341	0.3969	0.1407						190151 [ERBB3 (confirmed) Lethal congenital contractural syndrome 2];				0.0909	0.4318	0.4773	65	214	n/a	n/a
chr12	65108160	65108160	G	C	het		QUAL=17777;DP=565;AF=0.48;MQM=60;TRIO=HET,565,0.48,HOM,282,0.99,WT,371,0.00	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*2361C>G:		rs1061743	0.6064	0	0	0										0.2803	0.5682	0.1515	41	85	n/a	n/a
chr12	65108586	65108586	G	C	het		QUAL=6536;DP=246;AF=0.46;MQM=60;TRIO=HET,246,0.46,WT,116,0.00,HET,166,0.50	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*1935C>G:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr12	65109168	65109168	C	T	het		QUAL=6181;DP=199;AF=0.47;MQM=56;TRIO=HET,199,0.47,HOM,104,0.99,WT,128,0.00	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*1353G>A:	AluSx3	rs1269548	0.5939	0	0	0										0.2803	0.5682	0.1515	51	87	n/a	n/a
chr12	65110141	65110141	G	A	het		QUAL=13279;DP=474;AF=0.49;MQM=60;TRIO=HET,474,0.49,HOM,178,1.00,WT,302,0.01	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*380C>T:		rs674	0.7157	0	0	0										0.2803	0.5758	0.1439	41	86	n/a	n/a
chr12	65110252	65110252	G	A	het		QUAL=14627;DP=513;AF=0.48;MQM=60;TRIO=HET,513,0.48,HOM,206,1.00,WT,334,0.00	GNS	3'UTR	GNS:NM_002076.3:3'UTR:MODIFIER:exon14/14:c.*269C>T:		rs2279597	0.1953	0	0	0										0.053	0.4318	0.5152	9	61	n/a	n/a
chr12	65146532	65146532	C	T	het		QUAL=8730;DP=349;AF=0.42;MQM=60;TRIO=HET,349,0.42,HOM,125,1.00,WT,175,0.00	GNS	synonymous	GNS:NM_002076.3:synonymous:LOW:exon2/14:c.198G>A:p.Pro66Pro		rs1147096	0	0.648	0.5894	0.8958						607664 [GNS (provisional) Mucopolysaccharidosis type IIID];	RCV000079972.2 [benign]; 			0.3258	0.5455	0.1288	148	230	n/a	n/a
chr12	66358120	66358121	TT	-	het		QUAL=4312;DP=268;AF=0.44;MQM=60;TRIO=HET,268,0.44,HET,57,0.47,WT,115,0.00	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*1048_*1049delTT:	(TC)n	rs10573247	0.3327	0	0	0										0.0227	0.3333	0.6439	3	47	n/a	n/a
chr12	66358347	66358347	C	T	het		QUAL=7031;DP=187;AF=0.58;MQM=60;TRIO=HET,187,0.58,HOM,106,1.00,WT,173,0.01	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*1275C>T:		rs1042725	0.5825	0	0	0								CR078543 [CLASS=DFP MUT=REF PHEN="Increased height, association with" GENE=HMGA2]; 		0.2652	0.5227	0.2121	39	80	n/a	n/a
chr12	66358571	66358571	C	A	het		QUAL=3905;DP=192;AF=0.51;MQM=60;TRIO=HET,192,0.51,HET,48,0.46,WT,47,0.00	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*1499C>A:		rs1042729	0.0176	0	0	0										0.0076	0.1136	0.8788	1	15	n/a	n/a
chr12	66359752	66359752	C	A	het		QUAL=10405;DP=393;AF=0.49;MQM=60;TRIO=HET,393,0.49,HOM,129,0.99,WT,186,0.01	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*2680C>A:		rs8756	0.6919	0	0	0										0.3182	0.5	0.1818	46	76	n/a	n/a
chr12	66360068	66360068	C	T	het		QUAL=10920;DP=363;AF=0.49;MQM=60;TRIO=HET,363,0.49,HET,326,0.50,WT,473,0.00	HMGA2	3'UTR	HMGA2:NM_003483.4:3'UTR:MODIFIER:exon5/5:c.*2996C>T:		rs11175982	0.3325	0	0	0										0.0227	0.3333	0.6439	3	47	n/a	n/a
chr12	66741538	66741538	T	-	het		QUAL=4156;DP=161;AF=0.38;MQM=60;TRIO=HET,161,0.38,HET,61,0.61,HET,86,0.48	GRIP1	3'UTR	GRIP1:NM_021150.3:3'UTR:MODIFIER:exon24/24:c.*1261delA:,GRIP1:NM_001178074.1:3'UTR:MODIFIER:exon23/23:c.*1261delA:		rs397850337	0.477	0	0	0										0.1894	0.5152	0.2955	29	76	n/a	n/a
chr12	66742183	66742183	A	G	het		QUAL=19108;DP=525;AF=0.49;MQM=60;TRIO=HET,525,0.49,HET,293,0.48,HET,374,0.50	GRIP1	3'UTR	GRIP1:NM_021150.3:3'UTR:MODIFIER:exon24/24:c.*616T>C:,GRIP1:NM_001178074.1:3'UTR:MODIFIER:exon23/23:c.*616T>C:		rs1168308	0.5038	0	0	0										0.1818	0.5303	0.2879	28	78	n/a	n/a
chr12	66786091	66786091	G	C	hom		QUAL=13456;DP=139;AF=1.00;MQM=60;TRIO=HOM,139,1.00,HOM,133,1.00,HOM,152,1.00	GRIP1	missense	GRIP1:NM_021150.3:missense:MODERATE:exon18/24:c.2305C>G:p.Gln769Glu,GRIP1:NM_001178074.1:missense:MODERATE:exon18/23:c.2305C>G:p.Gln769Glu		rs13277	0.8437	0.949	0.9969	0.6692	7.3090	P		P,P,P,P	B,B,B,B	604597 [GRIP1 (provisional) Fraser syndrome];				1	0	0	443	4	n/a	n/a
chr12	66786171	66786171	A	C	het		QUAL=9784;DP=367;AF=0.52;MQM=60;TRIO=HET,367,0.52,WT,181,0.00,HET,217,0.53	GRIP1	missense	GRIP1:NM_021150.3:missense:MODERATE:exon18/24:c.2225T>G:p.Met742Arg,GRIP1:NM_001178074.1:missense:MODERATE:exon18/23:c.2225T>G:p.Met742Arg		rs144494437	0.0014	0.0018	0.0014	0.0002	1.3260	N,N		.,B,B,B,B	.,B,B,B,B	604597 [GRIP1 (provisional) Fraser syndrome];		CM112031 [CLASS=DM MUT=ALT PHEN="Autism" GENE=GRIP1]; 		0	0.053	0.947	0	11	3	n/a
chr12	81102891	81102891	C	A	het		QUAL=17369;DP=377;AF=0.46;MQM=60;TRIO=HET,377,0.46,HET,305,0.47,HET,445,0.50	MYF6	3'UTR	MYF6:NM_002469.2:3'UTR:MODIFIER:exon3/3:c.*152C>A:		rs3120	0.1064	0	0	0										0.0985	0.2955	0.6061	15	48	n/a	n/a
chr12	81102921	81102921	T	C	het		QUAL=22046;DP=336;AF=0.44;MQM=60;TRIO=HET,336,0.44,HET,258,0.48,HOM,417,1.00	MYF6	3'UTR	MYF6:NM_002469.2:3'UTR:MODIFIER:exon3/3:c.*182T>C:		rs3121	0.4585	0	0	0										0.1742	0.4167	0.4091	27	63	n/a	n/a
chr12	81103085	81103085	A	G	het		QUAL=10538;DP=480;AF=0.47;MQM=60;TRIO=HET,480,0.47,HET,83,0.45,HET,132,0.47	MYF6	3'UTR	MYF6:NM_002469.2:3'UTR:MODIFIER:exon3/3:c.*346A>G:		rs1047183	0.1056	0	0	0										0.0985	0.2955	0.6061	15	48	n/a	n/a
chr12	81103144	81103144	A	G	het		QUAL=4447;DP=124;AF=0.50;MQM=60;TRIO=HET,124,0.50,HET,39,0.41,HOM,64,1.00	MYF6	3'UTR	MYF6:NM_002469.2:3'UTR:MODIFIER:exon3/3:c.*405A>G:		rs1047185	0.4585	0	0	0										0.1742	0.4167	0.4091	27	63	n/a	n/a
chr12	88483273	88483273	A	-	hom		QUAL=8179;DP=138;AF=0.99;MQM=60;TRIO=HOM,138,0.99,HOM,65,0.98,HOM,67,1.00	CEP290	splice_region&intron	CEP290:NM_025114.3:splice_region&intron:LOW:exon30/53:c.3574-9delT:	AT_rich	rs398076824	0.8736	0.886	0.942	0.7147						610142 [CEP290 (confirmed) Joubert syndrome 5|Senior-Loken syndrome 6|Leber congenital amaurosis 10|Meckel syndrome 4|Bardet-Biedl syndrome 14];	RCV000082247.2 [benign]; 			0.8712	0.1212	0.0076	934	121	n/a	n/a
chr12	88505078	88505078	T	C	hom		QUAL=13765;DP=206;AF=1.00;MQM=60;TRIO=HOM,206,1.00,HOM,84,1.00,HOM,120,1.00	CEP290	synonymous	CEP290:NM_025114.3:synonymous:LOW:exon22/54:c.2268A>G:p.Ser756Ser		rs2468255	0.7646	0.875	0.9226	0.432						610142 [CEP290 (confirmed) Joubert syndrome 5|Senior-Loken syndrome 6|Leber congenital amaurosis 10|Meckel syndrome 4|Bardet-Biedl syndrome 14];	RCV000124245.1,RCV000114186.2 [benign,likely benign]; 			0.8636	0.1364	0	937	173	n/a	n/a
chr12	102154900	102154900	A	G	het		QUAL=6447;DP=243;AF=0.50;MQM=60;TRIO=HET,243,0.50,WT,146,0.00,HET,167,0.50	GNPTAB	splice_region&intron	GNPTAB:NM_024312.4:splice_region&intron:LOW:exon15/20:c.3135+5T>C:		rs759935	0.6905	0.598	0.5256	0.7356						607840 [GNPTAB (confirmed) Mucolipidosis III alpha/beta|Mucolipidosis II alpha/beta];	RCV000082191.2 [benign]; 			0.2727	0.553	0.1742	159	216	n/a	n/a
chr12	102158763	102158763	T	C	het		QUAL=11136;DP=434;AF=0.47;MQM=60;TRIO=HET,434,0.47,WT,209,0.01,HET,298,0.47	GNPTAB	synonymous	GNPTAB:NM_024312.4:synonymous:LOW:exon13/21:c.1932A>G:p.Thr644Thr		rs10778148	0.6514	0.588	0.5223	0.6409						607840 [GNPTAB (confirmed) Mucolipidosis III alpha/beta|Mucolipidosis II alpha/beta];	RCV000082189.2 [benign]; 		COSM1127589	0.2727	0.553	0.1742	157	216	n/a	n/a
chr12	102789901	102789901	G	A	het		QUAL=9088;DP=347;AF=0.48;MQM=60;TRIO=HET,347,0.48,WT,142,0.00,HET,229,0.48	IGF1	3'UTR	IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*6384C>T:,IGF1:NM_000618.3:3'UTR:MODIFIER:exon4/4:c.*6384C>T:,IGF1:NM_001111283.1:3'UTR:MODIFIER:exon5/5:c.*6418C>T:		rs6222	0.0202	0	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr12	102790780	102790780	A	T	het		QUAL=2048;DP=100;AF=0.62;MQM=59;TRIO=HET,100,0.62,HET,8,0.50,HOM,4,1.00	IGF1	3'UTR	IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*5505T>A:,IGF1:NM_000618.3:3'UTR:MODIFIER:exon4/4:c.*5505T>A:,IGF1:NM_001111283.1:3'UTR:MODIFIER:exon5/5:c.*5539T>A:	AluSx3	rs1140655	0.619	0	0	0										0.553	0.3258	0.1212	84	47	n/a	n/a
chr12	102791801	102791801	A	-	het		QUAL=3107;DP=144;AF=0.59;MQM=60;TRIO=HET,144,0.59,WT,21,0.00,HET,28,0.57	IGF1	3'UTR	IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*4484delT:,IGF1:NM_000618.3:3'UTR:MODIFIER:exon4/4:c.*4484delT:,IGF1:NM_001111283.1:3'UTR:MODIFIER:exon5/5:c.*4518delT:		rs397844200	0.0204	0	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr12	102792897	102792897	G	A	het		QUAL=5807;DP=226;AF=0.42;MQM=59;TRIO=HET,226,0.42,WT,110,0.00,HET,180,0.53	IGF1	3'UTR	IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*3388C>T:,IGF1:NM_000618.3:3'UTR:MODIFIER:exon4/4:c.*3388C>T:,IGF1:NM_001111283.1:3'UTR:MODIFIER:exon5/5:c.*3422C>T:	(TG)n	rs5742705	0.0208	0	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr12	102793569	102793569	C	T	het		QUAL=13646;DP=364;AF=0.50;MQM=60;TRIO=HET,364,0.50,WT,189,0.00,HOM,230,0.99	IGF1	3'UTR	IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*2716G>A:,IGF1:NM_000618.3:3'UTR:MODIFIER:exon4/4:c.*2716G>A:,IGF1:NM_001111283.1:3'UTR:MODIFIER:exon5/5:c.*2750G>A:		rs6214	0.4269	0	0	0										0.1742	0.5455	0.2803	25	81	n/a	n/a
chr12	102793921	102793921	T	C	het		QUAL=4404;DP=205;AF=0.51;MQM=59;TRIO=HET,205,0.51,WT,45,0.00,HET,64,0.56	IGF1	3'UTR	IGF1:NM_001111284.1:3'UTR:MODIFIER:exon4/4:c.*2364A>G:,IGF1:NM_000618.3:3'UTR:MODIFIER:exon4/4:c.*2364A>G:,IGF1:NM_001111283.1:3'UTR:MODIFIER:exon5/5:c.*2398A>G:		rs5742704	0.0208	0	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr12	103237468	103237468	G	C	hom		QUAL=2163;DP=45;AF=1.00;MQM=60;TRIO=HOM,45,1.00,HOM,8,1.00,HOM,14,1.00	PAH	synonymous	PAH:NM_000277.1:synonymous:LOW:exon11/13:c.1155C>G:p.Leu385Leu		rs772897	0.8403	0.858	0.839	0.8041						612349 [PAH (confirmed) Phenylketonuria|Hyperphenylalaninemia,non-PKU mild];	RCV000088769.1,RCV000153631.1 [not provided,benign]; 			0.6894	0.2576	0.053	316	123	n/a	n/a
chr12	103248924	103248924	C	T	hom		QUAL=21951;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HOM,212,1.00,HOM,329,1.00	PAH	synonymous	PAH:NM_000277.1:synonymous:LOW:exon6/13:c.696G>A:p.Gln232Gln		rs1126758	0.5465	0.578	0.5948	0.7683						612349 [PAH (confirmed) Phenylketonuria|Hyperphenylalaninemia,non-PKU mild];	RCV000089040.1,RCV000153637.1 [not provided,benign]; 			0.3106	0.5152	0.1742	151	223	n/a	n/a
chr12	103351826	103351826	T	C	het		QUAL=5534;DP=120;AF=0.48;MQM=60;TRIO=HET,120,0.48,HOM,117,1.00,WT,186,0.00	ASCL1	5'UTR	ASCL1:NM_004316.3:5'UTR:MODIFIER:exon1/2:c.-197T>C:		rs9782	0.3001	0	0	0										0.0682	0.4773	0.4545	11	70	n/a	n/a
chr12	103353209	103353209	A	-	hom		QUAL=10820;DP=125;AF=1.00;MQM=60;TRIO=HOM,125,1.00,HOM,105,0.99,HOM,129,0.99	ASCL1	3'UTR	ASCL1:NM_004316.3:3'UTR:MODIFIER:exon2/2:c.*126delA:	GA-rich	rs398076918	0.976	0	0	0										0.9394	0.0606	0	142	8	n/a	n/a
chr12	103353525	103353525	T	C	hom		QUAL=16381;DP=156;AF=1.00;MQM=60;TRIO=HOM,156,1.00,HOM,145,1.00,HOM,217,1.00	ASCL1	3'UTR	ASCL1:NM_004316.3:3'UTR:MODIFIER:exon2/2:c.*433T>C:		rs1391682	0.9764	0	0	0										0.9394	0.0606	0	142	8	n/a	n/a
chr12	103353538	103353538	A	G	hom		QUAL=17197;DP=176;AF=1.00;MQM=60;TRIO=HOM,176,1.00,HOM,152,1.00,HOM,212,1.00	ASCL1	3'UTR	ASCL1:NM_004316.3:3'UTR:MODIFIER:exon2/2:c.*446A>G:		rs2291854	0.8215	0	0	0										0.6894	0.2727	0.0379	102	42	n/a	n/a
chr12	103354187	103354187	T	-	hom		QUAL=8214;DP=158;AF=0.96;MQM=60;TRIO=HOM,158,0.96,HOM,46,1.00,HOM,59,0.98	ASCL1	3'UTR	ASCL1:NM_004316.3:3'UTR:MODIFIER:exon2/2:c.*1103delT:		rs34660835	0.8494	0	0	0										0.7727	0.2045	0.0227	115	31	n/a	n/a
chr12	106838340	106838340	T	C	het		QUAL=9829;DP=365;AF=0.48;MQM=60;TRIO=HET,365,0.48,HET,265,0.50,WT,295,0.00	POLR3B	synonymous	POLR3B:NM_018082.5:synonymous:LOW:exon19/28:c.2055T>C:p.Tyr685Tyr,POLR3B:NM_001160708.1:synonymous:LOW:exon19/28:c.1881T>C:p.Tyr627Tyr		rs10861607	0.3179	0.314	0.2583	0.0597						614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism];	RCV000118025.2 [likely benign]; 		COSM1358426	0.053	0.3712	0.5758	95	518	n/a	n/a
chr12	106848414	106848414	A	G	het		QUAL=6422;DP=265;AF=0.48;MQM=60;TRIO=HET,265,0.48,WT,143,0.00,HET,165,0.41	POLR3B	missense	POLR3B:NM_018082.5:missense:MODERATE:exon20/28:c.2218A>G:p.Thr740Ala,POLR3B:NM_001160708.1:missense:MODERATE:exon20/28:c.2044A>G:p.Thr682Ala		rs17038460	0.0266	0.047	0.0691	0.0175	9.3000	P	D	P	B	614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism];	RCV000118026.2 [likely benign]; 			0	0.1136	0.8864	16	167	n/a	n/a
chr12	106903321	106903321	T	C	het		QUAL=8851;DP=318;AF=0.51;MQM=60;TRIO=HET,318,0.51,HET,210,0.52,WT,275,0.00	POLR3B	synonymous	POLR3B:NM_018082.5:synonymous:LOW:exon28/28:c.3396T>C:p.Asn1132Asn,POLR3B:NM_001160708.1:synonymous:LOW:exon28/28:c.3222T>C:p.Asn1074Asn		rs13561	0.3249	0.324	0.2741	0.0894						614366 [POLR3B (provisional) Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism];	RCV000118027.2 [likely benign]; 		COSM3752870	0.053	0.3788	0.5682	108	522	n/a	n/a
chr12	106903674	106903674	A	G	het		QUAL=5397;DP=268;AF=0.49;MQM=60;TRIO=HET,268,0.49,HET,80,0.43,WT,140,0.00	POLR3B	3'UTR	POLR3B:NM_018082.5:3'UTR:MODIFIER:exon28/28:c.*347A>G:,POLR3B:NM_001160708.1:3'UTR:MODIFIER:exon28/28:c.*347A>G:		rs2288266	0.3249	0	0	0										0.053	0.3788	0.5682	9	56	n/a	n/a
chr12	109993106	109993106	G	T	het		QUAL=751;DP=17;AF=0.00;MQM=58;TRIO=HET,17,0.29,HET,3,0.33,HET,49,0.78	MMAB	3'UTR	MMAB:NM_052845.3:3'UTR:MODIFIER:exon9/9:c.*1727C>A:	AluSx1		0	0.0002	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr12	110240838	110240838	T	G	het		QUAL=12585;DP=233;AF=0.54;MQM=60;TRIO=HET,233,0.54,HET,200,0.54,HET,340,0.49	TRPV4	synonymous	TRPV4:NM_021625.4:synonymous:LOW:exon4/16:c.670A>C:p.Arg224Arg,TRPV4:NM_001177431.1:synonymous:LOW:exon4/16:c.568A>C:p.Arg190Arg,TRPV4:NM_001177428.1:synonymous:LOW:exon3/14:c.670A>C:p.Arg224Arg,TRPV4:NM_001177433.1:synonymous:LOW:exon3/13:c.670A>C:p.Arg224Arg,TRPV4:NM_147204.2:synonymous:LOW:exon3/14:c.670A>C:p.Arg224Arg		rs3825394	0.7544	0.633	0.5274	0.685						605427 [TRPV4 (confirmed) Brachyolmia type 3|Spondylometaphyseal dysplasia,Kozlowski type|Metatropic dysplasia|Hereditary motor and sensory neuropathy,type IIc|Scapuloperoneal spinal muscular atrophy|Sodium serum level QTL 1|Parastremmatic dwarfism|SED,Maroteaux type|Spinal muscular atrophy,distal,congenital nonprogressive|Digital arthropathy-brachydactyly,familial];			COSM3752895	0.3409	0.4848	0.1742	220	370	n/a	n/a
chr12	110784907	110784907	-	ATCA	het		QUAL=3545;DP=175;AF=0.45;MQM=56;TRIO=HET,175,0.45,HET,94,0.48,WT,120,0.00	ATP2A2	3'UTR,intron	ATP2A2:NM_170665.3:3'UTR:MODIFIER:exon20/20:c.*633_*636dupATCA:,ATP2A2:NM_001681.3:intron:MODIFIER:exon20/20:c.2980+782_2980+785dupATCA:		rs112750891	0.1378	0	0	0						108740 [ATP2A2 (confirmed) Darier disease|Acrokeratosis verruciformis];				0.0076	0.1515	0.8409	1	24	n/a	n/a
chr12	112944602	112944602	G	-	het		QUAL=5525;DP=224;AF=0.47;MQM=58;TRIO=HET,224,0.47,HET,156,0.46,WT,232,0.00	PTPN11	3'UTR	PTPN11:NM_002834.3:3'UTR:MODIFIER:exon16/16:c.*1006delG:	MLT1H	rs146940557	0.0351	0	0	0										0.0152	0.1591	0.8258	2	25	n/a	n/a
chr12	112944757	112944759	TGA	-	het		QUAL=1281;DP=35;AF=0.49;MQM=60;TRIO=HET,35,0.49,HET,62,0.44,WT,106,0.00	PTPN11	3'UTR	PTPN11:NM_002834.3:3'UTR:MODIFIER:exon16/16:c.*1199_*1201delATG:	(ATG)n		0	0	0	0										0.0606	0.3409	0.5985	9	53	n/a	n/a
chr12	116397088	116397088	A	T	het		QUAL=677;DP=45;AF=0.53;MQM=60;TRIO=HET,45,0.53,NONE,0,0,WT,4,0.00	MED13L	3'UTR	MED13L:NM_015335.4:3'UTR:MODIFIER:exon31/31:c.*1983T>A:		rs12423578	0.1745	0	0	0										0.0455	0.2045	0.75	7	33	n/a	n/a
chr12	116398626	116398626	A	C	het		QUAL=15515;DP=393;AF=0.52;MQM=60;TRIO=HET,393,0.52,WT,238,0.00,HOM,278,1.00	MED13L	3'UTR	MED13L:NM_015335.4:3'UTR:MODIFIER:exon31/31:c.*445T>G:		rs66898998	0.1324	0	0	0										0.1439	0.4545	0.4015	20	68	n/a	n/a
chr12	116406910	116406910	G	A	het		QUAL=5986;DP=189;AF=0.49;MQM=60;TRIO=HET,189,0.49,HET,183,0.54,WT,187,0.00	MED13L	splice_region&intron	MED13L:NM_015335.4:splice_region&intron:LOW:exon27/30:c.6068-8C>T:		rs61936939	0.0046	0.011	0.0157	0.003						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];				0	0.0227	0.9773	1	9	n/a	n/a
chr12	116408538	116408538	A	G	het		QUAL=7255;DP=270;AF=0.50;MQM=60;TRIO=HET,270,0.50,HET,187,0.47,WT,264,0.00	MED13L	synonymous	MED13L:NM_015335.4:synonymous:LOW:exon27/31:c.5928T>C:p.Thr1976Thr		rs2304460	0.1528	0.169	0.1805	0.0935	0.4130	P				608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];			COSM147620	0.0303	0.2803	0.6894	16	125	n/a	n/a
chr12	116429689	116429689	A	G	het		QUAL=10683;DP=300;AF=0.53;MQM=59;TRIO=HET,300,0.53,HET,383,0.48,WT,548,0.00	MED13L	synonymous	MED13L:NM_015335.4:synonymous:LOW:exon17/31:c.3070T>C:p.Leu1024Leu		rs1865787	0.1558	0.172	0.1863	0.0867						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];				0.0303	0.2803	0.6894	14	127	n/a	n/a
chr12	116445448	116445448	G	A	het		QUAL=251;DP=36;AF=0.39;MQM=52;TRIO=HET,36,0.39,WT,29,0.03,WT,50,0.04	MED13L	splice_region&intron	MED13L:NM_015335.4:splice_region&intron:LOW:exon10/30:c.2013-7C>T:	(A)n	rs199749418	0	0	0	0						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];			COSM3746277	0	0.0303	0.9697	0	7	n/a	n/a
chr12	116445450	116445450	C	A	het		QUAL=251;DP=36;AF=0.39;MQM=52;TRIO=HET,36,0.39,WT,29,0.03,WT,50,0.04	MED13L	splice_region&intron	MED13L:NM_015335.4:splice_region&intron:LOW:exon10/30:c.2013-9G>T:	(A)n	rs200367922	0	0	0	0						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];			COSM3746278	0	0.1818	0.8182	2	42	n/a	n/a
chr12	116446445	116446445	C	T	het		QUAL=8041;DP=257;AF=0.49;MQM=60;TRIO=HET,257,0.49,HET,235,0.53,WT,323,0.00	MED13L	synonymous	MED13L:NM_015335.4:synonymous:LOW:exon10/31:c.1773G>A:p.Gln591Gln		rs3741768	0.1434	0.163	0.1779	0.0724						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];			COSM3752943	0.0303	0.2803	0.6894	14	125	n/a	n/a
chr12	116457090	116457090	C	T	het		QUAL=9359;DP=345;AF=0.47;MQM=60;TRIO=HET,345,0.47,HET,246,0.52,WT,348,0.00	MED13L	synonymous	MED13L:NM_015335.4:synonymous:LOW:exon7/31:c.948G>A:p.Lys316Lys		rs61748072	0.0044	0.011	0.0151	0.003						608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1];				0	0.0227	0.9773	0	9	n/a	n/a
chr12	119632307	119632307	A	G	het		QUAL=3454;DP=124;AF=0.56;MQM=60;TRIO=HET,124,0.56,WT,96,0.00,HET,92,0.47	HSPB8	3'UTR	HSPB8:NM_014365.2:3'UTR:MODIFIER:exon3/3:c.*644A>G:		rs11038	0.3802	0	0	0										0.0758	0.4015	0.5227	12	61	n/a	n/a
chr12	119632347	119632347	G	A	het		QUAL=2975;DP=96;AF=0.59;MQM=60;TRIO=HET,96,0.59,WT,69,0.00,HET,74,0.50	HSPB8	3'UTR	HSPB8:NM_014365.2:3'UTR:MODIFIER:exon3/3:c.*684G>A:		rs1133026	0.137	0	0	0										0.0303	0.3333	0.6364	5	51	n/a	n/a
chr12	119632511	119632516	TAATAA	-	het		QUAL=1381;DP=30;AF=0.67;MQM=60;TRIO=HET,30,0.67,WT,3,0.00,HOM,30,0.97	HSPB8	3'UTR	HSPB8:NM_014365.2:3'UTR:MODIFIER:exon3/3:c.*866_*871delTAATAA:	(TAA)n	rs555638888	0	0	0	0										0.2348	0.1439	0.6212	34	23	n/a	n/a
chr12	120941215	120941215	T	C	het		QUAL=6279;DP=253;AF=0.51;MQM=59;TRIO=HET,253,0.51,HET,138,0.47,WT,217,0.00	COQ5	3'UTR	COQ5:NM_032314.3:3'UTR:MODIFIER:exon7/7:c.*372A>G:		rs7471	0.2646	0	0	0										0.1061	0.3788	0.5152	17	55	n/a	n/a
chr12	120966921	120966921	A	G	het		QUAL=5075;DP=259;AF=0.47;MQM=59;TRIO=HET,259,0.47,HET,94,0.59,WT,141,0.00	COQ5	synonymous	COQ5:NM_032314.3:synonymous:LOW:exon1/7:c.24T>C:p.Ala8Ala		rs3742052	0.2646	0.298	0.3115	0.1058									COSM3752963	0.1061	0.3788	0.5152	45	161	n/a	n/a
chr12	121432117	121432117	G	C	hom		QUAL=13624;DP=123;AF=0.98;MQM=59;TRIO=HOM,123,0.98,HET,273,0.53,HET,371,0.54	HNF1A	synonymous	HNF1A:NM_000545.5:synonymous:LOW:exon4/10:c.864G>C:p.Gly288Gly		rs56348580	0.1811	0	0.2633	0.182						142410 [HNF1A (confirmed) MODY,type III|Diabetes mellitus,noninsulin-dependent,2|Diabetes mellitus,insulin-dependent|Hepatic adenoma,somatic|Renal cell carcinoma|Diabetes mellitus,insulin-dependent,20];	RCV000117234.1 [benign]; RCV000125372.1 [benign]; 	CM067044 [CLASS=DM? MUT=ALT PHEN="Diabetes, MODY3" GENE=HNF1A]; 		0.1364	0.3485	0.5152	61	215	2	n/a
chr12	121437382	121437382	A	G	hom		QUAL=13781;DP=72;AF=1.00;MQM=59;TRIO=HOM,72,1.00,HOM,164,1.00,HOM,212,1.00	HNF1A	missense	HNF1A:NM_000545.5:missense:MODERATE:exon9/10:c.1720A>G:p.Ser574Gly		rs1169305	0.9852	0.996	0.9997	0.9619	0.3180	P	T	B	B	142410 [HNF1A (confirmed) MODY,type III|Diabetes mellitus,noninsulin-dependent,2|Diabetes mellitus,insulin-dependent|Hepatic adenoma,somatic|Renal cell carcinoma|Diabetes mellitus,insulin-dependent,20];	RCV000016077.24,RCV000030490.1 [pathogenic,benign]; RCV000121200.1 [not provided]; 	CM020516 [CLASS=DFP MUT=REF PHEN="Diabetes, type 2, association with" GENE=HNF1A]; 		1	0	0	493	1	2	n/a
chr12	121440263	121440263	G	A	hom		QUAL=9863;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HET,143,0.51,HET,176,0.49	HNF1A,C12orf43	3'UTR	HNF1A:NM_000545.5:3'UTR:MODIFIER:exon10/10:c.*1268G>A:,C12orf43:NM_001286191.1:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,C12orf43:NM_001286192.1:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,C12orf43:NM_001286195.1:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,C12orf43:NM_001286196.1:3'UTR:MODIFIER:exon6/6:c.*1693C>T:,C12orf43:NM_001286197.1:3'UTR:MODIFIER:exon5/5:c.*1693C>T:,C12orf43:NM_001286198.1:3'UTR:MODIFIER:exon7/7:c.*1693C>T:,C12orf43:NM_022895.2:3'UTR:MODIFIER:exon6/6:c.*1693C>T:		rs41279096	0.1054	0.067	0	0	0.2980	P	D							0.0227	0.1591	0.8182	8	53	n/a	n/a
chr12	122064774	122064779	CCGCCA	-	hom		QUAL=473;DP=7;AF=0.86;MQM=60;TRIO=HOM,7,0.86,HOM,4,1.00,HOM,10,1.00	ORAI1	disruptive_inframe_deletion	ORAI1:NM_032790.3:disruptive_inframe_deletion:MODERATE:exon1/2:c.138_143delACCGCC:p.Pro47_Pro48del	(CCG)n	rs531278468	0.9998	0	0	0						610277 [ORAI1 (provisional) Immunodeficiency 9|Myopathy,tubular aggregate,2];			COSM430547	0.8182	0.0076	0.1742	410	4	n/a	n/a
chr12	122295335	122295335	T	C	hom		QUAL=21349;DP=178;AF=1.00;MQM=60;TRIO=HOM,178,1.00,HOM,203,1.00,HOM,291,1.00	HPD	missense,5'UTR	HPD:NM_002150.2:missense:MODERATE:exon4/14:c.97A>G:p.Thr33Ala,HPD:NM_001171993.1:5'UTR:MODIFIER:exon6/16:c.-21A>G:		rs1154510	0.8764	0.85	0.8727	0.956	3.8970	P	T			609695 [HPD (confirmed) Tyrosinemia,type III|Hawkinsinuria];	RCV000001643.1 [pathogenic]; 	CM003889 [CLASS=DM? MUT=REF PHEN="Hawkinsinuria" GENE=HPD]; 	COSM3736057	0.7121	0.2652	0.0227	336	111	2	n/a
chr12	122756470	122756470	C	A	het		QUAL=5325;DP=226;AF=0.42;MQM=60;TRIO=HET,226,0.42,WT,91,0.00,HET,142,0.48	CLIP1	3'UTR	CLIP1:NM_001247997.1:3'UTR:MODIFIER:exon26/26:c.*952G>T:,CLIP1:NM_002956.2:3'UTR:MODIFIER:exon25/25:c.*952G>T:,CLIP1:NM_198240.1:3'UTR:MODIFIER:exon24/24:c.*952G>T:		rs112052364	0.0012	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr12	122812503	122812503	G	C	hom		QUAL=19286;DP=192;AF=0.99;MQM=59;TRIO=HOM,192,0.99,HET,249,0.49,HOM,311,0.99	CLIP1	missense	CLIP1:NM_001247997.1:missense:MODERATE:exon17/26:c.3240C>G:p.Asp1080Glu,CLIP1:NM_002956.2:missense:MODERATE:exon16/25:c.3207C>G:p.Asp1069Glu,CLIP1:NM_198240.1:missense:MODERATE:exon15/24:c.3102C>G:p.Asp1034Glu		rs1129167	0.4066	0.562	0.6267	0.1591	0.2800	P	T	B,B,B	B,B,B					0.4015	0.4697	0.1288	219	267	n/a	n/a
chr12	122817580	122817580	A	G	het		QUAL=5957;DP=230;AF=0.53;MQM=60;TRIO=HET,230,0.53,HET,128,0.51,WT,183,0.00	CLIP1	missense	CLIP1:NM_001247997.1:missense:MODERATE:exon15/26:c.2821T>C:p.Ser941Pro,CLIP1:NM_002956.2:missense:MODERATE:exon14/25:c.2788T>C:p.Ser930Pro,CLIP1:NM_198240.1:missense:MODERATE:exon13/24:c.2683T>C:p.Ser895Pro		rs17883517	0.0313	0.062	0.0987	0.017	8.6630	D	D	D,D,D	D,D,D				COSM3752996	0.0076	0.1136	0.8788	2	88	n/a	n/a
chr12	122956750	122956750	A	T	het		QUAL=143;DP=72;AF=0.21;MQM=48;TRIO=HET,72,0.21,WT,56,0.02,WT,74,0.00	ZCCHC8	3'UTR	ZCCHC8:NM_017612.4:3'UTR:MODIFIER:exon14/14:c.*1294T>A:			0	0	0	0										0	0	1	0	1	n/a	n/a
chr12	122956842	122956842	A	C	hom		QUAL=3880;DP=77;AF=1.00;MQM=51;TRIO=HOM,77,1.00,HET,32,0.53,HOM,49,1.00	ZCCHC8	3'UTR	ZCCHC8:NM_017612.4:3'UTR:MODIFIER:exon14/14:c.*1202T>G:	AluSq2	rs11608711	0.5791	0	0	0										0.3409	0.4848	0.1742	53	70	n/a	n/a
chr12	122957085	122957085	G	A	hom		QUAL=185;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,1,1.00,HOM,1,1.00	ZCCHC8	3'UTR	ZCCHC8:NM_017612.4:3'UTR:MODIFIER:exon14/14:c.*959C>T:		rs7132830	0.5789	0	0	0										0.1742	0.0833	0.7424	32	20	n/a	n/a
chr12	123718301	123718301	C	T	het		QUAL=10006;DP=190;AF=0.55;MQM=60;TRIO=HET,190,0.55,HOM,144,1.00,HET,164,0.53	C12orf65	5'UTR,intron	C12orf65:NM_001143905.2:5'UTR:MODIFIER:exon1/3:c.-169C>T:,C12orf65:NM_001194995.1:5'UTR:MODIFIER:exon1/3:c.-199C>T:,C12orf65:NM_152269.4:intron:MODIFIER:exon1/2:c.-29+223C>T:		rs1727332	0.5569	0	0	0										0.4773	0.3864	0.1364	74	57	n/a	n/a
chr12	123738494	123738494	C	T	het		QUAL=7773;DP=256;AF=0.56;MQM=60;TRIO=HET,256,0.56,WT,155,0.00,HET,215,0.53	C12orf65	synonymous	C12orf65:NM_001143905.2:synonymous:LOW:exon2/3:c.273C>T:p.Ile91Ile,C12orf65:NM_152269.4:synonymous:LOW:exon2/3:c.273C>T:p.Ile91Ile,C12orf65:NM_001194995.1:synonymous:LOW:exon2/3:c.273C>T:p.Ile91Ile		rs2280424	0.0909	0.056	0.0386	0.0433						613541 [C12orf65 (provisional) Combined oxidative phosphorylation deficiency 7|Spastic paraplegia 55,autosomal recessive];			COSM3998691	0	0.1515	0.8485	0	69	n/a	n/a
chr12	123741706	123741706	C	A	het		QUAL=3014;DP=137;AF=0.52;MQM=60;TRIO=HET,137,0.52,WT,69,0.00,HET,71,0.37	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*128C>A:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*128C>A:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*128C>A:		rs11554169	0.0935	0	0	0										0	0.1515	0.8485	0	21	n/a	n/a
chr12	123741776	123741776	T	C	hom		QUAL=14133;DP=215;AF=0.99;MQM=60;TRIO=HOM,215,0.99,HOM,101,1.00,HOM,121,1.00	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*198T>C:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*198T>C:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*198T>C:	AluSx1	rs1969354	0.6514	0	0	0										0.5758	0.3409	0.0833	87	52	n/a	n/a
chr12	123742032	123742032	A	C	het		QUAL=4997;DP=188;AF=0.50;MQM=58;TRIO=HET,188,0.50,WT,71,0.03,HET,112,0.60	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*454A>C:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*454A>C:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*454A>C:	AluSx1	rs76029248	0.0933	0	0	0										0	0.1515	0.8485	0	21	n/a	n/a
chr12	123742061	123742061	G	A	het		QUAL=7224;DP=215;AF=0.50;MQM=59;TRIO=HET,215,0.50,HOM,74,1.00,HET,125,0.38	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*483G>A:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*483G>A:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*483G>A:	AluSx1	rs1969355	0.5573	0	0	0										0.4697	0.4015	0.1288	73	59	n/a	n/a
chr12	123742093	123742093	T	G	hom		QUAL=14813;DP=251;AF=1.00;MQM=59;TRIO=HOM,251,1.00,HOM,83,1.00,HOM,136,1.00	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*515T>G:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*515T>G:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*515T>G:		rs1533703	0.6506	0	0	0										0.5758	0.3409	0.0833	87	52	n/a	n/a
chr12	123742271	123742274	AAAG	-	het		QUAL=2146;DP=93;AF=0.44;MQM=59;TRIO=HET,93,0.44,WT,23,0.00,HET,51,0.59	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*696_*699delGAAA:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*696_*699delGAAA:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*696_*699delGAAA:	L1ME3B	rs202152701	0.0933	0	0	0										0	0.1212	0.8788	0	17	n/a	n/a
chr12	123742287	123742289	TAC	-	het		QUAL=3084;DP=124;AF=0.56;MQM=59;TRIO=HET,124,0.56,WT,28,0.00,HET,53,0.57	C12orf65	3'UTR	C12orf65:NM_001143905.2:3'UTR:MODIFIER:exon3/3:c.*711_*713delCTA:,C12orf65:NM_152269.4:3'UTR:MODIFIER:exon3/3:c.*711_*713delCTA:,C12orf65:NM_001194995.1:3'UTR:MODIFIER:exon3/3:c.*711_*713delCTA:	L1ME3B	rs148010033	0.0933	0	0	0										0	0.1136	0.8864	0	15	n/a	n/a
chr12	124105848	124105848	A	G	hom		QUAL=32695;DP=346;AF=1.00;MQM=60;TRIO=HOM,346,1.00,HOM,263,1.00,HOM,399,1.00	EIF2B1	3'UTR	EIF2B1:NM_001414.3:3'UTR:MODIFIER:exon9/9:c.*455T>C:		rs7137332	0.9972	0	0	0										0.9848	0.0152	0	148	2	n/a	n/a
chr12	124197099	124197099	C	T	het		QUAL=365;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,HET,6,0.50,HET,18,0.61	ATP6V0A2	5'UTR	ATP6V0A2:NM_012463.3:5'UTR:MODIFIER:exon1/20:c.-14C>T:		rs1139320	0.2722	0.282	0.3747	0.3981							RCV000081542.2 [benign]; 			0.1742	0.3258	0.5	33	50	n/a	n/a
chr12	124209332	124209332	T	C	het		QUAL=8277;DP=216;AF=0.53;MQM=60;TRIO=HET,216,0.53,HET,141,0.49,HET,157,0.48	ATP6V0A2	synonymous	ATP6V0A2:NM_012463.3:synonymous:LOW:exon4/20:c.426T>C:p.Asn142Asn		rs1139789	0.751	0.679	0.6298	0.6795						611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA|Wrinkly skin syndrome];	RCV000081551.2 [benign]; 		COSM3753015	0.3636	0.4924	0.1439	173	211	n/a	n/a
chr12	124210782	124210782	T	C	het		QUAL=12135;DP=283;AF=0.48;MQM=60;TRIO=HET,283,0.48,HET,215,0.47,HET,256,0.53	ATP6V0A2	synonymous	ATP6V0A2:NM_012463.3:synonymous:LOW:exon5/20:c.471T>C:p.Ser157Ser		rs1399961	0.7498	0.676	0.6207	0.6773						611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA|Wrinkly skin syndrome];	RCV000081553.2 [benign]; 		COSM3753016	0.3636	0.4773	0.1591	171	208	n/a	n/a
chr12	124229429	124229429	T	C	het		QUAL=22301;DP=308;AF=0.53;MQM=60;TRIO=HET,308,0.53,HET,476,0.51,HET,588,0.49	ATP6V0A2	splice_region&synonymous	ATP6V0A2:NM_012463.3:splice_region&synonymous:LOW:exon13/20:c.1515T>C:p.Asn505Asn		rs7135542	0.7995	0.693	0.6314	0.8202						611716 [ATP6V0A2 (confirmed) Cutis laxa,autosomal recessive,type IIA|Wrinkly skin syndrome];	RCV000081547.2 [benign]; 		COSM1127520	0.3636	0.4924	0.1439	173	212	n/a	n/a
chr12	124243707	124243707	T	C	het		QUAL=9773;DP=258;AF=0.54;MQM=60;TRIO=HET,258,0.54,HET,142,0.39,HET,198,0.53	ATP6V0A2	3'UTR	ATP6V0A2:NM_012463.3:3'UTR:MODIFIER:exon20/20:c.*1128T>C:		rs10744162	0.6176	0	0	0										0.3182	0.5227	0.1591	47	77	n/a	n/a
chr12	124244272	124244272	C	G	het		QUAL=15491;DP=348;AF=0.49;MQM=60;TRIO=HET,348,0.49,HET,264,0.50,HET,345,0.52	ATP6V0A2	3'UTR	ATP6V0A2:NM_012463.3:3'UTR:MODIFIER:exon20/20:c.*1693C>G:		rs10846553	0.7915	0	0	0										0.3636	0.4924	0.1439	53	73	n/a	n/a
chr12	124246004	124246004	G	A	het		QUAL=20560;DP=456;AF=0.46;MQM=60;TRIO=HET,456,0.46,HET,360,0.53,HET,442,0.51	ATP6V0A2	3'UTR	ATP6V0A2:NM_012463.3:3'UTR:MODIFIER:exon20/20:c.*3425G>A:		rs2333834	0.6066	0	0	0										0.303	0.5379	0.1591	45	79	n/a	n/a
chr13	20761763	20761763	A	G	hom		QUAL=22077;DP=283;AF=1.00;MQM=60;TRIO=HOM,283,1.00,HOM,159,1.00,HOM,228,1.00	GJB2	3'UTR	GJB2:NM_004004.5:3'UTR:MODIFIER:exon2/2:c.*1277T>C:		rs7988691	0.9972	0	0	0										1	0	0	150	0	n/a	n/a
chr13	20761888	20761888	C	T	hom		QUAL=20374;DP=246;AF=1.00;MQM=60;TRIO=HOM,246,1.00,HOM,155,1.00,HOM,206,1.00	GJB2	3'UTR	GJB2:NM_004004.5:3'UTR:MODIFIER:exon2/2:c.*1152G>A:		rs7623	0.8934	0	0	0										0.9318	0.0682	0	141	9	n/a	n/a
chr13	20761973	20761973	C	A	hom		QUAL=30352;DP=472;AF=1.00;MQM=59;TRIO=HOM,472,1.00,HOM,188,1.00,HOM,262,1.00	GJB2	3'UTR	GJB2:NM_004004.5:3'UTR:MODIFIER:exon2/2:c.*1067G>T:		rs9237	0.8702	0	0	0										0.8485	0.1515	0	129	21	n/a	n/a
chr13	20762956	20762956	A	G	hom		QUAL=35555;DP=464;AF=0.99;MQM=60;TRIO=HOM,464,0.99,HOM,277,1.00,HOM,356,1.00	GJB2	3'UTR	GJB2:NM_004004.5:3'UTR:MODIFIER:exon2/2:c.*84T>C:		rs3751385	0.6867	0	0	0							RCV000029940.1 [benign]; 			0.6742	0.303	0.0227	106	41	n/a	n/a
chr13	20978006	20978006	A	G	hom		QUAL=32970;DP=372;AF=1.00;MQM=59;TRIO=HOM,372,1.00,HOM,292,1.00,HOM,372,1.00	CRYL1	3'UTR	CRYL1:NM_015974.2:3'UTR:MODIFIER:exon8/8:c.*262T>C:		rs7165	0.6903	0	0	0										0.5606	0.4015	0.0379	86	57	n/a	n/a
chr13	21063524	21063524	A	G	het		QUAL=10195;DP=237;AF=0.49;MQM=60;TRIO=HET,237,0.49,WT,185,0.00,HOM,215,1.00	CRYL1	synonymous	CRYL1:NM_015974.2:synonymous:LOW:exon3/8:c.261T>C:p.Gly87Gly		rs14236	0.2704	0.229	0.2278	0.4193									COSM3753610	0.053	0.3182	0.6288	21	107	n/a	n/a
chr13	23824783	23824783	T	G	hom		QUAL=9376;DP=128;AF=1.00;MQM=60;TRIO=HOM,128,1.00,HOM,90,1.00,HET,121,0.57	SGCG	synonymous	SGCG:NM_000231.2:synonymous:LOW:exon4/8:c.312T>G:p.Leu104Leu		rs1800351	0.5248	0.427	0.3686	0.6714						608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C];	RCV000078404.3 [benign]; 		COSM3753619	0.1818	0.4318	0.3864	71	203	n/a	n/a
chr13	23898509	23898509	T	C	het		QUAL=7582;DP=144;AF=0.53;MQM=60;TRIO=HET,144,0.53,WT,89,0.01,HOM,168,0.99	SGCG	splice_region&synonymous	SGCG:NM_000231.2:splice_region&synonymous:LOW:exon8/8:c.705T>C:p.Leu235Leu		rs1800353	0.6298	0.674	0.6653	0.4022						608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C];	RCV000078407.3 [benign]; 			0.447	0.4545	0.0985	206	198	n/a	n/a
chr13	23898664	23898664	A	G	hom		QUAL=13309;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HOM,94,1.00,HOM,166,1.00	SGCG	missense	SGCG:NM_000231.2:missense:MODERATE:exon8/8:c.860A>G:p.Asn287Ser		rs1800354	0.8778	0.882	0.8672	0.731	4.0170	P	T	B	B	608896 [SGCG (confirmed) Muscular dystrophy,limb-girdle,type 2C];	RCV000153942.1 [benign]; 		COSM4147635	0.6894	0.2879	0.0227	326	115	n/a	n/a
chr13	23898934	23898934	G	A	het		QUAL=17466;DP=479;AF=0.51;MQM=60;TRIO=HET,479,0.51,HOM,296,0.99,WT,442,0.01	SGCG	3'UTR	SGCG:NM_000231.2:3'UTR:MODIFIER:exon8/8:c.*254G>A:		rs3751371	0.3502	0	0	0										0.2197	0.4545	0.3258	34	64	n/a	n/a
chr13	23898975	23898975	T	C	het		QUAL=20740;DP=415;AF=0.50;MQM=60;TRIO=HET,415,0.50,WT,340,0.01,HOM,441,0.99	SGCG	3'UTR	SGCG:NM_000231.2:3'UTR:MODIFIER:exon8/8:c.*295T>C:		rs3829352	0.348	0	0	0										0.1894	0.3712	0.4394	28	58	n/a	n/a
chr13	23903220	23903224	TAAAG	-	het		QUAL=7085;DP=214;AF=0.49;MQM=60;TRIO=HET,214,0.49,WT,130,0.00,HET,211,0.56	SACS	3'UTR	SACS:NM_014363.5:3'UTR:MODIFIER:exon10/10:c.*1051_*1055delCTTTA:,SACS:NM_001278055.1:3'UTR:MODIFIER:exon8/8:c.*1051_*1055delCTTTA:		rs66920661	0.0345	0	0	0										0.0076	0.1591	0.8333	1	22	n/a	n/a
chr13	23903791	23903791	A	G	het		QUAL=14856;DP=469;AF=0.49;MQM=60;TRIO=HET,469,0.49,WT,195,0.02,HOM,220,0.98	SACS	3'UTR	SACS:NM_014363.5:3'UTR:MODIFIER:exon10/10:c.*484T>C:,SACS:NM_001278055.1:3'UTR:MODIFIER:exon8/8:c.*484T>C:		rs4770433	0.3444	0	0	0						604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];				0.1894	0.3712	0.4394	29	58	n/a	n/a
chr13	23907677	23907677	C	T	hom		QUAL=25209;DP=356;AF=1.00;MQM=60;TRIO=HOM,356,1.00,HOM,175,1.00,HOM,221,1.00	SACS	synonymous	SACS:NM_014363.5:synonymous:LOW:exon10/10:c.10338G>A:p.Gln3446Gln,SACS:NM_001278055.1:synonymous:LOW:exon8/8:c.9897G>A:p.Gln3299Gln		rs2737701	0.9854	0.996	0.9999	0.9542						604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];	RCV000118229.2 [likely benign]; 			0.9924	0.0076	0	1429	4	n/a	n/a
chr13	23908034	23908034	A	G	het		QUAL=15233;DP=397;AF=0.52;MQM=60;TRIO=HET,397,0.52,WT,197,0.00,HOM,258,1.00	SACS	synonymous	SACS:NM_014363.5:synonymous:LOW:exon10/10:c.9981T>C:p.Ala3327Ala,SACS:NM_001278055.1:synonymous:LOW:exon8/8:c.9540T>C:p.Ala3180Ala		rs2737700	0.3387	0.405	0.4406	0.1739						604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];	RCV000118235.2 [likely benign]; 		COSM3999043	0.1894	0.3712	0.4394	271	665	n/a	n/a
chr13	23929095	23929095	T	C	het		QUAL=10413;DP=320;AF=0.50;MQM=60;TRIO=HET,320,0.50,HOM,164,0.98,WT,247,0.00	SACS	synonymous	SACS:NM_014363.5:synonymous:LOW:exon8/10:c.1656A>G:p.Leu552Leu,SACS:NM_001278055.1:synonymous:LOW:exon6/8:c.1215A>G:p.Leu405Leu		rs1536365	0.0867	0.114	0.1163	0.0234	-0.2340	P				604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];	RCV000118231.2 [likely benign]; 		COSM3753621	0.0227	0.2045	0.7727	26	285	n/a	n/a
chr13	23930055	23930055	A	T	het		QUAL=10552;DP=387;AF=0.45;MQM=60;TRIO=HET,387,0.45,HOM,153,0.99,WT,248,0.01	SACS	missense	SACS:NM_014363.5:missense:MODERATE:exon8/10:c.696T>A:p.Asn232Lys,SACS:NM_001278055.1:missense:MODERATE:exon6/8:c.255T>A:p.Asn85Lys		rs2031640	0.0865	0.114	0.1165	0.0234	0.5360	P,P	T,.	D,P,P,.	P,P,B,.	604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];	RCV000118233.2 [likely benign]; 		COSM3753623	0.0227	0.2045	0.7727	25	287	n/a	n/a
chr13	23949252	23949252	G	A	het		QUAL=850;DP=14;AF=0.29;MQM=60;TRIO=HET,14,0.29,WT,32,0.00,HET,60,0.48	SACS	splice_region&intron	SACS:NM_014363.5:splice_region&intron:LOW:exon3/9:c.171+6C>T:,SACS:NM_001278055.1:splice_region&intron:LOW:exon2/7:c.-183+6C>T:		rs3751368	0.0895	0.059	0	0						604490 [SACS (provisional) Spastic ataxia,Charlevoix-Saguenay type];				0.0152	0.197	0.7879	39	381	n/a	n/a
chr13	24007783	24007783	C	T	het		QUAL=4168;DP=129;AF=0.57;MQM=60;TRIO=HET,129,0.57,HET,132,0.52,WT,178,0.00	SACS	5'UTR	SACS:NM_014363.5:5'UTR:MODIFIER:exon1/10:c.-531G>A:		rs73154650	0.03	0	0	0										0	0.0758	0.9242	0	10	n/a	n/a
chr13	25456631	25456631	-	T	het		QUAL=10032;DP=392;AF=0.41;MQM=60;TRIO=HET,392,0.41,WT,306,0.00,HET,344,0.47	CENPJ	3'UTR	CENPJ:NM_018451.4:3'UTR:MODIFIER:exon17/17:c.*683dupA:		rs397718122	0.3239	0	0	0										0.1591	0.4697	0.3712	22	71	n/a	n/a
chr13	25457005	25457007	CTT	-	het		QUAL=6473;DP=280;AF=0.49;MQM=60;TRIO=HET,280,0.49,HET,159,0.51,WT,185,0.00	CENPJ	3'UTR	CENPJ:NM_018451.4:3'UTR:MODIFIER:exon17/17:c.*308_*310delAAG:		rs34780182	0.1587	0	0	0										0.1061	0.3864	0.5076	19	55	n/a	n/a
chr13	25457207	25457207	T	C	hom		QUAL=18765;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,123,1.00,HOM,179,1.00	CENPJ	3'UTR	CENPJ:NM_018451.4:3'UTR:MODIFIER:exon17/17:c.*108A>G:		rs9318911	0.9667	0	0	0										1	0	0	150	0	n/a	n/a
chr13	25466774	25466774	T	C	hom		QUAL=7365;DP=86;AF=1.00;MQM=60;TRIO=HOM,86,1.00,HOM,88,1.00,HET,120,0.56	CENPJ	splice_region&intron	CENPJ:NM_018451.4:splice_region&intron:LOW:exon10/16:c.3216+7A>G:		rs9318917	0.7372	0.804	0.8308	0.645						609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive|Seckel syndrome 4];	RCV000145574.2 [benign]; 			0.6136	0.3561	0.0303	294	133	n/a	n/a
chr13	25466955	25466955	T	C	het		QUAL=8448;DP=223;AF=0.48;MQM=60;TRIO=HET,223,0.48,HET,143,0.45,HET,187,0.55	CENPJ	synonymous	CENPJ:NM_018451.4:synonymous:LOW:exon10/17:c.3042A>G:p.Glu1014Glu		rs3742165	0.484	0.539	0.5372	0.2853	0.1810	P				609279 [CENPJ (confirmed) Microcephaly 6,primary,autosomal recessive|Seckel syndrome 4];	RCV000145573.1 [benign]; 		COSM4147658	0.25	0.4848	0.2652	125	223	n/a	n/a
chr13	32676114	32676114	A	G	het		QUAL=7922;DP=288;AF=0.47;MQM=60;TRIO=HET,288,0.47,HET,185,0.56,WT,252,0.01	FRY	synonymous	FRY:NM_023037.2:synonymous:LOW:exon3/61:c.285A>G:p.Thr95Thr		rs364995	0.5815	0.605	0.6375	0.5881									COSM3753641	0.4091	0.447	0.1439	178	212	n/a	n/a
chr13	32758834	32758834	A	G	het		QUAL=5717;DP=197;AF=0.50;MQM=60;TRIO=HET,197,0.50,HOM,79,1.00,WT,111,0.01	FRY	splice_region&intron	FRY:NM_023037.2:splice_region&intron:LOW:exon25/60:c.3146+6A>G:		rs798971	0.8217	0.788	0.7531	0.7797										0.6136	0.3485	0.0379	248	178	n/a	n/a
chr13	32776603	32776603	T	C	het		QUAL=6652;DP=237;AF=0.50;MQM=59;TRIO=HET,237,0.50,HET,178,0.52,WT,248,0.00	FRY	synonymous	FRY:NM_023037.2:synonymous:LOW:exon31/61:c.3957T>C:p.Leu1319Leu		rs2428249	0.3458	0.385	0.4113	0.4136									COSM3765691	0.1364	0.4924	0.3712	56	213	n/a	n/a
chr13	32811607	32811607	G	A	hom		QUAL=17168;DP=174;AF=1.00;MQM=60;TRIO=HOM,174,1.00,HOM,229,1.00,HET,302,0.52	FRY	missense	FRY:NM_023037.2:missense:MODERATE:exon44/61:c.5902G>A:p.Gly1968Ser		rs2806639	0.2159	0.281	0.3132	0.3215	1.8580	P	T	B	B					0.0909	0.5152	0.3939	46	196	n/a	n/a
chr13	32870750	32870750	-	A	het		QUAL=531;DP=40;AF=0.08;MQM=60;TRIO=HET,40,0.08,HET,28,0.18,HET,54,0.31	FRY	3'UTR	FRY:NM_023037.2:3'UTR:MODIFIER:exon61/61:c.*1168dupA:		rs565605441	0.4924	0	0	0										0.1136	0.3409	0.5455	17	48	n/a	n/a
chr13	32890572	32890572	G	A	het		QUAL=8330;DP=299;AF=0.52;MQM=60;TRIO=HET,299,0.52,HET,199,0.50,WT,239,0.00	BRCA2	5'UTR	BRCA2:NM_000059.3:5'UTR:MODIFIER:exon2/27:c.-26G>A:		rs1799943	0.2093	0.243	0.2633	0.1026							RCV000112977.2 [benign]; RCV000114981.1,RCV000112978.1,RCV000112979.1 [not provided,benign,benign]; 	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer, sporadic, protection against" GENE=BRCA2]; 		0.0682	0.3712	0.5606	20	105	n/a	n/a
chr13	32906729	32906729	A	C	het		QUAL=12375;DP=392;AF=0.51;MQM=60;TRIO=HET,392,0.51,HET,133,0.54,HET,192,0.51	BRCA2	missense	BRCA2:NM_000059.3:missense:MODERATE:exon10/27:c.1114A>C:p.Asn372His		rs144848	0.2494	0.277	0.2859	0.1289	0.7570	P	T			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000009916.3 [other]; RCV000034427.1 [benign]; RCV000120303.2 [benign]; RCV000130720.1 [benign]; 	CM002750 [CLASS=DFP MUT=ALT PHEN="Breast cancer, association with" GENE=BRCA2]; 	COSM3753646	0.1212	0.3636	0.5152	94	372	1	n/a
chr13	32911888	32911888	A	G	het		QUAL=7966;DP=342;AF=0.51;MQM=60;TRIO=HET,342,0.51,HET,117,0.56,WT,155,0.00	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.3396A>G:p.Lys1132Lys		rs1801406	0.2668	0.293	0.3074	0.2261						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113169.1,RCV000113170.3 [benign,benign]; RCV000114982.2 [benign]; RCV000130987.1 [benign]; RCV000152873.1 [benign]; 			0.1136	0.4091	0.4773	98	478	n/a	n/a
chr13	32913055	32913055	A	G	hom		QUAL=17050;DP=269;AF=1.00;MQM=60;TRIO=HOM,269,1.00,HOM,115,1.00,HOM,123,1.00	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.4563A>G:p.Leu1521Leu		rs206075	0.974	0.993	0.9994	0.9296						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000160224.1,RCV000119245.1 [benign,benign]; RCV000123972.2 [benign]; RCV000132170.1 [benign]; RCV000152875.1 [benign]; 			0.9924	0	0.0076	1037	3	n/a	n/a
chr13	32915005	32915005	G	C	hom		QUAL=26878;DP=411;AF=1.00;MQM=60;TRIO=HOM,411,1.00,HOM,165,1.00,HOM,227,1.00	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.6513G>C:p.Val2171Val		rs206076	0.9736	0.993	0.9994	0.9287						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000119246.1 [benign]; RCV000123985.2 [benign]; RCV000152878.1,RCV000160234.1 [benign,benign]; 		COSM4147689	1	0	0	1040	5	1	n/a
chr13	32929232	32929232	A	G	het		QUAL=13270;DP=474;AF=0.49;MQM=60;TRIO=HET,474,0.49,HET,381,0.45,WT,499,0.00	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon14/27:c.7242A>G:p.Ser2414Ser		rs1799955	0.2326	0.224	0.2133	0.2077						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113739.3 [benign]; RCV000123992.2 [benign]; RCV000130994.1 [benign]; RCV000152882.1 [benign]; 			0.0682	0.3182	0.6136	48	387	n/a	n/a
chr13	32929387	32929387	T	C	hom		QUAL=25211;DP=288;AF=1.00;MQM=60;TRIO=HOM,288,1.00,HOM,218,1.00,HOM,276,1.00	BRCA2	missense	BRCA2:NM_000059.3:missense:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala		rs169547	0.9758	0.994	0.9994	0.9353	2.3530	P	T			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000045197.3 [benign]; RCV000113751.1,RCV000120357.2 [uncertain significance,benign]; 	CM960194 [CLASS=DM? MUT=REF PHEN="Breast cancer" GENE=BRCA2]; 		1	0	0	1057	4	2	n/a
chr13	32973439	32973439	A	G	het		QUAL=6993;DP=294;AF=0.47;MQM=60;TRIO=HET,294,0.47,HET,154,0.46,WT,194,0.00	BRCA2	3'UTR	BRCA2:NM_000059.3:3'UTR:MODIFIER:exon27/27:c.*532A>G:		rs11571836	0.1975	0	0	0										0.0682	0.3182	0.6136	10	77	n/a	n/a
chr13	32973737	32973737	T	-	het		QUAL=3280;DP=205;AF=0.42;MQM=60;TRIO=HET,205,0.42,HET,43,0.40,WT,86,0.02	BRCA2	3'UTR	BRCA2:NM_000059.3:3'UTR:MODIFIER:exon27/27:c.*839delT:		rs139813105	0.231	0	0	0										0.0682	0.3182	0.6136	10	76	n/a	n/a
chr13	36877519	36877519	-	ATA	het		QUAL=5247;DP=290;AF=0.43;MQM=60;TRIO=HET,290,0.43,HET,87,0.48,WT,147,0.00	SPG20	3'UTR	SPG20:NM_001142294.1:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:,SPG20:NM_001142296.1:3'UTR:MODIFIER:exon10/10:c.*980_*982dupTAT:,SPG20:NM_015087.4:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:,SPG20:NM_001142295.1:3'UTR:MODIFIER:exon9/9:c.*980_*982dupTAT:		rs200142976	0.004	0	0	0										0	0.0455	0.9545	0	6	n/a	n/a
chr13	36877656	36877656	C	T	het		QUAL=2141;DP=116;AF=0.53;MQM=59;TRIO=HET,116,0.53,WT,22,0.00,HET,28,0.36	SPG20	3'UTR	SPG20:NM_001142294.1:3'UTR:MODIFIER:exon9/9:c.*846G>A:,SPG20:NM_001142296.1:3'UTR:MODIFIER:exon10/10:c.*846G>A:,SPG20:NM_015087.4:3'UTR:MODIFIER:exon9/9:c.*846G>A:,SPG20:NM_001142295.1:3'UTR:MODIFIER:exon9/9:c.*846G>A:		rs1054152	0.1382	0	0	0										0.053	0.3182	0.6288	10	48	n/a	n/a
chr13	36877878	36877878	T	C	hom		QUAL=12146;DP=164;AF=1.00;MQM=60;TRIO=HOM,164,1.00,HOM,100,1.00,HOM,102,1.00	SPG20	3'UTR	SPG20:NM_001142294.1:3'UTR:MODIFIER:exon9/9:c.*624A>G:,SPG20:NM_001142296.1:3'UTR:MODIFIER:exon10/10:c.*624A>G:,SPG20:NM_015087.4:3'UTR:MODIFIER:exon9/9:c.*624A>G:,SPG20:NM_001142295.1:3'UTR:MODIFIER:exon9/9:c.*624A>G:	AT_rich	rs2148049	0.989	0	0	0										1	0	0	150	0	n/a	n/a
chr13	36920849	36920849	-	C	het		QUAL=2600;DP=41;AF=0.51;MQM=60;TRIO=HET,41,0.51,WT,199,0.00,HET,225,0.41	SPG20	5'UTR,intron	SPG20:NM_001142295.1:5'UTR:MODIFIER:exon1/9:c.-134dupG:,SPG20:NM_001142294.1:intron:MODIFIER:exon1/8:c.-2-10881dupG:		rs146524559	0.28	0	0	0										0.1818	0.4015	0.4167	31	58	n/a	n/a
chr13	36920890	36920890	G	C	hom		QUAL=12928;DP=42;AF=1.00;MQM=60;TRIO=HOM,42,1.00,HOM,164,1.00,HOM,213,1.00	SPG20	5'UTR,intron	SPG20:NM_001142295.1:5'UTR:MODIFIER:exon1/9:c.-174C>G:,SPG20:NM_001142294.1:intron:MODIFIER:exon1/8:c.-2-10921C>G:		rs4943362	1	0	0	0										1	0	0	150	0	n/a	n/a
chr13	36944274	36944274	C	T	het		QUAL=177;DP=13;AF=0.46;MQM=60;TRIO=HET,13,0.46,HOM,1,1.00,HOM,1,1.00	SPG20	5'UTR	SPG20:NM_001142294.1:5'UTR:MODIFIER:exon1/9:c.-51G>A:		rs4287440	0.7476	0	0	0										0.3636	0.2273	0.4091	55	35	n/a	n/a
chr13	37401918	37401918	T	-	hom		QUAL=20532;DP=216;AF=0.99;MQM=60;TRIO=HOM,216,0.99,HOM,179,0.99,HOM,255,1.00	RFXAP	3'UTR	RFXAP:NM_000538.3:3'UTR:MODIFIER:exon3/3:c.*33delT:		rs398022347	0.8011	0.876	0.9288	0.7296										0.7955	0.197	0.0076	136	29	n/a	n/a
chr13	37402440	37402440	T	C	hom		QUAL=19191;DP=292;AF=1.00;MQM=60;TRIO=HOM,292,1.00,HOM,121,1.00,HOM,156,1.00	RFXAP	3'UTR	RFXAP:NM_000538.3:3'UTR:MODIFIER:exon3/3:c.*550T>C:		rs9547679	0.7961	0	0	0										0.7955	0.197	0.0076	121	28	n/a	n/a
chr13	37403143	37403143	G	A	het		QUAL=10580;DP=343;AF=0.47;MQM=60;TRIO=HET,343,0.47,WT,202,0.00,HET,313,0.51	RFXAP	3'UTR	RFXAP:NM_000538.3:3'UTR:MODIFIER:exon3/3:c.*1253G>A:		rs10976	0.1414	0	0	0										0.0379	0.303	0.6591	6	45	n/a	n/a
chr13	39262057	39262057	G	A	hom		QUAL=15282;DP=82;AF=1.00;MQM=60;TRIO=HOM,82,1.00,HOM,176,1.00,HOM,227,1.00	FREM2	synonymous	FREM2:NM_207361.5:synonymous:LOW:exon1/24:c.576G>A:p.Glu192Glu		rs1868464	1	1	1	0.9993						608945 [FREM2 (provisional) Fraser syndrome];			COSM4147704	1	0	0	454	0	n/a	n/a
chr13	39263714	39263714	T	C	hom		QUAL=32798;DP=319;AF=1.00;MQM=59;TRIO=HOM,319,1.00,HOM,317,1.00,HOM,408,1.00	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon1/24:c.2233T>C:p.Ser745Pro		rs2496423	1	1	1	0.9993	3.1680	P	T	B	B	608945 [FREM2 (provisional) Fraser syndrome];				1	0	0	453	0	n/a	n/a
chr13	39264690	39264690	T	C	het		QUAL=14873;DP=393;AF=0.47;MQM=60;TRIO=HET,393,0.47,HET,214,0.48,HET,279,0.57	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon1/24:c.3209T>C:p.Phe1070Ser		rs2496425	0.4812	0.347	0.2744	0.7524	0.9280	P	T	B	B	608945 [FREM2 (provisional) Fraser syndrome];		CM065186 [CLASS=DP MUT=ALT PHEN="Colorectal cancer, increased risk, association with" GENE=FREM2]; 	COSM1366801	0.0833	0.4015	0.5152	36	177	n/a	n/a
chr13	39343822	39343822	C	T	het		QUAL=11607;DP=312;AF=0.48;MQM=60;TRIO=HET,312,0.48,HET,175,0.49,HET,292,0.47	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon4/24:c.5518C>T:p.Arg1840Trp		rs9603422	0.1418	0.121	0.1209	0.2154	0.8450	P	T	D	D	608945 [FREM2 (provisional) Fraser syndrome];				0.0227	0.2045	0.7727	9	97	n/a	n/a
chr13	39422624	39422624	C	T	het		QUAL=4021;DP=134;AF=0.49;MQM=60;TRIO=HET,134,0.49,WT,123,0.00,HET,124,0.52	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon8/24:c.6196C>T:p.Arg2066Cys		rs9548505	0.1096	0.122	0.1091	0.1416	4.8040	P	D	D,D	P,D	608945 [FREM2 (provisional) Fraser syndrome];			COSM3753678	0	0.1591	0.8409	7	76	n/a	n/a
chr13	39424253	39424253	C	G	het		QUAL=4053;DP=223;AF=0.44;MQM=60;TRIO=HET,223,0.44,WT,60,0.00,HET,66,0.47	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon9/24:c.6458C>G:p.Thr2153Ser		rs9548506	0.0919	0.117	0.0026	0.0018	3.4960	P	T	B,B	B,B	608945 [FREM2 (provisional) Fraser syndrome];			COSM3753679	0	0.1591	0.8409	7	76	n/a	n/a
chr13	39424254	39424254	T	C	het		QUAL=4053;DP=223;AF=0.44;MQM=60;TRIO=HET,223,0.44,WT,60,0.00,HET,66,0.47	FREM2	synonymous	FREM2:NM_207361.5:synonymous:LOW:exon9/24:c.6459T>C:p.Thr2153Thr		rs9548507	0.0919	0.117	0.0026	0.0009						608945 [FREM2 (provisional) Fraser syndrome];			COSM3753680	0	0.1591	0.8409	7	76	n/a	n/a
chr13	39430314	39430314	C	T	het		QUAL=16738;DP=262;AF=0.44;MQM=60;TRIO=HET,262,0.44,HET,190,0.56,HOM,291,1.00	FREM2	missense	FREM2:NM_207361.5:missense:MODERATE:exon12/24:c.6977C>T:p.Thr2326Ile		rs9548509	0.772	0.74	0.7005	0.7637	6.1370	P	T	B,B	B,B	608945 [FREM2 (provisional) Fraser syndrome];			COSM432379	0.4394	0.4924	0.0682	222	194	n/a	n/a
chr13	39433606	39433606	A	G	het		QUAL=28539;DP=401;AF=0.53;MQM=60;TRIO=HET,401,0.53,WT,483,0.00,HOM,704,0.99	FREM2	synonymous	FREM2:NM_207361.5:synonymous:LOW:exon14/24:c.7398A>G:p.Thr2466Thr		rs9532292	0.4367	0.373	0.3127	0.564						608945 [FREM2 (provisional) Fraser syndrome];			COSM3753681	0.0682	0.3939	0.5379	61	183	n/a	n/a
chr13	39455916	39455916	T	C	het		QUAL=13231;DP=469;AF=0.49;MQM=60;TRIO=HET,469,0.49,WT,188,0.01,HET,322,0.51	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*992T>C:		rs9532297	0.0845	0	0	0										0.0076	0.1515	0.8409	1	23	n/a	n/a
chr13	39455965	39455965	C	T	het		QUAL=13082;DP=489;AF=0.45;MQM=60;TRIO=HET,489,0.45,WT,231,0.00,HET,349,0.49	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*1041C>T:		rs9548521	0.0675	0	0	0										0	0.1212	0.8788	0	17	n/a	n/a
chr13	39456352	39456352	A	G	het		QUAL=11658;DP=404;AF=0.45;MQM=60;TRIO=HET,404,0.45,HET,164,0.52,HET,176,0.49	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*1428A>G:		rs9548522	0.4339	0	0	0										0.1742	0.5758	0.25	27	87	n/a	n/a
chr13	39456391	39456391	G	A	het		QUAL=9682;DP=442;AF=0.47;MQM=60;TRIO=HET,442,0.47,WT,164,0.00,HET,177,0.49	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*1467G>A:		rs9548523	0.0675	0	0	0										0	0.1212	0.8788	0	17	n/a	n/a
chr13	39457064	39457064	C	G	het		QUAL=22012;DP=622;AF=0.49;MQM=60;TRIO=HET,622,0.49,HET,295,0.50,HET,414,0.51	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*2140C>G:		rs7324632	0.4339	0	0	0										0.1742	0.5758	0.25	26	88	n/a	n/a
chr13	39459389	39459389	C	T	het		QUAL=7398;DP=192;AF=0.42;MQM=60;TRIO=HET,192,0.42,HET,96,0.46,HOM,99,1.00	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*4465C>T:		rs2027770	0.7474	0	0	0										0.3712	0.5455	0.0833	58	79	n/a	n/a
chr13	39460259	39460259	A	G	het		QUAL=4978;DP=223;AF=0.48;MQM=60;TRIO=HET,223,0.48,WT,78,0.00,HET,93,0.49	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5335A>G:		rs9548524	0.0843	0	0	0										0.0076	0.1515	0.8409	1	22	n/a	n/a
chr13	39460415	39460415	G	A	het		QUAL=14435;DP=349;AF=0.48;MQM=60;TRIO=HET,349,0.48,HET,133,0.56,HOM,200,1.00	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5491G>A:		rs2226913	0.7504	0	0	0										0.3788	0.5379	0.0833	60	77	n/a	n/a
chr13	39460486	39460486	C	G	het		QUAL=10752;DP=272;AF=0.50;MQM=60;TRIO=HET,272,0.50,HET,147,0.54,HET,201,0.61	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5562C>G:	(CATA)n	rs1945507	0.4341	0	0	0										0.1742	0.5758	0.25	27	87	n/a	n/a
chr13	39460540	39460540	T	-	het		QUAL=4991;DP=109;AF=0.44;MQM=59;TRIO=HET,109,0.44,HET,84,0.52,HOM,94,0.94	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5627delT:	AluSp	rs5802961	0.7486	0	0	0										0.3939	0.3258	0.2803	60	48	n/a	n/a
chr13	39460657	39460657	C	T	het		QUAL=4133;DP=147;AF=0.50;MQM=59;TRIO=HET,147,0.50,HET,41,0.56,HET,60,0.55	FREM2	3'UTR	FREM2:NM_207361.5:3'UTR:MODIFIER:exon24/24:c.*5733C>T:	AluSp	rs1945505	0.4343	0	0	0										0.1742	0.5758	0.25	26	88	n/a	n/a
chr13	41382711	41382711	A	T	het		QUAL=5629;DP=166;AF=0.54;MQM=55;TRIO=HET,166,0.54,WT,153,0.00,HET,183,0.49	SLC25A15	missense	SLC25A15:NM_014252.3:missense:MODERATE:exon6/7:c.760A>T:p.Ile254Leu		rs17849654	0.3227	0.37	0.4134	0.2034	1.3490	P		B,B	B,B	603861 [SLC25A15 (confirmed) Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome];	RCV000128071.1 [benign]; 		COSM3753692	0.1894	0.6136	0.197	149	373	n/a	n/a
chr13	41384156	41384156	A	G	het		QUAL=7383;DP=240;AF=0.53;MQM=59;TRIO=HET,240,0.53,WT,164,0.01,HET,211,0.50	SLC25A15	3'UTR	SLC25A15:NM_014252.3:3'UTR:MODIFIER:exon7/7:c.*353A>G:		rs9549293	0.4237	0	0	0										0.2197	0.5909	0.1894	33	86	n/a	n/a
chr13	41384318	41384318	A	G	het		QUAL=2412;DP=118;AF=0.54;MQM=58;TRIO=HET,118,0.54,WT,22,0.00,HET,28,0.64	SLC25A15	3'UTR	SLC25A15:NM_014252.3:3'UTR:MODIFIER:exon7/7:c.*515A>G:	AluSz	rs7322603	0.4237	0	0	0										0.2197	0.5909	0.1894	34	86	n/a	n/a
chr13	41384382	41384382	C	T	het		QUAL=2556;DP=140;AF=0.49;MQM=52;TRIO=HET,140,0.49,WT,12,0.00,HET,27,0.56	SLC25A15	3'UTR	SLC25A15:NM_014252.3:3'UTR:MODIFIER:exon7/7:c.*579C>T:	AluSz	rs7321976	0.4237	0	0	0										0.2197	0.5909	0.1894	33	87	n/a	n/a
chr13	48517289	48517289	A	G	hom		QUAL=30308;DP=437;AF=1.00;MQM=60;TRIO=HOM,437,1.00,HOM,213,1.00,HOM,265,1.00	SUCLA2	3'UTR	SUCLA2:NM_003850.2:3'UTR:MODIFIER:exon11/11:c.*217T>C:		rs4941618	0.9419	0	0	0										0.8333	0.1591	0.0076	125	24	n/a	n/a
chr13	48547467	48547467	A	T	hom		QUAL=13154;DP=204;AF=1.00;MQM=59;TRIO=HOM,204,1.00,HET,122,0.49,HOM,137,1.00	SUCLA2	missense	SUCLA2:NM_003850.2:missense:MODERATE:exon5/11:c.595T>A:p.Ser199Thr		rs7320366	0.6835	0.751	0.818	0.5937	4.7410	P	T	B	B	603921 [SUCLA2 (provisional) Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)];	RCV000128327.1 [benign]; 			0.5909	0.3788	0.0303	292	141	n/a	n/a
chr13	48563008	48563008	G	A	hom		QUAL=18320;DP=276;AF=1.00;MQM=60;TRIO=HOM,276,1.00,HET,162,0.40,HOM,207,1.00	SUCLA2	splice_region&intron	SUCLA2:NM_003850.2:splice_region&intron:LOW:exon3/10:c.371+9C>T:		rs6561424	0.6835	0.751	0.818	0.5935						603921 [SUCLA2 (provisional) Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)];	RCV000128325.1 [benign]; 			0.5909	0.3788	0.0303	285	125	n/a	n/a
chr13	78470350	78470350	A	G	hom		QUAL=7328;DP=159;AF=1.00;MQM=60;TRIO=HOM,159,1.00,HOM,37,1.00,HOM,36,1.00	EDNRB	3'UTR	EDNRB:NM_001201397.1:3'UTR:MODIFIER:exon8/8:c.*1985T>C:,EDNRB:NM_001122659.2:3'UTR:MODIFIER:exon7/7:c.*1985T>C:,EDNRB:NM_003991.3:3'UTR:MODIFIER:exon7/7:c.*227T>C:,EDNRB:NM_000115.3:3'UTR:MODIFIER:exon8/8:c.*1985T>C:		rs4885491	0.9255	0	0	0										0.697	0.2803	0.0227	106	41	n/a	n/a
chr13	78470568	78470568	G	A	het		QUAL=4126;DP=213;AF=0.47;MQM=60;TRIO=HET,213,0.47,WT,64,0.03,HET,59,0.58	EDNRB	3'UTR	EDNRB:NM_001201397.1:3'UTR:MODIFIER:exon8/8:c.*1767C>T:,EDNRB:NM_001122659.2:3'UTR:MODIFIER:exon7/7:c.*1767C>T:,EDNRB:NM_003991.3:3'UTR:MODIFIER:exon7/7:c.*9C>T:,EDNRB:NM_000115.3:3'UTR:MODIFIER:exon8/8:c.*1767C>T:		rs3027092	0.0146	0.011	0.0125	0.0014										0	0.0227	0.9773	0	11	n/a	n/a
chr13	78477674	78477674	A	G	hom		QUAL=24426;DP=328;AF=1.00;MQM=59;TRIO=HOM,328,1.00,HOM,182,1.00,HOM,224,1.00	EDNRB	synonymous	EDNRB:NM_001201397.1:synonymous:LOW:exon3/8:c.822T>C:p.Ser274Ser,EDNRB:NM_001122659.2:synonymous:LOW:exon2/7:c.552T>C:p.Ser184Ser,EDNRB:NM_003991.3:synonymous:LOW:exon2/7:c.552T>C:p.Ser184Ser,EDNRB:NM_000115.3:synonymous:LOW:exon3/8:c.552T>C:p.Ser184Ser		rs5348	0.9838	0.995	0.9998	0.956						131244 [EDNRB (confirmed) Hirschsprung disease,susceptibility to,2|ABCD syndrome|Waardenburg syndrome,type 4A];				1	0	0	454	0	n/a	n/a
chr13	78549635	78549635	C	T	het		QUAL=172;DP=9;AF=0.44;MQM=60;TRIO=HET,9,0.44,WT,7,0.00,HET,6,0.67	EDNRB	5'UTR	EDNRB:NM_000115.3:5'UTR:MODIFIER:exon1/8:c.-205G>A:	Harlequin-int	rs12720104	0.0146	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr13	100635377	100635377	C	T	het		QUAL=9342;DP=218;AF=0.46;MQM=59;TRIO=HET,218,0.46,WT,384,0.00,HET,452,0.44	ZIC2	synonymous	ZIC2:NM_007129.3:synonymous:LOW:exon1/3:c.1059C>T:p.His353His		rs1831992	0.0417	0.079	0.1128	0.0227						603073 [ZIC2 (provisional) Holoprosencephaly-5];	RCV000081471.2 [benign]; 			0.0227	0.1894	0.7879	7	77	n/a	n/a
chr13	100638392	100638392	G	A	hom		QUAL=27787;DP=545;AF=1.00;MQM=60;TRIO=HOM,545,1.00,HET,168,0.49,HOM,281,0.99	ZIC2	3'UTR	ZIC2:NM_007129.3:3'UTR:MODIFIER:exon3/3:c.*456G>A:		rs13542	0.3105	0	0	0										0.0455	0.4091	0.5455	16	93	n/a	n/a
chr13	102373563	102373563	A	T	hom		QUAL=25454;DP=326;AF=1.00;MQM=60;TRIO=HOM,326,1.00,HOM,168,1.00,HOM,261,1.00	FGF14	3'UTR	FGF14:NM_175929.2:3'UTR:MODIFIER:exon5/5:c.*1618T>A:,FGF14:NM_004115.3:3'UTR:MODIFIER:exon5/5:c.*1618T>A:		rs15608	0.8325	0	0	0										0.5152	0.4015	0.0833	78	69	n/a	n/a
chr13	102373569	102373569	C	A	het		QUAL=10431;DP=317;AF=0.44;MQM=60;TRIO=HET,317,0.44,HOM,177,0.99,WT,273,0.00	FGF14	3'UTR	FGF14:NM_175929.2:3'UTR:MODIFIER:exon5/5:c.*1612G>T:,FGF14:NM_004115.3:3'UTR:MODIFIER:exon5/5:c.*1612G>T:		rs1046197	0.3431	0	0	0										0.0985	0.5455	0.3561	15	81	n/a	n/a
chr13	102373790	102373790	-	TTTA	hom		QUAL=21051;DP=364;AF=0.95;MQM=60;TRIO=HOM,364,0.95,HOM,142,0.98,HOM,186,0.98	FGF14	3'UTR	FGF14:NM_175929.2:3'UTR:MODIFIER:exon5/5:c.*1387_*1390dupTAAA:,FGF14:NM_004115.3:3'UTR:MODIFIER:exon5/5:c.*1387_*1390dupTAAA:		rs5806245	0.4169	0	0	0										0.1591	0.5606	0.2803	24	87	n/a	n/a
chr13	102374208	102374208	-	T	het		QUAL=3969;DP=104;AF=0.54;MQM=59;TRIO=HET,104,0.54,HET,67,0.61,HET,87,0.61	FGF14	3'UTR	FGF14:NM_175929.2:3'UTR:MODIFIER:exon5/5:c.*972dupA:,FGF14:NM_004115.3:3'UTR:MODIFIER:exon5/5:c.*972dupA:		rs557319654	0.357	0	0	0										0.1288	0.4015	0.4697	20	59	n/a	n/a
chr13	103498198	103498198	A	G	het		QUAL=3711;DP=105;AF=0.43;MQM=59;TRIO=HET,105,0.43,HET,52,0.54,HOM,62,1.00	ERCC5,BIVM-ERCC5	5'UTR,intron	ERCC5:NM_000123.3:5'UTR:MODIFIER:exon1/15:c.-419A>G:,BIVM-ERCC5:NM_001204425.1:intron:MODIFIER:exon9/22:c.1450+6045A>G:		rs751402	0.6889	0	0	0										0.5833	0.3712	0.0455	88	55	n/a	n/a
chr13	103498375	103498375	T	C	het		QUAL=16944;DP=254;AF=0.44;MQM=60;TRIO=HET,254,0.44,HET,253,0.46,HOM,314,0.99	ERCC5,BIVM-ERCC5	5'UTR,intron	ERCC5:NM_000123.3:5'UTR:MODIFIER:exon1/15:c.-242T>C:,BIVM-ERCC5:NM_001204425.1:intron:MODIFIER:exon9/22:c.1451-6093T>C:		rs2296147	0.2979	0	0	0										0.197	0.5076	0.2955	31	74	n/a	n/a
chr13	103504517	103504517	T	C	het		QUAL=8792;DP=157;AF=0.51;MQM=60;TRIO=HET,157,0.51,HET,112,0.54,HOM,128,0.99	BIVM-ERCC5,ERCC5	synonymous	BIVM-ERCC5:NM_001204425.1:synonymous:LOW:exon10/23:c.1500T>C:p.His500His,ERCC5:NM_000123.3:synonymous:LOW:exon2/15:c.138T>C:p.His46His		rs1047768	0.493	0.529	0.5866	0.6609						133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G|Xeroderma pigmentosum,group G/Cockayne syndrome];	RCV000116990.2 [likely benign]; 		COSM3753565	0.2955	0.5076	0.197	363	573	n/a	n/a
chr13	103527849	103527849	G	C	hom		QUAL=17088;DP=243;AF=1.00;MQM=60;TRIO=HOM,243,1.00,HOM,115,1.00,HOM,156,1.00	BIVM-ERCC5,ERCC5	missense	BIVM-ERCC5:NM_001204425.1:missense:MODERATE:exon23/23:c.4519G>C:p.Gly1507Arg,ERCC5:NM_000123.3:missense:MODERATE:exon15/15:c.3157G>C:p.Gly1053Arg		rs9514066	0.9982	0.999	1	0.9925	3.2550	P	T	P	P	133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G|Xeroderma pigmentosum,group G/Cockayne syndrome];				1	0	0	1161	1	n/a	n/a
chr13	103527930	103527930	G	C	hom		QUAL=16122;DP=249;AF=1.00;MQM=60;TRIO=HOM,249,1.00,HOM,108,1.00,HOM,130,1.00	BIVM-ERCC5,ERCC5	missense	BIVM-ERCC5:NM_001204425.1:missense:MODERATE:exon23/23:c.4600G>C:p.Gly1534Arg,ERCC5:NM_000123.3:missense:MODERATE:exon15/15:c.3238G>C:p.Gly1080Arg		rs9514067	0.9972	0.999	1	0.9925	-0.3730	P	T	B	B	133530 [ERCC5 (confirmed) Xeroderma pigmentosum,group G|Xeroderma pigmentosum,group G/Cockayne syndrome];				1	0	0	1157	2	n/a	n/a
chr13	103528337	103528337	G	A	hom		QUAL=25152;DP=329;AF=1.00;MQM=60;TRIO=HOM,329,1.00,HOM,186,0.99,HOM,259,1.00	BIVM-ERCC5,ERCC5	3'UTR	BIVM-ERCC5:NM_001204425.1:3'UTR:MODIFIER:exon23/23:c.*84G>A:,ERCC5:NM_000123.3:3'UTR:MODIFIER:exon15/15:c.*84G>A:		rs873601	0.5495	0	0	0										0.5379	0.3712	0.0909	82	55	n/a	n/a
chr13	110818598	110818598	T	G	het		QUAL=11761;DP=302;AF=0.50;MQM=60;TRIO=HET,302,0.50,HET,218,0.43,HET,256,0.49	COL4A1	missense	COL4A1:NM_001845.4:missense:MODERATE:exon45/52:c.4002A>C:p.Gln1334His		rs3742207	0.2883	0.31	0.3413	0.2821	0.4600	P	T	B	B	120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];		CM083606 [CLASS=DP MUT=ALT PHEN="Myocardial infarction, protection, association with" GENE=COL4A1]; 	COSM3736081	0.1288	0.4924	0.3788	61	198	n/a	n/a
chr13	110819586	110819586	G	A	het		QUAL=10248;DP=156;AF=0.48;MQM=60;TRIO=HET,156,0.48,HET,216,0.54,HET,280,0.49	COL4A1	splice_region&intron	COL4A1:NM_001845.4:splice_region&intron:LOW:exon43/51:c.3877-9C>T:		rs589985	0.6554	0.672	0.6592	0.5635						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];				0.3788	0.4924	0.1288	199	199	n/a	n/a
chr13	110827574	110827574	T	A	hom		QUAL=15718;DP=184;AF=1.00;MQM=60;TRIO=HOM,184,1.00,HET,178,0.46,HOM,244,1.00	COL4A1	synonymous	COL4A1:NM_001845.4:synonymous:LOW:exon37/52:c.3189A>T:p.Arg1063Arg		rs874203	0.3179	0.352	0.3626	0.2839						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];				0.1212	0.3788	0.5	67	174	n/a	n/a
chr13	110827580	110827580	C	T	hom		QUAL=15171;DP=166;AF=1.00;MQM=60;TRIO=HOM,166,1.00,HET,186,0.47,HOM,252,1.00	COL4A1	synonymous	COL4A1:NM_001845.4:synonymous:LOW:exon37/52:c.3183G>A:p.Gly1061Gly		rs874204	0.3181	0.352	0.3626	0.2839						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];				0.1212	0.3788	0.5	68	174	n/a	n/a
chr13	110833702	110833702	C	T	hom		QUAL=10817;DP=152;AF=1.00;MQM=59;TRIO=HOM,152,1.00,HET,140,0.41,HOM,150,0.98	COL4A1	synonymous	COL4A1:NM_001845.4:synonymous:LOW:exon29/52:c.2130G>A:p.Pro710Pro		rs16975492	0.3071	0.348	0.3594	0.2478						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];			COSM4147573	0.1288	0.3636	0.5076	67	175	n/a	n/a
chr13	110839550	110839550	T	G	hom		QUAL=17011;DP=140;AF=0.99;MQM=60;TRIO=HOM,140,0.99,HOM,171,1.00,HOM,232,1.00	COL4A1	missense	COL4A1:NM_001845.4:missense:MODERATE:exon25/52:c.1663A>C:p.Thr555Pro		rs536174	1	1	0	0	5.9870	P	T	B	B	120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];				1	0	0	454	0	n/a	n/a
chr13	110857895	110857895	A	G	hom		QUAL=33037;DP=474;AF=1.00;MQM=60;TRIO=HOM,474,1.00,HOM,228,1.00,HOM,312,1.00	COL4A1	splice_region&intron	COL4A1:NM_001845.4:splice_region&intron:LOW:exon15/51:c.859-10T>C:		rs677877	0.5964	0.622	0.6401	0.4335						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];				0.3864	0.4773	0.1364	192	208	n/a	n/a
chr13	110859743	110859743	C	T	hom		QUAL=15060;DP=200;AF=1.00;MQM=60;TRIO=HOM,200,1.00,HOM,101,1.00,HOM,160,1.00	COL4A1	splice_region&intron	COL4A1:NM_001845.4:splice_region&intron:LOW:exon13/51:c.780+7G>A:		rs598893	0.596	0.621	0.6394	0.4305						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];				0.3864	0.4773	0.1364	192	209	n/a	n/a
chr13	110866265	110866265	G	A	hom		QUAL=14133;DP=207;AF=0.99;MQM=60;TRIO=HOM,207,0.99,HET,194,0.51,HET,306,0.51	COL4A1	splice_region&intron	COL4A1:NM_001845.4:splice_region&intron:LOW:exon3/51:c.234+8C>T:		rs9521650	0.1304	0.143	0.1536	0.0956						120130 [COL4A1 (confirmed) Porencephaly 1|Brain small vessel disease with hemorrhage|Angiopathy,hereditary,with nephropathy,aneurysms,and muscle|Brain small vessel disease with Axenfeld-Rieger anomaly|Hemorrhage,intracerebral,susceptibility to];				0.0379	0.2652	0.697	19	117	n/a	n/a
chr13	111077197	111077197	G	A	het		QUAL=15851;DP=250;AF=0.52;MQM=60;TRIO=HET,250,0.52,HET,240,0.53,HOM,259,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon5/48:c.297G>A:p.Thr99Thr		rs4238272	0.9427	0.961	0.9646	0.8655						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0.8788	0.1212	0	409	44	n/a	n/a
chr13	111098226	111098226	C	T	het		QUAL=3260;DP=134;AF=0.46;MQM=60;TRIO=HET,134,0.46,WT,75,0.00,HET,88,0.48	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon17/48:c.1008C>T:p.Pro336Pro		rs4103	0.4828	0.513	0.534	0.396						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];			COSM1365445	0.2803	0.4242	0.2955	134	214	n/a	n/a
chr13	111111173	111111173	G	A	het		QUAL=18615;DP=356;AF=0.49;MQM=60;TRIO=HET,356,0.49,HOM,246,1.00,HET,315,0.51	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon22/48:c.1488G>A:p.Pro496Pro		rs7990214	0.4914	0.528	0.6076	0.6486						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];			COSM3999021	0.3864	0.4924	0.1212	185	206	n/a	n/a
chr13	111111235	111111235	G	A	het		QUAL=11927;DP=133;AF=0.44;MQM=60;TRIO=HET,133,0.44,HOM,206,1.00,HET,265,0.48	COL4A2	missense	COL4A2:NM_001846.2:missense:MODERATE:exon22/48:c.1550G>A:p.Arg517Lys		rs7990383	0.5092	0.532	0.6068	0.6942	-1.2950	P	T	B	B	120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];			COSM3931786	0.3864	0.4924	0.1212	185	204	n/a	n/a
chr13	111117745	111117745	C	T	het		QUAL=4404;DP=133;AF=0.56;MQM=60;TRIO=HET,133,0.56,HOM,67,1.00,WT,91,0.02	COL4A2	splice_region&intron	COL4A2:NM_001846.2:splice_region&intron:LOW:exon24/47:c.1777-7C>T:		rs3803236	0.514	0.534	0.5977	0.6481						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0.3939	0.4621	0.1439	180	177	n/a	n/a
chr13	111121620	111121620	C	T	het		QUAL=3245;DP=186;AF=0.46;MQM=60;TRIO=HET,186,0.46,HET,96,0.30,WT,150,0.00	COL4A2	missense	COL4A2:NM_001846.2:missense:MODERATE:exon28/48:c.2152C>T:p.Pro718Ser		rs9583500	0.1909	0.171	0.1987	0.3007	1.2810	P	T	B	B	120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0.053	0.3485	0.5985	27	137	n/a	n/a
chr13	111130519	111130519	C	T	het		QUAL=2584;DP=70;AF=0.57;MQM=60;TRIO=HET,70,0.57,HOM,53,0.98,WT,68,0.00	COL4A2	splice_region&intron	COL4A2:NM_001846.2:splice_region&intron:LOW:exon30/47:c.2587+8C>T:		rs2281974	0.4691	0.358	0.3105	0.5171						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0.1439	0.4091	0.447	59	175	n/a	n/a
chr13	111154058	111154058	T	A	hom		QUAL=590;DP=11;AF=1.00;MQM=60;TRIO=HOM,11,1.00,HOM,4,1.00,HOM,5,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon41/48:c.3804T>A:p.Pro1268Pro		rs439831	0.9395	0.984	0.9985	0.8382						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0.6061	0	0.3939	391	1	n/a	n/a
chr13	111154061	111154061	T	C	hom		QUAL=590;DP=11;AF=1.00;MQM=60;TRIO=HOM,11,1.00,HOM,4,1.00,HOM,5,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon41/48:c.3807T>C:p.Gly1269Gly		rs409858	0.9395	0.984	0.9985	0.8379						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0.5985	0.0076	0.3939	389	2	n/a	n/a
chr13	111155773	111155773	T	C	hom		QUAL=3588;DP=65;AF=0.98;MQM=60;TRIO=HOM,65,0.98,HOM,24,1.00,HOM,32,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon43/48:c.4083T>C:p.Thr1361Thr		rs438758	0.9802	0.988	0.9993	0.9606						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				1	0	0	453	1	n/a	n/a
chr13	111156250	111156250	G	A	het		QUAL=195;DP=16;AF=0.50;MQM=60;TRIO=HET,16,0.50,HOM,1,1.00,WT,5,0.00	COL4A2	missense	COL4A2:NM_001846.2:missense:MODERATE:exon44/48:c.4195G>A:p.Val1399Ile		rs45520539	0.0144	0.031	0.0418	0.0066	-0.5270	N	T	P	B	120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0	0.0833	0.9167	0	43	n/a	n/a
chr13	111156499	111156499	C	T	hom		QUAL=18046;DP=106;AF=1.00;MQM=60;TRIO=HOM,106,1.00,HOM,224,1.00,HOM,250,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon45/48:c.4290C>T:p.Phe1430Phe		rs4771683	0.9359	0.983	0.9982	0.8334						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];			COSM4147578	1	0	0	452	2	n/a	n/a
chr13	111158874	111158874	A	G	hom		QUAL=21532;DP=187;AF=1.00;MQM=59;TRIO=HOM,187,1.00,HOM,196,1.00,HOM,289,1.00	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon46/48:c.4515A>G:p.Pro1505Pro		rs445348	0.752	0.829	0.9056	0.7999						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0.8182	0.1742	0.0076	386	62	n/a	n/a
chr13	111160304	111160304	G	A	het		QUAL=10050;DP=233;AF=0.53;MQM=60;TRIO=HET,233,0.53,WT,357,0.00,HET,456,0.47	COL4A2	synonymous	COL4A2:NM_001846.2:synonymous:LOW:exon47/48:c.4617G>A:p.Ala1539Ala		rs391859	0.1008	0.1	0.0949	0.0721						120090 [COL4A2 (confirmed) Porencephaly 2|Hemorrhage,intracerebral,susceptibility to];				0	0.1515	0.8485	4	83	n/a	n/a
chr13	111164614	111164614	T	C	het		QUAL=9341;DP=265;AF=0.58;MQM=59;TRIO=HET,265,0.58,WT,86,0.02,HOM,146,1.00	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*76T>C:		rs422733	0.4663	0	0	0										0.3561	0.4545	0.1894	55	66	n/a	n/a
chr13	111164629	111164630	AA	-	het		QUAL=6413;DP=173;AF=0.50;MQM=59;TRIO=HET,173,0.50,WT,70,0.03,HOM,132,0.95	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*101_*102delAA:		rs397838577	0.4677	0	0	0										0.3939	0.4167	0.1894	60	61	n/a	n/a
chr13	111164955	111164955	C	G	het		QUAL=12773;DP=170;AF=0.48;MQM=59;TRIO=HET,170,0.48,HOM,193,1.00,HET,263,0.54	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*417C>G:		rs10509	0.8868	0	0	0										0.8561	0.1364	0.0076	124	25	n/a	n/a
chr13	111165079	111165079	C	T	het		QUAL=11395;DP=264;AF=0.45;MQM=60;TRIO=HET,264,0.45,HOM,240,0.99,WT,269,0.00	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*541C>T:		rs1049906	0.5054	0	0	0										0.197	0.4697	0.3333	30	67	n/a	n/a
chr13	111165265	111165265	G	C	het		QUAL=5072;DP=139;AF=0.52;MQM=60;TRIO=HET,139,0.52,HOM,90,0.99,WT,112,0.03	COL4A2	3'UTR	COL4A2:NM_001846.2:3'UTR:MODIFIER:exon48/48:c.*727G>C:		rs15457	0.5108	0	0	0										0.2045	0.4621	0.3333	31	67	n/a	n/a
chr14	20757383	20757383	A	G	het		QUAL=3127;DP=146;AF=0.53;MQM=60;TRIO=HET,146,0.53,HET,50,0.60,WT,49,0.00	TTC5	3'UTR	TTC5:NM_138376.2:3'UTR:MODIFIER:exon10/10:c.*403T>C:		rs74596138	0.114	0	0	0										0	0.1288	0.8712	0	17	n/a	n/a
chr14	20764585	20764585	A	C	het		QUAL=22679;DP=386;AF=0.53;MQM=60;TRIO=HET,386,0.53,HET,281,0.48,HOM,352,1.00	TTC5	synonymous	TTC5:NM_138376.2:synonymous:LOW:exon6/10:c.660T>G:p.Ala220Ala		rs1953552	0.4012	0.458	0.5023	0.2642	-0.0430	P							COSM1128303	0.2424	0.5606	0.197	76	161	n/a	n/a
chr14	20770036	20770036	T	C	hom		QUAL=41077;DP=423;AF=1.00;MQM=59;TRIO=HOM,423,1.00,HOM,323,1.00,HOM,510,1.00	TTC5	missense	TTC5:NM_138376.2:missense:MODERATE:exon2/10:c.140A>G:p.Gln47Arg		rs3742945	0.7456	0.737	0.7319	0.7476	-0.3360	P	T	B	B				COSM1179594	0.553	0.4242	0.0227	177	126	n/a	n/a
chr14	20937588	20937588	G	A	het		QUAL=10834;DP=408;AF=0.54;MQM=59;TRIO=HET,408,0.54,HET,272,0.50,WT,412,0.00	PNP	5'UTR	PNP:NM_000270.3:5'UTR:MODIFIER:exon1/6:c.-96G>A:		rs17881206	0.0058	0	0	0										0	0.0455	0.9545	0	6	n/a	n/a
chr14	20942744	20942744	A	G	het		QUAL=14466;DP=251;AF=0.52;MQM=60;TRIO=HET,251,0.52,HOM,334,0.99,WT,417,0.00	PNP	splice_region&intron	PNP:NM_000270.3:splice_region&intron:LOW:exon3/5:c.285+10A>G:		rs1713420	0.2023	0.194	0.1994	0.3218						164050 [PNP (confirmed) Immunodeficiency due to purine nucleoside phosphorylase deficiency];				0.0379	0.3712	0.5909	15	155	n/a	n/a
chr14	20945355	20945355	C	T	het		QUAL=6608;DP=261;AF=0.48;MQM=60;TRIO=HET,261,0.48,HET,191,0.46,WT,220,0.00	PNP	3'UTR	PNP:NM_000270.3:3'UTR:MODIFIER:exon6/6:c.*595C>T:		rs17878900	0.0647	0	0	0										0	0.0833	0.9167	0	11	n/a	n/a
chr14	20945488	20945488	T	C	hom		QUAL=47295;DP=611;AF=1.00;MQM=59;TRIO=HOM,611,1.00,HOM,411,1.00,HOM,440,1.00	PNP	3'UTR	PNP:NM_000270.3:3'UTR:MODIFIER:exon6/6:c.*728T>C:		rs1760933	0.9774	0	0	0										0.9242	0.0758	0	137	13	n/a	n/a
chr14	23242828	23242828	T	C	hom		QUAL=12821;DP=174;AF=0.99;MQM=60;TRIO=HOM,174,0.99,HOM,112,0.99,HOM,125,1.00	SLC7A7	synonymous	SLC7A7:NM_001126105.2:synonymous:LOW:exon11/11:c.1527A>G:p.Lys509Lys,SLC7A7:NM_001126106.2:synonymous:LOW:exon11/11:c.1527A>G:p.Lys509Lys		rs1061040	0.7855	0.865	0.8995	0.5148						603593 [SLC7A7 (confirmed) Lysinuric protein intolerance];	RCV000128147.1 [benign]; 			0.803	0.197	0	364	86	n/a	n/a
chr14	23282110	23282110	A	G	het		QUAL=2790;DP=75;AF=0.40;MQM=59;TRIO=HET,75,0.40,HOM,71,1.00,WT,82,0.00	SLC7A7	splice_region&synonymous	SLC7A7:NM_001126105.2:splice_region&synonymous:LOW:exon3/11:c.498T>C:p.Ile166Ile,SLC7A7:NM_001126106.2:splice_region&synonymous:LOW:exon3/11:c.498T>C:p.Ile166Ile		rs8018462	0.5821	0.556	0.5283	0.4666						603593 [SLC7A7 (confirmed) Lysinuric protein intolerance];	RCV000128149.1 [benign]; 			0.25	0.5455	0.2045	116	224	n/a	n/a
chr14	23282449	23282449	C	T	het		QUAL=8319;DP=274;AF=0.55;MQM=59;TRIO=HET,274,0.55,HOM,118,1.00,WT,124,0.01	SLC7A7	synonymous	SLC7A7:NM_001126105.2:synonymous:LOW:exon3/11:c.159G>A:p.Ser53Ser,SLC7A7:NM_001126106.2:synonymous:LOW:exon3/11:c.159G>A:p.Ser53Ser		rs1805059	0.606	0.606	0.6034	0.4825						603593 [SLC7A7 (confirmed) Lysinuric protein intolerance];	RCV000128148.1 [benign]; 		COSM3753883	0.3636	0.4848	0.1515	156	220	n/a	n/a
chr14	23284572	23284572	A	G	het		QUAL=8445;DP=218;AF=0.42;MQM=60;TRIO=HET,218,0.42,HOM,173,1.00,WT,261,0.01	SLC7A7	5'UTR	SLC7A7:NM_001126105.2:5'UTR:MODIFIER:exon2/11:c.-86T>C:,SLC7A7:NM_001126106.2:5'UTR:MODIFIER:exon2/11:c.-86T>C:		rs2281677	0.5781	0.477	0	0										0.3561	0.4773	0.1667	94	145	n/a	n/a
chr14	23588642	23588642	G	A	het		QUAL=17903;DP=252;AF=0.50;MQM=59;TRIO=HET,252,0.50,HET,266,0.49,HOM,309,0.99	CEBPE	5'UTR	CEBPE:NM_001805.3:5'UTR:MODIFIER:exon1/2:c.-342C>T:		rs12434881	0.3231	0	0	0										0.2121	0.5076	0.2803	31	72	n/a	n/a
chr14	23588731	23588731	G	C	het		QUAL=16264;DP=186;AF=0.48;MQM=60;TRIO=HET,186,0.48,HET,243,0.46,HOM,326,0.99	CEBPE	5'UTR	CEBPE:NM_001805.3:5'UTR:MODIFIER:exon1/2:c.-431C>G:		rs2239635	0.6643	0	0	0										0.4545	0.5	0.0455	64	77	n/a	n/a
chr14	23902753	23902753	G	A	het		QUAL=7377;DP=134;AF=0.45;MQM=60;TRIO=HET,134,0.45,WT,117,0.02,HOM,181,1.00	MYH7	synonymous	MYH7:NM_000257.3:synonymous:LOW:exon3/40:c.189C>T:p.Thr63Thr		rs2069540	0.5204	0.488	0.4841	0.6123						160760 [MYH7 (confirmed) Cardiomyopathy,familial hypertrophic,1|Cardiomyopathy,dilated,1S|Myopathy,myosin storage|Laing distal myopathy|Scapuloperoneal syndrome,myopathic type|Left ventricular noncompaction 5];	RCV000035752.3 [benign]; RCV000127010.2 [benign]; 		COSM3753910	0.1667	0.553	0.2803	116	261	n/a	n/a
chr14	24718380	24718401	CTCCGGGAGCCCTGGACTCCCC	-	het		QUAL=5599;DP=11;AF=0.36;MQM=60;TRIO=HET,11,1.00,HOM,94,1.00,HOM,106,1.00	TGM1	3'UTR	TGM1:NM_000359.2:3'UTR:MODIFIER:exon15/15:c.*118_*139delGGGGAGTCCAGGGCTCCCGGAG:		rs531264904	0.9914	0	0	0										0.9015	0.0076	0.0909	136	1	n/a	n/a
chr14	24718402	24718402	C	A	het		QUAL=5599;DP=11;AF=0.36;MQM=60;TRIO=HET,11,1.00,WT,94,1.00,WT,106,1.00	TGM1	3'UTR	TGM1:NM_000359.2:3'UTR:MODIFIER:exon15/15:c.*117G>T:			0	0	0	0										0	0	1	0	0	n/a	n/a
chr14	24718515	24718515	G	A	hom		QUAL=26706;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,343,1.00,HET,443,0.49	TGM1	3'UTR	TGM1:NM_000359.2:3'UTR:MODIFIER:exon15/15:c.*4C>T:		rs2229463	0.7163	0.791	0.8598	0.6984										0.7121	0.2727	0.0152	325	113	n/a	n/a
chr14	29238048	29238048	C	-	het		QUAL=3684;DP=168;AF=0.43;MQM=59;TRIO=HET,168,0.43,WT,79,0.00,HET,108,0.47	FOXG1	3'UTR	FOXG1:NM_005249.4:3'UTR:MODIFIER:exon1/1:c.*100delC:		rs397788971	0.0737	0	0	0										0	0.1288	0.8712	0	17	n/a	n/a
chr14	32047217	32047217	T	C	het		QUAL=11020;DP=358;AF=0.47;MQM=60;TRIO=HET,358,0.47,HET,360,0.48,WT,353,0.01	NUBPL	5'UTR,intron	NUBPL:NM_001201573.1:5'UTR:MODIFIER:exon1/9:c.-12T>C:,NUBPL:NM_025152.2:intron:MODIFIER:exon3/10:c.291+12963T>C:	L2c	rs7142098	0.3041	0.33	0	0						613621 [NUBPL (provisional) Mitochondrial complex I deficiency];				0.197	0.447	0.3561	37	112	n/a	n/a
chr14	32183848	32183848	C	T	het		QUAL=17243;DP=244;AF=0.51;MQM=59;TRIO=HET,244,1.00,HET,132,1.00,WT,164,1.00	NUBPL	5'UTR,intron	NUBPL:NM_001201574.1:5'UTR:MODIFIER:exon1/6:c.-198C>T:,NUBPL:NM_025152.2:intron:MODIFIER:exon6/10:c.513+41068C>T:,NUBPL:NM_001201573.1:intron:MODIFIER:exon4/8:c.225+41068C>T:	MSTB	rs11623835	0.2829	0	0	0						613621 [NUBPL (provisional) Mitochondrial complex I deficiency];				0.1894	0.447	0.3636	26	65	n/a	n/a
chr14	32183849	32183849	A	G	hom		QUAL=17243;DP=244;AF=0.51;MQM=59;TRIO=HOM,244,1.00,HOM,132,1.00,HOM,164,1.00	NUBPL	5'UTR,intron	NUBPL:NM_001201574.1:5'UTR:MODIFIER:exon1/6:c.-197A>G:,NUBPL:NM_025152.2:intron:MODIFIER:exon6/10:c.513+41069A>G:,NUBPL:NM_001201573.1:intron:MODIFIER:exon4/8:c.225+41069A>G:	MSTB	rs11156699	0.7063	0	0	0						613621 [NUBPL (provisional) Mitochondrial complex I deficiency];				0.9242	0.0682	0.0076	140	9	n/a	n/a
chr14	32183970	32183970	A	T	het		QUAL=5631;DP=250;AF=0.50;MQM=59;TRIO=HET,250,0.50,HET,100,0.57,WT,105,0.00	NUBPL	5'UTR,intron	NUBPL:NM_001201574.1:5'UTR:MODIFIER:exon1/6:c.-76A>T:,NUBPL:NM_025152.2:intron:MODIFIER:exon6/10:c.513+41190A>T:,NUBPL:NM_001201573.1:intron:MODIFIER:exon4/8:c.225+41190A>T:	MLT1L	rs11624772	0.2829	0	0	0						613621 [NUBPL (provisional) Mitochondrial complex I deficiency];				0.1894	0.447	0.3636	26	65	n/a	n/a
chr14	35180389	35180389	T	A	het		QUAL=7994;DP=228;AF=0.51;MQM=60;TRIO=HET,228,0.51,HOM,78,1.00,HET,115,0.54	CFL2	3'UTR	CFL2:NM_021914.7:3'UTR:MODIFIER:exon4/4:c.*1682A>T:,CFL2:NM_001243645.1:3'UTR:MODIFIER:exon4/4:c.*1682A>T:,CFL2:NM_138638.4:3'UTR:MODIFIER:exon4/4:c.*1682A>T:		rs712301	0.3421	0.388	0	0										0.2424	0.5379	0.2197	70	139	n/a	n/a
chr14	35180678	35180678	T	-	het		QUAL=16729;DP=287;AF=0.52;MQM=60;TRIO=HET,287,0.52,HOM,220,0.98,HET,289,0.54	CFL2	3'UTR	CFL2:NM_021914.7:3'UTR:MODIFIER:exon4/4:c.*1393delA:,CFL2:NM_001243645.1:3'UTR:MODIFIER:exon4/4:c.*1393delA:,CFL2:NM_138638.4:3'UTR:MODIFIER:exon4/4:c.*1393delA:		rs398024763	0.6595	0.736	0	0										0.6515	0.3182	0.0303	177	102	n/a	n/a
chr14	36986023	36986023	A	-	het		QUAL=2519;DP=89;AF=0.07;MQM=59;TRIO=HET,89,0.07,HET,87,0.26,HET,129,0.09	NKX2-1	3'UTR	NKX2-1:NM_001079668.2:3'UTR:MODIFIER:exon3/3:c.*460delT:,NKX2-1:NM_003317.3:3'UTR:MODIFIER:exon2/2:c.*460delT:		rs5807883	0	0	0	0										0.0152	0.0606	0.9242	2	10	n/a	n/a
chr14	36986273	36986273	A	T	hom		QUAL=4672;DP=92;AF=0.99;MQM=60;TRIO=HOM,92,1.00,HET,29,0.97,HOM,39,1.00	NKX2-1	3'UTR	NKX2-1:NM_001079668.2:3'UTR:MODIFIER:exon3/3:c.*210T>A:,NKX2-1:NM_003317.3:3'UTR:MODIFIER:exon2/2:c.*210T>A:		rs10139625	0.6218	0	0	0										0.3636	0.5152	0.1212	58	75	n/a	n/a
chr14	50087753	50087753	T	C	het		QUAL=8809;DP=49;AF=0.39;MQM=60;TRIO=HET,49,0.39,HET,128,0.43,HOM,229,0.99	MGAT2	5'UTR	MGAT2:NM_002408.3:5'UTR:MODIFIER:exon1/1:c.-234T>C:		rs7519	0.2953	0.301	0	0										0.25	0.4924	0.2576	66	128	n/a	n/a
chr14	50712569	50712569	A	G	hom		QUAL=16505;DP=214;AF=1.00;MQM=59;TRIO=HOM,214,1.00,HOM,196,1.00,HET,231,0.46	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*1207T>C:	AluSq2	rs7157035	0.8377	0	0	0						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				0.7045	0.2803	0.0152	110	38	n/a	n/a
chr14	50712797	50712797	T	C	hom		QUAL=8666;DP=140;AF=1.00;MQM=54;TRIO=HOM,140,1.00,HOM,69,1.00,HET,134,0.51	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*979A>G:	AluSq2	rs1964845	0.8902	0	0	0						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				0.7045	0.2803	0.0152	111	37	n/a	n/a
chr14	50712852	50712852	T	A	hom		QUAL=9385;DP=161;AF=1.00;MQM=57;TRIO=HOM,161,1.00,HOM,79,1.00,HET,147,0.40	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*924A>T:	AluSq2	rs6572652	0.8377	0	0	0						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				0.6818	0.303	0.0152	106	42	n/a	n/a
chr14	50712980	50712980	A	G	het		QUAL=5682;DP=181;AF=0.52;MQM=59;TRIO=HET,181,0.52,HOM,88,1.00,WT,149,0.00	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*796T>C:	AluJb	rs74541550	0.2756	0	0	0						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				0.0379	0.3258	0.6364	6	52	n/a	n/a
chr14	50713679	50713679	T	G	hom		QUAL=10415;DP=183;AF=1.00;MQM=59;TRIO=HOM,183,1.00,HOM,62,1.00,HOM,78,1.00	L2HGDH	3'UTR	L2HGDH:NM_024884.2:3'UTR:MODIFIER:exon10/10:c.*97A>C:		rs7143186	0.999	0	0	0						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];				0.9924	0.0076	0	150	1	n/a	n/a
chr14	50769717	50769717	G	A	hom		QUAL=22218;DP=374;AF=1.00;MQM=60;TRIO=HOM,374,1.00,HOM,199,1.00,HET,218,0.50	L2HGDH	synonymous	L2HGDH:NM_024884.2:synonymous:LOW:exon2/10:c.159C>T:p.Ile53Ile		rs2297995	0.5966	0.57	0.5551	0.6117						609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];	RCV000146249.1 [likely benign]; 		COSM4150799	0.3258	0.447	0.2273	358	556	n/a	n/a
chr14	50778816	50778816	A	C	hom		QUAL=5550;DP=40;AF=1.00;MQM=60;TRIO=HOM,40,1.00,HOM,84,1.00,HET,115,0.51	L2HGDH	missense	L2HGDH:NM_024884.2:missense:MODERATE:exon1/10:c.53T>G:p.Leu18Arg		rs2275591	0.5727	0.555	0.5633	0.563	-4.0100	P	T	B,B	B,B	609584 [L2HGDH (confirmed) L-2-hydroxyglutaric aciduria];	RCV000146250.1 [likely benign]; 		COSM433105	0.3485	0.4242	0.2273	373	554	n/a	n/a
chr14	51054598	51054598	A	G	het		QUAL=9392;DP=209;AF=0.49;MQM=60;TRIO=HET,209,0.49,WT,229,0.00,HET,363,0.55	ATL1	synonymous	ATL1:NM_015915.4:synonymous:LOW:exon2/14:c.84A>G:p.Pro28Pro,ATL1:NM_001127713.1:synonymous:LOW:exon3/14:c.84A>G:p.Pro28Pro,ATL1:NM_181598.3:synonymous:LOW:exon2/13:c.84A>G:p.Pro28Pro		rs35014209	0.1641	0.136	0.1437	0.3141						606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant|Neuropathy,hereditary sensory,type ID];	RCV000020724.1 [benign]; RCV000116421.2 [likely benign]; RCV000123708.1 [benign]; 		COSM3753981	0.0076	0.2045	0.7879	13	163	n/a	n/a
chr14	51057727	51057727	G	A	hom		QUAL=16646;DP=293;AF=1.00;MQM=60;TRIO=HOM,293,1.00,HET,213,0.43,HET,245,0.46	ATL1	synonymous	ATL1:NM_015915.4:synonymous:LOW:exon3/14:c.351G>A:p.Glu117Glu,ATL1:NM_001127713.1:synonymous:LOW:exon4/14:c.351G>A:p.Glu117Glu,ATL1:NM_181598.3:synonymous:LOW:exon3/13:c.351G>A:p.Glu117Glu		rs1060197	0.8215	0.763	0.7288	0.9267						606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant|Neuropathy,hereditary sensory,type ID];	RCV000020720.1 [benign]; RCV000116420.2 [likely benign]; 			0.4697	0.4015	0.1288	371	306	1	n/a (2xTP)
chr14	51062357	51062357	G	A	het		QUAL=6745;DP=202;AF=0.49;MQM=60;TRIO=HET,202,0.49,WT,165,0.00,HET,229,0.49	ATL1	splice_region&intron	ATL1:NM_015915.4:splice_region&intron:LOW:exon6/13:c.630+7G>A:,ATL1:NM_001127713.1:splice_region&intron:LOW:exon7/13:c.630+7G>A:,ATL1:NM_181598.3:splice_region&intron:LOW:exon6/12:c.630+7G>A:		rs3759588	0.1494	0.133	0.1462	0.2755						606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant|Neuropathy,hereditary sensory,type ID];	RCV000123709.1 [benign]; 		COSM3999276	0.0152	0.197	0.7879	14	162	n/a	n/a
chr14	55308770	55308770	C	A	hom		QUAL=8153;DP=154;AF=1.00;MQM=60;TRIO=HOM,154,1.00,HOM,48,1.00,HOM,59,1.00	GCH1	3'UTR	GCH1:NM_000161.2:3'UTR:MODIFIER:exon6/6:c.*1965G>T:,GCH1:NM_001024024.1:3'UTR:MODIFIER:exon7/7:c.*1019G>T:,GCH1:NM_001024070.1:3'UTR:MODIFIER:exon7/7:c.*1015G>T:,GCH1:NM_001024071.1:3'UTR:MODIFIER:exon6/6:c.*987G>T:		rs6572984	0.99	0	0	0										1	0	0	160	0	n/a	n/a
chr14	55369502	55369502	A	G	hom		QUAL=1250;DP=8;AF=1.00;MQM=59;TRIO=HOM,8,1.00,HOM,14,1.00,HOM,20,1.00	GCH1	5'UTR	GCH1:NM_000161.2:5'UTR:MODIFIER:exon1/6:c.-121T>C:,GCH1:NM_001024024.1:5'UTR:MODIFIER:exon1/7:c.-121T>C:,GCH1:NM_001024070.1:5'UTR:MODIFIER:exon1/7:c.-121T>C:,GCH1:NM_001024071.1:5'UTR:MODIFIER:exon1/6:c.-121T>C:		rs1753589	0.9457	0	0	0										0.9167	0.0152	0.0682	143	4	n/a	n/a
chr14	57268443	57268443	C	T	het		QUAL=6262;DP=276;AF=0.43;MQM=60;TRIO=HET,276,0.43,HET,144,0.49,WT,193,0.00	OTX2	3'UTR	OTX2:NM_001270525.1:3'UTR:MODIFIER:exon3/3:c.*10G>A:,OTX2:NM_172337.2:3'UTR:MODIFIER:exon3/3:c.*10G>A:,OTX2:NM_001270523.1:3'UTR:MODIFIER:exon5/5:c.*10G>A:,OTX2:NM_001270524.1:3'UTR:MODIFIER:exon4/4:c.*10G>A:,OTX2:NM_021728.3:3'UTR:MODIFIER:exon5/5:c.*10G>A:		rs171978	0.0315	0.065	0.0914	0.0152										0.0076	0.1061	0.8864	7	57	n/a	n/a
chr14	64491695	64491695	T	C	hom		QUAL=28439;DP=388;AF=1.00;MQM=59;TRIO=HOM,388,1.00,HOM,230,1.00,HOM,252,1.00	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon40/116:c.5906T>C:p.Met1969Thr,SYNE2:NM_015180.4:missense:MODERATE:exon40/115:c.5906T>C:p.Met1969Thr		rs4902264	0.6789	0.812	0.8747	0.444	0.1190	P	T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118541.1 [benign]; 			0.75	0.2121	0.0379	584	173	n/a	n/a
chr14	64494278	64494278	C	T	hom		QUAL=16614;DP=284;AF=1.00;MQM=60;TRIO=HOM,284,1.00,HOM,96,1.00,HOM,118,1.00	SYNE2	synonymous	SYNE2:NM_182914.2:synonymous:LOW:exon43/116:c.6481C>T:p.Leu2161Leu,SYNE2:NM_015180.4:synonymous:LOW:exon43/115:c.6481C>T:p.Leu2161Leu		rs10151127	0.752	0.869	0.9222	0.565						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118543.1 [benign]; 			0.7955	0.197	0.0076	630	136	n/a	n/a
chr14	64496749	64496749	C	T	hom		QUAL=12531;DP=215;AF=1.00;MQM=60;TRIO=HOM,215,1.00,HOM,84,1.00,HOM,96,1.00	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon44/116:c.6851C>T:p.Ala2284Val,SYNE2:NM_015180.4:missense:MODERATE:exon44/115:c.6851C>T:p.Ala2284Val		rs4027402	0.6719	0.812	0.8783	0.4364	0.3380	P	T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118544.1 [benign]; 			0.7652	0.2045	0.0303	567	164	n/a	n/a
chr14	64497930	64497930	G	A	hom		QUAL=33073;DP=478;AF=1.00;MQM=60;TRIO=HOM,478,1.00,HOM,230,1.00,HOM,306,0.99	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon45/116:c.7076G>A:p.Ser2359Asn,SYNE2:NM_015180.4:missense:MODERATE:exon45/115:c.7076G>A:p.Ser2359Asn		rs4027404	0.7025	0.821	0.8782	0.5276	0.9820	P	T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118548.1 [benign]; 			0.7652	0.2045	0.0303	605	169	n/a	n/a
chr14	64498037	64498037	G	A	hom		QUAL=23583;DP=282;AF=1.00;MQM=60;TRIO=HOM,282,1.00,HOM,186,1.00,HOM,273,1.00	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon45/116:c.7183G>A:p.Ala2395Thr,SYNE2:NM_015180.4:missense:MODERATE:exon45/115:c.7183G>A:p.Ala2395Thr		rs4027405	0.8373	0.892	0.9227	0.7822	1.8170	P	T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118551.1 [benign]; 			0.803	0.1894	0.0076	651	134	n/a	n/a
chr14	64519035	64519035	A	G	hom		QUAL=25842;DP=289;AF=1.00;MQM=60;TRIO=HOM,289,1.00,HOM,234,1.00,HOM,259,1.00	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon48/116:c.8404A>G:p.Ser2802Gly,SYNE2:NM_015180.4:missense:MODERATE:exon48/115:c.8404A>G:p.Ser2802Gly		rs1890908	0.8618	0.907	0.9316	0.8704	-1.6090	P	T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118553.1 [benign]; 			0.8864	0.1136	0	680	96	n/a	n/a
chr14	64519455	64519455	A	G	hom		QUAL=31006;DP=401;AF=1.00;MQM=60;TRIO=HOM,401,1.00,HOM,228,1.00,HOM,311,1.00	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon48/116:c.8824A>G:p.Ile2942Val,SYNE2:NM_015180.4:missense:MODERATE:exon48/115:c.8824A>G:p.Ile2942Val		rs3829767	0.6651	0.802	0.8637	0.4132	-0.8420	P	T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118556.1 [benign]; 			0.7424	0.2348	0.0227	587	185	n/a	n/a
chr14	64522674	64522674	G	C	hom		QUAL=21727;DP=282;AF=1.00;MQM=60;TRIO=HOM,282,1.00,HOM,180,0.99,HOM,223,1.00	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon49/116:c.9757G>C:p.Asp3253His,SYNE2:NM_015180.4:missense:MODERATE:exon49/115:c.9757G>C:p.Asp3253His		rs8010911	0.6813	0.806	0.8635	0.4745	2.7620	P	T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118560.1 [benign]; 			0.7424	0.2348	0.0227	570	190	n/a	n/a
chr14	64522843	64522843	A	G	hom		QUAL=39976;DP=422;AF=1.00;MQM=60;TRIO=HOM,422,1.00,HOM,365,1.00,HOM,448,1.00	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon49/116:c.9926A>G:p.His3309Arg,SYNE2:NM_015180.4:missense:MODERATE:exon49/115:c.9926A>G:p.His3309Arg		rs8010699	0.6823	0.807	0.864	0.4793	1.1020	P	T	B,B	B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118561.1 [benign]; 			0.7424	0.2348	0.0227	572	189	n/a	n/a
chr14	64565536	64565536	C	T	het		QUAL=10421;DP=373;AF=0.53;MQM=60;TRIO=HET,373,0.53,WT,243,0.00,HET,306,0.45	SYNE2	synonymous	SYNE2:NM_182914.2:synonymous:LOW:exon63/116:c.12378C>T:p.Ser4126Ser,SYNE2:NM_015180.4:synonymous:LOW:exon63/115:c.12378C>T:p.Ser4126Ser		rs36007735	0.0024	0.0054	0.0079	0.0018						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];			COSM1240354	0	0.0303	0.9697	0	18	n/a	n/a
chr14	64612845	64612845	C	T	het		QUAL=8924;DP=256;AF=0.55;MQM=60;TRIO=HET,256,0.55,WT,157,0.00,HET,239,0.57	SYNE2	synonymous	SYNE2:NM_182914.2:synonymous:LOW:exon84/116:c.15543C>T:p.Ile5181Ile,SYNE2:NM_015180.4:synonymous:LOW:exon84/115:c.15543C>T:p.Ile5181Ile		rs11629287	0.4419	0.368	0.3393	0.5386						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118519.1 [benign]; 		COSM1128227	0.0606	0.4621	0.4773	92	328	n/a	n/a
chr14	64612858	64612858	C	A	het		QUAL=9550;DP=261;AF=0.56;MQM=60;TRIO=HET,261,0.56,WT,176,0.01,HET,265,0.57	SYNE2	missense	SYNE2:NM_182914.2:missense:MODERATE:exon84/116:c.15556C>A:p.Leu5186Met,SYNE2:NM_015180.4:missense:MODERATE:exon84/115:c.15556C>A:p.Leu5186Met		rs10151658	0.6318	0.502	0.4385	0.85	-0.5950	P	T	B,B,B,B	B,B,B,B	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118520.1 [benign]; 		COSM1128226	0.2197	0.4318	0.3485	181	362	n/a	n/a
chr14	64637147	64637147	C	A	het		QUAL=9012;DP=198;AF=0.50;MQM=60;TRIO=HET,198,0.50,WT,285,0.00,HET,386,0.51	SYNE2	synonymous	SYNE2:NM_182914.2:synonymous:LOW:exon94/116:c.17202C>A:p.Leu5734Leu,SYNE2:NM_015180.4:synonymous:LOW:exon94/115:c.17202C>A:p.Leu5734Leu		rs7161192	0.3658	0.329	0.325	0.3688						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118525.1 [benign]; 			0.0758	0.4545	0.4697	89	337	n/a	n/a
chr14	64656855	64656855	T	C	het		QUAL=7169;DP=225;AF=0.51;MQM=60;TRIO=HET,225,0.51,WT,137,0.01,HET,209,0.50	SYNE2	synonymous	SYNE2:NM_182914.2:synonymous:LOW:exon99/116:c.17938T>C:p.Leu5980Leu,SYNE2:NM_015180.4:synonymous:LOW:exon99/115:c.17938T>C:p.Leu5980Leu		rs2256191	0.487	0.394	0.362	0.7453						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118528.1 [benign]; 		COSM3999321	0.1364	0.5379	0.3258	134	358	n/a	n/a
chr14	64681193	64681193	C	T	het		QUAL=4834;DP=183;AF=0.49;MQM=60;TRIO=HET,183,0.49,WT,51,0.00,HOM,73,1.00	SYNE2	splice_region&intron	SYNE2:NM_182914.2:splice_region&intron:LOW:exon106/115:c.19333+5C>T:,SYNE2:NM_015180.4:splice_region&intron:LOW:exon106/114:c.19333+5C>T:,SYNE2:NM_182913.2:splice_region&intron:LOW:exon1/10:c.235+5C>T:		rs1152590	0.5833	0.441	0.3828	0.7537						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118529.1 [benign]; 			0.1818	0.5	0.3182	152	335	n/a	n/a
chr14	64686125	64686125	G	T	het		QUAL=6042;DP=114;AF=0.39;MQM=60;TRIO=HET,114,0.39,WT,110,0.00,HOM,155,1.00	SYNE2	synonymous	SYNE2:NM_182914.2:synonymous:LOW:exon110/116:c.19857G>T:p.Leu6619Leu,SYNE2:NM_015180.4:synonymous:LOW:exon109/115:c.19788G>T:p.Leu6596Leu,SYNE2:NM_182913.2:synonymous:LOW:exon5/11:c.759G>T:p.Leu253Leu,SYNE2:NM_182910.2:synonymous:LOW:exon3/9:c.381G>T:p.Leu127Leu		rs35648226	0.2097	0.24	0.2833	0.2165						608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant];	RCV000118530.1 [benign]; 			0.0833	0.4318	0.4848	75	307	n/a	n/a
chr14	64692630	64692630	G	C	het		QUAL=7775;DP=223;AF=0.46;MQM=60;TRIO=HET,223,0.46,WT,118,0.00,HOM,134,1.00	SYNE2	3'UTR	SYNE2:NM_182914.2:3'UTR:MODIFIER:exon116/116:c.*386G>C:,SYNE2:NM_015180.4:3'UTR:MODIFIER:exon115/115:c.*386G>C:,SYNE2:NM_182913.2:3'UTR:MODIFIER:exon11/11:c.*386G>C:,SYNE2:NM_182910.2:3'UTR:MODIFIER:exon9/9:c.*386G>C:		rs1152582	0.6895	0	0	0										0.3106	0.5076	0.1818	46	75	n/a	n/a
chr14	64692825	64692825	G	A	het		QUAL=6448;DP=177;AF=0.41;MQM=60;TRIO=HET,177,0.41,WT,114,0.00,HOM,128,1.00	SYNE2	3'UTR	SYNE2:NM_182914.2:3'UTR:MODIFIER:exon116/116:c.*581G>A:,SYNE2:NM_015180.4:3'UTR:MODIFIER:exon115/115:c.*581G>A:,SYNE2:NM_182913.2:3'UTR:MODIFIER:exon11/11:c.*581G>A:,SYNE2:NM_182910.2:3'UTR:MODIFIER:exon9/9:c.*581G>A:		rs7229	0.6909	0	0	0										0.3106	0.5076	0.1818	46	75	n/a	n/a
chr14	66974474	66974474	T	C	het		QUAL=4371;DP=144;AF=0.49;MQM=59;TRIO=HET,144,0.49,WT,123,0.01,HET,162,0.48	GPHN	5'UTR	GPHN:NM_020806.4:5'UTR:MODIFIER:exon1/23:c.-772T>C:,GPHN:NM_001024218.1:5'UTR:MODIFIER:exon1/22:c.-772T>C:		rs928553	0.4507	0.25	0	0										0.0379	0.3182	0.6439	15	77	n/a	n/a
chr14	67147816	67147816	T	C	het		QUAL=4076;DP=174;AF=0.48;MQM=60;TRIO=HET,174,0.48,WT,74,0.00,HET,87,0.49	GPHN	splice_region&intron	GPHN:NM_020806.4:splice_region&intron:LOW:exon1/22:c.65-9T>C:,GPHN:NM_001024218.1:splice_region&intron:LOW:exon1/21:c.65-9T>C:		rs3759753	0.4503	0.264	0.1448	0.6446						603930 [GPHN (confirmed) Molybdenum cofactor deficiency C];			COSM3999345	0.0379	0.3182	0.6439	21	124	n/a	n/a
chr14	68213571	68213571	C	T	hom		QUAL=44165;DP=540;AF=1.00;MQM=60;TRIO=HOM,540,1.00,HOM,331,1.00,HOM,468,1.00	ZFYVE26	3'UTR	ZFYVE26:NM_015346.3:3'UTR:MODIFIER:exon42/42:c.*1582G>A:		rs8017209	0.9501	0	0	0										0.9848	0.0152	0	147	3	n/a	n/a
chr14	68213744	68213744	G	A	hom		QUAL=24747;DP=358;AF=1.00;MQM=59;TRIO=HOM,358,1.00,HOM,176,1.00,HOM,211,1.00	ZFYVE26	3'UTR	ZFYVE26:NM_015346.3:3'UTR:MODIFIER:exon42/42:c.*1409C>T:		rs10288	0.9501	0	0	0										0.9848	0.0152	0	147	3	n/a	n/a
chr14	68213792	68213792	A	G	hom		QUAL=28067;DP=364;AF=1.00;MQM=60;TRIO=HOM,364,1.00,HOM,221,0.99,HOM,291,0.99	ZFYVE26	3'UTR	ZFYVE26:NM_015346.3:3'UTR:MODIFIER:exon42/42:c.*1361T>C:		rs1044126	0.3135	0	0	0										0.3106	0.4924	0.197	45	73	n/a	n/a
chr14	68234539	68234539	T	C	hom		QUAL=35093;DP=307;AF=1.00;MQM=60;TRIO=HOM,307,1.00,HOM,303,1.00,HOM,474,1.00	ZFYVE26	missense	ZFYVE26:NM_015346.3:missense:MODERATE:exon31/42:c.5672A>G:p.Asn1891Ser		rs3742883	0.9032	0.955	0.9858	0.8557	-0.3940	P	T	B	B	612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive];	RCV000118901.2 [likely benign]; 			0.9773	0.0227	0	747	14	n/a	n/a
chr14	68249499	68249499	C	T	hom		QUAL=11993;DP=228;AF=0.99;MQM=59;TRIO=HOM,228,0.99,HET,136,0.51,HET,158,0.54	ZFYVE26	missense&splice_region	ZFYVE26:NM_015346.3:missense&splice_region:MODERATE:exon21/42:c.4370G>A:p.Cys1457Tyr		rs2235967	0.1601	0.263	0.3537	0.0874	2.5290	P	T	B,B	B,B	612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive];	RCV000118900.2 [likely benign]; 		COSM3754058	0.1061	0.4773	0.4167	105	344	n/a	n/a
chr14	68257485	68257485	C	T	hom		QUAL=8479;DP=98;AF=0.99;MQM=60;TRIO=HOM,98,0.99,HET,154,0.54,HET,210,0.47	ZFYVE26	synonymous	ZFYVE26:NM_015346.3:synonymous:LOW:exon15/42:c.2559G>A:p.Leu853Leu		rs7143196	0.0747	0.146	0.2094	0.0418						612012 [ZFYVE26 (confirmed) Spastic paraplegia 15,autosomal recessive];	RCV000118895.2 [likely benign]; 			0.0455	0.3333	0.6212	32	246	n/a	n/a
chr14	75476071	75476071	G	C	hom		QUAL=38709;DP=432;AF=0.99;MQM=59;TRIO=HOM,432,0.99,HET,426,0.50,HOM,564,0.99	EIF2B2	3'UTR	EIF2B2:NM_014239.3:3'UTR:MODIFIER:exon8/8:c.*180G>C:		rs4556	0.5176	0	0	0										0.25	0.5606	0.1894	35	86	n/a	n/a
chr14	77741394	77741394	T	C	hom		QUAL=9489;DP=195;AF=1.00;MQM=59;TRIO=HOM,195,1.00,HET,70,0.46,HOM,78,0.97	POMT2	3'UTR	POMT2:NM_013382.5:3'UTR:MODIFIER:exon21/21:c.*2325A>G:		rs11547793	0.2913	0	0	0										0.0758	0.4167	0.5076	11	60	n/a	n/a
chr14	77741977	77741977	C	T	hom		QUAL=20218;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HET,206,0.53,HOM,252,1.00	POMT2	3'UTR	POMT2:NM_013382.5:3'UTR:MODIFIER:exon21/21:c.*1742G>A:		rs12894594	0.8522	0	0	0										0.7273	0.2273	0.0455	107	35	n/a	n/a
chr14	77742218	77742218	C	T	hom		QUAL=19379;DP=219;AF=0.99;MQM=60;TRIO=HOM,219,0.99,HET,239,0.50,HOM,275,1.00	POMT2	3'UTR	POMT2:NM_013382.5:3'UTR:MODIFIER:exon21/21:c.*1501G>A:		rs4141640	0.8558	0	0	0										0.7273	0.2424	0.0303	107	37	n/a	n/a
chr14	77743644	77743644	G	A	hom		QUAL=10293;DP=130;AF=0.97;MQM=60;TRIO=HOM,130,0.97,HET,91,0.62,HOM,149,0.99	POMT2	3'UTR	POMT2:NM_013382.5:3'UTR:MODIFIER:exon21/21:c.*75C>T:		rs1055592	0.2686	0	0	0										0.0758	0.3636	0.5606	11	52	n/a	n/a
chr14	77745193	77745193	A	C	hom		QUAL=23891;DP=117;AF=1.00;MQM=59;TRIO=HOM,117,1.00,HET,337,0.53,HOM,474,1.00	POMT2	synonymous	POMT2:NM_013382.5:synonymous:LOW:exon19/21:c.1911T>G:p.Leu637Leu		rs3209079	0.847	0.816	0.8097	0.8386	-0.7790	P				607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2];	RCV000118038.1 [benign]; RCV000127578.2,RCV000153051.1 [benign,benign]; 		COSM4148271	0.7121	0.2576	0.0303	329	108	n/a	n/a
chr14	77751925	77751925	C	T	hom		QUAL=17426;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HET,192,0.53,HOM,255,1.00	POMT2	synonymous	POMT2:NM_013382.5:synonymous:LOW:exon13/21:c.1383G>A:p.Arg461Arg		rs2270419	0.8582	0.821	0.8065	0.87						607439 [POMT2 (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,2|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,2|Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,2];	RCV000127577.2,RCV000153056.1 [benign,benign]; 		COSM4148272	0.7273	0.2424	0.0303	329	108	n/a	n/a
chr14	77893276	77893276	G	A	het		QUAL=13510;DP=335;AF=0.44;MQM=60;TRIO=HET,335,0.44,HET,268,0.51,HET,338,0.39	VIPAS39	3'UTR	VIPAS39:NM_001193314.1:3'UTR:MODIFIER:exon20/20:c.*683C>T:,VIPAS39:NM_001193315.1:3'UTR:MODIFIER:exon20/20:c.*683C>T:,VIPAS39:NM_001193316.1:3'UTR:MODIFIER:exon19/19:c.*683C>T:,VIPAS39:NM_001193317.1:3'UTR:MODIFIER:exon20/20:c.*683C>T:,VIPAS39:NM_022067.3:3'UTR:MODIFIER:exon21/21:c.*683C>T:		rs4223	0.4896	0	0	0										0.2348	0.5379	0.2273	35	79	n/a	n/a
chr14	77893431	77893431	A	G	hom		QUAL=28047;DP=339;AF=1.00;MQM=60;TRIO=HOM,339,1.00,HOM,242,1.00,HOM,267,1.00	VIPAS39	3'UTR	VIPAS39:NM_001193314.1:3'UTR:MODIFIER:exon20/20:c.*528T>C:,VIPAS39:NM_001193315.1:3'UTR:MODIFIER:exon20/20:c.*528T>C:,VIPAS39:NM_001193316.1:3'UTR:MODIFIER:exon19/19:c.*528T>C:,VIPAS39:NM_001193317.1:3'UTR:MODIFIER:exon20/20:c.*528T>C:,VIPAS39:NM_022067.3:3'UTR:MODIFIER:exon21/21:c.*528T>C:		rs8009177	0.9764	0	0	0										1	0	0	150	0	n/a	n/a
chr14	77923783	77923783	C	T	het		QUAL=15409;DP=344;AF=0.42;MQM=60;TRIO=HET,344,0.42,HET,324,0.51,HET,416,0.46	VIPAS39	5'UTR,intron	VIPAS39:NM_001193314.1:5'UTR:MODIFIER:exon1/20:c.-346G>A:,VIPAS39:NM_001193317.1:5'UTR:MODIFIER:exon1/20:c.-123G>A:,VIPAS39:NM_001193315.1:intron:MODIFIER:exon1/19:c.-1+55G>A:,VIPAS39:NM_001193316.1:intron:MODIFIER:exon1/18:c.-1+55G>A:,VIPAS39:NM_022067.3:intron:MODIFIER:exon1/20:c.-272+55G>A:		rs11845345	0.1396	0.17	0	0										0.0455	0.2879	0.6667	14	67	n/a	n/a
chr14	77973953	77973953	-	CA	hom		QUAL=13367;DP=187;AF=0.94;MQM=58;TRIO=HOM,187,0.94,HOM,125,1.00,HOM,127,0.98	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*4673_*4674insTG:	AluSz6	rs58831828	0.8512	0	0	0										0.8409	0.1591	0	126	24	n/a	n/a
chr14	77973982	77973982	T	C	hom		QUAL=19176;DP=306;AF=1.00;MQM=59;TRIO=HOM,306,1.00,HOM,133,1.00,HOM,144,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*4645A>G:		rs10132095	0.9451	0	0	0										1	0	0	150	0	n/a	n/a
chr14	77974181	77974181	C	A	hom		QUAL=9589;DP=176;AF=1.00;MQM=59;TRIO=HOM,176,1.00,HOM,53,1.00,HOM,62,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*4446G>T:		rs11159268	0.5962	0	0	0										0.4167	0.4545	0.1288	61	70	n/a	n/a
chr14	77974990	77974990	C	T	hom		QUAL=26958;DP=403;AF=0.99;MQM=60;TRIO=HOM,403,0.99,HOM,212,1.00,HOM,219,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*3637G>A:		rs1063271	0.769	0	0	0										0.6515	0.3258	0.0227	98	48	n/a	n/a
chr14	77975015	77975015	A	T	hom		QUAL=23541;DP=338;AF=1.00;MQM=60;TRIO=HOM,338,1.00,HOM,167,1.00,HOM,199,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*3612T>A:		rs2364160	0.9475	0	0	0										1	0	0	150	0	n/a	n/a
chr14	77975103	77975103	T	G	hom		QUAL=18876;DP=281;AF=1.00;MQM=60;TRIO=HOM,281,1.00,HOM,131,1.00,HOM,159,1.00	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*3524A>C:		rs1063270	0.7762	0	0	0										0.6515	0.3258	0.0227	98	48	n/a	n/a
chr14	77976325	77976325	T	C	hom		QUAL=21847;DP=318;AF=1.00;MQM=60;TRIO=HOM,318,1.00,HOM,142,1.00,HOM,191,0.99	SPTLC2	3'UTR	SPTLC2:NM_004863.3:3'UTR:MODIFIER:exon12/12:c.*2302A>G:		rs11159269	0.7606	0	0	0										0.6515	0.3258	0.0227	97	49	n/a	n/a
chr14	78028803	78028803	A	G	hom		QUAL=12464;DP=163;AF=1.00;MQM=60;TRIO=HOM,163,1.00,HOM,89,1.00,HOM,122,1.00	SPTLC2	synonymous	SPTLC2:NM_004863.3:synonymous:LOW:exon6/12:c.786T>C:p.Asn262Asn		rs2364602	0.8375	0.903	0.9341	0.6382	1.1100	P				605713 [SPTLC2 (provisional) Neuropathy,hereditary sensory and autonomic,type IC];				0.8636	0.1212	0.0152	396	54	n/a	n/a
chr14	81562998	81562998	T	C	het		QUAL=6569;DP=201;AF=0.50;MQM=60;TRIO=HET,201,0.50,HET,224,0.46,WT,283,0.00	TSHR	synonymous	TSHR:NM_000369.2:synonymous:LOW:exon7/10:c.561T>C:p.Asn187Asn,TSHR:NM_001018036.2:synonymous:LOW:exon7/9:c.561T>C:p.Asn187Asn,TSHR:NM_001142626.2:synonymous:LOW:exon7/9:c.561T>C:p.Asn187Asn		rs2075179	0.3001	0.191	0.1357	0.5313						603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational];			COSM3754139	0.0227	0.2803	0.697	8	105	n/a	n/a
chr14	81574959	81574959	A	G	het		QUAL=14550;DP=391;AF=0.49;MQM=60;TRIO=HET,391,0.49,HET,286,0.41,HET,353,0.43	TSHR	synonymous,intron	TSHR:NM_001018036.2:synonymous:LOW:exon9/9:c.696A>G:p.Leu232Leu,TSHR:NM_001142626.2:synonymous:LOW:exon9/9:c.759A>G:p.Leu253Leu,TSHR:NM_000369.2:intron:MODIFIER:exon8/9:c.692+163A>G:		rs3783942	0.6112	0.647	0.6566	0.6187						603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational];				0.3636	0.5	0.1364	219	193	n/a	n/a
chr14	81575005	81575005	C	A	het		QUAL=20958;DP=591;AF=0.46;MQM=60;TRIO=HET,591,0.46,HET,380,0.41,HET,507,0.45	TSHR	missense,intron	TSHR:NM_001018036.2:missense:MODERATE:exon9/9:c.742C>A:p.Arg248Ser,TSHR:NM_001142626.2:missense:MODERATE:exon9/9:c.805C>A:p.Arg269Ser,TSHR:NM_000369.2:intron:MODIFIER:exon8/9:c.692+209C>A:		rs3783941	0.6102	0.646	0.6566	0.6148	-0.9880	P	T	B,B	B,B	603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational];	RCV000122257.1 [not provided]; 			0.3636	0.5	0.1364	219	193	n/a	n/a
chr14	81610583	81610583	G	C	hom		QUAL=16055;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HOM,147,1.00,HOM,165,0.99	TSHR	missense	TSHR:NM_000369.2:missense:MODERATE:exon10/10:c.2181G>C:p.Glu727Asp		rs1991517	0.8968	0.9	0.9134	0.9428	-0.1250	P	T	B	B	603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational];	RCV000122254.1 [not provided]; 	CM994612 [CLASS=DFP MUT=REF PHEN="Toxic multinodular goitre, association with" GENE=TSHR]; 		0.8788	0.1212	0	373	56	n/a	n/a
chr14	81610942	81610942	C	T	het		QUAL=14773;DP=300;AF=0.50;MQM=60;TRIO=HET,300,0.50,HOM,158,1.00,HET,266,0.51	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*245C>T:		rs7144481	0.8433	0	0	0										0.803	0.1894	0.0076	119	30	n/a	n/a
chr14	81611849	81611849	T	A	het		QUAL=12357;DP=321;AF=0.53;MQM=60;TRIO=HET,321,0.53,HOM,121,1.00,HET,183,0.47	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*1152T>A:		rs2288494	0.8472	0	0	0										0.4318	0.2424	0.3258	61	33	n/a	n/a
chr14	81611850	81611850	-	T	het		QUAL=12357;DP=321;AF=0.53;MQM=60;TRIO=HET,321,0.53,HOM,121,1.00,HET,183,0.47	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*1154dupT:		rs3214569	0.8476	0	0	0										0.7879	0.2045	0.0076	117	32	n/a	n/a
chr14	81611919	81611919	G	C	het		QUAL=15194;DP=428;AF=0.54;MQM=60;TRIO=HET,428,0.54,HET,202,0.45,HET,254,0.52	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*1222G>C:		rs2288495	0.2931	0	0	0										0.2879	0.4697	0.2424	46	68	n/a	n/a
chr14	81612114	81612114	T	C	het		QUAL=10895;DP=240;AF=0.53;MQM=60;TRIO=HET,240,0.53,HET,178,0.50,HET,210,0.54	TSHR	3'UTR	TSHR:NM_000369.2:3'UTR:MODIFIER:exon10/10:c.*1417T>C:		rs2288496	0.2935	0	0	0										0.2879	0.4697	0.2424	46	68	n/a	n/a
chr14	88399623	88399623	T	C	hom		QUAL=19645;DP=264;AF=1.00;MQM=60;TRIO=HOM,264,1.00,HET,160,0.49,HOM,256,1.00	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*1453A>G:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*1453A>G:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*1453A>G:	L1ME2	rs405567	0.4479	0	0	0										0.2424	0.4545	0.303	38	69	n/a	n/a
chr14	88400087	88400087	C	T	hom		QUAL=27123;DP=505;AF=1.00;MQM=60;TRIO=HOM,505,1.00,HOM,141,1.00,HOM,178,1.00	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*989G>A:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*989G>A:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*989G>A:		rs370559	0.9409	0	0	0										0.9848	0.0152	0	220	3	n/a	n/a
chr14	88400353	88400353	C	T	hom		QUAL=37309;DP=563;AF=1.00;MQM=60;TRIO=HOM,563,1.00,HET,310,0.50,HOM,432,0.99	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*723G>A:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*723G>A:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*723G>A:		rs412915	0.4475	0.4	0	0						606890 [GALC (confirmed) Krabbe disease];				0.2424	0.447	0.3106	240	517	n/a	n/a
chr14	88400449	88400449	T	C	hom		QUAL=27134;DP=533;AF=1.00;MQM=60;TRIO=HOM,533,1.00,HOM,140,1.00,HOM,178,0.99	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*627A>G:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*627A>G:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*627A>G:		rs413750	0.9409	0	0	0						606890 [GALC (confirmed) Krabbe disease];				0.9773	0.0227	0	243	9	n/a	n/a
chr14	88400450	88400450	G	A	hom		QUAL=27134;DP=533;AF=1.00;MQM=60;TRIO=HOM,533,1.00,HET,140,1.00,HOM,178,0.99	GALC	3'UTR	GALC:NM_000153.3:3'UTR:MODIFIER:exon17/17:c.*626C>T:,GALC:NM_001201401.1:3'UTR:MODIFIER:exon16/16:c.*626C>T:,GALC:NM_001201402.1:3'UTR:MODIFIER:exon17/17:c.*626C>T:		rs432946	0.4475	0	0	0						606890 [GALC (confirmed) Krabbe disease];				0.2424	0.4545	0.303	68	108	n/a	n/a
chr14	88401213	88401213	T	C	hom		QUAL=28040;DP=322;AF=1.00;MQM=60;TRIO=HOM,322,1.00,HOM,242,1.00,HOM,309,1.00	GALC	missense	GALC:NM_000153.3:missense:MODERATE:exon17/17:c.1921A>G:p.Thr641Ala,GALC:NM_001201401.1:missense:MODERATE:exon16/16:c.1852A>G:p.Thr618Ala,GALC:NM_001201402.1:missense:MODERATE:exon17/17:c.1843A>G:p.Thr615Ala		rs421262	0.9407	0.983	0.9994	0.8722	0.5190	P	T	B	B	606890 [GALC (confirmed) Krabbe disease];	RCV000078197.2 [benign]; 	CM950521 [CLASS=DM? MUT=REF PHEN="Krabbe disease" GENE=GALC]; 		0.9848	0.0152	0	1420	10	2	n/a
chr14	88407734	88407734	G	C	hom		QUAL=8252;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,51,1.00,HOM,78,1.00	GALC	splice_region&intron	GALC:NM_000153.3:splice_region&intron:LOW:exon15/16:c.1834+5C>G:,GALC:NM_001201401.1:splice_region&intron:LOW:exon14/15:c.1765+5C>G:,GALC:NM_001201402.1:splice_region&intron:LOW:exon15/16:c.1756+5C>G:		rs448805	0.9409	0.983	0.9993	0.8706						606890 [GALC (confirmed) Krabbe disease];	RCV000078196.2 [benign]; 			0.9848	0.0152	0	1416	10	n/a	n/a
chr14	88407875	88407875	T	A	hom		QUAL=21027;DP=306;AF=1.00;MQM=60;TRIO=HOM,306,1.00,HOM,134,1.00,HOM,196,0.99	GALC	synonymous	GALC:NM_000153.3:synonymous:LOW:exon15/17:c.1698A>T:p.Val566Val,GALC:NM_001201401.1:synonymous:LOW:exon14/16:c.1629A>T:p.Val543Val,GALC:NM_001201402.1:synonymous:LOW:exon15/17:c.1620A>T:p.Val540Val		rs421466	0.9409	0.983	0.9994	0.8733						606890 [GALC (confirmed) Krabbe disease];	RCV000078195.2 [benign]; 			0.9848	0.0152	0	1410	10	n/a	n/a
chr14	88407888	88407888	A	G	hom		QUAL=16813;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HET,122,0.49,HOM,182,0.99	GALC	missense	GALC:NM_000153.3:missense:MODERATE:exon15/17:c.1685T>C:p.Ile562Thr,GALC:NM_001201401.1:missense:MODERATE:exon14/16:c.1616T>C:p.Ile539Thr,GALC:NM_001201402.1:missense:MODERATE:exon15/17:c.1607T>C:p.Ile536Thr		rs398607	0.4475	0.44	0.4813	0.6142	9.2700	P	D	P,P,P,P	B,B,B,B	606890 [GALC (confirmed) Krabbe disease];	RCV000078194.2 [benign]; 	CM140252 [CLASS=DFP MUT=ALT PHEN="Krabbe disease, late-onset" GENE=GALC]; 	COSM3754140	0.2424	0.4545	0.303	297	700	n/a	n/a
chr14	88411947	88411947	T	C	hom		QUAL=9715;DP=168;AF=1.00;MQM=59;TRIO=HOM,168,1.00,HOM,62,1.00,HOM,84,1.00	GALC	synonymous	GALC:NM_000153.3:synonymous:LOW:exon14/17:c.1620A>G:p.Thr540Thr,GALC:NM_001201401.1:synonymous:LOW:exon13/16:c.1551A>G:p.Thr517Thr,GALC:NM_001201402.1:synonymous:LOW:exon14/17:c.1542A>G:p.Thr514Thr		rs367327	0.9427	0.983	0.9994	0.8771						606890 [GALC (confirmed) Krabbe disease];	RCV000153295.1 [benign]; 			0.9848	0.0152	0	1418	10	n/a	n/a
chr14	88414211	88414211	G	A	hom		QUAL=14807;DP=213;AF=1.00;MQM=60;TRIO=HOM,213,1.00,HET,218,0.51,HET,301,0.51	GALC	synonymous	GALC:NM_000153.3:synonymous:LOW:exon13/17:c.1350C>T:p.Ser450Ser,GALC:NM_001201401.1:synonymous:LOW:exon12/16:c.1281C>T:p.Ser427Ser,GALC:NM_001201402.1:synonymous:LOW:exon13/17:c.1272C>T:p.Ser424Ser		rs398076	0.3666	0.372	0.3998	0.4256						606890 [GALC (confirmed) Krabbe disease];	RCV000078191.2 [benign]; 		COSM3999388	0.1288	0.4697	0.4015	197	676	n/a	n/a
chr14	88417096	88417096	A	-	hom		QUAL=10735;DP=151;AF=0.94;MQM=60;TRIO=HOM,151,0.94,HOM,81,0.93,HOM,151,0.96	GALC	splice_region&intron	GALC:NM_000153.3:splice_region&intron:LOW:exon10/16:c.1162-4delT:,GALC:NM_001201401.1:splice_region&intron:LOW:exon9/15:c.1093-4delT:,GALC:NM_001201402.1:splice_region&intron:LOW:exon10/16:c.1084-4delT:		rs398099546	0.9483	0	0	0						606890 [GALC (confirmed) Krabbe disease];	RCV000078190.2 [benign]; 			0.9848	0.0152	0	1395	42	2	n/a
chr14	89042180	89042180	T	G	hom		QUAL=12877;DP=186;AF=1.00;MQM=59;TRIO=HOM,186,1.00,HET,137,0.42,HOM,145,1.00	ZC3H14	splice_region&intron	ZC3H14:NM_024824.4:splice_region&intron:LOW:exon7/16:c.1023-4T>G:,ZC3H14:NM_001160103.1:splice_region&intron:LOW:exon7/16:c.1023-4T>G:,ZC3H14:NM_001160104.1:splice_region&intron:LOW:exon7/16:c.1023-4T>G:,ZC3H14:NM_207660.3:splice_region&intron:LOW:exon7/13:c.1023-4T>G:,ZC3H14:NM_207661.2:splice_region&intron:LOW:exon7/14:c.921-4T>G:		rs1469602	0.4858	0.618	0.7203	0.3429									COSM3999396	0.4773	0.4167	0.1061	230	173	n/a	n/a
chr14	89078927	89078927	A	G	hom		QUAL=10985;DP=182;AF=1.00;MQM=60;TRIO=HOM,182,1.00,HOM,65,1.00,HOM,73,1.00	ZC3H14	3'UTR	ZC3H14:NM_024824.4:3'UTR:MODIFIER:exon17/17:c.*832A>G:,ZC3H14:NM_001160103.1:3'UTR:MODIFIER:exon17/17:c.*832A>G:,ZC3H14:NM_001160104.1:3'UTR:MODIFIER:exon17/17:c.*832A>G:,ZC3H14:NM_207660.3:3'UTR:MODIFIER:exon14/14:c.*832A>G:,ZC3H14:NM_207661.2:3'UTR:MODIFIER:exon15/15:c.*832A>G:,ZC3H14:NM_207662.3:3'UTR:MODIFIER:exon7/7:c.*832A>G:		rs8008847	0.9103	0	0	0										0.9848	0.0152	0	146	4	n/a	n/a
chr14	89079324	89079324	A	-	het		QUAL=2050;DP=160;AF=0.05;MQM=59;TRIO=HET,160,0.05,HET,69,0.04,WT,92,0.33	ZC3H14	3'UTR	ZC3H14:NM_024824.4:3'UTR:MODIFIER:exon17/17:c.*1243delA:,ZC3H14:NM_001160103.1:3'UTR:MODIFIER:exon17/17:c.*1243delA:,ZC3H14:NM_001160104.1:3'UTR:MODIFIER:exon17/17:c.*1243delA:,ZC3H14:NM_207660.3:3'UTR:MODIFIER:exon14/14:c.*1243delA:,ZC3H14:NM_207661.2:3'UTR:MODIFIER:exon15/15:c.*1243delA:,ZC3H14:NM_207662.3:3'UTR:MODIFIER:exon7/7:c.*1243delA:		rs67812081	0.4209	0	0	0										0.0758	0.25	0.6742	11	34	n/a	n/a
chr14	92347680	92347680	A	G	hom		QUAL=27180;DP=317;AF=1.00;MQM=59;TRIO=HOM,317,1.00,HOM,301,1.00,HET,454,0.51	FBLN5	synonymous	FBLN5:NM_006329.3:synonymous:LOW:exon9/11:c.945T>C:p.Ile315Ile		rs2430347	0.7849	0.761	0.7412	0.7873						604580 [FBLN5 (confirmed) Cutis laxa,autosomal recessive,type IA|Cutis laxa,autosomal dominant 2|Macular degeneration,age-related,3];	RCV000150685.1 [benign]; 			0.5	0.3939	0.1061	243	173	n/a	n/a
chr14	92413987	92413987	G	A	het		QUAL=7607;DP=273;AF=0.53;MQM=60;TRIO=HET,273,0.53,HET,99,0.56,HET,166,0.44	FBLN5	5'UTR	FBLN5:NM_006329.3:5'UTR:MODIFIER:exon1/11:c.-414C>T:		rs7149187	0.2508	0	0	0										0.1439	0.4697	0.3864	22	69	n/a	n/a
chr14	92525145	92525145	A	G	het		QUAL=10617;DP=320;AF=0.49;MQM=60;TRIO=HET,320,0.49,HET,172,0.41,HET,226,0.45	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*5519T>C:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*5519T>C:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*5519T>C:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*5655T>C:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*5655T>C:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*5655T>C:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*5655T>C:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*5519T>C:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*5519T>C:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*5519T>C:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*5655T>C:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*5519T>C:		rs1047795	0.3007	0	0	0										0.0606	0.4091	0.5303	9	59	n/a	n/a
chr14	92525290	92525290	A	-	het		QUAL=574;DP=116;AF=0.16;MQM=60;TRIO=HET,116,0.16,HET,25,0.32,HET,29,0.17	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*5374delT:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*5374delT:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*5374delT:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*5510delT:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*5510delT:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*5510delT:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*5510delT:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*5374delT:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*5374delT:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*5374delT:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*5510delT:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*5374delT:		rs58982263	0	0	0	0										0.0076	0.0758	0.9167	1	12	n/a	n/a
chr14	92525471	92525471	C	T	hom		QUAL=10509;DP=116;AF=1.00;MQM=60;TRIO=HOM,116,1.00,HOM,88,1.00,HOM,117,1.00	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*5193G>A:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*5193G>A:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*5193G>A:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*5329G>A:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*5329G>A:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*5329G>A:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*5329G>A:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*5193G>A:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*5193G>A:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*5193G>A:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*5329G>A:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*5193G>A:		rs8022758	0.7508	0	0	0										0.5	0.4621	0.0379	71	70	n/a	n/a
chr14	92525613	92525613	C	T	het		QUAL=3329;DP=130;AF=0.41;MQM=60;TRIO=HET,130,0.41,HET,38,0.53,HET,54,0.57	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*5051G>A:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*5051G>A:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*5051G>A:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*5187G>A:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*5187G>A:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*5187G>A:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*5187G>A:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*5051G>A:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*5051G>A:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*5051G>A:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*5187G>A:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*5051G>A:		rs10151945	0.4706	0	0	0										0.1515	0.5227	0.3258	21	75	n/a	n/a
chr14	92525998	92525998	-	A	het		QUAL=2500;DP=102;AF=0.46;MQM=59;TRIO=HET,102,0.46,HET,33,0.48,HET,39,0.54	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4665dupT:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4665dupT:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4665dupT:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4801dupT:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4801dupT:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4801dupT:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4801dupT:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4665dupT:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4665dupT:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4665dupT:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4801dupT:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4665dupT:	AluSx1	rs552780970	0.3085	0	0	0										0.0606	0.4091	0.5303	9	59	n/a	n/a
chr14	92526157	92526157	G	A	het		QUAL=3484;DP=159;AF=0.48;MQM=58;TRIO=HET,159,0.48,HET,41,0.49,HET,56,0.38	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4507C>T:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4507C>T:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4507C>T:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4643C>T:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4643C>T:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4643C>T:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4643C>T:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4507C>T:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4507C>T:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4507C>T:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4643C>T:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4507C>T:	AluSx1	rs112733683	0.3143	0	0	0										0.0606	0.4091	0.5303	9	59	n/a	n/a
chr14	92526174	92526177	AAAG	-	het		QUAL=1749;DP=122;AF=0.33;MQM=59;TRIO=HET,122,0.33,HET,33,0.24,HET,48,0.27	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4487_*4490delCTTT:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4487_*4490delCTTT:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4487_*4490delCTTT:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4623_*4626delCTTT:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4623_*4626delCTTT:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4623_*4626delCTTT:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4623_*4626delCTTT:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4487_*4490delCTTT:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4487_*4490delCTTT:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4487_*4490delCTTT:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4623_*4626delCTTT:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4487_*4490delCTTT:	AluSx1	rs367993031	0.3149	0	0	0										0.053	0.3561	0.5909	8	52	n/a	n/a
chr14	92526240	92526240	A	C	het		QUAL=1832;DP=97;AF=0.42;MQM=59;TRIO=HET,97,0.42,HET,23,0.61,HET,34,0.32	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4424T>G:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4424T>G:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4424T>G:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4560T>G:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4560T>G:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4560T>G:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4560T>G:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4424T>G:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4424T>G:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4424T>G:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4560T>G:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4424T>G:		rs67089639	0.3007	0	0	0										0.0455	0.4242	0.5303	7	61	n/a	n/a
chr14	92526429	92526429	T	G	het		QUAL=364;DP=28;AF=0.46;MQM=56;TRIO=HET,28,0.46,HOM,1,1.00,HET,2,0.50	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4235A>C:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4235A>C:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4235A>C:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4371A>C:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4371A>C:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4371A>C:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4371A>C:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4235A>C:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4235A>C:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4235A>C:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4371A>C:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4235A>C:	AluSq2	rs8009456	0.3143	0	0	0										0.0227	0.1364	0.8409	4	20	n/a	n/a
chr14	92526630	92526630	A	G	het		QUAL=52;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,WT,1,0.00,HET,2,0.50	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*4034T>C:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*4034T>C:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*4034T>C:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*4170T>C:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*4170T>C:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*4170T>C:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*4170T>C:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*4034T>C:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*4034T>C:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*4034T>C:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*4170T>C:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*4034T>C:	AluSz	rs8008405	0.3139	0	0	0										0.0303	0.1894	0.7803	5	30	n/a	n/a
chr14	92527145	92527145	T	C	het		QUAL=4977;DP=144;AF=0.52;MQM=58;TRIO=HET,144,0.52,HET,60,0.55,HET,103,0.50	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*3519A>G:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*3519A>G:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*3519A>G:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*3655A>G:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*3655A>G:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*3655A>G:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*3655A>G:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*3519A>G:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*3519A>G:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*3519A>G:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*3655A>G:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*3519A>G:	AluSg4	rs1134378	0.3149	0	0	0										0.0606	0.4091	0.5303	9	59	n/a	n/a
chr14	92527164	92527164	T	C	het		QUAL=5312;DP=175;AF=0.51;MQM=59;TRIO=HET,175,0.51,HET,58,0.50,HET,98,0.52	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*3500A>G:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*3500A>G:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*3500A>G:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*3636A>G:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*3636A>G:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*3636A>G:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*3636A>G:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*3500A>G:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*3500A>G:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*3500A>G:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*3636A>G:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*3500A>G:	AluSg4	rs1134377	0.3141	0	0	0										0.0606	0.4091	0.5303	9	59	n/a	n/a
chr14	92527399	92527399	A	G	het		QUAL=9088;DP=303;AF=0.49;MQM=59;TRIO=HET,303,0.49,HET,84,0.48,HET,168,0.54	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*3265T>C:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*3265T>C:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*3265T>C:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*3401T>C:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*3401T>C:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*3401T>C:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*3401T>C:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*3265T>C:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*3265T>C:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*3265T>C:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*3401T>C:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*3265T>C:		rs1055996	0.2406	0	0	0										0.0606	0.3864	0.553	9	56	n/a	n/a
chr14	92527977	92527977	T	C	het		QUAL=15806;DP=447;AF=0.50;MQM=60;TRIO=HET,447,0.50,HET,236,0.50,HET,261,0.55	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*2687A>G:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*2687A>G:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*2687A>G:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*2823A>G:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*2823A>G:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*2823A>G:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*2823A>G:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*2687A>G:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*2687A>G:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*2687A>G:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*2823A>G:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*2687A>G:		rs11628764	0.1761	0	0	0										0.0303	0.3712	0.5985	6	53	n/a	n/a
chr14	92528429	92528429	C	T	het		QUAL=6550;DP=171;AF=0.46;MQM=59;TRIO=HET,171,0.46,HET,97,0.55,HET,167,0.53	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*2235G>A:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*2235G>A:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*2235G>A:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*2371G>A:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*2371G>A:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*2371G>A:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*2371G>A:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*2235G>A:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*2235G>A:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*2235G>A:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*2371G>A:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*2235G>A:	AluSx1	rs8019545	0.3165	0	0	0										0.0606	0.4091	0.5303	9	59	n/a	n/a
chr14	92530282	92530282	C	A	het		QUAL=10317;DP=295;AF=0.53;MQM=60;TRIO=HET,295,0.53,HET,155,0.50,HET,152,0.51	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*382G>T:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*382G>T:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*382G>T:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*518G>T:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*518G>T:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*518G>T:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*518G>T:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*382G>T:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*382G>T:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*382G>T:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*518G>T:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*382G>T:		rs910369	0.2877	0	0	0										0.0606	0.4091	0.5303	9	59	n/a	n/a
chr14	92530513	92530513	C	T	het		QUAL=5473;DP=226;AF=0.46;MQM=60;TRIO=HET,226,0.46,HET,64,0.53,HET,68,0.54	ATXN3	3'UTR	ATXN3:NM_004993.5:3'UTR:MODIFIER:exon11/11:c.*151G>A:,ATXN3:NM_001127696.1:3'UTR:MODIFIER:exon10/10:c.*151G>A:,ATXN3:NM_001127697.2:3'UTR:MODIFIER:exon9/9:c.*151G>A:,ATXN3:NM_001164774.1:3'UTR:MODIFIER:exon4/4:c.*287G>A:,ATXN3:NM_001164776.1:3'UTR:MODIFIER:exon5/5:c.*287G>A:,ATXN3:NM_001164777.1:3'UTR:MODIFIER:exon4/4:c.*287G>A:,ATXN3:NM_001164778.1:3'UTR:MODIFIER:exon7/7:c.*287G>A:,ATXN3:NM_001164779.1:3'UTR:MODIFIER:exon7/7:c.*151G>A:,ATXN3:NM_001164780.1:3'UTR:MODIFIER:exon8/8:c.*151G>A:,ATXN3:NM_001164781.1:3'UTR:MODIFIER:exon9/9:c.*151G>A:,ATXN3:NM_001164782.1:3'UTR:MODIFIER:exon3/3:c.*287G>A:,ATXN3:NM_030660.4:3'UTR:MODIFIER:exon10/10:c.*151G>A:		rs709930	0.2819	0	0	0										0.0606	0.4091	0.5303	9	59	n/a	n/a
chr14	92548785	92548785	C	T	het		QUAL=11486;DP=218;AF=0.47;MQM=60;TRIO=HET,218,0.47,HET,226,0.58,HET,279,0.48	ATXN3	missense,intron	ATXN3:NM_004993.5:missense:MODERATE:exon8/11:c.634G>A:p.Val212Met,ATXN3:NM_001127696.1:missense:MODERATE:exon7/10:c.589G>A:p.Val197Met,ATXN3:NM_001127697.2:missense:MODERATE:exon6/9:c.481G>A:p.Val161Met,ATXN3:NM_001164779.1:missense:MODERATE:exon4/7:c.271G>A:p.Val91Met,ATXN3:NM_001164780.1:missense:MODERATE:exon5/8:c.97G>A:p.Val33Met,ATXN3:NM_001164781.1:missense:MODERATE:exon6/9:c.424G>A:p.Val142Met,ATXN3:NM_030660.4:missense:MODERATE:exon7/10:c.469G>A:p.Val157Met,ATXN3:NM_001164774.1:intron:MODIFIER:exon2/3:c.190-11388G>A:,ATXN3:NM_001164776.1:intron:MODIFIER:exon3/4:c.235-11388G>A:,ATXN3:NM_001164777.1:intron:MODIFIER:exon2/3:c.70-11388G>A:,ATXN3:NM_001164778.1:intron:MODIFIER:exon5/6:c.387+10811G>A:,ATXN3:NM_001164782.1:intron:MODIFIER:exon1/2:c.25-11388G>A:		rs1048755	0.3251	0.271	0.2427	0.3318	2.2370	P	T	B,B,B,B,B	B,B,B,B,B	607047 [ATXN3 (confirmed) Machado-Joseph disease];	RCV000116481.2 [likely benign]; 		COSM3754169	0.0606	0.4091	0.5303	30	166	n/a	n/a
chr14	92549586	92549586	G	A	het		QUAL=8101;DP=302;AF=0.52;MQM=60;TRIO=HET,302,0.52,HET,103,0.48,HET,145,0.39	ATXN3	synonymous,5'UTR_premature_start_codon_gain,5'UTR,intron	ATXN3:NM_004993.5:synonymous:LOW:exon7/11:c.492C>T:p.Val164Val,ATXN3:NM_001127696.1:synonymous:LOW:exon6/10:c.447C>T:p.Val149Val,ATXN3:NM_001127697.2:synonymous:LOW:exon5/9:c.339C>T:p.Val113Val,ATXN3:NM_001164779.1:synonymous:LOW:exon3/7:c.129C>T:p.Val43Val,ATXN3:NM_001164781.1:synonymous:LOW:exon5/9:c.282C>T:p.Val94Val,ATXN3:NM_030660.4:synonymous:LOW:exon6/10:c.327C>T:p.Val109Val,ATXN3:NM_001164780.1:5'UTR_premature_start_codon_gain:LOW:exon4/8:c.-46C>T:,ATXN3:NM_001164780.1:5'UTR:MODIFIER:exon4/8:c.-46C>T:,ATXN3:NM_001164774.1:intron:MODIFIER:exon2/3:c.190-12189C>T:,ATXN3:NM_001164776.1:intron:MODIFIER:exon3/4:c.235-12189C>T:,ATXN3:NM_001164777.1:intron:MODIFIER:exon2/3:c.70-12189C>T:,ATXN3:NM_001164778.1:intron:MODIFIER:exon5/6:c.387+10010C>T:,ATXN3:NM_001164782.1:intron:MODIFIER:exon1/2:c.25-12189C>T:		rs16999141	0.5667	0.502	0.4766	0.6684						607047 [ATXN3 (confirmed) Machado-Joseph disease];	RCV000116480.2 [likely benign]; 		COSM147835	0.2348	0.5606	0.2045	91	239	n/a	n/a
chr14	93673580	93673580	A	G	het		QUAL=2991;DP=70;AF=0.37;MQM=60;TRIO=HET,70,0.37,WT,121,0.00,HET,166,0.52	UBR7	5'UTR	UBR7:NM_175748.3:5'UTR:MODIFIER:exon1/11:c.-57A>G:		rs2255370	0.3622	0.216	0	0										0.0909	0.4318	0.4773	34	117	n/a	n/a
chr14	93693422	93693422	C	T	het		QUAL=16779;DP=384;AF=0.48;MQM=59;TRIO=HET,384,0.48,HET,281,0.53,HET,381,0.50	UBR7	3'UTR	UBR7:NM_175748.3:3'UTR:MODIFIER:exon11/11:c.*41C>T:		rs2905	0.1945	0.273	0.3333	0.0679										0.1061	0.4091	0.4848	32	128	n/a	n/a
chr14	93693604	93693604	T	G	het		QUAL=18949;DP=355;AF=0.50;MQM=60;TRIO=HET,355,0.50,HET,367,0.45,HET,498,0.48	UBR7	3'UTR	UBR7:NM_175748.3:3'UTR:MODIFIER:exon11/11:c.*223T>G:		rs10144530	0.3878	0.317	0	0										0.2273	0.5152	0.2576	73	137	n/a	n/a
chr14	93693831	93693831	C	T	het		QUAL=14424;DP=346;AF=0.52;MQM=60;TRIO=HET,346,0.52,HET,219,0.52,HET,283,0.53	UBR7	3'UTR	UBR7:NM_175748.3:3'UTR:MODIFIER:exon11/11:c.*450C>T:		rs11621915	0.1939	0.186	0	0										0.1061	0.4091	0.4848	31	118	n/a	n/a
chr14	97321689	97321689	C	T	het		QUAL=10697;DP=187;AF=0.53;MQM=60;TRIO=HET,187,0.53,HET,192,0.56,HET,268,0.51	VRK1	synonymous	VRK1:NM_003384.2:synonymous:LOW:exon8/13:c.705C>T:p.Gly235Gly		rs2230532	0.4167	0.389	0.3514	0.1709	-0.6900	P				602168 [VRK1 (provisional) Pontocerebellar hypoplasia type 1A];	RCV000118848.2 [likely benign]; 			0.1515	0.4621	0.3864	162	496	n/a	n/a
chr14	106321590	106321590	C	A	hom		QUAL=21227;DP=246;AF=1.00;MQM=59;TRIO=HOM,246,1.00,HOM,207,1.00,HOM,264,1.00					rs12365	0.9149	0.97	0.9945	0.7345										1	0	0	437	8	n/a	n/a
chr14	106321913	106321913	G	A	hom		QUAL=22674;DP=287;AF=1.00;MQM=60;TRIO=HOM,287,1.00,HOM,197,0.99,HOM,242,0.99					rs1136534	0.5631	0.525	0.5109	0.6944										0.2727	0.3939	0.3333	99	202	n/a	n/a
chr15	23043896	23043896	G	A	hom		QUAL=22193;DP=372;AF=1.00;MQM=60;TRIO=HOM,372,1.00,HOM,122,1.00,HOM,169,1.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*4933C>T:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*4933C>T:		rs7181789	0.5557	0	0	0										0.2348	0.5606	0.2045	33	83	n/a	n/a
chr15	23046770	23046770	-	AA	het		QUAL=10530;DP=383;AF=0.43;MQM=60;TRIO=HET,383,0.43,HOM,174,0.96,WT,233,0.01	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*2058_*2059insTT:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*2058_*2059insTT:		rs3057642	0.7214	0	0	0										0.5227	0.4015	0.0758	79	59	n/a	n/a
chr15	23046848	23046848	T	C	hom		QUAL=30549;DP=470;AF=1.00;MQM=60;TRIO=HOM,470,1.00,HOM,197,1.00,HOM,238,1.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*1981A>G:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*1981A>G:		rs6606822	1	0	0	0										1	0	0	150	0	n/a	n/a
chr15	23046855	23046855	G	T	hom		QUAL=27051;DP=393;AF=1.00;MQM=60;TRIO=HOM,393,1.00,HOM,182,1.00,HOM,226,1.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*1974C>A:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*1974C>A:		rs6606823	0.9639	0	0	0										0.8409	0.1591	0	125	25	n/a	n/a
chr15	23046902	23046902	T	C	het		QUAL=11782;DP=343;AF=0.50;MQM=60;TRIO=HET,343,0.50,HOM,185,1.00,WT,216,0.01	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*1927A>G:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*1927A>G:		rs17807140	0.2558	0	0	0										0.1136	0.447	0.4394	15	64	n/a	n/a
chr15	23046982	23046982	-	T	het		QUAL=9920;DP=269;AF=0.48;MQM=60;TRIO=HET,269,0.48,HOM,186,0.96,WT,193,0.02	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*1846dupA:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*1846dupA:		rs113532349	0.2722	0	0	0										0.1136	0.447	0.4394	15	64	n/a	n/a
chr15	23047857	23047857	G	A	het		QUAL=9594;DP=244;AF=0.49;MQM=60;TRIO=HET,244,0.49,HOM,178,0.99,WT,244,0.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*972C>T:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*972C>T:	Tigger3a	rs8025849	0.6879	0	0	0										0.5227	0.4015	0.0758	79	59	n/a	n/a
chr15	23048542	23048542	A	G	het		QUAL=13823;DP=339;AF=0.52;MQM=60;TRIO=HET,339,0.52,HOM,248,1.00,WT,309,0.00	NIPA1	3'UTR	NIPA1:NM_144599.4:3'UTR:MODIFIER:exon5/5:c.*287T>C:,NIPA1:NM_001142275.1:3'UTR:MODIFIER:exon5/5:c.*287T>C:		rs3812924	0.1893	0	0	0										0.1136	0.447	0.4394	15	64	n/a	n/a
chr15	23052632	23052632	T	C	het		QUAL=7198;DP=190;AF=0.46;MQM=60;TRIO=HET,190,0.46,HOM,145,0.99,WT,224,0.00	NIPA1	synonymous	NIPA1:NM_144599.4:synonymous:LOW:exon4/5:c.441A>G:p.Thr147Thr,NIPA1:NM_001142275.1:synonymous:LOW:exon4/5:c.216A>G:p.Thr72Thr		rs11263683	0.7041	0.736	0.7352	0.4946						608145 [NIPA1 (confirmed) Spastic paraplegia 6,autosomal dominant];	RCV000117820.2 [likely benign]; 		COSM3999473	0.5606	0.3788	0.0606	397	305	n/a	n/a
chr15	23931507	23931507	G	A	hom		QUAL=8459;DP=166;AF=0.99;MQM=60;TRIO=HOM,166,0.99,HET,85,0.49,HET,126,0.47	NDN	synonymous	NDN:NM_002487.2:synonymous:LOW:exon1/1:c.858C>T:p.Asp286Asp		rs2192206	0.1895	0.215	0.2172	0.045						602117 [NDN (confirmed) Prader-Willi syndrome];			COSM3754246	0.0303	0.2955	0.6742	26	140	n/a	n/a
chr15	25219512	25219512	T	C	hom		QUAL=35143;DP=305;AF=0.99;MQM=60;TRIO=HOM,305,0.99,HOM,340,1.00,HOM,437,1.00	SNRPN,SNURF	5'UTR,3'UTR	SNRPN:NM_003097.3:5'UTR:MODIFIER:exon4/10:c.-89T>C:,SNRPN:NM_022806.2:5'UTR:MODIFIER:exon6/12:c.-89T>C:,SNRPN:NM_022807.2:5'UTR:MODIFIER:exon7/13:c.-89T>C:,SNRPN:NM_022808.2:5'UTR:MODIFIER:exon6/12:c.-89T>C:,SNRPN:NM_022805.2:5'UTR:MODIFIER:exon6/12:c.-89T>C:,SNURF:NM_005678.3:3'UTR:MODIFIER:exon4/10:c.*100T>C:		rs705	0.5218	0	0.4085	0.7421										0.1515	0.447	0.4015	30	76	n/a	n/a
chr15	32460419	32460419	C	T	het		QUAL=1103;DP=4;AF=0.50;MQM=26;TRIO=HET,4,0.50,HET,73,0.27,HET,116,0.23	CHRNA7	synonymous	CHRNA7:NM_001190455.2:synonymous:LOW:exon10/10:c.1356C>T:p.Gly452Gly,CHRNA7:NM_000746.5:synonymous:LOW:exon10/10:c.1269C>T:p.Gly423Gly			0	0.202	0	0						118511 [CHRNA7 (confirmed) Schizophrenia,neurophysiologic defect in];			COSM4148628	0.0379	0.447	0.5152	17	177	n/a	n/a
chr15	32460485	32460485	C	T	het		QUAL=11;DP=10;AF=0.30;MQM=27;TRIO=HET,10,0.30,HET,58,0.12,WT,97,0.00	CHRNA7	synonymous	CHRNA7:NM_001190455.2:synonymous:LOW:exon10/10:c.1422C>T:p.Asn474Asn,CHRNA7:NM_000746.5:synonymous:LOW:exon10/10:c.1335C>T:p.Asn445Asn		rs200301018	0	0.032	0	0						118511 [CHRNA7 (confirmed) Schizophrenia,neurophysiologic defect in];			COSM3815832	0	0.4015	0.5985	1	115	n/a	n/a
chr15	34522679	34522679	C	T	hom		QUAL=12307;DP=155;AF=1.00;MQM=60;TRIO=HOM,155,1.00,HET,132,0.42,HOM,166,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*3403G>A:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*3403G>A:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*3403G>A:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*3403G>A:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*3403G>A:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*3403G>A:		rs4530104	0.5449	0	0	0										0.4015	0.4545	0.1439	57	68	n/a	n/a
chr15	34522985	34522985	C	G	hom		QUAL=21761;DP=251;AF=1.00;MQM=60;TRIO=HOM,251,1.00,HOM,198,1.00,HOM,208,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*3097G>C:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*3097G>C:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*3097G>C:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*3097G>C:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*3097G>C:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*3097G>C:		rs4238571	0.9671	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr15	34524590	34524590	A	G	hom		QUAL=15676;DP=215;AF=1.00;MQM=59;TRIO=HOM,215,1.00,HOM,111,0.99,HOM,152,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*1492T>C:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*1492T>C:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*1492T>C:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*1492T>C:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*1492T>C:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*1492T>C:	AluSz	rs6495640	0.9457	0	0	0										0.9924	0.0076	0	149	1	n/a	n/a
chr15	34524995	34524995	G	T	hom		QUAL=27101;DP=326;AF=1.00;MQM=59;TRIO=HOM,326,1.00,HET,272,0.50,HOM,376,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*1087C>A:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*1087C>A:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*1087C>A:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*1087C>A:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*1087C>A:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*1087C>A:		rs4779660	0.7895	0	0	0										0.7045	0.2803	0.0152	103	44	n/a	n/a
chr15	34525035	34525035	T	C	hom		QUAL=30860;DP=397;AF=1.00;MQM=60;TRIO=HOM,397,1.00,HET,291,0.51,HOM,393,1.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*1047A>G:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*1047A>G:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*1047A>G:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*1047A>G:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*1047A>G:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*1047A>G:		rs4780233	0.5861	0	0	0										0.4015	0.4621	0.1364	57	69	n/a	n/a
chr15	34525258	34525258	A	G	het		QUAL=6776;DP=336;AF=0.47;MQM=60;TRIO=HET,336,0.47,HET,94,0.51,WT,166,0.00	SLC12A6	3'UTR	SLC12A6:NM_133647.1:3'UTR:MODIFIER:exon25/25:c.*824T>C:,SLC12A6:NM_005135.2:3'UTR:MODIFIER:exon25/25:c.*824T>C:,SLC12A6:NM_001042497.1:3'UTR:MODIFIER:exon24/24:c.*824T>C:,SLC12A6:NM_001042494.1:3'UTR:MODIFIER:exon26/26:c.*824T>C:,SLC12A6:NM_001042496.1:3'UTR:MODIFIER:exon26/26:c.*824T>C:,SLC12A6:NM_001042495.1:3'UTR:MODIFIER:exon26/26:c.*824T>C:		rs75307067	0.0421	0	0	0										0	0.197	0.803	0	27	n/a	n/a
chr15	34528948	34528948	G	A	hom		QUAL=29896;DP=346;AF=1.00;MQM=60;TRIO=HOM,346,1.00,HET,303,0.50,HOM,426,1.00	SLC12A6	synonymous	SLC12A6:NM_133647.1:synonymous:LOW:exon22/25:c.3003C>T:p.Leu1001Leu,SLC12A6:NM_005135.2:synonymous:LOW:exon22/25:c.2850C>T:p.Leu950Leu,SLC12A6:NM_001042497.1:synonymous:LOW:exon21/24:c.2958C>T:p.Leu986Leu,SLC12A6:NM_001042494.1:synonymous:LOW:exon23/26:c.2826C>T:p.Leu942Leu,SLC12A6:NM_001042496.1:synonymous:LOW:exon23/26:c.2976C>T:p.Leu992Leu,SLC12A6:NM_001042495.1:synonymous:LOW:exon23/26:c.2826C>T:p.Leu942Leu		rs4577050	0.5721	0.651	0.6783	0.4341						604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy];	RCV000147486.1 [benign]; 		COSM3754265	0.3864	0.4773	0.1364	183	193	n/a	n/a
chr15	34551082	34551082	G	A	het		QUAL=11432;DP=376;AF=0.47;MQM=60;TRIO=HET,376,0.47,HET,344,0.51,WT,422,0.00	SLC12A6	synonymous	SLC12A6:NM_133647.1:synonymous:LOW:exon4/25:c.475C>T:p.Leu159Leu,SLC12A6:NM_005135.2:synonymous:LOW:exon4/25:c.322C>T:p.Leu108Leu,SLC12A6:NM_001042497.1:synonymous:LOW:exon3/24:c.430C>T:p.Leu144Leu,SLC12A6:NM_001042494.1:synonymous:LOW:exon5/26:c.298C>T:p.Leu100Leu,SLC12A6:NM_001042496.1:synonymous:LOW:exon5/26:c.448C>T:p.Leu150Leu,SLC12A6:NM_001042495.1:synonymous:LOW:exon5/26:c.298C>T:p.Leu100Leu		rs7164902	0.2768	0.251	0.2434	0.216						604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy];	RCV000147488.1 [benign]; 		COSM3754272	0.1061	0.3106	0.5833	51	149	n/a	n/a
chr15	34610964	34610964	G	C	het		QUAL=10196;DP=551;AF=0.46;MQM=60;TRIO=HET,551,0.46,HET,182,0.46,WT,239,0.00	SLC12A6	5'UTR,intron	SLC12A6:NM_005135.2:5'UTR:MODIFIER:exon1/25:c.-85C>G:,SLC12A6:NM_133647.1:intron:MODIFIER:exon1/24:c.271+17647C>G:,SLC12A6:NM_001042497.1:intron:MODIFIER:exon1/23:c.271+17647C>G:,SLC12A6:NM_001042494.1:intron:MODIFIER:exon2/25:c.94+17647C>G:,SLC12A6:NM_001042496.1:intron:MODIFIER:exon2/25:c.244+17647C>G:,SLC12A6:NM_001042495.1:intron:MODIFIER:exon2/25:c.94+17647C>G:		rs347867	0.4515	0	0	0						604878 [SLC12A6 (confirmed) Agenesis of the corpus callosum with peripheral neuropathy];				0.1136	0.3333	0.553	19	54	n/a	n/a
chr15	34629024	34629024	C	T	het		QUAL=4896;DP=256;AF=0.48;MQM=60;TRIO=HET,256,0.48,HET,85,0.55,WT,114,0.00	SLC12A6	5'UTR,intron	SLC12A6:NM_133647.1:5'UTR:MODIFIER:exon1/25:c.-143G>A:,SLC12A6:NM_001042497.1:5'UTR:MODIFIER:exon1/24:c.-143G>A:,SLC12A6:NM_001042494.1:intron:MODIFIER:exon1/25:c.-98-222G>A:,SLC12A6:NM_001042496.1:intron:MODIFIER:exon1/25:c.-14-156G>A:,SLC12A6:NM_001042495.1:intron:MODIFIER:exon1/25:c.-98-222G>A:		rs73374490	0.2107	0	0	0										0.0303	0.3485	0.6212	5	57	n/a	n/a
chr15	40710723	40710723	G	A	hom		QUAL=31083;DP=489;AF=1.00;MQM=60;TRIO=HOM,489,1.00,HET,455,0.48,HET,548,0.47	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*261G>A:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*261G>A:		rs2075624	0.3578	0	0	0										0.0379	0.4015	0.5606	6	62	n/a	n/a
chr15	40711270	40711270	C	G	hom		QUAL=9826;DP=144;AF=1.00;MQM=57;TRIO=HOM,144,1.00,HOM,101,0.99,HET,151,0.46	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*808C>G:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*808C>G:	AluSq2	rs2075625	0.5074	0	0	0										0.2273	0.5682	0.2045	68	138	n/a	n/a
chr15	40711933	40711933	G	A	hom		QUAL=2307;DP=54;AF=1.00;MQM=48;TRIO=HOM,54,1.00,HOM,7,1.00,HOM,13,1.00	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*1471G>A:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*1471G>A:	AluSg7	rs4923865	0.5869	0	0	0										0.4621	0.4167	0.1212	74	62	n/a	n/a
chr15	40712039	40712039	C	G	hom		QUAL=1264;DP=38;AF=1.00;MQM=55;TRIO=HOM,38,1.00,HOM,3,1.00,HET,3,0.33	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*1577C>G:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*1577C>G:	AluSg	rs11630850	0.5068	0	0	0										0.1894	0.3788	0.4318	36	57	n/a	n/a
chr15	40712072	40712072	C	T	hom		QUAL=1104;DP=34;AF=0.97;MQM=52;TRIO=HOM,34,0.97,HOM,5,1.00,HET,4,0.75	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*1610C>T:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*1610C>T:	AluSg	rs11630878	0.507	0	0	0										0.2121	0.4394	0.3485	37	64	n/a	n/a
chr15	40712349	40712349	G	-	hom		QUAL=18272;DP=196;AF=1.00;MQM=59;TRIO=HOM,196,1.00,HOM,162,1.00,HET,241,0.99	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*1893delG:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*1893delG:		rs398026948	0.507	0	0	0										0.2197	0.5758	0.2045	57	96	n/a	n/a
chr15	40712737	40712737	T	C	hom		QUAL=20145;DP=188;AF=0.99;MQM=60;TRIO=HOM,188,0.99,HOM,189,1.00,HOM,257,1.00	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*2275T>C:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*2275T>C:		rs11790	0.6112	0	0	0										0.447	0.4545	0.0985	114	117	n/a	n/a
chr15	40713306	40713306	T	C	hom		QUAL=23208;DP=343;AF=0.99;MQM=60;TRIO=HOM,343,0.99,HOM,203,0.99,HET,304,0.56	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*2844T>C:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*2844T>C:		rs7207	0.5072	0	0	0										0.2197	0.5758	0.2045	38	83	n/a	n/a
chr15	40713491	40713491	A	-	hom		QUAL=13423;DP=197;AF=0.98;MQM=60;TRIO=HOM,197,0.98,HOM,151,0.99,HET,202,0.47	IVD	3'UTR	IVD:NM_002225.3:3'UTR:MODIFIER:exon12/12:c.*3036delA:,IVD:NM_001159508.1:3'UTR:MODIFIER:exon11/11:c.*3036delA:		rs5812161	0.5072	0	0	0										0.2197	0.5758	0.2045	37	83	n/a	n/a
chr15	42704105	42704105	C	T	hom		QUAL=35529;DP=357;AF=1.00;MQM=60;TRIO=HOM,357,1.00,HOM,358,1.00,HOM,424,1.00	CAPN3	3'UTR	CAPN3:NM_000070.2:3'UTR:MODIFIER:exon24/24:c.*134C>T:,CAPN3:NM_024344.1:3'UTR:MODIFIER:exon23/23:c.*134C>T:,CAPN3:NM_173087.1:3'UTR:MODIFIER:exon21/21:c.*134C>T:,CAPN3:NM_173088.1:3'UTR:MODIFIER:exon13/13:c.*134C>T:,CAPN3:NM_173089.1:3'UTR:MODIFIER:exon9/9:c.*134C>T:,CAPN3:NM_173090.1:3'UTR:MODIFIER:exon10/10:c.*134C>T:		rs3098423	0.9912	0	0	0						114240 [CAPN3 (confirmed) Muscular dystrophy,limb-girdle,type 2A];				0.9697	0.0227	0.0076	251	4	n/a	n/a
chr15	43212818	43212818	C	G	hom		QUAL=880;DP=4;AF=1.00;MQM=58;TRIO=HOM,4,1.00,HOM,5,1.00,HOM,22,1.00	TTBK2	5'UTR	TTBK2:NM_173500.3:5'UTR:MODIFIER:exon1/15:c.-250G>C:		rs12437637	0.5387	0	0	0										0.4167	0.2273	0.3561	57	32	n/a	n/a
chr15	43236612	43236612	C	T	hom		QUAL=18180;DP=257;AF=1.00;MQM=60;TRIO=HOM,257,1.00,HOM,118,1.00,HOM,170,1.00	UBR1	3'UTR	UBR1:NM_174916.2:3'UTR:MODIFIER:exon47/47:c.*915G>A:		rs7178567	0.8442	0	0	0										0.8258	0.1667	0.0076	126	23	n/a	n/a
chr15	43237203	43237203	T	C	hom		QUAL=11853;DP=200;AF=1.00;MQM=60;TRIO=HOM,200,1.00,HOM,67,1.00,HOM,86,1.00	UBR1	3'UTR	UBR1:NM_174916.2:3'UTR:MODIFIER:exon47/47:c.*324A>G:		rs3803341	0.7869	0	0	0										0.8258	0.1667	0.0076	125	23	n/a	n/a
chr15	43237414	43237414	C	T	het		QUAL=11175;DP=389;AF=0.49;MQM=60;TRIO=HET,389,0.49,HET,293,0.52,WT,380,0.00	UBR1	3'UTR	UBR1:NM_174916.2:3'UTR:MODIFIER:exon47/47:c.*113G>A:		rs62020698	0.0347	0	0	0										0.0076	0.197	0.7955	1	26	n/a	n/a
chr15	44943757	44943757	A	G	het		QUAL=23876;DP=334;AF=0.53;MQM=60;TRIO=HET,334,0.53,HOM,372,1.00,HET,462,0.48	SPG11	missense	SPG11:NM_025137.3:missense:MODERATE:exon6/40:c.1388T>C:p.Phe463Ser,SPG11:NM_001160227.1:missense:MODERATE:exon6/38:c.1388T>C:p.Phe463Ser		rs3759871	0.4748	0.466	0.4557	0.5255	1.2260	P	T	B,B,B,B	B,B,B,B	610844 [SPG11 (confirmed) Spastic paraplegia 11,autosomal recessive];	RCV000034172.2 [benign]; RCV000118403.2 [likely benign]; 		COSM147894	0.2348	0.447	0.3182	170	365	1	n/a
chr15	45385496	45385496	A	T	het		QUAL=10412;DP=324;AF=0.46;MQM=60;TRIO=HET,324,0.46,HOM,185,0.99,WT,299,0.00	DUOX2	3'UTR	DUOX2:NM_014080.4:3'UTR:MODIFIER:exon34/34:c.*852T>A:		rs4775744	0.2302	0	0	0										0.0076	0.1818	0.8106	1	26	n/a	n/a
chr15	45392075	45392075	G	A	hom		QUAL=19473;DP=116;AF=0.99;MQM=60;TRIO=HOM,116,0.99,HET,310,0.51,HOM,355,1.00	DUOX2	missense	DUOX2:NM_014080.4:missense:MODERATE:exon25/34:c.3200C>T:p.Ser1067Leu		rs269868	0.7202	0.864	0.9246	0.2689	7.9340	P	D	B	B	606759 [DUOX2 (confirmed) Thryoid dyshormonogenesis 6];		CM085371 [CLASS=DM? MUT=REF PHEN="Hypothyroidism, transient" GENE=DUOX2]; 	COSM4148787	0.8182	0.1818	0	377	70	2	n/a
chr15	45400358	45400358	C	G	hom		QUAL=15046;DP=134;AF=1.00;MQM=59;TRIO=HOM,134,1.00,HOM,126,1.00,HOM,218,1.00	DUOX2	synonymous	DUOX2:NM_014080.4:synonymous:LOW:exon13/34:c.1461G>C:p.Gly487Gly		rs269860	0.8614	0.941	0.9714	0.6324						606759 [DUOX2 (confirmed) Thryoid dyshormonogenesis 6];			COSM4148789	0.9545	0.0455	0	434	20	n/a	n/a
chr15	45404066	45404066	G	A	hom		QUAL=1639;DP=13;AF=1.00;MQM=60;TRIO=HOM,13,1.00,HET,19,0.53,HOM,33,1.00	DUOX2	missense	DUOX2:NM_014080.4:missense:MODERATE:exon5/34:c.413C>T:p.Pro138Leu		rs2001616	0.76	0.86	0.9031	0.4304	2.4090	P	T	B	B	606759 [DUOX2 (confirmed) Thryoid dyshormonogenesis 6];			COSM4148790	0.7879	0.2121	0	361	85	n/a	n/a
chr15	45408414	45408414	C	G	hom		QUAL=28071;DP=210;AF=1.00;MQM=59;TRIO=HOM,210,1.00,HOM,295,1.00,HOM,394,1.00	DUOXA2	missense	DUOXA2:NM_207581.3:missense:MODERATE:exon3/6:c.298C>G:p.Arg100Gly		rs2576090	0.8584	0.961	0.9994	0.5839	7.3630	P	T	B	B	612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5];				1	0	0	452	1	n/a	n/a
chr15	45408710	45408710	A	G	hom		QUAL=11238;DP=98;AF=1.00;MQM=60;TRIO=HOM,98,1.00,HOM,121,1.00,HOM,148,1.00	DUOXA2	splice_region&intron	DUOXA2:NM_207581.3:splice_region&intron:LOW:exon3/5:c.341-4A>G:		rs2554459	0.9203	0.981	0.9999	0.8						612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5];				0.9924	0.0076	0	451	3	n/a	n/a
chr15	45408933	45408933	T	C	hom		QUAL=10287;DP=99;AF=1.00;MQM=60;TRIO=HOM,99,1.00,HET,120,0.54,HOM,181,1.00	DUOXA2	splice_region&intron	DUOXA2:NM_207581.3:splice_region&intron:LOW:exon4/5:c.554+6T>C:		rs2576092	0.7642	0.871	0.9179	0.4313						612772 [DUOXA2 (provisional) Thyroid dyshormonogenesis 5];				0.803	0.197	0	365	80	n/a	n/a
chr15	48580713	48580713	T	C	hom		QUAL=23392;DP=333;AF=1.00;MQM=60;TRIO=HOM,333,1.00,HOM,149,1.00,HOM,237,1.00	SLC12A1	missense&splice_region	SLC12A1:NM_000338.2:missense&splice_region:MODERATE:exon23/27:c.2873T>C:p.Val958Ala,SLC12A1:NM_001184832.1:missense&splice_region:MODERATE:exon23/27:c.2873T>C:p.Val958Ala		rs1552311	0.9978	0.998	1	0.9924	1.0800	P	T	B,B	B,B	600839 [SLC12A1 (confirmed) Bartter syndrome,type 1];				1	0	0	453	0	n/a	n/a
chr15	48595192	48595192	G	T	hom		QUAL=19584;DP=320;AF=1.00;MQM=60;TRIO=HOM,320,1.00,HET,149,0.52,HOM,192,1.00	SLC12A1	3'UTR	SLC12A1:NM_000338.2:3'UTR:MODIFIER:exon27/27:c.*110G>T:,SLC12A1:NM_001184832.1:3'UTR:MODIFIER:exon27/27:c.*110G>T:		rs8025278	0.7352	0	0	0										0.9015	0.0985	0	136	14	n/a	n/a
chr15	48595366	48595366	A	G	hom		QUAL=18453;DP=274;AF=1.00;MQM=60;TRIO=HOM,274,1.00,HET,142,0.49,HOM,218,1.00	SLC12A1	3'UTR	SLC12A1:NM_000338.2:3'UTR:MODIFIER:exon27/27:c.*284A>G:,SLC12A1:NM_001184832.1:3'UTR:MODIFIER:exon27/27:c.*284A>G:		rs12902028	0.6961	0	0	0										0.9167	0.0833	0	139	11	n/a	n/a
chr15	48596166	48596166	A	T	hom		QUAL=13593;DP=204;AF=1.00;MQM=60;TRIO=HOM,204,1.00,HOM,96,1.00,HOM,126,1.00	SLC12A1	3'UTR	SLC12A1:NM_000338.2:3'UTR:MODIFIER:exon27/27:c.*1084A>T:,SLC12A1:NM_001184832.1:3'UTR:MODIFIER:exon27/27:c.*1084A>T:		rs12438818	0.8207	0	0	0										0.947	0.053	0	143	7	n/a	n/a
chr15	48701029	48701029	C	T	hom		QUAL=26368;DP=392;AF=1.00;MQM=60;TRIO=HOM,392,1.00,HOM,182,0.99,HOM,221,1.00	FBN1	3'UTR	FBN1:NM_000138.4:3'UTR:MODIFIER:exon66/66:c.*2158G>A:		rs11070641	0.7823	0	0	0										0.5909	0.3561	0.053	91	50	n/a	n/a
chr15	48701612	48701612	A	C	hom		QUAL=31681;DP=404;AF=1.00;MQM=60;TRIO=HOM,404,1.00,HOM,254,1.00,HOM,320,1.00	FBN1	3'UTR	FBN1:NM_000138.4:3'UTR:MODIFIER:exon66/66:c.*1575T>G:		rs4775760	0.6569	0	0	0										0.5833	0.3636	0.053	90	51	n/a	n/a
chr15	48702457	48702457	C	A	hom		QUAL=37549;DP=404;AF=1.00;MQM=60;TRIO=HOM,404,1.00,HOM,320,1.00,HOM,405,1.00	FBN1	3'UTR	FBN1:NM_000138.4:3'UTR:MODIFIER:exon66/66:c.*730G>T:		rs13598	0.9193	0	0	0										0.7955	0.2045	0	121	28	n/a	n/a
chr15	48702873	48702873	G	A	hom		QUAL=52281;DP=599;AF=1.00;MQM=60;TRIO=HOM,599,1.00,HOM,433,1.00,HOM,551,1.00	FBN1	3'UTR	FBN1:NM_000138.4:3'UTR:MODIFIER:exon66/66:c.*314C>T:		rs1042078	0.6	0	0	0										0.5	0.4242	0.0758	76	62	n/a	n/a
chr15	48807637	48807637	C	T	hom		QUAL=34046;DP=389;AF=1.00;MQM=59;TRIO=HOM,389,1.00,HOM,295,1.00,HOM,392,1.00	FBN1	missense	FBN1:NM_000138.4:missense:MODERATE:exon12/66:c.1415G>A:p.Cys472Tyr		rs4775765	1	1	0	0	5.9640	P	T	B	B	134797 [FBN1 (confirmed) Marfan syndrome|Ectopia lentis,familial|MASS syndrome|Weill-Marchesani syndrome 2,dominant|Aortic aneurysm,ascending,and dissection|Stiff skin syndrome|Acromicric dysplasia|Geleophysic dysplasia 2];				1	0	0	454	0	n/a	n/a
chr15	48902965	48902965	G	A	het		QUAL=9155;DP=357;AF=0.45;MQM=60;TRIO=HET,357,0.45,WT,187,0.00,HET,237,0.51	FBN1	synonymous	FBN1:NM_000138.4:synonymous:LOW:exon4/66:c.306C>T:p.Cys102Cys		rs25388	0.0008	0.0041	0.007	0.0009						134797 [FBN1 (confirmed) Marfan syndrome|Ectopia lentis,familial|MASS syndrome|Weill-Marchesani syndrome 2,dominant|Aortic aneurysm,ascending,and dissection|Stiff skin syndrome|Acromicric dysplasia|Geleophysic dysplasia 2];	RCV000125026.1 [benign]; RCV000154417.1 [benign]; 			0	0.0076	0.9924	0	3	n/a	n/a
chr15	49044538	49044538	C	G	hom		QUAL=12300;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HET,175,0.51,HET,209,0.57	CEP152	splice_region&intron	CEP152:NM_001194998.1:splice_region&intron:LOW:exon21/26:c.3466+8G>C:,CEP152:NM_014985.3:splice_region&intron:LOW:exon21/25:c.3466+8G>C:		rs2306187	0.3247	0.199	0.1154	0.4885						613529 [CEP152 (provisional) Microcephaly 9,primary,autosomal recessive|Seckel syndrome 5];	RCV000081686.3 [benign]; RCV000124240.1 [benign]; 			0.0076	0.1894	0.803	5	96	n/a	n/a
chr15	49103244	49103244	T	C	hom		QUAL=10005;DP=165;AF=1.00;MQM=60;TRIO=HOM,165,1.00,HET,132,0.50,HET,175,0.47	CEP152	5'UTR	CEP152:NM_001194998.1:5'UTR:MODIFIER:exon1/27:c.-94A>G:,CEP152:NM_014985.3:5'UTR:MODIFIER:exon1/26:c.-94A>G:		rs2304546	0.1971	0	0	0										0	0.1364	0.8636	0	23	n/a	n/a
chr15	51296015	51296015	G	A	het		QUAL=7780;DP=297;AF=0.47;MQM=60;TRIO=HET,297,0.47,WT,117,0.00,HET,184,0.50	AP4E1	3'UTR	AP4E1:NM_007347.4:3'UTR:MODIFIER:exon21/21:c.*1156G>A:,AP4E1:NM_001252127.1:3'UTR:MODIFIER:exon21/21:c.*1156G>A:		rs2619685	0.1566	0	0	0										0.0152	0.2955	0.6894	2	46	n/a	n/a
chr15	52601750	52601750	A	G	hom		QUAL=38652;DP=369;AF=1.00;MQM=59;TRIO=HOM,369,1.00,HOM,394,1.00,HOM,434,1.00	MYO5A	3'UTR	MYO5A:NM_000259.3:3'UTR:MODIFIER:exon41/41:c.*4143T>C:,MYO5A:NM_001142495.1:3'UTR:MODIFIER:exon40/40:c.*4143T>C:		rs2414136	0.977	0	0	0										1	0	0	150	0	n/a	n/a
chr15	52603363	52603363	G	A	hom		QUAL=27322;DP=462;AF=1.00;MQM=60;TRIO=HOM,462,1.00,HET,344,0.48,HET,452,0.47	MYO5A	3'UTR	MYO5A:NM_000259.3:3'UTR:MODIFIER:exon41/41:c.*2530C>T:,MYO5A:NM_001142495.1:3'UTR:MODIFIER:exon40/40:c.*2530C>T:		rs7176482	0.3063	0	0	0										0.3561	0.447	0.197	54	68	n/a	n/a
chr15	52604136	52604136	-	TTTGTCATT	hom		QUAL=6320;DP=126;AF=0.93;MQM=60;TRIO=HOM,126,0.93,HOM,37,0.92,HOM,50,0.98	MYO5A	3'UTR	MYO5A:NM_000259.3:3'UTR:MODIFIER:exon41/41:c.*1756_*1757insAATGACAAA:,MYO5A:NM_001142495.1:3'UTR:MODIFIER:exon40/40:c.*1756_*1757insAATGACAAA:		rs11282676	0.9766	0	0	0										0.9697	0.0152	0.0152	145	2	n/a	n/a
chr15	52667552	52667552	G	A	hom		QUAL=29914;DP=393;AF=1.00;MQM=59;TRIO=HOM,393,1.00,HOM,236,1.00,HOM,282,1.00	MYO5A	synonymous	MYO5A:NM_000259.3:synonymous:LOW:exon20/41:c.2526C>T:p.Ile842Ile,MYO5A:NM_001142495.1:synonymous:LOW:exon20/40:c.2526C>T:p.Ile842Ile		rs2414145	0.8446	0.951	0.9953	0.6175						160777 [MYO5A (confirmed) Griscelli syndrome,type 1];				0.9773	0.0227	0	445	9	n/a	n/a
chr15	52689526	52689526	T	C	hom		QUAL=34485;DP=383;AF=0.99;MQM=60;TRIO=HOM,383,0.99,HOM,286,1.00,HOM,388,1.00	MYO5A	synonymous	MYO5A:NM_000259.3:synonymous:LOW:exon10/41:c.1191A>G:p.Thr397Thr,MYO5A:NM_001142495.1:synonymous:LOW:exon10/40:c.1191A>G:p.Thr397Thr		rs2924130	0.9617	0.989	0.9998	0.8872						160777 [MYO5A (confirmed) Griscelli syndrome,type 1];				0.9924	0.0076	0	453	1	n/a	n/a
chr15	52689631	52689631	T	G	hom		QUAL=21998;DP=167;AF=1.00;MQM=59;TRIO=HOM,167,1.00,HOM,214,1.00,HOM,306,1.00	MYO5A	missense	MYO5A:NM_000259.3:missense:MODERATE:exon10/41:c.1086A>C:p.Glu362Asp,MYO5A:NM_001142495.1:missense:MODERATE:exon10/40:c.1086A>C:p.Glu362Asp		rs1724577	0.8868	0.963	0.9958	0.729	-0.1140	P	T	B,B	B,B	160777 [MYO5A (confirmed) Griscelli syndrome,type 1];			COSM4128297	0.9773	0.0227	0	445	7	n/a	n/a
chr15	55495545	55495545	T	C	het		QUAL=10553;DP=390;AF=0.49;MQM=60;TRIO=HET,390,0.49,WT,192,0.00,HET,245,0.50	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*2160A>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*2160A>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*2160A>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*2160A>G:		rs62020099	0.0036	0	0	0										0	0.0152	0.9848	0	3	n/a	n/a
chr15	55495698	55495698	C	T	het		QUAL=2953;DP=140;AF=0.47;MQM=42;TRIO=HET,140,0.47,HET,68,0.47,WT,128,0.01	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*2007G>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*2007G>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*2007G>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*2007G>A:	AluY	rs6493769	0.2654	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55495774	55495774	A	G	het		QUAL=1332;DP=76;AF=0.36;MQM=46;TRIO=HET,76,0.36,HET,50,0.40,WT,85,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1931T>C:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1931T>C:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1931T>C:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1931T>C:	AluY	rs6493770	0.2652	0	0	0										0.0303	0.2727	0.697	6	42	n/a	n/a
chr15	55495779	55495779	A	T	het		QUAL=175;DP=40;AF=0.10;MQM=51;TRIO=HET,40,0.10,HET,32,0.28,WT,70,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1926T>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1926T>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1926T>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1926T>A:	AluY	rs8028801	0.2656	0	0	0										0.0379	0.0909	0.8712	6	13	n/a	n/a
chr15	55495782	55495782	-	TTA	het		QUAL=175;DP=40;AF=0.10;MQM=51;TRIO=HET,40,0.10,HET,32,0.28,WT,70,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1922_*1923insTAA:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1922_*1923insTAA:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1922_*1923insTAA:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1922_*1923insTAA:	AluY	rs555244731	0	0	0	0										0	0.053	0.947	1	8	n/a	n/a
chr15	55495786	55495786	T	A	het		QUAL=206;DP=60;AF=0.08;MQM=51;TRIO=HET,60,0.08,HET,30,0.33,WT,77,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1919A>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1919A>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1919A>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1919A>T:	AluY		0	0	0	0										0	0.0606	0.9394	0	9	n/a	n/a
chr15	55495790	55495790	T	A	het		QUAL=206;DP=60;AF=0.08;MQM=51;TRIO=HET,60,0.08,HET,30,0.33,WT,77,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1915A>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1915A>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1915A>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1915A>T:	AluY		0	0	0	0										0	0.0606	0.9394	0	9	n/a	n/a
chr15	55495801	55495801	T	A	het		QUAL=2059;DP=87;AF=0.47;MQM=48;TRIO=HET,87,0.47,HET,53,0.60,WT,64,0.02	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1904A>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1904A>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1904A>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1904A>T:	AluY	rs28620827	0	0	0	0										0	0.1288	0.8712	0	18	n/a	n/a
chr15	55495963	55495963	T	C	het		QUAL=6743;DP=282;AF=0.44;MQM=59;TRIO=HET,282,0.44,HET,171,0.49,WT,267,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1742A>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1742A>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1742A>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1742A>G:		rs1061824	0.2652	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55496043	55496043	T	A	het		QUAL=3777;DP=135;AF=0.48;MQM=60;TRIO=HET,135,0.48,HET,122,0.47,WT,173,0.01	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1662A>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1662A>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1662A>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1662A>T:		rs1061823	0.2654	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55496058	55496058	A	C	het		QUAL=3631;DP=141;AF=0.46;MQM=60;TRIO=HET,141,0.46,HET,109,0.47,WT,159,0.01	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1647T>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1647T>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1647T>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1647T>G:		rs1061822	0.2654	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55496111	55496111	T	C	het		QUAL=3626;DP=193;AF=0.41;MQM=60;TRIO=HET,193,0.41,HET,65,0.49,WT,91,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1594A>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1594A>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1594A>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1594A>G:		rs1061821	0.2652	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55496278	55496278	C	T	het		QUAL=4136;DP=200;AF=0.52;MQM=60;TRIO=HET,200,0.52,HET,44,0.50,WT,60,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1427G>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1427G>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1427G>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1427G>A:		rs1061875	0.2652	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55496287	55496287	A	T	het		QUAL=3853;DP=185;AF=0.51;MQM=59;TRIO=HET,185,0.51,HET,46,0.50,WT,58,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*1418T>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*1418T>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*1418T>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*1418T>A:		rs1061874	0.2654	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55496756	55496756	T	C	het		QUAL=7935;DP=336;AF=0.46;MQM=60;TRIO=HET,336,0.46,HET,177,0.46,WT,245,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*949A>G:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*949A>G:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*949A>G:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*949A>G:		rs1061873	0.265	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55496769	55496769	G	T	het		QUAL=7902;DP=333;AF=0.46;MQM=60;TRIO=HET,333,0.46,HET,176,0.47,WT,265,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*936C>A:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*936C>A:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*936C>A:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*936C>A:		rs1061870	0.2652	0	0	0										0.0303	0.2727	0.697	6	43	n/a	n/a
chr15	55496853	55496853	G	A	het		QUAL=5455;DP=261;AF=0.46;MQM=60;TRIO=HET,261,0.46,HET,112,0.47,WT,204,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*852C>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*852C>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*852C>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*852C>T:		rs3179664	0.3267	0	0	0										0.0303	0.2803	0.6894	6	44	n/a	n/a
chr15	55497691	55497691	G	A	het		QUAL=13070;DP=531;AF=0.47;MQM=60;TRIO=HET,531,0.47,HET,355,0.45,WT,399,0.00	RAB27A	3'UTR	RAB27A:NM_004580.4:3'UTR:MODIFIER:exon6/6:c.*14C>T:,RAB27A:NM_183234.2:3'UTR:MODIFIER:exon7/7:c.*14C>T:,RAB27A:NM_183236.2:3'UTR:MODIFIER:exon7/7:c.*14C>T:,RAB27A:NM_183235.2:3'UTR:MODIFIER:exon7/7:c.*14C>T:		rs1050931	0.2648	0.201	0.1858	0.4783									COSN164951	0.0303	0.2727	0.697	7	49	n/a	n/a
chr15	65369395	65369395	C	T	hom		QUAL=294;DP=2;AF=1.00;MQM=60;TRIO=HOM,2,1.00,HOM,11,1.00,WT,14,0.00	KBTBD13	missense	KBTBD13:NM_001101362.2:missense:MODERATE:exon1/1:c.242C>T:p.Ala81Val		rs2919358	0.5218	0.283	0.3457	0.5038	7.2510	P	T	P	P	613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant];	RCV000117309.1 [benign]; 		COSM3749303	0.1742	0.2197	0.6061	73	148	n/a	n/a
chr15	65369531	65369531	G	T	het		QUAL=476;DP=2;AF=0.50;MQM=60;TRIO=HET,2,0.50,HOM,17,1.00,WT,14,0.00	KBTBD13	synonymous	KBTBD13:NM_001101362.2:synonymous:LOW:exon1/1:c.378G>T:p.Ala126Ala		rs2946642	0.5016	0.299	0.3296	0.4707						613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant];	RCV000117310.1 [benign]; 		COSM3754413	0.197	0.303	0.5	73	154	n/a	n/a
chr15	65369951	65369951	A	G	hom		QUAL=3484;DP=18;AF=1.00;MQM=60;TRIO=HOM,18,1.00,HOM,43,1.00,HOM,53,1.00	KBTBD13	synonymous	KBTBD13:NM_001101362.2:synonymous:LOW:exon1/1:c.798A>G:p.Glu266Glu		rs2919359	0.9038	0.86	0.8643	0.9162						613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant];	RCV000117312.1 [benign]; 		COSM3749304	0.7879	0.1591	0.053	346	69	n/a	n/a
chr15	65370353	65370353	T	C	hom		QUAL=16422;DP=101;AF=0.99;MQM=59;TRIO=HOM,101,0.99,HOM,181,1.00,HOM,253,1.00	KBTBD13	synonymous	KBTBD13:NM_001101362.2:synonymous:LOW:exon1/1:c.1200T>C:p.Gly400Gly		rs2919360	0.9894	0.995	0.997	0.9749						613727 [KBTBD13 (provisional) Nemaline myopathy 6,autosomal dominant];	RCV000117308.1 [benign]; 		COSM3754414	0.9773	0.0227	0	441	3	n/a	n/a
chr15	65370652	65370652	T	C	het		QUAL=15397;DP=336;AF=0.51;MQM=59;TRIO=HET,336,0.51,WT,280,0.00,HOM,327,0.98	KBTBD13	3'UTR	KBTBD13:NM_001101362.2:3'UTR:MODIFIER:exon1/1:c.*122T>C:		rs12901617	0.3908	0	0	0										0.25	0.5	0.25	36	77	n/a	n/a
chr15	65370835	65370835	C	T	hom		QUAL=23245;DP=292;AF=1.00;MQM=59;TRIO=HOM,292,1.00,HOM,187,1.00,HOM,260,1.00	KBTBD13	3'UTR	KBTBD13:NM_001101362.2:3'UTR:MODIFIER:exon1/1:c.*305C>T:		rs2946643	0.8894	0	0	0										0.8106	0.1591	0.0303	121	23	n/a	n/a
chr15	65371050	65371050	A	G	het		QUAL=15751;DP=412;AF=0.49;MQM=60;TRIO=HET,412,0.49,WT,156,0.00,HOM,280,1.00	KBTBD13	3'UTR	KBTBD13:NM_001101362.2:3'UTR:MODIFIER:exon1/1:c.*520A>G:		rs12904843	0.3433	0	0	0										0.197	0.553	0.25	29	83	n/a	n/a
chr15	65371427	65371427	A	G	het		QUAL=17104;DP=270;AF=0.51;MQM=60;TRIO=HET,270,0.51,WT,282,0.01,HOM,411,1.00	KBTBD13	3'UTR	KBTBD13:NM_001101362.2:3'UTR:MODIFIER:exon1/1:c.*897A>G:		rs12905499	0.3832	0	0	0										0.2121	0.5379	0.25	31	81	n/a	n/a
chr15	68499321	68499321	T	C	het		QUAL=1500;DP=39;AF=0.49;MQM=60;TRIO=HET,39,0.49,HOM,21,1.00,HET,28,0.39					rs8028241	0.4842	0	0	0										0.2424	0.5758	0.1818	38	83	n/a	n/a
chr15	68499661	68499661	G	A	het		QUAL=384;DP=14;AF=0.50;MQM=60;TRIO=HET,14,0.50,HOM,7,1.00,WT,2,0.00	CLN6	3'UTR	CLN6:NM_017882.2:3'UTR:MODIFIER:exon7/7:c.*817C>T:		rs8142	0.405	0	0	0										0.2348	0.4167	0.3485	37	60	n/a	n/a
chr15	68500317	68500317	-	AC	het		QUAL=6590;DP=65;AF=0.34;MQM=60;TRIO=HET,65,0.34,WT,94,0.93,HET,148,0.51	CLN6	3'UTR	CLN6:NM_017882.2:3'UTR:MODIFIER:exon7/7:c.*155_*156dupGT:	(CA)n		0	0	0	0										0.0379	0.5152	0.447	5	75	n/a	n/a
chr15	68500318	68500321	ACAC	-	het		QUAL=6590;DP=65;AF=0.40;MQM=60;TRIO=HET,65,0.40,HOM,94,0.00,HET,148,0.34	CLN6	3'UTR	CLN6:NM_017882.2:3'UTR:MODIFIER:exon7/7:c.*157_*160delGTGT:	(CA)n	rs147451294	0	0	0	0										0.2273	0.447	0.3258	36	65	n/a	n/a
chr15	72635829	72635829	A	C	hom		QUAL=7981;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HOM,52,1.00,HOM,59,1.00	HEXA	3'UTR	HEXA:NM_000520.4:3'UTR:MODIFIER:exon14/14:c.*589T>G:		rs11629508	0.6933	0	0	0										0.8712	0.1288	0	130	20	n/a	n/a
chr15	72635903	72635903	C	T	hom		QUAL=9469;DP=119;AF=1.00;MQM=60;TRIO=HOM,119,1.00,HOM,84,1.00,HOM,100,1.00	HEXA	3'UTR	HEXA:NM_000520.4:3'UTR:MODIFIER:exon14/14:c.*515G>A:		rs3087652	0.6929	0	0	0										0.8712	0.1288	0	130	20	n/a	n/a
chr15	72637795	72637795	T	C	hom		QUAL=21226;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,205,1.00,HOM,216,1.00	HEXA	synonymous	HEXA:NM_000520.4:synonymous:LOW:exon13/14:c.1518A>G:p.Glu506Glu		rs4777502	0.877	0.964	0.998	0.6185						606869 [HEXA (confirmed) Tay-Sachs disease|GM2-gangliosidosis,several forms|Hex A pseudodeficiency];	RCV000079051.4 [other]; 			1	0	0	1466	14	n/a	n/a
chr15	72638892	72638892	T	C	hom		QUAL=7767;DP=88;AF=1.00;MQM=60;TRIO=HOM,88,1.00,HOM,56,1.00,HOM,92,1.00	HEXA	missense	HEXA:NM_000520.4:missense:MODERATE:exon11/14:c.1306A>G:p.Ile436Val		rs1800431	0.8764	0.964	0.998	0.6198	-0.2020	P	T	B,B	B,B	606869 [HEXA (confirmed) Tay-Sachs disease|GM2-gangliosidosis,several forms|Hex A pseudodeficiency];	RCV000079049.4 [other]; 			1	0	0	1464	14	n/a	n/a
chr15	72668304	72668304	A	G	het		QUAL=5153;DP=121;AF=0.53;MQM=60;TRIO=HET,121,0.53,WT,181,0.01,HET,226,0.47	HEXA	missense	HEXA:NM_000520.4:missense:MODERATE:exon1/14:c.10T>C:p.Ser4Pro		rs146938346	0	0.0001	0.0003	0	-0.1370	N	T	P,P	B,B	606869 [HEXA (confirmed) Tay-Sachs disease|GM2-gangliosidosis,several forms|Hex A pseudodeficiency];		CM045965 [CLASS=DM? MUT=ALT PHEN="Beta-hexosaminidase pseudodeficiency" GENE=HEXA]; 		0	0.0076	0.9924	0	6	n/a	n/a
chr15	72978552	72978552	C	T	het		QUAL=3017;DP=111;AF=0.28;MQM=60;TRIO=HET,111,0.28,HET,80,0.56,HET,80,0.43	BBS4	5'UTR	BBS4:NM_033028.4:5'UTR:MODIFIER:exon1/16:c.-17C>T:,BBS4:NM_001252678.1:5'UTR:MODIFIER:exon1/15:c.-486C>T:		rs56368716	0.0375	0.041	0.0791	0.0148							RCV000020935.2 [benign]; 			0	0.1364	0.8636	2	59	n/a	n/a
chr15	73002035	73002035	G	A	hom		QUAL=24074;DP=292;AF=1.00;MQM=59;TRIO=HOM,292,1.00,HOM,207,1.00,HOM,242,1.00	BBS4	splice_region&intron	BBS4:NM_033028.4:splice_region&intron:LOW:exon2/15:c.77-6G>A:,BBS4:NM_001252678.1:splice_region&intron:LOW:exon1/14:c.-445-6G>A:		rs8033604	0.9421	0.983	0.9997	0.8194						600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4];				1	0	0	449	5	n/a	n/a
chr15	73023937	73023937	T	C	hom		QUAL=40878;DP=369;AF=1.00;MQM=60;TRIO=HOM,369,1.00,HOM,386,1.00,HOM,481,1.00	BBS4	synonymous	BBS4:NM_033028.4:synonymous:LOW:exon12/16:c.906T>C:p.Phe302Phe,BBS4:NM_001252678.1:synonymous:LOW:exon11/15:c.390T>C:p.Phe130Phe		rs12914333	0.9605	0.987	0.9999	0.8703						600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4];	RCV000152839.1 [benign]; 			1	0	0	449	5	n/a	n/a
chr15	73027478	73027478	T	C	hom		QUAL=32404;DP=365;AF=1.00;MQM=60;TRIO=HOM,365,1.00,HET,345,0.53,HOM,426,1.00	BBS4	missense	BBS4:NM_033028.4:missense:MODERATE:exon13/16:c.1061T>C:p.Ile354Thr,BBS4:NM_001252678.1:missense:MODERATE:exon12/15:c.545T>C:p.Ile182Thr		rs2277598	0.4289	0.573	0.6404	0.3221	-0.2460	P	T	B,B,B,B	B,B,B,B	600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4];	RCV000020938.2 [benign]; RCV000132688.1 [likely benign]; RCV000152842.1 [benign]; 	CM1010466 [CLASS=FP MUT=REF PHEN="Altered function" GENE=BBS4]; 	COSM3999596	0.3485	0.4697	0.1818	190	201	n/a	n/a
chr15	74472199	74472199	C	T	hom		QUAL=20875;DP=252;AF=0.99;MQM=60;TRIO=HOM,252,0.99,HOM,232,1.00,HET,328,0.51	STRA6	3'UTR	STRA6:NM_001199042.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_022369.3:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001142618.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001199041.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001142617.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001142619.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:,STRA6:NM_001199040.1:3'UTR:MODIFIER:exon19/19:c.*222G>A:		rs10910	0.5327	0	0	0										0.5985	0.3258	0.0758	82	56	n/a	n/a
chr15	74476340	74476340	G	C	het		QUAL=5838;DP=66;AF=0.52;MQM=60;TRIO=HET,66,0.52,WT,133,0.00,HOM,166,0.99	STRA6	splice_region&intron	STRA6:NM_001199042.1:splice_region&intron:LOW:exon13/18:c.1284-10C>G:,STRA6:NM_022369.3:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:NM_001142618.1:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:NM_001199041.1:splice_region&intron:LOW:exon13/18:c.1212-10C>G:,STRA6:NM_001142617.1:splice_region&intron:LOW:exon13/18:c.1167-10C>G:,STRA6:NM_001142619.1:splice_region&intron:LOW:exon13/18:c.1140-10C>G:,STRA6:NM_001199040.1:splice_region&intron:LOW:exon13/18:c.1278-10C>G:		rs2277608	0.2081	0.195	0.142	0.0962						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];			COSM147951	0.053	0.2348	0.7121	19	120	n/a	n/a
chr15	74487024	74487024	A	G	het		QUAL=20484;DP=374;AF=0.51;MQM=60;TRIO=HET,374,0.51,WT,320,0.00,HOM,448,1.00	STRA6	3'UTR,intron	STRA6:NM_001142620.1:3'UTR:MODIFIER:exon6/6:c.*919T>C:,STRA6:NM_001199042.1:intron:MODIFIER:exon7/18:c.714+619T>C:,STRA6:NM_022369.3:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:NM_001142618.1:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:NM_001199041.1:intron:MODIFIER:exon7/18:c.642+619T>C:,STRA6:NM_001142617.1:intron:MODIFIER:exon7/18:c.597+619T>C:,STRA6:NM_001142619.1:intron:MODIFIER:exon7/18:c.570+619T>C:,STRA6:NM_001199040.1:intron:MODIFIER:exon7/18:c.708+619T>C:	L2a	rs58138979	0.0531	0	0	0						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				0.0227	0.2045	0.7727	3	30	n/a	n/a
chr15	74487036	74487036	T	A	het		QUAL=21218;DP=366;AF=0.51;MQM=60;TRIO=HET,366,0.51,WT,319,0.00,HOM,471,1.00	STRA6	3'UTR,intron	STRA6:NM_001142620.1:3'UTR:MODIFIER:exon6/6:c.*907A>T:,STRA6:NM_001199042.1:intron:MODIFIER:exon7/18:c.714+607A>T:,STRA6:NM_022369.3:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:NM_001142618.1:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:NM_001199041.1:intron:MODIFIER:exon7/18:c.642+607A>T:,STRA6:NM_001142617.1:intron:MODIFIER:exon7/18:c.597+607A>T:,STRA6:NM_001142619.1:intron:MODIFIER:exon7/18:c.570+607A>T:,STRA6:NM_001199040.1:intron:MODIFIER:exon7/18:c.708+607A>T:	L2a	rs351224	0.4922	0	0	0						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				0.2424	0.5227	0.2348	33	78	n/a	n/a
chr15	74495556	74495557	TG	-	het		QUAL=764;DP=50;AF=0.40;MQM=60;TRIO=HET,50,0.40,HOM,10,1.00,WT,11,0.00	STRA6	5'UTR,intron,transcript	STRA6:NM_001142618.1:5'UTR:MODIFIER:exon1/19:c.-229_-228delCA:,STRA6:NM_001199041.1:intron:MODIFIER:exon1/18:c.31-934_31-933delCA:,STRA6:NM_001142617.1:intron:MODIFIER:exon1/18:c.-15-934_-15-933delCA:,STRA6:NM_001142619.1:intron:MODIFIER:exon1/18:c.-15-934_-15-933delCA:,STRA6:NM_001199040.1:intron:MODIFIER:exon1/18:c.97-934_97-933delCA:,STRA6:NM_001142620.1:intron:MODIFIER:exon1/5:c.-15-934_-15-933delCA:,STRA6:NM_001142618.1:transcript:MODIFIER::c.-229_-228delCA:		rs372268345	0.2927	0	0	0						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				0.1136	0.447	0.4394	16	68	n/a	n/a
chr15	74500105	74500105	G	A	het		QUAL=9310;DP=261;AF=0.48;MQM=59;TRIO=HET,261,0.48,HET,360,0.51,WT,420,0.00	STRA6	5'UTR_premature_start_codon_gain,5'UTR,intron	STRA6:NM_001199041.1:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-38C>T:,STRA6:NM_001199041.1:5'UTR:MODIFIER:exon1/19:c.-38C>T:,STRA6:NM_001142617.1:intron:MODIFIER:exon1/18:c.-16+1036C>T:,STRA6:NM_001142619.1:intron:MODIFIER:exon1/18:c.-16+1036C>T:,STRA6:NM_001199040.1:intron:MODIFIER:exon1/18:c.96+1595C>T:,STRA6:NM_001142620.1:intron:MODIFIER:exon1/5:c.-16+1036C>T:		rs12915846	0.1999	0.166	0	0						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				0.0758	0.5	0.4242	11	75	n/a	n/a
chr15	74500238	74500238	C	T	het		QUAL=12637;DP=248;AF=0.50;MQM=59;TRIO=HET,248,0.50,HET,604,0.48,WT,682,0.00	STRA6	5'UTR,intron	STRA6:NM_001199041.1:5'UTR:MODIFIER:exon1/19:c.-171G>A:,STRA6:NM_001142617.1:intron:MODIFIER:exon1/18:c.-16+903G>A:,STRA6:NM_001142619.1:intron:MODIFIER:exon1/18:c.-16+903G>A:,STRA6:NM_001199040.1:intron:MODIFIER:exon1/18:c.96+1462G>A:,STRA6:NM_001142620.1:intron:MODIFIER:exon1/5:c.-16+903G>A:		rs10152959	0.226	0	0	0						610745 [STRA6 (provisional) Microphthalmia,syndromic 9|Microphthalmia,isolated,with coloboma 8];				0.0758	0.5	0.4242	11	75	n/a	n/a
chr15	74658315	74658315	-	A	hom		QUAL=2456;DP=8;AF=1.00;MQM=60;TRIO=HOM,8,1.00,HOM,40,1.00,HOM,44,0.98	CYP11A1	5'UTR,intron	CYP11A1:NM_001099773.1:5'UTR:MODIFIER:exon1/9:c.-465dupT:,CYP11A1:NM_000781.2:intron:MODIFIER:exon1/8:c.269+1342dupT:		rs386383486	0.9998	0	0	0						118485 [CYP11A1 (confirmed) Adrenal insufficiency,congenital,with 46XY sex reversal,partial or complete];				1	0	0	149	0	n/a	n/a
chr15	75185670	75185670	A	G	het		QUAL=6450;DP=103;AF=0.52;MQM=60;TRIO=HET,103,0.52,HOM,158,1.00,WT,185,0.00	MPI	splice_region&intron,intron	MPI:NM_002435.2:splice_region&intron:LOW:exon5/7:c.670+9A>G:,MPI:NM_001289155.1:splice_region&intron:LOW:exon5/6:c.670+9A>G:,MPI:NM_001289156.1:splice_region&intron:LOW:exon4/6:c.520+9A>G:,MPI:NM_001289157.1:intron:MODIFIER:exon4/6:c.487+527A>G:		rs7495739	0.3383	0.436	0.546	0.325						154550 [MPI (confirmed) Congenital disorder of glycosylation,type Ib];	RCV000080014.2 [benign]; 		COSM4128400	0.2197	0.447	0.3333	115	210	n/a	n/a
chr15	75189930	75189930	A	G	het		QUAL=6423;DP=177;AF=0.47;MQM=60;TRIO=HET,177,0.47,HOM,123,0.99,WT,193,0.00	MPI	synonymous,3'UTR	MPI:NM_002435.2:synonymous:LOW:exon8/8:c.1131A>G:p.Val377Val,MPI:NM_001289156.1:synonymous:LOW:exon7/7:c.981A>G:p.Val327Val,MPI:NM_001289157.1:synonymous:LOW:exon7/7:c.948A>G:p.Val316Val,MPI:NM_001289155.1:3'UTR:MODIFIER:exon7/7:c.*58A>G:		rs1130741	0.3387	0.437	0.5464	0.325						154550 [MPI (confirmed) Congenital disorder of glycosylation,type Ib];	RCV000080011.2 [benign]; 			0.2197	0.447	0.3333	115	210	n/a	n/a
chr15	76508684	76508684	T	A	hom		QUAL=14992;DP=221;AF=1.00;MQM=60;TRIO=HOM,221,1.00,HOM,107,1.00,HOM,136,1.00	ETFA	3'UTR	ETFA:NM_000126.3:3'UTR:MODIFIER:exon12/12:c.*216A>T:,ETFA:NM_001127716.1:3'UTR:MODIFIER:exon11/11:c.*216A>T:		rs1803550	0.9742	0	0	0										1	0	0	150	0	n/a	n/a
chr15	76673716	76673716	T	C	het		QUAL=7459;DP=184;AF=0.54;MQM=60;TRIO=HET,184,0.54,HOM,144,0.99,WT,184,0.00	SCAPER	splice_region&intron	SCAPER:NM_020843.2:splice_region&intron:LOW:exon27/30:c.3705+3A>G:,SCAPER:NM_001145923.1:splice_region&intron:LOW:exon28/31:c.2967+3A>G:		rs3765115	0.4157	0.366	0.3125	0.2642										0.1136	0.4318	0.4545	46	126	n/a	n/a
chr15	76726465	76726465	G	T	het		QUAL=6435;DP=223;AF=0.45;MQM=60;TRIO=HET,223,0.45,HOM,112,1.00,WT,200,0.00	SCAPER	missense	SCAPER:NM_020843.2:missense:MODERATE:exon25/31:c.3265C>A:p.Pro1089Thr,SCAPER:NM_001145923.1:missense:MODERATE:exon26/32:c.2527C>A:p.Pro843Thr		rs1607017	0.356	0.35	0.3086	0.1266	0.6870	P	T	B,B	B,B					0.1212	0.4242	0.4545	43	125	n/a	n/a
chr15	77085740	77085740	C	A	hom		QUAL=14684;DP=102;AF=1.00;MQM=60;TRIO=HOM,102,1.00,HOM,173,1.00,HOM,194,1.00	SCAPER	splice_region&intron,intron	SCAPER:NM_001145923.1:splice_region&intron:LOW:exon7/31:c.-125-8G>T:,SCAPER:NM_020843.2:intron:MODIFIER:exon7/30:c.772+1881G>T:	MER21B	rs3102707	0.9673	0	0	0										1	0	0	160	0	n/a	n/a
chr15	77087785	77087785	T	C	het		QUAL=3217;DP=106;AF=0.50;MQM=60;TRIO=HET,106,0.50,HOM,55,1.00,WT,66,0.00	SCAPER	splice_region&intron	SCAPER:NM_020843.2:splice_region&intron:LOW:exon6/30:c.612-4A>G:,SCAPER:NM_001145923.1:splice_region&intron:LOW:exon6/31:c.-286-4A>G:		rs11852395	0.3532	0.334	0.2846	0.1395										0.1136	0.4318	0.4545	38	120	n/a	n/a
chr15	77176158	77176158	T	C	het		QUAL=5020;DP=158;AF=0.39;MQM=60;TRIO=HET,158,0.39,HOM,96,0.99,WT,123,0.00	SCAPER	start_lost	SCAPER:NM_020843.2:start_lost:HIGH:exon1/31:c.1A>G:p.Met1?		rs3812908	0.4177	0.312	0.2864	0.3185	2.6450	P,P	T,T	P,.	P,.					0.1136	0.4167	0.4697	43	129	n/a	n/a
chr15	77176200	77176200	A	T	het		QUAL=5645;DP=200;AF=0.40;MQM=60;TRIO=HET,200,0.40,HOM,99,0.98,WT,132,0.00	SCAPER	5'UTR	SCAPER:NM_020843.2:5'UTR:MODIFIER:exon1/31:c.-42T>A:		rs3812909	0.4169	0.296	0.2849	0.3158	0.4960	P	T							0.1212	0.4091	0.4697	28	89	n/a	n/a
chr15	85326955	85326955	G	A	het		QUAL=6968;DP=219;AF=0.49;MQM=59;TRIO=HET,219,0.49,WT,190,0.00,HET,213,0.52	ZNF592	missense	ZNF592:NM_014630.2:missense:MODERATE:exon4/11:c.1049G>A:p.Arg350His		rs61737677	0.0138	0.0084	0.0083	0.0318	4.6240	N	D	D	D	613624 [ZNF592 (provisional) Spinocerebellar ataxia,autosomal recessive 5];				0	0.0076	0.9924	0	22	n/a	n/a
chr15	85347114	85347114	T	C	hom		QUAL=22881;DP=253;AF=1.00;MQM=60;TRIO=HOM,253,1.00,HOM,187,1.00,HOM,280,1.00	ZNF592	3'UTR	ZNF592:NM_014630.2:3'UTR:MODIFIER:exon11/11:c.*1490T>C:		rs9806315	0.867	0	0	0										0.6061	0.3485	0.0455	92	52	n/a	n/a
chr15	85347673	85347673	T	C	het		QUAL=6132;DP=190;AF=0.47;MQM=60;TRIO=HET,190,0.47,WT,175,0.00,HET,203,0.51	ZNF592	3'UTR	ZNF592:NM_014630.2:3'UTR:MODIFIER:exon11/11:c.*2049T>C:		rs114257982	0.028	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr15	85348172	85348172	G	T	het		QUAL=10998;DP=366;AF=0.50;MQM=60;TRIO=HET,366,0.50,HET,285,0.55,WT,396,0.00	ZNF592	3'UTR	ZNF592:NM_014630.2:3'UTR:MODIFIER:exon11/11:c.*2548G>T:	MIRb	rs1719	0.0585	0	0	0										0.0152	0.1364	0.8485	2	19	n/a	n/a
chr15	85348551	85348551	G	C	het		QUAL=7009;DP=265;AF=0.48;MQM=60;TRIO=HET,265,0.48,WT,106,0.00,HET,157,0.57	ZNF592	3'UTR	ZNF592:NM_014630.2:3'UTR:MODIFIER:exon11/11:c.*2927G>C:		rs117658444	0.0142	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr15	89835937	89835937	A	G	het		QUAL=9155;DP=285;AF=0.54;MQM=60;TRIO=HET,285,0.54,HET,255,0.51,WT,288,0.00	FANCI	missense	FANCI:NM_001113378.1:missense:MODERATE:exon21/38:c.2011A>G:p.Ile671Val,FANCI:NM_018193.2:missense:MODERATE:exon21/37:c.2011A>G:p.Ile671Val		rs139814895	0.0038	0.0039	0.0006	0	1.0600	D	T	B,B,B	B,B,B	611360 [FANCI (provisional) Fanconi anemia,complementation group I];				0	0.0076	0.9924	0	5	n/a	n/a
chr15	89837139	89837139	G	T	het		QUAL=4691;DP=216;AF=0.44;MQM=60;TRIO=HET,216,0.44,HET,117,0.42,WT,153,0.00	FANCI	synonymous	FANCI:NM_001113378.1:synonymous:LOW:exon23/38:c.2367G>T:p.Ala789Ala,FANCI:NM_018193.2:synonymous:LOW:exon23/37:c.2367G>T:p.Ala789Ala		rs11857960	0.0789	0.028	0.0028	0.2448						611360 [FANCI (provisional) Fanconi anemia,complementation group I];				0	0.0076	0.9924	0	10	n/a	n/a
chr15	89838236	89838236	G	A	hom		QUAL=29273;DP=408;AF=1.00;MQM=60;TRIO=HOM,408,1.00,HOM,181,1.00,HOM,291,1.00	FANCI	synonymous,intron	FANCI:NM_001113378.1:synonymous:LOW:exon24/38:c.2547G>A:p.Lys849Lys,FANCI:NM_018193.2:intron:MODIFIER:exon23/36:c.2456+1008G>A:		rs7183618	0.9808	0.958	0.9465	0.9913						611360 [FANCI (provisional) Fanconi anemia,complementation group I];				0.9167	0.0833	0	445	44	n/a	n/a
chr15	89838293	89838293	A	C	het		QUAL=6640;DP=265;AF=0.50;MQM=60;TRIO=HET,265,0.50,HET,151,0.50,WT,247,0.00	FANCI	missense,intron	FANCI:NM_001113378.1:missense:MODERATE:exon24/38:c.2604A>C:p.Glu868Asp,FANCI:NM_018193.2:intron:MODIFIER:exon23/36:c.2456+1065A>C:		rs118031800	0.0038	0.0041	0	0	-0.0490	D	T	B	B	611360 [FANCI (provisional) Fanconi anemia,complementation group I];				0	0.0076	0.9924	0	5	n/a	n/a
chr15	89848645	89848645	-	T	het		QUAL=17162;DP=637;AF=0.49;MQM=60;TRIO=HET,637,0.49,HET,511,0.49,WT,664,0.00	FANCI	splice_region&intron	FANCI:NM_001113378.1:splice_region&intron:LOW:exon30/37:c.3255+5_3255+6insT:,FANCI:NM_018193.2:splice_region&intron:LOW:exon29/36:c.3075+5_3075+6insT:		rs200261324	0.0036	0.0039	0.0004	0						611360 [FANCI (provisional) Fanconi anemia,complementation group I];				0	0.0076	0.9924	0	5	n/a	n/a
chr15	89858602	89858602	T	C	het		QUAL=13021;DP=190;AF=0.44;MQM=60;TRIO=HET,190,0.44,HOM,175,1.00,HET,293,0.55	FANCI	synonymous	FANCI:NM_001113378.1:synonymous:LOW:exon37/38:c.3906T>C:p.Gly1302Gly,FANCI:NM_018193.2:synonymous:LOW:exon36/37:c.3726T>C:p.Gly1242Gly		rs1138465	0.4123	0.412	0.3959	0.4364						611360 [FANCI (provisional) Fanconi anemia,complementation group I];			COSM3754560	0.0833	0.4848	0.4318	79	225	n/a	n/a
chr15	89860350	89860350	A	C	het		QUAL=4202;DP=164;AF=0.53;MQM=60;TRIO=HET,164,0.53,HOM,21,1.00,HET,54,0.39	FANCI,POLG	3'UTR,intron	FANCI:NM_001113378.1:3'UTR:MODIFIER:exon38/38:c.*660A>C:,FANCI:NM_018193.2:3'UTR:MODIFIER:exon37/37:c.*660A>C:,POLG:NM_001126131.1:intron:MODIFIER:exon22/22:c.3643+257T>G:,POLG:NM_002693.2:intron:MODIFIER:exon22/22:c.3643+257T>G:		rs1061316	0.4459	0	0	0						174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive|Progressive external ophthalmoplegia,autosomal dominant|Mitochondrial DNA depletion syndrome 4B (MNGIE type)|Mitochondrial DNA depletion syndrome 4A (Alpers type)|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)];				0.0758	0.4924	0.4318	13	72	n/a	n/a
chr15	89867380	89867380	C	T	het		QUAL=5200;DP=247;AF=0.43;MQM=60;TRIO=HET,247,0.43,HET,157,0.44,WT,234,0.00	POLG	synonymous	POLG:NM_001126131.1:synonymous:LOW:exon11/23:c.2028G>A:p.Ala676Ala,POLG:NM_002693.2:synonymous:LOW:exon11/23:c.2028G>A:p.Ala676Ala		rs373550219	0	0.0004	0.0003	0						174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive|Progressive external ophthalmoplegia,autosomal dominant|Mitochondrial DNA depletion syndrome 4B (MNGIE type)|Mitochondrial DNA depletion syndrome 4A (Alpers type)|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)];	RCV000127516.1 [benign]; 			0	0.0076	0.9924	0	7	n/a	n/a
chr15	89872249	89872249	C	T	het		QUAL=4850;DP=199;AF=0.46;MQM=60;TRIO=HET,199,0.46,HET,137,0.47,WT,160,0.00	POLG	synonymous	POLG:NM_001126131.1:synonymous:LOW:exon4/23:c.948G>A:p.Lys316Lys,POLG:NM_002693.2:synonymous:LOW:exon4/23:c.948G>A:p.Lys316Lys		rs61756401	0.0036	0.0039	0.0006	0						174763 [POLG (provisional) Progressive external ophthalmoplegia,autosomal recessive|Progressive external ophthalmoplegia,autosomal dominant|Mitochondrial DNA depletion syndrome 4B (MNGIE type)|Mitochondrial DNA depletion syndrome 4A (Alpers type)|Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)];	RCV000118023.2 [likely benign]; RCV000127554.2 [other]; 	CM133443 [CLASS=DM? MUT=ALT PHEN="SANDO" GENE=POLG]; 		0	0.0076	0.9924	0	8	2	n/a
chr15	90171306	90171306	A	G	het		QUAL=11830;DP=378;AF=0.50;MQM=59;TRIO=HET,378,0.50,WT,277,0.01,HET,366,0.49	KIF7	3'UTR	KIF7:NM_198525.2:3'UTR:MODIFIER:exon19/19:c.*344T>C:		rs1054435	0.4485	0	0	0										0.2045	0.4545	0.3409	28	70	n/a	n/a
chr15	90172600	90172600	G	A	het		QUAL=1524;DP=55;AF=0.64;MQM=59;TRIO=HET,55,0.64,WT,32,0.00,HET,52,0.46	KIF7	splice_region&intron	KIF7:NM_198525.2:splice_region&intron:LOW:exon17/18:c.3517+6C>T:		rs74251725	0.2752	0.3	0.3338	0.1111						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000117423.2 [likely benign]; 			0.1818	0.4773	0.3409	67	195	n/a	n/a
chr15	90173734	90173734	-	AG	het		QUAL=7123;DP=118;AF=0.24;MQM=60;TRIO=HET,118,0.24,HOM,138,0.94,HET,182,0.48	KIF7	splice_region&intron	KIF7:NM_198525.2:splice_region&intron:LOW:exon15/18:c.3112-11_3112-10insCT:		rs35820949	0.4922	0.45	0.5674	0.5879						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];				0.1364	0.2955	0.5682	54	106	n/a	n/a
chr15	90174789	90174789	C	T	het		QUAL=1348;DP=49;AF=0.31;MQM=60;TRIO=HET,49,0.31,HET,23,0.87,HET,47,0.28	KIF7	synonymous	KIF7:NM_198525.2:synonymous:LOW:exon15/19:c.3048G>A:p.Ser1016Ser		rs9672286	0.4511	0.447	0.5716	0.4923						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000082817.4 [other]; 		COSM3932193	0.197	0.4621	0.3409	120	217	n/a	n/a
chr15	90174824	90174824	C	T	het		QUAL=1656;DP=57;AF=0.42;MQM=60;TRIO=HET,57,0.42,HET,22,0.86,HET,49,0.33	KIF7	missense	KIF7:NM_198525.2:missense:MODERATE:exon15/19:c.3013G>A:p.Gly1005Arg		rs12900805	0.4393	0.406	0.5674	0.4607	1.1430	P	T	B,B	B,B	611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000082815.4 [other]; 			0.197	0.4621	0.3409	121	217	n/a	n/a
chr15	90176073	90176073	C	A	het		QUAL=810;DP=18;AF=0.11;MQM=60;TRIO=HET,18,0.11,HOM,17,1.00,HET,32,0.41	KIF7	missense	KIF7:NM_198525.2:missense:MODERATE:exon14/19:c.2873G>T:p.Ser958Ile		rs3803530	0.4383	0.523	0.5737	0.4661	1.1000	P	T	P,B	B,B	611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000082813.4 [other]; 			0.1894	0.3939	0.4167	119	201	n/a	n/a
chr15	90176432	90176432	T	G	hom		QUAL=10437;DP=86;AF=1.00;MQM=60;TRIO=HOM,86,1.00,HOM,87,1.00,HOM,153,1.00	KIF7	synonymous	KIF7:NM_198525.2:synonymous:LOW:exon13/19:c.2658A>C:p.Ala886Ala		rs3803531	0.7945	0.852	0.9124	0.7885						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000117420.2 [likely benign]; 		COSM147979	0.7424	0.25	0.0076	357	94	n/a	n/a
chr15	90191827	90191827	T	C	hom		QUAL=710;DP=15;AF=1.00;MQM=60;TRIO=HOM,15,1.00,HOM,5,1.00,HOM,6,1.00	KIF7	missense	KIF7:NM_198525.2:missense:MODERATE:exon5/19:c.1102A>G:p.Thr368Ala		rs8037349	0.8614	0.879	0.9045	0.9658	-0.4760	P	T	B	B	611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000082811.4 [other]; 		COSM4128555	0.6818	0.1439	0.1742	348	75	n/a	n/a
chr15	90195967	90195967	C	G	hom		QUAL=26976;DP=219;AF=1.00;MQM=60;TRIO=HOM,219,1.00,HOM,297,0.99,HOM,361,1.00	KIF7	synonymous	KIF7:NM_198525.2:synonymous:LOW:exon2/19:c.195G>C:p.Ala65Ala		rs8179066	0.8602	0.86	0.9079	0.9666						611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000117415.3 [other]; 			0.7576	0.2197	0.0227	360	90	n/a	n/a
chr15	90196008	90196008	C	T	het		QUAL=7220;DP=160;AF=0.54;MQM=59;TRIO=HET,160,0.54,WT,280,0.00,HET,346,0.45	KIF7	missense	KIF7:NM_198525.2:missense:MODERATE:exon2/19:c.154G>A:p.Asp52Asn		rs8179065	0.2424	0.203	0	0	0.7100	P	D	B	B	611254 [KIF7 (provisional) Hydrolethalus syndrome 2|Acrocallosal syndrome|Joubert syndrome 12];	RCV000117413.2 [likely benign]; 		COSM3754564	0.1667	0.3712	0.4621	48	187	n/a	n/a
chr15	91312823	91312823	T	C	hom		QUAL=1957;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HET,10,0.30,HET,8,0.88	BLM	splice_region&intron	BLM:NM_000057.3:splice_region&intron:LOW:exon12/21:c.2555+7T>C:,BLM:NM_001287246.1:splice_region&intron:LOW:exon13/22:c.2555+7T>C:,BLM:NM_001287247.1:splice_region&intron:LOW:exon12/19:c.2555+7T>C:,BLM:NM_001287248.1:splice_region&intron:LOW:exon12/21:c.1430+7T>C:		rs3815003	0.3666	0.286	0.2777	0.5858						604610 [BLM (confirmed) Bloom syndrome];	RCV000078057.4 [other]; 			0.0833	0.2803	0.6364	87	380	n/a	n/a
chr15	91337479	91337479	G	A	het		QUAL=4350;DP=150;AF=0.47;MQM=60;TRIO=HET,150,0.47,WT,110,0.00,HET,128,0.48	BLM	synonymous	BLM:NM_000057.3:synonymous:LOW:exon16/22:c.3102G>A:p.Thr1034Thr,BLM:NM_001287246.1:synonymous:LOW:exon17/23:c.3102G>A:p.Thr1034Thr,BLM:NM_001287247.1:synonymous:LOW:exon16/20:c.3102G>A:p.Thr1034Thr,BLM:NM_001287248.1:synonymous:LOW:exon16/22:c.1977G>A:p.Thr659Thr		rs2227933	0.1512	0.161	0.182	0.1895						604610 [BLM (confirmed) Bloom syndrome];	RCV000078059.4 [other]; RCV000123848.2 [benign]; 			0.0303	0.2803	0.6894	31	311	n/a	n/a
chr15	91346923	91346923	C	A	het		QUAL=8114;DP=260;AF=0.52;MQM=60;TRIO=HET,260,0.52,WT,195,0.00,HET,245,0.50	BLM	synonymous,intron	BLM:NM_000057.3:synonymous:LOW:exon18/22:c.3531C>A:p.Ala1177Ala,BLM:NM_001287246.1:synonymous:LOW:exon19/23:c.3531C>A:p.Ala1177Ala,BLM:NM_001287248.1:synonymous:LOW:exon18/22:c.2406C>A:p.Ala802Ala,BLM:NM_001287247.1:intron:MODIFIER:exon17/19:c.3358+5356C>A:		rs2227934	0.1332	0.155	0.1824	0.1242						604610 [BLM (confirmed) Bloom syndrome];	RCV000078060.4 [other]; 			0.0303	0.2727	0.697	31	309	n/a	n/a
chr15	91354505	91354505	C	T	het		QUAL=9994;DP=254;AF=0.48;MQM=60;TRIO=HET,254,0.48,WT,214,0.00,HET,340,0.56	BLM	synonymous	BLM:NM_000057.3:synonymous:LOW:exon21/22:c.3945C>T:p.Leu1315Leu,BLM:NM_001287246.1:synonymous:LOW:exon22/23:c.3945C>T:p.Leu1315Leu,BLM:NM_001287247.1:synonymous:LOW:exon19/20:c.3552C>T:p.Leu1184Leu,BLM:NM_001287248.1:synonymous:LOW:exon21/22:c.2820C>T:p.Leu940Leu		rs1063147	0.1328	0.156	0.1837	0.1272						604610 [BLM (confirmed) Bloom syndrome];	RCV000078061.4 [other]; 			0.0303	0.2727	0.697	31	309	n/a	n/a
chr15	91354521	91354521	G	A	het		QUAL=11882;DP=276;AF=0.50;MQM=60;TRIO=HET,276,0.50,HOM,233,0.99,WT,354,0.00	BLM	missense	BLM:NM_000057.3:missense:MODERATE:exon21/22:c.3961G>A:p.Val1321Ile,BLM:NM_001287246.1:missense:MODERATE:exon22/23:c.3961G>A:p.Val1321Ile,BLM:NM_001287247.1:missense:MODERATE:exon19/20:c.3568G>A:p.Val1190Ile,BLM:NM_001287248.1:missense:MODERATE:exon21/22:c.2836G>A:p.Val946Ile		rs7167216	0.0671	0.066	0.0664	0.0928	-0.6680	P	T	B,B	B,B	604610 [BLM (confirmed) Bloom syndrome];	RCV000116501.3 [likely benign]; 			0.0152	0.0985	0.8864	8	99	n/a	n/a
chr15	91543761	91543761	C	T	het		QUAL=23179;DP=404;AF=0.48;MQM=60;TRIO=HET,404,0.48,HOM,311,1.00,HET,426,0.50	VPS33B	missense	VPS33B:NM_018668.4:missense:MODERATE:exon20/23:c.1540G>A:p.Gly514Ser,VPS33B:NM_001289148.1:missense:MODERATE:exon19/22:c.1459G>A:p.Gly487Ser,VPS33B:NM_001289149.1:missense:MODERATE:exon19/22:c.1267G>A:p.Gly423Ser		rs11073964	0.7678	0.563	0.3981	0.8803	4.2670	P	T	B,B	B,B	608552 [VPS33B (provisional) Arthrogryposis,renal dysfunction,and cholestasis 1];			COSM3754589	0.1667	0.5379	0.2955	90	223	n/a	n/a
chr15	91548601	91548601	G	A	het		QUAL=20045;DP=286;AF=0.50;MQM=59;TRIO=HET,286,0.50,HOM,294,1.00,HET,380,0.50	VPS33B	splice_region&intron	VPS33B:NM_018668.4:splice_region&intron:LOW:exon14/22:c.1105+9C>T:,VPS33B:NM_001289148.1:splice_region&intron:LOW:exon13/21:c.1024+9C>T:,VPS33B:NM_001289149.1:splice_region&intron:LOW:exon13/21:c.832+9C>T:		rs3826033	0.2081	0.179	0.1272	0.0316						608552 [VPS33B (provisional) Arthrogryposis,renal dysfunction,and cholestasis 1];			COSM3999688	0.0303	0.197	0.7727	8	94	n/a	n/a
chr15	91565804	91565804	A	G	het		QUAL=14846;DP=425;AF=0.51;MQM=59;TRIO=HET,425,0.51,HOM,182,0.99,HET,198,0.48	VPS33B	5'UTR	VPS33B:NM_018668.4:5'UTR:MODIFIER:exon1/23:c.-325T>C:,VPS33B:NM_001289148.1:5'UTR:MODIFIER:exon1/22:c.-325T>C:,VPS33B:NM_001289149.1:5'UTR:MODIFIER:exon1/22:c.-536T>C:		rs11073967	0.7566	0	0	0										0.1515	0.553	0.2955	24	82	n/a	n/a
chr15	97347632	97347632	C	T	het		QUAL=7708;DP=231;AF=0.50;MQM=60;TRIO=HET,231,0.50,HOM,128,0.99,WT,299,0.00					rs12902162	0.2879	0	0	0										0.1439	0.4621	0.3939	20	67	n/a	n/a
chr15	101109677	101109677	C	A	hom		QUAL=10116;DP=143;AF=1.00;MQM=60;TRIO=HOM,143,1.00,HET,131,0.58,HET,179,0.53	LINS	missense	LINS:NM_001040616.2:missense:MODERATE:exon7/7:c.2040G>T:p.Arg680Ser		rs8451	0.3115	0.385	0.4694	0.2826	-0.3100	P	T	B	B	610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM147993	0.2121	0.4318	0.3561	93	232	n/a	n/a
chr15	101109794	101109794	C	G	hom		QUAL=8584;DP=175;AF=1.00;MQM=60;TRIO=HOM,175,1.00,HET,66,0.56,HET,92,0.55	LINS	missense	LINS:NM_001040616.2:missense:MODERATE:exon7/7:c.1923G>C:p.Glu641Asp		rs12157	0.3115	0.385	0.4694	0.2826	0.0660	P	T	B	B	610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM3999451	0.2121	0.4318	0.3561	93	231	n/a	n/a
chr15	101109818	101109818	G	A	hom		QUAL=9213;DP=197;AF=0.99;MQM=60;TRIO=HOM,197,0.99,HET,74,0.53,HET,88,0.53	LINS	synonymous	LINS:NM_001040616.2:synonymous:LOW:exon7/7:c.1899C>T:p.Asp633Asp		rs12460	0.4563	0.505	0.5578	0.3936						610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM4148339	0.3409	0.4091	0.25	157	207	n/a	n/a
chr15	101109893	101109893	C	A	hom		QUAL=9040;DP=190;AF=0.99;MQM=60;TRIO=HOM,190,0.99,HET,113,0.49,HET,107,0.50	LINS	synonymous	LINS:NM_001040616.2:synonymous:LOW:exon7/7:c.1824G>T:p.Gly608Gly		rs6598356	0.3117	0.385	0.4693	0.2828						610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM3999452	0.2121	0.4318	0.3561	93	231	n/a	n/a
chr15	101110265	101110265	T	A	hom		QUAL=15017;DP=332;AF=1.00;MQM=60;TRIO=HOM,332,1.00,HET,112,0.49,HET,141,0.48	LINS	synonymous	LINS:NM_001040616.2:synonymous:LOW:exon7/7:c.1452A>T:p.Thr484Thr		rs2411836	0.3115	0.381	0.4689	0.2819						610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM147994	0.2121	0.4318	0.3561	91	223	n/a	n/a
chr15	101110302	101110302	C	G	hom		QUAL=17967;DP=426;AF=1.00;MQM=59;TRIO=HOM,426,1.00,HET,95,0.52,HET,138,0.53	LINS	missense	LINS:NM_001040616.2:missense:MODERATE:exon7/7:c.1415G>C:p.Ser472Thr		rs2411837	0.2548	0	0.4322	0.1568	-0.1740	P	T	B	B	610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM147995	0.1894	0.4091	0.4015	73	212	n/a	n/a
chr15	101113862	101113862	C	T	hom		QUAL=9799;DP=189;AF=1.00;MQM=60;TRIO=HOM,189,1.00,HOM,62,1.00,HOM,67,1.00	LINS	missense	LINS:NM_001040616.2:missense:MODERATE:exon5/7:c.1216G>A:p.Val406Met		rs12719734	0.8952	0.954	0.9934	0.9548	2.0920	P	T	B,B	B,B	610350 [LINS (provisional) Mental retardation,autosomal recessive 27];				0.9924	0.0076	0	461	5	n/a	n/a
chr15	101113950	101113950	A	G	hom		QUAL=13864;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HET,163,0.44,HET,206,0.50	LINS	synonymous	LINS:NM_001040616.2:synonymous:LOW:exon5/7:c.1128T>C:p.Ser376Ser		rs12592868	0.3275	0.388	0.4698	0.3212						610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM3999453	0.2121	0.4318	0.3561	94	238	n/a	n/a
chr15	101114418	101114418	G	A	hom		QUAL=5379;DP=137;AF=1.00;MQM=60;TRIO=HOM,137,1.00,HET,32,0.59,HET,37,0.54	LINS	synonymous	LINS:NM_001040616.2:synonymous:LOW:exon5/7:c.660C>T:p.Phe220Phe		rs8039437	0.3143	0.384	0.4627	0.2741						610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM3722371	0.2121	0.4318	0.3561	86	214	n/a	n/a
chr15	101120963	101120963	T	C	hom		QUAL=31940;DP=564;AF=1.00;MQM=60;TRIO=HOM,564,1.00,HET,331,0.50,HET,459,0.51	LINS	missense	LINS:NM_001040616.2:missense:MODERATE:exon2/7:c.85A>G:p.Ile29Val		rs11247226	0.2985	0.38	0.4697	0.2288	-2.6700	P	T	B,B	B,B	610350 [LINS (provisional) Mental retardation,autosomal recessive 27];			COSM3936697	0.2121	0.4318	0.3561	91	228	n/a	n/a
chr15	101142449	101142449	G	T	hom		QUAL=7190;DP=98;AF=1.00;MQM=60;TRIO=HOM,98,1.00,HET,129,0.42,HET,186,0.48					rs7166822	0.3448	0	0	0										0.2121	0.4242	0.3636	29	69	n/a	n/a
chr16	1250559	1250559	T	C	hom		QUAL=13089;DP=77;AF=0.97;MQM=59;TRIO=HOM,77,0.97,HET,336,0.45,HET,393,0.49	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon7/35:c.1107T>C:p.Ile369Ile,CACNA1H:NM_001005407.1:synonymous:LOW:exon7/34:c.1107T>C:p.Ile369Ile		rs8044363	0.3327	0.376	0.4269	0.4609						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000152871.1 [benign]; 	CM071580 [CLASS=DP MUT=ALT PHEN="Epilepsy, childhood absence, association with" GENE=CACNA1H]; 	COSM3999711	0.1136	0.4394	0.447	67	197	n/a	n/a
chr16	1252259	1252259	A	G	hom		QUAL=330;DP=2;AF=1.00;MQM=60;TRIO=HOM,2,1.00,HET,10,0.60,HET,9,0.56	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon9/35:c.1809A>G:p.Arg603Arg,CACNA1H:NM_001005407.1:synonymous:LOW:exon9/34:c.1809A>G:p.Arg603Arg		rs9934839	0.3966	0.371	0.5142	0.6149						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000082063.2 [benign]; 	CM071579 [CLASS=DP MUT=REF PHEN="Epilepsy, childhood absence, association with" GENE=CACNA1H]; 	COSM3754629	0.1667	0.2121	0.6212	85	157	n/a	n/a
chr16	1260481	1260481	T	C	het		QUAL=14909;DP=101;AF=0.51;MQM=59;TRIO=HET,101,0.51,HOM,269,1.00,HET,365,0.46	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon19/35:c.3957T>C:p.Asp1319Asp,CACNA1H:NM_001005407.1:synonymous:LOW:exon19/34:c.3957T>C:p.Asp1319Asp		rs8063574	0.9199	0.859	0.8148	0.9103						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000082071.2 [benign]; 		COSM4128660	0.553	0.4091	0.0379	294	147	n/a	n/a
chr16	1261219	1261219	A	G	het		QUAL=16068;DP=83;AF=0.37;MQM=59;TRIO=HET,83,0.37,HOM,295,0.99,HET,390,0.51	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon22/35:c.4275A>G:p.Ser1425Ser,CACNA1H:NM_001005407.1:synonymous:LOW:exon22/34:c.4275A>G:p.Ser1425Ser		rs2753326	0.7097	0.642	0.5985	0.7309						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];			COSM3765851	0.3561	0.5	0.1439	168	215	n/a	n/a
chr16	1261222	1261222	A	G	het		QUAL=16068;DP=83;AF=0.37;MQM=59;TRIO=HET,83,0.37,HOM,295,0.99,HET,390,0.51	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon22/35:c.4278A>G:p.Ser1426Ser,CACNA1H:NM_001005407.1:synonymous:LOW:exon22/34:c.4278A>G:p.Ser1426Ser		rs2753325	0.7097	0.642	0.5988	0.7315						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];			COSM3765853	0.3561	0.5	0.1439	168	215	n/a	n/a
chr16	1261282	1261282	T	C	het		QUAL=16890;DP=68;AF=0.53;MQM=59;TRIO=HET,68,0.53,HOM,314,1.00,HET,381,0.50	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon22/35:c.4338T>C:p.Ile1446Ile,CACNA1H:NM_001005407.1:synonymous:LOW:exon22/34:c.4338T>C:p.Ile1446Ile		rs4984637	0.9177	0.859	0.8167	0.9094						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];			COSM3765856	0.553	0.4091	0.0379	295	146	n/a	n/a
chr16	1268494	1268494	C	T	het		QUAL=22295;DP=174;AF=0.45;MQM=60;TRIO=HET,174,0.45,HOM,421,0.99,HET,504,0.47	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon33/35:c.5730C>T:p.Asp1910Asp,CACNA1H:NM_001005407.1:synonymous:LOW:exon32/34:c.5712C>T:p.Asp1904Asp		rs2745136	0.6991	0.549	0.6192	0.7152						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];			COSM3754639	0.3636	0.5076	0.1288	164	220	n/a	n/a
chr16	1269029	1269029	T	C	het		QUAL=2215;DP=23;AF=0.39;MQM=60;TRIO=HET,23,0.39,HOM,47,0.98,HET,61,0.33	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon34/35:c.5947T>C:p.Leu1983Leu,CACNA1H:NM_001005407.1:synonymous:LOW:exon33/34:c.5929T>C:p.Leu1977Leu		rs2738893	0.6917	0.527	0.6412	0.6996						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];				0.3561	0.5	0.1439	163	218	n/a	n/a
chr16	1270162	1270162	G	A	het		QUAL=4757;DP=41;AF=0.44;MQM=60;TRIO=HET,41,0.44,HOM,84,1.00,HET,129,0.52	CACNA1H	missense	CACNA1H:NM_021098.2:missense:MODERATE:exon35/35:c.6230G>A:p.Arg2077His,CACNA1H:NM_001005407.1:missense:MODERATE:exon34/34:c.6212G>A:p.Arg2071His		rs1054645	0.7007	0.628	0.608	0.7275	-0.6630	P	T	B,B	B,B	607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000082076.2 [benign]; 		COSM434645	0.3561	0.5	0.1439	167	216	n/a	n/a
chr16	1270349	1270349	T	C	het		QUAL=2551;DP=53;AF=0.38;MQM=60;TRIO=HET,53,0.38,HOM,40,1.00,HET,51,0.53	CACNA1H	synonymous	CACNA1H:NM_021098.2:synonymous:LOW:exon35/35:c.6417T>C:p.Asp2139Asp,CACNA1H:NM_001005407.1:synonymous:LOW:exon34/34:c.6399T>C:p.Asp2133Asp		rs4247094	0.9139	0.851	0.8332	0.9176						607904 [CACNA1H (provisional) Epilepsy,idiopathic generalized,susceptibility to,6|Epilepsy,childhood absence,susceptibility to,6];	RCV000082078.2 [benign]; 		COSM3749328	0.553	0.4015	0.0455	255	116	n/a	n/a
chr16	1271189	1271189	G	A	het		QUAL=11595;DP=111;AF=0.49;MQM=59;TRIO=HET,111,0.49,HOM,196,0.99,HET,254,0.53	CACNA1H	3'UTR	CACNA1H:NM_021098.2:3'UTR:MODIFIER:exon35/35:c.*195G>A:,CACNA1H:NM_001005407.1:3'UTR:MODIFIER:exon34/34:c.*195G>A:		rs2248457	0.6933	0	0	0										0.3636	0.5076	0.1288	51	79	n/a	n/a
chr16	1495243	1495243	T	G	hom		QUAL=3398;DP=49;AF=1.00;MQM=60;TRIO=HOM,49,1.00,HET,35,0.54,HOM,42,1.00	CLCN7	3'UTR	CLCN7:NM_001287.5:3'UTR:MODIFIER:exon25/25:c.*1389A>C:,CLCN7:NM_001114331.2:3'UTR:MODIFIER:exon24/24:c.*1389A>C:		rs710900	0.9189	0	0	0										0.8712	0.1212	0.0076	128	21	n/a	n/a
chr16	1495745	1495745	G	A	hom		QUAL=1778;DP=19;AF=0.95;MQM=60;TRIO=HOM,19,0.95,HET,14,0.64,HOM,37,1.00	CLCN7	3'UTR	CLCN7:NM_001287.5:3'UTR:MODIFIER:exon25/25:c.*887C>T:,CLCN7:NM_001114331.2:3'UTR:MODIFIER:exon24/24:c.*887C>T:		rs6600146	0.9066	0	0	0										0.6667	0.303	0.0303	101	41	n/a	n/a
chr16	1495746	1495746	G	A	hom		QUAL=1778;DP=19;AF=0.95;MQM=60;TRIO=HOM,19,0.95,HET,14,0.64,HOM,37,1.00	CLCN7	3'UTR	CLCN7:NM_001287.5:3'UTR:MODIFIER:exon25/25:c.*886C>T:,CLCN7:NM_001114331.2:3'UTR:MODIFIER:exon24/24:c.*886C>T:		rs1050834	0.9066	0	0	0										0.6667	0.303	0.0303	101	42	n/a	n/a
chr16	1503879	1503879	T	A	het		QUAL=10494;DP=215;AF=0.49;MQM=60;TRIO=HET,215,0.49,HET,185,0.56,HET,250,0.51	CLCN7	synonymous	CLCN7:NM_001287.5:synonymous:LOW:exon14/25:c.1170A>T:p.Ala390Ala,CLCN7:NM_001114331.2:synonymous:LOW:exon13/24:c.1098A>T:p.Ala366Ala		rs2235579	0.5559	0.532	0.5014	0.5248						602727 [CLCN7 (confirmed) Osteopetrosis,autosomal recessive 4|Osteopetrosis,autosomal dominant 2];			COSM3754669	0.2727	0.4848	0.2424	126	224	n/a	n/a
chr16	2150466	2150466	T	A	het		QUAL=5490;DP=144;AF=0.45;MQM=49;TRIO=HET,144,0.45,HET,262,0.44,WT,342,0.00	PKD1	missense	PKD1:NM_001009944.2:missense:MODERATE:exon27/46:c.9499A>T:p.Ile3167Phe,PKD1:NM_000296.3:missense:MODERATE:exon27/46:c.9499A>T:p.Ile3167Phe		rs139945204	0.0002	0.0011	0.001	0	1.3330	D	D	D,D	P,D	601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];		CM022663 [CLASS=DM MUT=ALT PHEN="Polycystic kidney disease 1" GENE=PKD1]; 	COSM3754779	0	0.0076	0.9924	0	1	n/a	n/a
chr16	2160494	2160494	C	T	het		QUAL=5524;DP=239;AF=0.46;MQM=59;TRIO=HET,239,0.46,HET,119,0.61,WT,151,0.01	PKD1	synonymous	PKD1:NM_001009944.2:synonymous:LOW:exon15/46:c.4674G>A:p.Thr1558Thr,PKD1:NM_000296.3:synonymous:LOW:exon15/46:c.4674G>A:p.Thr1558Thr		rs79884128	0.0711	0.075	0.0751	0.013						601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];			COSM3754780	0.0076	0.1061	0.8864	1	57	n/a	n/a
chr16	2164808	2164808	C	T	het		QUAL=4397;DP=4;AF=0.50;MQM=31;TRIO=HET,4,0.50,HOM,88,1.00,HET,148,0.40	PKD1	missense	PKD1:NM_001009944.2:missense:MODERATE:exon11/46:c.2216G>A:p.Arg739Gln,PKD1:NM_000296.3:missense:MODERATE:exon11/46:c.2216G>A:p.Arg739Gln		rs40433	0.9792	0.79	0	0	0.0910	P	T	B,B	B,B	601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];			COSM4128808	0.7955	0.1515	0.053	249	37	n/a	n/a
chr16	2167874	2167874	G	A	hom		QUAL=7594;DP=64;AF=0.98;MQM=30;TRIO=HOM,64,0.98,HOM,117,1.00,HET,122,0.56	PKD1	synonymous	PKD1:NM_001009944.2:synonymous:LOW:exon5/46:c.1119C>T:p.Leu373Leu,PKD1:NM_000296.3:synonymous:LOW:exon5/46:c.1119C>T:p.Leu373Leu		rs199685642	0.9443	0.844	0	0						601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];			COSM4128810	0.6288	0.3333	0.0379	177	112	n/a	n/a
chr16	2167970	2167970	G	A	het		QUAL=1221;DP=14;AF=0.36;MQM=30;TRIO=HET,14,0.36,WT,88,0.00,HET,83,0.48	PKD1	synonymous	PKD1:NM_001009944.2:synonymous:LOW:exon5/46:c.1023C>T:p.Ala341Ala,PKD1:NM_000296.3:synonymous:LOW:exon5/46:c.1023C>T:p.Ala341Ala		rs11643513	0.026	0.014	0	0						601313 [PKD1 (confirmed) Polycystic kidney disease,adult type I];				0	0.0682	0.9318	1	29	n/a	n/a
chr16	2331430	2331430	A	G	hom		QUAL=25604;DP=276;AF=1.00;MQM=59;TRIO=HOM,276,1.00,HOM,227,1.00,HOM,304,1.00	ABCA3	synonymous	ABCA3:NM_001089.2:synonymous:LOW:exon27/33:c.4116T>C:p.Ser1372Ser		rs149532	0.901	0.919	0.9152	0.7798						601615 [ABCA3 (provisional) Surfactant metabolism dysfunction,pulmonary,3];	RCV000150112.1 [benign]; 		COSM4128822	0.8636	0.1288	0.0076	375	73	n/a	n/a
chr16	2348528	2348528	G	C	het		QUAL=3254;DP=119;AF=0.43;MQM=60;TRIO=HET,119,0.43,HET,136,0.43,WT,203,0.00	ABCA3	synonymous	ABCA3:NM_001089.2:synonymous:LOW:exon15/33:c.1755C>G:p.Pro585Pro		rs323043	0.0817	0.143	0.1979	0.0748						601615 [ABCA3 (provisional) Surfactant metabolism dysfunction,pulmonary,3];	RCV000155454.1 [benign]; 		COSM3754801	0.0152	0.2348	0.75	17	118	n/a	n/a
chr16	2551147	2551147	C	T	het		QUAL=5209;DP=167;AF=0.47;MQM=59;TRIO=HET,167,0.47,HET,194,0.47,WT,222,0.00	TBC1D24	3'UTR	TBC1D24:NM_001199107.1:3'UTR:MODIFIER:exon8/8:c.*188C>T:,TBC1D24:NM_020705.2:3'UTR:MODIFIER:exon7/7:c.*188C>T:		rs62040717	0.0284	0	0	0						613577 [TBC1D24 (provisional) Myoclonic epilepsy,infantile,familial|Epileptic encephalopathy,early infantile,16|DOOR syndrome|Deafness,autosomal recessive 86];				0.0076	0.2197	0.7727	1	32	n/a	n/a
chr16	3292398	3292398	A	G	het		QUAL=300;DP=18;AF=0.56;MQM=43;TRIO=HET,18,0.56,HOM,3,1.00,WT,4,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*743T>C:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*1293T>C:	AluSx	rs170387	0.6943	0	0	0										0.25	0.3106	0.4394	36	48	n/a	n/a
chr16	3292666	3292666	T	C	het		QUAL=7178;DP=140;AF=0.39;MQM=55;TRIO=HET,140,0.39,HOM,189,0.99,WT,235,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*475A>G:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*1025A>G:	AluSx	rs11466052	0.6514	0	0	0										0.2424	0.5152	0.2424	37	77	n/a	n/a
chr16	3292667	3292667	G	C	het		QUAL=7178;DP=140;AF=0.39;MQM=55;TRIO=HET,140,0.39,HOM,189,0.99,WT,235,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*474C>G:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*1024C>G:	AluSx	rs11466051	0.6512	0	0	0										0.2424	0.5152	0.2424	37	77	n/a	n/a
chr16	3292673	3292675	AAA	-	het		QUAL=4260;DP=66;AF=0.17;MQM=57;TRIO=HET,66,0.17,HOM,119,0.02,WT,139,0.27	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*466_*468delTTT:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*1016_*1018delTTT:	AluSx	rs61379197	0.6571	0	0	0										0.3864	0.3182	0.2955	60	47	n/a	n/a
chr16	3292874	3292874	C	T	het		QUAL=15464;DP=223;AF=0.56;MQM=60;TRIO=HET,223,0.56,HOM,365,1.00,WT,426,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*267G>A:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*817G>A:		rs2741918	0.6462	0	0	0										0.2348	0.5227	0.2424	35	79	n/a	n/a
chr16	3292896	3292896	C	T	het		QUAL=16981;DP=294;AF=0.55;MQM=60;TRIO=HET,294,0.55,HOM,370,1.00,WT,399,0.00	MEFV	3'UTR	MEFV:NM_000243.2:3'UTR:MODIFIER:exon10/10:c.*245G>A:,MEFV:NM_001198536.1:3'UTR:MODIFIER:exon9/9:c.*795G>A:		rs2741919	0.6398	0	0	0										0.2348	0.5227	0.2424	35	79	n/a	n/a
chr16	3293888	3293888	C	T	het		QUAL=17016;DP=290;AF=0.51;MQM=60;TRIO=HET,290,0.51,WT,326,0.00,HOM,379,1.00	MEFV	missense,synonymous	MEFV:NM_001198536.1:missense:MODERATE:exon8/9:c.1306G>A:p.Gly436Arg,MEFV:NM_000243.2:synonymous:LOW:exon9/10:c.1764G>A:p.Pro588Pro		rs1231122	0.3536	0.394	0.4655	0.3416	0.1690	P	T			608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000126738.1,RCV000030177.1 [benign,benign]; 		COSM3754867	0.2424	0.5227	0.2348	101	230	n/a	n/a
chr16	3293922	3293922	A	T	het		QUAL=18740;DP=295;AF=0.54;MQM=60;TRIO=HET,295,0.54,WT,361,0.00,HOM,432,1.00	MEFV	missense,intron	MEFV:NM_001198536.1:missense:MODERATE:exon8/9:c.1272T>A:p.Asp424Glu,MEFV:NM_000243.2:intron:MODIFIER:exon8/9:c.1760-30T>A:		rs1231123	0.3113	0.376	0.4598	0.2997	-0.0680	P				608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];				0.2273	0.5379	0.2348	99	229	n/a	n/a
chr16	3297073	3297073	A	G	het		QUAL=12019;DP=141;AF=0.48;MQM=60;TRIO=HET,141,0.48,HOM,320,1.00,WT,361,0.00	MEFV	synonymous	MEFV:NM_000243.2:synonymous:LOW:exon5/10:c.1530T>C:p.Asp510Asp,MEFV:NM_001198536.1:synonymous:LOW:exon4/9:c.897T>C:p.Asp299Asp		rs224206	0.6631	0.61	0.5345	0.6814						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030175.1 [benign]; 			0.2348	0.5227	0.2424	123	229	n/a	n/a
chr16	3297175	3297175	T	C	het		QUAL=14004;DP=269;AF=0.52;MQM=60;TRIO=HET,269,0.52,HOM,312,1.00,WT,371,0.01	MEFV	synonymous	MEFV:NM_000243.2:synonymous:LOW:exon5/10:c.1428A>G:p.Gln476Gln,MEFV:NM_001198536.1:synonymous:LOW:exon4/9:c.795A>G:p.Gln265Gln		rs224207	0.6506	0.606	0.5323	0.6395						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];				0.2348	0.5227	0.2424	123	229	n/a	n/a
chr16	3297181	3297181	C	T	het		QUAL=12700;DP=239;AF=0.49;MQM=59;TRIO=HET,239,0.49,HOM,301,1.00,WT,357,0.01	MEFV	synonymous	MEFV:NM_000243.2:synonymous:LOW:exon5/10:c.1422G>A:p.Glu474Glu,MEFV:NM_001198536.1:synonymous:LOW:exon4/9:c.789G>A:p.Glu263Glu		rs224208	0.639	0.603	0.5326	0.6331						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030172.1 [benign]; 			0.2348	0.5227	0.2424	123	228	n/a	n/a
chr16	3299749	3299749	G	A	het		QUAL=2663;DP=81;AF=0.53;MQM=60;TRIO=HET,81,0.53,HOM,56,0.98,WT,58,0.00	MEFV	synonymous	MEFV:NM_000243.2:synonymous:LOW:exon3/10:c.942C>T:p.Arg314Arg,MEFV:NM_001198536.1:synonymous:LOW:exon2/9:c.309C>T:p.Arg103Arg		rs224213	0.6907	0.625	0.5394	0.7057						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030188.1 [benign]; 		COSM3754868	0.25	0.5152	0.2348	130	225	n/a	n/a
chr16	3304573	3304573	G	T	hom		QUAL=2510;DP=50;AF=0.98;MQM=60;TRIO=HOM,50,0.98,HOM,20,1.00,HET,35,0.57	MEFV	synonymous,intron	MEFV:NM_000243.2:synonymous:LOW:exon2/10:c.495C>A:p.Ala165Ala,MEFV:NM_001198536.1:intron:MODIFIER:exon1/8:c.277+1738C>A:		rs224223	0.3864	0.39	0.4546	0.4912						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030184.1 [benign]; 		COSM1128970	0.2803	0.4318	0.2879	102	193	n/a	n/a
chr16	3304654	3304654	T	C	hom		QUAL=1001;DP=6;AF=1.00;MQM=59;TRIO=HOM,6,1.00,HOM,10,1.00,HET,31,0.68	MEFV	synonymous,intron	MEFV:NM_000243.2:synonymous:LOW:exon2/10:c.414A>G:p.Gly138Gly,MEFV:NM_001198536.1:intron:MODIFIER:exon1/8:c.277+1657A>G:		rs224224	0.3866	0.426	0.4536	0.4914						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030183.1 [benign]; RCV000126740.1 [benign]; 		COSM3754870	0.2727	0.3485	0.3788	98	175	n/a	n/a
chr16	3304762	3304762	A	G	hom		QUAL=955;DP=22;AF=1.00;MQM=60;TRIO=HOM,22,1.00,HOM,3,1.00,HET,10,0.90	MEFV	synonymous,intron	MEFV:NM_000243.2:synonymous:LOW:exon2/10:c.306T>C:p.Asp102Asp,MEFV:NM_001198536.1:intron:MODIFIER:exon1/8:c.277+1549T>C:		rs224225	0.3894	0.434	0.464	0.5005						608107 [MEFV (confirmed) Familial Mediterranean fever,AR|Familial Mediterranean fever,AD];	RCV000030182.1 [benign]; 		COSM435205	0.2879	0.4015	0.3106	103	175	n/a	n/a
chr16	3775717	3775717	C	T	hom		QUAL=17800;DP=265;AF=1.00;MQM=60;TRIO=HOM,265,1.00,HOM,116,1.00,HOM,161,1.00	CREBBP	3'UTR	CREBBP:NM_004380.2:3'UTR:MODIFIER:exon31/31:c.*2002G>A:,CREBBP:NM_001079846.1:3'UTR:MODIFIER:exon30/30:c.*2002G>A:		rs1635400	0.9808	0	0	0										1	0	0	150	0	n/a	n/a
chr16	3776414	3776426	CGCCCACCTCAGT	-	het		QUAL=8823;DP=71;AF=0.48;MQM=59;TRIO=HET,71,0.48,HET,151,0.76,HET,247,0.79	CREBBP	3'UTR	CREBBP:NM_004380.2:3'UTR:MODIFIER:exon31/31:c.*1293_*1305delACTGAGGTGGGCG:,CREBBP:NM_001079846.1:3'UTR:MODIFIER:exon30/30:c.*1293_*1305delACTGAGGTGGGCG:		rs397702757	0.979	0	0	0										0.7652	0.2197	0.0152	115	31	n/a	n/a
chr16	5132636	5132636	C	T	hom		QUAL=17601;DP=179;AF=1.00;MQM=57;TRIO=HOM,179,1.00,HET,345,0.54,HET,410,0.47	ALG1	synonymous	ALG1:NM_019109.4:synonymous:LOW:exon11/13:c.1149C>T:p.Phe383Phe		rs1047732	0.5198	0.524	0.5035	0.4042						605907 [ALG1 (provisional) Congenital disorder of glycosylation,type Ik];	RCV000081982.2 [benign]; 		COSM3754927	0.3333	0.5076	0.1591	110	173	n/a	n/a
chr16	5135380	5135380	A	G	hom		QUAL=17782;DP=313;AF=0.99;MQM=47;TRIO=HOM,313,0.99,HET,192,0.58,HET,258,0.47	ALG1,FAM86A	3'UTR	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*498A>G:,FAM86A:NM_201400.3:3'UTR:MODIFIER:exon8/8:c.*253T>C:,FAM86A:NM_001289029.1:3'UTR:MODIFIER:exon6/6:c.*253T>C:,FAM86A:NM_201598.3:3'UTR:MODIFIER:exon7/7:c.*253T>C:		rs6775	0.5595	0	0	0										0.25	0.553	0.197	39	84	n/a	n/a
chr16	5135947	5135947	C	G	hom		QUAL=12443;DP=175;AF=0.99;MQM=56;TRIO=HOM,175,0.99,HET,166,0.57,HET,246,0.51	ALG1,FAM86A	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*1065C>G:,FAM86A:NM_201400.3:intron:MODIFIER:exon7/7:c.893-214G>C:,FAM86A:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-214G>C:,FAM86A:NM_201598.3:intron:MODIFIER:exon6/6:c.791-214G>C:		rs4483845	0.5687	0	0	0										0.3561	0.5076	0.1364	53	78	n/a	n/a
chr16	5135979	5135979	T	C	hom		QUAL=20723;DP=217;AF=1.00;MQM=59;TRIO=HOM,217,1.00,HOM,169,1.00,HOM,257,1.00	ALG1,FAM86A	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*1097T>C:,FAM86A:NM_201400.3:intron:MODIFIER:exon7/7:c.893-246A>G:,FAM86A:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-246A>G:,FAM86A:NM_201598.3:intron:MODIFIER:exon6/6:c.791-246A>G:		rs4238853	0.9852	0	0	0										1	0	0	150	0	n/a	n/a
chr16	5136320	5136320	G	A	hom		QUAL=8167;DP=97;AF=1.00;MQM=53;TRIO=HOM,97,1.00,HOM,79,1.00,HOM,98,1.00	ALG1,FAM86A	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*1438G>A:,FAM86A:NM_201400.3:intron:MODIFIER:exon7/7:c.893-587C>T:,FAM86A:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-587C>T:,FAM86A:NM_201598.3:intron:MODIFIER:exon6/6:c.791-587C>T:	AluSz	rs12922304	0.9599	0	0	0										1	0	0	150	0	n/a	n/a
chr16	5136336	5136339	AAAA	-	hom		QUAL=1630;DP=37;AF=0.76;MQM=57;TRIO=HOM,37,0.76,HET,32,0.56,HET,38,0.45	ALG1,FAM86A	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*1468_*1471delAAAA:,FAM86A:NM_201400.3:intron:MODIFIER:exon7/7:c.893-606_893-603delTTTT:,FAM86A:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-606_710-603delTTTT:,FAM86A:NM_201598.3:intron:MODIFIER:exon6/6:c.791-606_791-603delTTTT:	AluSz	rs556079793	0.748	0	0	0										0.4318	0.3561	0.2121	64	54	n/a	n/a
chr16	5136900	5136900	C	A	hom		QUAL=17661;DP=150;AF=1.00;MQM=56;TRIO=HOM,150,1.00,HOM,163,1.00,HOM,248,1.00	ALG1,FAM86A	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*2018C>A:,FAM86A:NM_201400.3:intron:MODIFIER:exon7/7:c.893-1167G>T:,FAM86A:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-1167G>T:,FAM86A:NM_201598.3:intron:MODIFIER:exon6/6:c.791-1167G>T:	AluSz	rs4786595	0.9599	0	0	0										1	0	0	150	0	n/a	n/a
chr16	5136901	5136901	C	G	hom		QUAL=17661;DP=150;AF=1.00;MQM=56;TRIO=HOM,150,1.00,HOM,163,1.00,HOM,248,1.00	ALG1,FAM86A	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*2019C>G:,FAM86A:NM_201400.3:intron:MODIFIER:exon7/7:c.893-1168G>C:,FAM86A:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-1168G>C:,FAM86A:NM_201598.3:intron:MODIFIER:exon6/6:c.791-1168G>C:	AluSz	rs4786596	0.9599	0	0	0										1	0	0	150	0	n/a	n/a
chr16	5137069	5137069	C	G	hom		QUAL=16755;DP=258;AF=1.00;MQM=58;TRIO=HOM,258,1.00,HET,232,0.48,HET,277,0.51	ALG1,FAM86A	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*2187C>G:,FAM86A:NM_201400.3:intron:MODIFIER:exon7/7:c.893-1336G>C:,FAM86A:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-1336G>C:,FAM86A:NM_201598.3:intron:MODIFIER:exon6/6:c.791-1336G>C:		rs12928220	0.3704	0	0	0										0.2121	0.5	0.2879	34	75	n/a	n/a
chr16	5137285	5137285	A	G	hom		QUAL=30107;DP=435;AF=1.00;MQM=59;TRIO=HOM,435,1.00,HOM,217,1.00,HOM,259,1.00	ALG1,FAM86A	3'UTR,intron	ALG1:NM_019109.4:3'UTR:MODIFIER:exon13/13:c.*2403A>G:,FAM86A:NM_201400.3:intron:MODIFIER:exon7/7:c.893-1552T>C:,FAM86A:NM_001289029.1:intron:MODIFIER:exon5/5:c.710-1552T>C:,FAM86A:NM_201598.3:intron:MODIFIER:exon6/6:c.791-1552T>C:		rs4786597	0.9619	0	0	0										1	0	0	150	0	n/a	n/a
chr16	8807140	8807140	-	A	het		QUAL=502;DP=31;AF=0.10;MQM=60;TRIO=HET,31,0.10,HET,27,0.37,HET,31,0.29	ABAT	5'UTR,intron	ABAT:NM_000663.4:5'UTR:MODIFIER:exon1/16:c.-609dupA:,ABAT:NM_020686.5:intron:MODIFIER:exon1/15:c.-41-22401dupA:		rs554719618	0.4525	0	0	0										0.0455	0.2045	0.75	6	30	n/a	n/a
chr16	8873456	8873456	T	C	het		QUAL=10587;DP=144;AF=0.49;MQM=60;TRIO=HET,144,0.49,HET,262,0.52,HET,316,0.44	ABAT	splice_region&intron	ABAT:NM_000663.4:splice_region&intron:LOW:exon15/15:c.1381+9T>C:,ABAT:NM_020686.5:splice_region&intron:LOW:exon15/15:c.1381+9T>C:,ABAT:NM_001127448.1:splice_region&intron:LOW:exon15/15:c.1381+9T>C:		rs1079348	0.35	0.302	0.2958	0.4181						137150 [ABAT (provisional) GABA-transaminase deficiency];				0.0833	0.447	0.4697	45	186	n/a	n/a
chr16	8875529	8875529	G	T	het		QUAL=1800;DP=98;AF=0.39;MQM=60;TRIO=HET,98,0.39,HET,27,0.48,HET,23,0.43	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*242G>T:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*242G>T:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*242G>T:		rs2270288	0.3738	0	0	0										0.2348	0.4545	0.3106	38	66	n/a	n/a
chr16	8875545	8875545	G	C	het		QUAL=2405;DP=99;AF=0.57;MQM=60;TRIO=HET,99,0.57,HET,26,0.42,HET,16,0.69	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*258G>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*258G>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*258G>C:		rs737695	0.3239	0	0	0										0.0758	0.4015	0.5227	12	57	n/a	n/a
chr16	8875763	8875763	T	C	het		QUAL=3027;DP=69;AF=0.62;MQM=60;TRIO=HET,69,0.62,HET,57,0.46,HET,77,0.40	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*476T>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*476T>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*476T>C:		rs1731071	0.3902	0	0	0										0.0909	0.4091	0.5	14	59	n/a	n/a
chr16	8875799	8875799	G	A	het		QUAL=4711;DP=108;AF=0.45;MQM=60;TRIO=HET,108,0.45,HET,76,0.51,HET,104,0.66	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*512G>A:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*512G>A:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*512G>A:		rs3743798	0.3712	0	0	0										0.2348	0.4621	0.303	38	67	n/a	n/a
chr16	8875858	8875858	A	C	het		QUAL=5950;DP=214;AF=0.43;MQM=60;TRIO=HET,214,0.43,HET,99,0.44,HET,148,0.42	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*571A>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*571A>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*571A>C:		rs1641031	0.3928	0	0	0										0.0985	0.3939	0.5076	15	57	n/a	n/a
chr16	8875861	8875861	A	G	het		QUAL=5950;DP=214;AF=0.43;MQM=60;TRIO=HET,214,0.43,HET,99,0.44,HET,148,0.42	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*574A>G:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*574A>G:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*574A>G:		rs1641032	0.3932	0	0	0										0.0985	0.3939	0.5076	15	57	n/a	n/a
chr16	8876202	8876202	C	G	het		QUAL=14230;DP=310;AF=0.54;MQM=59;TRIO=HET,310,0.54,HET,245,0.49,HET,339,0.45	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*915C>G:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*915C>G:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*915C>G:		rs3743801	0.385	0	0	0										0.25	0.447	0.303	40	65	n/a	n/a
chr16	8876277	8876277	G	C	het		QUAL=15129;DP=299;AF=0.52;MQM=60;TRIO=HET,299,0.52,HET,296,0.47,HET,370,0.48	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*990G>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*990G>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*990G>C:		rs4985000	0.6064	0	0	0										0.5152	0.3864	0.0985	79	56	n/a	n/a
chr16	8876418	8876418	G	A	het		QUAL=19124;DP=362;AF=0.49;MQM=60;TRIO=HET,362,0.49,HET,336,0.48,HET,459,0.53	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*1131G>A:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*1131G>A:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*1131G>A:		rs7205816	0.5503	0	0	0										0.4015	0.4545	0.1439	62	67	n/a	n/a
chr16	8876692	8876692	C	T	het		QUAL=18586;DP=456;AF=0.50;MQM=60;TRIO=HET,456,0.50,HET,299,0.52,HET,323,0.56	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*1405C>T:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*1405C>T:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*1405C>T:		rs7201586	0.2788	0	0	0										0.0379	0.3712	0.5909	7	52	n/a	n/a
chr16	8876880	8876880	T	A	het		QUAL=13877;DP=247;AF=0.47;MQM=60;TRIO=HET,247,0.47,HET,250,0.55,HET,333,0.52	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*1593T>A:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*1593T>A:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*1593T>A:		rs1061842	0.3862	0	0	0										0.2197	0.4773	0.303	36	69	n/a	n/a
chr16	8877220	8877220	T	C	hom		QUAL=45000;DP=365;AF=1.00;MQM=60;TRIO=HOM,365,1.00,HOM,483,1.00,HOM,531,1.00	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*1933T>C:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*1933T>C:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*1933T>C:	L2c	rs4985036	0.9081	0	0	0										0.8788	0.1212	0	133	17	n/a	n/a
chr16	8877401	8877401	G	A	het		QUAL=23045;DP=420;AF=0.53;MQM=60;TRIO=HET,420,0.53,HET,429,0.50,HET,516,0.52	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*2114G>A:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*2114G>A:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*2114G>A:		rs11648372	0.6068	0	0	0										0.5076	0.3939	0.0985	78	57	n/a	n/a
chr16	8877854	8877854	C	G	het		QUAL=7282;DP=240;AF=0.44;MQM=60;TRIO=HET,240,0.44,HET,94,0.45,HET,140,0.54	ABAT	3'UTR	ABAT:NM_000663.4:3'UTR:MODIFIER:exon16/16:c.*2567C>G:,ABAT:NM_020686.5:3'UTR:MODIFIER:exon16/16:c.*2567C>G:,ABAT:NM_001127448.1:3'UTR:MODIFIER:exon16/16:c.*2567C>G:		rs12597124	0.6054	0	0	0										0.5076	0.3939	0.0985	78	57	n/a	n/a
chr16	8900241	8900241	G	A	het		QUAL=645;DP=32;AF=0.53;MQM=60;TRIO=HET,32,0.53,WT,7,0.00,HET,8,0.63	PMM2	synonymous	PMM2:NM_000303.2:synonymous:LOW:exon4/8:c.324G>A:p.Ala108Ala		rs62031146	0.0148	0.018	0.0192	0.005						601785 [PMM2 (confirmed) Congenital disorder of glycosylation,type Ia];	RCV000117997.2 [likely benign]; 			0.0076	0.0303	0.9621	4	55	n/a	n/a
chr16	8941818	8941818	A	C	het		QUAL=3519;DP=119;AF=0.40;MQM=60;TRIO=HET,119,0.40,HET,143,0.45,WT,172,0.00	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*136A>C:		rs2075827	0.259	0	0	0										0.0455	0.3409	0.6136	8	50	n/a	n/a
chr16	8941857	8941857	G	A	het		QUAL=4490;DP=213;AF=0.41;MQM=60;TRIO=HET,213,0.41,HET,138,0.41,WT,164,0.00	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*175G>A:		rs2072688	0.2694	0	0	0										0.0455	0.3409	0.6136	8	50	n/a	n/a
chr16	8941934	8941934	C	A	het		QUAL=3747;DP=83;AF=0.55;MQM=60;TRIO=HET,83,0.55,HET,69,0.61,HET,64,0.69	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*252C>A:		rs2075828	0.3962	0	0	0										0.2348	0.5303	0.2348	37	76	n/a	n/a
chr16	8942473	8942473	G	C	hom		QUAL=18561;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HOM,129,1.00,HOM,171,0.99	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*791G>C:		rs2437722	0.9209	0	0	0										0.8788	0.1061	0.0152	132	16	n/a	n/a
chr16	8942679	8942679	A	G	het		QUAL=4800;DP=152;AF=0.59;MQM=60;TRIO=HET,152,0.59,HET,111,0.54,WT,150,0.00	PMM2	3'UTR	PMM2:NM_000303.2:3'UTR:MODIFIER:exon8/8:c.*997A>G:		rs1056898	0.2905	0	0	0										0.0455	0.3485	0.6061	8	51	n/a	n/a
chr16	9848471	9848471	T	G	hom		QUAL=10891;DP=198;AF=1.00;MQM=60;TRIO=HOM,198,1.00,HOM,70,1.00,HOM,58,1.00	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*8535A>C:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*8741A>C:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*8535A>C:		rs767749	0.7506	0	0	0										0.7348	0.2348	0.0303	109	35	n/a	n/a
chr16	9850397	9850397	A	G	hom		QUAL=27919;DP=317;AF=1.00;MQM=60;TRIO=HOM,317,1.00,HOM,240,1.00,HOM,278,1.00	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*6609T>C:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6815T>C:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*6609T>C:		rs1420040	0.4233	0	0	0										0.2197	0.5227	0.2576	32	79	n/a	n/a
chr16	9850857	9850857	G	C	hom		QUAL=36357;DP=439;AF=0.99;MQM=60;TRIO=HOM,439,0.99,HOM,296,1.00,HOM,372,0.99	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*6149C>G:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6355C>G:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*6149C>G:		rs9940680	0.4163	0	0	0										0.2197	0.5076	0.2727	33	76	n/a	n/a
chr16	9850878	9850878	T	C	hom		QUAL=29709;DP=311;AF=0.99;MQM=59;TRIO=HOM,311,0.99,HOM,267,1.00,HOM,337,0.99	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*6128A>G:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6334A>G:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*6128A>G:		rs9933624	0.4173	0	0	0										0.2348	0.5152	0.25	35	77	n/a	n/a
chr16	9851122	9851122	C	T	hom		QUAL=24445;DP=411;AF=1.00;MQM=60;TRIO=HOM,411,1.00,HOM,155,0.98,HOM,182,0.99	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*5884G>A:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6090G>A:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*5884G>A:		rs8045712	0.3676	0	0	0										0.197	0.5076	0.2955	29	77	n/a	n/a
chr16	9851188	9851188	G	A	hom		QUAL=13060;DP=252;AF=1.00;MQM=59;TRIO=HOM,252,1.00,HOM,70,1.00,HOM,94,1.00	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*5818C>T:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*6024C>T:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*5818C>T:		rs8044472	0.7522	0	0	0										0.7197	0.2348	0.0455	108	34	n/a	n/a
chr16	9851216	9851216	T	-	het		QUAL=550;DP=144;AF=0.13;MQM=60;TRIO=HET,144,0.13,HET,39,0.28,HET,59,0.10	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*5790delA:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*5996delA:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*5790delA:	AT_rich		0	0	0	0										0.0076	0.0985	0.8939	1	14	n/a	n/a
chr16	9854389	9854389	C	G	hom		QUAL=30527;DP=459;AF=0.99;MQM=59;TRIO=HOM,459,0.99,HOM,232,1.00,HOM,250,1.00	GRIN2A	3'UTR	GRIN2A:NM_000833.4:3'UTR:MODIFIER:exon14/14:c.*2617G>C:,GRIN2A:NM_001134408.2:3'UTR:MODIFIER:exon14/14:c.*2823G>C:,GRIN2A:NM_001134407.2:3'UTR:MODIFIER:exon13/13:c.*2617G>C:		rs62034910	0.374	0	0	0										0.197	0.5227	0.2803	30	78	n/a	n/a
chr16	10995933	10995933	A	G	hom		QUAL=12891;DP=129;AF=1.00;MQM=60;TRIO=HOM,129,1.00,HOM,112,1.00,HOM,172,1.00	CIITA	missense,intron	CIITA:NM_001286402.1:missense:MODERATE:exon7/20:c.523A>G:p.Arg175Gly,CIITA:NM_000246.3:missense:MODERATE:exon7/20:c.520A>G:p.Arg174Gly,CIITA:NM_001286403.1:intron:MODIFIER:exon6/17:c.481+518A>G:		rs8046121	0.9872	0.996	1	0.9502	1.7160	P	T	B,B	B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM4128622	1	0	0	453	1	n/a	n/a
chr16	11000848	11000848	G	C	het		QUAL=2209;DP=82;AF=0.59;MQM=60;TRIO=HET,82,0.59,WT,55,0.00,HET,45,0.51	CIITA	missense,intron	CIITA:NM_001286402.1:missense:MODERATE:exon11/20:c.1502G>C:p.Gly501Ala,CIITA:NM_000246.3:missense:MODERATE:exon11/20:c.1499G>C:p.Gly500Ala,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-1992G>C:		rs4774	0.259	0.29	0.2923	0.2572	0.7060	P	T	B,B,B	B,B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];		CM102885 [CLASS=DP MUT=ALT PHEN="Multiple sclerosis, increased risk, association with" GENE=CIITA]; 	COSM434601	0.1136	0.4394	0.447	52	168	n/a	n/a
chr16	11001691	11001691	C	T	het		QUAL=5382;DP=148;AF=0.55;MQM=59;TRIO=HET,148,0.55,WT,187,0.00,HET,232,0.47	CIITA	missense,intron	CIITA:NM_001286402.1:missense:MODERATE:exon11/20:c.2345C>T:p.Ser782Leu,CIITA:NM_000246.3:missense:MODERATE:exon11/20:c.2342C>T:p.Ser781Leu,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-1149C>T:		rs13330686	0.0397	0.063	0.0821	0.0363	-0.2870	P	T	B,B,B,B	B,B,B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];				0.0379	0.2045	0.7576	7	79	n/a	n/a
chr16	11001694	11001694	T	C	het		QUAL=5382;DP=148;AF=0.55;MQM=59;TRIO=HET,148,0.55,WT,187,0.00,HET,232,0.47	CIITA	missense,intron	CIITA:NM_001286402.1:missense:MODERATE:exon11/20:c.2348T>C:p.Val783Ala,CIITA:NM_000246.3:missense:MODERATE:exon11/20:c.2345T>C:p.Val782Ala,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-1146T>C:		rs13336804	0.0399	0.063	0.0835	0.0364	0.4060	P	T	B,B,B,B	B,B,B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM3754601	0.0379	0.2045	0.7576	7	79	n/a	n/a
chr16	11001743	11001743	G	A	het		QUAL=2959;DP=102;AF=0.39;MQM=60;TRIO=HET,102,0.39,HET,113,0.58,WT,139,0.00	CIITA	synonymous,intron	CIITA:NM_001286402.1:synonymous:LOW:exon11/20:c.2397G>A:p.Pro799Pro,CIITA:NM_000246.3:synonymous:LOW:exon11/20:c.2394G>A:p.Pro798Pro,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-1097G>A:		rs2229320	0.1893	0.207	0.2019	0.0519						600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM3754602	0.0379	0.3485	0.6136	20	159	n/a	n/a
chr16	11001914	11001914	G	A	het		QUAL=2208;DP=80;AF=0.51;MQM=59;TRIO=HET,80,0.51,WT,49,0.00,HET,61,0.52	CIITA	synonymous,intron	CIITA:NM_001286402.1:synonymous:LOW:exon11/20:c.2568G>A:p.Ala856Ala,CIITA:NM_000246.3:synonymous:LOW:exon11/20:c.2565G>A:p.Ala855Ala,CIITA:NM_001286403.1:intron:MODIFIER:exon9/17:c.860-926G>A:		rs2229321	0.0397	0.063	0.0876	0.0383						600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM3754603	0.0379	0.2045	0.7576	8	78	n/a	n/a
chr16	11002904	11002904	G	A	het		QUAL=18637;DP=132;AF=0.45;MQM=59;TRIO=HET,132,0.45,HOM,322,0.99,HET,450,0.49	CIITA	synonymous	CIITA:NM_001286402.1:synonymous:LOW:exon12/20:c.2679G>A:p.Thr893Thr,CIITA:NM_000246.3:synonymous:LOW:exon12/20:c.2676G>A:p.Thr892Thr,CIITA:NM_001286403.1:synonymous:LOW:exon10/18:c.924G>A:p.Thr308Thr		rs2228238	0.6631	0.683	0.6991	0.5086						600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];				0.4545	0.4318	0.1136	226	174	n/a	n/a
chr16	11002927	11002927	A	G	hom		QUAL=36200;DP=264;AF=1.00;MQM=59;TRIO=HOM,264,1.00,HOM,373,1.00,HOM,509,1.00	CIITA	missense	CIITA:NM_001286402.1:missense:MODERATE:exon12/20:c.2702A>G:p.Gln901Arg,CIITA:NM_000246.3:missense:MODERATE:exon12/20:c.2699A>G:p.Gln900Arg,CIITA:NM_001286403.1:missense:MODERATE:exon10/18:c.947A>G:p.Gln316Arg		rs7197779	0.9287	0.979	0.9994	0.7642	0.8840	P	T	B,B	B,B	600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];				1	0	0	453	1	n/a	n/a
chr16	11016045	11016045	C	T	het		QUAL=6876;DP=215;AF=0.47;MQM=59;TRIO=HET,215,0.47,WT,177,0.00,HET,257,0.49	CIITA	synonymous	CIITA:NM_001286402.1:synonymous:LOW:exon17/20:c.3174C>T:p.Cys1058Cys,CIITA:NM_000246.3:synonymous:LOW:exon17/20:c.3171C>T:p.Cys1057Cys,CIITA:NM_001286403.1:synonymous:LOW:exon15/18:c.1419C>T:p.Cys473Cys		rs2229322	0.1048	0.101	0.1084	0.0778						600005 [CIITA (provisional) Bare lymphocyte syndrome,type II,complementation group A|Rheumatoid arthritis,susceptibility to];			COSM148019	0.0303	0.1667	0.803	8	76	n/a	n/a
chr16	11018622	11018622	T	C	het		QUAL=6695;DP=210;AF=0.52;MQM=60;TRIO=HET,210,0.52,HET,204,0.49,WT,244,0.00	CIITA	3'UTR	CIITA:NM_001286402.1:3'UTR:MODIFIER:exon20/20:c.*910T>C:,CIITA:NM_000246.3:3'UTR:MODIFIER:exon20/20:c.*910T>C:,CIITA:NM_001286403.1:3'UTR:MODIFIER:exon18/18:c.*910T>C:		rs1139564	0.6917	0	0	0										0.6364	0.3106	0.053	97	46	n/a	n/a
chr16	11642242	11642242	T	C	hom		QUAL=15132;DP=211;AF=1.00;MQM=60;TRIO=HOM,211,1.00,HOM,151,1.00,HET,191,0.52	LITAF	3'UTR	LITAF:NM_001136472.1:3'UTR:MODIFIER:exon4/4:c.*1251A>G:,LITAF:NM_004862.3:3'UTR:MODIFIER:exon4/4:c.*1251A>G:,LITAF:NM_001136473.1:3'UTR:MODIFIER:exon5/5:c.*1376A>G:		rs7102	0.4105	0.364	0	0										0.1212	0.4015	0.4773	38	139	n/a	n/a
chr16	11642445	11642445	T	-	het		QUAL=4225;DP=251;AF=0.36;MQM=60;TRIO=HET,251,0.36,HET,114,0.44,HET,129,0.14	LITAF	3'UTR	LITAF:NM_001136472.1:3'UTR:MODIFIER:exon4/4:c.*1048delA:,LITAF:NM_004862.3:3'UTR:MODIFIER:exon4/4:c.*1048delA:,LITAF:NM_001136473.1:3'UTR:MODIFIER:exon5/5:c.*1173delA:		rs71778957	0	0	0	0										0.0227	0.2727	0.7045	5	56	n/a	n/a
chr16	11642910	11642910	-	A	hom		QUAL=11218;DP=195;AF=0.91;MQM=59;TRIO=HOM,195,0.91,HOM,134,0.93,HET,163,0.41	LITAF	3'UTR	LITAF:NM_001136472.1:3'UTR:MODIFIER:exon4/4:c.*582dupT:,LITAF:NM_004862.3:3'UTR:MODIFIER:exon4/4:c.*582dupT:,LITAF:NM_001136473.1:3'UTR:MODIFIER:exon5/5:c.*707dupT:	AT_rich	rs398119229	0.3732	0	0	0										0.0985	0.3788	0.5227	27	136	n/a	n/a
chr16	11647492	11647492	T	C	het		QUAL=16957;DP=325;AF=0.43;MQM=60;TRIO=HET,325,0.43,WT,390,0.00,HOM,392,1.00	LITAF	missense	LITAF:NM_001136472.1:missense:MODERATE:exon3/4:c.274A>G:p.Ile92Val,LITAF:NM_004862.3:missense:MODERATE:exon3/4:c.274A>G:p.Ile92Val,LITAF:NM_001136473.1:missense:MODERATE:exon3/5:c.274A>G:p.Ile92Val		rs4280262	0.1026	0.162	0.2129	0.0724	0.2440	P	T	B,B	B,B	603795 [LITAF (confirmed) Charcot-Marie-Tooth disease,type 1C];		CM1410967 [CLASS=DFP MUT=ALT PHEN="Charcot-Marie-Tooth disease 1a/Neuropathy with liability to pressure palsies, earlier onset, association with" GENE=LITAF]; 		0.0606	0.3409	0.5985	22	155	n/a	n/a
chr16	14026007	14026007	G	A	hom		QUAL=26879;DP=298;AF=1.00;MQM=60;TRIO=HOM,298,1.00,HOM,241,1.00,HOM,284,1.00	ERCC4	splice_region&intron	ERCC4:NM_005236.2:splice_region&intron:LOW:exon5/10:c.974-7G>A:		rs254942	0.9465	0.966	0.979	0.9957						133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F|XFE progeroid syndrome|Fanconi anemia,complementation group Q|Xeroderma pigmentosum,type F/Cockayne syndrome];				0.9091	0.0909	0	1089	72	n/a	n/a
chr16	14041958	14041958	T	C	het		QUAL=10410;DP=259;AF=0.50;MQM=59;TRIO=HET,259,0.50,WT,317,0.00,HET,386,0.49	ERCC4	synonymous	ERCC4:NM_005236.2:synonymous:LOW:exon11/11:c.2505T>C:p.Ser835Ser		rs1799801	0.2412	0.272	0.294	0.1734						133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F|XFE progeroid syndrome|Fanconi anemia,complementation group Q|Xeroderma pigmentosum,type F/Cockayne syndrome];	RCV000116988.2 [likely benign]; 			0.0909	0.4621	0.447	110	476	n/a	n/a
chr16	14042108	14042108	G	A	het		QUAL=16866;DP=565;AF=0.50;MQM=60;TRIO=HET,565,0.50,WT,406,0.00,HET,480,0.48	ERCC4	synonymous	ERCC4:NM_005236.2:synonymous:LOW:exon11/11:c.2655G>A:p.Thr885Thr		rs16963255	0.0046	0.011	0.0142	0.0023						133520 [ERCC4 (confirmed) Xeroderma pigmentosum,group F|XFE progeroid syndrome|Fanconi anemia,complementation group Q|Xeroderma pigmentosum,type F/Cockayne syndrome];				0	0.0455	0.9545	0	32	n/a	n/a
chr16	14042688	14042688	G	T	het		QUAL=13239;DP=329;AF=0.47;MQM=60;TRIO=HET,329,0.47,WT,427,0.00,HET,532,0.46	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*484G>T:		rs3743538	0.3496	0	0	0										0.1136	0.4773	0.4091	17	70	n/a	n/a
chr16	14042930	14042930	G	C	het		QUAL=6523;DP=281;AF=0.47;MQM=60;TRIO=HET,281,0.47,WT,100,0.01,HET,137,0.47	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*726G>C:		rs2276464	0.2376	0	0	0										0.0909	0.4621	0.447	14	66	n/a	n/a
chr16	14043014	14043014	G	A	het		QUAL=8183;DP=322;AF=0.50;MQM=60;TRIO=HET,322,0.50,WT,124,0.00,HET,188,0.49	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*810G>A:		rs2276465	0.2592	0	0	0										0.1136	0.4697	0.4167	17	69	n/a	n/a
chr16	14043175	14043175	C	G	het		QUAL=7395;DP=186;AF=0.48;MQM=60;TRIO=HET,186,0.48,WT,188,0.00,HET,268,0.51	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*971C>G:		rs2276466	0.2372	0	0	0										0.0909	0.4621	0.447	14	66	n/a	n/a
chr16	14044717	14044717	C	A	het		QUAL=7515;DP=202;AF=0.56;MQM=60;TRIO=HET,202,0.56,WT,130,0.01,HET,219,0.52	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*2513C>A:		rs11075223	0.2592	0	0	0										0.1136	0.4697	0.4167	17	69	n/a	n/a
chr16	14044776	14044776	C	-	het		QUAL=5821;DP=143;AF=0.49;MQM=60;TRIO=HET,143,0.49,WT,154,0.00,HET,222,0.53	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*2577delC:		rs61422086	0.2596	0	0	0										0.1136	0.4621	0.4242	17	68	n/a	n/a
chr16	14044781	14044781	C	A	het		QUAL=5821;DP=143;AF=0.49;MQM=60;TRIO=HET,143,0.49,WT,154,0.00,HET,222,0.53	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*2577C>A:		rs56012340	0.2133	0	0	0										0.0455	0.2348	0.7197	6	33	n/a	n/a
chr16	14045236	14045236	G	T	het		QUAL=4921;DP=218;AF=0.47;MQM=60;TRIO=HET,218,0.47,WT,84,0.00,HET,91,0.51	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*3032G>T:		rs4781562	0.2574	0	0	0										0.0909	0.4242	0.4848	14	61	n/a	n/a
chr16	14045399	14045399	G	A	het		QUAL=10651;DP=385;AF=0.50;MQM=60;TRIO=HET,385,0.50,WT,232,0.00,HET,279,0.46	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*3195G>A:		rs4781563	0.2139	0	0	0										0.0909	0.4394	0.4697	14	63	n/a	n/a
chr16	14046150	14046150	T	-	het		QUAL=7708;DP=367;AF=0.47;MQM=60;TRIO=HET,367,0.47,WT,68,0.00,HET,125,0.52	ERCC4	3'UTR	ERCC4:NM_005236.2:3'UTR:MODIFIER:exon11/11:c.*3953delT:		rs397778750	0.2133	0	0	0										0.0909	0.4394	0.4697	14	63	n/a	n/a
chr16	20360101	20360101	G	A	hom		QUAL=6776;DP=65;AF=1.00;MQM=59;TRIO=HOM,65,1.00,HOM,73,1.00,HOM,84,1.00	UMOD	synonymous	UMOD:NM_001278614.1:synonymous:LOW:exon4/12:c.621C>T:p.Cys207Cys,UMOD:NM_001008389.2:synonymous:LOW:exon3/11:c.522C>T:p.Cys174Cys,UMOD:NM_003361.3:synonymous:LOW:exon3/11:c.522C>T:p.Cys174Cys		rs7193058	0.5439	0.501	0.7678	0.723						191845 [UMOD (confirmed) Hyperuricemic nephropathy,familial juvenile 1|Medullary cystic kidney disease 2|Glomerulocystic kidney disease with hyperuricemia and isosthenuria];	RCV000080093.2 [benign]; 		COSM3749348	0.4697	0.4394	0.0909	253	155	n/a	n/a
chr16	23197545	23197545	C	G	het		QUAL=4808;DP=126;AF=0.48;MQM=60;TRIO=HET,126,0.48,WT,144,0.00,HET,192,0.52	SCNN1G	splice_region&intron	SCNN1G:NM_001039.3:splice_region&intron:LOW:exon1/12:c.-44-4C>G:		rs5731	0.1969	0.235	0.2434	0.1256										0.0455	0.4394	0.5152	8	72	n/a	n/a
chr16	23197562	23197562	A	G	het		QUAL=4910;DP=102;AF=0.47;MQM=60;TRIO=HET,102,0.47,WT,178,0.00,HET,228,0.52	SCNN1G	5'UTR	SCNN1G:NM_001039.3:5'UTR:MODIFIER:exon2/13:c.-31A>G:		rs5732	0.1969	0.236	0.2438	0.1259										0.0455	0.4394	0.5152	8	68	n/a	n/a
chr16	23200761	23200761	T	C	het		QUAL=10937;DP=362;AF=0.49;MQM=60;TRIO=HET,362,0.49,WT,262,0.00,HET,354,0.48	SCNN1G	synonymous	SCNN1G:NM_001039.3:synonymous:LOW:exon3/13:c.387T>C:p.Tyr129Tyr		rs5734	0.239	0.302	0.3208	0.1689						600761 [SCNN1G (confirmed) Liddle syndrome|Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 3];	RCV000151819.1 [benign]; 			0.0682	0.5606	0.3712	38	199	n/a	n/a
chr16	23200848	23200848	T	C	het		QUAL=12067;DP=303;AF=0.48;MQM=60;TRIO=HET,303,0.48,WT,333,0.00,HET,469,0.51	SCNN1G	synonymous	SCNN1G:NM_001039.3:synonymous:LOW:exon3/13:c.474T>C:p.Ile158Ile		rs5735	0.2392	0.302	0.3209	0.1691						600761 [SCNN1G (confirmed) Liddle syndrome|Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 3];	RCV000151820.1 [benign]; 		COSM4128821	0.0682	0.5606	0.3712	38	200	n/a	n/a
chr16	23227362	23227362	A	G	het		QUAL=18154;DP=318;AF=0.49;MQM=60;TRIO=HET,318,0.49,HET,239,0.53,HOM,291,1.00	SCNN1G	3'UTR	SCNN1G:NM_001039.3:3'UTR:MODIFIER:exon13/13:c.*572A>G:		rs5728	0.3395	0	0	0										0.1894	0.4394	0.3712	29	69	n/a	n/a
chr16	23227449	23227449	T	C	het		QUAL=14264;DP=304;AF=0.47;MQM=60;TRIO=HET,304,0.47,HET,183,0.48,HOM,215,1.00	SCNN1G	3'UTR	SCNN1G:NM_001039.3:3'UTR:MODIFIER:exon13/13:c.*659T>C:		rs9922851	0.3395	0	0	0										0.1894	0.4394	0.3712	29	69	n/a	n/a
chr16	23227579	23227579	T	C	het		QUAL=24434;DP=429;AF=0.51;MQM=60;TRIO=HET,429,0.51,HET,293,0.39,HOM,428,1.00	SCNN1G	3'UTR	SCNN1G:NM_001039.3:3'UTR:MODIFIER:exon13/13:c.*789T>C:	MIR	rs9923016	0.3389	0	0	0										0.1894	0.4394	0.3712	29	69	n/a	n/a
chr16	23360199	23360199	T	C	het		QUAL=7903;DP=293;AF=0.49;MQM=59;TRIO=HET,293,0.49,HET,268,0.44,WT,392,0.00	SCNN1B	synonymous	SCNN1B:NM_000336.2:synonymous:LOW:exon2/13:c.279T>C:p.Pro93Pro		rs238547	0.7885	0.635	0.5485	0.8851						600760 [SCNN1B (confirmed) Liddle syndrome|Pseudohypoaldosteronism,type I|Bronchiectasis with or without elevated sweat chloride 1];	RCV000151814.1 [benign]; 			0.4015	0.4773	0.1212	182	209	n/a	n/a
chr16	23399946	23399947	TT	-	het		QUAL=257;DP=25;AF=0.24;MQM=60;TRIO=HET,25,0.24,WT,6,0.17,WT,15,0.13	COG7	3'UTR	COG7:NM_153603.3:3'UTR:MODIFIER:exon17/17:c.*294_*295delAA:	AluSz6		0	0	0	0										0.0227	0.0758	0.9015	3	11	n/a	n/a
chr16	23400054	23400054	T	C	het		QUAL=7997;DP=208;AF=0.45;MQM=57;TRIO=HET,208,0.45,HET,164,0.48,HET,197,0.48	COG7	3'UTR	COG7:NM_153603.3:3'UTR:MODIFIER:exon17/17:c.*187A>G:	AluSg	rs250588	0.361	0	0	0										0.0455	0.3864	0.5682	6	59	n/a	n/a
chr16	23400194	23400194	G	A	het		QUAL=16287;DP=288;AF=0.52;MQM=60;TRIO=HET,288,0.52,HET,324,0.50,HET,437,0.49	COG7	3'UTR	COG7:NM_153603.3:3'UTR:MODIFIER:exon17/17:c.*47C>T:		rs250587	0.2436	0.203	0.1688	0.277										0.0379	0.3182	0.6439	6	51	n/a	n/a
chr16	23457291	23457291	A	-	het		QUAL=2288;DP=44;AF=0.27;MQM=60;TRIO=HET,44,0.27,HET,66,0.47,HET,121,0.44	COG7	splice_region&intron	COG7:NM_153603.3:splice_region&intron:LOW:exon1/16:c.170-9delT:		rs71379679	0	0	0	0						606978 [COG7 (confirmed) Congenital disorder of glycosylation,type IIe];				0	0.2576	0.7424	1	42	n/a	n/a
chr16	23646191	23646191	T	C	het		QUAL=7198;DP=153;AF=0.52;MQM=60;TRIO=HET,153,0.52,WT,242,0.00,HET,271,0.53	PALB2	missense	PALB2:NM_024675.3:missense:MODERATE:exon4/13:c.1676A>G:p.Gln559Arg		rs152451	0.1508	0.106	0.0909	0.2208	0.4010	P	T	B	B	610355 [PALB2 (provisional) Fanconi anemia,complementation group N|Breast cancer,susceptibility to|Pancreatic cancer,susceptibility to,3];	RCV000114486.1 [benign]; RCV000121747.1 [not provided]; RCV000128962.1 [benign]; 	CM1312156 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=PALB2]; 		0	0.2576	0.7424	10	196	n/a	n/a
chr16	28944396	28944396	C	G	hom		QUAL=9979;DP=100;AF=1.00;MQM=59;TRIO=HOM,100,1.00,HOM,89,1.00,HOM,132,0.98	CD19	missense	CD19:NM_001178098.1:missense:MODERATE:exon3/15:c.520C>G:p.Leu174Val,CD19:NM_001770.5:missense:MODERATE:exon3/15:c.520C>G:p.Leu174Val		rs2904880	0.8303	0.729	0.6876	0.9294	0.0920	P	T	B,B	B,B	107265 [CD19 (provisional) Immunodeficiency,common variable,3];				0.5227	0.4015	0.0758	252	163	n/a	n/a
chr16	28950051	28950051	G	A	het		QUAL=4045;DP=129;AF=0.40;MQM=60;TRIO=HET,129,0.40,HET,160,0.53,WT,179,0.00	CD19	missense	CD19:NM_001178098.1:missense:MODERATE:exon13/15:c.1544G>A:p.Arg515His,CD19:NM_001770.5:missense:MODERATE:exon13/15:c.1541G>A:p.Arg514His		rs34763945	0.0182	0.04	0.0643	0.0141	0.2880	N	T	B,B	B,B	107265 [CD19 (provisional) Immunodeficiency,common variable,3];				0	0.053	0.947	2	50	n/a	n/a
chr16	29825126	29825126	T	C	hom		QUAL=21021;DP=111;AF=1.00;MQM=59;TRIO=HOM,111,1.00,HOM,239,1.00,HOM,338,1.00	PRRT2	synonymous	PRRT2:NM_001256442.1:synonymous:LOW:exon2/3:c.751T>C:p.Leu251Leu,PRRT2:NM_001256443.1:synonymous:LOW:exon2/2:c.751T>C:p.Leu251Leu,PRRT2:NM_145239.2:synonymous:LOW:exon2/4:c.751T>C:p.Leu251Leu		rs11150573	0.9918	0.998	1	0.9727						614386 [PRRT2 (provisional) Episodic kinesigenic dyskinesia 1|Seizures,benign familial infantile,2|Convulsions,familial infantile,with paroxysmal choreoathetosis];	RCV000127623.1,RCV000153784.1 [benign,benign]; 			1	0	0	832	0	n/a	n/a
chr16	29826538	29826538	T	C	hom		QUAL=20109;DP=195;AF=1.00;MQM=59;TRIO=HOM,195,1.00,HOM,184,1.00,HOM,247,1.00	PRRT2	3'UTR	PRRT2:NM_001256442.1:3'UTR:MODIFIER:exon3/3:c.*579T>C:,PRRT2:NM_001256443.1:3'UTR:MODIFIER:exon2/2:c.*1263T>C:,PRRT2:NM_145239.2:3'UTR:MODIFIER:exon4/4:c.*579T>C:		rs10204	0.7816	0	0	0										0.7727	0.2197	0.0076	117	32	n/a	n/a
chr16	29827103	29827103	A	-	het		QUAL=373;DP=27;AF=0.19;MQM=58;TRIO=HET,27,0.19,HET,25,0.20,HET,30,0.23	PRRT2	3'UTR	PRRT2:NM_001256442.1:3'UTR:MODIFIER:exon3/3:c.*1159delA:,PRRT2:NM_001256443.1:3'UTR:MODIFIER:exon2/2:c.*1843delA:,PRRT2:NM_145239.2:3'UTR:MODIFIER:exon4/4:c.*1159delA:			0	0	0	0										0	0.1591	0.8409	0	22	n/a	n/a
chr16	30194840	30194840	A	G	het		QUAL=5272;DP=103;AF=0.50;MQM=60;TRIO=HET,103,0.50,HET,132,0.49,HET,162,0.38	CORO1A	5'UTR	CORO1A:NM_001193333.2:5'UTR:MODIFIER:exon1/12:c.-326A>G:,CORO1A:NM_007074.3:5'UTR:MODIFIER:exon1/11:c.-208A>G:		rs930392	0.7911	0	0	0										0.3864	0.4697	0.1439	54	71	n/a	n/a
chr16	30198151	30198151	A	G	het		QUAL=7365;DP=147;AF=0.60;MQM=59;TRIO=HET,147,0.60,HET,153,0.48,HET,177,0.44	CORO1A	synonymous	CORO1A:NM_001193333.2:synonymous:LOW:exon5/12:c.336A>G:p.Pro112Pro,CORO1A:NM_007074.3:synonymous:LOW:exon4/11:c.336A>G:p.Pro112Pro		rs1132812	0.7941	0.651	0.5534	0.8909						605000 [CORO1A (provisional) Immunodeficiency 8];			COSM3721331	0.4015	0.4848	0.1136	172	203	n/a	n/a
chr16	31191482	31191482	A	G	hom		QUAL=21243;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,200,1.00,HOM,276,1.00	FUS	5'UTR	FUS:NM_004960.3:5'UTR:MODIFIER:exon1/15:c.-54A>G:,FUS:NM_001170634.1:5'UTR:MODIFIER:exon1/15:c.-54A>G:,FUS:NM_001170937.1:5'UTR:MODIFIER:exon1/15:c.-54A>G:		rs929867	0.9391	0.982	0.9997	0.8136										1	0	0	305	1	n/a	n/a
chr16	31193942	31193942	C	A	het		QUAL=14016;DP=403;AF=0.54;MQM=60;TRIO=HET,403,0.54,WT,333,0.00,HET,435,0.53	FUS	synonymous	FUS:NM_004960.3:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly,FUS:NM_001170634.1:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly,FUS:NM_001170937.1:synonymous:LOW:exon3/15:c.147C>A:p.Gly49Gly		rs741810	0.279	0.322	0.2901	0.0731						137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,autosomal recessive,with or without frontotemporal dementia|Tremor,hereditary essential,4];			COSM3754865	0.1136	0.4621	0.4242	63	288	n/a	n/a
chr16	31195279	31195279	C	T	het		QUAL=4568;DP=219;AF=0.44;MQM=60;TRIO=HET,219,0.44,HET,109,0.53,WT,155,0.01	FUS	synonymous	FUS:NM_004960.3:synonymous:LOW:exon4/15:c.291C>T:p.Tyr97Tyr,FUS:NM_001170634.1:synonymous:LOW:exon4/15:c.288C>T:p.Tyr96Tyr,FUS:NM_001170937.1:synonymous:LOW:exon4/15:c.291C>T:p.Tyr97Tyr		rs1052352	0.4738	0.518	0.5549	0.2695						137070 [FUS (confirmed) Amyotrophic lateral sclerosis 6,autosomal recessive,with or without frontotemporal dementia|Tremor,hereditary essential,4];				0.3333	0.4394	0.2273	283	334	n/a	n/a
chr16	31202800	31202800	G	A	het		QUAL=8609;DP=366;AF=0.48;MQM=59;TRIO=HET,366,0.48,WT,171,0.00,HET,212,0.44	FUS	3'UTR	FUS:NM_004960.3:3'UTR:MODIFIER:exon15/15:c.*41G>A:,FUS:NM_001170634.1:3'UTR:MODIFIER:exon15/15:c.*41G>A:,FUS:NM_001170937.1:3'UTR:MODIFIER:exon15/15:c.*41G>A:		rs80301724	0.0044	0.0066	0.0058	0.0016								CR121643 [CLASS=DM MUT=ALT PHEN="Amyotrophic lateral sclerosis" GENE=FUS]; 		0.0076	0.0833	0.9091	1	15	n/a	n/a
chr16	31203529	31203529	G	C	het		QUAL=8955;DP=370;AF=0.46;MQM=60;TRIO=HET,370,0.46,WT,184,0.00,HET,223,0.45	FUS	3'UTR	FUS:NM_004960.3:3'UTR:MODIFIER:exon15/15:c.*770G>C:,FUS:NM_001170634.1:3'UTR:MODIFIER:exon15/15:c.*770G>C:,FUS:NM_001170937.1:3'UTR:MODIFIER:exon15/15:c.*770G>C:		rs4889537	0.2817	0.338	0	0										0.1136	0.4621	0.4242	25	110	n/a	n/a
chr16	31204235	31204235	T	C	hom		QUAL=40276;DP=446;AF=1.00;MQM=60;TRIO=HOM,446,1.00,HOM,334,1.00,HOM,432,1.00	FUS	3'UTR	FUS:NM_004960.3:3'UTR:MODIFIER:exon15/15:c.*1476T>C:,FUS:NM_001170634.1:3'UTR:MODIFIER:exon15/15:c.*1476T>C:,FUS:NM_001170937.1:3'UTR:MODIFIER:exon15/15:c.*1476T>C:		rs11860134	0.991	0.997	0	0										1	0	0	289	1	n/a	n/a
chr16	56545175	56545175	T	C	het		QUAL=13519;DP=330;AF=0.46;MQM=60;TRIO=HET,330,0.46,HOM,263,1.00,WT,387,0.00	BBS2	missense	BBS2:NM_031885.3:missense:MODERATE:exon3/17:c.367A>G:p.Ile123Val		rs11373	0.2636	0.209	0.1798	0.2261	0.4020	P	T	B,B	B,B	606151 [BBS2 (confirmed) Bardet-Biedl syndrome 2];		CM144738 [CLASS=DFP MUT=ALT PHEN="Bardet-Biedl syndrome" GENE=BBS2]; 		0.0455	0.25	0.7045	19	118	n/a	n/a
chr16	56548501	56548501	C	T	hom		QUAL=19267;DP=243;AF=1.00;MQM=60;TRIO=HOM,243,1.00,HOM,161,1.00,HOM,201,1.00	BBS2	missense	BBS2:NM_031885.3:missense:MODERATE:exon2/17:c.209G>A:p.Ser70Asn		rs4784677	0.9964	0.994	0.9923	0.9986	5.0110	P	T			606151 [BBS2 (confirmed) Bardet-Biedl syndrome 2];	RCV000004838.2 [pathogenic]; 	CM012900 [CLASS=DM MUT=REF PHEN="Bardet-Biedl syndrome" GENE=BBS2]; 		0.9697	0.0303	0	444	10	2	n/a
chr16	56554016	56554016	A	G	hom		QUAL=8282;DP=98;AF=1.00;MQM=59;TRIO=HOM,98,1.00,HOM,65,1.00,HOM,119,1.00					rs12446354	0.997	0	0	0										0.9848	0.0152	0	148	2	n/a	n/a
chr16	57495026	57495026	T	C	hom		QUAL=25012;DP=268;AF=1.00;MQM=60;TRIO=HOM,268,1.00,HOM,226,1.00,HOM,295,1.00	COQ9	3'UTR	COQ9:NM_020312.3:3'UTR:MODIFIER:exon9/9:c.*490T>C:		rs223870	0.9926	0	0	0										0.9167	0.0833	0	237	17	n/a	n/a
chr16	66514962	66514962	C	T	het		QUAL=13568;DP=218;AF=0.48;MQM=60;TRIO=HET,218,0.48,HOM,332,0.99,WT,460,0.00	BEAN1	3'UTR,intron	BEAN1:NM_001178020.2:3'UTR:MODIFIER:exon5/5:c.*134C>T:,BEAN1:NM_001136106.4:3'UTR:MODIFIER:exon4/4:c.*134C>T:,BEAN1:NM_001197224.2:intron:MODIFIER:exon3/4:c.114-1819C>T:,BEAN1:NM_001197225.2:intron:MODIFIER:exon3/4:c.114-1823C>T:	(CA)n	rs3743709	0.111	0	0	0						612051 [BEAN1 (provisional) Spinocerebellar ataxia 31];				0.0227	0.0606	0.9167	3	13	n/a	n/a
chr16	66527192	66527192	G	A	het		QUAL=6000;DP=94;AF=0.50;MQM=60;TRIO=HET,94,0.50,HOM,159,0.99,WT,183,0.00	BEAN1	missense,3'UTR	BEAN1:NM_001197225.2:missense:MODERATE:exon5/5:c.475G>A:p.Gly159Arg,BEAN1:NM_001197224.2:3'UTR:MODIFIER:exon5/5:c.*224G>A:		rs58468753	0.1114	0.041	0	0						612051 [BEAN1 (provisional) Spinocerebellar ataxia 31];				0.0227	0.0606	0.9167	4	38	n/a	n/a
chr16	66584002	66584002	T	C	het		QUAL=9523;DP=249;AF=0.54;MQM=60;TRIO=HET,249,0.54,HOM,112,0.97,HET,156,0.57	TK2	5'UTR,intron	TK2:NM_004614.4:5'UTR:MODIFIER:exon1/10:c.-38A>G:,TK2:NM_001172644.1:5'UTR:MODIFIER:exon1/9:c.-38A>G:,TK2:NM_001172645.1:5'UTR:MODIFIER:exon1/9:c.-38A>G:,TK2:NM_001271934.1:5'UTR:MODIFIER:exon1/11:c.-280A>G:,TK2:NM_001172643.1:intron:MODIFIER:exon1/9:c.31+154A>G:,TK2:NM_001271935.1:intron:MODIFIER:exon1/7:c.31+154A>G:		rs3743716	0.3259	0.195	0.1081	0.4863	0.3800	P	T	B	B	188250 [TK2 (confirmed) Mitochondrial DNA depletion syndrome 2 (myopathic type)];	RCV000125522.1 [benign]; 		COSM435490	0.0303	0.2424	0.7273	5	52	n/a	n/a
chr16	67311767	67311767	G	A	het		QUAL=7690;DP=268;AF=0.45;MQM=60;TRIO=HET,268,0.45,HET,300,0.44,WT,441,0.00	PLEKHG4	5'UTR	PLEKHG4:NM_015432.3:5'UTR:MODIFIER:exon1/21:c.-2181G>A:		rs8050745	0.241	0	0	0										0.0076	0.0833	0.9091	2	25	n/a	n/a
chr16	67313805	67313805	G	A	het		QUAL=4130;DP=175;AF=0.46;MQM=60;TRIO=HET,175,0.46,HET,102,0.54,WT,154,0.00	PLEKHG4	5'UTR	PLEKHG4:NM_001129727.1:5'UTR:MODIFIER:exon3/23:c.-143G>A:,PLEKHG4:NM_015432.3:5'UTR:MODIFIER:exon1/21:c.-143G>A:,PLEKHG4:NM_001129728.1:5'UTR:MODIFIER:exon2/22:c.-143G>A:,PLEKHG4:NM_001129729.1:5'UTR:MODIFIER:exon2/22:c.-143G>A:,PLEKHG4:NM_001129731.1:5'UTR:MODIFIER:exon1/20:c.-143G>A:		rs141261466	0.0062	0	0	0										0	0.0227	0.9773	0	5	n/a	n/a
chr16	67316234	67316234	C	T	het		QUAL=3242;DP=119;AF=0.53;MQM=59;TRIO=HET,119,0.53,HET,101,0.49,WT,100,0.01	PLEKHG4	missense	PLEKHG4:NM_001129727.1:missense:MODERATE:exon10/23:c.1235C>T:p.Thr412Ile,PLEKHG4:NM_015432.3:missense:MODERATE:exon8/21:c.1235C>T:p.Thr412Ile,PLEKHG4:NM_001129728.1:missense:MODERATE:exon9/22:c.1235C>T:p.Thr412Ile,PLEKHG4:NM_001129729.1:missense:MODERATE:exon9/22:c.1235C>T:p.Thr412Ile,PLEKHG4:NM_001129731.1:missense:MODERATE:exon7/20:c.992C>T:p.Thr331Ile		rs11860295	0.244	0.129	0.0749	0.5582	0.0090	P	T	D,B	P,B		RCV000117985.2 [likely benign]; 			0.0076	0.0833	0.9091	16	137	n/a	n/a
chr16	67318242	67318242	A	G	het		QUAL=1902;DP=87;AF=0.46;MQM=60;TRIO=HET,87,0.46,HET,81,0.35,WT,119,0.00	PLEKHG4	missense	PLEKHG4:NM_001129727.1:missense:MODERATE:exon13/23:c.1574A>G:p.Asp525Gly,PLEKHG4:NM_015432.3:missense:MODERATE:exon11/21:c.1574A>G:p.Asp525Gly,PLEKHG4:NM_001129728.1:missense:MODERATE:exon12/22:c.1574A>G:p.Asp525Gly,PLEKHG4:NM_001129729.1:missense:MODERATE:exon12/22:c.1574A>G:p.Asp525Gly,PLEKHG4:NM_001129731.1:missense:MODERATE:exon10/20:c.1331A>G:p.Asp444Gly		rs8044843	0.2816	0.163	0.1041	0.6106	0.6240	P	T	B,B	B,B		RCV000117986.2 [likely benign]; 		COSM3765919	0.0227	0.1061	0.8712	22	192	n/a	n/a
chr16	67320223	67320223	G	A	het		QUAL=249;DP=15;AF=0.47;MQM=60;TRIO=HET,15,0.47,HET,11,0.36,WT,22,0.00	PLEKHG4	missense	PLEKHG4:NM_001129727.1:missense:MODERATE:exon16/23:c.2489G>A:p.Arg830His,PLEKHG4:NM_015432.3:missense:MODERATE:exon14/21:c.2489G>A:p.Arg830His,PLEKHG4:NM_001129728.1:missense:MODERATE:exon15/22:c.2489G>A:p.Arg830His,PLEKHG4:NM_001129729.1:missense:MODERATE:exon15/22:c.2489G>A:p.Arg830His,PLEKHG4:NM_001129731.1:missense:MODERATE:exon13/20:c.2246G>A:p.Arg749His		rs3868142	0.2414	0.129	0.0751	0.55	2.0690	P	D	B,B	B,B		RCV000117987.2 [likely benign]; 		COSM4129187	0	0.0455	0.9545	15	130	n/a	n/a
chr16	67469733	67469733	C	A	het		QUAL=7169;DP=146;AF=0.51;MQM=60;TRIO=HET,146,0.51,HET,303,0.52,WT,347,0.00	HSD11B2	synonymous	HSD11B2:NM_000196.3:synonymous:LOW:exon2/5:c.468C>A:p.Thr156Thr		rs5479	0.0927	0.059	0.0408	0.1895						614232 [HSD11B2 (confirmed) Apparent mineralocorticoid excess];		CM057710 [CLASS=DP MUT=ALT PHEN="Hypertension, association with" GENE=HSD11B2]; 	COSM4129203	0.0076	0.0682	0.9242	4	39	n/a	n/a
chr16	67469915	67469915	G	A	het		QUAL=9750;DP=347;AF=0.44;MQM=59;TRIO=HET,347,0.44,HET,336,0.49,WT,382,0.00	HSD11B2	synonymous	HSD11B2:NM_000196.3:synonymous:LOW:exon3/5:c.534G>A:p.Glu178Glu		rs45483293	0.0144	0.031	0.0399	0.0089						614232 [HSD11B2 (confirmed) Apparent mineralocorticoid excess];				0.0076	0.0682	0.9242	2	37	n/a	n/a
chr16	69373414	69373414	T	C	hom		QUAL=3702;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HET,48,0.52,HET,85,0.46	COG8	synonymous	COG8:NM_032382.4:synonymous:LOW:exon1/6:c.42A>G:p.Thr14Thr		rs11542583	0.2576	0.283	0.3167	0.3395						606979 [COG8 (confirmed) Congenital disorder of glycosylation,type IIh];	RCV000082299.2 [benign]; 		COSM4129245	0.0682	0.4545	0.4773	41	179	n/a	n/a
chr16	70287177	70287177	A	G	hom		QUAL=21135;DP=141;AF=0.99;MQM=59;TRIO=HOM,141,0.99,HOM,224,1.00,HOM,304,1.00	AARS	synonymous	AARS:NM_001605.2:synonymous:LOW:exon20/21:c.2715T>C:p.Val905Val		rs4081753	0.8812	0.823	0.7937	0.9577						601065 [AARS (confirmed) Charcot-Marie-Tooth disease,axonal,type 2N];			COSM435653	0.6136	0.3409	0.0455	298	139	n/a	n/a
chr16	70303580	70303580	G	A	het		QUAL=21928;DP=183;AF=0.49;MQM=60;TRIO=HET,183,0.49,HET,308,0.54,HOM,454,0.99	AARS	synonymous	AARS:NM_001605.2:synonymous:LOW:exon7/21:c.903C>T:p.His301His		rs2070203	0.4253	0.466	0.5008	0.4711						601065 [AARS (confirmed) Charcot-Marie-Tooth disease,axonal,type 2N];		CM995271 [CLASS=FP MUT=ALT PHEN="Altered mRNA folding" GENE=AARS]; 		0.2121	0.5303	0.2576	107	232	n/a	n/a
chr16	74747267	74747267	G	C	het		QUAL=4663;DP=236;AF=0.46;MQM=60;TRIO=HET,236,0.46,WT,96,0.00,HET,102,0.53	FA2H	3'UTR	FA2H:NM_024306.4:3'UTR:MODIFIER:exon7/7:c.*821C>G:		rs573058036	0.0014	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr16	74747451	74747451	C	G	het		QUAL=1512;DP=62;AF=0.50;MQM=60;TRIO=HET,62,0.50,HOM,18,1.00,WT,34,0.00	FA2H	3'UTR	FA2H:NM_024306.4:3'UTR:MODIFIER:exon7/7:c.*637G>C:		rs56033857	0.2378	0	0	0										0.1439	0.4773	0.3788	20	71	n/a	n/a
chr16	74750405	74750405	G	A	het		QUAL=19747;DP=150;AF=0.47;MQM=60;TRIO=HET,150,0.47,HOM,337,0.99,HET,424,0.53	FA2H	synonymous	FA2H:NM_024306.4:synonymous:LOW:exon6/7:c.879C>T:p.Pro293Pro		rs2301865	0.7252	0.768	0.8055	0.7336						611026 [FA2H (provisional) Spastic paraplegia 35,autosomal recessive];	RCV000117012.1 [benign]; 			0.6288	0.3333	0.0379	478	257	n/a	n/a
chr16	81399026	81399026	C	T	het		QUAL=5103;DP=164;AF=0.49;MQM=60;TRIO=HET,164,0.49,WT,142,0.00,HET,178,0.46	GAN	missense	GAN:NM_022041.3:missense:MODERATE:exon9/11:c.1445C>T:p.Ala482Val		rs146576740	0.0008	0.0016	0.0027	0	1.8290	N	T	B	B	605379 [GAN (confirmed) Giant axonal neuropathy-1];				0	0.0379	0.9621	0	8	3	n/a
chr16	81411448	81411448	G	A	hom		QUAL=21805;DP=320;AF=0.99;MQM=60;TRIO=HOM,320,0.99,HOM,217,1.00,HET,295,0.45	GAN	3'UTR	GAN:NM_022041.3:3'UTR:MODIFIER:exon11/11:c.*247G>A:		rs2216769	0.6276	0	0	0										0.3864	0.4773	0.1364	59	70	n/a	n/a
chr16	81411673	81411673	C	G	hom		QUAL=33062;DP=449;AF=1.00;MQM=59;TRIO=HOM,449,1.00,HOM,365,1.00,HET,426,0.43	GAN	3'UTR	GAN:NM_022041.3:3'UTR:MODIFIER:exon11/11:c.*472C>G:		rs1816122	0.6711	0	0	0										0.4091	0.4621	0.1288	63	68	n/a	n/a
chr16	81411793	81411793	T	A	hom		QUAL=20629;DP=286;AF=0.99;MQM=60;TRIO=HOM,286,0.99,HOM,210,1.00,HET,262,0.45	GAN	3'UTR	GAN:NM_022041.3:3'UTR:MODIFIER:exon11/11:c.*592T>A:		rs1345895	0.6418	0	0	0										0.4091	0.4545	0.1364	63	67	n/a	n/a
chr16	81412168	81412168	G	A	hom		QUAL=14917;DP=271;AF=1.00;MQM=60;TRIO=HOM,271,1.00,HOM,87,1.00,HET,166,0.54	GAN	3'UTR	GAN:NM_022041.3:3'UTR:MODIFIER:exon11/11:c.*967G>A:		rs12920236	0.3055	0	0	0										0.303	0.4848	0.2121	46	71	n/a	n/a
chr16	83941726	83941726	C	T	het		QUAL=3164;DP=98;AF=0.41;MQM=60;TRIO=HET,98,0.41,HET,132,0.51,WT,173,0.00	MLYCD	splice_region&intron	MLYCD:NM_012213.2:splice_region&intron:LOW:exon2/4:c.642-5C>T:		rs2278037	0.0773	0.064	0.0455	0.1073						606761 [MLYCD (provisional) Malonyl-CoA decarboxylase deficiency];	RCV000081530.2 [benign]; RCV000126784.1 [benign]; 	CS016047 [CLASS=DM? MUT=ALT PHEN="Malonyl-CoA decarboxylase deficiency" GENE=MLYCD]; 		0.0152	0.0985	0.8864	3	33	2	n/a
chr16	83941821	83941821	G	A	het		QUAL=5996;DP=249;AF=0.45;MQM=60;TRIO=HET,249,0.45,HET,156,0.51,WT,209,0.00	MLYCD	synonymous	MLYCD:NM_012213.2:synonymous:LOW:exon3/5:c.732G>A:p.Ser244Ser		rs2278038	0.0481	0.056	0.0459	0.0115						606761 [MLYCD (provisional) Malonyl-CoA decarboxylase deficiency];	RCV000126785.1 [benign]; 		COSM3755130	0.0152	0.0985	0.8864	3	33	n/a	n/a
chr16	83949506	83949506	T	C	het		QUAL=11426;DP=431;AF=0.52;MQM=60;TRIO=HET,431,0.52,HET,297,0.45,WT,346,0.00	MLYCD	3'UTR	MLYCD:NM_012213.2:3'UTR:MODIFIER:exon5/5:c.*412T>C:		rs1127382	0.1556	0	0	0										0.0227	0.1515	0.8258	3	21	n/a	n/a
chr16	85945231	85945231	C	T	het		QUAL=6835;DP=204;AF=0.47;MQM=60;TRIO=HET,204,0.47,HET,232,0.56,WT,235,0.00	IRF8	synonymous	IRF8:NM_002163.2:synonymous:LOW:exon4/9:c.414C>T:p.Cys138Cys		rs8052064	0.0875	0.123	0.1405	0.1303						601565 [IRF8 (provisional) Monocyte and dendritic cell deficiency,recessive|CD11C+/CD1C+ dendritic cell deficiency,dominant];				0.0227	0.2652	0.7121	9	102	n/a	n/a
chr16	85955242	85955242	C	T	hom		QUAL=10781;DP=177;AF=1.00;MQM=60;TRIO=HOM,177,1.00,HET,159,0.52,HET,168,0.48	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*354C>T:		rs10514611	0.1905	0	0	0								CR127264 [CLASS=DFP MUT=ALT PHEN="Tuberculosis, association with" GENE=IRF8]; 		0.053	0.3636	0.5833	10	52	n/a	n/a
chr16	85955304	85955304	G	T	hom		QUAL=11944;DP=219;AF=1.00;MQM=60;TRIO=HOM,219,1.00,HOM,78,1.00,HOM,78,1.00	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*416G>T:		rs1568391	0.6751	0	0	0										0.3333	0.4697	0.197	50	70	n/a	n/a
chr16	85955671	85955671	C	T	hom		QUAL=31070;DP=372;AF=1.00;MQM=60;TRIO=HOM,372,1.00,HOM,268,1.00,HOM,304,1.00	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*783C>T:		rs1044873	0.3548	0	0	0										0.1591	0.5303	0.3106	25	76	n/a	n/a
chr16	85955730	85955730	A	-	hom		QUAL=29902;DP=310;AF=0.97;MQM=60;TRIO=HOM,310,0.97,HOM,306,0.99,HOM,349,0.99	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*843delA:		rs397844297	0.7362	0	0	0										0.3333	0.4697	0.197	50	71	n/a	n/a
chr16	85956044	85956044	A	T	hom		QUAL=4590;DP=114;AF=1.00;MQM=60;TRIO=HOM,114,1.00,HOM,16,1.00,HOM,16,1.00	IRF8	3'UTR	IRF8:NM_002163.2:3'UTR:MODIFIER:exon9/9:c.*1156A>T:		rs6638	0.6538	0	0	0										0.3333	0.4621	0.2045	50	69	n/a	n/a
chr16	88494947	88494947	T	C	hom		QUAL=11347;DP=70;AF=1.00;MQM=59;TRIO=HOM,70,1.00,HOM,113,1.00,HOM,190,0.99	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon1/2:c.1069T>C:p.Ser357Pro		rs11648572	0.989	0.973	0	0	-0.4430	P	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM4129466	0.9697	0.0303	0	413	26	n/a	n/a
chr16	88494976	88494976	A	C	hom		QUAL=12553;DP=103;AF=1.00;MQM=59;TRIO=HOM,103,1.00,HOM,120,1.00,HOM,183,1.00	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon1/2:c.1098A>C:p.Arg366Ser		rs11640794	0.855	0.901	0	0	0.5620	P	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];				0.9091	0.0833	0.0076	389	47	n/a	n/a
chr16	88495407	88495407	G	C	hom		QUAL=5122;DP=35;AF=1.00;MQM=59;TRIO=HOM,35,1.00,HOM,50,1.00,HOM,89,1.00	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon1/2:c.1529G>C:p.Gly510Ala		rs7199961	0.9916	0.998	0	0	0.1520	P	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM3755187	0.9924	0.0076	0	436	1	n/a	n/a
chr16	88495654	88495654	A	G	hom		QUAL=5857;DP=44;AF=1.00;MQM=59;TRIO=HOM,44,1.00,HOM,60,1.00,HOM,97,1.00	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon1/2:c.1776A>G:p.Pro592Pro		rs12927001	0.8748	0.906	0	0						612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM4129467	0.9242	0.0682	0.0076	394	49	n/a	n/a
chr16	88496008	88496008	T	C	het		QUAL=2538;DP=25;AF=0.36;MQM=59;TRIO=HET,25,0.36,HET,32,0.31,HOM,70,1.00	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon1/2:c.2130T>C:p.Pro710Pro		rs12918876	0.6044	0.644	0	0						612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM4129468	0.4848	0.4167	0.0985	226	154	n/a	n/a
chr16	88497031	88497031	T	C	hom		QUAL=1982;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,22,1.00,HOM,39,1.00	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon1/2:c.3153T>C:p.Ile1051Ile		rs9924504	1	1	0	0						612078 [ZNF469 (confirmed) Brittle cornea syndrome];				0.8409	0.0076	0.1515	416	1	n/a	n/a
chr16	88497394	88497394	T	C	het		QUAL=1863;DP=46;AF=0.48;MQM=59;TRIO=HET,46,0.48,WT,73,0.00,HET,75,0.55	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon2/2:c.3432T>C:p.Arg1144Arg		rs111557381	0.0381	0.043	0	0						612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM3755188	0	0.0758	0.9242	1	48	n/a	n/a
chr16	88497400	88497400	G	A	hom		QUAL=5818;DP=40;AF=1.00;MQM=59;TRIO=HOM,40,1.00,HOM,75,1.00,HOM,74,1.00	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon2/2:c.3438G>A:p.Pro1146Pro		rs9938800	0.9026	0.943	0	0						612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM3755189	0.8939	0.1061	0	390	25	n/a	n/a
chr16	88497446	88497446	A	G	het		QUAL=5403;DP=62;AF=0.61;MQM=59;TRIO=HET,62,0.61,HOM,86,1.00,HET,103,0.52	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon2/2:c.3484A>G:p.Lys1162Glu		rs7197071	0.8189	0.867	0.9243	0.5606	-0.3040	P	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM3755190	0.8258	0.1742	0	368	72	n/a	n/a
chr16	88498221	88498221	C	T	hom		QUAL=13234;DP=109;AF=1.00;MQM=59;TRIO=HOM,109,1.00,HOM,140,1.00,HOM,177,0.99	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon2/2:c.4259C>T:p.Pro1420Leu		rs4782300	0.8442	0.868	0.9157	0.789	2.7110	P	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM3755191	0.7803	0.2045	0.0152	368	75	n/a	n/a
chr16	88498297	88498297	T	G	hom		QUAL=18691;DP=132;AF=1.00;MQM=59;TRIO=HOM,132,1.00,HOM,234,1.00,HOM,244,1.00	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon2/2:c.4335T>G:p.Ser1445Ser		rs12445417	0.8464	0.918	0.9708	0.5383						612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM4129472	0.9167	0.0833	0	422	31	n/a	n/a
chr16	88499539	88499539	C	G	hom		QUAL=17868;DP=234;AF=1.00;MQM=59;TRIO=HOM,234,1.00,HOM,148,1.00,HOM,187,1.00	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon2/2:c.5577C>G:p.Thr1859Thr		rs9931465	0.7796	0.85	0.931	0.5643						612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM435898	0.803	0.1894	0.0076	374	74	n/a	n/a
chr16	88501034	88501034	G	C	het		QUAL=899;DP=45;AF=0.40;MQM=60;TRIO=HET,45,0.40,HET,17,0.53,HET,10,0.50	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon2/2:c.7072G>C:p.Gly2358Arg		rs12598474	0.2951	0.234	0	0	-1.1320	P	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM472205	0.1061	0.4242	0.4697	61	187	n/a	n/a
chr16	88501971	88501971	T	A	het		QUAL=4625;DP=66;AF=0.47;MQM=60;TRIO=HET,66,0.47,HET,97,0.53,HET,130,0.52	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon2/2:c.8009T>A:p.Leu2670Gln		rs3812956	0.2943	0.257	0.3909	0.2175	-1.0570	P	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM3755192	0.0909	0.4318	0.4773	57	188	n/a	n/a
chr16	88502482	88502482	C	T	het		QUAL=7396;DP=165;AF=0.58;MQM=59;TRIO=HET,165,0.58,HET,120,0.50,HET,159,0.55	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon2/2:c.8520C>T:p.Arg2840Arg		rs3812953	0.47	0.473	0	0						612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM435901	0.303	0.4848	0.2121	118	209	n/a	n/a
chr16	88502505	88502505	A	G	hom		QUAL=11596;DP=115;AF=1.00;MQM=59;TRIO=HOM,115,1.00,HOM,113,1.00,HOM,144,1.00	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon2/2:c.8543A>G:p.His2848Arg		rs1983014	0.9962	0.998	0.9997	0.9848	4.7990	P	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];				1	0	0	453	0	n/a	n/a
chr16	88504206	88504206	G	C	het		QUAL=3072;DP=48;AF=0.50;MQM=60;TRIO=HET,48,0.50,HET,211,0.39,WT,289,0.00	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon2/2:c.10244G>C:p.Gly3415Ala			0	0.0012	0	0	0.5390	N	T	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];				0	0.0152	0.9848	0	3	n/a	n/a
chr16	88504850	88504850	G	C	het		QUAL=8128;DP=118;AF=0.49;MQM=59;TRIO=HET,118,0.49,HET,172,0.52,HET,226,0.51	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon2/2:c.10888G>C:p.Glu3630Gln		rs1105066	0.391	0.314	0.4154	0.5329	-0.5190	P	T	P	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];				0.1439	0.4015	0.4545	76	191	n/a	n/a
chr16	88504868	88504868	A	G	hom		QUAL=14636;DP=87;AF=0.99;MQM=59;TRIO=HOM,87,0.99,HOM,166,1.00,HOM,230,1.00	ZNF469	missense	ZNF469:NM_001127464.1:missense:MODERATE:exon2/2:c.10906A>G:p.Thr3636Ala		rs904783	0.9992	0.999	1	0.9993	-1.3970	P	D	B	B	612078 [ZNF469 (confirmed) Brittle cornea syndrome];			COSM4129476	1	0	0	467	0	n/a	n/a
chr16	88505635	88505635	A	G	het		QUAL=10888;DP=124;AF=0.46;MQM=59;TRIO=HET,124,0.46,HET,180,0.52,HOM,203,1.00	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon2/2:c.11673A>G:p.Pro3891Pro		rs4782301	0.7963	0.755	0.7657	0.7984						612078 [ZNF469 (confirmed) Brittle cornea syndrome];				0.6515	0.2576	0.0909	284	146	n/a	n/a
chr16	88505734	88505734	C	T	hom		QUAL=21579;DP=202;AF=1.00;MQM=60;TRIO=HOM,202,1.00,HOM,207,1.00,HOM,255,1.00	ZNF469	synonymous	ZNF469:NM_001127464.1:synonymous:LOW:exon2/2:c.11772C>T:p.Ser3924Ser		rs4782362	0.9872	0.995	1	0.9603						612078 [ZNF469 (confirmed) Brittle cornea syndrome];				1	0	0	449	1	n/a	n/a
chr16	88505748	88505748	G	A	het		QUAL=4733;DP=167;AF=0.42;MQM=60;TRIO=HET,167,0.42,HET,193,0.43,WT,234,0.00	ZNF469	3'UTR	ZNF469:NM_001127464.1:3'UTR:MODIFIER:exon2/2:c.*8G>A:		rs45504291	0.2214	0.201	0	0										0.0833	0.3106	0.6061	25	145	n/a	n/a
chr16	88506358	88506358	T	G	hom		QUAL=31799;DP=279;AF=1.00;MQM=59;TRIO=HOM,279,1.00,HOM,336,1.00,HOM,379,1.00	ZNF469	3'UTR	ZNF469:NM_001127464.1:3'UTR:MODIFIER:exon2/2:c.*618T>G:		rs3859020	0.9473	0	0	0										0.9773	0.0227	0	146	4	n/a	n/a
chr16	88506528	88506528	G	A	hom		QUAL=20958;DP=189;AF=0.99;MQM=59;TRIO=HOM,189,0.99,HOM,205,1.00,HOM,290,1.00	ZNF469	3'UTR	ZNF469:NM_001127464.1:3'UTR:MODIFIER:exon2/2:c.*788G>A:		rs3894713	0.9862	0	0	0										1	0	0	150	0	n/a	n/a
chr16	88506600	88506600	T	-	het		QUAL=11559;DP=166;AF=0.46;MQM=60;TRIO=HET,166,0.46,HET,195,0.46,HOM,241,0.93	ZNF469	3'UTR	ZNF469:NM_001127464.1:3'UTR:MODIFIER:exon2/2:c.*870delT:		rs35684712	0.5501	0	0	0										0.4318	0.4242	0.1439	67	63	n/a	n/a
chr16	88506741	88506741	A	G	hom		QUAL=11932;DP=115;AF=1.00;MQM=60;TRIO=HOM,115,1.00,HOM,132,0.99,HOM,130,1.00	ZNF469	3'UTR	ZNF469:NM_001127464.1:3'UTR:MODIFIER:exon2/2:c.*1001A>G:		rs3848234	0.8409	0	0	0										0.75	0.2348	0.0152	114	34	n/a	n/a
chr16	88713236	88713236	A	G	hom		QUAL=22024;DP=186;AF=1.00;MQM=59;TRIO=HOM,186,1.00,HET,310,0.48,HOM,385,1.00	CYBA	missense	CYBA:NM_000101.3:missense:MODERATE:exon4/6:c.214T>C:p.Tyr72His		rs4673	0.6643	0.69	0.6565	0.5532	4.4150	P	T	D	D	608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA];	RCV000002351.1 [benign]; 	CM983302 [CLASS=DFP MUT=REF PHEN="Coronary artery disease, lower risk, association" GENE=CYBA]; 	COSM3755197	0.3939	0.4621	0.1439	173	215	n/a	n/a
chr16	88713501	88713501	A	G	hom		QUAL=5440;DP=90;AF=1.00;MQM=59;TRIO=HOM,90,1.00,HET,54,0.46,HOM,62,1.00	CYBA	splice_region&intron	CYBA:NM_000101.3:splice_region&intron:LOW:exon3/5:c.203+8T>C:		rs4782393	0.366	0.467	0.5036	0.3154						608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA];				0.2424	0.447	0.3106	103	203	n/a	n/a
chr16	88717386	88717386	T	C	hom		QUAL=1491;DP=20;AF=1.00;MQM=60;TRIO=HOM,20,1.00,HOM,11,1.00,HOM,20,1.00	CYBA	synonymous	CYBA:NM_000101.3:synonymous:LOW:exon1/6:c.36A>G:p.Glu12Glu		rs8053867	0.9956	0.999	1	0.9918						608508 [CYBA (confirmed) Chronic granulomatous disease,autosomal,due to deficiency of CYBA];			COSM4129484	0.9773	0	0.0227	448	0	n/a	n/a
chr16	89238190	89238190	G	A	hom		QUAL=6078;DP=89;AF=1.00;MQM=59;TRIO=HOM,89,1.00,HOM,89,0.98,HET,76,0.53	CDH15	5'UTR	CDH15:NM_004933.2:5'UTR:MODIFIER:exon1/14:c.-50G>A:		rs12927793	0.251	0.326	0.5528	0.1606										0.3106	0.4848	0.2045	46	78	n/a	n/a
chr16	89597221	89597221	A	G	het		QUAL=19571;DP=137;AF=0.50;MQM=59;TRIO=HET,137,0.50,HOM,358,1.00,HET,443,0.50	SPG7	splice_region&intron	SPG7:NM_003119.3:splice_region&intron:LOW:exon7/16:c.987+5A>G:,SPG7:NM_199367.2:splice_region&intron:LOW:exon7/9:c.987+5A>G:		rs4785691	0.5294	0.473	0.4448	0.4231						602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive];				0.2197	0.5	0.2803	265	539	n/a	n/a
chr16	89603586	89603586	A	G	het		QUAL=7076;DP=143;AF=0.47;MQM=59;TRIO=HET,143,0.47,HOM,101,1.00,HET,140,0.44	SPG7	3'UTR,intron	SPG7:NM_199367.2:3'UTR:MODIFIER:exon10/10:c.*268A>G:,SPG7:NM_003119.3:intron:MODIFIER:exon9/16:c.1324+4542A>G:		rs382745	0.5387	0	0	0						602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive];				0.2197	0.5	0.2803	33	76	n/a	n/a
chr16	89603698	89603698	-	T	het		QUAL=3324;DP=130;AF=0.35;MQM=60;TRIO=HET,130,0.35,WT,82,0.00,HET,116,0.56	SPG7	3'UTR,intron	SPG7:NM_199367.2:3'UTR:MODIFIER:exon10/10:c.*380_*381insT:,SPG7:NM_003119.3:intron:MODIFIER:exon9/16:c.1324+4654_1324+4655insT:		rs3833827	0.4359	0	0	0						602783 [SPG7 (provisional) Spastic paraplegia 7,autosomal recessive];				0.2803	0.5076	0.2121	41	77	n/a	n/a
chr16	89623746	89623746	G	T	het		QUAL=5171;DP=215;AF=0.46;MQM=60;TRIO=HET,215,0.46,WT,120,0.00,HET,141,0.48	SPG7	3'UTR	SPG7:NM_003119.3:3'UTR:MODIFIER:exon17/17:c.*245G>T:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chr16	89804336	89804336	T	-	het		QUAL=6414;DP=217;AF=0.39;MQM=59;TRIO=HET,217,0.39,WT,232,0.00,HET,291,0.44	FANCA,ZNF276	3'UTR,intron	FANCA:NM_000135.2:3'UTR:MODIFIER:exon43/43:c.*673delA:,FANCA:NM_001286167.1:3'UTR:MODIFIER:exon43/43:c.*770delA:,ZNF276:NM_001113525.1:intron:MODIFIER:exon10/10:c.1574+23delT:,ZNF276:NM_152287.3:intron:MODIFIER:exon10/10:c.1349+23delT:		rs17233826	0	0.485	0	0										0.1364	0.4318	0.4318	22	71	n/a	n/a
chr16	89804855	89804855	C	T	het		QUAL=11729;DP=312;AF=0.51;MQM=60;TRIO=HET,312,0.51,WT,328,0.00,HET,442,0.47	ZNF276,FANCA	3'UTR	ZNF276:NM_001113525.1:3'UTR:MODIFIER:exon11/11:c.*201C>T:,FANCA:NM_000135.2:3'UTR:MODIFIER:exon43/43:c.*154G>A:,ZNF276:NM_152287.3:3'UTR:MODIFIER:exon11/11:c.*201C>T:,FANCA:NM_001286167.1:3'UTR:MODIFIER:exon43/43:c.*251G>A:		rs1230	0.6977	0	0	0										0.1591	0.4545	0.3864	25	69	n/a	n/a
chr16	89836323	89836323	C	T	het		QUAL=7757;DP=212;AF=0.48;MQM=60;TRIO=HET,212,0.48,WT,200,0.00,HET,270,0.53	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:NM_001286167.1:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp		rs7195066	0.6667	0.467	0.3142	0.6586	0.3050	P	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120927.1 [not provided]; 	CM137288 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA]; 	COSM435949	0.1061	0.4848	0.4091	110	401	2	n/a
chr16	89838078	89838078	A	G	het		QUAL=5367;DP=129;AF=0.47;MQM=59;TRIO=HET,129,0.47,WT,191,0.00,HET,250,0.47	FANCA	splice_region&intron	FANCA:NM_000135.2:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.431	0.3077	0.5045						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				0.0909	0.4394	0.4697	85	395	n/a	n/a
chr16	89849480	89849480	C	T	het		QUAL=9467;DP=232;AF=0.53;MQM=60;TRIO=HET,232,0.53,WT,270,0.00,HET,317,0.55	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:NM_001286167.1:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.624	0.499	0.381	0.6804	-0.0380	P	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120917.1 [not provided]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer, association with" GENE=FANCA]; 		0.1515	0.5303	0.3182	165	473	n/a	n/a
chr16	89865103	89865103	T	A	het		QUAL=12465;DP=401;AF=0.49;MQM=60;TRIO=HET,401,0.49,WT,316,0.00,HET,410,0.47	FANCA	3'UTR,intron	FANCA:NM_001018112.1:3'UTR:MODIFIER:exon11/11:c.*384A>T:,FANCA:NM_000135.2:intron:MODIFIER:exon10/42:c.893+471A>T:,FANCA:NM_001286167.1:intron:MODIFIER:exon10/42:c.893+471A>T:		rs11076626	0.6913	0	0	0						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				0.1667	0.4545	0.3788	27	69	n/a	n/a
chr16	89865242	89865242	T	C	het		QUAL=6859;DP=209;AF=0.52;MQM=60;TRIO=HET,209,0.52,WT,191,0.00,HET,243,0.49	FANCA	3'UTR,intron	FANCA:NM_001018112.1:3'UTR:MODIFIER:exon11/11:c.*245A>G:,FANCA:NM_000135.2:intron:MODIFIER:exon10/42:c.893+332A>G:,FANCA:NM_001286167.1:intron:MODIFIER:exon10/42:c.893+332A>G:		rs10852623	0.6871	0	0	0						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				0.1667	0.4545	0.3788	27	69	n/a	n/a
chr16	89866043	89866043	T	C	het		QUAL=10037;DP=297;AF=0.47;MQM=60;TRIO=HET,297,0.47,WT,244,0.00,HET,331,0.50	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001286167.1:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001018112.1:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala		rs7190823	0.6905	0.517	0.3937	0.7257	0.4020	P	T	B,B,B,B,B,B	B,B,B,B,B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120967.1 [not provided]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer, association with" GENE=FANCA]; 		0.1667	0.4545	0.3788	150	434	n/a	n/a
chr17	1247850	1247851	AG	-	het		QUAL=3994;DP=227;AF=0.44;MQM=59;TRIO=HET,227,0.44,HET,102,0.38,WT,130,0.00	YWHAE	3'UTR	YWHAE:NM_006761.4:3'UTR:MODIFIER:exon6/6:c.*890_*891delCT:		rs147204530	0.0379	0	0	0										0.0152	0.1591	0.8258	2	21	n/a	n/a
chr17	1248466	1248466	C	T	het		QUAL=6224;DP=349;AF=0.44;MQM=60;TRIO=HET,349,0.44,HET,117,0.33,WT,160,0.00	YWHAE	3'UTR	YWHAE:NM_006761.4:3'UTR:MODIFIER:exon6/6:c.*275G>A:		rs7266	0.0379	0	0	0										0.0152	0.1591	0.8258	2	21	n/a	n/a
chr17	2586229	2586229	A	G	het		QUAL=27842;DP=577;AF=0.47;MQM=60;TRIO=HET,577,0.47,HET,321,0.47,HOM,415,1.00	PAFAH1B1	3'UTR	PAFAH1B1:NM_000430.3:3'UTR:MODIFIER:exon11/11:c.*1133A>G:		rs4790356	0.8367	0	0	0										0.8258	0.1742	0	126	24	n/a	n/a
chr17	2588917	2588931	TTTTTTTTTTTTTTT	-	hom		QUAL=244;DP=5;AF=0.80;MQM=60;TRIO=HOM,5,0.80,HOM,4,1.00,HOM,6,0.67				(T)n	rs529283484	0.9982	0	0	0										0.25	0.25	0.5	39	37	n/a	n/a
chr17	3377396	3377396	C	G	hom		QUAL=12845;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HET,108,0.49,HOM,131,1.00					rs11078450	0.1945	0	0	0										0.2652	0.4167	0.3182	39	63	n/a	n/a
chr17	3402521	3402521	C	A	hom		QUAL=12669;DP=204;AF=1.00;MQM=60;TRIO=HOM,204,1.00,HOM,87,1.00,HOM,108,1.00	ASPA	3'UTR	ASPA:NM_000049.2:3'UTR:MODIFIER:exon6/6:c.*139C>A:,ASPA:NM_001128085.1:3'UTR:MODIFIER:exon7/7:c.*139C>A:	L2a	rs1552830	0.9992	0	0	0										1	0	0	150	0	n/a	n/a
chr17	3540042	3540042	G	A	het		QUAL=3741;DP=139;AF=0.47;MQM=59;TRIO=HET,139,0.47,HET,111,0.51,WT,121,0.00	CTNS	5'UTR,intron	CTNS:NM_004937.2:5'UTR:MODIFIER:exon1/12:c.-313G>A:,CTNS:NM_001031681.2:intron:MODIFIER:exon1/12:c.-230+40G>A:		rs17707869	0.154	0	0	0										0.0455	0.3106	0.6439	6	42	n/a	n/a
chr17	3559823	3559823	G	A	het		QUAL=6845;DP=192;AF=0.46;MQM=60;TRIO=HET,192,0.46,HET,302,0.47,WT,416,0.00	CTNS	synonymous	CTNS:NM_001031681.2:synonymous:LOW:exon8/13:c.504G>A:p.Thr168Thr,CTNS:NM_004937.2:synonymous:LOW:exon8/12:c.504G>A:p.Thr168Thr		rs1800528	0.1506	0.179	0.1815	0.0468						606272 [CTNS (confirmed) Cystinosis,nephropathic|Cystinosis,ocular nonnephropathic|Cystinosis,late-onset juvenile or adolescent nephropathic|Cystinosis,atypical nephropathic];				0.0606	0.3409	0.5985	16	121	n/a	n/a
chr17	3561396	3561396	C	T	hom		QUAL=31801;DP=219;AF=1.00;MQM=59;TRIO=HOM,219,1.00,HOM,319,1.00,HOM,466,1.00	CTNS	missense	CTNS:NM_001031681.2:missense:MODERATE:exon10/13:c.779C>T:p.Thr260Ile,CTNS:NM_004937.2:missense:MODERATE:exon10/12:c.779C>T:p.Thr260Ile		rs161400	0.8183	0.918	0.9556	0.5994	2.3950	P	T	B,B,B	B,B,B	606272 [CTNS (confirmed) Cystinosis,nephropathic|Cystinosis,ocular nonnephropathic|Cystinosis,late-onset juvenile or adolescent nephropathic|Cystinosis,atypical nephropathic];				0.8712	0.1136	0.0152	391	57	n/a	n/a
chr17	3564068	3564068	G	A	het		QUAL=2980;DP=155;AF=0.46;MQM=59;TRIO=HET,155,0.46,HET,70,0.41,WT,87,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*40G>A:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*405G>A:		rs760273	0.1973	0.21	0.2036	0.1278										0.0606	0.3485	0.5909	8	51	n/a	n/a
chr17	3564073	3564073	A	G	het		QUAL=3154;DP=161;AF=0.48;MQM=59;TRIO=HET,161,0.48,HET,67,0.39,WT,89,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*45A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*410A>G:		rs3826496	0.1977	0.21	0.2035	0.1269										0.0606	0.3485	0.5909	8	51	n/a	n/a
chr17	3564084	3564084	T	C	het		QUAL=2932;DP=152;AF=0.49;MQM=59;TRIO=HET,152,0.49,HET,70,0.36,WT,94,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*56T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*421T>C:		rs760274	0.1973	0	0	0										0.0606	0.3485	0.5909	8	50	n/a	n/a
chr17	3564218	3564218	T	C	het		QUAL=5286;DP=248;AF=0.40;MQM=60;TRIO=HET,248,0.40,HET,184,0.40,WT,274,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*190T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*555T>C:		rs1048646	0.1983	0	0	0										0.0606	0.3485	0.5909	8	50	n/a	n/a
chr17	3564235	3564235	A	G	het		QUAL=6914;DP=313;AF=0.42;MQM=60;TRIO=HET,313,0.42,HET,208,0.42,WT,299,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*207A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*572A>G:		rs3826493	0.2053	0	0	0										0.0606	0.3485	0.5909	8	50	n/a	n/a
chr17	3564290	3564290	T	C	het		QUAL=7674;DP=343;AF=0.45;MQM=59;TRIO=HET,343,0.45,HET,203,0.45,WT,293,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*262T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*627T>C:	L3	rs1048647	0.1983	0	0	0										0.0606	0.3485	0.5909	8	50	n/a	n/a
chr17	3564294	3564294	T	C	het		QUAL=7674;DP=343;AF=0.45;MQM=59;TRIO=HET,343,0.45,HET,203,0.45,WT,293,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*266T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*631T>C:	L3	rs1048648	0.1981	0	0	0										0.0606	0.3485	0.5909	8	50	n/a	n/a
chr17	3564378	3564378	C	T	het		QUAL=7369;DP=253;AF=0.49;MQM=59;TRIO=HET,253,0.49,HET,184,0.59,WT,245,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*350C>T:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*715C>T:		rs1048649	0.1967	0	0	0										0.0606	0.3485	0.5909	8	50	n/a	n/a
chr17	3564401	3564401	T	G	hom		QUAL=22919;DP=266;AF=1.00;MQM=60;TRIO=HOM,266,1.00,HOM,174,1.00,HOM,259,1.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*373T>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*738T>G:		rs224562	0.9954	0	0	0										1	0	0	150	0	n/a	n/a
chr17	3564687	3564687	C	T	het		QUAL=4194;DP=154;AF=0.27;MQM=59;TRIO=HET,154,0.27,HET,276,0.41,WT,491,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*659C>T:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1024C>T:		rs1048673	0.1947	0	0	0										0.0758	0.3409	0.5833	10	49	n/a	n/a
chr17	3564688	3564688	A	G	het		QUAL=4194;DP=154;AF=0.27;MQM=59;TRIO=HET,154,0.27,HET,276,0.41,WT,491,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*660A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1025A>G:		rs1048674	0.1939	0	0	0										0.0758	0.3409	0.5833	10	49	n/a	n/a
chr17	3564693	3564693	-	GTC	het		QUAL=2047;DP=133;AF=0.18;MQM=59;TRIO=HET,133,0.18,HET,237,0.32,WT,477,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*666_*668dupGTC:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1031_*1033dupGTC:		rs397831765	0.1923	0	0	0										0.0758	0.3333	0.5909	10	48	n/a	n/a
chr17	3564716	3564716	T	G	het		QUAL=5820;DP=183;AF=0.43;MQM=59;TRIO=HET,183,0.43,HET,239,0.47,WT,391,0.01	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*688T>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1053T>G:		rs1048677	0	0	0	0										0.0758	0.2348	0.6894	10	35	n/a	n/a
chr17	3564779	3564779	C	T	het		QUAL=4708;DP=213;AF=0.40;MQM=59;TRIO=HET,213,0.40,HET,197,0.38,WT,342,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*751C>T:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1116C>T:		rs1048682	0.1929	0	0	0										0.0682	0.3409	0.5909	9	49	n/a	n/a
chr17	3564815	3564815	A	G	het		QUAL=4369;DP=217;AF=0.41;MQM=60;TRIO=HET,217,0.41,HET,148,0.36,WT,278,0.01	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*787A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1152A>G:		rs2235104	0.1871	0	0	0										0.0758	0.3333	0.5909	10	48	n/a	n/a
chr17	3564837	3564838	CT	-	het		QUAL=4051;DP=263;AF=0.38;MQM=59;TRIO=HET,263,0.38,HET,136,0.33,WT,255,0.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*811_*812delCT:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1176_*1177delCT:		rs397857879	0.1931	0	0	0										0.0758	0.3333	0.5909	10	48	n/a	n/a
chr17	3565103	3565103	A	G	het		QUAL=5465;DP=140;AF=0.46;MQM=60;TRIO=HET,140,0.46,HOM,108,1.00,WT,158,0.01	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*1075A>G:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1440A>G:		rs161398	0.742	0	0	0										0.4697	0.3864	0.1439	67	60	n/a	n/a
chr17	3565606	3565606	A	-	het		QUAL=7959;DP=129;AF=0.76;MQM=58;TRIO=HET,129,0.76,HET,97,0.79,HET,154,0.80	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*1592delA:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*1957delA:	AluSq2	rs397856854	0.4742	0	0	0										0.4318	0.2803	0.2879	66	40	n/a	n/a
chr17	3565969	3565969	T	C	hom		QUAL=21262;DP=199;AF=0.99;MQM=59;TRIO=HOM,199,0.99,HOM,215,1.00,HOM,260,1.00	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*1941T>C:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*2306T>C:		rs161397	0.6384	0	0	0										0.6667	0.303	0.0303	100	45	n/a	n/a
chr17	3566045	3566045	-	C	hom		QUAL=11749;DP=109;AF=0.95;MQM=59;TRIO=HOM,109,0.95,HOM,135,0.99,HOM,153,0.98	CTNS	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*2018dupC:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*2383dupC:		rs397702352	0.7676	0	0	0										0.697	0.2727	0.0303	105	41	n/a	n/a
chr17	3566232	3566232	C	T	het		QUAL=6617;DP=232;AF=0.54;MQM=60;TRIO=HET,232,0.54,HOM,104,1.00,WT,126,0.01	CTNS,TAX1BP3	3'UTR	CTNS:NM_001031681.2:3'UTR:MODIFIER:exon13/13:c.*2204C>T:,TAX1BP3:NM_014604.3:3'UTR:MODIFIER:exon4/4:c.*810G>A:,CTNS:NM_004937.2:3'UTR:MODIFIER:exon12/12:c.*2569C>T:,TAX1BP3:NM_001204698.1:3'UTR:MODIFIER:exon3/3:c.*810G>A:		rs7093	0.3616	0	0	0										0.1667	0.4242	0.4091	22	64	n/a	n/a
chr17	4801125	4801125	C	G	het		QUAL=632;DP=20;AF=0.50;MQM=60;TRIO=HET,20,0.50,HET,25,0.64,WT,31,0.00	MINK1,CHRNE	3'UTR	MINK1:NM_153827.4:3'UTR:MODIFIER:exon32/32:c.*543C>G:,CHRNE:NM_000080.3:3'UTR:MODIFIER:exon12/12:c.*906G>C:,MINK1:NM_001024937.3:3'UTR:MODIFIER:exon32/32:c.*543C>G:,MINK1:NM_015716.4:3'UTR:MODIFIER:exon31/31:c.*543C>G:,MINK1:NM_170663.4:3'UTR:MODIFIER:exon32/32:c.*543C>G:		rs9914357	0.2153	0	0	0										0	0.1515	0.8485	0	21	n/a	n/a
chr17	4801273	4801273	-	CTC	het		QUAL=1695;DP=21;AF=0.86;MQM=58;TRIO=HET,21,0.86,HET,18,0.67,HOM,39,0.87	MINK1,CHRNE	3'UTR	MINK1:NM_153827.4:3'UTR:MODIFIER:exon32/32:c.*693_*695dupTCC:,CHRNE:NM_000080.3:3'UTR:MODIFIER:exon12/12:c.*755_*757dupGAG:,MINK1:NM_001024937.3:3'UTR:MODIFIER:exon32/32:c.*693_*695dupTCC:,MINK1:NM_015716.4:3'UTR:MODIFIER:exon31/31:c.*693_*695dupTCC:,MINK1:NM_170663.4:3'UTR:MODIFIER:exon32/32:c.*693_*695dupTCC:		rs538982347	0	0	0	0										0.6136	0.2879	0.0985	93	43	n/a	n/a
chr17	4801286	4801286	C	T	hom		QUAL=2255;DP=28;AF=0.96;MQM=60;TRIO=HOM,28,0.96,HOM,21,0.81,HOM,39,0.95	MINK1,CHRNE	3'UTR	MINK1:NM_153827.4:3'UTR:MODIFIER:exon32/32:c.*704C>T:,CHRNE:NM_000080.3:3'UTR:MODIFIER:exon12/12:c.*745G>A:,MINK1:NM_001024937.3:3'UTR:MODIFIER:exon32/32:c.*704C>T:,MINK1:NM_015716.4:3'UTR:MODIFIER:exon31/31:c.*704C>T:,MINK1:NM_170663.4:3'UTR:MODIFIER:exon32/32:c.*704C>T:		rs1053751	0.7712	0	0	0										0.7045	0.2197	0.0758	107	32	n/a	n/a
chr17	4801288	4801288	A	C	hom		QUAL=2255;DP=28;AF=0.96;MQM=58;TRIO=HOM,28,0.96,HOM,21,0.81,HET,39,0.95	MINK1,CHRNE	3'UTR	MINK1:NM_153827.4:3'UTR:MODIFIER:exon32/32:c.*706A>C:,CHRNE:NM_000080.3:3'UTR:MODIFIER:exon12/12:c.*743T>G:,MINK1:NM_001024937.3:3'UTR:MODIFIER:exon32/32:c.*706A>C:,MINK1:NM_015716.4:3'UTR:MODIFIER:exon31/31:c.*706A>C:,MINK1:NM_170663.4:3'UTR:MODIFIER:exon32/32:c.*706A>C:		rs1053754	0.3662	0	0	0										0.3636	0.4091	0.2273	55	60	n/a	n/a
chr17	4802685	4802685	G	A	het		QUAL=2718;DP=100;AF=0.54;MQM=60;TRIO=HET,100,0.54,HET,58,0.71,WT,84,0.00	CHRNE	splice_region&intron	CHRNE:NM_000080.3:splice_region&intron:LOW:exon9/11:c.1033-6C>T:		rs2075763	0.1062	0.051	0.0534	0.0358						100725 [CHRNE (confirmed) Myasthenic syndrome,slow-channel congenital|Myasthenic syndrome,fast-channel congenital|Myasthenic syndrome,congenital,associated with acetylcholine receptor deficiency];	RCV000116734.2 [likely benign]; 			0	0.1439	0.8561	4	54	n/a	n/a
chr17	7127718	7127718	T	C	het		QUAL=7365;DP=268;AF=0.50;MQM=60;TRIO=HET,268,0.50,HET,240,0.47,WT,265,0.00	ACADVL	splice_region&intron	ACADVL:NM_001270447.1:splice_region&intron:LOW:exon17/20:c.1674+6T>C:,ACADVL:NM_000018.3:splice_region&intron:LOW:exon16/19:c.1605+6T>C:,ACADVL:NM_001033859.2:splice_region&intron:LOW:exon15/18:c.1539+6T>C:,ACADVL:NM_001270448.1:splice_region&intron:LOW:exon15/18:c.1377+6T>C:		rs17671352	0.5198	0.598	0.6261	0.4362						609575 [ACADVL (confirmed) VLCAD deficiency];	RCV000077908.2 [benign]; RCV000123479.1 [benign]; 			0.4621	0.4167	0.1212	212	188	n/a	n/a
chr17	7360110	7360110	T	C	het		QUAL=11986;DP=342;AF=0.52;MQM=60;TRIO=HET,342,0.52,WT,264,0.00,HET,362,0.54	CHRNB1	3'UTR	CHRNB1:NM_000747.2:3'UTR:MODIFIER:exon11/11:c.*68T>C:		rs2302764	0.3057	0	0	0										0.0152	0.2803	0.7045	2	44	n/a	n/a
chr17	7490810	7490810	G	A	het		QUAL=9981;DP=316;AF=0.49;MQM=60;TRIO=HET,316,0.49,HOM,170,1.00,WT,156,0.01	MPDU1	missense	MPDU1:NM_004870.3:missense:MODERATE:exon7/7:c.685G>A:p.Ala229Thr		rs10852891	0.1562	0.154	0.1673	0.1766	0.8700	P,P	T,T	P,.	B,.	604041 [MPDU1 (confirmed) Congenital disorder of glycosylation,type If];	RCV000081188.2 [benign]; 		COSM3766188	0.0076	0.2121	0.7803	12	85	n/a	n/a
chr17	7491177	7491177	G	T	hom		QUAL=36033;DP=350;AF=1.00;MQM=59;TRIO=HOM,350,1.00,HOM,305,1.00,HOM,442,1.00	MPDU1	3'UTR	MPDU1:NM_004870.3:3'UTR:MODIFIER:exon7/7:c.*308G>T:		rs4227	0.6819	0.655	0	0						604041 [MPDU1 (confirmed) Congenital disorder of glycosylation,type If];				0.553	0.3712	0.0758	166	103	n/a	n/a
chr17	10297658	10297658	A	G	het		QUAL=15747;DP=442;AF=0.49;MQM=55;TRIO=HET,442,0.49,WT,515,0.00,HET,608,0.45	MYH8	missense	MYH8:NM_002472.2:missense:MODERATE:exon35/40:c.5074T>C:p.Trp1692Arg		rs8069834	0.4854	0.509	0.583	0.7208	0.9480	P	T	B	B	160741 [MYH8 (confirmed) Carney complex variant|Trismus-pseudocamptodactyly syndrome];	RCV000117692.1 [benign]; 		COSM3765969	0.3409	0.4318	0.2273	158	208	n/a	n/a
chr17	10304500	10304500	C	T	het		QUAL=7952;DP=315;AF=0.46;MQM=60;TRIO=HET,315,0.46,WT,111,0.00,HET,165,0.62	MYH8	synonymous	MYH8:NM_002472.2:synonymous:LOW:exon25/40:c.3117G>A:p.Gly1039Gly		rs3744553	0.0505	0.059	0.0634	0.0211						160741 [MYH8 (confirmed) Carney complex variant|Trismus-pseudocamptodactyly syndrome];	RCV000117687.1 [benign]; 		COSM3999995	0.0076	0.1288	0.8636	3	52	n/a	n/a
chr17	10318636	10318636	A	G	het		QUAL=32099;DP=576;AF=0.53;MQM=59;TRIO=HET,576,0.53,HOM,425,1.00,HET,515,0.48	MYH8	synonymous	MYH8:NM_002472.2:synonymous:LOW:exon8/40:c.714T>C:p.Thr238Thr		rs8068729	0.8624	0.922	0.9457	0.6829						160741 [MYH8 (confirmed) Carney complex variant|Trismus-pseudocamptodactyly syndrome];	RCV000117694.1 [benign]; 			0.803	0.1894	0.0076	367	83	n/a	n/a
chr17	10324980	10324980	C	T	het		QUAL=9005;DP=258;AF=0.44;MQM=60;TRIO=HET,258,0.44,HOM,87,0.99,HET,150,0.53	MYH8	splice_region,5'UTR	MYH8:NM_002472.2:splice_region:LOW:exon2/40:c.-31G>A:,MYH8:NM_002472.2:5'UTR:MODIFIER:exon2/40:c.-31G>A:		rs2277648	0.4365	0	0	0										0.1515	0.3939	0.4545	20	65	n/a	n/a
chr17	10427924	10427924	G	A	het		QUAL=22136;DP=378;AF=0.42;MQM=48;TRIO=HET,378,0.42,HET,485,0.47,HET,598,0.51	MYH2	synonymous	MYH2:NM_001100112.1:synonymous:LOW:exon35/40:c.5034C>T:p.Ala1678Ala,MYH2:NM_017534.5:synonymous:LOW:exon35/40:c.5034C>T:p.Ala1678Ala		rs1042236	0.3189	0.256	0.1572	0.113						160740 [MYH2 (confirmed) Inclusion body myopathy-3];			COSM3765976	0.0303	0.2576	0.7121	7	114	n/a	n/a
chr17	10448769	10448769	A	T	het		QUAL=15442;DP=255;AF=0.47;MQM=59;TRIO=HET,255,0.47,HOM,224,0.99,HET,297,0.49	MYH2	synonymous	MYH2:NM_001100112.1:synonymous:LOW:exon5/40:c.399T>A:p.Pro133Pro,MYH2:NM_017534.5:synonymous:LOW:exon5/40:c.399T>A:p.Pro133Pro		rs11078850	0.5168	0.481	0.4083	0.332						160740 [MYH2 (confirmed) Inclusion body myopathy-3];				0.2348	0.4318	0.3333	82	223	n/a	n/a
chr17	10450816	10450816	T	C	het		QUAL=22413;DP=286;AF=0.45;MQM=59;TRIO=HET,286,0.45,HOM,351,1.00,HET,437,0.53	MYH2	synonymous	MYH2:NM_001100112.1:synonymous:LOW:exon4/40:c.324A>G:p.Glu108Glu,MYH2:NM_017534.5:synonymous:LOW:exon4/40:c.324A>G:p.Glu108Glu		rs12600539	0.5435	0.492	0.4126	0.4004						160740 [MYH2 (confirmed) Inclusion body myopathy-3];			COSM3765977	0.2424	0.4318	0.3258	90	219	n/a	n/a
chr17	10453015	10453015	T	C	het		QUAL=8960;DP=414;AF=0.42;MQM=60;TRIO=HET,414,0.42,HET,253,0.46,WT,342,0.00	MYH2	5'UTR_premature_start_codon_gain,5'UTR	MYH2:NM_017534.5:5'UTR_premature_start_codon_gain:LOW:exon1/40:c.-126A>G:,MYH2:NM_017534.5:5'UTR:MODIFIER:exon1/40:c.-126A>G:		rs74967762	0.0765	0	0	0										0	0.0758	0.9242	0	10	n/a	n/a
chr17	10536018	10536018	G	A	het		QUAL=20972;DP=306;AF=0.48;MQM=60;TRIO=HET,306,0.48,WT,365,0.00,HOM,501,1.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon34/41:c.4731C>T:p.Ile1577Ile		rs2285479	0.4696	0.609	0.7287	0.301						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];	RCV000117675.1 [benign]; 		COSM4000000	0.4015	0.4621	0.1364	195	198	n/a	n/a
chr17	10541515	10541515	C	T	het		QUAL=23647;DP=253;AF=0.50;MQM=59;TRIO=HET,253,0.50,WT,472,0.01,HOM,636,1.00	MYH3	missense	MYH3:NM_002470.3:missense:MODERATE:exon27/41:c.3574G>A:p.Ala1192Thr		rs2285477	0.5865	0.69	0.7892	0.574	-0.4290	P	T	B	B	160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];	RCV000117670.1 [benign]; 		COSM4000001	0.5	0.4091	0.0909	235	178	n/a	n/a
chr17	10541741	10541741	A	G	het		QUAL=3380;DP=62;AF=0.39;MQM=60;TRIO=HET,62,0.39,HOM,103,0.98,WT,190,0.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon27/41:c.3348T>C:p.Ile1116Ile		rs201626	0.261	0.185	0.0884	0.1301						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];	RCV000117669.1 [benign]; 		COSM1749857	0.0227	0.2424	0.7348	6	93	n/a	n/a
chr17	10542471	10542471	T	G	het		QUAL=10594;DP=272;AF=0.58;MQM=60;TRIO=HET,272,0.58,WT,141,0.01,HOM,170,0.99	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon25/41:c.3138A>C:p.Arg1046Arg		rs2285475	0.4665	0.608	0.7283	0.2955						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];	RCV000117668.1 [benign]; 		COSM4000003	0.4015	0.4621	0.1364	196	197	n/a	n/a
chr17	10542765	10542765	A	G	het		QUAL=9901;DP=204;AF=0.52;MQM=60;TRIO=HET,204,0.52,WT,155,0.01,HOM,200,1.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon24/41:c.2952T>C:p.Ser984Ser		rs2285474	0.4665	0.608	0.7287	0.2955						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];	RCV000117665.1 [benign]; 		COSM4000004	0.4015	0.4621	0.1364	195	195	n/a	n/a
chr17	10542886	10542886	T	C	het		QUAL=13210;DP=229;AF=0.48;MQM=60;TRIO=HET,229,0.48,WT,242,0.00,HOM,296,0.99	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon23/41:c.2916A>G:p.Thr972Thr		rs2285472	0.4663	0.608	0.7288	0.2955						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];	RCV000117664.1 [benign]; 		COSM4000005	0.4015	0.4621	0.1364	195	198	n/a	n/a
chr17	10543463	10543463	T	C	het		QUAL=18368;DP=252;AF=0.51;MQM=59;TRIO=HET,252,0.51,WT,364,0.01,HOM,437,1.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon22/41:c.2532A>G:p.Ala844Ala		rs2285469	0.4665	0.608	0.7288	0.2955						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];	RCV000117662.1 [benign]; 		COSM4000006	0.4015	0.4621	0.1364	196	197	n/a	n/a
chr17	10544416	10544416	G	T	het		QUAL=15744;DP=287;AF=0.48;MQM=60;TRIO=HET,287,0.48,WT,276,0.01,HOM,355,1.00	MYH3	synonymous	MYH3:NM_002470.3:synonymous:LOW:exon19/41:c.2151C>A:p.Gly717Gly		rs876657	0	0.608	0.7287	0.2948						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];	RCV000117661.1 [benign]; 		COSM4000007	0.4015	0.4621	0.1364	192	188	n/a	n/a
chr17	10544697	10544697	A	-	het		QUAL=10762;DP=205;AF=0.46;MQM=60;TRIO=HET,205,0.46,WT,198,0.01,HOM,260,0.98	MYH3	splice_region&intron	MYH3:NM_002470.3:splice_region&intron:LOW:exon17/40:c.1960-8delT:		rs397857823	0.4673	0	0	0						160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A|Arthrogryposis,distal,type 2B];				0.4318	0.4242	0.1439	195	150	n/a	n/a
chr17	10583714	10583714	G	C	hom		QUAL=14241;DP=234;AF=1.00;MQM=60;TRIO=HOM,234,1.00,HET,175,0.51,HET,200,0.57	SCO1	3'UTR	SCO1:NM_004589.3:3'UTR:MODIFIER:exon6/6:c.*722C>G:		rs7512	0.4778	0	0	0										0.1667	0.5303	0.303	28	79	n/a	n/a
chr17	10584116	10584116	C	T	hom		QUAL=14936;DP=145;AF=1.00;MQM=59;TRIO=HOM,145,1.00,HOM,151,1.00,HOM,218,1.00	SCO1	3'UTR	SCO1:NM_004589.3:3'UTR:MODIFIER:exon6/6:c.*320G>A:		rs2040570	1	0	0	0										1	0	0	150	0	n/a	n/a
chr17	13972811	13972811	G	A	hom		QUAL=467;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,HOM,2,1.00,HOM,10,1.00	COX10	5'UTR	COX10:NM_001303.3:5'UTR:MODIFIER:exon1/7:c.-112G>A:		rs6502330	0.9956	0	0	0										0.7273	0	0.2727	109	0	n/a	n/a
chr17	13980058	13980058	A	T	het		QUAL=11185;DP=429;AF=0.46;MQM=60;TRIO=HET,429,0.46,WT,229,0.00,HET,293,0.53	COX10	missense	COX10:NM_001303.3:missense:MODERATE:exon3/7:c.184A>T:p.Thr62Ser		rs2230351	0.0615	0.076	0.0681	0.0143	6.0420	P,P	.,T	.,B	.,B	602125 [COX10 (confirmed) Mitochondrial complex IV deficiency|Leigh syndrome due to mitochondrial COX4 deficiency];	RCV000124571.1 [benign]; 		COSM4000018	0.0076	0.1364	0.8561	4	48	n/a	n/a
chr17	13980350	13980350	G	A	het		QUAL=22188;DP=402;AF=0.54;MQM=60;TRIO=HET,402,0.54,HOM,276,1.00,HET,384,0.50	COX10	missense	COX10:NM_001303.3:missense:MODERATE:exon3/7:c.476G>A:p.Arg159Gln		rs2072279	0.4639	0.494	0.5156	0.4412	7.1630	P,P	D,T	B,B	B,B	602125 [COX10 (confirmed) Mitochondrial complex IV deficiency|Leigh syndrome due to mitochondrial COX4 deficiency];	RCV000124574.1 [benign]; 			0.2879	0.4773	0.2348	131	212	n/a	n/a
chr17	14095309	14095309	A	G	het		QUAL=7913;DP=180;AF=0.46;MQM=52;TRIO=HET,180,0.46,HOM,104,0.99,HET,155,0.48	COX10	synonymous	COX10:NM_001303.3:synonymous:LOW:exon6/7:c.699A>G:p.Pro233Pro		rs2230354	0.5483	0.585	0.5908	0.4805						602125 [COX10 (confirmed) Mitochondrial complex IV deficiency|Leigh syndrome due to mitochondrial COX4 deficiency];	RCV000124560.1 [benign]; 		COSM3765989	0.4167	0.4167	0.1667	167	202	n/a	n/a
chr17	14110669	14110670	TT	-	het		QUAL=3175;DP=160;AF=0.40;MQM=60;TRIO=HET,160,0.40,HET,105,0.46,WT,132,0.02	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*151_*152delTT:	AT_rich	rs200239586	0.2021	0	0	0										0.0455	0.1667	0.7879	7	28	n/a	n/a
chr17	14110852	14110852	T	C	het		QUAL=7417;DP=214;AF=0.48;MQM=60;TRIO=HET,214,0.48,HET,273,0.48,WT,396,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*322T>C:		rs11078233	0.1991	0	0	0										0.0227	0.2121	0.7652	4	35	n/a	n/a
chr17	14110901	14110901	A	G	het		QUAL=6587;DP=222;AF=0.47;MQM=60;TRIO=HET,222,0.47,HET,238,0.43,WT,340,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*371A>G:		rs11078234	0.2206	0	0	0										0.0227	0.2273	0.75	4	37	n/a	n/a
chr17	14111176	14111176	C	A	het		QUAL=7704;DP=244;AF=0.46;MQM=60;TRIO=HET,244,0.46,HET,257,0.53,WT,318,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*646C>A:		rs7214082	0.1995	0	0	0										0.0227	0.2273	0.75	4	37	n/a	n/a
chr17	14111287	14111287	T	C	het		QUAL=10141;DP=357;AF=0.48;MQM=60;TRIO=HET,357,0.48,HET,259,0.54,WT,307,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*757T>C:		rs1802618	0.2001	0	0	0										0.0227	0.2273	0.75	4	37	n/a	n/a
chr17	14111361	14111362	CT	-	het		QUAL=8094;DP=292;AF=0.45;MQM=60;TRIO=HET,292,0.45,HET,297,0.46,WT,374,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*833_*834delCT:		rs397763766	0.1999	0	0	0										0.0227	0.2273	0.75	4	37	n/a	n/a
chr17	14111606	14111606	T	C	het		QUAL=9595;DP=407;AF=0.51;MQM=60;TRIO=HET,407,0.51,HET,173,0.53,WT,207,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*1076T>C:		rs1050216	0.2133	0	0	0										0.0227	0.2273	0.75	4	37	n/a	n/a
chr17	14111797	14111797	A	G	het		QUAL=7681;DP=319;AF=0.51;MQM=60;TRIO=HET,319,0.51,HET,139,0.50,WT,169,0.00	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*1267A>G:		rs75844637	0.0086	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chr17	14111915	14111915	C	T	het		QUAL=8610;DP=300;AF=0.48;MQM=60;TRIO=HET,300,0.48,WT,158,0.00,HET,223,0.54	COX10	3'UTR	COX10:NM_001303.3:3'UTR:MODIFIER:exon7/7:c.*1385C>T:		rs1050223	0.2266	0	0	0										0.1288	0.4091	0.4621	21	64	n/a	n/a
chr17	15133706	15133707	AG	-	hom		QUAL=10361;DP=236;AF=0.89;MQM=60;TRIO=HOM,236,0.89,HET,122,0.39,HET,166,0.51	PMP22	3'UTR	PMP22:NM_000304.3:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:,PMP22:NM_153322.2:3'UTR:MODIFIER:exon4/4:c.*527_*528delCT:,PMP22:NM_001281455.1:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:,PMP22:NM_153321.2:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:,PMP22:NM_001281456.1:3'UTR:MODIFIER:exon5/5:c.*527_*528delCT:		rs71699667	0.3193	0	0	0										0.1364	0.5379	0.3258	21	80	n/a	n/a
chr17	15134175	15134175	T	G	hom		QUAL=25136;DP=307;AF=1.00;MQM=60;TRIO=HOM,307,1.00,HOM,299,1.00,HET,380,0.46	PMP22	3'UTR	PMP22:NM_000304.3:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:NM_153322.2:3'UTR:MODIFIER:exon4/4:c.*59A>C:,PMP22:NM_001281455.1:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:NM_153321.2:3'UTR:MODIFIER:exon5/5:c.*59A>C:,PMP22:NM_001281456.1:3'UTR:MODIFIER:exon5/5:c.*59A>C:		rs13422	0.5954	0.531	0	0										0.2424	0.5682	0.1894	36	86	n/a	n/a
chr17	15931693	15931693	G	A	het		QUAL=12030;DP=289;AF=0.51;MQM=60;TRIO=HET,289,0.51,HET,202,0.46,HET,247,0.52	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*857G>A:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*857G>A:		rs72821769	0.0327	0.048	0	0										0.0152	0.2045	0.7803	3	59	n/a	n/a
chr17	15932071	15932071	-	TT	hom		QUAL=6345;DP=120;AF=0.96;MQM=60;TRIO=HOM,120,0.96,HOM,60,0.98,HET,74,0.49	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*1236_*1237dupTT:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*1236_*1237dupTT:		rs386385756	0.4944	0.462	0	0										0.3939	0.5152	0.0909	113	138	n/a	n/a
chr17	15932420	15932420	-	GAG	het		QUAL=1441;DP=68;AF=0.29;MQM=59;TRIO=HET,68,0.29,WT,47,0.00,HET,85,0.35	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*1584_*1585insGAG:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*1584_*1585insGAG:			0	0.011	0	0										0	0.053	0.947	0	8	n/a	n/a
chr17	15932422	15932422	-	AGTAAAAA	het		QUAL=1442;DP=69;AF=0.30;MQM=59;TRIO=HET,69,0.30,WT,43,0.00,HET,85,0.35	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*1586_*1587insAGTAAAAA:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*1586_*1587insAGTAAAAA:			0	0.011	0	0										0	0.053	0.947	0	7	n/a	n/a
chr17	15932627	15932627	T	C	hom		QUAL=9529;DP=199;AF=1.00;MQM=60;TRIO=HOM,199,1.00,HOM,53,1.00,HET,84,0.45	TTC19	3'UTR	TTC19:NM_017775.3:3'UTR:MODIFIER:exon10/10:c.*1791T>C:,TTC19:NM_001271420.1:3'UTR:MODIFIER:exon10/10:c.*1791T>C:		rs9890012	0.3674	0.411	0	0										0.3636	0.5152	0.1212	102	143	n/a	n/a
chr17	16842912	16842912	A	G	het		QUAL=1078;DP=38;AF=0.37;MQM=60;TRIO=HET,38,0.37,HET,58,0.41,WT,65,0.00	TNFRSF13B	synonymous	TNFRSF13B:NM_012452.2:synonymous:LOW:exon5/5:c.831T>C:p.Ser277Ser		rs11078355	0.5952	0.492	0.4095	0.6147						604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2|Immunodeficiency,common variable,2];			COSM3766008	0.197	0.4924	0.3106	102	227	n/a	n/a
chr17	16852206	16852206	A	C	het		QUAL=7845;DP=232;AF=0.47;MQM=60;TRIO=HET,232,0.47,HET,283,0.48,WT,346,0.00	TNFRSF13B	synonymous	TNFRSF13B:NM_012452.2:synonymous:LOW:exon3/5:c.291T>G:p.Pro97Pro		rs35062843	0.0485	0.042	0.0344	0.0261						604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2|Immunodeficiency,common variable,2];				0.0076	0.0909	0.9015	1	40	n/a	n/a
chr17	16855878	16855878	C	T	hom		QUAL=18778;DP=164;AF=0.99;MQM=60;TRIO=HOM,164,0.99,HOM,189,0.99,HOM,265,0.99	TNFRSF13B	synonymous	TNFRSF13B:NM_012452.2:synonymous:LOW:exon2/5:c.81G>A:p.Thr27Thr		rs8072293	0.8996	0.811	0.7402	0.9451						604907 [TNFRSF13B (provisional) Immunoglobulin A deficiency 2|Immunodeficiency,common variable,2];	RCV000030561.1 [benign]; 			0.6288	0.2879	0.0833	253	154	n/a	n/a
chr17	17697106	17697108	CAG	-	het		QUAL=4938;DP=36;AF=0.36;MQM=60;TRIO=HET,36,0.36,HET,290,0.51,HET,359,0.09	RAI1	disruptive_inframe_deletion	RAI1:NM_030665.3:disruptive_inframe_deletion:MODERATE:exon3/6:c.870_872delGCA:p.Gln291del	(CAG)n		0	0	0	0						607642 [RAI1 (confirmed) Smith-Magenis syndrome];				0.1894	0.4848	0.3258	61	248	n/a	n/a
chr17	17698254	17698254	G	A	hom		QUAL=7912;DP=123;AF=1.00;MQM=59;TRIO=HOM,123,1.00,HOM,56,1.00,HOM,79,0.99	RAI1	synonymous	RAI1:NM_030665.3:synonymous:LOW:exon3/6:c.1992G>A:p.Pro664Pro		rs8067439	0.3998	0.506	0.6216	0.5611						607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000082257.4 [other]; 		COSM3766018	0.303	0.4924	0.2045	164	203	n/a	n/a
chr17	17700573	17700573	T	C	het		QUAL=3023;DP=160;AF=0.43;MQM=60;TRIO=HET,160,0.43,HET,56,0.63,WT,106,0.00	RAI1	synonymous	RAI1:NM_030665.3:synonymous:LOW:exon3/6:c.4311T>C:p.Pro1437Pro		rs4925112	0.0946	0.064	0.0602	0.2472						607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000082268.4 [other]; 			0.0076	0.1136	0.8788	3	45	n/a	n/a
chr17	17700792	17700792	C	T	het		QUAL=3524;DP=82;AF=0.37;MQM=60;TRIO=HET,82,0.37,HET,175,0.54,WT,227,0.00	RAI1	synonymous	RAI1:NM_030665.3:synonymous:LOW:exon3/6:c.4530C>T:p.Pro1510Pro		rs35686634	0.0731	0.058	0.0593	0.1735						607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000082270.4 [other]; 			0.0076	0.1136	0.8788	3	44	n/a	n/a
chr17	17707105	17707105	T	C	het		QUAL=14610;DP=186;AF=0.47;MQM=60;TRIO=HET,186,0.47,HET,212,0.58,HOM,249,1.00	RAI1	synonymous	RAI1:NM_030665.3:synonymous:LOW:exon4/6:c.5601T>C:p.Ile1867Ile		rs3818717	0.2406	0.421	0.5619	0.1897	-1.2000	P	T			607642 [RAI1 (confirmed) Smith-Magenis syndrome];	RCV000082273.4 [other]; 		COSM3766019	0.2348	0.4848	0.2803	129	219	n/a	n/a
chr17	17714717	17714717	G	A	het		QUAL=140;DP=39;AF=0.21;MQM=58;TRIO=HET,39,0.21,HET,14,0.14,HET,28,0.14	RAI1,SREBF1	3'UTR	RAI1:NM_030665.3:3'UTR:MODIFIER:exon6/6:c.*1422G>A:,SREBF1:NM_001005291.2:3'UTR:MODIFIER:exon20/20:c.*1219C>T:,SREBF1:NM_004176.4:3'UTR:MODIFIER:exon19/19:c.*1219C>T:			0	0	0	0										0	0.053	0.947	0	8	n/a	n/a
chr17	19578873	19578873	A	T	hom		QUAL=19679;DP=330;AF=1.00;MQM=60;TRIO=HOM,330,1.00,HET,239,0.51,HET,308,0.47	ALDH3A2	splice_region,splice_region&synonymous,3'UTR	ALDH3A2:NM_001031806.1:splice_region:LOW:exon11/11:c.*44A>T:,ALDH3A2:NM_000382.2:splice_region&synonymous:LOW:exon10/10:c.1446A>T:p.Ala482Ala,ALDH3A2:NM_001031806.1:3'UTR:MODIFIER:exon11/11:c.*44A>T:		rs7216	0.6785	0.615	0.5598	0.5329						609523 [ALDH3A2 (confirmed) Sjogren-Larsson syndrome];			COSM3766033	0.3561	0.4545	0.1894	223	372	n/a	n/a
chr17	19580494	19580494	A	G	hom		QUAL=24575;DP=524;AF=1.00;MQM=60;TRIO=HOM,524,1.00,HET,237,0.44,HET,285,0.43	ALDH3A2	3'UTR	ALDH3A2:NM_001031806.1:3'UTR:MODIFIER:exon11/11:c.*1665A>G:,ALDH3A2:NM_000382.2:3'UTR:MODIFIER:exon10/10:c.*1609A>G:		rs7215	0.6042	0	0	0										0.3333	0.4545	0.2121	49	71	n/a	n/a
chr17	19580761	19580762	AC	-	het		QUAL=5153;DP=141;AF=0.89;MQM=60;TRIO=HET,141,0.89,HET,57,0.49,HET,80,0.48	ALDH3A2	3'UTR	ALDH3A2:NM_001031806.1:3'UTR:MODIFIER:exon11/11:c.*1935_*1936delCA:,ALDH3A2:NM_000382.2:3'UTR:MODIFIER:exon10/10:c.*1879_*1880delCA:		rs397843671	0.3273	0	0	0										0.1288	0.4924	0.3788	19	74	n/a	n/a
chr17	26864302	26864302	G	C	het		QUAL=11789;DP=113;AF=0.60;MQM=59;TRIO=HET,113,0.60,HOM,190,1.00,HET,241,0.50	FOXN1	missense	FOXN1:NM_003593.2:missense:MODERATE:exon8/8:c.1795G>C:p.Ala599Pro		rs532648	0.3928	0.322	0.2813	0.5688	0.5980	P	T	B	B	600838 [FOXN1 (provisional) T-cell immunodeficiency,congenital alopecia,and nail dystrophy];			COSM4000076	0.0985	0.4394	0.4621	40	186	n/a	n/a
chr17	29483108	29483108	C	T	het		QUAL=5961;DP=239;AF=0.51;MQM=60;TRIO=HET,239,0.51,WT,189,0.00,HET,208,0.33	NF1	synonymous	NF1:NM_001042492.2:synonymous:LOW:exon2/58:c.168C>T:p.Ser56Ser,NF1:NM_001128147.2:synonymous:LOW:exon2/15:c.168C>T:p.Ser56Ser,NF1:NM_000267.3:synonymous:LOW:exon2/57:c.168C>T:p.Ser56Ser		rs17881168	0.0046	0.012	0.0209	0.0036						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Melanoma,desmoplastic neurotrophic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				0	0.0455	0.9545	1	40	n/a	n/a
chr17	29508775	29508775	G	A	het		QUAL=7635;DP=323;AF=0.45;MQM=60;TRIO=HET,323,0.45,WT,140,0.00,HET,186,0.46	NF1	synonymous	NF1:NM_001042492.2:synonymous:LOW:exon7/58:c.702G>A:p.Leu234Leu,NF1:NM_001128147.2:synonymous:LOW:exon7/15:c.702G>A:p.Leu234Leu,NF1:NM_000267.3:synonymous:LOW:exon7/57:c.702G>A:p.Leu234Leu		rs1801052	0.5118	0.622	0.7101	0.3098						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Melanoma,desmoplastic neurotrophic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];			COSM3755378	0.4394	0.4394	0.1212	432	377	n/a	n/a
chr17	29553485	29553485	G	A	het		QUAL=7629;DP=131;AF=0.54;MQM=59;TRIO=HET,131,0.54,HOM,110,1.00,HET,137,0.57	NF1	synonymous	NF1:NM_001042492.2:synonymous:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:NM_000267.3:synonymous:LOW:exon18/57:c.2034G>A:p.Pro678Pro		rs2285892	0.4968	0.382	0.2891	0.6648						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Melanoma,desmoplastic neurotrophic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				0.1212	0.4242	0.4545	83	380	n/a	n/a
chr17	29559088	29559088	C	T	het		QUAL=225;DP=63;AF=0.22;MQM=51;TRIO=HET,63,0.22,HET,25,0.08,WT,42,0.05	NF1	splice_region&intron	NF1:NM_001042492.2:splice_region&intron:LOW:exon24/57:c.3198-3C>T:,NF1:NM_000267.3:splice_region&intron:LOW:exon24/56:c.3198-3C>T:			0	0	0	0						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Melanoma,desmoplastic neurotrophic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				0	0.0152	0.9848	0	3	2	n/a
chr17	29702031	29702032	TA	-	het		QUAL=118;DP=6;AF=0.67;MQM=60;TRIO=HET,6,0.67,HOM,1,1.00,NONE,0,0	NF1	3'UTR	NF1:NM_001042492.2:3'UTR:MODIFIER:exon58/58:c.*873_*874delAT:,NF1:NM_000267.3:3'UTR:MODIFIER:exon57/57:c.*873_*874delAT:	AT_rich	rs397856963	0.5551	0	0	0										0.0985	0.2424	0.6591	14	41	n/a	n/a
chr17	29703374	29703374	G	A	het		QUAL=14036;DP=271;AF=0.54;MQM=60;TRIO=HET,271,0.54,HOM,182,0.99,HET,201,0.55	NF1	3'UTR	NF1:NM_001042492.2:3'UTR:MODIFIER:exon58/58:c.*2201G>A:,NF1:NM_000267.3:3'UTR:MODIFIER:exon57/57:c.*2201G>A:		rs7406983	0.5306	0	0	0										0.1212	0.447	0.4318	17	67	n/a	n/a
chr17	29703438	29703438	C	G	het		QUAL=11684;DP=330;AF=0.47;MQM=60;TRIO=HET,330,0.47,HOM,124,0.99,HET,134,0.58	NF1	3'UTR	NF1:NM_001042492.2:3'UTR:MODIFIER:exon58/58:c.*2265C>G:,NF1:NM_000267.3:3'UTR:MODIFIER:exon57/57:c.*2265C>G:		rs1800845	0.5587	0	0	0										0.1212	0.447	0.4318	17	67	n/a	n/a
chr17	29704002	29704002	T	C	het		QUAL=13394;DP=415;AF=0.50;MQM=60;TRIO=HET,415,0.50,WT,339,0.01,HET,431,0.51	NF1	3'UTR	NF1:NM_001042492.2:3'UTR:MODIFIER:exon58/58:c.*2829T>C:,NF1:NM_000267.3:3'UTR:MODIFIER:exon57/57:c.*2829T>C:		rs1048317	0.6126	0	0	0										0.4091	0.4167	0.1742	60	65	n/a	n/a
chr17	33901918	33901921	TAAG	-	het		QUAL=2244;DP=127;AF=0.48;MQM=60;TRIO=HET,127,0.48,HET,32,0.56,WT,41,0.00	PEX12	3'UTR	PEX12:NM_000286.2:3'UTR:MODIFIER:exon3/3:c.*880_*883delCTTA:		rs35050283	0.4465	0	0	0										0.2424	0.4545	0.303	36	68	n/a	n/a
chr17	33901965	33901965	C	G	het		QUAL=5844;DP=196;AF=0.54;MQM=60;TRIO=HET,196,0.54,HET,69,0.51,HET,91,0.46	PEX12	3'UTR	PEX12:NM_000286.2:3'UTR:MODIFIER:exon3/3:c.*836G>C:		rs10068	0.401	0	0	0										0.1667	0.4545	0.3788	25	65	n/a	n/a
chr17	33905468	33905468	A	G	hom		QUAL=13840;DP=173;AF=1.00;MQM=60;TRIO=HOM,173,1.00,HOM,166,1.00,HET,232,0.49	PEX12	5'UTR	PEX12:NM_000286.2:5'UTR:MODIFIER:exon1/3:c.-428T>C:		rs321600	0.8774	0	0	0										0.6061	0.3636	0.0303	91	53	n/a	n/a
chr17	37822311	37822311	A	C	het		QUAL=10253;DP=189;AF=0.51;MQM=60;TRIO=HET,189,0.51,WT,217,0.00,HOM,235,1.00	TCAP	synonymous	TCAP:NM_003673.3:synonymous:LOW:exon2/2:c.453A>C:p.Ala151Ala		rs1053651	0.5497	0.669	0.7122	0.4349						604488 [TCAP (confirmed) Muscular dystrophy,limb-girdle,type 2G|Cardiomyopathy,dilated,1N];	RCV000154431.1,RCV000037796.5 [benign,benign]; RCV000128377.1 [benign]; 		COSM436493	0.5606	0.3333	0.1061	267	205	n/a	n/a
chr17	38783971	38783972	TT	-	hom		QUAL=4113;DP=107;AF=0.99;MQM=59;TRIO=HOM,107,0.99,HOM,15,1.00,HOM,20,1.00					rs59835738	0	0	0	0										0.3636	0.3561	0.2803	53	56	n/a	n/a
chr17	40465420	40465420	G	A	het		QUAL=9;DP=31;AF=0.23;MQM=50;TRIO=HET,31,0.23,HET,34,0.09,HET,38,0.13	STAT3	3'UTR	STAT3:NM_139276.2:3'UTR:MODIFIER:exon24/24:c.*2343C>T:,STAT3:NM_213662.1:3'UTR:MODIFIER:exon24/24:c.*2437C>T:,STAT3:NM_003150.3:3'UTR:MODIFIER:exon24/24:c.*2343C>T:	(A)n	rs200029754	0	0	0	0										0	0.0455	0.9545	0	10	n/a	n/a
chr17	40465422	40465422	C	A	het		QUAL=9;DP=31;AF=0.23;MQM=50;TRIO=HET,31,0.23,HET,34,0.09,HET,38,0.13	STAT3	3'UTR	STAT3:NM_139276.2:3'UTR:MODIFIER:exon24/24:c.*2341G>T:,STAT3:NM_213662.1:3'UTR:MODIFIER:exon24/24:c.*2435G>T:,STAT3:NM_003150.3:3'UTR:MODIFIER:exon24/24:c.*2341G>T:	(A)n		0	0	0	0										0	0.0227	0.9773	0	7	n/a	n/a
chr17	40466092	40466092	G	A	het		QUAL=10239;DP=164;AF=0.55;MQM=60;TRIO=HET,164,0.55,HET,134,0.62,HOM,164,1.00	STAT3	3'UTR	STAT3:NM_139276.2:3'UTR:MODIFIER:exon24/24:c.*1671C>T:,STAT3:NM_213662.1:3'UTR:MODIFIER:exon24/24:c.*1765C>T:,STAT3:NM_003150.3:3'UTR:MODIFIER:exon24/24:c.*1671C>T:		rs1053004	0.4499	0	0	0										0.3636	0.5076	0.1288	59	72	n/a	n/a
chr17	40466869	40466869	C	T	het		QUAL=897;DP=172;AF=0.28;MQM=56;TRIO=HET,172,0.28,HET,52,0.15,HET,64,0.17	STAT3	3'UTR	STAT3:NM_139276.2:3'UTR:MODIFIER:exon24/24:c.*894G>A:,STAT3:NM_213662.1:3'UTR:MODIFIER:exon24/24:c.*988G>A:,STAT3:NM_003150.3:3'UTR:MODIFIER:exon24/24:c.*894G>A:	AluSc8		0	0	0	0										0	0.0455	0.9545	0	8	n/a	n/a
chr17	40689455	40689455	T	C	hom		QUAL=21536;DP=188;AF=0.99;MQM=60;TRIO=HOM,188,0.99,HOM,197,1.00,HOM,291,1.00	NAGLU	synonymous	NAGLU:NM_000263.3:synonymous:LOW:exon2/6:c.423T>C:p.Ser141Ser		rs659497	0.9976	0.995	0.9923	0.9995						609701 [NAGLU (confirmed) Mucopolysaccharidosis type IIIB (Sanfilippo B)];	RCV000078458.2 [benign]; 			1	0	0	450	4	n/a	n/a
chr17	40696233	40696233	C	G	hom		QUAL=2804;DP=42;AF=1.00;MQM=60;TRIO=HOM,42,1.00,HOM,17,1.00,HOM,30,1.00	NAGLU	missense	NAGLU:NM_000263.3:missense:MODERATE:exon6/6:c.2209C>G:p.Arg737Gly		rs86312	0.8592	0.905	0.9447	0.6618	0.8780	P	T	P	B	609701 [NAGLU (confirmed) Mucopolysaccharidosis type IIIB (Sanfilippo B)];	RCV000078456.2,RCV000078457.2 [benign,benign]; 		COSM4130095	0.9167	0.0833	0	388	59	n/a	n/a
chr17	42085150	42085150	T	C	hom		QUAL=338;DP=7;AF=1.00;MQM=59;TRIO=HOM,7,1.00,HOM,4,1.00,HOM,2,1.00	NAGS	splice_region&intron	NAGS:NM_153006.2:splice_region&intron:LOW:exon6/6:c.1451+9T>C:		rs228773	0.9603	0.927	0.9359	0.897						608300 [NAGS (confirmed) N-acetylglutamate synthase deficiency];				0.5833	0.0152	0.4015	349	29	n/a	n/a
chr17	42085972	42085972	C	T	hom		QUAL=16368;DP=263;AF=0.99;MQM=59;TRIO=HOM,263,0.99,HOM,144,1.00,HET,227,0.52	NAGS	3'UTR	NAGS:NM_153006.2:3'UTR:MODIFIER:exon7/7:c.*3C>T:		rs186636	0.4756	0.566	0.6483	0.4249										0.447	0.4621	0.0909	193	198	n/a	n/a
chr17	42086180	42086180	C	T	hom		QUAL=32635;DP=353;AF=1.00;MQM=60;TRIO=HOM,353,1.00,HOM,281,1.00,HOM,385,1.00	NAGS	3'UTR	NAGS:NM_153006.2:3'UTR:MODIFIER:exon7/7:c.*211C>T:		rs640631	0.8948	0	0	0										0.9242	0.0758	0	138	12	n/a	n/a
chr17	42148205	42148205	C	T	het		QUAL=1236;DP=44;AF=0.59;MQM=58;TRIO=HET,44,0.59,HOM,24,0.96,WT,38,0.00	G6PC3	5'UTR_premature_start_codon_gain,5'UTR	G6PC3:NM_138387.3:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-129C>T:,G6PC3:NM_138387.3:5'UTR:MODIFIER:exon1/6:c.-129C>T:		rs228758	0.3231	0.37	0	0										0.2955	0.4924	0.2121	75	145	n/a	n/a
chr17	42983193	42983193	A	G	het		QUAL=7690;DP=161;AF=0.51;MQM=60;TRIO=HET,161,0.51,HET,152,0.54,HET,173,0.47	GFAP	3'UTR	GFAP:NM_002055.4:3'UTR:MODIFIER:exon9/9:c.*1522T>C:		rs17027	0.2438	0	0	0										0.0758	0.4091	0.5152	12	63	n/a	n/a
chr17	42984085	42984085	C	T	het		QUAL=9338;DP=305;AF=0.49;MQM=59;TRIO=HET,305,0.49,WT,250,0.00,HET,319,0.50	GFAP	3'UTR	GFAP:NM_002055.4:3'UTR:MODIFIER:exon9/9:c.*630G>A:	FLAM_A	rs72828813	0.0036	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr17	42984687	42984687	G	C	het		QUAL=4648;DP=115;AF=0.54;MQM=60;TRIO=HET,115,0.54,HET,67,0.49,HET,98,0.53	GFAP	3'UTR	GFAP:NM_002055.4:3'UTR:MODIFIER:exon9/9:c.*28C>G:		rs11558961	0.2438	0.267	0.277	0.2374							RCV000056816.1 [not provided]; 			0.0758	0.4091	0.5152	13	78	n/a	n/a
chr17	42987523	42987523	G	A	het		QUAL=10965;DP=200;AF=0.44;MQM=59;TRIO=HET,200,0.44,HET,223,0.47,HET,350,0.50	GFAP	missense,3'UTR,intron	GFAP:NM_001131019.2:missense:MODERATE:exon8/8:c.1277C>T:p.Thr426Met,GFAP:NM_001242376.1:3'UTR:MODIFIER:exon7/7:c.*314C>T:,GFAP:NM_002055.4:intron:MODIFIER:exon7/8:c.1171+460C>T:		rs9908084	0.1056	0.137	0.1669	0.0953	1.9410	P	D	B	B	137780 [GFAP (confirmed) Alexander disease];			COSM3755582	0.0379	0.2803	0.6818	37	325	n/a	n/a
chr17	42987524	42987524	T	C	het		QUAL=10965;DP=200;AF=0.44;MQM=59;TRIO=HET,200,0.44,HET,223,0.47,HET,350,0.50	GFAP	missense,3'UTR,intron	GFAP:NM_001131019.2:missense:MODERATE:exon8/8:c.1276A>G:p.Thr426Ala,GFAP:NM_001242376.1:3'UTR:MODIFIER:exon7/7:c.*313A>G:,GFAP:NM_002055.4:intron:MODIFIER:exon7/8:c.1171+459A>G:		rs9916491	0.2436	0.267	0.2743	0.2411	0.7530	P	T	B	B	137780 [GFAP (confirmed) Alexander disease];			COSM4000176	0.0758	0.4091	0.5152	91	438	n/a	n/a
chr17	45196190	45196190	T	C	het		QUAL=9696;DP=269;AF=0.53;MQM=60;TRIO=HET,269,0.53,HET,131,0.56,HET,165,0.50	CDC27	3'UTR	CDC27:NM_001114091.2:3'UTR:MODIFIER:exon19/19:c.*2111A>G:,CDC27:NM_001256.4:3'UTR:MODIFIER:exon19/19:c.*2111A>G:,CDC27:NM_001293089.1:3'UTR:MODIFIER:exon19/19:c.*2111A>G:,CDC27:NM_001293091.1:3'UTR:MODIFIER:exon18/18:c.*2111A>G:		rs1713494	0.2808	0	0	0										0.1742	0.4621	0.3636	24	67	n/a	n/a
chr17	45219669	45219669	G	A	het		QUAL=628;DP=102;AF=0.25;MQM=26;TRIO=HET,102,0.25,WT,25,0.00,WT,34,0.00	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon11/19:c.1322C>T:p.Ser441Phe,CDC27:NM_001256.4:missense:MODERATE:exon11/19:c.1304C>T:p.Ser435Phe,CDC27:NM_001293089.1:missense:MODERATE:exon11/19:c.1304C>T:p.Ser435Phe,CDC27:NM_001293091.1:missense:MODERATE:exon10/18:c.1121C>T:p.Ser374Phe		rs11491191	0	0.035	0	0	4.9730	D	D	D,D,D,D	P,P,P,P				COSM3932635	0	0.5909	0.4091	0	89	n/a	n/a
chr17	45234303	45234303	G	C	het		QUAL=1468;DP=128;AF=0.37;MQM=34;TRIO=HET,128,0.37,HET,41,0.22,HET,41,0.22	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly,CDC27:NM_001256.4:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly,CDC27:NM_001293089.1:missense:MODERATE:exon7/19:c.818C>G:p.Ala273Gly,CDC27:NM_001293091.1:missense:MODERATE:exon6/18:c.635C>G:p.Ala212Gly		rs200611688	0	0.438	0	0	9.2600	D	T	B,P,P,B	B,B,B,B				COSM1178871	0	0.9773	0.0227	0	215	n/a	n/a
chr17	45234407	45234407	A	-	het		QUAL=3664;DP=216;AF=0.32;MQM=34;TRIO=HET,216,0.32,HET,81,0.28,HET,107,0.35	CDC27	frameshift	CDC27:NM_001114091.2:frameshift:HIGH:exon7/19:c.714delT:p.Ala238fs,CDC27:NM_001256.4:frameshift:HIGH:exon7/19:c.714delT:p.Ala238fs,CDC27:NM_001293089.1:frameshift:HIGH:exon7/19:c.714delT:p.Ala238fs,CDC27:NM_001293091.1:frameshift:HIGH:exon6/18:c.531delT:p.Ala177fs		rs112848754	0	0.488	0	0										0	0.6894	0.3106	0	199	1	n/a
chr17	45234417	45234417	A	G	het		QUAL=3088;DP=206;AF=0.28;MQM=34;TRIO=HET,206,0.28,HET,75,0.29,HET,107,0.31	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr,CDC27:NM_001256.4:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr,CDC27:NM_001293089.1:missense:MODERATE:exon7/19:c.704T>C:p.Ile235Thr,CDC27:NM_001293091.1:missense:MODERATE:exon6/18:c.521T>C:p.Ile174Thr		rs193061947	0	0.481	0	0	8.7540	D	T	B,B,B,B	B,B,B,B				COSM4130264	0	0.7727	0.2273	0	220	n/a	n/a
chr17	45234420	45234420	T	G	het		QUAL=3088;DP=206;AF=0.28;MQM=34;TRIO=HET,206,0.28,HET,75,0.29,HET,107,0.31	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser,CDC27:NM_001256.4:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser,CDC27:NM_001293089.1:missense:MODERATE:exon7/19:c.701A>C:p.Tyr234Ser,CDC27:NM_001293091.1:missense:MODERATE:exon6/18:c.518A>C:p.Tyr173Ser		rs78493795	0	0.483	0	0	7.5220	P	T	B,B,B,B	B,B,B,B				COSM3734972	0	0.7348	0.2652	0	211	n/a	n/a
chr17	45234449	45234449	G	A	het		QUAL=1485;DP=176;AF=0.13;MQM=35;TRIO=HET,176,0.13,HET,75,0.21,HET,105,0.30	CDC27	synonymous	CDC27:NM_001114091.2:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr,CDC27:NM_001256.4:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr,CDC27:NM_001293089.1:synonymous:LOW:exon7/19:c.672C>T:p.Tyr224Tyr,CDC27:NM_001293091.1:synonymous:LOW:exon6/18:c.489C>T:p.Tyr163Tyr		rs112216339	0	0.367	0	0									COSM1383887	0	0.8485	0.1515	0	174	n/a	n/a
chr17	45234707	45234707	T	A	het		QUAL=3333;DP=382;AF=0.30;MQM=35;TRIO=HET,382,0.30,HET,150,0.06,WT,154,0.05	CDC27	missense	CDC27:NM_001114091.2:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe,CDC27:NM_001256.4:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe,CDC27:NM_001293089.1:missense:MODERATE:exon6/19:c.519A>T:p.Leu173Phe,CDC27:NM_001293091.1:missense:MODERATE:exon5/18:c.336A>T:p.Leu112Phe		rs75353677	0	0.454	0	0	0.5090	D	T	P,B,P,B	B,B,P,B				COSM1737258	0	0.6212	0.3788	0	202	n/a	n/a
chr17	45234760	45234760	-	A	het		QUAL=1302;DP=98;AF=0.21;MQM=60;TRIO=HET,98,0.21,HET,56,0.16,HET,64,0.52	CDC27	splice_region&intron	CDC27:NM_001114091.2:splice_region&intron:LOW:exon5/18:c.476-11_476-10insT:,CDC27:NM_001256.4:splice_region&intron:LOW:exon5/18:c.476-11_476-10insT:,CDC27:NM_001293089.1:splice_region&intron:LOW:exon5/18:c.476-11_476-10insT:,CDC27:NM_001293091.1:splice_region&intron:LOW:exon4/17:c.293-11_293-10insT:		rs577503859	0	0	0	0										0.0227	0.3864	0.5909	13	64	n/a	n/a
chr17	45368337	45368337	A	C	het		QUAL=19866;DP=229;AF=0.50;MQM=60;TRIO=HET,229,0.50,HET,296,0.55,HOM,344,0.99	ITGB3	synonymous	ITGB3:NM_000212.2:synonymous:LOW:exon9/15:c.1143A>C:p.Val381Val		rs15908	0.4311	0.39	0.3665	0.4212						173470 [ITGB3 (confirmed) Glanzmann thrombasthenia|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant];				0.1818	0.553	0.2652	91	211	n/a	n/a
chr17	45369777	45369777	A	G	het		QUAL=5880;DP=104;AF=0.51;MQM=59;TRIO=HET,104,0.51,WT,102,0.01,HOM,145,1.00	ITGB3	synonymous	ITGB3:NM_000212.2:synonymous:LOW:exon10/15:c.1533A>G:p.Glu511Glu		rs4642	0.2873	0.286	0.2914	0.2694						173470 [ITGB3 (confirmed) Glanzmann thrombasthenia|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant];			COSM4000179	0.1136	0.447	0.4394	54	182	n/a	n/a
chr17	45369789	45369789	G	A	het		QUAL=5249;DP=109;AF=0.43;MQM=60;TRIO=HET,109,0.43,WT,91,0.01,HOM,132,1.00	ITGB3	synonymous	ITGB3:NM_000212.2:synonymous:LOW:exon10/15:c.1545G>A:p.Arg515Arg		rs4634	0.2873	0.286	0.2913	0.2694						173470 [ITGB3 (confirmed) Glanzmann thrombasthenia|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant];			COSM1383913	0.1136	0.447	0.4394	54	182	n/a	n/a
chr17	45385012	45385012	C	T	het		QUAL=8036;DP=181;AF=0.53;MQM=60;TRIO=HET,181,0.53,HET,353,0.47,WT,373,0.00	ITGB3	splice_region&intron	ITGB3:NM_000212.2:splice_region&intron:LOW:exon14/14:c.2301+9C>T:		rs3809863	0.399	0.434	0.4758	0.4852						173470 [ITGB3 (confirmed) Glanzmann thrombasthenia|Thrombocytopenia,neonatal alloimmune|Myocardial infarction,susceptibility to|Purpura,posttransfusion|Bleeding disorder,platelet-type,16,autosomal dominant];				0.1818	0.5076	0.3106	83	213	n/a	n/a
chr17	45388586	45388586	T	A	het		QUAL=8733;DP=280;AF=0.44;MQM=60;TRIO=HET,280,0.44,HOM,174,1.00,WT,267,0.01	ITGB3	3'UTR	ITGB3:NM_000212.2:3'UTR:MODIFIER:exon15/15:c.*1016T>A:		rs3809865	0.7234	0	0	0										0.553	0.3864	0.0606	84	55	n/a	n/a
chr17	46020698	46020698	C	T	het		QUAL=7970;DP=254;AF=0.54;MQM=60;TRIO=HET,254,0.54,HET,230,0.49,WT,343,0.00	PNPO	synonymous	PNPO:NM_018129.3:synonymous:LOW:exon2/7:c.165C>T:p.Ser55Ser		rs11079804	0.1625	0.182	0.1708	0.0749						603287 [PNPO (provisional) Pyridoxamine 5'-phosphate oxidase deficiency];	RCV000118001.2 [likely benign]; 		COSM1179771	0.0379	0.3258	0.6364	11	136	n/a	n/a
chr17	46026031	46026031	G	C	het		QUAL=12453;DP=386;AF=0.47;MQM=60;TRIO=HET,386,0.47,HET,419,0.50,WT,573,0.00	PNPO	3'UTR	PNPO:NM_018129.3:3'UTR:MODIFIER:exon7/7:c.*1883G>C:	MER5A1	rs1986694	0.1132	0	0	0										0	0.197	0.803	0	30	n/a	n/a
chr17	46026156	46026156	A	G	het		QUAL=20568;DP=253;AF=0.49;MQM=59;TRIO=HET,253,0.49,HOM,314,1.00,HET,424,0.47	PNPO	3'UTR	PNPO:NM_018129.3:3'UTR:MODIFIER:exon7/7:c.*2008A>G:	Tigger19a	rs1986693	0.8079	0	0	0										0.6742	0.2879	0.0379	102	43	n/a	n/a
chr17	48252804	48252804	T	C	hom		QUAL=861;DP=9;AF=1.00;MQM=60;TRIO=HOM,9,1.00,HOM,4,1.00,HOM,15,1.00	SGCA	3'UTR	SGCA:NM_000023.2:3'UTR:MODIFIER:exon9/10:c.*6T>C:,SGCA:NM_001135697.1:3'UTR:MODIFIER:exon7/8:c.*6T>C:		rs2696288	0.9219	0.955	0.9589	0.7995							RCV000153940.1 [benign]; 			0.8182	0.0227	0.1591	391	24	n/a	n/a
chr17	48261852	48261852	A	G	het		QUAL=3363;DP=165;AF=0.47;MQM=58;TRIO=HET,165,0.47,HOM,39,0.95,WT,71,0.00	COL1A1	3'UTR	COL1A1:NM_000088.3:3'UTR:MODIFIER:exon51/51:c.*1011T>C:	(A)n	rs1061970	0	0	0	0										0	0.2348	0.7652	0	36	n/a	n/a
chr17	48262181	48262181	-	TGCT	het		QUAL=4496;DP=41;AF=0.39;MQM=60;TRIO=HET,41,0.39,WT,135,0.00,HOM,148,0.97	COL1A1	3'UTR	COL1A1:NM_000088.3:3'UTR:MODIFIER:exon51/51:c.*681_*682insAGCA:		rs112626388	0.5803	0	0	0										0.4318	0.4697	0.0985	64	71	n/a	n/a
chr17	48262775	48262775	A	G	het		QUAL=4672;DP=82;AF=0.40;MQM=60;TRIO=HET,82,0.40,HOM,126,0.98,WT,168,0.00	COL1A1	3'UTR	COL1A1:NM_000088.3:3'UTR:MODIFIER:exon51/51:c.*88T>C:		rs1061237	0.3786	0	0	0										0.0985	0.3561	0.5455	15	52	n/a	n/a
chr17	48265475	48265475	A	G	het		QUAL=3969;DP=66;AF=0.50;MQM=60;TRIO=HET,66,0.50,HET,203,0.51,WT,278,0.01	COL1A1	synonymous	COL1A1:NM_000088.3:synonymous:LOW:exon44/51:c.3243T>C:p.Val1081Val		rs1800217	0.004	0.006	0.0049	0.0009						120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I|OI type II|OI type III|OI type IV|Ehlers-Danlos syndrome,type I|Ehlers-Danlos syndrome,type VIIA|Osteoporosis|Caffey disease|Bone mineral density variation QTL];				0	0.0379	0.9621	0	12	n/a	n/a
chr17	48265495	48265495	T	C	hom		QUAL=14638;DP=65;AF=0.98;MQM=59;TRIO=HOM,65,0.98,HOM,175,1.00,HOM,246,1.00	COL1A1	missense	COL1A1:NM_000088.3:missense:MODERATE:exon44/51:c.3223A>G:p.Thr1075Ala		rs1800215	0.9788	0.979	0.9834	0.9465	0.5710	P	T	B	B	120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I|OI type II|OI type III|OI type IV|Ehlers-Danlos syndrome,type I|Ehlers-Danlos syndrome,type VIIA|Osteoporosis|Caffey disease|Bone mineral density variation QTL];			COSM4130378	0.9773	0.0152	0.0076	444	9	n/a	n/a
chr17	48268223	48268223	A	G	hom		QUAL=44051;DP=190;AF=1.00;MQM=59;TRIO=HOM,190,1.00,HOM,475,1.00,HOM,722,1.00	COL1A1	synonymous	COL1A1:NM_000088.3:synonymous:LOW:exon33/51:c.2298T>C:p.Thr766Thr		rs2734272	0.9998	1	0.9999	0.9998						120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I|OI type II|OI type III|OI type IV|Ehlers-Danlos syndrome,type I|Ehlers-Danlos syndrome,type VIIA|Osteoporosis|Caffey disease|Bone mineral density variation QTL];			COSM4130379	1	0	0	454	0	n/a	n/a
chr17	48653354	48653354	C	A	het		QUAL=10547;DP=89;AF=0.44;MQM=60;TRIO=HET,89,0.44,HET,164,0.47,HOM,232,1.00	CACNA1G	synonymous	CACNA1G:NM_018896.4:synonymous:LOW:exon8/38:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256324.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256325.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256326.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256327.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256328.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256329.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256330.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256331.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256332.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256333.1:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256334.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256359.1:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256360.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_001256361.1:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198376.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198377.2:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198378.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198379.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198380.2:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198382.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198383.2:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198384.2:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198385.2:synonymous:LOW:exon8/37:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198386.2:synonymous:LOW:exon8/35:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198387.2:synonymous:LOW:exon8/34:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198388.2:synonymous:LOW:exon8/34:c.1591C>A:p.Arg531Arg,CACNA1G:NM_198396.2:synonymous:LOW:exon8/36:c.1591C>A:p.Arg531Arg		rs12449998	0.524	0.429	0.4556	0.2003									COSM436876	0.2652	0.447	0.2879	102	219	n/a	n/a
chr17	48692881	48692881	C	T	het		QUAL=5213;DP=30;AF=0.50;MQM=60;TRIO=HET,30,0.50,HOM,178,0.99,WT,212,0.00	CACNA1G	splice_region&intron	CACNA1G:NM_018896.4:splice_region&intron:LOW:exon27/37:c.4911+8C>T:,CACNA1G:NM_001256324.1:splice_region&intron:LOW:exon26/35:c.4857+8C>T:,CACNA1G:NM_001256325.1:splice_region&intron:LOW:exon27/35:c.4932+8C>T:,CACNA1G:NM_001256326.1:splice_region&intron:LOW:exon26/35:c.4776+8C>T:,CACNA1G:NM_001256327.1:splice_region&intron:LOW:exon27/35:c.4911+8C>T:,CACNA1G:NM_001256328.1:splice_region&intron:LOW:exon26/34:c.4857+8C>T:,CACNA1G:NM_001256329.1:splice_region&intron:LOW:exon27/35:c.4809+8C>T:,CACNA1G:NM_001256330.1:splice_region&intron:LOW:exon26/34:c.4776+8C>T:,CACNA1G:NM_001256331.1:splice_region&intron:LOW:exon26/34:c.4755+8C>T:,CACNA1G:NM_001256332.1:splice_region&intron:LOW:exon26/34:c.4740+8C>T:,CACNA1G:NM_001256333.1:splice_region&intron:LOW:exon27/36:c.4911+8C>T:,CACNA1G:NM_001256334.1:splice_region&intron:LOW:exon26/35:c.4878+8C>T:,CACNA1G:NM_001256359.1:splice_region&intron:LOW:exon27/35:c.4830+8C>T:,CACNA1G:NM_001256360.1:splice_region&intron:LOW:exon26/34:c.4803+8C>T:,CACNA1G:NM_001256361.1:splice_region&intron:LOW:exon26/34:c.4797+8C>T:,CACNA1G:NM_198376.2:splice_region&intron:LOW:exon25/34:c.4809+8C>T:,CACNA1G:NM_198377.2:splice_region&intron:LOW:exon26/36:c.4878+8C>T:,CACNA1G:NM_198378.2:splice_region&intron:LOW:exon26/34:c.4878+8C>T:,CACNA1G:NM_198379.2:splice_region&intron:LOW:exon25/34:c.4809+8C>T:,CACNA1G:NM_198380.2:splice_region&intron:LOW:exon26/35:c.4878+8C>T:,CACNA1G:NM_198382.2:splice_region&intron:LOW:exon26/34:c.4842+8C>T:,CACNA1G:NM_198383.2:splice_region&intron:LOW:exon26/35:c.4842+8C>T:,CACNA1G:NM_198384.2:splice_region&intron:LOW:exon27/35:c.4911+8C>T:,CACNA1G:NM_198385.2:splice_region&intron:LOW:exon27/36:c.4911+8C>T:,CACNA1G:NM_198386.2:splice_region&intron:LOW:exon26/34:c.4857+8C>T:,CACNA1G:NM_198387.2:splice_region&intron:LOW:exon25/33:c.4809+8C>T:,CACNA1G:NM_198388.2:splice_region&intron:LOW:exon25/33:c.4788+8C>T:,CACNA1G:NM_198396.2:splice_region&intron:LOW:exon25/35:c.4809+8C>T:		rs8066527	0.2001	0.279	0.3417	0.2408										0.1212	0.3712	0.5076	55	199	n/a	n/a
chr17	48703752	48703752	T	C	het		QUAL=4970;DP=143;AF=0.59;MQM=60;TRIO=HET,143,0.59,HOM,73,1.00,WT,94,0.01	CACNA1G	synonymous	CACNA1G:NM_018896.4:synonymous:LOW:exon38/38:c.6774T>C:p.Pro2258Pro,CACNA1G:NM_001256324.1:synonymous:LOW:exon36/36:c.6585T>C:p.Pro2195Pro,CACNA1G:NM_001256325.1:synonymous:LOW:exon36/36:c.6516T>C:p.Pro2172Pro,CACNA1G:NM_001256326.1:synonymous:LOW:exon36/36:c.6504T>C:p.Pro2168Pro,CACNA1G:NM_001256327.1:synonymous:LOW:exon36/36:c.6474T>C:p.Pro2158Pro,CACNA1G:NM_001256328.1:synonymous:LOW:exon35/35:c.6420T>C:p.Pro2140Pro,CACNA1G:NM_001256329.1:synonymous:LOW:exon36/36:c.6393T>C:p.Pro2131Pro,CACNA1G:NM_001256330.1:synonymous:LOW:exon35/35:c.6360T>C:p.Pro2120Pro,CACNA1G:NM_001256331.1:synonymous:LOW:exon35/35:c.6339T>C:p.Pro2113Pro,CACNA1G:NM_001256332.1:synonymous:LOW:exon35/35:c.6324T>C:p.Pro2108Pro,CACNA1G:NM_001256333.1:synonymous:LOW:exon37/37:c.6258T>C:p.Pro2086Pro,CACNA1G:NM_001256334.1:synonymous:LOW:exon36/36:c.6225T>C:p.Pro2075Pro,CACNA1G:NM_001256359.1:synonymous:LOW:exon36/36:c.6414T>C:p.Pro2138Pro,CACNA1G:NM_001256360.1:synonymous:LOW:exon35/35:c.6387T>C:p.Pro2129Pro,CACNA1G:NM_001256361.1:synonymous:LOW:exon35/35:c.6381T>C:p.Pro2127Pro,CACNA1G:NM_198376.2:synonymous:LOW:exon35/35:c.6156T>C:p.Pro2052Pro,CACNA1G:NM_198377.2:synonymous:LOW:exon37/37:c.6741T>C:p.Pro2247Pro,CACNA1G:NM_198378.2:synonymous:LOW:exon35/35:c.6462T>C:p.Pro2154Pro,CACNA1G:NM_198379.2:synonymous:LOW:exon35/35:c.6537T>C:p.Pro2179Pro,CACNA1G:NM_198380.2:synonymous:LOW:exon36/36:c.6606T>C:p.Pro2202Pro,CACNA1G:NM_198382.2:synonymous:LOW:exon35/35:c.6426T>C:p.Pro2142Pro,CACNA1G:NM_198383.2:synonymous:LOW:exon36/36:c.6561T>C:p.Pro2187Pro,CACNA1G:NM_198384.2:synonymous:LOW:exon36/36:c.6495T>C:p.Pro2165Pro,CACNA1G:NM_198385.2:synonymous:LOW:exon37/37:c.6639T>C:p.Pro2213Pro,CACNA1G:NM_198386.2:synonymous:LOW:exon35/35:c.6441T>C:p.Pro2147Pro,CACNA1G:NM_198387.2:synonymous:LOW:exon34/34:c.6393T>C:p.Pro2131Pro,CACNA1G:NM_198388.2:synonymous:LOW:exon34/34:c.6372T>C:p.Pro2124Pro,CACNA1G:NM_198396.2:synonymous:LOW:exon36/36:c.6672T>C:p.Pro2224Pro		rs739925	0.3672	0.398	0.433	0.5069									COSM4130403	0.2045	0.4545	0.3409	97	230	n/a	n/a
chr17	48703986	48703986	G	A	het		QUAL=1984;DP=56;AF=0.57;MQM=59;TRIO=HET,56,0.57,WT,60,0.00,HET,83,0.45	CACNA1G	synonymous	CACNA1G:NM_018896.4:synonymous:LOW:exon38/38:c.7008G>A:p.Pro2336Pro,CACNA1G:NM_001256324.1:synonymous:LOW:exon36/36:c.6819G>A:p.Pro2273Pro,CACNA1G:NM_001256325.1:synonymous:LOW:exon36/36:c.6750G>A:p.Pro2250Pro,CACNA1G:NM_001256326.1:synonymous:LOW:exon36/36:c.6738G>A:p.Pro2246Pro,CACNA1G:NM_001256327.1:synonymous:LOW:exon36/36:c.6708G>A:p.Pro2236Pro,CACNA1G:NM_001256328.1:synonymous:LOW:exon35/35:c.6654G>A:p.Pro2218Pro,CACNA1G:NM_001256329.1:synonymous:LOW:exon36/36:c.6627G>A:p.Pro2209Pro,CACNA1G:NM_001256330.1:synonymous:LOW:exon35/35:c.6594G>A:p.Pro2198Pro,CACNA1G:NM_001256331.1:synonymous:LOW:exon35/35:c.6573G>A:p.Pro2191Pro,CACNA1G:NM_001256332.1:synonymous:LOW:exon35/35:c.6558G>A:p.Pro2186Pro,CACNA1G:NM_001256333.1:synonymous:LOW:exon37/37:c.6492G>A:p.Pro2164Pro,CACNA1G:NM_001256334.1:synonymous:LOW:exon36/36:c.6459G>A:p.Pro2153Pro,CACNA1G:NM_001256359.1:synonymous:LOW:exon36/36:c.6648G>A:p.Pro2216Pro,CACNA1G:NM_001256360.1:synonymous:LOW:exon35/35:c.6621G>A:p.Pro2207Pro,CACNA1G:NM_001256361.1:synonymous:LOW:exon35/35:c.6615G>A:p.Pro2205Pro,CACNA1G:NM_198376.2:synonymous:LOW:exon35/35:c.6390G>A:p.Pro2130Pro,CACNA1G:NM_198377.2:synonymous:LOW:exon37/37:c.6975G>A:p.Pro2325Pro,CACNA1G:NM_198378.2:synonymous:LOW:exon35/35:c.6696G>A:p.Pro2232Pro,CACNA1G:NM_198379.2:synonymous:LOW:exon35/35:c.6771G>A:p.Pro2257Pro,CACNA1G:NM_198380.2:synonymous:LOW:exon36/36:c.6840G>A:p.Pro2280Pro,CACNA1G:NM_198382.2:synonymous:LOW:exon35/35:c.6660G>A:p.Pro2220Pro,CACNA1G:NM_198383.2:synonymous:LOW:exon36/36:c.6795G>A:p.Pro2265Pro,CACNA1G:NM_198384.2:synonymous:LOW:exon36/36:c.6729G>A:p.Pro2243Pro,CACNA1G:NM_198385.2:synonymous:LOW:exon37/37:c.6873G>A:p.Pro2291Pro,CACNA1G:NM_198386.2:synonymous:LOW:exon35/35:c.6675G>A:p.Pro2225Pro,CACNA1G:NM_198387.2:synonymous:LOW:exon34/34:c.6627G>A:p.Pro2209Pro,CACNA1G:NM_198388.2:synonymous:LOW:exon34/34:c.6606G>A:p.Pro2202Pro,CACNA1G:NM_198396.2:synonymous:LOW:exon36/36:c.6906G>A:p.Pro2302Pro		rs9893223	0.1927	0.115	0.0513	0.3241									COSM436908	0.0076	0.1136	0.8788	3	55	n/a	n/a
chr17	48704800	48704800	A	C	het		QUAL=1758;DP=64;AF=0.75;MQM=60;TRIO=HET,64,0.75,HOM,11,1.00,WT,7,0.00	CACNA1G	3'UTR	CACNA1G:NM_018896.4:3'UTR:MODIFIER:exon38/38:c.*688A>C:,CACNA1G:NM_001256324.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256325.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256326.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256327.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256328.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256329.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256330.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256331.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256332.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256333.1:3'UTR:MODIFIER:exon37/37:c.*688A>C:,CACNA1G:NM_001256334.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256359.1:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_001256360.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_001256361.1:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198376.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198377.2:3'UTR:MODIFIER:exon37/37:c.*688A>C:,CACNA1G:NM_198378.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198379.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198380.2:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_198382.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198383.2:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_198384.2:3'UTR:MODIFIER:exon36/36:c.*688A>C:,CACNA1G:NM_198385.2:3'UTR:MODIFIER:exon37/37:c.*688A>C:,CACNA1G:NM_198386.2:3'UTR:MODIFIER:exon35/35:c.*688A>C:,CACNA1G:NM_198387.2:3'UTR:MODIFIER:exon34/34:c.*688A>C:,CACNA1G:NM_198388.2:3'UTR:MODIFIER:exon34/34:c.*688A>C:,CACNA1G:NM_198396.2:3'UTR:MODIFIER:exon36/36:c.*688A>C:	(TA)n	rs34036927	0.1348	0.149	0	0										0.0758	0.3485	0.5758	24	111	n/a	n/a
chr17	56283089	56283089	C	-	hom		QUAL=15795;DP=309;AF=0.96;MQM=60;TRIO=HOM,309,0.96,HET,192,0.48,HET,237,0.54	MKS1	3'UTR	MKS1:NM_017777.3:3'UTR:MODIFIER:exon18/18:c.*351delG:,MKS1:NM_001165927.1:3'UTR:MODIFIER:exon18/18:c.*351delG:		rs35298266	0.0152	0.019	0	0										0	0.1364	0.8636	0	28	n/a	n/a
chr17	56290334	56290334	T	C	hom		QUAL=11532;DP=140;AF=0.99;MQM=60;TRIO=HOM,140,0.99,HOM,97,1.00,HOM,125,1.00	MKS1	splice_region&intron	MKS1:NM_017777.3:splice_region&intron:LOW:exon8/17:c.858+9A>G:,MKS1:NM_001165927.1:splice_region&intron:LOW:exon8/17:c.828+9A>G:		rs3826300	0.4808	0.446	0.4414	0.7887						609883 [MKS1 (confirmed) Meckel syndrome 1|Bardet-Biedl syndrome 13];	RCV000114214.2 [likely benign]; 		COSM4000228	0.2576	0.5303	0.2121	101	223	n/a	n/a
chr17	57076104	57076104	T	A	het		QUAL=4365;DP=177;AF=0.46;MQM=60;TRIO=HET,177,0.46,HET,28,0.54,HOM,37,1.00	TRIM37	3'UTR,intron	TRIM37:NM_015294.3:3'UTR:MODIFIER:exon24/24:c.*634A>T:,TRIM37:NM_001005207.2:intron:MODIFIER:exon24/24:c.2891+638A>T:		rs28475409	0.3277	0	0	0						605073 [TRIM37 (confirmed) Mulibrey nanism];				0.1591	0.4545	0.3864	25	68	n/a	n/a
chr17	57184162	57184162	A	C	het		QUAL=1088;DP=13;AF=0.46;MQM=59;TRIO=HET,13,0.46,HET,16,0.38,HOM,28,0.96	TRIM37	5'UTR	TRIM37:NM_001005207.2:5'UTR:MODIFIER:exon1/25:c.-340T>G:,TRIM37:NM_015294.3:5'UTR:MODIFIER:exon1/24:c.-340T>G:		rs7503190	0.6118	0	0	0										0.3106	0.3485	0.3409	48	51	n/a	n/a
chr17	62006129	62006129	-	G	het		QUAL=1240;DP=58;AF=0.47;MQM=60;TRIO=HET,58,0.47,WT,34,0.00,HET,38,0.53	CD79B	3'UTR	CD79B:NM_001039933.1:3'UTR:MODIFIER:exon6/6:c.*456dupC:,CD79B:NM_000626.2:3'UTR:MODIFIER:exon6/6:c.*456dupC:,CD79B:NM_021602.2:3'UTR:MODIFIER:exon5/5:c.*456dupC:		rs554643850	0.0014	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr17	62006406	62006406	A	G	het		QUAL=2305;DP=97;AF=0.46;MQM=60;TRIO=HET,97,0.46,HET,65,0.46,WT,121,0.00	CD79B	3'UTR	CD79B:NM_001039933.1:3'UTR:MODIFIER:exon6/6:c.*180T>C:,CD79B:NM_000626.2:3'UTR:MODIFIER:exon6/6:c.*180T>C:,CD79B:NM_021602.2:3'UTR:MODIFIER:exon5/5:c.*180T>C:		rs147717759	0.003	0	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr17	62018002	62018002	C	A	het		QUAL=6611;DP=186;AF=0.52;MQM=60;TRIO=HET,186,0.52,WT,210,0.00,HET,241,0.49	SCN4A	3'UTR	SCN4A:NM_000334.4:3'UTR:MODIFIER:exon24/24:c.*129G>T:		rs140026321	0.0016	0	0	0										0	0.0152	0.9848	0	2	n/a	n/a
chr17	62028920	62028920	C	G	het		QUAL=5321;DP=186;AF=0.47;MQM=59;TRIO=HET,186,0.47,HET,168,0.52,WT,192,0.00	SCN4A	missense	SCN4A:NM_000334.4:missense:MODERATE:exon14/24:c.2717G>C:p.Ser906Thr		rs41280102	0.005	0.0094	0.0161	0.0025	0.5540	N	T	B	B	603967 [SCN4A (confirmed) Hyperkalemic periodic paralysis,type 2|Paramyotonia congenita|Myotonia congenita,atypical,acetazolamide-responsive|Myasthenic syndrome,acetazolamide-responsive|Hypokalemic periodic paralysis,type 2];	RCV000020269.1 [benign]; RCV000078659.4 [other]; 	CM034679 [CLASS=FP MUT=ALT PHEN="Impaired slow inactivation" GENE=SCN4A]; 		0	0.0455	0.9545	0	12	2	n/a
chr17	62041068	62041068	T	C	hom		QUAL=7683;DP=104;AF=1.00;MQM=60;TRIO=HOM,104,1.00,HOM,62,1.00,HOM,81,1.00	SCN4A	missense	SCN4A:NM_000334.4:missense:MODERATE:exon10/24:c.1570A>G:p.Ser524Gly		rs6504191	0.9443	0.926	0.9192	0.9078	1.3430	P	T	B	B	603967 [SCN4A (confirmed) Hyperkalemic periodic paralysis,type 2|Paramyotonia congenita|Myotonia congenita,atypical,acetazolamide-responsive|Myasthenic syndrome,acetazolamide-responsive|Hypokalemic periodic paralysis,type 2];	RCV000118264.2 [benign]; 		COSM4130494	0.8485	0.1439	0.0076	383	68	n/a	n/a
chr17	71197323	71197323	G	C	het		QUAL=10354;DP=362;AF=0.48;MQM=60;TRIO=HET,362,0.48,WT,289,0.00,HET,377,0.39	COG1	missense	COG1:NM_018714.2:missense:MODERATE:exon7/14:c.1357G>C:p.Glu453Gln		rs62621249	0.0503	0.067	0.0844	0.0347	4.1400	P	T	P,P,P	B,B,B	606973 [COG1 (confirmed) Congenital disorder of glycosylation,type IIg];	RCV000081961.2 [benign]; 		COSM3755789	0	0.0833	0.9167	7	64	n/a	n/a
chr17	72912265	72912265	C	G	hom		QUAL=9400;DP=89;AF=0.99;MQM=59;TRIO=HOM,89,0.99,HOM,132,1.00,HET,142,0.61	USH1G	3'UTR	USH1G:NM_173477.4:3'UTR:MODIFIER:exon3/3:c.*1903G>C:,USH1G:NM_001282489.2:3'UTR:MODIFIER:exon3/3:c.*1903G>C:		rs1568448	0.354	0	0	0										0.1667	0.4091	0.4242	23	64	n/a	n/a
chr17	72913797	72913797	T	-	hom		QUAL=15880;DP=126;AF=1.00;MQM=60;TRIO=HOM,126,1.00,HOM,172,1.00,HOM,246,1.00	USH1G	3'UTR	USH1G:NM_173477.4:3'UTR:MODIFIER:exon3/3:c.*371delA:,USH1G:NM_001282489.2:3'UTR:MODIFIER:exon3/3:c.*371delA:		rs55654382	1	0	0	0										0.9848	0	0.0152	148	0	n/a	n/a
chr17	73269258	73269258	G	C	hom		QUAL=42648;DP=269;AF=1.00;MQM=59;TRIO=HOM,269,1.00,HOM,462,1.00,HOM,591,1.00	SLC25A19	3'UTR	SLC25A19:NM_001126121.1:3'UTR:MODIFIER:exon8/8:c.*274C>G:,SLC25A19:NM_001126122.1:3'UTR:MODIFIER:exon7/7:c.*274C>G:,SLC25A19:NM_021734.4:3'UTR:MODIFIER:exon8/8:c.*274C>G:		rs7198	0.5365	0	0	0										0.4697	0.4545	0.0758	77	73	n/a	n/a
chr17	73269530	73269530	A	G	hom		QUAL=34268;DP=290;AF=1.00;MQM=60;TRIO=HOM,290,1.00,HOM,318,1.00,HOM,440,1.00	SLC25A19	3'UTR	SLC25A19:NM_001126121.1:3'UTR:MODIFIER:exon8/8:c.*2T>C:,SLC25A19:NM_001126122.1:3'UTR:MODIFIER:exon7/7:c.*2T>C:,SLC25A19:NM_021734.4:3'UTR:MODIFIER:exon8/8:c.*2T>C:		rs1809352	0.9002	0.928	0.9166	0.7783										0.8712	0.1212	0.0076	390	56	n/a	n/a
chr17	73269676	73269676	C	T	hom		QUAL=32096;DP=287;AF=1.00;MQM=59;TRIO=HOM,287,1.00,HOM,293,1.00,HOM,423,1.00	SLC25A19	synonymous	SLC25A19:NM_001126121.1:synonymous:LOW:exon8/8:c.819G>A:p.Leu273Leu,SLC25A19:NM_001126122.1:synonymous:LOW:exon7/7:c.819G>A:p.Leu273Leu,SLC25A19:NM_021734.4:synonymous:LOW:exon8/8:c.819G>A:p.Leu273Leu		rs4789164	0.5302	0.652	0.6778	0.1621						606521 [SLC25A19 (confirmed) Microcephaly,Amish type|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)];	RCV000118371.2 [likely benign]; 			0.4621	0.4621	0.0758	174	220	n/a	n/a
chr17	73279624	73279624	A	G	hom		QUAL=10084;DP=84;AF=1.00;MQM=60;TRIO=HOM,84,1.00,HOM,97,1.00,HOM,131,1.00	SLC25A19	synonymous	SLC25A19:NM_001126121.1:synonymous:LOW:exon5/8:c.339T>C:p.Tyr113Tyr,SLC25A19:NM_001126122.1:synonymous:LOW:exon4/7:c.339T>C:p.Tyr113Tyr,SLC25A19:NM_021734.4:synonymous:LOW:exon5/8:c.339T>C:p.Tyr113Tyr		rs7213318	0.8896	0.961	0.9969	0.8173						606521 [SLC25A19 (confirmed) Microcephaly,Amish type|Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)];	RCV000118368.2 [likely benign]; 		COSM4130610	0.9848	0.0152	0	444	10	n/a	n/a
chr17	73285461	73285461	A	C	hom		QUAL=7786;DP=85;AF=1.00;MQM=60;TRIO=HOM,85,1.00,HOM,74,1.00,HOM,99,1.00	SLC25A19	5'UTR	SLC25A19:NM_001126121.1:5'UTR:MODIFIER:exon1/8:c.-155T>G:,SLC25A19:NM_001126122.1:5'UTR:MODIFIER:exon1/7:c.-65T>G:,SLC25A19:NM_021734.4:5'UTR:MODIFIER:exon1/8:c.-139T>G:		rs2291033	0.8612	0	0	0										0.9848	0.0152	0	145	5	n/a	n/a
chr17	73518203	73518203	G	C	hom		QUAL=21426;DP=179;AF=1.00;MQM=59;TRIO=HOM,179,1.00,HOM,219,1.00,HOM,290,0.99	TSEN54	missense	TSEN54:NM_207346.2:missense:MODERATE:exon8/11:c.1041G>C:p.Lys347Asn		rs9911502	0.4447	0.542	0.6987	0.2303	3.6300	P	T	D	P	608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 4];	RCV000147767.2 [benign]; 		COSM437385	0.4242	0.4167	0.1591	460	507	n/a	n/a
chr17	73518284	73518284	G	C	hom		QUAL=15683;DP=103;AF=1.00;MQM=60;TRIO=HOM,103,1.00,HOM,183,1.00,HOM,223,1.00	TSEN54	synonymous	TSEN54:NM_207346.2:synonymous:LOW:exon8/11:c.1122G>C:p.Arg374Arg		rs6501820	0.8143	0.78	0.9149	0.9743						608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 4];	RCV000082834.3 [benign]; 			0.7803	0.2045	0.0152	902	190	n/a	n/a
chr17	73519413	73519413	C	T	hom		QUAL=32864;DP=334;AF=0.99;MQM=60;TRIO=HOM,334,0.99,HOM,342,1.00,HOM,420,1.00	TSEN54	missense	TSEN54:NM_207346.2:missense:MODERATE:exon9/11:c.1310C>T:p.Ala437Val		rs8064529	0.5613	0.624	0.7019	0.5803	0.3350	P	T	P	B	608755 [TSEN54 (provisional) Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 4];	RCV000147771.1 [benign]; 			0.4242	0.4167	0.1591	466	509	n/a	n/a
chr17	73750859	73750859	C	G	hom		QUAL=23796;DP=177;AF=1.00;MQM=59;TRIO=HOM,177,1.00,HOM,391,1.00,HET,494,0.45	ITGB4	synonymous	ITGB4:NM_000213.3:synonymous:LOW:exon34/40:c.4521C>G:p.Pro1507Pro,ITGB4:NM_001005731.1:synonymous:LOW:exon33/39:c.4311C>G:p.Pro1437Pro,ITGB4:NM_001005619.1:synonymous:LOW:exon32/39:c.4311C>G:p.Pro1437Pro		rs8669	0.3772	0.452	0.4769	0.1482						147557 [ITGB4 (confirmed) Epidermolysis bullosa,junctional,with pyloric atresia|Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa of hands and feet];			COSM3755858	0.2197	0.5379	0.2424	100	241	n/a	n/a
chr17	73753503	73753503	T	C	hom		QUAL=31506;DP=154;AF=0.99;MQM=59;TRIO=HOM,154,0.99,HOM,392,0.99,HOM,465,1.00	ITGB4	missense	ITGB4:NM_000213.3:missense:MODERATE:exon40/40:c.5336T>C:p.Leu1779Pro,ITGB4:NM_001005731.1:missense:MODERATE:exon39/39:c.5126T>C:p.Leu1709Pro,ITGB4:NM_001005619.1:missense:MODERATE:exon39/39:c.5285T>C:p.Leu1762Pro		rs871443	0.5715	0.713	0.7692	0.2803	4.7950	P	T	D,D,D	D,P,P	147557 [ITGB4 (confirmed) Epidermolysis bullosa,junctional,with pyloric atresia|Epidermolysis bullosa,junctional,non-Herlitz type|Epidermolysis bullosa of hands and feet];			COSM3722198	0.5379	0.3939	0.0682	250	176	n/a	n/a
chr17	73753661	73753661	C	T	hom		QUAL=23084;DP=153;AF=0.99;MQM=59;TRIO=HOM,153,0.99,HOM,278,1.00,HOM,361,1.00	ITGB4	3'UTR	ITGB4:NM_000213.3:3'UTR:MODIFIER:exon40/40:c.*25C>T:,ITGB4:NM_001005731.1:3'UTR:MODIFIER:exon39/39:c.*25C>T:,ITGB4:NM_001005619.1:3'UTR:MODIFIER:exon39/39:c.*25C>T:		rs9367	0.653	0.736	0.7964	0.5399										0.5379	0.4015	0.0606	90	65	n/a	n/a
chr17	73939298	73939298	A	-	het		QUAL=852;DP=76;AF=0.28;MQM=59;TRIO=HET,76,0.28,HET,20,0.20,HET,28,0.36	ACOX1	3'UTR	ACOX1:NM_004035.6:3'UTR:MODIFIER:exon14/14:c.*3531delT:,ACOX1:NM_001185039.1:3'UTR:MODIFIER:exon14/14:c.*3531delT:,ACOX1:NM_007292.5:3'UTR:MODIFIER:exon14/14:c.*3531delT:	AluSx1		0	0	0	0										0	0.1439	0.8561	0	19	n/a	n/a
chr17	73942196	73942196	C	G	het		QUAL=2894;DP=115;AF=0.48;MQM=60;TRIO=HET,115,0.48,HET,90,0.46,WT,117,0.00	ACOX1	3'UTR	ACOX1:NM_004035.6:3'UTR:MODIFIER:exon14/14:c.*633G>C:,ACOX1:NM_001185039.1:3'UTR:MODIFIER:exon14/14:c.*633G>C:,ACOX1:NM_007292.5:3'UTR:MODIFIER:exon14/14:c.*633G>C:		rs71382188	0.0266	0	0	0										0	0.1515	0.8485	0	22	n/a	n/a
chr17	73949540	73949540	G	C	hom		QUAL=19465;DP=160;AF=0.99;MQM=60;TRIO=HOM,160,0.99,HOM,196,1.00,HOM,255,1.00	ACOX1	missense	ACOX1:NM_004035.6:missense:MODERATE:exon7/14:c.936C>G:p.Ile312Met,ACOX1:NM_001185039.1:missense:MODERATE:exon7/14:c.822C>G:p.Ile274Met,ACOX1:NM_007292.5:missense:MODERATE:exon7/14:c.936C>G:p.Ile312Met		rs1135640	0.5507	0.642	0.6491	0.2347	1.0860	P	T	B,B,B,B	B,B,B,B	609751 [ACOX1 (confirmed) Peroxisomal acyl-CoA oxidase deficiency];			COSM3755875	0.3788	0.4697	0.1515	175	209	n/a	n/a
chr17	75372339	75372339	C	T	het		QUAL=7273;DP=91;AF=0.57;MQM=60;TRIO=HET,91,0.57,HET,109,0.49,HOM,148,1.00	SEPT9	5'UTR,intron	SEPT9:NM_001113494.1:5'UTR:MODIFIER:exon1/11:c.-558C>T:,SEPT9:NM_001113491.1:intron:MODIFIER:exon2/11:c.77-25802C>T:,SEPT9:NM_001293695.1:intron:MODIFIER:exon1/10:c.20-25802C>T:,SEPT9:NM_001113492.1:intron:MODIFIER:exon2/11:c.-416-25802C>T:,SEPT9:NM_006640.4:intron:MODIFIER:exon1/10:c.23-25802C>T:,SEPT9:NM_001113493.1:intron:MODIFIER:exon1/10:c.55+2705C>T:		rs312826	0.6066	0	0	0						604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic];				0.4167	0.4015	0.1818	61	61	n/a	n/a
chr17	75494705	75494705	A	G	hom		QUAL=3590;DP=26;AF=1.00;MQM=60;TRIO=HOM,26,1.00,HOM,38,1.00,HOM,53,1.00	SEPT9	missense	SEPT9:NM_001113491.1:missense:MODERATE:exon12/12:c.1726A>G:p.Met576Val,SEPT9:NM_001293695.1:missense:MODERATE:exon11/11:c.1669A>G:p.Met557Val,SEPT9:NM_001113492.1:missense:MODERATE:exon12/12:c.1234A>G:p.Met412Val,SEPT9:NM_006640.4:missense:MODERATE:exon11/11:c.1672A>G:p.Met558Val,SEPT9:NM_001113493.1:missense:MODERATE:exon11/11:c.1705A>G:p.Met569Val,SEPT9:NM_001113494.1:missense:MODERATE:exon11/11:c.1234A>G:p.Met412Val,SEPT9:NM_001293696.1:missense:MODERATE:exon10/10:c.1054A>G:p.Met352Val,SEPT9:NM_001113496.1:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:NM_001293697.1:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:NM_001293698.1:missense:MODERATE:exon10/10:c.973A>G:p.Met325Val,SEPT9:NM_001113495.1:missense:MODERATE:exon10/10:c.1390A>G:p.Met464Val		rs2627223	0.9066	0.934	0.94	0.7975	0.0380	P	T	B,B,B,B,B,B	B,B,B,B,B,B	604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic];			COSM4130692	0.9394	0.0455	0.0152	410	41	n/a	n/a
chr17	75494787	75494787	-	C	hom		QUAL=744;DP=4;AF=1.00;MQM=59;TRIO=HOM,4,1.00,HET,9,0.89,HOM,21,0.95	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*55dupC:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*55dupC:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*55dupC:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*55dupC:		rs5822173	0.9363	0.854	0	0										0.8258	0.0682	0.1061	199	16	n/a	n/a
chr17	75495840	75495840	T	C	hom		QUAL=8529;DP=64;AF=1.00;MQM=59;TRIO=HOM,64,1.00,HOM,89,1.00,HOM,126,1.00	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*1100T>C:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*1100T>C:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*1100T>C:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*1100T>C:		rs407525	0.9876	0	0	0										0.9621	0.0379	0	177	5	n/a	n/a
chr17	75496342	75496342	T	C	hom		QUAL=17179;DP=135;AF=1.00;MQM=59;TRIO=HOM,135,1.00,HOM,182,1.00,HOM,221,1.00	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*1602T>C:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*1602T>C:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*1602T>C:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*1602T>C:		rs448767	0.9864	0	0	0										0.9621	0.0379	0	153	5	n/a	n/a
chr17	75496361	75496361	A	G	hom		QUAL=20784;DP=187;AF=1.00;MQM=60;TRIO=HOM,187,1.00,HOM,212,1.00,HOM,248,1.00	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*1621A>G:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*1621A>G:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*1621A>G:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*1621A>G:		rs2627222	0.9864	0	0	0										0.9621	0.0379	0	150	5	n/a	n/a
chr17	75496460	75496460	T	C	hom		QUAL=6281;DP=70;AF=1.00;MQM=60;TRIO=HOM,70,1.00,HET,135,0.50,HET,142,0.57	SEPT9	3'UTR	SEPT9:NM_001113491.1:3'UTR:MODIFIER:exon12/12:c.*1720T>C:,SEPT9:NM_001293695.1:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:NM_001113492.1:3'UTR:MODIFIER:exon12/12:c.*1720T>C:,SEPT9:NM_006640.4:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:NM_001113493.1:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:NM_001113494.1:3'UTR:MODIFIER:exon11/11:c.*1720T>C:,SEPT9:NM_001293696.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:NM_001113496.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:NM_001293697.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:NM_001293698.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:,SEPT9:NM_001113495.1:3'UTR:MODIFIER:exon10/10:c.*1720T>C:		rs445507	0.4321	0	0	0										0.2348	0.4621	0.303	43	66	n/a	n/a
chr17	76127431	76127431	G	C	hom		QUAL=10519;DP=91;AF=1.00;MQM=60;TRIO=HOM,91,1.00,HOM,102,0.98,HOM,151,1.00	TMC8,TMC6	5'UTR,intron	TMC8:NM_152468.4:5'UTR:MODIFIER:exon2/16:c.-239G>C:,TMC6:NM_007267.6:intron:MODIFIER:exon1/19:c.-75+991C>G:	MIRc	rs383603	0.6987	0	0	0										0.5909	0.3864	0.0227	91	54	n/a	n/a
chr17	76130575	76130575	A	T	hom		QUAL=10530;DP=72;AF=1.00;MQM=60;TRIO=HOM,72,1.00,HET,152,0.53,HOM,196,1.00	TMC8	missense	TMC8:NM_152468.4:missense:MODERATE:exon8/16:c.917A>T:p.Asn306Ile		rs7208422	0.5523	0.514	0.4894	0.6857	1.3510	P	T	B,B	B,B	605829 [TMC8 (confirmed) Epidermodysplasia verruciformis];		CM091876 [CLASS=DP MUT=ALT PHEN="Epidermodysplasia verruciformis, susceptibility in HIV, association" GENE=TMC8]; 		0.3333	0.4621	0.2045	140	215	n/a	n/a
chr17	76130947	76130947	G	T	het		QUAL=9176;DP=55;AF=0.58;MQM=60;TRIO=HET,55,0.58,HET,255,0.49,HET,279,0.52	TMC8	splice_region&intron	TMC8:NM_152468.4:splice_region&intron:LOW:exon8/15:c.988-4G>T:		rs62079073	0.0777	0.078	0.0813	0.0856						605829 [TMC8 (confirmed) Epidermodysplasia verruciformis];				0.0152	0.2348	0.75	4	93	n/a	n/a
chr17	76131070	76131070	G	A	het		QUAL=21930;DP=137;AF=0.50;MQM=60;TRIO=HET,137,0.50,HET,369,0.50,HOM,442,0.99	TMC8	synonymous	TMC8:NM_152468.4:synonymous:LOW:exon9/16:c.1107G>A:p.Glu369Glu		rs12452890	0.5403	0.534	0.5206	0.6857						605829 [TMC8 (confirmed) Epidermodysplasia verruciformis];				0.3864	0.447	0.1667	169	208	n/a	n/a
chr17	76137198	76137198	T	G	hom		QUAL=3292;DP=44;AF=1.00;MQM=60;TRIO=HOM,44,1.00,HOM,31,1.00,HOM,34,1.00	TMC8	3'UTR	TMC8:NM_152468.4:3'UTR:MODIFIER:exon16/16:c.*5T>G:		rs369764	0.9986	0.995	0.9936	0.9987										0.9924	0.0076	0	393	4	n/a	n/a
chr17	76137337	76137337	C	G	het		QUAL=5275;DP=93;AF=0.45;MQM=60;TRIO=HET,93,0.45,HET,62,0.53,HOM,88,1.00	TMC8	3'UTR	TMC8:NM_152468.4:3'UTR:MODIFIER:exon16/16:c.*144C>G:		rs454138	0.6569	0	0	0										0.4697	0.4318	0.0985	75	62	n/a	n/a
chr17	76137477	76137477	T	G	het		QUAL=2252;DP=85;AF=0.51;MQM=60;TRIO=HET,85,0.51,HET,22,0.50,HET,38,0.42	TMC8	3'UTR	TMC8:NM_152468.4:3'UTR:MODIFIER:exon16/16:c.*284T>G:		rs2871647	0.1296	0	0	0										0.0303	0.2652	0.7045	5	39	n/a	n/a
chr17	76138577	76138577	A	G	het		QUAL=15376;DP=217;AF=0.53;MQM=59;TRIO=HET,217,0.53,HET,213,0.52,HOM,275,1.00	TMC8	3'UTR	TMC8:NM_152468.4:3'UTR:MODIFIER:exon16/16:c.*1384A>G:		rs4789015	0.5795	0	0	0										0.4167	0.447	0.1364	64	65	n/a	n/a
chr17	78075462	78075462	G	C	het		QUAL=1410;DP=76;AF=0.51;MQM=59;TRIO=HET,76,0.51,WT,20,0.00,HET,36,0.53	GAA	5'UTR,intron	GAA:NM_000152.3:5'UTR:MODIFIER:exon1/20:c.-260G>C:,GAA:NM_001079803.1:intron:MODIFIER:exon1/20:c.-113+38G>C:,GAA:NM_001079804.1:intron:MODIFIER:exon1/19:c.-33+38G>C:		rs2304849	0.118	0	0	0										0.0455	0.3333	0.6212	7	49	n/a	n/a
chr17	78078709	78078709	T	C	hom		QUAL=3710;DP=48;AF=0.98;MQM=59;TRIO=HOM,48,0.98,HOM,37,1.00,HET,57,0.63	GAA	synonymous	GAA:NM_000152.3:synonymous:LOW:exon2/20:c.324T>C:p.Cys108Cys,GAA:NM_001079803.1:synonymous:LOW:exon3/21:c.324T>C:p.Cys108Cys,GAA:NM_001079804.1:synonymous:LOW:exon2/20:c.324T>C:p.Cys108Cys		rs1800300	0.7145	0.731	0.749	0.6975						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078180.3 [benign]; 		COSM3755978	0.5833	0.3258	0.0909	270	152	n/a	n/a
chr17	78079544	78079544	C	G	hom		QUAL=21788;DP=218;AF=1.00;MQM=60;TRIO=HOM,218,1.00,HOM,268,1.00,HET,377,0.51	GAA	splice_region&intron	GAA:NM_000152.3:splice_region&intron:LOW:exon2/19:c.547-4C>G:,GAA:NM_001079803.1:splice_region&intron:LOW:exon3/20:c.547-4C>G:,GAA:NM_001079804.1:splice_region&intron:LOW:exon2/19:c.547-4C>G:		rs3816256	0.6028	0.675	0.7384	0.5445						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078182.3 [benign]; 			0.5606	0.3485	0.0909	261	158	n/a	n/a
chr17	78079597	78079597	A	G	hom		QUAL=16777;DP=157;AF=0.99;MQM=59;TRIO=HOM,157,0.99,HOM,243,1.00,HET,340,0.47	GAA	missense	GAA:NM_000152.3:missense:MODERATE:exon3/20:c.596A>G:p.His199Arg,GAA:NM_001079803.1:missense:MODERATE:exon4/21:c.596A>G:p.His199Arg,GAA:NM_001079804.1:missense:MODERATE:exon3/20:c.596A>G:p.His199Arg		rs1042393	0.6008	0.674	0.7383	0.5443	-0.2170	P	T	B	B	606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078183.3 [benign]; 		COSM3755979	0.5606	0.3485	0.0909	261	158	n/a	n/a
chr17	78079643	78079643	C	T	het		QUAL=8498;DP=136;AF=0.51;MQM=60;TRIO=HET,136,0.51,HOM,211,1.00,WT,285,0.00	GAA	synonymous	GAA:NM_000152.3:synonymous:LOW:exon3/20:c.642C>T:p.Ser214Ser,GAA:NM_001079803.1:synonymous:LOW:exon4/21:c.642C>T:p.Ser214Ser,GAA:NM_001079804.1:synonymous:LOW:exon3/20:c.642C>T:p.Ser214Ser		rs1800301	0.106	0.18	0.22	0.079						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078184.3 [benign]; 		COSM3755980	0.0833	0.3636	0.553	41	154	n/a	n/a
chr17	78079669	78079669	G	A	hom		QUAL=10611;DP=103;AF=0.98;MQM=60;TRIO=HOM,103,0.98,HOM,176,1.00,HET,241,0.47	GAA	missense	GAA:NM_000152.3:missense:MODERATE:exon3/20:c.668G>A:p.Arg223His,GAA:NM_001079803.1:missense:MODERATE:exon4/21:c.668G>A:p.Arg223His,GAA:NM_001079804.1:missense:MODERATE:exon3/20:c.668G>A:p.Arg223His		rs1042395	0.6024	0.675	0.7381	0.5441	-0.0440	P	T	B	B	606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078185.3 [benign]; 		COSM3721877	0.5606	0.3485	0.0909	259	155	n/a	n/a
chr17	78081526	78081526	-	GCAGCGG	het		QUAL=6134;DP=20;AF=0.30;MQM=60;TRIO=HET,20,0.30,HET,186,0.69,HET,221,0.40	GAA	splice_region&intron	GAA:NM_000152.3:splice_region&intron:LOW:exon4/19:c.858+5_858+6insGCAGCGG:,GAA:NM_001079803.1:splice_region&intron:LOW:exon5/20:c.858+5_858+6insGCAGCGG:,GAA:NM_001079804.1:splice_region&intron:LOW:exon4/19:c.858+5_858+6insGCAGCGG:		rs372331052	0	0	0	0						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078186.2 [benign]; 			0.4773	0.3636	0.1591	207	174	n/a	n/a
chr17	78081529	78081529	G	A	het		QUAL=1663;DP=47;AF=0.34;MQM=60;TRIO=HET,47,0.34,HET,235,0.25,HET,255,0.11	GAA	splice_region&intron	GAA:NM_000152.3:splice_region&intron:LOW:exon4/19:c.858+8G>A:,GAA:NM_001079803.1:splice_region&intron:LOW:exon5/20:c.858+8G>A:,GAA:NM_001079804.1:splice_region&intron:LOW:exon4/19:c.858+8G>A:	GC_rich	rs5822325	0	0.0076	0	0						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000117108.2 [benign]; 			0	0.3561	0.6439	0	86	n/a	n/a
chr17	78082504	78082504	G	A	hom		QUAL=12124;DP=120;AF=0.99;MQM=59;TRIO=HOM,120,0.99,HOM,159,1.00,HET,212,0.50	GAA	synonymous	GAA:NM_000152.3:synonymous:LOW:exon8/20:c.1203G>A:p.Gln401Gln,GAA:NM_001079803.1:synonymous:LOW:exon9/21:c.1203G>A:p.Gln401Gln,GAA:NM_001079804.1:synonymous:LOW:exon8/20:c.1203G>A:p.Gln401Gln		rs1800304	0.6028	0.673	0.738	0.5393						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078155.3 [benign]; 		COSM3755981	0.5606	0.3485	0.0909	259	159	n/a	n/a
chr17	78084769	78084769	G	A	het		QUAL=7234;DP=196;AF=0.40;MQM=60;TRIO=HET,196,0.40,WT,276,0.00,HET,316,0.49	GAA	synonymous	GAA:NM_000152.3:synonymous:LOW:exon11/20:c.1581G>A:p.Arg527Arg,GAA:NM_001079803.1:synonymous:LOW:exon12/21:c.1581G>A:p.Arg527Arg,GAA:NM_001079804.1:synonymous:LOW:exon11/20:c.1581G>A:p.Arg527Arg		rs1042396	0.1595	0.231	0.2816	0.0683						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078160.3 [benign]; 		COSM148357	0.0909	0.3409	0.5682	33	172	n/a	n/a
chr17	78091405	78091405	G	A	hom		QUAL=1044;DP=16;AF=1.00;MQM=59;TRIO=HOM,16,1.00,HOM,15,1.00,HET,15,0.33	GAA	missense	GAA:NM_000152.3:missense:MODERATE:exon17/20:c.2338G>A:p.Val780Ile,GAA:NM_001079803.1:missense:MODERATE:exon18/21:c.2338G>A:p.Val780Ile,GAA:NM_001079804.1:missense:MODERATE:exon17/20:c.2338G>A:p.Val780Ile		rs1126690	0.7119	0.728	0.7499	0.7006	-0.3890	P	T	B	B	606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078171.3 [benign]; 		COSM3755982	0.6288	0.2576	0.1136	277	139	n/a	n/a
chr17	78092063	78092063	G	A	hom		QUAL=6798;DP=48;AF=0.98;MQM=60;TRIO=HOM,48,0.98,HOM,109,0.99,HET,137,0.51	GAA	synonymous	GAA:NM_000152.3:synonymous:LOW:exon18/20:c.2553G>A:p.Gly851Gly,GAA:NM_001079803.1:synonymous:LOW:exon19/21:c.2553G>A:p.Gly851Gly,GAA:NM_001079804.1:synonymous:LOW:exon18/20:c.2553G>A:p.Gly851Gly		rs1042397	0.5094	0.577	0.6427	0.5309						606800 [GAA (confirmed) Glycogen storage disease II];	RCV000078176.3 [benign]; 		COSM3766205	0.4394	0.4394	0.1212	202	189	n/a	n/a
chr17	78093549	78093549	G	T	hom		QUAL=952;DP=30;AF=0.97;MQM=60;TRIO=HOM,30,0.97,HET,9,0.33,HET,17,0.41	GAA	3'UTR	GAA:NM_000152.3:3'UTR:MODIFIER:exon20/20:c.*419G>T:,GAA:NM_001079803.1:3'UTR:MODIFIER:exon21/21:c.*419G>T:,GAA:NM_001079804.1:3'UTR:MODIFIER:exon20/20:c.*419G>T:		rs7567	0.156	0	0	0										0.0909	0.3258	0.5833	13	49	n/a	n/a
chr17	78183396	78183396	A	G	het		QUAL=34814;DP=241;AF=0.32;MQM=58;TRIO=HET,241,0.32,HET,735,0.47,HOM,761,1.00	SGSH	3'UTR	SGSH:NM_000199.3:3'UTR:MODIFIER:exon8/8:c.*855T>C:		rs1046832	0.4507	0	0	0										0.3712	0.4167	0.2121	57	63	n/a	n/a
chr17	78183403	78183403	G	C	het		QUAL=43816;DP=232;AF=0.38;MQM=58;TRIO=HET,232,0.38,HET,775,0.54,HOM,932,1.00	SGSH	3'UTR	SGSH:NM_000199.3:3'UTR:MODIFIER:exon8/8:c.*848C>G:		rs709677	0.6542	0	0	0										0.5303	0.3258	0.1439	82	48	n/a	n/a
chr17	78183411	78183411	T	C	het		QUAL=44219;DP=239;AF=0.38;MQM=58;TRIO=HET,239,0.38,HET,742,0.58,HOM,953,1.00	SGSH	3'UTR	SGSH:NM_000199.3:3'UTR:MODIFIER:exon8/8:c.*840A>G:		rs709678	0.647	0	0	0										0.5152	0.3409	0.1439	79	51	n/a	n/a
chr17	78183936	78183936	G	A	het		QUAL=8843;DP=113;AF=0.42;MQM=60;TRIO=HET,113,0.42,HET,148,0.49,HOM,171,1.00	SGSH	3'UTR	SGSH:NM_000199.3:3'UTR:MODIFIER:exon8/8:c.*315C>T:		rs2071148	0.4483	0	0	0										0.3939	0.4015	0.2045	60	61	n/a	n/a
chr17	78184393	78184393	C	T	het		QUAL=5300;DP=148;AF=0.46;MQM=60;TRIO=HET,148,0.46,HET,224,0.49,WT,300,0.00	SGSH	missense	SGSH:NM_000199.3:missense:MODERATE:exon8/8:c.1367G>A:p.Arg456His		rs7503034	0.3458	0.354	0.3314	0.2208	-0.3080	P	T	B	B	605270 [SGSH (confirmed) Mucopolysaccharidisis type IIIA (Sanfilippo A)];	RCV000078352.2 [benign]; 		COSM3755983	0.1136	0.3712	0.5152	52	169	n/a	n/a
chr17	79478019	79478019	G	A	hom		QUAL=35127;DP=333;AF=1.00;MQM=59;TRIO=HOM,333,1.00,HOM,326,1.00,HOM,473,1.00	ACTG1	synonymous	ACTG1:NM_001199954.1:synonymous:LOW:exon5/6:c.918C>T:p.Tyr306Tyr,ACTG1:NM_001614.3:synonymous:LOW:exon5/6:c.918C>T:p.Tyr306Tyr		rs1139405	0.7562	0.79	0.8162	0.6344						102560 [ACTG1 (confirmed) Deafness,autosomal dominant 20/26|Baraitser-Winter syndrome 2];	RCV000037126.4 [other]; 		COSM1387303	0.7121	0.2652	0.0227	294	140	n/a	n/a
chr17	79479808	79479808	C	T	hom		QUAL=213;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,HET,6,0.33,HOM,6,1.00	ACTG1	5'UTR	ACTG1:NM_001199954.1:5'UTR:MODIFIER:exon1/6:c.-174G>A:,ACTG1:NM_001614.3:5'UTR:MODIFIER:exon1/6:c.-55G>A:		rs7503278	0.7344	0.775	0	0										0.553	0.1136	0.3333	162	61	n/a	n/a
chr17	79479843	79479843	C	G	hom		QUAL=81;DP=1;AF=1.00;MQM=60;TRIO=HOM,1,1.00,WT,4,0.00,HET,11,0.36	ACTG1	5'UTR	ACTG1:NM_001199954.1:5'UTR:MODIFIER:exon1/6:c.-209G>C:,ACTG1:NM_001614.3:5'UTR:MODIFIER:exon1/6:c.-90G>C:		rs542961891	0.0034	0.014	0	0										0.0076	0.0076	0.9848	1	3	n/a	n/a
chr17	79891147	79891147	T	C	hom		QUAL=29755;DP=171;AF=1.00;MQM=60;TRIO=HOM,171,1.00,HOM,346,1.00,HOM,443,1.00	PYCR1	synonymous,intron	PYCR1:NM_001282281.1:synonymous:LOW:exon8/8:c.984A>G:p.Ser328Ser,PYCR1:NM_006907.3:synonymous:LOW:exon7/7:c.903A>G:p.Ser301Ser,PYCR1:NM_001282279.1:synonymous:LOW:exon7/7:c.810A>G:p.Ser270Ser,PYCR1:NM_001282280.1:synonymous:LOW:exon8/8:c.903A>G:p.Ser301Ser,PYCR1:NM_153824.2:intron:MODIFIER:exon7/7:c.867+36A>G:		rs61747618	0.986	0.995	0.9999	0.9455						179035 [PYCR1 (provisional) Cutis laxa,autosomal recessive,type IIB|Cutis laxa,autosomal recessive,type IIIB];			COSM4130834	1	0	0	454	0	n/a	n/a
chr17	80036877	80036877	A	G	het		QUAL=2039;DP=29;AF=0.41;MQM=59;TRIO=HET,29,0.41,HET,59,0.56,HET,78,0.41	FASN	3'UTR	FASN:NM_004104.4:3'UTR:MODIFIER:exon43/43:c.*142T>C:		rs11550611	0.5885	0	0	0										0.4545	0.4394	0.1061	72	62	n/a	n/a
chr17	80045086	80045086	G	C	het		QUAL=2543;DP=66;AF=0.50;MQM=60;TRIO=HET,66,0.50,HET,110,0.51,WT,126,0.00	FASN	synonymous	FASN:NM_004104.4:synonymous:LOW:exon21/43:c.3267C>G:p.Ala1089Ala		rs4485435	0.223	0.181	0	0									COSM4130849	0.0455	0.3333	0.6212	26	141	n/a	n/a
chr17	80051183	80051183	A	G	het		QUAL=6292;DP=149;AF=0.46;MQM=59;TRIO=HET,149,0.46,WT,153,0.01,HOM,136,0.99	FASN	synonymous	FASN:NM_004104.4:synonymous:LOW:exon5/43:c.567T>C:p.Asn189Asn		rs2228309	0.3918	0.458	0.5617	0.5021									COSM3756037	0.2197	0.4924	0.2879	119	218	n/a	n/a
chr17	80572628	80572628	A	G	het		QUAL=6305;DP=262;AF=0.44;MQM=60;TRIO=HET,262,0.44,WT,116,0.00,HET,162,0.52	WDR45B	3'UTR	WDR45B:NM_019613.3:3'UTR:MODIFIER:exon10/10:c.*1167T>C:		rs1059672	0.631	0	0	0										0.2955	0.5227	0.1818	44	78	n/a	n/a
chr17	80573272	80573272	A	G	hom		QUAL=10456;DP=176;AF=1.00;MQM=58;TRIO=HOM,176,1.00,HET,134,0.46,HET,174,0.53	WDR45B	3'UTR	WDR45B:NM_019613.3:3'UTR:MODIFIER:exon10/10:c.*523T>C:		rs9271	0.8634	0	0	0										0.7045	0.2803	0.0152	108	40	n/a	n/a
chr17	80579609	80579609	T	C	het		QUAL=5686;DP=205;AF=0.51;MQM=60;TRIO=HET,205,0.51,WT,147,0.00,HET,179,0.47	WDR45B	missense	WDR45B:NM_019613.3:missense:MODERATE:exon6/10:c.494A>G:p.His165Arg		rs74895287	0.0132	0.013	0.0176	0.035	7.5030	D	T	B	B				COSM3756047	0	0.0985	0.9015	1	22	n/a	n/a
chr17	80585094	80585094	C	T	het		QUAL=6208;DP=192;AF=0.55;MQM=57;TRIO=HET,192,0.55,HET,199,0.47,WT,214,0.00	WDR45B	synonymous	WDR45B:NM_019613.3:synonymous:LOW:exon4/10:c.318G>A:p.Lys106Lys		rs2291393	0.2007	0.231	0.2516	0.1119									COSM3756048	0.0682	0.4394	0.4924	37	169	n/a	n/a
chr18	2917152	2917152	T	C	het		QUAL=9719;DP=339;AF=0.52;MQM=60;TRIO=HET,339,0.52,HET,242,0.49,WT,340,0.00	LPIN2	3'UTR	LPIN2:NM_014646.2:3'UTR:MODIFIER:exon20/20:c.*3139A>G:		rs1164	0.142	0	0	0										0.053	0.3106	0.6364	8	49	n/a	n/a
chr18	2917357	2917357	G	A	het		QUAL=22149;DP=645;AF=0.52;MQM=60;TRIO=HET,645,0.52,HET,191,0.55,HOM,225,1.00	LPIN2	3'UTR	LPIN2:NM_014646.2:3'UTR:MODIFIER:exon20/20:c.*2934C>T:		rs7980	0.5455	0	0	0										0.3788	0.4924	0.1288	54	76	n/a	n/a
chr18	2919343	2919343	-	T	hom		QUAL=14986;DP=321;AF=0.92;MQM=60;TRIO=HOM,321,0.92,HET,173,0.51,HET,216,0.52	LPIN2	3'UTR	LPIN2:NM_014646.2:3'UTR:MODIFIER:exon20/20:c.*947dupA:		rs3840906	0.3265	0	0	0										0.1515	0.5227	0.3258	27	74	n/a	n/a
chr18	2919606	2919606	A	T	het		QUAL=12551;DP=283;AF=0.41;MQM=60;TRIO=HET,283,0.41,HOM,171,1.00,HET,245,0.51	LPIN2	3'UTR	LPIN2:NM_014646.2:3'UTR:MODIFIER:exon20/20:c.*685T>A:		rs607549	0.6913	0	0	0										0.5455	0.3788	0.0758	81	57	n/a	n/a
chr18	3412167	3412167	C	T	hom		QUAL=1736;DP=40;AF=0.98;MQM=59;TRIO=HOM,40,0.98,HET,18,0.50,HOM,18,1.00	TGIF1	5'UTR	TGIF1:NM_174886.2:5'UTR:MODIFIER:exon1/4:c.-203C>T:		rs11571505	0.6166	0	0	0										0.3182	0.4848	0.197	45	73	n/a	n/a
chr18	3447725	3447725	C	T	het		QUAL=11197;DP=585;AF=0.43;MQM=60;TRIO=HET,585,0.43,HET,213,0.52,WT,291,0.00	TGIF1	5'UTR,intron	TGIF1:NM_173207.2:5'UTR:MODIFIER:exon1/3:c.-13C>T:,TGIF1:NM_174886.2:intron:MODIFIER:exon2/3:c.-44-8627C>T:,TGIF1:NM_001278686.1:intron:MODIFIER:exon2/3:c.-44-8627C>T:		rs238137	0.0837	0.048	0.0355	0.1337										0	0.0682	0.9318	0	15	n/a	n/a
chr18	3450455	3450455	C	A	het		QUAL=9167;DP=134;AF=0.43;MQM=60;TRIO=HET,134,0.43,HOM,245,0.99,WT,291,0.00	TGIF1	5'UTR,intron	TGIF1:NM_001278684.1:5'UTR:MODIFIER:exon2/4:c.-33C>A:,TGIF1:NM_173208.2:5'UTR:MODIFIER:exon2/4:c.-33C>A:,TGIF1:NM_003244.3:5'UTR:MODIFIER:exon1/3:c.-33C>A:,TGIF1:NM_174886.2:intron:MODIFIER:exon2/3:c.-44-5897C>A:,TGIF1:NM_001278686.1:intron:MODIFIER:exon2/3:c.-44-5897C>A:,TGIF1:NM_173207.2:intron:MODIFIER:exon1/2:c.58+2660C>A:,TGIF1:NM_001278682.1:intron:MODIFIER:exon1/2:c.25+801C>A:,TGIF1:NM_173209.2:intron:MODIFIER:exon1/2:c.-45+387C>A:		rs238132	0.2839	0.098	0.125	0.5154						602630 [TGIF1 (confirmed) Holoprosencephaly-4];				0.0606	0.1818	0.7576	12	38	n/a	n/a
chr18	3452223	3452223	T	-	het		QUAL=551;DP=21;AF=0.38;MQM=59;TRIO=HET,21,0.38,WT,33,0.00,HET,43,0.33	TGIF1	frameshift,intron	TGIF1:NM_170695.3:frameshift:HIGH:exon1/3:c.246delT:p.Pro82fs,TGIF1:NM_174886.2:intron:MODIFIER:exon2/3:c.-44-4129delT:,TGIF1:NM_001278686.1:intron:MODIFIER:exon2/3:c.-44-4129delT:,TGIF1:NM_173207.2:intron:MODIFIER:exon1/2:c.59-4129delT:,TGIF1:NM_001278682.1:intron:MODIFIER:exon1/2:c.25+2569delT:,TGIF1:NM_001278684.1:intron:MODIFIER:exon2/3:c.16+1720delT:,TGIF1:NM_173208.2:intron:MODIFIER:exon2/3:c.16+1720delT:,TGIF1:NM_173209.2:intron:MODIFIER:exon1/2:c.-45+2155delT:,TGIF1:NM_003244.3:intron:MODIFIER:exon1/2:c.16+1720delT:,TGIF1:NM_173210.2:intron:MODIFIER:exon1/2:c.-45+450delT:		rs11571510	0.2556	0	0	0						602630 [TGIF1 (confirmed) Holoprosencephaly-4];			COSM296436	0.2121	0.4773	0.3106	62	141	1	n/a
chr18	3457606	3457606	C	T	het		QUAL=7774;DP=234;AF=0.50;MQM=59;TRIO=HET,234,0.50,HET,236,0.54,WT,313,0.00	TGIF1	missense	TGIF1:NM_170695.3:missense:MODERATE:exon3/3:c.874C>T:p.Pro292Ser,TGIF1:NM_174886.2:missense:MODERATE:exon4/4:c.427C>T:p.Pro143Ser,TGIF1:NM_001278686.1:missense:MODERATE:exon4/4:c.427C>T:p.Pro143Ser,TGIF1:NM_173207.2:missense:MODERATE:exon3/3:c.529C>T:p.Pro177Ser,TGIF1:NM_001278682.1:missense:MODERATE:exon3/3:c.496C>T:p.Pro166Ser,TGIF1:NM_001278684.1:missense:MODERATE:exon4/4:c.487C>T:p.Pro163Ser,TGIF1:NM_173208.2:missense:MODERATE:exon4/4:c.487C>T:p.Pro163Ser,TGIF1:NM_173209.2:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser,TGIF1:NM_003244.3:missense:MODERATE:exon3/3:c.487C>T:p.Pro163Ser,TGIF1:NM_173210.2:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser,TGIF1:NM_173211.1:missense:MODERATE:exon3/3:c.427C>T:p.Pro143Ser		rs4468717	0.0313	0.06	0.0777	0.0166	3.6330	D	T	P,P,P	B,B,B	602630 [TGIF1 (confirmed) Holoprosencephaly-4];				0	0.2121	0.7879	2	71	n/a	n/a
chr18	6943264	6943264	G	A	hom		QUAL=28730;DP=282;AF=1.00;MQM=60;TRIO=HOM,282,1.00,HOM,273,1.00,HOM,336,1.00	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon62/63:c.8982C>T:p.Asp2994Asp		rs2016639	0.2861	0.331	0.3321	0.0688									COSM148377	0.0985	0.447	0.4545	45	185	n/a	n/a
chr18	6980523	6980523	T	C	hom		QUAL=20780;DP=231;AF=1.00;MQM=60;TRIO=HOM,231,1.00,HOM,257,1.00,HET,292,0.51	LAMA1	missense	LAMA1:NM_005559.3:missense:MODERATE:exon42/63:c.6004A>G:p.Lys2002Glu		rs607230	0.6937	0.727	0.7147	0.5534	1.4670	P	T	B	B					0.4773	0.4394	0.0833	233	175	n/a	n/a
chr18	6985631	6985631	C	T	hom		QUAL=27816;DP=387;AF=0.99;MQM=60;TRIO=HOM,387,0.99,HOM,309,0.99,HET,365,0.47	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon38/63:c.5391G>A:p.Leu1797Leu		rs617206	0.5521	0.515	0.427	0.4982									COSM3756200	0.2121	0.4848	0.303	78	224	n/a	n/a
chr18	7008591	7008591	T	C	het		QUAL=8081;DP=308;AF=0.54;MQM=60;TRIO=HET,308,0.54,HET,171,0.46,WT,242,0.00	LAMA1	missense	LAMA1:NM_005559.3:missense:MODERATE:exon28/63:c.4018A>G:p.Met1340Val		rs662471	0.1871	0.238	0.2998	0.2433	-0.0350	P	D	P	B					0.0606	0.3712	0.5682	33	181	n/a	n/a
chr18	7012123	7012123	A	G	het		QUAL=9989;DP=234;AF=0.46;MQM=60;TRIO=HET,234,0.46,HOM,212,1.00,WT,334,0.01	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon24/63:c.3378T>C:p.Gly1126Gly		rs9946794	0.4201	0.377	0.3894	0.7594									COSM438362	0.1212	0.4848	0.3939	64	213	n/a	n/a
chr18	7017322	7017322	A	G	het		QUAL=19510;DP=433;AF=0.48;MQM=60;TRIO=HET,433,0.48,HOM,395,1.00,WT,555,0.00	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon20/63:c.2763T>C:p.Cys921Cys		rs539713	0.5475	0.519	0.535	0.8414									COSM4131076	0.2803	0.4545	0.2652	134	220	n/a	n/a
chr18	7023371	7023371	A	G	het		QUAL=1703;DP=52;AF=0.48;MQM=60;TRIO=HET,52,0.48,HET,52,0.63,WT,59,0.00	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon19/63:c.2493T>C:p.Cys831Cys		rs684634	0.4373	0.38	0.3799	0.7533									COSM1179774	0.0758	0.447	0.4773	48	208	n/a	n/a
chr18	7033037	7033037	G	A	het		QUAL=8967;DP=278;AF=0.50;MQM=59;TRIO=HET,278,0.50,HOM,157,0.97,WT,225,0.00	LAMA1	synonymous	LAMA1:NM_005559.3:synonymous:LOW:exon15/63:c.2109C>T:p.Ala703Ala		rs621993	0.4066	0.384	0.4044	0.6407										0.0985	0.4545	0.447	60	210	n/a	n/a
chr18	9117867	9117867	T	C	hom		QUAL=11207;DP=234;AF=1.00;MQM=60;TRIO=HOM,234,1.00,HOM,42,1.00,HOM,54,1.00	NDUFV2	missense	NDUFV2:NM_021074.4:missense:MODERATE:exon2/8:c.86T>C:p.Val29Ala		rs906807	0.779	0.8	0.8194	0.7608	1.5370	P	T	B	B	600532 [NDUFV2 (confirmed) Mitochondrial complex I deficiency];	RCV000009621.1 [uncertain significance]; RCV000117718.2 [likely benign]; RCV000127170.1 [benign]; 	CM983407 [CLASS=DP MUT=REF PHEN="Parkinson disease, susceptibility to, association" GENE=NDUFV2]; 	COSM3773839	0.6136	0.3409	0.0455	317	122	n/a	n/a
chr18	9119489	9119489	A	T	het		QUAL=10740;DP=399;AF=0.49;MQM=56;TRIO=HET,399,0.49,HET,247,0.51,WT,299,0.00	NDUFV2	synonymous	NDUFV2:NM_021074.4:synonymous:LOW:exon4/8:c.201A>T:p.Val67Val		rs41274300	0.0751	0.084	0.1129	0.1627						600532 [NDUFV2 (confirmed) Mitochondrial complex I deficiency];	RCV000117717.2 [likely benign]; 		COSM4131120	0.0227	0.2803	0.697	8	113	n/a	n/a
chr18	9134344	9134344	T	C	het		QUAL=3655;DP=113;AF=0.55;MQM=60;TRIO=HET,113,0.55,HET,118,0.51,WT,142,0.00					rs62088771	0.0034	0	0	0										0	0.0379	0.9621	0	6	n/a	n/a
chr18	12348285	12348285	T	C	hom		QUAL=16285;DP=210;AF=1.00;MQM=60;TRIO=HOM,210,1.00,HET,180,0.46,HOM,212,1.00	AFG3L2	synonymous	AFG3L2:NM_006796.2:synonymous:LOW:exon13/17:c.1650A>G:p.Glu550Glu		rs11553521	0.7099	0.749	0.7831	0.7717						604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28|Ataxia,spastic,5,autosomal recessive];	RCV000116249.2 [likely benign]; RCV000123557.1 [benign]; 		COSM148398	0.5833	0.3712	0.0455	849	484	n/a	n/a
chr18	12351342	12351342	C	T	hom		QUAL=16849;DP=192;AF=1.00;MQM=59;TRIO=HOM,192,1.00,HET,192,0.53,HOM,249,1.00	AFG3L2	synonymous	AFG3L2:NM_006796.2:synonymous:LOW:exon11/17:c.1389G>A:p.Leu463Leu		rs11080572	0.6232	0.72	0.7808	0.5014						604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28|Ataxia,spastic,5,autosomal recessive];	RCV000116248.2 [likely benign]; RCV000123556.1 [benign]; 		COSM148399	0.5682	0.3864	0.0455	843	486	n/a	n/a
chr18	12359920	12359920	G	A	hom		QUAL=14520;DP=178;AF=1.00;MQM=59;TRIO=HOM,178,1.00,HET,146,0.52,HOM,198,0.99	AFG3L2	splice_region&intron	AFG3L2:NM_006796.2:splice_region&intron:LOW:exon7/16:c.752+6C>T:		rs8097342	0.6196	0.718	0.779	0.5011						604581 [AFG3L2 (confirmed) Spinocerebellar ataxia 28|Ataxia,spastic,5,autosomal recessive];	RCV000123554.1 [benign]; 		COSM148400	0.5682	0.3864	0.0455	829	478	n/a	n/a
chr18	21119777	21119777	G	A	hom		QUAL=15295;DP=190;AF=1.00;MQM=60;TRIO=HOM,190,1.00,HET,206,0.48,HOM,209,1.00	NPC1	splice_region&synonymous	NPC1:NM_000271.4:splice_region&synonymous:LOW:exon18/25:c.2793C>T:p.Asn931Asn		rs1140458	0.484	0.489	0.4698	0.3879						607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];	RCV000020228.2 [benign]; RCV000078475.4 [other]; 		COSM437978	0.2121	0.4545	0.3333	245	555	n/a	n/a
chr18	21120444	21120444	T	C	hom		QUAL=28612;DP=553;AF=1.00;MQM=60;TRIO=HOM,553,1.00,HET,196,0.54,HOM,219,0.99	NPC1	missense	NPC1:NM_000271.4:missense:MODERATE:exon17/25:c.2572A>G:p.Ile858Val		rs1805082	0.4858	0.49	0.4706	0.3883	4.9470	P	T	B,B	B,B	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];	RCV000020227.2 [benign]; RCV000078474.4 [other]; 			0.2121	0.4621	0.3258	246	553	1	n/a
chr18	21123537	21123537	A	-	het		QUAL=1399;DP=41;AF=0.32;MQM=60;TRIO=HET,41,0.32,HET,48,0.42,HET,44,0.20	NPC1	splice_region&intron	NPC1:NM_000271.4:splice_region&intron:LOW:exon13/24:c.2131-5delT:	AT_rich		0	0	0	0						607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];				0.0152	0.3333	0.6515	10	253	2	n/a
chr18	21124917	21124917	G	C	het		QUAL=51;DP=10;AF=0.60;MQM=60;TRIO=HET,10,0.60,WT,82,0.00,WT,44,0.00	NPC1	splice_region&intron	NPC1:NM_000271.4:splice_region&intron:LOW:exon12/24:c.1947+7C>G:		rs56394541	0	0	0	0						607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];				0	0.0227	0.9773	0	5	2	n/a
chr18	21124945	21124945	C	G	hom		QUAL=5347;DP=51;AF=0.98;MQM=60;TRIO=HOM,51,0.98,HET,109,0.23,HOM,111,1.00	NPC1	missense	NPC1:NM_000271.4:missense:MODERATE:exon12/25:c.1926G>C:p.Met642Ile		rs1788799	0.8317	0.718	0.645	0.9097	3.3010	P	T	B,B	B,B	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];	RCV000020225.2,RCV000078467.4 [benign,other]; 			0.4091	0.4394	0.1515	486	522	n/a	n/a
chr18	21134786	21134786	G	A	het		QUAL=9122;DP=212;AF=0.48;MQM=60;TRIO=HET,212,0.48,WT,245,0.00,HET,359,0.52	NPC1	missense	NPC1:NM_000271.4:missense:MODERATE:exon9/25:c.1489C>T:p.His497Tyr			0	0	0	0	6.4200	D	T	B,B	B,B	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];				0	0.0076	0.9924	0	1	3	n/a
chr18	21140432	21140432	T	C	hom		QUAL=2438;DP=41;AF=0.98;MQM=59;TRIO=HOM,41,0.98,HET,31,0.42,HOM,29,1.00	NPC1	missense	NPC1:NM_000271.4:missense:MODERATE:exon6/25:c.644A>G:p.His215Arg		rs1805081	0.2187	0.327	0.4026	0.0878	0.5890	P	T	B	B	607623 [NPC1 (confirmed) Niemann-Pick disease,type C1|Niemann-Pick disease,type D];	RCV000078484.4 [other]; RCV000158944.1 [benign]; 			0.1364	0.3939	0.4697	156	507	n/a	n/a
chr18	21413869	21413869	T	C	het		QUAL=21802;DP=338;AF=0.48;MQM=60;TRIO=HET,338,0.48,HET,322,0.52,HOM,364,0.99	LAMA3	synonymous	LAMA3:NM_198129.1:synonymous:LOW:exon24/75:c.2901T>C:p.Ala967Ala,LAMA3:NM_001127717.1:synonymous:LOW:exon24/74:c.2901T>C:p.Ala967Ala		rs9962023	0.6244	0.662	0.7008	0.5468						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];			COSM4130939	0.4545	0.4848	0.0606	215	202	n/a	n/a
chr18	21437931	21437931	G	C	het		QUAL=27134;DP=345;AF=0.52;MQM=60;TRIO=HET,345,0.52,HET,385,0.52,HOM,518,0.99	LAMA3	synonymous	LAMA3:NM_198129.1:synonymous:LOW:exon33/75:c.4260G>C:p.Gly1420Gly,LAMA3:NM_001127717.1:synonymous:LOW:exon33/74:c.4260G>C:p.Gly1420Gly		rs867449	0.3437	0.496	0.6237	0.2987						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				0.303	0.5303	0.1667	150	222	n/a	n/a
chr18	21441717	21441717	C	T	het		QUAL=10966;DP=126;AF=0.50;MQM=60;TRIO=HET,126,0.50,HET,137,0.50,HOM,220,1.00	LAMA3	synonymous	LAMA3:NM_198129.1:synonymous:LOW:exon35/75:c.4530C>T:p.Pro1510Pro,LAMA3:NM_001127717.1:synonymous:LOW:exon35/74:c.4530C>T:p.Pro1510Pro		rs12965685	0.3407	0.493	0.6173	0.2666						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				0.3106	0.5227	0.1667	150	221	n/a	n/a
chr18	21481233	21481233	C	G	het		QUAL=5330;DP=239;AF=0.53;MQM=60;TRIO=HET,239,0.53,HET,96,0.46,WT,137,0.00	LAMA3	synonymous	LAMA3:NM_198129.1:synonymous:LOW:exon48/75:c.6147C>G:p.Ala2049Ala,LAMA3:NM_001127717.1:synonymous:LOW:exon47/74:c.5979C>G:p.Ala1993Ala,LAMA3:NM_000227.3:synonymous:LOW:exon11/38:c.1320C>G:p.Ala440Ala,LAMA3:NM_001127718.1:synonymous:LOW:exon10/37:c.1152C>G:p.Ala384Ala		rs1154226	0.1683	0.234	0.2712	0.0576						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];			COSM1179776	0.0455	0.4167	0.5379	26	186	n/a	n/a
chr18	21511034	21511034	C	A	het		QUAL=6184;DP=213;AF=0.55;MQM=60;TRIO=HET,213,0.55,HET,132,0.61,WT,196,0.00	LAMA3	missense	LAMA3:NM_198129.1:missense:MODERATE:exon65/75:c.8445C>A:p.Asn2815Lys,LAMA3:NM_001127717.1:missense:MODERATE:exon64/74:c.8277C>A:p.Asn2759Lys,LAMA3:NM_000227.3:missense:MODERATE:exon28/38:c.3618C>A:p.Asn1206Lys,LAMA3:NM_001127718.1:missense:MODERATE:exon27/37:c.3450C>A:p.Asn1150Lys		rs1154232	0.1567	0.189	0.199	0.0622	-0.0070	P	T	B,B,B,B	B,B,B,B	600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				0.0303	0.3182	0.6515	19	152	n/a	n/a
chr18	21511089	21511089	A	G	hom		QUAL=22630;DP=270;AF=1.00;MQM=60;TRIO=HOM,270,1.00,HOM,174,1.00,HOM,249,1.00	LAMA3	missense	LAMA3:NM_198129.1:missense:MODERATE:exon65/75:c.8500A>G:p.Ser2834Gly,LAMA3:NM_001127717.1:missense:MODERATE:exon64/74:c.8332A>G:p.Ser2778Gly,LAMA3:NM_000227.3:missense:MODERATE:exon28/38:c.3673A>G:p.Ser1225Gly,LAMA3:NM_001127718.1:missense:MODERATE:exon27/37:c.3505A>G:p.Ser1169Gly		rs1154233	1	1	0	0	-1.2560	P	T	B,B,B,B	B,B,B,B	600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				1	0	0	454	0	n/a	n/a
chr18	21511172	21511172	G	C	hom		QUAL=17262;DP=192;AF=1.00;MQM=60;TRIO=HOM,192,1.00,HOM,150,1.00,HOM,199,1.00	LAMA3	splice_region&intron	LAMA3:NM_198129.1:splice_region&intron:LOW:exon65/74:c.8576+7G>C:,LAMA3:NM_001127717.1:splice_region&intron:LOW:exon64/73:c.8408+7G>C:,LAMA3:NM_000227.3:splice_region&intron:LOW:exon28/37:c.3749+7G>C:,LAMA3:NM_001127718.1:splice_region&intron:LOW:exon27/36:c.3581+7G>C:		rs1258107	0.9489	0.973	0.993	0.8979						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				0.947	0.053	0	432	20	n/a	n/a
chr18	21513768	21513768	C	T	het		QUAL=3458;DP=135;AF=0.46;MQM=60;TRIO=HET,135,0.46,HET,88,0.55,WT,105,0.04	LAMA3	synonymous	LAMA3:NM_198129.1:synonymous:LOW:exon67/75:c.8731C>T:p.Leu2911Leu,LAMA3:NM_001127717.1:synonymous:LOW:exon66/74:c.8563C>T:p.Leu2855Leu,LAMA3:NM_000227.3:synonymous:LOW:exon30/38:c.3904C>T:p.Leu1302Leu,LAMA3:NM_001127718.1:synonymous:LOW:exon29/37:c.3736C>T:p.Leu1246Leu		rs1131521	0.1484	0.186	0.1985	0.0431						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];			COSM3756100	0.0303	0.3182	0.6515	19	151	n/a	n/a
chr18	21529722	21529722	G	A	het		QUAL=12077;DP=221;AF=0.52;MQM=60;TRIO=HET,221,0.52,HET,177,0.49,HOM,190,1.00	LAMA3	splice_region&intron	LAMA3:NM_198129.1:splice_region&intron:LOW:exon70/74:c.9352-7G>A:,LAMA3:NM_001127717.1:splice_region&intron:LOW:exon69/73:c.9184-7G>A:,LAMA3:NM_000227.3:splice_region&intron:LOW:exon33/37:c.4525-7G>A:,LAMA3:NM_001127718.1:splice_region&intron:LOW:exon32/36:c.4357-7G>A:		rs2241643	0.359	0.537	0.6809	0.2785						600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type|Epidermolysis bullosa,generalized atrophic benign|Laryngoonychocutaneous syndrome];				0.3788	0.5076	0.1136	176	209	n/a	n/a
chr18	21534701	21534701	C	A	het		QUAL=18723;DP=276;AF=0.46;MQM=60;TRIO=HET,276,0.46,HET,254,0.46,HOM,339,1.00	LAMA3	3'UTR	LAMA3:NM_198129.1:3'UTR:MODIFIER:exon75/75:c.*89C>A:,LAMA3:NM_001127717.1:3'UTR:MODIFIER:exon74/74:c.*89C>A:,LAMA3:NM_000227.3:3'UTR:MODIFIER:exon38/38:c.*89C>A:,LAMA3:NM_001127718.1:3'UTR:MODIFIER:exon37/37:c.*89C>A:		rs1051149	0.3596	0	0	0										0.3864	0.5	0.1136	58	77	n/a	n/a
chr18	21534703	21534703	C	T	het		QUAL=18723;DP=276;AF=0.46;MQM=60;TRIO=HET,276,0.46,HET,254,0.46,HOM,339,1.00	LAMA3	3'UTR	LAMA3:NM_198129.1:3'UTR:MODIFIER:exon75/75:c.*91C>T:,LAMA3:NM_001127717.1:3'UTR:MODIFIER:exon74/74:c.*91C>T:,LAMA3:NM_000227.3:3'UTR:MODIFIER:exon38/38:c.*91C>T:,LAMA3:NM_001127718.1:3'UTR:MODIFIER:exon37/37:c.*91C>T:		rs1051150	0.3596	0	0	0										0.3864	0.5	0.1136	58	77	n/a	n/a
chr18	31320229	31320229	A	G	het		QUAL=14240;DP=367;AF=0.50;MQM=60;TRIO=HET,367,0.50,HET,223,0.45,HET,264,0.55	ASXL3	missense	ASXL3:NM_030632.1:missense:MODERATE:exon11/12:c.2861A>G:p.Asn954Ser		rs2282632	0.7033	0.595	0.5178	0.7846	0.4050	P	T	B	B	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome];				0.2803	0.4848	0.2348	68	159	n/a	n/a
chr18	31323848	31323848	A	G	het		QUAL=11506;DP=377;AF=0.46;MQM=60;TRIO=HET,377,0.46,WT,299,0.00,HET,418,0.44	ASXL3	missense	ASXL3:NM_030632.1:missense:MODERATE:exon12/12:c.4036A>G:p.Ile1346Val		rs61995734	0.0246	0.016	0.0163	0.0555	0.4170	N	T	B	B	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome];				0	0.0227	0.9773	0	4	n/a	n/a
chr18	31324934	31324934	A	G	het		QUAL=18890;DP=344;AF=0.52;MQM=60;TRIO=HET,344,0.52,HET,347,0.45,HET,503,0.50	ASXL3	missense	ASXL3:NM_030632.1:missense:MODERATE:exon12/12:c.5122A>G:p.Met1708Val		rs7232237	0.6791	0.586	0.5134	0.7378	-1.4340	P	T	B	B	615115 [ASXL3 (provisional) Bainbridge-Ropers syndrome];				0.2576	0.5	0.2424	65	157	n/a	n/a
chr18	31327296	31327296	A	C	het		QUAL=9212;DP=395;AF=0.48;MQM=60;TRIO=HET,395,0.48,WT,176,0.01,HET,215,0.51	ASXL3	3'UTR	ASXL3:NM_030632.1:3'UTR:MODIFIER:exon12/12:c.*737A>C:		rs7243541	0.2169	0	0	0										0.0076	0.2197	0.7727	1	35	n/a	n/a
chr18	33713287	33713287	T	A	het		QUAL=14845;DP=378;AF=0.46;MQM=60;TRIO=HET,378,0.46,HET,271,0.48,HET,313,0.48	ELP2	splice_region&intron	ELP2:NM_001242875.1:splice_region&intron:LOW:exon2/22:c.217+8T>A:,ELP2:NM_001242879.1:splice_region&intron:LOW:exon2/18:c.217+8T>A:,ELP2:NM_001242876.1:splice_region&intron:LOW:exon2/20:c.217+8T>A:,ELP2:NM_001242877.1:splice_region&intron:LOW:exon2/20:c.217+8T>A:,ELP2:NM_001242878.1:splice_region&intron:LOW:exon2/19:c.217+8T>A:,ELP2:NM_018255.2:splice_region&intron:LOW:exon2/21:c.217+8T>A:		rs1785905	0.3205	0.342	0.371	0.3668										0.1212	0.4773	0.4015	66	210	n/a	n/a
chr18	33718326	33718326	A	C	het		QUAL=8984;DP=262;AF=0.42;MQM=60;TRIO=HET,262,0.42,HET,169,0.56,HET,149,0.50	ELP2	missense	ELP2:NM_001242875.1:missense:MODERATE:exon4/23:c.382A>C:p.Thr128Pro,ELP2:NM_001242879.1:missense:MODERATE:exon4/19:c.382A>C:p.Thr128Pro,ELP2:NM_001242876.1:missense:MODERATE:exon4/21:c.382A>C:p.Thr128Pro,ELP2:NM_001242877.1:missense:MODERATE:exon4/21:c.382A>C:p.Thr128Pro,ELP2:NM_001242878.1:missense:MODERATE:exon4/20:c.382A>C:p.Thr128Pro,ELP2:NM_018255.2:missense:MODERATE:exon4/22:c.382A>C:p.Thr128Pro		rs1785934	0.3205	0.342	0.3713	0.3663	0.6540	P	T	B,B,B,B,B,B	B,B,B,B,B,B					0.1212	0.4773	0.4015	66	211	n/a	n/a
chr18	33719434	33719434	C	T	het		QUAL=7812;DP=152;AF=0.51;MQM=60;TRIO=HET,152,0.51,HET,133,0.48,HET,216,0.51	ELP2	synonymous,intron	ELP2:NM_001242875.1:synonymous:LOW:exon6/23:c.576C>T:p.Ala192Ala,ELP2:NM_001242876.1:synonymous:LOW:exon5/21:c.498C>T:p.Ala166Ala,ELP2:NM_001242879.1:intron:MODIFIER:exon4/18:c.445+1045C>T:,ELP2:NM_001242877.1:intron:MODIFIER:exon4/20:c.445+1045C>T:,ELP2:NM_001242878.1:intron:MODIFIER:exon4/19:c.445+1045C>T:,ELP2:NM_018255.2:intron:MODIFIER:exon5/21:c.523+599C>T:		rs1785932	0.2452	0.208	0	0										0.1136	0.4848	0.4015	51	194	n/a	n/a
chr18	33725931	33725931	G	A	het		QUAL=11274;DP=322;AF=0.48;MQM=60;TRIO=HET,322,0.48,HET,176,0.44,HET,249,0.46	ELP2	missense	ELP2:NM_001242875.1:missense:MODERATE:exon11/23:c.1108G>A:p.Val370Met,ELP2:NM_001242879.1:missense:MODERATE:exon7/19:c.703G>A:p.Val235Met,ELP2:NM_001242876.1:missense:MODERATE:exon10/21:c.1030G>A:p.Val344Met,ELP2:NM_001242877.1:missense:MODERATE:exon9/21:c.835G>A:p.Val279Met,ELP2:NM_001242878.1:missense:MODERATE:exon9/20:c.835G>A:p.Val279Met,ELP2:NM_018255.2:missense:MODERATE:exon10/22:c.913G>A:p.Val305Met		rs1785928	0.3217	0.343	0.3712	0.369	0.2480	P	T	B,B,B,B,B,B	B,B,B,B,B,B				COSM1388588	0.1212	0.4773	0.4015	66	211	n/a	n/a
chr18	33750046	33750046	C	T	het		QUAL=6379;DP=117;AF=0.50;MQM=60;TRIO=HET,117,0.50,HET,119,0.56,HET,150,0.55	ELP2	synonymous	ELP2:NM_001242875.1:synonymous:LOW:exon21/23:c.2292C>T:p.Cys764Cys,ELP2:NM_001242879.1:synonymous:LOW:exon17/19:c.1887C>T:p.Cys629Cys,ELP2:NM_001242876.1:synonymous:LOW:exon19/21:c.2082C>T:p.Cys694Cys,ELP2:NM_001242877.1:synonymous:LOW:exon19/21:c.2019C>T:p.Cys673Cys,ELP2:NM_001242878.1:synonymous:LOW:exon18/20:c.1887C>T:p.Cys629Cys,ELP2:NM_018255.2:synonymous:LOW:exon20/22:c.2097C>T:p.Cys699Cys		rs8299	0.3237	0.351	0.3844	0.3686									COSM1388592	0.1439	0.4545	0.4015	75	208	n/a	n/a
chr18	42260911	42260911	G	T	het		QUAL=2468;DP=104;AF=0.40;MQM=60;TRIO=HET,104,0.40,HET,70,0.53,WT,108,0.00	SETBP1	5'UTR_premature_start_codon_gain,5'UTR,intron	SETBP1:NM_015559.2:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-248G>T:,SETBP1:NM_015559.2:5'UTR:MODIFIER:exon1/6:c.-248G>T:,SETBP1:NM_001130110.1:intron:MODIFIER:exon1/3:c.-173+551G>T:		rs563748893	0.0018	0	0	0									COSN148355	0	0.0606	0.9394	0	8	n/a	n/a
chr18	42456653	42456653	G	A	hom		QUAL=7596;DP=135;AF=1.00;MQM=60;TRIO=HOM,135,1.00,HET,90,0.48,HET,133,0.53	SETBP1	missense,intron	SETBP1:NM_001130110.1:missense:MODERATE:exon4/4:c.664G>A:p.Ala222Thr,SETBP1:NM_015559.2:intron:MODIFIER:exon3/5:c.540+7405G>A:		rs663651	0.493	0.484	0	0	-0.9690	P	T	B	B	611060 [SETBP1 (provisional) Schinzel-Giedion midface retraction syndrome];	RCV000147471.1 [likely benign]; 			0.303	0.5303	0.1667	137	224	n/a	n/a
chr18	42456670	42456670	-	TCTT	hom		QUAL=5852;DP=130;AF=0.86;MQM=60;TRIO=HOM,130,0.86,HET,77,0.43,HET,116,0.48	SETBP1	frameshift,intron	SETBP1:NM_001130110.1:frameshift:HIGH:exon4/4:c.681_682insTCTT:p.Thr228fs,SETBP1:NM_015559.2:intron:MODIFIER:exon3/5:c.540+7422_540+7423insTCTT:		rs3085861	0.4938	0.482	0.5397	0.5243						611060 [SETBP1 (provisional) Schinzel-Giedion midface retraction syndrome];			COSM1480329	0.2955	0.5379	0.1667	133	223	2	n/a
chr18	42529996	42529996	G	C	het		QUAL=6650;DP=184;AF=0.49;MQM=60;TRIO=HET,184,0.49,HET,247,0.49,WT,324,0.01	SETBP1	missense	SETBP1:NM_015559.2:missense:MODERATE:exon4/6:c.691G>C:p.Val231Leu		rs11082414	0.1567	0.193	0.2044	0.148	-0.1230	P	T	B	B	611060 [SETBP1 (provisional) Schinzel-Giedion midface retraction syndrome];	RCV000147472.1 [benign]; 			0.0379	0.2576	0.7045	24	117	n/a	n/a
chr18	42533130	42533130	A	G	hom		QUAL=18537;DP=284;AF=1.00;MQM=59;TRIO=HOM,284,1.00,HOM,125,1.00,HOM,177,0.99	SETBP1	synonymous	SETBP1:NM_015559.2:synonymous:LOW:exon4/6:c.3825A>G:p.Ser1275Ser		rs8096662	0.9069	0.877	0.8638	0.9694						611060 [SETBP1 (provisional) Schinzel-Giedion midface retraction syndrome];	RCV000147461.1,RCV000147462.1,RCV000147463.1 [uncertain significance,benign,uncertain significance]; 			0.7955	0.1818	0.0227	335	92	n/a	n/a
chr18	42646635	42646635	T	-	het		QUAL=1871;DP=100;AF=0.55;MQM=60;TRIO=HET,100,0.55,HET,22,0.14,HET,20,0.65	SETBP1	3'UTR	SETBP1:NM_015559.2:3'UTR:MODIFIER:exon6/6:c.*2987delT:		rs34125334	0.3756	0	0	0										0.1061	0.3106	0.5833	14	42	n/a	n/a
chr18	46987023	46987023	C	G	het		QUAL=2975;DP=58;AF=0.50;MQM=59;TRIO=HET,58,0.50,HET,138,0.53,WT,164,0.01	DYM	5'UTR	DYM:NM_017653.3:5'UTR:MODIFIER:exon1/17:c.-309G>C:		rs28364579	0.1194	0	0	0										0	0.1515	0.8485	0	22	n/a	n/a
chr18	52889712	52889712	-	A	het		QUAL=750;DP=95;AF=0.26;MQM=59;TRIO=HET,95,0.26,WT,26,0.04,HET,27,0.15	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*5553dupT:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*5553dupT:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*5553dupT:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*5553dupT:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*5553dupT:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*5553dupT:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*5553dupT:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*5553dupT:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*5553dupT:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*5553dupT:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*5553dupT:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*5553dupT:		rs71670792	0.2208	0	0	0										0.053	0.2273	0.7197	7	33	n/a	n/a
chr18	52889967	52889967	T	C	het		QUAL=8926;DP=278;AF=0.49;MQM=60;TRIO=HET,278,0.49,WT,88,0.00,HOM,135,0.99	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*5299A>G:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*5299A>G:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*5299A>G:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*5299A>G:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*5299A>G:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*5299A>G:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*5299A>G:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*5299A>G:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*5299A>G:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*5299A>G:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*5299A>G:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*5299A>G:		rs1261085	0.3974	0	0	0										0.1515	0.4848	0.3636	24	72	n/a	n/a
chr18	52890160	52890160	A	G	het		QUAL=7039;DP=274;AF=0.47;MQM=60;TRIO=HET,274,0.47,WT,99,0.00,HOM,94,1.00	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*5106T>C:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*5106T>C:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*5106T>C:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*5106T>C:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*5106T>C:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*5106T>C:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*5106T>C:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*5106T>C:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*5106T>C:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*5106T>C:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*5106T>C:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*5106T>C:		rs1261084	0.4437	0	0	0										0.1894	0.4621	0.3485	29	69	n/a	n/a
chr18	52890913	52890914	TT	-	het		QUAL=2758;DP=133;AF=0.41;MQM=60;TRIO=HET,133,0.41,WT,25,0.00,HOM,50,0.80	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*4352_*4353delAA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*4352_*4353delAA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*4352_*4353delAA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*4352_*4353delAA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*4352_*4353delAA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*4352_*4353delAA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*4352_*4353delAA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*4352_*4353delAA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*4352_*4353delAA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*4352_*4353delAA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*4352_*4353delAA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*4352_*4353delAA:	T-rich	rs11431395	0.508	0	0	0										0.197	0.4242	0.3788	32	61	n/a	n/a
chr18	52890946	52890946	-	TC	het		QUAL=3562;DP=192;AF=0.33;MQM=60;TRIO=HET,192,0.33,WT,32,0.00,HOM,68,0.93	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*4319_*4320insGA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*4319_*4320insGA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*4319_*4320insGA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*4319_*4320insGA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*4319_*4320insGA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*4319_*4320insGA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*4319_*4320insGA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*4319_*4320insGA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*4319_*4320insGA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*4319_*4320insGA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*4319_*4320insGA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*4319_*4320insGA:	T-rich	rs373174214	0.4145	0	0	0										0.1591	0.4697	0.3712	23	70	n/a	n/a
chr18	52891284	52891284	T	-	het		QUAL=2414;DP=117;AF=0.50;MQM=60;TRIO=HET,117,0.50,WT,19,0.00,HET,40,0.55	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*3982delA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*3982delA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*3982delA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*3982delA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*3982delA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*3982delA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*3982delA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*3982delA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*3982delA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*3982delA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*3982delA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*3982delA:	AT_rich	rs35555522	0.2376	0	0	0										0.0606	0.197	0.7424	8	28	n/a	n/a
chr18	52891396	52891396	T	-	het		QUAL=2721;DP=92;AF=0.30;MQM=60;TRIO=HET,92,0.30,HET,46,0.28,HET,73,0.75	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*3870delA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*3870delA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*3870delA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*3870delA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*3870delA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*3870delA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*3870delA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*3870delA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*3870delA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*3870delA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*3870delA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*3870delA:		rs573970404	0	0	0	0										0.0985	0.2803	0.6212	14	39	n/a	n/a
chr18	52893255	52893255	-	A	het		QUAL=3971;DP=268;AF=0.43;MQM=60;TRIO=HET,268,0.43,WT,63,0.00,HET,56,0.34	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*2010dupT:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*2010dupT:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*2010dupT:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*2010dupT:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*2010dupT:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*2010dupT:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*2010dupT:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*2010dupT:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*2010dupT:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*2010dupT:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*2010dupT:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*2010dupT:		rs550740474	0.224	0	0	0										0.0682	0.4091	0.5227	9	65	n/a	n/a
chr18	52893505	52893505	T	-	het		QUAL=10442;DP=347;AF=0.42;MQM=60;TRIO=HET,347,0.42,WT,147,0.01,HOM,201,0.97	TCF4	3'UTR	TCF4:NM_001243226.2:3'UTR:MODIFIER:exon21/21:c.*1761delA:,TCF4:NM_001243236.1:3'UTR:MODIFIER:exon13/13:c.*1761delA:,TCF4:NM_001243234.1:3'UTR:MODIFIER:exon13/13:c.*1761delA:,TCF4:NM_001243235.1:3'UTR:MODIFIER:exon13/13:c.*1761delA:,TCF4:NM_001243232.1:3'UTR:MODIFIER:exon16/16:c.*1761delA:,TCF4:NM_001243233.1:3'UTR:MODIFIER:exon16/16:c.*1761delA:,TCF4:NM_001243231.1:3'UTR:MODIFIER:exon18/18:c.*1761delA:,TCF4:NM_001083962.1:3'UTR:MODIFIER:exon20/20:c.*1761delA:,TCF4:NM_001243230.1:3'UTR:MODIFIER:exon19/19:c.*1761delA:,TCF4:NM_003199.2:3'UTR:MODIFIER:exon20/20:c.*1761delA:,TCF4:NM_001243227.1:3'UTR:MODIFIER:exon19/19:c.*1761delA:,TCF4:NM_001243228.1:3'UTR:MODIFIER:exon20/20:c.*1761delA:		rs71674214	0.346	0	0	0										0.1212	0.4773	0.4015	17	72	n/a	n/a
chr18	52895531	52895531	T	C	het		QUAL=7433;DP=237;AF=0.50;MQM=60;TRIO=HET,237,0.50,WT,88,0.00,HOM,116,1.00	TCF4	synonymous	TCF4:NM_001243226.2:synonymous:LOW:exon20/21:c.2247A>G:p.Ser749Ser,TCF4:NM_001243236.1:synonymous:LOW:exon12/13:c.1449A>G:p.Ser483Ser,TCF4:NM_001243234.1:synonymous:LOW:exon12/13:c.1461A>G:p.Ser487Ser,TCF4:NM_001243235.1:synonymous:LOW:exon12/13:c.1449A>G:p.Ser483Ser,TCF4:NM_001243232.1:synonymous:LOW:exon15/16:c.1728A>G:p.Ser576Ser,TCF4:NM_001243233.1:synonymous:LOW:exon15/16:c.1539A>G:p.Ser513Ser,TCF4:NM_001243231.1:synonymous:LOW:exon17/18:c.1803A>G:p.Ser601Ser,TCF4:NM_001083962.1:synonymous:LOW:exon19/20:c.1941A>G:p.Ser647Ser,TCF4:NM_001243230.1:synonymous:LOW:exon18/19:c.1920A>G:p.Ser640Ser,TCF4:NM_003199.2:synonymous:LOW:exon19/20:c.1929A>G:p.Ser643Ser,TCF4:NM_001243227.1:synonymous:LOW:exon18/19:c.1869A>G:p.Ser623Ser,TCF4:NM_001243228.1:synonymous:LOW:exon19/20:c.1959A>G:p.Ser653Ser		rs8766	0.3425	0.371	0.3886	0.318						602272 [TCF4 (confirmed) Pitt-Hopkins syndrome];	RCV000079460.3 [benign]; RCV000128388.1 [benign]; 			0.1212	0.4773	0.4015	58	218	n/a	n/a
chr18	53070914	53070914	G	A	het		QUAL=22348;DP=515;AF=0.52;MQM=60;TRIO=HET,515,0.52,WT,304,0.00,HOM,413,1.00	TCF4	missense,intron	TCF4:NM_001243232.1:missense:MODERATE:exon1/16:c.32C>T:p.Ala11Val,TCF4:NM_001243226.2:intron:MODIFIER:exon6/20:c.611-165C>T:,TCF4:NM_001243233.1:intron:MODIFIER:exon1/15:c.-86-165C>T:,TCF4:NM_001243231.1:intron:MODIFIER:exon3/17:c.179-165C>T:,TCF4:NM_001083962.1:intron:MODIFIER:exon5/19:c.305-165C>T:,TCF4:NM_001243230.1:intron:MODIFIER:exon4/18:c.299-165C>T:,TCF4:NM_003199.2:intron:MODIFIER:exon5/19:c.305-165C>T:,TCF4:NM_001243227.1:intron:MODIFIER:exon4/18:c.233-165C>T:,TCF4:NM_001243228.1:intron:MODIFIER:exon5/19:c.305-165C>T:		rs17522826	0.1923	0.152	0	0	2.9740	P	D	B	B	602272 [TCF4 (confirmed) Pitt-Hopkins syndrome];	RCV000147721.1 [likely benign]; 			0.0606	0.3409	0.5985	18	137	n/a	n/a
chr18	53303101	53303101	C	G	hom		QUAL=14492;DP=176;AF=1.00;MQM=59;TRIO=HOM,176,1.00,HOM,105,1.00,HOM,164,1.00	TCF4	missense	TCF4:NM_001243226.2:missense:MODERATE:exon1/21:c.28G>C:p.Ala10Pro		rs611326	0.9968	0.999	1	0.996	1.4190	P	T	B	B	602272 [TCF4 (confirmed) Pitt-Hopkins syndrome];				1	0	0	403	0	n/a	n/a
chr18	53303150	53303150	T	C	het		QUAL=4114;DP=122;AF=0.55;MQM=60;TRIO=HET,122,0.55,WT,91,0.00,HET,129,0.52	TCF4	5'UTR_premature_start_codon_gain,5'UTR	TCF4:NM_001243226.2:5'UTR_premature_start_codon_gain:LOW:exon1/21:c.-22A>G:,TCF4:NM_001243226.2:5'UTR:MODIFIER:exon1/21:c.-22A>G:		rs77891683	0.0048	0.0093	0.0196	0.004										0	0.0227	0.9773	0	3	n/a	n/a
chr18	55313705	55313705	T	-	het		QUAL=1502;DP=96;AF=0.43;MQM=60;TRIO=HET,96,0.43,WT,19,0.00,HET,38,0.26	ATP8B1,LOC100505549	3'UTR,intron	ATP8B1:NM_005603.4:3'UTR:MODIFIER:exon28/28:c.*2015delA:,LOC100505549:NM_001242804.1:intron:MODIFIER:exon2/2:c.139+4427delT:		rs35833803	0.1753	0	0	0										0.0076	0.2652	0.7273	1	39	n/a	n/a
chr18	55314211	55314211	T	C	het		QUAL=3129;DP=142;AF=0.50;MQM=60;TRIO=HET,142,0.50,WT,34,0.00,HET,60,0.48	ATP8B1,LOC100505549	3'UTR,intron	ATP8B1:NM_005603.4:3'UTR:MODIFIER:exon28/28:c.*1509A>G:,LOC100505549:NM_001242804.1:intron:MODIFIER:exon2/2:c.139+4927T>C:		rs1968274	0.3085	0	0	0										0.0758	0.3939	0.5303	11	56	n/a	n/a
chr18	55314820	55314820	C	A	het		QUAL=8337;DP=309;AF=0.52;MQM=60;TRIO=HET,309,0.52,WT,166,0.00,HET,215,0.41	ATP8B1,LOC100505549	3'UTR,intron	ATP8B1:NM_005603.4:3'UTR:MODIFIER:exon28/28:c.*900G>T:,LOC100505549:NM_001242804.1:intron:MODIFIER:exon2/2:c.139+5536C>A:		rs4940950	0.4661	0	0	0										0.3182	0.4773	0.2045	47	71	n/a	n/a
chr18	55317676	55317676	C	T	hom		QUAL=32027;DP=342;AF=1.00;MQM=60;TRIO=HOM,342,1.00,HOM,292,1.00,HOM,371,1.00	ATP8B1,LOC100505549	missense,intron	ATP8B1:NM_005603.4:missense:MODERATE:exon27/28:c.3454G>A:p.Ala1152Thr,LOC100505549:NM_001242804.1:intron:MODIFIER:exon2/2:c.139+8392C>T:		rs222581	0.9998	1	1	0.9964	2.0100	P	T	B	B	602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1|Cholestasis,benign recurrent intrahepatic|Cholestasis,intrahepatic,of pregnancy,1];				1	0	0	454	0	n/a	n/a
chr18	55362532	55362532	T	G	hom		QUAL=16433;DP=248;AF=1.00;MQM=60;TRIO=HOM,248,1.00,HOM,94,1.00,HOM,148,1.00	ATP8B1	synonymous	ATP8B1:NM_005603.4:synonymous:LOW:exon10/28:c.811A>C:p.Arg271Arg		rs319443	0.9926	0.997	0.9999	0.9698						602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1|Cholestasis,benign recurrent intrahepatic|Cholestasis,intrahepatic,of pregnancy,1];				1	0	0	454	0	n/a	n/a
chr18	55364852	55364852	A	G	hom		QUAL=32246;DP=424;AF=1.00;MQM=60;TRIO=HOM,424,1.00,HOM,248,1.00,HOM,336,1.00	ATP8B1	splice_region&synonymous	ATP8B1:NM_005603.4:splice_region&synonymous:LOW:exon8/28:c.696T>C:p.Asp232Asp		rs319438	0.9946	0.998	0.9999	0.9798						602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1|Cholestasis,benign recurrent intrahepatic|Cholestasis,intrahepatic,of pregnancy,1];				1	0	0	453	1	n/a	n/a
chr18	77473127	77473127	C	T	hom		QUAL=12952;DP=185;AF=1.00;MQM=60;TRIO=HOM,185,1.00,HET,190,0.53,HET,229,0.54	CTDP1	missense	CTDP1:NM_004715.4:missense:MODERATE:exon7/13:c.1019C>T:p.Thr340Met,CTDP1:NM_048368.3:missense:MODERATE:exon7/12:c.1019C>T:p.Thr340Met,CTDP1:NM_001202504.1:missense:MODERATE:exon7/13:c.662C>T:p.Thr221Met		rs2279103	0.0827	0.136	0.1788	0.0386	0.0990	P	T	B,B,B	B,B,B	604927 [CTDP1 (provisional) Congenital cataracts,facial dysmorphism,and neuropathy];				0.0076	0.2727	0.7197	4	118	n/a	n/a
chr18	77513721	77513721	T	C	hom		QUAL=37131;DP=245;AF=1.00;MQM=60;TRIO=HOM,245,1.00,HOM,395,1.00,HOM,549,1.00	CTDP1	synonymous,3'UTR	CTDP1:NM_004715.4:synonymous:LOW:exon13/13:c.2817T>C:p.Asp939Asp,CTDP1:NM_001202504.1:synonymous:LOW:exon13/13:c.2460T>C:p.Asp820Asp,CTDP1:NM_048368.3:3'UTR:MODIFIER:exon12/12:c.*50T>C:		rs626169	0.8952	0.966	0.9934	0.7072						604927 [CTDP1 (provisional) Congenital cataracts,facial dysmorphism,and neuropathy];	RCV000116845.2 [likely benign]; 		COSM4131107	0.9924	0.0076	0	445	8	n/a	n/a
chr18	77513841	77513841	G	A	hom		QUAL=16890;DP=262;AF=1.00;MQM=59;TRIO=HOM,262,1.00,HET,250,0.49,HET,342,0.47	CTDP1	3'UTR	CTDP1:NM_004715.4:3'UTR:MODIFIER:exon13/13:c.*51G>A:,CTDP1:NM_048368.3:3'UTR:MODIFIER:exon12/12:c.*170G>A:,CTDP1:NM_001202504.1:3'UTR:MODIFIER:exon13/13:c.*51G>A:		rs76088733	0.1306	0.178	0.2268	0.0979										0.0076	0.3182	0.6742	1	50	n/a	n/a
chr19	863356	863356	C	T	het		QUAL=12246;DP=305;AF=0.51;MQM=59;TRIO=HET,305,0.51,HET,449,0.53,WT,565,0.00	CFD	3'UTR	CFD:NM_001928.2:3'UTR:MODIFIER:exon5/5:c.*118C>T:	AluJo	rs10506	0.2754	0	0	0										0.0303	0.2273	0.7424	5	34	n/a	n/a
chr19	863609	863609	A	-	het		QUAL=172;DP=89;AF=0.15;MQM=60;TRIO=HET,89,0.15,HET,20,0.30,WT,26,0.04	CFD	3'UTR	CFD:NM_001928.2:3'UTR:MODIFIER:exon5/5:c.*361delA:	AluJo		0	0	0	0										0	0.0606	0.9394	0	10	n/a	n/a
chr19	1388538	1388538	C	T	het		QUAL=3813;DP=65;AF=0.55;MQM=60;TRIO=HET,65,0.55,HOM,49,1.00,HET,71,0.55	NDUFS7	missense	NDUFS7:NM_024407.4:missense:MODERATE:exon3/8:c.68C>T:p.Pro23Leu		rs1142530	0.4557	0.543	0.6229	0.3801	0.8850	P	T	B,B,B	B,B,B	601825 [NDUFS7 (provisional) Leigh syndrome];	RCV000117716.2 [likely benign]; 		COSM4131259	0.3636	0.4773	0.1591	166	210	n/a	n/a
chr19	1398750	1398750	C	T	het		QUAL=10848;DP=289;AF=0.48;MQM=59;TRIO=HET,289,0.48,WT,345,0.00,HET,404,0.52	GAMT	synonymous,intron	GAMT:NM_138924.2:synonymous:LOW:exon5/5:c.735G>A:p.Ala245Ala,GAMT:NM_000156.5:intron:MODIFIER:exon5/5:c.570+165G>A:		rs74253480	0.0114	0.0037	0.0136	0.0027						601240 [GAMT (provisional) Cerebral creatine deficiency syndrome 2];	RCV000125193.1 [benign]; 			0	0.0303	0.9697	0	10	n/a	n/a
chr19	3631036	3631036	A	G	hom		QUAL=25107;DP=279;AF=1.00;MQM=59;TRIO=HOM,279,1.00,HOM,211,1.00,HOM,288,1.00	PIP5K1C	3'UTR	PIP5K1C:NM_001195733.1:3'UTR:MODIFIER:exon17/17:c.*2129T>C:,PIP5K1C:NM_012398.2:3'UTR:MODIFIER:exon18/18:c.*2129T>C:		rs4807493	0.8508	0	0	0										0.7045	0.25	0.0455	109	35	n/a	n/a
chr19	3631569	3631569	C	G	hom		QUAL=1124;DP=30;AF=1.00;MQM=59;TRIO=HOM,30,1.00,HET,4,0.75,HOM,5,1.00	PIP5K1C	3'UTR	PIP5K1C:NM_001195733.1:3'UTR:MODIFIER:exon17/17:c.*1596G>C:,PIP5K1C:NM_012398.2:3'UTR:MODIFIER:exon18/18:c.*1596G>C:		rs4807494	0.8452	0	0	0										0.6591	0.2273	0.1136	101	33	n/a	n/a
chr19	3631694	3631694	G	A	hom		QUAL=2746;DP=56;AF=1.00;MQM=60;TRIO=HOM,56,1.00,HET,28,0.71,HOM,25,1.00	PIP5K1C	3'UTR	PIP5K1C:NM_001195733.1:3'UTR:MODIFIER:exon17/17:c.*1471C>T:,PIP5K1C:NM_012398.2:3'UTR:MODIFIER:exon18/18:c.*1471C>T:		rs4806946	0.398	0	0	0										0.4394	0.3636	0.197	68	54	n/a	n/a
chr19	3653525	3653525	C	T	het		QUAL=30211;DP=173;AF=0.44;MQM=59;TRIO=HET,173,0.44,HET,484,0.55,HOM,640,1.00	PIP5K1C	synonymous	PIP5K1C:NM_001300849.1:synonymous:LOW:exon7/17:c.684G>A:p.Ser228Ser,PIP5K1C:NM_001195733.1:synonymous:LOW:exon7/17:c.684G>A:p.Ser228Ser,PIP5K1C:NM_012398.2:synonymous:LOW:exon7/18:c.684G>A:p.Ser228Ser		rs2074957	0.5429	0.56	0.5647	0.4607						606102 [PIP5K1C (provisional) Lethal congenital contractural syndrome 3];			COSM4131725	0.3333	0.4924	0.1742	167	202	n/a	n/a
chr19	4090422	4090422	G	T	het		QUAL=5618;DP=115;AF=0.50;MQM=60;TRIO=HET,115,0.50,HET,269,0.51,WT,358,0.00	MAP2K2	3'UTR	MAP2K2:NM_030662.3:3'UTR:MODIFIER:exon11/11:c.*174C>A:		rs6630	0.1717	0	0	0										0.0076	0.1439	0.8485	1	25	n/a	n/a
chr19	4101062	4101062	G	T	het		QUAL=4325;DP=100;AF=0.51;MQM=53;TRIO=HET,100,0.51,HOM,93,1.00,WT,146,0.01	MAP2K2	synonymous	MAP2K2:NM_030662.3:synonymous:LOW:exon6/11:c.660C>A:p.Ile220Ile		rs10250	0.4333	0.44	0.485	0.2871						601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4];	RCV000039490.2 [benign]; RCV000149846.1 [benign]; 		COSM1481088	0.1591	0.5	0.3409	90	217	n/a	n/a
chr19	4102449	4102449	G	A	het		QUAL=8501;DP=131;AF=0.46;MQM=59;TRIO=HET,131,0.46,WT,321,0.00,HET,434,0.49	MAP2K2	splice_region&synonymous	MAP2K2:NM_030662.3:splice_region&synonymous:LOW:exon4/11:c.453C>T:p.Asp151Asp		rs17851657	0.1112	0.155	0.1934	0.0439						601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4];	RCV000039484.2 [benign]; RCV000149845.2 [benign]; 		COSM1129849	0.0379	0.4091	0.553	18	166	n/a	n/a
chr19	4117528	4117528	G	A	het		QUAL=5171;DP=175;AF=0.46;MQM=57;TRIO=HET,175,0.46,HET,173,0.51,WT,236,0.00	MAP2K2	synonymous	MAP2K2:NM_030662.3:synonymous:LOW:exon2/11:c.192C>T:p.Val64Val		rs8157	0.0583	0.062	0.0599	0.0695						601263 [MAP2K2 (provisional) Cardiofaciocutaneous syndrome 4];	RCV000039473.2 [benign]; 			0	0.0985	0.9015	0	64	n/a	n/a
chr19	5891299	5891299	C	T	het		QUAL=1033;DP=38;AF=0.50;MQM=59;TRIO=HET,38,0.50,WT,21,0.00,HOM,22,0.95	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*1629G>A:	AluSx1	rs1674158	0.475	0	0	0										0.1591	0.4773	0.3636	26	68	n/a	n/a
chr19	5891746	5891746	G	C	hom		QUAL=15656;DP=134;AF=1.00;MQM=60;TRIO=HOM,134,1.00,HET,226,0.46,HOM,263,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*1182C>G:	L2b	rs1678866	0.6272	0	0	0										0.4167	0.4394	0.1439	62	67	n/a	n/a
chr19	5892267	5892267	G	T	het		QUAL=3156;DP=110;AF=0.50;MQM=59;TRIO=HET,110,0.50,HET,103,0.49,WT,169,0.01	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*661C>A:		rs74500071	0.098	0	0	0										0.0152	0.197	0.7879	3	28	n/a	n/a
chr19	5892317	5892317	C	T	hom		QUAL=8712;DP=75;AF=0.99;MQM=60;TRIO=HOM,75,0.99,HET,85,0.51,HOM,170,0.99	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*611G>A:		rs1626918	0.641	0	0	0										0.3712	0.4848	0.1439	56	73	n/a	n/a
chr19	5892382	5892382	C	T	hom		QUAL=7587;DP=65;AF=1.00;MQM=60;TRIO=HOM,65,1.00,HET,64,0.45,HOM,149,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*546G>A:		rs1678867	0.7272	0	0	0										0.4167	0.4394	0.1439	62	67	n/a	n/a
chr19	5892433	5892433	C	T	het		QUAL=4403;DP=79;AF=0.46;MQM=60;TRIO=HET,79,0.46,WT,50,0.02,HOM,112,0.99	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*495G>A:		rs1627779	0.4742	0	0	0										0.1591	0.5	0.3409	26	71	n/a	n/a
chr19	5892486	5892486	C	T	hom		QUAL=7070;DP=73;AF=1.00;MQM=60;TRIO=HOM,73,1.00,HET,67,0.57,HOM,118,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*442G>A:		rs1628564	0.5839	0	0	0										0.2424	0.5758	0.1818	39	81	n/a	n/a
chr19	5892568	5892568	G	T	hom		QUAL=8537;DP=108;AF=1.00;MQM=60;TRIO=HOM,108,1.00,HET,84,0.55,HOM,115,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*360C>A:		rs1629368	0.5759	0	0	0										0.2424	0.5758	0.1818	39	81	n/a	n/a
chr19	5892585	5892585	G	A	het		QUAL=2809;DP=120;AF=0.40;MQM=59;TRIO=HET,120,0.40,HET,83,0.54,WT,126,0.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*343C>T:		rs60236148	0.0891	0	0	0										0.0152	0.1667	0.8182	3	23	n/a	n/a
chr19	5892743	5892743	C	T	het		QUAL=6822;DP=100;AF=0.43;MQM=59;TRIO=HET,100,0.43,WT,124,0.01,HOM,181,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*185G>A:		rs10432306	0.4127	0	0	0										0.1591	0.4924	0.3485	26	69	n/a	n/a
chr19	5892770	5892770	C	T	hom		QUAL=12793;DP=104;AF=1.00;MQM=59;TRIO=HOM,104,1.00,HET,141,0.48,HOM,233,1.00	NDUFA11	3'UTR	NDUFA11:NM_001193375.1:3'UTR:MODIFIER:exon4/4:c.*158G>A:		rs1631032	0.5859	0	0	0										0.2424	0.5833	0.1742	39	82	n/a	n/a
chr19	5892954	5892954	T	C	het		QUAL=13159;DP=169;AF=0.44;MQM=60;TRIO=HET,169,0.44,WT,246,0.00,HOM,349,0.99	NDUFA11	missense	NDUFA11:NM_001193375.1:missense:MODERATE:exon4/4:c.661A>G:p.Thr221Ala	MIR	rs1678868	0.477	0.354	0	0	-0.0270	P	D	B	B	612638 [NDUFA11 (provisional) Mitochondrial complex I deficiency];				0.1667	0.4924	0.3409	71	186	n/a	n/a
chr19	5903807	5903807	G	T	hom		QUAL=26765;DP=164;AF=0.99;MQM=60;TRIO=HOM,164,0.99,HET,368,0.53,HOM,547,1.00	NDUFA11	5'UTR	NDUFA11:NM_001193375.1:5'UTR:MODIFIER:exon1/4:c.-88C>A:,NDUFA11:NM_175614.4:5'UTR:MODIFIER:exon1/4:c.-88C>A:		rs8108064	0.6815	0.638	0	0										0.3561	0.4848	0.1591	117	132	n/a	n/a
chr19	5903936	5903936	T	C	hom		QUAL=15059;DP=75;AF=0.99;MQM=60;TRIO=HOM,75,0.99,HET,204,0.55,HOM,310,1.00	NDUFA11	5'UTR	NDUFA11:NM_001193375.1:5'UTR:MODIFIER:exon1/4:c.-217A>G:,NDUFA11:NM_175614.4:5'UTR:MODIFIER:exon1/4:c.-217A>G:		rs1056987	0.7266	0.674	0	0										0.4167	0.447	0.1364	134	124	n/a	n/a
chr19	6677989	6677989	G	A	het		QUAL=24244;DP=287;AF=0.48;MQM=60;TRIO=HET,287,0.48,HOM,389,1.00,HET,456,0.52	C3	synonymous	C3:NM_000064.2:synonymous:LOW:exon41/41:c.4896C>T:p.Pro1632Pro		rs17030	0.5329	0.524	0.5169	0.4977						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];			COSM3766459	0.3182	0.4318	0.25	131	209	n/a	n/a
chr19	6679511	6679511	C	T	het		QUAL=21467;DP=340;AF=0.52;MQM=59;TRIO=HET,340,0.52,HOM,313,1.00,HET,378,0.52	C3	splice_region&intron	C3:NM_000064.2:splice_region&intron:LOW:exon36/40:c.4457-4G>A:		rs2277984	0.5244	0.521	0.5174	0.4546						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];				0.3106	0.4318	0.2576	130	210	n/a	n/a
chr19	6696597	6696597	G	A	hom		QUAL=37471;DP=253;AF=1.00;MQM=60;TRIO=HOM,253,1.00,HOM,463,1.00,HOM,520,1.00	C3	splice_region&intron	C3:NM_000064.2:splice_region&intron:LOW:exon22/40:c.2863+7C>T:		rs2287845	0.7324	0.666	0.6181	0.7043						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];				0.4015	0.4621	0.1364	204	192	n/a	n/a
chr19	6697406	6697406	A	G	hom		QUAL=14839;DP=200;AF=0.99;MQM=60;TRIO=HOM,200,0.99,HOM,138,1.00,HOM,138,1.00	C3	synonymous	C3:NM_000064.2:synonymous:LOW:exon21/41:c.2745T>C:p.Ala915Ala		rs423490	0.8149	0.789	0.7533	0.7608						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];				0.5985	0.3409	0.0606	273	155	n/a	n/a
chr19	6702157	6702157	C	G	hom		QUAL=22740;DP=231;AF=0.98;MQM=60;TRIO=HOM,231,0.98,HOM,205,1.00,HOM,268,1.00	C3	synonymous	C3:NM_000064.2:synonymous:LOW:exon19/41:c.2421G>C:p.Val807Val		rs428453	0.7324	0.666	0.6188	0.702						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];			COSM3757394	0.4015	0.4621	0.1364	202	194	n/a	n/a
chr19	6702598	6702598	G	A	hom		QUAL=19981;DP=180;AF=0.99;MQM=60;TRIO=HOM,180,0.99,HOM,193,1.00,HOM,263,1.00	C3	splice_region&intron	C3:NM_000064.2:splice_region&intron:LOW:exon17/40:c.2246-8C>T:		rs406514	0.8149	0.789	0.7535	0.7578						120700 [C3 (confirmed) C3 deficiency|Hemolytic uremic syndrome,atypical,susceptibility to,5|Macular degeneration,age-related,9];				0.5985	0.3409	0.0606	273	155	n/a	n/a
chr19	7112265	7112265	G	A	het		QUAL=269;DP=25;AF=0.40;MQM=60;TRIO=HET,25,0.40,WT,3,0.00,HOM,1,1.00					rs12150997	0.3019	0	0	0										0.0303	0.197	0.7727	4	31	n/a	n/a
chr19	7112593	7112593	G	A	het		QUAL=10625;DP=306;AF=0.50;MQM=60;TRIO=HET,306,0.50,WT,137,0.00,HOM,189,0.99	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*4474C>T:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*4474C>T:		rs1052371	0.3075	0	0	0										0.053	0.3864	0.5606	7	56	n/a	n/a
chr19	7112645	7112645	C	A	het		QUAL=8048;DP=234;AF=0.49;MQM=60;TRIO=HET,234,0.49,WT,179,0.00,HET,261,0.54	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*4422G>T:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*4422G>T:		rs12642	0.1248	0	0	0										0.0455	0.3409	0.6136	6	50	n/a	n/a
chr19	7114213	7114213	C	A	het		QUAL=9394;DP=329;AF=0.40;MQM=60;TRIO=HET,329,0.40,WT,261,0.00,HET,346,0.48	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*2854G>T:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*2854G>T:		rs1864193	0.1282	0	0	0										0.0455	0.3258	0.6288	6	48	n/a	n/a
chr19	7114288	7114288	C	T	het		QUAL=21444;DP=365;AF=0.47;MQM=60;TRIO=HET,365,0.47,HOM,308,0.99,HET,410,0.50	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*2779G>A:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*2779G>A:		rs3745551	0.7177	0	0	0										0.3712	0.4394	0.1894	60	63	n/a	n/a
chr19	7114920	7114920	-	T	het		QUAL=2381;DP=90;AF=0.42;MQM=60;TRIO=HET,90,0.42,HOM,25,1.00,HET,44,0.43	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*2146dupA:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*2146dupA:		rs71915849	0	0	0	0										0.3636	0.4318	0.2045	58	63	n/a	n/a
chr19	7115057	7115057	C	T	het		QUAL=1083;DP=64;AF=0.45;MQM=60;TRIO=HET,64,0.45,WT,14,0.00,HET,15,0.47	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*2010G>A:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*2010G>A:		rs55972112	0.125	0	0	0										0.053	0.3106	0.6364	7	46	n/a	n/a
chr19	7115651	7115651	T	-	het		QUAL=19066;DP=330;AF=0.44;MQM=60;TRIO=HET,330,0.44,WT,325,0.00,HOM,484,0.98	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*1416delA:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*1416delA:		rs3833238	0.3325	0	0	0										0.1061	0.4167	0.4773	14	60	n/a	n/a
chr19	7116136	7116136	-	T	het		QUAL=1698;DP=92;AF=0.38;MQM=59;TRIO=HET,92,0.38,HET,25,0.56,HET,28,0.50	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*930dupA:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*930dupA:	T-rich	rs397813616	0.8291	0	0	0										0.3561	0.3939	0.25	55	59	n/a	n/a
chr19	7116283	7116283	G	C	het		QUAL=7638;DP=238;AF=0.51;MQM=60;TRIO=HET,238,0.51,WT,185,0.00,HET,238,0.49	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*784C>G:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*784C>G:		rs1051651	0.2959	0	0	0										0.1061	0.3485	0.5455	15	50	n/a	n/a
chr19	7116963	7116963	T	C	het		QUAL=7347;DP=165;AF=0.45;MQM=60;TRIO=HET,165,0.45,HET,96,0.46,HOM,109,1.00	INSR	3'UTR	INSR:NM_000208.2:3'UTR:MODIFIER:exon22/22:c.*104A>G:,INSR:NM_001079817.1:3'UTR:MODIFIER:exon21/21:c.*104A>G:		rs1051690	0.8774	0	0	0								CR082021 [CLASS=DFP MUT=REF PHEN="Colorectal cancer, increased risk, association with" GENE=INSR]; 		0.7121	0.2576	0.0303	105	41	n/a	n/a
chr19	7125297	7125297	G	A	het		QUAL=4321;DP=91;AF=0.48;MQM=60;TRIO=HET,91,0.48,WT,149,0.02,HET,221,0.46	INSR	synonymous	INSR:NM_000208.2:synonymous:LOW:exon17/22:c.3255C>T:p.His1085His,INSR:NM_001079817.1:synonymous:LOW:exon16/21:c.3219C>T:p.His1073His		rs1799817	0.2925	0.227	0.1757	0.2204						147670 [INSR (confirmed) Leprechaunism|Rabson-Mendenhall syndrome|Diabetes mellitus,insulin-resistant,with acanthosis nigricans|Hyperinsulinemic hypoglycemia,familial,5];		CM092295 [CLASS=DP MUT=ALT PHEN="Polycystic ovary syndrome, in lean women, association with" GENE=INSR]; 	COSM4001048	0.0909	0.3561	0.553	33	156	n/a	n/a
chr19	7141775	7141775	G	A	het		QUAL=1630;DP=46;AF=0.46;MQM=60;TRIO=HET,46,0.46,WT,36,0.00,HOM,32,1.00	INSR	synonymous	INSR:NM_000208.2:synonymous:LOW:exon13/22:c.2595C>T:p.Asn865Asn,INSR:NM_001079817.1:synonymous:LOW:exon12/21:c.2559C>T:p.Asn853Asn		rs2229431	0.0869	0.061	0.0574	0.1523						147670 [INSR (confirmed) Leprechaunism|Rabson-Mendenhall syndrome|Diabetes mellitus,insulin-resistant,with acanthosis nigricans|Hyperinsulinemic hypoglycemia,familial,5];				0.0076	0.1515	0.8409	2	63	n/a	n/a
chr19	7166376	7166376	C	T	het		QUAL=3588;DP=157;AF=0.48;MQM=60;TRIO=HET,157,0.48,HET,94,0.48,WT,119,0.00	INSR	synonymous	INSR:NM_000208.2:synonymous:LOW:exon8/22:c.1650G>A:p.Ala550Ala,INSR:NM_001079817.1:synonymous:LOW:exon8/21:c.1650G>A:p.Ala550Ala		rs2059806	0.2448	0.255	0.2416	0.1941						147670 [INSR (confirmed) Leprechaunism|Rabson-Mendenhall syndrome|Diabetes mellitus,insulin-resistant,with acanthosis nigricans|Hyperinsulinemic hypoglycemia,familial,5];		CM004252 [CLASS=DP MUT=ALT PHEN="Reduced diastolic blood pressure, association with" GENE=INSR]; 	COSM4132751	0.0227	0.3409	0.6364	22	142	n/a	n/a
chr19	7593589	7593589	C	T	het		QUAL=26640;DP=168;AF=0.48;MQM=59;TRIO=HET,168,0.48,HOM,486,0.99,HET,614,0.50	MCOLN1	splice_region&synonymous	MCOLN1:NM_020533.2:splice_region&synonymous:LOW:exon8/14:c.984C>T:p.Asn328Asn		rs612862	0.2556	0.287	0.3356	0.236						605248 [MCOLN1 (confirmed) Mucolipidosis IV];			COSM4132764	0.0985	0.5758	0.3258	55	207	n/a	n/a
chr19	7703605	7703605	C	T	het		QUAL=684;DP=36;AF=0.42;MQM=60;TRIO=HET,36,0.42,HET,18,0.56,WT,19,0.00	STXBP2	splice_region&intron	STXBP2:NM_001272034.1:splice_region&intron:LOW:exon1/18:c.38-7C>T:,STXBP2:NM_001127396.2:splice_region&intron:LOW:exon1/18:c.38-7C>T:,STXBP2:NM_006949.3:splice_region&intron:LOW:exon1/18:c.38-7C>T:		rs8104339	0.4824	0.404	0.3874	0.503						601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5];				0.1212	0.4394	0.4394	76	198	n/a	n/a
chr19	7711221	7711221	T	C	het		QUAL=4215;DP=89;AF=0.48;MQM=59;TRIO=HET,89,0.48,HET,191,0.50,WT,318,0.00	STXBP2	synonymous	STXBP2:NM_001272034.1:synonymous:LOW:exon16/19:c.1476T>C:p.Asp492Asp,STXBP2:NM_001127396.2:synonymous:LOW:exon16/19:c.1434T>C:p.Asp478Asp,STXBP2:NM_006949.3:synonymous:LOW:exon16/19:c.1443T>C:p.Asp481Asp		rs10001	0.5042	0.403	0.3741	0.4966						601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5];			COSM1178455	0.1364	0.4621	0.4015	73	204	n/a	n/a
chr19	7712277	7712277	A	G	het		QUAL=271;DP=12;AF=0.42;MQM=60;TRIO=HET,12,0.42,HET,17,0.41,WT,26,0.00	STXBP2	missense	STXBP2:NM_001272034.1:missense:MODERATE:exon18/19:c.1609A>G:p.Ile537Val,STXBP2:NM_001127396.2:missense:MODERATE:exon18/19:c.1567A>G:p.Ile523Val,STXBP2:NM_006949.3:missense:MODERATE:exon18/19:c.1576A>G:p.Ile526Val		rs6791	0.7061	0.632	0.6123	0.7747	-0.1760	P	T	B,B,B,B	B,B,B,B	601717 [STXBP2 (provisional) Hemophagocytic lymphohistiocytosis,familial,5];			COSM440643	0.3485	0.4773	0.1742	173	208	n/a	n/a
chr19	8376431	8376431	G	A	het		QUAL=10984;DP=306;AF=0.46;MQM=60;TRIO=HET,306,0.46,HET,459,0.45,WT,576,0.00	NDUFA7	synonymous	NDUFA7:NM_005001.3:synonymous:LOW:exon4/4:c.300C>T:p.Pro100Pro		rs561	0.1382	0	0.1901	0.0554										0.0227	0.2879	0.6894	7	135	n/a	n/a
chr19	10265312	10265312	T	C	hom		QUAL=16360;DP=186;AF=1.00;MQM=60;TRIO=HOM,186,1.00,HOM,159,1.00,HOM,168,1.00	DNMT1	synonymous	DNMT1:NM_001130823.1:synonymous:LOW:exon21/41:c.1782A>G:p.Thr594Thr,DNMT1:NM_001379.2:synonymous:LOW:exon20/40:c.1734A>G:p.Thr578Thr		rs721186	0.9958	0.991	0.986	0.9968						126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant];				0.9545	0.0455	0	440	13	n/a	n/a
chr19	10267077	10267077	T	C	het		QUAL=9611;DP=219;AF=0.47;MQM=60;TRIO=HET,219,0.47,HET,183,0.53,HET,226,0.48	DNMT1	synonymous	DNMT1:NM_001130823.1:synonymous:LOW:exon18/41:c.1389A>G:p.Pro463Pro,DNMT1:NM_001379.2:synonymous:LOW:exon17/40:c.1341A>G:p.Pro447Pro		rs2228611	0.5339	0.518	0.4893	0.4948						126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant];				0.25	0.4697	0.2803	104	210	n/a	n/a
chr19	10270747	10270747	A	-	het		QUAL=9200;DP=240;AF=0.45;MQM=60;TRIO=HET,240,0.45,HET,177,0.50,HET,245,0.46	DNMT1	splice_region&intron	DNMT1:NM_001130823.1:splice_region&intron:LOW:exon14/40:c.1044-8delT:,DNMT1:NM_001379.2:splice_region&intron:LOW:exon13/39:c.996-8delT:		rs397859148	0	0	0	0						126375 [DNMT1 (confirmed) Neuropathy,hereditary sensory,type IE|Cerebellar ataxia,deafness,and narcolepsy,autosomal dominant];				0.3864	0.4621	0.1515	208	162	n/a	n/a
chr19	10939792	10939792	T	C	het		QUAL=4817;DP=152;AF=0.54;MQM=59;TRIO=HET,152,0.54,WT,147,0.00,HET,174,0.46	DNM2	synonymous	DNM2:NM_001005360.2:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:NM_001005361.2:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:NM_001005362.2:synonymous:LOW:exon18/20:c.2127T>C:p.Ala709Ala,DNM2:NM_001190716.1:synonymous:LOW:exon19/21:c.2139T>C:p.Ala713Ala,DNM2:NM_004945.3:synonymous:LOW:exon18/20:c.2127T>C:p.Ala709Ala		rs2229920	0.3383	0.309	0.2912	0.2606						602378 [DNM2 (confirmed) Charcot-Marie-Tooth disease,dominant intermediate B|Myopathy,centronuclear|Charcot-Marie-Tooth disease,axonal,type 2M|Lethal congenital contracture syndrome 5];	RCV000145914.1 [likely benign]; 		COSM3766264	0.0682	0.3712	0.5606	33	188	n/a	n/a
chr19	11105608	11105608	T	C	het		QUAL=8747;DP=196;AF=0.48;MQM=60;TRIO=HET,196,0.48,WT,288,0.01,HET,373,0.49	SMARCA4	synonymous	SMARCA4:NM_001128849.1:synonymous:LOW:exon9/36:c.1524T>C:p.His508His,SMARCA4:NM_001128844.1:synonymous:LOW:exon10/36:c.1524T>C:p.His508His,SMARCA4:NM_003072.3:synonymous:LOW:exon9/35:c.1524T>C:p.His508His,SMARCA4:NM_001128845.1:synonymous:LOW:exon8/33:c.1524T>C:p.His508His,SMARCA4:NM_001128846.1:synonymous:LOW:exon8/33:c.1524T>C:p.His508His,SMARCA4:NM_001128847.1:synonymous:LOW:exon8/33:c.1524T>C:p.His508His,SMARCA4:NM_001128848.1:synonymous:LOW:exon8/33:c.1524T>C:p.His508His		rs7935	0.3115	0.333	0.3409	0.3037						603254 [SMARCA4 (provisional) Rhabdoid tumor predisposition syndrome 2|Mental retardation,autosomal dominant 16];	RCV000114302.1 [benign]; 		COSM4131185	0.0985	0.4318	0.4697	61	215	n/a	n/a
chr19	12772090	12772090	C	T	het		QUAL=10934;DP=217;AF=0.47;MQM=60;TRIO=HET,217,0.47,HET,481,0.51,WT,571,0.00	MAN2B1	missense	MAN2B1:NM_000528.3:missense:MODERATE:exon7/24:c.1010G>A:p.Arg337Gln,MAN2B1:NM_001173498.1:missense:MODERATE:exon7/24:c.1010G>A:p.Arg337Gln		rs1133330	0.2484	0.31	0.399	0.313	-0.0410	P	T	B,B	B,B	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II];	RCV000079070.4 [other]; 		COSM1582962	0.1667	0.5	0.3333	73	222	n/a	n/a
chr19	12772165	12772165	G	A	het		QUAL=10815;DP=234;AF=0.38;MQM=60;TRIO=HET,234,0.38,HET,537,0.48,WT,659,0.00	MAN2B1	missense	MAN2B1:NM_000528.3:missense:MODERATE:exon7/24:c.935C>T:p.Thr312Ile,MAN2B1:NM_001173498.1:missense:MODERATE:exon7/24:c.935C>T:p.Thr312Ile		rs1054487	0.3279	0.34	0.4108	0.537	1.9380	P	T	B,B	B,B	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II];	RCV000079081.4 [other]; 		COSM1178457	0.1742	0.5	0.3258	83	217	n/a	n/a
chr19	12774208	12774208	G	C	het		QUAL=11328;DP=326;AF=0.47;MQM=59;TRIO=HET,326,0.47,WT,344,0.01,HET,430,0.47	MAN2B1	missense	MAN2B1:NM_000528.3:missense:MODERATE:exon6/24:c.832C>G:p.Leu278Val,MAN2B1:NM_001173498.1:missense:MODERATE:exon6/24:c.832C>G:p.Leu278Val		rs1054486	0.2394	0.257	0.2893	0.3756	-0.4280	P	T	B,B	B,B	609458 [MAN2B1 (confirmed) Mannosidosis,alpha-,types I and II];	RCV000079080.4 [other]; 			0.1136	0.3409	0.5455	47	174	n/a	n/a
chr19	13227354	13227354	G	A	het		QUAL=4831;DP=169;AF=0.52;MQM=60;TRIO=HET,169,0.52,WT,113,0.00,HET,156,0.48	TRMT1	5'UTR_premature_start_codon_gain,5'UTR,intron	TRMT1:NM_001142554.1:5'UTR_premature_start_codon_gain:LOW:exon1/15:c.-141C>T:,TRMT1:NM_017722.3:5'UTR_premature_start_codon_gain:LOW:exon1/16:c.-141C>T:,TRMT1:NM_001142554.1:5'UTR:MODIFIER:exon1/15:c.-141C>T:,TRMT1:NM_017722.3:5'UTR:MODIFIER:exon1/16:c.-141C>T:,TRMT1:NM_001136035.2:intron:MODIFIER:exon1/16:c.-32-109C>T:		rs2302159	0.098	0	0	0										0.0076	0.1742	0.8182	1	25	n/a	n/a
chr19	13317491	13317493	TTA	-	hom		QUAL=7053;DP=131;AF=0.95;MQM=60;TRIO=HOM,131,0.95,HOM,59,0.95,HET,81,0.49	CACNA1A	3'UTR	CACNA1A:NM_023035.2:3'UTR:MODIFIER:exon47/47:c.*634_*636delTAA:,CACNA1A:NM_000068.3:3'UTR:MODIFIER:exon47/47:c.*1367_*1369delTAA:,CACNA1A:NM_001127221.1:3'UTR:MODIFIER:exon47/47:c.*1367_*1369delTAA:,CACNA1A:NM_001127222.1:3'UTR:MODIFIER:exon47/47:c.*634_*636delTAA:,CACNA1A:NM_001174080.1:3'UTR:MODIFIER:exon47/47:c.*1367_*1369delTAA:	AT_rich	rs544252445	0.5569	0	0	0										0.2121	0.5076	0.2803	63	125	n/a	n/a
chr19	13317980	13317980	G	T	hom		QUAL=3630;DP=36;AF=0.97;MQM=59;TRIO=HOM,36,0.97,HOM,51,1.00,HET,66,0.53	CACNA1A	3'UTR	CACNA1A:NM_023035.2:3'UTR:MODIFIER:exon47/47:c.*147C>A:,CACNA1A:NM_000068.3:3'UTR:MODIFIER:exon47/47:c.*880C>A:,CACNA1A:NM_001127221.1:3'UTR:MODIFIER:exon47/47:c.*880C>A:,CACNA1A:NM_001127222.1:3'UTR:MODIFIER:exon47/47:c.*147C>A:,CACNA1A:NM_001174080.1:3'UTR:MODIFIER:exon47/47:c.*880C>A:		rs7254351	0.508	0	0	0										0.2045	0.5076	0.2879	55	109	n/a	n/a
chr19	13445208	13445208	C	T	het		QUAL=3939;DP=138;AF=0.42;MQM=60;TRIO=HET,138,0.42,HET,137,0.50,WT,135,0.00	CACNA1A	synonymous	CACNA1A:NM_023035.2:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:NM_000068.3:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:NM_001127221.1:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:NM_001127222.1:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu,CACNA1A:NM_001174080.1:synonymous:LOW:exon8/47:c.1182G>A:p.Glu394Glu		rs2248069	0.6412	0.685	0.6879	0.5487						601011 [CACNA1A (confirmed) Migraine,familial hemiplegic,1|Episodic ataxia,type 2|Spinocerebellar ataxia 6|Migraine,familial hemiplegic,1,with progressive cerebellar ataxia];	RCV000079475.4 [other]; 			0.3939	0.4773	0.1288	522	461	1	n/a (2xTP)
chr19	14038791	14038791	C	T	hom		QUAL=12501;DP=189;AF=0.99;MQM=59;TRIO=HOM,189,0.99,HET,205,0.49,HET,238,0.50	CC2D1A	missense	CC2D1A:NM_017721.4:missense:MODERATE:exon23/29:c.2402C>T:p.Thr801Met		rs2305777	0.125	0.209	0.2672	0.0438	3.9450	P	T	P,D,D	B,D,D	610055 [CC2D1A (provisional) Mental retardation,autosomal recessive 3];	RCV000116591.2 [likely benign]; 		COSM4000530	0.053	0.3788	0.5682	32	164	n/a	n/a
chr19	14040896	14040896	G	A	het		QUAL=2693;DP=79;AF=0.57;MQM=59;TRIO=HET,79,0.57,HET,98,0.51,WT,137,0.00	CC2D1A	missense	CC2D1A:NM_017721.4:missense:MODERATE:exon27/29:c.2716G>A:p.Ala906Thr		rs11669628	0.1332	0.132	0.1258	0.0332	-2.5760	P	T	B,B,B	B,B,B	610055 [CC2D1A (provisional) Mental retardation,autosomal recessive 3];	RCV000116594.2 [likely benign]; 		COSM1750675	0.0076	0.2045	0.7879	6	104	n/a	n/a
chr19	15270583	15270583	G	A	hom		QUAL=24901;DP=310;AF=1.00;MQM=60;TRIO=HOM,310,1.00,HOM,269,1.00,HET,374,0.51	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*890C>T:		rs1044123	0.6238	0	0	0										0.4394	0.4394	0.1212	65	67	n/a	n/a
chr19	15270665	15270665	C	T	hom		QUAL=23343;DP=266;AF=1.00;MQM=60;TRIO=HOM,266,1.00,HOM,270,1.00,HET,376,0.51	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*808G>A:		rs1044116	0.6238	0	0	0										0.4394	0.4394	0.1212	65	67	n/a	n/a
chr19	15270805	15270805	C	A	hom		QUAL=9128;DP=130;AF=1.00;MQM=59;TRIO=HOM,130,1.00,HOM,99,0.99,HET,141,0.50	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*668G>T:		rs1044055	0.6234	0	0	0										0.4394	0.4394	0.1212	65	67	n/a	n/a
chr19	15270910	15270910	A	G	hom		QUAL=5270;DP=114;AF=1.00;MQM=60;TRIO=HOM,114,1.00,HET,56,0.45,HET,67,0.54	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*563T>C:		rs77669983	0.011	0	0	0										0	0.0758	0.9242	0	12	n/a	n/a
chr19	15271135	15271135	T	G	hom		QUAL=4579;DP=63;AF=1.00;MQM=60;TRIO=HOM,63,1.00,HOM,34,1.00,HOM,53,1.00	NOTCH3	3'UTR	NOTCH3:NM_000435.2:3'UTR:MODIFIER:exon33/33:c.*338A>C:	L1M4c	rs7247906	0.8708	0	0	0										0.7045	0.2576	0.0379	106	37	n/a	n/a
chr19	15271771	15271771	G	A	hom		QUAL=3507;DP=22;AF=1.00;MQM=60;TRIO=HOM,22,1.00,HOM,60,1.00,HET,72,0.51	NOTCH3	missense	NOTCH3:NM_000435.2:missense:MODERATE:exon33/33:c.6668C>T:p.Ala2223Val		rs1044009	0.6294	0.694	0.8013	0.603	1.1220	P	T	B	B	600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];			COSM3756390	0.4697	0.4091	0.1212	251	165	n/a	n/a
chr19	15273381	15273381	A	G	hom		QUAL=23015;DP=201;AF=1.00;MQM=60;TRIO=HOM,201,1.00,HOM,228,1.00,HOM,307,1.00	NOTCH3	splice_region&intron	NOTCH3:NM_000435.2:splice_region&intron:LOW:exon31/32:c.5816-8T>C:		rs4809030	0.869	0.873	0.8967	0.975						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];				0.7045	0.2576	0.0379	352	94	n/a	n/a
chr19	15278057	15278057	A	G	hom		QUAL=9766;DP=128;AF=1.00;MQM=59;TRIO=HOM,128,1.00,HOM,83,1.00,HOM,110,1.00	NOTCH3	splice_region&intron	NOTCH3:NM_000435.2:splice_region&intron:LOW:exon29/32:c.5362+3T>C:		rs1548555	0.87	0.874	0.8966	0.9764						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];				0.7045	0.2576	0.0379	352	94	n/a	n/a
chr19	15285052	15285052	T	C	hom		QUAL=22596;DP=171;AF=1.00;MQM=59;TRIO=HOM,171,1.00,HOM,217,1.00,HOM,345,1.00	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon25/33:c.4563A>G:p.Pro1521Pro		rs1044006	0.8718	0.863	0.8998	0.9777						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];			COSM1480700	0.7045	0.2576	0.0379	351	91	n/a	n/a
chr19	15292437	15292437	T	C	hom		QUAL=8384;DP=62;AF=1.00;MQM=59;TRIO=HOM,62,1.00,HOM,85,1.00,HOM,126,1.00	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon17/33:c.2742A>G:p.Pro914Pro		rs1043997	0.739	0.734	0.8701	0.6364						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];			COSM4131309	0.6515	0.3106	0.0379	309	124	n/a	n/a
chr19	15295134	15295134	G	A	hom		QUAL=13921;DP=117;AF=0.99;MQM=60;TRIO=HOM,117,0.99,HOM,208,1.00,HET,274,0.49	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon16/33:c.2538C>T:p.Cys846Cys		rs1043996	0.52	0.642	0.7151	0.2762						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];			COSM4131312	0.3864	0.5227	0.0909	202	202	n/a	n/a
chr19	15299051	15299051	G	A	het		QUAL=3143;DP=120;AF=0.54;MQM=59;TRIO=HET,120,0.54,HET,86,0.49,WT,85,0.00	NOTCH3	missense	NOTCH3:NM_000435.2:missense:MODERATE:exon9/33:c.1487C>T:p.Pro496Leu		rs11670799	0.0036	0.01	0.0215	0.0039	4.5180	D	T	P,D	P,P	600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];				0	0.0227	0.9773	1	21	n/a	n/a
chr19	15300136	15300136	A	G	het		QUAL=6496;DP=181;AF=0.51;MQM=60;TRIO=HET,181,0.51,HET,259,0.44,WT,286,0.00	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon7/33:c.1140T>C:p.Pro380Pro		rs61749020	0.0152	0.026	0.038	0.0188						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];			COSM3773843	0	0.0606	0.9394	1	43	n/a	n/a
chr19	15302844	15302844	T	C	hom		QUAL=37451;DP=191;AF=1.00;MQM=59;TRIO=HOM,191,1.00,HOM,455,1.00,HOM,548,1.00	NOTCH3	synonymous	NOTCH3:NM_000435.2:synonymous:LOW:exon4/33:c.606A>G:p.Ala202Ala		rs1043994	0.8558	0.858	0.8776	0.9122						600276 [NOTCH3 (confirmed) Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy|Myofibromatosis,infantile 2];				0.7273	0.2424	0.0303	335	111	n/a	n/a
chr19	17935585	17935586	AA	-	het		QUAL=4488;DP=84;AF=0.56;MQM=60;TRIO=HET,84,0.56,HET,61,1.00,WT,122,0.41					rs10580414	0.3197	0	0	0										0.1742	0.2879	0.5379	23	42	n/a	n/a
chr19	17935626	17935626	T	C	het		QUAL=7429;DP=186;AF=0.49;MQM=59;TRIO=HET,186,0.49,HOM,80,1.00,HET,153,0.44	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*1926A>G:	L2c	rs11888	0.398	0	0	0										0.1439	0.447	0.4091	21	68	n/a	n/a
chr19	17936259	17936259	G	A	het		QUAL=4015;DP=140;AF=0.47;MQM=59;TRIO=HET,140,0.47,HOM,61,1.00,WT,62,0.00	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*1293C>T:		rs73014967	0.1591	0	0	0										0.0758	0.3712	0.553	11	55	n/a	n/a
chr19	17936898	17936898	T	A	het		QUAL=91;DP=15;AF=0.33;MQM=60;TRIO=HET,15,0.33,HET,4,0.25,WT,11,0.00	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*654A>T:	FLAM_A	rs71332114	0.2077	0	0	0										0.0152	0.0303	0.9545	2	5	n/a	n/a
chr19	17937104	17937104	G	T	het		QUAL=568;DP=31;AF=0.65;MQM=50;TRIO=HET,31,0.65,HET,4,0.75,WT,7,0.00	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*448C>A:	AluSz	rs3212802	0.2194	0	0	0										0.0227	0.1818	0.7955	3	25	n/a	n/a
chr19	17937429	17937429	A	G	het		QUAL=5633;DP=108;AF=0.57;MQM=60;TRIO=HET,108,0.57,HOM,122,1.00,WT,176,0.00	JAK3	3'UTR	JAK3:NM_000215.3:3'UTR:MODIFIER:exon24/24:c.*123T>C:		rs3008	0.5401	0	0	0										0.197	0.5833	0.2197	31	87	n/a	n/a
chr19	17945696	17945696	C	T	het		QUAL=4725;DP=228;AF=0.51;MQM=60;TRIO=HET,228,0.51,HET,102,0.37,WT,149,0.00	JAK3	missense	JAK3:NM_000215.3:missense:MODERATE:exon16/24:c.2164G>A:p.Val722Ile		rs3213409	0.0036	0.0086	0.0133	0.002	1.5240	N	D	B,B	B,B	600173 [JAK3 (provisional) SCID,autosomal recessive,T-negative/B-positive type];	RCV000121262.1 [not provided]; 	CM000172 [CLASS=DM? MUT=ALT PHEN="Immunodeficiency, severe combined" GENE=JAK3]; 	COSM34213	0	0.0303	0.9697	0	18	n/a	n/a
chr19	18001686	18001686	G	A	het		QUAL=4616;DP=116;AF=0.56;MQM=60;TRIO=HET,116,0.56,WT,171,0.01,HET,213,0.44	SLC5A5	splice_region&intron	SLC5A5:NM_000453.2:splice_region&intron:LOW:exon13/14:c.1652-9G>A:		rs4808708	0.1246	0.179	0.2362	0.1251						601843 [SLC5A5 (provisional) Thyroid dyshormonogenesis 1];				0.0303	0.4167	0.553	31	165	n/a	n/a
chr19	18004912	18004912	T	C	het		QUAL=4173;DP=191;AF=0.39;MQM=60;TRIO=HET,191,0.39,WT,114,0.01,HET,150,0.41	SLC5A5	3'UTR	SLC5A5:NM_000453.2:3'UTR:MODIFIER:exon15/15:c.*226T>C:		rs12327843	0.152	0	0	0										0.0379	0.3333	0.6288	5	53	n/a	n/a
chr19	18180413	18180413	C	G	het		QUAL=12359;DP=102;AF=0.56;MQM=60;TRIO=HET,102,0.56,HET,315,0.48,HET,394,0.51	IL12RB1	missense	IL12RB1:NM_001290024.1:missense:MODERATE:exon11/18:c.1252G>C:p.Gly418Arg,IL12RB1:NM_001290023.1:missense:MODERATE:exon10/17:c.1132G>C:p.Gly378Arg,IL12RB1:NM_005535.2:missense:MODERATE:exon10/17:c.1132G>C:p.Gly378Arg		rs401502	0.2516	0.284	0.3094	0.1968	-1.8560	P	T	B,B	B,B	601604 [IL12RB1 (provisional) Mycobacterial and salmonella infections,susceptibility to];		CM030471 [CLASS=DP MUT=ALT PHEN="Tuberculosis, susceptibility to, association with" GENE=IL12RB1]; 		0.1136	0.4924	0.3939	55	199	n/a	n/a
chr19	18180451	18180451	A	G	het		QUAL=15277;DP=174;AF=0.51;MQM=60;TRIO=HET,174,0.51,HET,360,0.45,HET,469,0.51	IL12RB1	missense	IL12RB1:NM_001290024.1:missense:MODERATE:exon11/18:c.1214T>C:p.Met405Thr,IL12RB1:NM_001290023.1:missense:MODERATE:exon10/17:c.1094T>C:p.Met365Thr,IL12RB1:NM_005535.2:missense:MODERATE:exon10/17:c.1094T>C:p.Met365Thr		rs375947	0.2686	0.289	0.3108	0.2581	-0.9480	P	T	B,B	B,B	601604 [IL12RB1 (provisional) Mycobacterial and salmonella infections,susceptibility to];		CM030470 [CLASS=DP MUT=ALT PHEN="Tuberculosis, susceptibility to, association with" GENE=IL12RB1]; 	COSM4000562	0.1136	0.4924	0.3939	55	199	n/a	n/a
chr19	18181569	18181569	A	G	het		QUAL=6682;DP=118;AF=0.45;MQM=59;TRIO=HET,118,0.45,HET,166,0.47,HET,193,0.47	IL12RB1	3'UTR,intron	IL12RB1:NM_153701.2:3'UTR:MODIFIER:exon10/10:c.*450T>C:,IL12RB1:NM_001290024.1:intron:MODIFIER:exon10/17:c.1142-1046T>C:,IL12RB1:NM_001290023.1:intron:MODIFIER:exon9/16:c.1022-1046T>C:,IL12RB1:NM_005535.2:intron:MODIFIER:exon9/16:c.1022-1046T>C:	AluJo	rs845380	0.6585	0	0	0						601604 [IL12RB1 (provisional) Mycobacterial and salmonella infections,susceptibility to];				0.553	0.3939	0.053	81	62	n/a	n/a
chr19	18186575	18186575	G	A	het		QUAL=8166;DP=143;AF=0.41;MQM=60;TRIO=HET,143,0.41,HET,189,0.47,HET,227,0.49	IL12RB1	synonymous	IL12RB1:NM_001290024.1:synonymous:LOW:exon8/18:c.804C>T:p.Pro268Pro,IL12RB1:NM_001290023.1:synonymous:LOW:exon7/17:c.684C>T:p.Pro228Pro,IL12RB1:NM_005535.2:synonymous:LOW:exon7/17:c.684C>T:p.Pro228Pro,IL12RB1:NM_153701.2:synonymous:LOW:exon7/10:c.684C>T:p.Pro228Pro		rs17852635	0.2298	0.277	0.3157	0.1337						601604 [IL12RB1 (provisional) Mycobacterial and salmonella infections,susceptibility to];			COSM4000565	0.1212	0.5	0.3788	55	199	n/a	n/a
chr19	18186618	18186618	T	C	het		QUAL=9597;DP=136;AF=0.57;MQM=59;TRIO=HET,136,0.57,HET,216,0.46,HET,260,0.50	IL12RB1	missense	IL12RB1:NM_001290024.1:missense:MODERATE:exon8/18:c.761A>G:p.Gln254Arg,IL12RB1:NM_001290023.1:missense:MODERATE:exon7/17:c.641A>G:p.Gln214Arg,IL12RB1:NM_005535.2:missense:MODERATE:exon7/17:c.641A>G:p.Gln214Arg,IL12RB1:NM_153701.2:missense:MODERATE:exon7/10:c.641A>G:p.Gln214Arg		rs11575934	0.2294	0.276	0.3157	0.1312	-0.2090	P	T	B,B,B	B,B,B	601604 [IL12RB1 (provisional) Mycobacterial and salmonella infections,susceptibility to];		CM984025 [CLASS=DM? MUT=ALT PHEN="Mycobacterial infection" GENE=IL12RB1]; 	COSM4131453	0.1212	0.4848	0.3939	55	197	2	n/a
chr19	18191664	18191664	C	G	het		QUAL=6314;DP=127;AF=0.49;MQM=60;TRIO=HET,127,0.49,HET,157,0.38,HET,186,0.54	IL12RB1	synonymous	IL12RB1:NM_001290024.1:synonymous:LOW:exon5/18:c.507G>C:p.Val169Val,IL12RB1:NM_001290023.1:synonymous:LOW:exon4/17:c.387G>C:p.Val129Val,IL12RB1:NM_005535.2:synonymous:LOW:exon4/17:c.387G>C:p.Val129Val,IL12RB1:NM_153701.2:synonymous:LOW:exon4/10:c.387G>C:p.Val129Val		rs11086087	0.13	0.118	0.1152	0.0554						601604 [IL12RB1 (provisional) Mycobacterial and salmonella infections,susceptibility to];			COSM4000568	0.0076	0.2727	0.7197	8	102	n/a	n/a
chr19	33882222	33882222	G	A	het		QUAL=1101;DP=32;AF=0.56;MQM=60;TRIO=HET,32,0.56,HET,52,0.40,WT,76,0.00	PEPD	synonymous	PEPD:NM_000285.3:synonymous:LOW:exon13/15:c.1131C>T:p.His377His,PEPD:NM_001166056.1:synonymous:LOW:exon11/13:c.1008C>T:p.His336His,PEPD:NM_001166057.1:synonymous:LOW:exon11/13:c.939C>T:p.His313His		rs17569	0.0984	0.129	0.1471	0.0228						613230 [PEPD (confirmed) Prolidase deficiency];				0.0076	0.2955	0.697	5	128	n/a	n/a
chr19	33953912	33953912	A	G	het		QUAL=10172;DP=297;AF=0.48;MQM=60;TRIO=HET,297,0.48,HET,310,0.53,WT,435,0.00	PEPD	synonymous,intron	PEPD:NM_000285.3:synonymous:LOW:exon9/15:c.660T>C:p.Tyr220Tyr,PEPD:NM_001166057.1:synonymous:LOW:exon7/13:c.468T>C:p.Tyr156Tyr,PEPD:NM_001166056.1:intron:MODIFIER:exon7/12:c.548+15040T>C:		rs3745969	0.0298	0.038	0.0335	0.0058						613230 [PEPD (confirmed) Prolidase deficiency];				0	0.0833	0.9167	0	23	n/a	n/a
chr19	34872382	34872382	G	A	het		QUAL=11353;DP=233;AF=0.49;MQM=60;TRIO=HET,233,0.49,WT,441,0.00,HET,554,0.44	GPI	synonymous	GPI:NM_001289789.1:synonymous:LOW:exon10/19:c.879G>A:p.Lys293Lys,GPI:NM_001184722.1:synonymous:LOW:exon9/18:c.795G>A:p.Lys265Lys,GPI:NM_000175.3:synonymous:LOW:exon9/18:c.762G>A:p.Lys254Lys,GPI:NM_001289790.1:synonymous:LOW:exon8/17:c.678G>A:p.Lys226Lys		rs1864139	0.12	0.081	0.0513	0.2059						172400 [GPI (confirmed) Hemolytic anemia,nonspherocytic,due to glucose phosphate isomerase deficiency];				0.0152	0.1439	0.8409	5	61	n/a	n/a
chr19	34891482	34891482	C	G	het		QUAL=35737;DP=451;AF=0.48;MQM=60;TRIO=HET,451,0.48,HOM,546,1.00,HET,712,0.48	GPI	3'UTR	GPI:NM_001289789.1:3'UTR:MODIFIER:exon19/19:c.*541C>G:,GPI:NM_001184722.1:3'UTR:MODIFIER:exon18/18:c.*541C>G:,GPI:NM_000175.3:3'UTR:MODIFIER:exon18/18:c.*541C>G:,GPI:NM_001289790.1:3'UTR:MODIFIER:exon17/17:c.*541C>G:		rs4619515	0.8826	0.799	0	0										0.8636	0.1212	0.0152	131	17	n/a	n/a
chr19	34891955	34891955	T	-	het		QUAL=35;DP=29;AF=0.10;MQM=60;TRIO=HET,29,0.10,HET,10,0.30,HET,14,0.07	GPI	3'UTR	GPI:NM_001289789.1:3'UTR:MODIFIER:exon19/19:c.*1027delT:,GPI:NM_001184722.1:3'UTR:MODIFIER:exon18/18:c.*1027delT:,GPI:NM_000175.3:3'UTR:MODIFIER:exon18/18:c.*1027delT:,GPI:NM_001289790.1:3'UTR:MODIFIER:exon17/17:c.*1027delT:	AluJb		0	0	0	0										0.0076	0.0455	0.947	1	7	n/a	n/a
chr19	35524824	35524824	T	C	het		QUAL=9059;DP=166;AF=0.50;MQM=60;TRIO=HET,166,0.50,WT,261,0.00,HET,393,0.53	SCN1B	missense,intron	SCN1B:NM_199037.3:missense:MODERATE:exon3/3:c.629T>C:p.Leu210Pro,SCN1B:NM_001037.4:intron:MODIFIER:exon3/5:c.448+181T>C:		rs55742440	0.3776	0.327	0.3721	0.5091	0.0050	P		B	B	600235 [SCN1B (confirmed) Epilepsy,generalized,with febrile seizures plus,type 1|Brugada syndrome 5|Cardiac conduction defect,nonspecific|Atrial fibrillation,familial,13];	RCV000127905.1 [benign]; 		COSM4131651	0.1212	0.4242	0.4545	83	190	n/a	n/a
chr19	36139172	36139172	G	A	hom		QUAL=7952;DP=58;AF=0.98;MQM=60;TRIO=HOM,58,0.98,HET,175,0.49,HET,249,0.47	COX6B1	5'UTR	COX6B1:NM_001863.4:5'UTR:MODIFIER:exon1/4:c.-145G>A:		rs10420252	0.1148	0	0	0										0	0.1591	0.8409	2	26	n/a	n/a
chr19	36316710	36316710	T	C	hom		QUAL=14959;DP=220;AF=1.00;MQM=60;TRIO=HOM,220,1.00,HOM,146,1.00,HET,194,0.47	NPHS1	3'UTR	NPHS1:NM_004646.3:3'UTR:MODIFIER:exon29/29:c.*706A>G:		rs80296922	0.0162	0	0	0										0.0076	0.0985	0.8939	1	15	n/a	n/a
chr19	36317556	36317556	C	A	hom		QUAL=19510;DP=234;AF=0.98;MQM=60;TRIO=HOM,234,0.98,HOM,264,1.00,HET,274,0.47	NPHS1	splice_region&intron	NPHS1:NM_004646.3:splice_region&intron:LOW:exon28/28:c.3595-9G>T:		rs77309273	0.0198	0.041	0.051	0.0077						602716 [NPHS1 (provisional) Nephrotic syndrome,type 1];				0.0076	0.0985	0.8939	2	36	n/a	n/a
chr19	36322270	36322270	C	T	hom		QUAL=41654;DP=268;AF=0.98;MQM=60;TRIO=HOM,268,0.98,HOM,461,1.00,HOM,602,1.00	NPHS1	synonymous	NPHS1:NM_004646.3:synonymous:LOW:exon26/29:c.3315G>A:p.Ser1105Ser		rs2071327	0.3676	0.392	0.3837	0.1067						602716 [NPHS1 (provisional) Nephrotic syndrome,type 1];				0.1515	0.4015	0.447	69	187	n/a	n/a
chr19	36342212	36342212	C	T	het		QUAL=9409;DP=281;AF=0.47;MQM=60;TRIO=HET,281,0.47,HOM,168,0.99,WT,267,0.01	NPHS1	missense	NPHS1:NM_004646.3:missense:MODERATE:exon3/29:c.349G>A:p.Glu117Lys		rs3814995	0.2919	0.311	0.3056	0.0919	2.5550	P	T	D	D	602716 [NPHS1 (provisional) Nephrotic syndrome,type 1];			COSM3756680	0.0833	0.4091	0.5076	38	185	n/a	n/a
chr19	36487146	36487146	A	G	het		QUAL=4612;DP=165;AF=0.52;MQM=60;TRIO=HET,165,0.52,WT,105,0.00,HET,131,0.47	SDHAF1	3'UTR	SDHAF1:NM_001042631.2:3'UTR:MODIFIER:exon1/1:c.*622A>G:		rs7925	0.0948	0	0	0										0.0758	0.2652	0.6591	10	38	n/a	n/a
chr19	36583651	36583651	G	A	het		QUAL=10913;DP=258;AF=0.48;MQM=59;TRIO=HET,258,0.48,WT,291,0.00,HET,427,0.50	WDR62	synonymous	WDR62:NM_001083961.1:synonymous:LOW:exon19/32:c.2271G>A:p.Leu757Leu,WDR62:NM_173636.4:synonymous:LOW:exon19/32:c.2271G>A:p.Leu757Leu		rs61494900	0.1228	0.106	0.1035	0.2281						613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000147931.1 [benign]; 			0.0303	0.2045	0.7652	13	98	n/a	n/a
chr19	36590329	36590329	T	C	hom		QUAL=12151;DP=102;AF=1.00;MQM=60;TRIO=HOM,102,1.00,HET,182,0.48,HOM,214,0.99	WDR62	missense	WDR62:NM_001083961.1:missense:MODERATE:exon22/32:c.2549T>C:p.Leu850Ser,WDR62:NM_173636.4:missense:MODERATE:exon22/32:c.2549T>C:p.Leu850Ser		rs2285745	0.6542	0.64	0.6493	0.7206	0.7020	P	T	B,B	B,B	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000147938.1 [benign]; 		COSM4131728	0.3485	0.5	0.1515	180	207	n/a	n/a
chr19	36594063	36594063	C	T	het		QUAL=8145;DP=211;AF=0.53;MQM=60;TRIO=HET,211,0.53,WT,201,0.00,HET,305,0.49	WDR62	synonymous	WDR62:NM_001083961.1:synonymous:LOW:exon29/32:c.3468C>T:p.Leu1156Leu,WDR62:NM_173636.4:synonymous:LOW:exon29/32:c.3453C>T:p.Leu1151Leu		rs17851502	0.1212	0.106	0.1029	0.222						613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000147957.1 [benign]; 			0.0303	0.2045	0.7652	13	98	n/a	n/a
chr19	36594659	36594659	A	T	hom		QUAL=16693;DP=211;AF=1.00;MQM=59;TRIO=HOM,211,1.00,HET,277,0.53,HET,343,0.55	WDR62	missense	WDR62:NM_001083961.1:missense:MODERATE:exon30/32:c.3929A>T:p.Gln1310Leu,WDR62:NM_173636.4:missense:MODERATE:exon30/32:c.3914A>T:p.Gln1305Leu		rs2074435	0.7296	0.653	0.6051	0.7833	0.5110	P	T	B,B	B,B	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000079454.3 [benign]; 		COSM3756682	0.3258	0.5	0.1742	169	210	n/a	n/a
chr19	36595436	36595436	A	C	hom		QUAL=2238;DP=31;AF=0.97;MQM=60;TRIO=HOM,31,0.97,HOM,24,1.00,HET,46,0.50	WDR62	missense	WDR62:NM_001083961.1:missense:MODERATE:exon31/32:c.4170A>C:p.Leu1390Phe,WDR62:NM_173636.4:missense:MODERATE:exon31/32:c.4155A>C:p.Leu1385Phe		rs1008328	0.7163	0.742	0.7763	0.6959	0.3220	P	T	B,B	B,B	613583 [WDR62 (confirmed) Microcephaly 2,primary,autosomal recessive,with or without cortical malformations];	RCV000147972.2 [benign]; 		COSM1129883	0.5682	0.3864	0.0455	264	169	n/a	n/a
chr19	38935280	38935280	A	G	het		QUAL=6235;DP=136;AF=0.53;MQM=60;TRIO=HET,136,0.53,WT,170,0.01,HET,237,0.52	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon7/106:c.594A>G:p.Leu198Leu,RYR1:NM_001042723.1:synonymous:LOW:exon7/105:c.594A>G:p.Leu198Leu		rs2229139	0.5433	0.603	0.6434	0.5243						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079154.3 [other]; RCV000119644.1 [not provided]; 			0.4621	0.3864	0.1515	195	190	n/a	n/a
chr19	38939408	38939408	T	C	het		QUAL=11438;DP=217;AF=0.44;MQM=59;TRIO=HET,217,0.44,HET,190,0.41,HOM,197,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon11/106:c.1077T>C:p.Ala359Ala,RYR1:NM_001042723.1:synonymous:LOW:exon11/105:c.1077T>C:p.Ala359Ala		rs10406027	0.904	0.884	0.8764	0.9319						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079119.3 [benign]; RCV000119418.1 [not provided]; 		COSM4131781	0.7955	0.1742	0.0303	350	84	n/a	n/a
chr19	38946182	38946182	G	A	het		QUAL=23984;DP=263;AF=0.47;MQM=59;TRIO=HET,263,0.47,HET,337,0.53,HOM,476,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon15/106:c.1668G>A:p.Ser556Ser,RYR1:NM_001042723.1:synonymous:LOW:exon15/105:c.1668G>A:p.Ser556Ser		rs2288888	0.5713	0.636	0.6721	0.554						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079135.3 [benign]; RCV000119582.1 [not provided]; 			0.4848	0.4091	0.1061	211	186	n/a	n/a
chr19	38949904	38949904	C	T	het		QUAL=11760;DP=202;AF=0.54;MQM=60;TRIO=HET,202,0.54,HET,145,0.48,HOM,191,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon19/106:c.2286C>T:p.Pro762Pro,RYR1:NM_001042723.1:synonymous:LOW:exon19/105:c.2286C>T:p.Pro762Pro		rs3745847	0.5541	0.621	0.6579	0.5372						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079136.3 [benign]; RCV000119595.1 [not provided]; 		COSM4131782	0.4848	0.3864	0.1288	204	188	n/a	n/a
chr19	38959680	38959680	C	T	hom		QUAL=30356;DP=193;AF=1.00;MQM=60;TRIO=HOM,193,1.00,HET,449,0.50,HOM,526,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon26/106:c.3456C>T:p.Ile1152Ile,RYR1:NM_001042723.1:synonymous:LOW:exon26/105:c.3456C>T:p.Ile1152Ile		rs11083462	0.4493	0.395	0.3544	0.4385						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079140.3 [benign]; RCV000119611.1 [not provided]; 		COSM148605	0.1439	0.3636	0.4924	60	195	n/a	n/a
chr19	38965952	38965952	T	C	het		QUAL=3427;DP=102;AF=0.44;MQM=60;TRIO=HET,102,0.44,HET,137,0.52,WT,174,0.00	RYR1	splice_region&intron	RYR1:NM_000540.2:splice_region&intron:LOW:exon28/105:c.4161-6T>C:,RYR1:NM_001042723.1:splice_region&intron:LOW:exon28/104:c.4161-6T>C:		rs55845760	0.2171	0.119	0.1131	0.3949						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079145.3 [benign]; 			0	0.197	0.803	8	85	n/a	n/a
chr19	38981284	38981284	A	G	het		QUAL=13140;DP=280;AF=0.56;MQM=60;TRIO=HET,280,0.56,HOM,249,1.00,WT,248,0.01	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon37/106:c.6039A>G:p.Lys2013Lys,RYR1:NM_001042723.1:synonymous:LOW:exon37/105:c.6039A>G:p.Lys2013Lys		rs2228068	0.0751	0.092	0.0981	0.0352						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079155.3 [benign]; RCV000119646.1 [not provided]; 		COSM4131783	0.0076	0.1288	0.8636	10	65	n/a	n/a
chr19	38983180	38983180	G	T	het		QUAL=8094;DP=196;AF=0.41;MQM=59;TRIO=HET,196,0.41,HOM,184,0.99,WT,229,0.00	RYR1	missense	RYR1:NM_000540.2:missense:MODERATE:exon38/106:c.6178G>T:p.Gly2060Cys,RYR1:NM_001042723.1:missense:MODERATE:exon38/105:c.6178G>T:p.Gly2060Cys		rs35364374	0.0549	0.069	0.0713	0.0127	0.6150	N	T	D,P	P,B	180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000056058.1 [benign]; RCV000079156.3 [benign]; RCV000119647.1 [not provided]; 			0.0076	0.0909	0.9015	4	52	n/a	n/a
chr19	38991516	38991516	G	A	het		QUAL=11275;DP=216;AF=0.54;MQM=60;TRIO=HET,216,0.54,WT,307,0.00,HET,450,0.54	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon47/106:c.7500G>A:p.Ala2500Ala,RYR1:NM_001042723.1:synonymous:LOW:exon47/105:c.7500G>A:p.Ala2500Ala		rs2228072	0.1508	0.114	0.0863	0.1196						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079165.3,RCV000119716.1 [benign,not provided]; 			0.0076	0.1894	0.803	3	88	n/a	n/a
chr19	38991543	38991543	G	A	het		QUAL=13090;DP=288;AF=0.50;MQM=60;TRIO=HET,288,0.50,WT,336,0.00,HET,505,0.53	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon47/106:c.7527G>A:p.Val2509Val,RYR1:NM_001042723.1:synonymous:LOW:exon47/105:c.7527G>A:p.Val2509Val		rs2071088	0.136	0.111	0.0862	0.0921						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079166.3 [benign]; RCV000119720.1 [not provided]; 			0.0076	0.1894	0.803	3	88	n/a	n/a
chr19	38993372	38993372	A	G	het		QUAL=735;DP=12;AF=0.25;MQM=60;TRIO=HET,12,0.25,WT,21,0.00,HOM,26,1.00	RYR1	splice_region&intron	RYR1:NM_000540.2:splice_region&intron:LOW:exon48/105:c.7835+5A>G:,RYR1:NM_001042723.1:splice_region&intron:LOW:exon48/104:c.7835+5A>G:		rs1469695	0.4219	0.328	0.2482	0.4424						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079170.3 [benign]; RCV000119729.1 [not provided]; 			0.0606	0.3864	0.553	32	172	n/a	n/a
chr19	38993547	38993547	C	T	het		QUAL=5283;DP=156;AF=0.48;MQM=59;TRIO=HET,156,0.48,WT,78,0.00,HOM,107,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon49/106:c.7863C>T:p.His2621His,RYR1:NM_001042723.1:synonymous:LOW:exon49/105:c.7863C>T:p.His2621His		rs2229142	0.2378	0.181	0.1417	0.1893						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079172.3 [benign]; RCV000119732.1 [not provided]; 		COSM148609	0.0303	0.2955	0.6742	11	132	n/a	n/a
chr19	38994910	38994910	G	A	het		QUAL=9948;DP=252;AF=0.48;MQM=59;TRIO=HET,252,0.48,WT,163,0.01,HOM,194,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon50/106:c.7977G>A:p.Thr2659Thr,RYR1:NM_001042723.1:synonymous:LOW:exon50/105:c.7977G>A:p.Thr2659Thr		rs2229144	0.4123	0.325	0.2488	0.4576						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079174.3 [benign]; RCV000119736.1 [not provided]; 		COSM148610	0.053	0.447	0.5	30	184	n/a	n/a
chr19	38995438	38995438	T	C	het		QUAL=9599;DP=164;AF=0.53;MQM=60;TRIO=HET,164,0.53,WT,180,0.01,HOM,223,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon51/106:c.8118T>C:p.Ile2706Ile,RYR1:NM_001042723.1:synonymous:LOW:exon51/105:c.8118T>C:p.Ile2706Ile		rs2960340	0.4151	0.326	0.2492	0.4576						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079175.3 [benign]; RCV000119738.1 [not provided]; 		COSM148611	0.053	0.447	0.5	30	184	n/a	n/a
chr19	38995510	38995510	T	C	het		QUAL=14828;DP=303;AF=0.49;MQM=59;TRIO=HET,303,0.49,WT,276,0.01,HOM,315,1.00	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon51/106:c.8190T>C:p.Asp2730Asp,RYR1:NM_001042723.1:synonymous:LOW:exon51/105:c.8190T>C:p.Asp2730Asp		rs2915951	0.4171	0.329	0.2545	0.4585						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079176.3 [benign]; RCV000119741.1 [not provided]; 		COSM148612	0.0606	0.4394	0.5	31	184	n/a	n/a
chr19	38995975	38995975	G	A	het		QUAL=5107;DP=147;AF=0.47;MQM=60;TRIO=HET,147,0.47,WT,76,0.00,HOM,91,0.99	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon53/106:c.8337G>A:p.Glu2779Glu,RYR1:NM_001042723.1:synonymous:LOW:exon53/105:c.8337G>A:p.Glu2779Glu		rs2915952	0.406	0.32	0.2476	0.4267						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079177.3 [benign]; RCV000119745.1 [not provided]; 		COSM148613	0.053	0.447	0.5	30	180	n/a	n/a
chr19	38996990	38996990	T	C	het		QUAL=13992;DP=234;AF=0.53;MQM=59;TRIO=HET,234,0.53,WT,258,0.01,HOM,323,0.99	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon55/106:c.8589T>C:p.Ser2863Ser,RYR1:NM_001042723.1:synonymous:LOW:exon55/105:c.8589T>C:p.Ser2863Ser		rs2229146	0.4081	0.326	0.2542	0.4296						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079178.3 [benign]; RCV000119753.1 [not provided]; 		COSM148614	0.0606	0.4394	0.5	31	182	n/a	n/a
chr19	39002725	39002725	A	G	het		QUAL=3946;DP=96;AF=0.50;MQM=60;TRIO=HET,96,0.50,WT,106,0.00,HOM,89,0.98	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon62/106:c.9186A>G:p.Pro3062Pro,RYR1:NM_001042723.1:synonymous:LOW:exon62/105:c.9186A>G:p.Pro3062Pro		rs2071089	0.4069	0.325	0.2513	0.4271						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079184.3 [benign]; RCV000119767.1 [not provided]; 		COSM3756756	0.053	0.447	0.5	30	185	n/a	n/a
chr19	39010053	39010053	C	T	het		QUAL=230;DP=7;AF=0.57;MQM=60;TRIO=HET,7,0.57,WT,7,0.00,HET,7,0.86	RYR1	synonymous	RYR1:NM_000540.2:synonymous:LOW:exon67/106:c.10218C>T:p.Tyr3406Tyr,RYR1:NM_001042723.1:synonymous:LOW:exon67/105:c.10218C>T:p.Tyr3406Tyr		rs41274330	0.1022	0.072	0.0457	0.0123						180901 [RYR1 (confirmed) Malignant hyperthermia susceptibility 1|Central core disease|Minicore myopathy with external ophthalmoplegia|Neuromuscular disease,congenital,with uniform type 1 fiber|King-Denborough syndrome];	RCV000079116.3 [benign]; RCV000119405.1 [not provided]; 			0.0076	0.0606	0.9318	2	45	n/a	n/a
chr19	40900865	40900865	C	T	hom		QUAL=12582;DP=103;AF=1.00;MQM=59;TRIO=HOM,103,1.00,HOM,124,0.99,HOM,180,0.99	PRX	missense,3'UTR	PRX:NM_181882.2:missense:MODERATE:exon7/7:c.3394G>A:p.Gly1132Arg,PRX:NM_020956.2:3'UTR:MODIFIER:exon6/6:c.*3599G>A:		rs268674	0.9655	0.947	0.9357	0.9891	-0.1040	P	T	B	B	605725 [PRX (provisional) Dejerine-Sottas disease,autosomal recessive|Charcot-Marie-Tooth disease,type 4F];	RCV000118080.2 [likely benign]; 		COSM3756794	0.8333	0.1667	0	384	69	n/a	n/a
chr19	40901604	40901604	A	G	het		QUAL=8972;DP=190;AF=0.54;MQM=59;TRIO=HET,190,0.54,HOM,200,0.99,WT,284,0.00	PRX	synonymous,3'UTR	PRX:NM_181882.2:synonymous:LOW:exon7/7:c.2655T>C:p.Pro885Pro,PRX:NM_020956.2:3'UTR:MODIFIER:exon6/6:c.*2860T>C:		rs268672	0.5319	0.507	0.5176	0.7878						605725 [PRX (provisional) Dejerine-Sottas disease,autosomal recessive|Charcot-Marie-Tooth disease,type 4F];	RCV000118076.2 [likely benign]; 		COSM4131847	0.1742	0.4924	0.3333	108	223	n/a	n/a
chr19	40901614	40901614	A	G	het		QUAL=8567;DP=194;AF=0.52;MQM=59;TRIO=HET,194,0.52,HOM,191,0.99,WT,256,0.01	PRX	missense,3'UTR	PRX:NM_181882.2:missense:MODERATE:exon7/7:c.2645T>C:p.Val882Ala,PRX:NM_020956.2:3'UTR:MODIFIER:exon6/6:c.*2850T>C:		rs268671	0.5319	0.507	0.5178	0.7892	2.6800	P	T	B	B	605725 [PRX (provisional) Dejerine-Sottas disease,autosomal recessive|Charcot-Marie-Tooth disease,type 4F];	RCV000118075.2 [likely benign]; 		COSM4000733	0.1742	0.4924	0.3333	108	224	n/a	n/a
chr19	41892269	41892269	C	T	hom		QUAL=5812;DP=52;AF=1.00;MQM=60;TRIO=HOM,52,1.00,HOM,64,1.00,HOM,70,1.00				L2b	rs3826713	0.5044	0	0	0						608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];				0.2879	0.4924	0.2197	45	72	n/a	n/a
chr19	41903220	41903220	G	A	hom		QUAL=28833;DP=231;AF=1.00;MQM=60;TRIO=HOM,231,1.00,HOM,290,1.00,HOM,394,1.00	EXOSC5	missense	EXOSC5:NM_020158.3:missense:MODERATE:exon1/6:c.14C>T:p.Thr5Met		rs10853751	0.6144	0.595	0.6016	0.81	-0.0950	P	T	B	B	608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];				0.2879	0.4924	0.2197	108	155	n/a	n/a
chr19	41903699	41903699	T	G	het		QUAL=1007;DP=66;AF=0.36;MQM=60;TRIO=HET,66,0.36,HET,25,0.48,WT,39,0.00	BCKDHA	5'UTR	BCKDHA:NM_000709.3:5'UTR:MODIFIER:exon1/9:c.-34T>G:,BCKDHA:NM_001164783.1:5'UTR:MODIFIER:exon1/9:c.-34T>G:		rs45500792	0.0825	0.115	0.1419	0.0395						608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];	RCV000079215.2 [benign]; RCV000123828.1 [benign]; 			0	0.2424	0.7576	0	39	n/a	n/a
chr19	41916549	41916549	C	A	het		QUAL=2803;DP=63;AF=0.56;MQM=60;TRIO=HET,63,0.56,HET,139,0.45,WT,177,0.01	BCKDHA	missense	BCKDHA:NM_000709.3:missense:MODERATE:exon2/9:c.116C>A:p.Pro39His,BCKDHA:NM_001164783.1:missense:MODERATE:exon2/9:c.116C>A:p.Pro39His		rs11549936	0.0553	0.098	0.136	0.0238	-1.4150	P	T	B,B,B	B,B,B	608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];	RCV000079222.4 [other]; RCV000123827.1 [benign]; 		COSM4131898	0	0.2273	0.7727	9	107	n/a	n/a
chr19	41928652	41928652	C	T	hom		QUAL=16339;DP=110;AF=0.99;MQM=59;TRIO=HOM,110,0.99,HOM,180,1.00,HOM,243,1.00	BCKDHA	synonymous	BCKDHA:NM_000709.3:synonymous:LOW:exon7/9:c.972C>T:p.Phe324Phe,BCKDHA:NM_001164783.1:synonymous:LOW:exon7/9:c.969C>T:p.Phe323Phe		rs284652	0.6164	0.599	0.6076	0.8098						608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];	RCV000079266.4 [other]; 		COSM3933055	0.2879	0.5076	0.2045	161	224	n/a	n/a
chr19	41930396	41930396	A	G	hom		QUAL=4645;DP=68;AF=0.97;MQM=59;TRIO=HOM,68,0.97,HOM,43,1.00,HOM,52,1.00	BCKDHA	synonymous	BCKDHA:NM_000709.3:synonymous:LOW:exon9/9:c.1221A>G:p.Leu407Leu,BCKDHA:NM_001164783.1:synonymous:LOW:exon9/9:c.1218A>G:p.Leu406Leu		rs4674	0.617	0.6	0.6086	0.8105						608348 [BCKDHA (confirmed) Maple syrup urine disease,type Ia];	RCV000079224.4 [other]; 			0.2955	0.5	0.2045	163	222	n/a	n/a
chr19	45854919	45854919	T	G	hom		QUAL=20998;DP=134;AF=0.99;MQM=59;TRIO=HOM,134,0.99,HET,329,0.44,HOM,408,1.00	ERCC2	missense	ERCC2:NM_000400.3:missense:MODERATE:exon23/23:c.2251A>C:p.Lys751Gln		rs13181	0.2366	0.33	0.3724	0.2354	1.1980	P	T	B,B	B,B	126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D|Trichothiodystrophy|Cerebrooculofacioskeletal syndrome 2];	RCV000120777.1 [not provided]; 	CM004814 [CLASS=DFP MUT=ALT PHEN="Basal cell carcinoma, reduced risk, association with" GENE=ERCC2]; 	COSM4132125	0.1894	0.447	0.3636	188	529	n/a	n/a
chr19	45855524	45855524	G	A	hom		QUAL=7008;DP=126;AF=1.00;MQM=60;TRIO=HOM,126,1.00,HET,45,0.56,HOM,76,1.00	ERCC2	synonymous	ERCC2:NM_000400.3:synonymous:LOW:exon22/23:c.2133C>T:p.Asp711Asp		rs1052555	0.1823	0.285	0.3331	0.1135						126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D|Trichothiodystrophy|Cerebrooculofacioskeletal syndrome 2];		CM052870 [CLASS=DP MUT=ALT PHEN="Reduced risk oligodendroglioma development, association" GENE=ERCC2]; 	COSM3756953	0.1364	0.447	0.4167	154	510	n/a	n/a
chr19	45867259	45867259	C	T	hom		QUAL=5192;DP=41;AF=1.00;MQM=60;TRIO=HOM,41,1.00,HET,67,0.45,HOM,97,1.00	ERCC2	missense	ERCC2:NM_000400.3:missense:MODERATE:exon10/23:c.934G>A:p.Asp312Asn,ERCC2:NM_001130867.1:missense:MODERATE:exon9/12:c.862G>A:p.Asp288Asn		rs1799793	0.1945	0.213	0.3172	0.0976	7.1920	P	T	B,P,B	B,B,B	126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D|Trichothiodystrophy|Cerebrooculofacioskeletal syndrome 2];	RCV000120789.1 [not provided]; 	CM015299 [CLASS=DFP MUT=ALT PHEN="Increased response to UV, association with" GENE=ERCC2]; 	COSM3749519	0.1894	0.4015	0.4091	188	524	n/a	n/a
chr19	45868309	45868309	T	G	hom		QUAL=24077;DP=136;AF=1.00;MQM=59;TRIO=HOM,136,1.00,HET,353,0.48,HOM,466,1.00	ERCC2	synonymous	ERCC2:NM_000400.3:synonymous:LOW:exon6/23:c.468A>C:p.Arg156Arg,ERCC2:NM_001130867.1:synonymous:LOW:exon5/12:c.396A>C:p.Arg132Arg		rs238406	0.6362	0.588	0.5585	0.8656						126340 [ERCC2 (confirmed) Xeroderma pigmentosum,group D|Trichothiodystrophy|Cerebrooculofacioskeletal syndrome 2];		CM057545 [CLASS=DP MUT=REF PHEN="Lung adenocarcinoma, increased risk, association with" GENE=ERCC2]; 		0.4167	0.4091	0.1742	392	575	n/a	n/a
chr19	45910672	45910672	A	G	hom		QUAL=9442;DP=198;AF=0.99;MQM=60;TRIO=HOM,198,0.99,HOM,56,1.00,HET,95,0.47	ERCC1,CD3EAP	3'UTR,intron	ERCC1:NM_001166049.1:3'UTR:MODIFIER:exon9/9:c.*2261T>C:,ERCC1:NM_001983.3:3'UTR:MODIFIER:exon10/10:c.*2261T>C:,CD3EAP:NM_001297590.1:intron:MODIFIER:exon2/2:c.170+179A>G:,CD3EAP:NM_012099.1:intron:MODIFIER:exon2/2:c.164+179A>G:	MER41D	rs1046282	0.3249	0	0	0										0.0909	0.3409	0.5682	13	49	n/a	n/a
chr19	45911320	45911320	A	-	hom		QUAL=21902;DP=190;AF=0.96;MQM=59;TRIO=HOM,190,0.96,HOM,306,0.98,HET,435,0.56	ERCC1,CD3EAP	3'UTR,intron	ERCC1:NM_001166049.1:3'UTR:MODIFIER:exon9/9:c.*1613delT:,ERCC1:NM_001983.3:3'UTR:MODIFIER:exon10/10:c.*1613delT:,CD3EAP:NM_001297590.1:intron:MODIFIER:exon2/2:c.171-62delA:,CD3EAP:NM_012099.1:intron:MODIFIER:exon2/2:c.165-62delA:	AluSx1	rs11314106	0	0	0	0										0.0758	0.303	0.6212	11	43	n/a	n/a
chr19	45912490	45912492	AAG	-	hom		QUAL=13541;DP=149;AF=0.99;MQM=60;TRIO=HOM,149,0.99,HOM,188,0.97,HET,217,0.52	CD3EAP,ERCC1	disruptive_inframe_deletion,3'UTR	CD3EAP:NM_001297590.1:disruptive_inframe_deletion:MODERATE:exon3/3:c.1287_1289delGAA:p.Lys430del,CD3EAP:NM_012099.1:disruptive_inframe_deletion:MODERATE:exon3/3:c.1281_1283delGAA:p.Lys428del,ERCC1:NM_001166049.1:3'UTR:MODIFIER:exon9/9:c.*441_*443delCTT:,ERCC1:NM_001983.3:3'UTR:MODIFIER:exon10/10:c.*441_*443delCTT:	(GAA)n	rs374686338	0	0	0	0									COSM1481223	0.0758	0.3485	0.5758	30	198	n/a	n/a
chr19	45912736	45912736	C	A	hom		QUAL=11617;DP=126;AF=1.00;MQM=59;TRIO=HOM,126,1.00,HOM,166,0.99,HET,179,0.47	CD3EAP,ERCC1	missense,3'UTR	CD3EAP:NM_001297590.1:missense:MODERATE:exon3/3:c.1516C>A:p.Gln506Lys,CD3EAP:NM_012099.1:missense:MODERATE:exon3/3:c.1510C>A:p.Gln504Lys,ERCC1:NM_001166049.1:3'UTR:MODIFIER:exon9/9:c.*197G>T:,ERCC1:NM_001983.3:3'UTR:MODIFIER:exon10/10:c.*197G>T:		rs3212986	0.2951	0.271	0.2459	0.2913	-1.3970	P	T	B,B	B,B			CM005461 [CLASS=DP MUT=REF PHEN="Glioma, adult-onset, association with" GENE=CD3EAP]; 		0.0833	0.3485	0.5682	37	154	n/a	n/a
chr19	45923653	45923653	A	G	hom		QUAL=24168;DP=172;AF=0.99;MQM=60;TRIO=HOM,172,0.99,HOM,355,0.99,HET,454,0.52	ERCC1	synonymous	ERCC1:NM_202001.2:synonymous:LOW:exon3/8:c.354T>C:p.Asn118Asn,ERCC1:NM_001166049.1:synonymous:LOW:exon4/9:c.354T>C:p.Asn118Asn,ERCC1:NM_001983.3:synonymous:LOW:exon4/10:c.354T>C:p.Asn118Asn		rs11615	0.6689	0.5	0.3722	0.8677						126380 [ERCC1 (confirmed) Cerebrooculofacioskeletal syndrome 4];				0.1591	0.5076	0.3333	83	201	n/a	n/a
chr19	45998346	45998346	C	A	hom		QUAL=15094;DP=235;AF=1.00;MQM=60;TRIO=HOM,235,1.00,HET,206,0.45,HET,324,0.45	RTN2	splice_region&intron	RTN2:NM_005619.4:splice_region&intron:LOW:exon2/10:c.79+7G>T:,RTN2:NM_206900.2:splice_region&intron:LOW:exon2/9:c.79+7G>T:		rs2298887	0.1494	0.157	0.1579	0.1718						603183 [RTN2 (provisional) Spastic paraplegia 12,autosomal dominant];				0.0606	0.2727	0.6667	21	224	n/a	n/a
chr19	46031606	46031606	T	C	hom		QUAL=25043;DP=273;AF=1.00;MQM=60;TRIO=HOM,273,1.00,HOM,251,1.00,HOM,274,1.00	OPA3	3'UTR	OPA3:NM_001017989.2:3'UTR:MODIFIER:exon2/2:c.*708A>G:		rs7259834	0.9888	0	0	0										0.9545	0.0455	0	144	6	n/a	n/a
chr19	46049982	46049982	A	G	hom		QUAL=854;DP=22;AF=1.00;MQM=60;TRIO=HOM,22,1.00,HOM,7,1.00,HOM,1,1.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*6790T>C:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-17268T>C:	AluSz	rs10422253	0.7754	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.6591	0.2273	0.1136	99	34	n/a	n/a
chr19	46050760	46050760	T	C	het		QUAL=21175;DP=369;AF=0.53;MQM=60;TRIO=HET,369,0.53,HET,395,0.54,HET,479,0.51	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*6012A>G:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-18046A>G:	L2b	rs11083772	0.638	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.4394	0.447	0.1136	62	68	n/a	n/a
chr19	46051915	46051915	T	A	het		QUAL=2582;DP=129;AF=0.41;MQM=60;TRIO=HET,129,0.41,HET,44,0.93,WT,60,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*4857A>T:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-19201A>T:	(T)n	rs4803833	0.761	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.3409	0.5152	0.1439	50	77	n/a	n/a
chr19	46051920	46051922	TTT	-	het		QUAL=1458;DP=84;AF=0.37;MQM=60;TRIO=HET,84,0.37,HOM,31,0.81,WT,37,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*4850_*4852delAAA:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-19208_143-19206delAAA:	(T)n	rs10577501	0.761	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.4167	0.4167	0.1667	59	66	n/a	n/a
chr19	46052454	46052454	A	G	het		QUAL=19643;DP=387;AF=0.56;MQM=60;TRIO=HET,387,0.56,HOM,386,1.00,WT,525,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*4318T>C:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-19740T>C:		rs4802261	0.7584	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.4242	0.4394	0.1364	61	68	n/a	n/a
chr19	46052621	46052625	CAGGG	-	het		QUAL=10836;DP=149;AF=0.46;MQM=60;TRIO=HET,149,0.46,HOM,295,0.99,WT,400,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*4147_*4151delCCCTG:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-19911_143-19907delCCCTG:	(CAGGG)n	rs397714484	0.7584	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.3788	0.4394	0.1818	55	68	n/a	n/a
chr19	46052898	46052898	C	T	het		QUAL=5917;DP=186;AF=0.51;MQM=56;TRIO=HET,186,0.51,HET,186,0.48,WT,212,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*3874G>A:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-20184G>A:	AluSz6	rs62109650	0.1546	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.0833	0.3409	0.5758	12	50	n/a	n/a
chr19	46053385	46053385	C	T	het		QUAL=2073;DP=94;AF=0.51;MQM=59;TRIO=HET,94,0.51,HOM,18,1.00,WT,21,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*3387G>A:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-20671G>A:	AluSx1	rs3760844	0.7602	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.4242	0.4394	0.1364	61	68	n/a	n/a
chr19	46053655	46053655	-	GCT	het		QUAL=10194;DP=254;AF=0.40;MQM=60;TRIO=HET,254,0.40,HOM,247,0.97,WT,335,0.01	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*3114_*3116dupAGC:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-20944_143-20942dupAGC:		rs542311224	0.7574	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.4242	0.4394	0.1364	61	68	n/a	n/a
chr19	46054822	46054822	C	T	het		QUAL=17224;DP=452;AF=0.45;MQM=60;TRIO=HET,452,0.45,HOM,355,0.99,WT,420,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*1950G>A:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-22108G>A:	MLT1C	rs4404183	0.7568	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.4242	0.4394	0.1364	61	68	n/a	n/a
chr19	46055477	46055477	-	T	het		QUAL=1977;DP=165;AF=0.35;MQM=60;TRIO=HET,165,0.35,HET,44,0.30,WT,74,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*1294dupA:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-22764dupA:		rs74313320	0.3183	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.1515	0.4394	0.4091	24	64	n/a	n/a
chr19	46055786	46055786	T	-	het		QUAL=1863;DP=46;AF=0.57;MQM=58;TRIO=HET,46,0.57,HET,46,0.74,HET,52,0.29	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*986delA:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-23072delA:	AluSx1	rs377547137	0.6052	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.0455	0.3939	0.5606	7	55	n/a	n/a
chr19	46056620	46056620	C	T	het		QUAL=13934;DP=217;AF=0.48;MQM=59;TRIO=HET,217,0.48,HOM,344,1.00,WT,364,0.00	OPA3	3'UTR,intron	OPA3:NM_025136.3:3'UTR:MODIFIER:exon2/2:c.*152G>A:,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-23906G>A:		rs3826861	0.7107	0	0	0						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];				0.4242	0.4394	0.1364	62	68	n/a	n/a
chr19	46057081	46057081	A	G	het		QUAL=5430;DP=120;AF=0.53;MQM=60;TRIO=HET,120,0.53,HOM,112,1.00,WT,160,0.00	OPA3	synonymous,intron	OPA3:NM_025136.3:synonymous:LOW:exon2/2:c.231T>C:p.Ala77Ala,OPA3:NM_001017989.2:intron:MODIFIER:exon1/1:c.143-24367T>C:		rs3826860	0.767	0.702	0.6428	0.7602						606580 [OPA3 (confirmed) 3-methylglutaconic aciduria,type III|Optic atrophy 3 with cataract];	RCV000020908.1 [benign]; RCV000082252.4 [other]; RCV000132683.1 [likely benign]; 		COSM439792	0.4242	0.4394	0.1364	571	651	1	n/a
chr19	47258674	47258674	C	T	het		QUAL=200;DP=16;AF=0.44;MQM=60;TRIO=HET,16,0.44,WT,8,0.00,HET,9,0.33	FKRP	5'UTR	FKRP:NM_001039885.2:5'UTR:MODIFIER:exon4/4:c.-34C>T:,FKRP:NM_024301.4:5'UTR:MODIFIER:exon4/4:c.-34C>T:		rs3201779	0.1038	0.175	0.2281	0.0608							RCV000082170.3 [benign]; 			0.053	0.25	0.697	7	34	n/a	n/a
chr19	50411012	50411012	C	T	het		QUAL=5945;DP=179;AF=0.56;MQM=53;TRIO=HET,179,0.56,WT,125,0.00,HET,170,0.54	NUP62,IL4I1	3'UTR,intron	NUP62:NM_001193357.1:3'UTR:MODIFIER:exon2/2:c.*484G>A:,NUP62:NM_012346.4:3'UTR:MODIFIER:exon2/2:c.*484G>A:,NUP62:NM_153718.3:3'UTR:MODIFIER:exon2/2:c.*484G>A:,NUP62:NM_153719.3:3'UTR:MODIFIER:exon3/3:c.*484G>A:,NUP62:NM_016553.4:3'UTR:MODIFIER:exon3/3:c.*484G>A:,IL4I1:NM_001258017.1:intron:MODIFIER:exon2/9:c.-227-3434G>A:,IL4I1:NM_001258018.1:intron:MODIFIER:exon2/9:c.-285-3434G>A:,IL4I1:NM_172374.2:intron:MODIFIER:exon2/9:c.-227-3434G>A:	AluSz	rs1127729	0.0677	0	0	0										0.0076	0.2424	0.75	2	34	n/a	n/a
chr19	50411742	50411742	A	G	het		QUAL=31997;DP=278;AF=0.52;MQM=59;TRIO=HET,278,0.52,HET,472,0.52,HOM,635,1.00	NUP62,IL4I1	synonymous,intron	NUP62:NM_001193357.1:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,NUP62:NM_012346.4:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,NUP62:NM_153718.3:synonymous:LOW:exon2/2:c.1323T>C:p.Asp441Asp,NUP62:NM_153719.3:synonymous:LOW:exon3/3:c.1323T>C:p.Asp441Asp,NUP62:NM_016553.4:synonymous:LOW:exon3/3:c.1323T>C:p.Asp441Asp,IL4I1:NM_001258017.1:intron:MODIFIER:exon2/9:c.-227-4164T>C:,IL4I1:NM_001258018.1:intron:MODIFIER:exon2/9:c.-285-4164T>C:,IL4I1:NM_172374.2:intron:MODIFIER:exon2/9:c.-227-4164T>C:		rs892028	0.974	0.944	0.9286	0.9837						605815 [NUP62 (confirmed) Striatonigral degeneration,infantile];	RCV000117863.2 [likely benign]; 			0.8788	0.1061	0.0152	402	47	n/a	n/a
chr19	50412417	50412417	G	A	het		QUAL=5773;DP=61;AF=0.44;MQM=60;TRIO=HET,61,0.44,WT,144,0.00,HOM,165,1.00	NUP62,IL4I1	synonymous,intron	NUP62:NM_001193357.1:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,NUP62:NM_012346.4:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,NUP62:NM_153718.3:synonymous:LOW:exon2/2:c.648C>T:p.Ser216Ser,NUP62:NM_153719.3:synonymous:LOW:exon3/3:c.648C>T:p.Ser216Ser,NUP62:NM_016553.4:synonymous:LOW:exon3/3:c.648C>T:p.Ser216Ser,IL4I1:NM_001258017.1:intron:MODIFIER:exon2/9:c.-227-4839C>T:,IL4I1:NM_001258018.1:intron:MODIFIER:exon2/9:c.-285-4839C>T:,IL4I1:NM_172374.2:intron:MODIFIER:exon2/9:c.-227-4839C>T:		rs999583	0.8604	0.792	0.7579	0.9044						605815 [NUP62 (confirmed) Striatonigral degeneration,infantile];	RCV000117865.2 [likely benign]; 		COSM3757052	0.6667	0.2803	0.053	289	137	n/a	n/a
chr19	51850290	51850290	G	A	het		QUAL=5862;DP=73;AF=0.59;MQM=60;TRIO=HET,73,0.59,HOM,90,1.00,HET,133,0.47	ETFB	missense	ETFB:NM_001014763.1:missense:MODERATE:exon4/5:c.734C>T:p.Thr245Met,ETFB:NM_001985.2:missense:MODERATE:exon5/6:c.461C>T:p.Thr154Met		rs1130426	0.4197	0.489	0.5587	0.5089	3.6820	P	D	D,D	P,P	130410 [ETFB (confirmed) Glutaric acidemia IIB];	RCV000079961.2 [benign]; 		COSM3721677	0.3788	0.4015	0.2197	148	213	n/a	n/a
chr19	54385820	54385820	C	T	hom		QUAL=5503;DP=41;AF=1.00;MQM=60;TRIO=HOM,41,1.00,HOM,62,1.00,HOM,87,1.00	PRKCG	synonymous	PRKCG:NM_002739.3:synonymous:LOW:exon1/18:c.72C>T:p.Ala24Ala		rs2547362	0.8964	0.946	0.9552	0.7399						176980 [PRKCG (confirmed) Spinocerebellar ataxia 14];	RCV000118063.2 [likely benign]; 			0.9167	0.0833	0	1054	72	2	n/a (2xTP)
chr19	54394965	54394965	T	C	het		QUAL=11838;DP=171;AF=0.51;MQM=60;TRIO=HET,171,0.51,HET,249,0.45,HET,354,0.51	PRKCG	synonymous	PRKCG:NM_002739.3:synonymous:LOW:exon6/18:c.567T>C:p.Asn189Asn		rs3745406	0.3295	0.398	0.4092	0.2229						176980 [PRKCG (confirmed) Spinocerebellar ataxia 14];	RCV000118062.2 [likely benign]; 		COSM148736	0.1894	0.4773	0.3333	214	535	2	n/a (1xTP)
chr19	54695163	54695163	T	C	het		QUAL=188;DP=5;AF=0.60;MQM=60;TRIO=HET,5,0.60,WT,2,0.00,HOM,6,1.00	TSEN34	5'UTR,intron	TSEN34:NM_001077446.3:5'UTR:MODIFIER:exon1/4:c.-53T>C:,TSEN34:NM_001282333.1:intron:MODIFIER:exon1/5:c.6-49T>C:,TSEN34:NM_024075.4:intron:MODIFIER:exon1/4:c.-4-49T>C:,TSEN34:NM_001282332.1:intron:MODIFIER:exon1/4:c.-4-49T>C:		rs593073	0.7418	0.605	0	0										0.3864	0.1591	0.4545	54	23	n/a	n/a
chr19	54697079	54697079	C	T	het		QUAL=18876;DP=173;AF=0.50;MQM=60;TRIO=HET,173,0.50,HET,268,0.56,HOM,358,1.00	TSEN34	synonymous	TSEN34:NM_001282333.1:synonymous:LOW:exon5/6:c.804C>T:p.Pro268Pro,TSEN34:NM_024075.4:synonymous:LOW:exon5/5:c.795C>T:p.Pro265Pro,TSEN34:NM_001282332.1:synonymous:LOW:exon5/5:c.795C>T:p.Pro265Pro,TSEN34:NM_001077446.3:synonymous:LOW:exon4/4:c.795C>T:p.Pro265Pro		rs7595	0.7482	0.772	0.8176	0.846						608754 [TSEN34 (provisional) Pontocerebellar hypoplasia type 2C];	RCV000147766.1 [benign]; 			0.5758	0.3788	0.0455	708	292	n/a	n/a
chr19	54697602	54697602	G	A	het		QUAL=5116;DP=122;AF=0.60;MQM=60;TRIO=HET,122,0.60,HET,40,0.68,HOM,61,1.00	TSEN34	3'UTR	TSEN34:NM_001282333.1:3'UTR:MODIFIER:exon6/6:c.*76G>A:,TSEN34:NM_024075.4:3'UTR:MODIFIER:exon5/5:c.*385G>A:,TSEN34:NM_001282332.1:3'UTR:MODIFIER:exon5/5:c.*385G>A:,TSEN34:NM_001077446.3:3'UTR:MODIFIER:exon4/4:c.*385G>A:	MIRb	rs36622	0.7482	0	0	0										0.5758	0.3788	0.0455	163	81	n/a	n/a
chr19	54697714	54697714	C	T	het		QUAL=6760;DP=179;AF=0.50;MQM=60;TRIO=HET,179,0.50,HET,64,0.61,HOM,77,1.00	TSEN34	3'UTR	TSEN34:NM_001282333.1:3'UTR:MODIFIER:exon6/6:c.*188C>T:,TSEN34:NM_024075.4:3'UTR:MODIFIER:exon5/5:c.*497C>T:,TSEN34:NM_001282332.1:3'UTR:MODIFIER:exon5/5:c.*497C>T:,TSEN34:NM_001077446.3:3'UTR:MODIFIER:exon4/4:c.*497C>T:	MIRb	rs36621	0.7488	0	0	0										0.5758	0.3788	0.0455	158	75	n/a	n/a
chr19	54698196	54698198	GGA	-	het		QUAL=9884;DP=271;AF=0.54;MQM=60;TRIO=HET,271,0.54,HET,105,0.46,HOM,154,0.99	TSEN34	3'UTR	TSEN34:NM_001282333.1:3'UTR:MODIFIER:exon6/6:c.*671_*673delGAG:,TSEN34:NM_024075.4:3'UTR:MODIFIER:exon5/5:c.*980_*982delGAG:,TSEN34:NM_001282332.1:3'UTR:MODIFIER:exon5/5:c.*980_*982delGAG:,TSEN34:NM_001077446.3:3'UTR:MODIFIER:exon4/4:c.*980_*982delGAG:		rs528941856	0	0	0	0										0.25	0.4697	0.2803	40	72	n/a	n/a
chr19	55644325	55644325	A	C	hom		QUAL=250;DP=7;AF=1.00;MQM=60;TRIO=HOM,7,1.00,HOM,1,1.00,NONE,0,0	TNNT1	synonymous	TNNT1:NM_003283.5:synonymous:LOW:exon14/14:c.795T>G:p.Arg265Arg,TNNT1:NM_001126132.2:synonymous:LOW:exon14/14:c.747T>G:p.Arg249Arg,TNNT1:NM_001126133.2:synonymous:LOW:exon13/13:c.714T>G:p.Arg238Arg,TNNT1:NM_001291774.1:synonymous:LOW:exon14/14:c.714T>G:p.Arg238Arg		rs890868	0.9804	0.987	0.9998	1						191041 [TNNT1 (confirmed) Nemaline myopathy 5,Amish type];	RCV000024552.1,RCV000154008.1 [not provided,benign]; 			0.303	0	0.697	348	0	n/a	n/a
chr19	55658387	55658387	T	C	het		QUAL=1019;DP=15;AF=0.47;MQM=60;TRIO=HET,15,0.47,WT,54,0.00,HET,64,0.45	TNNT1	missense&splice_region	TNNT1:NM_003283.5:missense&splice_region:MODERATE:exon3/14:c.35A>G:p.Glu12Gly,TNNT1:NM_001126132.2:missense&splice_region:MODERATE:exon3/14:c.35A>G:p.Glu12Gly,TNNT1:NM_001126133.2:missense&splice_region:MODERATE:exon3/13:c.35A>G:p.Glu12Gly,TNNT1:NM_001291774.1:missense&splice_region:MODERATE:exon4/14:c.35A>G:p.Glu12Gly		rs112562759	0.0359	0.07	0.0977	0.0175	2.0130	D	T	B,B,B,B	B,B,B,B	191041 [TNNT1 (confirmed) Nemaline myopathy 5,Amish type];	RCV000024560.1 [not provided]; RCV000080082.3 [benign]; 			0.0152	0.1818	0.803	6	71	n/a	n/a
chr19	55660537	55660537	T	C	hom		QUAL=17209;DP=138;AF=1.00;MQM=60;TRIO=HOM,138,1.00,HOM,175,1.00,HOM,231,1.00	TNNT1	5'UTR	TNNT1:NM_003283.5:5'UTR:MODIFIER:exon1/14:c.-20A>G:,TNNT1:NM_001126132.2:5'UTR:MODIFIER:exon1/14:c.-20A>G:,TNNT1:NM_001126133.2:5'UTR:MODIFIER:exon1/13:c.-20A>G:,TNNT1:NM_001291774.1:5'UTR:MODIFIER:exon1/14:c.-115A>G:		rs9636153	0.8101	0.785	0	0	-0.9490	P	T				RCV000024550.1 [not provided]; 			0.7197	0.2273	0.053	186	55	n/a	n/a
chr20	3214819	3214819	T	G	het		QUAL=10587;DP=178;AF=0.44;MQM=60;TRIO=HET,178,0.44,WT,400,0.01,HET,518,0.50	SLC4A11	synonymous	SLC4A11:NM_001174090.1:synonymous:LOW:exon5/20:c.562A>C:p.Arg188Arg,SLC4A11:NM_032034.3:synonymous:LOW:exon4/19:c.481A>C:p.Arg161Arg,SLC4A11:NM_001174089.1:synonymous:LOW:exon5/20:c.433A>C:p.Arg145Arg		rs3827075	0.4798	0.436	0.3973	0.6441						610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy 2,autosomal recessive|Corneal endothelial dystrophy and perceptive deafness|Corneal dystrophy,Fuchs endothelial,4];				0.1364	0.4167	0.447	60	205	n/a	n/a
chr20	3215548	3215548	C	A	het		QUAL=9350;DP=325;AF=0.46;MQM=59;TRIO=HET,325,0.46,WT,232,0.00,HET,330,0.56	SLC4A11	splice_region&intron	SLC4A11:NM_001174090.1:splice_region&intron:LOW:exon2/19:c.218-8G>T:,SLC4A11:NM_032034.3:splice_region&intron:LOW:exon1/18:c.137-8G>T:,SLC4A11:NM_001174089.1:splice_region&intron:LOW:exon2/19:c.89-8G>T:		rs3803957	0.2724	0.299	0.2836	0.2118						610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy 2,autosomal recessive|Corneal endothelial dystrophy and perceptive deafness|Corneal dystrophy,Fuchs endothelial,4];			COSM4001880	0.053	0.3333	0.6136	27	179	n/a	n/a
chr20	3218355	3218355	C	G	het		QUAL=6801;DP=141;AF=0.50;MQM=60;TRIO=HET,141,0.50,WT,206,0.00,HET,303,0.49	SLC4A11	5'UTR_premature_start_codon_gain,5'UTR,intron	SLC4A11:NM_032034.3:5'UTR_premature_start_codon_gain:LOW:exon1/19:c.-30G>C:,SLC4A11:NM_032034.3:5'UTR:MODIFIER:exon1/19:c.-30G>C:,SLC4A11:NM_001174090.1:intron:MODIFIER:exon1/19:c.173-121G>C:,SLC4A11:NM_001174089.1:intron:MODIFIER:exon1/19:c.44-121G>C:		rs3827076	0.4503	0.411	0.3737	0.5447						610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy 2,autosomal recessive|Corneal endothelial dystrophy and perceptive deafness|Corneal dystrophy,Fuchs endothelial,4];				0.1364	0.3712	0.4924	22	64	n/a	n/a
chr20	3218634	3218634	G	C	het		QUAL=4610;DP=112;AF=0.51;MQM=59;TRIO=HET,112,0.51,WT,107,0.00,HET,185,0.50	SLC4A11	missense,intron	SLC4A11:NM_001174090.1:missense:MODERATE:exon1/20:c.77C>G:p.Pro26Arg,SLC4A11:NM_001174089.1:intron:MODIFIER:exon1/19:c.44-400C>G:		rs3810562	0.6416	0.496	0	0	-0.8580	P	T	B	B	610206 [SLC4A11 (confirmed) Corneal endothelial dystrophy 2,autosomal recessive|Corneal endothelial dystrophy and perceptive deafness|Corneal dystrophy,Fuchs endothelial,4];			COSM330384	0.3333	0.4394	0.2273	125	197	n/a	n/a
chr20	3870124	3870124	G	C	hom		QUAL=440;DP=2;AF=1.00;MQM=59;TRIO=HOM,2,1.00,HOM,11,1.00,HOM,3,1.00	PANK2	missense,intron	PANK2:NM_153638.2:missense:MODERATE:exon1/7:c.377G>C:p.Gly126Ala,PANK2:NM_024960.4:intron:MODIFIER:exon1/6:c.-246+573G>C:		rs3737084	0.8792	0.837	0.9156	0.9827	1.0190	P	T	B	B	606157 [PANK2 (provisional) Neurodegeneration with brain iron accumulation 1|HARP syndrome];	RCV000082679.2 [benign]; 		COSM4134538	0.6061	0.0909	0.303	588	149	n/a	n/a
chr20	3891347	3891347	T	G	het		QUAL=10838;DP=355;AF=0.45;MQM=60;TRIO=HET,355,0.45,WT,256,0.00,HET,340,0.49	PANK2	missense	PANK2:NM_153638.2:missense:MODERATE:exon3/7:c.1105T>G:p.Ser369Ala,PANK2:NM_024960.4:missense:MODERATE:exon3/7:c.232T>G:p.Ser78Ala,PANK2:NM_153640.2:missense:MODERATE:exon3/7:c.232T>G:p.Ser78Ala			0	0	0	0	0.9130	N	T	B	B	606157 [PANK2 (provisional) Neurodegeneration with brain iron accumulation 1|HARP syndrome];				0	0.0076	0.9924	0	1	3	n/a
chr20	10618574	10618574	T	C	het		QUAL=6718;DP=212;AF=0.51;MQM=60;TRIO=HET,212,0.51,HOM,95,1.00,WT,117,0.01	JAG1	3'UTR	JAG1:NM_000214.2:3'UTR:MODIFIER:exon26/26:c.*1572A>G:		rs8708	0.4742	0	0	0										0.303	0.4924	0.2045	50	70	n/a	n/a
chr20	10620386	10620386	A	G	het		QUAL=8690;DP=261;AF=0.49;MQM=60;TRIO=HET,261,0.49,HOM,140,1.00,WT,182,0.01	JAG1	synonymous	JAG1:NM_000214.2:synonymous:LOW:exon26/26:c.3417T>C:p.Tyr1139Tyr		rs1051419	0.7127	0.659	0.6391	0.8992						601920 [JAG1 (confirmed) Alagille syndrome|Tetralogy of Fallot|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000150844.1,RCV000125430.1 [benign,benign]; 		COSM3758426	0.4091	0.4697	0.1212	202	198	n/a	n/a
chr20	10633237	10633237	G	A	het		QUAL=3478;DP=85;AF=0.65;MQM=59;TRIO=HET,85,0.65,HOM,65,0.98,WT,91,0.00	JAG1	synonymous	JAG1:NM_000214.2:synonymous:LOW:exon6/26:c.765C>T:p.Tyr255Tyr		rs1131695	0.4233	0.453	0.4663	0.3434						601920 [JAG1 (confirmed) Alagille syndrome|Tetralogy of Fallot|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000150845.1,RCV000132569.1 [benign,likely benign]; 		COSM3758427	0.3182	0.4242	0.2576	143	203	n/a	n/a
chr20	10653469	10653469	C	T	het		QUAL=7958;DP=212;AF=0.54;MQM=60;TRIO=HET,212,0.54,HET,335,0.46,WT,471,0.00	JAG1	synonymous	JAG1:NM_000214.2:synonymous:LOW:exon2/26:c.267G>A:p.Gly89Gly		rs1051415	0.0653	0.093	0.1067	0.025						601920 [JAG1 (confirmed) Alagille syndrome|Tetralogy of Fallot|Deafness,congenital heart defects,and posterior embryotoxon];	RCV000035331.2 [benign]; RCV000125428.1 [benign]; 			0.0076	0.1061	0.8864	4	57	n/a	n/a
chr20	10654563	10654563	A	C	het		QUAL=4010;DP=85;AF=0.45;MQM=59;TRIO=HET,85,0.45,HET,90,0.44,HET,112,0.54	JAG1	5'UTR	JAG1:NM_000214.2:5'UTR:MODIFIER:exon1/26:c.-385T>G:		rs1051412	0.5545	0	0	0										0.25	0.5152	0.2348	38	74	n/a	n/a
chr20	13798449	13798470	ACAGTCATCAGTTTATTGTTAA	-	hom		QUAL=5340;DP=81;AF=1.00;MQM=60;TRIO=HOM,81,1.00,HET,97,0.51,HET,103,0.50	NDUFAF5	3'UTR	NDUFAF5:NM_024120.4:3'UTR:MODIFIER:exon11/11:c.*593_*614delACAGTCATCAGTTTATTGTTAA:,NDUFAF5:NM_001039375.2:3'UTR:MODIFIER:exon10/10:c.*593_*614delACAGTCATCAGTTTATTGTTAA:		rs35624053	0.2426	0.272	0	0										0.1212	0.4621	0.4167	22	67	n/a	n/a
chr20	13798776	13798776	T	C	hom		QUAL=23962;DP=228;AF=1.00;MQM=60;TRIO=HOM,228,1.00,HOM,254,1.00,HOM,265,1.00	NDUFAF5	3'UTR	NDUFAF5:NM_024120.4:3'UTR:MODIFIER:exon11/11:c.*920T>C:,NDUFAF5:NM_001039375.2:3'UTR:MODIFIER:exon10/10:c.*920T>C:		rs2423752	0.8872	0.856	0	0										0.8939	0.1061	0	134	16	n/a	n/a
chr20	25281027	25281027	C	T	het		QUAL=5567;DP=137;AF=0.50;MQM=60;TRIO=HET,137,0.50,WT,177,0.00,HET,243,0.47	ABHD12	3'UTR,intron	ABHD12:NM_001042472.2:3'UTR:MODIFIER:exon13/13:c.*454G>A:,ABHD12:NM_015600.4:intron:MODIFIER:exon12/12:c.1157+1828G>A:		rs41309917	0.0194	0	0	0						613599 [ABHD12 (provisional) Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract];				0	0.0682	0.9318	0	11	n/a	n/a
chr20	25288632	25288632	G	A	hom		QUAL=10749;DP=157;AF=1.00;MQM=59;TRIO=HOM,157,1.00,HOM,123,1.00,HET,154,0.42	ABHD12	synonymous	ABHD12:NM_015600.4:synonymous:LOW:exon9/13:c.837C>T:p.Arg279Arg,ABHD12:NM_001042472.2:synonymous:LOW:exon9/13:c.837C>T:p.Arg279Arg		rs6107027	0.3361	0.469	0.5198	0.2685						613599 [ABHD12 (provisional) Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract];	RCV000116215.2 [likely benign]; 		COSM4134340	0.3258	0.4545	0.2197	415	699	n/a	n/a
chr20	31022959	31022959	T	C	hom		QUAL=35626;DP=378;AF=1.00;MQM=60;TRIO=HOM,378,1.00,HOM,299,1.00,HOM,400,1.00	ASXL1	missense	ASXL1:NM_015338.5:missense:MODERATE:exon12/12:c.2444T>C:p.Leu815Pro		rs6058694	1	1	1	0.9998	-0.1360	P	T	B,B	B,B	612990 [ASXL1 (provisional) Bohring-Opitz syndrome|Myelodysplastic syndrome,somatic];				1	0	0	458	0	n/a	n/a
chr20	31024274	31024274	T	C	hom		QUAL=14745;DP=310;AF=1.00;MQM=59;TRIO=HOM,310,1.00,HOM,83,0.99,HET,122,0.51	ASXL1	synonymous	ASXL1:NM_015338.5:synonymous:LOW:exon12/12:c.3759T>C:p.Ser1253Ser		rs4911231	0.4058	0.418	0.3856	0.1922						612990 [ASXL1 (provisional) Bohring-Opitz syndrome|Myelodysplastic syndrome,somatic];			COSM4134435	0.1136	0.553	0.3333	61	217	n/a	n/a
chr20	31025163	31025163	A	G	hom		QUAL=37984;DP=391;AF=1.00;MQM=60;TRIO=HOM,391,1.00,HOM,494,0.99,HET,528,0.54	ASXL1	3'UTR	ASXL1:NM_015338.5:3'UTR:MODIFIER:exon12/12:c.*22A>G:		rs2295764	0.4	0.406	0.3652	0.1879										0.1061	0.5227	0.3712	22	80	n/a	n/a
chr20	31025231	31025231	T	C	hom		QUAL=31620;DP=348;AF=0.99;MQM=60;TRIO=HOM,348,0.99,HOM,388,0.99,HET,436,0.56	ASXL1	3'UTR	ASXL1:NM_015338.5:3'UTR:MODIFIER:exon12/12:c.*90T>C:		rs2295763	0.3998	0	0	0										0.1061	0.5227	0.3712	18	75	n/a	n/a
chr20	31025535	31025535	A	G	hom		QUAL=23339;DP=359;AF=1.00;MQM=60;TRIO=HOM,359,1.00,HOM,230,1.00,HET,263,0.54	ASXL1	3'UTR	ASXL1:NM_015338.5:3'UTR:MODIFIER:exon12/12:c.*394A>G:		rs2295762	0.4289	0	0	0										0.1061	0.5227	0.3712	18	75	n/a	n/a
chr20	31386347	31386347	T	C	hom		QUAL=6830;DP=144;AF=1.00;MQM=59;TRIO=HOM,144,1.00,HOM,41,1.00,HET,72,0.46	DNMT3B	synonymous	DNMT3B:NM_006892.3:synonymous:LOW:exon15/23:c.1572T>C:p.Cys524Cys,DNMT3B:NM_001207055.1:synonymous:LOW:exon13/19:c.1386T>C:p.Cys462Cys,DNMT3B:NM_001207056.1:synonymous:LOW:exon12/18:c.1284T>C:p.Cys428Cys,DNMT3B:NM_175848.1:synonymous:LOW:exon14/22:c.1512T>C:p.Cys504Cys,DNMT3B:NM_175849.1:synonymous:LOW:exon14/20:c.1512T>C:p.Cys504Cys,DNMT3B:NM_175850.2:synonymous:LOW:exon14/22:c.1548T>C:p.Cys516Cys		rs6058891	0.7558	0.579	0.4491	0.833						602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1];			COSM4134442	0.2348	0.4621	0.303	105	213	n/a	n/a
chr20	31386449	31386449	T	C	hom		QUAL=1154;DP=21;AF=1.00;MQM=60;TRIO=HOM,21,1.00,HOM,11,1.00,HET,20,0.45	DNMT3B	splice_region&synonymous	DNMT3B:NM_006892.3:splice_region&synonymous:LOW:exon15/23:c.1674T>C:p.Tyr558Tyr,DNMT3B:NM_001207055.1:splice_region&synonymous:LOW:exon13/19:c.1488T>C:p.Tyr496Tyr,DNMT3B:NM_001207056.1:splice_region&synonymous:LOW:exon12/18:c.1386T>C:p.Tyr462Tyr,DNMT3B:NM_175848.1:splice_region&synonymous:LOW:exon14/22:c.1614T>C:p.Tyr538Tyr,DNMT3B:NM_175849.1:splice_region&synonymous:LOW:exon14/20:c.1614T>C:p.Tyr538Tyr,DNMT3B:NM_175850.2:splice_region&synonymous:LOW:exon14/22:c.1650T>C:p.Tyr550Tyr		rs2424922	0.7558	0.577	0.4477	0.8316						602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1];			COSM4134444	0.2348	0.4545	0.3106	103	211	n/a	n/a
chr20	31387954	31387954	C	G	hom		QUAL=19342;DP=171;AF=0.99;MQM=59;TRIO=HOM,171,0.99,HOM,269,1.00,HET,348,0.51	DNMT3B	splice_region&intron	DNMT3B:NM_006892.3:splice_region&intron:LOW:exon16/22:c.1760-5C>G:,DNMT3B:NM_001207055.1:splice_region&intron:LOW:exon14/18:c.1574-5C>G:,DNMT3B:NM_001207056.1:splice_region&intron:LOW:exon13/17:c.1472-5C>G:,DNMT3B:NM_175848.1:splice_region&intron:LOW:exon15/21:c.1700-5C>G:,DNMT3B:NM_175849.1:splice_region&intron:LOW:exon15/19:c.1700-5C>G:,DNMT3B:NM_175850.2:splice_region&intron:LOW:exon15/21:c.1736-5C>G:		rs1997797	0.7141	0.566	0.4484	0.7011						602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1];				0.2348	0.4621	0.303	102	215	n/a	n/a
chr20	31388636	31388636	T	C	hom		QUAL=19641;DP=194;AF=1.00;MQM=60;TRIO=HOM,194,1.00,HOM,249,1.00,HET,347,0.50	DNMT3B	splice_region&intron	DNMT3B:NM_006892.3:splice_region&intron:LOW:exon17/22:c.1906-5T>C:,DNMT3B:NM_001207055.1:splice_region&intron:LOW:exon15/18:c.1720-5T>C:,DNMT3B:NM_001207056.1:splice_region&intron:LOW:exon14/17:c.1618-5T>C:,DNMT3B:NM_175848.1:splice_region&intron:LOW:exon16/21:c.1846-5T>C:,DNMT3B:NM_175849.1:splice_region&intron:LOW:exon16/19:c.1846-5T>C:,DNMT3B:NM_175850.2:splice_region&intron:LOW:exon16/21:c.1882-5T>C:		rs2424928	0.7426	0.574	0.449	0.783						602900 [DNMT3B (confirmed) Immunodeficiency-centromeric instability-facial anomalies syndrome 1];				0.2348	0.4621	0.303	105	213	n/a	n/a
chr20	31396536	31396536	A	G	hom		QUAL=26191;DP=511;AF=1.00;MQM=59;TRIO=HOM,511,1.00,HOM,199,1.00,HET,240,0.47	DNMT3B	3'UTR	DNMT3B:NM_006892.3:3'UTR:MODIFIER:exon23/23:c.*827A>G:,DNMT3B:NM_001207055.1:3'UTR:MODIFIER:exon19/19:c.*827A>G:,DNMT3B:NM_001207056.1:3'UTR:MODIFIER:exon18/18:c.*827A>G:,DNMT3B:NM_175848.1:3'UTR:MODIFIER:exon22/22:c.*827A>G:,DNMT3B:NM_175849.1:3'UTR:MODIFIER:exon20/20:c.*827A>G:,DNMT3B:NM_175850.2:3'UTR:MODIFIER:exon22/22:c.*827A>G:		rs2424932	0.8047	0	0	0										0.4167	0.3864	0.197	58	63	n/a	n/a
chr20	31397020	31397020	T	-	hom		QUAL=9016;DP=189;AF=0.99;MQM=53;TRIO=HOM,189,0.99,HOM,73,0.93,HET,83,0.45	DNMT3B	3'UTR	DNMT3B:NM_006892.3:3'UTR:MODIFIER:exon23/23:c.*1318delT:,DNMT3B:NM_001207055.1:3'UTR:MODIFIER:exon19/19:c.*1318delT:,DNMT3B:NM_001207056.1:3'UTR:MODIFIER:exon18/18:c.*1318delT:,DNMT3B:NM_175848.1:3'UTR:MODIFIER:exon22/22:c.*1318delT:,DNMT3B:NM_175849.1:3'UTR:MODIFIER:exon20/20:c.*1318delT:,DNMT3B:NM_175850.2:3'UTR:MODIFIER:exon22/22:c.*1318delT:		rs398088406	0.7093	0	0	0										0.2197	0.4773	0.303	32	74	n/a	n/a
chr20	43034693	43034693	C	T	het		QUAL=2304;DP=83;AF=0.45;MQM=60;TRIO=HET,83,0.45,WT,88,0.00,HET,102,0.46	HNF4A	splice_region&intron	HNF4A:NM_000457.4:splice_region&intron:LOW:exon1/9:c.116-5C>T:,HNF4A:NM_001030004.2:splice_region&intron:LOW:exon1/7:c.50-5C>T:,HNF4A:NM_001287184.1:splice_region&intron:LOW:exon2/8:c.41-5C>T:,HNF4A:NM_001030003.2:splice_region&intron:LOW:exon1/9:c.50-5C>T:,HNF4A:NM_001287182.1:splice_region&intron:LOW:exon2/10:c.41-5C>T:,HNF4A:NM_001287183.1:splice_region&intron:LOW:exon2/10:c.41-5C>T:,HNF4A:NM_175914.4:splice_region&intron:LOW:exon1/9:c.50-5C>T:,HNF4A:NM_178850.2:splice_region&intron:LOW:exon1/7:c.116-5C>T:,HNF4A:NM_001258355.1:splice_region&intron:LOW:exon2/10:c.95-5C>T:,HNF4A:NM_178849.2:splice_region&intron:LOW:exon1/9:c.116-5C>T:		rs745975	0.1687	0.2	0.2348	0.1039						600281 [HNF4A (confirmed) MODY,type I|Diabetes mellitus,noninsulin-dependent];	RCV000117237.2 [likely benign]; 	CS004500 [CLASS=DP MUT=ALT PHEN="Diabetes, type 2, association with" GENE=HNF4A]; 		0.0455	0.3182	0.6364	25	129	n/a	n/a
chr20	43034783	43034783	C	T	het		QUAL=5690;DP=186;AF=0.49;MQM=60;TRIO=HET,186,0.49,WT,170,0.00,HET,202,0.48	HNF4A	synonymous	HNF4A:NM_000457.4:synonymous:LOW:exon2/10:c.201C>T:p.Ala67Ala,HNF4A:NM_001030004.2:synonymous:LOW:exon2/8:c.135C>T:p.Ala45Ala,HNF4A:NM_001287184.1:synonymous:LOW:exon3/9:c.126C>T:p.Ala42Ala,HNF4A:NM_001030003.2:synonymous:LOW:exon2/10:c.135C>T:p.Ala45Ala,HNF4A:NM_001287182.1:synonymous:LOW:exon3/11:c.126C>T:p.Ala42Ala,HNF4A:NM_001287183.1:synonymous:LOW:exon3/11:c.126C>T:p.Ala42Ala,HNF4A:NM_175914.4:synonymous:LOW:exon2/10:c.135C>T:p.Ala45Ala,HNF4A:NM_178850.2:synonymous:LOW:exon2/8:c.201C>T:p.Ala67Ala,HNF4A:NM_001258355.1:synonymous:LOW:exon3/11:c.180C>T:p.Ala60Ala,HNF4A:NM_178849.2:synonymous:LOW:exon2/10:c.201C>T:p.Ala67Ala		rs736823	0.0146	0.033	0.0583	0.0134						600281 [HNF4A (confirmed) MODY,type I|Diabetes mellitus,noninsulin-dependent];	RCV000117236.1 [benign]; RCV000125377.1 [benign]; 			0	0.0455	0.9545	3	27	n/a	n/a
chr20	43059211	43059211	A	C	het		QUAL=26805;DP=422;AF=0.50;MQM=59;TRIO=HET,422,0.50,HOM,357,1.00,HET,485,0.52	HNF4A	3'UTR	HNF4A:NM_000457.4:3'UTR:MODIFIER:exon10/10:c.*906A>C:,HNF4A:NM_001030003.2:3'UTR:MODIFIER:exon10/10:c.*906A>C:,HNF4A:NM_001287182.1:3'UTR:MODIFIER:exon11/11:c.*906A>C:,HNF4A:NM_001287183.1:3'UTR:MODIFIER:exon11/11:c.*906A>C:,HNF4A:NM_175914.4:3'UTR:MODIFIER:exon10/10:c.*906A>C:,HNF4A:NM_001258355.1:3'UTR:MODIFIER:exon11/11:c.*906A>C:,HNF4A:NM_178849.2:3'UTR:MODIFIER:exon10/10:c.*906A>C:		rs3212210	0.5713	0	0	0										0.4848	0.4318	0.0833	74	61	n/a	n/a
chr20	43059238	43059256	GAGGAAGAATGGTGTGGGA	-	het		QUAL=7087;DP=163;AF=0.27;MQM=60;TRIO=HET,163,0.27,HOM,220,0.99,WT,389,0.00	HNF4A	3'UTR	HNF4A:NM_000457.4:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_001030003.2:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_001287182.1:3'UTR:MODIFIER:exon11/11:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_001287183.1:3'UTR:MODIFIER:exon11/11:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_175914.4:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_001258355.1:3'UTR:MODIFIER:exon11/11:c.*937_*955delAAGAATGGTGTGGGAGAGG:,HNF4A:NM_178849.2:3'UTR:MODIFIER:exon10/10:c.*937_*955delAAGAATGGTGTGGGAGAGG:		rs72137187	0.1881	0	0	0										0.0379	0.2955	0.6667	5	47	n/a	n/a
chr20	43059596	43059603	TCCTCCCT	-	het		QUAL=5044;DP=132;AF=0.36;MQM=60;TRIO=HET,132,0.36,WT,217,0.00,HET,284,0.46	HNF4A	3'UTR	HNF4A:NM_000457.4:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_001030003.2:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_001287182.1:3'UTR:MODIFIER:exon11/11:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_001287183.1:3'UTR:MODIFIER:exon11/11:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_175914.4:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_001258355.1:3'UTR:MODIFIER:exon11/11:c.*1299_*1306delTCCTCCCT:,HNF4A:NM_178849.2:3'UTR:MODIFIER:exon10/10:c.*1299_*1306delTCCTCCCT:	MIRb	rs397840964	0.0517	0	0	0										0	0.1667	0.8333	0	25	n/a	n/a
chr20	43264927	43264927	C	T	hom		QUAL=15996;DP=238;AF=1.00;MQM=60;TRIO=HOM,238,1.00,HOM,125,1.00,HOM,149,1.00	ADA	splice_region&synonymous	ADA:NM_000022.2:splice_region&synonymous:LOW:exon2/12:c.36G>A:p.Val12Val		rs394105	0.9822	0.995	0.9999	0.9548						608958 [ADA (confirmed) Severe combined immunodeficiency due to ADA deficiency|Adenosine deaminase deficiency,partial];	RCV000029300.1 [benign]; 			1	0	0	454	0	n/a	n/a
chr20	44519643	44519643	G	A	het		QUAL=4430;DP=48;AF=0.50;MQM=60;TRIO=HET,48,0.50,HET,69,0.41,HOM,96,1.00	NEURL2,CTSA	5'UTR	NEURL2:NM_080749.3:5'UTR:MODIFIER:exon1/2:c.-13C>T:,CTSA:NM_000308.2:5'UTR:MODIFIER:exon1/15:c.-322G>A:,NEURL2:NM_001278535.1:5'UTR:MODIFIER:exon1/2:c.-13C>T:,CTSA:NM_001127695.1:5'UTR:MODIFIER:exon1/15:c.-422G>A:,CTSA:NM_001167594.1:5'UTR:MODIFIER:exon1/14:c.-322G>A:		rs2868362	0.3842	0.404	0.4525	0.1743										0.3333	0.4697	0.197	54	74	n/a	n/a
chr20	44520238	44520240	CTG	-	het		QUAL=2954;DP=17;AF=0.53;MQM=60;TRIO=HET,17,0.53,HET,65,0.55,HOM,61,0.98	CTSA	disruptive_inframe_deletion	CTSA:NM_000308.2:disruptive_inframe_deletion:MODERATE:exon2/15:c.108_110delGCT:p.Leu37del,CTSA:NM_001127695.1:disruptive_inframe_deletion:MODERATE:exon2/15:c.54_56delGCT:p.Leu19del,CTSA:NM_001167594.1:disruptive_inframe_deletion:MODERATE:exon2/14:c.108_110delGCT:p.Leu37del	(CTG)n	rs397839006	0.6494	0	0	0						613111 [CTSA (confirmed) Galactosialidosis];			COSM443915	0.4091	0.4697	0.1212	187	194	n/a	n/a
chr20	44523547	44523547	G	A	het		QUAL=26133;DP=205;AF=0.47;MQM=60;TRIO=HET,205,0.47,HET,443,0.49,HOM,503,1.00	CTSA	splice_region&intron	CTSA:NM_000308.2:splice_region&intron:LOW:exon10/14:c.1002+7G>A:,CTSA:NM_001127695.1:splice_region&intron:LOW:exon10/14:c.948+7G>A:,CTSA:NM_001167594.1:splice_region&intron:LOW:exon9/13:c.951+7G>A:		rs2075961	0.6783	0.66	0.6183	0.6675						613111 [CTSA (confirmed) Galactosialidosis];				0.4091	0.4773	0.1136	194	199	n/a	n/a
chr20	44523782	44523782	C	T	het		QUAL=14943;DP=86;AF=0.47;MQM=60;TRIO=HET,86,0.47,HET,265,0.50,HOM,317,1.00	CTSA	splice_region&intron	CTSA:NM_000308.2:splice_region&intron:LOW:exon11/14:c.1142+10C>T:,CTSA:NM_001127695.1:splice_region&intron:LOW:exon11/14:c.1088+10C>T:,CTSA:NM_001167594.1:splice_region&intron:LOW:exon10/13:c.1091+10C>T:		rs4608591	0.6799	0.66	0.618	0.6729						613111 [CTSA (confirmed) Galactosialidosis];				0.4091	0.4773	0.1136	194	198	n/a	n/a
chr20	44746982	44746982	T	C	hom		QUAL=3909;DP=60;AF=1.00;MQM=60;TRIO=HOM,60,1.00,HOM,27,1.00,HOM,38,1.00	CD40	5'UTR	CD40:NM_001250.4:5'UTR:MODIFIER:exon1/9:c.-1T>C:,CD40:NM_152854.2:5'UTR:MODIFIER:exon1/8:c.-1T>C:		rs1883832	0.7712	0.752	0.7343	0.9371								CR052074 [CLASS=DFP MUT=REF PHEN="Graves' disease, association with" GENE=CD40]; 		0.5227	0.3788	0.0985	243	176	n/a	n/a
chr20	47626847	47626847	T	C	het		QUAL=13025;DP=298;AF=0.48;MQM=60;TRIO=HET,298,0.48,HET,223,0.49,HET,328,0.48	ARFGEF2	synonymous	ARFGEF2:NM_006420.2:synonymous:LOW:exon27/39:c.3663T>C:p.Gly1221Gly		rs2295580	0.3542	0.319	0.3453	0.5182						605371 [ARFGEF2 (confirmed) Periventricular heterotopia with microcephaly];	RCV000116402.2 [likely benign]; RCV000123687.1 [benign]; 		COSM1412311	0.0758	0.4545	0.4697	41	200	n/a	n/a
chr20	47651492	47651492	G	A	het		QUAL=15888;DP=357;AF=0.50;MQM=60;TRIO=HET,357,0.50,HET,284,0.51,HET,337,0.49	ARFGEF2	3'UTR	ARFGEF2:NM_006420.2:3'UTR:MODIFIER:exon39/39:c.*1756G>A:		rs6019602	0.3462	0	0	0										0.0682	0.447	0.4848	9	65	n/a	n/a
chr20	47652254	47652254	A	G	het		QUAL=8055;DP=171;AF=0.43;MQM=60;TRIO=HET,171,0.43,HET,128,0.59,HET,197,0.49	ARFGEF2	3'UTR	ARFGEF2:NM_006420.2:3'UTR:MODIFIER:exon39/39:c.*2518A>G:		rs707533	0.3462	0	0	0										0.0682	0.447	0.4848	9	65	n/a	n/a
chr20	47652338	47652338	A	G	het		QUAL=6860;DP=231;AF=0.41;MQM=60;TRIO=HET,231,0.41,HET,87,0.56,HET,126,0.49	ARFGEF2	3'UTR	ARFGEF2:NM_006420.2:3'UTR:MODIFIER:exon39/39:c.*2602A>G:		rs707534	0.3462	0	0	0										0.0682	0.447	0.4848	9	65	n/a	n/a
chr20	47652530	47652530	-	A	het		QUAL=1420;DP=95;AF=0.35;MQM=59;TRIO=HET,95,0.35,HET,40,0.20,HET,46,0.28	ARFGEF2	3'UTR	ARFGEF2:NM_006420.2:3'UTR:MODIFIER:exon39/39:c.*2806dupA:		rs397957165	0.3411	0	0	0										0.0303	0.3106	0.6591	4	45	n/a	n/a
chr20	49551780	49551780	-	A	het		QUAL=1218;DP=123;AF=0.21;MQM=60;TRIO=HET,123,0.21,WT,45,0.02,HET,60,0.42	DPM1	splice_region&intron	DPM1:NM_003859.1:splice_region&intron:LOW:exon8/8:c.679-8_679-7insT:		rs560680352	0	0	0	0						603503 [DPM1 (provisional) Congenital disorder of glycosylation,type Ie];				0.0303	0.2955	0.6742	27	103	n/a	n/a
chr20	57020760	57020777	GTGTGTGTGTGTGTGTGT	-	het		QUAL=2432;DP=124;AF=0.29;MQM=60;TRIO=HET,124,0.29,HET,113,0.51,WT,164,0.00	VAPB	3'UTR	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*1469_*1486delGTGTGTGTGTGTGTGTGT:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*1539_*1556delGTGTGTGTGTGTGTGTGT:	(TG)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chr20	57022713	57022720	TGTGTGCA	-	hom		QUAL=10280;DP=91;AF=0.97;MQM=60;TRIO=HOM,91,0.97,HOM,130,0.99,HOM,133,0.97	VAPB	3'UTR	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*3444_*3451delCATGTGTG:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*3514_*3521delCATGTGTG:	(TG)n	rs201983028	0.9091	0.872	0	0										0.7727	0.1894	0.0379	223	52	n/a	n/a
chr20	57023343	57023343	C	T	het		QUAL=9800;DP=415;AF=0.47;MQM=60;TRIO=HET,415,0.47,HET,262,0.43,WT,344,0.00	VAPB	3'UTR	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*4052C>T:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*4122C>T:		rs76295834	0.021	0.021	0	0										0	0.1364	0.8636	0	38	n/a	n/a
chr20	57023737	57023737	G	A	het		QUAL=6767;DP=301;AF=0.50;MQM=60;TRIO=HET,301,0.50,HET,115,0.52,WT,162,0.01	VAPB	3'UTR	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*4446G>A:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*4516G>A:		rs79623348	0.027	0.023	0	0										0	0.1364	0.8636	0	38	n/a	n/a
chr20	57024159	57024159	C	T	het		QUAL=3948;DP=167;AF=0.58;MQM=59;TRIO=HET,167,0.58,HET,75,0.44,WT,118,0.00	VAPB	3'UTR	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*4868C>T:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*4938C>T:		rs74748993	0.0212	0.022	0	0										0	0.1364	0.8636	0	38	n/a	n/a
chr20	57024541	57024541	T	C	het		QUAL=6153;DP=313;AF=0.42;MQM=60;TRIO=HET,313,0.42,HET,149,0.42,WT,171,0.00	VAPB	3'UTR	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*5250T>C:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*5320T>C:		rs6015274	0.4832	0.404	0	0										0.2197	0.5455	0.2348	63	144	n/a	n/a
chr20	57024589	57024589	C	T	het		QUAL=7652;DP=365;AF=0.45;MQM=60;TRIO=HET,365,0.45,HET,170,0.42,WT,218,0.00	VAPB	3'UTR	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*5298C>T:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*5368C>T:		rs6015275	0.2091	0.221	0	0										0.0303	0.4394	0.5303	15	109	n/a	n/a
chr20	57025407	57025410	TCTG	-	het		QUAL=9138;DP=332;AF=0.44;MQM=60;TRIO=HET,332,0.44,HET,301,0.50,WT,414,0.00	VAPB	3'UTR	VAPB:NM_004738.4:3'UTR:MODIFIER:exon6/6:c.*6121_*6124delCTGT:,VAPB:NM_001195677.1:3'UTR:MODIFIER:exon3/3:c.*6191_*6194delCTGT:		rs143261907	0.0214	0.02	0	0										0	0.1364	0.8636	0	38	n/a	n/a
chr20	57415110	57415110	A	G	hom		QUAL=15591;DP=119;AF=0.99;MQM=59;TRIO=HOM,119,0.99,HOM,236,1.00,HET,284,0.52	GNAS	5'UTR	GNAS:NM_016592.2:5'UTR:MODIFIER:exon1/13:c.-52A>G:		rs1800900	0.5976	0	0.6288	0.4326										0.4394	0.3864	0.1742	68	55	n/a	n/a
chr20	57478807	57478807	C	T	het		QUAL=34634;DP=589;AF=0.48;MQM=60;TRIO=HET,589,0.48,WT,570,0.00,HOM,792,1.00	GNAS	synonymous,3'UTR	GNAS:NM_080425.2:synonymous:LOW:exon5/13:c.2322C>T:p.Ile774Ile,GNAS:NM_000516.4:synonymous:LOW:exon5/13:c.393C>T:p.Ile131Ile,GNAS:NM_001077488.2:synonymous:LOW:exon5/13:c.396C>T:p.Ile132Ile,GNAS:NM_001077489.2:synonymous:LOW:exon4/12:c.348C>T:p.Ile116Ile,GNAS:NM_080426.2:synonymous:LOW:exon4/12:c.351C>T:p.Ile117Ile,GNAS:NM_016592.2:3'UTR:MODIFIER:exon5/13:c.*299C>T:,GNAS:NM_001077490.1:3'UTR:MODIFIER:exon5/13:c.*254C>T:		rs7121	0.6444	0.547	0.4928	0.7485	-0.3130	P				139320 [GNAS (confirmed) Pseudohypoparathyroidism Ia|McCune-Albright syndrome|Pseudohypoparathyroidism Ic|Osseous heteroplasia,progressive|Pseudohypoparathyroidism Ib|Prolonged bleeding time,brachydactyly and mental retardation|Acromegaly|Pseudopseudohypoparathyroidism|Prolonged bleeding time,brachydactyly,and mental retardation|ACTH-independent macronodular adrenal hyperplasia];		CM023931 [CLASS=DP MUT=REF PHEN="Essential hypertension, association with" GENE=GNAS]; 	COSM3758662	0.3182	0.4545	0.2273	148	224	n/a	n/a
chr20	57899654	57899654	C	-	het		QUAL=3481;DP=130;AF=0.57;MQM=60;TRIO=HET,130,0.57,HET,84,0.54,HET,102,0.08	EDN3	3'UTR,intron	EDN3:NM_207032.1:3'UTR:MODIFIER:exon5/5:c.*241delC:,EDN3:NM_207033.1:3'UTR:MODIFIER:exon4/4:c.*149delC:,EDN3:NM_207034.1:3'UTR:MODIFIER:exon5/5:c.*149delC:,EDN3:NM_000114.2:intron:MODIFIER:exon5/5:c.*16-88delC:		rs397866060	0	0	0	0										0.0682	0.3561	0.5758	11	51	n/a	n/a
chr20	61974862	61974862	C	T	het		QUAL=10244;DP=141;AF=0.50;MQM=60;TRIO=HET,141,0.50,WT,387,0.00,HET,512,0.51	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3228G>A:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3228G>A:		rs45601435	0.0262	0.044	0	0										0.0076	0.0985	0.8939	3	31	n/a	n/a
chr20	61974929	61974929	-	AT	het		QUAL=7800;DP=181;AF=0.41;MQM=60;TRIO=HET,181,0.41,WT,301,0.00,HET,393,0.47	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3160_*3161insAT:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3160_*3161insAT:	MER74A	rs79237427	0.1134	0.139	0	0										0.0152	0.2121	0.7727	6	56	n/a	n/a
chr20	61974986	61974986	C	A	het		QUAL=5306;DP=89;AF=0.46;MQM=59;TRIO=HET,89,0.46,WT,195,0.01,HET,268,0.51	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3104G>T:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3104G>T:	MER74A	rs45543134	0.0789	0.106	0	0										0.0152	0.2121	0.7727	6	54	n/a	n/a
chr20	61974991	61974991	-	G	het		QUAL=4696;DP=94;AF=0.40;MQM=59;TRIO=HET,94,0.40,WT,194,0.00,HET,251,0.48	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3098dupC:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3098dupC:	MER74A	rs148816386	0.0292	0.043	0	0										0	0.1061	0.8939	2	30	n/a	n/a
chr20	61975084	61975084	A	G	het		QUAL=2967;DP=78;AF=0.53;MQM=59;TRIO=HET,78,0.53,WT,84,0.00,HET,120,0.54	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*3006T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*3006T>C:	MER74A	rs45620536	0.0835	0.105	0	0										0.0152	0.2121	0.7727	6	55	n/a	n/a
chr20	61975091	61975091	A	G	het		QUAL=2534;DP=73;AF=0.45;MQM=59;TRIO=HET,73,0.45,WT,79,0.00,HET,108,0.52	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2999T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2999T>C:	MER74A	rs45600338	0.0771	0.105	0	0										0.0152	0.2121	0.7727	6	54	n/a	n/a
chr20	61975378	61975378	A	G	het		QUAL=6269;DP=193;AF=0.47;MQM=60;TRIO=HET,193,0.47,WT,185,0.00,HET,250,0.48	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2712T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2712T>C:	L1ME3	rs6090378	0.0677	0.078	0	0										0.0076	0.0985	0.8939	3	32	n/a	n/a
chr20	61975624	61975624	G	C	het		QUAL=9040;DP=254;AF=0.46;MQM=60;TRIO=HET,254,0.46,WT,321,0.00,HET,331,0.50	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2466C>G:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2466C>G:	L1ME3	rs45494793	0.0296	0.042	0	0										0.0076	0.0985	0.8939	3	31	n/a	n/a
chr20	61975829	61975829	-	T	het		QUAL=2987;DP=120;AF=0.43;MQM=59;TRIO=HET,120,0.43,WT,134,0.04,HET,141,0.39	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2260dupA:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2260dupA:		rs568329035	0.2746	0	0	0										0.0227	0.3106	0.6667	11	81	n/a	n/a
chr20	61975846	61975846	-	A	het		QUAL=2296;DP=126;AF=0.38;MQM=59;TRIO=HET,126,0.38,WT,116,0.03,HET,115,0.33	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2243dupT:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2243dupT:		rs551959449	0.2885	0	0	0										0.053	0.3333	0.6136	18	88	n/a	n/a
chr20	61976028	61976028	G	A	het		QUAL=4949;DP=112;AF=0.48;MQM=59;TRIO=HET,112,0.48,WT,167,0.00,HET,209,0.53	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2062C>T:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2062C>T:		rs45536037	0.0296	0.044	0	0										0.0076	0.0985	0.8939	3	31	n/a	n/a
chr20	61976032	61976032	A	G	het		QUAL=4949;DP=112;AF=0.48;MQM=59;TRIO=HET,112,0.48,WT,167,0.00,HET,209,0.53	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*2058T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*2058T>C:		rs45523232	0.0296	0.044	0	0										0.0076	0.0985	0.8939	3	31	n/a	n/a
chr20	61976530	61976530	C	T	het		QUAL=2918;DP=69;AF=0.38;MQM=60;TRIO=HET,69,0.38,WT,78,0.00,HET,128,0.52	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*1560G>A:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*1560G>A:		rs45476096	0.0262	0.042	0	0										0.0076	0.0909	0.9015	3	30	n/a	n/a
chr20	61976920	61976920	T	C	het		QUAL=1516;DP=70;AF=0.49;MQM=60;TRIO=HET,70,0.49,WT,53,0.00,HET,48,0.42	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*1170A>G:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*1170A>G:		rs41283006	0.0487	0.07	0	0										0.0076	0.0985	0.8939	3	29	n/a	n/a
chr20	61977015	61977015	C	T	het		QUAL=372;DP=30;AF=0.40;MQM=60;TRIO=HET,30,0.40,WT,16,0.00,HET,14,0.29	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*1075G>A:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*1075G>A:		rs41283008	0.0302	0.045	0	0										0	0.1061	0.8939	2	32	n/a	n/a
chr20	61977049	61977049	G	C	het		QUAL=465;DP=42;AF=0.38;MQM=58;TRIO=HET,42,0.38,WT,15,0.00,HET,13,0.23	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*1041C>G:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*1041C>G:		rs41283010	0.0302	0.045	0	0										0.0076	0.0985	0.8939	3	31	n/a	n/a
chr20	61977335	61977335	A	G	het		QUAL=711;DP=37;AF=0.43;MQM=60;TRIO=HET,37,0.43,WT,22,0.00,HET,29,0.34	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*755T>C:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*755T>C:		rs45624232	0.0751	0.114	0	0										0.0152	0.2121	0.7727	6	56	n/a	n/a
chr20	61977373	61977373	G	A	het		QUAL=715;DP=35;AF=0.46;MQM=60;TRIO=HET,35,0.46,WT,31,0.00,HET,34,0.32	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*717C>T:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*717C>T:		rs45556643	0.0304	0.048	0	0										0.0076	0.0985	0.8939	3	31	n/a	n/a
chr20	61977556	61977556	G	A	het		QUAL=11636;DP=149;AF=0.53;MQM=60;TRIO=HET,149,0.53,HET,278,0.48,HET,305,0.55	CHRNA4	3'UTR	CHRNA4:NM_000744.6:3'UTR:MODIFIER:exon6/6:c.*534C>T:,CHRNA4:NM_001256573.1:3'UTR:MODIFIER:exon6/6:c.*534C>T:		rs2236196	0.6142	0.591	0	0								CR077876 [CLASS=DFP MUT=REF PHEN="Nicotine dependence, association with" GENE=CHRNA4]; 		0.4773	0.447	0.0758	145	123	n/a	n/a
chr20	61981104	61981104	C	T	het		QUAL=4963;DP=43;AF=0.42;MQM=60;TRIO=HET,43,0.42,HET,150,0.43,HET,213,0.49	CHRNA4	synonymous	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.1659G>A:p.Ala553Ala,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.1131G>A:p.Ala377Ala		rs1044397	0.3518	0.471	0.5418	0.1511						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000079314.4 [other]; 		COSM3758737	0.2803	0.5076	0.2121	101	150	n/a	n/a
chr20	61981134	61981134	G	A	het		QUAL=7471;DP=92;AF=0.45;MQM=60;TRIO=HET,92,0.45,HET,182,0.50,HET,252,0.48	CHRNA4	synonymous	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.1629C>T:p.Ser543Ser,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.1101C>T:p.Ser367Ser		rs1044396	0.3235	0.459	0.5409	0.1493						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000079313.4 [other]; 		COSM3758738	0.2803	0.4924	0.2273	99	148	n/a	n/a
chr20	61981536	61981536	A	G	hom		QUAL=15379;DP=102;AF=1.00;MQM=59;TRIO=HOM,102,1.00,HET,209,0.56,HOM,284,1.00	CHRNA4	synonymous	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.1227T>C:p.Cys409Cys,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.699T>C:p.Cys233Cys		rs2229960	0.8708	0.926	0.9487	0.6777						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000079311.4 [other]; 		COSM4134782	0.8939	0.0909	0.0152	401	42	n/a	n/a
chr20	61981554	61981554	C	A	hom		QUAL=14378;DP=83;AF=0.99;MQM=60;TRIO=HOM,83,0.99,HET,226,0.53,HOM,286,1.00	CHRNA4	synonymous	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.1209G>T:p.Pro403Pro,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.681G>T:p.Pro227Pro		rs2229959	0.7338	0.821	0.8806	0.4989						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000079310.4 [other]; 		COSM4134783	0.7197	0.2348	0.0455	326	112	n/a	n/a
chr20	61982085	61982085	A	G	hom		QUAL=71434;DP=400;AF=1.00;MQM=59;TRIO=HOM,400,1.00,HET,1094,0.51,HOM,1308,1.00	CHRNA4	synonymous	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.678T>C:p.Cys226Cys,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.150T>C:p.Cys50Cys		rs1044394	0.8636	0.92	0.9342	0.6659						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000116723.2 [likely benign]; 			0.8788	0.1061	0.0152	403	49	n/a	n/a
chr20	61982124	61982124	A	G	hom		QUAL=64120;DP=447;AF=1.00;MQM=59;TRIO=HOM,447,1.00,HET,965,0.51,HOM,1148,1.00	CHRNA4	synonymous	CHRNA4:NM_000744.6:synonymous:LOW:exon5/6:c.639T>C:p.Asp213Asp,CHRNA4:NM_001256573.1:synonymous:LOW:exon5/6:c.111T>C:p.Asp37Asp		rs1044393	0.7572	0.835	0.8793	0.5477						118504 [CHRNA4 (confirmed) Epilepsy,nocturnal frontal lobe,1|Nicotine addiction,susceptibility to];	RCV000116722.2 [likely benign]; 			0.7197	0.2348	0.0455	327	117	n/a	n/a
chr20	62037879	62037879	A	C	het		QUAL=55;DP=11;AF=0.45;MQM=58;TRIO=HET,11,0.45,HET,19,0.11,HET,44,0.16	KCNQ2	3'UTR	KCNQ2:NM_172107.2:3'UTR:MODIFIER:exon17/17:c.*118T>G:,KCNQ2:NM_004518.4:3'UTR:MODIFIER:exon15/15:c.*118T>G:,KCNQ2:NM_172106.1:3'UTR:MODIFIER:exon16/16:c.*118T>G:,KCNQ2:NM_172108.3:3'UTR:MODIFIER:exon16/16:c.*118T>G:			0	0	0	0										0	0.1136	0.8864	0	15	n/a	n/a
chr20	62038277	62038277	T	G	het		QUAL=1382;DP=47;AF=0.53;MQM=60;TRIO=HET,47,0.53,HET,61,0.43,WT,104,0.00	KCNQ2	missense	KCNQ2:NM_172107.2:missense:MODERATE:exon17/17:c.2339A>C:p.Asn780Thr,KCNQ2:NM_004518.4:missense:MODERATE:exon15/15:c.2255A>C:p.Asn752Thr,KCNQ2:NM_172106.1:missense:MODERATE:exon16/16:c.2285A>C:p.Asn762Thr,KCNQ2:NM_172108.3:missense:MODERATE:exon16/16:c.2246A>C:p.Asn749Thr		rs1801475	0.5905	0.604	0.6439	0.5099	1.8720	P	T	B,B,B,B	B,B,B,B	602235 [KCNQ2 (confirmed) Seizures,benign neonatal,1|Myokymia|Epileptic encephalopathy,early infantile,7];	RCV000020987.1 [benign]; RCV000082686.3 [benign]; RCV000126472.1 [benign]; 		COSM3758741	0.4242	0.4545	0.1212	186	223	n/a	n/a
chr20	62565646	62565646	G	A	het		QUAL=3286;DP=123;AF=0.52;MQM=60;TRIO=HET,123,0.52,WT,68,0.00,HET,98,0.52	DNAJC5	3'UTR	DNAJC5:NM_025219.2:3'UTR:MODIFIER:exon5/5:c.*2725G>A:		rs11554628	0.031	0	0	0										0	0.1742	0.8258	0	25	n/a	n/a
chr21	34787312	34787312	A	G	het		QUAL=6304;DP=224;AF=0.54;MQM=60;TRIO=HET,224,0.54,HET,184,0.44,WT,311,0.00	IFNGR2	missense	IFNGR2:NM_005534.3:missense:MODERATE:exon2/7:c.191A>G:p.Gln64Arg		rs9808753	0.272	0.196	0.1376	0.2249	0.1630	P		B,B	B,B	147569 [IFNGR2 (confirmed) Mycobacterial infection,atypical,familial disseminated];		CM1111763 [CLASS=DP MUT=REF PHEN="Non-Hodgkin lymphoma, increased risk, association with" GENE=IFNGR2]; 	COSM3758854	0.0227	0.1439	0.8333	12	89	n/a	n/a
chr21	34809693	34809693	C	T	het		QUAL=6158;DP=98;AF=0.51;MQM=60;TRIO=HET,98,0.51,HOM,87,1.00,HET,102,0.59	IFNGR2	3'UTR	IFNGR2:NM_005534.3:3'UTR:MODIFIER:exon7/7:c.*424C>T:		rs1059293	0.6807	0	0	0										0.2273	0.4091	0.3636	33	65	n/a	n/a
chr21	38123320	38123320	-	A	het		QUAL=2862;DP=213;AF=0.32;MQM=60;TRIO=HET,213,0.32,WT,74,0.03,HET,94,0.35	HLCS	3'UTR	HLCS:NM_000411.6:3'UTR:MODIFIER:exon12/12:c.*3226dupT:,HLCS:NM_001242784.1:3'UTR:MODIFIER:exon12/12:c.*3226dupT:,HLCS:NM_001242785.1:3'UTR:MODIFIER:exon12/12:c.*3226dupT:		rs397947707	0	0	0	0										0.0076	0.1591	0.8333	1	22	n/a	n/a
chr21	38123404	38123404	-	AT	het		QUAL=4864;DP=272;AF=0.39;MQM=60;TRIO=HET,272,0.39,WT,77,0.00,HET,112,0.40	HLCS	3'UTR	HLCS:NM_000411.6:3'UTR:MODIFIER:exon12/12:c.*3141_*3142dupAT:,HLCS:NM_001242784.1:3'UTR:MODIFIER:exon12/12:c.*3141_*3142dupAT:,HLCS:NM_001242785.1:3'UTR:MODIFIER:exon12/12:c.*3141_*3142dupAT:		rs5843777	0.3524	0	0	0										0.2273	0.4621	0.3106	31	71	n/a	n/a
chr21	38123925	38123925	C	T	het		QUAL=14102;DP=361;AF=0.55;MQM=59;TRIO=HET,361,0.55,WT,355,0.00,HET,451,0.53	HLCS	3'UTR	HLCS:NM_000411.6:3'UTR:MODIFIER:exon12/12:c.*2622G>A:,HLCS:NM_001242784.1:3'UTR:MODIFIER:exon12/12:c.*2622G>A:,HLCS:NM_001242785.1:3'UTR:MODIFIER:exon12/12:c.*2622G>A:		rs14407	0.4465	0	0	0										0.2197	0.4545	0.3258	31	69	n/a	n/a
chr21	38308774	38308774	C	T	het		QUAL=10648;DP=306;AF=0.50;MQM=60;TRIO=HET,306,0.50,HET,378,0.51,WT,443,0.00	HLCS	missense	HLCS:NM_000411.6:missense:MODERATE:exon5/12:c.971G>A:p.Arg324His,HLCS:NM_001242784.1:missense:MODERATE:exon5/12:c.971G>A:p.Arg324His,HLCS:NM_001242785.1:missense:MODERATE:exon5/12:c.971G>A:p.Arg324His		rs61732501	0.007	0.0097	0.0121	0.0027	-2.1740	N	T	B,B	B,B	609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency];	RCV000125363.1 [benign]; 			0	0.0227	0.9773	0	11	n/a	n/a
chr21	38320006	38320006	C	G	het		QUAL=19137;DP=574;AF=0.47;MQM=60;TRIO=HET,574,0.47,HET,283,0.53,HET,334,0.53	HLCS	5'UTR,intron	HLCS:NM_001242784.1:5'UTR:MODIFIER:exon3/12:c.-485G>C:,HLCS:NM_000411.6:intron:MODIFIER:exon2/11:c.-257-1552G>C:,HLCS:NM_001242785.1:intron:MODIFIER:exon2/11:c.-257-1552G>C:		rs13047776	0.494	0	0	0						609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency];				0.3182	0.4621	0.2197	49	70	n/a	n/a
chr21	38320007	38320007	T	G	het		QUAL=19137;DP=574;AF=0.47;MQM=60;TRIO=HET,574,0.47,HET,283,0.53,HET,334,0.53	HLCS	5'UTR,intron	HLCS:NM_001242784.1:5'UTR:MODIFIER:exon3/12:c.-486A>C:,HLCS:NM_000411.6:intron:MODIFIER:exon2/11:c.-257-1553A>C:,HLCS:NM_001242785.1:intron:MODIFIER:exon2/11:c.-257-1553A>C:		rs13048613	0.4948	0	0	0						609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency];				0.3182	0.4621	0.2197	49	70	n/a	n/a
chr21	38320591	38320591	G	A	het		QUAL=132;DP=27;AF=0.30;MQM=58;TRIO=HET,27,0.30,HET,17,0.12,WT,10,0.00	HLCS	splice_region&intron,intron	HLCS:NM_001242784.1:splice_region&intron:LOW:exon2/11:c.-1066-4C>T:,HLCS:NM_000411.6:intron:MODIFIER:exon2/11:c.-257-2137C>T:,HLCS:NM_001242785.1:intron:MODIFIER:exon2/11:c.-257-2137C>T:	AluSg		0	0	0	0						609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency];				0	0.0076	0.9924	0	1	n/a	n/a
chr21	38353268	38353268	-	TCCG	het		QUAL=463;DP=7;AF=0.43;MQM=60;TRIO=HET,7,0.43,HET,35,0.46,WT,52,0.00	HLCS	intron	HLCS:NM_000411.6:intron:MODIFIER:exon1/11:c.-393+9189_-393+9190insCGGA:		rs71328533	0.3405	0	0	0										0.0985	0.4015	0.5	15	61	n/a	n/a
chr21	38782911	38782911	T	C	het		QUAL=8030;DP=268;AF=0.52;MQM=59;TRIO=HET,268,0.52,WT,222,0.00,HET,227,0.53	DYRK1A	5'UTR	DYRK1A:NM_101395.2:5'UTR:MODIFIER:exon2/13:c.-138T>C:	AluJr	rs9981736	0.5543	0	0	0										0.2273	0.5379	0.2348	34	80	n/a	n/a
chr21	38791581	38791581	A	C	het		QUAL=17353;DP=657;AF=0.49;MQM=60;TRIO=HET,657,0.49,WT,323,0.00,HET,410,0.54	DYRK1A	5'UTR,intron	DYRK1A:NM_130436.2:5'UTR:MODIFIER:exon1/11:c.-1096A>C:,DYRK1A:NM_101395.2:intron:MODIFIER:exon2/12:c.-76-1020A>C:		rs2835726	0.5	0	0	0										0.2273	0.5152	0.2576	32	78	n/a	n/a
chr21	38792131	38792131	T	C	het		QUAL=6051;DP=237;AF=0.48;MQM=60;TRIO=HET,237,0.48,WT,102,0.00,HET,136,0.56	DYRK1A	5'UTR,intron	DYRK1A:NM_130436.2:5'UTR:MODIFIER:exon1/11:c.-546T>C:,DYRK1A:NM_101395.2:intron:MODIFIER:exon2/12:c.-76-470T>C:		rs13049514	0.0996	0	0	0										0.0076	0.2424	0.75	1	36	n/a	n/a
chr21	44473425	44473425	G	A	hom		QUAL=22357;DP=269;AF=1.00;MQM=60;TRIO=HOM,269,1.00,HET,268,0.47,HOM,296,1.00	CBS	3'UTR	CBS:NM_000071.2:3'UTR:MODIFIER:exon17/17:c.*565C>T:,CBS:NM_001178008.1:3'UTR:MODIFIER:exon17/17:c.*565C>T:,CBS:NM_001178009.1:3'UTR:MODIFIER:exon18/18:c.*351C>T:	L1MB5	rs706209	0.3654	0	0	0										0.25	0.5152	0.2348	37	77	n/a	n/a
chr21	44473446	44473446	A	G	hom		QUAL=22657;DP=297;AF=1.00;MQM=60;TRIO=HOM,297,1.00,HET,242,0.47,HOM,281,1.00	CBS	3'UTR	CBS:NM_000071.2:3'UTR:MODIFIER:exon17/17:c.*544T>C:,CBS:NM_001178008.1:3'UTR:MODIFIER:exon17/17:c.*544T>C:,CBS:NM_001178009.1:3'UTR:MODIFIER:exon18/18:c.*330T>C:	L1MB5	rs706208	0.3662	0	0	0										0.25	0.5152	0.2348	37	77	n/a	n/a
chr21	44480616	44480616	G	A	hom		QUAL=13208;DP=101;AF=1.00;MQM=60;TRIO=HOM,101,1.00,HET,184,0.51,HOM,243,1.00	CBS	synonymous	CBS:NM_000071.2:synonymous:LOW:exon12/17:c.1080C>T:p.Ala360Ala,CBS:NM_001178008.1:synonymous:LOW:exon12/17:c.1080C>T:p.Ala360Ala,CBS:NM_001178009.1:synonymous:LOW:exon12/18:c.1080C>T:p.Ala360Ala		rs1801181	0.2955	0.331	0.3592	0.0744	-2.6190	P				613381 [CBS (confirmed) Homocystinuria,B6-responsive and nonresponsive types|Thrombosis,hyperhomocysteinemic];	RCV000078107.2 [benign]; RCV000124155.1 [benign]; 		COSM3758920	0.1818	0.4773	0.3409	67	202	n/a	n/a
chr21	45193728	45193728	G	C	het		QUAL=7069;DP=235;AF=0.52;MQM=60;TRIO=HET,235,0.52,HET,198,0.54,WT,279,0.00	CSTB	3'UTR	CSTB:NM_000100.3:3'UTR:MODIFIER:exon3/3:c.*355C>G:	MIR	rs143062585	0.007	0	0	0										0	0.0227	0.9773	0	4	n/a	n/a
chr21	45709568	45709568	C	T	het		QUAL=4613;DP=103;AF=0.43;MQM=60;TRIO=HET,103,0.43,WT,149,0.00,HET,205,0.56	AIRE	synonymous	AIRE:NM_000383.3:synonymous:LOW:exon6/14:c.681C>T:p.Gly227Gly		rs1055311	0.1176	0.22	0.2754	0.059						607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia];	RCV000116302.2 [likely benign]; 		COSM3758929	0.0455	0.3636	0.5909	26	177	n/a	n/a
chr21	45712290	45712290	G	A	het		QUAL=2016;DP=84;AF=0.45;MQM=60;TRIO=HET,84,0.45,HET,103,0.39,WT,142,0.00	AIRE	splice_region&intron	AIRE:NM_000383.3:splice_region&intron:LOW:exon9/13:c.1095+6G>A:		rs1800525	0.1496	0.078	0.0849	0.0971						607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia];	RCV000116292.2 [likely benign]; 			0	0.2424	0.7576	3	91	n/a	n/a
chr21	45712977	45712977	T	C	het		QUAL=2309;DP=29;AF=0.41;MQM=60;TRIO=HET,29,0.41,HOM,36,0.97,HET,81,0.44	AIRE	synonymous	AIRE:NM_000383.3:synonymous:LOW:exon10/14:c.1197T>C:p.Ala399Ala		rs1800521	0.3562	0.347	0.3481	0.4824						607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia];	RCV000116299.2 [likely benign]; 		COSM444569	0.1136	0.4773	0.4091	55	213	n/a	n/a
chr21	45714294	45714294	C	T	het		QUAL=378;DP=15;AF=0.53;MQM=60;TRIO=HET,15,0.53,HET,13,0.69,WT,11,0.00	AIRE	missense	AIRE:NM_000383.3:missense:MODERATE:exon12/14:c.1411C>T:p.Arg471Cys		rs74203920	0.0044	0.0085	0.0115	0.0025	0.0570	D	D	D,D	P,P	607358 [AIRE (confirmed) Autoimmune polyendocrinopathy syndrome,type I,with or without reversible metaphyseal dysplasia];	RCV000116295.2 [likely benign]; 	CM109490 [CLASS=DM? MUT=ALT PHEN="Hypoparathyroidism without APECED" GENE=AIRE]; 		0	0.0455	0.9545	0	11	n/a	n/a
chr21	46311813	46311813	A	G	het		QUAL=10924;DP=102;AF=0.55;MQM=60;TRIO=HET,102,0.55,WT,219,0.00,HOM,297,1.00	ITGB2	synonymous	ITGB2:NM_000211.3:synonymous:LOW:exon11/16:c.1323T>C:p.Val441Val,ITGB2:NM_001127491.1:synonymous:LOW:exon11/16:c.1323T>C:p.Val441Val		rs235326	0.763	0.688	0.6665	0.9135						600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency];			COSM3766671	0.447	0.447	0.1061	206	206	n/a	n/a
chr21	46314907	46314907	T	A	hom		QUAL=27075;DP=212;AF=1.00;MQM=60;TRIO=HOM,212,1.00,HOM,303,1.00,HOM,328,1.00	ITGB2	missense	ITGB2:NM_000211.3:missense:MODERATE:exon9/16:c.1062A>T:p.Gln354His,ITGB2:NM_001127491.1:missense:MODERATE:exon9/16:c.1062A>T:p.Gln354His		rs235330	1	1	0.9998	1	-0.9340	P	D	B,P	B,P	600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency];	RCV000087107.1 [not provided]; 		COSM4135040	1	0	0	454	0	n/a	n/a
chr21	46320313	46320313	C	T	het		QUAL=3188;DP=59;AF=0.41;MQM=59;TRIO=HET,59,0.41,HET,75,0.52,HET,88,0.52	ITGB2	synonymous	ITGB2:NM_000211.3:synonymous:LOW:exon7/16:c.819G>A:p.Gly273Gly,ITGB2:NM_001127491.1:synonymous:LOW:exon7/16:c.819G>A:p.Gly273Gly		rs2230528	0.223	0.242	0.2415	0.1668						600065 [ITGB2 (confirmed) Leukocyte adhesion deficiency];	RCV000087125.1 [not provided]; 			0.0379	0.4242	0.5379	36	177	n/a	n/a
chr21	46348700	46348700	T	G	hom		QUAL=12665;DP=129;AF=1.00;MQM=60;TRIO=HOM,129,1.00,HOM,133,1.00,HOM,137,1.00	ITGB2	5'UTR	ITGB2:NM_001127491.1:5'UTR:MODIFIER:exon1/16:c.-135A>C:		rs9982872	0.9884	0	0	0										0.9848	0.0152	0	157	2	n/a	n/a
chr21	46875564	46875564	T	C	het		QUAL=18133;DP=208;AF=0.48;MQM=60;TRIO=HET,208,0.48,HOM,286,1.00,HET,385,0.47	COL18A1	synonymous,intron	COL18A1:NM_030582.3:synonymous:LOW:exon1/42:c.120T>C:p.His40His,COL18A1:NM_130445.2:intron:MODIFIER:exon2/42:c.107-12592T>C:		rs914230	0.9884	0.97	0.9569	0.9943						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];				0.9242	0.0758	0	420	34	n/a	n/a
chr21	46876083	46876083	A	G	het		QUAL=4669;DP=63;AF=0.59;MQM=60;TRIO=HET,63,0.59,HET,108,0.52,HET,134,0.44	COL18A1	synonymous,intron	COL18A1:NM_030582.3:synonymous:LOW:exon1/42:c.639A>G:p.Pro213Pro,COL18A1:NM_130445.2:intron:MODIFIER:exon2/42:c.107-12073A>G:		rs2236451	0.3756	0.334	0.325	0.5022						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];			COSM4004828	0.0833	0.4924	0.4242	49	192	n/a	n/a
chr21	46908355	46908355	T	C	het		QUAL=7444;DP=224;AF=0.51;MQM=59;TRIO=HET,224,0.51,HET,240,0.51,WT,295,0.00	COL18A1	synonymous	COL18A1:NM_030582.3:synonymous:LOW:exon17/42:c.2460T>C:p.Leu820Leu,COL18A1:NM_130445.2:synonymous:LOW:exon18/43:c.1920T>C:p.Leu640Leu		rs11702425	0.3199	0.305	0.2959	0.3483						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];			COSM3758951	0.0758	0.447	0.4773	36	187	n/a	n/a
chr21	46924426	46924434	GGCCCCCCA	-	het		QUAL=569;DP=5;AF=0.60;MQM=60;TRIO=HET,5,1.00,HET,11,1.00,HET,12,1.00	COL18A1	frameshift&splice_acceptor&splice_donor&splice_region&splice_region&splice_region&intron	COL18A1:NM_030582.3:frameshift&splice_acceptor&splice_donor&splice_region&splice_region&splice_region&intron:HIGH:exon33/42:c.3364_3365-2delGGCCCCCCA:p.Gly1122fs,COL18A1:NM_130445.2:frameshift&splice_acceptor&splice_donor&splice_region&splice_region&splice_region&intron:HIGH:exon34/43:c.2824_2825-2delGGCCCCCCA:p.Gly942fs	GC_rich	rs149296338	0	0	0	0						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];			COSM1031439	0.8485	0.0833	0.0682	368	26	2	n/a
chr21	46924434	46924434	A	C	het		QUAL=569;DP=5;AF=0.60;MQM=60;TRIO=HET,5,1.00,HET,11,1.00,HET,12,1.00	COL18A1	splice_acceptor	COL18A1:NM_030582.3:splice_acceptor:HIGH:exon33/41:c.3365-2A>C:,COL18A1:NM_130445.2:splice_acceptor:HIGH:exon34/42:c.2825-2A>C:	GC_rich	rs28696990	0	0	0	0						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];				0.0227	0.1515	0.8258	5	42	2	n/a
chr21	46927489	46927489	A	G	het		QUAL=3030;DP=120;AF=0.39;MQM=60;TRIO=HET,120,0.39,HET,145,0.39,WT,219,0.00	COL18A1	synonymous	COL18A1:NM_030582.3:synonymous:LOW:exon38/42:c.3762A>G:p.Thr1254Thr,COL18A1:NM_130445.2:synonymous:LOW:exon39/43:c.3222A>G:p.Thr1074Thr		rs12483761	0.1184	0.121	0.1319	0.1404						120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];				0.0227	0.2424	0.7348	6	97	n/a	n/a
chr21	46931109	46931109	G	A	het		QUAL=2536;DP=77;AF=0.52;MQM=60;TRIO=HET,77,0.52,HET,94,0.46,WT,140,0.00	COL18A1	missense	COL18A1:NM_030582.3:missense:MODERATE:exon41/42:c.4309G>A:p.Asp1437Asn,COL18A1:NM_130445.2:missense:MODERATE:exon42/43:c.3769G>A:p.Asp1257Asn		rs12483377	0.0443	0.059	0.0878	0.0358	5.7980	P	T	D,D,D,D	D,D,D,D	120328 [COL18A1 (confirmed) Knobloch syndrome,type 1];	RCV000018655.26 [pathogenic]; 		COSM1579620	0.0152	0.2121	0.7727	3	71	2	n/a
chr21	46932618	46932618	G	C	het		QUAL=5643;DP=197;AF=0.49;MQM=59;TRIO=HET,197,0.49,HET,164,0.50,WT,176,0.00	COL18A1	3'UTR	COL18A1:NM_030582.3:3'UTR:MODIFIER:exon42/42:c.*306G>C:,COL18A1:NM_130445.2:3'UTR:MODIFIER:exon43/43:c.*306G>C:		rs17004785	0.1036	0	0	0										0.0152	0.2197	0.7652	2	29	n/a	n/a
chr21	47410931	47410931	T	C	hom		QUAL=6592;DP=116;AF=0.99;MQM=60;TRIO=HOM,116,0.99,HET,89,0.46,HET,135,0.45	COL6A1	synonymous	COL6A1:NM_001848.2:synonymous:LOW:exon15/35:c.1095T>C:p.Gly365Gly		rs1980982	0.5449	0.531	0.5603	0.7481						120220 [COL6A1 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000079742.3 [benign]; 		COSM3758956	0.2803	0.4924	0.2273	125	232	n/a	n/a
chr21	47423389	47423389	G	A	hom		QUAL=7382;DP=76;AF=0.99;MQM=60;TRIO=HOM,76,0.99,HET,146,0.53,HET,183,0.55	COL6A1	missense	COL6A1:NM_001848.2:missense:MODERATE:exon35/35:c.2549G>A:p.Arg850His		rs1053312	0.2702	0.283	0.3093	0.3985	-0.0010	P	T	B	B	120220 [COL6A1 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000079798.3 [benign]; 		COSM3758957	0.1288	0.4015	0.4697	44	192	n/a	n/a
chr21	47423507	47423507	G	A	hom		QUAL=3630;DP=34;AF=1.00;MQM=60;TRIO=HOM,34,1.00,HET,79,0.53,HET,93,0.55	COL6A1	synonymous	COL6A1:NM_001848.2:synonymous:LOW:exon35/35:c.2667G>A:p.Ala889Ala		rs1053315	0.2682	0.283	0.3102	0.3901						120220 [COL6A1 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000079801.4 [other]; 		COSM329269	0.1288	0.4015	0.4697	43	190	n/a	n/a
chr21	47423636	47423636	C	T	hom		QUAL=2600;DP=57;AF=1.00;MQM=59;TRIO=HOM,57,1.00,HET,44,0.45,HET,27,0.37	COL6A1	synonymous	COL6A1:NM_001848.2:synonymous:LOW:exon35/35:c.2796C>T:p.Ser932Ser		rs1053320	0.2642	0.268	0.2885	0.4026						120220 [COL6A1 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy];	RCV000079807.3 [benign]; 		COSM444608	0.0909	0.3788	0.5303	33	177	n/a	n/a
chr21	47424187	47424187	A	G	hom		QUAL=8809;DP=139;AF=1.00;MQM=59;TRIO=HOM,139,1.00,HOM,86,0.99,HET,127,0.44	COL6A1	3'UTR	COL6A1:NM_001848.2:3'UTR:MODIFIER:exon35/35:c.*260A>G:		rs1053331	0.8704	0	0	0										0.7576	0.2197	0.0227	139	38	n/a	n/a
chr21	47424275	47424287	CTCCTGCCCTGCC	-	het		QUAL=2558;DP=26;AF=0.77;MQM=60;TRIO=HET,26,0.77,HET,77,0.47,HET,118,0.36	COL6A1	3'UTR	COL6A1:NM_001848.2:3'UTR:MODIFIER:exon35/35:c.*357_*369delTGCCCTCCTGCCC:		rs372241676	0.0469	0	0	0										0.0152	0.1742	0.8106	3	28	n/a	n/a
chr21	47424346	47424346	A	G	hom		QUAL=12600;DP=92;AF=1.00;MQM=60;TRIO=HOM,92,1.00,HOM,172,1.00,HET,268,0.54	COL6A1	3'UTR	COL6A1:NM_001848.2:3'UTR:MODIFIER:exon35/35:c.*419A>G:		rs9254	0.882	0	0	0										0.75	0.2273	0.0227	176	56	n/a	n/a
chr21	47538960	47538960	G	A	hom		QUAL=23843;DP=196;AF=1.00;MQM=60;TRIO=HOM,196,1.00,HOM,241,1.00,HOM,308,1.00	COL6A2	missense	COL6A2:NM_001849.3:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn,COL6A2:NM_058174.2:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn,COL6A2:NM_058175.2:missense:MODERATE:exon14/28:c.1196G>A:p.Ser399Asn		rs2839110	0.7053	0.772	0.8279	0.5366	0.3610	P	T	B,B,B	B,B,B	120240 [COL6A2 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy|Myosclerosis,congenital];	RCV000079842.3 [benign]; 		COSM3758959	0.6742	0.25	0.0758	285	149	n/a	n/a
chr21	47542861	47542861	A	G	hom		QUAL=20738;DP=130;AF=0.99;MQM=60;TRIO=HOM,130,0.99,HOM,234,1.00,HOM,310,1.00	COL6A2	splice_region&intron	COL6A2:NM_001849.3:splice_region&intron:LOW:exon21/27:c.1671+10A>G:,COL6A2:NM_058174.2:splice_region&intron:LOW:exon21/27:c.1671+10A>G:,COL6A2:NM_058175.2:splice_region&intron:LOW:exon21/27:c.1671+10A>G:		rs915786	0.8474	0.812	0.8171	0.9462						120240 [COL6A2 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy|Myosclerosis,congenital];	RCV000079853.4 [other]; 			0.6894	0.2348	0.0758	288	147	n/a	n/a
chr21	47545768	47545768	G	A	hom		QUAL=24533;DP=217;AF=1.00;MQM=60;TRIO=HOM,217,1.00,HOM,241,1.00,HOM,356,1.00	COL6A2	missense	COL6A2:NM_001849.3:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His,COL6A2:NM_058174.2:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His,COL6A2:NM_058175.2:missense:MODERATE:exon26/28:c.2039G>A:p.Arg680His		rs1042917	0.394	0.477	0.5012	0.2408	4.7640	P	T	D,D,D	D,P,P	120240 [COL6A2 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy|Myosclerosis,congenital];	RCV000079868.3 [benign]; 		COSM3758962	0.1515	0.5	0.3485	96	226	n/a	n/a
chr21	47545823	47545823	G	A	hom		QUAL=25604;DP=208;AF=0.95;MQM=59;TRIO=HOM,208,0.95,HOM,290,0.98,HOM,406,0.99	COL6A2	synonymous	COL6A2:NM_001849.3:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala,COL6A2:NM_058174.2:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala,COL6A2:NM_058175.2:synonymous:LOW:exon26/28:c.2094G>A:p.Ala698Ala		rs13052956	0.3942	0.475	0.5003	0.2417						120240 [COL6A2 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy|Myosclerosis,congenital];	RCV000079869.3 [benign]; 		COSM3758966	0.1515	0.5	0.3485	97	225	n/a	n/a
chr21	47545826	47545826	C	T	hom		QUAL=25604;DP=208;AF=0.95;MQM=59;TRIO=HOM,208,0.95,HOM,290,0.98,HOM,406,0.99	COL6A2	synonymous	COL6A2:NM_001849.3:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly,COL6A2:NM_058174.2:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly,COL6A2:NM_058175.2:synonymous:LOW:exon26/28:c.2097C>T:p.Gly699Gly		rs13046639	0.394	0.475	0.5005	0.241						120240 [COL6A2 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy|Myosclerosis,congenital];	RCV000079870.3 [benign]; 		COSM3758967	0.1515	0.5	0.3485	97	225	n/a	n/a
chr21	47545913	47545913	G	A	het		QUAL=16097;DP=170;AF=0.46;MQM=59;TRIO=HET,170,0.46,HET,395,0.48,HET,532,0.49	COL6A2	synonymous	COL6A2:NM_001849.3:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val,COL6A2:NM_058174.2:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val,COL6A2:NM_058175.2:synonymous:LOW:exon26/28:c.2184G>A:p.Val728Val		rs2839114	0.3221	0.374	0.373	0.1325						120240 [COL6A2 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy|Myosclerosis,congenital];	RCV000079875.3 [benign]; 		COSM3758970	0.0682	0.4621	0.4697	45	211	n/a	n/a
chr21	47549629	47549629	T	A	hom		QUAL=19144;DP=186;AF=0.98;MQM=60;TRIO=HOM,186,0.98,HOM,190,0.99,HOM,249,1.00	COL6A2	3'UTR,intron	COL6A2:NM_058174.2:3'UTR:MODIFIER:exon28/28:c.*224T>A:,COL6A2:NM_058175.2:3'UTR:MODIFIER:exon28/28:c.*787T>A:,COL6A2:NM_001849.3:intron:MODIFIER:exon27/27:c.2462-2239T>A:		rs1044598	0.3868	0	0	0						120240 [COL6A2 (confirmed) Bethlem myopathy|Ullrich congenital muscular dystrophy|Myosclerosis,congenital];				0.1288	0.5152	0.3561	18	79	n/a	n/a
chr21	47744038	47744038	G	-	hom		QUAL=6531;DP=26;AF=1.00;MQM=60;TRIO=HOM,26,1.00,HOM,99,1.00,HOM,105,1.00	PCNT	5'UTR	PCNT:NM_006031.5:5'UTR:MODIFIER:exon1/47:c.-100delG:		rs398081651	0.7672	0	0	0										0.6667	0.2803	0.053	100	41	n/a	n/a
chr21	47754471	47754471	G	A	het		QUAL=5506;DP=549;AF=0.11;MQM=47;TRIO=HET,549,0.11,HET,1014,0.23,WT,1231,0.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon3/47:c.428G>A:p.Arg143His		rs58106867	0	0	0	0	-2.2830	N	T	D,D	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147125.1 [likely benign]; 		COSM1165940	0	0.053	0.947	0	26	2	n/a
chr21	47766650	47766650	G	A	hom		QUAL=9248;DP=79;AF=0.99;MQM=59;TRIO=HOM,79,0.99,HOM,170,1.00,HET,161,0.42	PCNT	splice_region&intron	PCNT:NM_006031.5:splice_region&intron:LOW:exon4/46:c.721-7G>A:		rs2839217	0.2999	0.32	0.3777	0.2079						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147195.1 [benign]; 			0.1742	0.5	0.3258	79	218	n/a	n/a
chr21	47773103	47773103	C	A	hom		QUAL=26645;DP=216;AF=1.00;MQM=60;TRIO=HOM,216,1.00,HOM,351,1.00,HET,477,0.54	PCNT	synonymous	PCNT:NM_006031.5:synonymous:LOW:exon10/47:c.1542C>A:p.Ser514Ser		rs2249057	0.2895	0.319	0.3307	0.2349						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147090.1 [benign]; 		COSM1130514	0.1288	0.5	0.3712	60	213	n/a	n/a
chr21	47777063	47777063	G	A	hom		QUAL=20718;DP=189;AF=1.00;MQM=60;TRIO=HOM,189,1.00,HOM,189,0.99,HOM,271,1.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon13/47:c.2111G>A:p.Gly704Glu		rs2839223	0.8486	0.856	0.8757	0.9292	3.8370	P	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147093.1 [benign]; 		COSM4135102	0.6894	0.2803	0.0303	322	122	n/a	n/a
chr21	47783796	47783796	T	C	hom		QUAL=9996;DP=128;AF=1.00;MQM=60;TRIO=HOM,128,1.00,HOM,91,1.00,HOM,115,0.99	PCNT	synonymous	PCNT:NM_006031.5:synonymous:LOW:exon14/47:c.2556T>C:p.Ala852Ala		rs8131546	0.847	0	0.8769	0.93						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147097.1 [benign]; 		COSM444637	0.6894	0.2803	0.0303	315	115	n/a	n/a
chr21	47786494	47786494	C	T	hom		QUAL=2489;DP=54;AF=1.00;MQM=60;TRIO=HOM,54,1.00,HOM,10,1.00,HOM,20,1.00	PCNT	splice_region&intron	PCNT:NM_006031.5:splice_region&intron:LOW:exon14/46:c.2610-5C>T:		rs2839226	0.6577	0.748	0.8052	0.4612						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147099.1 [benign]; 			0.6061	0.3333	0.0606	270	159	n/a	n/a
chr21	47786817	47786817	C	G	hom		QUAL=32285;DP=152;AF=1.00;MQM=60;TRIO=HOM,152,1.00,HOM,357,1.00,HOM,501,1.00	PCNT	synonymous	PCNT:NM_006031.5:synonymous:LOW:exon15/47:c.2928C>G:p.Leu976Leu		rs2839228	0.8389	0.853	0.8748	0.8954						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147104.1 [benign]; 		COSM1414625	0.6894	0.2803	0.0303	322	124	n/a	n/a
chr21	47787002	47787002	T	C	hom		QUAL=22447;DP=113;AF=1.00;MQM=60;TRIO=HOM,113,1.00,HOM,247,0.99,HOM,378,1.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon15/47:c.3113T>C:p.Val1038Ala		rs6518289	0.8377	0.852	0.8752	0.8983	-0.9870	P	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147106.1 [benign]; 			0.6818	0.2879	0.0303	321	125	n/a	n/a
chr21	47811272	47811272	C	T	hom		QUAL=5815;DP=55;AF=0.98;MQM=59;TRIO=HOM,55,0.98,HOM,97,1.00,HET,110,0.48	PCNT	synonymous	PCNT:NM_006031.5:synonymous:LOW:exon21/47:c.4197C>T:p.Asp1399Asp		rs3737438	0.3015	0.259	0.3344	0.1953						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147122.1 [benign]; 		COSM444639	0.1742	0.4924	0.3333	78	217	n/a	n/a
chr21	47832836	47832836	A	G	het		QUAL=7433;DP=148;AF=0.48;MQM=59;TRIO=HET,148,0.48,WT,284,0.00,HET,361,0.45	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon29/47:c.6080A>G:p.Gln2027Arg		rs147189224	0.0008	0.0019	0.0024	0.0007	4.5150	N	T	D,D	D,D	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];				0	0.0076	0.9924	0	2	3	n/a
chr21	47836653	47836653	C	T	het		QUAL=3280;DP=92;AF=0.43;MQM=60;TRIO=HET,92,0.43,HET,60,0.62,HET,72,0.46	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon30/47:c.6821C>T:p.Pro2274Leu		rs2070425	0.2496	0.269	0.2562	0.1642	0.0390	P	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147179.1 [benign]; 		COSM3759001	0.0985	0.447	0.4545	42	169	n/a	n/a
chr21	47850484	47850484	G	C	hom		QUAL=20846;DP=147;AF=0.99;MQM=59;TRIO=HOM,147,0.99,HOM,223,1.00,HOM,301,1.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon37/47:c.7977G>C:p.Gln2659His		rs2070426	0.4882	0.452	0.5569	0.3419	-3.2770	P	D	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147219.1 [benign]; 		COSM3759003	0.4015	0.4848	0.1136	162	215	n/a	n/a
chr21	47851753	47851753	A	G	hom		QUAL=19068;DP=205;AF=1.00;MQM=59;TRIO=HOM,205,1.00,HOM,173,0.99,HOM,214,1.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon38/47:c.8375A>G:p.Gln2792Arg		rs2073376	0.6699	0.639	0.6403	0.7923	0.2460	P	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147222.2 [benign]; 		COSM4135105	0.4848	0.4318	0.0833	205	214	n/a	n/a
chr21	47852085	47852085	G	A	het		QUAL=7234;DP=271;AF=0.41;MQM=60;TRIO=HET,271,0.41,HET,263,0.50,WT,354,0.00	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon38/47:c.8707G>A:p.Ala2903Thr		rs35147998	0.0385	0.061	0.0828	0.017	3.8120	N	T	B	B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147227.1,RCV000147228.1 [likely benign,benign]; 			0.0152	0.1288	0.8561	2	75	n/a	n/a
chr21	47860764	47860764	T	C	het		QUAL=3276;DP=131;AF=0.61;MQM=60;TRIO=HET,131,0.61,HET,32,0.91,WT,73,0.00	PCNT	splice_region&intron	PCNT:NM_006031.5:splice_region&intron:LOW:exon42/46:c.9394-4T>C:		rs2839260	0.1058	0.126	0.169	0.1396						605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147245.1 [benign]; 			0.0303	0.3182	0.6515	11	147	n/a	n/a
chr21	47863757	47863757	A	C	het		QUAL=2482;DP=90;AF=0.44;MQM=59;TRIO=HET,90,0.44,WT,64,0.00,HET,94,0.46	PCNT	missense	PCNT:NM_006031.5:missense:MODERATE:exon45/47:c.9735A>C:p.Arg3245Ser		rs2073380	0.2063	0.228	0.215	0.0808	-0.0160	P	T	B,B	B,B	605925 [PCNT (confirmed) Microcephalic osteodysplastic primordial dwarfism,type II];	RCV000147250.1 [benign]; 		COSM1751704	0.0455	0.3636	0.5909	25	165	n/a	n/a
chr22	17565888	17565888	C	A	hom		QUAL=6054;DP=29;AF=1.00;MQM=60;TRIO=HOM,29,1.00,HET,106,0.58,HOM,110,1.00	IL17RA	5'UTR	IL17RA:NM_014339.6:5'UTR:MODIFIER:exon1/13:c.-94C>A:,IL17RA:NM_001289905.1:5'UTR:MODIFIER:exon1/12:c.-94C>A:		rs13053694	0.3195	0	0	0										0.2652	0.4848	0.25	40	72	n/a	n/a
chr22	17565932	17565932	T	C	hom		QUAL=5539;DP=23;AF=1.00;MQM=60;TRIO=HOM,23,1.00,HOM,78,1.00,HOM,85,1.00	IL17RA	5'UTR	IL17RA:NM_014339.6:5'UTR:MODIFIER:exon1/13:c.-50T>C:,IL17RA:NM_001289905.1:5'UTR:MODIFIER:exon1/12:c.-50T>C:		rs917864	0.775	0.251	0	0										0.7121	0.2652	0.0227	109	37	n/a	n/a
chr22	17565974	17565974	G	C	hom		QUAL=3121;DP=9;AF=1.00;MQM=59;TRIO=HOM,9,1.00,HOM,46,1.00,HOM,54,1.00	IL17RA	5'UTR	IL17RA:NM_014339.6:5'UTR:MODIFIER:exon1/13:c.-8G>C:,IL17RA:NM_001289905.1:5'UTR:MODIFIER:exon1/12:c.-8G>C:		rs917865	0.7748	0.488	0	0										0.7045	0.2576	0.0379	288	95	n/a	n/a
chr22	17591089	17591089	G	A	het		QUAL=13433;DP=238;AF=0.44;MQM=59;TRIO=HET,238,0.44,HOM,224,1.00,HET,263,0.44	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*379G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*379G>A:	L2c	rs2895332	0.731	0	0	0										0.4242	0.4848	0.0909	66	68	n/a	n/a
chr22	17591144	17591144	C	T	het		QUAL=7065;DP=179;AF=0.51;MQM=58;TRIO=HET,179,0.51,HOM,146,1.00,WT,164,0.01	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*434C>T:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*434C>T:	AluSz	rs3179921	0.5397	0	0	0										0.3258	0.5227	0.1515	49	75	n/a	n/a
chr22	17591388	17591388	A	-	het		QUAL=269;DP=17;AF=0.35;MQM=58;TRIO=HET,17,0.35,HET,10,0.60,WT,6,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*696delA:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*696delA:	AluSz	rs35219112	0.502	0	0	0										0.0227	0.0909	0.8864	3	13	n/a	n/a
chr22	17591697	17591697	G	A	het		QUAL=5457;DP=144;AF=0.44;MQM=59;TRIO=HET,144,0.44,HOM,108,1.00,WT,147,0.01	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*987G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*987G>A:	AluJo	rs882644	0.5555	0	0	0										0.3106	0.553	0.1364	47	79	n/a	n/a
chr22	17591973	17591973	G	T	het		QUAL=3546;DP=40;AF=0.65;MQM=60;TRIO=HET,40,0.65,HOM,54,0.98,HET,72,0.75	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*1263G>T:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*1263G>T:	L2c	rs887795	0	0	0	0										0.5985	0.3561	0.0455	95	48	n/a	n/a
chr22	17593048	17593049	AT	-	het		QUAL=11496;DP=384;AF=0.47;MQM=60;TRIO=HET,384,0.47,HET,414,0.49,WT,581,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*2338_*2339delAT:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*2338_*2339delAT:		rs57380532	0.1152	0	0	0										0.0076	0.2121	0.7803	2	31	n/a	n/a
chr22	17593685	17593685	G	A	het		QUAL=17067;DP=325;AF=0.54;MQM=60;TRIO=HET,325,0.54,HOM,221,1.00,HET,291,0.46	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*2975G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*2975G>A:		rs887796	0.8367	0	0	0										0.6439	0.303	0.053	101	41	n/a	n/a
chr22	17593880	17593880	T	-	het		QUAL=2887;DP=188;AF=0.31;MQM=60;TRIO=HET,188,0.31,HOM,46,1.00,WT,100,0.02	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*3179delT:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*3179delT:	(T)n	rs111392920	0	0	0	0										0.197	0.4015	0.4015	29	54	n/a	n/a
chr22	17594623	17594623	C	T	het		QUAL=7561;DP=214;AF=0.52;MQM=59;TRIO=HET,214,0.52,HET,231,0.54,WT,346,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*3913C>T:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*3913C>T:		rs11702918	0.1134	0	0	0										0.0076	0.2121	0.7803	2	31	n/a	n/a
chr22	17594755	17594755	G	A	het		QUAL=6845;DP=214;AF=0.45;MQM=60;TRIO=HET,214,0.45,HET,268,0.46,WT,359,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*4045G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*4045G>A:	MIR	rs11703539	0.0984	0	0	0										0.0076	0.2045	0.7879	1	30	n/a	n/a
chr22	17594886	17594886	T	C	het		QUAL=17808;DP=408;AF=0.53;MQM=60;TRIO=HET,408,0.53,HOM,337,0.99,WT,451,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*4176T>C:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*4176T>C:		rs738035	0.4874	0	0	0										0.2955	0.5682	0.1364	45	81	n/a	n/a
chr22	17594915	17594915	G	A	het		QUAL=20088;DP=428;AF=0.56;MQM=60;TRIO=HET,428,0.56,HOM,373,1.00,WT,471,0.00	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*4205G>A:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*4205G>A:		rs738034	0.4864	0	0	0										0.2955	0.5682	0.1364	45	81	n/a	n/a
chr22	17595070	17595070	T	G	het		QUAL=18298;DP=457;AF=0.49;MQM=60;TRIO=HET,457,0.49,HOM,343,1.00,WT,378,0.01	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*4360T>G:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*4360T>G:		rs5992628	0.486	0	0	0										0.2955	0.5682	0.1364	45	81	n/a	n/a
chr22	17596178	17596178	T	C	het		QUAL=15992;DP=420;AF=0.52;MQM=60;TRIO=HET,420,0.52,HOM,160,1.00,HET,221,0.50	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*5468T>C:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*5468T>C:	MIRc	rs4819962	0.6186	0	0	0										0.4924	0.4167	0.0909	75	62	n/a	n/a
chr22	17596388	17596388	G	C	het		QUAL=12632;DP=313;AF=0.54;MQM=60;TRIO=HET,313,0.54,HOM,132,1.00,HET,153,0.58	IL17RA	3'UTR	IL17RA:NM_014339.6:3'UTR:MODIFIER:exon13/13:c.*5678G>C:,IL17RA:NM_001289905.1:3'UTR:MODIFIER:exon12/12:c.*5678G>C:		rs1654	0.8369	0	0	0										0.6439	0.3106	0.0455	101	42	n/a	n/a
chr22	18570974	18570974	C	T	het		QUAL=8016;DP=250;AF=0.48;MQM=59;TRIO=HET,250,0.48,WT,209,0.00,HET,281,0.49	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*133C>T:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*133C>T:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*133C>T:		rs200243782	0.001	0.0012	0	0										0	0.0227	0.9773	0	3	n/a	n/a
chr22	18571008	18571008	G	A	hom		QUAL=23203;DP=278;AF=1.00;MQM=59;TRIO=HOM,278,1.00,HET,240,0.47,HOM,342,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*167G>A:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*167G>A:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*167G>A:		rs464385	0.4227	0.5	0	0	-0.0230	P	D							0.4242	0.4318	0.1439	64	65	n/a	n/a
chr22	18571670	18571670	A	G	hom		QUAL=32910;DP=296;AF=1.00;MQM=60;TRIO=HOM,296,1.00,HOM,319,1.00,HOM,394,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*829A>G:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*829A>G:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*829A>G:		rs362057	0.9958	0	0	0										0.9773	0.0152	0.0076	147	2	n/a	n/a
chr22	18571828	18571828	T	C	hom		QUAL=32624;DP=385;AF=1.00;MQM=59;TRIO=HOM,385,1.00,HOM,274,1.00,HOM,365,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*987T>C:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*987T>C:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*987T>C:		rs361807	0.8734	0	0	0										0.8106	0.1667	0.0227	119	28	n/a	n/a
chr22	18572106	18572106	T	A	hom		QUAL=13383;DP=182;AF=0.98;MQM=59;TRIO=HOM,182,0.98,HET,169,0.50,HOM,164,0.99	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*1265T>A:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*1265T>A:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*1265T>A:		rs456551	0.4231	0	0	0										0.4242	0.4318	0.1439	64	65	n/a	n/a
chr22	18572371	18572371	-	TTGG	het		QUAL=23561;DP=224;AF=0.72;MQM=60;TRIO=HET,224,0.72,HOM,311,0.94,HOM,401,0.94	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*1532_*1535dupTGGT:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*1532_*1535dupTGGT:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*1532_*1535dupTGGT:		rs397708785	0.868	0	0	0										0.6212	0.2955	0.0833	90	46	n/a	n/a
chr22	18572499	18572499	-	CTCA	hom		QUAL=12052;DP=122;AF=0.96;MQM=53;TRIO=HOM,122,0.96,HOM,153,0.99,HOM,177,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*1661_*1662insACTC:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*1661_*1662insACTC:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*1661_*1662insACTC:	AluY	rs361571	0.9952	0	0	0										0.9545	0.0152	0.0303	143	2	n/a	n/a
chr22	18572892	18572892	A	G	hom		QUAL=10512;DP=166;AF=1.00;MQM=60;TRIO=HOM,166,1.00,HOM,71,1.00,HOM,83,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*2051A>G:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*2051A>G:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*2051A>G:		rs361946	0.8734	0	0	0										0.8106	0.1667	0.0227	119	28	n/a	n/a
chr22	18573122	18573122	T	C	hom		QUAL=23652;DP=254;AF=1.00;MQM=60;TRIO=HOM,254,1.00,HOM,192,1.00,HOM,281,1.00	PEX26	3'UTR	PEX26:NM_001127649.2:3'UTR:MODIFIER:exon5/5:c.*2281T>C:,PEX26:NM_001199319.1:3'UTR:MODIFIER:exon5/5:c.*2281T>C:,PEX26:NM_017929.5:3'UTR:MODIFIER:exon6/6:c.*2281T>C:	L2b	rs362209	0.996	0	0	0										0.9848	0.0152	0	148	2	n/a	n/a
chr22	21213380	21213380	C	T	hom		QUAL=14168;DP=149;AF=1.00;MQM=59;TRIO=HOM,149,1.00,HOM,127,1.00,HOM,209,0.99	SNAP29	5'UTR_premature_start_codon_gain,5'UTR	SNAP29:NM_004782.3:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-19C>T:,SNAP29:NM_004782.3:5'UTR:MODIFIER:exon1/5:c.-19C>T:		rs1061063	0.4639	0.508	0.5276	0.3922										0.303	0.4848	0.2121	46	79	n/a	n/a
chr22	21213416	21213416	A	G	hom		QUAL=20854;DP=192;AF=1.00;MQM=59;TRIO=HOM,192,1.00,HOM,198,0.99,HOM,296,0.99	SNAP29	synonymous	SNAP29:NM_004782.3:synonymous:LOW:exon1/5:c.18A>G:p.Lys6Lys		rs1061064	0.4036	0.502	0.5235	0.2081						604202 [SNAP29 (provisional) Cerebral dysgenesis,neuropathy,ichthyosis,and palmoplantar keratoderma syndrome];			COSM444738	0.303	0.4848	0.2121	129	211	n/a	n/a
chr22	21242608	21242611	CACA	-	het		QUAL=2534;DP=17;AF=0.65;MQM=59;TRIO=HET,17,0.65,HET,64,0.78,HET,94,0.45	SNAP29	3'UTR	SNAP29:NM_004782.3:3'UTR:MODIFIER:exon5/5:c.*517_*520delACAC:	(CA)n		0	0	0	0										0.0758	0.1667	0.7576	13	22	n/a	n/a
chr22	21244940	21244940	A	G	hom		QUAL=344;DP=10;AF=1.00;MQM=47;TRIO=HOM,10,1.00,HOM,1,1.00,HET,4,0.75	SNAP29	3'UTR	SNAP29:NM_004782.3:3'UTR:MODIFIER:exon5/5:c.*2816A>G:	AluY	rs165739	0.8321	0	0	0										0.4167	0.1515	0.4318	71	20	n/a	n/a
chr22	23915370	23915370	G	A	het		QUAL=2541;DP=96;AF=0.47;MQM=59;TRIO=HET,96,0.47,HET,73,0.56,WT,82,0.01	IGLL1	3'UTR	IGLL1:NM_020070.3:3'UTR:MODIFIER:exon3/3:c.*83C>T:,IGLL1:NM_152855.2:3'UTR:MODIFIER:exon2/2:c.*354C>T:		rs8141940	0.1204	0	0	0										0	0.0909	0.9091	1	14	n/a	n/a
chr22	23915610	23915610	A	T	het		QUAL=6077;DP=173;AF=0.42;MQM=56;TRIO=HET,173,0.42,HET,240,0.54,WT,294,0.00	IGLL1	missense,3'UTR	IGLL1:NM_020070.3:missense:MODERATE:exon3/3:c.485T>A:p.Met162Lys,IGLL1:NM_152855.2:3'UTR:MODIFIER:exon2/2:c.*114T>A:		rs111903752	0.0383	0.031	0.0293	0.0654	2.2680	N	D	B	B	146770 [IGLL1 (confirmed) Agammaglobulinemia 2];			COSM228749	0	0.0455	0.9545	0	19	n/a	n/a
chr22	23915652	23915652	G	A	het		QUAL=7290;DP=232;AF=0.44;MQM=57;TRIO=HET,232,0.44,WT,218,0.00,HET,252,0.52	IGLL1	missense,3'UTR	IGLL1:NM_020070.3:missense:MODERATE:exon3/3:c.443C>T:p.Thr148Ile,IGLL1:NM_152855.2:3'UTR:MODIFIER:exon2/2:c.*72C>T:		rs73157031	0.1388	0.15	0.1333	0.0295	0.2820	P	D	B	B	146770 [IGLL1 (confirmed) Agammaglobulinemia 2];			COSM149263	0.053	0.1742	0.7727	13	87	n/a	n/a
chr22	24891292	24891292	C	G	hom		QUAL=11415;DP=88;AF=1.00;MQM=60;TRIO=HOM,88,1.00,HOM,175,1.00,HET,211,0.56	UPB1	5'UTR	UPB1:NM_016327.2:5'UTR:MODIFIER:exon1/10:c.-80C>G:		rs2070474	0.5327	0	0	0							RCV000086537.1 [not provided]; 			0.3106	0.5303	0.1591	46	80	n/a	n/a
chr22	31003138	31003138	A	G	hom		QUAL=6401;DP=70;AF=1.00;MQM=59;TRIO=HOM,70,1.00,HOM,58,1.00,HOM,91,0.99	TCN2	5'UTR	TCN2:NM_000355.3:5'UTR:MODIFIER:exon1/9:c.-181A>G:,TCN2:NM_001184726.1:5'UTR:MODIFIER:exon1/9:c.-181A>G:		rs2240433	0.5545	0	0	0										0.2879	0.5076	0.2045	45	77	n/a	n/a
chr22	31011610	31011610	G	C	hom		QUAL=17524;DP=209;AF=1.00;MQM=60;TRIO=HOM,209,1.00,HET,310,0.50,HET,356,0.51	TCN2	missense	TCN2:NM_000355.3:missense:MODERATE:exon6/9:c.776G>C:p.Arg259Pro,TCN2:NM_001184726.1:missense:MODERATE:exon6/9:c.695G>C:p.Arg232Pro		rs1801198	0.5797	0.567	0.5657	0.7653	0.1460	P	T	B,B,B	B,B,B	613441 [TCN2 (confirmed) Transcobalamin II deficiency];	RCV000000117.1 [benign]; 	CM022466 [CLASS=DFP MUT=REF PHEN="Decreased holo TCII levels, association with" GENE=TCN2]; 	COSM4002151	0.2955	0.5152	0.1894	130	224	n/a	n/a
chr22	31022635	31022635	C	T	hom		QUAL=17344;DP=241;AF=0.99;MQM=59;TRIO=HOM,241,0.99,HET,225,0.59,HET,335,0.53	TCN2	3'UTR	TCN2:NM_000355.3:3'UTR:MODIFIER:exon9/9:c.*127C>T:,TCN2:NM_001184726.1:3'UTR:MODIFIER:exon9/9:c.*127C>T:		rs12160073	0.0675	0	0	0										0.0227	0.2045	0.7727	3	33	n/a	n/a
chr22	33669492	33669492	G	C	het		QUAL=10048;DP=390;AF=0.49;MQM=60;TRIO=HET,390,0.49,HET,232,0.50,WT,319,0.00	LARGE	3'UTR	LARGE:NM_004737.4:3'UTR:MODIFIER:exon16/16:c.*921C>G:,LARGE:NM_133642.3:3'UTR:MODIFIER:exon15/15:c.*921C>G:		rs16992034	0.0543	0	0	0										0.0076	0.0985	0.8939	1	15	n/a	n/a
chr22	33670584	33670584	G	A	het		QUAL=5213;DP=168;AF=0.50;MQM=60;TRIO=HET,168,0.50,HET,158,0.51,WT,175,0.00	LARGE	synonymous	LARGE:NM_004737.4:synonymous:LOW:exon16/16:c.2100C>T:p.Asn700Asn,LARGE:NM_133642.3:synonymous:LOW:exon15/15:c.2100C>T:p.Asn700Asn		rs17722172	0.021	0.047	0.0714	0.015						603590 [LARGE (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,6|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,6];	RCV000081178.4 [other]; 			0.0076	0.0985	0.8939	4	49	n/a	n/a
chr22	34022284	34022284	G	A	het		QUAL=18807;DP=330;AF=0.48;MQM=60;TRIO=HET,330,0.48,HET,363,0.53,HET,486,0.49	LARGE	synonymous	LARGE:NM_004737.4:synonymous:LOW:exon5/16:c.435C>T:p.Ala145Ala,LARGE:NM_133642.3:synonymous:LOW:exon4/15:c.435C>T:p.Ala145Ala		rs86487	0.4129	0.477	0.4836	0.1636						603590 [LARGE (confirmed) Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,6|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,6];	RCV000081181.3 [other]; 		COSM4156187	0.2652	0.5606	0.1742	117	233	n/a	n/a
chr22	37271882	37271882	T	C	hom		QUAL=15741;DP=112;AF=1.00;MQM=59;TRIO=HOM,112,1.00,HOM,183,0.99,HOM,226,1.00	NCF4	missense,intron	NCF4:NM_013416.3:missense:MODERATE:exon8/9:c.815T>C:p.Leu272Pro,NCF4:NM_000631.4:intron:MODIFIER:exon8/9:c.758+57T>C:		rs2075939	0.8281	0.834	0.8353	0.9378	0.2940	P		B	B	601488 [NCF4 (provisional) Granulomatous disease,chronic,autosomal recessive,cytochrome b-positive,type III];			COSM4156206	0.6364	0.2955	0.0682	313	119	n/a	n/a
chr22	38369027	38369027	C	T	het		QUAL=9629;DP=166;AF=0.48;MQM=60;TRIO=HET,166,0.48,HOM,146,0.99,HET,192,0.44	SOX10,POLR2F	3'UTR,intron	SOX10:NM_006941.3:3'UTR:MODIFIER:exon4/4:c.*475G>A:,POLR2F:NM_001301130.1:intron:MODIFIER:exon4/5:c.293+5850C>T:,POLR2F:NM_001301131.1:intron:MODIFIER:exon4/4:c.293+5850C>T:		rs139883	0.6084	0	0	0										0.3106	0.5152	0.1742	55	74	n/a	n/a
chr22	38369976	38369976	A	G	het		QUAL=3888;DP=92;AF=0.57;MQM=60;TRIO=HET,92,0.57,HOM,46,1.00,HET,71,0.45	SOX10,POLR2F	synonymous,intron	SOX10:NM_006941.3:synonymous:LOW:exon4/4:c.927T>C:p.His309His,POLR2F:NM_001301130.1:intron:MODIFIER:exon4/5:c.293+6799A>G:,POLR2F:NM_001301131.1:intron:MODIFIER:exon4/4:c.293+6799A>G:		rs139884	0.7133	0.653	0.6338	0.8168						602229 [SOX10 (confirmed) Waardenburg syndrome,type 4C|Waardenburg syndrome,type 2E,with or without neurologic involvement|PCWH syndrome];			COSM4156245	0.3182	0.5076	0.1742	295	354	n/a	n/a
chr22	41323897	41323897	G	A	het		QUAL=855;DP=71;AF=0.13;MQM=36;TRIO=HET,71,0.45,WT,18,0.44,WT,18,0.67	XPNPEP3	3'UTR	XPNPEP3:NM_022098.3:3'UTR:MODIFIER:exon10/10:c.*1458G>A:	AluY		0	0	0	0										0	0.0909	0.9091	0	15	n/a	n/a
chr22	41324205	41324205	C	T	het		QUAL=227;DP=44;AF=0.32;MQM=56;TRIO=HET,44,0.32,HET,27,0.11,HET,37,0.08	XPNPEP3	3'UTR	XPNPEP3:NM_022098.3:3'UTR:MODIFIER:exon10/10:c.*1766C>T:	AluSx3	rs371229000	0	0	0	0										0	0.0303	0.9697	0	4	n/a	n/a
chr22	41325068	41325068	G	A	hom		QUAL=17449;DP=233;AF=1.00;MQM=60;TRIO=HOM,233,1.00,HOM,214,1.00,HET,264,0.45	XPNPEP3	3'UTR	XPNPEP3:NM_022098.3:3'UTR:MODIFIER:exon10/10:c.*2629G>A:		rs2899341	0.5946	0	0	0										0.25	0.4773	0.2727	41	68	n/a	n/a
chr22	41326137	41326137	G	T	het		QUAL=174;DP=34;AF=0.26;MQM=46;TRIO=HET,34,0.26,WT,1,0.00,NONE,0,0	XPNPEP3	3'UTR	XPNPEP3:NM_022098.3:3'UTR:MODIFIER:exon10/10:c.*3698G>T:	AluSc8	rs376352212	0	0	0	0										0	0.0152	0.9848	0	3	n/a	n/a
chr22	42454354	42454354	G	A	hom		QUAL=21020;DP=316;AF=1.00;MQM=60;TRIO=HOM,316,1.00,HET,289,0.49,HET,343,0.52	NAGA	3'UTR	NAGA:NM_000262.2:3'UTR:MODIFIER:exon9/9:c.*1929C>T:	L1MC5a	rs5758566	0.6476	0	0	0										0.4621	0.4318	0.1061	69	67	n/a	n/a
chr22	42454494	42454494	A	-	hom		QUAL=19552;DP=278;AF=0.91;MQM=59;TRIO=HOM,278,0.91,HOM,192,0.96,HOM,201,0.95	NAGA	3'UTR	NAGA:NM_000262.2:3'UTR:MODIFIER:exon9/9:c.*1789delT:		rs534922853	0	0	0	0										0.8864	0.0985	0.0152	132	15	n/a	n/a
chr22	42454950	42454950	A	G	het		QUAL=13476;DP=445;AF=0.47;MQM=60;TRIO=HET,445,0.47,HET,380,0.52,WT,445,0.00	NAGA	3'UTR	NAGA:NM_000262.2:3'UTR:MODIFIER:exon9/9:c.*1333T>C:		rs1063392	0.4595	0	0	0										0.2727	0.4621	0.2652	41	68	n/a	n/a
chr22	42455248	42455248	C	T	het		QUAL=13272;DP=361;AF=0.45;MQM=60;TRIO=HET,361,0.45,WT,343,0.00,HET,465,0.53	NAGA	3'UTR	NAGA:NM_000262.2:3'UTR:MODIFIER:exon9/9:c.*1035G>A:		rs62238588	0.0306	0	0	0										0	0.1288	0.8712	0	20	n/a	n/a
chr22	42458827	42458827	G	C	het		QUAL=80;DP=8;AF=0.50;MQM=60;TRIO=HET,8,0.50,WT,7,0.00,HET,4,0.25	NAGA	splice_region&intron	NAGA:NM_000262.2:splice_region&intron:LOW:exon7/8:c.957+4C>G:		rs55715427	0.0298	0.058	0.0902	0.0154						104170 [NAGA (confirmed) Schindler disease,type I|Kanzaki disease|Schindler disease,type III];				0	0.053	0.947	2	61	n/a	n/a
chr22	42463814	42463814	C	T	hom		QUAL=15216;DP=172;AF=0.99;MQM=60;TRIO=HOM,172,0.99,HET,274,0.47,HET,379,0.51	NAGA	synonymous	NAGA:NM_000262.2:synonymous:LOW:exon3/9:c.279G>A:p.Pro93Pro		rs133369	0.6769	0.673	0.6656	0.5976						104170 [NAGA (confirmed) Schindler disease,type I|Kanzaki disease|Schindler disease,type III];			COSM3759227	0.4621	0.4318	0.1061	207	199	n/a	n/a
chr22	42466509	42466509	C	G	hom		QUAL=20530;DP=306;AF=0.99;MQM=59;TRIO=HOM,306,0.99,HET,293,0.48,HET,375,0.52	NAGA	5'UTR	NAGA:NM_000262.2:5'UTR:MODIFIER:exon1/9:c.-208G>C:		rs133375	0.6424	0	0	0										0.4621	0.4318	0.1061	69	67	n/a	n/a
chr22	42522550	42522550	G	A	het		QUAL=34;DP=7;AF=0.43;MQM=42;TRIO=HET,7,0.43,WT,1,0.00,WT,1,0.00	CYP2D6	3'UTR	CYP2D6:NM_000106.5:3'UTR:MODIFIER:exon9/9:c.*26C>T:,CYP2D6:NM_001025161.2:3'UTR:MODIFIER:exon8/8:c.*26C>T:		rs201759814	0	0.023	0	0										0.0152	0.1288	0.8561	2	21	n/a	n/a
chr22	42523003	42523003	A	G	hom		QUAL=962;DP=9;AF=1.00;MQM=31;TRIO=HOM,9,1.00,WT,109,0.01,HET,156,0.21	CYP2D6	splice_region&intron	CYP2D6:NM_000106.5:splice_region&intron:LOW:exon7/8:c.1174-9T>C:,CYP2D6:NM_001025161.2:splice_region&intron:LOW:exon6/7:c.1021-9T>C:		rs116917064	0	0.126	0	0						124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];				0.447	0.2803	0.2727	195	107	n/a	n/a
chr22	42523528	42523528	C	T	het		QUAL=3328;DP=148;AF=0.20;MQM=52;TRIO=HET,148,0.20,WT,134,0.00,HET,461,0.23	CYP2D6	missense	CYP2D6:NM_000106.5:missense:MODERATE:exon7/9:c.1094G>A:p.Arg365His,CYP2D6:NM_001025161.2:missense:MODERATE:exon6/8:c.941G>A:p.Arg314His		rs1058172	0	0.12	0	0	7.6100	P	D	D,D,D	D,D,D	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];			COSM445067	0	0.1742	0.8258	0	83	n/a	n/a
chr22	42523636	42523636	C	A	het		QUAL=801;DP=107;AF=0.34;MQM=40;TRIO=HET,107,0.34,WT,104,0.04,HET,328,0.07	CYP2D6	missense&splice_region	CYP2D6:NM_000106.5:missense&splice_region:MODERATE:exon7/9:c.986G>T:p.Arg329Leu,CYP2D6:NM_001025161.2:missense&splice_region:MODERATE:exon6/8:c.833G>T:p.Arg278Leu		rs3915951	0	0.074	0	0	0.4480	D	T	B,B,B	B,B,B	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];			COSM225813	0	0.2576	0.7424	0	55	n/a	n/a
chr22	42523943	42523943	A	G	hom		QUAL=16084;DP=181;AF=0.99;MQM=56;TRIO=HOM,181,0.99,WT,242,0.02,HET,663,0.50	CYP2D6	missense	CYP2D6:NM_000106.5:missense:MODERATE:exon6/9:c.886T>C:p.Cys296Arg,CYP2D6:NM_001025161.2:missense:MODERATE:exon5/8:c.733T>C:p.Cys245Arg		rs16947	0.6408	0.656	0.6573	0.4866	-1.2000	P		B,B	B,B	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];	RCV000018391.26 [pathogenic]; 	CM930187 [CLASS=DFP MUT=REF PHEN="Parkinson disease, association with" GENE=CYP2D6]; 	COSM1130422	0.4621	0.4167	0.1212	211	187	n/a	n/a
chr22	42524795	42524795	A	G	het		QUAL=1774;DP=95;AF=0.19;MQM=55;TRIO=HET,95,0.19,HET,303,0.21,WT,268,0.00	CYP2D6	synonymous	CYP2D6:NM_000106.5:synonymous:LOW:exon4/9:c.657T>C:p.Phe219Phe,CYP2D6:NM_001025161.2:synonymous:LOW:exon3/8:c.504T>C:p.Phe168Phe		rs28371713	0	0.286	0	0						124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];			COSM1632629	0	0.5379	0.4621	0	278	n/a	n/a
chr22	42524947	42524947	C	T	het		QUAL=5934;DP=59;AF=0.93;MQM=48;TRIO=HET,59,0.93,WT,143,0.00,HET,300,0.48	CYP2D6	splice_acceptor	CYP2D6:NM_000106.5:splice_acceptor:HIGH:exon3/8:c.506-1G>A:,CYP2D6:NM_001025161.2:splice_acceptor:HIGH:exon2/7:c.353-1G>A:		rs3892097	0.0931	0.11	0.1907	0.0729	5.1840	P				124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];	RCV000018385.22 [pathogenic]; 	CS900241 [CLASS=FP MUT=ALT PHEN="Poor metaboliser" GENE=CYP2D6]; 		0.0455	0.2424	0.7121	19	121	2	n/a
chr22	42526694	42526694	G	A	hom		QUAL=2549;DP=36;AF=0.94;MQM=59;TRIO=HOM,36,0.94,WT,44,0.00,HET,106,0.54	CYP2D6	missense	CYP2D6:NM_000106.5:missense:MODERATE:exon1/9:c.100C>T:p.Pro34Ser,CYP2D6:NM_001025161.2:missense:MODERATE:exon1/8:c.100C>T:p.Pro34Ser		rs1065852	0.238	0.204	0.2238	0.1195	7.1060	P	D	D,P	D,P	124030 [CYP2D6 (confirmed) Debrisoquine sensitivity|Codeine sensitivity];	RCV000018389.22 [pathogenic]; 	CM900081 [CLASS=FP MUT=ALT PHEN="Poor metaboliser" GENE=CYP2D6]; 		0.053	0.2803	0.6667	22	134	2	n/a
chr22	43032742	43032742	C	T	het		QUAL=6361;DP=144;AF=0.49;MQM=60;TRIO=HET,144,0.49,HET,307,0.48,WT,416,0.00	CYB5R3	synonymous	CYB5R3:NM_001171660.1:synonymous:LOW:exon2/9:c.231G>A:p.Pro77Pro,CYB5R3:NM_001129819.2:synonymous:LOW:exon2/9:c.63G>A:p.Pro21Pro,CYB5R3:NM_001171661.1:synonymous:LOW:exon3/10:c.63G>A:p.Pro21Pro,CYB5R3:NM_007326.4:synonymous:LOW:exon2/9:c.63G>A:p.Pro21Pro,CYB5R3:NM_000398.6:synonymous:LOW:exon2/9:c.132G>A:p.Pro44Pro		rs5996200	0.0737	0.113	0.1553	0.1094						613213 [CYB5R3 (confirmed) Methemoglobinemia,type I|Methemoglobinemia,type II];				0.053	0.3409	0.6061	11	131	n/a	n/a
chr22	46239934	46239934	C	T	het		QUAL=10472;DP=402;AF=0.52;MQM=60;TRIO=HET,402,0.52,HET,238,0.44,WT,325,0.00	ATXN10	3'UTR	ATXN10:NM_013236.3:3'UTR:MODIFIER:exon12/12:c.*383C>T:,ATXN10:NM_001167621.1:3'UTR:MODIFIER:exon11/11:c.*383C>T:		rs9614791	0.02	0	0	0										0.0076	0.1136	0.8788	1	18	n/a	n/a
chr22	50297591	50297591	G	A	het		QUAL=6991;DP=190;AF=0.43;MQM=59;TRIO=HET,190,0.43,HET,297,0.50,WT,426,0.00	ALG12	synonymous	ALG12:NM_024105.3:synonymous:LOW:exon10/10:c.1362C>T:p.Val454Val		rs12163163	0.0012	0.001	0.0006	0	0.0060	N	D			607144 [ALG12 (confirmed) Congenital disorder of glycosylation,type Ig];				0	0.0076	0.9924	0	2	n/a	n/a
chr22	50498030	50498030	-	C	het		QUAL=3403;DP=156;AF=0.38;MQM=60;TRIO=HET,156,0.38,HET,164,0.41,WT,174,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*1981dupG:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*1981dupG:		rs145385166	0.1322	0	0	0										0.0303	0.2424	0.7273	4	37	n/a	n/a
chr22	50498176	50498176	C	T	het		QUAL=5808;DP=135;AF=0.47;MQM=60;TRIO=HET,135,0.47,HET,127,0.57,HET,136,0.44	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*1836G>A:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*1836G>A:		rs11703598	0.0563	0	0	0										0.0227	0.2424	0.7348	3	37	n/a	n/a
chr22	50498389	50498389	C	A	het		QUAL=5751;DP=147;AF=0.48;MQM=59;TRIO=HET,147,0.48,HET,86,0.49,HET,121,0.60	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*1623G>T:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*1623G>T:		rs35730155	0.151	0	0	0										0.0227	0.25	0.7273	3	38	n/a	n/a
chr22	50499021	50499021	A	C	het		QUAL=9049;DP=181;AF=0.53;MQM=59;TRIO=HET,181,0.53,HET,436,0.47,WT,557,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*991T>G:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*991T>G:		rs11704648	0.1304	0	0	0										0.0303	0.2424	0.7273	4	37	n/a	n/a
chr22	50499075	50499075	G	A	het		QUAL=6451;DP=206;AF=0.47;MQM=59;TRIO=HET,206,0.47,HET,323,0.40,WT,454,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*937C>T:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*937C>T:		rs41283491	0.1306	0	0	0										0.0303	0.2424	0.7273	4	37	n/a	n/a
chr22	50499164	50499164	T	C	het		QUAL=1493;DP=47;AF=0.30;MQM=57;TRIO=HET,47,0.30,HET,126,0.40,WT,230,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*848A>G:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*848A>G:		rs147031924	0.1084	0	0	0										0.0303	0.1894	0.7803	4	28	n/a	n/a
chr22	50499165	50499165	G	A	het		QUAL=1493;DP=47;AF=0.30;MQM=57;TRIO=HET,47,0.30,HET,126,0.40,WT,230,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*847C>T:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*847C>T:		rs186840663	0.1082	0	0	0										0.0303	0.1742	0.7955	4	26	n/a	n/a
chr22	50499169	50499169	G	A	het		QUAL=1493;DP=47;AF=0.30;MQM=57;TRIO=HET,47,0.30,HET,126,0.40,WT,230,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*843C>T:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*843C>T:		rs41283493	0.1082	0	0	0										0.0303	0.1515	0.8182	4	22	n/a	n/a
chr22	50499239	50499239	C	T	het		QUAL=6085;DP=86;AF=0.47;MQM=58;TRIO=HET,86,0.47,HET,129,0.64,HET,260,0.37	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*773G>A:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*773G>A:		rs4838880	0.1793	0	0	0										0.0303	0.2727	0.697	4	41	n/a	n/a
chr22	50499634	50499634	-	GACCCCC	het		QUAL=2647;DP=171;AF=0.30;MQM=59;TRIO=HET,171,0.30,HET,175,0.33,WT,285,0.00	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*377_*378insGGGGGTC:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*377_*378insGGGGGTC:		rs368794754	0.1304	0	0	0										0.0227	0.2424	0.7348	3	37	n/a	n/a
chr22	50499964	50499964	T	C	het		QUAL=10839;DP=167;AF=0.46;MQM=60;TRIO=HET,167,0.46,HET,265,0.46,HET,326,0.45	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*48A>G:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*48A>G:		rs137919	0.2829	0.297	0.2895	0.1117										0.1136	0.4167	0.4697	20	69	n/a	n/a
chr22	50499967	50499967	T	C	het		QUAL=12655;DP=154;AF=0.58;MQM=60;TRIO=HET,154,0.58,HET,257,0.55,HET,324,0.54	MLC1	3'UTR	MLC1:NM_015166.3:3'UTR:MODIFIER:exon12/12:c.*45A>G:,MLC1:NM_139202.2:3'UTR:MODIFIER:exon12/12:c.*45A>G:		rs2072873	0.1504	0.146	0.1378	0.168										0.0227	0.25	0.7273	3	43	n/a	n/a
chr22	50502469	50502469	A	G	het		QUAL=661;DP=35;AF=0.40;MQM=59;TRIO=HET,35,0.40,HET,60,0.30,WT,88,0.00	MLC1	synonymous	MLC1:NM_015166.3:synonymous:LOW:exon11/12:c.1053T>C:p.Ala351Ala,MLC1:NM_139202.2:synonymous:LOW:exon11/12:c.1053T>C:p.Ala351Ala		rs11568190	0	0.011	0	0						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117623.2 [likely benign]; 		COSM1416978	0.0076	0.1439	0.8485	2	55	n/a	n/a
chr22	50502491	50502491	T	C	het		QUAL=1740;DP=67;AF=0.48;MQM=59;TRIO=HET,67,0.48,HET,85,0.40,WT,116,0.00	MLC1	missense	MLC1:NM_015166.3:missense:MODERATE:exon11/12:c.1031A>G:p.Asn344Ser,MLC1:NM_139202.2:missense:MODERATE:exon11/12:c.1031A>G:p.Asn344Ser		rs11568188	0.1312	0.082	0.1272	0.0663	0.6210	P	T	B,B,B	B,B,B	605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000020711.2 [benign]; RCV000117622.2 [likely benign]; 		COSM1416980	0.0303	0.2348	0.7348	13	123	n/a	n/a
chr22	50502526	50502526	A	G	het		QUAL=3450;DP=128;AF=0.48;MQM=60;TRIO=HET,128,0.48,HET,128,0.46,WT,171,0.00	MLC1	synonymous	MLC1:NM_015166.3:synonymous:LOW:exon11/12:c.996T>C:p.Ser332Ser,MLC1:NM_139202.2:synonymous:LOW:exon11/12:c.996T>C:p.Ser332Ser		rs11568187	0.1312	0.128	0.139	0.074						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117629.2 [likely benign]; 		COSM3722537	0.0303	0.2348	0.7348	13	124	n/a	n/a
chr22	50502544	50502544	G	A	het		QUAL=4376;DP=161;AF=0.48;MQM=59;TRIO=HET,161,0.48,HET,152,0.47,WT,177,0.01	MLC1	synonymous	MLC1:NM_015166.3:synonymous:LOW:exon11/12:c.978C>T:p.Cys326Cys,MLC1:NM_139202.2:synonymous:LOW:exon11/12:c.978C>T:p.Cys326Cys		rs11568186	0.1312	0.128	0.1393	0.0744						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117628.2 [likely benign]; 			0.0303	0.2424	0.7273	9	122	n/a	n/a
chr22	50502636	50502636	G	A	het		QUAL=2175;DP=54;AF=0.20;MQM=60;TRIO=HET,54,0.20,HET,135,0.51,WT,190,0.01	MLC1	splice_region&intron	MLC1:NM_015166.3:splice_region&intron:LOW:exon10/11:c.895-9C>T:,MLC1:NM_139202.2:splice_region&intron:LOW:exon10/11:c.895-9C>T:		rs11568185	0.1316	0.108	0.1312	0.0705						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117627.2 [likely benign]; 			0.0303	0.2424	0.7273	14	190	n/a	n/a
chr22	50515270	50515270	T	C	het		QUAL=10153;DP=235;AF=0.50;MQM=59;TRIO=HET,235,0.50,HET,403,0.53,WT,441,0.00	MLC1	splice_region&synonymous	MLC1:NM_015166.3:splice_region&synonymous:LOW:exon7/12:c.597A>G:p.Ser199Ser,MLC1:NM_139202.2:splice_region&synonymous:LOW:exon7/12:c.597A>G:p.Ser199Ser		rs6010164	0.1306	0.127	0.1187	0.1019						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117626.2 [likely benign]; 		COSM4002217	0.0303	0.1818	0.7879	12	165	n/a	n/a
chr22	50515273	50515273	G	A	het		QUAL=10153;DP=235;AF=0.50;MQM=59;TRIO=HET,235,0.50,HET,403,0.53,WT,441,0.00	MLC1	synonymous	MLC1:NM_015166.3:synonymous:LOW:exon7/12:c.594C>T:p.Tyr198Tyr,MLC1:NM_139202.2:synonymous:LOW:exon7/12:c.594C>T:p.Tyr198Tyr		rs6010165	0.1306	0.127	0.1187	0.1017						605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000117625.2 [likely benign]; 		COSM4002218	0.0303	0.1818	0.7879	12	165	n/a	n/a
chr22	50515843	50515843	C	A	het		QUAL=2880;DP=96;AF=0.45;MQM=60;TRIO=HET,96,0.45,HET,110,0.49,WT,151,0.00	MLC1	missense	MLC1:NM_015166.3:missense:MODERATE:exon6/12:c.512G>T:p.Cys171Phe,MLC1:NM_139202.2:missense:MODERATE:exon6/12:c.512G>T:p.Cys171Phe		rs6010260	0.1216	0.123	0.1185	0.0708	2.1120	P	D	B,B,B,B	B,B,B,B	605908 [MLC1 (confirmed) Megalencephalic leukoencephalopathy with subcortical cysts];	RCV000020714.2 [benign]; RCV000117624.2 [likely benign]; 			0.0303	0.1818	0.7879	12	165	n/a	n/a
chr22	50524250	50524250	-	C	het		QUAL=10737;DP=122;AF=0.77;MQM=59;TRIO=HET,122,0.77,HOM,127,0.94,HOM,183,0.95	MLC1	5'UTR	MLC1:NM_015166.3:5'UTR:MODIFIER:exon1/12:c.-527dupG:		rs137931	0.6719	0	0	0										0.4924	0.4773	0.0303	78	67	n/a	n/a
chr22	50524285	50524285	C	T	het		QUAL=4739;DP=149;AF=0.47;MQM=60;TRIO=HET,149,0.47,HET,86,0.38,HET,139,0.43	MLC1	5'UTR	MLC1:NM_015166.3:5'UTR:MODIFIER:exon1/12:c.-561G>A:		rs4838883	0.1494	0	0	0										0.0303	0.2576	0.7121	4	38	n/a	n/a
chr22	50962208	50962208	T	G	het		QUAL=3542;DP=139;AF=0.50;MQM=60;TRIO=HET,139,0.50,WT,84,0.00,HET,79,0.53	SCO2,NCAPH2	synonymous,3'UTR	SCO2:NM_001169109.1:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:NM_001169111.1:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:NM_005138.2:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,SCO2:NM_001169110.1:synonymous:LOW:exon2/2:c.633A>C:p.Ala211Ala,NCAPH2:NM_001185011.1:3'UTR:MODIFIER:exon20/20:c.*404T>G:,NCAPH2:NM_152299.3:3'UTR:MODIFIER:exon20/20:c.*404T>G:		rs12148	0.6556	0.638	0.6169	0.6707						604272 [SCO2 (provisional) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1|Myopia 6];	RCV000128016.1 [benign]; 			0.3864	0.4848	0.1288	158	224	n/a	n/a
chr22	50962782	50962782	C	G	het		QUAL=2288;DP=92;AF=0.43;MQM=60;TRIO=HET,92,0.43,WT,45,0.02,HET,75,0.49	SCO2,NCAPH2	missense,3'UTR	SCO2:NM_001169109.1:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:NM_001169111.1:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:NM_005138.2:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,SCO2:NM_001169110.1:missense:MODERATE:exon2/2:c.59G>C:p.Arg20Pro,NCAPH2:NM_001185011.1:3'UTR:MODIFIER:exon20/20:c.*978C>G:,NCAPH2:NM_152299.3:3'UTR:MODIFIER:exon20/20:c.*978C>G:		rs140523	0.6516	0.633	0.617	0.6573	-3.5700	P	T	B	B	604272 [SCO2 (provisional) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1|Myopia 6];	RCV000128012.1 [benign]; 		COSM1484348	0.3864	0.4848	0.1288	168	220	n/a	n/a
chr22	50963965	50963965	C	G	het		QUAL=1874;DP=50;AF=0.54;MQM=60;TRIO=HET,50,0.54,WT,48,0.00,HET,76,0.53	SCO2	5'UTR,intron	SCO2:NM_001169111.1:5'UTR:MODIFIER:exon1/2:c.-108G>C:,SCO2:NM_005138.2:5'UTR:MODIFIER:exon1/2:c.-78G>C:,SCO2:NM_001169109.1:intron:MODIFIER:exon1/1:c.-14+710G>C:,SCO2:NM_001169110.1:intron:MODIFIER:exon1/1:c.-14+465G>C:		rs131806	0.5339	0	0	0										0.3409	0.4773	0.1818	52	72	n/a	n/a
chr22	50964862	50964862	G	A	hom		QUAL=47;DP=4;AF=1.00;MQM=60;TRIO=HOM,4,1.00,WT,8,0.00,WT,3,0.00	TYMP,SCO2	synonymous,5'UTR	TYMP:NM_001257989.1:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:NM_001113755.2:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:NM_001113756.2:synonymous:LOW:exon7/9:c.972C>T:p.Ala324Ala,TYMP:NM_001257988.1:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:NM_001953.4:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,SCO2:NM_001169109.1:5'UTR:MODIFIER:exon1/2:c.-201C>T:		rs131804	0.5329	0.526	0.6751	0.5186						131222 [TYMP (confirmed) Mitochondrial DNA depletion syndrome 1 (MNGIE type)];	RCV000118808.2 [likely benign]; RCV000126200.1 [benign]; 			0.2652	0.2348	0.5	98	163	n/a	n/a
chr22	51062051	51062051	G	T	het		QUAL=3551;DP=165;AF=0.44;MQM=58;TRIO=HET,165,0.44,WT,52,0.00,HOM,53,1.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*1522C>A:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*1522C>A:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*1522C>A:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*1522C>A:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*1522C>A:	AluSx	rs6009939	0.3321	0	0	0										0.0303	0.3485	0.6212	4	48	n/a	n/a
chr22	51062222	51062222	G	C	het		QUAL=158;DP=14;AF=0.50;MQM=51;TRIO=HET,14,0.50,WT,1,0.00,NONE,0,0	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*1351C>G:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*1351C>G:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*1351C>G:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*1351C>G:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*1351C>G:	AluSx	rs131717	0.4762	0	0	0										0.2576	0.2045	0.5379	42	32	n/a	n/a
chr22	51062654	51062654	T	C	hom		QUAL=5760;DP=74;AF=0.99;MQM=55;TRIO=HOM,74,0.99,HET,57,0.53,HOM,88,1.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*919A>G:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*919A>G:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*919A>G:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*919A>G:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*919A>G:	AluSp	rs5770805	0.8349	0	0	0										0.5379	0.3788	0.0833	83	56	n/a	n/a
chr22	51062718	51062718	C	T	het		QUAL=2568;DP=87;AF=0.47;MQM=50;TRIO=HET,87,0.47,HET,103,0.47,WT,142,0.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*855G>A:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*855G>A:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*855G>A:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*855G>A:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*855G>A:	AluSp	rs7288050	0.349	0	0	0										0.1667	0.5076	0.3258	29	76	n/a	n/a
chr22	51062832	51062832	G	A	het		QUAL=10675;DP=294;AF=0.48;MQM=60;TRIO=HET,294,0.48,WT,268,0.00,HET,385,0.50	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*741C>T:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*741C>T:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*741C>T:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*741C>T:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*741C>T:	L2	rs8142033	0.1773	0	0	0										0	0.2197	0.7803	0	31	n/a	n/a
chr22	51062891	51062891	C	G	het		QUAL=5965;DP=171;AF=0.56;MQM=60;TRIO=HET,171,0.56,HET,227,0.42,WT,331,0.00	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*682G>C:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*682G>C:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*682G>C:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*682G>C:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*682G>C:		rs7288338	0.351	0	0	0										0.1818	0.5	0.3182	31	75	n/a	n/a
chr22	51062938	51062938	C	T	het		QUAL=9283;DP=122;AF=0.46;MQM=59;TRIO=HET,122,0.46,WT,198,0.00,HOM,249,0.98	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*635G>A:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*635G>A:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*635G>A:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*635G>A:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*635G>A:		rs5770953	0.3588	0	0	0										0.0303	0.3485	0.6212	4	48	n/a	n/a
chr22	51063477	51063477	T	C	het		QUAL=14231;DP=204;AF=0.49;MQM=59;TRIO=HET,204,0.49,WT,579,0.00,HET,731,0.49	ARSA	3'UTR	ARSA:NM_000487.5:3'UTR:MODIFIER:exon8/8:c.*96A>G:,ARSA:NM_001085425.2:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:NM_001085426.2:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:NM_001085427.2:3'UTR:MODIFIER:exon9/9:c.*96A>G:,ARSA:NM_001085428.2:3'UTR:MODIFIER:exon8/8:c.*96A>G:		rs6151429	0.0499	0	0	0							RCV000003190.1 [pathogenic]; RCV000020309.1 [pathogenic]; 	CR890137 [CLASS=DP MUT=ALT PHEN="Arylsulphatase A pseudodeficiency, association" GENE=ARSA]; 		0	0.1818	0.8182	0	26	2	n/a
chr22	51064039	51064039	G	C	het		QUAL=11920;DP=197;AF=0.56;MQM=59;TRIO=HET,197,0.56,HET,204,0.66,HET,287,0.45	ARSA	missense	ARSA:NM_000487.5:missense:MODERATE:exon7/8:c.1178C>G:p.Thr393Ser,ARSA:NM_001085425.2:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser,ARSA:NM_001085426.2:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser,ARSA:NM_001085427.2:missense:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser,ARSA:NM_001085428.2:missense:MODERATE:exon7/8:c.920C>G:p.Thr307Ser		rs743616	0.4056	0.483	0.5302	0.394	0.1030	P	T	B	B	607574 [ARSA (confirmed) Metachromatic leukodystrophy];	RCV000020311.1 [pathogenic]; RCV000078937.2 [benign]; 	CM910052 [CLASS=DP MUT=ALT PHEN="Phenotype modifier, association with" GENE=ARSA]; 		0.2121	0.5076	0.2803	307	569	2	n/a
chr22	51064416	51064416	T	C	het		QUAL=7447;DP=160;AF=0.48;MQM=59;TRIO=HET,160,0.48,WT,281,0.00,HET,302,0.54	ARSA	missense	ARSA:NM_000487.5:missense:MODERATE:exon6/8:c.1055A>G:p.Asn352Ser,ARSA:NM_001085425.2:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser,ARSA:NM_001085426.2:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser,ARSA:NM_001085427.2:missense:MODERATE:exon7/9:c.1055A>G:p.Asn352Ser,ARSA:NM_001085428.2:missense:MODERATE:exon6/8:c.797A>G:p.Asn266Ser		rs2071421	0.2248	0.132	0.1227	0.2992	1.7670	P	T	B	B	607574 [ARSA (confirmed) Metachromatic leukodystrophy];	RCV000003191.1 [benign]; RCV000020310.1 [pathogenic]; RCV000078931.2 [not provided]; 	CM890013 [CLASS=DP MUT=ALT PHEN="Arylsulphatase A pseudodeficiency, association" GENE=ARSA]; 	COSM4004968	0	0.2879	0.7121	16	297	2	n/a
chrM	72	72	T	C	hom		QUAL=218850;DP=3548;AF=0.99;MQM=56;TRIO=HOM,3548,0.99,HOM,3602,0.99,WT,4263,0.00						0	0	0	0										0.0152	0	0.9848	2	0	n/a	n/a
chrM	73	73	G	A	hom		QUAL=218850;DP=3548;AF=0.99;MQM=56;TRIO=HOM,3548,0.99,HOM,3602,0.99,WT,4263,0.00						0	0	0	0										0.4015	0	0.5985	65	0	n/a	n/a
chrM	150	150	T	C	hom		QUAL=246168;DP=4217;AF=1.00;MQM=59;TRIO=HOM,4217,1.00,HOM,3373,1.00,WT,4176,0.01						0	0	0	0										0.9091	0	0.0909	142	1	n/a	n/a
chrM	195	195	C	T	hom		QUAL=196394;DP=3669;AF=1.00;MQM=59;TRIO=HOM,3669,1.00,HOM,2422,1.00,WT,3368,0.00						0	0	0	0										0.8182	0	0.1818	131	0	n/a	n/a
chrM	302	302	-	C	het		QUAL=56128;DP=991;AF=0.51;MQM=59;TRIO=HET,991,0.82,HET,293,0.83,WT,1431,0.97						0	0	0	0										0.0152	0.0758	0.9091	4	11	n/a	n/a
chrM	311	311	T	C	het		QUAL=56128;DP=991;AF=0.51;MQM=57;TRIO=HET,991,0.82,HET,293,0.83,WT,1431,0.97						0	0	0	0										0.0076	0.1515	0.8409	1	20	n/a	n/a
chrM	410	410	A	T	hom		QUAL=184824;DP=2930;AF=1.00;MQM=59;TRIO=HOM,2930,1.00,HOM,1052,1.00,HOM,1724,1.00						0	0	0	0										0.9924	0	0.0076	161	0	n/a	n/a
chrM	2354	2354	C	T	hom		QUAL=334382;DP=4573;AF=1.00;MQM=59;TRIO=HOM,4573,1.00,HOM,2581,1.00,HOM,2966,1.00						0	0	0	0										0.9924	0	0.0076	160	0	n/a	n/a
chrM	2485	2485	C	T	hom		QUAL=167395;DP=3135;AF=1.00;MQM=49;TRIO=HOM,3135,1.00,HOM,1056,1.00,HOM,1184,1.00						0	0	0	0										1	0	0	161	0	n/a	n/a
chrM	4581	4581	G	A	hom		QUAL=156765;DP=2732;AF=0.99;MQM=31;TRIO=HOM,2732,0.99,HOM,2131,0.99,WT,2505,0.00						0	0	0	0										0.0152	0	0.9848	2	0	n/a	n/a
chrM	5581	5581	C	T	hom		QUAL=256752;DP=2908;AF=1.00;MQM=43;TRIO=HOM,2908,1.00,HOM,2416,1.00,HOM,2706,1.00						0	0	0	0										1	0	0	159	0	n/a	n/a
chrM	8702	8702	G	A	hom		QUAL=256474;DP=3192;AF=1.00;MQM=55;TRIO=HOM,3192,1.00,HOM,2171,1.00,HOM,2570,1.00						0	0	0	0										0.9697	0	0.0303	155	0	n/a	n/a
chrM	9378	9378	G	A	hom		QUAL=383538;DP=3040;AF=1.00;MQM=46;TRIO=HOM,3040,1.00,HOM,4075,1.00,HOM,4833,1.00						0	0	0	0										0.9924	0	0.0076	160	0	n/a	n/a
chrM	9541	9541	C	T	hom		QUAL=330537;DP=4445;AF=1.00;MQM=59;TRIO=HOM,4445,1.00,HOM,2688,1.00,HOM,3278,1.00						0	0	0	0										0.9697	0	0.0303	156	0	n/a	n/a
chrM	10399	10399	G	A	hom		QUAL=256147;DP=4664;AF=1.00;MQM=59;TRIO=HOM,4664,1.00,HOM,3084,1.00,WT,3712,0.01						0	0	0	0										0.7727	0	0.2273	126	0	n/a	n/a
chrM	10820	10820	G	A	hom		QUAL=377871;DP=5013;AF=1.00;MQM=57;TRIO=HOM,5013,1.00,HOM,3022,1.00,HOM,3621,1.00						0	0	0	0										0.9924	0	0.0076	161	0	n/a	n/a
chrM	10874	10874	C	T	hom		QUAL=406100;DP=5918;AF=1.00;MQM=59;TRIO=HOM,5918,1.00,HOM,3034,1.00,HOM,3551,1.00						0	0	0	0										0.9621	0	0.0379	156	0	n/a	n/a
chrM	11018	11018	C	T	hom		QUAL=353301;DP=5220;AF=1.00;MQM=53;TRIO=HOM,5220,1.00,HOM,2739,1.00,HOM,3169,1.00						0	0	0	0										0.9924	0	0.0076	160	1	n/a	n/a
chrM	11720	11720	A	G	hom		QUAL=490828;DP=6093;AF=0.99;MQM=50;TRIO=HOM,6093,1.00,HOM,3973,1.00,WT,5244,1.00						0	0	0	0										0.4167	0	0.5833	70	0	n/a	n/a
chrM	11723	11723	C	T	hom		QUAL=490828;DP=6093;AF=0.99;MQM=57;TRIO=HOM,6093,1.00,HOM,3973,1.00,HOM,5244,1.00						0	0	0	0										1	0	0	161	0	n/a	n/a
chrM	12706	12706	T	C	hom		QUAL=447360;DP=5196;AF=0.98;MQM=59;TRIO=HOM,5196,0.98,HOM,4023,0.97,HOM,4642,1.00						0	0	0	0										0.8788	0	0.1212	144	0	n/a	n/a
chrM	12851	12851	G	A	hom		QUAL=524329;DP=7098;AF=1.00;MQM=58;TRIO=HOM,7098,1.00,HOM,4364,1.00,HOM,4864,1.00						0	0	0	0										1	0	0	162	0	n/a	n/a
chrM	14213	14213	C	T	hom		QUAL=298867;DP=3888;AF=1.00;MQM=54;TRIO=HOM,3888,1.00,HOM,2533,1.00,HOM,2778,1.00						0	0	0	0										1	0	0	161	0	n/a	n/a
chrM	14371	14371	A	G	hom		QUAL=189938;DP=3853;AF=0.99;MQM=59;TRIO=HOM,3853,0.99,HOM,2141,1.00,WT,2333,0.00						0	0	0	0										0.0076	0	0.9924	1	0	n/a	n/a
chrM	14581	14581	G	A	hom		QUAL=216360;DP=4391;AF=1.00;MQM=56;TRIO=HOM,4391,1.00,HOM,988,1.00,HOM,1155,1.00						0	0	0	0										0.9924	0	0.0076	160	0	n/a	n/a
chrM	14767	14767	T	C	hom		QUAL=171414;DP=3226;AF=1.00;MQM=59;TRIO=HOM,3226,1.00,HOM,2079,0.99,WT,2270,0.00						0	0	0	0										0.4242	0	0.5758	70	1	n/a	n/a
chrM	14906	14906	A	G	hom		QUAL=354527;DP=4723;AF=1.00;MQM=57;TRIO=HOM,4723,1.00,HOM,2971,1.00,HOM,3247,1.00						0	0	0	0										0.8712	0	0.1288	142	0	n/a	n/a
chrM	15302	15302	A	G	hom		QUAL=360209;DP=4082;AF=1.00;MQM=59;TRIO=HOM,4082,1.00,HOM,3435,1.00,HOM,3596,1.00						0	0	0	0										0.9545	0	0.0455	154	0	n/a	n/a
chrM	15905	15905	C	T	hom		QUAL=299823;DP=5893;AF=0.99;MQM=59;TRIO=HOM,5893,0.99,HOM,3302,0.99,WT,3765,0.00						0	0	0	0										0.0152	0	0.9848	2	0	n/a	n/a
chrM	15933	15933	C	T	hom		QUAL=473887;DP=7082;AF=1.00;MQM=59;TRIO=HOM,7082,1.00,HOM,3333,1.00,HOM,3782,1.00						0	0	0	0										0.9924	0	0.0076	160	0	n/a	n/a
chrM	16173	16173	C	T	hom		QUAL=416199;DP=5317;AF=1.00;MQM=59;TRIO=HOM,5317,1.00,HOM,3919,1.00,HOM,3885,1.00						0	0	0	0										0.9773	0	0.0227	158	0	n/a	n/a
chrM	16184	16184	C	-	hom		QUAL=293363;DP=4621;AF=0.80;MQM=59;TRIO=HOM,4621,0.80,HOM,3393,0.93,HOM,3418,0.91						0	0	0	0										0.3788	0.2955	0.3258	64	42	n/a	n/a
chrM	16185	16185	C	A	hom		QUAL=293363;DP=4621;AF=0.80;MQM=59;TRIO=HOM,4621,0.80,HOM,3393,0.93,HOM,3418,0.91						0	0	0	0										0.053	0.3485	0.5985	7	49	n/a	n/a
chrM	16191	16191	C	T	het		QUAL=361820;DP=5099;AF=0.92;MQM=59;TRIO=HET,5099,0.92,HOM,3889,0.96,HOM,3983,0.96						0	0	0	0										0.2121	0.3106	0.4773	31	44	n/a	n/a
chrM	16225	16225	T	C	hom		QUAL=502135;DP=6509;AF=1.00;MQM=59;TRIO=HOM,6509,1.00,HOM,4389,1.00,HOM,4617,1.00						0	0	0	0										0.8636	0	0.1364	139	0	n/a	n/a
chrM	16300	16300	T	C	hom		QUAL=331247;DP=6044;AF=0.99;MQM=59;TRIO=HOM,6044,0.99,HOM,4193,0.99,WT,4768,0.00						0	0	0	0										0.0455	0	0.9545	6	0	n/a	n/a
chrM	16322	16322	T	C	hom		QUAL=481341;DP=5527;AF=1.00;MQM=59;TRIO=HOM,5527,1.00,HOM,4347,1.00,HOM,4842,1.00						0	0	0	0										0.9924	0	0.0076	160	0	n/a	n/a
chrX	2856155	2856155	C	T	hom		QUAL=5933;DP=74;AF=1.00;MQM=59;TRIO=HOM,74,1.00,HOM,69,0.99,HOM,58,1.00	ARSE	missense	ARSE:NM_001282628.1:missense:MODERATE:exon10/12:c.1345G>A:p.Gly449Ser,ARSE:NM_000047.2:missense:MODERATE:exon9/11:c.1270G>A:p.Gly424Ser,ARSE:NM_001282631.1:missense:MODERATE:exon8/10:c.1135G>A:p.Gly379Ser		rs35143646	0.5746	0.664	0.6707	0.1793	6.3350	P	T	P,P,P	P,B,P		RCV000145026.1 [benign]; 			0.6742	0.1439	0.1818	347	73	n/a	n/a
chrX	5808861	5808861	G	A	hom		QUAL=12579;DP=194;AF=0.99;MQM=60;TRIO=HOM,194,0.99,HET,150,0.55,HOM,113,1.00	NLGN4X	3'UTR	NLGN4X:NM_001282145.1:3'UTR:MODIFIER:exon7/7:c.*1997C>T:,NLGN4X:NM_001282146.1:3'UTR:MODIFIER:exon6/6:c.*1997C>T:,NLGN4X:NM_020742.3:3'UTR:MODIFIER:exon6/6:c.*1997C>T:,NLGN4X:NM_181332.2:3'UTR:MODIFIER:exon6/6:c.*1997C>T:		rs1882260	0.7083	0	0	0										0.6742	0.1591	0.1667	170	31	n/a	n/a
chrX	5810090	5810090	A	G	hom		QUAL=3794;DP=95;AF=0.99;MQM=60;TRIO=HOM,95,0.99,HET,57,0.47,WT,26,0.00	NLGN4X	3'UTR	NLGN4X:NM_001282145.1:3'UTR:MODIFIER:exon7/7:c.*768T>C:,NLGN4X:NM_001282146.1:3'UTR:MODIFIER:exon6/6:c.*768T>C:,NLGN4X:NM_020742.3:3'UTR:MODIFIER:exon6/6:c.*768T>C:,NLGN4X:NM_181332.2:3'UTR:MODIFIER:exon6/6:c.*768T>C:	(TATATG)n	rs3810685	0.3687	0	0	0										0.3182	0.2652	0.4167	92	45	n/a	n/a
chrX	5810574	5810574	C	T	hom		QUAL=10452;DP=204;AF=1.00;MQM=60;TRIO=HOM,204,1.00,HET,250,0.46,WT,176,0.00	NLGN4X	3'UTR	NLGN4X:NM_001282145.1:3'UTR:MODIFIER:exon7/7:c.*284G>A:,NLGN4X:NM_001282146.1:3'UTR:MODIFIER:exon6/6:c.*284G>A:,NLGN4X:NM_020742.3:3'UTR:MODIFIER:exon6/6:c.*284G>A:,NLGN4X:NM_181332.2:3'UTR:MODIFIER:exon6/6:c.*284G>A:		rs3810686	0.3674	0	0	0										0.3258	0.2576	0.4167	94	44	n/a	n/a
chrX	10588431	10588431	C	A	hom		QUAL=14612;DP=266;AF=0.98;MQM=59;TRIO=HOM,266,0.98,HET,436,0.50,WT,233,0.00	MID1	5'UTR,intron	MID1:NM_000381.3:5'UTR:MODIFIER:exon1/10:c.-158G>T:,MID1:NM_033289.1:5'UTR:MODIFIER:exon1/10:c.-158G>T:,MID1:NM_001098624.2:intron:MODIFIER:exon1/9:c.-56-52788G>T:,MID1:NM_033290.3:intron:MODIFIER:exon1/9:c.-56-52788G>T:		rs147326498	0.0037	0	0	0										0	0.0076	0.9924	2	1	n/a	n/a
chrX	12725042	12725042	C	T	het		QUAL=197;DP=8;AF=0.13;MQM=56;TRIO=HET,8,0.13,WT,12,0.17,WT,10,0.60	FRMPD4	splice_region&intron	FRMPD4:NM_014728.3:splice_region&intron:LOW:exon12/16:c.1287+8C>T:			0	0	0	0										0	0.053	0.947	0	12	n/a	n/a
chrX	12739294	12739294	A	G	hom		QUAL=8965;DP=157;AF=1.00;MQM=60;TRIO=HOM,157,1.00,HET,281,0.45,WT,188,0.01	FRMPD4	3'UTR	FRMPD4:NM_014728.3:3'UTR:MODIFIER:exon17/17:c.*642A>G:		rs3827468	0.2662	0	0	0										0.2121	0.25	0.5379	92	64	n/a	n/a
chrX	12739359	12739359	G	C	hom		QUAL=8703;DP=138;AF=0.99;MQM=59;TRIO=HOM,138,0.99,HET,311,0.45,WT,182,0.00	FRMPD4	3'UTR	FRMPD4:NM_014728.3:3'UTR:MODIFIER:exon17/17:c.*707G>C:		rs5979716	0.0885	0	0	0										0.0303	0.053	0.9167	12	11	n/a	n/a
chrX	12740371	12740371	A	G	hom		QUAL=6748;DP=118;AF=0.99;MQM=60;TRIO=HOM,118,0.99,HOM,93,1.00,WT,55,0.00	FRMPD4	3'UTR	FRMPD4:NM_014728.3:3'UTR:MODIFIER:exon17/17:c.*1719A>G:		rs5978572	0.5089	0	0	0										0.2273	0.2348	0.5379	62	34	n/a	n/a
chrX	12741502	12741502	T	G	hom		QUAL=13400;DP=172;AF=0.99;MQM=60;TRIO=HOM,172,0.99,HOM,245,1.00,WT,181,0.01	FRMPD4	3'UTR	FRMPD4:NM_014728.3:3'UTR:MODIFIER:exon17/17:c.*2850T>G:		rs5979717	0.631	0	0	0										0.5227	0.2121	0.2652	76	29	n/a	n/a
chrX	13752895	13752895	G	T	hom		QUAL=3469;DP=91;AF=1.00;MQM=59;TRIO=HOM,91,1.00,HET,80,0.40,WT,56,0.02	OFD1	5'UTR	OFD1:NM_003611.2:5'UTR:MODIFIER:exon1/23:c.-296G>T:		rs2285635	0.3767	0	0	0							RCV000034056.2 [benign]; 			0.1136	0.1818	0.7045	40	31	n/a	n/a
chrX	14868806	14868806	A	G	hom		QUAL=78;DP=3;AF=1.00;MQM=60;TRIO=HOM,3,1.00,HET,2,0.50,WT,1,0.00	FANCB	splice_region&intron	FANCB:NM_001018113.1:splice_region&intron:LOW:exon6/9:c.1327-10T>C:,FANCB:NM_152633.2:splice_region&intron:LOW:exon5/8:c.1327-10T>C:		rs2905223	0.4336	0.514	0.5893	0.4918							RCV000079364.2 [benign]; 			0.1591	0.0379	0.803	247	69	n/a	n/a
chrX	14887147	14887147	C	G	hom		QUAL=9395;DP=173;AF=0.99;MQM=60;TRIO=HOM,173,0.99,HET,236,0.47,WT,163,0.00	FANCB	5'UTR,intron	FANCB:NM_001018113.1:5'UTR:MODIFIER:exon2/10:c.-173G>C:,FANCB:NM_152633.2:intron:MODIFIER:exon1/8:c.-70-3445G>C:		rs2188383	0.5256	0	0	0										0.4924	0.1818	0.3258	123	31	n/a	n/a
chrX	15337614	15337614	T	C	hom		QUAL=2410;DP=63;AF=1.00;MQM=60;TRIO=HOM,63,1.00,HET,39,0.41,WT,32,0.00	PIGA	3'UTR	PIGA:NM_002641.3:3'UTR:MODIFIER:exon6/6:c.*2014A>G:,PIGA:NM_020473.3:3'UTR:MODIFIER:exon5/5:c.*2014A>G:		rs3434	0.3608	0	0	0										0.3106	0.2348	0.4545	76	40	n/a	n/a
chrX	15337849	15337849	-	A	hom		QUAL=5287;DP=92;AF=0.95;MQM=60;TRIO=HOM,92,0.95,HOM,85,0.98,WT,57,0.00	PIGA	3'UTR	PIGA:NM_002641.3:3'UTR:MODIFIER:exon6/6:c.*1778dupT:,PIGA:NM_020473.3:3'UTR:MODIFIER:exon5/5:c.*1778dupT:		rs397950456	0.5783	0	0	0										0.3939	0.2045	0.4015	95	36	n/a	n/a
chrX	15337882	15337882	A	T	hom		QUAL=5205;DP=122;AF=1.00;MQM=60;TRIO=HOM,122,1.00,HET,80,0.48,WT,54,0.00	PIGA	3'UTR	PIGA:NM_002641.3:3'UTR:MODIFIER:exon6/6:c.*1746T>A:,PIGA:NM_020473.3:3'UTR:MODIFIER:exon5/5:c.*1746T>A:		rs3087965	0.3793	0	0	0										0.3258	0.2197	0.4545	78	38	n/a	n/a
chrX	15338002	15338002	A	G	hom		QUAL=4820;DP=111;AF=0.99;MQM=59;TRIO=HOM,111,0.99,HET,81,0.44,WT,60,0.00	PIGA	3'UTR	PIGA:NM_002641.3:3'UTR:MODIFIER:exon6/6:c.*1626T>C:,PIGA:NM_020473.3:3'UTR:MODIFIER:exon5/5:c.*1626T>C:		rs3661	0.4146	0	0	0										0.3258	0.2197	0.4545	77	38	n/a	n/a
chrX	15844899	15844899	A	-	het		QUAL=900;DP=41;AF=0.00;MQM=60;TRIO=HET,41,0.00,HET,23,0.26,WT,7,0.43	AP1S2	3'UTR	AP1S2:NM_001272071.1:3'UTR:MODIFIER:exon6/6:c.*549delT:,AP1S2:NM_003916.4:3'UTR:MODIFIER:exon5/5:c.*549delT:		rs201939651	0	0	0	0										0.0758	0.1136	0.8106	17	17	n/a	n/a
chrX	15845010	15845010	T	-	het		QUAL=376;DP=53;AF=0.17;MQM=58;TRIO=HET,53,0.17,HET,11,0.45,HET,6,0.33	AP1S2	3'UTR	AP1S2:NM_001272071.1:3'UTR:MODIFIER:exon6/6:c.*438delA:,AP1S2:NM_003916.4:3'UTR:MODIFIER:exon5/5:c.*438delA:		rs35656473	0.2276	0	0	0										0.0606	0.0379	0.9015	14	6	n/a	n/a
chrX	17753436	17753436	A	T	hom		QUAL=18754;DP=179;AF=1.00;MQM=60;TRIO=HOM,179,1.00,HOM,223,1.00,HOM,167,1.00	NHS	3'UTR	NHS:NM_001291867.1:3'UTR:MODIFIER:exon9/9:c.*2852A>T:,NHS:NM_198270.3:3'UTR:MODIFIER:exon8/8:c.*2852A>T:,NHS:NM_001136024.3:3'UTR:MODIFIER:exon9/9:c.*2852A>T:,NHS:NM_001291868.1:3'UTR:MODIFIER:exon8/8:c.*2852A>T:		rs5909331	1	0	0	0										1	0	0	243	0	n/a	n/a
chrX	21392728	21392730	GCA	-	het		QUAL=4346;DP=4;AF=0.25;MQM=60;TRIO=HET,4,1.00,HET,172,0.48,HET,116,0.93	CNKSR2	5'UTR	CNKSR2:NM_014927.3:5'UTR:MODIFIER:exon1/22:c.-268_-266delAGC:,CNKSR2:NM_001168648.1:5'UTR:MODIFIER:exon1/21:c.-268_-266delAGC:,CNKSR2:NM_001168649.1:5'UTR:MODIFIER:exon1/20:c.-268_-266delAGC:,CNKSR2:NM_001168647.1:5'UTR:MODIFIER:exon1/21:c.-268_-266delAGC:	(CAG)n		0	0	0	0										0.0758	0.1136	0.8106	11	17	n/a	n/a
chrX	21392748	21392748	A	C	het		QUAL=4346;DP=4;AF=0.25;MQM=60;TRIO=HET,4,1.00,WT,172,0.48,HET,116,0.93	CNKSR2	5'UTR	CNKSR2:NM_014927.3:5'UTR:MODIFIER:exon1/22:c.-268A>C:,CNKSR2:NM_001168648.1:5'UTR:MODIFIER:exon1/21:c.-268A>C:,CNKSR2:NM_001168649.1:5'UTR:MODIFIER:exon1/20:c.-268A>C:,CNKSR2:NM_001168647.1:5'UTR:MODIFIER:exon1/21:c.-268A>C:	(CAG)n	rs111387801	0.2498	0	0	0										0.0455	0.3939	0.5606	6	56	n/a	n/a
chrX	21672413	21672413	C	A	het		QUAL=1361;DP=99;AF=0.57;MQM=51;TRIO=HET,99,0.57,HET,24,0.33,HET,20,0.15	CNKSR2	3'UTR	CNKSR2:NM_014927.3:3'UTR:MODIFIER:exon22/22:c.*1774C>A:,CNKSR2:NM_001168647.1:3'UTR:MODIFIER:exon21/21:c.*1774C>A:	(A)n	rs202179371	0	0	0	0									COSN200730	0.0076	0.3106	0.6818	1	45	n/a	n/a
chrX	21861434	21861434	A	G	hom		QUAL=12210;DP=95;AF=1.00;MQM=60;TRIO=HOM,95,1.00,HET,250,0.50,HOM,165,1.00	MBTPS2	splice_region&synonymous	MBTPS2:NM_015884.3:splice_region&synonymous:LOW:exon2/11:c.222A>G:p.Gln74Gln		rs3213451	0.4577	0.415	0.3896	0.466							RCV000081783.2 [benign]; 		COSM3759448	0.2879	0.2273	0.4848	204	99	n/a	n/a
chrX	21901903	21901903	G	A	hom		QUAL=14596;DP=160;AF=0.99;MQM=60;TRIO=HOM,160,0.99,HET,249,0.53,HOM,164,0.99	MBTPS2	3'UTR	MBTPS2:NM_015884.3:3'UTR:MODIFIER:exon11/11:c.*1130G>A:		rs5951476	0.4281	0	0	0										0.2955	0.2424	0.4621	82	39	n/a	n/a
chrX	23412685	23412685	T	C	hom		QUAL=9041;DP=114;AF=1.00;MQM=59;TRIO=HOM,114,1.00,HET,121,0.53,HOM,103,1.00	PTCHD1	3'UTR	PTCHD1:NM_173495.2:3'UTR:MODIFIER:exon3/3:c.*383T>C:		rs5926307	0.5513	0	0	0										0.4015	0.2348	0.3636	59	34	n/a	n/a
chrX	23412936	23412936	T	C	hom		QUAL=18545;DP=209;AF=1.00;MQM=60;TRIO=HOM,209,1.00,HET,308,0.56,HOM,199,0.98	PTCHD1	3'UTR	PTCHD1:NM_173495.2:3'UTR:MODIFIER:exon3/3:c.*634T>C:		rs1317583	0.6302	0	0	0										0.4015	0.2348	0.3636	59	34	n/a	n/a
chrX	24073761	24073761	C	T	hom		QUAL=14221;DP=163;AF=1.00;MQM=59;TRIO=HOM,163,1.00,HOM,181,1.00,HOM,118,1.00	EIF2S3	synonymous	EIF2S3:NM_001415.3:synonymous:LOW:exon2/12:c.99C>T:p.His33His		rs36018672	0.3632	0.547	0.6748	0.1937	0.0700	P					RCV000116975.2 [likely benign]; 		COSM3759454	0.5606	0.2424	0.197	270	73	n/a	n/a
chrX	24095043	24095043	C	T	het		QUAL=5505;DP=114;AF=0.89;MQM=57;TRIO=HET,114,0.89,HOM,59,0.95,HET,32,0.88	EIF2S3	3'UTR	EIF2S3:NM_001415.3:3'UTR:MODIFIER:exon12/12:c.*141C>T:	(T)n	rs5949273	0.365	0	0	0										0.2045	0.2576	0.5379	34	35	n/a	n/a
chrX	24096526	24096526	A	-	het		QUAL=170;DP=133;AF=0.09;MQM=59;TRIO=HET,133,0.09,WT,42,0.05,HET,29,0.28	EIF2S3	3'UTR	EIF2S3:NM_001415.3:3'UTR:MODIFIER:exon12/12:c.*1635delA:	MER5B		0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chrX	25022104	25022104	T	-	het		QUAL=1025;DP=37;AF=0.49;MQM=60;TRIO=HET,37,0.49,HET,57,0.35,HET,44,0.16	ARX	3'UTR	ARX:NM_139058.2:3'UTR:MODIFIER:exon5/5:c.*683delA:	AT_rich	rs67950419	0.4731	0	0	0										0.1591	0.2576	0.5833	23	35	n/a	n/a
chrX	28807442	28807442	G	A	hom		QUAL=7655;DP=84;AF=0.99;MQM=60;TRIO=HOM,84,0.99,HOM,85,1.00,HOM,67,1.00	IL1RAPL1	5'UTR	IL1RAPL1:NM_014271.3:5'UTR:MODIFIER:exon2/11:c.-19G>A:		rs6526806	0.7351	0.583	0.492	0.8941										0.4773	0.2045	0.3182	186	40	n/a	n/a
chrX	30686141	30686141	G	A	hom		QUAL=6082;DP=129;AF=0.98;MQM=57;TRIO=HOM,129,0.98,HET,113,0.52,WT,93,0.00	GK	synonymous	GK:NM_001205019.1:synonymous:LOW:exon3/21:c.165G>A:p.Gln55Gln,GK:NM_000167.5:synonymous:LOW:exon3/19:c.165G>A:p.Gln55Gln,GK:NM_001128127.2:synonymous:LOW:exon3/20:c.165G>A:p.Gln55Gln,GK:NM_203391.3:synonymous:LOW:exon3/20:c.165G>A:p.Gln55Gln		rs34795481	0.0313	0.052	0.076	0.0125										0.0379	0.0682	0.8939	27	28	n/a	n/a
chrX	30747199	30747199	C	T	hom		QUAL=7187;DP=148;AF=0.99;MQM=37;TRIO=HOM,148,0.99,HET,161,0.44,WT,107,0.00	GK	3'UTR	GK:NM_001205019.1:3'UTR:MODIFIER:exon21/21:c.*340C>T:,GK:NM_000167.5:3'UTR:MODIFIER:exon19/19:c.*340C>T:,GK:NM_001128127.2:3'UTR:MODIFIER:exon20/20:c.*340C>T:,GK:NM_203391.3:3'UTR:MODIFIER:exon20/20:c.*340C>T:		rs3931219	0.0318	0	0	0										0.0379	0.0682	0.8939	10	10	n/a	n/a
chrX	30749081	30749081	T	C	hom		QUAL=23093;DP=228;AF=1.00;MQM=60;TRIO=HOM,228,1.00,HOM,286,1.00,HOM,187,1.00	GK	3'UTR	GK:NM_001205019.1:3'UTR:MODIFIER:exon21/21:c.*2222T>C:,GK:NM_000167.5:3'UTR:MODIFIER:exon19/19:c.*2222T>C:,GK:NM_001128127.2:3'UTR:MODIFIER:exon20/20:c.*2222T>C:,GK:NM_203391.3:3'UTR:MODIFIER:exon20/20:c.*2222T>C:		rs2170611	0.8011	0	0	0										0.7197	0.1439	0.1364	107	21	n/a	n/a
chrX	30749142	30749142	T	G	hom		QUAL=21620;DP=174;AF=1.00;MQM=60;TRIO=HOM,174,1.00,HOM,300,1.00,HOM,183,1.00	GK	3'UTR	GK:NM_001205019.1:3'UTR:MODIFIER:exon21/21:c.*2283T>G:,GK:NM_000167.5:3'UTR:MODIFIER:exon19/19:c.*2283T>G:,GK:NM_001128127.2:3'UTR:MODIFIER:exon20/20:c.*2283T>G:,GK:NM_203391.3:3'UTR:MODIFIER:exon20/20:c.*2283T>G:		rs5927599	0.7581	0	0	0										0.7197	0.1439	0.1364	107	21	n/a	n/a
chrX	31138589	31138589	T	C	hom		QUAL=9522;DP=150;AF=0.99;MQM=60;TRIO=HOM,150,0.99,HET,114,0.58,HOM,75,1.00	DMD	3'UTR	DMD:NM_004006.2:3'UTR:MODIFIER:exon79/79:c.*1447A>G:,DMD:NM_004015.2:3'UTR:MODIFIER:exon18/18:c.*1447A>G:,DMD:NM_004016.2:3'UTR:MODIFIER:exon17/17:c.*1361A>G:,DMD:NM_004017.2:3'UTR:MODIFIER:exon17/17:c.*1447A>G:,DMD:NM_004018.2:3'UTR:MODIFIER:exon16/16:c.*1361A>G:,DMD:NM_004014.2:3'UTR:MODIFIER:exon25/25:c.*1447A>G:,DMD:NM_004013.2:3'UTR:MODIFIER:exon36/36:c.*1447A>G:,DMD:NM_004020.3:3'UTR:MODIFIER:exon32/32:c.*1447A>G:,DMD:NM_004021.2:3'UTR:MODIFIER:exon35/35:c.*1361A>G:,DMD:NM_004022.2:3'UTR:MODIFIER:exon34/34:c.*1361A>G:,DMD:NM_004023.2:3'UTR:MODIFIER:exon31/31:c.*1361A>G:,DMD:NM_004011.3:3'UTR:MODIFIER:exon51/51:c.*1447A>G:,DMD:NM_004012.3:3'UTR:MODIFIER:exon51/51:c.*1447A>G:,DMD:NM_004010.3:3'UTR:MODIFIER:exon79/79:c.*1447A>G:,DMD:NM_004009.3:3'UTR:MODIFIER:exon79/79:c.*1447A>G:,DMD:NM_000109.3:3'UTR:MODIFIER:exon79/79:c.*1447A>G:		rs3361	0.3542	0	0	0										0.1439	0.1818	0.6742	41	34	n/a	n/a
chrX	31196550	31196550	T	-	het		QUAL=2443;DP=171;AF=0.12;MQM=60;TRIO=HET,171,0.12,HET,133,0.06,HET,100,0.77	DMD	3'UTR,intron	DMD:NM_004019.2:3'UTR:MODIFIER:exon9/9:c.*232delA:,DMD:NM_004006.2:intron:MODIFIER:exon70/78:c.10223+236delA:,DMD:NM_004015.2:intron:MODIFIER:exon9/17:c.1019+236delA:,DMD:NM_004016.2:intron:MODIFIER:exon9/16:c.1019+236delA:,DMD:NM_004017.2:intron:MODIFIER:exon9/16:c.1019+236delA:,DMD:NM_004018.2:intron:MODIFIER:exon9/15:c.1019+236delA:,DMD:NM_004014.2:intron:MODIFIER:exon16/24:c.2036+236delA:,DMD:NM_004013.2:intron:MODIFIER:exon27/35:c.2843+236delA:,DMD:NM_004020.3:intron:MODIFIER:exon27/31:c.2843+236delA:,DMD:NM_004021.2:intron:MODIFIER:exon27/34:c.2843+236delA:,DMD:NM_004022.2:intron:MODIFIER:exon27/33:c.2843+236delA:,DMD:NM_004023.2:intron:MODIFIER:exon27/30:c.2843+236delA:,DMD:NM_004011.3:intron:MODIFIER:exon42/50:c.6200+236delA:,DMD:NM_004012.3:intron:MODIFIER:exon42/50:c.6191+236delA:,DMD:NM_004010.3:intron:MODIFIER:exon70/78:c.9854+236delA:,DMD:NM_004009.3:intron:MODIFIER:exon70/78:c.10211+236delA:,DMD:NM_000109.3:intron:MODIFIER:exon70/78:c.10199+236delA:		rs11333372	0.4111	0	0	0										0.1515	0.197	0.6515	43	27	n/a	n/a
chrX	31496350	31496350	C	T	hom		QUAL=9175;DP=113;AF=1.00;MQM=60;TRIO=HOM,113,1.00,HOM,96,1.00,HOM,77,1.00	DMD	missense	DMD:NM_004006.2:missense:MODERATE:exon59/79:c.8810G>A:p.Arg2937Gln,DMD:NM_004014.2:missense:MODERATE:exon5/25:c.623G>A:p.Arg208Gln,DMD:NM_004013.2:missense:MODERATE:exon16/36:c.1430G>A:p.Arg477Gln,DMD:NM_004020.3:missense:MODERATE:exon16/32:c.1430G>A:p.Arg477Gln,DMD:NM_004021.2:missense:MODERATE:exon16/35:c.1430G>A:p.Arg477Gln,DMD:NM_004022.2:missense:MODERATE:exon16/34:c.1430G>A:p.Arg477Gln,DMD:NM_004023.2:missense:MODERATE:exon16/31:c.1430G>A:p.Arg477Gln,DMD:NM_004011.3:missense:MODERATE:exon31/51:c.4787G>A:p.Arg1596Gln,DMD:NM_004012.3:missense:MODERATE:exon31/51:c.4778G>A:p.Arg1593Gln,DMD:NM_004010.3:missense:MODERATE:exon59/79:c.8441G>A:p.Arg2814Gln,DMD:NM_004009.3:missense:MODERATE:exon59/79:c.8798G>A:p.Arg2933Gln,DMD:NM_000109.3:missense:MODERATE:exon59/79:c.8786G>A:p.Arg2929Gln		rs1800280	0.8819	0.898	0.9392	0.9877	0.8710	P	T	B,B,B,B,B,B,B,B,B	B,B,B,B,B,B,B,B,B		RCV000124712.1,RCV000152765.1 [benign,benign]; 	CM135605 [CLASS=DM? MUT=REF PHEN="Muscular dystrophy, Duchenne" GENE=DMD]; 		0.9394	0.0455	0.0152	579	15	2	n/a
chrX	31697636	31697636	A	G	hom		QUAL=9664;DP=87;AF=0.99;MQM=60;TRIO=HOM,87,0.99,HET,172,0.49,HOM,131,0.99	DMD	synonymous	DMD:NM_004006.2:synonymous:LOW:exon53/79:c.7728T>C:p.Asn2576Asn,DMD:NM_004013.2:synonymous:LOW:exon10/36:c.348T>C:p.Asn116Asn,DMD:NM_004020.3:synonymous:LOW:exon10/32:c.348T>C:p.Asn116Asn,DMD:NM_004021.2:synonymous:LOW:exon10/35:c.348T>C:p.Asn116Asn,DMD:NM_004022.2:synonymous:LOW:exon10/34:c.348T>C:p.Asn116Asn,DMD:NM_004023.2:synonymous:LOW:exon10/31:c.348T>C:p.Asn116Asn,DMD:NM_004011.3:synonymous:LOW:exon25/51:c.3705T>C:p.Asn1235Asn,DMD:NM_004012.3:synonymous:LOW:exon25/51:c.3696T>C:p.Asn1232Asn,DMD:NM_004010.3:synonymous:LOW:exon53/79:c.7359T>C:p.Asn2453Asn,DMD:NM_004009.3:synonymous:LOW:exon53/79:c.7716T>C:p.Asn2572Asn,DMD:NM_000109.3:synonymous:LOW:exon53/79:c.7704T>C:p.Asn2568Asn		rs1801188	0.1812	0.172	0.2027	0.1067	1.0650	P					RCV000080769.2 [benign]; RCV000124706.1 [benign]; 		COSM3759471	0.1667	0.1364	0.697	102	64	n/a	n/a
chrX	31893307	31893307	T	G	hom		QUAL=3781;DP=64;AF=0.98;MQM=60;TRIO=HOM,64,0.98,HET,118,0.50,WT,68,0.00	DMD	splice_donor	DMD:NM_004006.2:splice_donor:HIGH:exon48/78:c.7095+1A>C:,DMD:NM_004013.2:splice_donor:HIGH:exon5/35:c.-286+1A>C:,DMD:NM_004020.3:splice_donor:HIGH:exon5/31:c.-286+1A>C:,DMD:NM_004021.2:splice_donor:HIGH:exon5/34:c.-286+1A>C:,DMD:NM_004022.2:splice_donor:HIGH:exon5/33:c.-286+1A>C:,DMD:NM_004023.2:splice_donor:HIGH:exon5/30:c.-286+1A>C:,DMD:NM_004011.3:splice_donor:HIGH:exon20/50:c.3072+1A>C:,DMD:NM_004012.3:splice_donor:HIGH:exon20/50:c.3063+1A>C:,DMD:NM_004010.3:splice_donor:HIGH:exon48/78:c.6726+1A>C:,DMD:NM_004009.3:splice_donor:HIGH:exon48/78:c.7083+1A>C:,DMD:NM_000109.3:splice_donor:HIGH:exon48/78:c.7071+1A>C:		rs1800275	0.1833	0.22	0.2178	0.1816	2.4550	P,P	T,.	D,D,D,D,D,.	D,D,D,D,D,.		RCV000124703.1,RCV000152810.1 [benign,benign]; 		COSM3759472	0.1288	0.1515	0.7197	88	70	n/a	n/a
chrX	38547308	38547308	C	A	hom		QUAL=16867;DP=208;AF=1.00;MQM=60;TRIO=HOM,208,1.00,HOM,368,0.99,WT,297,0.00	TSPAN7	3'UTR	TSPAN7:NM_004615.3:3'UTR:MODIFIER:exon8/8:c.*123C>A:		rs15765	0.7115	0	0	0										0.5909	0.1818	0.2273	146	27	n/a	n/a
chrX	38547862	38547862	G	A	hom		QUAL=13478;DP=174;AF=0.99;MQM=60;TRIO=HOM,174,0.99,HOM,245,1.00,WT,168,0.01	TSPAN7	3'UTR	TSPAN7:NM_004615.3:3'UTR:MODIFIER:exon8/8:c.*677G>A:		rs10333	0.7229	0	0	0										0.5909	0.1818	0.2273	145	28	n/a	n/a
chrX	38548083	38548083	G	A	hom		QUAL=6004;DP=128;AF=0.98;MQM=60;TRIO=HOM,128,0.98,HOM,58,1.00,WT,47,0.00	TSPAN7	3'UTR	TSPAN7:NM_004615.3:3'UTR:MODIFIER:exon8/8:c.*898G>A:		rs3269	0.72	0	0	0										0.5833	0.1894	0.2273	145	28	n/a	n/a
chrX	39911629	39911629	C	T	hom		QUAL=9461;DP=204;AF=0.99;MQM=60;TRIO=HOM,204,0.99,HET,198,0.50,WT,137,0.00	BCOR	synonymous	BCOR:NM_001123385.1:synonymous:LOW:exon15/15:c.5001G>A:p.Ser1667Ser,BCOR:NM_017745.5:synonymous:LOW:exon15/15:c.4899G>A:p.Ser1633Ser,BCOR:NM_001123383.1:synonymous:LOW:exon15/15:c.4899G>A:p.Ser1633Ser,BCOR:NM_001123384.1:synonymous:LOW:exon14/14:c.4845G>A:p.Ser1615Ser		rs375878497	0	0.0001	0.0001	0.0003	-1.5110	D								0	0.0076	0.9924	0	1	n/a	n/a
chrX	39933339	39933339	A	G	hom		QUAL=15603;DP=113;AF=1.00;MQM=60;TRIO=HOM,113,1.00,HOM,235,1.00,HOM,142,0.99	BCOR	synonymous	BCOR:NM_001123385.1:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp,BCOR:NM_017745.5:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp,BCOR:NM_001123383.1:synonymous:LOW:exon4/15:c.1260T>C:p.Asp420Asp,BCOR:NM_001123384.1:synonymous:LOW:exon4/14:c.1260T>C:p.Asp420Asp		rs5917933	0.903	0.889	0.8792	0.9249							RCV000081809.4 [other]; 		COSM4156840	0.7803	0.1136	0.1061	505	54	n/a	n/a
chrX	43571197	43571197	A	C	hom		QUAL=7617;DP=141;AF=0.99;MQM=60;TRIO=HOM,141,0.99,HET,202,0.50,WT,148,0.00	MAOA	synonymous,5'UTR	MAOA:NM_000240.3:synonymous:LOW:exon4/15:c.385A>C:p.Arg129Arg,MAOA:NM_001270458.1:5'UTR:MODIFIER:exon5/16:c.-15A>C:		rs1800464	0.1571	0.074	0.041	0.4993							RCV000117593.2 [likely benign]; 			0.0227	0.053	0.9242	25	24	n/a	n/a
chrX	43591036	43591036	G	T	hom		QUAL=20695;DP=188;AF=0.99;MQM=60;TRIO=HOM,188,0.99,HOM,289,1.00,HOM,169,0.99	MAOA	synonymous	MAOA:NM_000240.3:synonymous:LOW:exon8/15:c.891G>T:p.Arg297Arg,MAOA:NM_001270458.1:synonymous:LOW:exon9/16:c.492G>T:p.Arg164Arg		rs6323	0.6249	0.646	0.7045	0.8532							RCV000078415.4 [other]; 	CM073190 [CLASS=DP MUT=REF PHEN="Bipolar disorder, association with" GENE=MAOA]; 	COSM4156846	0.5909	0.2197	0.1894	375	87	n/a	n/a
chrX	43603391	43603391	T	C	hom		QUAL=27792;DP=315;AF=1.00;MQM=60;TRIO=HOM,315,1.00,HOM,291,1.00,HOM,228,1.00	MAOA	synonymous	MAOA:NM_000240.3:synonymous:LOW:exon14/15:c.1410T>C:p.Asp470Asp,MAOA:NM_001270458.1:synonymous:LOW:exon15/16:c.1011T>C:p.Asp337Asp		rs1137070	0.5518	0.619	0.7035	0.6201							RCV000078414.4 [other]; 			0.5909	0.2197	0.1894	372	90	n/a	n/a
chrX	43604841	43604841	A	G	hom		QUAL=6799;DP=125;AF=1.00;MQM=60;TRIO=HOM,125,1.00,HOM,41,1.00,HOM,34,1.00	MAOA	3'UTR	MAOA:NM_000240.3:3'UTR:MODIFIER:exon15/15:c.*1081A>G:,MAOA:NM_001270458.1:3'UTR:MODIFIER:exon16/16:c.*1081A>G:		rs3027407	0.551	0	0	0										0.5909	0.2197	0.1894	146	34	n/a	n/a
chrX	43605100	43605100	A	-	hom		QUAL=4252;DP=118;AF=0.95;MQM=60;TRIO=HOM,118,0.95,HET,60,0.42,WT,49,0.00	MAOA	3'UTR	MAOA:NM_000240.3:3'UTR:MODIFIER:exon15/15:c.*1341delA:,MAOA:NM_001270458.1:3'UTR:MODIFIER:exon16/16:c.*1341delA:			0	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a
chrX	43818002	43818002	C	A	hom		QUAL=18790;DP=398;AF=0.99;MQM=60;TRIO=HOM,398,0.99,HET,387,0.50,WT,208,0.00	NDP	5'UTR	NDP:NM_000266.3:5'UTR:MODIFIER:exon2/3:c.-111G>T:		rs45501198	0.0132	0	0	0										0.0076	0.0152	0.9773	2	6	n/a	n/a
chrX	44938563	44938563	G	A	hom		QUAL=4697;DP=95;AF=1.00;MQM=60;TRIO=HOM,95,1.00,HET,139,0.41,WT,92,0.00	KDM6A	synonymous	KDM6A:NM_001291415.1:synonymous:LOW:exon21/30:c.3267G>A:p.Gln1089Gln,KDM6A:NM_001291416.1:synonymous:LOW:exon20/29:c.3132G>A:p.Gln1044Gln,KDM6A:NM_001291417.1:synonymous:LOW:exon19/28:c.2976G>A:p.Gln992Gln,KDM6A:NM_001291418.1:synonymous:LOW:exon18/27:c.2874G>A:p.Gln958Gln,KDM6A:NM_001291421.1:synonymous:LOW:exon18/27:c.2223G>A:p.Gln741Gln,KDM6A:NM_021140.3:synonymous:LOW:exon20/29:c.3111G>A:p.Gln1037Gln		rs20539	0.2217	0.235	0.1885	0.0329	1.8190	P					RCV000146125.2 [benign]; 		COSM1179848	0.1667	0.1212	0.7121	115	66	n/a	n/a
chrX	47061018	47061018	C	G	hom		QUAL=16825;DP=83;AF=1.00;MQM=60;TRIO=HOM,83,1.00,HOM,275,1.00,HOM,174,1.00	UBA1	splice_region&intron	UBA1:NM_003334.3:splice_region&intron:LOW:exon8/25:c.811+9C>G:,UBA1:NM_153280.2:splice_region&intron:LOW:exon8/25:c.811+9C>G:		rs4239964	0.9711	0.978	0.9841	0.9982										0.9773	0.0227	0	533	8	n/a	n/a
chrX	47466361	47466361	A	G	hom		QUAL=20946;DP=172;AF=0.99;MQM=60;TRIO=HOM,172,0.99,HOM,311,1.00,HOM,177,1.00	SYN1	synonymous	SYN1:NM_006950.3:synonymous:LOW:exon3/13:c.510T>C:p.Asn170Asn,SYN1:NM_133499.2:synonymous:LOW:exon3/13:c.510T>C:p.Asn170Asn		rs1142636	0.3687	0.371	0.3786	0.4329							RCV000082513.4 [other]; 			0.2424	0.1818	0.5758	163	80	n/a	n/a
chrX	48759204	48759204	C	T	hom		QUAL=9255;DP=54;AF=1.00;MQM=60;TRIO=HOM,54,1.00,HOM,251,0.99,WT,162,0.01	PQBP1	splice_region&intron	PQBP1:NM_001032381.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_001032382.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_001032383.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_144495.2:splice_region&intron:LOW:exon3/5:c.180-3C>T:,PQBP1:NM_001167989.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_001167990.1:splice_region&intron:LOW:exon3/6:c.156-3C>T:,PQBP1:NM_001032384.1:splice_region&intron:LOW:exon3/6:c.180-3C>T:,PQBP1:NM_005710.2:splice_region&intron:LOW:exon2/5:c.180-3C>T:,PQBP1:NM_001167992.1:splice_region&intron:LOW:exon2/5:c.180-3C>T:		rs741932	0.6254	0.612	0.5932	0.5392							RCV000081326.4 [other]; 			0.5076	0.1818	0.3106	331	78	n/a	n/a
chrX	49646968	49646968	G	A	het		QUAL=27;DP=20;AF=0.20;MQM=57;TRIO=HET,20,0.20,HET,4,0.25,WT,2,0.00	USP27X	3'UTR	USP27X:NM_001145073.2:3'UTR:MODIFIER:exon1/1:c.*741G>A:	(A)n	rs199555442	0	0	0	0										0	0.0606	0.9394	0	9	n/a	n/a
chrX	50334711	50334714	TTTC	-	het		QUAL=286;DP=12;AF=0.75;MQM=46;TRIO=HET,12,1.00,HOM,1,1.00,NONE,0,0	SHROOM4	3'UTR	SHROOM4:NM_020717.3:3'UTR:MODIFIER:exon9/9:c.*4981_*4984delGAAA:	(TTTC)n		0	0	0	0										0.1136	0.0455	0.8409	51	16	n/a	n/a
chrX	50334714	50334721	CTTTCTTT	-	het		QUAL=286;DP=12;AF=0.75;MQM=40;TRIO=HET,12,1.00,WT,1,1.00,NONE,0,0	SHROOM4	3'UTR	SHROOM4:NM_020717.3:3'UTR:MODIFIER:exon9/9:c.*4974_*4981delAAAGAAAG:	(TTTC)n		0	0	0	0										0	0	1	0	0	n/a	n/a
chrX	53220836	53220836	G	T	hom		QUAL=18769;DP=171;AF=1.00;MQM=60;TRIO=HOM,171,1.00,HOM,238,1.00,HOM,156,1.00	KDM5C	3'UTR	KDM5C:NM_004187.3:3'UTR:MODIFIER:exon26/26:c.*1313C>A:,KDM5C:NM_001146702.1:3'UTR:MODIFIER:exon24/24:c.*1090C>A:,KDM5C:NM_001282622.1:3'UTR:MODIFIER:exon26/26:c.*1313C>A:		rs1886889	0.8072	0	0	0										0.9394	0.0303	0.0303	230	5	n/a	n/a
chrX	53221259	53221259	-	G	hom		QUAL=4781;DP=70;AF=0.97;MQM=60;TRIO=HOM,70,0.97,HOM,70,0.97,HOM,24,0.96	KDM5C	3'UTR	KDM5C:NM_004187.3:3'UTR:MODIFIER:exon26/26:c.*889dupC:,KDM5C:NM_001146702.1:3'UTR:MODIFIER:exon24/24:c.*666dupC:,KDM5C:NM_001282622.1:3'UTR:MODIFIER:exon26/26:c.*889dupC:	MIRb	rs75167298	0.765	0	0	0										0.9545	0.0303	0.0152	153	5	n/a	n/a
chrX	53222043	53222043	-	C	het		QUAL=104;DP=2;AF=0.50;MQM=60;TRIO=HET,2,0.50,HOM,5,0.20,HET,4,0.75	KDM5C	3'UTR,intron	KDM5C:NM_004187.3:3'UTR:MODIFIER:exon26/26:c.*105dupG:,KDM5C:NM_001282622.1:3'UTR:MODIFIER:exon26/26:c.*105dupG:,KDM5C:NM_001146702.1:intron:MODIFIER:exon23/23:c.4047-25dupG:		rs150558161	0.7759	0.886	0	0										0.6667	0.0303	0.303	270	7	n/a	n/a
chrX	53449568	53449568	G	A	hom		QUAL=15610;DP=161;AF=1.00;MQM=60;TRIO=HOM,161,1.00,HOM,229,1.00,HOM,136,1.00	SMC1A	5'UTR_premature_start_codon_gain,5'UTR	SMC1A:NM_006306.3:5'UTR_premature_start_codon_gain:LOW:exon1/25:c.-19C>T:,SMC1A:NM_001281463.1:5'UTR_premature_start_codon_gain:LOW:exon1/26:c.-231C>T:,SMC1A:NM_006306.3:5'UTR:MODIFIER:exon1/25:c.-19C>T:,SMC1A:NM_001281463.1:5'UTR:MODIFIER:exon1/26:c.-231C>T:		rs1264011	0.3984	0.515	0.5838	0.0941							RCV000081383.2 [benign]; 			0.5227	0.1818	0.2955	179	35	n/a	n/a
chrX	53559668	53559668	C	A	hom		QUAL=9821;DP=116;AF=1.00;MQM=60;TRIO=HOM,116,1.00,HOM,195,1.00,WT,107,0.00	HUWE1	3'UTR	HUWE1:NM_031407.6:3'UTR:MODIFIER:exon84/84:c.*602G>T:		rs12836234	0.057	0	0	0										0.0682	0.0909	0.8409	14	15	n/a	n/a
chrX	53563589	53563589	A	G	hom		QUAL=19753;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HOM,311,1.00,HOM,170,1.00	HUWE1	synonymous	HUWE1:NM_031407.6:synonymous:LOW:exon79/84:c.12177T>C:p.Gly4059Gly		rs426298	0.995	0.998	0.9997	0.9784	-0.3880	P					RCV000082281.4 [other]; 			1	0	0	618	1	1	n/a
chrX	53641647	53641647	T	C	hom		QUAL=4768;DP=66;AF=1.00;MQM=60;TRIO=HOM,66,1.00,HOM,90,0.98,WT,69,0.01	HUWE1	synonymous	HUWE1:NM_031407.6:synonymous:LOW:exon23/84:c.2109A>G:p.Ser703Ser		rs6638360	0.3897	0.49	0.5378	0.0975							RCV000117252.2 [likely benign]; 			0.4773	0.1591	0.3636	268	91	n/a	n/a
chrX	53713601	53713601	C	T	het		QUAL=1310;DP=50;AF=0.24;MQM=60;TRIO=HET,50,0.24,HET,136,0.31,WT,81,0.00	HUWE1	5'UTR	HUWE1:NM_031407.6:5'UTR:MODIFIER:exon1/84:c.-330G>A:	(CCCCAG)n	rs5978184	0.1881	0	0	0										0.053	0.4091	0.5379	10	59	n/a	n/a
chrX	53713640	53713640	G	C	hom		QUAL=8994;DP=71;AF=1.00;MQM=59;TRIO=HOM,71,1.00,HOM,138,1.00,HOM,81,1.00	HUWE1	5'UTR	HUWE1:NM_031407.6:5'UTR:MODIFIER:exon1/84:c.-369C>G:		rs2333864	1	0	0	0										0.9697	0.0152	0.0152	200	2	n/a	n/a
chrX	66944120	66944120	A	-	hom		QUAL=2342;DP=45;AF=0.96;MQM=60;TRIO=HOM,45,0.96,HET,72,0.56,HET,68,0.16	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*447delA:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*447delA:	(CAAAAA)n	rs11351755	0.6805	0	0	0										0.7045	0.1818	0.1136	121	25	n/a	n/a
chrX	66945740	66945740	T	C	hom		QUAL=23105;DP=168;AF=1.00;MQM=60;TRIO=HOM,168,1.00,HOM,337,1.00,HOM,193,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*2057T>C:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*2057T>C:		rs5919413	0.8593	0	0	0										1	0	0	150	0	n/a	n/a
chrX	66946851	66946851	T	C	hom		QUAL=14812;DP=169;AF=1.00;MQM=60;TRIO=HOM,169,1.00,HOM,184,1.00,HOM,109,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*3168T>C:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*3168T>C:		rs1931537	0.8593	0	0	0										1	0	0	149	0	n/a	n/a
chrX	66948019	66948019	-	T	het		QUAL=4469;DP=134;AF=0.78;MQM=60;TRIO=HET,134,0.78,HET,38,0.84,HOM,22,0.91	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*4345dupT:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*4345dupT:		rs397737842	0.8416	0	0	0										0.8712	0.1212	0.0076	131	17	n/a	n/a
chrX	66949722	66949722	C	T	hom		QUAL=9967;DP=130;AF=1.00;MQM=60;TRIO=HOM,130,1.00,HOM,117,1.00,HOM,72,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*6039C>T:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*6039C>T:		rs7440	0.8585	0	0	0										1	0	0	150	0	n/a	n/a
chrX	66950023	66950025	AAG	-	hom		QUAL=3491;DP=27;AF=0.96;MQM=60;TRIO=HOM,27,0.96,HOM,54,1.00,HOM,31,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*6344_*6346delAGA:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*6344_*6346delAGA:		rs553562941	0	0	0	0										0.9697	0.0227	0.0076	144	4	n/a	n/a
chrX	66950105	66950105	C	T	hom		QUAL=9644;DP=121;AF=1.00;MQM=60;TRIO=HOM,121,1.00,HOM,111,1.00,HOM,60,1.00	AR	3'UTR	AR:NM_000044.3:3'UTR:MODIFIER:exon8/8:c.*6422C>T:,AR:NM_001011645.2:3'UTR:MODIFIER:exon8/8:c.*6422C>T:		rs2362520	0.8583	0	0	0										1	0	0	150	0	n/a	n/a
chrX	67263222	67263222	G	A	hom		QUAL=354;DP=6;AF=1.00;MQM=47;TRIO=HOM,6,1.00,HOM,3,1.00,HOM,4,1.00	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*3792C>T:	L1HS	rs7883184	0.1195	0	0	0										0.1136	0.0833	0.803	34	18	n/a	n/a
chrX	67263229	67263229	A	G	het		QUAL=142;DP=4;AF=0.75;MQM=51;TRIO=HET,4,0.75,HOM,2,1.00,HOM,2,1.00	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*3785T>C:		rs184510922	0	0	0	0										0.053	0.0606	0.8864	9	32	n/a	n/a
chrX	67263293	67263293	A	G	hom		QUAL=1024;DP=16;AF=1.00;MQM=60;TRIO=HOM,16,1.00,HOM,11,1.00,HOM,5,1.00	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*3721T>C:		rs7888212	0.5189	0	0	0										0.25	0.1667	0.5833	68	29	n/a	n/a
chrX	67263844	67263844	C	T	hom		QUAL=15454;DP=193;AF=1.00;MQM=60;TRIO=HOM,193,1.00,HOM,162,0.99,HOM,120,0.98	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*3170G>A:		rs492933	0.5094	0	0	0										0.2727	0.197	0.5303	71	34	n/a	n/a
chrX	67265417	67265417	G	T	hom		QUAL=11454;DP=98;AF=1.00;MQM=60;TRIO=HOM,98,1.00,HOM,147,1.00,HOM,107,0.98	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*1597C>A:		rs2254886	0.4297	0	0	0										0.2652	0.197	0.5379	70	34	n/a	n/a
chrX	67265915	67265915	-	T	hom		QUAL=4962;DP=72;AF=0.99;MQM=60;TRIO=HOM,72,0.99,HOM,48,0.98,HOM,37,1.00	OPHN1	3'UTR	OPHN1:NM_002547.2:3'UTR:MODIFIER:exon25/25:c.*1098dupA:	Charlie4z	rs397698299	0.1823	0	0	0										0.197	0.1667	0.6364	52	30	n/a	n/a
chrX	69080840	69080840	G	A	hom		QUAL=13275;DP=142;AF=1.00;MQM=60;TRIO=HOM,142,1.00,HOM,167,1.00,HOM,101,1.00	EDA	3'UTR,intron	EDA:NM_001005610.3:3'UTR:MODIFIER:exon2/2:c.*141G>A:,EDA:NM_001005613.3:3'UTR:MODIFIER:exon3/3:c.*186G>A:,EDA:NM_001399.4:intron:MODIFIER:exon1/7:c.397-96037G>A:,EDA:NM_001005609.1:intron:MODIFIER:exon1/7:c.397-96037G>A:,EDA:NM_001005612.2:intron:MODIFIER:exon1/7:c.397-96037G>A:	L1MEd	rs1203003	1	0	0	0										1	0	0	257	0	n/a	n/a
chrX	69258515	69258515	T	G	hom		QUAL=11503;DP=181;AF=1.00;MQM=60;TRIO=HOM,181,1.00,HET,141,0.52,HOM,90,1.00	EDA	3'UTR	EDA:NM_001399.4:3'UTR:MODIFIER:exon8/8:c.*3056T>G:,EDA:NM_001005609.1:3'UTR:MODIFIER:exon8/8:c.*3056T>G:,EDA:NM_001005612.2:3'UTR:MODIFIER:exon8/8:c.*3056T>G:		rs3795170	0.3939	0	0	0										0.2576	0.2045	0.5379	75	35	n/a	n/a
chrX	69626739	69626739	C	T	hom		QUAL=5455;DP=101;AF=1.00;MQM=59;TRIO=HOM,101,1.00,HET,149,0.48,WT,102,0.00	KIF4A	splice_region&intron	KIF4A:NM_012310.4:splice_region&intron:LOW:exon27/30:c.3073-4C>T:		rs10482161	0.0601	0.068	0.0852	0.1166										0.0455	0.1061	0.8485	18	29	n/a	n/a
chrX	69640700	69640700	C	T	hom		QUAL=8919;DP=192;AF=0.99;MQM=60;TRIO=HOM,192,0.99,HET,172,0.49,WT,117,0.00	KIF4A	3'UTR	KIF4A:NM_012310.4:3'UTR:MODIFIER:exon31/31:c.*585C>T:		rs1063088	0.0257	0	0	0										0.0455	0.0985	0.8561	13	15	n/a	n/a
chrX	69724731	69724731	G	T	hom		QUAL=13564;DP=252;AF=1.00;MQM=59;TRIO=HOM,252,1.00,HET,360,0.50,WT,250,0.01	DLG3	3'UTR	DLG3:NM_021120.3:3'UTR:MODIFIER:exon19/19:c.*2612G>T:,DLG3:NM_020730.2:3'UTR:MODIFIER:exon14/14:c.*2612G>T:,DLG3:NM_001166278.1:3'UTR:MODIFIER:exon12/12:c.*2612G>T:		rs3828017	0.5592	0	0	0										0.3561	0.2424	0.4015	91	41	n/a	n/a
chrX	70390007	70390007	-	CACA	het		QUAL=918;DP=31;AF=0.39;MQM=58;TRIO=HET,31,0.39,HET,82,0.28,WT,56,0.00	NLGN3	3'UTR	NLGN3:NM_181303.1:3'UTR:MODIFIER:exon8/8:c.*78_*81dupACAC:,NLGN3:NM_001166660.1:3'UTR:MODIFIER:exon6/6:c.*78_*81dupACAC:,NLGN3:NM_018977.3:3'UTR:MODIFIER:exon7/7:c.*78_*81dupACAC:	(CA)n	rs35156036	0	0	0	0										0	0.0379	0.9621	0	5	n/a	n/a
chrX	70469182	70469182	G	A	hom		QUAL=17915;DP=168;AF=0.99;MQM=60;TRIO=HOM,168,0.99,HOM,213,1.00,HOM,163,1.00	ZMYM3	3'UTR,intron	ZMYM3:NM_001171163.1:3'UTR:MODIFIER:exon7/7:c.*111C>T:,ZMYM3:NM_005096.3:intron:MODIFIER:exon7/24:c.1470+129C>T:,ZMYM3:NM_201599.2:intron:MODIFIER:exon7/24:c.1470+129C>T:,ZMYM3:NM_001171162.1:intron:MODIFIER:exon7/24:c.1470+129C>T:	L1ME3Cz	rs2341539	0.9992	0	0	0										1	0	0	243	0	n/a	n/a
chrX	73803117	73803117	T	A	het		QUAL=1747;DP=216;AF=0.07;MQM=41;TRIO=HET,216,0.07,WT,309,0.00,HET,245,0.26	RLIM	3'UTR	RLIM:NM_016120.3:3'UTR:MODIFIER:exon4/4:c.*8158A>T:,RLIM:NM_183353.2:3'UTR:MODIFIER:exon5/5:c.*8158A>T:			0	0	0	0										0	0.6894	0.3106	0	125	n/a	n/a
chrX	73803129	73803129	G	A	het		QUAL=1913;DP=216;AF=0.09;MQM=41;TRIO=HET,216,0.09,WT,325,0.00,HET,271,0.25	RLIM	3'UTR	RLIM:NM_016120.3:3'UTR:MODIFIER:exon4/4:c.*8146C>T:,RLIM:NM_183353.2:3'UTR:MODIFIER:exon5/5:c.*8146C>T:			0	0	0	0										0	0.7045	0.2955	0	133	n/a	n/a
chrX	73956893	73956893	T	G	het		QUAL=470;DP=53;AF=0.47;MQM=60;TRIO=HET,53,0.47,WT,48,0.00,WT,31,0.00	KIAA2022	3'UTR	KIAA2022:NM_001008537.2:3'UTR:MODIFIER:exon4/4:c.*2347A>C:		rs199521894	0	0	0	0										0	0.1818	0.8182	0	38	n/a	n/a
chrX	73958629	73958629	G	A	hom		QUAL=9355;DP=115;AF=1.00;MQM=60;TRIO=HOM,115,1.00,HOM,104,1.00,HOM,62,1.00	KIAA2022	3'UTR	KIAA2022:NM_001008537.2:3'UTR:MODIFIER:exon4/4:c.*611C>T:		rs2209549	0.4095	0	0	0										0.7424	0.1439	0.1136	190	24	n/a	n/a
chrX	74589117	74589117	C	T	hom		QUAL=16292;DP=172;AF=0.99;MQM=59;TRIO=HOM,172,0.99,HOM,203,1.00,HOM,128,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*3696G>A:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*3696G>A:		rs7052314	0.4199	0	0	0										0.7197	0.1742	0.1061	109	26	n/a	n/a
chrX	74589173	74589176	TGTG	-	hom		QUAL=8604;DP=70;AF=0.74;MQM=59;TRIO=HOM,70,0.74,HOM,172,0.85,HET,114,0.92	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*3637_*3640delCACA:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*3637_*3640delCACA:	(TG)n		0	0	0	0										0.3106	0.2803	0.4091	47	41	n/a	n/a
chrX	74590136	74590136	G	C	hom		QUAL=13773;DP=122;AF=1.00;MQM=60;TRIO=HOM,122,1.00,HOM,180,1.00,HOM,115,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2677C>G:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2677C>G:		rs1998494	0.8127	0	0	0										0.947	0.0455	0.0076	142	7	n/a	n/a
chrX	74590180	74590180	G	A	hom		QUAL=13464;DP=170;AF=1.00;MQM=60;TRIO=HOM,170,1.00,HOM,150,1.00,HOM,81,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2633C>T:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2633C>T:		rs1998493	0.8127	0	0	0										0.947	0.0455	0.0076	142	7	n/a	n/a
chrX	74590258	74590258	G	T	hom		QUAL=13782;DP=189;AF=0.99;MQM=60;TRIO=HOM,189,0.99,HOM,163,1.00,HOM,83,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2555C>A:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2555C>A:		rs1998492	0.813	0	0	0										0.947	0.0455	0.0076	142	7	n/a	n/a
chrX	74590359	74590368	TTTTTTTTTT	-	het		QUAL=2831;DP=25;AF=0.40;MQM=59;TRIO=HET,25,0.40,HET,61,0.67,HET,36,0.78	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2444_*2453delAAAAAAAAAA:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2444_*2453delAAAAAAAAAA:	AluSp		0	0	0	0										0.2121	0.3258	0.4621	31	46	n/a	n/a
chrX	74590359	74590369	TTTTTTTTTTT	-	het		QUAL=2831;DP=25;AF=0.36;MQM=59;TRIO=HET,25,0.36,HET,61,0.15,HET,36,0.19	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*2444_*2454delAAAAAAAAAAA:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*2444_*2454delAAAAAAAAAAA:	AluSp		0	0	0	0										0.0152	0.2045	0.7803	2	30	n/a	n/a
chrX	74591706	74591706	T	C	hom		QUAL=11057;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HOM,112,1.00,HOM,68,1.00	ZDHHC15	3'UTR	ZDHHC15:NM_144969.2:3'UTR:MODIFIER:exon12/12:c.*1107A>G:,ZDHHC15:NM_001146256.1:3'UTR:MODIFIER:exon11/11:c.*1107A>G:		rs2146770	0.9253	0	0	0										1	0	0	150	0	n/a	n/a
chrX	74743194	74743194	C	G	hom		QUAL=6522;DP=70;AF=1.00;MQM=60;TRIO=HOM,70,1.00,HOM,99,1.00,HOM,43,1.00	ZDHHC15	5'UTR	ZDHHC15:NM_144969.2:5'UTR:MODIFIER:exon1/12:c.-335G>C:,ZDHHC15:NM_001146256.1:5'UTR:MODIFIER:exon1/11:c.-335G>C:,ZDHHC15:NM_001146257.1:5'UTR:MODIFIER:exon1/3:c.-335G>C:		rs11796028	0.3846	0	0	0										0.7045	0.1894	0.1061	108	27	n/a	n/a
chrX	76762375	76762375	C	T	het		QUAL=124;DP=50;AF=0.20;MQM=53;TRIO=HET,50,0.20,WT,12,0.00,WT,8,0.00	ATRX	3'UTR	ATRX:NM_000489.4:3'UTR:MODIFIER:exon35/35:c.*1454G>A:,ATRX:NM_138270.3:3'UTR:MODIFIER:exon34/34:c.*1454G>A:	(T)n		0.3462	0	0	0										0	0.0379	0.9621	0	7	n/a	n/a
chrX	77298857	77298857	G	A	hom		QUAL=15655;DP=103;AF=1.00;MQM=60;TRIO=HOM,103,1.00,HOM,236,1.00,HOM,131,1.00	ATP7A	missense	ATP7A:NM_000052.6:missense:MODERATE:exon21/23:c.4048G>A:p.Glu1350Lys,ATP7A:NM_001282224.1:missense:MODERATE:exon20/22:c.3814G>A:p.Glu1272Lys		rs4826245	1	1	0	0	7.0780	P	T	B	B		RCV000078036.2 [benign]; 			1	0	0	619	0	n/a	n/a
chrX	79925246	79925246	A	G	hom		QUAL=2446;DP=44;AF=1.00;MQM=60;TRIO=HOM,44,1.00,HOM,15,1.00,HOM,14,1.00	BRWD3	3'UTR	BRWD3:NM_153252.4:3'UTR:MODIFIER:exon41/41:c.*6862T>C:		rs2063579	0.5211	0	0	0										0.6061	0.2197	0.1742	89	32	n/a	n/a
chrX	79931832	79931835	GTGT	-	hom		QUAL=13381;DP=68;AF=1.00;MQM=59;TRIO=HOM,68,1.00,HOM,226,0.98,HOM,161,0.98	BRWD3	3'UTR	BRWD3:NM_153252.4:3'UTR:MODIFIER:exon41/41:c.*273_*276delACAC:	(TG)n	rs397895620	0.5136	0	0	0										0.6212	0.2121	0.1667	150	36	n/a	n/a
chrX	79943569	79943569	T	C	hom		QUAL=14368;DP=116;AF=0.99;MQM=60;TRIO=HOM,116,0.99,HOM,206,1.00,HOM,115,1.00	BRWD3	missense&splice_region	BRWD3:NM_153252.4:missense&splice_region:MODERATE:exon34/41:c.3863A>G:p.Lys1288Arg		rs3122407	0.9897	0.997	1	0.9731	0.1700	P		B	B					1	0	0	618	1	n/a	n/a
chrX	80065236	80065237	AG	-	hom		QUAL=1291;DP=5;AF=1.00;MQM=60;TRIO=HOM,5,1.00,HOM,26,0.92,HOM,23,0.96				(GA)n	rs199953219	0.8167	0	0	0										0.8788	0.0909	0.0303	173	18	n/a	n/a
chrX	99550883	99550883	G	A	hom		QUAL=912;DP=26;AF=0.96;MQM=60;TRIO=HOM,26,0.96,HET,15,0.53,WT,12,0.00	PCDH19	3'UTR	PCDH19:NM_001184880.1:3'UTR:MODIFIER:exon6/6:c.*392C>T:,PCDH19:NM_001105243.1:3'UTR:MODIFIER:exon5/5:c.*392C>T:,PCDH19:NM_020766.2:3'UTR:MODIFIER:exon5/5:c.*392C>T:		rs1335268	0.2299	0	0	0										0.1894	0.1742	0.6364	54	32	n/a	n/a
chrX	99661969	99661969	G	A	hom		QUAL=10373;DP=119;AF=0.99;MQM=59;TRIO=HOM,119,0.99,HET,441,0.50,WT,279,0.00	PCDH19	synonymous	PCDH19:NM_001184880.1:synonymous:LOW:exon1/6:c.1627C>T:p.Leu543Leu,PCDH19:NM_001105243.1:synonymous:LOW:exon1/5:c.1627C>T:p.Leu543Leu,PCDH19:NM_020766.2:synonymous:LOW:exon1/5:c.1627C>T:p.Leu543Leu		rs1953337	0.0861	0.204	0.2876	0.0478							RCV000079603.3 [benign]; 		COSM3759554	0.1667	0.1818	0.6515	117	68	n/a	n/a
chrX	99926122	99926122	G	A	hom		QUAL=31485;DP=259;AF=1.00;MQM=60;TRIO=HOM,259,1.00,HOM,413,1.00,HOM,287,1.00	SRPX2	3'UTR	SRPX2:NM_014467.2:3'UTR:MODIFIER:exon11/11:c.*138G>A:		rs5967163	0.9656	0	0	0										1	0	0	243	0	n/a	n/a
chrX	100532621	100532621	T	C	hom		QUAL=6633;DP=185;AF=0.99;MQM=60;TRIO=HOM,185,0.99,HET,91,0.44,WT,70,0.00	TAF7L	missense	TAF7L:NM_024885.3:missense:MODERATE:exon9/13:c.922A>G:p.Ser308Gly,TAF7L:NM_001168474.1:missense:MODERATE:exon9/13:c.664A>G:p.Ser222Gly		rs35899692	0.1804	0.144	0.1356	0.2451	2.3940	P	T	B,B	B,B				COSM3759316	0.0833	0.0909	0.8258	65	47	n/a	n/a
chrX	100547933	100547933	A	G	hom		QUAL=28046;DP=201;AF=1.00;MQM=60;TRIO=HOM,201,1.00,HOM,422,1.00,HOM,258,1.00	TAF7L	missense	TAF7L:NM_024885.3:missense:MODERATE:exon1/13:c.101T>C:p.Leu34Pro		rs5951328	0.995	0.99	0.9886	0.9971	-1.2920	P	T	B	B					0.9848	0.0076	0.0076	539	3	n/a	n/a
chrX	103046527	103046527	G	-	hom		QUAL=16817;DP=201;AF=1.00;MQM=60;TRIO=HOM,201,1.00,HOM,183,1.00,HOM,131,1.00	PLP1	3'UTR	PLP1:NM_000533.3:3'UTR:MODIFIER:exon7/7:c.*1005delG:,PLP1:NM_001128834.1:3'UTR:MODIFIER:exon8/8:c.*1005delG:,PLP1:NM_199478.1:3'UTR:MODIFIER:exon7/7:c.*1005delG:		rs398087861	1	0	0	0										1	0	0	243	0	n/a	n/a
chrX	119560599	119560599	T	C	hom		QUAL=9575;DP=151;AF=1.00;MQM=60;TRIO=HOM,151,1.00,HET,111,0.49,HOM,80,1.00	LAMP2	3'UTR	LAMP2:NM_001122606.1:3'UTR:MODIFIER:exon9/9:c.*1740A>G:,LAMP2:NM_002294.2:3'UTR:MODIFIER:exon9/9:c.*4579A>G:		rs42885	0.7097	0	0	0										0.4697	0.2424	0.2879	112	39	n/a	n/a
chrX	119561929	119561929	A	G	hom		QUAL=7107;DP=135;AF=1.00;MQM=60;TRIO=HOM,135,1.00,HET,159,0.53,WT,81,0.00	LAMP2	3'UTR	LAMP2:NM_001122606.1:3'UTR:MODIFIER:exon9/9:c.*410T>C:,LAMP2:NM_002294.2:3'UTR:MODIFIER:exon9/9:c.*3249T>C:		rs41300908	0.0032	0	0	0										0	0.0227	0.9773	2	3	n/a	n/a
chrX	119571157	119571157	-	AT	het		QUAL=1798;DP=61;AF=0.82;MQM=59;TRIO=HET,61,0.82,HET,33,0.39,WT,26,0.00	LAMP2	3'UTR,intron	LAMP2:NM_013995.2:3'UTR:MODIFIER:exon9/9:c.*1850_*1851dupAT:,LAMP2:NM_001122606.1:intron:MODIFIER:exon8/8:c.1093+4426_1093+4427dupAT:,LAMP2:NM_002294.2:intron:MODIFIER:exon8/8:c.1093+4426_1093+4427dupAT:	(TATATG)n	rs113932840	0.3033	0	0	0										0.0227	0.197	0.7803	9	38	n/a	n/a
chrX	119571268	119571268	A	-	het		QUAL=1265;DP=45;AF=0.09;MQM=59;TRIO=HET,45,0.09,HET,20,0.00,HET,16,0.63	LAMP2	3'UTR,intron	LAMP2:NM_013995.2:3'UTR:MODIFIER:exon9/9:c.*1740delT:,LAMP2:NM_001122606.1:intron:MODIFIER:exon8/8:c.1093+4316delT:,LAMP2:NM_002294.2:intron:MODIFIER:exon8/8:c.1093+4316delT:			0	0	0	0										0.0303	0.1667	0.803	5	23	n/a	n/a
chrX	119571541	119571541	T	C	hom		QUAL=8083;DP=93;AF=1.00;MQM=60;TRIO=HOM,93,1.00,HOM,82,1.00,HOM,67,1.00	LAMP2	3'UTR,intron	LAMP2:NM_013995.2:3'UTR:MODIFIER:exon9/9:c.*1468A>G:,LAMP2:NM_001122606.1:intron:MODIFIER:exon8/8:c.1093+4044A>G:,LAMP2:NM_002294.2:intron:MODIFIER:exon8/8:c.1093+4044A>G:		rs42889	0.7889	0	0	0										0.5303	0.2121	0.2576	122	35	n/a	n/a
chrX	119572556	119572561	CACACA	-	hom		QUAL=1776;DP=20;AF=0.85;MQM=59;TRIO=HOM,20,0.85,HET,47,0.89,WT,17,0.76	LAMP2	3'UTR,intron	LAMP2:NM_013995.2:3'UTR:MODIFIER:exon9/9:c.*448_*453delTGTGTG:,LAMP2:NM_001122606.1:intron:MODIFIER:exon8/8:c.1093+3024_1093+3029delTGTGTG:,LAMP2:NM_002294.2:intron:MODIFIER:exon8/8:c.1093+3024_1093+3029delTGTGTG:	(CA)n		0	0	0	0										0.053	0.0682	0.8788	14	14	n/a	n/a
chrX	119590533	119590533	T	A	hom		QUAL=3308;DP=52;AF=1.00;MQM=60;TRIO=HOM,52,1.00,HET,37,0.49,HOM,35,1.00	LAMP2	synonymous	LAMP2:NM_001122606.1:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val,LAMP2:NM_002294.2:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val,LAMP2:NM_013995.2:synonymous:LOW:exon2/9:c.156A>T:p.Val52Val		rs12097	0.3809	0.397	0.4261	0.3502							RCV000037405.4 [benign]; RCV000126562.2 [benign]; RCV000126562.2 [benign]; 		COSM4156559	0.3485	0.2803	0.3712	234	98	n/a	n/a
chrX	122318386	122318386	-	G	hom		QUAL=6882;DP=57;AF=1.00;MQM=60;TRIO=HOM,57,1.00,HOM,92,0.99,HOM,76,1.00	GRIA3	5'UTR	GRIA3:NM_000828.4:5'UTR:MODIFIER:exon1/16:c.-2_-1insG:,GRIA3:NM_001256743.1:5'UTR:MODIFIER:exon1/4:c.-2_-1insG:,GRIA3:NM_007325.4:5'UTR:MODIFIER:exon1/16:c.-2_-1insG:		rs58044961	1	1	1	0.9989										1	0	0	612	0	n/a	n/a
chrX	122336600	122336600	-	G	het		QUAL=15880;DP=86;AF=0.86;MQM=60;TRIO=HET,86,0.86,HOM,318,0.97,HOM,188,0.95	GRIA3	frameshift,intron	GRIA3:NM_001256743.1:frameshift:HIGH:exon3/4:c.384dupG:p.Pro129fs,GRIA3:NM_000828.4:intron:MODIFIER:exon2/15:c.268+16761dupG:,GRIA3:NM_007325.4:intron:MODIFIER:exon2/15:c.268+16761dupG:		rs11452643	0.9995	1	0	0										0.9242	0.0682	0.0076	532	35	2	n/a
chrX	122622950	122622953	ACAC	-	hom		QUAL=2387;DP=54;AF=0.83;MQM=59;TRIO=HOM,54,0.83,HET,28,0.93,WT,19,0.63	GRIA3	3'UTR	GRIA3:NM_000828.4:3'UTR:MODIFIER:exon16/16:c.*404_*407delCACA:,GRIA3:NM_007325.4:3'UTR:MODIFIER:exon16/16:c.*404_*407delCACA:	(CA)n		0	0	0	0										0.053	0.0682	0.8788	9	9	n/a	n/a
chrX	123034511	123034511	A	C	hom		QUAL=10400;DP=75;AF=0.99;MQM=60;TRIO=HOM,75,0.99,HOM,145,1.00,HOM,102,0.99	XIAP	missense	XIAP:NM_001167.3:missense:MODERATE:exon6/7:c.1268A>C:p.Gln423Pro,XIAP:NM_001204401.1:missense:MODERATE:exon6/7:c.1268A>C:p.Gln423Pro		rs5956583	0.3036	0.33	0.3536	0.472	2.0790	P	D	B	B			CM097066 [CLASS=DFP MUT=REF PHEN="Periodic fever, idiopathic, association with" GENE=XIAP]; 	COSM3759346	0.2652	0.197	0.5379	150	93	n/a	n/a
chrX	123044718	123044718	A	-	het		QUAL=386;DP=36;AF=0.31;MQM=51;TRIO=HET,36,0.31,HET,12,0.25,HET,12,0.25	XIAP	3'UTR	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*3702delA:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*3702delA:	AluY		0	0	0	0										0	0.1061	0.8939	0	21	n/a	n/a
chrX	123045327	123045327	-	A	het		QUAL=310;DP=7;AF=0.71;MQM=57;TRIO=HET,7,0.71,HET,7,0.86,HET,3,0.67	XIAP	3'UTR	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*4309dupA:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*4309dupA:	AluSp	rs397713705	0.3038	0	0	0										0.053	0.0303	0.9167	23	28	n/a	n/a
chrX	123045641	123045641	C	T	hom		QUAL=8431;DP=92;AF=0.99;MQM=60;TRIO=HOM,92,0.99,HOM,92,1.00,HOM,75,1.00	XIAP	3'UTR	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*4610C>T:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*4610C>T:		rs9856	0.5844	0.546	0	0										0.4545	0.2576	0.2879	134	54	n/a	n/a
chrX	123046199	123046199	A	-	het		QUAL=560;DP=56;AF=0.02;MQM=60;TRIO=HET,56,0.02,WT,31,0.32,HET,25,0.04	XIAP	3'UTR	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*5180delA:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*5180delA:		rs60841987	0.3023	0	0	0										0.0909	0.2652	0.6439	24	55	n/a	n/a
chrX	123046272	123046272	A	T	hom		QUAL=10469;DP=167;AF=1.00;MQM=60;TRIO=HOM,167,1.00,HOM,104,1.00,HOM,57,0.96	XIAP	3'UTR	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*5241A>T:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*5241A>T:	MER2	rs5958343	0.5846	0.551	0	0										0.4545	0.2576	0.2879	134	54	n/a	n/a
chrX	123046537	123046537	T	-	het		QUAL=2686;DP=78;AF=0.69;MQM=59;TRIO=HET,78,0.69,HET,34,0.68,HET,24,0.75	XIAP	3'UTR	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*5519delT:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*5519delT:	AluSz		0	0	0	0										0.25	0.2424	0.5076	75	54	n/a	n/a
chrX	123046923	123046923	T	G	hom		QUAL=5191;DP=45;AF=1.00;MQM=59;TRIO=HOM,45,1.00,HOM,73,1.00,HOM,47,1.00	XIAP	3'UTR	XIAP:NM_001167.3:3'UTR:MODIFIER:exon7/7:c.*5892T>G:,XIAP:NM_001204401.1:3'UTR:MODIFIER:exon7/7:c.*5892T>G:	AluSx	rs6648556	0.6212	0.552	0	0										0.4621	0.2576	0.2803	134	54	n/a	n/a
chrX	123506104	123506104	T	A	hom		QUAL=6214;DP=102;AF=1.00;MQM=60;TRIO=HOM,102,1.00,HOM,86,1.00,WT,57,0.00	SH2D1A	3'UTR	SH2D1A:NM_002351.4:3'UTR:MODIFIER:exon4/4:c.*863T>A:,SH2D1A:NM_001114937.2:3'UTR:MODIFIER:exon4/4:c.*863T>A:		rs7876065	0.814	0	0	0										0.7955	0.1136	0.0909	201	17	n/a	n/a
chrX	128938958	128938958	T	C	hom		QUAL=15130;DP=216;AF=1.00;MQM=60;TRIO=HOM,216,1.00,HOM,156,1.00,HOM,103,1.00	ZDHHC9	3'UTR	ZDHHC9:NM_001008222.2:3'UTR:MODIFIER:exon10/10:c.*1388A>G:,ZDHHC9:NM_016032.3:3'UTR:MODIFIER:exon11/11:c.*1388A>G:		rs1053486	0.6196	0	0	0										0.9091	0.0455	0.0455	227	7	n/a	n/a
chrX	129283520	129283520	A	G	hom		QUAL=16403;DP=176;AF=1.00;MQM=60;TRIO=HOM,176,1.00,HOM,203,1.00,HOM,132,0.99	AIFM1	synonymous,intron	AIFM1:NM_004208.3:synonymous:LOW:exon3/16:c.273T>C:p.Asp91Asp,AIFM1:NM_001130847.3:synonymous:LOW:exon3/17:c.273T>C:p.Asp91Asp,AIFM1:NM_145812.2:synonymous:LOW:exon3/16:c.261T>C:p.Asp87Asp,AIFM1:NM_145813.2:intron:MODIFIER:exon1/7:c.107-12360T>C:		rs1139851	0.4911	0.431	0.3971	0.7075									COSM1465604	0.3258	0.2273	0.447	210	99	n/a	n/a
chrX	132888208	132888208	A	-	het		QUAL=1056;DP=44;AF=0.25;MQM=60;TRIO=HET,44,0.25,HET,48,0.60,HET,21,0.19	GPC3	splice_region&intron	GPC3:NM_001164617.1:splice_region&intron:LOW:exon2/8:c.338-5delT:,GPC3:NM_001164618.1:splice_region&intron:LOW:exon2/7:c.290-5delT:,GPC3:NM_001164619.1:splice_region&intron:LOW:exon1/6:c.176-5delT:,GPC3:NM_004484.3:splice_region&intron:LOW:exon2/7:c.338-5delT:		rs370737647	0	0	0	0										0	0.0833	0.9167	3	16	n/a	n/a
chrX	135251679	135251679	-	A	het		QUAL=3024;DP=100;AF=0.66;MQM=60;TRIO=HET,100,0.66,HOM,48,0.94,WT,39,0.00	FHL1	5'UTR,intron	FHL1:NM_001159704.1:5'UTR:MODIFIER:exon1/6:c.-478dupA:,FHL1:NM_001159702.2:intron:MODIFIER:exon1/7:c.-100-378dupA:,FHL1:NM_001159703.1:intron:MODIFIER:exon1/5:c.-100-378dupA:,FHL1:NM_001449.4:intron:MODIFIER:exon1/6:c.-100-378dupA:,FHL1:NM_001159700.1:intron:MODIFIER:exon1/6:c.-100-378dupA:		rs397710404	0	0	0	0										0.5758	0.25	0.1742	152	39	n/a	n/a
chrX	135292022	135292022	C	T	hom		QUAL=11206;DP=91;AF=0.99;MQM=59;TRIO=HOM,91,0.99,HOM,140,1.00,HOM,133,1.00	FHL1	splice_region&intron	FHL1:NM_001159702.2:splice_region&intron:LOW:exon7/7:c.889-8C>T:,FHL1:NM_001159703.1:splice_region&intron:LOW:exon5/5:c.502-8C>T:,FHL1:NM_001449.4:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:NM_001159700.1:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:NM_001159704.1:splice_region&intron:LOW:exon5/5:c.689-8C>T:,FHL1:NM_001167819.1:splice_region&intron:LOW:exon6/6:c.689-8C>T:,FHL1:NM_001159701.1:splice_region&intron:LOW:exon5/5:c.776-8C>T:,FHL1:NM_001159699.1:splice_region&intron:LOW:exon5/5:c.737-8C>T:	(TTTTC)n	rs2076705	0.5197	0.49	0.4397	0.2887										0.4015	0.2121	0.3864	206	93	n/a	n/a
chrX	135292164	135292164	G	A	hom		QUAL=8697;DP=182;AF=0.99;MQM=60;TRIO=HOM,182,0.99,HET,202,0.45,WT,149,0.00	FHL1	missense,3'UTR	FHL1:NM_001449.4:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:NM_001159700.1:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:NM_001159704.1:missense:MODERATE:exon6/6:c.823G>A:p.Asp275Asn,FHL1:NM_001167819.1:missense:MODERATE:exon7/7:c.823G>A:p.Asp275Asn,FHL1:NM_001159701.1:missense:MODERATE:exon6/6:c.910G>A:p.Asp304Asn,FHL1:NM_001159699.1:missense:MODERATE:exon6/6:c.871G>A:p.Asp291Asn,FHL1:NM_001159702.2:3'UTR:MODIFIER:exon8/8:c.*51G>A:,FHL1:NM_001159703.1:3'UTR:MODIFIER:exon6/6:c.*51G>A:		rs151315725	0.0048	0.011	0.0186	0.0034	6.2260	D	T	P,B	B,B					0	0.0076	0.9924	6	5	n/a	n/a
chrX	135293082	135293082	G	A	hom		QUAL=18857;DP=221;AF=0.99;MQM=60;TRIO=HOM,221,0.99,HOM,214,1.00,HOM,140,1.00	FHL1	3'UTR	FHL1:NM_001159702.2:3'UTR:MODIFIER:exon8/8:c.*969G>A:,FHL1:NM_001159703.1:3'UTR:MODIFIER:exon6/6:c.*969G>A:,FHL1:NM_001449.4:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:NM_001159700.1:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:NM_001159704.1:3'UTR:MODIFIER:exon6/6:c.*898G>A:,FHL1:NM_001167819.1:3'UTR:MODIFIER:exon7/7:c.*898G>A:,FHL1:NM_001159701.1:3'UTR:MODIFIER:exon6/6:c.*898G>A:,FHL1:NM_001159699.1:3'UTR:MODIFIER:exon6/6:c.*898G>A:		rs9018	0.5068	0.438	0	0										0.3864	0.2273	0.3864	144	64	n/a	n/a
chrX	135742258	135742258	C	T	hom		QUAL=2202;DP=57;AF=1.00;MQM=58;TRIO=HOM,57,1.00,HET,43,0.47,WT,33,0.00	CD40LG	3'UTR	CD40LG:NM_000074.2:3'UTR:MODIFIER:exon5/5:c.*684C>T:			0.0029	0	0	0										0	0.0076	0.9924	0	2	n/a	n/a
chrX	147031538	147031538	C	T	hom		QUAL=4516;DP=69;AF=1.00;MQM=60;TRIO=HOM,69,1.00,HOM,40,1.00,HOM,30,1.00	FMR1	3'UTR	FMR1:NM_002024.5:3'UTR:MODIFIER:exon17/17:c.*1174C>T:,FMR1:NM_001185075.1:3'UTR:MODIFIER:exon16/16:c.*1188C>T:,FMR1:NM_001185076.1:3'UTR:MODIFIER:exon16/16:c.*1174C>T:,FMR1:NM_001185081.1:3'UTR:MODIFIER:exon15/15:c.*1188C>T:,FMR1:NM_001185082.1:3'UTR:MODIFIER:exon16/16:c.*1174C>T:		rs25704	0.4956	0.261	0	0								CR114249 [CLASS=DP MUT=ALT PHEN="Epithelial ovarian cancer, increased risk, association" GENE=FMR1]; 		0.1894	0.1212	0.6894	77	47	n/a	n/a
chrX	148055144	148055144	A	G	hom		QUAL=15775;DP=87;AF=1.00;MQM=60;TRIO=HOM,87,1.00,HOM,253,1.00,HOM,159,1.00	AFF2	splice_region&intron	AFF2:NM_002025.3:splice_region&intron:LOW:exon16/20:c.3404+7A>G:,AFF2:NM_001169122.1:splice_region&intron:LOW:exon15/19:c.3299+7A>G:,AFF2:NM_001169123.1:splice_region&intron:LOW:exon16/20:c.3374+7A>G:,AFF2:NM_001169124.1:splice_region&intron:LOW:exon15/19:c.3299+7A>G:,AFF2:NM_001169125.1:splice_region&intron:LOW:exon15/19:c.3287+7A>G:,AFF2:NM_001170628.1:splice_region&intron:LOW:exon13/17:c.2327+7A>G:		rs5980615	0.9542	0.984	0.9993	0.8224							RCV000079971.5 [other]; 			1	0	0	615	1	n/a	n/a
chrX	148079639	148079639	A	C	hom		QUAL=12466;DP=137;AF=1.00;MQM=60;TRIO=HOM,137,1.00,HOM,138,1.00,HOM,98,1.00	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*6777A>C:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*6777A>C:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*6777A>C:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*6777A>C:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*6777A>C:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*6777A>C:		rs16994920	0.876	0	0	0										0.9545	0.0227	0.0227	226	7	n/a	n/a
chrX	148079740	148079740	A	C	hom		QUAL=18848;DP=160;AF=1.00;MQM=60;TRIO=HOM,160,1.00,HOM,262,1.00,HOM,160,1.00	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*6878A>C:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*6878A>C:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*6878A>C:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*6878A>C:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*6878A>C:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*6878A>C:		rs58901446	0.8707	0	0	0										0.9545	0.0227	0.0227	228	6	n/a	n/a
chrX	148079877	148079877	T	C	hom		QUAL=18277;DP=158;AF=1.00;MQM=60;TRIO=HOM,158,1.00,HOM,236,1.00,HOM,164,0.99	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*7015T>C:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*7015T>C:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*7015T>C:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*7015T>C:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*7015T>C:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*7015T>C:		rs16994922	0.8302	0	0	0										0.9545	0.0227	0.0227	228	6	n/a	n/a
chrX	148081140	148081140	A	G	hom		QUAL=21347;DP=143;AF=1.00;MQM=59;TRIO=HOM,143,1.00,HOM,313,1.00,HOM,215,1.00	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*8278A>G:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*8278A>G:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*8278A>G:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*8278A>G:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*8278A>G:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*8278A>G:	(TG)n	rs184050542	0.9966	0	0	0										1	0	0	241	0	n/a	n/a
chrX	148081451	148081451	A	G	hom		QUAL=13028;DP=175;AF=1.00;MQM=60;TRIO=HOM,175,1.00,HOM,138,1.00,HOM,77,0.99	AFF2	3'UTR	AFF2:NM_002025.3:3'UTR:MODIFIER:exon21/21:c.*8589A>G:,AFF2:NM_001169122.1:3'UTR:MODIFIER:exon20/20:c.*8589A>G:,AFF2:NM_001169123.1:3'UTR:MODIFIER:exon21/21:c.*8589A>G:,AFF2:NM_001169124.1:3'UTR:MODIFIER:exon20/20:c.*8589A>G:,AFF2:NM_001169125.1:3'UTR:MODIFIER:exon20/20:c.*8589A>G:,AFF2:NM_001170628.1:3'UTR:MODIFIER:exon18/18:c.*8589A>G:		rs141776682	1	0	0	0										1	0	0	243	0	n/a	n/a
chrX	149826503	149826503	G	A	hom		QUAL=3751;DP=64;AF=1.00;MQM=60;TRIO=HOM,64,1.00,HOM,57,1.00,WT,35,0.00	MTM1	splice_region&intron	MTM1:NM_000252.2:splice_region&intron:LOW:exon11/14:c.1260+3G>A:		rs222410	0.657	0.56	0.4987	0.8834							RCV000078428.3 [other]; 			0.5	0.1667	0.3333	297	91	n/a	n/a
chrX	153008675	153008675	G	A	het		QUAL=469;DP=82;AF=0.32;MQM=30;TRIO=HET,82,0.32,WT,356,0.00,WT,204,0.00	ABCD1	splice_region&synonymous	ABCD1:NM_000033.3:splice_region&synonymous:LOW:exon9/10:c.1866G>A:p.Arg622Arg		rs201197921	0	0	0	0									COSM1636441	0	0.8561	0.1439	0	142	n/a	n/a
chrX	153008984	153008984	G	A	het		QUAL=640;DP=70;AF=0.40;MQM=31;TRIO=HET,70,0.40,WT,286,0.00,WT,180,0.00	ABCD1	missense	ABCD1:NM_000033.3:missense:MODERATE:exon10/10:c.2033G>A:p.Gly678Asp		rs75125350	0	0.0002	0	0	9.4050	P	T	D	D					0	0.6667	0.3333	0	120	n/a	n/a
chrX	153009017	153009017	G	A	het		QUAL=424;DP=69;AF=0.33;MQM=32;TRIO=HET,69,0.33,WT,257,0.00,WT,166,0.00	ABCD1	missense	ABCD1:NM_000033.3:missense:MODERATE:exon10/10:c.2066G>A:p.Arg689His			0	0	0	0	7.5710	D	D	D	D					0	0.7045	0.2955	0	123	n/a	n/a
chrX	153009027	153009027	G	A	het		QUAL=34;DP=57;AF=0.21;MQM=35;TRIO=HET,57,0.21,WT,239,0.00,WT,164,0.00	ABCD1	synonymous	ABCD1:NM_000033.3:synonymous:LOW:exon10/10:c.2076G>A:p.Leu692Leu			0	0	0	0										0	0.5	0.5	0	89	n/a	n/a
chrX	153009350	153009350	G	A	het		QUAL=345;DP=59;AF=0.27;MQM=35;TRIO=HET,59,0.27,WT,61,0.00,WT,50,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*161G>A:			0	0	0	0										0	0.6212	0.3788	0	111	n/a	n/a
chrX	153009352	153009352	A	G	het		QUAL=345;DP=59;AF=0.27;MQM=35;TRIO=HET,59,0.27,WT,61,0.00,WT,50,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*163A>G:		rs191015436	0	0	0	0										0	0.6364	0.3636	0	112	n/a	n/a
chrX	153009364	153009364	G	A	het		QUAL=627;DP=79;AF=0.32;MQM=32;TRIO=HET,79,0.32,WT,63,0.00,WT,53,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*175G>A:			0	0	0	0										0	0.7045	0.2955	0	117	n/a	n/a
chrX	153009385	153009385	C	G	het		QUAL=289;DP=54;AF=0.30;MQM=31;TRIO=HET,54,0.30,WT,68,0.00,WT,53,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*196C>G:		rs367591611	0	0	0	0										0	0.553	0.447	0	90	n/a	n/a
chrX	153009386	153009386	G	T	het		QUAL=289;DP=54;AF=0.30;MQM=31;TRIO=HET,54,0.30,WT,68,0.00,WT,53,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*197G>T:		rs371380320	0	0	0	0										0	0.4773	0.5227	0	79	n/a	n/a
chrX	153009448	153009448	A	G	het		QUAL=579;DP=50;AF=0.44;MQM=35;TRIO=HET,50,0.44,WT,76,0.00,WT,54,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*259A>G:		rs374092960	0	0	0	0										0	0.8939	0.1061	0	201	n/a	n/a
chrX	153009488	153009488	C	T	het		QUAL=252;DP=61;AF=0.25;MQM=34;TRIO=HET,61,0.25,WT,77,0.00,WT,54,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*299C>T:		rs201959080	0	0	0	0										0	0.5758	0.4242	0	107	n/a	n/a
chrX	153009510	153009510	G	C	het		QUAL=86;DP=46;AF=0.22;MQM=32;TRIO=HET,46,0.22,WT,83,0.00,WT,59,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*321G>C:			0	0	0	0										0	0.1591	0.8409	0	25	n/a	n/a
chrX	153009665	153009665	A	G	het		QUAL=990;DP=121;AF=0.31;MQM=34;TRIO=HET,121,0.31,WT,162,0.01,WT,91,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*476A>G:		rs372234126	0	0	0	0										0	0.7652	0.2348	0	184	n/a	n/a
chrX	153009670	153009670	G	T	het		QUAL=1750;DP=142;AF=0.45;MQM=38;TRIO=HET,142,0.45,WT,161,0.01,WT,91,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*481G>T:		rs199942817	0	0	0	0										0	0.9167	0.0833	0	218	n/a	n/a
chrX	153009719	153009719	G	A	het		QUAL=2774;DP=149;AF=0.68;MQM=39;TRIO=HET,149,0.68,WT,161,0.00,WT,92,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*530G>A:		rs67211405	0	0	0	0										0	0.9394	0.0606	0	233	n/a	n/a
chrX	153009769	153009769	C	G	het		QUAL=152;DP=69;AF=0.23;MQM=39;TRIO=HET,69,0.23,WT,194,0.00,WT,96,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*580C>G:			0	0	0	0										0	0.0379	0.9621	0	10	n/a	n/a
chrX	153009770	153009770	A	G	het		QUAL=152;DP=69;AF=0.23;MQM=39;TRIO=HET,69,0.23,WT,194,0.00,WT,96,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*581A>G:			0	0	0	0										0	0.0303	0.9697	0	9	n/a	n/a
chrX	153009774	153009774	G	A	het		QUAL=152;DP=69;AF=0.23;MQM=39;TRIO=HET,69,0.23,WT,194,0.00,WT,96,0.00	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*585G>A:			0	0	0	0										0	0.0303	0.9697	0	9	n/a	n/a
chrX	153009818	153009818	A	G	het		QUAL=802;DP=120;AF=0.23;MQM=35;TRIO=HET,120,0.23,WT,246,0.06,HET,167,0.16	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*629A>G:			0	0	0	0										0	0.5909	0.4091	0	89	n/a	n/a
chrX	153009838	153009838	C	A	het		QUAL=1783;DP=154;AF=0.27;MQM=34;TRIO=HET,154,0.27,HET,257,0.08,HET,182,0.21	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*649C>A:		rs372449563	0	0	0	0										0	0.7727	0.2273	0	123	n/a	n/a
chrX	153009876	153009876	G	C	het		QUAL=2114;DP=98;AF=0.31;MQM=34;TRIO=HET,98,0.31,HET,240,0.10,HET,186,0.26	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*687G>C:		rs377207559	0	0	0	0										0	0.9394	0.0606	0	193	n/a	n/a
chrX	153009912	153009912	G	C	het		QUAL=1055;DP=33;AF=0.21;MQM=34;TRIO=HET,33,0.21,HET,213,0.10,HET,169,0.28	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*723G>C:		rs369704281	0	0	0	0										0	0.8788	0.1212	0	168	n/a	n/a
chrX	153009914	153009914	G	T	het		QUAL=1055;DP=33;AF=0.21;MQM=34;TRIO=HET,33,0.21,HET,213,0.10,HET,169,0.28	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*725G>T:		rs202120253	0	0	0	0										0	0.8561	0.1439	0	163	n/a	n/a
chrX	153010059	153010059	G	T	het		QUAL=4487;DP=97;AF=0.63;MQM=37;TRIO=HET,97,0.63,HET,117,0.29,HET,134,0.51	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*870G>T:		rs72616452	0	0	0	0										0	0.8409	0.1591	0	221	n/a	n/a
chrX	153010090	153010090	G	A	het		QUAL=4131;DP=106;AF=0.60;MQM=37;TRIO=HET,106,0.60,HET,133,0.26,HET,135,0.50	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*901G>A:		rs75637470	0	0	0	0										0	0.7652	0.2348	0	209	n/a	n/a
chrX	153010092	153010092	G	A	het		QUAL=4131;DP=106;AF=0.60;MQM=37;TRIO=HET,106,0.60,HET,133,0.26,HET,135,0.50	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*903G>A:		rs78155328	0	0	0	0										0	0.7576	0.2424	0	209	n/a	n/a
chrX	153010137	153010137	C	T	het		QUAL=1813;DP=85;AF=0.15;MQM=37;TRIO=HET,85,0.15,HET,157,0.16,HET,126,0.40	ABCD1	3'UTR	ABCD1:NM_000033.3:3'UTR:MODIFIER:exon10/10:c.*948C>T:		rs112109783	0	0	0	0										0	0.8333	0.1667	0	203	n/a	n/a
chrX	153127735	153127735	G	A	hom		QUAL=2265;DP=32;AF=1.00;MQM=60;TRIO=HOM,32,1.00,HET,125,0.42,WT,96,0.00	L1CAM	3'UTR	L1CAM:NM_000425.4:3'UTR:MODIFIER:exon28/28:c.*383C>T:,L1CAM:NM_001143963.2:3'UTR:MODIFIER:exon26/26:c.*383C>T:,L1CAM:NM_024003.3:3'UTR:MODIFIER:exon27/27:c.*383C>T:,L1CAM:NM_001278116.1:3'UTR:MODIFIER:exon29/29:c.*383C>T:		rs41311708	0.0207	0	0	0										0.0152	0.053	0.9318	8	8	n/a	n/a
chrX	153170980	153170980	T	G	hom		QUAL=2067;DP=28;AF=1.00;MQM=60;TRIO=HOM,28,1.00,HOM,24,1.00,HOM,18,1.00	AVPR2	splice_region&intron	AVPR2:NM_000054.4:splice_region&intron:LOW:exon1/2:c.26-6T>G:,AVPR2:NM_001146151.1:splice_region&intron:LOW:exon1/1:c.26-6T>G:		rs56689668	0.9992	0.998	0	0										0.9924	0.0076	0	505	4	n/a	n/a
chrX	153215839	153215839	G	A	hom		QUAL=4610;DP=29;AF=1.00;MQM=59;TRIO=HOM,29,1.00,HOM,73,1.00,HOM,56,1.00	HCFC1	synonymous	HCFC1:NM_005334.2:synonymous:LOW:exon24/26:c.5859C>T:p.Cys1953Cys		rs3027875	0.1913	0.432	0.6301	0.0849	-0.6000	P					RCV000081294.4 [other]; 		COSM457076	0.447	0.1667	0.3864	247	71	n/a	n/a
chrX	153292180	153292180	T	C	hom		QUAL=16537;DP=163;AF=1.00;MQM=60;TRIO=HOM,163,1.00,HOM,220,1.00,HOM,130,1.00	MECP2	3'UTR	MECP2:NM_004992.3:3'UTR:MODIFIER:exon4/4:c.*3638A>G:		rs2734647	0.6262	0	0	0										0.7652	0.0985	0.1364	188	20	n/a	n/a
chrX	153294542	153294542	T	C	hom		QUAL=16045;DP=126;AF=0.99;MQM=60;TRIO=HOM,126,0.99,HOM,238,1.00,HOM,153,1.00	MECP2	3'UTR	MECP2:NM_004992.3:3'UTR:MODIFIER:exon4/4:c.*1276A>G:	GA-rich	rs2853337	0.9936	0	0	0										1	0	0	243	0	n/a	n/a
chrX	153629155	153629155	A	G	hom		QUAL=13417;DP=172;AF=0.99;MQM=44;TRIO=HOM,172,0.99,HOM,155,1.00,HOM,92,1.00	RPL10	missense	RPL10:NM_001256577.1:missense:MODERATE:exon6/6:c.442A>G:p.Ile148Val,RPL10:NM_001256580.1:missense:MODERATE:exon6/6:c.497A>G:p.Asn166Ser,RPL10:NM_006013.3:missense:MODERATE:exon7/7:c.605A>G:p.Asn202Ser		rs12012747	0.6689	0.815	0	0	1.2780	P,P	T,T	B,B	B,B		RCV000081344.4 [other]; 			0.7652	0.1136	0.1212	518	44	n/a	n/a
chrX	153630255	153630255	G	C	hom		QUAL=21544;DP=191;AF=1.00;MQM=60;TRIO=HOM,191,1.00,HOM,297,1.00,HOM,174,1.00	RPL10,DNASE1L1	3'UTR	RPL10:NM_001256577.1:3'UTR:MODIFIER:exon6/6:c.*891G>C:,DNASE1L1:NM_001009932.1:3'UTR:MODIFIER:exon10/10:c.*793C>G:,RPL10:NM_001256580.1:3'UTR:MODIFIER:exon6/6:c.*1060G>C:,RPL10:NM_006013.3:3'UTR:MODIFIER:exon7/7:c.*1060G>C:,DNASE1L1:NM_006730.2:3'UTR:MODIFIER:exon8/8:c.*793C>G:,DNASE1L1:NM_001009933.1:3'UTR:MODIFIER:exon9/9:c.*793C>G:,DNASE1L1:NM_001009934.1:3'UTR:MODIFIER:exon8/8:c.*793C>G:		rs12877	0.6678	0	0	0										0.8182	0.0985	0.0833	206	16	n/a	n/a
chrX	153630293	153630293	C	T	hom		QUAL=20196;DP=181;AF=1.00;MQM=60;TRIO=HOM,181,1.00,HOM,303,1.00,HOM,159,1.00	RPL10,DNASE1L1	3'UTR	RPL10:NM_001256577.1:3'UTR:MODIFIER:exon6/6:c.*929C>T:,DNASE1L1:NM_001009932.1:3'UTR:MODIFIER:exon10/10:c.*755G>A:,RPL10:NM_001256580.1:3'UTR:MODIFIER:exon6/6:c.*1098C>T:,RPL10:NM_006013.3:3'UTR:MODIFIER:exon7/7:c.*1098C>T:,DNASE1L1:NM_006730.2:3'UTR:MODIFIER:exon8/8:c.*755G>A:,DNASE1L1:NM_001009933.1:3'UTR:MODIFIER:exon9/9:c.*755G>A:,DNASE1L1:NM_001009934.1:3'UTR:MODIFIER:exon8/8:c.*755G>A:		rs12559	0.6681	0	0	0										0.8182	0.0985	0.0833	207	16	n/a	n/a
chrX	153649813	153649813	G	C	hom		QUAL=8031;DP=72;AF=1.00;MQM=60;TRIO=HOM,72,1.00,HOM,106,1.00,HOM,79,1.00	TAZ	3'UTR	TAZ:NM_000116.3:3'UTR:MODIFIER:exon11/11:c.*470G>C:,TAZ:NM_181311.2:3'UTR:MODIFIER:exon10/10:c.*470G>C:,TAZ:NM_181312.2:3'UTR:MODIFIER:exon10/10:c.*470G>C:,TAZ:NM_181313.2:3'UTR:MODIFIER:exon9/9:c.*470G>C:		rs743547	0	0.853	0	0										0.8333	0.0833	0.0833	333	20	n/a	n/a
chrX	153994596	153994596	G	T	hom		QUAL=17859;DP=195;AF=1.00;MQM=60;TRIO=HOM,195,1.00,HOM,224,1.00,HOM,140,1.00	DKC1	synonymous	DKC1:NM_001363.4:synonymous:LOW:exon5/15:c.369G>T:p.Thr123Thr,DKC1:NM_001142463.2:synonymous:LOW:exon5/15:c.369G>T:p.Thr123Thr,DKC1:NM_001288747.1:synonymous:LOW:exon5/14:c.369G>T:p.Thr123Thr		rs2728532	0.9926	0.998	1	0.9776	-3.5150	P					RCV000153151.1 [benign]; 			1	0	0	620	0	n/a	n/a
chrX	154064200	154064200	C	T	hom		QUAL=10995;DP=171;AF=1.00;MQM=60;TRIO=HOM,171,1.00,HOM,102,1.00,HOM,57,1.00	F8	3'UTR	F8:NM_000132.3:3'UTR:MODIFIER:exon26/26:c.*1672G>A:,F8:NM_019863.2:3'UTR:MODIFIER:exon5/5:c.*1672G>A:	LTR37B	rs1050705	0.556	0	0	0										0.6061	0.1742	0.2197	126	30	n/a	n/a
chrX	154064580	154064580	T	C	hom		QUAL=10720;DP=112;AF=1.00;MQM=60;TRIO=HOM,112,1.00,HOM,123,0.99,HOM,91,1.00	F8	3'UTR	F8:NM_000132.3:3'UTR:MODIFIER:exon26/26:c.*1292A>G:,F8:NM_019863.2:3'UTR:MODIFIER:exon5/5:c.*1292A>G:		rs1396947	0.9926	0	0	0										1	0	0	243	0	n/a	n/a
chrX	154488153	154488153	C	T	hom		QUAL=7765;DP=180;AF=1.00;MQM=60;TRIO=HOM,180,1.00,HET,101,0.52,WT,78,0.00	RAB39B	3'UTR	RAB39B:NM_171998.3:3'UTR:MODIFIER:exon2/2:c.*1935G>A:			0.0005	0	0	0										0	0.0076	0.9924	0	1	n/a	n/a